PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Guskiewicz, KM; Register-Mihalik, JK				Guskiewicz, Kevin M.; Register-Mihalik, Johna K.			Postconcussive Impairment Differences Across a Multifaceted Concussion Assessment Protocol	PM&R			English	Article							SPORTS-RELATED CONCUSSION; MILD HEAD-INJURY; POSTURAL STABILITY; NEUROPSYCHOLOGICAL ASSESSMENT; RELIABLE CHANGE; SYMPTOM SCALE; SENSITIVITY; RECOVERY; VALIDITY; DEFICITS	Objective: To examine the proportion of athletes with concussion and with impairment disagreements across various clinical concussion assessment measures. Design: Quasi-experimental repeated measures design. Setting: Clinical research laboratory. Participants: A sample of 100 collegiate-aged athletes participated in the study (mean [SD] age, 18.5 +/- 1.1 years; mean [SD] height, 180.6 +/- 9.9 cm; mean [SD] weight, 84.1 +/- 20.6 kg). Methods or Interventions: Participants completed preseason baseline and postconcussive injury assessments on a clinical assessment battery, including a 17-item graded symptom checklist, a computerized neurocognitive assessment, and a balance performance assessment. Main Outcome Measurements: Symptom severity total score, 8 cognitive domain scores from the Automated Neuropsychological Assessment Metrics, and the composite balance score obtained from the Sensory Organization Test served as outcome measures for the study. McNemar tests of paired proportions were then used to analyze impairment disagreements (where one measure identified impairments not identified by the other) between the study outcome measures. The a level was set to .05 a priori. Results: We observed significant disagreements between symptom severity total scores, and all other measures used in the study in which symptom severity total scores identified more impairments than all other measures. In addition, we observed significant disagreements for half of the clinical measures used in the study, with disagreement proportions that ranged from 22%-52%. Conclusions: Our study underscores the importance of using a multifaceted approach for management of concussion that includes assessment of symptom severity, cognitive function, and balance. Use of this multifaceted approach also can aid clinicians in understanding other comorbidities that may complicate the management of concussion. PM R 2011;3:S445-S451	[Guskiewicz, Kevin M.; Register-Mihalik, Johna K.] Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA		Guskiewicz, KM (corresponding author), Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Dept Exercise & Sport Sci, CB 8700,209 Fetzer Hall, Chapel Hill, NC 27599 USA.	gus@email.unc.edu		Register-Mihalik, Johna/0000-0002-4229-4743; Guskiewicz, Kevin/0000-0002-8682-2130			Bleiberg J, 1998, J HEAD TRAUMA REHAB, V13, P36, DOI 10.1097/00001199-199804000-00006; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Broglio SP, 2008, CLIN J SPORT MED, V18, P148, DOI 10.1097/JSM.0b013e318164f42a; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Brown CN, 2007, J ATHL TRAINING, V42, P515; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; Giza CC, 2001, J ATHL TRAINING, V36, P228; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kuehl MD, 2010, CLIN J SPORT MED, V20, P86, DOI 10.1097/JSM.0b013e3181cf4534; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Mailer BJ, 2008, J SPORT REHABIL, V17, P11, DOI 10.1123/jsr.17.1.11; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2009, PM&R, V1, P406, DOI 10.1016/j.pmrj.2009.03.010; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Notebaert AJ, 2005, J ATHL TRAINING, V40, P320; Parsons TD, 2009, INT J NEUROSCI, V119, P492, DOI 10.1080/00207450802330876; Patel AV, 2007, J ATHL TRAINING, V42, P66; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Piland SG, 2006, MED SCI SPORT EXER, V38, P27, DOI 10.1249/01.mss.0000183186.98212.d5; Piland SG, 2003, J ATHL TRAINING, V38, P104; Register-Mihalik J, 2007, CLIN J SPORT MED, V17, P282, DOI 10.1097/JSM.0b013e31804ca68a; Register-Mihalik JK, 2008, NEUROSURGERY, V63, P76, DOI 10.1227/01.NEU.0000335073.39728.CE; Register-Mihalik JK, 2009, SPORTS HEALTH, V1, P61, DOI 10.1177/1941738108325920; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19	29	18	18	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-1482	1934-1563		PM&R	PM&R	OCT	2011	3	10		3			S445	S451		10.1016/j.pmrj.2011.08.009			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	966YK	WOS:000305873100013	22035688				2022-02-06	
J	Denes, Z; Barsi, P; Szel, I; Boros, E; Fazekas, G				Denes, Zoltan; Barsi, Peter; Szel, Istvan; Boros, Erzsebet; Fazekas, Gabor			Complication during postacute rehabilitation: patients with posttraumatic hydrocephalus	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article						hydrocephalus; rehabilitation; traumatic brain injury		The objective of this study was to determine the incidence of posttraumatic hydrocephalus (PTH) among patients in our rehabilitation unit for traumatic brain injury. Furthermore, we aimed to assess the effect of shunt implantation and to identify the postoperative complication rate. This is a retrospective cohort study, in which between 2000 and 2009, data were collected from inpatients with traumatic brain injury complicated by PTH. During this period, 55 patients in our unit presented with PTH; all of these patients underwent ventricular shunt implantation. The incidence of PTH treated with shunt implantation was 4.8%. The mean age of the patients was 32 years (range 14-75 years). In 22 cases, the hydrocephalus was diagnosed in our rehabilitation unit (40%). Other patients were diagnosed and shunted before being transferred to our department. The median time of shunting was 80 days (range 20-270 days) after brain trauma. On the basis of scores of the functional independence measure, improvement could be observed in 43 cases (78%), the mean score improvement was 40 (2-81). Postoperative complications were seen in 10 patients (18%): four due to infections and six due to shunt failure. Revision was necessary in all 10 cases. Almost half of the diagnoses of PTH were established in the postacute rehabilitation unit, and all complications after shunt implantation were also recognized there. Precise clinical observation is necessary for diagnosis of PTH. Early diagnosis and treatment are important to prevent secondary complications. Teamwork and good cooperation between acute and postacute care are necessary for successful rehabilitation of patients with traumatic brain injury.	[Denes, Zoltan; Szel, Istvan; Boros, Erzsebet; Fazekas, Gabor] Natl Inst Med Rehabil, H-1121 Budapest, Hungary; [Barsi, Peter] Semmelweis Univ, Janos Szentagothai Ctr, MRI Res Unit, H-1085 Budapest, Hungary		Denes, Z (corresponding author), Natl Inst Med Rehabil, Szanatorium Str 19th, H-1121 Budapest, Hungary.	z.denes@rehabint.hu	Denes, Zoltan/ABD-3470-2021				ADAMS RD, 2005, PRINCIPLES NEUROLOGY, P529; Dandy WE, 1914, AM J DIS CHILD, V8, P406; Groswasser Z, 1988, Brain Inj, V2, P267, DOI 10.3109/02699058809150897; Guyot LL, 2000, NEUROL RES, V22, P25; Jiao Qing-fang, 2007, Chin J Traumatol, V10, P159; KATZ RT, 1989, AM J PHYS MED REHAB, V68, P91, DOI 10.1097/00002060-198904000-00009; Kim Seok Won, 2005, [Journal of Korean Neurosurgical Society, 대한신경외과학회지], V38, P211; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; MORI K, 1995, BRAIN DEV-JPN, V17, P338, DOI 10.1016/0387-7604(95)00070-R; Paoletti P, 1983, J Neurosurg Sci, V27, P171; STREGE JR, 2004, GERMAN MED SCI; Tribl G, 2000, BRAIN INJURY, V14, P345	12	18	18	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0342-5282			INT J REHABIL RES	Int. J. Rehabil. Res.	SEP	2011	34	3					222	226		10.1097/MRR.0b013e328346e87d			5	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	805MS	WOS:000293731700006	21555949				2022-02-06	
J	Ueno, M; Yamashita, T				Ueno, Masaki; Yamashita, Toshihide			Kinematic analyses reveal impaired locomotion following injury of the motor cortex in mice	EXPERIMENTAL NEUROLOGY			English	Article						Cortical injury; Kinematic analyses; Locomotion; Mice; Motor cortex; Treadmill	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; QUADRUPEDAL LOCOMOTION; CORTICOSPINAL TRACT; AXONAL PLASTICITY; STROKE RECOVERY; C-FOS; MOUSE; NEURONS; RAT	Brain injury in the motor cortex can result in deleterious functional deficits of skilled and fine motor functions. However, in contrast to humans, the destruction of cortex and its descending fibers has been thought not to cause remarkable deficits in simple locomotion in quadropedal animals. In the present study, we aimed to investigate in detail how lesion of the sensorimotor cortex affected locomotion ability in mice using the KinemaTracer system, a novel video-based kinematic analyzer. We found that traumatic injury to the left sensorimotor cortex induced several apparent deficits in the movement of contralesional right limbs during treadmill locomotion. The step length of right limbs decreased, and the speed in the forward direction was abrogated in the swing phase. The coordinates and angle of each joint were also changed after the injury. Some of the abnormal values in these parameters gradually recovered near the control level. The number of cFos-expressing neurons following locomotion significantly decreased in the right side of the spinal cord in injured mice, suggesting a role for cortex and descending fibers in locomotion. In contrast, interlimb coordination did not change remarkably even after the injury, supporting the notion that the basic locomotor pattern was determined by intraspinal neural circuits. These results indicate that the motor cortex and its descending fibers regulate several aspects of fine limb movement during locomotion. Our findings provide practical parameters to assess motor deficits and recovery following cortical injury in mice. (C) 2011 Elsevier Inc. All rights reserved.	[Ueno, Masaki; Yamashita, Toshihide] Osaka Univ, Dept Mol Neurosci, Grad Sch Med, Suita, Osaka 5650871, Japan; CREST, JST, Chiyoda Ku, Tokyo 1020075, Japan		Ueno, M (corresponding author), Osaka Univ, Dept Mol Neurosci, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	ms-ueno@molneu.med.osaka-u.ac.jp; yamashita@molneu.med.osaka-u.ac.jp	Ueno, Masaki/J-1216-2019	Ueno, Masaki/0000-0003-1484-9921; Yamashita, Toshihide/0000-0003-4559-7018	JSPSMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science	This study was supported by a Grant-in-Aid for Young Scientists (S) from JSPS to T.Y., and a Grant-in-Aid for Young Scientists (B) to M.U.	Ahn SN, 2006, SPINAL CORD, V44, P547, DOI 10.1038/sj.sc.3101862; Asante CO, 2010, J NEUROPHYSIOL, V104, P3189, DOI 10.1152/jn.00671.2010; Ballion B, 2001, EUR J NEUROSCI, V14, P1727, DOI 10.1046/j.0953-816x.2001.01794.x; Barriere G, 2008, J NEUROSCI, V28, P3976, DOI 10.1523/JNEUROSCI.5692-07.2008; Benowitz LI, 2010, NEUROBIOL DIS, V37, P259, DOI 10.1016/j.nbd.2009.11.009; Brooks SP, 2009, NAT REV NEUROSCI, V10, P519, DOI 10.1038/nrn2652; Clarke KA, 1999, PHYSIOL BEHAV, V66, P723, DOI 10.1016/S0031-9384(98)00343-6; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; Dai X, 2005, J NEUROPHYSIOL, V93, P3442, DOI 10.1152/jn.00578.2004; Drew T, 2004, PROG BRAIN RES, V143, P251, DOI 10.1016/S0079-6123(03)43025-2; DREW T, 1988, BRAIN RES, V457, P181, DOI 10.1016/0006-8993(88)90073-X; Drew T, 2002, BRAIN RES REV, V40, P178, DOI 10.1016/S0165-0173(02)00200-X; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Hantman AW, 2010, NAT NEUROSCI, V13, P1233, DOI 10.1038/nn.2637; Herbin M, 2004, J COMP PHYSIOL A, V190, P895, DOI 10.1007/s00359-004-0545-0; Herbin M, 2007, BEHAV BRAIN RES, V181, P173, DOI 10.1016/j.bbr.2007.04.001; Juvin L, 2005, J NEUROSCI, V25, P6025, DOI 10.1523/JNEUROSCI.0696-05.2005; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Krajacic A, 2010, BEHAV BRAIN RES, V214, P323, DOI 10.1016/j.bbr.2010.05.053; Leblond H, 2003, J NEUROSCI, V23, P11411; Lee JK, 2004, J NEUROSCI, V24, P6209, DOI 10.1523/JNEUROSCI.1643-04.2004; Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547; Maier IC, 2008, J NEUROSCI, V28, P9386, DOI 10.1523/JNEUROSCI.1697-08.2008; Matsuyama K, 2004, PROG BRAIN RES, V143, P239, DOI 10.1016/S0079-6123(03)43024-0; Metz GAS, 1998, BEHAV BRAIN RES, V96, P37, DOI 10.1016/S0166-4328(97)00195-2; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Neumann M, 2009, J NEUROSCI METH, V176, P34, DOI 10.1016/j.jneumeth.2008.08.026; Omoto S, 2010, J NEUROSCI, V30, P13045, DOI 10.1523/JNEUROSCI.3228-10.2010; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; Orlovsky GN, 1999, NEURONAL CONTROL LOC; Pearson KG, 2005, J NEUROSCI METH, V148, P36, DOI 10.1016/j.jneumeth.2005.04.006; ROSSIGNOL, 1996, HDB PHYSL, V12, P173; Serradj N, 2009, BEHAV BRAIN RES, V201, P59, DOI 10.1016/j.bbr.2009.01.030; Starkey ML, 2005, EXP NEUROL, V195, P524, DOI 10.1016/j.expneurol.2005.06.017; Zorner B, 2010, NAT METHODS, V7, P701, DOI 10.1038/nmeth.1484	35	18	18	2	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886			EXP NEUROL	Exp. Neurol.	AUG	2011	230	2					280	290		10.1016/j.expneurol.2011.05.006			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	783CF	WOS:000292058400014	21619878				2022-02-06	
J	Hassett, LM; Tate, RL; Moseley, AM; Gillett, LE				Hassett, Leanne M.; Tate, Robyn L.; Moseley, Anne M.; Gillett, Lauren E.			Injury severity, age and pre-injury exercise history predict adherence to a home-based exercise programme in adults with traumatic brain injury	BRAIN INJURY			English	Article						Exercise; brain injuries; physical therapy (specialty); patient compliance	PHYSICAL-ACTIVITY PARTICIPATION; PSYCHOMETRIC PROPERTIES; FITNESS; PEOPLE; DISABILITIES; MAINTENANCE; RELIABILITY; EFFICACY; CAPACITY; VALIDITY	Purpose: To explore factors that may influence exercise adherence in adults with traumatic brain injury (TBI) within the International Classification of Functioning, Disability and Health (ICF) theoretical model. Participants: Thirty participants with TBI who had been randomized to a home-based exercise programme in a recently conducted randomized controlled trial. Methods: Impairments in body functions, environmental factors and personal factors were explored as predictors for exercise adherence. Significant variables were entered into binary logistic regression analyses to determine their combined power to predict exercise adherence. Results: Greater injury severity, older age and a pre-injury exercise history of walking or jogging positively influenced exercise adherence. As a combined set the three predictor variables accurately classified 82% of participants as adherent or non-adherent and were able to explain 49% of the variance (sensitivity = 67%; specificity = 89%). Conclusion: These results demonstrate people with severe injuries are able to exercise independently and suggest that in order to maximize adherence to an exercise programme, clinicians need to consider exercise history when prescribing the type of exercise. The results also provide factors within the ICF theoretical model to investigate in a large-scale study of exercise adherence after TBI.	[Hassett, Leanne M.; Gillett, Lauren E.] Liverpool Hosp, Brain Injury Rehabil Unit, Sydney, NSW, Australia; [Tate, Robyn L.] Univ Sydney, Sydney Sch Med, Rehabil Studies Unit, Sydney, NSW 2006, Australia; [Moseley, Anne M.] George Inst Global Hlth, Sydney, NSW, Australia		Hassett, LM (corresponding author), Liverpool Hosp, Brain Injury Rehabil Unit, Locked Bag 7103, Liverpool Bc, NSW 1871, Australia.	leanne.hassett@sswahs.nsw.gov.au		Hassett, Leanne/0000-0002-3546-1822	Motor Accidents Authority of New South Wales, Australia; Menzies Foundation	This research was funded by a grant from the Motor Accidents Authority of New South Wales, Australia; and a scholarship from the Menzies Foundation to the first author.	BECKER E, 1978, SCAND J REHABIL MED, V10, P47; Benton A., 1978, MULTILINGUAL APHASIA; Brown TA, 1997, BEHAV RES THER, V35, P79, DOI 10.1016/S0005-7967(96)00068-X; FINLAY O, 1993, PHYSIOTHERAPY, V79, P845; Forkan R, 2006, PHYS THER, V86, P401, DOI 10.1093/ptj/86.3.401; Gordon WA, 1998, J HEAD TRAUMA REHAB, V13, P58, DOI 10.1097/00001199-199808000-00006; Hassett LM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006123.pub2; Hassett LM, 2007, BRAIN INJURY, V21, P1069, DOI 10.1080/02699050701630375; Hassett LM, 2009, J REHABIL MED, V41, P247, DOI 10.2340/16501977-0316; JANKOWSKI LW, 1990, ARCH PHYS MED REHAB, V71, P500; KING AC, 1988, AM J CARDIOL, V61, P628, DOI 10.1016/0002-9149(88)90778-3; KING AC, 1991, JAMA-J AM MED ASSOC, V266, P1535, DOI 10.1001/jama.266.11.1535; KING AC, 1994, ADV EXERCISE ADHEREN, P183; Kinne S, 1999, DISABIL REHABIL, V21, P15, DOI 10.1080/096382899298052; Lovibond S.H., 1996, MANUAL DEPRESSION AN, V2nd ed.; Malina RM, 1996, RES Q EXERCISE SPORT, V67, pS48, DOI 10.1080/02701367.1996.10608853; MUTRIE N, 1999, ADHERENCE ISSUES SPO, P75; Palmer-McLean K, 2003, ACSMS EXERCISE MANAG, P238; Ready AE, 2005, J SPORT MED PHYS FIT, V45, P199; Reavenall S, 2010, INT J THER REHABIL, V17, P360, DOI 10.12968/ijtr.2010.17.7.48893; Resnick B, 2000, NURS RES, V49, P154, DOI 10.1097/00006199-200005000-00007; Rimmer JH, 2004, AM J PREV MED, V26, P419, DOI 10.1016/j.amepre.2004.02.002; Rimmer JH, 1999, PHYS THER, V79, P495, DOI 10.1093/ptj/79.5.495; Rimmer JH, 2000, ARCH PHYS MED REHAB, V81, P182; Romberg A, 2004, NEUROLOGY, V63, P2034, DOI 10.1212/01.WNL.0000145761.38400.65; SALLIS JF, 1987, PREV MED, V16, P825, DOI 10.1016/0091-7435(87)90022-3; Sallis JF, 1997, RES Q EXERCISE SPORT, V68, P345, DOI 10.1080/02701367.1997.10608015; Simpson G, 2001, J HEAD TRAUMA REHAB, V16, P556, DOI 10.1097/00001199-200112000-00004; SULLIVAN S J, 1990, Brain Injury, V4, P407, DOI 10.3109/02699059009026194; Tabachnick B. G., 2013, USING MULTIVARIATE S, V6th; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; Trost SG, 2002, MED SCI SPORT EXER, V34, P1996, DOI 10.1097/00005768-200212000-00020; van den Broek MD, 2005, J HEAD TRAUMA REHAB, V20, P464, DOI 10.1097/00001199-200509000-00007; Vitale AE, 1997, BRAIN INJURY, V11, P67, DOI 10.1080/026990597123827; Watts R, 1999, BRAIN INJURY, V13, P113, DOI 10.1080/026990599121773; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; World Health Organization, 2007, INT CLASS FUNCT DIS; ZENCIUS A H, 1991, Brain Injury, V5, P369, DOI 10.3109/02699059109008109	39	18	19	0	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2011	25	7-8					698	706		10.3109/02699052.2011.579934			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	769RJ	WOS:000291035600006	21604929				2022-02-06	
J	Liraz-Zaltsman, S; Alexandrovich, AG; Trembovler, V; Fishbein, I; Yaka, R; Shohami, E; Biegon, A				Liraz-Zaltsman, Sigal; Alexandrovich, Alexander G.; Trembovler, Victoria; Fishbein, Ianai; Yaka, Rami; Shohami, Esther; Biegon, Anat			Regional Sensitivity to Neuroinflammation: In Vivo and In Vitro Studies	SYNAPSE			English	Article						neuroinflammation; regional sensitivity; autoradiography; cognitive deficits; LPS; peripheral benzodiazepine receptors; translocator protein	PERIPHERAL BENZODIAZEPINE-RECEPTORS; TRAUMATIC BRAIN-INJURY; CLOSED-HEAD INJURY; PROTEIN 18 KDA; NMDA RECEPTORS; BINDING-SITES; COGNITIVE IMPAIRMENT; NEURONAL DEATH; RAT-BRAIN; MICROGLIA	Background: Neuroinflammation is involved in several acute-onset neuropathologies such as meningitis, encephalitis, stroke, and traumatic brain injury as well as in neurodegenerative diseases. All of these patholologies are associated with cognitive deficits. Using a model of pure neuroinflammation (intracisternal injection of endotoxin in mice), we tested the hypothesis that brain regions involved in cognition are the most vulnerable to inflammatory insults, and this vulnerability is an inherent property of neocortical neurons. Methods: Mice (n = 10/group) injected with endotoxin (LPS) or saline in the cisterna magna underwent neurobehavioral and cognitive testing followed by quantitative autoradiographic assessment of regional neuroinflammation with [3H]PK11195, an established marker of microgliosis. In parallel, cocultures of cortical and striatal neurons taken from embryonic day 19 rat embryos or postnatal day 1 mice expressing green fluorescent protein were exposed for 24 h to the proinflammatory cytokine TNFalpha, glutamate, or a combination of the two agents. Results: LPS-treated mice exhibited significant deficits in memory and significant increases in specific PK11195 binding in cortical and hippocampal regions, but not in striatum. Cultured neurons of cortical origin showed significantly lower survival rate relative to striatal neurons in response to TNFalpha, glutamate, or a combination of the two agents. Furthermore, TNFalpha exerted neuroprotective rather than neurotoxic effects in the striatal but not in the cortical neurons. Conclusions: These results suggest that the cortex is inherently more sensitive than the striatum to the deleterious effects of neuroinflammation, and may offer an explanation for the preponderance of cognitive deficits in neuropathologies with a neuroinflammatory component. Synapse 65: 634-642, 2011. (C) 2010 Wiley-Liss, Inc.	[Liraz-Zaltsman, Sigal; Biegon, Anat] Sheba Med Ctr, Joseph Sagol Neurosci Ctr, Ramat Gan, Israel; [Liraz-Zaltsman, Sigal; Alexandrovich, Alexander G.; Trembovler, Victoria; Yaka, Rami; Shohami, Esther] Hebrew Univ Jerusalem, Sch Pharm, Dept Pharmacol, IL-91120 Jerusalem, Israel; [Yaka, Rami] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Biegon, Anat] Brookhaven Natl Lab, Dept Med, Upton, NY 11973 USA		Biegon, A (corresponding author), Bldg 490 Med, Upton, NY 11973 USA.	biegon@bnl.gov			BSFUS-Israel Binational Science Foundation [2005-021-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS050285] Funding Source: NIH RePORTER	Contract grant sponsor: BSF; Contract grant number: 2005-021-01	Anderson V, 1997, J Int Neuropsychol Soc, V3, P147; Arvin B, 1996, NEUROSCI BIOBEHAV R, V20, P445, DOI 10.1016/0149-7634(95)00026-7; Banati RB, 1997, J NEUROCYTOL, V26, P77, DOI 10.1023/A:1018567510105; Banati RB, 2000, BRAIN, V123, P2321, DOI 10.1093/brain/123.11.2321; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Betarbet R, 2000, J NEUROCHEM, V74, P1166; Biegon A, 2002, J NEUROCHEM, V82, P924, DOI 10.1046/j.1471-4159.2002.01050.x; BOJE KMK, 1995, J PHARMACOL EXP THER, V274, P1199; Carter JA, 2003, BRAIN RES REV, V43, P57, DOI 10.1016/S0165-0173(03)00192-9; Chauveau F, 2008, EUR J NUCL MED MOL I, V35, P2304, DOI 10.1007/s00259-008-0908-9; Chen MK, 2008, PHARMACOL THERAPEUT, V118, P1, DOI 10.1016/j.pharmthera.2007.12.004; DUBOIS A, 1988, BRAIN RES, V445, P77, DOI 10.1016/0006-8993(88)91076-1; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Floyd RA, 2000, ADV RES NEURODEGENER, V8, P387; Ghoshal A, 2007, GLIA, V55, P483, DOI 10.1002/glia.20474; GIULIAN D, 1993, STROKE, V24, pI84; Grossman R, 2003, NEUROIMAGE, V20, P1971, DOI 10.1016/j.neuroimage.2003.06.003; Hauss-Wegrzyniak B, 2000, BRAIN RES, V859, P157, DOI 10.1016/S0006-8993(00)01999-5; Hoogman M, 2007, J NEUROL NEUROSUR PS, V78, P1092, DOI 10.1136/jnnp.2006.110023; Kim WG, 2000, J NEUROSCI, V20, P6309, DOI 10.1523/JNEUROSCI.20-16-06309.2000; Maeda J, 2007, BRAIN RES, V1157, P100, DOI 10.1016/j.brainres.2007.04.054; McGeer E G, 1988, Alzheimer Dis Assoc Disord, V2, P331, DOI 10.1097/00002093-198802040-00001; Miyazawa N, 1995, ACTA NEUROCHIR, V137, P207, DOI 10.1007/BF02187195; Noble F, 2007, NEUROSCI LETT, V424, P106, DOI 10.1016/j.neulet.2007.07.005; Pickering M, 2005, EXP PHYSIOL, V90, P663, DOI 10.1113/expphysiol.2005.030734; Pikis A, 1996, CLIN PEDIATR, V35, P72, DOI 10.1177/000992289603500204; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Quintana A, 2005, J NEUROSCI RES, V82, P701, DOI 10.1002/jnr.20680; Rao VLR, 2000, EXP NEUROL, V161, P102, DOI 10.1006/exnr.1999.7269; Rosi S, 2005, J NEUROSCI, V25, P723, DOI 10.1523/JNEUROSCI.4469-04.2005; Sayyah M, 2003, EPILEPSY RES, V57, P175, DOI 10.1016/j.eplepsyres.2003.11.002; Segal M, 2003, EUR J NEUROSCI, V17, P2573, DOI 10.1046/j.1460-9568.2003.02696.x; Semmler A, 2007, EXP NEUROL, V204, P733, DOI 10.1016/j.expneurol.2007.01.003; Sparkman NL, 2005, PHYSIOL BEHAV, V86, P244, DOI 10.1016/j.physbeh.2005.07.016; Sparkman NL, 2005, PHYSIOL BEHAV, V85, P278, DOI 10.1016/j.physbeh.2005.04.015; STEPHENSON DT, 1995, J NEUROSCI, V15, P5263; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Venneti S, 2006, PROG NEUROBIOL, V80, P308, DOI 10.1016/j.pneurobio.2006.10.002; Wenk GL, 2000, BRAIN RES, V885, P1, DOI 10.1016/S0006-8993(00)02792-X; Willard LB, 1999, NEUROSCIENCE, V88, P193	40	18	18	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0887-4476	1098-2396		SYNAPSE	Synapse	JUL	2011	65	7					634	642		10.1002/syn.20889			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	748WY	WOS:000289424900010	21108236	Green Accepted			2022-02-06	
J	Richmond, R; Aldaghlas, TA; Burke, C; Rizzo, AG; Griffen, M; Pullarkat, R				Richmond, Robyn; Aldaghlas, Tayseer A.; Burke, Christine; Rizzo, Anne G.; Griffen, Margaret; Pullarkat, Ranjit			Age: Is It All in the Head? Factors Influencing Mortality in Elderly Patients With Head Injuries	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Elderly; Traumatic brain injury; Motor vehicle crashes; Mortality; CIREN	TRAUMATIC BRAIN-INJURY; PROSPECTIVE MULTICENTER TRIAL	Background: Elderly patients, an increasing segment of the population, who sustain traumatic brain injury (TBI) are known to have worse outcomes, including higher mortality. This objective of this study was to examine the Crash Injury Research Engineering Network and to determine at what age motor vehicle crash fatalities from head injuries increased. Methods: The Crash Injury Research Engineering Network database was queried from 1996 to 2009. Study inclusion criteria were adult vehicle occupants with TBI, with an Abbreviated Injury Scale score >= 2. The age at which mortality increased was calculated. Patients younger and older than this cutoff age were compared to determine differences in crash characteristics. The determined cutoff age was compared with one found in a larger, population-based database. Results: There were 915 patients who met the study criteria. An increase in mortality was seen at age 60 years despite no difference in Injury Severity Score and a decrease in crash severity. Patients <= 60 years were more likely to have alcohol involved, to be in a rollover crash, and had higher crash speeds. Comparing the element of the crash attributed to the head injury, the patients >60 years were more likely to have struck the airbag, door, and seat. An analysis of the larger database revealed an increase in mortality at age 70 years. Conclusions: There was a higher mortality secondary to head injuries in those older than 60 years involved in motor vehicle crashes. Improved safety measures in vehicle design may decrease the number of head injuries seen in the older population.	[Richmond, Robyn; Aldaghlas, Tayseer A.; Burke, Christine; Rizzo, Anne G.; Griffen, Margaret; Pullarkat, Ranjit] Inova Fairfax Hosp, Inova Reg Trauma Ctr, Falls Church, VA 22042 USA		Richmond, R (corresponding author), Inova Fairfax Hosp, Inova Reg Trauma Ctr, 3000 Gallows Rd, Falls Church, VA 22042 USA.	robyn.richmond@inova.org					*DEP TRANSP, 2008, TRAFF SAF FACTS 2008; Harris C, 2003, J AM COLL SURGEONS, V197, P711, DOI 10.1016/S1072-7515(03)00729-4; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Livingston DH, 2005, J TRAUMA, V59, P1298, DOI 10.1097/01.ta.0000196002.03681.18; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Stitzel Joel D, 2008, Ann Adv Automot Med, V52, P235; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; [No title captured]	10	18	18	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUL	2011	71	1					E8	E11		10.1097/TA.0b013e3181fbaa46			4	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	790RR	WOS:000292607400002	21336200				2022-02-06	
J	Kompanje, EJO; de Groot, YJ; Bakker, J				Kompanje, Erwin J. O.; de Groot, Yorick J.; Bakker, Jan			Is Organ Donation From Brain Dead Donors Reaching an Inescapable and Desirable Nadir?	TRANSPLANTATION			English	Article						Transplantation; Brain death; Organ donation	ANEURYSMAL SUBARACHNOID HEMORRHAGE; CARDIAC DEATH; INTRACRANIAL ANEURYSM; SINGLE-CENTER; CASE-FATALITY; RISK-FACTORS; TRANSPLANTATION; POPULATION; MORTALITY; POINT	The brain dead patient is the ideal multiorgan donor. Conversely, brain death (BD) is an undesirable outcome of critical care medicine. Conditions that can lead to the state of BD are limited. An analysis showed that a (aneurysmal) subarachnoid hemorrhage, traumatic brain injury, or intracerebral hemorrhage in 83% precede the state of BD. Because of better prevention and treatment options, we should anticipate on an inescapable and desirable decline of BD. In this article, we offer arguments for this statement and discuss alternatives to maintain a necessary level of donor organs for transplantation.	[Kompanje, Erwin J. O.; de Groot, Yorick J.; Bakker, Jan] Erasmus MC Univ Med Ctr, Dept Intens Care Med, NL-3000 CA Rotterdam, Netherlands		Kompanje, EJO (corresponding author), Erasmus MC Univ Med Ctr, Dept Intens Care Med, POB 2040, NL-3000 CA Rotterdam, Netherlands.	e.j.o.kompanje@erasmusmc.nl	Bakker, Jan/A-4011-2009	Bakker, Jan/0000-0003-2236-7391			Alshekhlee A, 2010, STROKE, V41, P1471, DOI 10.1161/STROKEAHA.110.580647; ANTOMMARIA AH, 1902, JAMA-J AM MED ASSOC, P301; Bernat JL, 2010, CHEST, V138, P13, DOI 10.1378/chest.10-0649; Bernat JL, 2010, HASTINGS CENT REP, V40, P3, DOI 10.1353/hcr.0.0258; Boucek MM, 2008, NEW ENGL J MED, V359, P709, DOI 10.1056/NEJMoa0800660; Connolly E S Jr, 1999, J Stroke Cerebrovasc Dis, V8, P248, DOI 10.1016/S1052-3057(99)80074-3; Davis CL, 2011, TRANSPL INT, V24, P344, DOI 10.1111/j.1432-2277.2010.01212.x; de Groot YJ, 2009, JAMA-J AM MED ASSOC, V302, P845; de Groot YJ, 2010, INTENS CARE MED, V36, P1488, DOI 10.1007/s00134-010-1848-y; de Groot YJ, 2009, JAMA-J AM MED ASSOC, V302, P844, DOI 10.1001/jama.2009.1207; De Oliveira NC, 2010, J THORAC CARDIOV SUR, V139, P1306, DOI 10.1016/j.jtcvs.2010.02.004; Dubbeld J, 2010, BRIT J SURG, V97, P744, DOI 10.1002/bjs.7043; Glynn LG, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005182.pub4; Gortmaker SL, 1996, CRIT CARE MED, V24, P432, DOI 10.1097/00003246-199603000-00012; Halpern SD, 2010, JAMA-J AM MED ASSOC, V304, P2592, DOI 10.1001/jama.2010.1824; Hop JW, 1997, STROKE, V28, P660, DOI 10.1161/01.STR.28.3.660; Kirste G, 2010, CHIRURG, V81, P778, DOI 10.1007/s00104-009-1871-0; Kompanje EJO, 2006, INTENS CARE MED, V32, P217, DOI 10.1007/s00134-005-0001-9; KOMPANJE EJO, 2009, HUMAN RIGHTS BIOMEDI, P235; Kopits E, 2008, J TRANSP ECON POLICY, V42, P129; Koshy L, 2010, CEREBROVASC DIS, V29, P268, DOI 10.1159/000275501; Linn FHH, 1996, STROKE, V27, P625, DOI 10.1161/01.STR.27.4.625; Lovelock CE, 2010, NEUROLOGY, V74, P1494, DOI 10.1212/WNL.0b013e3181dd42b3; Jimenez-Yepes CM, 2008, STROKE, V39, P1344, DOI 10.1161/STROKEAHA.107.504019; Mascia L, 2010, JAMA-J AM MED ASSOC, V304, P2620, DOI 10.1001/jama.2010.1796; Meers C, 2009, TRANSPL P, V41, P572, DOI 10.1016/j.transproceed.2008.12.029; MEES SMD, 2007, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000277.PUB3; Molyneux AJ, 2009, LANCET NEUROL, V8, P427, DOI 10.1016/S1474-4422(09)70080-8; Naiman A, 2010, CAN MED ASSOC J, V182, P761, DOI 10.1503/cmaj.091130; National Highway Traffic Safety Administration, 2010, EARL EST MOT VEH TRA; Opdam HI, 2004, INTENS CARE MED, V30, P1390, DOI 10.1007/s00134-004-2185-9; Peden M, 2004, WORLD REPORT ROAD TR, p[217, xv]; Prager LM, 2006, J HEART LUNG TRANSPL, V25, P1206, DOI 10.1016/j.healun.2006.06.014; Rodriguez-Arias D, 2010, LANCET, V376, P1109, DOI 10.1016/S0140-6736(10)61342-6; Saidi RF, 2010, AM J TRANSPLANT, V10, P2536, DOI 10.1111/j.1600-6143.2010.03215.x; Sandvei MS, 2009, STROKE, V40, P1958, DOI 10.1161/STROKEAHA.108.539544; Siminoff LA, 2001, JAMA-J AM MED ASSOC, V286, P71, DOI 10.1001/jama.286.1.71; Sprung CL, 2003, JAMA-J AM MED ASSOC, V290, P790, DOI 10.1001/jama.290.6.790; Stegmayr B, 2004, STROKE, V35, P2059, DOI 10.1161/01.STR.0000138451.07853.b6; Truog RD, 2008, NEW ENGL J MED, V359, P674, DOI 10.1056/NEJMp0804474; van der Schaaf I, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003085.pub2; van Gijn J, 2001, BRAIN, V124, P249, DOI 10.1093/brain/124.2.249; Veatch RM, 2008, NEW ENGL J MED, V359, P672, DOI 10.1056/NEJMp0805451; Weber M, 2002, NEW ENGL J MED, V347, P248, DOI 10.1056/NEJMoa020274; *WHO, 2010, AG IT 11 21 HUM ORG; WILKINSON D, 2010, BIOETHICS; Woo D, 2009, NEUROLOGY, V72, P695, DOI 10.1212/01.wnl.0000342999.99907.fd	47	18	20	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0041-1337			TRANSPLANTATION	Transplantation	JUN 15	2011	91	11					1177	1180		10.1097/TP.0b013e3182180567			4	Immunology; Surgery; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Surgery; Transplantation	769JN	WOS:000291008800004	21494178				2022-02-06	
J	Bryan, CJ; Hernandez, AM				Bryan, Craig J.; Hernandez, Ann M.			Predictors of Post-Traumatic Headache Severity Among Deployed Military Personnel	HEADACHE			English	Article						post-traumatic headache; traumatic brain injury; military population	TRAUMATIC BRAIN-INJURY; CHRONIC PAIN; SLEEP; PTSD; EPIDEMIOLOGY; VETERANS; STRESS	Objective.- The current study used a cross-sectional observational design to evaluate the relationship between psychological, physiological, and contextual factors and headache severity among 133 deployed military personnel and 4 civilian contractors diagnosed with mild traumatic brain injury (mTBI) referred to a combat support hospital in Iraq. Background.- Although TBI and headache sequelae have been documented for military combatants, little is known about factors associated with headache severity. Methods.- Military personnel (n = 157) and civilian (n = 4) contractors referred to a combat support hospital in Iraq underwent a standardized intake evaluation which included computerized neurocognitive testing, psychological and physical health questionnaires, a clinical interview, and a physical examination by a physician. Results.- Results of zero-inflated Poisson regression modeling suggest that insomnia is associated with increased likelihood for endorsement of any headache, but loss of consciousness, post-traumatic stress disorder symptoms, and slowed reaction time only are predictive of headache severity. Among the subset of patients presenting to the combat support hospital within 7 days of mTBI (n = 101), number of TBI symptoms demonstrated a non-significant trend toward increased likelihood of headache endorsement of any kind, with loss of consciousness, post-traumatic stress disorder, and slowed reaction time demonstrating significant relationships with headache severity. Conclusion.- Knowledge of predictors of post-concussive headache onset and severity may assist clinicians in making important decisions regarding treatment recommendations for veterans with mTBI.	[Bryan, Craig J.; Hernandez, Ann M.] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA		Hernandez, AM (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, 7550 IH 10 W,Suite 1325, San Antonio, TX 78229 USA.			Bryan, Craig/0000-0002-9714-0733			Afari N, 2009, HEADACHE, V49, P1267, DOI 10.1111/j.1526-4610.2009.01517.x; [Anonymous], 2007, AUT NEUR ASS METR CO; Asmundson GJG, 2002, CAN J PSYCHIAT, V47, P930, DOI 10.1177/070674370204701004; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Chaput G, 2009, SLEEP MED, V10, P713, DOI 10.1016/j.sleep.2008.07.015; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Couch JR, 2001, HEADACHE, V41, P559, DOI 10.1046/j.1526-4610.2001.041006559.x; COUCH JR, 1995, NEUROREHAB NEURAL RE, V9, P83; De Benedittis G, 1983, J Neurosurg Sci, V27, P177; Evans RW., 2006, NEUROLOGY TRAUMA, P95; Foo H, 2003, SLEEP MED REV, V7, P145, DOI 10.1053/smrv.2002.0224; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Jensen O K, 2001, Ugeskr Laeger, V163, P5029; Kopta SM, 2002, PSYCHOTHER RES, V12, P413, DOI 10.1093/ptr/12.4.413; Lautenbacher S, 2006, SLEEP MED REV, V10, P357, DOI 10.1016/j.smrv.2005.08.001; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; Nash JM, 2006, HEADACHE, V46, P1377, DOI 10.1111/j.1526-4610.2006.00580.x; Neely ET, 2009, HEADACHE, V49, P1089, DOI 10.1111/j.1526-4610.2009.001460.x; Ouellet MC, 2004, NEUROREHAB NEURAL RE, V18, P187, DOI 10.1177/1545968304271405; Ruff RL, 2008, J REHABIL RES DEV, V45, P941, DOI 10.1682/JRRD.2008.02.0028; Sharp TJ, 2001, CLIN PSYCHOL REV, V21, P857, DOI 10.1016/S0272-7358(00)00071-4; Smith MT, 2004, SLEEP MED REV, V8, P119, DOI 10.1016/S1087-0792(03)00044-3; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Weathers F.W., 1993, ANN CONV INT SOC TRA	29	18	18	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0017-8748	1526-4610		HEADACHE	Headache	JUN	2011	51	6					945	953		10.1111/j.1526-4610.2011.01887.x			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	772GH	WOS:000291221800012	21457255				2022-02-06	
J	Gong, D; Zhang, S; Liu, L; Dong, JF; Guo, XB; Hao, M; Tu, Y; Diao, YF; Zhang, JN				Gong, Dasen; Zhang, Sai; Liu, Li; Dong, Jingfei; Guo, Xinbin; Hao, Mu; Tu, Yue; Diao, Yunfeng; Zhang, Jianning			Dynamic Changes of Vascular Endothelial Growth Factor and Angiopoietin-1 in Association With Circulating Endothelial Progenitor Cells After Severe Traumatic Brain Injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Vascular endothelial growth factor; Angiopoietin-1; Endothelial progenitor cells; Traumatic brain injury	TIE2 RECEPTOR; CD34(+) CELLS; EXPRESSION; ANGIOGENESIS; BLOOD; VEGF; STROKE; LIGAND	Background: Vascular endothelial growth factor (VEGF) and angiopoietin-1 (Ang-1) can promote angiogenesis and vascular stability after brain injury. Circulating endothelial progenitor cells (EPCs) also play a crucial role in neovascularization and tissue repair after traumatic brain injury (TBI). We sought to compare the expression of VEGF and Ang-1 in serum and the circulating EPCs in patients after severe TBI with that of healthy control subjects. Methods: We obtained peripheral blood and serum samples from 21 patients with severe TBI and 11 healthy control subjects. EPCs in blood samples from severe TBI patients and healthy controls were quantified by flow cytometry 1 day, 4 days, 7 days, 14 days, and 21 days after severe TBI. VEGF and Ang-1 were measured by enzyme linked immunosorbent assay at the same time points. Results: Compared with control subjects, circulating EPCs in patients with severe TBI decreased 4 days (p < 0.05), but increased 7 days and 14 days (p < 0.05) after TBI. VEGF increased significantly during the follow-up period (p < 0.05). Ang-1 increased gradually and reached peak at 7 days and 14 days after TBI. The circulating EPCs were significantly correlated with VEGF and Ang-1 at 7 days and 14 days after severe TBI. Conclusions: Our results suggest that the increased VEGF and Ang-1 are closely related to increase in circulating EPCs in response to severe TBI, which may be needed for vascular repairs after severe TBI.	[Zhang, Jianning] Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Dept Neurosurg, Tianjin 300052, Peoples R China; [Zhang, Sai; Tu, Yue; Diao, Yunfeng] Wujing Med Coll, Affiliated Hosp, Dept Neurosurg, Tianjin, Peoples R China; [Dong, Jingfei] Baylor Coll Med, Dept Med, Thrombosis Res Sect, Houston, TX 77030 USA; [Guo, Xinbin] Zhengzhou Univ, Affiliated Hosp 1, Dept Intervent, Zhengzhou, Henan, Peoples R China; [Hao, Mu] Chinese Acad Med Sci, Inst Hematol, State Key Lab Expt Hematol, Tianjin, Peoples R China; Chinese Acad Med Sci, Blood Dis Hosp, Tianjin, Peoples R China; Peking Union Med Coll, Tianjin, Peoples R China; Minist Educ, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Tianjin 300052, Peoples R China; Tianjin Key Lab Injuries Variat & Regenerat Nervo, Tianjin 300052, Peoples R China		Zhang, JN (corresponding author), Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Dept Neurosurg, 154 Anshan Rd, Tianjin 300052, Peoples R China.	jianningzhang@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30772229]; National 973 ProjectNational Basic Research Program of China [2005CB522600]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HL 71895]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL071895] Funding Source: NIH RePORTER	Supported by National Natural Science Foundation of China Grant 30772229; National 973 Project Grant 2005CB522600; and the NIH Grant HL 71895.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Beck L, 1997, FASEB J, V11, P365, DOI 10.1096/fasebj.11.5.9141503; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; DVORAK HF, 1995, AM J PATHOL, V146, P1029; Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481; Gu WG, 2001, ACTA NEUROPATHOL, V102, P216; Guo XB, 2009, J NEUROTRAUM, V26, P1337, DOI [10.1089/neu.2008.0733, 10.1089/neu.2008-0733]; Han S, 2010, BRAIN, V133, P1026, DOI 10.1093/brain/awq034; Hayashi T, 1998, J CEREBR BLOOD F MET, V18, P887, DOI 10.1097/00004647-199808000-00009; Herrera JJ, 2010, J NEUROTRAUM, V27, P2067, DOI 10.1089/neu.2010.1403; Herrera JJ, 2009, J NEUROTRAUM, V26, P995, DOI [10.1089/neu.2008.0779, 10.1089/neu.2008-0779]; IWAMA A, 1993, BIOCHEM BIOPH RES CO, V195, P301, DOI 10.1006/bbrc.1993.2045; Jiang SG, 2004, P NATL ACAD SCI USA, V101, P16891, DOI 10.1073/pnas.0404398101; Li B, 2006, FASEB J, V20, P1495, DOI 10.1096/fj.05-5137fje; Liu L, 2007, J NEUROTRAUM, V24, P936, DOI 10.1089/neu.2006.0250; Liu Y, 2010, NEUROBIOL DIS, V37, P384, DOI 10.1016/j.nbd.2009.10.018; Martinez A, 2006, CANCER LETT, V236, P157, DOI 10.1016/j.canlet.2005.04.008; Murayama T, 2002, EXP HEMATOL, V30, P967, DOI 10.1016/S0301-472X(02)00867-6; Nourhaghighi N, 2003, LAB INVEST, V83, P1211, DOI 10.1097/01.LAB.0000082383.40635.FE; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Paczkowska E, 2005, EUR J HAEMATOL, V75, P461, DOI 10.1111/j.1600-0609.2005.00536.x; Skold MK, 2006, EUR J NEUROSCI, V23, P21, DOI 10.1111/j.1460-9568.2005.04527.x; Skold MK, 2005, J NEUROTRAUM, V22, P353, DOI 10.1089/neu.2005.22.353; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Zhang ZG, 2002, NEUROSCIENCE, V113, P683, DOI 10.1016/S0306-4522(02)00175-6	25	18	22	1	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUN	2011	70	6					1480	1484		10.1097/TA.0b013e31821ac9e1			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	775QR	WOS:000291478500037	21817986				2022-02-06	
J	Hoogerdijk, B; Runge, U; Haugboelle, J				Hoogerdijk, Barbara; Runge, Ulla; Haugboelle, Jette			The adaptation process after traumatic brain injury An individual and ongoing occupational struggle to gain a new identity	SCANDINAVIAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						Occupational therapy; situated learning process; occupation; re-identification; narrative	STROKE; EXPERIENCES; RECOVERY; ADULTS; LIFE	The aim of this study is to understand better how individuals with traumatic brain injury make sense of their adaptation process and their performance of occupations within this process. For this study, four participants were interviewed twice. Thereafter analyses following a narrative approach led to the construction of four individual narratives. The results indicate that the adaptation process following traumatic brain injury is (1) a necessary struggle to gain a new identity; (2) facilitated by engagement in familiar occupations in familiar environments; (3) a protracted learning process that continues long after rehabilitation ends; (4) individual and situated. The results suggest that healthcare professionals including occupational therapists should: allow individuals with traumatic brain injury to test and practise their abilities within their own home environments; provide them with the necessary space to practise on their own; guide them in using their own and new strategies in a way that is both efficient and personally satisfying. Finally, this study discusses whether rehabilitation services should be offered over a protracted period of time. Professional support following the rehabilitation period--precisely the period in which they are trying to establish a meaningful existence with their disabilities--could be a more useful path to follow.	[Hoogerdijk, Barbara] Rehabil Ctr Heliomare, Dept Occupat Therapy, NL-1949 EC Wijk Aan Zee, Netherlands; [Runge, Ulla] Runge Consult, Copenhagen, Denmark; [Haugboelle, Jette] Univ Coll Sjaelland, Fac Occupat Therapy, Naestved, Denmark		Hoogerdijk, B (corresponding author), Rehabil Ctr Heliomare, Dept Occupat Therapy, Relweg 51, NL-1949 EC Wijk Aan Zee, Netherlands.	b.hoogerdijk@heliomare.nl			Rehabilitation Centre Heliomare at Wijk aan Zee, the NetherlandsNetherlands Government	The authors would like to thank the four participants who were generously willing to share their time and stories with the first-named author. This study was part of the European Master of Science in Occupational Therapy programme and was supported by Rehabilitation Centre Heliomare at Wijk aan Zee, the Netherlands.	Bendz M, 2000, SOC SCI MED, V51, P713, DOI 10.1016/S0277-9536(99)00486-4; Blair S.E.E., 2000, BRIT J OCCUP THER, V63, P231, DOI [https://doi.org/10.1177/030802260006300508, DOI 10.1177/030802260006300508]; Bontje P, 2004, AM J OCCUP THER, V58, P140, DOI 10.5014/ajot.58.2.140; Brown D, 2006, BRAIN INJURY, V20, P937, DOI 10.1080/02699050600909821; Burton CR, 2000, J ADV NURS, V32, P301, DOI 10.1046/j.1365-2648.2000.01477.x; Christiansen CH, 1999, AM J OCCUP THER, V53, P547, DOI 10.5014/ajot.53.6.547; Daniels R, 2002, SCAND J OCCUP THER, V9, P167, DOI DOI 10.1080/110381202605; *DUTCH HEART ASS, 2001, REV BER; Easton KL, 1999, GERIATR NURS, V20, P70, DOI 10.1053/gn.1999.v20.97009; Fleming Jennifer M, 2006, Can J Occup Ther, V73, P44; FORTMEIER S, 2002, PATIENTS VIEW; Goodfellow J., 1998, WRITING QUALITATIVE, P175; Gracey F, 2008, NEUROPSYCHOL REHABIL, V18, P627, DOI 10.1080/09602010802041238; Gray JM, 1998, AM J OCCUP THER, V52, P354, DOI 10.5014/ajot.52.5.354; Hill H, 1999, BRAIN INJURY, V13, P839, DOI 10.1080/026990599121043; KIELHOFNER G, 2008, MODEL HUMAN OCCUPATI, P107; Kincheloe J.L., 1994, HDB QUALITATIVE RES HDB QUALITATIVE RES, P138; Kirkevold M, 2002, DISABIL REHABIL, V24, P887, DOI 10.1080/09638280210142239; Klinger L, 2005, J OCCUP SCI, V12, P9, DOI 10.1080/14427591.2005.9686543; Mee J., 2004, BRIT J OCCUP THER, V67, P225; Molineux M., 2003, J OCCUP SCI, V10, P52, DOI 10.1080/14427591.2003.9686511; Muenchberger H, 2008, BRAIN INJURY, V22, P979, DOI 10.1080/02699050802530532; Nelson DL, 1996, AM J OCCUP THER, V50, P775, DOI 10.5014/ajot.50.10.775; Polkinghorne DE, 1996, AM J OCCUP THER, V50, P299, DOI 10.5014/ajot.50.4.299; PriceLackey P, 1996, AM J OCCUP THER, V50, P306, DOI 10.5014/ajot.50.4.306; Sabari JS, 1998, AM J OCCUP THER, V52, P299, DOI 10.5014/ajot.52.4.299; SCHJERNING J, 2004, LIFE FAST LANE QUALI; SCHKADE JK, 1992, AM J OCCUP THER, V46, P829, DOI 10.5014/ajot.46.9.829; Seibert PS, 2002, BRAIN INJURY, V16, P837, DOI 10.1080/02699050210131939; Strandberg T, 2009, SOC WORK HEALTH CARE, V48, P276, DOI 10.1080/00981380802599240; Tham K, 2000, AM J OCCUP THER, V54, P398, DOI 10.5014/ajot.54.4.398; TOGLIA JP, 1991, AM J OCCUP THER, V45, P505, DOI 10.5014/ajot.45.6.505; White MA, 2000, DISABIL REHABIL, V22, P140	33	18	18	0	19	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1103-8128			SCAND J OCCUP THER	Scand. J. Occup. Ther.	JUN	2011	18	2					122	132		10.3109/11038121003645985			11	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	763OV	WOS:000290570500006	20384550				2022-02-06	
J	Barry, CM; Helps, SC; van den Heuvel, C; Vink, R				Barry, Christine M.; Helps, Stephen C.; van den Heuvel, Corinna; Vink, Robert			Characterizing the role of the neuropeptide substance P in experimental subarachnoid hemorrhage	BRAIN RESEARCH			English	Article						Subarachnoid hemorrhage; Brain edema; Substance P; Neurological outcome; Intracranial pressure	TRAUMATIC BRAIN-INJURY; FUNCTIONAL DEFICITS; HYPERBARIC-OXYGEN; RAT MODEL; EDEMA; STROKE	Background: Raised intracranial pressure (ICP) following SAH predicts poor outcome and is due to hemorrhage volume and possibly, brain edema, hydrocephalus and increased volume of circulating intracranial blood. Interventions that reduce edema may therefore reduce ICP and improve outcome. The neuropeptide substance P (SP) mediates vasogenic edema formation in animal models of ischemic stroke, intracerebral hemorrhage and brain trauma, and may contribute to development of increased ICP. SP (NK1 tachykinin receptor) blockade using n-acetyl-1-tryptophan (NAT) reduces edema and improves outcome in these models. This study therefore assessed whether SP mediates edema formation in experimental SAH. Methods: SAH was induced in rats by either injection of autologous blood into the prechiasmatic cistern (injection SAN) or by arterial puncture of the Circle of Willis (filament SAN). NAT was injected (i.v.) 30 min after SAH induction. Subgroups were assessed for brain water content, SP and albumin immunoreactivity, and functional outcome at 5, 24 and 48 h or ICP over 5 h. Results: A secondary ICP increase occurred within 2 h of SAH. Brain edema followed filament SAH (p < 0.001) and correlated with functional deficits (r = 0.8, p < 0.01). Increased albumin immunoreactivity (p < 0.001) indicated vasogenic edema. However, NAT treatment did not improve ICP, edema or outcome. Conclusions: Experimental SAN produced secondary ICP elevation, vasogenic brain edema and functional deficits, although it is unclear if edema contributed to ICP. Blockade of SP did not improve any outcome parameters, suggesting that neurogenic inflammation may be less critical than other factors in these models. (C) 2011 Elsevier B.V. All rights reserved.	[Barry, Christine M.] Univ Adelaide, Sch Med Sci, Discipline Anat & Pathol, Adelaide, SA 5005, Australia; Univ Adelaide, Sch Med Sci, Adelaide Ctr Neurosci Res, Adelaide, SA 5005, Australia		Barry, CM (corresponding author), Univ Adelaide, Sch Med Sci, Discipline Anat & Pathol, Adelaide, SA 5005, Australia.	Christine.barry@adelaide.edu.au	Vink, Robert/S-5616-2019; Vink, Robert/J-7351-2012; Barry, Christine/M-6775-2018	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667; Barry, Christine/0000-0002-5227-3524	Neurosurgical Research Foundation (Australia); National Stroke Foundation of Australia	Supported, in part, by the Neurosurgical Research Foundation (Australia) and the National Stroke Foundation of Australia.	BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; BEDERSON JB, 1995, STROKE, V26, P1086, DOI 10.1161/01.STR.26.6.1086; Claassen J, 2002, STROKE, V33, P1225, DOI 10.1161/01.STR.0000015624.29071.1F; Donkin JJ, 2009, J CEREBR BLOOD F MET, V29, P1388, DOI 10.1038/jcbfm.2009.63; DONKIN JJ, 2006, DISCIPLINE PATHOLOGY, P308; Gao C, 2008, AUTON NEUROSCI-BASIC, V141, P22, DOI 10.1016/j.autneu.2008.04.007; Huang J, 2002, NEUROSURGERY, V51, P1101, DOI 10.1097/00006123-200211000-00001; Huang ZX, 2007, BRAIN RES, V1153, P204, DOI 10.1016/j.brainres.2007.03.061; Ingall T, 2000, STROKE, V31, P1054, DOI 10.1161/01.STR.31.5.1054; JOHSHITA H, 1990, STROKE, V21, P1051, DOI 10.1161/01.STR.21.7.1051; Kleinig TJ, 2010, STROKE, V41, pE212; Li ZQ, 2009, BRAIN RES, V1264, P98, DOI 10.1016/j.brainres.2009.01.055; Nimmo AJ, 2004, NEUROPEPTIDES, V38, P40, DOI 10.1016/j.npep.2003.12.003; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; Ostrowski RP, 2005, J CEREBR BLOOD F MET, V25, P554, DOI 10.1038/sj.jcbfm.9600048; Park S, 2004, STROKE, V35, P2412, DOI 10.1161/01.STR.0000141162.29864.e9; Prunell GF, 2002, NEUROREPORT, V13, P2553, DOI 10.1097/00001756-200212200-00034; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Scholler K, 2007, BRAIN RES, V1142, P237, DOI 10.1016/j.brainres.2007.01.034; THAL SC, 2009, J NEUROSURG; Thal SC, 2008, J NEUROL SCI, V268, P150, DOI 10.1016/j.jns.2007.12.002; Turner RJ, 2006, ACTA NEUROCHIR SUPPL, V96, P263; Vink R, 2010, NEUROTHERAPEUTICS, V7, P74, DOI 10.1016/j.nurt.2009.10.018; Yatsushige H, 2007, J NEUROSCI RES, V85, P1436, DOI 10.1002/jnr.21281; Yatsushige H, 2006, J NEUROTRAUM, V23, P1874, DOI 10.1089/neu.2006.23.1874	25	18	18	0	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	MAY 10	2011	1389						143	151		10.1016/j.brainres.2011.02.082			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	767VK	WOS:000290886300015	21377453				2022-02-06	
J	Lo, BWY; Kyu, HH; Jichici, D; Upton, AM; Akl, EA; Meade, MO				Lo, Benjamin W. Y.; Kyu, Hmwe H.; Jichici, Draga; Upton, Adrian M.; Akl, Elie A.; Meade, Maureen O.			Meta-Analysis of Randomized Trials on First Line and Adjunctive Levetiracetam	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article							ADD-ON THERAPY; REFRACTORY PARTIAL SEIZURES; PLACEBO-CONTROLLED TRIAL; MULTICENTER DOUBLE-BLIND; CHINESE PATIENTS; EFFICACY; SAFETY; TOLERABILITY; PHENYTOIN; EPILEPSY	Context: New evidence suggests that levetiracetam may be as effective as traditional agents, with better safety profile. Objective: To synthesize evidence regarding efficacy and tolerability of levetiracetam as first line, adjunctive or prophylactic antiepileptic agent. Study Selection & Data Extraction: Eligible studies were randomized controlled trials (RCTs) of levetiracetam used in adults with epilepsy. MEDLINE, EMBASE, CENTRAL, CINHAL, PAPERSFIRST, PROCEEDINGSFIRST, PROQUEST and conference proceedings identified studies (to September 30, 2010). Two investigators independently selected, appraised studies, collected and analyzed data. Results: Of ten eligible randomized trials, eight investigated adjunctive levetiracetam for refractory seizures, one as monotherapy for newly diagnosed seizures, one as monotherapy for prophylaxis. Eight RCTs of adjunctive levetiracetam were of moderate quality (GRADE criteria), with two showing lack of allocation concealment. Meta-analyses showed adjunctive levetiracetam was more effective than placebo in achieving at least 50% reduction of seizure frequency, when added to baseline antiepileptic regimen (pooled RR 2.15 [1.65,2.82], I-2 = 45%, p value (heterogeneity) = 0.08, p value (overall effect) < 0.01). Likelihood of serious adverse events necessitating withdrawal from study was not significantly different between levetiracetam and control (pooled RR 1.37 [0.88,2.13], I-2 = 0%, p value (heterogeneity) = 0.84, p value (overall effect) = 0.17). Subgroup analyses suggested similar effects across different dosages. Sensitivity analysis of studies with adequate concealment showed similar effects. Conclusions: Levetiracetam is an effective adjunctive agent for refractory epilepsy. More studies are needed to establish whether it is effective as monotherapy for newly diagnosed seizures, and for prophylaxis in traumatic brain injury.	[Lo, Benjamin W. Y.] McMaster Univ, Fac Hlth Sci, Div Crit Care Med, Dept Clin Edpiemiol & Biostat, Hamilton, ON L8N 3Z5, Canada; [Lo, Benjamin W. Y.] Univ Toronto, Div Neurosurg, Toronto, ON, Canada; [Akl, Elie A.] SUNY Buffalo, Dept Med, Buffalo, NY 14260 USA		Lo, BWY (corresponding author), McMaster Univ, Fac Hlth Sci, Div Crit Care Med, Dept Clin Edpiemiol & Biostat, Room 2U,1200 Main St W, Hamilton, ON L8N 3Z5, Canada.		Akl, Elie A/R-2079-2016; Akl, Elie/K-5269-2019	Akl, Elie A/0000-0002-3444-8618; 			Ben-Menachem E, 2000, EPILEPSIA, V41, P1276, DOI 10.1111/j.1528-1157.2000.tb04605.x; Berkovic SF, 2007, NEUROLOGY, V69, P1751, DOI 10.1212/01.wnl.0000268699.34614.d3; Betts T, 2000, SEIZURE-EUR J EPILEP, V9, P80, DOI 10.1053/seiz.2000.0380; Brodie MJ, 2007, NEUROLOGY, V68, P402, DOI 10.1212/01.wnl.0000252941.50833.4a; Cereghino JJ, 2000, NEUROLOGY, V55, P236, DOI 10.1212/WNL.55.2.236; Cramer JA, 2003, EPILEPSY BEHAV, V4, P124, DOI 10.1016/S1525-5050(03)00005-2; DAYA S, 2006, EVIDENCE BASED OBSTE, V8, P71, DOI DOI 10.1016/J.EBOBGYN.2006.10.001; French J, 2001, EPILEPSY RES, V47, P77, DOI 10.1016/S0920-1211(01)00296-0; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Higgins JPT, COCHRANE HDB SYSTEMA; Jones KE, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E3; Leppik I, 2003, EPILEPSIA, V44, P1350, DOI 10.1046/j.1528-1157.2003.62802.x; Lim DA, 2009, J NEURO-ONCOL, V93, P349, DOI 10.1007/s11060-008-9781-4; Milligan TA, 2008, NEUROLOGY, V71, P665, DOI 10.1212/01.wnl.0000324624.52935.46; Noachtar S, 2008, NEUROLOGY, V70, P607, DOI 10.1212/01.wnl.0000297512.18364.40; Otoul C, 2005, CLIN NEUROPHARMACOL, V28, P72, DOI 10.1097/01.wnf.0000159956.87511.67; Peltola J, 2009, EPILEPSIA, V50, P406, DOI 10.1111/j.1528-1167.2008.01817.x; Schunemann HJ, 2006, AM J RESP CRIT CARE, V174, P605, DOI 10.1164/rccm.200602-197ST; Shorvon SD, 2000, EPILEPSIA, V41, P1179, DOI 10.1111/j.1528-1157.2000.tb00323.x; Steinhoff BJ, 2007, EPILEPSY RES, V76, P6, DOI 10.1016/j.eplepsyres.2007.06.002; Szaflarski JP, 2010, NEUROCRIT CARE, V12, P165, DOI 10.1007/s12028-009-9304-y; Tsai JJ, 2006, EPILEPSIA, V47, P72, DOI 10.1111/j.1528-1167.2006.00372.x; Wu XY, 2009, EPILEPSIA, V50, P398, DOI 10.1111/j.1528-1167.2008.01729.x; Xiao Z, 2009, EUR NEUROL, V61, P233, DOI 10.1159/000197109	24	18	18	0	6	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0317-1671	2057-0155		CAN J NEUROL SCI	Can. J. Neurol. Sci.	MAY	2011	38	3					475	486		10.1017/S0317167100011902			12	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	774IQ	WOS:000291379300021	21515509	Bronze			2022-02-06	
J	Zhang, Y; Popovich, P				Zhang, Yi; Popovich, Phillip			Roles of Autoantibodies in Central Nervous System Injury	DISCOVERY MEDICINE			English	Article							SPINAL-CORD-INJURY; BLOOD-BRAIN-BARRIER; TOLL-LIKE RECEPTORS; GLUTAMATE-RECEPTOR; BASIC-PROTEIN; CELL-DEATH; ANTIBODIES; DISEASE; REPAIR; INFLAMMATION	Stroke, traumatic brain injury (TBI), and spinal cord injury (SCI) cause irreversible damage to the nervous system. Although these are neurological disorders, pathology and loss of function also occur outside the nervous system and are often not easily explained by paralysis or impaired neural function. Emerging data indicate that much of the pathological sequelae that accompanies CNS trauma has characteristics of a self-directed immunological disease. Here, we outline those data, describing basic mechanisms of B cell activation and autoantibody synthesis after CNS injury. A summary of the anti-CNS autoantibodies that have been identified in humans and animals is provided along with a discussion of how autoantibodies may affect survival of neuronal and non-neuronal tissues and whether autoimmune reactions are feasible therapeutic targets after CNS trauma. [Discovery Medicine 11(60):395-402, May 2011]	[Zhang, Yi; Popovich, Phillip] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA		Popovich, P (corresponding author), Ohio State Univ, Dept Neurosci, 460 W 12th Ave, Columbus, OH 43210 USA.	phillip.popovich@osumc.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS047175, NS067260]; Ray W. Poppleton Endowment; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS047175, R21NS067260] Funding Source: NIH RePORTER	Supported in part by NIH NS047175 and NS067260 and the Ray W. Poppleton Endowment.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Ankeny DP, 2006, J NEUROCHEM, V99, P1073, DOI 10.1111/j.1471-4159.2006.04147.x; Ankeny DP, 2010, TRENDS IMMUNOL, V31, P332, DOI 10.1016/j.it.2010.06.006; Ankeny DP, 2009, J CLIN INVEST, V119, P2990, DOI 10.1172/JCI39780; Archelos JJ, 2000, TRENDS NEUROSCI, V23, P317, DOI 10.1016/S0166-2236(00)01575-7; Bansal V, 2009, J NEUROTRAUM, V26, P1353, DOI [10.1089/neu.2008.0858, 10.1089/neu.2008-0858]; Basten A, 2010, CURR OPIN IMMUNOL, V22, P566, DOI 10.1016/j.coi.2010.08.001; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Berger T, 2003, NEW ENGL J MED, V349, P139, DOI 10.1056/NEJMoa022328; Bornstein NM, 2001, NEUROLOGY, V56, P529, DOI 10.1212/WNL.56.4.529; Bronstein JM, 1999, NEUROLOGY, V53, P154, DOI 10.1212/WNL.53.1.154; Carrasco YR, 2006, CURR OPIN IMMUNOL, V18, P286, DOI 10.1016/j.coi.2006.03.013; Carvey PM, 2009, J NEUROCHEM, V111, P291, DOI 10.1111/j.1471-4159.2009.06319.x; Cesarman-Maus G, 2011, STROKE, V42, P501, DOI 10.1161/STROKEAHA.110.592121; CHAPMAN J, 1988, NEUROSCI LETT, V86, P235, DOI 10.1016/0304-3940(88)90577-0; Colasanti T, 2009, J NEUROIMMUNOL, V212, P3, DOI 10.1016/j.jneuroim.2009.05.003; Dambinova SA, 2003, CLIN CHEM, V49, P1752, DOI 10.1373/49.10.1752; Dambinova SA, 2002, STROKE, V33, P1181, DOI 10.1161/01.STR.0000014922.83673.86; DAVIDOFF GN, 1992, ARCH PHYS MED REHAB, V73, P275; Davies AL, 2007, ARCH PHYS MED REHAB, V88, P1384, DOI 10.1016/j.apmr.2007.08.004; Davydova TV, 2007, B EXP BIOL MED+, V143, P182, DOI 10.1007/s10517-007-0044-8; DeGiorgio LA, 2001, NAT MED, V7, P1189, DOI 10.1038/nm1101-1189; Diamond B, 2009, NAT REV IMMUNOL, V9, P449, DOI 10.1038/nri2529; Double KL, 2009, EXP NEUROL, V217, P297, DOI 10.1016/j.expneurol.2009.03.002; Duan B, 2006, AUTOIMMUN REV, V5, P403, DOI 10.1016/j.autrev.2005.10.007; Ehrenstein MR, 2010, NAT REV IMMUNOL, V10, P778, DOI 10.1038/nri2849; Ganor Y, 2005, EXP NEUROL, V195, P92, DOI 10.1016/j.expneurol.2005.04.002; Ghosn EEB, 2011, P NATL ACAD SCI USA, V108, P2879, DOI 10.1073/pnas.1019764108; Gruden MA, 2007, J NEUROIMMUNOL, V186, P181, DOI 10.1016/j.jneuroim.2007.03.023; Gruden MA, 2011, J NEUROIMMUNOL, V233, P221, DOI 10.1016/j.jneuroim.2010.12.001; Harwood NE, 2010, ANNU REV IMMUNOL, V28, P185, DOI 10.1146/annurev-immunol-030409-101216; Hayes KC, 2002, J NEUROTRAUM, V19, P753, DOI 10.1089/08977150260139129; Jones TB, 2005, CURR PHARM DESIGN, V11, P1223, DOI 10.2174/1381612053507468; Knopf PM, 1998, J IMMUNOL, V161, P692; Kobayashi T, 2008, INT IMMUNOL, V20, P881, DOI 10.1093/intimm/dxn049; Kowal C, 2004, IMMUNITY, V21, P179, DOI 10.1016/j.immuni.2004.07.011; Kurosaki T, 2010, ANNU REV IMMUNOL, V28, P21, DOI 10.1146/annurev.immunol.021908.132541; Leinhase I, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-55; Liu JW, 2004, SPINE, V29, P164, DOI 10.1097/01.BRS.0000107234.74249.CD; Lopez-Escribano H, 2002, ARTHRITIS RHEUM, V46, P3290, DOI 10.1002/art.10684; Mackay F, 2003, ANNU REV IMMUNOL, V21, P231, DOI 10.1146/annurev.immunol.21.120601.141152; Martin F, 2006, ANNU REV IMMUNOL, V24, P467, DOI 10.1146/annurev.immunol.24.021605.090517; McGonagle D, 2006, PLOS MED, V3, P1242, DOI 10.1371/journal.pmed.0030297; McKnight K, 2005, NEUROLOGY, V65, P1730, DOI 10.1212/01.wnl.0000187129.66353.13; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Mocco J, 2006, CIRC RES, V99, P209, DOI 10.1161/01.RES.0000232544.90675.42; Nath A, 2003, NEUROMOL MED, V3, P29, DOI 10.1385/NMM:3:1:29; OLSSON T, 1990, ANN NEUROL, V27, P132, DOI 10.1002/ana.410270207; Peltola JT, 2000, AM J MED, V109, P712, DOI 10.1016/S0002-9343(00)00617-3; Perry VH, 2003, NAT REV NEUROSCI, V4, P103, DOI 10.1038/nrn1032; Popovich PG, 2001, J NEUROTRAUM, V18, P957, DOI 10.1089/089771501750451866; Popovich PG, 2008, NAT REV NEUROSCI, V9, P481, DOI 10.1038/nrn2398; Prochazka M, 1971, Int Surg, V55, P322; Qiao F, 2006, AM J PATHOL, V169, P1039, DOI 10.2353/ajpath.2006.060248; Rite I, 2007, J NEUROCHEM, V101, P1567, DOI 10.1111/j.1471-4159.2007.04567.x; Sewell DL, 2004, J NEUROIMMUNOL, V155, P55, DOI 10.1016/j.jneuroim.2004.06.003; Shoenfeld Y, 2007, ANN NY ACAD SCI, V1108, P227, DOI 10.1196/annals.1422.025; SINGH VK, 1993, BRAIN BEHAV IMMUN, V7, P97, DOI 10.1006/brbi.1993.1010; Singh VK, 1997, PEDIATR NEUROL, V17, P88, DOI 10.1016/S0887-8994(97)00045-3; Skoda D, 2006, BRAIN RES BULL, V68, P213, DOI 10.1016/j.brainresbull.2005.05.032; Stagg CJ, 2010, EPILEPSIA, V51, P1898, DOI 10.1111/j.1528-1167.2010.02644.x; Tanne D, 1998, STROKE, V29, P1755, DOI 10.1161/01.STR.29.9.1755; Teeling JL, 2009, NEUROSCIENCE, V158, P1062, DOI 10.1016/j.neuroscience.2008.07.031; Ten VS, 2010, J NEUROSCI, V30, P2077, DOI 10.1523/JNEUROSCI.5249-09.2010; Trivedi A, 2006, CLIN NEUROSCI RES, V6, P283, DOI 10.1016/j.cnr.2006.09.007; Urbanus RT, 2009, LANCET NEUROL, V8, P998, DOI 10.1016/S1474-4422(09)70239-X; Vaccari JPDR, 2008, J NEUROSCI, V28, P3404, DOI 10.1523/JNEUROSCI.0157-08.2008; Vargas ME, 2010, P NATL ACAD SCI USA, V107, P11993, DOI 10.1073/pnas.1001948107; Warrington AE, 2010, J CLIN IMMUNOL, V30, pS50, DOI 10.1007/s10875-010-9406-5; Watzlawik J, 2010, GLIA, V58, P1782, DOI 10.1002/glia.21048; Wilhelm KR, 2007, EUR J NEUROL, V14, P327, DOI 10.1111/j.1468-1331.2006.01667.x; Wright BR, 2009, ARCH NEUROL-CHICAGO, V66, P1456, DOI 10.1001/archneurol.2009.262; Zappia M, 2002, ACTA NEUROL SCAND, V106, P54, DOI 10.1034/j.1600-0404.2002.01240.x; Zhang M, 2004, P NATL ACAD SCI USA, V101, P3886, DOI 10.1073/pnas.0400347101	74	18	18	0	1	DISCOVERY MEDICINE	TIMONIUM	10 GERARD AVE, STE 201, TIMONIUM, MD 21093 USA	1539-6509	1944-7930		DISCOV MED	Discov. Med.	MAY	2011	11	60					395	402					8	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	V27VA	WOS:000208639500002	21616038				2022-02-06	
J	Oliva, AA; Kang, Y; Truettner, JS; Sanchez-Molano, J; Furones, C; Yool, AJ; Atkins, CM				Oliva, A. A., Jr.; Kang, Y.; Truettner, J. S.; Sanchez-Molano, J.; Furones, C.; Yool, A. J.; Atkins, C. M.			FLUID-PERCUSSION BRAIN INJURY INDUCES CHANGES IN AQUAPORIN CHANNEL EXPRESSION	NEUROSCIENCE			English	Article						aquaporin; edema; fluid-percussion; traumatic brain injury; water channel	AQP4 EXPRESSION; WATER TRANSPORT; RAT-BRAIN; EDEMA; LACTATE; HOMEOSTASIS; ASTROCYTE; TRAUMA; CELLS; MODEL	Edema, the accumulation of excess fluid, is a major pathological change in the brain that contributes significantly to pathology and mortality after moderate to severe brain injury. Edema is regulated by aquaporin (AQP) channels which transport water across cellular membranes. Six AQPs are found in the brain (1, 3, 4, 5, 8, and 9), and previous studies have found that AQP4 is regulated after traumatic brain injury (TBI). To further understand how AQPs contribute to brain edema, we investigated whether expression of AQP1, 3, and 9 are also regulated after TBI. Adult male Sprague Dawley rats received moderate parasagittal fluid-percussion brain injury (FPI) or sham surgery. After induction of FPI, the injured, ipsilateral parietal cortex and hippocampus were dissected and analyzed by Western blotting. We observed a small decrease in AQP3 and 4 levels at 7 days after FPI in the ipsilateral, parietal cortex. Both AQP1 and 9 significantly increased within 30 min post-injury and remained elevated for up to 6 h in the ipsilateral, parietal cortex. Aqp1 and 9 mRNA levels were also significantly increased at 30 min post-FPI. Administration of an AQP1 and 4 antagonist, AqB013, non-significantly increased brain water content in sham, non-injured animals, and did not prevent edema formation 24 h after trauma in either the parietal cortex or hippocampus. These results indicate that Aqp1 and 9 mRNA and protein levels increase after moderate parasagittal FPI and that an inhibitor of AQP1 and 4 does not decrease edema after moderate parasagittal FPI. (c) 2011 IBRO. Published by Elsevier Ltd. All rights reserved.	[Atkins, C. M.] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Dept Neurol Surg, Miami, FL 33136 USA; [Yool, A. J.] Univ Adelaide, Sch Mol & Biomed Sci, Discipline Physiol, Adelaide, SA, Australia		Atkins, CM (corresponding author), Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Dept Neurol Surg, POB 016960 R-48, Miami, FL 33136 USA.	catkins@med.miami.edu	Yool, Andrea/AAK-9907-2020	Yool, Andrea/0000-0003-1283-585X; Atkins, Coleen/0000-0003-4718-7493	The Miami Project to Cure Paralysis; The Buoniconti Fund to Cure Paralysis; the Channel 7 Children's Research Foundation, Australia	This work was supported by The Miami Project to Cure Paralysis, The Buoniconti Fund to Cure Paralysis, and the Channel 7 Children's Research Foundation, Australia. We thank Dr. C. Falo for scientific input, Dr. G. Flynn for providing AqB013, and Drs. Helen Bramlett and Michael Norenberg for critical reading of the manuscript.	Agre P, 2004, NEUROSCIENCE, V129, P849, DOI 10.1016/j.neuroscience.2004.10.001; Arima H, 2003, J BIOL CHEM, V278, P44525, DOI 10.1074/jbc.M304368200; Badaut J, 2004, NEUROSCIENCE, V129, P971, DOI 10.1016/j.neuroscience.2004.06.035; Badaut J, 2004, NEUROSCIENCE, V128, P27, DOI 10.1016/j.neuroscience.2004.05.042; Badaut J, 2001, J CEREBR BLOOD F MET, V21, P477, DOI 10.1097/00004647-200105000-00001; Chen T, 2000, ACT NEUR S, V76, P359; D'Ambrosio R, 1999, J NEUROSCI, V19, P8152; Ding JY, 2009, NEUROSCI LETT, V453, P68, DOI 10.1016/j.neulet.2009.01.077; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Elkjaer ML, 2000, BIOCHEM BIOPH RES CO, V276, P1118, DOI 10.1006/bbrc.2000.3505; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Hwang IK, 2007, J NEUROSCI RES, V85, P2470, DOI 10.1002/jnr.21381; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; Ke CS, 2001, NEUROSCI LETT, V301, P21, DOI 10.1016/S0304-3940(01)01589-0; Kiening KL, 2002, NEUROSCI LETT, V324, P105, DOI 10.1016/S0304-3940(02)00180-5; Kim SW, 2001, J AM SOC NEPHROL, V12, P2019, DOI 10.1681/ASN.V12102019; Lescot T, 2010, J NEUROTRAUM, V27, P85, DOI 10.1089/neu.2009.0982; Levasseur JE, 2006, NEUROSURGERY, V59, P1122, DOI 10.1227/01.NEU.0000245581.00908.AF; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Manley GT, 2004, NEUROSCIENCE, V129, P983, DOI 10.1016/j.neuroscience.2004.06.088; Marcoux J, 2008, CRIT CARE MED, V36, P2871, DOI 10.1097/CCM.0b013e318186a4a0; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; Matsuzaki T, 1999, J HISTOCHEM CYTOCHEM, V47, P1275, DOI 10.1177/002215549904701007; Migliati E, 2009, MOL PHARMACOL, V76, P105, DOI 10.1124/mol.108.053744; Misawa T, 2008, ACTA NEUROPATHOL, V116, P247, DOI 10.1007/s00401-008-0387-x; Nesic O, 2008, J NEUROCHEM, V105, P628, DOI 10.1111/j.1471-4159.2007.05177.x; Newcombe VFJ, 2008, ACTA NEUROCHIR SUPPL, V102, P247, DOI 10.1007/978-3-211-85578-2_47; Nielsen S, 1997, J NEUROSCI, V17, P171; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Park E, 2009, J CEREBR BLOOD F MET, V29, P575, DOI 10.1038/jcbfm.2008.151; Pasco A, 2007, J NEUROTRAUM, V24, P1321, DOI 10.1089/neu.2006.0136; Rash JE, 1998, P NATL ACAD SCI USA, V95, P11981, DOI 10.1073/pnas.95.20.11981; Rojek AM, 2007, P NATL ACAD SCI USA, V104, P3609, DOI 10.1073/pnas.0610894104; Roudier N, 1998, J BIOL CHEM, V273, P8407, DOI 10.1074/jbc.273.14.8407; Speake T, 2003, BBA-BIOMEMBRANES, V1609, P80, DOI 10.1016/S0005-2736(02)00658-2; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Sun MC, 2003, J NEUROSURG, V98, P565, DOI 10.3171/jns.2003.98.3.0565; Taya K, 2008, ACTA NEUROCHIR SUPPL, V102, P425, DOI 10.1007/978-3-211-85578-2_83; Tomura S, 2011, J NEUROTRAUM, V28, P237, DOI 10.1089/neu.2010.1443; Tran ND, 2010, J NEUROSURG, V112, P1095, DOI 10.3171/2009.8.JNS081704; Umenishi F, 2003, J BIOL CHEM, V278, P15765, DOI 10.1074/jbc.M209980200; Venero JL, 2001, PROG NEUROBIOL, V63, P321, DOI 10.1016/S0301-0082(00)00035-6; Verkman AS, 2006, BBA-BIOMEMBRANES, V1758, P1085, DOI 10.1016/j.bbamem.2006.02.018; Wilson AJ, 2010, CELL TISSUE RES, V340, P159, DOI 10.1007/s00441-010-0927-2; Zhang GW, 2010, J ETHNOPHARMACOL, V128, P433, DOI 10.1016/j.jep.2010.01.032; Zhao J, 2005, J NEUROSCI RES, V82, P499, DOI 10.1002/jnr.20649; Zhou SN, 2008, NEUROL RES, V30, P400, DOI 10.1179/174313208X300431	50	18	18	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	APR 28	2011	180						272	279		10.1016/j.neuroscience.2011.02.020			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	748MV	WOS:000289395600028	21329742				2022-02-06	
J	Fahlenkamp, AV; Coburn, M; Czaplik, M; Ryang, YM; Kipp, M; Rossaint, R; Beyer, C				Fahlenkamp, Astrid V.; Coburn, Mark; Czaplik, Michael; Ryang, Yu-Mi; Kipp, Markus; Rossaint, Rolf; Beyer, Cordian			Expression analysis of the early chemokine response 4 h after in vitro traumatic brain injury	INFLAMMATION RESEARCH			English	Article						Brain trauma; Neuroinflammation; Cytokines; Chemokines; Array	ENDOTHELIAL-CELLS; SLICE CULTURES; RAT; PATHOPHYSIOLOGY; CYTOKINES; MCP-1; MODEL	The importance of cytokine- and chemokine-mediated neuroinflammation in the progress of brain injury is becoming increasingly evident. We investigated the early local cytokine and chemokine expression and the development of tissue injury after moderate mechanical hippocampus trauma. Mouse organotypic hippocampal slice cultures. Drop-weight trauma in the CA1 region of the hippocampus. Staining of necrotic tissue, PCR array and evaluation, real-time PCR, statistical analysis with a two-tailed, independent t test. At 12 and 24 h after trauma, the tissue injury spread from the primary mechanical lesion to the entire hippocampal formation. A pronounced up-regulation of distinct chemokine transcripts was found 4 h after in vitro traumatic brain injury which preceded the development of the secondary injury. The enhanced expression of inflammatory genes might contribute to the development of the secondary trauma and could pinpoint future neuroinflammatory and neuroprotective targets for research and treatment.	[Fahlenkamp, Astrid V.; Coburn, Mark; Czaplik, Michael; Rossaint, Rolf] Rhein Westfal TH Aachen, Univ Hosp Aachen, Dept Anesthesiol, D-52074 Aachen, Germany; [Fahlenkamp, Astrid V.; Kipp, Markus; Beyer, Cordian] Rhein Westfal TH Aachen, Fac Med, Inst Neuroanat, D-52074 Aachen, Germany; [Ryang, Yu-Mi] Tech Univ Munich, Dept Neurosurg, Klinikum Rechts Isar, D-81675 Munich, Germany		Coburn, M (corresponding author), Rhein Westfal TH Aachen, Univ Hosp Aachen, Dept Anesthesiol, Pauwelsstr 30, D-52074 Aachen, Germany.	mcoburn@ukaachen.de	Ryang, Yu-Mi/Q-8373-2016; Czaplik, Michael/G-1120-2012; Kipp, Markus/K-2694-2015	Ryang, Yu-Mi/0000-0002-9045-5038; Coburn, Mark/0000-0002-7930-0270	AVF (Forschungsrotation); AVF (START)Austrian Science Fund (FWF)	We would like to thank J. Hoffmann and R. Blaumeiser-Debarry for their excellent technical assistance. The study was supported by two grants allocated to AVF (Forschungsrotation and START, both RWTH Aachen University) and two grants allocated to MK (Hertie-Stiftung; START, RWTH Aachen University).	Adamchik Y, 2000, BRAIN RES PROTOC, V5, P153, DOI 10.1016/S1385-299X(00)00007-6; [Anonymous], IMAGEJ IMAGE PROCESS; Babcock AA, 2003, J NEUROSCI, V23, P7922; Coburn M, 2008, CRIT CARE MED, V36, P588, DOI 10.1097/01.CCM.0B013E3181611F8A6; Cross AK, 1999, J NEUROSCI RES, V55, P17, DOI 10.1002/(SICI)1097-4547(19990101)55:1<17::AID-JNR3>3.0.CO;2-J; Di Pietro V, 2010, J NEUROTRAUM, V27, P349, DOI 10.1089/neu.2009.1095; Fahlenkamp AV, 2011, J MOL NEUROSCI, V45, P48, DOI 10.1007/s12031-010-9432-z; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Ghirnikar RS, 1996, J NEUROSCI RES, V46, P727; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Israelsson C, 2010, EUR J NEUROSCI, V31, P852, DOI 10.1111/j.1460-9568.2010.07105.x; Loetscher PD, 2009, CRIT CARE, V13, DOI 10.1186/cc8214; Lumpkins K, 2008, J TRAUMA, V64, P358, DOI 10.1097/TA.0b013e318160df9b; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Morrison B, 2000, NEUROSCIENCE, V96, P131, DOI 10.1016/S0306-4522(99)00537-0; Omari KM, 2004, J NEUROIMMUNOL, V146, P203, DOI 10.1016/j.jneuroim.2003.10.032; Rhodes JKJ, 2009, J NEUROTRAUM, V26, P507, DOI 10.1089/neu.2008.0686; Rossaint J, 2009, CRIT CARE, V13, DOI 10.1186/cc7795; *SABIOSCIENCES, SABIOSCIENCES WEB BA; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Stefini R, 2008, J NEUROSURG, V108, P958, DOI 10.3171/JNS/2008/108/5/0958; Szczucinski A, 2007, EUR NEUROL, V58, P228, DOI 10.1159/000107945; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Woller G, 2008, J LEUKOCYTE BIOL, V83, P936, DOI 10.1189/jlb.0907592; Yates CC, 2008, AM J PATHOL, V173, P643, DOI 10.2353/ajpath.2008.070990; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	27	18	18	0	4	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1023-3830			INFLAMM RES	Inflamm. Res.	APR	2011	60	4					379	387		10.1007/s00011-010-0281-6			9	Cell Biology; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Immunology	735XZ	WOS:000288455400009	21104293				2022-02-06	
J	Mandalari, G; Genovese, T; Bisignano, C; Mazzon, E; Wickham, MSJ; Di Paola, R; Bisignano, G; Cuzzocrea, S				Mandalari, G.; Genovese, T.; Bisignano, C.; Mazzon, E.; Wickham, M. S. J.; Di Paola, R.; Bisignano, G.; Cuzzocrea, S.			Neuroprotective effects of almond skins in experimental spinal cord injury	CLINICAL NUTRITION			English	Article						Almond skins; Trauma; Inflammation; Oxidative stress; Apoptosis	NITRIC-OXIDE SYNTHASE; NF-KAPPA-B; IMPROVES FUNCTIONAL RECOVERY; TRAUMATIC BRAIN-INJURY; NECROSIS-FACTOR-ALPHA; CELL-DEATH; GENE-EXPRESSION; ACTIVATION; DECOMPRESSION; MODULATION	Background & Aims: Functional deficits following spinal cord injury (SCI) arise from both mechanical injury and from secondary tissue reactions involving inflammation. Natural almond skins (NS) were tested to evaluate anti-inflammatory effects on an animal model of SO. Methods: SCI was induced by the application of vascular clips to the dura via a four-level T5-T8 laminectomy. In the present study, to elucidate whether the protective effects of NS are related to the total phenolic content, we also investigated the effect of a blanched (BS) almond skins (industrially obtained by removing bran from the nut) in SCI. NS and BS (30 mg/kg respectively) were administered per os, 1 h and 6 h, after SCI. Results: SCI in mice resulted in severe injury characterized by edema, tissue damage, production of inflammatory mediators and apoptosis (measured by Bax, Bcl-2 and Tunel assay). NS treatment, 1 and 6 h after SCI, reduced all parameters of inflammation as neutrophil infiltration, NF-kappa B activation, PAR formation, iNOS expression and apoptosis. However, treatment with BS did not exert any protective effect. Conclusions: Our results suggest that NS treatment, reducing the development of inflammation and tissue injury, may be useful in the treatment of SCI. (C) 2010 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.	[Genovese, T.; Mazzon, E.; Di Paola, R.; Cuzzocrea, S.] Univ Messina, Sch Med, Dept Clin & Expt Med & Pharmacol, I-98100 Messina, Italy; [Mandalari, G.; Bisignano, C.; Bisignano, G.] Univ Messina, Pharmacobiol Dept, I-98100 Messina, Italy; [Mandalari, G.; Wickham, M. S. J.] Inst Food Res, Norwich NR4 7UA, Norfolk, England; [Cuzzocrea, S.] IRCCS Ctr Neurolesi Bonino Pulejo, Messina, Italy		Cuzzocrea, S (corresponding author), Univ Messina, Sch Med, Dept Clin & Expt Med & Pharmacol, Policlin Univ Via C Valeria, I-98100 Messina, Italy.	salvator@unime.it	Mazzon, Emanuela/AAL-4334-2020; di paola, rosanna/U-4356-2019	di paola, rosanna/0000-0001-6725-8581; Bisignano, Giuseppe/0000-0002-9201-7867; GENOVESE, Tiziana/0000-0002-3335-7327; mazzon, emanuela/0000-0002-5073-717X	IRCCS Centro Neurolesi "Bonino-Pulejo", Messina, Italy	This study was supported by a grant from IRCCS Centro Neurolesi "Bonino-Pulejo", Messina, Italy (SC). We thank Carmelo La Spada for excellent technical assistance during this study, Caterina Cutrona for secretarial assistance and Valentina Malvagni for editorial assistance with the paper. Natural almond and blanched almond skins were supplied by the Almond Board California.	Adler JE, 2009, PAIN MED, V10, P1229, DOI 10.1111/j.1526-4637.2009.00708.x; Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; ANDERSON DK, 1993, ANN EMERG MED, V22, P987, DOI 10.1016/S0196-0644(05)82739-8; Balasundram N, 2006, FOOD CHEM, V99, P191, DOI 10.1016/j.foodchem.2005.07.042; Bao F, 2006, NEUROSCIENCE, V140, P1011, DOI 10.1016/j.neuroscience.2006.02.061; Bao F, 2003, J NEUROSCI RES, V71, P220, DOI 10.1002/jnr.10481; Beattie MS, 2002, PROG BRAIN RES, V137, P37; Beni SM, 2004, FASEB J, V18, P149, DOI 10.1096/fj.03-0323fje; Bethea JR, 1999, J NEUROTRAUM, V16, P851, DOI 10.1089/neu.1999.16.851; Bethea JR, 1998, J NEUROSCI, V18, P3251; Brambilla R, 2005, J EXP MED, V202, P145, DOI 10.1084/jem.20041918; Chen JF, 2007, PROG NEUROBIOL, V83, P310, DOI 10.1016/j.pneurobio.2007.09.002; CHITTENDEN T, 1995, NATURE, V374, P733, DOI 10.1038/374733a0; Cuzzocrea S, 2006, J PHARMACOL EXP THER, V319, P127, DOI 10.1124/jpet.106.108076; DOLAN EJ, 1980, J NEUROSURG, V53, P749, DOI 10.3171/jns.1980.53.6.0749; Genovese T, 2005, J PINEAL RES, V38, P198, DOI 10.1111/j.1600-079X.2004.00194.x; Genovese T, 2006, J NEUROSURG-SPINE, V4, P145, DOI 10.3171/spi.2006.4.2.145; Genovese T, 2008, BENEFICIAL EFFECTS E; Greenacre SAB, 2001, FREE RADICAL RES, V34, P541, DOI 10.1080/10715760100300471; GUHA A, 1987, PARAPLEGIA, V25, P324, DOI 10.1038/sc.1987.61; Hamada Y, 1996, FREE RADICAL BIO MED, V20, P1, DOI 10.1016/0891-5849(95)02017-9; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P446, DOI 10.1016/0003-9861(92)90433-W; Kasahara K, 2006, SPINE, V31, P2059, DOI 10.1097/01.brs.0000231893.21964.f2; Knekt P, 2002, AM J CLIN NUTR, V76, P560, DOI 10.1093/ajcn/76.3.560; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; La Rosa G, 2004, J NEUROSURG-SPINE, V1, P311, DOI 10.3171/spi.2004.1.3.0311; Lee DY, 2006, BIOCHEM BIOPH RES CO, V346, P727, DOI 10.1016/j.bbrc.2006.05.174; Lipton SA, 1997, NAT MED, V3, P20, DOI 10.1038/nm0197-20; Liu CL, 2002, CHINESE MED J-PEKING, V115, P740; Liu DX, 2005, J NEUROTRAUM, V22, P1123, DOI 10.1089/neu.2005.22.1123; Liu RH, 2004, J NUTR, V134, p3479S, DOI 10.1093/jn/134.12.3479S; Mandalari G, 2010, FOOD CHEM, V122, P1083, DOI 10.1016/j.foodchem.2010.03.079; Mandalari G, 2010, J FOOD COMPOS ANAL, V23, P166, DOI 10.1016/j.jfca.2009.08.015; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; Milbury PE, 2006, J AGR FOOD CHEM, V54, P5027, DOI 10.1021/jf0603937; Mir M, 2008, J NEUROIMMUNOL, V204, P101, DOI 10.1016/j.jneuroim.2008.07.002; Mullane K, 1989, Prog Clin Biol Res, V301, P39; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; ONeill LAJ, 1997, TRENDS NEUROSCI, V20, P252, DOI 10.1016/S0166-2236(96)01035-1; Park E, 2004, J NEUROTRAUM, V21, P754, DOI 10.1089/0897715041269641; Pellegrini M, 1999, J CLIN IMMUNOL, V19, P365, DOI 10.1023/A:1020598632068; Pieper AA, 1999, TRENDS PHARMACOL SCI, V20, P171, DOI 10.1016/S0165-6147(99)01292-4; Pizzi M, 2002, J BIOL CHEM, V277, P20717, DOI 10.1074/jbc.M201014200; Qiu JX, 2004, J NEUROSCI RES, V77, P108, DOI 10.1002/jnr.20156; Reiter RJ, 2007, J PHYSIOL PHARMACOL, V58, P5; Salvemini D, 1998, DRUG NEWS PERSPECT, V11, P204; Samdani AF, 1997, STROKE, V28, P1283, DOI 10.1161/01.STR.28.6.1283; Scott GS, 1999, ANN NEUROL, V45, P120, DOI 10.1002/1531-8249(199901)45:1<120::AID-ART18>3.0.CO;2-I; Shackelford DA, 2003, MOL BRAIN RES, V115, P173, DOI 10.1016/S0169-328X(03)00206-7; Shiva S, 2004, BIOCHEM SOC SYMP, V71, P107; TATOR CH, 1995, BRAIN PATHOL, V5, P407, DOI 10.1111/j.1750-3639.1995.tb00619.x; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Turker M, 2005, ARCH ORTHOP TRAUM SU, V125, P336, DOI 10.1007/s00402-005-0816-4; Verma IM, 2004, ANN RHEUM DIS, V63, P57, DOI 10.1136/ard.2004.028266; Wada K, 1999, J NEUROTRAUM, V16, P203, DOI 10.1089/neu.1999.16.203; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; White FA, 1998, J NEUROSCI, V18, P1428; Winkler T, 2002, AMINO ACIDS, V23, P273, DOI 10.1007/s00726-001-0138-y; Wu KL, 2009, J NEUROTRAUMA; Xu J, 2001, J NEUROTRAUM, V18, P523, DOI 10.1089/089771501300227323; Zhao XR, 2001, J NEUROSCI RES, V64, P121, DOI 10.1002/jnr.1059	61	18	19	0	8	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0261-5614	1532-1983		CLIN NUTR	Clin. Nutr.	APR	2011	30	2					221	233		10.1016/j.clnu.2010.08.002			13	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	756KJ	WOS:000290009800014	20864228				2022-02-06	
J	Ouckama, R; Pearsall, DJ				Ouckama, Ryan; Pearsall, David J.			Evaluation of a flexible force sensor for measurement of helmet foam impact performance	JOURNAL OF BIOMECHANICS			English	Article						Impact biomechanics; Head injury; Helmets; Concussion; Material testing	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; INTRACRANIAL-PRESSURE; ACCELERATION; EPIDEMIOLOGY; BIOMECHANICS; CONCUSSION; FOOTBALL; CRITERIA	The association between translational head acceleration and concussion remains unclear and provides a weak predictive measure for this type of injury; thus, alternative methods of helmet evaluation are warranted. Recent finite element analysis studies suggest that better estimates of concussion risk can be obtained when regional parameters of the cranium, brain and surrounding tissues are included. Lacking, however, are empirical data at the head-helmet interface with regards to contact area and force. Hence, the purpose of this study was to evaluate a system to capture the impact force distribution of helmet foams. Thirteen Flexiforce (R) sensors were arranged in a 5 x 5 cm array, secured to a load cell. Three densities of foam were repeatedly impacted with 5J of energy during ambient (20 degrees C) and cold (-25 degrees C) conditions. RMS error, calculated relative to the global force registered by the load cell, was < 1.5% of the measurement range during individual calibration of the Flexiforce (R) sensors. RMS error was 5% of the measured range for the global force estimated by the sensor array. Load distribution measurement revealed significant differences between repeated impacts of cold temperature foams for which acceleration results were non-significant. The sensor array, covering only 36% of the total area, possessed sufficient spatial and temporal resolution to capture dynamic load distribution patterns. Implementation of this force mapping system is not limited to helmet testing. Indeed it may be adopted to assess other body regions vulnerable to contact injuries (e.g., chest, hip and shin protectors). (c) 2010 Elsevier Ltd. All rights reserved.	[Ouckama, Ryan; Pearsall, David J.] McGill Univ, Dept Kinesiol & Phys Educ, Ice Hockey Res Grp IHRG, Montreal, PQ H2W 1S4, Canada		Ouckama, R (corresponding author), McGill Univ, Dept Kinesiol & Phys Educ, Ice Hockey Res Grp IHRG, 475 Pine Ave W, Montreal, PQ H2W 1S4, Canada.	ryan.ouckama@mail.mcgill.ca	Pearsall, David/C-9353-2014	Pearsall, David/0000-0002-4382-3504	Natural Sciences and Engineering Research Council of Canada (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC); Le Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT)FQRNT; Bauer Hockey Corporation in St-Jerome, Quebec	This study was supported by the Industrial Innovation Scholarship from the Natural Sciences and Engineering Research Council of Canada (NSERC), Le Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT) and the Bauer Hockey Corporation in St-Jerome, Quebec.	[Anonymous], 2007, F104507 ASTM; [Anonymous], 2009, Z262109 CSA; Bishop PJ, 1993, SAFETY ICE HOCKEY, P175; Bland JM, 2010, INT J NURS STUD, V47, P931, DOI 10.1016/j.ijnurstu.2009.10.001; Cui L, 2009, MATER DESIGN, V30, P3414, DOI 10.1016/j.matdes.2009.03.044; Faul M, 2010, TRAUMATIC BRAIN INJU; FORERO R, 2009, OPTIMISATION ENERG 1; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; GURDJIAN ES, 1966, J TRAUM, V6, P600, DOI 10.1097/00005373-196609000-00005; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Hootman JM, 2007, J ATHL TRAINING, V42, P311; ISO, 2003, 10256 ISO; King AI, 2000, ANNU REV BIOMED ENG, V2, P55, DOI 10.1146/annurev.bioeng.2.1.55; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; Mueller FO, 1998, CLIN SPORT MED, V17, P169, DOI 10.1016/S0278-5919(05)70071-5; TEKSCAN I, 2009, FLEXIFORCE SENSOR US; Tommasone BA, 2006, J ATHL TRAINING, V41, P470; Viano DC, 2005, NEUROSURGERY, V56, P266, DOI 10.1227/01.neu.0000150035.54230.3C; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749	23	18	18	0	35	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290			J BIOMECH	J. Biomech.	MAR 15	2011	44	5					904	909		10.1016/j.jbiomech.2010.11.035			6	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	742FD	WOS:000288925800018	21194694				2022-02-06	
J	Zhang, BL; Chen, X; Tan, T; Yang, Z; Carlos, D; Jiang, RC; Zhang, JN				Zhang Bao-liang; Chen Xin; Tan Tao; Yang Zhuo; Carlos, Dayao; Jiang Rong-cai; Zhang Jian-ning			Traumatic brain injury impairs synaptic plasticity in hippocampus in rats	CHINESE MEDICAL JOURNAL			English	Article						traumatic brain injury; long-term potentiation; hippocampus; dentate gyrus; cornu ammonis 3 area	SPATIAL MEMORY; DENTATE GYRUS; DEFICITS	Background Traumatic brain injury (TBI) often causes cognitive deficits and remote symptomatic epilepsy. Hippocampal regional excitability is associated with the cognitive function. However, little is known about injury-induced neuronal loss and subsequent alterations of hippocampal regional excitability. The present study was designed to determine whether TBI may impair the cellular circuit in the hippocampus. Methods Forty male Wistar rats were randomized into control (n=20) and TBI groups (n=20). Long-term potentiation, extracellular input/output curves, and hippocampal parvalbumin-immunoreactive and cholecystokinin-immunoreactive interneurons were compared between the two groups. Results TBI resulted in a significantly increased excitability in the dentate gyrus (DG), but a significantly decreased excitability in the cornu ammonis 1 (CA1) area. Using design-based stereological injury procedures, we induced interneuronal loss in the DG and CA3 subregions in the hippocampus, but not in the CA1 area. Conclusions TBI leads to the impairment of hippocampus synaptic plasticity due to the changing of interneuronal interaction. The injury-induced disruption of synaptic efficacy within the hippocampal circuit may underlie the observed cognitive deficits and symptomatic epilepsy. Chin Med J 2011;124(5):740-745	[Zhang Bao-liang; Chen Xin; Carlos, Dayao; Jiang Rong-cai; Zhang Jian-ning] Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin 300052, Peoples R China; [Zhang Bao-liang; Chen Xin; Carlos, Dayao; Jiang Rong-cai; Zhang Jian-ning] Tianjin Neurol Inst, Tianjin 300052, Peoples R China; [Zhang Bao-liang; Chen Xin; Carlos, Dayao; Jiang Rong-cai; Zhang Jian-ning] Minist Educ, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Tianjin 300052, Peoples R China; [Zhang Bao-liang; Chen Xin; Carlos, Dayao; Jiang Rong-cai; Zhang Jian-ning] Tianjin Key Lab Injuries Variat & Regenerat Nervo, Tianjin 300052, Peoples R China; [Tan Tao] Tianjin Med Univ, Sch Biomed Engn, Tianjin 300070, Peoples R China; [Yang Zhuo] Nankai Univ, Sch Med, Tianjin 300071, Peoples R China		Zhang, JN (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin 300052, Peoples R China.	jianningzhang@hotmail.com	Tan, Tao/F-5535-2010	Tan, Tao/0000-0002-4571-3296	National "973 Projects" of ChinaNational Basic Research Program of China [2005CB522605]; Tianjin Science and Technology Development Plan [05YFGDSF02500]; Tianjin Natural Science FoundationNatural Science Foundation of Tianjin [033611511]	This work was supported by grants from the National "973 Projects" of China (No. 2005CB522605), Tianjin Science and Technology Development Plan (No. 05YFGDSF02500) and Tianjin Natural Science Foundation (No. 033611511).	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Altinbilek B, 2007, EUR J NEUROSCI, V26, P1166, DOI 10.1111/j.1460-9568.2007.05742.x; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Coulter DA, 1996, EPILEPSY RES, V26, P81, DOI 10.1016/S0920-1211(96)00044-7; DASH PK, 1995, J NEUROSCI, V15, P2030, DOI 10.1523/JNEUROSCI.15-03-02030.1995; FREUND TF, 1996, HIPPOCAMPUS, V6, P345; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; HALASY K, 1993, EUR J NEUROSCI, V5, P411, DOI 10.1111/j.1460-9568.1993.tb00508.x; HAN ZS, 1993, EUR J NEUROSCI, V5, P395, DOI 10.1111/j.1460-9568.1993.tb00507.x; LAURER HL, 2002, ENCY HUMAN BRAIN, P93; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; RINK A, 1995, AM J PATHOL, V147, P1575; SMITH KR, 1994, ARCH NEUROL-CHICAGO, V51, P653, DOI 10.1001/archneur.1994.00540190029012; Su ZJ, 2009, J NEUROTRAUM, V26, P1695, DOI 10.1089/neu.2008.0519; Toth Z, 1997, J NEUROSCI, V17, P8106; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052	18	18	18	0	10	CHINESE MEDICAL ASSOC	BEIJING	42 DONGSI XIDAJIE, BEIJING 100710, PEOPLES R CHINA	0366-6999			CHINESE MED J-PEKING	Chin. Med. J.	MAR 5	2011	124	5					740	745		10.3760/cma.j.issn.0366-6999.2011.05.020			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	743TC	WOS:000289040600020	21518569				2022-02-06	
J	Armstead, WM; Kiessling, JW; Cines, DB; Higazi, AA				Armstead, William M.; Kiessling, J. Willis; Cines, Douglas B.; Higazi, Abd Al-Roof			Glucagon Protects Against Impaired NMDA-Mediated Cerebrovasodilation and Cerebral Autoregulation during Hypotension after Brain Injury by Activating cAMP Protein Kinase A and Inhibiting Upregulation of tPA	JOURNAL OF NEUROTRAUMA			English	Article						autoregulation; cerebral circulation; glucagon; NMDA; signal transduction; tPA; traumatic brain injury	TISSUE-PLASMINOGEN ACTIVATOR; CEREBROSPINAL-FLUID; BLOOD-FLOW; HEMODYNAMICS; MODULATION; RECEPTOR; INSULIN	Outcome of traumatic brain injury (TBI) is impaired by hyperglycemia, hypotension, and glutamate, and improved by insulin. Insulin reduces glutamate concentration, making it uncertain whether its beneficial effect accrues from euglycemia. Glucagon decreases CNS glutamate, lessens neuronal cell injury, and improves neurological scores in mice after TBI. In vitro, glucagon limits NMDA-mediated excitotoxicity by increasing cAMP and protein kinase A (PKA). NMDA receptor activation couples cerebral blood flow (CBF) to metabolism. Dilation induced by NMDA is impaired after fluid percussion brain injury (FPI) due to upregulation of endogenous tPA, which further disturbs cerebral autoregulation during hypotension after fluid percussion injury (FPI). We hypothesized that glucagon prevents impaired NMDA receptor-mediated dilation after FPI by upregulating cAMP, which decreases release of tPA. NMDA-induced pial artery dilation (PAD) was reversed to vasoconstriction after FPI. Glucagon 30 min before or 30 min after FPI blocked NMDA-mediated vasoconstriction and restored the response to vasodilation. PAD during hypotension was blunted after FPI, but protected by glucagon. Glucagon prevented FPI-induced reductions in CSF cAMP, yielding a net increase in cAMP, and blocked FPI-induced elevation of CSF tPA. Co-administration of the PKA antagonist Rp 8Br cAMPs prevented glucagon-mediated preservation of NMDA-mediated dilation after FPI. The pKA agonist Sp 8Br cAMPs prevented impairment of NMDA-induced dilation. These data indicate that glucagon protects against impaired cerebrovasodilation by upregulating cAMP, which decreases release of tPA, suggesting that it may provide neuroprotection when given after TBI, or prior to certain neurosurgical or cardiac interventions in which the incidence of perioperative ischemia is high.	[Armstead, William M.; Kiessling, J. Willis] Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Armstead, William M.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; [Cines, Douglas B.; Higazi, Abd Al-Roof] Univ Penn, Dept Pathol, Philadelphia, PA 19104 USA; [Higazi, Abd Al-Roof] Hadassah Univ Hosp, Dept Clin Biochem, IL-91120 Jerusalem, Israel; [Higazi, Abd Al-Roof] Hebrew Univ Jerusalem, Hadassah Med Sch, IL-91010 Jerusalem, Israel		Armstead, WM (corresponding author), Univ Penn, Dept Anesthesiol & Crit Care, 3620 Hamilton Walk,JM3, Philadelphia, PA 19104 USA.	armsteaw@uphs.upenn.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS53410, HD57355, HL76406, CA83121, HL76206, HL07971, HL81864, HL77760, HL82545]; University of Pennsylvania Institute for Translational Medicine and Therapeutics; Israeli Science FoundationIsrael Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD057355] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA083121] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [P01HL076406, T32HL007971, R21HL081864, R01HL076206, R01HL077760] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS053410] Funding Source: NIH RePORTER	This research was supported by grants from the National Institutes of Health (NS53410 and HD57355 to W. M. A.; HL76406, CA83121, HL76206, HL07971, and HL81864 to D. B. C.; and HL77760 and HL82545 to A. A. R. H.), the University of Pennsylvania Institute for Translational Medicine and Therapeutics (to D. B. C.), and the Israeli Science Foundation (to A.A.R.H.).	Armstead WM, 2011, NEUROL RES, V33, P726, DOI 10.1179/016164110X12807570509853; Armstead WM, 2009, J CEREBR BLOOD F MET, V29, P524, DOI 10.1038/jcbfm.2008.142; Armstead WM, 2005, DEV BRAIN RES, V156, P139, DOI 10.1016/j.devbraines.2005.02.012; Armstead WM, 2002, DEV BRAIN RES, V139, P19, DOI 10.1016/S0165-3806(02)00511-4; Armstead WM, 1997, BRAIN RES, V768, P177, DOI 10.1016/S0006-8993(97)00641-0; Atkins CM, 2007, EXP NEUROL, V208, P145, DOI 10.1016/j.expneurol.2007.08.011; Bilotta F, 2008, NEUROCRIT CARE, V9, P159, DOI 10.1007/s12028-008-9084-9; BROCKMAN RP, 1975, AM J PHYSIOL, V229, P1344, DOI 10.1152/ajplegacy.1975.229.5.1344; Fanne Rami Abu, 2011, J Neurosurg, V114, P85, DOI 10.3171/2010.4.JNS10263; Faraci FM, 1998, PHYSIOL REV, V78, P53, DOI 10.1152/physrev.1998.78.1.53; Gottlieb M, 2003, J NEUROCHEM, V87, P119, DOI 10.1046/j.1471-4159.2003.01972.x; LAPTOOK AR, 1983, BRAIN RES, V276, P51, DOI 10.1016/0006-8993(83)90547-4; LEFFLER CW, 1989, AM J PHYSIOL, V257, pH1917, DOI 10.1152/ajpheart.1989.257.6.H1917; LEFFLER CW, 1985, PEDIATR RES, V19, P1160, DOI 10.1203/00006450-198511000-00009; Liu-DeRyke X, 2009, NEUROCRIT CARE, V11, P151, DOI 10.1007/s12028-009-9228-6; Lovshin JA, 2004, ENDOCRINOLOGY, V145, P3495, DOI 10.1210/en.2004-0100; Nelson D, 2005, PRINCIPLES BIOCH, P543; Nicole O, 2001, NAT MED, V7, P59, DOI 10.1038/83358; Park L, 2008, P NATL ACAD SCI USA, V105, P1073, DOI 10.1073/pnas.0708823105; Pawlak R, 2005, P NATL ACAD SCI USA, V102, P443, DOI 10.1073/pnas.0406454102; Salim A, 2009, AM SURGEON, V75, P25; TSIRKA SE, 1995, NATURE, V377, P340, DOI 10.1038/377340a0; Wang YMF, 1998, NAT MED, V4, P228, DOI 10.1038/nm0298-228; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; Zhang H, 2001, CLIN CHEM, V47, P1458	25	18	18	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR	2011	28	3					451	457		10.1089/neu.2010.1659			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	734WD	WOS:000288370600010	21375400	Green Published			2022-02-06	
J	Hakan, T; Toklu, HZ; Biber, N; Celik, H; Erzik, C; Ogunc, AV; Cetinel, S; Sener, G				Hakan, Tayfun; Toklu, Hale Zerrin; Biber, Necat; Celik, Hasan; Erzik, Can; Ogunc, Ayliz Velioglu; Cetinel, Sule; Sener, Goksel			Meloxicam Exerts Neuroprotection on Spinal Cord Trauma in Rats	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						COX-2; glutathione; lipid peroxidation; meloxicam; neuroprotection; spinal cord injury	OXIDATIVE STRESS; BRAIN-INJURY; CYCLOOXYGENASE-2; GLUTATHIONE; METABOLISM; CONTUSION; DAMAGE; ACID	Traumatic injury to the central nervous system results in the delayed dysfunction and neuronal death. Impaired mitochondrial function, generation of reactive oxygen species (ROS), and lipid peroxidation occur soon after traumatic spinal cord injury (SCI), while the activation of compensatory molecules that neutralize ROS occurs at later time points. The aim of the current study was to investigate the putative neuroprotective effect of the COX2 inhibitor meloxicam in a rat model of SCI. In order to induce SCI, a standard weight-drop method that induced a moderately severe injury (100 g/cm force) at T10, was used. Injured animals were given either 2 mg/kg meloxicam or saline 30 min postinjury by intraperitoneal injection. At seven days postinjury, neurological examination was performed and rats were decapitated. Spinal cord samples were taken for histological examination or determination of malondialdehyde (MDA) and glutathione (GSH) levels, myeloperoxidase (MPO) activity and DNA fragmentation. Formation of ROS in spinal cord tissue samples was monitored by using a chemiluminescence (CL) technique. SCI caused a significant decrease in spinal cord GSH content, which was accompanied with significant increases in CL, MDA levels, MPO activity, and DNA damage. On the other hand, meloxicam treatment reversed all these biochemical parameters as well as SCI-induced histopathological alterations. Furthermore, impairment of the neurological functions due to SCI was improved by meloxicam treatment. The present study suggests that meloxicam, reduces SCI-induced oxidative stress and exerts neuroprotection by inhibiting lipid peroxidation, GSH depletion, and DNA fragmentation.	[Hakan, Tayfun; Biber, Necat; Celik, Hasan] Haydarpasa Numune EAH, Beyin & Sinir Cerrahisi Klin, TR-34668 Istanbul, Turkey; [Toklu, Hale Zerrin; Sener, Goksel] Marmara Univ, Sch Pharm, Istanbul, Turkey; [Erzik, Can; Cetinel, Sule] Marmara Univ, Sch Med, Istanbul, Turkey; [Ogunc, Ayliz Velioglu] Marmara Univ, Vocat Sch Hlth Related Profess 10, Istanbul, Turkey		Hakan, T (corresponding author), Haydarpasa Numune EAH, Beyin & Sinir Cerrahisi Klin, Tibbiye Caddesi, TR-34668 Istanbul, Turkey.	tayfunhakan@yahoo.com	cetinel, sule/AAB-8510-2022; Sener, Goksel/AAN-4461-2021; Erzik, Can/AAZ-5485-2021; Toklu, Hale/AAR-2330-2020; Hakan, Tayfun/P-8626-2015; Hakan, Tayfun/O-9979-2019	Sener, Goksel/0000-0001-7444-6193; Erzik, Can/0000-0002-7914-1169; Toklu, Hale/0000-0002-9797-3591; Hakan, Tayfun/0000-0003-1444-7076; Hakan, Tayfun/0000-0003-1444-7076			Adachi K, 2005, NEUROSCI RES, V51, P73, DOI 10.1016/j.neures.2004.10.007; Agha AM, 1999, PHARMACOL RES, V40, P385, DOI 10.1006/phrs.1999.0522; Allen AR., 1911, JAMA-J AM MED ASSOC, V57, P878, DOI DOI 10.1001/JAMA.1911.04260090100008; Arafa HMM, 2007, EUR J PHARMACOL, V564, P181, DOI 10.1016/j.ejphar.2007.02.065; Azbill RD, 1997, BRAIN RES, V765, P283, DOI 10.1016/S0006-8993(97)00573-8; BEUTLER E, 1963, J LAB CLIN MED, V61, P882; Buege J A, 1978, Methods Enzymol, V52, P302; Burton K, 1967, METHODS ENZ, VXII, P163; Cemil B, 2010, ACTA NEUROCHIR, V152, P1583, DOI 10.1007/s00701-010-0702-x; Emerit J, 2004, BIOMED PHARMACOTHER, V58, P39, DOI 10.1016/j.biopha.2003.11.004; Engelhardt G, 1996, BIOCHEM PHARMACOL, V51, P29, DOI 10.1016/0006-2952(95)02110-8; GALE K, 1985, EXP NEUROL, V88, P123, DOI 10.1016/0014-4886(85)90118-9; Hakan T, 2010, NEUROL RES, V32, P629, DOI 10.1179/016164109X12464612122731; Haklar G, 1998, MARMARA MED J, V11, P55; Hall Edward D, 2004, NeuroRx, V1, P80, DOI 10.1602/neurorx.1.1.80; HILLEGASS LM, 1990, J PHARMACOL METHOD, V24, P285, DOI 10.1016/0160-5402(90)90013-B; Kamencic H, 2001, FASEB J, V15, P243, DOI 10.1096/fj.00-0228com; Lapchak PA, 2001, STROKE, V32, P1220, DOI 10.1161/01.STR.32.5.1220; Lopez-Vales R, 2010, J NEUROSCI, V30, P3220, DOI 10.1523/JNEUROSCI.5770-09.2010; Matthias C, 2006, ANTICANCER RES, V26, P2003; Minghetti L, 1998, PROG NEUROBIOL, V54, P99, DOI 10.1016/S0301-0082(97)00052-X; Ogino K, 1997, PHARMACOLOGY, V55, P44, DOI 10.1159/000139511; Pompella A, 2003, BIOCHEM PHARMACOL, V66, P1499, DOI 10.1016/S0006-2952(03)00504-5; Resnick DK, 1998, J NEUROTRAUM, V15, P1005, DOI 10.1089/neu.1998.15.1005; Slemmer JE, 2008, CURR MED CHEM, V15, P404, DOI 10.2174/092986708783497337; Smith WL, 1996, ADV IMMUNOL, V62, P167, DOI 10.1016/S0065-2776(08)60430-7; Strauss KI, 2002, J NEUROTRAUM, V19, P627, DOI 10.1089/089771502753754091; Tilleux S, 2007, J NEUROSCI RES, V85, P2059, DOI 10.1002/jnr.21325; Toklu HZ, 2010, J SPINAL CORD MED, V33, P401, DOI 10.1080/10790268.2010.11689719; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489	30	18	21	0	10	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0020-7454			INT J NEUROSCI	Int. J. Neurosci.	MAR	2011	121	3					142	148		10.3109/00207454.2010.537415			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	739MG	WOS:000288721300005	21138398				2022-02-06	
J	Dhar, R; Murphy-Human, T				Dhar, Rajat; Murphy-Human, Theresa			A Bolus of Conivaptan Lowers Intracranial Pressure in a Patient with Hyponatremia after Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Hyponatremia; Vasopressin; Intracranial pressure	ARGININE-VASOPRESSIN V-1; HYPERTONIC SALINE; RECEPTOR ANTAGONIST; CEREBRAL EDEMA; ANTIDIURETIC-HORMONE; WATER-CONTENT; MANNITOL; VOLUME; STROKE; MODULATION	Hyponatremia may complicate brain injury and exacerbate cerebral edema and intracranial pressure (ICP). Vasopressin-receptor antagonists (such as conivaptan) are promising novel agents to treat hyponatremia that act by inducing aquaresis. It is unclear whether raising serum sodium in this way could also confer an acute osmotic benefit, reducing brain water and thereby ICP. We evaluated the effect of a bolus of conivaptan on ICP in a patient with hyponatremia after traumatic brain injury (TBI). A 22-year-old suffered severe TBI with occlusive left carotid dissection. Her course was complicated by left hemispheric infarcts with cerebral edema and intermittently elevated ICP. Conivaptan 20-mg IV was given as a bolus when serum sodium rapidly dropped to 128 mEq/l. This dose resulted in significant aquaresis, with over 1 l per hour of dilute urine peaking at 3-5 h after the dose. By 8 h, sodium had risen to 146 mEq/l. ICP had been stable at 11-15 mmHg for several hours prior to the dose, remained in this range for 2 h after, but then fell to 2 mmHg at 4 h, and remained reduced out to 8 h. Cerebral perfusion pressure, initially stable at 60-80 mmHg, rose to over 90 mmHg at 4 h. In this preliminary case report, a single dose of conivaptan not only resulted in rapid correction of acute hyponatremia, but also a significant fall in ICP temporally associated with peak aquaresis. Vasopressin-receptor antagonists, by reversing osmotic shifts, may be novel agents to control ICP and cerebral edema, especially in the setting of falling sodium.	[Dhar, Rajat] Washington Univ, Sch Med, Dept Neurol, Div Neurocrit Care, St Louis, MO 63110 USA; [Murphy-Human, Theresa] Barnes Jewish Hosp, Intens Care Unit, Dept Clin Pharm & Neurol Neurosurg, St Louis, MO 63110 USA		Dhar, R (corresponding author), Washington Univ, Sch Med, Dept Neurol, Div Neurocrit Care, Campus Box 8111,660 S Euclid Ave, St Louis, MO 63110 USA.	dharr@neuro.wustl.edu		Dhar, Rajat/0000-0002-5167-5097			*AST PHARM US INC, 2007, VAPR CON HYDR INJ PR; BORN JD, 1985, SURG NEUROL, V23, P383, DOI 10.1016/0090-3019(85)90212-5; Brimioulle S, 2008, INTENS CARE MED, V34, P125, DOI 10.1007/s00134-007-0905-7; Carpenter J, 2007, NEUROCRIT CARE, V6, P195, DOI 10.1007/s12028-007-0032-x; Decaux G, 2008, LANCET, V371, P1624, DOI 10.1016/S0140-6736(08)60695-9; Fernandez N, 2001, BRIT J PHARMACOL, V132, P1837, DOI 10.1038/sj.bjp.0704034; Francony G, 2008, CRIT CARE MED, V36, P795, DOI 10.1097/CCM.0B013E3181643B41; GULLANS SR, 1993, ANNU REV MED, V44, P289, DOI 10.1146/annurev.med.44.1.289; Kerwin AJ, 2009, J TRAUMA, V67, P277, DOI 10.1097/TA.0b013e3181acc726; Keyrouz SG, 2008, NEUROCRIT CARE, V9, P204, DOI 10.1007/s12028-008-9118-3; Kleindienst A, 2006, ACTA NEUROCHIR SUPPL, V96, P303; Koenig MA, 2008, NEUROLOGY, V70, P1023, DOI 10.1212/01.wnl.0000304042.05557.60; Larive LL, 2004, NEUROCRIT CARE, V1, P435, DOI 10.1385/NCC:1:4:435; Liu XQ, 2010, NEUROCRIT CARE, V12, P124, DOI 10.1007/s12028-009-9277-x; Manno EM, 1999, NEUROLOGY, V52, P583, DOI 10.1212/WNL.52.3.583; Molnar AH, 2008, PROG BRAIN RES, V170, P519, DOI 10.1016/S0079-6123(08)00439-1; Moro N, 2007, SURG NEUROL, V68, P387, DOI 10.1016/j.surneu.2006.11.052; Murphy T, 2009, NEUROCRIT CARE, V11, P14, DOI 10.1007/s12028-008-9179-3; Nathan BR, 2007, NEUROCRIT CARE, V6, P72, DOI 10.1385/NCC:6:1:72; Niermann H, 2001, J NEUROSCI, V21, P3045, DOI 10.1523/JNEUROSCI.21-09-03045.2001; Paczynski RP, 1997, STROKE, V28, P1437, DOI 10.1161/01.STR.28.7.1437; RAICHLE ME, 1978, BRAIN RES, V143, P191, DOI 10.1016/0006-8993(78)90766-7; Rosenberg G A, 1990, Adv Neurol, V52, P149; Sherlock M, 2009, POSTGRAD MED J, V85, P171, DOI 10.1136/pgmj.2008.072819; Shuaib A, 2002, STROKE, V33, P3033, DOI 10.1161/01.STR.0000039405.31526.06; Sterns RH, 2006, AM J MED, V119, pS12, DOI 10.1016/j.amjmed.2006.05.003; Taya K, 2008, ACTA NEUROCHIR SUPPL, V102, P425, DOI 10.1007/978-3-211-85578-2_83; Trabold R, 2008, J NEUROTRAUM, V25, P1459, DOI 10.1089/neu.2008.0597; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; Vakili A, 2005, J CEREBR BLOOD F MET, V25, P1012, DOI 10.1038/sj.jcbfm.9600097; Videen TO, 2001, NEUROLOGY, V57, P2120, DOI 10.1212/WNL.57.11.2120; Wakai A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001049.pub4; Wright WL, 2009, NEUROCRIT CARE, V11, P6, DOI 10.1007/s12028-008-9152-1	33	18	21	0	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933			NEUROCRIT CARE	Neurocrit. Care	FEB	2011	14	1					97	102		10.1007/s12028-010-9366-x			6	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	708WF	WOS:000286394300017	20440600				2022-02-06	
J	Lockhart, P; Cronin, D; Williams, K; Ouellet, S				Lockhart, Philip; Cronin, Duane; Williams, Kevin; Ouellet, Simon			Investigation of Head Response to Blast Loading	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Blast; Explosive; Head; Injury; CONWEP; LS-Dyna	TRAUMATIC BRAIN-INJURY	Background: Head injury resulting from blast loading, specifically mild traumatic brain injury, has been identified as a possible and important blast-related injury for soldiers in modern conflict zones. A study was undertaken to evaluate head response to blast loading scenarios using an explicit finite element numerical model and to comment on the potential for head injury. Methods: The blast loading and simplified human body numerical models were validated using impulse, peak acceleration and the Head Injury Criterion from experimental blast test data. A study was then undertaken to evaluate head response at varying distances and orientations from the explosive. Results: The accelerations and injury metrics for the head increased with decreasing distance to the explosive, as expected, but were also significant at intermediate distances from the explosive for larger charge sizes and intermediate heights of burst. Varying lateral position with constant standoff did not have a significant effect on the head kinematic response. Conclusions: The head injury criteria considered were exceeded in close proximity to the explosive (< 35 charge radii) and depended on the height of burst for the range of charge sizes considered. The injury criteria were also exceeded at intermediate distances for larger charge sizes because of the influence of the mach stem. Although the injury criteria used in this study are typically applied to longer duration events, and may not be applicable for shorter duration blast loading, aggressive loading is predicted at small standoff distances and confirmed by the resulting head kinematics.	[Lockhart, Philip; Cronin, Duane] Univ Waterloo, Waterloo, ON N2L 3G1, Canada; [Williams, Kevin; Ouellet, Simon] Def R&D, Quebec City, PQ, Canada		Lockhart, P (corresponding author), 200 Univ Ave W, Waterloo, ON N2L 3G1, Canada.	plockhar@lagavulin.uwaterloo.ca		Cronin, Duane/0000-0001-7538-0560	Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR; Defense R&D Canada, Valcartier; Med-Eng Systems Inc.; Martec	Supported by Natural Sciences and Engineering Research Council of Canada; Defense R&D Canada, Valcartier; Med-Eng Systems Inc.; and Martec.	AYVAZYAN H, 1986, STRUCTURES RESIST EF, V2; Bowen IG, 1968, DASA2113; BULSON PS, 1997, EXPLOSIVE LOADING EN; CHENG H, 1994, GENERATOR BODY MANUA; CLEMEDSON CJ, 1956, BLAST INJURY; Cronin D. S., 2008, P PERS ARM SYST S, P84; *DEP ARM, 1967, EXPLOSIVES DEMOLITIO; DHARANEEPATHY MV, 1995, COMPUT STRUCT, V54, P587, DOI 10.1016/0045-7949(94)00380-L; Dionne JP, 2002, REDUCTION BLAST INDU; Gennarelli T., 2003, ANN P ASS ADV AUTOMO, V47, P624; Gruss E, 2006, J TRAUMA, V60, P1284, DOI 10.1097/01.ta.0000220015.21948.ec; HALLQUIST JO, 2006, LSDYNA THEORY MANUAL; Hetherington J., 1994, BLAST BALLISTIC LOAD; Hutchinson J, 1998, APPL MATH COMPUT, V96, P1, DOI 10.1016/S0096-3003(97)10106-0; HYDE D, 1998, 58551 TM; *LIV SOFT TECHN CO, 2008, LOAD BLAST ENHANCED; *LIV SOFT TECHN CO, 2008, ENHANCED BLAST LOADI; Makris A, 2000, REDUCTION BLAST INDU; MANSEAU J, 2006, P 19 INT S MIL ASP B; NAHUM AM, 2001, ACCIDENTAL INJURY BI; Newman J, 2000, P 44 STAPP CAR CRASH; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; STUHMILLER JH, 2008, BIQPJHSCH10; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; WILLIAMS K, 2004, TEST PLAN MABIL DEV	25	18	19	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	FEB	2011	70	2					E29	E36		10.1097/TA.0b013e3181de3f4b			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	719FV	WOS:000287187700002	20664376				2022-02-06	
J	Tong, M; Qualls-Creekmore, E; Browning, KN; Travagli, RA; Holmes, GM				Tong, M.; Qualls-Creekmore, E.; Browning, K. N.; Travagli, R. A.; Holmes, G. M.			Experimental spinal cord injury in rats diminishes vagally-mediated gastric responses to cholecystokinin-8s	NEUROGASTROENTEROLOGY AND MOTILITY			English	Article						brainstem; gastrointestinal motility; gas-trointestinal transit; vago-vagal reflexes	NUCLEUS-TRACTUS-SOLITARIUS; GASTROINTESTINAL SATIETY SIGNALS; BRAIN-STEM; AFFERENT NEURONS; FOOD-INTAKE; IN-VITRO; MYENTERIC PLEXUS; FOS EXPRESSION; LEPTIN ACTION; AWAKE RATS	Background We have shown recently that our model of experimental high-thoracic spinal cord injury (T3-SCI) mirrors the gastrointestinal clinical presentation of neurotrauma patients, whereby T3-SCI animals show diminished gastric emptying and dysmotility. In this study we used cholecystokinin as a model peptide to test the hypothesis that the T3-SCI induced gastroparesis is due, in part, to an impaired vagally-mediated response to gastrointestinal peptides. Methods We measured the responses to sulfated cholecystokinin (CCK-8s) in control and T3-SCI (3 or 21 days after injury) rats utilizing: (i) c-fos expression in the nucleus tractus solitarius (NTS) following peripherally administered CCK-8s; (ii) in vivo gastric tone and motility following unilateral microinjection of CCK-8s into the dorsal vagal complex (DVC); and (iii) whole cell recordings of glutamatergic synaptic inputs to NTS neurons. Key Results Our results show that: (i) medullary c-fos expression in response to peripheral CCK-8s was significantly lower in T3-SCI rats 3 days after the injury, but recovered to control values at 3 weeks post-SCI, (ii) Unilateral microinjection of CCK-8s in the DVC induced a profound gastric relaxation in control animals, but did not induce any response in T3-SCI rats at both 3 and 21 days after SCI, (iii) Perfusion with CCK-8s increased glutamatergic currents in 55% of NTS neurons from control rats, but failed to induce any response in NTS neurons from T3-SCI rats. Conclusions & Inferences Our data indicate alterations of vagal responses to CCK-8s in T3-SCI rats that may reflect a generalized impairment of gastric vagal neurocircuitry, leading to a reduction of gastric functions after SCI.	[Tong, M.; Qualls-Creekmore, E.; Holmes, G. M.] Louisiana State Univ, Pennington Biomed Res Ctr, Neurotrauma & Nutr Lab, Baton Rouge, LA 70808 USA; [Browning, K. N.; Travagli, R. A.] Penn State Univ, Coll Med, Dept Neural & Behav Sci, Hershey, PA USA		Holmes, GM (corresponding author), Louisiana State Univ, Pennington Biomed Res Ctr, Neurotrauma & Nutr Lab, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	holmesgm@pbrc.edu	Qualls-Creekmore, Emily/N-1983-2017	Browning, Kirsteen/0000-0002-5062-3703	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NINDS 49177, NIDDK 55530]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK055530, P30DK072476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS049177] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health Grants NINDS 49177 (G. M. Holmes) and NIDDK 55530 (R. A. Travagli).	Appleyard SM, 2005, J NEUROSCI, V25, P3578, DOI 10.1523/JNEUROSCI.4177-04.2005; Baptista V, 2007, AM J PHYSIOL-REG I, V292, pR1092, DOI 10.1152/ajpregu.00517.2006; Baptista V, 2005, J NEUROPHYSIOL, V94, P2763, DOI 10.1152/jn.00351.2005; Baptista V, 2005, BRAIN RES, V1052, P139, DOI 10.1016/j.brainres.2005.05.073; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; BERLLY MH, 1984, ARCH PHYS MED REHAB, V65, P687; BLACKSHAW LA, 1990, J AUTONOM NERV SYST, V31, P191, DOI 10.1016/0165-1838(90)90185-L; Blevins JE, 2010, FORUM NUTR, V63, P133, DOI 10.1159/000264401; Blevins JE, 2004, AM J PHYSIOL-REG I, V287, pR87, DOI 10.1152/ajpregu.00604.2003; Blevins JE, 2000, BRAIN RES, V860, P1, DOI 10.1016/S0006-8993(99)02477-4; BRANCHEREAU P, 1993, J NEUROPHYSIOL, V70, P2584, DOI 10.1152/jn.1993.70.6.2584; BRANCHEREAU P, 1992, J PHARMACOL EXP THER, V260, P1433; Broberger C, 2001, BRAIN RES, V903, P128, DOI 10.1016/S0006-8993(01)02468-4; Burdyga G, 2006, NEUROSCIENCE, V137, P1405, DOI 10.1016/j.neuroscience.2005.10.057; Burdyga G, 2004, J NEUROSCI, V24, P2708, DOI 10.1523/JNEUROSCI.5404-03.2004; Burdyga G, 2008, J NEUROSCI, V28, P11583, DOI 10.1523/JNEUROSCI.2493-08.2008; Cosman B C, 1991, J Am Paraplegia Soc, V14, P175; Date Y, 2005, ENDOCRINOLOGY, V146, P3518, DOI 10.1210/en.2004-1240; Dockray GJ, 2006, PHYSIOLOGY OF THE GASTROINTESTINAL TRACT, VOLS 1 AND 2, 4TH EDITION, P91; FEALEY RD, 1984, GASTROENTEROLOGY, V87, P69; FRASER KA, 1992, EXP PHYSIOL, V77, P225, DOI 10.1113/expphysiol.1992.sp003579; Gamboa-Esteves FO, 2001, BRAIN RES, V921, P195, DOI 10.1016/S0006-8993(01)03118-3; Gondim FAA, 1999, SPINAL CORD, V37, P793, DOI 10.1038/sj.sc.3100923; Gondim FDA, 2001, AUTON NEUROSCI-BASIC, V87, P52; Hatanaka S, 1997, JPN J PHARMACOL, V74, P105, DOI 10.1254/jjp.74.105; Holmes GM, 2009, GASTROENTEROLOGY, V136, pA577; Holmes GM, 2009, AM J PHYSIOL-GASTR L, V296, pG621, DOI 10.1152/ajpgi.90567.2008; Holzer P, 2002, NEUROGASTROENT MOTIL, V14, P459, DOI 10.1046/j.1365-2982.2002.00353.x; Kabatas S, 2008, NEUROSCIENCE, V154, P1627, DOI 10.1016/j.neuroscience.2008.04.071; Kirshblum SC, 2002, ARCH PHYS MED REHAB, V83, pS50, DOI 10.1053/apmr.2002.32156; LIBH, 1995, BRAIN RES B, V37, P589; MENETREY D, 1991, EUR J NEUROSCI, V3, P249, DOI 10.1111/j.1460-9568.1991.tb00087.x; MENETREY D, 1987, J COMP NEUROL, V255, P439, DOI 10.1002/cne.902550310; Moran TH, 2004, AM J PHYSIOL-GASTR L, V286, pG183, DOI 10.1152/ajpgi.00434.2003; Morton GJ, 2005, J CLIN INVEST, V115, P703, DOI 10.1172/JCI200522081; NINOMURCIA M, 1991, AM J ROENTGENOL, V158, P279; Peters JH, 2004, ENDOCRINOLOGY, V145, P3652, DOI 10.1210/en.2004-0221; Primeaux SD, 2007, AM J PHYSIOL-REG I, V293, pR1102, DOI 10.1152/ajpregu.00224.2007; Qualls-Creekmore E, 2010, NEUROGASTROENT MOTIL, V22, P62, DOI 10.1111/j.1365-2982.2009.01347.x; RAYBOULD HE, 1988, AM J PHYSIOL, V255, pG242, DOI 10.1152/ajpgi.1988.255.2.G242; Raybould HE, 2007, CURR OPIN PHARMACOL, V7, P570, DOI 10.1016/j.coph.2007.09.006; RENEHAN WE, 1995, AM J PHYSIOL-GASTR L, V268, pG780, DOI 10.1152/ajpgi.1995.268.5.G780; RINAMAN L, 1993, J COMP NEUROL, V338, P475, DOI 10.1002/cne.903380402; RITTER RC, 1994, ANN NY ACAD SCI, V713, P255, DOI 10.1111/j.1749-6632.1994.tb44073.x; Rodrigues CL, 2001, DIGEST DIS SCI, V46, P1604, DOI 10.1023/A:1010624730975; Sayegh AI, 2000, BRAIN RES, V878, P155, DOI 10.1016/S0006-8993(00)02731-1; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; SEGAL JL, 1995, AM J GASTROENTEROL, V90, P466; Simasko SM, 2003, AM J PHYSIOL-GASTR L, V285, pG1204, DOI 10.1152/ajpgi.00132.2003; STINNEFORD JG, 1993, PARAPLEGIA, V31, P384, DOI 10.1038/sc.1993.64; Sullivan CN, 2007, AM J PHYSIOL-REG I, V292, pR1071, DOI 10.1152/ajpregu.00490.2006; Takahashi T, 1999, J AUTONOM NERV SYST, V75, P123, DOI 10.1016/S0165-1838(98)00181-7; TALMAN WT, 1991, AM J PHYSIOL, V261, pR217, DOI 10.1152/ajpregu.1991.261.1.R217; TAPIA R, 1985, NEUROSCI BIOBEHAV R, V9, P391, DOI 10.1016/0149-7634(85)90017-X; Tong M, 2009, NEUROGASTROENT MOTIL, V21, P197, DOI 10.1111/j.1365-2982.2008.01215.x; Travagli RA, 2006, ANNU REV PHYSIOL, V68, P279, DOI 10.1146/annurev.physiol.68.040504.094635; Viard E, 2007, AM J PHYSIOL-GASTR L, V293, pG493, DOI 10.1152/ajpgi.00118.2007; Wan S, 2008, J NEUROSCI, V28, P4957, DOI 10.1523/JNEUROSCI.5398-07.2008; Wan SX, 2007, AM J PHYSIOL-GASTR L, V293, pG484, DOI 10.1152/ajpgi.00116.2007; Wolf C, 2003, SPINAL CORD, V41, P347, DOI 10.1038/sj.sc.3101440; Woods SC, 2004, AM J PHYSIOL-GASTR L, V286, pG7, DOI 10.1152/ajpgi.00448.2003; Xue B, 2009, NEUROGASTROENT MOTIL, V21, P322, DOI 10.1111/j.1365-2982.2008.01225.x; Zheng ZL, 2005, AM J PHYSIOL-GASTR L, V288, pG1066, DOI 10.1152/ajpgi.00497.2004; Zittel TT, 1999, BRAIN RES, V846, P1, DOI 10.1016/S0006-8993(99)01842-9	64	18	18	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1350-1925	1365-2982		NEUROGASTROENT MOTIL	Neurogastroenterol. Motil.	FEB	2011	23	2					e69	e79		10.1111/j.1365-2982.2010.01616.x			11	Gastroenterology & Hepatology; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Gastroenterology & Hepatology; Neurosciences & Neurology	706IM	WOS:000286211600004	20950355	Green Accepted			2022-02-06	
J	Tsirka, V; Simos, PG; Vakis, A; Kanatsouli, K; Vourkas, M; Erimaki, S; Pachou, E; Stam, CJ; Micheloyannis, S				Tsirka, Vasso; Simos, Panagiotis G.; Vakis, Antonios; Kanatsouli, Kassiani; Vourkas, Michael; Erimaki, Sofia; Pachou, Ellie; Stam, Cornelis Jan; Micheloyannis, Sifis			Mild traumatic brain injury: Graph-model characterization of brain networks for episodic memory	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Article						Small-World Networks; Graph theory; Synchronization likelihood; Mild traumatic brain injury; Episodic memory; Declarative memory	SMALL-WORLD NETWORKS; HUMAN NEOCORTICAL OSCILLATIONS; HEAD TRAUMA; THEORETICAL ANALYSIS; THETA-OSCILLATIONS; EEG ALPHA; FUNCTIONAL CONNECTIVITY; PHASE SYNCHRONIZATION; RECOGNITION MEMORY; QUANTITATIVE EEG	Episodic memory is among the cognitive functions that can be affected in the acute phase following mild traumatic brain injury (MTBI). The present study used EEG recordings to evaluate global synchronization and network organization of rhythmic activity during the encoding and recognition phases of an episodic memory task varying in stimulus type (kaleidoscope images, pictures, words, and pseudowords). Synchronization of oscillatory activity was assessed using a linear and nonlinear connectivity estimator and network analyses were performed using algorithms derived from graph theory. Twenty five MTBI patients (tested within days post-injury) and healthy volunteers were closely matched on demographic variables, verbal ability, psychological status variables, as well as on overall task performance. Patients demonstrated sub-optimal network organization, as reflected by changes in graph parameters in the theta and alpha bands during both encoding and recognition. There were no group differences in spectral energy during task performance or on network parameters during a control condition (rest). Evidence of less optimally organized functional networks during memory tasks was more prominent for pictorial than for verbal stimuli. (C) 2010 Elsevier B.V. All rights reserved.	[Tsirka, Vasso; Vakis, Antonios; Kanatsouli, Kassiani; Erimaki, Sofia; Pachou, Ellie; Micheloyannis, Sifis] Univ Crete, Dept Med, Clin Res Lab Widen, GR-71409 Iraklion, Greece; [Simos, Panagiotis G.] Univ Crete, Dept Psychol, Rethimnon, Greece; [Vourkas, Michael] Inst Educ Technol, Iraklion, Greece; [Stam, Cornelis Jan] Vrije Univ Amsterdam Med Ctr, Dept Clin Neurophysiol, Amsterdam, Netherlands		Tsirka, V (corresponding author), Mitropolitou Kallidou 5, Thessaloniki 54655, Greece.	tsirkav@yahoo.com	SIMOS, PANAGIOTIS/L-2107-2019	SIMOS, PANAGIOTIS/0000-0002-0116-8564	BIOPATTERN EU	This research was supported in part by the BIOPATTERN EU program.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Alstott J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000408; Babiloni C, 2006, BRAIN RES BULL, V68, P203, DOI 10.1016/j.brainresbull.2005.04.019; Babiloni C, 2009, HUM BRAIN MAPP, V30, P2077, DOI 10.1002/hbm.20648; Bassett DS, 2009, CURR OPIN NEUROL, V22, P340, DOI 10.1097/WCO.0b013e32832d93dd; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Burgess AP, 1997, NEUROREPORT, V8, P1039, DOI 10.1097/00001756-199703030-00044; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Calmels C, 2010, PSYCHOPHYSIOLOGY, V47, P799, DOI 10.1111/j.1469-8986.2010.00985.x; Cao C, 2010, IEEE T NEUR SYS REH, V18, P11, DOI 10.1109/TNSRE.2009.2027704; De Monte VE, 2006, BRAIN INJURY, V20, P1345, DOI 10.1080/02699050601082073; Doppelmayr M, 1998, NEUROSCI LETT, V257, P41, DOI 10.1016/S0304-3940(98)00805-2; Fingelkurts A, 2003, NEUROIMAGE, V20, P529, DOI 10.1016/S1053-8119(03)00305-7; Ford MR, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199606000-00004; Gaetz M, 2002, CLIN NEUROPHYSIOL, V113, P1665, DOI 10.1016/S1388-2457(02)00270-5; Gaetz M, 2001, J HEAD TRAUMA REHAB, V16, P386, DOI 10.1097/00001199-200108000-00008; Gaetz M, 2000, BRAIN INJURY, V14, P1077; GENTILINI M, 1989, MILD HEAD INJURY, P163; Gevins A, 1997, CEREB CORTEX, V7, P374, DOI 10.1093/cercor/7.4.374; Gronwall D, 1989, MILD HEAD INJURY, P153; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Jensen O, 2002, EUR J NEUROSCI, V15, P1395, DOI 10.1046/j.1460-9568.2002.01975.x; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kirk IJ, 2003, CORTEX, V39, P993, DOI 10.1016/S0010-9452(08)70874-8; KLIMESCH W, 1994, ELECTROEN CLIN NEURO, V91, P428, DOI 10.1016/0013-4694(94)90164-3; Klimesch W, 1996, NEUROREPORT, V7, P1235, DOI 10.1097/00001756-199605170-00002; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2001, COGNITIVE BRAIN RES, V12, P33, DOI 10.1016/S0926-6410(01)00024-6; Klimesch W, 2001, NEUROSCI LETT, V302, P49, DOI 10.1016/S0304-3940(01)01656-1; Klimesch W, 2008, BRAIN RES, V1235, P31, DOI 10.1016/j.brainres.2008.06.049; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lewine JD, 1999, AM J NEURORADIOL, V20, P857; Micheloyannis S, 2006, SCHIZOPHR RES, V87, P60, DOI 10.1016/j.schres.2006.06.028; Micheloyannis S, 2006, NEUROSCI LETT, V402, P273, DOI 10.1016/j.neulet.2006.04.006; Micheloyannis S, 2009, HUM BRAIN MAPP, V30, P200, DOI 10.1002/hbm.20492; Montez T, 2006, NEUROIMAGE, V33, P1117, DOI 10.1016/j.neuroimage.2006.06.066; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Nunez PL, 2001, HUM BRAIN MAPP, V13, P125, DOI 10.1002/hbm.1030; Nuwer M, 1997, NEUROLOGY, V49, P277, DOI 10.1212/WNL.49.1.277; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; Osipova D, 2006, J NEUROSCI, V26, P7523, DOI 10.1523/JNEUROSCI.1948-06.2006; Papanicolaou, 2006, AMNESIAS CLIN TXB ME, P30; Pointinger H, 2002, BRAIN INJURY, V16, P799, DOI 10.1080/02699050210131911; Ponten SC, 2009, EXP NEUROL, V217, P197, DOI 10.1016/j.expneurol.2009.02.001; Raghavachari S, 2006, J NEUROPHYSIOL, V95, P1630, DOI 10.1152/jn.00409.2005; Raskin S. A., 2000, NEUROPSYCHOLOGICAL M, P93; Rizzuto DS, 2006, NEUROIMAGE, V31, P1352, DOI 10.1016/j.neuroimage.2006.01.009; Rizzuto DS, 2003, P NATL ACAD SCI USA, V100, P7931, DOI 10.1073/pnas.0732061100; Rubinov M, 2009, HUM BRAIN MAPP, V30, P403, DOI 10.1002/hbm.20517; Ruff R. M., 1989, MILD HEAD INJURY, P176; Sauseng P, 2008, NEUROSCI BIOBEHAV R, V32, P1001, DOI 10.1016/j.neubiorev.2008.03.014; Sauseng P, 2008, NEUROIMAGE, V40, P308, DOI 10.1016/j.neuroimage.2007.11.032; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Stam CJ, 2002, PHYSICA D, V163, P236, DOI 10.1016/S0167-2789(01)00386-4; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Summerfield C, 2005, NEUROREPORT, V16, P117, DOI 10.1097/00001756-200502080-00008; THATCHER RW, 1989, ELECTROEN CLIN NEURO, V73, P94, DOI 10.1016/0013-4694(89)90188-0; Tsirka V, 2010, INT J NEUROSCI, V120, P184, DOI 10.3109/00207450903585308; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Voller B, 1999, BRAIN INJURY, V13, P821, DOI 10.1080/026990599121214; Wallace BE, 2001, J HEAD TRAUMA REHAB, V16, P165, DOI 10.1097/00001199-200104000-00006; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wechsler D., 2011, WECHSLER ABBREVIATED; Whitham EM, 2008, CLIN NEUROPHYSIOL, V119, P1166, DOI 10.1016/j.clinph.2008.01.024	72	18	18	2	16	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	FEB	2011	79	2					89	96		10.1016/j.ijpsycho.2010.09.006			8	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology; Physiology	733WH	WOS:000288294700002	20863861				2022-02-06	
J	Batts, C; Andrews, DL				Batts, Callie; Andrews, David L.			'Tactical athletes': the United States Paralympic Military Program and the mobilization of the disabled soldier/athlete	SPORT IN SOCIETY			English	Article								Since the commencement of the wars in Iraq and Afghanistan, over 35,000 American military personnel have returned home with serious physical and psychological wounds, including amputations, traumatic brain injuries and paralysis. In 2004, amidst an increasingly militarized culture shaped by Bush-era wartime policies, the US Paralympics, a division of the US Olympic Committee, created the Paralympic Military Program (PMP) to introduce sport to these recently disabled soldiers. The PMP emphasizes the rehabilitative benefits of sport, but also pursues the implicit goal of discovering potential elite athletes capable of representing the USA in international competitions. The emergence of this new subjectivity of the elite soldier/athlete is a significant development in the continuing relationship between sport and the American military. This discussion illustrates how - as a symbol of both military and sporting constituencies - the body of the soldier/athlete is far from benign and apolitical. Rather, it is a malleable site upon which contemporary cultural meanings and political demands are inscribed and mobilized. Thus the PMP is worthy of critical examination as a site of production of 'anatomies of national fantasy'and 'corporeal flagging' that deflect attention away from the devastating consequences of war and ultimately promote an advancing American imperialism.	[Batts, Callie; Andrews, David L.] Univ Maryland, Dept Kinesiol, College Pk, MD 20742 USA		Andrews, DL (corresponding author), Univ Maryland, Dept Kinesiol, College Pk, MD 20742 USA.	dla@umd.edu					Abdel Shehid Gamal, 2002, J SPORT SOC ISSUES, V26, P317; Abrahamson A., WOUNDED VETERANS FIN; Armitage J., 2003, BODY SOC, V9, P1, DOI DOI 10.1177/135703403773684612; ATKINSON M, 2002, OLYMPIKA INT J OLYMP, V11, P53; BACEVICH A.J, 2005, NEW AM MILITARISM AM; Baker P., 2009, NY TIMES, pA6; Berger RJ, 2004, QUAL INQ, V10, P794, DOI 10.1177/1077800403261857; Berger RJ, 2008, J CONTEMP ETHNOGR, V37, P647, DOI 10.1177/0891241607309892; Berlant Lauren, 1991, ANATOMY NATL FANTASY; Bledsoe Greg, WOUNDED WARRIORS AIM; Boggs Carl, 2005, IMPERIAL DELUSIONS A; Bourke J., 1996, DISMEMBERING MALE ME; Bowman Larry, 2000, 9 J BASEBALL HIST CU, V9, P35; Burnham G, 2006, LANCET, V368, P1421, DOI 10.1016/S0140-6736(06)69491-9; Butterworth M.L, 2005, COMMUNICATION CRITIC, V2, P107, DOI [10.1080/14791420500082635, DOI 10.1080/14791420500082635]; Carden-Coyne Ana., 2007, EUR REV HIST, V14, P543; Chu David S.C., 2008, COMMUNICATION; COPELAND L, 2007, US TODAY, pA4; Gajewski K.A., 2008, HUMANIST, V68, P48; Gincel Richard, 2009, SAN DIEGO BUSINESS J, V30, P1; Gincel Richard, 2009, SAN DIEGO BUSINESS J, V30, P35; Giroux H., 2004, TERROR NEOLIBERALISM; Giroux Henry, 2007, U CHAINS CONFRONTING; Glasser R. J., 2006, WOUNDED VIETNAM IRAQ; GOLDEN M, 1998, SPORT SOC ANCIENT GR; Grabham E, 2009, BODY SOC, V15, P63, DOI 10.1177/1357034X08100147; Grey Charles Hables, 2003, BODY SOC, V9, p[4, 215, 224]; Hargreaves J, 2007, ROUTL CRIT STUD SPOR, P1; Howe PD, 2008, ROUTL CRIT STUD SPOR, P1; Hughes B., 2000, BODY CULTURE SOC INT, P29; Hughes B., 2002, DISABILITY STUDIES T, P61; Huss K., DISABLED VETS REDEPL; Kim Albert, 2001, SPORTS ILLUSTRATED, V94, P30; King S, 2009, J SPORT SOC ISSUES, V33, P5, DOI 10.1177/0193723508328631; King S, 2008, CULT STUD-CRIT METHO, V8, P527, DOI 10.1177/1532708608321575; Kuehn BM, 2009, JAMA-J AM MED ASSOC, V301, P1111, DOI 10.1001/jama.2009.342; Kusz KW, 2007, J SPORT SOC ISSUES, V31, P77, DOI 10.1177/0193723506296820; Kyle D.G., 2007, SPORT SPECTACLE ANCI; Mark Muckenfuss, 2009, PRESS ENTERPRIS 1016; McRuer Robert, 2006, CRIP THEORY CULTURAL; Michaelis V, 2007, US TODAY, pC1; Olberding M., COMPETITION BEGINS 1; Pine A., 2008, US NAVAL I P, V134, P44; Pope Steven W., 1997, PATRIOTIC GAMES SPOR; Salemme E, TRAINING VETS 2008 P; Saltman KJ, 2003, BODY SOC, V9, P49, DOI DOI 10.1177/135703403773684649; Sandahl C, 2003, GLQ-J LESBIAN GAY ST, V9, P25, DOI 10.1215/10642684-9-1-2-25; Semenza G M, 2001, Renaiss Q, V54, P1251, DOI 10.2307/1261972; Silk M, 2005, SOCIOL SPORT J, V22, P447, DOI 10.1123/ssj.22.4.447; SPARKES A, 1999, TALKING BODIES MENS, P76; Stempel C, 2006, J SPORT SOC ISSUES, V30, P79, DOI 10.1177/0193723505282472; Swartz L, 2008, DISABIL SOC, V23, P187, DOI 10.1080/09687590701841232; Titchkosky Tanya., 2007, READING WRITING DISA; Turse Nick, 2008, COMPLEX MILITARY INV; United States Department of Health and Human Services, PAR MIL PROGR GRANT; Wakefield WE, 1997, PLAYING WIN SPORTS A; Zinn Howard, 2005, JUST WAR; Zinser Lynn, 2005, NY TIMES, pD1; Zirin, 2008, PEOPLES HIST SPORTS	59	18	18	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1743-0437	1743-0445		SPORT SOC	Sport Soc.		2011	14	5					553	568		10.1080/17430437.2011.574350			16	Hospitality, Leisure, Sport & Tourism; Sociology	Emerging Sources Citation Index (ESCI)	Social Sciences - Other Topics; Sociology	V94YX	WOS:000213165400001					2022-02-06	
J	Casson, IR; Viano, DC; Powell, JW; Pellman, EJ				Casson, Ira R.; Viano, David C.; Powell, John W.; Pellman, Elliot J.			Repeat Concussions in the National Football League	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						concussion; traumatic brain injury; injury surveillance; epidemiology; repeat or multiple concussions; sport; head injury		Background: Repeat concussion is an important issue in the National Football League (NFL). An initial description of repeat injuries was published for 6 years (1996-2001). Hypothesis: The characteristics and frequency of repeat concussion in the NFL have not changed in the subsequent 6 years (2002-2007). Study Design: Case control. Methods: From 1996 to 2007, concussions were reported using a standardized form documenting signs and symptoms, loss of consciousness and medical action taken. Data on repeat concussions were analyzed for the 12 years and compared between the 2 periods. Results: In 2002-2007, 152 players had repeat concussions (vs 160 in 1996-2001); 44 had 3+ head injuries (vs 52). The positions most often associated with repeat concussion in 2002-2007 were the defensive secondary, kick unit, running back, and linebacker. The odds for repeat concussion were elevated for wide receivers, tight ends, and linebackers but lower than in the earlier period. During 2002-2007, over half of players with repeat concussion were removed from play, and fewer immediately returned (vs 1996-2001). The average duration between concussions was 1.25 years for 2002-2007 and 1.65 years for the 12-year period. Over 12 years, 7.6% of all repeat concussions occurred within 2 weeks of the prior concussion. Conclusions: The defensive secondary, kick unit, running back, and linebacker have the highest incidence of repeat concussion. During 2002-2007, more than half of players with repeat concussion were removed from play, and only a fraction immediately returned. Although concussion was managed more conservatively by team physicians in the recent 6 years, repeat concussions occurred at similar rates during both periods.	[Casson, Ira R.] Long Isl Jewish Med Ctr, Dept Neurol, New Hyde Pk, NY USA; [Casson, Ira R.] Albert Einstein Coll Med, Dept Neurol, Bronx, NY USA; [Viano, David C.] ProBiomech LLC, 265 Warrington Rd, Bloomfield, MI 48304 USA; [Powell, John W.] Michigan State Univ, Dept Kinesiol & Radiol, E Lansing, MI USA; [Pellman, Elliot J.] ProHLTH Care Associates, LLP, New York, NY USA; [Pellman, Elliot J.] Mt Sinai Sch Med, Dept Med & Orthoped, New York, NY USA		Viano, DC (corresponding author), ProBiomech LLC, 265 Warrington Rd, Bloomfield, MI 48304 USA.	dviano@comcast.net					American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Casson IR, CONCUSSION ATHLETES; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Casson IR, 2009, PHYS MED REH CLIN N, V20, P195, DOI 10.1016/j.pmr.2008.10.006; Congress of Neurological Surgeons, 1966, CLIN NEUROSURG, VIn: Vol 12, P386; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Pellman E, 2004, NEUROSURGERY, V55, P860, DOI 10.1227/01.NEU.0000137657.00146.7D; Pellman EJ, 2005, NEUROSURGERY, V56, P79, DOI 10.1227/01.NEU.0000150180.16552.8D; Pellman EJ, 2004, NEUROSURGERY, V55, P1100, DOI 10.1227/01.NEU.0000147063.12873.F5; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Viano DC, 2006, NEUROSURGERY, V59, P591, DOI 10.1227/01.NEU.0000231851.97287.C2	11	18	18	0	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	JAN-FEB	2011	3	1					11	24		10.1177/1941738110391413			14	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	V19RT	WOS:000214836800002	23015986	Green Published			2022-02-06	
J	Hynes, CA; Stone, VE; Kelso, LA				Hynes, Catherine A.; Stone, Valerie E.; Kelso, Louise A.			Social and emotional competence in traumatic brain injury: New and established assessment tools	SOCIAL NEUROSCIENCE			English	Article						Traumatic brain injury; Social skills; Emotions; Head injury	HEAD-INJURY; ASPERGER-SYNDROME; SELF-AWARENESS; MIND; DEFICITS; INDIVIDUALS; RECOGNITION; IMPAIRMENTS; PERCEPTION; INVENTORY	Chronic social/emotional deficits are common in moderate to severe traumatic brain injury (TBI), leading to significant functional difficulties. Objective, quantitative tools for assessing social/emotional competence are an important adjunct to cognitive assessments. We review existing social/emotional measures, conclude that theory of mind tests are not adequate for clinical assessments of social competence, and explain the development and piloting of novel measures in a small group of moderate to severe TBI patients (N = 16) and non-brain-damaged controls (N = 16). The novel measures are the Global Interpersonal Skills Test (GIST), a questionnaire measuring informant-rated social skills; the Assessment of Social Context (ASC), a video-based task examining understanding of others' emotions, attitudes, and intentions; the Social Interpretations Test, a social framing task based on Heider and Simmel (1944); and Awareness of Interoception, a heartbeat-detection paradigm related to physiological self-awareness. In a MANOVA, other-rated social skills (GIST), ASC, and Awareness of Interoception scores were significantly lower for TBI patients than controls. ASC, r(31)=.655, and Social Interpretations, r(31)=.460, scores were significantly correlated with informant-rated social skills (GIST). We encourage clinicians to add social/emotional measures to assessments of TBI patients.	[Stone, Valerie E.] Answers Brain Injury LLC, Golden, CO 80401 USA; [Hynes, Catherine A.; Stone, Valerie E.; Kelso, Louise A.] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia; [Hynes, Catherine A.] Kent & Medway NHS & Social Care Partnership Trust, Rehabil Serv, Maidstone, Kent, England; [Kelso, Louise A.] Griffith Univ, Sch Psychol, Mt Gravatt, Qld 4122, Australia		Stone, VE (corresponding author), Answers Brain Injury LLC, 601-C 16th St 191, Golden, CO 80401 USA.	vestone@gmail.com	Stone, Valerie E/J-3388-2019		Uniquest Trailblazer Award; Commonwealth Government of AustraliaAustralian Government; University of Queensland (UQ)University of Queensland; UQ Social and Behavioral Sciences; UQ International Living Allowance Scholarship	Original studies reported here were the doctoral dissertation research of Catherine Hynes, PhD (awarded 2009, University of Queensland), and the Honours Thesis research (GIST validation) of Louise Kelso, BPSc Hons (awarded 2006, University of Queensland). This research was supported by a Uniquest Trailblazer Award, an Endeavour International Postgraduate Research Scholarship from the Commonwealth Government of Australia, a University of Queensland (UQ) Research Development Grant, a UQ Social and Behavioral Sciences Tuition Fee Waiver Scholarship, and a UQ International Living Allowance Scholarship. The authors would like to thank the following people for their contributions to this research: Dana Schneider, Katrina Van Der List, Tirta Susilo, and Trudy Sinnamon (data collection); Anna Yuen and James White (acting in video clips); Paul Jackson (programming help); Dr Ron Hazelton (help with recruitment); and Beth O'Brien (statistical assistance).	Arango-Lasprilla JC, 2008, BRAIN INJURY, V22, P565, DOI 10.1080/02699050802172004; Baldo JV, 2006, J INT NEUROPSYCH SOC, V12, P896, DOI 10.1017/S1355617706061078; Barrash J, 2000, DEV NEUROPSYCHOL, V18, P355, DOI 10.1207/S1532694205Barrash; Barrett LF, 2004, J PERS SOC PSYCHOL, V87, P684, DOI 10.1037/0022-3514.87.5.684; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Berlin HA, 2004, BRAIN, V127, P1108, DOI 10.1093/brain/awh135; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Blais MC, 2007, BRAIN INJURY, V21, P357, DOI 10.1080/02699050701311075; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; Boone K. B., 2007, ASSESSMENT FEIGNED C; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Castelli F, 2002, BRAIN, V125, P1839, DOI 10.1093/brain/awf189; Channon S, 2005, BRAIN LANG, V93, P123, DOI 10.1016/j.bandl.2004.09.002; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; de Sousa A, 2011, CORTEX, V47, P526, DOI 10.1016/j.cortex.2010.02.004; de Sousa A, 2010, NEUROPSYCHOLOGIA, V48, P3585, DOI 10.1016/j.neuropsychologia.2010.08.008; Devinsky O., 2004, NEUROLOGY COGNITIVE, V68; Drummond SS, 2004, BRAIN INJURY, V18, P41, DOI 10.1080/0269905031000149461; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Garmoe W, 2005, J HEAD TRAUMA REHAB, V20, P348, DOI 10.1097/00001199-200507000-00006; Graham DP, 2008, ANN NY ACAD SCI, V1141, P148, DOI 10.1196/annals.1441.029; Gregory C, 2002, BRAIN, V125, P752, DOI 10.1093/brain/awf079; Gronwall D., 1998, HEAD INJURY FACTS; Hamsher K., 1989, MULTILINGUAL APHASIA; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P991, DOI 10.1016/S0003-9993(99)90049-7; Happe F, 1999, COGNITION, V70, P211, DOI 10.1016/S0010-0277(99)00005-0; HAPPE FGE, 1994, J AUTISM DEV DISORD, V24, P129, DOI 10.1007/BF02172093; Hart T, 2004, ARCH PHYS MED REHAB, V85, P1450, DOI 10.1016/j.apmr.2004.01.030; Hawley LA, 2010, BRAIN INJURY, V24, P1292, DOI 10.3109/02699052.2010.506866; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Heberlein AS, 2004, P NATL ACAD SCI USA, V101, P7487, DOI 10.1073/pnas.0308220101; Heider F, 1944, AM J PSYCHOL, V57, P243, DOI 10.2307/1416950; Jorge RE, 2005, CURR OPIN PSYCHIATR, V18, P289, DOI 10.1097/01.yco.0000165600.90928.92; Kertesz A, 1997, CAN J NEUROL SCI, V24, P29, DOI 10.1017/S0317167100021053; Kim E, 2002, NEUROREHABILITATION, V17, P297; Klin A, 2000, J CHILD PSYCHOL PSYC, V41, P831, DOI 10.1111/1469-7610.00671; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; Kringelbach ML, 2003, NEUROIMAGE, V20, P1371, DOI 10.1016/S1053-8119(03)00393-8; Lang PJ, 2005, A6 U FLOR CTR RES PS; Lee TMC, 2005, MOL PSYCHIATR, V10, P450, DOI 10.1038/sj.mp.4001595; LEVENSON RW, 1992, PSYCHOL SCI, V3, P23, DOI 10.1111/j.1467-9280.1992.tb00251.x; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Linscott RJ, 1996, BRAIN INJURY, V10, P397, DOI 10.1080/026990596124269; LOWE MR, 1978, BEHAV THER, V9, P535, DOI 10.1016/S0005-7894(78)80126-9; Malloy P.F., 2001, FRONTAL SYSTEMS BEHA; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2004, NEUROPSYCHOL REHABIL, V14, P285, DOI 10.1080/09602010343000237; McDonald S, 1996, BRAIN LANG, V53, P81, DOI 10.1006/brln.1996.0038; McDonald S., 2002, AWARENESS SOCIAL INF; McDonald S, 2009, NEUROPSYCHOL REHABIL, V19, P321, DOI 10.1080/09602010802193989; McGann W, 1997, BRAIN INJURY, V11, P621, DOI 10.1080/026990597123179; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Milders M, 2006, NEUROPSYCHOLOGY, V20, P400, DOI 10.1037/0894-4105.20.4.400; Muller F, 2010, CORTEX, V46, P1088, DOI 10.1016/j.cortex.2009.08.014; Nelson LD, 1998, ARCH CLIN NEUROPSYCH, V13, P549, DOI 10.1016/S0887-6177(97)00052-8; NHMRC, 2009, AUSTR GUID RED HLTH; Nyhus E, 2009, BRAIN COGNITION, V71, P437, DOI 10.1016/j.bandc.2009.03.005; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Pagulayan KF, 2008, ARCH PHYS MED REHAB, V89, P1887, DOI 10.1016/j.apmr.2008.03.019; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; *PSYCH CORP, 2001, WECHSL TEST AD READ; *PSYCH CORP, 1997, WECHSL AD INT SCAL; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rochat L, 2009, J NEUROPSYCHOL, V3, P213, DOI 10.1348/174866408X397656; Saunders JC, 2006, NEUROPSYCHOLOGY, V20, P224, DOI 10.1037/0894-4105.20.2.224; Shamay-Tsoory SG, 2005, COGN BEHAV NEUROL, V18, P55, DOI 10.1097/01.wnn.0000152228.90129.99; Shamay-Tsoory SG, 2003, J COGNITIVE NEUROSCI, V15, P324, DOI 10.1162/089892903321593063; Shamay-Tsoory SG, 2007, NEUROPSYCHOLOGIA, V45, P3054, DOI 10.1016/j.neuropsychologia.2007.05.021; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); SPSS/IBM, 2007, STAT PACK SOC SCI; Stone V.E., 2011, OXFORD HDB SOCIAL NE, P455; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Wiens S, 2000, COGNITION EMOTION, V14, P417, DOI 10.1080/026999300378905; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P259, DOI 10.1080/13803390902976940; Yamasato M, 2007, PSYCHIAT CLIN NEUROS, V61, P658, DOI 10.1111/j.1440-1819.2007.01720.x	86	18	18	1	21	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1747-0919	1747-0927		SOC NEUROSCI-UK	Soc. Neurosci.		2011	6	5-6			SI		599	614		10.1080/17470919.2011.584447			16	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	882NL	WOS:000299570500014	21777158				2022-02-06	
J	Koskinen, S; Hokkinen, EM; Wilson, L; Sarajuuri, J; Von Steinbuchel, N; Truelle, JL				Koskinen, Sanna; Hokkinen, Eeva-Maija; Wilson, Lindsay; Sarajuuri, Jaana; Von Steinbuechel, Nicole; Truelle, Jean-Luc			Comparison of subjective and objective assessments of outcome after traumatic brain injury using the International Classification of Functioning, Disability and Health (ICF)	DISABILITY AND REHABILITATION			English	Article						Outcome; HRQoL; TBI; ICF; QOLIBRI; GOSE	QUALITY-OF-LIFE; HEAD-INJURY; PROSPECTIVE COHORT; YOUNG-PEOPLE; CORE SETS; FOLLOW-UP; REHABILITATION; SATISFACTION; QOLIBRI; ADULTS	Purpose. The aim is to examine two aspects of outcome after traumatic brain injury (TBI). Functional outcome was assessed by the Glasgow Outcome Scale - Extended (GOSE) and by clinician ratings, while health-related quality of life (HRQoL) was assessed by the Quality of Life after Brain Injury (QOLIBRI). Method. The GOSE and the QOLIBRI were linked to the International Classification of Functioning, Disability and Health (ICF) to analyse their content. Functional outcome on ICF categories was assessed by rehabilitation clinicians in 55 participants with TBI and was compared to the participants' own judgements of their HRQoL. Results. The QOLIBRI was linked to 42 and the GOSE to 57 two-level ICF categories covering 78% of the categories on the ICF brief core set for TBI. The closest agreement in the views of the professionals and the participants was found on the Physical Problems and Cognition scales of the QOLIBRI. Conclusions. The problems encountered after TBI are well covered by the QOLIBRI and the GOSE. They capture important domains that are not traditionally sufficiently documented, especially in the domains of interpersonal relationships, social and leisure activities, self and the environment. The findings indicate that they are useful and complementary outcome measures for TBI. In rehabilitation, they can serve as tools in assessment, setting meaningful goals and creating therapeutic alliance.	[Koskinen, Sanna; Hokkinen, Eeva-Maija; Sarajuuri, Jaana] Kapyla Rehabil Ctr, Helsinki 00251, Finland; [Wilson, Lindsay] Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland; [Von Steinbuechel, Nicole] Univ Gottingen, Dept Med Psychol & Med Sociol, Gottingen, Germany; [Truelle, Jean-Luc] CHU Raymond Poincare, Serv Med Phys & Readapt, Garches, France		Koskinen, S (corresponding author), Kapyla Rehabil Ctr, POB 103, Helsinki 00251, Finland.	sannakos@gmail.com	Wilson, Lindsay/O-8883-2019; Wilson, Lindsay/A-3659-2009; Sarajuuri, Jaana/AAD-8665-2019	Wilson, Lindsay/0000-0003-4113-2328; Wilson, Lindsay/0000-0003-4113-2328; Sarajuuri, Jaana/0000-0002-6432-0295; Koskinen, Sanna/0000-0002-3453-5084	EVO of the Kapyla Rehabilitation Centre; Alfred Kordelin Foundation, Finland; Finnish Cultural FoundationFinnish Cultural FoundationFinnish IT center for science	The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper. This study was funded by EVO funding of the Kapyla Rehabilitation Centre, and by grants from the Alfred Kordelin Foundation, Finland, and the Finnish Cultural Foundation.	Alachini B, 2010, EUR J PHYS REHAB MED, V46, P27; Andelic N, 2010, DISABIL REHABIL, V32, P1122, DOI 10.3109/09638280903410722; [Anonymous], 1999, JAMA, V282, P974; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Bernabeu M, 2009, NEUROREHAB NEURAL RE, V23, P464, DOI 10.1177/1545968308328725; Branca B, 2004, J HEAD TRAUMA REHAB, V19, P40, DOI 10.1097/00001199-200401000-00005; Bullinger M, 2002, RESTOR NEUROL NEUROS, V20, P111; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Cieza A, 2005, J REHABIL MED, V37, P212, DOI 10.1080/16501970510040263; Cieza A, 2005, QUAL LIFE RES, V14, P1225, DOI 10.1007/s11136-004-4773-0; Cieza A, 2004, J REHABIL MED, V36, P9, DOI 10.1080/16501960410015353; Cieza A, 2002, J REHABIL MED, V34, P205, DOI 10.1080/165019702760279189; Coons SJ, 2000, PHARMACOECONOMICS, V17, P13, DOI 10.2165/00019053-200017010-00002; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P445, DOI 10.1097/00001199-200411000-00003; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; Dijkers M, 1999, AM J PHYS MED REHAB, V78, P286, DOI 10.1097/00002060-199905000-00022; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Fuhrer MJ, 2000, DISABIL REHABIL, V22, P481, DOI 10.1080/096382800413961; HERRMAN H, 1993, QUAL LIFE RES, V2, P153; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Hoffman JM, 2007, AM J PHYS MED REHAB, V86, P962, DOI 10.1097/PHM.0b013e31815b5ee5; JENNETT B, 1975, LANCET, V1, P480; Jorge RE, 2005, CURR OPIN PSYCHIATR, V18, P289, DOI 10.1097/01.yco.0000165600.90928.92; Judd T, 1999, NEUROPSYCHOTHERAPY C; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; Koskinen S, 2007, J REHABIL MED, V39, P467, DOI 10.2340/16501977-0077; Kozlowski O., 2002, Annales de Readaptation et de Medecine Physique, V45, P466, DOI 10.1016/S0168-6054(02)00297-0; Machamer J, 2002, J CLIN EXP NEUROPSYC, V24, P420, DOI 10.1076/jcen.24.4.420.1040; Mailhan L, 2005, BRAIN INJURY, V19, P227, DOI 10.1080/02699050410001720149; Mazaux JM, 2002, ACT NEUR S, V79, P49; Mazaux JM, 1998, DISABIL REHABIL, V20, P435, DOI 10.3109/09638289809166108; McCarthy ML, 2006, ARCH PHYS MED REHAB, V87, P953, DOI 10.1016/j.apmr.2006.03.007; Neugebauer E, 2002, RESTOR NEUROL NEUROS, V20, P161; Oppermann JD, 2004, BRAIN INJURY, V18, P941, DOI 10.1080/02699050410001671919; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Pierce CA, 2006, AM J PHYS MED REHAB, V85, P889, DOI 10.1097/01.phm.0000242615.43129.ae; Scarponi F, 2009, DISABIL REHABIL, V31, pS134, DOI 10.3109/09638280903317906; Seibert PS, 2002, BRAIN INJURY, V16, P837, DOI 10.1080/02699050210131939; Stucki G, 2008, EUR J PHYS REHAB MED, V44, P315; Stucki G, 2003, DISABIL REHABIL, V25, P628, DOI 10.1080/09638280110070221; Stucki G, 2007, J REHABIL MED, V39, P279, DOI 10.2340/16501977-0041; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; Ueda S, 2003, DISABIL REHABIL, V25, P596, DOI 10.1080/0963828031000137108; Underhill AT, 2003, BRAIN INJURY, V17, P973, DOI 10.1080/0269905031000110418; Van Baalen B, 2003, DISABIL REHABIL, V25, P9, DOI 10.1080/713813430; Vickery CD, 2005, BRAIN INJURY, V19, P657, DOI 10.1080/02699050400005218; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540; World Health Organization, ICF CHECKL VERS 2 1A; World Health Organization, 2007, INT CLASS FUNCT DIS; Zitnay GA, 2008, J NEUROTRAUM, V25, P1135, DOI 10.1089/neu.2008.0599	58	18	18	0	21	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2011	33	25-26					2464	2478		10.3109/09638288.2011.574776			15	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	851RO	WOS:000297288800008	21534850				2022-02-06	
J	Kuo, JR; Lo, CJ; Chang, CP; Lin, MT; Chio, CC				Kuo, Jinn-Rung; Lo, Chong-Jeh; Chang, Ching-Ping; Lin, Mao-Tsun; Chio, Chung-Ching			Attenuation of Brain Nitrosative and Oxidative Damage by Brain Cooling during Experimental Traumatic Brain Injury	JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY			English	Article							THERAPEUTIC HYPOTHERMIA; STRESS; ISCHEMIA; INFUSION; STROKE; RATS; NEUROPROTECTION; DYSFUNCTION; APOPTOSIS; LESSONS	The aim of the present study was to ascertain whether brain cooling causes attenuation of traumatic brain injury by reducing brain nitrostative and oxidative damage. Brain cooling was accomplished by infusion of 5mL of 4 degrees C saline over 5 minutes via the external jugular vein. Immediately after the onset of traumatic brain injury, rats were randomized into two groups and given 37 degrees C or 4 degrees C normal saline. Another group of rats were used as sham operated controls. Behavioral and biochemical assessments were conducted on 72 hours after brain injury or sham operation. As compared to those of the sham-operated controls, the 37 degrees C saline-treated brain injured animals displayed motor deficits, higher cerebral contusion volume and incidence, higher oxidative damage (e. g., lower values of cerebral superoxide dismutase, catalase, glutathione peroxidase and glutathione reductase, but higher values of cerebral malondialdehyde), and higher nitrostative damage (e. g., higher values of neuronal nitric oxide synthase and 3-nitrotyrosine). All the motor deficits and brain nitrostative and oxidative damage were significantly reduced by retrograde perfusion of 4 degrees C saline via the jugular vein. Our data suggest that brain cooling may improve the outcomes of traumatic brain injury in rats by reducing brain nitrostative and oxidative damage.	[Lin, Mao-Tsun] Chi Mei Med Ctr, Dept Med Res, Tainan 710, Taiwan; [Kuo, Jinn-Rung; Lo, Chong-Jeh] Natl Cheng Kung Univ, Inst Clin Med, Sch Med, Tainan 704, Taiwan; [Kuo, Jinn-Rung; Chang, Ching-Ping] So Taiwan Univ, Dept Biotechnol, Tainan 710, Taiwan; [Kuo, Jinn-Rung; Chio, Chung-Ching] Chi Mei Med Ctr, Dept Surg, Tainan 710, Taiwan; [Lo, Chong-Jeh] Chang Gung Mem Hosp, Div Trauma & Emergency Surg, Kaohsiung 833, Taiwan; [Lo, Chong-Jeh] Kaohsiung Med Ctr, Kaohsiung 833, Taiwan; [Lin, Mao-Tsun] Taipei Med Univ, Grad Inst Dis Prevent & Control, Taipei 112, Taiwan		Lin, MT (corresponding author), Chi Mei Med Ctr, Dept Med Res, Tainan 710, Taiwan.	891201@mail.chimei.org.tw; chiocc@ms28.hinet.net			National Science Council of the TaiwanMinistry of Science and Technology, Taiwan [NSC96-2314-B-384-002, NSC96-2314-B-384-003-MY3]	Financial support for this paper was provided in part by grants from the National Science Council of the Taiwan (NSC96-2314-B-384-002 and NSC96-2314-B-384-003-MY3).	Bayir H, 2005, J CEREBR BLOOD F MET, V25, P673, DOI 10.1038/sj.jcbfm.9600068; Bayir H, 2009, CRIT CARE MED, V37, P689, DOI 10.1097/CCM.0b013e318194abf2; Bivin W. S., 1979, The laboratory rat. Volume I. Biology and diseases., P73; Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001; Chang MW, 2008, J NEUROSCI METH, V168, P186, DOI 10.1016/j.jneumeth.2007.09.013; Chio CC, 2007, SHOCK, V28, P284, DOI 10.1097/SHK.0b013e3180311e60; Clifton GL, 2002, J NEUROTRAUM, V19, P293, DOI 10.1089/089771502753594864; Darwish RS, 2007, J TRAUMA, V63, P439, DOI 10.1097/TA.0b013e318069178a; DeKosky ST, 2004, J NEUROCHEM, V90, P998, DOI 10.1111/j.1471-4159.2004.02575.x; Ding YC, 2004, NEUROSURGERY, V54, P956, DOI 10.1227/01.NEU.0000114513.96704.29; Gladstone DJ, 2002, STROKE, V33, P2123, DOI 10.1161/01.STR.0000025518.34157.51; Guven H, 2002, J TRAUMA, V53, P66, DOI 10.1097/00005373-200207000-00014; GUYTON AC, 1991, TXB MED PHYSL, P679; Guyton AC, 1991, TXB MED PHYSL, P274; Hall ED, 1999, ANN NY ACAD SCI, V890, P462, DOI 10.1111/j.1749-6632.1999.tb08025.x; Hsu SF, 2006, SHOCK, V26, P210, DOI 10.1097/01.shk.0000223124.49265.10; Krieger DW, 2004, STROKE, V35, P1482, DOI 10.1161/01.STR.0000126118.44249.5c; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maier CM, 2002, NEUROBIOL DIS, V11, P28, DOI 10.1006/nbdi.2002.0513; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Peluffo H, 2004, J NEUROCHEM, V89, P602, DOI 10.1046/j.1471-4159.2004.02363.x; Pilitsis JG, 2003, NEUROSCI LETT, V349, P136, DOI 10.1016/S0304-3940(03)00803-6; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Vendrame M, 2004, STROKE, V35, P2390, DOI 10.1161/01.STR.0000141681.06735.9b; Wang JL, 2005, SHOCK, V23, P161, DOI 10.1097/01.shk.0000150779.47107.d5; Wang Y, 1997, J NEUROSCI, V17, P4341; Wen YS, 2005, J TRAUMA, V58, P577, DOI 10.1097/01.TA.0000152635.99243.30; Wright JE, 2005, CRIT CARE NURS Q, V28, P150, DOI 10.1097/00002727-200504000-00007; Yakovlev AG, 1997, J NEUROSCI, V17, P7415	32	18	18	0	2	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1110-7243	1110-7251		J BIOMED BIOTECHNOL	J. Biomed. Biotechnol.		2011									145214	10.1155/2011/145214			8	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Research & Experimental Medicine	744IA	WOS:000289086900001		Green Published, gold, Green Submitted			2022-02-06	
J	Le, K; Coelho, C; Mozeiko, J; Krueger, F; Grafman, J				Le, Karen; Coelho, Carl; Mozeiko, Jennifer; Krueger, Frank; Grafman, Jordan			Measuring goodness of story narratives: Implications for traumatic brain injury	APHASIOLOGY			English	Article; Proceedings Paper	40th Clinical Aphasiology Conference (CAC)	MAY 23-27, 2010	Isle of Palms, SC			Discourse production; Narrative discourse; Traumatic brain injury; Discourse analysis; Penetrating head injury; Story narratives	CLOSED-HEAD-INJURY; PRAGMATIC LANGUAGE-SKILLS; DISCOURSE PRODUCTION; WORKING-MEMORY; CHILDREN; ADULTS; COMPREHENSION; ABILITY; NEEDS	Background: This study examined the utility of story ogoodnesso, a measure of organisation and completeness, in quantifying narrative discourse deficits following traumatic brain injury (TBI). In an initial study, the story goodness measure demonstrated sensitivity and reliability in distinguishing individuals who had TBI from those who were non-brain-injured. Aims: The purpose of the current study was to validate previous findings of the story goodness index, specifically in discriminating performance between groups and identifying performance subgroups, in a larger sample of participants with TBI. Methods Procedures: A total of 46 non-brain-injured adults and 171 adults with TBI participated. Story retellings were analysed for story grammar and story completeness. The two discourse scores were then plotted as coordinates, which allowed for quantification of story goodness. Statistical analyses included a multivariate analysis of variance and calculation of Pearson correlation coefficients for the discourse measures. Outcomes Results: Results indicated that participants' scores clustered differentially across quadrants between groups and discriminated groups into four distinct categories of story ogoodnesso. Conclusions: Findings paralleled those found in the initial study, suggesting that story goodness is a sensitive measure for examining the discourse of individuals with TBI. The story goodness has potential clinical utility and may have implications for investigation of discourse impairments in other clinical populations and treatment of discourse deficits.	[Grafman, Jordan] NINDS, Cognit Neurosci Sect, Magnuson Clin Ctr, Bethesda, MD 20892 USA; [Le, Karen; Coelho, Carl; Mozeiko, Jennifer] Univ Connecticut, Dept Commun Sci, Storrs, CT 06268 USA		Grafman, J (corresponding author), NINDS, Cognit Neurosci Sect, Magnuson Clin Ctr, Bldg 10,7D43,MSC 1440,10 Ctr Dr, Bethesda, MD 20892 USA.	GrafmanJ@ninds.nih.gov		Grafman, Jordan H./0000-0001-8645-4457			Barrett J., 1998, OLD MCDONALD HAD APA, V2nd; Biddle KR, 1996, J COMMUN DISORD, V29, P447, DOI 10.1016/0021-9924(95)00038-0; Body R, 2004, BRAIN INJURY, V18, P707, DOI 10.1080/02699050310001596914; Brookshire BL, 2000, J INT NEUROPSYCH SOC, V6, P741, DOI 10.1017/S1355617700677019; Chapman SB, 2006, BRAIN LANG, V97, P178, DOI 10.1016/j.bandl.2005.10.002; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; Chapman SB, 2001, J HEAD TRAUMA REHAB, V16, P441, DOI 10.1097/00001199-200110000-00004; Coelho CA, 2003, APHASIOLOGY, V17, P499, DOI 10.1080/02687030344000111; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); Coelho Carl A., 2007, Seminars in Speech and Language, V28, P122, DOI 10.1055/s-2007-970570; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; Ewing-Cobbs L, 1998, BRAIN LANG, V61, P395, DOI 10.1006/brln.1997.1884; GLOSSER G, 1991, BRAIN LANG, V40, P67, DOI 10.1016/0093-934X(91)90117-J; HARTLEY L L, 1992, Brain Injury, V6, P271, DOI 10.3109/02699059209029669; Hay E, 2005, AM J SPEECH-LANG PAT, V14, P324, DOI 10.1044/1058-0360(2005/031); HEILMAN KM, 1971, J NEUROL NEUROSUR PS, V34, P265, DOI 10.1136/jnnp.34.3.265; Hunt K., 1965, 3 NCTE; Jorgensen M, 2009, BRAIN INJURY, V23, P727, DOI 10.1080/02699050903133954; Kaplan E, 1983, BOSTON NAMING TEST; Le K, 2011, J SPEECH LANG HEAR R, V54, P118, DOI 10.1044/1092-4388(2010/09-0022); LILES BZ, 1989, J SPEECH HEAR DISORD, V54, P356, DOI 10.1044/jshd.5403.356; Mar RA, 2004, NEUROPSYCHOLOGIA, V42, P1414, DOI 10.1016/j.neuropsychologia.2003.12.016; MCDONALD S, 1993, BRAIN LANG, V44, P28, DOI 10.1006/brln.1993.1003; MCDONALD S, 1995, BRAIN INJURY, V9, P255, DOI 10.3109/02699059509008197; MERRITT DD, 1987, J SPEECH HEAR RES, V30, P539, DOI 10.1044/jshr.3004.539; PLAG JA, 1967, PERS PSYCHOL, V20, P323, DOI 10.1111/j.1744-6570.1967.tb01527.x; Snow P, 1997, APHASIOLOGY, V11, P947, DOI 10.1080/02687039708249421; Tucker FM, 1998, BRAIN INJURY, V12, P783, DOI 10.1080/026990598122179; U. S. Department of Defense, 1984, TEST MAN ARM SERV VO; Youse KM, 2005, BRAIN INJURY, V19, P1001, DOI 10.1080/02699050500109951	30	18	18	0	10	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0268-7038	1464-5041		APHASIOLOGY	Aphasiology		2011	25	6-7					748	760	PII 938548156	10.1080/02687038.2010.539696			13	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	775XO	WOS:000291497000008		Green Submitted			2022-02-06	
J	Leemann, B; Laganaro, M; Chetelat-Mabillard, D; Schnider, A				Leemann, Beatrice; Laganaro, Marina; Chetelat-Mabillard, Daphne; Schnider, Armin			Crossover Trial of Subacute Computerized Aphasia Therapy for Anomia With the Addition of Either Levodopa or Placebo	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						aphasia; levodopa; stroke; traumatic brain injury; rehabilitation	OPEN-LABEL TRIAL; DOUBLE-BLIND; NONFLUENT APHASIA; COGNITIVE REHABILITATION; BROMOCRIPTINE; STROKE; PHARMACOTHERAPY; PIRACETAM; RECOVERY; MEMORY	Background. The effect of levodopa on recovery from aphasia is controversial. Objective. To determine whether levodopa enhances the effect of intensive computer-assisted therapy (CAT) of anomia in the postacute stage of aphasia. Methods. Double-blind multiple case study with intrasubject crossover design comparing the effect of levodopa (100 mg) versus placebo, each given for 2 weeks. Subjects. Twelve patients with onset of aphasia from 2 to 9 weeks after stroke or traumatic brain injury were compared on naming performance on items trained and not trained with CAT. Subjects were randomized to either levodopa or placebo first, separated by a 1-week washout, and then switched to the other drug intervention for the second 2-week CAT intervention. The subjects also received routine aphasia therapies during these periods. Results. All patients improved their naming performance for items trained by CAT in both periods (P = .001). No significant difference was found between the placebo and levodopa phases. Conclusion. Administration of levodopa for 2 weeks during the postacute stage of aphasia did not augment the positive effects of subacute intensive language treatment with CAT for a spoken naming task.	[Leemann, Beatrice] Hop Univ Geneve, Serv Neuroreeduc, CH-1211 Geneva 14, Switzerland; [Laganaro, Marina] Univ Neuchatel, CH-2000 Neuchatel, Switzerland		Leemann, B (corresponding author), Hop Univ Geneve, Serv Neuroreeduc, CH-1211 Geneva 14, Switzerland.	beatrice.leemann@hcuge.ch		Laganaro, Marina/0000-0002-4054-0939			ALBERT ML, 1988, NEUROLOGY, V38, P877, DOI 10.1212/WNL.38.6.877; Bragoni M, 2000, NEUROL SCI, V21, P19, DOI 10.1007/s100720070114; Cappa SF, 2003, EUR J NEUROL, V10, P11, DOI 10.1046/j.1468-1331.2003.00537.x; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; de Boissezon X, 2007, BRAIN LANG, V102, P114, DOI 10.1016/j.bandl.2006.07.004; ENDERBY P, 1994, CLIN NEUROPHARMACOL, V17, P320, DOI 10.1097/00002826-199408000-00003; Floel A, 2005, ANN NEUROL, V58, P121, DOI 10.1002/ana.20536; Gold M, 2000, BRAIN LANG, V74, P141, DOI 10.1006/brln.2000.2332; Gupta SR, 1995, NEUROLOGY, V45, P2170, DOI 10.1212/WNL.45.12.2170; Huber W, 1997, ARCH PHYS MED REHAB, V78, P245, DOI 10.1016/S0003-9993(97)90028-9; Jay TM, 2003, PROG NEUROBIOL, V69, P375, DOI 10.1016/S0301-0082(03)00085-6; Knecht S, 2004, ANN NEUROL, V56, P20, DOI 10.1002/ana.20125; Laganaro M, 2006, NEUROPSYCHOL REHABIL, V16, P630, DOI 10.1080/09602010543000064; Liepert J, 2008, CURR OPIN NEUROL, V21, P639, DOI 10.1097/WCO.0b013e32831897a3; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Rosser N, 2008, ARCH PHYS MED REHAB, V89, P1633, DOI 10.1016/j.apmr.2008.02.030; Sabe L, 1995, NEUROLOGY, V45, P2272, DOI 10.1212/WNL.45.12.2272; SABE L, 1992, NEUROLOGY, V42, P1637, DOI 10.1212/WNL.42.8.1637; Scheidtmann K, 2001, LANCET, V358, P787, DOI 10.1016/S0140-6736(01)05966-9; Seniow J, 2009, J NEUROL SCI, V283, P214, DOI 10.1016/j.jns.2009.02.336; Vitali P, 2007, NEUROREHAB NEURAL RE, V21, P152, DOI 10.1177/1545968306294735; Walker-Batson D, 2001, STROKE, V32, P2093, DOI 10.1161/hs0901.095720; Wertz R, 2004, APHASIOLOGY, V18, P229, DOI 10.1080/02687030444000048; Whiting E, 2008, BRAIN LANG, V104, P254, DOI 10.1016/j.bandl.2007.03.003	24	18	18	0	8	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683			NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	JAN	2011	25	1					43	47		10.1177/1545968310376938			5	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	700MS	WOS:000285747800005	20834044	Green Accepted			2022-02-06	
B	Lester, P; Leskin, G; Woodward, K; Saltzman, W; Nash, W; Mogil, C; Paley, B; Beardslee, W		Wadsworth, SM; Riggs, D		Lester, Patricia; Leskin, Gregory; Woodward, Kirsten; Saltzman, William; Nash, William; Mogil, Catherine; Paley, Blair; Beardslee, William			Wartime Deployment and Military Children: Applying Prevention Science to Enhance Family Resilience	RISK AND RESILIENCE IN U S MILITARY FAMILIES			English	Article; Book Chapter							POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH PROBLEMS; ADOLESCENT CHILDREN; VIETNAM VETERANS; COMBAT VETERANS; LOW-INCOME; PARENTS; INTERVENTION; IMPACT	During wartime, military families and children make extraordinary sacrifices for their country. This chapter reviews the impact of wartime deployments and parental combat-related mental health problems on military children, as well as risk and protective factors that may serve to guide preventive interventions for military families facing multiple deployments, combat operational stress, and psychological injuries. Using a public health prevention approach, we describe the adaptation of evidence-based interventions to support psychological health in military families. This adaptation is FOCUS (Families Over Coming Under Stress), a family-centered preventive intervention designed to enhance the strengths of family members, manage deployment-related stressors and reminders, and maintain positive family growth and psychological adjustment throughout the stages of deployment. Supported by the U.S. Bureau of Navy Medicine and Surgery (BUMED), military leadership, community providers, and families, this intervention has been implemented through a large-scale service demonstration project to support military families.	[Lester, Patricia; Leskin, Gregory; Saltzman, William; Mogil, Catherine] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, FOCUS, Los Angeles, CA 90095 USA; [Leskin, Gregory] Natl Ctr PTSD VA Palo Alto, Palo Alto, CA USA; [Woodward, Kirsten] USN, Wounded & Injured Support Directorate 3, Bur Med & Surg, Washington, DC USA; [Saltzman, William] Calif State Univ Long Beach, Long Beach, CA 90840 USA; [Paley, Blair] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Beardslee, William] Harvard Univ, Sch Med, Boston, MA USA; [Beardslee, William] Childrens Hosp, Dept Psychiat, Baer Prevent Initiat, Boston, MA 02115 USA		Lester, P (corresponding author), Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, FOCUS, Los Angeles, CA 90095 USA.	plester@mednet.ucla.edu					Ahnert L, 2004, CHILD DEV, V75, P639, DOI 10.1111/j.1467-8624.2004.00698.x; *AM AC PED, 2009, MIL YOUTH COP SEP FA; American Psychological Association, 2007, PSYCH NEEDS US MIL S; [Anonymous], 2006, DEV PSYCHOPATHOLOGY; Baker DG, 2009, MIL MED, V174, P773; Beardslee WR, 2007, J FAM PSYCHOL, V21, P703, DOI 10.1037/0893-3200.21.4.703; BEARDSLEE WR, 1988, AM J PSYCHIAT, V145, P63; Beardslee WR, 2003, PEDIATRICS, V112, pE119, DOI 10.1542/peds.112.2.e119; BEARDSLEE WR, 1984, PEDIATR ANN, V13, P32; Beardslee WR, 2009, ZERO 3, V29, P34; Beardslee WR., 1994, HDB DEPRESSION CHILD, P463; Belsky J, 2002, DEV PSYCHOPATHOL, V14, P293, DOI 10.1017/S0954579402002067; Bonds DD, 2007, J FAM PSYCHOL, V21, P288, DOI 10.1037/0893-3200.21.2.288; Bourg C, 1999, ARMED FORCES SOC, V25, P633, DOI 10.1177/0095327X9902500406; Bowlby J., 1973, ATTACHMENT LOSS; Bowlby J, 1980, ATTACHMENT LOSS VOLU; Bowlby J., 1988, SECURE BASE PARENT C; Bowlby J., 1969, ATTACHMENT LOSS VOL; Burrell LM, 2006, ARMED FORCES SOC, V33, P43, DOI 10.1177/0002764206288804; CARROLL EM, 1985, J ABNORM PSYCHOL, V94, P329, DOI 10.1037/0021-843X.94.3.329; CHANDRA A, 2008, UNDERSTANDING IMPACT; Chartrand MM, 2008, ARCH PEDIAT ADOL MED, V162, P1009, DOI 10.1001/archpedi.162.11.1009; Compas BE, 1989, PRIMARY PREVENTION P, P60; Cosgrove L., 2009, COMMUNICATION DISORD, V30, P77, DOI [https://doi.org/10.1177/1525740108328227, DOI 10.1177/1525740108328227]; Cox M.J., 2001, INTERPARENTAL CONFLI, P249, DOI DOI 10.1017/CBO9780511527838.011; Cox MJ, 1997, ANNU REV PSYCHOL, V48, P243, DOI 10.1146/annurev.psych.48.1.243; D'Angelo EJ, 2009, FAM PROCESS, V48, P269, DOI 10.1111/j.1545-5300.2009.01281.x; Davidson AC, 2001, AUST NZ J PSYCHIAT, V35, P345, DOI 10.1046/j.1440-1614.2001.00897.x; Dekel R, 2008, AM J ORTHOPSYCHIAT, V78, P281, DOI 10.1037/a0013955; Dybdahl R, 2001, CHILD DEV, V72, P1214, DOI 10.1111/1467-8624.00343; Eaton KM, 2008, MIL MED, V173, P1051, DOI 10.7205/MILMED.173.11.1051; Erbes C, 2007, MIL MED, V172, P359, DOI 10.7205/MILMED.172.4.359; EREL O, 1995, PSYCHOL BULL, V118, P108, DOI 10.1037/0033-2909.118.1.108; Faber AJ, 2008, J FAM PSYCHOL, V22, P222, DOI 10.1037/0893-3200.22.2.222; Feinberg ME, 2008, J FAM PSYCHOL, V22, P253, DOI 10.1037/0893-3200.22.2.253; Feinberg ME, 2002, CLIN CHILD FAM PSYCH, V5, P173, DOI 10.1023/A:1019695015110; Flake EM, 2009, J DEV BEHAV PEDIATR, V30, P271, DOI 10.1097/DBP.0b013e3181aac6e4; Friedman MJ, 2006, AM J PSYCHIAT, V163, P586, DOI 10.1176/appi.ajp.163.4.586; Galovski T, 2004, AGGRESS VIOLENT BEH, V9, P477, DOI 10.1016/S1359-1789(03)00045-4; Gibbs DA, 2007, JAMA-J AM MED ASSOC, V298, P528, DOI 10.1001/jama.298.5.528; GONZALEZ S, 1989, FAM PROCESS, V28, P69, DOI 10.1111/j.1545-5300.1989.00069.x; Hoge CQ, 2004, NEW ENGL J MED, V351, P2471; Hosek J., 2006, DEPLOYMENTS AFFECT S; Huebner AJ, 2007, FAM RELAT, V56, P112, DOI 10.1111/j.1741-3729.2007.00445.x; Jensen PS, 1996, J AM ACAD CHILD PSY, V35, P433, DOI 10.1097/00004583-199604000-00009; Kang HK, 2005, NEW ENGL J MED, V352, P1289, DOI 10.1056/NEJMp058024; Laor N, 2001, AM J PSYCHIAT, V158, P1020, DOI 10.1176/appi.ajp.158.7.1020; Layne CM, 2008, J AM ACAD CHILD PSY, V47, P1048, DOI 10.1097/CHI.0b013e31817eecae; LAYNE CM, 1999, TRAUMA GRIEF FOCUSED; LAYNE CM, 2002, UCLA TRAUMA GR UNPUB; Lester P, 2003, J DEV BEHAV PEDIATR, V24, P242, DOI 10.1097/00004703-200308000-00004; LESTER P, 2001, AM AC CHILD AD PSYCH; LESTER P, 2008, EVIDENCE BASED TREAT, P170; Lester P, 2010, J AM ACAD CHILD PSY, V49, P310, DOI 10.1016/j.jaac.2010.01.003; Lew HL, 2006, J REHABIL RES DEV, V43, pVII, DOI 10.1682/JRRD.2006.05.0054; Lincoln A, 2008, J CLIN PSYCHOL, V64, P984, DOI 10.1002/jclp.20520; McCarroll JE, 2008, CHILD ABUSE REV, V17, P108, DOI 10.1002/car.986; McFarlane AC, 2009, CURR OPIN PSYCHIATR, V22, P369, DOI 10.1097/YCO.0b013e32832c9064; *MIL CHILD ED COAL, 2007, MIL CHILD FACTS 2007; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Minuchin S., 1981, FAMILY THERAPY TECHN; Murray John S, 2002, J Spec Pediatr Nurs, V7, P127; Nachmias M, 1996, CHILD DEV, V67, P508, DOI 10.2307/1131829; Nash WP, OPERATIONAL IN PRESS; NASH WP, 2007, COMBAT STRESS INJURI, P103; National Research Council and Institute of Medicine, 2009, DEPR PAR PAR CHILDR; O'Connor E, 2007, J APPL DEV PSYCHOL, V28, P458, DOI 10.1016/j.appdev.2007.06.007; OCONNELL ME, 1994, BOARD CHILDREN YOUTH; Office of the Deputy Under Secretary of Defense, 2007, DEM 2007 PROF MIL CO; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Palmer C, 2008, MIL PSYCHOL, V20, P205, DOI 10.1080/08995600802118858; PATTERSON JM, 1987, J ADOLESCENCE, V10, P163, DOI 10.1016/S0140-1971(87)80086-6; Podorefsky DL, 2001, J AM ACAD CHILD PSY, V40, P879, DOI 10.1097/00004583-200108000-00008; Reger GM, 2009, TELEMED J E-HEALTH, V15, P101, DOI 10.1089/tmj.2008.0050; Rentz ED, 2007, AM J EPIDEMIOL, V165, P1199, DOI 10.1093/aje/kwm008; Riggs DS, 1998, J TRAUMA STRESS, V11, P87, DOI 10.1023/A:1024409200155; ROSEN LN, 1993, MIL MED, V158, P465, DOI 10.1093/milmed/158.7.465; Rotheram-Borus MJ, 2004, ARCH PEDIAT ADOL MED, V158, P742, DOI 10.1001/archpedi.158.8.742; Rotheram-Borus MJ, 2001, J CONSULT CLIN PSYCH, V69, P763, DOI 10.1037//0022-006X.69.5.763; Rotherarn-Borus MJ, 2003, AIDS, V17, P1217, DOI 10.1097/01.aids.0000060337.12269.1d; Ruscio AM, 2002, J TRAUMA STRESS, V15, P351, DOI 10.1023/A:1020125006371; RUTTER M, 1984, PSYCHOL MED, V14, P853, DOI 10.1017/S0033291700019838; RUTTER M, 1966, I PSYCHIAT MAUDSLEY, V16; Saltzman W. R., 2002, CHILD CHILD PSYCHIAT, V12, P319; Saltzman William R., 2009, FOCUS MILITARY FAMIL; Saltzman WR, 2001, GROUP DYN-THEOR RES, V5, P291, DOI 10.1037/1089-2699.5.4.291; SALTZMAN WR, 2007, PROJECT FOCUS MILITA; SALTZMAN WR, 2008, TREATING TRAUMATIZED; Schoppe-Sullivan SJ, 2009, J CHILD PSYCHOL PSYC, V50, P698, DOI 10.1111/j.1469-7610.2008.02009.x; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; SEGAL MW, 1986, ARMED FORCES SOC, V13, P9, DOI 10.1177/0095327X8601300101; SOLANTAUS T, INT J MENTA IN PRESS, V11, P15; Spoth Richard L, 2002, Prev Sci, V3, P145, DOI 10.1023/A:1019924615322; Sroufe LA, 2005, ATTACH HUM DEV, V7, P349, DOI 10.1080/14616730500365928; Stein JA, 1999, FAM PROCESS, V38, P193, DOI 10.1111/j.1545-5300.1999.00193.x; *US MAR CORPS, 2006, MCRP611CNTTP115M MAR; Waldrep DA, 2004, IRAQ WAR CLIN GUIDE, P83; Walsh F, 2007, FAM PROCESS, V46, P207, DOI 10.1111/j.1545-5300.2007.00205.x; Westerink J, 1999, AUST NZ J PSYCHIAT, V33, P841, DOI 10.1046/j.1440-1614.1999.00638.x; [No title captured]; [No title captured], DOI DOI 10.1177/1359104502007001006	101	18	18	0	9	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES			978-1-4419-7063-3				2011							149	173		10.1007/978-1-4419-7064-0_8	10.1007/978-1-4419-7064-0		25	Psychology, Clinical; Psychology, Developmental	Book Citation Index – Social Sciences & Humanities (BKCI-SSH)	Psychology	BSJ70	WOS:000284727200008					2022-02-06	
J	Li, LZ; Bao, YJ; Zhao, M				Li, Li-Zhuo; Bao, Yi-Jun; Zhao, Min			17Beta-estradiol attenuates programmed cell death in cortical pericontusional zone following traumatic brain injury via upregulation of ERalpha and inhibition of caspase-3 activation	NEUROCHEMISTRY INTERNATIONAL			English	Article						17Beta-estradiol; Cortical pericontusional zone; Estrogen receptor; Caspase-3	ESTROGEN-RECEPTOR-ALPHA; ESTRADIOL-MEDIATED PROTECTION; CENTRAL-NERVOUS-SYSTEM; CEREBRAL-ISCHEMIA; FOCAL ISCHEMIA; APOPTOSIS; RAT; BETA; PROGESTERONE; CONTUSIONS	Pericontusional zone (PCZ) of traumatic cerebral contusion is a target of pharmacological intervention. It is well studied that 17beta-estradiol has a protective role in ischemic brain injury, but its role in brain protection of traumatic brain damage deserves further investigation, especially in pericontusional zone. Here we show that 17beta-estradiol enhances the protein expression and mRNA induction of estrogen alpha receptor (ERalpha) and prevents from programmed cell death in cortical pericontusional zone. ERalpha specific antagonist blocks this protective effect of 17beta-estradiol. Caspase-3 activation occurs in cortical pericontusional zone of the oil-treated injured rat brain and its activation is inhibited by 17beta-estradiol treatment. Additionally. ERalpha specific antagonist reverses this inhibition. Pan-caspase inhibitor also protect cortical pericontusional zone from programmed cell death. Our present study indicates 17beta-estradiol protects from programmed cell death in cortical pericontusional zone via enhancement of ERalpha and decrease of caspase-3 activation. (C) 2010 Elsevier Ltd. All rights reserved.	[Li, Li-Zhuo; Zhao, Min] China Med Univ, Emergency Dept, Shengjing Hosp, Shenyang 110004, Liaoning, Peoples R China; [Bao, Yi-Jun] China Med Univ, Dept Neurosurg, Hosp 1, Shenyang 110004, Liaoning, Peoples R China		Li, LZ (corresponding author), China Med Univ, Emergency Dept, Shengjing Hosp, 36 Sanhao St, Shenyang 110004, Liaoning, Peoples R China.	lilizhuo1@hotmail.com			Natural Science Foundation of Liaoning Provincial Science and Technology Commission, Liaoning, China [20071051]	This study was supported by Grant from Natural Science Foundation of Liaoning Provincial Science and Technology Commission, Liaoning, China (No. 20071051).	BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; Bruce-Keller AJ, 2007, J NEUROTRAUM, V24, P203, DOI 10.1089/neu.2006.0163; Chen G, 2008, ANN CLIN LAB SCI, V38, P65; Chen SH, 2009, CRIT CARE MED, V37, P3097, DOI 10.1097/CCM.0b013e3181bc7986; Davoli MA, 2002, NEUROSCIENCE, V115, P125, DOI 10.1016/S0306-4522(02)00376-7; Dubal DB, 1999, J NEUROSCI, V19, P6385; Dubal DB, 1998, J CEREBR BLOOD F MET, V18, P1253, DOI 10.1097/00004647-199811000-00012; Dubal DB, 2001, P NATL ACAD SCI USA, V98, P1952, DOI 10.1073/pnas.98.4.1952; Dubal DB, 2006, ENDOCRINOLOGY, V147, P3076, DOI 10.1210/en.2005-1177; Duran-Vilaregut J, 2010, NEUROCHEM INT, V56, P443, DOI 10.1016/j.neuint.2009.12.001; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Goodman YD, 1996, J NEUROCHEM, V66, P1836; Green PS, 2000, INT J DEV NEUROSCI, V18, P347, DOI 10.1016/S0736-5748(00)00017-4; Harms C, 2001, J NEUROSCI, V21, P2600, DOI 10.1523/JNEUROSCI.21-08-02600.2001; Hewitt SC, 2000, BREAST CANCER RES, V2, P345, DOI 10.1186/bcr79; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Kushi H, 2003, ACTA NEUROCHIR SUPPL, V86, P339; LANDERS J P, 1992, Critical Reviews in Eukaryotic Gene Expression, V2, P19; Lebesgue D, 2006, J NEUROTRAUM, V23, P1814, DOI 10.1089/neu.2006.23.1814; Minambres E, 2008, J NEUROTRAUM, V25, P581, DOI 10.1089/neu.2007.0398; Namura S, 1998, J NEUROSCI, V18, P3659; Ng I, 2000, NEUROSURGERY, V46, P949, DOI 10.1097/00006123-200004000-00034; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Nilsen J, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-74; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; Shughrue PJ, 1997, J COMP NEUROL, V388, P507, DOI 10.1002/(SICI)1096-9861(19971201)388:4<507::AID-CNE1>3.0.CO;2-6; Simpkins JW, 1997, J NEUROSURG, V87, P724, DOI 10.3171/jns.1997.87.5.0724; Soustiel JF, 2005, J NEUROTRAUM, V22, P345, DOI 10.1089/neu.2005.22.345; Springer JE, 2001, CLIN CHEM LAB MED, V39, P299, DOI 10.1515/CCLM.2001.046; Suzuki S, 2007, P NATL ACAD SCI USA, V104, P6013, DOI 10.1073/pnas.0610394104; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Vegeto E, 2003, P NATL ACAD SCI USA, V100, P9614, DOI 10.1073/pnas.1531957100; Willingham MC, 1999, J HISTOCHEM CYTOCHEM, V47, P1101, DOI 10.1177/002215549904700901; Wise PM, 2001, FRONT NEUROENDOCRIN, V22, P33, DOI 10.1006/frne.2000.0207; Woolley CS, 1999, CURR OPIN NEUROBIOL, V9, P349, DOI 10.1016/S0959-4388(99)80051-8; Yakovlev AG, 2001, MOL NEUROBIOL, V24, P131	39	18	19	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	JAN	2011	58	1					126	133		10.1016/j.neuint.2010.11.006			8	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	718HM	WOS:000287111700017	21093516				2022-02-06	
J	McCauley, SR; Pedroza, C; Chapman, SB; Cook, LG; Vasquez, AC; Levin, HS				McCauley, Stephen R.; Pedroza, Claudia; Chapman, Sandra B.; Cook, Lori G.; Vasquez, Ana C.; Levin, Harvey S.			Monetary incentive effects on event-based prospective memory three months after traumatic brain injury in children	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Event-based prospective memory; Traumatic brain injury; Monetary incentives; Motivation; Memory rehabilitation; Pediatrics	PATIENTS PERFORMING ACTIVITIES; CUE-DISTINCTIVENESS; TASK INTERRUPTION; POCKET MONEY; ADULTS; AGE; SENSITIVITY; IMPAIRMENT; INTENTIONS; ALLOWANCE	Information regarding the remediation of event-based prospective memory (EB-PM) impairments following pediatric traumatic brain injury (TBI) is scarce. Addressing this, two levels of monetary incentives were used to improve EB-PM in children ages 7 to 16 years with orthopedic injuries (OI, n = 51), or moderate (n = 25) and severe (n = 39) TBI at approximately 3 months postinjury. The EB-PM task consisted of the child giving a specific verbal response to a verbal cue from the examiner while performing a battery of neuropsychological measures (ongoing task). Significant effects were found for age-at-test, motivation condition, period, and group. Within-group analyses indicated that OI and moderate TBI groups performed significantly better under the high-than under the low-incentive condition, but the severe TBI group demonstrated no significant improvement. These results indicate that EB-PM can be significantly improved at 3 months postinjury in children with moderate, but not severe, TBI.	[McCauley, Stephen R.] Baylor Coll Med, Cognit Neurosci Lab, Dept Pediat, Houston, TX 77030 USA; [Pedroza, Claudia] Univ Texas Med Sch Houston, Ctr Clin Res & Evidence Based Med, Houston, TX USA; [McCauley, Stephen R.; Levin, Harvey S.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [McCauley, Stephen R.; Levin, Harvey S.] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Chapman, Sandra B.; Cook, Lori G.] Univ Texas Dallas, Ctr Brain Hlth, Dallas, TX 75230 USA		McCauley, SR (corresponding author), Baylor Coll Med, Cognit Neurosci Lab, Dept Pediat, 1709 Dryden Rd,Ste 1200, Houston, TX 77030 USA.	mccauley@bcm.edu		Pedroza, Claudia/0000-0003-4235-1282	National Center for Medical Rehabilitation Research [K23 HD-40896]; National Institute Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-21889]; General Clinical Research Center at Texas Children's Hospital, Houston; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD040896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER	This work was supported by National Center for Medical Rehabilitation Research Grant K23 HD-40896 ("Prospective memory in normal and head-injured children," awarded to Stephen R. McCauley) and National Institute Neurological Disorders and Stroke Grant NS-21889 ("Neurobehavioral outcome of head injury in children," awarded to Harvey S. Levin). The information in this manuscript and the manuscript itself have never been published either electronically or in print. None of the authors have any financial or other relationship(s) that could be construed as a conflict of interest with respect to the content of this manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Medical Rehabilitation Research or the National Institutes of Health. We thank the participants and their families for their interest and willingness to be part of this research. I would like to extend my personal appreciation to Mark A. McDaniel and Harvey S. Levin who graciously served as mentors on my K-23 mentored patient-oriented research career development award. We also acknowledge the support of the General Clinical Research Center at Texas Children's Hospital, Houston.	Baddeley A., 1990, HUMAN MEMORY; Barnet-Verzat C, 2002, J ECON PSYCHOL, V23, P339, DOI 10.1016/S0167-4870(02)00080-6; Best D. L., 1992, MEMORY IMPROVEMENT I, P122; BRANDIMONTE MA, 1994, Q J EXP PSYCHOL-A, V47, P565, DOI 10.1080/14640749408401128; COCKBURN J, 1995, CORTEX, V31, P87, DOI 10.1016/S0010-9452(13)80107-4; Cohen J, 1988, POWER ANAL BEHAV SCI; *COMM INJ SCAL, 1990, ABBR INJ SCAL; Driscoll I, 2005, NEUROPSYCHOLOGY, V19, P28, DOI 10.1037/0894-4105.19.1.28; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; Fortin S, 2002, BRAIN COGNITION, V48, P361, DOI 10.1006/brcg.2001.1378; Fortin S, 2003, CORTEX, V39, P273, DOI 10.1016/S0010-9452(08)70109-6; Furnham A, 1999, BRIT J DEV PSYCHOL, V17, P585, DOI 10.1348/026151099165492; Furnham A, 2000, EUR PSYCHOL, V5, P202, DOI 10.1027//1016-9040.5.3.202; Furst C., 1986, COGNITIVE REHABILITA, V4, P24; GENTRY M, 1990, PERS SOC PSYCHOL B, V16, P241, DOI 10.1177/0146167290162005; Groot YCT, 2002, J INT NEUROPSYCH SOC, V8, P645, DOI 10.1017/S1355617702801321; Guajardo NR, 2000, COGNITIVE DEV, V15, P75, DOI 10.1016/S0885-2014(00)00016-2; Hannon R, 1995, REHABIL PSYCHOL, V40, P289, DOI 10.1037/0090-5550.40.4.289; Harris J. E., 1984, EVERYDAY MEMORY ACTI, P71; Hauser RM, 1997, SOCIOL METHODOL, V27, P177, DOI 10.1111/1467-9531.271028; Henry JD, 2007, J CLIN EXP NEUROPSYC, V29, P457, DOI 10.1080/13803390600762717; Hicks JL, 2005, AM J PSYCHOL, V118, P1; HUPPERT FA, 1993, J CLIN EXP NEUROPSYC, V15, P805, DOI 10.1080/01688639308402597; Kerns KA, 2001, CHILD NEUROPSYCHOL, V7, P162, DOI 10.1076/chin.7.3.162.8744; Kerns KA, 2000, J INT NEUROPSYCH SOC, V6, P62, DOI 10.1017/S1355617700611074; Kidder DP, 1997, AGING NEUROPSYCHOL C, V4, P93, DOI 10.1080/13825589708256639; Kinsella G, 1996, BRAIN INJURY, V10, P499, DOI 10.1080/026990596124214; Kliegel M, 2004, BRAIN COGNITION, V56, P43, DOI 10.1016/j.bandc.2004.05.005; Knight RG, 2006, J INT NEUROPSYCH SOC, V12, P8, DOI 10.1017/S1355617706060048; Knight RG, 2005, BRAIN INJURY, V19, P19, DOI 10.1080/02699050410001720022; KVAVILASHVILI L, 1992, APPL COGNITIVE PSYCH, V6, P507, DOI 10.1002/acp.2350060605; KVAVILASHVILI L, 1987, BRIT J PSYCHOL, V78, P507, DOI 10.1111/j.2044-8295.1987.tb02265.x; Kvavilashvili L, 2001, DEV PSYCHOL, V37, P418, DOI 10.1037//0012-1649.37.3.418; Larson MJ, 2007, J INT NEUROPSYCH SOC, V13, P615, DOI 10.1017/S1355617707070762; Louda J., 2007, Z NEUROPSYCHOL, V18, P91, DOI [10.1080/09602010600831004, DOI 10.1080/09602010600831004]; Mathias JL, 2005, BRAIN INJURY, V19, P271, DOI 10.1080/02699050400005028; MAYLOR EA, 1990, Q J EXP PSYCHOL-A, V42, P471, DOI 10.1080/14640749008401233; McCauley SR, 2004, DEV NEUROPSYCHOL, V25, P5, DOI 10.1207/s15326942dn2501&2_2; McCauley SR, 2010, CHILD NEUROPSYCHOL, V16, P293, DOI 10.1080/09297041003601470; McCauley SR, 2010, J INT NEUROPSYCH SOC, V16, P335, DOI 10.1017/S135561770999138X; McCauley SR, 2009, NEUROPSYCHOLOGY, V23, P201, DOI 10.1037/a0014192; McDaniel M A, 1993, Memory, V1, P23, DOI 10.1080/09658219308258223; McDaniel M.A., 1996, PROSPECT MEM THEORY, P115; McQueen, 2003, BRAIN IMPAIR, V4, P135, DOI [10.1375/brim.4.2.135.270, DOI 10.1375/BRIM.4.2.135.27024]; MEACHAM JA, 1976, PROSPECTIVE REMEMBER; Neisser U., 1982, MEMORY OBSERVED REME, P327; Neul SKT, 2001, CHILD FAM BEHAV THER, V23, P37, DOI 10.1300/J019v23n04_03; PASTORE DR, 1992, COMPREHENSIVE ADOLES; Raskin SA, 2009, BRAIN IMPAIR, V10, P76, DOI 10.1375/brim.10.1.76; Roche NL, 2007, NEUROPSYCHOL REHABIL, V17, P314, DOI 10.1080/09602010600831004; Roche NL, 2002, BRAIN INJURY, V16, P931, DOI 10.1080/02699050210138581; RUTHER NM, 1993, M SE PSYCH ASS; Salthouse TA, 2004, MEM COGNITION, V32, P1133, DOI 10.3758/BF03196887; Shum D, 1999, J CLIN EXP NEUROPSYC, V21, P49, DOI 10.1076/jcen.21.1.49.943; Taylor HG, 2004, DEV NEUROPSYCHOL, V25, P199, DOI 10.1207/s15326942dn2501&2_11; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; TEASDALE G, 1974, LANCET, V2, P81; Thone-Otto AIT, 2003, INT J PSYCHOL, V38, P236, DOI 10.1080/00207590344000169; Ward H, 2005, CHILD NEUROPSYCHOL, V11, P527, DOI 10.1080/09297040490920186; Ward H, 2004, BRAIN INJURY, V18, P471, DOI 10.1080/02699050310001646107; Ward H, 2007, CHILD NEUROPSYCHOL, V13, P219, DOI 10.1080/09297040600910003; WILKINS AJ, 1978, PRACTICAL ASPECTS ME; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; WILSON B, 1987, REHABILITATION MEMOR; Winograd E., 1988, PRACTICAL ASPECTS ME, V1, P348; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617	67	18	19	0	8	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2011	33	6					639	646		10.1080/13803395.2010.547844			8	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	882GA	WOS:000299550100004	21347945	Green Accepted			2022-02-06	
J	Schramm, P; Klein, KU; Pape, M; Berres, M; Werner, C; Kochs, E; Engelhard, K				Schramm, Patrick; Klein, Klaus Ulrich; Pape, Monika; Berres, Manfred; Werner, Christian; Kochs, Eberhard; Engelhard, Kristin			Serial Measurement of Static and Dynamic Cerebrovascular Autoregulation After Brain Injury	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						traumatic brain injury; intracranial hemorrhage; dynamic cerebrovascular autoregulation; static cerebrovascular autoregulation; transcranial Doppler sonography	CEREBRAL PERFUSION-PRESSURE; HEAD-INJURY; INTRACEREBRAL HEMORRHAGE; BLOOD-FLOW; MANAGEMENT; METABOLISM; PROPOFOL; THERAPY; HUMANS	Background: In patients with neuronal injury, the knowledge of the status of cerebrovascular autoregulation can help to optimize the management of the cerebral perfusion pressure. This study characterizes dynamic and static cerebrovascular autoregulation during the first 7 days after severe traumatic brain injury or intracranial hemorrhage. Methods: After approval from the IRB, 16 patients were studied. Cerebral blood flow velocity (CBFV) was measured daily for the assessment of dynamic (10 patients) and static (16 patients) cerebrovascular autoregulation in both the middle cerebral arteries using the transcranial Doppler sonography. Dynamic cerebrovascular autoregulation (dAR) was measured using the cuff-deflation method and was expressed by the index of the dAR. The index of the static cerebrovascular autoregulation (sAR) was calculated from changes in the CBFV in relation to drug-induced alterations of the arterial blood pressure. For statistical analyses, t test and mixed effect model were used. Results: Both dAR and sAR after brain injury were impaired in most of the patients. The chronologic sequence of the dAR at the ipsilateral injured hemisphere showed a significant decrease until day 4 followed by an incomplete recovery (P < 0.002). Changes in sAR were similar, however, they did not gain statistical significance. CBFV was lower at day 1-2 after injury in comparison with day 4 to 7 (P < 0.02). Conclusion: Daily measured dAR and sAR were impaired after brain injury with a nadir on day 4 and consecutive incomplete recovery over time.	[Schramm, Patrick; Klein, Klaus Ulrich; Pape, Monika; Werner, Christian; Engelhard, Kristin] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anesthesiol, D-55131 Mainz, Germany; [Berres, Manfred] Johannes Gutenberg Univ Mainz, Univ Med Ctr, IMBEI, D-55131 Mainz, Germany; [Berres, Manfred] RheinAhrCampus Remagen, Remagen, Germany; [Kochs, Eberhard] Tech Univ Munich, Klinikum Rechts Isar, Dept Anesthesiol, D-8000 Munich, Germany		Schramm, P (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anesthesiol, Langenbeckstr 1, D-55131 Mainz, Germany.	schrammp@uni-mainz.de	Schramm, Patrick/AAM-1482-2020	Schramm, Patrick/0000-0001-5158-6708; Klein, Klaus Ulrich/0000-0001-7446-0542			Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Broderick J, 2007, CIRCULATION, V116, pE391, DOI 10.1161/CIRCULATIONAHA.107.183689; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Engelhard K, 2001, CAN J ANAESTH, V48, P1034, DOI 10.1007/BF03016597; Engelhard K, 2001, ACTA ANAESTH SCAND, V45, P971, DOI 10.1034/j.1399-6576.2001.450809.x; Grande PO, 2002, ACTA ANAESTH SCAND, V46, P929, DOI 10.1034/j.1399-6576.2002.460802.x; Hlatky R, 2002, J NEUROSURG, V97, P1054, DOI 10.3171/jns.2002.97.5.1054; Lagerkranser M, 1997, J NEUROSURG ANESTH, V9, P188, DOI 10.1097/00008506-199704000-00015; Lang EW, 2003, J NEUROTRAUM, V20, P69, DOI 10.1089/08977150360517191; Mahony PJ, 2000, STROKE, V31, P476, DOI 10.1161/01.STR.31.2.476; Mascia L, 2000, INTENS CARE MED, V26, P202, DOI 10.1007/s001340050046; Moppett IK, 2008, BRIT J ANAESTH, V100, P240, DOI 10.1093/bja/aem374; Naredi S, 2001, ACTA ANAESTH SCAND, V45, P402, DOI 10.1034/j.1399-6576.2001.045004402.x; Peterson E, 2009, J TRAUMA, V67, P944, DOI 10.1097/TA.0b013e3181ae6e6d; Reinhard M, 2010, INTENS CARE MED, V36, P264, DOI 10.1007/s00134-009-1698-7; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Steiner LA, 2003, ANESTH ANALG, V97, P572, DOI 10.1213/01.ANE.0000070234.17226.B0; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Sviri GE, 2009, J NEUROSURG, V111, P695, DOI 10.3171/2008.10.17686; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014	21	18	19	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0898-4921			J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JAN	2011	23	1					41	44		10.1097/ANA.0b013e3181f35854			4	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	692FC	WOS:000285137200008	21252706				2022-02-06	
J	Tjaden, K; Wilding, G				Tjaden, Kris; Wilding, Greg			The Impact of Rate Reduction and Increased Loudness on Fundamental Frequency Characteristics in Dysarthria	FOLIA PHONIATRICA ET LOGOPAEDICA			English	Article						Dysarthria; Fundamental frequency; Speaking rate; Loudness	TRAUMATIC BRAIN-INJURY; SOUND PRESSURE LEVEL; CONVERSATIONAL SPEECH; PARKINSONS-DISEASE; ACOUSTIC CHARACTERISTICS; MULTIPLE-SCLEROSIS; AMERICAN ENGLISH; SPEAKING RATE; CLEAR SPEECH; INTELLIGIBILITY	Objective: This study examined the extent to which articulatory rate reduction and increased loudness were associated with adjustments in utterance-level measures of fundamental frequency (F(0)) variability for speakers with dysarthria and healthy controls that have been shown to impact on intelligibility in previously published studies. More generally, the current study sought to compare and contrast how a slowerthan-normal rate and increased vocal loudness impact on a variety of utterance-level F(0) characteristics for speakers with dysarthria and healthy controls. Patients and Methods: Eleven speakers with Parkinson's disease, 15 speakers with multiple sclerosis, and 14 healthy control speakers were audio recorded while reading a passage in habitual, loud, and slow conditions. Magnitude production was used to elicit variations in rate and loudness. Acoustic measures of duration, intensity and F(0) were obtained. Results and Conclusions: For all speaker groups, a slower-than-normalarticulatory rate and increased vocal loudness had distinct effects on F(0) relative to the habitual condition, including a tendency for measures of F(0) variation to be greater in the loud condition and reduced in the slow condition. These results suggest implications for the treatment of dysarthria. Copyright (C) 2010 S. Karger AG, Basel	[Tjaden, Kris] SUNY Buffalo, Dept Commun Disorders & Sci, Buffalo, NY 14214 USA; [Wilding, Greg] SUNY Buffalo, Dept Biostat, Buffalo, NY 14214 USA		Tjaden, K (corresponding author), SUNY Buffalo, Dept Commun Disorders & Sci, 122 Cary Hall,3435 Main St, Buffalo, NY 14214 USA.	Tjaden@buffalo.edu			NIDCDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01DC004689]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01DC004689] Funding Source: NIH RePORTER	We thank Beth Hilczmayer and Erin Szajta for their assistance with the acoustic analyses as well as Miranda Crumb and Grace Liu for their assistance with data reduction and entry. Portions of this study were reported at the 2008 Conference on Motor Speech. Research supported by NIDCD R01DC004689.	Beukelman DR, 2002, J MED SPEECH-LANG PA, V10, P237; Binns C, 2007, J ACOUST SOC AM, V122, P1765, DOI 10.1121/1.2751394; Bradlow AR, 1996, SPEECH COMMUN, V20, P255, DOI 10.1016/S0167-6393(96)00063-5; Bunton K, 2001, CLIN LINGUIST PHONET, V15, P181; Bunton K, 2006, FOLIA PHONIATR LOGO, V58, P323, DOI 10.1159/000094567; COOPER WE, 1981, FUNDAMENTAL FREQUENC; Dromey C, 1998, J SPEECH LANG HEAR R, V41, P1003, DOI 10.1044/jslhr.4105.1003; Dromey C, 2000, J MED SPEECH-LANG PA, V8, P155; Duffy, 2005, MOTOR SPEECH DISORDE; Ferguson SH, 2007, J SPEECH LANG HEAR R, V50, P1241, DOI 10.1044/1092-4388(2007/087); Goberman AM, 2005, J COMMUN DISORD, V38, P215, DOI 10.1016/j.jcomdis.2004.10.001; HOLMBERG EB, 1988, J ACOUST SOC AM, V84, P511, DOI 10.1121/1.396829; Kain AB, 2007, SPEECH COMMUN, V49, P743, DOI 10.1016/j.specom.2007.05.001; KIM HH, 1994, THESIS U WISCONSIN M; Kleinow J, 2001, J SPEECH LANG HEAR R, V44, P1041, DOI 10.1044/1092-4388(2001/082); Krause JC, 2004, J ACOUST SOC AM, V115, P362, DOI 10.1121/1.1635842; Ladd DR, 1999, J ACOUST SOC AM, V106, P1543, DOI 10.1121/1.427151; Laures JS, 1999, J SPEECH LANG HEAR R, V42, P1148, DOI 10.1044/jslhr.4205.1148; LEDORZE G, 1992, EUR J DISORDER COMM, V27, P313; LIEBERMAN P, 1985, J ACOUST SOC AM, V77, P649, DOI 10.1121/1.391883; LIEBERMAN P, 1967, INTONATION PERCEPTIO; Liss J. M., 2007, MOTOR SPEECH DISORDE, P187; MASSEN B, 1984, J ACOUST SOC AM, V76, P1673; McHenry MA, 2003, J SPEECH LANG HEAR R, V46, P702, DOI 10.1044/1092-4388(2003/055); McHenry MA, 2006, J MED SPEECH-LANG PA, V14, P197; MILENKOVIC P, 2003, TF32 COMPUTER PROGRA; MILENKOVIC P, 1997, CSPEECH VERSION 4 0; Patel R, 2008, J SPEECH LANG HEAR R, V51, P209, DOI 10.1044/1092-4388(2008/016); PICHENY MA, 1986, J SPEECH HEAR RES, V29, P434, DOI 10.1044/jshr.2904.434; Sapir S, 2001, J MED SPEECH-LANG PA, V9, P141; Spitzer SM, 2007, J ACOUST SOC AM, V122, P3678, DOI 10.1121/1.2801545; STATHOPOULOS ET, 1993, J SPEECH HEAR RES, V36, P64, DOI 10.1044/jshr.3601.64; Stathopoulos ET, 1997, J SPEECH LANG HEAR R, V40, P595, DOI 10.1044/jslhr.4003.595; Steppling ML, 2002, PERCEPT PSYCHOPHYS, V64, P451, DOI 10.3758/BF03194717; Tjaden K, 2005, J SPEECH LANG HEAR R, V48, P261, DOI 10.1044/1092-4388(2005/018); Tjaden K, 2004, J SPEECH LANG HEAR R, V47, P766, DOI 10.1044/1092-4388(2004/058); TURNER GS, 1993, J SPEECH HEAR RES, V36, P1134, DOI 10.1044/jshr.3606.1134; Wang YT, 2005, FOLIA PHONIATR LOGO, V57, P59, DOI 10.1159/000083569; Watson PJ, 2008, AM J SPEECH-LANG PAT, V17, P348, DOI 10.1044/1058-0360(2008/07-0048); Weismer G, 2001, FOLIA PHONIATR LOGO, V53, P1, DOI 10.1159/000052649; WINGFIELD A, 1984, J SPEECH HEAR RES, V27, P125; YORKSTON K, 2003, J SPEECH LANG HEAR R, V46, P80; Yorkston KM, 2007, J MED SPEECH-LANG PA, V15, pXI	43	18	18	0	13	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1021-7762			FOLIA PHONIATR LOGO	Folia Phoniatr. Logop.		2011	63	4					178	186		10.1159/000316315			9	Audiology & Speech-Language Pathology; Otorhinolaryngology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Otorhinolaryngology; Rehabilitation	854AE	WOS:000297466100002	20938199	Green Published, Bronze			2022-02-06	
J	Tlustos, SJ; Chiu, CYP; Walz, NC; Holland, SK; Bernard, L; Wade, SL				Tlustos, Sarah J.; Chiu, C. -Y. Peter; Walz, Nicolay Chertkoff; Holland, Scott K.; Bernard, Lori; Wade, Shari L.			Neural Correlates of Interference Control in Adolescents with Traumatic Brain Injury: Functional Magnetic Resonance Imaging Study of the Counting Stroop Task	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Childhood brain disorder; Inhibition; Executive functions; Brain imaging; Adolescent; Head injury	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; ANTERIOR CINGULATE CORTEX; WORKING-MEMORY; COGNITIVE-CONTROL; RETROSPECTIVE ESTIMATION; RESPONSE-INHIBITION; EXECUTIVE FUNCTIONS; EARLY-CHILDHOOD; HEAD-INJURY; ACTIVATION	Difficulty in inhibition or cognitive control is a common and significant sequela of pediatric traumatic brain injury (TBI). The present study used functional MRI to examine one specific inhibitory function, interference control, in 11 adolescents, aged 12-16 years, (mean age, 15.7 years) with TBI who were at least 1 year postinjury and 11 age-matched typically developing control participants (TC) (mean age, 15.2 years). Participants completed a Counting Stroop task with 2 main conditions: (I) a neutral condition requiring the counting of animal words and (2) an interference condition in which mismatched number words were counted. Both TBI and TC adolescents activated similar networks of brain regions relevant to interference control, but the TBI group showed higher levels of activation relative to the TC group in multiple brain areas within this network, including predominantly right frontal and parietal regions. Findings of greater activation of the relevant neural network in the TBI group are consistent with recent fMRI findings using other interference control paradigms with individuals with a history of TBI. (JINS, 2011, 17, 181-189)	[Tlustos, Sarah J.; Chiu, C. -Y. Peter] Univ Cincinnati, Dept Psychol, Cincinnati, OH 45221 USA; [Chiu, C. -Y. Peter] Univ Cincinnati, Dept Commun Sci & Disorders, Cincinnati, OH 45221 USA; [Walz, Nicolay Chertkoff; Holland, Scott K.; Wade, Shari L.] Univ Cincinnati, Coll Med, Cincinnati, OH 45221 USA; [Walz, Nicolay Chertkoff] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Behav Med & Clin Psychol, Cincinnati, OH USA; [Holland, Scott K.] Cincinnati Childrens Hosp Med Ctr, Dept Radiol, Cincinnati Childrens Hosp Res Fdn, Cincinnati, OH USA; [Bernard, Lori; Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Phys Med & Rehabil, Cincinnati, OH USA		Chiu, CYP (corresponding author), Univ Cincinnati, Dept Psychol, 101A Dyer Hall,ML 0376, Cincinnati, OH 45221 USA.	peter.chiu@uc.edu		Holland, Scott/0000-0003-3719-0875	National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [RO1-MH073764]; National Institute on Disability and Rehabilitation Research in the Department of Education [H133G050239]; Ohio Department of Public Safety; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH073764] Funding Source: NIH RePORTER	This work was supported in part by (I) NIH grant RO1-MH073764 from the National Institute of Mental Health; (2) H133G050239 from the National Institute on Disability and Rehabilitation Research in the Department of Education, and (3) EMS/Trauma grant from the Ohio Department of Public Safety. The information in this manuscript is an original contribution to the literature and has not previously been published, electronically or in print. The authors certify that we know of no conflict of interest, and we adhere to the ethical guidelines of the Helsinki Declaration. We thank three anonymous reviewers for providing numerous helpful comments and suggestions for improving the manuscript. The order of the first two authors was determined by a coin toss.	Aarts E, 2008, J NEUROSCI, V28, P4671, DOI 10.1523/JNEUROSCI.4400-07.2008; Anderson V, 1998, BRAIN INJURY, V12, P937, DOI 10.1080/026990598121990; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Bush G, 1998, HUM BRAIN MAPP, V6, P270, DOI 10.1002/(SICI)1097-0193(1998)6:4<270::AID-HBM6>3.3.CO;2-H; Bush G, 2003, MOL PSYCHIATR, V8, P60, DOI 10.1038/sj.mp.4001217; Bush G, 1999, BIOL PSYCHIAT, V45, P1542, DOI 10.1016/S0006-3223(99)00083-9; Casey BJ, 2005, TRENDS COGN SCI, V9, P104, DOI 10.1016/j.tics.2005.01.011; Catroppa C, 2005, J INT NEUROPSYCH SOC, V11, P84, DOI 10.1017/S1355617705050101; Catroppa C, 2003, DEV NEUROPSYCHOL, V23, P359, DOI 10.1207/S15326942DN2303_3; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Crosnoe R, 2008, J RES ADOLESCENCE, V18, P23, DOI 10.1111/j.1532-7795.2008.00549.x; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dunn, 2007, PPVT 4 PEABODY PICTU; E-Prime, E PRIM COMP SOFTW; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; Ewing-Cobbs L, 1998, CHILD NEUROPSYCHOL, V4, P35, DOI 10.1076/chin.4.1.35.3194; Fan J, 2003, NEUROIMAGE, V18, P42, DOI 10.1006/nimg.2002.1319; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Guy SC, 2004, BRIEF SR BEHAV RATIN; HU XP, 1995, MAGNET RESON MED, V34, P201, DOI 10.1002/mrm.1910340211; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kramer ME, 2008, J INT NEUROPSYCH SOC, V14, P424, DOI 10.1017/S1355617708080545; Kramer ME, 2009, J PEDIATR REHAB MED, V2, P255, DOI 10.3233/PRM-2009-0091; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Le TH, 1996, MAGNET RESON MED, V35, P290, DOI 10.1002/mrm.1910350305; Ledberg A, 1998, NEUROIMAGE, V8, P113, DOI 10.1006/nimg.1998.0336; Levin HS, 2009, DEV NEUROREHABIL, V12, P320, DOI 10.3109/17518420903087673; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Max JE, 2005, J AM ACAD CHILD PSY, V44, P443, DOI 10.1097/01.chi.0000156661.38576.0f; Mayer AR, 2009, HUM BRAIN MAPP, V30, P4152, DOI 10.1002/hbm.20836; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; Muzik O, 2000, NEUROIMAGE, V12, P538, DOI 10.1006/nimg.2000.0651; Newsome MR, 2008, NEUROPSYCHOLOGY, V22, P419, DOI 10.1037/0894-4105.22.4.419; Newsome MR, 2007, NEUROCASE, V13, P16, DOI 10.1080/13554790601186629; Newsome MR, 2007, CORTEX, V43, P95, DOI 10.1016/S0010-9452(08)70448-9; Orme DR, 2004, REHABIL PSYCHOL, V49, P250, DOI 10.1037/0090-5550.49.3.250; PENNINGTON BF, 1994, MAC FDN MEN, P243; Posner MI, 2007, ANNU REV PSYCHOL, V58, P1, DOI 10.1146/annurev.psych.58.110405.085516; Ridderinkhof KR, 2004, BRAIN COGNITION, V56, P129, DOI 10.1016/j.bandc.2004.09.016; Sanchez-Carrion R, 2008, NEUROIMAGE, V43, P421, DOI 10.1016/j.neuroimage.2008.08.003; Schachar R, 2004, DEV NEUROPSYCHOL, V25, P179, DOI 10.1207/s15326942dn2501&2_10; Scheibel RS, 2009, J NEUROTRAUM, V26, P1447, DOI 10.1089/neu.2008.0736; Scheibel RS, 2007, NEUROREHAB NEURAL RE, V21, P36, DOI 10.1177/1545968306294730; Schmithorst VJ, 2007, NEUROIMAGE, V35, P406, DOI 10.1016/j.neuroimage.2006.11.046; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; Talairach J., 1988, COPLANAR STEREOTACTI; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Wechsler D, 2003, WECHSLER INTELLIGENC; Wigfield A., 1994, J EARLY ADOLESC, V14, P102, DOI [https://doi.org/10.1177/027243169401400202, DOI 10.1177/027243169401400202]; Wilke M, 2002, HUM BRAIN MAPP, V17, P48, DOI 10.1002/hbm.10053; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; Xiong JH, 1995, HUM BRAIN MAPP, V3, P287, DOI 10.1002/hbm.460030404; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64	58	18	18	1	11	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JAN	2011	17	1					181	189		10.1017/S1355617710001414			9	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	702KX	WOS:000285894700020	21092356	Green Accepted			2022-02-06	
J	Coomber, B; Gibson, CL				Coomber, Ben; Gibson, Claire L.			Sustained levels of progesterone prior to the onset of cerebral ischemia are not beneficial to female mice	BRAIN RESEARCH			English	Article						Aquaporins; Cerebral edema; Focal cerebral ischemia; Progesterone; Stroke	TRAUMATIC BRAIN-INJURY; ARTERY OCCLUSION; PLASMA PROGESTERONE; FOCAL ISCHEMIA; STROKE INJURY; NITRIC-OXIDE; ESTROGEN; EDEMA; MECHANISMS; EXPRESSION	Female gender, which is abolished following ovariectomy and reproductive senescence, is associated with improved outcome following cerebral stroke. Estrogen replacement partially restores this benefit of the female gender but the effect of progesterone in hormone-deficient animals is currently unknown. We evaluated various outcomes following middle cerebral artery occlusion (MCAO) in ovariectomised female mice, with a physiologically relevant restoration of progesterone levels. Ovariectomised female mice had significantly elevated plasma (P=<0.05) and brain progesterone levels (P=<0.01) following implantation of a 21-day release pellet (50 mg) compared with mice that received placebo implants 7 days prior to undergoing 60 min MCAO. Assessment of well-being (body weight recovery) and neurological score at 24 h and 48 h post-MCAO indicated that MCAO significantly worsened outcome compared with sham-operated mice but progesterone had no effect. MCAO resulted in a substantial lesion formation and a significant increase (P<0.05) in ipsilateral brain water content, both of which were not affected by progesterone treatment. Furthermore, there was no significant alteration in ipsilateral Aquaporin-4 (AQP4) expression following MCAO or progesterone treatment. The present study indicates that sustained physiologically relevant levels of progesterone prior to cerebral ischemia neither benefited nor worsened outcomes in previously ovariectomised female mice. (C) 2010 Elsevier B.V. All rights reserved.	[Coomber, Ben; Gibson, Claire L.] Univ Leicester, Sch Psychol, Leicester LE1 9HN, Leics, England		Gibson, CL (corresponding author), Univ Leicester, Sch Psychol, Henry Wellcome Bldg,Lancaster Rd, Leicester LE1 9HN, Leics, England.	cg95@le.ac.uk		Gibson, Claire/0000-0002-3358-7341	Research Into Ageing [317]	This work was funded by Research Into Ageing (317 to CLG).	Alkayed NJ, 1998, STROKE, V29, P159, DOI 10.1161/01.STR.29.1.159; Alkayed NJ, 2000, STROKE, V31, P161, DOI 10.1161/01.STR.31.1.161; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Chen JL, 1999, J NEUROL SCI, V171, P24, DOI 10.1016/S0022-510X(99)00247-6; Danton GH, 2003, J NEUROPATH EXP NEUR, V62, P127, DOI 10.1093/jnen/62.2.127; Dubal DB, 1998, J CEREBR BLOOD F MET, V18, P1253, DOI 10.1097/00004647-199811000-00012; DUVDEVANI R, 1995, J NEUROTRAUM, V12, P65, DOI 10.1089/neu.1995.12.65; FARR SA, 1995, PHYSIOL BEHAV, V58, P715, DOI 10.1016/0031-9384(95)00124-2; Fox J.G., 2006, MOUSE BIOMEDICAL RES, V3; FRYDENLUND DS, 2006, P NATL ACAD SCI USA, V103, P1353; Frye CA, 1998, BRAIN RES, V808, P72, DOI 10.1016/S0006-8993(98)00764-1; Gebel JM, 2002, STROKE, V33, P2636, DOI 10.1161/01.STR.0000035283.34109.EA; Gibson CL, 2005, EXP NEUROL, V193, P522, DOI 10.1016/j.expneurol.2005.01.009; Gibson CL, 2004, J CEREBR BLOOD F MET, V24, P805, DOI 10.1097/01.WCB.0000125365.83980.00; Gibson CL, 2005, J NEUROPATH EXP NEUR, V64, P763, DOI 10.1097/01.jnen.0000179196.10032.dd; Gibson CL, 2008, BRAIN, V131, P318, DOI 10.1093/brain/awm183; Gibson CL, 2009, NEUROSCIENTIST, V15, P324, DOI 10.1177/1073858409333069; Gonzalez-Vidal MD, 1998, ARCH MED RES, V29, P117; Grossman KJ, 2000, BEHAV BRAIN RES, V116, P141, DOI 10.1016/S0166-4328(00)00275-8; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Hayakawa K, 2008, NEUROPHARMACOLOGY, V55, P1280, DOI 10.1016/j.neuropharm.2008.06.040; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; Hurn PD, 2000, J CEREBR BLOOD F MET, V20, P631, DOI 10.1097/00004647-200004000-00001; HURN PD, 2002, PHARM CEREBRAL ISCHE, P17; Jiang N, 1996, BRAIN RES, V735, P101, DOI 10.1016/0006-8993(96)00605-1; KOMEYEV A, 1993, J NEUROCHEM, V61, P2041; Kumon Y, 2000, J NEUROSURG, V92, P848, DOI 10.3171/jns.2000.92.5.0848; LIU Y, 2008, J CEREB BLOOD FLOW M, V28, P1898; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Loihl AK, 1999, BRAIN RES, V830, P155, DOI 10.1016/S0006-8993(99)01388-8; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Murphy SJ, 2000, STROKE, V31, P1173, DOI 10.1161/01.STR.31.5.1173; Murphy SJ, 2004, ILAR J, V45, P147, DOI 10.1093/ilar.45.2.147; Murphy SJ, 2002, J CEREBR BLOOD F MET, V22, P1181, DOI 10.1097/01.WCB.0000037990.07114.07; MURR SM, 1974, ENDOCRINOLOGY, V94, P1209, DOI 10.1210/endo-94-4-1209; Rash JE, 1998, P NATL ACAD SCI USA, V95, P11981, DOI 10.1073/pnas.95.20.11981; Rogers DC, 1997, STROKE, V28, P2060, DOI 10.1161/01.STR.28.10.2060; ROOF RL, 1992, RESTOR NEUROL NEUROS, V4, P425, DOI 10.3233/RNN-1992-4608; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Rusa R, 1999, STROKE, V30, P1665, DOI 10.1161/01.STR.30.8.1665; SAITO TR, 1982, JPN J VET SCI, V44, P125; Simpkins JW, 1997, J NEUROSURG, V87, P724, DOI 10.3171/jns.1997.87.5.0724; SMITH SS, 1994, PROG NEUROBIOL, V44, P55, DOI 10.1016/0301-0082(94)90057-4; Toung TK, 2000, STROKE, V31, P2701, DOI 10.1161/01.STR.31.11.2701; Turtzo LC, 2008, CEREBROVASC DIS, V26, P462, DOI 10.1159/000155983; WASSERTHEILSMOL.S, 2003, WOMENS HLTH, V289, P2673; Wise PM, 2001, BRAIN RES REV, V37, P313, DOI 10.1016/S0165-0173(01)00136-9; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Yahata T, 1996, CELL IMMUNOL, V171, P269, DOI 10.1006/cimm.1996.9988	51	18	18	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	NOV 18	2010	1361						124	132		10.1016/j.brainres.2010.09.037			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	679WQ	WOS:000284191900013	20850417				2022-02-06	
J	Gyorgy, AB; Walker, J; Wingo, D; Eidelman, O; Pollard, HB; Molnar, A; Agoston, DV				Gyorgy, Andrea B.; Walker, John; Wingo, Dan; Eidelman, Ofer; Pollard, Harvey B.; Molnar, Andras; Agoston, Denes V.			Reverse phase protein microarray technology in traumatic brain injury	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Antibody specificity; Reverse phase protein microarray; Bioinformatics; Traumatic brain injury	VALIDATION; CANCER; PROTEOMICS; PATHWAYS; MEDICINE; ANTIBODY; TISSUE	Antibody based, high throughput proteomics technology represents an exciting new approach in understanding the pathobiologies of complex disorders such as cancer, stroke and traumatic brain injury. Reverse phase protein microarray (RPPA) can complement the classical methods based on mass spectrometry as a high throughput validation and quantification method. RPPA technology can address problematic issues, such as sample complexity, sensitivity, quantification, reproducibility and throughput, which are currently associated with mass spectrometry-based approaches. However, there are technical challenges, predominantly associated with the selection and use of antibodies, preparation and representation of samples and with analyzing and quantifying primary RPPA data. Here we present ways to identify and overcome some of the current issues associated with RPPA. We believe that using stringent quality controls, improved bioinformatics analysis and interpretation of primary RPPA data, this method will significantly contribute in generating new level of understanding about complex disorders at the level of systems biology. Published by Elsevier B.V.	[Gyorgy, Andrea B.; Walker, John; Wingo, Dan; Eidelman, Ofer; Pollard, Harvey B.; Molnar, Andras; Agoston, Denes V.] Uniformed Serv Univ Hlth Sci, Sch Med, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA		Gyorgy, AB (corresponding author), USU, Dept Anat Physiol & Genet, Program Neurosci, Neurosurg Program Natl Capital Consortium,Sch Med, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	agyorgy@usuhs.mil			Defense Advanced Research Projects Agency (DARPA)United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)	The work was funded by Defense Advanced Research Projects Agency (DARPA) Preventing Violent Explosive Neurologic Trauma (PREVENT) program. We thank Members of the PREVENT Team for providing the biosamples for our analysis and Ms. Nicole Draghic for her editorial assistance.	AGOSTON DV, 2009, J NEUROTRAUMA; Aguilar-Mahecha A, 2006, OMICS, V10, P311, DOI 10.1089/omi.2006.10.311; ANDERSON T, 2009, PROTEOMICS; BAUMAN RA, 2009, J NEUROTRAUMA; Belluco C, 2005, CLIN CHIM ACTA, V357, P180, DOI 10.1016/j.cccn.2005.03.024; Bjorling E, 2008, MOL CELL PROTEOMICS, V7, P2028, DOI 10.1074/mcp.M800264-MCP200; Bordeaux J, 2010, BIOTECHNIQUES, V48, P197, DOI 10.2144/000113382; Breitling R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-100; Chan SM, 2004, NAT MED, V10, P1390, DOI 10.1038/nm1139; Espina V, 2003, PROTEOMICS, V3, P2091, DOI 10.1002/pmic.200300592; Espina Virginia, 2007, V383, P321, DOI 10.1007/978-1-59745-335-6_21; Espina V, 2009, CLIN LAB MED, V29, P1, DOI 10.1016/j.cll.2009.03.001; Espina Virginia, 2009, V520, P89, DOI 10.1007/978-1-60327-811-9_7; GYORGY A, J NEUROTRAUMA UNPUB; Kricka LJ, 2008, MOL BIOTECHNOL, V38, P19, DOI 10.1007/s12033-007-0066-5; Kumble KD, 2003, ANAL BIOANAL CHEM, V377, P812, DOI 10.1007/s00216-003-2088-6; Liotta LA, 2003, NATURE, V425, P905, DOI 10.1038/425905a; Liotta LA, 2003, CANCER CELL, V3, P317, DOI 10.1016/S1535-6108(03)00086-2; Liotta Lance A, 2003, Clin Adv Hematol Oncol, V1, P460; MacBeath G, 2002, NAT GENET, V32, P526, DOI 10.1038/ng1037; Madoz-Gurpide J, 2001, PROTEOMICS, V1, P1279, DOI 10.1002/1615-9861(200110)1:10<1279::AID-PROT1279>3.0.CO;2-W; Marina O, 2008, J PROTEOME RES, V7, P2059, DOI 10.1021/pr700892h; Nishizuka S, 2008, CURR OPIN BIOTECH, V19, P41, DOI 10.1016/j.copbio.2007.11.007; Paweletz CP, 2001, ONCOGENE, V20, P1981, DOI 10.1038/sj.onc.1204265; Poetz O, 2005, MECH AGEING DEV, V126, P161, DOI 10.1016/j.mad.2004.09.030; Pollard HB, 2007, PROTEOM CLIN APPL, V1, P934, DOI 10.1002/prca.200700154; Ramaswamy Anitha, 2005, Proteome Sci, V3, P9, DOI 10.1186/1477-5956-3-9; Schweitzer B, 2002, CURR OPIN BIOTECH, V13, P14, DOI 10.1016/S0958-1669(02)00278-1; Shingyoji M, 2005, TALANTA, V67, P472, DOI 10.1016/j.talanta.2005.06.064; Spurrier B, 2008, NAT PROTOC, V3, P1796, DOI 10.1038/nprot.2008.179; VanMeter A, 2007, EXPERT REV MOL DIAGN, V7, P625, DOI 10.1586/14737159.7.5.625; Wulfkuhle JD, 2006, NAT CLIN PRACT ONCOL, V3, P256, DOI 10.1038/ncponc0485; Zong Yaping, 2007, V381, P363	33	18	18	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270			J NEUROSCI METH	J. Neurosci. Methods	SEP 30	2010	192	1					96	101		10.1016/j.jneumeth.2010.07.029			6	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	671CM	WOS:000283477500012	20674607				2022-02-06	
J	Klin, Y; Zlotnik, A; Boyko, M; Ohayon, S; Shapira, Y; Teichberg, VI				Klin, Yael; Zlotnik, Alexander; Boyko, Matthew; Ohayon, Sharon; Shapira, Yoram; Teichberg, Vivian I.			Distribution of radiolabeled L-glutamate and D-aspartate from blood into peripheral tissues in naive rats: Significance for brain neuroprotection	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						Brain; Glutamate; Blood; Organ distribution; Neuroprotection	HUMAN HEAD-INJURY; EXCITATORY AMINO-ACIDS; CEREBROSPINAL-FLUID; ISCHEMIC-STROKE; NEURONAL DEATH; RELEASE; METABOLISM; TRANSPORTERS; BARRIER; HUMANS	Excess L-glutamate (glutamate) levels in brain interstitial and cerebrospinal fluids (ISF and CSF, respectively) are the hallmark of several neurodegenerative conditions such as stroke, traumatic brain injury or amyotrophic lateral sclerosis. Its removal could prevent the glutamate excitotoxicity that causes long-lasting neurological deficits. As in previous studies, we have established the role of blood glutamate levels in brain neuroprotection, we have now investigated the contribution of the peripheral organs to the homeostasis of glutamate in blood. We have administered naive rats with intravenous injections of either L-[1-C-14]Glutamic acid (L-[1-C-14] Glu), L-[G-H-3] Glutamic acid (L-[G-H-3] Glu) or D-[2,3-H-3] Aspartic acid (D-[2,3-H-3] Asp), a non-metabolized analog of glutamate, and have followed their distribution into peripheral organs. We have observed that the decay of the radioactivity associated with 01-14C1 Glu and L-[G-H-3] Glu was faster than that associated with glutamate non-metabolized analog, D-[2,3-H-3] Asp. L-[1-C-14] Glu was subjected in blood to a rapid decarboxylation with the loss of (CO2)-C-14. The three major sequestrating organs, serving as depots for the eliminated glutamate and/or its metabolites were skeletal muscle, liver and gut, contributing together 92% or 87% of total L-[U-C-14] Glu or D-[2,3-H-3] Asp radioactivity capture. L-[U-C-14] Glu and D-[2,3-H-3] Asp showed a different organ sequestration pattern. We conclude that glutamate is rapidly eliminated from the blood into peripheral tissues, mainly in non-metabolized form. The liver plays a central role in glutamate metabolism and serves as an origin for glutamate metabolites that redistribute into skeletal muscle and gut. The findings of this study suggest now that pharmacological manipulations that reduce the liver glutamate release rate or cause a boosting of the skeletal muscle glutamate pumping rate are likely to cause brain neuroprotection. (C) 2010 Elsevier Inc. All rights reserved.	[Klin, Yael; Teichberg, Vivian I.] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Zlotnik, Alexander; Boyko, Matthew; Ohayon, Sharon; Shapira, Yoram] Soroka Med Ctr, Div Anesthesiol, IL-84101 Beer Sheva, Israel; [Zlotnik, Alexander; Boyko, Matthew; Ohayon, Sharon; Shapira, Yoram] Ben Gurion Univ Negev, IL-84105 Beer Sheva, Israel		Teichberg, VI (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	Vivian.teichberg@weizmann.ac.il		Boyko, Matthew/0000-0003-3116-1643	Braintact Ltd	V.I.T. has received a grant from Braintact Ltd. as well as consultancy fees.	BAKER AJ, 1993, J NEUROSURG, V79, P369, DOI 10.3171/jns.1993.79.3.0369; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Camacho A, 2006, ARCH MED RES, V37, P11, DOI 10.1016/j.arcmed.2005.05.014; Castillo J, 1997, LANCET, V349, P79, DOI 10.1016/S0140-6736(96)04453-4; Castillo J, 1996, STROKE, V27, P1060, DOI 10.1161/01.STR.27.6.1060; Castillo J, 2002, NEUROLOGY, V58, P624, DOI 10.1212/WNL.58.4.624; CHEN M, 1991, ANN NEUROL, V30, P62, DOI 10.1002/ana.410300112; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.neuro.13.1.171; CHOI DW, 1994, PROG BRAIN RES, V100, P47; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Davalos A, 1997, STROKE, V28, P708, DOI 10.1161/01.STR.28.4.708; EGER EI, 1974, UPTAKE INHALED ANEST; Gottlieb M, 2003, J NEUROCHEM, V87, P119, DOI 10.1046/j.1471-4159.2003.01972.x; Graham TE, 2000, AM J PHYSIOL-ENDOC M, V278, pE83, DOI 10.1152/ajpendo.2000.278.1.E83; Hediger MA, 1999, AM J PHYSIOL-RENAL, V277, pF477, DOI 10.1152/ajprenal.1999.277.4.F477; Johnston MV, 2001, PEDIATR RES, V49, P735, DOI 10.1203/00006450-200106000-00003; Koura SS, 1998, ACT NEUR S, V71, P244; LAJTHA A, 1959, J NEUROCHEM, V3, P322, DOI 10.1111/j.1471-4159.1959.tb12638.x; Mate M, 2009, EUR J PHARMACOL, V604, P51, DOI 10.1016/j.ejphar.2008.12.022; MATTHEWS JC, 2005, EXPRESSION NONORGANE; Nagy D, 2009, CELL MOL NEUROBIOL, V29, P827, DOI 10.1007/s10571-009-9364-8; O'Kane RL, 1999, J BIOL CHEM, V274, P31891, DOI 10.1074/jbc.274.45.31891; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Patterson BW, 2002, AM J PHYSIOL-ENDOC M, V282, pE931, DOI 10.1152/ajpendo.00359.2001; PETROFF CP, 1965, INT J APPL RADIAT IS, V16, P599, DOI 10.1016/0020-708X(65)90096-7; Richards DA, 2003, PHARMACOL RES, V48, P101, DOI 10.1016/S1043-6618(03)00081-1; Rose ME, 2002, BRAIN RES, V943, P15, DOI 10.1016/S0006-8993(02)02471-X; RUTTEN MJ, 1987, BRAIN RES, V425, P301, DOI 10.1016/0006-8993(87)90513-0; Serena J, 2001, STROKE, V32, P1154, DOI 10.1161/01.STR.32.5.1154; Teichberg VI, 2009, NEUROSCIENCE, V158, P301, DOI 10.1016/j.neuroscience.2008.02.075; Teichberg VI, 2007, P NATL ACAD SCI USA, V104, P7315, DOI 10.1073/pnas.0702450104; THOMASSEN A, 1991, METABOLISM, V40, P378, DOI 10.1016/0026-0495(91)90148-P; Vesce S, 2007, INT REV NEUROBIOL, V82, P57, DOI 10.1016/S0074-7742(07)82003-4; Wieraszko A, 2009, NEUROSCI LETT, V458, P19, DOI 10.1016/j.neulet.2009.04.024; Zauner A, 1996, ACT NEUR S, V67, P40; Zhang H, 2001, CLIN CHEM, V47, P1458; Zlotnik A, 2007, EXP NEUROL, V203, P213, DOI 10.1016/j.expneurol.2006.08.021; Zlotnik A, 2009, J NEUROSURG ANESTH, V21, P235, DOI 10.1097/ANA.0b013e3181a2bf0b	38	18	20	0	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	SEP 3	2010	399	4					694	698		10.1016/j.bbrc.2010.07.144			5	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	650HQ	WOS:000281840200040	20691657				2022-02-06	
J	Kulbatski, I				Kulbatski, Iris			Stem/Precursor Cell-Based CNS Therapy: The Importance of Circumventing Immune Suppression by Transplanting Autologous Cells	STEM CELL REVIEWS AND REPORTS			English	Article						Stem/precursor cells; Central nervous system; Transplantation; Autologous; Immunosuppresion; Immunomodulation; Neural repair; Bone marrow stromal cells; Neurotrauma; Neurodegeneration	PLURIPOTENT STEM-CELLS; SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; MICROGLIAL CELLS; STROMAL CELLS; AUTOIMMUNE ENCEPHALOMYELITIS; FUNCTIONAL RECOVERY; MULTIPLE-SCLEROSIS; PROGENITOR-CELLS; NEUROPROTECTION	Stem/precursor cell (SPC) therapy for neuro-degeneration and neurotrauma has enormous therapeutic potential, but despite ongoing research efforts the success of clinical trials remains limited. Therapies that utilize immune suppression in combination with SPC transplantation have thus far failed to consider the beneficial role of the immune system in central nervous system (CNS) recovery. Systemic immune suppression may prevent neural repair, and in some cases exacerbate the underlying disorder. Until about a decade ago, immunosuppression for CNS disorders was viewed as a therapeutic target, based on the perception that all immune activity in the CNS was destructive. However, recent studies show that the infiltration of blood-borne immune cells into the CNS following neurotrauma and during chronic neurodegeneration promote CNS protection and regeneration. In the context of SPC therapies, although immune suppression prevents rejection of non-autologous cell grafts, it also prevents the restorative immune response by eliminating the immune mediated guidance cues that are required for SPCs to migrate to the location they are needed, and preventing SPC-mediated immunomodulation. This article argues in favor of transplanting autologous SPCs, particularly bone marrow derived cells. The therapeutic use of autologous SPCs for neural repair circumvents the need for concomitant immune suppression, exploits the immunomodulatory capacity of these cells, and maintains the immune niche that supports neural repair and is required to guide these cells to their appropriate locations. Overall, such an approach accommodates the requirements for translational therapeutics, and provides a standardized platform for reconciling the inherent controversies in the science.	Cedars Sinai Med Ctr, Maxine Dunitz Neurosurg Inst, Los Angeles, CA 90048 USA		Kulbatski, I (corresponding author), Cedars Sinai Med Ctr, Maxine Dunitz Neurosurg Inst, Davis Res Bldg 2029,8700 Beverly Blvd, Los Angeles, CA 90048 USA.	iris.kulbatski@sympatico.ca					Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Amariglio N, 2009, PLOS MED, V6, P221, DOI 10.1371/journal.pmed.1000029; ARMSTRONG RC, 1990, J NEUROSCI RES, V27, P400, DOI 10.1002/jnr.490270319; Baker M, 2009, NATURE, V457, P941, DOI 10.1038/457941a; Bechmann I, 2001, RESTOR NEUROL NEUROS, V19, P189; Beers DR, 2008, P NATL ACAD SCI USA, V105, P15558, DOI 10.1073/pnas.0807419105; Belmadani A, 2006, J NEUROSCI, V26, P3182, DOI 10.1523/JNEUROSCI.0156-06.2006; Ben-Hur T, 2003, MOL CELL NEUROSCI, V24, P623, DOI 10.1016/S1044-7431(03)00218-5; Ben-Hur T, 2008, J NEUROL SCI, V265, P102, DOI 10.1016/j.jns.2007.05.007; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Butovsky O, 2007, EUR J NEUROSCI, V26, P413, DOI 10.1111/j.1460-9568.2007.05652.x; Cao QL, 2001, EXP NEUROL, V167, P48, DOI 10.1006/exnr.2000.7536; CHAO CC, 1992, J IMMUNOL, V149, P2736; Chiu IM, 2008, P NATL ACAD SCI USA, V105, P17913, DOI 10.1073/pnas.0804610105; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Einstein O, 2007, ANN NEUROL, V61, P209, DOI 10.1002/ana.21033; Glezer I, 2007, NEUROSCIENCE, V147, P867, DOI 10.1016/j.neuroscience.2007.02.055; Gris D, 2004, J NEUROSCI, V24, P4043, DOI 10.1523/JNEUROSCI.5343-03.2004; Himes BT, 2006, NEUROREHAB NEURAL RE, V20, P278, DOI 10.1177/1545968306286976; Hofstetter HH, 2003, J NEUROIMMUNOL, V134, P25, DOI 10.1016/S0165-5728(02)00358-2; Horner PJ, 2000, J NEUROSCI, V20, P2218; Hyun I, 2008, CELL STEM CELL, V3, P607, DOI 10.1016/j.stem.2008.11.009; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Jalving M, 2009, CURR OPIN MOL THER, V11, P383; Johansson CB, 1999, EXP CELL RES, V253, P733, DOI 10.1006/excr.1999.4678; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Karussis D, 2008, J NEUROL SCI, V265, P131, DOI 10.1016/j.jns.2007.05.005; Kulbatski I, 2005, CURR DRUG TARGETS, V6, P111, DOI 10.2174/1389450053345037; Lalive PH, 2005, EUR J IMMUNOL, V35, P727, DOI 10.1002/eji.200425430; Le Blanc K, 2004, SCAND J IMMUNOL, V60, P307, DOI 10.1111/j.0300-9475.2004.01483.x; Lee H, 2009, REGEN MED, V4, P759, DOI 10.2217/RME.09.46; Leon S, 2000, J NEUROSCI, V20, P4615, DOI 10.1523/JNEUROSCI.20-12-04615.2000; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; LININGTON C, 1993, EUR J IMMUNOL, V23, P1364, DOI 10.1002/eji.1830230627; Mabon PJ, 2000, EXP NEUROL, V166, P52, DOI 10.1006/exnr.2000.7488; Mahmood A, 2005, NEUROSURGERY, V57, P1026, DOI 10.1227/01.NEU.0000181369.76323.50; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Majed HH, 2006, J NEUROSCI, V26, P1730, DOI 10.1523/JNEUROSCI.0702-05.2006; Malm TM, 2005, NEUROBIOL DIS, V18, P134, DOI 10.1016/j.nbd.2004.09.009; Mansilla E, 2005, TRANSPL P, V37, P292, DOI 10.1016/j.transproceed.2005.01.070; Mathews DJH, 2008, NEUROLOGY, V71, P288, DOI 10.1212/01.wnl.0000316436.13659.80; McDonald JW, 2004, J NEUROTRAUM, V21, P383, DOI 10.1089/089771504323004539; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Moalem G, 1999, NAT MED, V5, P49, DOI 10.1038/4734; Namiki J, 1999, J NEUROPATH EXP NEUR, V58, P489, DOI 10.1097/00005072-199905000-00008; Nasef A, 2008, REGEN MED, V3, P531, DOI 10.2217/17460751.3.4.531; Neumann J, 2006, FASEB J, V20, P714, DOI 10.1096/fj.05-4882fje; Park HC, 2005, TISSUE ENG, V11, P913, DOI 10.1089/ten.2005.11.913; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Polazzi E, 2001, GLIA, V36, P271, DOI 10.1002/glia.1115; Popovich PG, 1999, EXP NEUROL, V158, P351, DOI 10.1006/exnr.1999.7118; Popovich PG, 2001, J NEUROPATH EXP NEUR, V60, P676, DOI 10.1093/jnen/60.7.676; Popovich PG, 2002, J NEUROPATH EXP NEUR, V61, P623, DOI 10.1093/jnen/61.7.623; Rapalino O, 1998, NAT MED, V4, P814, DOI 10.1038/nm0798-814; Rolletschek A, 2009, BIOL CHEM, V390, P845, DOI 10.1515/BC.2009.103; Schwartz M, 2001, J NEUROIMMUNOL, V113, P185, DOI 10.1016/S0165-5728(00)00447-1; Schwartz M, 2008, TRENDS PHARMACOL SCI, V29, P287, DOI 10.1016/j.tips.2008.03.006; Shihabuddin LS, 2000, J NEUROSCI, V20, P8727; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Slavin S, 2008, CLIN NEUROL NEUROSUR, V110, P943, DOI 10.1016/j.clineuro.2008.01.014; Smyth MJ, 2006, ADV IMMUNOL, V90, P1, DOI 10.1016/S0065-2776(06)90001-7; Stirling DP, 2004, J NEUROSCI, V24, P2182, DOI 10.1523/JNEUROSCI.5275-03.2004; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; Sykova E, 2006, CELL TRANSPLANT, V15, P675, DOI 10.3727/000000006783464381; Tator CH, 2006, NEUROSURGERY, V59, P957, DOI 10.1227/01.NEU.0000245591.16087.89; Temple S, 1999, CURR OPIN NEUROBIOL, V9, P135, DOI 10.1016/S0959-4388(99)80017-8; Ting AE, 2008, CRIT REV ONCOL HEMAT, V65, P81, DOI 10.1016/j.critrevonc.2007.09.007; Uccelli A, 2006, EXPERT OPIN BIOL TH, V6, P17, DOI 10.1517/14712598.6.1.17; Weiss S, 1996, J NEUROSCI, V16, P7599; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496; Zhang J, 2005, EXP NEUROL, V195, P16, DOI 10.1016/j.expneurol.2005.03.018; Zhang SC, 2003, J HEMATOTH STEM CELL, V12, P625, DOI 10.1089/15258160360732650; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629; Ziv Y, 2006, P NATL ACAD SCI USA, V103, P13174, DOI 10.1073/pnas.0603747103	76	18	18	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	2629-3269	2629-3277		STEM CELL REV REP	Stem Cell Rev. Rep.	FAL	2010	6	3					405	410		10.1007/s12015-010-9141-6			6	Cell & Tissue Engineering; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine	647WD	WOS:000281649900009	20300887				2022-02-06	
J	Cheng, JL; Yang, YJ; Li, HL; Wang, J; Wang, MH; Zhang, Y				Cheng Jing-liang; Yang Yun-jun; Li Hua-li; Wang Juan; Wang Mei-hao; Zhang Yong			In vivo tracing of superparamagnetic iron oxide-labeled bone marrow mesenchymal stem cells transplanted for traumatic brain injury by susceptibility weighted imaging in a rat model	CHINESE JOURNAL OF TRAUMATOLOGY			English	Article						Mesenchymal stem cells; Brain injuries; Echo-planar imaging		Objective: To label rat bone marrow mesenchymal stem cells (BMSCs) with superparamagnetic iron oxide (SPIO) in vitro, and to monitor the survival and location of these labeled BMSCs in a rat model of traumatic brain injury (TBI) by susceptibility weighted imaging (SWI) sequence. Methods: BMSCs were cultured in vitro and then labeled with SPIO. Totally 24 male Sprague Dawley(SD) rats weighing 200-250 g were randomly divided into 4 groups: Groups A-D (n=6 for each group). Moderate TBI models of all the rats were developed in the left hemisphere following Feeney's method. Group A was the experimental group and stereotaxic transplantation of BMSCs labeled with SPIO into the region nearby the contusion was conducted in this group 24 hours after TBI modeling. The other three groups were control groups with transplantation of SPIO, unlabeled BMSCs and injection of nutrient solution respectively conducted in Groups B, C and D at the same time. Monitoring of these SPIO-labeled BMSCs by SWI was performed one day, one week and three weeks after implantation. Results: Numerous BMSCs were successfully labeled with SPIO. They were positive for Prussian blue staining and intracytoplasm positive blue stained particles were found under a microscope (x200). Scattered little iron particles were observed in the vesicles by electron microscopy (x5000). MRI of the transplantation sites of the left hemisphere demonstrated a low signal intensity on magnitude images, phase images and SWI images for all the test rats in Group A, and the lesion in the left parietal cortex demonstrated a semicircular low intensity on SWI images, which clearly showed the distribution and migration of BMSCs in the first and third weeks. For Group B, a low signal intensity by MRI was only observed on the first day but undetected during the following examination. No signals were observed in Groups C and D at any time points. Conclusion: SWI sequence in vivo can consecutively and noninvasively trace and demonstrate the status and distribution of BMSCs labeled with SPIO in the brain of TBI model rats.	[Cheng Jing-liang; Yang Yun-jun; Li Hua-li; Wang Juan; Wang Mei-hao; Zhang Yong] Zhengzhou Univ, Affiliated Hosp 1, Dept Radiol, Zhengzhou 450052, Henan, Peoples R China		Cheng, JL (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Radiol, Zhengzhou 450052, Henan, Peoples R China.	cjr.chjl@vip.163.com					Belayev L, 2007, BRAIN RES, V1157, P146, DOI 10.1016/j.brainres.2007.04.077; Dunning MD, 2004, J NEUROSCI, V24, P9799, DOI 10.1523/JNEUROSCI.3126-04.2004; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Ge F, 2005, CHIN J CLIN NEUROSCI, V13, P152; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Himes N, 2004, MAGN RESON MED, V52, P1214, DOI 10.1002/mrm.20220; [刘祖黎 Liu Zuli], 2005, [功能材料, Journal of Functional Materials], V36, P350; Meng QH, 2006, CHIN J NEUROMED, V5, P898; [吴旭 Wu Xu], 2005, [中国法医学杂志, Chinese Journal of Forensic Medicine], V20, P1; Wu Z, 2009, J MAGN RESON IMAGING, V29, P177, DOI 10.1002/jmri.21617; Yang ZH, 2007, GUIDELINES MAGNETIC, P324; 薛静, 2006, [中华放射学杂志, Chinese Journal of Radiology], V40, P213	12	18	22	0	1	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	1008-1275			CHIN J TRAUMATOL	Chin. J. Traumatol.	JUN	2010	13	3					173	177		10.3760/cma.j.issn.1008-1275.2010.03.008			5	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	VF0ZE	WOS:000441901200009	20515596				2022-02-06	
J	Mao, Q; Jia, F; Zhang, XH; Qiu, YM; Ge, JW; Bao, WJ; Luo, QZ; Jiang, JY				Mao, Qing; Jia, Feng; Zhang, Xiao-hua; Qiu, Yong-ming; Ge, Jian-wei; Bao, Wen-jing; Luo, Qi-zhong; Jiang, Ji-yao			The Up-Regulation of Voltage-Gated Sodium Channel Na(V)1.6 Expression Following Fluid Percussion Traumatic Brain Injury in Rats	NEUROSURGERY			English	Article						mRNA; Na-v 1.6; Protein; Rat; Sodium channel; Traumatic brain injury	NERVOUS-SYSTEM; MODEL; NA+; NEUROPROTECTION; LOCALIZATION; FOS	BACKGROUND: The influx of Na+ and the depolarization mediated by voltage-gated sodium channels (VGSCs) is an early event in traumatic brain injury (TBI) induced cellular abnormalities and is therefore well positioned as an upstream target for pharmacologic modulation of the pathological responses to TBI. Alteration in the expression of the VGSC a-subunit has occurred in a variety of neuropathological states including focal cerebral ischemia, spinal injury, and epilepsy. OBJECTIVE: In this study, changes in Na(v)1.6 mRNA and protein expression were investigated in rat hippocampus after TBI. METHODS: Forty-eight adult male Sprague Dawley rats were randomly assigned to control or TBI groups. TBI was induced with a lateral fluid percussion device. Expression of mRNA and protein for Nav1.6 in the bilateral hippocampus was examined at 2, 12, 24, and 72 hours after injury by real-time quantitative polymerase chain reaction and Western blot. Immunofluorescence was performed to localize the expression of Nav1.6 protein in the hippocampus. RESULTS: Expression of Nav1.6 mRNA was significantly up-regulated in the bilateral hippocampus at 2 and 12 hours post-TBI. Significant up-regulation of Nav1.6 protein was identified in the ipsilateral hippocampus from 2 to 72 hours post-TBI and in the contralateral hippocampus from 2 to 24 hours post-TBI. Expression of Nav1.6 occurred predominantly in neurons in the hippocampus. CONCLUSION: Results of the study showed significant up-regulation of mRNA and protein for Nav1.6 in rat hippocampal neurons after TBI.	[Mao, Qing; Jia, Feng; Zhang, Xiao-hua; Qiu, Yong-ming; Ge, Jian-wei; Luo, Qi-zhong; Jiang, Ji-yao] Shanghai Jiao Tong Univ, Sch Med, Shanghai RenJi Hosp, Dept Neurosurg, Shanghai 200127, Peoples R China; [Mao, Qing] Shanghai Punan Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Bao, Wen-jing] Chinese Natl Human Genome Ctr Shanghai, Shanghai, Peoples R China		Jiang, JY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai RenJi Hosp, Dept Neurosurg, Shanghai 200127, Peoples R China.	Jiangjyb@online.sh.cn			National Key Basic Research ProjectNational Basic Research Program of China [2005CB522604]; National Science and Nature Grant [30973086]; Science and Technology Committee of ShanghaiShanghai Science & Technology Committee [07JC14038]; Program for Shanghai Outstanding Medical Academic Leader	This work was supported by grants from National Key Basic Research Project (No. 2005CB522604), National Science and Nature Grant (No. 30973086), Science and Technology Committee of Shanghai (No. 07JC14038), and the Program for Shanghai Outstanding Medical Academic Leader. The authors have no personal financial or institutional interest in any of the drugs, materials, or devices described in this article.	Ates O, 2007, NEUROL RES, V29, P317, DOI 10.1179/016164107X159225; Blumenfeld H, 2008, EPILEPSIA, V49, P400, DOI 10.1111/j.1528-1167.2007.01458.x; CHAUDHURI A, 1997, NEUROREPORT, V8, P13; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Faden AI, 2002, CURR OPIN NEUROL, V15, P707, DOI 10.1097/00019052-200212000-00008; Goldin AL, 2002, J EXP BIOL, V205, P575; Goldin AL, 2001, ANNU REV PHYSIOL, V63, P871, DOI 10.1146/annurev.physiol.63.1.871; Hains BC, 2003, J NEUROSCI, V23, P8881; Hemmings HC, 2004, J NEUROSURG ANESTH, V16, P100, DOI 10.1097/00008506-200401000-00022; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; Marban E, 1998, J PHYSIOL-LONDON, V508, P647, DOI 10.1111/j.1469-7793.1998.647bp.x; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Ravens U, 1999, PHARMACOL RES, V39, P167, DOI 10.1006/phrs.1998.0416; SMEYNE RJ, 1993, NATURE, V363, P166, DOI 10.1038/363166a0; Stys PK, 2004, CURR MOL MED, V4, P113, DOI 10.2174/1566524043479220; Taylor C P, 1997, Adv Pharmacol, V39, P47, DOI 10.1016/S1054-3589(08)60069-1; Trimmer JS, 2004, ANNU REV PHYSIOL, V66, P477, DOI 10.1146/annurev.physiol.66.032102.113328; Vink R, 2002, EXPERT OPIN INV DRUG, V11, P1375, DOI 10.1517/13543784.11.10.1375; Whitaker W, 1999, NEUROREPORT, V10, P3703, DOI 10.1097/00001756-199911260-00044; Wilson Y, 2002, P NATL ACAD SCI USA, V99, P3252, DOI 10.1073/pnas.042701199; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Yao C, 2005, LIFE SCI, V77, P1116, DOI 10.1016/j.lfs.2005.02.008; Yao C, 2002, NEUROTOX RES, V4, P67, DOI 10.1080/10298420290007646; Zhou W, 2004, BIOPHYS J, V87, P3862, DOI 10.1529/biophysj.104.045963	24	18	20	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-396X			NEUROSURGERY	Neurosurgery	JUN	2010	66	6					1134	1139		10.1227/01.NEU.0000369612.31946.A2			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	600RY	WOS:000278006200037	20421839				2022-02-06	
J	Li, WJ; Wu, SS; Ahmad, M; Jiang, JF; Liu, H; Nagayama, T; Rose, ME; Tyurin, VA; Tyurina, YY; Borisenko, GG; Belikova, N; Chen, J; Kagan, VE; Graham, SH				Li, Wenjin; Wu, Shasha; Ahmad, Muzamil; Jiang, Jianfei; Liu, Hao; Nagayama, Tetsuya; Rose, Marie E.; Tyurin, Vladimir A.; Tyurina, Yulia Y.; Borisenko, Grigory G.; Belikova, Natalia; Chen, Jun; Kagan, Valerian E.; Graham, Steven H.			The cyclooxygenase site, but not the peroxidase site of cyclooxygenase-2 is required for neurotoxicity in hypoxic and ischemic injury	JOURNAL OF NEUROCHEMISTRY			English	Article						cell death; cyclooxygenase-2; hypoxia; ischemia; prostaglandin	PROSTAGLANDIN-H-SYNTHASE; TRAUMATIC BRAIN-INJURY; CEREBRAL-ISCHEMIA; ASCORBIC-ACID; CELL-DEATH; ENDOPEROXIDE SYNTHASE; REACTION-MECHANISM; SUPEROXIDE ANION; GENE-EXPRESSION; MOUSE MODEL	P>Cyclooxygenase-2 (COX-2) activity has been implicated in the pathogenesis of ischemic injury, but the exact mechanisms responsible for its toxicity remain unclear. Infection of primary neurons with an adenovirus expressing wild type (WT) COX-2 increased the susceptibility of neurons to hypoxia. Infection with an adenoviral vector expressing COX-2 with a mutation at the cyclooxygenase site did not increase susceptibility to hypoxia, whereas over-expression of COX-2 with a mutation in the peroxidase site produced similar susceptibility to hypoxia as WT COX-2. Primary neuronal cultures obtained from transgenic mice bearing a mutation in the COX-2 cylooxygenase site were protected from hypoxia. Mice with a mutation in the cyclooxygenase site had smaller infarctions 24 h after 70 min of middle cerebral artery occlusion than WT control mice. COX-2 activity had no effect on the formation of protein carbonyls. Ascorbate radicals were detected by electron paramagnetic resonance as a product of recombinant COX-2 activity and were blocked by COX-2 inhibitors. Similarly, formation of ascorbate radicals was inhibited in the presence of COX-2 inhibitors and in homogenates obtained from COX-2 null mice. Taken together, these results indicate that the cyclooxygenase activity of COX-2 is necessary to exacerbate neuronal hypoxia/ischemia injury rather than the peroxidase activity of the enzyme.	[Li, Wenjin; Wu, Shasha; Ahmad, Muzamil; Liu, Hao; Nagayama, Tetsuya; Rose, Marie E.; Chen, Jun; Graham, Steven H.] Univ Pittsburgh, VA Pittsburgh Healthcare Syst, Geriatr Res Educ & Clin Ctr, Pittsburgh, PA USA; [Li, Wenjin; Wu, Shasha; Ahmad, Muzamil; Liu, Hao; Nagayama, Tetsuya; Rose, Marie E.; Chen, Jun; Graham, Steven H.] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA; [Jiang, Jianfei; Tyurin, Vladimir A.; Tyurina, Yulia Y.; Borisenko, Grigory G.; Belikova, Natalia; Kagan, Valerian E.] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA USA		Graham, SH (corresponding author), VA Pittsburgh Healthcare, Geriatr Res Educ & Clin Ctr 00GRH, Highland Dr, Pittsburgh, PA 15205 USA.	sgra@pitt.edu		Kagan, Valerian E./0000-0002-7245-1885; Tyurin, Vladimir/0000-0002-3474-1697; Tyurina, Yulia/0000-0003-0287-2091	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS37549, HL70755, R03TW007320]; VA Merit Review program (SHG)US Department of Veterans Affairs; Pennsylvania Department of Health [SAP 4100027294]; FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [R03TW007320] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL070755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030318, R01NS037459, R01NS037549] Funding Source: NIH RePORTER	The authors thank Pat Strickler for secretarial support. The Y371F mouse model was provided by Dr. Colin Funk of Queen's University, Kingston, Ontario. WT COX-2, H374Y COX-2 and Y371F COX-2 cDNAs were a gift of Dr. L.J. Marnett (Vanderbilt University, Nashville, TN). SC58125 and recombinant COX-2 were a gift of Peter Isakson (Monsanto-Searle, Saint Louis, MO.). This work was supported by NIH NS37549 and the VA Merit Review program (SHG), and by NIH Grants HL70755, R03TW007320 and the Pennsylvania Department of Health SAP 4100027294 (VEK). The authors declare no conflict of interest.	Ahmad M, 2006, EUR J NEUROSCI, V23, P35, DOI 10.1111/j.1460-9568.2005.04540.x; Ahmad M, 2008, J NEUROSCI RES, V86, P3605, DOI 10.1002/jnr.21809; Armstead WM, 2003, ANESTHESIOLOGY, V98, P1378, DOI 10.1097/00000542-200306000-00012; ARMSTEAD WM, 1988, AM J PHYSIOL, V255, pH401, DOI 10.1152/ajpheart.1988.255.2.H401; Beal MF, 2002, FREE RADICAL BIO MED, V32, P797, DOI 10.1016/S0891-5849(02)00780-3; Candelario-Jalil E, 2003, J NEUROCHEM, V86, P545, DOI 10.1046/j.1471-4159.2003.01812.x; Candelario-Jalil E, 2006, J NEUROIMMUNOL, V174, P39, DOI 10.1016/j.jneuroim.2006.01.003; Chan PH, 1996, STROKE, V27, P1124, DOI 10.1161/01.STR.27.6.1124; Chan PH, 2001, J CEREBR BLOOD F MET, V21, P2, DOI 10.1097/00004647-200101000-00002; CHEN J, 1995, J NEUROSURG, V83, P99, DOI 10.3171/jns.1995.83.1.0099; Drachman DB, 2002, ANN NEUROL, V52, P771, DOI 10.1002/ana.10374; Goodwin DC, 2000, BIOCHEMISTRY-US, V39, P5422, DOI 10.1021/bi992752f; GRUNEWALD RA, 1993, BRAIN RES REV, V18, P123, DOI 10.1016/0165-0173(93)90010-W; Han SS, 2004, J CELL BIOCHEM, V93, P257, DOI 10.1002/jcb.20116; HASTINGS TG, 1995, J NEUROCHEM, V64, P919; Ho L, 1998, J NEUROIMMUNOL, V89, P142, DOI 10.1016/S0165-5728(98)00132-5; Horakova L, 1997, NEUROPHARMACOLOGY, V36, P177, DOI 10.1016/S0028-3908(96)00165-7; Ichimura S, 2007, J BIOL CHEM, V282, P16681, DOI 10.1074/jbc.M610785200; Im JY, 2006, FREE RADICAL BIO MED, V41, P960, DOI 10.1016/j.freeradbiomed.2006.06.001; Jiang JF, 2004, J NEUROCHEM, V90, P1036, DOI 10.1111/j.1471-4159.2004.02577.x; KAGAN VE, 1994, BIOCHEMISTRY-US, V33, P9651, DOI 10.1021/bi00198a034; KARTHEIN R, 1988, EUR J BIOCHEM, V171, P313, DOI 10.1111/j.1432-1033.1988.tb13792.x; Kawano T, 2006, NAT MED, V12, P225, DOI 10.1038/nm1362; Kim SH, 2000, ARTHRITIS RES, V2, P293, DOI 10.1186/ar104; KUKREJA RC, 1986, CIRC RES, V59, P612, DOI 10.1161/01.RES.59.6.612; Kunz T, 2006, RESTOR NEUROL NEUROS, V24, P55; Landino LM, 1997, J BIOL CHEM, V272, P21565, DOI 10.1074/jbc.272.34.21565; Li WJ, 2008, NEUROCHEM RES, V33, P490, DOI 10.1007/s11064-007-9462-2; Lopez-Lluch G, 2005, ARCH BIOCHEM BIOPHYS, V436, P32, DOI 10.1016/j.abb.2004.12.031; Lu GQ, 1999, J BIOL CHEM, V274, P16162, DOI 10.1074/jbc.274.23.16162; Maeda K, 1999, J CEREBR BLOOD F MET, V19, P1092, DOI 10.1097/00004647-199910000-00005; Manabe Y, 2004, ANN NEUROL, V55, P668, DOI 10.1002/ana.20078; Marnett LJ, 2000, CURR OPIN CHEM BIOL, V4, P545, DOI 10.1016/S1367-5931(00)00130-7; Nakayama M, 1998, P NATL ACAD SCI USA, V95, P10954, DOI 10.1073/pnas.95.18.10954; NELSON CW, 1992, AM J PHYSIOL, V263, pH1356, DOI 10.1152/ajpheart.1992.263.5.H1356; Nogawa S, 1997, J NEUROSCI, V17, P2746; O'Brien PJ, 1978, BIOCHEM SOC T, V6, P1169, DOI 10.1042/bst0061169; Patel M, 1996, NEURON, V16, P345, DOI 10.1016/S0896-6273(00)80052-5; Pepicelli O, 2005, J NEUROCHEM, V93, P1561, DOI 10.1111/j.1471-4159.2005.03150.x; Rice ME, 2000, TRENDS NEUROSCI, V23, P209, DOI 10.1016/S0166-2236(99)01543-X; ROSE RC, 1993, FASEB J, V7, P1135, DOI 10.1096/fasebj.7.12.8375611; SHIMOKAWA T, 1990, J BIOL CHEM, V265, P20073; SMITH BJ, 1991, CHEM-BIOL INTERACT, V79, P245, DOI 10.1016/0009-2797(91)90108-J; Smith WL, 2002, PROSTAG OTH LIPID M, V68-9, P115, DOI 10.1016/S0090-6980(02)00025-4; Spektor G, 2005, NAT CLIN PRACT CARD, V2, P290, DOI 10.1038/ncpcardio0214; Teismann P, 2003, P NATL ACAD SCI USA, V100, P5473, DOI 10.1073/pnas.0837397100; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; van der Donk WA, 2002, BIOCHEMISTRY-US, V41, P15451, DOI 10.1021/bi026938h; Xiang ZM, 2002, GENE EXPRESSION, V10, P271, DOI 10.3727/000000002783992352; YAMAGATA K, 1993, NEURON, V11, P371, DOI 10.1016/0896-6273(93)90192-T; Yin XM, 2002, J BIOL CHEM, V277, P42074, DOI 10.1074/jbc.M204991200; Yu Y, 2006, NAT MED, V12, P699, DOI 10.1038/nm1412	52	18	18	0	1	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0022-3042			J NEUROCHEM	J. Neurochem.	MAY	2010	113	4					965	977		10.1111/j.1471-4159.2010.06674.x			13	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	583EM	WOS:000276656100015	20236388	Bronze, Green Accepted			2022-02-06	
J	Swanson, CA; Burns, JC; Peterson, BM				Swanson, Craig A.; Burns, Jane C.; Peterson, Brad M.			Low Plasma D-Dimer Concentration Predicts the Absence of Traumatic Brain Injury in Children	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Head trauma; Biomarker; D-dimer; CT	MINOR HEAD-INJURY; SIGNIFICANT INTRACRANIAL INJURY; NEW-ORLEANS CRITERIA; COMPUTED-TOMOGRAPHY; HEMOSTATIC SYSTEM; CT; RULE; VALIDATION; S100B; METAANALYSIS	Background: Head Computerized Tomography (CT) has significant risks, especially in children. To reduce this burden, we sought to develop a biomarker panel that predicts the absence of traumatic brain injury (TBI) on head CT. Methods: We conducted a prospective cohort observational study followed by validation in a retrospective cohort at a regional pediatric trauma center. The prospective cohort included 57 consecutive children evaluated for TBI in the emergency department between September 2007 and March 2008. At the time of initial evaluation, blood was obtained to measure electrolytes, coagulation markers, complete blood count, and plasma levels of s100 beta, D-dimer, and matrix metalloproteinase-9. We conducted routine statistical analysis to determine which predicted TBI on head CT. The independent retrospective cohort included 57 consecutive patients evaluated for the same indication. Results: All patients generally met common clinical criteria (such as the CHALICE criteria 4) for head CT after trauma. Plasma levels of D-dimer were associated with TBI on head CT by univariate analysis (p < 0.001). Other markers including prothrombin time, partial thromboplastin time, and s100 beta were not. D-Dimer also had the strongest association in multivariate analysis (p = 0.02). This association was independent of and stronger than the baseline Glascow Coma Scale (p = 0.08). A D-dimer level cut-off of 500 pg/mu l had 94% negative predictive value (p < 0.001) for brain injury on head CT. The discriminatory capacity of this D-dimer level was confirmed in the independent retrospective cohort. Conclusions: In children who meet clinical criteria for a head CT scan after trauma, low plasma D-dimer suggests the absence of significant brain injury.	[Swanson, Craig A.; Burns, Jane C.; Peterson, Brad M.] Sutter Community Hosp, Sacramento, CA USA		Swanson, CA (corresponding author), Sutter Community Hosp, Sacramento, CA USA.	cswanson@stanfordalumni.org			NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K24HL074864] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K24 HL074864-05, K24 HL074864] Funding Source: Medline		ANDREW M, 1990, AM J PEDIAT HEMATOL, V12, P95; ANDREW M, 1992, BLOOD, V80, P1998, DOI 10.1182/blood.V80.8.1998.1998; Bakhtiari K, 2004, CRIT CARE MED, V32, P2416, DOI 10.1097/01.CCM.0000147769.07699.E3; Bayir A, 2006, NEUROL INDIA, V54, P363, DOI 10.4103/0028-3886.28106; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Blackwell CD, 2007, ANN EMERG MED, V49, P320, DOI 10.1016/j.annemergmed.2006.09.025; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Delgado P, 2006, NEUROLOGY, V67, P94, DOI 10.1212/01.wnl.0000223349.97278.e0; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Dunning J, 2004, J NEUROTRAUM, V21, P877, DOI 10.1089/0897715041526122; Dunning J, 2004, ARCH DIS CHILD, V89, P653, DOI 10.1136/adc.2003.027722; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Haydel MJ, 2003, ANN EMERG MED, V42, P507, DOI 10.1067/S0196-0644(03)00512-2; Meythaler JM, 2003, ARCH PHYS MED REHAB, V84, P285, DOI 10.1053/apmr.2003.50116; Morel N, 2008, J TRAUMA, V64, P698, DOI 10.1097/TA.0b013e31816493ad; Muller K, 2007, J TRAUMA, V62, P1452, DOI 10.1097/TA.0b013e318047bfaa; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Piazza O, 2007, PEDIATR NEUROSURG, V43, P258, DOI 10.1159/000103304; Pickering A, 2008, EMERG MED J, V25, P88, DOI 10.1136/emj.2007.046631; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Smits M, 2007, RADIOLOGY, V245, P831, DOI 10.1148/radiol.2452061509; Sosothikul D, 2007, J PEDIAT HEMATOL ONC, V29, P19, DOI 10.1097/MPH.0b013e3180308749; Stein SC, 2006, J TRAUMA, V61, P558, DOI 10.1097/01.ta.0000233766.60315.5e; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Wells PS, 2003, NEW ENGL J MED, V349, P1227, DOI 10.1056/NEJMoa023153; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011	28	18	20	1	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAY	2010	68	5					1072	1077		10.1097/TA.0b013e3181d7a6f2			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	595MQ	WOS:000277615200009	20453761	Green Accepted			2022-02-06	
J	O'Callaghan, AM; McAllister, L; Wilson, L				O'Callaghan, Anna Mary; McAllister, Lindy; Wilson, Linda			Experiences of care reported by adults with traumatic brain injury	INTERNATIONAL JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article; Proceedings Paper	Speech Pathology Australia National Conference	MAY 17-21, 2009	Adelaide, AUSTRALIA			Traumatic brain injury (TBI); best practice; consumer preferences; clinical care guidelines; healthcare funding	CLINICAL-PRACTICE GUIDELINES; SEVERE HEAD-INJURY; CAREGIVER BURDEN; CONSUMER PARTICIPATION; RELATIVES VIEW; OUTCOMES; REHABILITATION; MANAGEMENT; REINTEGRATION; INDIVIDUALS	This paper investigates the continuum of care experienced by adults and their significant others following a moderate to severe traumatic brain injury (TBI) in Victoria, Australia. Clinical care guidelines exist defining best practice in TBI rehabilitation, but little is currently known about the experiences of those who sustain a TBI their needs and the barriers they encounter when attempting to access services. This paper presents the journeys of 202 Victorians admitted for acute care following a moderate to severe TBI over 4 years. Results of this study indicate very few participants report receiving services in line with recommendations made in clinical care guidelines. In addition reported access to services was noted to vary according to allocated healthcare funding (i.e., compensable vs. private vs. public). Clinicians' consideration of healthcare consumers' experiences are essential if services provided are to match consumers' needs.	[Wilson, Linda] Charles Sturt Univ, Sch Community Hlth, Albury, NSW 2640, Australia		Wilson, L (corresponding author), Charles Sturt Univ, Sch Community Hlth, POB 789, Albury, NSW 2640, Australia.	liwilson@csu.edu.au	Copley, Anna/D-1067-2011; McAllister, Lindy/C-8027-2009; Wilson, Linda/P-8523-2015	Copley, Anna/0000-0003-1784-9070; Wilson, Linda/0000-0003-4175-7125			*ACC COMP CORP NZ, 2004, TRAUM BRAIN INJ REH; *ACC REH COMP INS, 1998, MED J AUSTRALIA, V167, P293; [Anonymous], 2008, GUID PREH MAN SEV TR; Avesani R, 2005, BRAIN INJURY, V19, P933, DOI 10.1080/02699050400002371; Bastian H, 1996, INT J QUAL HEALTH C, V8, P485, DOI 10.1093/intqhc/8.5.485; *BRAIN TRAUM FDN, 2007, J NEUROTRAUMA S, V1; *BRAIN TRAUM FDN, 2006, NEUROSURGERY S   MAR; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P151, DOI 10.1053/apmr.2003.50123; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Coetzer R, 2005, INT J REHABIL RES, V28, P361, DOI 10.1097/00004356-200512000-00010; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Feild M, 1990, CLIN PRACTICE GUIDEL; Frattali C, 2003, J MED SPEECH-LANG PA, V11, pIX; Gillham B., 2000, DEV QUESTIONNAIRE; Hodgkinson A, 2000, J HEAD TRAUMA REHAB, V15, P1208, DOI 10.1097/00001199-200012000-00003; HUMPHREYS J, 1997, 4 NAT RUR HLTH C; Humphreys JS, 1997, MED J AUSTRALIA, V166, P577, DOI 10.5694/j.1326-5377.1997.tb123267.x; *I TRAUM HLTH INJ, 2006, IN MAN CLOS HEAD INJ; Jackson C., 2000, DESIGNING ANAL QUEST; Kaplan CP, 2001, BRAIN INJURY, V15, P725, DOI 10.1080/02699050010005913; KAPLAN SH, 1989, MED CARE, V27, pS110, DOI 10.1097/00005650-198903001-00010; Karlovits T, 1999, BRAIN INJURY, V13, P845; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Lefebvre H, 2005, BRAIN INJURY, V19, P585, DOI 10.1080/02699050400025026; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Maas AIR, 2002, NEUROL RES, V24, P19, DOI 10.1179/016164102101199495; MACPHAIL M, 1998, ACCOMMODATION SUPPOR; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; MCAULEY I, 2007, HLTH POLICY AUSTR RE; Mcilvoy L, 2001, J Neurosci Nurs, V33, P72; McNaughton H., 2004, TRAUMATIC BRAIN INJU; Motor Accidents Authority NSW, 2008, GUID MILD TRAUM BRAI; Muus K, 2006, J HEAD TRAUMA REHAB, V21, P431, DOI 10.1097/00001199-200609000-00052; Nabors N, 2002, BRAIN INJURY, V16, P1039, DOI 10.1080/02699050210155285; National Institute for Clinical Excellence, 2007, HEAD INJ TRIAG ASS I; Nelson William A, 2007, Healthc Exec, V22, P36; New Zealand Guidelines Group, 2006, TRAUM BRAIN INJ DIAG; NEWBERRY L, 2001, NEW DIRECTION FOLLOW; OCONNOR P, 2002, 43 INJCAT AUSTR I HL; PENCHANSKY R, 1981, MED CARE, V19, P127, DOI 10.1097/00005650-198102000-00001; Rankin N, 2000, EUR J CANCER CARE, V9, P97; RAO JN, 1995, BRIT MED J, V311, P1023; Rosenthal M, 1996, J HEAD TRAUMA REHAB, V11, P40, DOI 10.1097/00001199-199610000-00005; Royal College of Physicians and British Society of Rehabilitation Medicine, 2003, REH FOLL ACQ BRAIN I; Schootman M, 2000, BRAIN INJURY, V14, P373; SELIGMAN M, 1993, PSYCHOL TODAY    SPR; Spain DA, 1998, J TRAUMA, V45, P101, DOI 10.1097/00005373-199807000-00022; Stringer K, 1999, STUDY ACCOMMODATION; Tooth L, 2001, BRAIN INJURY, V15, P613, DOI 10.1080/02699050010013923; *TRAFF ACC COMM, 2003, CLIENT INF; TREVENA L, 2004, CLIN PRACTICE GUIDEL; Turkstra L. S., 2008, ASHA LEADER      JUL, P10; TURNERSTOKES L, 2005, COCHRANE COLLABORATI, V4, P1; World Health Organisation Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; [No title captured]	62	18	18	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1754-9507	1754-9515		INT J SPEECH-LANG PA	Int. J. Speech-Lang. Pathol.	APR	2010	12	2			SI		107	123		10.3109/17549500903431774			17	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	581GW	WOS:000276510800005	20420352				2022-02-06	
J	Alachini, B; Pisoni, C; Cieza, A; Cazzulani, B; Giustini, A; Pistarini, C				Alachini, B.; Pisoni, C.; Cieza, A.; Cazzulani, B.; Giustini, A.; Pistarini, C.		Italian Network	Developing ICF core set for subjects with traumatic brain injury: an Italian clinical perspective	EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Brain injury; Disability evaluation; Cross sectional studies	QUALITY-OF-LIFE; INTERNATIONAL CLASSIFICATION; HEALTH ICF; DISABILITY; REHABILITATION; MODERATE; MODEL	Aim. The objective of this empirical study is to describe functioning and health of individuals with traumatic brain injury (TBI) and to identify the most common problems using the International Classification of Functioning Disability and Health (ICF). The specific aims are to describe the prevalence of problems in functioning as defined by the ICF of individuals with TBI, and to identify categories that explain most of the variance of the external standards. Methods. 261 TBI patients from 24 Italian centres members of the Italian Network were consecutively enrolled into the study between July 2008 and January 2009. The study was conducted as an empirical cross-sectional study. Results. The Extended ICF checklist captures the problems of TBI patients: many problems were reported within body function and body structure, but the most impaired categories were in Activity and Participation domain: the impaired categories reflect restrictions in challenging activities or activities related to later stages of recovery. The Environmental Factors in ICF were most frequently scored as facilitators: the support of the family is the most important environmental factor emerged, together with health professional. Conclusion. This study describes and identifies the most common problems in functioning of persons with TBI in an Italian sample. It emphasizes the importance of approaching the description of functioning and disability from a comprehensive perspective including not only body functions and structures but also activities and participation domains and environmental factors.	[Alachini, B.; Pisoni, C.; Pistarini, C.] Salvatore Maugeri Fdn, IRCCS, Sci Inst Pavia, Neurorehabil Unit, Pavia, Italy; [Cieza, A.] Univ Munich, Dept Phys Med & Rehabil, WHO FIC CC DIMDI, Munich, Germany; [Cazzulani, B.] Univ Pavia, Dept Phys Med & Rehabil, I-27100 Pavia, Italy; [Giustini, A.] San Pancrazio Rehabil Hosp, HSS Santo Stefano Grp, Trento, Italy		Pistarini, C (corresponding author), Fdn Salvatore Maugeri, IRCCS, Ist Sci Pavia, Operat Unit Neurorehabil, Via Salvatore Maugeri 10, I-27100 Pavia, Italy.	caterina.pistarini@fsm.it	Casanova, Emanuela/AAD-3643-2022; Cazzulani, Benedetta/AAC-1818-2020; Pisoni, Camilla/P-8491-2019; Pistarini, CATERINA/K-5234-2018	Casanova, Emanuela/0000-0002-5727-3769; Cazzulani, Benedetta/0000-0002-1219-9163; Pisoni, Camilla/0000-0001-9292-9682; Pistarini, CATERINA/0000-0001-8925-0484			Bernabeu M, 2009, NEUROREHAB NEURAL RE, V23, P464, DOI 10.1177/1545968308328725; Bilbao A, 2003, NEUROREHABILITATION, V18, P239; Cieza A, 2005, J REHABIL MED, V37, P212, DOI 10.1080/16501970510040263; Cieza A, 2004, J REHABIL MED, V36, P9, DOI 10.1080/16501960410015353; Cieza A, 2002, J REHABIL MED, V34, P205, DOI 10.1080/165019702760279189; Crooks Carol Y, 2007, Phys Med Rehabil Clin N Am, V18, P681, DOI 10.1016/j.pmr.2007.06.005; Grill E, 2005, DISABIL REHABIL, V27, P459, DOI 10.1080/09638280400014063; Grimes DA, 2002, LANCET, V359, P57, DOI 10.1016/S0140-6736(02)07283-5; Heegaard W, 2007, EMERG MED CLIN N AM, V25, P655, DOI 10.1016/j.emc.2007.07.001; Koskinen S, 2007, J REHABIL MED, V39, P467, DOI 10.2340/16501977-0077; Lovasik D, 2001, Crit Care Nurs Q, V23, P24; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; McArthur DL, 2004, BRAIN PATHOL, V14, P185, DOI 10.1111/j.1750-3639.2004.tb00052.x; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Parikh S, 2007, INT ANESTHESIOL CLIN, V45, P119, DOI 10.1097/AIA.0b013e318078cfe7; Petchprapai Nutthita, 2007, J Neurosci Nurs, V39, P260; Pierce CA, 2006, AM J PHYS MED REHAB, V85, P889, DOI 10.1097/01.phm.0000242615.43129.ae; Pisoni C, 2008, EUR J PHYS REHAB MED, V44, P377; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Ragnarsson KT, 2002, RESTOR NEUROL NEUROS, V20, P103; Sangha O, 2003, ARTHRIT RHEUM-ARTHR, V49, P156, DOI 10.1002/art.10993; Simpson G, 2000, BRAIN INJURY, V14, P125, DOI 10.1080/026990500120790; Stucki G, 2005, AM J PHYS MED REHAB, V84, P733, DOI 10.1097/01.phm.0000179521.70639.83; Stucki G, 2002, DISABIL REHABIL, V24, P932, DOI 10.1080/09638280210148594; Stucki G, 2002, DISABIL REHABIL, V24, P281, DOI 10.1080/09638280110105222; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; *WHOQOL GROUP, 1994, INT J MENTAL HLTH, V23; World Health Organization, 2007, INT CLASS FUNCT DIS; World Health Organization, INT CLASS FUNCT DIS	30	18	19	0	0	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	1973-9087	1973-9095		EUR J PHYS REHAB MED	Eur. J. Phys. Rehabil. Med.	MAR	2010	46	1					27	36					10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	578JR	WOS:000276290100005	20332723				2022-02-06	
J	Brown, AW; Malec, JF; Mandrekar, J; Diehl, NN; Dikmen, SS; Sherer, M; Hart, T; Novack, TA				Brown, Allen W.; Malec, James F.; Mandrekar, Jay; Diehl, Nancy N.; Dikmen, Sureyya S.; Sherer, Mark; Hart, Tessa; Novack, Thomas A.			Predictive utility of weekly post-traumatic amnesia assessments after brain injury: A multicentre analysis	BRAIN INJURY			English	Article						Outcome; rehabilitation; measurement	GLASGOW OUTCOME SCALE; CLOSED-HEAD INJURY; FUNCTIONAL INDEPENDENCE; GALVESTON ORIENTATION; REHABILITATION; SEVERITY; LOG; COMPLAINTS; RECOVERY; DURATION	Primary objective: To consider the duration of post-traumatic amnesia (PTA) as a single predictor variable to determine whether categories of PTA duration exist that predict 1-year outcomes after traumatic brain injury (TBI). Research design: Using the TBI Model System database (n=5250), the duration of PTA that predicts 1-year outcomes was calculated. Logistic regression was used to determine whether a single predictive threshold value existed. Classification and regression tree analysis then determined whether multiple threshold values existed. The area under the ROC curve and percentage correct classification were also calculated to discriminate classification accuracy and choose the best predictive thresholds. Results: A single threshold value of PTA days was identified for all variables. At 1 year, PTA that extended into week 7 after injury predicted total FIM(TM) and FIM(TM) sub-scales. One-year employment and global outcomes were predicted by PTA extending into week 4 after injury. Independent living was predicted by PTA extending into the 8th week after injury. Conclusion: After moderate-to-severe TBI, determining the presence of PTA at weekly intervals can efficiently determine injury severity while providing meaningful precision when used in research and clinical outcome prediction.	[Brown, Allen W.; Mandrekar, Jay] Mayo Clin, Rochester, MN 55905 USA; [Malec, James F.] Rehab Hosp Indiana, Indianapolis, IN USA; [Diehl, Nancy N.] Mayo Clin, Jacksonville, FL 32224 USA; [Dikmen, Sureyya S.] Univ Washington, Seattle, WA 98195 USA; [Sherer, Mark] TIRR Mem Hermann, Houston, TX USA; [Hart, Tessa] Moss Rehabil Res Inst, Elkins Pk, PA USA; [Novack, Thomas A.] Univ Alabama, Birmingham, AL USA		Brown, AW (corresponding author), Mayo Clin, 100 1st St SW, Rochester, MN 55905 USA.	brown.allen@mayo.edu		Brown, Allen W./0000-0001-7228-3351	National Institute on Disability and Rehabilitation Research, United States Department of EducationUS Department of Education	We gratefully acknowledge the assistance of the Traumatic Brain Injury National Data and Statistical Centre located at Craig Hospital in Englewood, Colorado. This work was supported by Traumatic Brain Injury Model Systems grants from the National Institute on Disability and Rehabilitation Research, United States Department of Education.	American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; BISHARA S N, 1992, Brain Injury, V6, P373, DOI 10.3109/02699059209034952; Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; Bode RK, 2000, J HEAD TRAUMA REHAB, V15, P637, DOI 10.1097/00001199-200002000-00004; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; De Guise E, 2005, BRAIN INJURY, V19, P1087, DOI 10.1080/02699050500149882; DEIRDRE RD, 2004, BRAIN INJURY, V18, P221; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Ellenberg JH, 1996, ARCH NEUROL-CHICAGO, V53, P782, DOI 10.1001/archneur.1996.00550080104018; Frey KL, 2007, BRAIN INJURY, V21, P513, DOI 10.1080/02699050701311026; GRANGER CV, 1990, ARCH PHYS MED REHAB, V71, P870; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; Nakase-Richardson R, 2009, ARCH PHYS MED REHAB, V90, P17, DOI 10.1016/j.apmr.2008.06.030; Novack TA, 2000, J HEAD TRAUMA REHAB, V15, P957, DOI 10.1097/00001199-200006000-00008; Ponsford J, 2004, BRAIN INJURY, V18, P603, DOI 10.1080/02699050310001646152; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Smith A., 1961, ARCH NEUROL-CHICAGO, V5, P16, DOI DOI 10.1001/ARCHNEUR.1961.00450130006002; Tate RL, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.074989; Tate RL, 2000, J NEUROL NEUROSUR PS, V68, P178, DOI 10.1136/jnnp.68.2.178; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Therneau T. M, 1997, INTRO RECURSIVE PART INTRO RECURSIVE PART, V61; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Wilde EA, 2006, BRAIN INJURY, V20, P695, DOI 10.1080/02699050600744079; Williams B.A., 2006, FINDING OPTIMAL CUTP, V79; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zafonte RD, 1997, ARCH PHYS MED REHAB, V78, P1103, DOI 10.1016/S0003-9993(97)90135-0	35	18	18	0	4	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	MAR	2010	24	3					472	478		10.3109/02699051003610466			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	574JR	WOS:000275985800003	20184404				2022-02-06	
J	Colantonio, A; Mroczek, D; Patel, J; Lewko, J; Fergenbaum, J; Brison, R				Colantonio, Angela; Mroczek, David; Patel, Jigisha; Lewko, John; Fergenbaum, Jennifer; Brison, Robert			Examining Occupational Traumatic Brain Injury in Ontario	CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE			English	Article						Traumatic brain injury; epidemiology; workplace		Objective: Occupational traumatic brain injuries disrupt the lives of workers and carry major economic repercussions. To date, there has been limited information on brain injuries that occur at work across injury severity levels in Canada. The aim of this study was to provide an overview of occupational traumatic brain injuries in Ontario, with a focus on the sex of the workers. Methods: For this cross-sectional study, data from the Ontario Workplace Safety and Insurance Board were used. A retrospective chart review was conducted of over 1,500 claim files from the year 2004 with the diagnostic codes of concussion and intracranial injury. Severity was assessed according to data on days off work. Results: The average age of those injured was 37.8 years. The breakdown by sex shows that 57.8% of claims for occupational traumatic brain injury involved males. The most common mechanism of injury was being "struck by or against", followed by "falls". Most of the occupational traumatic brain injuries were from the manufacturing, and government and related services sectors. The highest rate, however, was shown for transportation and storage (81.5/100,000), followed by government and related services (56.6/100,000) and primary industries (47/100,000). Conclusions: An examination of occupational traumatic brain injuries across a range of severities reveals a profile that is different from that associated with more severely injured workers: there were many more women in particular industries who were injured and more injuries involving being struck by an object. This paper provides data on key industries, mechanisms and contributing factors involved in work-related traumatic brain injury that result in claims to the Workplace Safety and Insurance Board.	[Colantonio, Angela] Univ Toronto, Toronto Rehabil Inst, Dept Occupat Sci, Toronto, ON M5G 1V7, Canada; [Lewko, John] Laurentian Univ, Sudbury, ON P3E 2C6, Canada; [Brison, Robert] Queens Univ, Dept Emergency Med, Kingston, ON, Canada		Colantonio, A (corresponding author), Univ Toronto, Toronto Rehabil Inst, Dept Occupat Sci, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada.	Angela.colantonio@utoronto.ca		Salerno, Jennifer/0000-0001-7282-5579; Colantonio, Angela/0000-0003-2094-4765			Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Colantonio A, 2009, BRAIN INJURY, V23, P873, DOI 10.1080/02699050903036033; de Guise E, 2005, CAN J NEUROL SCI, V32, P186, DOI 10.1017/S0317167100003954; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; HEYER NJ, 1994, AM J PUBLIC HEALTH, V84, P1106, DOI 10.2105/AJPH.84.7.1106; Kim H, 2006, NEUROREHABILITATION, V21, P269; KISNER SM, 1994, J OCCUP ENVIRON MED, V36, P137, DOI 10.1097/00043764-199402000-00008; Kristman VL, 2008, BRAIN INJURY, V22, P51, DOI 10.1080/02699050701849991; Lett Ronald, 2002, Inj Control Saf Promot, V9, P199, DOI 10.1076/icsp.9.3.199.8708; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; O'Connor C, 2005, PSYCHOL REP, V97, P169, DOI 10.2466/PR0.97.5.169-179; Smith JR, 2004, MACROMOL RAPID COMM, V25, P127, DOI 10.1002/marc.200300193; Tricco AC, 2006, BRAIN INJURY, V20, P719, DOI 10.1080/02699050600664640; *WSIB, 2004, STAT SUPPL 2004 ANN	14	18	18	1	4	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	0008-4263	1920-7476		CAN J PUBLIC HEALTH	Can. J. Public Health-Rev. Can. Sante Publ.	MAR-APR	2010	101			1			S58	S62		10.1007/BF03403848			5	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	602II	WOS:000278132300010	20629449	Green Published			2022-02-06	
J	Hu, SL; Li, F; Luo, HS; Xia, YZ; Zhang, JQ; Hu, R; Cui, GY; Meng, H; Feng, H				Hu, Shengli; Li, Fei; Luo, Haishui; Xia, Yongzhi; Zhang, Jiuquan; Hu, Rong; Cui, Gaoyu; Meng, Hui; Feng, Hua			Amelioration of rCBF and PbtO(2) following TBI at high altitude by hyperbaric oxygen pre-conditioning	NEUROLOGICAL RESEARCH			English	Article						High altitude; hyperbaric oxygen; pre-conditioning; traumatic brain injury	ISCHEMIA-REPERFUSION INJURY; CEREBRAL-ARTERY OCCLUSION; ACUTE MOUNTAIN-SICKNESS; BLOOD-FLOW; TOLERANCE	Objectives: Hypobaric hypoxia at high altitude can lead to brain damage and pre-conditioning with hyperbaric oxygen (HBO) can reduce ischemic/hypoxic brain injury. This study investigates the effects of high altitude on traumatic brain injury (TBI) and examines the neuroprotection provided by HBO preconditioning against TBI. Methods: Rats were randomly divided into four groups: HBO pre-conditioning group (HBOP, n=10), high altitude group (HA, n=10), plain control group (PC, n=10) and plain sham operation group (sham, n=10). All groups were subjected to head trauma by weight drop device except for the sham group. Rats from each group were examined for neurological function, regional cerebral blood flow (rCBF) and brain tissue oxygen pressure (PbtO(2)) and were killed for analysis by transmission electron microscope. Results: The score of neurological deficits in the HA group was highest, followed by the HBOP group and the PC group, respectively. Both rCBF and PbtO(2) were the lowest in the HA group. Brain morphology and structure seen via the transmission electron microscope was diminished in the HA group, while fewer pathological injuries occurred in the HBOP and PC groups. Conclusions: High altitude aggravates TBI significantly and HBO pre-conditioning can attenuate TBI in rats at high altitude by improvement of rCBF and PbtO(2). Pre-treatment with HBO might be beneficial for people traveling to high altitude locations.	[Hu, Shengli; Li, Fei; Luo, Haishui; Xia, Yongzhi; Zhang, Jiuquan; Hu, Rong; Cui, Gaoyu; Meng, Hui; Feng, Hua] Third Mil Med Univ, Southwest Hosp, Dept Neurosurg, Chongqing 400038, Peoples R China		Feng, H (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Neurosurg, Gaotanyan 29, Chongqing 400038, Peoples R China.	fenghua8888@yahoo.com.cn	Feng, Hua/AAX-4121-2021; ZHANG, JIUQUAN/X-8389-2019	Feng, Hua/0000-0003-4489-9217; Zhang, Jiuquan/0000-0003-0239-6988	PLA in China [06MB241, 01L049]	This work was supported by the medical research program of PLA in China (nos. 06MB241 and 01L049). The authors thank Jiasi Bai (Department of Central laboratory, Southwest Hospital), Shibing Zhang and Quan Xie (Hyperbaric Oxygen Center, Southwest Hospital) for technical assistance.	Akca O, 1999, LANCET, V354, P41, DOI 10.1016/S0140-6736(99)00874-0; Basnyat B, 2003, LANCET, V361, P1967, DOI 10.1016/S0140-6736(03)13591-X; Clarke C, 2006, POSTGRAD MED J, V82, P748, DOI 10.1136/pgmj.2006.047662; Dong HL, 2002, ANESTHESIOLOGY, V96, P907, DOI 10.1097/00000542-200204000-00018; FAYED N, 2006, AM J MED, V119; Freiberger JJ, 2006, BRAIN RES, V1075, P213, DOI 10.1016/j.brainres.2005.12.088; Gallagher SA, 2004, EMERG MED CLIN N AM, V22, P329, DOI 10.1016/j.emc.2004.02.001; Gertsch JH, 2002, HIGH ALT MED BIOL, V3, P29, DOI 10.1089/152702902753639522; Gurer A, 2006, TRANSPL P, V38, P3337, DOI 10.1016/j.transproceed.2006.10.184; HACKETT PH, 1976, LANCET, V2, P1149; Hackett PH, 2001, NEW ENGL J MED, V345, P107, DOI 10.1056/NEJM200107123450206; Inoue Y, 2005, J NEUROTRAUM, V22, P1411, DOI 10.1089/neu.2005.22.1411; Kelly DF, 1997, J NEUROSURG, V86, P633, DOI 10.3171/jns.1997.86.4.0633; Lim YJ, 2004, ANESTHESIOLOGY, V100, P562, DOI 10.1097/00000542-200403000-00015; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Pettigrew LC, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-47; Prass K, 2000, BRAIN RES, V871, P146, DOI 10.1016/S0006-8993(00)02264-2; Qin Zhiyong, 2007, Neurosurg Focus, V22, pE13, DOI 10.3171/foc.2007.22.5.14; Queen SA, 1997, BRAIN RES, V777, P42, DOI 10.1016/S0006-8993(97)00717-8; Schoch HJ, 2002, BRAIN, V125, P2549, DOI 10.1093/brain/awf257; Wada K, 2001, NEUROSURGERY, V49, P160; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Xiong LZ, 2000, CHINESE MED J-PEKING, V113, P836; Yogaratnam JZ, 2006, CARDIOVASC REVASCULA, V7, P146, DOI 10.1016/j.carrev.2006.04.006; Yu SY, 2005, J SURG RES, V128, P28, DOI 10.1016/j.jss.2005.04.025	25	18	25	1	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	MAR	2010	32	2					173	178		10.1179/174313209X414524			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	558XJ	WOS:000274781900011	20158955				2022-02-06	
J	Vannorsdall, TD; Cascella, NG; Rao, V; Pearlson, GD; Gordon, B; Schretlen, DJ				Vannorsdall, Tracy D.; Cascella, Nicola G.; Rao, Vani; Pearlson, Godfrey D.; Gordon, Barry; Schretlen, David J.			A Morphometric Analysis of Neuroanatomic Abnormalities in Traumatic Brain Injury	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							VOXEL-BASED MORPHOMETRY; UNITED-STATES; HEAD-INJURY; SEVERITY; NEUROPATHOLOGY; MATTER; COMA	Cognitive and structural brain abnormalities are common following traumatic brain injury (TBI). The authors compared cognition and brain structure in 14 TBI survivors and 28 matched healthy comparison subjects. TBI survivors showed reduced cerebral volume, due mainly to white matter changes, and poorer attention, psychomotor speed, and memory. Severity of white matter abnormality correlated with worse performance on several cognitive measures that distinguished between groups. Using voxel-based morphometry, regions of reduced white matter concentration were found throughout the cerebrum along with more localized gray matter reductions. Findings suggest that diffuse rather than focal aspects of TBI contribute most to cognitive outcome. (The Journal of Neuropsychiatry and Clinical Neurosciences 2010; 22: 173-181)	[Vannorsdall, Tracy D.; Cascella, Nicola G.; Rao, Vani; Pearlson, Godfrey D.; Gordon, Barry; Schretlen, David J.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA		Schretlen, DJ (corresponding author), Johns Hopkins Univ Hosp, 600 N Wolfe St,Meyer 218, Baltimore, MD 21287 USA.	dschret@jhmi.edu		Vannorsdall, Tracy/0000-0003-3103-1371			Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Benedict, 2001, HOPKINS VERBAL LEARN; Benedict H. R. B., 1997, BRIEF VISUOSPATIAL M; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Heaton R.K., 1981, WISCONSIN CARD SORTI; Kim J, 2008, NEUROIMAGE, V39, P1014, DOI 10.1016/j.neuroimage.2007.10.005; KlOve H, 1963, MED CLIN N AM; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; *MATHWORKS INC, 2005, MATL; NELSON HE, 1976, CORTEX, V11, P918; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rey A., 1964, ARCH PSYCHOL, V28, P215; Rey A., 1993, CLIN NEUROPSYCHOL, V7, P4; ROSS BL, 1994, AM J PHYS MED REHAB, V73, P341, DOI 10.1097/00002060-199409000-00007; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Schretlen D., 1997, BRIEF TEST ATTENTION; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Smith CD, 2007, NEUROBIOL AGING, V28, P1075, DOI 10.1016/j.neurobiolaging.2006.05.018; Spreen O., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI [10.1080/13854048908403285, DOI 10.1080/13854048908403285]; *SPSS, 2007, SPSS WIND REL 15 0; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tomaiuolo F, 2005, J NEUROTRAUM, V22, P76, DOI 10.1089/neu.2005.22.76; Trivedi MA, 2007, J NEUROTRAUM, V24, P766, DOI 10.1089/neu.2006.0205	31	18	18	0	7	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SPR	2010	22	2					173	181					9	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	595ZY	WOS:000277654200005	20463111				2022-02-06	
J	Bales, JW; Ma, XC; Yan, HQ; Jenkins, LW; Dixon, CE				Bales, James W.; Ma, Xiecheng; Yan, Hong Q.; Jenkins, Larry W.; Dixon, C. Edward			Expression of Protein Phosphatase 2B (Calcineurin) Subunit A Isoforms in Rat Hippocampus after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						calcineurin; hippocampus; traumatic brain injury	LONG-TERM POTENTIATION; CONTROLLED CORTICAL IMPACT; FLUID PERCUSSION INJURY; SYNAPTIC PLASTICITY; CYCLOSPORINE-A; RECEPTOR FUNCTION; WORKING-MEMORY; IN-VIVO; DEFICITS; CALCIUM	Calcineurin (CaN) is a calcium/calmodulin-dependent phosphatase directly activated by calcium as a result of neuronal activation that is important for neuronal function. CaN subunit isoforms are implicated in long-term potentiation (LTP), long-term depression (LTD), and structural plasticity. CaN inhibitors are also beneficial to cognitive outcomes in animal models of traumatic brain injury (TBI). There are known changes in the CaN A (CnA) subunit following fluid percussion injury (FPI). The CnA subunit has two isoforms: CnA alpha and CnA beta. The effect of moderate controlled cortical impact (CCI) on distribution of CnA isoforms was examined at 2 h and 2 weeks post-injury. CnA distribution was assayed by immunohistochemistry and graded for non-parametric analysis. Acutely CnA isoforms showed reduced immunoreactivity in stratum radiatum processes of the ipsilateral CA1 and CA1-2. There was also a significant alteration in the immunoreactivity of both CnA isoforms in the ipsilateral dentate gyrus, predominantly within the hidden blade. Alterations in CnA isoform regional distribution within the CA1, CA1-2, and dentate gyrus may have significant implications for persistent hippocampal dysfunction following TBI, including dysfunction in hippocampal plasticity. Understanding alterations in CnA isoform distribution may help improve the targeting of current therapeutic interventions and/or the development of new treatments for TBI.	[Dixon, C. Edward] Univ Pittsburgh, Dept Neurol Surg, Brain Trauma Res Ctr, Pittsburgh, PA 15260 USA; [Bales, James W.; Dixon, C. Edward] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA; [Bales, James W.] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA 15260 USA		Dixon, CE (corresponding author), Univ Pittsburgh, Dept Neurol Surg, Brain Trauma Res Ctr, 201 Hill Bldg,3434 5th Ave, Pittsburgh, PA 15260 USA.	dixonec@upmc.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030318, R01NS060672] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS060672-01A2, P50 NS030318, P50 NS030318-150014, R01 NS060672] Funding Source: Medline		Albensi BC, 2000, EXP NEUROL, V162, P385, DOI 10.1006/exnr.1999.7338; Asai A, 1999, J BIOL CHEM, V274, P34450, DOI 10.1074/jbc.274.48.34450; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Butcher SP, 1997, J NEUROSCI, V17, P6939; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; D'Ambrosio R, 1998, BRAIN RES, V786, P64, DOI 10.1016/S0006-8993(97)01412-1; Dell'Acqua ML, 2006, EUR J CELL BIOL, V85, P627, DOI 10.1016/j.ejcb.2006.01.010; Deshpande LS, 2008, NEUROSCI LETT, V441, P115, DOI 10.1016/j.neulet.2008.05.113; Dixon CE, 1997, J NEUROTRAUM, V14, P161, DOI 10.1089/neu.1997.14.161; Dixon CE, 1996, PHARMACOL BIOCHEM BE, V53, P679, DOI 10.1016/0091-3057(95)02069-1; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Eastwood SL, 2005, EUR J NEUROSCI, V22, P3017, DOI 10.1111/j.1460-9568.2005.04518.x; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; Friberg H, 1998, J NEUROSCI, V18, P5151, DOI 10.1523/JNEUROSCI.18-14-05151.1998; Groth RD, 2003, BIOCHEM BIOPH RES CO, V311, P1159, DOI 10.1016/j.bbrc.2003.09.002; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; Hashimoto T, 1998, J NEUROCHEM, V70, P1289; HOVDA DA, 1992, J NEUROTRAUM, V9, pS47; HOVDA DA, 1990, ACT NEUR S, V51, P331; Huang RQ, 1998, J PHARMACOL EXP THER, V286, P243; Kayyali US, 1997, J NEUROCHEM, V68, P1668; KLEE CB, 1979, P NATL ACAD SCI USA, V76, P6270, DOI 10.1073/pnas.76.12.6270; Kline AE, 2000, NEUROSCI LETT, V280, P163, DOI 10.1016/S0304-3940(00)00797-7; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Kurz JE, 2005, BRAIN RES, V1048, P153, DOI 10.1016/j.brainres.2005.04.062; Kurz JE, 2005, J NEUROTRAUM, V22, P476, DOI 10.1089/neu.2005.22.476; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Lemon N, 2006, J NEUROSCI, V26, P7723, DOI 10.1523/JNEUROSCI.1454-06.2006; Li SM, 2003, NAT NEUROSCI, V6, P526, DOI 10.1038/nn1049; Liu YL, 2007, MOL PSYCHIATR, V12, P966, DOI 10.1038/sj.mp.4001977; Lu YM, 2000, NEURON, V26, P197, DOI 10.1016/S0896-6273(00)81150-2; MANALAN AS, 1983, P NATL ACAD SCI-BIOL, V80, P4291, DOI 10.1073/pnas.80.14.4291; Mbye LH, 2009, J CEREBR BLOOD F MET, V29, P87, DOI 10.1038/jcbfm.2008.93; Morioka M, 1999, PROG NEUROBIOL, V58, P1, DOI 10.1016/S0301-0082(98)00073-2; Muller RU, 1996, J GEN PHYSIOL, V107, P663, DOI 10.1085/jgp.107.6.663; Okonkwo DO, 2003, NEUROREPORT, V14, P463, DOI 10.1097/01.wnr.0000058958.85541.d3; Okonkwo DO, 1999, NEUROREPORT, V10, P353, DOI 10.1097/00001756-199902050-00026; REEVES TM, 1995, EXP BRAIN RES, V106, P248; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Sanders MJ, 2000, BRAIN RES, V861, P69, DOI 10.1016/S0006-8993(00)01986-7; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; SHAPIRA Y, 1989, Neurological Research, V11, P169; Sick TJ, 1998, BRAIN RES, V785, P287, DOI 10.1016/S0006-8993(97)01418-2; Sun DA, 2008, EUR J NEUROSCI, V27, P1659, DOI 10.1111/j.1460-9568.2008.06156.x; TONG G, 1995, SCIENCE, V267, P1510, DOI 10.1126/science.7878472; Uchino H, 2008, J ANESTH, V22, P253, DOI 10.1007/s00540-008-0617-3; VICTOR RG, 1995, P NATL ACAD SCI USA, V92, P6269, DOI 10.1073/pnas.92.14.6269; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Wang JH, 1996, LEARN MEMORY, V3, P170, DOI 10.1101/lm.3.2-3.170; Winder DG, 2001, NAT REV NEUROSCI, V2, P461, DOI 10.1038/35081514; Wu HY, 2004, J BIOL CHEM, V279, P4929, DOI 10.1074/jbc.M309767200; Yakel JL, 1997, TRENDS PHARMACOL SCI, V18, P124, DOI 10.1016/S0165-6147(97)01046-8; Yan HQ, 2000, BRAIN RES, V887, P134, DOI 10.1016/S0006-8993(00)03002-X; Yang SA, 2000, BIOCHEMISTRY-US, V39, P16147, DOI 10.1021/bi001321q; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2; Zhuo M, 1999, P NATL ACAD SCI USA, V96, P4650, DOI 10.1073/pnas.96.8.4650	59	18	18	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2010	27	1					109	120		10.1089/neu.2009.1072			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	548RF	WOS:000273983200009	19751097	Green Published, Green Accepted			2022-02-06	
J	Bootes, K; Chapparo, C				Bootes, Kylie; Chapparo, Christine			Difficulties with multitasking on return to work after TBI: A critical case study	WORK-A JOURNAL OF PREVENTION ASSESSMENT & REHABILITATION			English	Article							STRATEGY APPLICATION; BRAIN INJURY; INTERVENTION	Work performance research highlights that psychometric cognitive measures and cognitive component information processing measures are strong predictors of success in multitasking work environments [14]. People with a mild to moderate traumatic brain injury (TBI) returning to a job requiring multitasking, may have difficulty succeeding despite pre-morbid equivalent cognitive scores. A critical case study is presented to begin to determine what aspects of information processing contribute to difficulties in multitasking work performance, for people with a TBI. The Perceive Recall Plan and Perform (PRPP) System of Task Analysis: Workplace Interview (i.e. PRPP@WORK) is used with the employer to obtain information processing scores. Results indicate substantial information processing deficits were perceived by the employer for the employee with a TBI. Future larger studies of people with a TBI who return to work that requires multitasking are needed to more clearly indicate: the level of multitasking they perform; what aspects of information processing hinder their work performance; the impact on performance of perceived cognitive load by the person with a TBI and the type and impact of support provided to improve their work performance.	[Chapparo, Christine] Univ Sydney, Fac Hlth Sci, Discipline Occupat Therapy, Lidcombe, NSW 1825, Australia		Chapparo, C (corresponding author), Univ Sydney, Fac Hlth Sci, Discipline Occupat Therapy, POB 170, Lidcombe, NSW 1825, Australia.	c.chapparo@usyd.edu.au					Barshi Immanuel, 2009, MULTITASKING MYTH HA; BOOTES K, 2003, PRPP SYSTEM WORKPLAC; Bootes Kylie, 2002, Work, V19, P255; Burgess PW, 2000, PSYCHOL RES-PSYCH FO, V63, P279, DOI 10.1007/s004269900006; BURGESS PW, PROSPECTIVE MEMORY, P236; Chan D, 2002, HUM PERFORM, V15, P233, DOI 10.1207/S15327043HUP1503_01; CHAPPARO C, 1997, MONOGRAPH OCCUPATION, V1, P189; Clark R.C., 2006, EFFICIENCY LEARNING; Fleming J, 1999, BRAIN INJURY, V13, P417; Fry K, 2002, AUSTR OCCUPATIONAL T, V49, P182, DOI 10.1046/j.1440-1630.2002.00337.x; HAMBLETON RK, 2003, APPL PSYCH MEAS, V7, P33; HOCKSTAFF JE, 1991, 5 NAT FOR ISS VOC AS, P185; Huffcutt AI, 2001, J APPL PSYCHOL, V86, P897, DOI 10.1037//0021-9010.86.5.897; Kinney T.B., 2008, 23 ANN C SOC IND ORG; LOHRI J, 2004, THESIS U SYDNEY LIDC; Mateer CA, 2006, NEUROREHABILITATION, V21, P315; Nott MT, 2008, BRAIN INJURY, V22, P669, DOI 10.1080/02699050802227170; Nott MT, 2009, AUST OCCUP THER J, V56, P307, DOI 10.1111/j.1440-1630.2008.00763.x; NOTT MT, 2007, AUSTR OCCUPATIONAL T, V55, P199; Paas F, 2003, EDUC PSYCHOL-US, V38, P63, DOI 10.1207/S15326985EP3801_8; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; PONSFORD JL, 1993, NEUROPSYCHOL REHABIL, V3, P5; Ree MJ, 2002, HUM PERFORM, V15, P3; Gouveia PAR, 2007, BRAIN COGNITION, V63, P240, DOI 10.1016/j.bandc.2006.09.001; Romiszowski A, 1984, DESIGNING INSTRUCTIO; Salminen A.L., 2006, AUST OCCUP THER J, V53, DOI [10.1111/j.1440-1630.2006.00540.x, DOI 10.1111/J.1440-1630.2006.00540.X, https://doi.org/10.1111/j.1440-1630.2006.00540.x]; Sbordone RJ, 2001, NEUROREHABILITATION, V16, P199; Schmidt FL, 1998, PSYCHOL BULL, V124, P262, DOI 10.1037/0033-2909.124.2.262; Schraagen Jan Maarten, 2000, COGNITIVE TASK ANAL; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; SHAW L, 2008, ERGONOMICS THERAPIST, P103; Slifer KJ, 1997, BRAIN INJURY, V11, P877; STAKE RE, 2005, ART CASE STUDY; Swan L, 2004, BRAIN INJURY, V18, P143, DOI 10.1080/02699050310001596923; Tenopyr ML, 2002, HUM PERFORM, V15, P107, DOI 10.1207/S15327043HUP1501&02_07; Wei J, 2003, HUM FACTORS ERGONOM, V13, P59, DOI 10.1002/hfm.10028; Yin R.K., 2002, APPL SOCIAL RES METH, V5, DOI DOI 10.1086/421629	37	18	19	1	7	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1051-9815	1875-9270		WORK	Work		2010	36	2					207	216		10.3233/WOR-2010-01021			10	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	629FW	WOS:000280181500009	20634614				2022-02-06	
J	Cazzato, V; Basso, D; Cutini, S; Bisiacchi, P				Cazzato, Valentina; Basso, Demis; Cutini, Simone; Bisiacchi, Patrizia			Gender differences in visuospatial planning: An eye movements study	BEHAVIOURAL BRAIN RESEARCH			English	Article						Gender differences; Visuospatial planning; Navigation; Strategy; Optimisation; Eye movements	CLOSED-HEAD INJURY; SEX-DIFFERENCES; SPATIAL ABILITY; STRATEGIES; KNOWLEDGE; TASKS	Gender studies report a male advantage in several visuospatial abilities. Only few studies however, have evaluated differences in visuospatial planning behaviour with regard to gender. This study was aimed at exploring whether gender may affect the choice of cognitive strategies in a visuospatial planning task and, if oculomotor measures could assist in disentangling the cognitive processes involved. A computerised task based on the travelling salesperson problem paradigm, the Maps test, was used to investigate these issues. Participants were required to optimise time and space of a path travelling among a set of sub-goals in a spatially constrained environment. Behavioural results suggest that there are no gender differences in the initial visual processing of the stimuli, but rather during the execution of the plan, with males showing a shorter execution time and a higher path length optimisation than females. Males often showed changes of heuristics during the execution while females seemed to prefer a constant strategy. Moreover, a better performance in behavioural and oculomotor measures seemed to suggest that males are more able than females in either the optimisation of spatial features or the realisation of the planned scheme. Despite inconclusive findings, the results support previous research and provide insight into the level of cognitive processing involved in navigation and planning tasks, with regard to the influence of gender. (C) 2009 Elsevier B.V. All rights reserved.	[Basso, Demis; Bisiacchi, Patrizia] Univ Padua, Dept Gen Psychol, I-35100 Padua, Italy; [Cazzato, Valentina] Univ Roma La Sapienza, Dept Psychol, Rome, Italy; [Cazzato, Valentina] Santa Lucia Fdn, Neuroimaging Lab, Rome, Italy; [Cutini, Simone] Univ Padua, Dept Dev Psychol, I-35100 Padua, Italy		Basso, D (corresponding author), Univ Padua, Dept Gen Psychol, I-35100 Padua, Italy.	demis.basso@unipd.it	BISIACCHI, PATRIZIA/B-8976-2008; Basso, Demis/Q-4782-2017	BISIACCHI, PATRIZIA/0000-0003-2760-8000; Basso, Demis/0000-0002-4595-3513	Italian PRIN2005Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)	This work was supported by the Italian PRIN2005 awarded to P.S.B. The authors wish to thank the two anonymous reviewers for the thoughtful suggestions which sensibly improved the initial manuscript, and Dr. Rita Younan for language revisions. Individual contribution: D.B. and P.S.B. conceived the study, D.B. and S.C. prepared the materials, V.C. collected the data, V.C., D.B. and S.C. analysed the data, V.C. and D.B. wrote the manuscript, which was revised by all authors.	Alderman N, 2003, J INT NEUROPSYCH SOC, V9, P31, DOI 10.1017/S1355617703910046; Basso D, 2006, EXP BRAIN RES, V171, P411, DOI 10.1007/s00221-006-0457-z; Basso D, 2001, BRAIN COGNITION, V46, P38, DOI 10.1016/S0278-2626(01)80029-4; BASSO D, 2005, THESIS U ROME SAPIEN; BASSO D, 1999, AIP C NAZ SEZ PSIC S, P155; Basso Demis, 2006, Cogn Process, V7, P73, DOI 10.1007/s10339-006-0034-1; Beatty J., 2000, HDB PSYCHOPHYSIOLOGY, V2, P142; Bisiacchi PS, 1998, BRAIN COGNITION, V37, P113; BISIACCHI PS, 2002, IAPS B PEOPLE ENV ST, V21, P1; BISIACCHI PS, 1999, NEUROPSICOLOGIA INVE, P185; Buss D., 2003, EVOLUTIONARY PSYCHOL; BYRNE R, 1977, COGNITION, V5, P287, DOI 10.1016/0010-0277(77)90019-1; Byrnes JP, 1999, PSYCHOL BULL, V125, P367, DOI 10.1037/0033-2909.125.3.367; Carpenter P. A., 1986, ADV PSYCHOL HUMAN IN, V3, P221; Chen CH, 2009, J ENVIRON PSYCHOL, V29, P220, DOI 10.1016/j.jenvp.2008.07.003; Choi J., 1996, EVOL COGN, V2, P165, DOI DOI 10.1016/S0191-8869(02)00105-8; Coluccia E, 2004, J ENVIRON PSYCHOL, V24, P329, DOI 10.1016/j.jenvp.2004.08.006; d'Acremont M, 2006, INT J BEHAV DEV, V30, P352, DOI 10.1177/0165025406066740; Dabbs JM, 1998, EVOL HUM BEHAV, V19, P89, DOI 10.1016/S1090-5138(97)00107-4; DUNCAN J, 1986, COGNITIVE NEUROPSYCH, V3, P271, DOI 10.1080/02643298608253360; Feigenbaum, 1981, HDB ARTIFICIAL INTEL, V1; GALEA LAM, 1993, PERS INDIV DIFFER, V14, P53, DOI 10.1016/0191-8869(93)90174-2; Gigerenzer G., 1999, SIMPLE HEURISTICS MA; Gitelman DR, 2002, BEHAV RES METH INS C, V34, P605, DOI 10.3758/BF03195488; GOEL V, 1995, NEUROPSYCHOLOGIA, V33, P623, DOI 10.1016/0028-3932(95)90866-P; Graham SM, 2000, MEM COGNITION, V28, P1191, DOI 10.3758/BF03211820; Halpern DF, 2004, CURR DIR PSYCHOL SCI, V13, P135, DOI 10.1111/j.0963-7214.2004.00292.x; HAYES-ROTH B, 1979, Cognitive Science, V3, P275, DOI 10.1207/s15516709cog0304_1; Helsgaun K, 2000, EUR J OPER RES, V126, P106, DOI 10.1016/S0377-2217(99)00284-2; HIRTLE SC, 1985, MEM COGNITION, V13, P208, DOI 10.3758/BF03197683; HIRTLE SC, 1992, GEOFORUM, V23, P227, DOI 10.1016/0016-7185(92)90019-Z; JONKER J, 2003, BRAIN COGNITION, V52, P231; KAHNEMAN D, 1966, SCIENCE, V154, P1583, DOI 10.1126/science.154.3756.1583; Kimura D., 1999, SEX COGNITION; Klatzky R. L., 1998, Spatial Cognition. An Interdisciplinary Approach to Representing and Processing Spatial Knowledge, P1; Klippel A, 2009, COGN PROCESS, V10, P175, DOI 10.1007/s10339-008-0251-x; Law AS, 2006, ACTA PSYCHOL, V122, P27, DOI 10.1016/j.actpsy.2005.09.002; Lawton CA, 2002, SEX ROLES, V47, P389, DOI 10.1023/A:1021668724970; LAWTON CA, 1994, SEX ROLES, V30, P765, DOI 10.1007/BF01544230; Lawton CA, 2001, SEX ROLES, V44, P321, DOI 10.1023/A:1010981616842; MacGregor JN, 1996, PERCEPT PSYCHOPHYS, V58, P527, DOI 10.3758/BF03213088; McManis MH, 2001, PSYCHOPHYSIOLOGY, V38, P222, DOI 10.1017/S0048577201991140; Mueller SC, 2008, BEHAV BRAIN RES, V193, P209, DOI 10.1016/j.bbr.2008.05.017; Murakoshi S, 2000, ENVIRON BEHAV, V32, P756, DOI 10.1177/00139160021972784; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Payne J.W., 1993, ADAPTIVE DECISION MA; Rilea SL, 2008, BRAIN COGNITION, V67, P168, DOI 10.1016/j.bandc.2008.01.001; Sandstrom NJ, 1998, COGNITIVE BRAIN RES, V6, P351, DOI 10.1016/S0926-6410(98)00002-0; Saucier DM, 2002, BEHAV NEUROSCI, V116, P403, DOI 10.1037//0735-7044.116.3.403; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; SIMON HA, 1976, COGNITIVE PSYCHOL, V8, P86, DOI 10.1016/0010-0285(76)90005-0; TAKEDA M, 1976, HUMAN ENG, V12, P175; Tenbrink T, 2009, COGN PROCESS, V10, P143, DOI 10.1007/s10339-008-0225-z; Vogeley K, 2003, TRENDS COGN SCI, V7, P38, DOI 10.1016/S1364-6613(02)00003-7; VOYER D, 1995, PSYCHOL BULL, V117, P250, DOI 10.1037/0033-2909.117.2.250; Weiss EM, 2003, PERS INDIV DIFFER, V35, P863, DOI 10.1016/S0191-8869(02)00288-X; WITKIN HA, 1950, J PERS, V19, P1, DOI 10.1111/j.1467-6494.1950.tb01084.x	58	18	20	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	JAN	2010	206	2					177	183		10.1016/j.bbr.2009.09.010			7	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	523KD	WOS:000272071100003	19761799	Green Submitted			2022-02-06	
J	Chang, MC; Jang, SH				Chang, Min Cheol; Jang, Sung Ho			Corpus callosum injury in patients with diffuse axonal injury: A diffusion tensor imaging study	NEUROREHABILITATION			English	Article						Diffuse axonal injury; diffuse tensor imaging; corpus callosum; brain injury	TRAUMATIC BRAIN-INJURY; WHITE-MATTER INJURY; CLOSED-HEAD TRAUMA; CORTICOSPINAL TRACT; MR; INTEGRITY; LESIONS; TRACTOGRAPHY; FEATURES; MODERATE	Little is known about diffusion tensor image (DTI) findings of corpus callosum (CC) injury in patients with diffuse axonal injury (DAI). In the present study, we investigated the presence and extent of CC injury in patients with DAI. Twenty patients with DAI and 20 age-and sex-matched normal healthy controls subjects were recruited. Patients were divided into two groups according to the presence of a CC lesion on conventional brain MRI, namely, the CC (+) group (8 patients) and the CC (-) group (12 patients). DTIs were acquired using a sensitivity-encoding head coil at 1.5 T. The CC was divided into six mid-sagittal segments: the genu, rostral midbody, anterior midbody, posterior midbody, isthmus, and splenium. Fractional anisotropies (FA) and apparent diffusion coefficients (ADCs) were measured. FA values of all CC segments in DAI patients were significantly lower than those of controls (p < 0.001); whereas ADC values were either similar or marginally higher. FA values of the six sagittal segments in the CC (-) and (+) groups were significantly lower than those of controls, and ADC values were slightly higher, or showed no change. CC lesions may be present in DAI patients, irrespective of detection on conventional brain MRI. The authors suggest the probability that in cases of corpus callosum injury, DTI can offer a powerful means of detecting DAI.	[Chang, Min Cheol; Jang, Sung Ho] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Taegu 705717, South Korea		Jang, SH (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyungdong, Taegu 705717, South Korea.	strokerehab@hanmail.net					ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Ahn YH, 2006, NEUROREHABILITATION, V21, P239; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Beaulieu C, 1996, MAGNET RESON MED, V36, P627, DOI 10.1002/mrm.1910360419; BIEGON A, 1994, NEUROBIOL AGING, V15, P393, DOI 10.1016/0197-4580(94)90070-1; GENTRY LR, 1988, AM J NEURORADIOL, V9, P101, DOI 10.2214/ajr.150.3.663; GENTRY LR, 1989, RADIOLOGY, V171, P177, DOI 10.1148/radiology.171.1.2928523; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; Godefroy O, 2003, J NEUROL, V250, P1, DOI 10.1007/s00415-003-0918-2; GRAHAM DI, 1997, GREENFIELDS NEUROPAT, P104; Han BS, 2007, NEUROREHABILITATION, V22, P151; Hong JH, 2009, BRAIN RES BULL, V80, P30, DOI 10.1016/j.brainresbull.2009.05.021; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kuroki N, 2006, BIOL PSYCHIAT, V60, P22, DOI 10.1016/j.biopsych.2005.09.021; LEVIN H, 1994, J NEUROPSYCH CLIN N, V6, P443; Mazziotta J, 2001, J AM MED INFORM ASSN, V8, P401, DOI 10.1136/jamia.2001.0080401; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Neil JJ, 2008, J MAGN RESON IMAGING, V27, P1, DOI 10.1002/jmri.21087; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Ptak T, 2003, AM J ROENTGENOL, V181, P1401, DOI 10.2214/ajr.181.5.1811401; Rugg-Gunn FJ, 2001, J NEUROL NEUROSUR PS, V70, P530, DOI 10.1136/jnnp.70.4.530; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; SUGIYAMA K, J NEUROTRAUMA; Sugiyama K, 2007, BRAIN INJURY, V21, P413, DOI 10.1080/02699050701311042; Takei K, 2008, SCHIZOPHR RES, V103, P52, DOI 10.1016/j.schres.2008.03.008; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208	39	18	19	0	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2010	26	4					339	345		10.3233/NRE-2010-0571			7	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	632NE	WOS:000280430600007	20555157				2022-02-06	
J	Cohen, M; Ylvisaker, M; Hamilton, J; Kemp, L; Claiman, B				Cohen, Michelle; Ylvisaker, Mark; Hamilton, Joanna; Kemp, Lisa; Claiman, Barb			Errorless learning of functional life skills in an individual with three aetiologies of severe memory and executive function impairment	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Errorless learning; Memory treatment; Community rehabilitation; Cost-effective long-term intervention; Cognitive-Communication	COGNITIVE-BEHAVIORAL SUPPORTS; TRAUMATIC BRAIN-INJURY; YOUNG-CHILDREN; TBI; REHABILITATION; AMNESIA; REPLICATION; HM	Errorless learning (EL) procedures have been shown to be effective in teaching new information and new procedures to individuals with severe memory impairment. The published studies have been based on comparatively short-term interventions delivered to individuals with relatively circumscribed impairments. In this single case study, we explore the usefulness of errorless learning procedures used for seven years with an adult with profound and complicated memory and executive function impairments associated with three distinct aetiologies. In primary functional areas targeted by the intervention, outcome was documented by behavioural descriptions and a frequency rating scale. Caregiver burden was documented with qualitative descriptors. A financial cost-benefit analysis is also provided. In the absence of change in underlying neuropsychological impairments, DI's everyday functioning in critical areas improved substantially, with corresponding reduction in supports and improved quality of life. Caregiver burden was reduced to acceptable levels and cost-benefit analysis demonstrates substantial ongoing cost savings.	[Cohen, Michelle] Michelle Cohen & Associates, Toronto, ON, Canada; [Ylvisaker, Mark] Coll St Rose Albany, New York, NY USA		Cohen, M (corresponding author), CASLPO S LP C, 35 Denlow Blvd, Don Mills, ON M3B 1P6, Canada.	mcohen101@rogers.com					BADDELEY A, 1994, NEUROPSYCHOLOGIA, V32, P53, DOI 10.1016/0028-3932(94)90068-X; Bourgeois MS, 2007, BRAIN INJURY, V21, P1245, DOI 10.1080/02699050701727452; Brush JA, 1998, THERAPY TECHNIQUE IM; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Clare L, 2008, NEUROPSYCHOL REV, V18, P1, DOI 10.1007/s11065-008-9051-4; Detterman DL, 1993, TRANSFER TRIAL INTEL; Ebbinghaus H., 1913, MEMORY CONTRIBUTION; Ehlhardt LA, 2008, NEUROPSYCHOL REHABIL, V18, P300, DOI 10.1080/09602010701733190; Evans JJ, 2000, NEUROPSYCHOL REHABIL, V10, P67, DOI 10.1080/096020100389309; Feeney T, 2006, BRAIN INJURY, V20, P629, DOI 10.1080/02699050600744194; Feeney TJ, 2008, J POSIT BEHAV INTERV, V10, P115, DOI 10.1177/1098300707312540; FEENEY TJ, 1995, J HEAD TRAUMA REHAB, V10, P67; Feeney TJ, 2003, J HEAD TRAUMA REHAB, V18, P33, DOI 10.1097/00001199-200301000-00006; GRAF P, 1985, J EXP PSYCHOL LEARN, V11, P386, DOI 10.1037/0278-7393.11.2.386; GUGER S, 2001, 29 ANN M INT NEUR SO; Hillary FG, 2003, J CLIN EXP NEUROPSYC, V25, P49, DOI 10.1076/jcen.25.1.49.13631; IZARD CE, 1993, PSYCHOL REV, V100, P68; Kessels RPC, 2003, J CLIN EXP NEUROPSYC, V25, P805, DOI 10.1076/jcen.25.6.805.16474; Komatsu S, 2000, NEUROPSYCHOL REHABIL, V10, P113, DOI 10.1080/096020100389200; Korsakoff S., 1889, REV PHILOS, V5, P501; Mesulam MM, 2002, PRINCIPLES FRONTAL L, P8, DOI [10.1093/acprof:oso/9780195134971.003.0002, DOI 10.1093/ACPROF:OSO/9780195134971.003.0002]; MILNER B, 1968, NEUROPSYCHOLOGIA, V6, P215, DOI 10.1016/0028-3932(68)90021-3; MOFFAT N, 1992, CLIN MANAGEMENT MEMO, P86, DOI DOI 10.1007/978-1-4899-4523-5_4; Ostergaard Arne L., 1993, P327; SALMON DP, 1995, CURR OPIN NEUROBIOL, V5, P184, DOI 10.1016/0959-4388(95)80025-5; Schacter Daniel L., 1996, SEARCHING MEMORY BRA; SHIMAMURA AP, 1993, IMPLICIT MEMORY NEW, P327; Squire Larry R., 1994, P203; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Squire LR., 1987, MEMORY BRAIN; Stark C, 2005, NEUROPSYCHOLOGY, V19, P139, DOI 10.1037/0894-4105.19.2.139; Tailby R, 2003, NEUROPSYCHOLOGIA, V41, P1230, DOI 10.1016/S0028-3932(03)00036-8; Turkstra LS, 2005, J MED SPEECH-LANG PA, V13, P205; World Health Organization, 2007, INT CLASS FUNCT DIS; Ylvisaker M., 1998, COLLABORATIVE BRAIN; Ylvisaker M., 2002, FORGET IT SOURCES TH, P147; YLVISAKER M, 2007, BRAIN IMPAIR, V8, P1	37	18	20	2	20	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2010	20	3					355	376	PII 918620014	10.1080/09602010903309401			22	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	598RZ	WOS:000277857200003	20077313				2022-02-06	
J	FitzGerald, A; Aditya, H; Prior, A; McNeill, E; Pentland, B				FitzGerald, Alasdair; Aditya, Hosakere; Prior, Anthony; McNeill, Ewan; Pentland, Brian			Anoxic brain injury: Clinical patterns and functional outcomes. A study of 93 cases	BRAIN INJURY			English	Article						Anoxia-hypoxia; brain injury; functional outcome; cognition; rehabilitation	CARDIAC-ARREST; DEMOGRAPHIC-VARIABLES; CEREBRAL HYPOXIA; ADULT SURVIVORS; ENCEPHALOPATHY; REHABILITATION; MYOCLONUS; EPILEPSY; SEQUELAE; MEMORY	Background: Anoxic brain injury (ABI) is a syndrome of diverse aetiology, most case series published to date being confined to ABI of a single aetiology or to a limited numbers of patients. Methods: This study performed a retrospective analysis on all patients admitted for rehabilitation following ABI over a 14-year period. It identified 93 cases and presents a summary of their clinical patterns and functional and psychometric outcome measures. In addition a database involving 584 patients admitted for rehabilitation following traumatic brain injury (TBI) during the same time interval was used to compare demographic, functional and cognitive patterns. Conclusions: Relative to TBI, there was a peak frequency of ABI in males aged 60 years and in females in their late 20s. ABI patients were referred later for rehabilitation, had similar lengths of stay, but made slower progress, with poorer outcomes and were more likely to be transferred to residential care. Those with ABI had more severe impairments on cognitive assessment relative to those with TBI, being particularly susceptible to impairments in memory, especially visual memory or short-term memory. Neurological impairments of speech and language were present in 72 patients; visual field loss in eight and cortical blindness in 10; six suffered myoclonus and 10 late epilepsy.	[FitzGerald, Alasdair; Pentland, Brian] Astley Ainslie Hosp, Dept Neurorehabil, Edinburgh EH3 9HL, Midlothian, Scotland; [Aditya, Hosakere] St Johns Hosp, Dept Psychiat, Livingston, Scotland; [Prior, Anthony; McNeill, Ewan] Astley Ainslie Hosp, Dept Neuropsychol, Edinburgh EH3 9HL, Midlothian, Scotland; [Pentland, Brian] Univ Edinburgh, Dept Rehabil Studies, Edinburgh EH8 9YL, Midlothian, Scotland		FitzGerald, A (corresponding author), Astley Ainslie Hosp, Dept Neurorehabil, Edinburgh EH3 9HL, Midlothian, Scotland.	alasdair.fitzgerald@nhs.net					Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Auer RN, 2002, GREENFIELDS NEUROPAT, V7th, P233; BEREK K, 1995, STROKE, V26, P543, DOI 10.1161/01.STR.26.4.543; BHATIA KP, 1994, BRAIN, V117, P859, DOI 10.1093/brain/117.4.859; BHATT MH, 1993, NEUROLOGY, V43, P314, DOI 10.1212/WNL.43.2.314; Bigler E D, 1988, Arch Clin Neuropsychol, V3, P383, DOI 10.1016/0887-6177(88)90052-2; Burgess P.W., 1997, HAYLING BRIXTON TEST; Burkala EJ, 2005, AIDS, V19, P675, DOI 10.1097/01.aids.0000166090.31693.aa; Caine D, 2000, J INT NEUROPSYCH SOC, V6, P86, DOI 10.1017/S1355617700611116; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; CORKIN S, 1985, ANN NY ACAD SCI, V444, P10, DOI 10.1111/j.1749-6632.1985.tb37577.x; CORWIN J, 1993, CLIN NEUROPSYCHOL, V7, P3, DOI 10.1080/13854049308401883; Crawford JR, 1997, CLIN NEUROPSYCHOL, V11, P192, DOI 10.1080/13854049708407050; Crawford JR, 2001, BRIT J CLIN PSYCHOL, V40, P97, DOI 10.1348/014466501163517; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; Fertl E, 2000, RESUSCITATION, V47, P231, DOI 10.1016/S0300-9572(00)00239-2; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gale SD, 1999, BRAIN INJURY, V13, P229, DOI 10.1080/026990599121601; Garcia-Molina A, 2006, BRAIN INJURY, V20, P1139, DOI 10.1080/02699050600983248; Hall K. M., 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199308020-00008; Hamsher K., 1989, MULTILINGUAL APHASIA; Herman ST, 2002, NEUROLOGY, V59, pS21, DOI 10.1212/WNL.59.9_suppl_5.S21; Hollows S. E., 1985, ADULT MEMORY INFORM; HOPKINS RO, 1995, BRAIN COGNITION, V27, P180, DOI 10.1006/brcg.1995.1016; Hopkins RO, 2005, NEUROPSYCHOLOGY, V19, P233, DOI 10.1037/0894-4105.19.2.233; Hopkins RO, 2004, J INT NEUROPSYCH SOC, V10, P957, DOI 10.1017/S1355617704107108; HORN S, 1992, Brain Injury, V6, P321, DOI 10.3109/02699059209034946; Kandiah P, 2006, SEMIN NEUROL, V26, P413, DOI 10.1055/s-2006-948322; Khot S, 2006, SEMIN NEUROL, V26, P422, DOI 10.1055/s-2006-948323; LANCE JW, 1963, BRAIN, V86, P111, DOI 10.1093/brain/86.1.111; LEVY DE, 1985, JAMA-J AM MED ASSOC, V253, P1420, DOI 10.1001/jama.253.10.1420; Lim C, 2004, NEUROLOGY, V63, P1774, DOI 10.1212/01.WNL.0000144189.83077.8E; Lishman WA, 1998, PSYCHOL CONSEQUENCES, P546; Middelkamp W, 2007, CLIN REHABIL, V21, P425, DOI 10.1177/0269215507075307; Nelson H.E., 1991, NATL ADULT READING T, V2nd ed.; RANDOLPH C, 1998, REPEATABLE BATTERY N; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Schmidt JG, 1997, J NEUROL REHABIL, V11, P189; Shah MK, 2004, BRAIN INJURY, V18, P111, DOI 10.1080/0269905031000149551; Shah MK, 2007, J NEUROL SCI, V260, P95, DOI 10.1016/j.jns.2007.04.012; Sivan AB., 1992, BENTON VISUAL RETENT; SNYDER BD, 2003, NEUROLOGY CLIN PRACT, P1665; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; TRESPASSER Z, 1989, ARCH PHYS MED REHAB, V70, P186; VOLPE BT, 1983, ARCH NEUROL-CHICAGO, V40, P436, DOI 10.1001/archneur.1983.04050070066017; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wechsler D., 1997, WECHSLER TEST ADULT; WIJDICKS EFM, 1994, ANN NEUROL, V35, P239, DOI 10.1002/ana.410350219; Wilson BA, 1996, BRAIN INJURY, V10, P863, DOI 10.1080/026990596123846; Wilson FC, 2003, NEUROREHABILITATION, V18, P291	52	18	18	0	16	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2010	24	11					1311	1323		10.3109/02699052.2010.506864			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	667MY	WOS:000283198800005	20722503				2022-02-06	
J	Handratta, V; Hsu, E; Vento, J; Yang, C; Tanev, K				Handratta, Venkatesh; Hsu, Ellen; Vento, John; Yang, Clifford; Tanev, Kaloyan			Neuroimaging findings and brain-behavioral correlates in a former boxer with chronic traumatic brain injury	NEUROCASE			English	Article						Chronic traumatic brain injury; Dementia; Traumatic brain injury; Dementia pugilistica; Neuroimaging; Neuropsychiatry; Brain behavior relationships	CAVUM SEPTI PELLUCIDI; NATIONAL-FOOTBALL-LEAGUE; CORTICAL CELL-CULTURE; GLUTAMATE NEUROTOXICITY; BIPOLAR DISORDER; RAT; SCHIZOPHRENIA; PREVALENCE; VERGAE; ENCEPHALOPATHY	Chronic traumatic brain injury (CTBI) is associated with contact sports such as boxing. CTBI results from repetitive blows to the head rather than from a single impact. CTBI individuals present with motor symptoms (incoordination, spasticity, parkinsonism), cognitive impairment (executive dysfunction, memory deficits) and neuropsychiatric symptoms (irritability, affective disturbances). The structural and functional neuroimaging findings and clinical presentation of a CTBI case are described. We propose hypotheses about the pathophysiology of the observed neuroimaging findings and their relationship to the neuropsychiatric symptoms of the patients.	[Handratta, Venkatesh; Hsu, Ellen; Vento, John; Yang, Clifford; Tanev, Kaloyan] Univ Connecticut, Ctr Hlth, Farmington, CT USA		Tanev, K (corresponding author), Massachusetts Gen Hosp, 55 Fruit St, Boston, MA 02114 USA.	ktanev@partners.org					ADAMS CWM, 1989, J NEUROL NEUROSUR PS, V52, P600, DOI 10.1136/jnnp.52.5.600; Aminov M, 1995, Vestn Rentgenol Radiol, P5; Arciniegas DB, 2001, NEUROPSYCHIATRY INTR; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; Bodensteiner JB, 1998, J CHILD NEUROL, V13, P120, DOI 10.1177/088307389801300305; BOGDANOFF B, 1989, NEUROLOGY, V39, P991, DOI 10.1212/WNL.39.7.991; Bruyn GW, 1977, HDB CLIN NEUROLOGY, P299; Cantu RC, 2007, NEUROSURGERY, V61, P223, DOI 10.1227/01.NEU.0000255514.73967.90; CASSON IR, 1984, JAMA-J AM MED ASSOC, V251, P2663, DOI 10.1001/jama.251.20.2663; CHOI DW, 1988, J NEUROSCI, V8, P185; CHOI DW, 1987, J NEUROSCI, V7, P357; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; CRITCHLEY E, 1937, MED ANN, P318; Cummings J., 2003, NEUROPSYCHIATRY BEHA; DEGREEF G, 1992, PSYCHIAT RES-NEUROIM, V45, P1, DOI 10.1016/0925-4927(92)90009-S; Dixon CE, 1998, J NEUROTRAUM, V15, P95, DOI 10.1089/neu.1998.15.95; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Fitch MT, 1999, J NEUROSCI, V19, P8182; Fitch MT, 1997, EXP NEUROL, V148, P587, DOI 10.1006/exnr.1997.6701; Flashman LA, 2007, PSYCHIAT RES-NEUROIM, V154, P147, DOI 10.1016/j.pscychresns.2006.09.001; Fujiwara S, 1993, Nihon Hoigaku Zasshi, V47, P387; GRAFMAN J, 1986, BRAIN, V109, P1127, DOI 10.1093/brain/109.6.1127; GUTERMAN A, 1987, SPORTS MED, V4, P194, DOI 10.2165/00007256-198704030-00004; HUGHES RA, 1955, ARCH NEURO PSYCHIATR, V74, P259, DOI 10.1001/archneurpsyc.1955.02330150025004; Isaksson J, 2001, ACTA NEUROPATHOL, V102, P246; JOHNSON J, 1969, BRIT J PSYCHIAT, V115, P45, DOI 10.1192/bjp.115.518.45; JORDAN BD, 1990, JAMA-J AM MED ASSOC, V263, P1670, DOI 10.1001/jama.263.12.1670; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; JORGE RE, 1993, AM J PSYCHIAT, V150, P916; KASTE M, 1982, LANCET, V2, P1186; Kim MJ, 2007, BIPOLAR DISORD, V9, P274, DOI 10.1111/j.1399-5618.2007.00442.x; Kubota H, 1968, Nihon Geka Hokan, V37, P437; LARROCHE JC, 1961, BIOL NEONATORUM, V3, P193; Marklund N, 2001, ACTA NEUROCHIR, V143, P73, DOI 10.1007/s007010170141; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; MAWDSLEY C, 1963, LANCET, V2, P795; McCrory P, 2002, BRIT J SPORT MED, V36, P157, DOI 10.1136/bjsm.36.3.157; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; MENDEZ MF, 1995, INT J PSYCHIAT MED, V25, P249, DOI 10.2190/CUMK-THT1-X98M-WB4C; Mustafa B, 2005, J NEUROPSYCH CLIN N, V17, P122, DOI 10.1176/appi.neuropsych.17.1.122; Nopoulos P, 1997, BIOL PSYCHIAT, V41, P1102, DOI 10.1016/S0006-3223(96)00209-0; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; OTERUELO FT, 1986, ANAT ANZEIGER, V162, P271; Pearce JMS, 2008, EUR NEUROL, V59, P332, DOI 10.1159/000121428; Rabadi MH, 2001, CLIN J SPORT MED, V11, P194, DOI 10.1097/00042752-200107000-00011; Rajarethinam R, 2001, SCHIZOPHR RES, V48, P201, DOI 10.1016/S0920-9964(00)00110-9; Roberts AH, 1969, BRAIN DAMAGE BOXERS; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; ROBINSON RG, 2000, NEUROPSYCHIATRY TRAU, P219; Scoffings DJ, 2008, CLIN RADIOL, V63, P210, DOI 10.1016/j.crad.2007.07.008; SHAW CM, 1969, BRAIN, V92, P213, DOI 10.1093/brain/92.1.213; Shioiri T, 1996, PSYCHOL MED, V26, P431, DOI 10.1017/S0033291700034838; SUTTON RL, 1994, ACTA NEUROCHIR, P446; Takahashi T, 2007, PROG NEURO-PSYCHOPH, V31, P1235, DOI 10.1016/j.pnpbp.2007.04.019; Unterharnscheidt F, 1995, Rev Neurol, V23, P1027; VANWAGENEN WP, 1934, AM J CANCER, V20, P539; Yang D N, 1997, J Am Optom Assoc, V68, P519; Zazryn T, 2007, SPORTS MED, V37, P467, DOI 10.2165/00007256-200737060-00001; Zhang LJ, 2003, AM J NEURORADIOL, V24, P52; Zhu S G, 1991, Zhonghua Wai Ke Za Zhi, V29, P244; ZHU SG, 1991, ZHONGHUA WAI KE ZA Z, V29, P271	63	18	18	0	15	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1355-4794	1465-3656		NEUROCASE	Neurocase		2010	16	2					125	134		10.1080/13554790903329166			10	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	569LY	WOS:000275599800004	19967598				2022-02-06	
J	Horton, AM; Soper, HV; Reynolds, CR				Horton, Arthur MacNeill, Jr.; Soper, Henry V.; Reynolds, Cecil R.			Executive Functions in Children with Traumatic Brain Injury	APPLIED NEUROPSYCHOLOGY			English	Article						children; executive functioning; neuropsychology; traumatic brain injury	ATTENTIONAL DEFICITS; TASK-PERFORMANCE; EARLY-CHILDHOOD; HEAD-INJURY; DAMAGE; TRAIL; TBI	The maturational course of the development of executive functioning abilities is dependent on the functional capacity of the human brain. Unfortunately, there is a dearth of standardized functional assessments of executive functioning abilities for children. The present article describes neurodevelopment of executive functioning and several recent measures of executive functioning that have been developed to assess maturational periods of specific executive functions. Clinical implications of these results for traumatically brain-injured children are described.	[Horton, Arthur MacNeill, Jr.] Psych Associates Maryland, Bethesda, MD USA; [Soper, Henry V.] Fielding Grad Univ, Psychol Program, Santa Barbara, CA USA; [Reynolds, Cecil R.] Texas A&M Univ, Dept Educ Psychol, Bastrop, TX USA		Horton, AM (corresponding author), 5903 Lone Oak Dr, Bethesda, MD 20814 USA.	drmachorton@hotmail.com					Anderson SW, 2000, DEV NEUROPSYCHOL, V18, P281, DOI 10.1207/S1532694202Anderson; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; BENTON AL, 1968, NEUROPSYCHOLOGIA, V6, P53, DOI 10.1016/0028-3932(68)90038-9; Campbell CGN, 2004, CAN J NEUROL SCI, V31, P213, DOI 10.1017/S0317167100053853; Catroppa C, 2003, DEV NEUROPSYCHOL, V23, P359, DOI 10.1207/S15326942DN2303_3; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Chan RCK, 2001, BRAIN INJURY, V15, P71, DOI 10.1080/02699050150209156; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; ESTES WK, 1974, AM PSYCHOL, V29, P740, DOI 10.1037/h0037458; Fenwick T, 1999, CHILD NEUROPSYCHOL, V5, P213, DOI 10.1076/0929-7049(199912)05:04;1-R;FT213; Fletcher-Janzen E., 1989, HDB CLIN CHILD NEURO, P17, DOI 10.1007/978-1-4899-6807-4_2; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; Hamsher K., 1989, MULTILINGUAL APHASIA; Hartlage L. C., 1975, PEDIAT PSYCHOL, V3, P23; HARTLAGE LC, 1986, NEUROPSYCHOLOGY HDB, P441; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Heaton R.K., 1981, WISCONSIN CARD SORTI; High Jr WM, 2005, REHABILITATION TRAUM; HORTON AM, 1994, BEHAV INTERVENTIONS; HORTON AM, 2008, NEUROPSYCHOLOGY HDB, P3; Horton AM, 1986, CHILD NEUROPSYCHOL, V2, P299; HYND GW, 1988, PEDIAT NEUROPSYCHOLO; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; Leclercq M, 2000, J CLIN EXP NEUROPSYC, V22, P339, DOI 10.1076/1380-3395(200006)22:3;1-V;FT339; Levine B, 2005, COGN BEHAV NEUROL, V18, P45, DOI 10.1097/01.wnn.0000152227.13001.c3; Levine B., 2002, PRINCIPLES FRONTAL L, P448; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Luria A.R., 1966, HIGHER CORTICAL FUNC; MILNER B, 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI 10.1001/archneur.1963.00460070100010; Mitrushina MN, 1999, HDB NORMATIVE DATA N; Morgan JE, 2008, TXB CLIN NEUROPSYCHO, P158; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Reitan R.M., 1974, CLIN NEUROPSYCHOLOGY; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Reynolds C. R., 2003, COMPREHENSIVE TRAIL; REYNOLDS CR, 1997, HDB CLIN CHILD NEURO; Reynolds CR, 2006, TEST VERBAL CONCEPTU; Romine CB, 2005, APPL NEUROPSYCHOL, V12, P190, DOI 10.1207/s15324826an1204_2; ROSEN W G, 1980, Journal of Clinical Neuropsychology, V2, P135, DOI 10.1080/01688638008403788; ROTH RM, 2008, NEUROPSYCHOLOGY HDB, P217; Spiers MV., 2001, PRINCIPLES NEUROPSYC; Stuss DT, 2001, PSYCHOL ASSESSMENT, V13, P230, DOI 10.1037//1040-3590.13.2.230; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Verdejo-Garcia A, 2006, J INT NEUROPSYCH SOC, V12, P405, DOI 10.1017/S1355617706060486; Wolfson, 1993, HALSTEAD REITAN NEUR; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Ylvisaker M. E., 1998, TRAUMATIC BRAIN INJU	50	18	18	1	24	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0908-4282			APPL NEUROPSYCHOL	Appl. Neuropsychol.		2010	17	2					99	103	PII 922163073	10.1080/09084281003708944			5	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	596CX	WOS:000277662800004	20467949				2022-02-06	
J	Lull, N; Noe, E; Lull, JJ; Garcia-Panach, J; Chirivella, J; Ferri, J; Lopez-Aznar, D; Sopena, P; Robles, M				Lull, Nuria; Noe, Enrique; Jose Lull, Juan; Garcia-Panach, Javier; Chirivella, Javier; Ferri, Joan; Lopez-Aznar, Diego; Sopena, Pablo; Robles, Montse			Voxel-based statistical analysis of thalamic glucose metabolism in traumatic brain injury: Relationship with consciousness and cognition	BRAIN INJURY			English	Article						Voxel-based analysis; positron emission tomography; consciousness; PET-FDG; prognosis; thalamus; traumatic brain injury	DIFFUSE AXONAL INJURY; REGIONAL CEREBRAL METABOLISM; PERSISTENT VEGETATIVE STATE; SEVERE HEAD-INJURY; POSTTRAUMATIC AMNESIA; MRI; CONNECTIVITY; MODERATE; PET; CONSEQUENCES	Objective: To study the relationship between thalamic glucose metabolism and neurological outcome after severe traumatic brain injury (TBI). Methods: Forty-nine patients with severe and closed TBI and 10 healthy control subjects with F-18-FDG PET were studied. Patients were divided into three groups: MCS&VS group (n = 17), patients in a vegetative or a minimally conscious state; In-PTA group (n = 12), patients in a state of post-traumatic amnesia (PTA); and Out-PTA group (n = 20), patients who had emerged from PTA. SPM5 software implemented in MATLAB 7 was used to determine the quantitative differences between patients and controls. FDG-PET images were spatially normalized and an automated thalamic ROI mask was generated. Group differences were analysed with two sample voxel-wise t-tests. Results: Thalamic hypometabolism was the most prominent in patients with low consciousness (MCS&VS group) and the thalamic hypometabolism in the In-PTA group was more prominent than that in the Out-PTA group. Healthy control subjects showed the greatest thalamic metabolism. These differences in metabolism were more pronounced in the internal regions of the thalamus. Conclusions: The results confirm the vulnerability of the thalamus to suffer the effect of the dynamic forces generated during a TBI. Patients with thalamic hypometabolism could represent a sub-set of subjects that are highly vulnerable to neurological disability after TBI.	[Lull, Nuria; Jose Lull, Juan; Garcia-Panach, Javier; Robles, Montse] Univ Politecn Valencia, Grp Informat Biomed, Inst Aplicac Tecnol Informac & Comunicac Avanzada, E-46071 Valencia, Spain; [Lull, Nuria] Univ CEU Cardenal Herrera, Valencia, Spain; [Noe, Enrique; Garcia-Panach, Javier; Chirivella, Javier; Ferri, Joan] FIVAN, Serv Dano Cerebral, Hosp NISA, Valencia, Spain; [Lopez-Aznar, Diego; Sopena, Pablo] Hosp 9 Octubre, Serv PET Med Nucl, Valencia, Spain		Noe, E (corresponding author), Hosp Valencia Mar, Serv Dano Cerebral, Hosp NISA, C Rio Tajo 1, Valencia 46011, Spain.	enoe@comv.es	Sopena-Novales, Pablo/AAA-4427-2019; Lull, Juan Jose/AAB-5154-2019; Robles, Montserrat/A-6722-2016	Sopena-Novales, Pablo/0000-0002-0560-0051; Lull, Juan Jose/0000-0002-4399-950X; Robles, Montserrat/0000-0002-7705-1389; Noe Sebastian, Enrique/0000-0002-2547-8727			Ahmed S, 2000, BRAIN INJURY, V14, P765; Anderson CV, 1996, J NEUROTRAUM, V13, P59, DOI 10.1089/neu.1996.13.59; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Brandstack N, 2006, BRAIN INJURY, V20, P409, DOI 10.1080/02699050500487951; Fearing MA, 2008, J CHILD NEUROL, V23, P729, DOI 10.1177/0883073808314159; Firsching R, 2001, ACTA NEUROCHIR, V143, P263; Gallagher CN, 2007, CURR OPIN NEUROL, V20, P403, DOI 10.1097/WCO.0b013e32821b987b; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Giacino J, 2005, J HEAD TRAUMA REHAB, V20, P30, DOI 10.1097/00001199-200501000-00005; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gispert JD, 2003, NEUROIMAGE, V19, P601, DOI 10.1016/S1053-8119(03)00072-7; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Grados MA, 2001, J NEUROL NEUROSUR PS, V70, P350, DOI 10.1136/jnnp.70.3.350; Guye M, 2008, CURR OPIN NEUROL, V21, P393, DOI 10.1097/WCO.0b013e3283065cfb; ICHISE M, 1994, J NUCL MED, V35, P217; Kim J, 2008, NEUROIMAGE, V39, P1014, DOI 10.1016/j.neuroimage.2007.10.005; KINNEY HC, 1994, NEW ENGL J MED, V330, P1469, DOI 10.1056/NEJM199405263302101; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Laureys S, 1999, NEUROIMAGE, V9, P377, DOI 10.1006/nimg.1998.0414; Laureys S, 1999, J NEUROL NEUROSUR PS, V67, P121, DOI 10.1136/jnnp.67.1.121; Laureys S, 2000, LANCET, V355, P1790, DOI 10.1016/S0140-6736(00)02271-6; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Levine B, 2006, J NEUROTRAUM, V23, P1396, DOI 10.1089/neu.2006.23.1396; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Maxwell WL, 2006, J NEUROPATH EXP NEUR, V65, P478, DOI 10.1097/01.jnen.0000229241.28619.75; Metting Z, 2007, LANCET NEUROL, V6, P699, DOI 10.1016/S1474-4422(07)70191-6; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Mitelman SA, 2006, BRAIN RES, V1114, P125, DOI 10.1016/j.brainres.2006.07.043; Nakashima T, 2007, AM J NEURORADIOL, V28, P236; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.080523; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; OLEARY DDM, 1994, ANNU REV NEUROSCI, V17, P419, DOI 10.1146/annurev.neuro.17.1.419; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Price CJ, 2002, NEUROCASE, V8, P345, DOI 10.1076/neur.8.4.345.16186; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; TOMMASINO C, 1995, J NEUROSURG ANESTH, V7, P109, DOI 10.1097/00008506-199504000-00006; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uzan M, 2003, J NEUROL NEUROSUR PS, V74, P33, DOI 10.1136/jnnp.74.1.33; Van der Werf YD, 2002, BRAIN RES REV, V39, P107, DOI 10.1016/S0165-0173(02)00181-9; WILSON JTL, 1994, J NEUROL NEUROSUR PS, V57, P198, DOI 10.1136/jnnp.57.2.198; WILSON JTL, 1995, J NEUROL NEUROSUR PS, V59, P328, DOI 10.1136/jnnp.59.3.328; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208; Zeman A, 2001, BRAIN, V124, P1263, DOI 10.1093/brain/124.7.1263	47	18	19	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2010	24	9					1098	1107		10.3109/02699052.2010.494592			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	636RH	WOS:000280756700006	20597637	Green Published			2022-02-06	
J	Mrakovcic, L; Wildburger, R; Jaganjac, M; Cindric, M; Cipak, A; Sunjic, SB; Waeg, G; Milankovic, AM; Zarkovic, N				Mrakovcic, Lidija; Wildburger, Renate; Jaganjac, Morana; Cindric, Marina; Cipak, Ana; Sunjic, Suzana Borovic; Waeg, Georg; Milankovic, Andrea M.; Zarkovic, Neven			Lipid peroxidation product 4-hydroxynonenal as factor of oxidative homeostasis supporting bone regeneration with bioactive glasses	ACTA BIOCHIMICA POLONICA			English	Article; Proceedings Paper	Open Workshop on Natural and Synthetic Antioxidants	SEP 25-26, 2009	Rzeszow, POLAND	COST B 35 WG 4		bone regeneration; bioactive glass; lipid peroxidation; 4-hydroxynonenal; oxidative homeostasis	TRAUMATIC BRAIN INJURY; IN-VITRO; GROWTH; CELLS; DIFFERENTIATION; SCAFFOLDS; OSTEOBLASTS; ACTIVATION; CERAMICS	Bone regeneration is a process of vital importance since fractures of long bones and large joints have a highly deleterious impact on both, individuals and society. Numerous attempts have been undertaken to alleviate this severe medical and social problem by development of novel bioactive materials, among which bioactive glass is the most attractive because of its osteoconductive and osteostimulative properties. Since lipid peroxidation is an important component of systematic stress response in patients with traumatic brain injuries and bone fractures, studies have been undertaken of the molecular mechanisms of the involvement of 4-hydroxynonenal (HNE), an end product of lipid peroxidation, in cellular growth regulation. We found that HNE generated in bone cells grown in vitro on the surfaces of bioactive glasses 4555 and 13-93. This raises an interesting possibility of combined action of HNE and ionic bioglass dissolution products in enhanced osteogenesis probably through a mitogen-activated protein kinase (MAPK) pathway. While the proposed mechanism still has to be elucidated, the finding of HNE generation on bioglass offers a new interpretation of the osteoinducting mechanisms of bioglass and suggests the possibility of tissue engineering based on manipulations of oxidative homeostasis.	[Mrakovcic, Lidija; Jaganjac, Morana; Cipak, Ana; Sunjic, Suzana Borovic; Zarkovic, Neven] Rudjer Boskovic Inst, Dept Mol Med, Zagreb, Croatia; [Wildburger, Renate] Med Univ, LKH Clin Traumatol, Graz, Austria; [Cindric, Marina] Clin Hosp Ctr Zagreb, Fac Med, Dept Pathol, Zagreb, Croatia; [Waeg, Georg] Karl Franzens Univ Graz, Inst Mol Biosci, Graz, Austria; [Milankovic, Andrea M.] Rudjer Boskovic Inst, NMR Ctr, Zagreb, Croatia		Zarkovic, N (corresponding author), Rudjer Boskovic Inst, Dept Mol Med, Zagreb, Croatia.	zarkovic@irb.hr	Milkovic, Lidija/F-5097-2019; Zarkovic, Neven/AAG-5836-2019; Jaganjac, Morana/AAX-2526-2020	Milkovic, Lidija/0000-0002-4484-039X; Zarkovic, Neven/0000-0001-5032-0369; Jaganjac, Morana/0000-0001-5051-1843			Awasthi YC, 2005, METHOD ENZYMOL, V401, P379, DOI 10.1016/S0076-6879(05)01024-4; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; BOROVIC S, 2007, PROGR CELL GROWTH PR, P187; BOROVIC SS, 2005, BIOFACTORS, V24, P141; Borovic S, 2007, REDOX REP, V12, P50, DOI 10.1179/135100007X162194; Borovic S, 2006, FREE RADICAL RES, V40, P809, DOI 10.1080/10715760600693422; Brown RF, 2008, ACTA BIOMATER, V4, P387, DOI 10.1016/j.actbio.2007.07.006; Buckwalter J A, 1996, Instr Course Lect, V45, P387; Buckwalter J A, 1996, Instr Course Lect, V45, P371; Chen KCW, 2007, MOL VIS, V13, P374; Chen ZH, 2005, J BIOL CHEM, V280, P41921, DOI 10.1074/jbc.M508556200; Colnot C, 2005, CLIN ORTHOP RELAT R, P69, DOI 10.1097/01.blo.0000167251.26164.37; Day RM, 2004, BIOMATERIALS, V25, P5857, DOI 10.1016/j.biomaterials.2004.01.043; Deschaseaux F, 2009, TRENDS MOL MED, V15, P417, DOI 10.1016/j.molmed.2009.07.002; Dimitriou R, 2005, INJURY, V36, P1392, DOI 10.1016/j.injury.2005.07.019; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Fu Q, 2008, ACTA BIOMATER, V4, P1854, DOI 10.1016/j.actbio.2008.04.019; Hench LL., 1971, J BIOMED MAT RES, V2, P117, DOI [10.1002/jbm.820050611, DOI 10.1002/JBM.820050611]; Henrotin YE, 2003, OSTEOARTHR CARTILAGE, V11, P747, DOI 10.1016/S1063-4584(03)00150-X; Kakishita H, 2001, LIFE SCI, V69, P689, DOI 10.1016/S0024-3205(01)01166-3; Kamata H, 1999, CELL SIGNAL, V11, P1, DOI 10.1016/S0898-6568(98)00037-0; KITSUGI T, 1987, J BIOMED MATER RES, V21, P1255, DOI 10.1002/jbm.820211008; Leonarduzzi G, 2004, FREE RADICAL BIO MED, V37, P1694, DOI 10.1016/j.freeradbiomed.2004.08.027; Mattson MP, 2000, J MOL NEUROSCI, V14, P175, DOI 10.1385/JMN:14:3:175; Niki E, 2009, FREE RADICAL BIO MED, V47, P469, DOI 10.1016/j.freeradbiomed.2009.05.032; Ohgushi H, 1996, J BIOMED MATER RES, V32, P341, DOI 10.1002/(SICI)1097-4636(199611)32:3<341::AID-JBM6>3.0.CO;2-S; Ramana KV, 2006, J BIOL CHEM, V281, P17652, DOI 10.1074/jbc.M600270200; Tsigkou O, 2009, BIOMATERIALS, V30, P3542, DOI 10.1016/j.biomaterials.2009.03.019; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6; Waeg G, 1996, FREE RADICAL RES, V25, P149, DOI 10.3109/10715769609149920; Wildburger R, 2001, WIEN KLIN WOCHENSCHR, V113, P119; WILDBURGER R, 1995, EUR J CLIN CHEM CLIN, V33, P693; WILDBURGER R, 1994, BONE MINER, V27, P183, DOI 10.1016/S0169-6009(08)80192-4; Wildburger R, 2000, WIEN KLIN WOCHENSCHR, V112, P798; WILDBURGER R, 1997, BIOFACTORS, V6, P292; Wildburger R, 2009, TURK KLIN TIP BILIM, V29, P189; Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503; Yan J, 2006, J PHARMACOL EXP THER, V319, P613, DOI 10.1124/jpet.106.109850; Zarkovic K, 1997, SHOCK, SEPSIS AND ORGAN FAILURE, P146; ZARKOVIC N, 2009, P EUR SOC FREE RAD R, P37; Zarkovic Neven, 2003, Molecular Aspects of Medicine, V24, P281, DOI 10.1016/S0098-2997(03)00023-2	41	18	19	1	4	ACTA BIOCHIMICA POLONICA	WARSAW	PASTEURA 3, 02-093 WARSAW, POLAND	0001-527X			ACTA BIOCHIM POL	Acta Biochim. Pol.		2010	57	2					173	178					6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology	619GJ	WOS:000279416900007	20512168				2022-02-06	
J	Rasquin, SMC; Bouwens, SFM; Dijcks, B; Winkens, I; Bakx, WGM; van Heugten, CM				Rasquin, S. M. C.; Bouwens, S. F. M.; Dijcks, B.; Winkens, I.; Bakx, W. G. M.; van Heugten, C. M.			Effectiveness of a low intensity outpatient cognitive rehabilitation programme for patients in the chronic phase after acquired brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Brain injury; Cognitive rehabilitation; Outpatient; Chronic; Goal attainment	COMMUNITY INTEGRATION; RANDOMIZED-TRIAL; STROKE; IMPACT; QUESTIONNAIRE; INDIVIDUALS; VALIDATION; ADJUSTMENT; FAMILIES; MODERATE	The aim of this prospective cohort study was to examine the effectiveness of a low intensity outpatient cognitive rehabilitation programme for patients with acquired brain injury in the chronic phase. Twenty-seven patients with acquired brain injury (i.e., stroke, traumatic brain injury, subarachnoid haemorrhage; 52% male) with a mean age of 49.5 (SD 9.2) years and 25 relatives with a mean age of 48.8 (SD 8.8) years were recruited to the study. Mean time since injury in the patient group was 1.9 years (SD 2.0). The group programme consisted of 15 weekly sessions of 2.5 hours and included cognitive strategy training, social skills training, and psycho-education. Patients also received homework. Relatives were invited to attend twice. Repeated measurements were taken: prior to treatment (baseline, T0); directly after treatment (T1, 21 weeks); and at follow-up (T2, 45 weeks). Primary outcome measures were individualised goals (GAS), cognitive failures (CFQ), and quality of life (SA-SIP). Patients did improve significantly on individual goals (p .05) between T0 and T1 and the level of attainment remained stable between T1 and T2. Goals were mostly set in the cognitive and behavioural domains. There were no significant differences between the measurements (T0-T1-T2) on the CFQ and the SA-SIP. The programme had a positive effect on the individual goals set by the patients. However, this did not result in a higher participation level or a better quality of life. This may be due to the low intensity and short duration of the programme.	[Rasquin, S. M. C.; Bakx, W. G. M.] Adelante Rehabil, Hoensbroek, Netherlands; [Rasquin, S. M. C.; Bouwens, S. F. M.; Winkens, I.; van Heugten, C. M.] Maastricht Univ, Sch Mental Hlth & Neurosci, Dept Psychiat & Neuropsychol, Maastricht, Netherlands; [Dijcks, B.; Winkens, I.] Vilans, Utrecht, Netherlands; [van Heugten, C. M.] Ctr Excellence Rehabil Med, Utrecht, Netherlands; [van Heugten, C. M.] Rudolf Magnus Inst Neurosci, NL-3508 TA Utrecht, Netherlands; [van Heugten, C. M.] Maastricht Univ, Dept Neuropsychol & Psychopharmacol, Fac Psychol & Neurosci, Maastricht, Netherlands		Rasquin, SMC (corresponding author), POB 88, NL-6430 AB Hoensbroek, Netherlands.	s.rasquin@adelante-zorggroep.nl					Arrindell WA, 2003, SYMPTOM CHECKLIST; Beutler LE, 2003, J CLIN PSYCHOL, V59, P1151, DOI 10.1002/jclp.10216; Boothroyd Roger A, 2004, Ment Health Serv Res, V6, P143, DOI 10.1023/B:MHSR.0000036488.12833.6e; Bouwens SFM, 2009, CLIN REHABIL, V23, P310, DOI 10.1177/0269215508101744; Brickenkamp R., 1998, D2 TEST ATTENTION; Brickenkamp R., 1962, AUFMERKSAMKEITS BELA; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Burgess P, 1996, BEHAV ASSESSMENT DYS; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Dittmar C, 1997, Appl Neuropsychol, V4, P50, DOI 10.1207/s15324826an0401_6; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; Fisher K, 2008, CLIN REHABIL, V22, P252, DOI 10.1177/0269215507081928; Fraas M, 2007, BRAIN INJURY, V21, P1267, DOI 10.1080/02699050701721794; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Geurtsen GJ, 2008, BRAIN INJURY, V22, P545, DOI 10.1080/02699050802132479; Geusgens CAV, 2007, J REHABIL MED, V39, P425, DOI 10.2340/16501977-0092; Gordon JE, 1999, AGE AGEING, V28, P275, DOI 10.1093/ageing/28.3.275; Graetz P., 1992, AKENSE AFASIETEST NE; Hibbard MR, 2002, J HEAD TRAUMA REHAB, V17, P112, DOI 10.1097/00001199-200204000-00004; JORM AF, 1989, PSYCHOL MED, V19, P1015, DOI 10.1017/S0033291700005742; JOYCE BM, 1994, AM J PHYS MED REHAB, V73, P10, DOI 10.1097/00002060-199473010-00003; KIRESUK TJ, 1968, COMMUNITY MENT HLT J, V4, P443, DOI 10.1007/BF01530764; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Liu C, 2004, CLIN REHABIL, V18, P398, DOI 10.1191/0269215504cr741oa; LUTEIJN F, 1983, MANUAL GRONINGER INT; Malec JF, 2001, ARCH PHYS MED REHAB, V82, P885, DOI 10.1053/apmr.2001.23895; McAllister TW, 1997, COMMUNITY MENT HLT J, V33, P341, DOI 10.1023/A:1025055426260; McColl MA, 2001, ARCH PHYS MED REHAB, V82, P429, DOI 10.1053/apmr.2001.22195; Miller L J, 1998, Appl Neuropsychol, V5, P172, DOI 10.1207/s15324826an0504_2; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Osterrieth PA, 1994, ARCH PSYCHOL, V30, P286; Paniak C, 2000, BRAIN INJURY, V14, P219; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; Rapoport MJ, 2000, BRAIN INJURY, V14, P749; Reitan R.M., 1956, TRAIL MAKING TEST MA; Rey A, 1958, LEXAMEN CLINIQUE PSY; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; ROBINSON BC, 1983, J GERONTOL, V38, P344, DOI 10.1093/geronj/38.3.344; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Sarajuuri JM, 2005, ARCH PHYS MED REHAB, V86, P2296, DOI 10.1016/j.apmr.2005.06.018; Schreurs PJG., 1993, UTRECHTSE COPING LIJ; SCHULING J, 1993, STROKE, V24, P1173, DOI 10.1161/01.STR.24.8.1173; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tiersky LA, 2005, ARCH PHYS MED REHAB, V86, P1565, DOI 10.1016/j.apmr.2005.03.013; Turner-Stokes L, 2002, CLIN REHABIL, V16, P231, DOI 10.1191/0269215502cr487oa; van Boxtel M., 2006, TIJDSCHRIFT NEUROPSY, V1, P37; van der Naalt J, 2001, J CLIN EXP NEUROPSYC, V23, P837, DOI 10.1076/jcen.23.6.837.1018; vanStraten A, 1997, STROKE, V28, P2155, DOI 10.1161/01.STR.28.11.2155; VISSERMEILY J, 2007, NEDERLANDS TIJDSCHRI, V15, P2753; Wechsler D., 1997, WECHSLER ADULT INTEL, VIII; Wilson BA, 2002, J HEAD TRAUMA REHAB, V17, P542, DOI 10.1097/00001199-200212000-00006; Wilson BA, 2000, NEUROPSYCHOL REV, V10, P233, DOI 10.1023/A:1026464827874; Wyller TB, 2003, CLIN REHABIL, V17, P410, DOI 10.1191/0269215503cr627oa; Ylvisaker M, 2002, J HEAD TRAUMA REHAB, V17, P191, DOI 10.1097/00001199-200206000-00002	60	18	18	0	14	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0960-2011			NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2010	20	5					760	777	PII 922908508	10.1080/09602011.2010.484645			18	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	648YB	WOS:000281730300007	20544502	Green Submitted			2022-02-06	
J	Schutz, LE; Rivers, KO; McNamara, E; Schutz, JA; Lobato, EJ				Schutz, Larry E.; Rivers, Kenyatta O.; McNamara, Elizabeth; Schutz, Judith A.; Lobato, Emilio J.			TRAUMATIC BRAIN INJURY IN K-12 STUDENTS: WHERE HAVE ALL THE CHILDREN GONE?	INTERNATIONAL JOURNAL OF SPECIAL EDUCATION			English	Article								When children who are permanently disabled by traumatic brain injury (TBI) return to school, most are placed in mainstream classrooms and incorrectly presumed capable of resuming their education. Only one to two percent are classified as students with TBI, qualifying them for the services they need for their education. The failure to properly classify so many children, attributed to a lack of training and to acceptance of inaccurate popular stereotypes, places 98 to 99 percent at risk of academic failure and personal maladjustment. The failure to identify these children needs to be addressed by TBI education and training for parents and professionals. This paper discusses the scope of the problem of improperly classified students, examines explanations for the pervasive failure to classify them accurately, and discusses potential solutions.	[Schutz, Larry E.; Rivers, Kenyatta O.; McNamara, Elizabeth] Univ Cent Florida, Orlando, FL 32816 USA; [Schutz, Judith A.] Sch Dist Osceola Cty, Kissimmee, FL USA; [Lobato, Emilio J.] GiveBack Inc, Orlando, FL USA		Schutz, LE (corresponding author), Univ Cent Florida, Orlando, FL 32816 USA.						Anderson V, 2006, AM J PHYS MED REHAB, V85, P767, DOI 10.1097/01.phm.0000233176.08480.22; Anderson VA, 2003, STUD NEUROPSYCHOL DE, P217; Arroyos-Jurado E., 2006, EXCEPTIONALITY, V14, P125, DOI [10.1207/s15327035ex1403_2, DOI 10.1207/S15327035EX1403_2]; Begali V., 1992, HEAD INJURY CHILDREN; BERROL S, 1982, HEAD INJURY REHABILI; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Blosser J, 1997, J HEAD TRAUMA REHAB, V12, P21, DOI 10.1097/00001199-199704000-00004; Blosser JL, 2003, PEDIAT TRAUMATIC BRA; Blosser JL, 1991, J HEAD TRAUMA REHAB, V6, P73; BOLL TJ, 1982, HEAD INJURY, P363; Carney J., 1995, EDUCATORS MANUAL WHA, P49; CHAPMAN SB, 2007, BRAIN INJ PROF, V3, P10; Clark E, 1996, J LEARN DISABIL, V29, P549, DOI 10.1177/002221949602900509; Cockrell J. L., 1990, COMMUNITY INTEGRATIO, P287; Cohen S. B., 1986, J HEAD TRAUMA REHAB, V1, P22; Corbett S. L., 1996, ED STUDENTS TRAUMATI; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Crovits H., 1983, CORTEX, V19, P207; DAmato RC, 1996, J LEARN DISABIL, V29, P670, DOI 10.1177/002221949602900611; Deaton A., 1990, TRAUMATIC BRAIN INJU, P231; Deidrick KKM, 2005, PREV SCH FAIL, V49, P23, DOI 10.3200/PSFL.49.4.23-33; DEPOMPEI R, 1994, ED DIMENSIONS ACQUIR, P489; DePompei R, 2008, J HEAD TRAUMA REHAB, V23, P191, DOI 10.1097/01.HTR.0000327251.16010.3b; Dettmer JL, 2007, J HEAD TRAUMA REHAB, V22, P339, DOI 10.1097/01.HTR.0000300229.13490.c7; DISCALA C, 1991, ARCH PHYS MED REHAB, V72, P662; DiScala C., 1993, PEDIAT TRAUMA REGIST; Dise-Lewis J., 2006, 2 FED INT C TRAUM BR; Doster J, 2001, Tenn Med, V94, P100; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Ewing-Cobbs L, 1990, TRAUMATIC BRAIN INJU, P107; Ewing-Cobbs L., 1998, HEAD INJURY CHILDREN, P11; Farmer JE, 1997, REHABIL PSYCHOL, V42, P273; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; Florida Department of Education, 2006, 12740 FLOR DEP ED; Forsyth R J, 2005, Pediatr Rehabil, V8, P140; FUNK P, 1996, PHYS DISABILITIES ED, V15, P49; Glang A, 2004, NEUROREHABILITATION, V19, P219; GLANG A, 1996, CHILDREN ACQUIRED BR, P149; Glang A, 2007, J HEAD TRAUMA REHAB, V22, P198, DOI 10.1097/01.HTR.0000271121.42523.3a; Goldberg E., 2001, THE EXECUTIVE BRAIN; Gordon WR, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199812000-00006; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P331; Greenspan AI, 2000, BRAIN INJURY, V14, P417; GREENSPAN AI, 1994, PEDIATRICS, V94, P425; Gronwall D., 1999, HEAD INJURY FACTS; Guare R., 2004, EXECUTIVE SKILLS CHI; Guilmette TJ, 2004, ARCH CLIN NEUROPSYCH, V19, P183, DOI 10.1016/S0887-6177(03)00025-8; HAGEN C, 1982, COGNITIVE REHABILITA, P131; Halligan P., 2005, EFFECTIVENESS REHABI, pxi; Hawley CA, 2004, BRAIN INJURY, V18, P645, DOI 10.1080/02699050310001646189; Hawley CA, 2002, BRAIN INJURY, V16, P969, DOI 10.1080/02699050210147239; HIBBARD M, 2001, STUDENTS TRAUMATIC B; Hooper S. R., 2006, EXCEPTIONALITY, V14, P172; Hux D, 1998, BRAIN INJURY, V12, P667; Hux K, 1999, BRAIN INJURY, V13, P447; Hux K, 1996, LANG SPEECH HEAR SER, V27, P171, DOI 10.1044/0161-1461.2702.171; Hux K, 2006, BRAIN INJURY, V20, P547, DOI 10.1080/02699050600676784; Iowa Department of Education, 2007, CONS SERV STUD BRAIN; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; Jennett B., 1997, HEAD INJURY, P439; KATZ DI, 2006, COGNITIVE REHABILITA; KINGSTON WJ, 1985, SEMIN NEUROL, V5, pU197; Kinsella G J, 1997, J Int Neuropsychol Soc, V3, P608; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; KRAUS JF, 2005, TXB TRAUMATIC BRAIN, P3; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lash M., 1995, ED MANUAL WHAT ED NE, P41; LAZAR MF, 1995, J HEAD TRAUMA REHAB, V10, P55, DOI 10.1097/00001199-199510000-00007; Lehr E., 1990, COMMUNITY INTEGRATIO, P301; Levin H., 1979, J PEDIATR PSYCHOL, V4, P389, DOI DOI 10.1093/JPEPSY/4.4.389; Levin HS., 1982, NEUROBEHAVIORAL CONS; Martin T., 2001, TRAUMATIC BRAIN INJU; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P125, DOI 10.1016/S0003-9993(96)90156-2; Max J, 2005, TXB TRAUMATIC BRAIN, P477; Max JE, 1999, J INT NEUROPSYCH SOC, V5, P58, DOI 10.1017/S1355617799511089; Max JE, 2000, J INT NEUROPSYCH SOC, V6, P279, DOI 10.1017/S1355617700633039; Max JE, 1998, J NEUROPSYCH CLIN N, V10, P290, DOI 10.1176/jnp.10.3.290; McCullagh S, 2005, TXB TRAUMATIC BRAIN, P321; MCDONALD CM, 1994, ARCH PHYS MED REHAB, V75, P328, DOI 10.1016/0003-9993(94)90038-8; McGuire LM, 1998, BRAIN INJURY, V12, P207, DOI 10.1080/026990598122683; Minnesota Department of Education, 2006, TOT SPEC ED SYST MAN; Mira M. P., 1992, TRAUMATIC BRAIN INJU; MIRA MP, 1991, FOCUS EXCEPT CHILD, V23, P1; Naugle R. J., 1990, NEUROPSYCHOLOGY EVER, P56; ODDY M, 1993, NEUROPSYCHOL REHABIL, V3, P301, DOI 10.1080/09602019308401444; Rivara Frederick P., 1986, J HEAD TRAUMA REHAB, V1, P7; Rivers K. O., 2007, ANN M AM SPEECH LANG; Rosen CD, 1986, HEAD TRAUMA ED REINT; Russell N, 1993, LANG SPEECH HEAR SER, V24, P67; Savage R. C., 1994, ED DIMENSIONS ACQUIR, P3; Savage R. C., 1991, HEAD INJURY FAMILY M, P203; Savage R. C., 1995, ED MANUAL WHAT ED NE, P1; Savage Ronald C, 2005, Pediatr Rehabil, V8, P92; Schutz L., 2005, AM PSYCH ASS ANN M W; Schutz L., 2000, FLORIDA J COMMUNICAT, V20, P28; Schutz L, 2004, UNDERSTANDING OVERCO; Schutz LE, 2008, LANG SPEECH HEAR SER, V39, P104, DOI 10.1044/0161-1461(2008/011); Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; SEGALOWITZ SJ, 1991, J LEARN DISABIL, V24, P551, DOI 10.1177/002221949102400907; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Singer J., 1997, STUDENTS ACQUIRED BR, P73; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Sohlberg M., 2001, COGNITIVE REHABILITA; Stuss DT, 1992, NEUROPSY NEUROPSY BE, V5; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; Tatzmann M., 2006, FOCUS ON RESULTS; Taylor HG, 2003, REHABIL PSYCHOL, V48, P227, DOI 10.1037/0090-5550.48.4.227; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Todis B., 1997, STUDENTS ACQUIRED BR, P33; Triplett G, 1996, PERCEPT MOTOR SKILL, V83, P1344, DOI 10.2466/pms.1996.83.3f.1344; Tucker B. F., 1992, INTERV SCH CLIN, V17, P198; Tyler J. S., 1997, STUDENTS ACQUIRED BR, P323; Tyler S. T., 2000, TBI INTENSIVE TRAINI; WAALAND PK, 1990, COMMUNITY INTEGRATIO, P225; Walker N. W., 1997, BEST PRACTICES ASSES; Walker S., 2005, EDUCATING CHILDREN T; WILLER B, 1993, ARCH CLIN NEUROPSYCH, V8, P461, DOI 10.1016/0887-6177(93)90009-P; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Winqvist S, 2007, NEUROEPIDEMIOLOGY, V29, P136, DOI 10.1159/000110741; Ylvisaker M, 2001, J HEAD TRAUMA REHAB, V16, P76, DOI 10.1097/00001199-200102000-00009; Ylvisaker M., 1998, TRAUMATIC BRAIN INJU, P159; Ylvisaker M., 1994, EDUCATORS MANUAL WHA, P41; YLVISAKER M, 2005, REHABILITATION TRAUM, P205; [No title captured]	128	18	18	0	0	INT JOURNAL SPECIAL EDUCATION	VANCOUVER	C/O DR MARG CSAPO, 2889 HIGHBURY ST, VANCOUVER, BC 00000, CANADA	0827-3383			INT J SPEC EDUC	Int. J. Spec. Educ.		2010	25	2					55	71					17	Education, Special	Emerging Sources Citation Index (ESCI)	Education & Educational Research	V22XB	WOS:000215053400007					2022-02-06	
J	Smith, MM; Arnett, PA				Smith, Megan M.; Arnett, Peter A.			Awareness of executive functioning deficits in multiple sclerosis: Self versus informant ratings of impairment	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Multiple sclerosis; Awareness; Cognition; Caregivers; Questionnaire; Neuropsychology	TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL IMPAIRMENT; DYSEXECUTIVE SYNDROME; WORKING-MEMORY; DEPRESSION; DYSFUNCTION; MS; QUESTIONNAIRE; PERFORMANCE; METAMEMORY	This study investigates the accuracy of self and informant ratings of executive dysfunction in a multiple sclerosis (MS) and control sample. Participants completed a neuropsychological battery. Participants and informants completed depression measures and the Dysexecutive Questionnaire (DEX). MS participants rated themselves more impaired than controls, while informants' ratings were not statistically different. MS participants' performance on executive tasks was more highly correlated with self than informant DEX ratings. Discrepancies between informant DEX ratings and executive performance were related to executive functioning for the MS participants only. Overall, results indicate that MS patients were able to accurately rate their executive functioning.	[Smith, Megan M.; Arnett, Peter A.] Penn State Univ, University Pk, PA 16802 USA		Smith, MM (corresponding author), Univ Iowa, Dept Psychiat, 1-308 MEB, Iowa City, IA 52242 USA.	megan-m-smith@uiowa.edu					Alderman N, 2001, NEUROPSYCHOL REHABIL, V11, P529, DOI 10.1080/09602010042000231; ALLEN C C, 1990, Brain Injury, V4, P7, DOI 10.3109/02699059009026143; Arnett PA, 2001, J INT NEUROPSYCH SOC, V7, P665, DOI 10.1017/S1355617701766027; Basso MR, 2008, J CLIN EXP NEUROPSYC, V30, P920, DOI 10.1080/13803390801888733; BEATTY WW, 1991, J CLIN EXP NEUROPSYC, V13, P309, DOI 10.1080/01688639108401046; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Benedict RHB, 2004, MULT SCLER J, V10, P675, DOI 10.1191/1352458504ms1098oa; Bennett PC, 2005, J INT NEUROPSYCH SOC, V11, P376, DOI 10.1017/S1355617705050423; Bivona U, 2008, J INT NEUROPSYCH SOC, V14, P862, DOI 10.1017/S1355617708081125; Bruce JM, 2004, J CLIN EXP NEUROPSYC, V26, P200, DOI 10.1076/jcen.26.2.200.28081; Burgess P, 1996, BEHAV ASSESSMENT DYS; Carone DA, 2005, J INT NEUROPSYCH SOC, V11, P574, DOI 10.1017/S135561770505068X; CAVALLO M M, 1992, Brain Injury, V6, P327, DOI 10.3109/02699059209034947; Chan RCK, 2001, BRIT J PSYCHOL, V92, P551, DOI 10.1348/000712601162338; Chiaravalloti ND, 2003, COGN BEHAV NEUROL, V16, P54, DOI 10.1097/00146965-200303000-00007; Christodoulou C, 2005, J INT NEUROPSYCH SOC, V11, P614, DOI 10.1017/S1355617705050733; Daneman M, 1996, PSYCHON B REV, V3, P422, DOI 10.3758/BF03214546; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; Evans JJ, 1997, PSYCHOL MED, V27, P635, DOI 10.1017/S0033291797004790; Fleming JM, 1996, BRAIN INJURY, V10, P1; Gold SM, 2001, MULT SCLER J, V7, P119, DOI 10.1191/135245801678227649; Heffernan Thomas, 2004, Irish Journal of Psychological Medicine, V21, P122, DOI 10.1017/S0790966700008545; Hoogervorst ELJ, 2001, NEUROLOGY, V56, P934, DOI 10.1212/WNL.56.7.934; Jonker C, 2000, INT J GERIATR PSYCH, V15, P983, DOI 10.1002/1099-1166(200011)15:11<983::AID-GPS238>3.0.CO;2-5; Kujala P, 1996, ACTA NEUROL SCAND, V93, P329; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; Malloy P.F., 2001, FRONTAL SYSTEMS BEHA; Malloy P. F., 1998, CLIN NEUROPSYCHOLOGY, P573; Maor Y, 2001, MULT SCLER, V7, P131, DOI 10.1191/135245801678227658; Marrie RA, 2005, MULT SCLER J, V11, P69, DOI 10.1191/1352458505ms1110oa; Matotek K, 2001, Appl Neuropsychol, V8, P204, DOI 10.1207/09084280152829048; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Middleton LS, 2006, ARCH CLIN NEUROPSYCH, V21, P487, DOI 10.1016/j.acn.2006.06.008; Nyenhuis DL, 1998, J PERS ASSESS, V70, P386, DOI 10.1207/s15327752jpa7002_14; Odhuba RA, 2005, BRIT J CLIN PSYCHOL, V44, P269, DOI 10.1348/014466505X29431; Ownsworth T, 2006, NEUROPSYCHOL REHABIL, V16, P415, DOI 10.1080/09602010500505641; Podewils LJ, 2003, PSYCHOSOMATICS, V44, P461, DOI 10.1176/appi.psy.44.6.461; Randolph JJ, 2001, CLIN NEUROPSYCHOL, V15, P357, DOI 10.1076/clin.15.3.357.10278; RANDOLPH JJ, 2003, ARCH CLIN NEUROPSYCH, V619, P1; RATCLIFF R, 1993, PSYCHOL BULL, V114, P510, DOI 10.1037/0033-2909.114.3.510; Robertson I., 1994, TEST EVERYDAY ATTENT; TAYLOR R, 1990, BRIT J CLIN PSYCHOL, V29, P251, DOI 10.1111/j.2044-8260.1990.tb00882.x; Trenerry MR, 1989, STROOP NEUROPSYCHOLO; Wilson BA, 1998, NEUROPSYCHOL REHABIL, V8, P213, DOI 10.1080/713755570; Zachary R. A., 1986, SHIPLEY I LIVING SCA	47	18	18	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2010	32	7					780	787	PII 919993334	10.1080/13803390903540307			8	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	631WB	WOS:000280380200012	20306356				2022-02-06	
J	Wrona, RM				Wrona, Ronald M.			Disability and return to work outcomes after traumatic brain injury: Results from the Washington State Industrial Insurance Fund	DISABILITY AND REHABILITATION			English	Article						Traumatic brain injury; workers' compensation administrative data; disability outcomes; return to work outcomes	MODEL	Introduction. This article contains a description of community traumatic brain injury (TBI) treatment patterns and outcomes based solely on workers' compensation administrative records for Washington State. Methods. Administrative records available from the Washington State Department of Labor and Industries data warehouse of administrative records are used to describe medical rehabilitation services and return to work (RTW) referrals for cases of TBI between 1 January 1998 and 31 December 2002. These data represent official records for disability determination and referral for vocational rehabilitation (VR) services. Results. At total of 797 cases were identified all of which had identifiable treatment trajectories. No disability was the outcome in 9.0% of cases; temporary disability in 53.5% of cases, permanent disability in 31.1% of cases. Only 48% of surviving cases include a medical rehabilitation phase. This phase included only inpatient services in 26.5% of referred cases, only ambulatory services in 59.6% and both inpatient and ambulatory services in 13.9%. Only about half of surviving cases were referred for RTW services. Employment rates were similar to those published from other state rehabilitation programs. Conclusions. State/community treatment and disability outcome patterns are more diverse than the expected sequence of acute treatment, medical rehabilitation and VR. Employment rates after referral for VR were 65%.	Western Kentucky Univ, Dept Publ Hlth, Owensboro, KY 42303 USA		Wrona, RM (corresponding author), Western Kentucky Univ, Dept Publ Hlth, 4441 Greenacre Dr, Owensboro, KY 42303 USA.	ronwrona@roadrunner.com	Wrona, Ronald/W-9319-2019		National Institute for Occupational Safety and HealthUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH) [5U01OH07292-01]; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTHUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH) [U01OH007292] Funding Source: NIH RePORTER	This publication was supported by Grant/Cooperative Agreement 5U01OH07292-01 from the National Institute for Occupational Safety and Health, while the author was employed by the state of Washington. Its contents are solely the responsibility of the author and do not necessarily represent the official views of the National Institute for Occupational Safety and Health.	Brown AW, 2004, NEUROREHABILITATION, V19, P37; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Johnstone B, 2006, NEUROREHABILITATION, V21, P335; Malec JF, 2006, BRAIN INJURY, V20, P227, DOI 10.1080/02699050500488124; Pransky G, 2005, J OCCUP REHABIL, V15, P453, DOI 10.1007/s10926-005-8027-y; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Thurman DJ., 1995, GUIDELINES SURVEILLA; Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001; Wrona RM, 2006, J SAFETY RES, V37, P75, DOI 10.1016/j.jsr.2005.08.008; Wyman DO, 1999, AM FAM PHYSICIAN, V59, P844	10	18	18	0	7	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0963-8288			DISABIL REHABIL	Disabil. Rehabil.		2010	32	8					650	655		10.3109/09638280903186327			6	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	575WI	WOS:000276100100006	20205578				2022-02-06	
J	Shum, D; Gill, H; Banks, M; Maujean, A; Griffin, J; Ward, H				Shum, David; Gill, Hannah; Banks, Miranda; Maujean, Annick; Griffin, Janelle; Ward, Heather			Planning Ability Following Moderate to Severe Traumatic Brain Injury: Performance on a 4-Disk Version of the Tower of London	BRAIN IMPAIRMENT			English	Article						planning; Tower of London; adults; TBI	CLOSED-HEAD INJURY; TASK; CHILDREN	This study aimed to assess planning ability in adults with traumatic brain injury (TBI) using a 4-disk version of the Tower of London (TOL). Thirty three individuals with TBI were compared with equivalent numbers of matched controls. Overall, the TOL4 was shown to be sensitive to the effects of brain injury, with the TBI group performing significantly more poorly on this version of the planning test than the matched controls. More specifically, group differences were found to be related to the complexity of the planning problems, particularly among a TBI subgroup with localised prefrontal damage. Results of the study provide support for the adverse effects of TBI on planning ability, and the important role of the prefrontal cortex in planning.	[Shum, David] Griffith Univ, Griffith Inst Hlth & Med Res, Brisbane, Qld 4111, Australia; [Shum, David; Banks, Miranda; Maujean, Annick] Griffith Univ, Sch Psychol, Brisbane, Qld 4111, Australia; [Gill, Hannah] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia; [Griffin, Janelle] Princess Alexandra Hosp, Occupat Therapy Dept, Brain Injury Rehabil Unit, Brisbane, Qld 4102, Australia; [Ward, Heather] Albany Creek Specialists Ctr, Brisbane, Qld, Australia		Shum, D (corresponding author), Griffith Univ, Sch Psychol, Mt Gravatt Campus,176 Messines Ridge Rd, Mt Gravatt, Qld 4122, Australia.	d.shum@griffith.edu.au	Shum, David/A-3914-2008; Gullo, Hannah/C-5011-2008	Shum, David/0000-0002-4810-9262; Maujean, Annick/0000-0002-9623-1369; GULLO, Hannah/0000-0003-4238-4033			Anderson P, 1996, CLIN NEUROPSYCHOL, V10, P54, DOI 10.1080/13854049608406663; Baker K, 2001, CLIN NEUROPSYCHOL, V15, P309; Cockburn J, 1995, J Int Neuropsychol Soc, V1, P537; Culbertson WC, 1998, ASSESSMENT, V5, P215, DOI 10.1177/107319119800500302; Jefferson AL, 2006, ARCH CLIN NEUROPSYCH, V21, P311, DOI 10.1016/j.acn.2006.03.007; Kaller CP, 2004, COGNITIVE BRAIN RES, V20, P462, DOI 10.1016/j.cogbrainres.2004.04.002; KRIKORIAN R, 1994, J CLIN EXP NEUROPSYC, V16, P840, DOI 10.1080/01688639408402697; Levin H S, 1997, J Int Neuropsychol Soc, V3, P598; Levin H. S., 1994, NEUROPSYCHOLOGY, V87, P171, DOI DOI 10.1037/0894-4105.8.2.171; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Rasmussen IA, 2006, ACTA NEUROPSYCHIATR, V18, P216, DOI 10.1111/j.1601-5215.2006.00145.x; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Shum D, 2000, BRAIN COGNITION, V44, P59; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; TEASDALE G, 1974, LANCET, V2, P81; TUNSTALL J, 1999, IMPROVING UTIL UNPUB	17	18	20	1	6	AUSTRALIAN ACAD PRESS	BOWEN HILLS	32 JEAYS ST, BOWEN HILLS, QLD 4006, AUSTRALIA	1443-9646			BRAIN IMPAIR	Brain Impair.	DEC	2009	10	3					320	324		10.1375/brim.10.3.320			5	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	548OG	WOS:000273972400005		Green Published			2022-02-06	
J	Tian, HL; Guo, Y; Hu, J; Rong, BY; Wang, G; Gao, WW; Chen, SW; Chen, H				Tian, Heng-Li; Guo, Yan; Hu, Jin; Rong, Bo-Ying; Wang, Gan; Gao, Wen-Wei; Chen, Shi-Wen; Chen, Hao			Clinical Characterization of Comatose Patients With Cervical Spine Injury and Traumatic Brain Injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Cervical spine injury; Cervical stability; Skull fracture; Traumatic brain injury	CORD-INJURY; HEAD	Background: Reports on the risk factors for combined craniocervical spine injury in comatose patients are rare. The incidence of concomitant cervical injury in comatose patients with traumatic brain injury (TBI) was determined herein. Methods: One thousand twenty-six comatose patients with TBI were examined. The clinical characteristics of combined craniocervical trauma were documented, including type and location of cervical injury, occurrence of hypotension, and dyspnea. Results: Seventy-one patients (6.92%) sustained cervical spine injury. The most common injury region included the upper cervical segments, demonstrated in 37 (52.11%) of 71 patients. Of the 71 patients who sustained combined craniocervical spine injury, 42 (59.15%) had hypotension, including 26 (36.62%) with dyspnea. With regard to the association between the severity of TBI and the incidence of the cervical injury, a significant difference was apparent between patients with an initial Glasgow Coma Scale (GCS) score of 3-5 and those with an initial GCS score of 9-12 (11.62% compared with 4.03%, p < 0.01). Regarding the relationship between the mechanism of injury and the occurrence of cervical spine injury, cervical spine injury was associated at a significantly higher incidence with motorcycle accident-related head trauma as compared with nonmotorcycle accident-related trauma (10.32% vs. 4.68%, p < 0.01). Conclusion: Patients who Sustained TBI as a result of motorcycle accidents and those exhibiting a lower GCS score are at the highest risk for concomitant cervical spine injury.	[Tian, Heng-Li; Guo, Yan; Hu, Jin; Rong, Bo-Ying; Wang, Gan; Gao, Wen-Wei; Chen, Shi-Wen; Chen, Hao] Shanghai Jiao Tong Univ, Dept Neurosurg, Shanghai People Hosp 6, Shanghai 200030, Peoples R China		Chen, H (corresponding author), Shanghai Jiao Tong Univ, Dept Neurosurg, Shanghai People Hosp 6, Shanghai 200030, Peoples R China.	chenhao_316@yahoo.com.cn		Chen, Hao/0000-0002-9943-9237	Shanghai Council for Nature and Science [03ZR14059]	Supported in part by a grant from the Shanghai Council for Nature and Science (Grant no. 03ZR14059).	Ayas N T, 1999, J Spinal Cord Med, V22, P97; BUCHOLZ RW, 1979, J TRAUMA, V19, P768, DOI 10.1097/00005373-197910000-00009; Cooper D J, 2005, Crit Care Resusc, V7, P181; Drainer EK, 2003, INJURY, V34, P330, DOI 10.1016/S0020-1383(02)00260-7; Hadley Mark N, 2002, Clin Neurosurg, V49, P407; Harrahill M, 1997, J Emerg Nurs, V23, P282, DOI 10.1016/S0099-1767(97)90032-5; Holly LT, 2002, J NEUROSURG, V96, P285, DOI 10.3171/spi.2002.96.3.0285; Iida H, 1999, J TRAUMA, V46, P450, DOI 10.1097/00005373-199903000-00018; KACH K, 1993, HELV CHIR ACTA, V59, P655; Lu K, 2000, SPINE, V25, P1332, DOI 10.1097/00007632-200006010-00003; Mathias CJ, 2006, PROG BRAIN RES, V152, P231, DOI 10.1016/S0079-6123(05)52015-6; MICHAEL D B, 1989, Journal of Neurotrauma, V6, P177; OLLER DW, 1992, ACCIDENT ANAL PREV, V24, P187, DOI 10.1016/0001-4575(92)90036-I; Piatt JH, 2006, J NEUROSURG-SPINE, V5, P210, DOI 10.3171/spi.2006.5.3.210; Swartz EE, 2005, J ATHL TRAINING, V40, P155; Vinit S, 2006, J NEUROTRAUM, V23, P1137, DOI 10.1089/neu.2006.23.1137	16	18	20	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	DEC	2009	67	6					1305	1310		10.1097/TA.0b013e31819db57c			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	531IL	WOS:000272658100037	20009682				2022-02-06	
J	Aminmansour, B; Ghorbani, A; Sharifi, D; Shemshaki, H; Ahmadi, A				Aminmansour, Bahram; Ghorbani, Abbas; Sharifi, Davood; Shemshaki, Hamidreza; Ahmadi, Amin			Cerebral vasospasm following traumatic subarachnoid hemorrhage	JOURNAL OF RESEARCH IN MEDICAL SCIENCES			English	Article						Cerebral Vasospasm; Subarachnoid Hemorrhage; Trauma; Traumatic Brain Injury	TRANSCRANIAL DOPPLER ULTRASOUND; SEVERE HEAD-INJURY; POSTTRAUMATIC VASOSPASM; BRAIN-INJURY; BLOOD-FLOW; IMPACT; ULTRASONOGRAPHY; NIMODIPINE; SPASM	BACKGROUND: Cerebral vasospasm is a preventable cause of death and disability in patients who experience aneurysmal subarachnoid hemorrhage (SAH). The aim of this study is to investigate the incidence of cerebral vasospasm following traumatic SAH and its relationship with different brain injuries and severity of trauma. METHODS: This cross-sectional study was conducted from October 2006 to March 2007 in department of Neurosurgery in Al-Zahra Hospital. Consecutive head-injured patients who had SAH on the basis of an admission CT scan were prospectively evaluated. The severity of the trauma was evaluated by determining Glasgow Coma Scale (GCS) score on admission. Transcranial Doppler ultrasonography evaluations were performed at least 48 hours after admission and one week thereafter. Vasospasm in the MCA and ACA was defined by mean flow velocity (FV) of more than 120 cm/sec with a Lindegaard index (MVA/ICA FV ratio) higher than 3. Basilar artery vasospasm was defined by FV higher than 85 cm/sec. RESULTS: Seventy seven patients with tSAH were enrolled from whom 13 were excluded. The remaining were 52 (81.2%) men and 12 (18.7%) women, with a mean age of 37.89 years. Trauma was severe in 11 (17.2%), moderate in 13 (20.3%), and mild in 40 (62.5%) patients. From all, 27 patients (42.1%) experienced at least one vasospasm during the study period and MCA vasospasm was the most common in the first and second weeks (55.5%). CONCLUSIONS: Traumatic SAH is associated with a high incidence of cerebral vasospasm with a higher probability in patients with severe TBI.	[Aminmansour, Bahram; Sharifi, Davood] Isfahan Univ Med Sci, Dept Neurosurg, Sch Med, Esfahan, Iran; [Ghorbani, Abbas] Isfahan Univ Med Sci, Dept Neurol, Sch Med, Esfahan, Iran; [Shemshaki, Hamidreza; Ahmadi, Amin] Isfahan Univ Med Sci, Med Students Res Comm, Esfahan, Iran		Sharifi, D (corresponding author), Isfahan Univ Med Sci, Dept Neurosurg, Sch Med, Esfahan, Iran.	d_sharifi@resident.mui.ac.ir	Aminmansour, Bahram/C-8048-2018; Sharifi, Davoud/E-6922-2019	Aminmansour, Bahram/0000-0002-2961-2815	Vice Chancellor for Research of Isfahan University of Medical Sciences	The authors would like to appreciate the kind assistance and financial support provided by the Vice Chancellor for Research of Isfahan University of Medical Sciences. Also, we are thankful to Dr. Ali Gholamrezaei (Isfahan University of Medical Sciences) who helped us in editing this report.	AASLID R, 1984, J NEUROSURG, V60, P37, DOI 10.3171/jns.1984.60.1.0037; AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Abraszko R, 1996, J CLIN NEUROSCI, V3, P21, DOI 10.1016/S0967-5868(96)90078-8; Crowley RW, 2008, DRUG DISCOV TODAY, V13, P254, DOI 10.1016/j.drudis.2007.11.010; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; HALEY EC, 1992, STROKE, V23, P205, DOI 10.1161/01.STR.23.2.205; Harders A, 1996, J NEUROSURG, V85, P82, DOI 10.3171/jns.1996.85.1.0082; KAKARIEKA A, 1994, J NEURAL TRANSM-SUPP, P13; Lindegaard K F, 1988, Acta Neurochir Suppl (Wien), V42, P81; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; Mattioli C, 2003, J NEUROSURG, V98, P37, DOI 10.3171/jns.2003.98.1.0037; MAYBERG MR, 1994, CIRCULATION, V90, P2592, DOI 10.1161/01.CIR.90.5.2592; Morris GF, 1999, J NEUROSURG, V91, P737, DOI 10.3171/jns.1999.91.5.0737; Oertel M, 2005, J NEUROSURG, V103, P812, DOI 10.3171/jns.2005.103.5.0812; SANDER D, 1993, J NEUROL SCI, V119, P1, DOI 10.1016/0022-510X(93)90185-2; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; Soustiel JF, 2002, ACTA NEUROCHIR, V144, P137, DOI 10.1007/s007010200016; Soustiel JF, 1998, NEUROSURGERY, V43, P282, DOI 10.1097/00006123-199808000-00061; Sviri GE, 2006, STROKE, V37, P2738, DOI 10.1161/01.STR.0000244765.29502.85; Taneda M, 1996, J NEUROSURG, V84, P762, DOI 10.3171/jns.1996.84.5.0762; Vajramani GV, 1999, BRIT J NEUROSURG, V13, P468, DOI 10.1080/02688699943277; WEBER M, 1990, NEUROSURGERY, V27, P106, DOI 10.1227/00006123-199007000-00015; Zubkov ZY, 2000, SURG NEUROL, V53, P126; Zurynski YA, 1998, J CLIN NEUROSCI, V5, P146, DOI 10.1016/S0967-5868(98)90028-5	25	18	19	0	2	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1735-1995	1735-7136		J RES MED SCI	J. Res. Med. Sci.	NOV-DEC	2009	14	6					343	348					6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	538SN	WOS:000273204400002	21772907				2022-02-06	
J	Galvin, J; Froude, EH; Imms, C				Galvin, Jane; Froude, Elspeth H.; Imms, Christine			Sensory Processing Abilities of Children Who Have Sustained Traumatic Brain Injuries	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						brain injuries; child behavior; sensation; sensation disorders	HEAD-INJURY; NATIONAL SAMPLE; EVERYDAY LIFE; DISABILITIES; CHILDHOOD; ATTENTION; PROFILE; ADOLESCENTS; PERFORMANCE; RECOVERY	OBJECTIVE. This study describes the sensory processing abilities of children ages 3-10 who sustained a moderate or severe traumatic brain injury l METHOD. We used a prospective, descriptive study design with convenience sampling of 20 children who were admitted to a pediatric neurosurgical unit. Caregivers provided information regarding their child's sensory processing abilities using the Sensory Profile (Dunn, 1999). We also collected demographic information related to the mechanism and severity of injury. Data were analyzed descriptively, and summary statistics were used to describe the Sensory Profiles of the children in comparison to normative data. RESULTS. Proportionally more children with TBI than children in the normative sample demonstrated behaviors outside of the typical range in all sections of the Sensory Profile except for oral sensory processing. CONCLUSION. These findings strongly support the need to include evaluation of sensory processing in any clinical assessment of children who have sustained TBI.	[Galvin, Jane] Royal Childrens Hosp, Victorian Paediat Rehabil Serv, Parkville, Vic 3052, Australia; [Galvin, Jane; Froude, Elspeth H.; Imms, Christine] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Galvin, Jane; Froude, Elspeth H.; Imms, Christine] La Trobe Univ, Sch Occupat Therapy, Melbourne, Vic, Australia; [Imms, Christine] Royal Childrens Hosp, Occupat Therapy Dept, Parkville, Vic 3052, Australia		Galvin, J (corresponding author), Royal Childrens Hosp, Victorian Paediat Rehabil Serv, Flemington Rd, Parkville, Vic 3052, Australia.	jane.galvin@rch.org.au	Imms, Christine/G-9537-2018	Imms, Christine/0000-0001-9055-3554; Froude, Elspeth/0000-0002-6863-2317			Aitken ME, 2004, ARCH PHYS MED REHAB, V85, P567, DOI 10.1016/j.apmr.2003.06.018; Anderson V, 1998, NEUROPSYCHOL REHABIL, V8, P283; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Ayres A. J., 1972, SENSORY INTEGRATION; Baranek GT, 2002, AM J OCCUP THER, V56, P538, DOI 10.5014/ajot.56.5.538; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; CaseSmith J, 1997, AM J OCCUP THER, V51, P496, DOI 10.5014/ajot.51.7.496; DAVIES PM, 1994, STARTING AGAIN EARLY; DeGangi GAP, 1991, INFANTS YOUNG CHILDR, V3, P1; Dennis M, 2000, J COMMUN DISORD, V33, P321, DOI 10.1016/S0021-9924(00)00028-9; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; Drummond A., 2005, BRIT J OCCUPATIONAL, V68, P324, DOI https://doi.org/10.1177/030802260506800707; Dunn W, 1997, INFANT YOUNG CHILD, V9, P23, DOI 10.1097/00001163-199704000-00005; Dunn W, 2002, OTJR-OCCUP PARTICI H, V22, P4, DOI 10.1177/153944920202200102; Dunn W, 2002, AM J OCCUP THER, V56, P97, DOI 10.5014/ajot.56.1.97; Dunn W, 2001, AM J OCCUP THER, V55, P608, DOI 10.5014/ajot.55.6.608; Dunn W, 1997, AM J OCCUP THER, V51, P490, DOI 10.5014/ajot.51.7.490; Dunn W., 1999, SENSORY PROFILE USER; Dunn W., 2002, FOCUS AUTISM DEV DIS, V17, P172, DOI DOI 10.1177/108835760201700; Dunn W, 2007, INFANT YOUNG CHILD, V20, P84, DOI 10.1097/01.IYC.0000264477.05076.5d; Edwards S., 2002, NEUROLOGICAL PHYSIOT, P89; Erhardt RP, 1990, DEV VISUAL DYSFUNCTI; Ermer J, 1998, AM J OCCUP THER, V52, P283, DOI 10.5014/ajot.52.4.283; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; Hayden ME, 2000, J HEAD TRAUMA REHAB, V15, P1000, DOI 10.1097/00001199-200008000-00004; Hubel DH, 1988, EYE BRAIN VISION; Kandel E.R., 2000, PRINCIPLES NEURAL SC; KEINTZ MA, 1997, AM J OCCUPATIONAL TH, V51, P530; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; MILLER C, 2000, GENOME BIOL, V1, P4; Moore J., 1996, J OCCUPATIONAL SCI A, V3, P16; MOORE J, 1995, CLOSED HEAD INJURY C; Muller SV, 2002, ARCH PHYS MED REHAB, V83, P115, DOI 10.1053/apmr.2002.27472; O'Flaherty SJ, 2000, ARCH PHYS MED REHAB, V81, P723, DOI 10.1016/S0003-9993(00)90100-X; Sarno S, 2003, BRAIN INJURY, V17, P413, DOI 10.1080/0269905031000070161; Sellars C., 2004, PEDIAT BRAIN INJURY; Shumway-Cook A., 1995, MOTOR CONTROL THEORY; Slomine BS, 2002, BRAIN INJURY, V16, P759, DOI 10.1080/02699050210127286; Spence C, 2002, BEHAV BRAIN RES, V135, P57, DOI 10.1016/S0166-4328(02)00155-9; Spence C, 2001, PERCEPT PSYCHOPHYS, V63, P330, DOI 10.3758/BF03194473; TEASDALE G, 1974, LANCET, V2, P81	42	18	19	0	6	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490			AM J OCCUP THER	Am. J. Occup. Ther.	NOV-DEC	2009	63	6					701	709		10.5014/ajot.63.6.701			9	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	532EZ	WOS:000272729500005	20092106				2022-02-06	
J	Liao, ZB; Jiang, GY; Tang, ZH; Zhi, XG; Sun, XC; Tang, WY; Wu, MJ				Liao, Z. B.; Jiang, G. Y.; Tang, Z. H.; Zhi, X. G.; Sun, X. C.; Tang, W. Y.; Wu, M. J.			Erythropoietin can promote survival of cerebral cells by downregulating Bax gene after traumatic brain injury in rats	NEUROLOGY INDIA			English	Article						Bax; cell death; rhEPO; traumatic brain injury	ALTERNATIVE COMPLEMENT PATHWAY; CLOSED-HEAD INJURY; NEURONAL DEATH; APOPTOSIS; ACTIVATION; ISCHEMIA; NEUROPROTECTION; EXPRESSION; MODULATION; MECHANISMS	Background: Traumatic brain injury (TBI) is an important cause of adult mortality and morbidity. Erythropoietin (Epo) has been shown to promote the viability of cerebral cells by upregulating Bcl-2 gene; however, Epo may exert its antiapoptotic effect via the differential regulation of the expression of genes involved in the apoptotic process. Aim: The present study examined the neuroprotective effect of Epo as a survival factor through the regulation of the Bax. Materials and Methods: Wistar rats were randomly divided into three groups: Recombinant human EPO treated (rhEPO) TBI, vehicle-treated TBI, and sham-operated. Traumatic brain injury was induced by the Feeney free-falling model. Rats were killed 5, 12, 24, 72, 120, or 168 h after TBI. Regulation of Bcl-2 was detected by reverse transcription-polymerase chain reaction (RT-PCR), western blotting and immunofluorescence. Results: Bax mRNA and protein levels were lower in the rhEPO)-treated rat brains than in the vehicle-treated rat brains. Induction of Bax expression peaked at 24 h and remained stable for 72-120 h in vehicle-treated rat brains, whereas induction of Bax expression was only slightly elevated in rhEPO-treated rat brains. The number of TdT-mediated dUTP Nick-End Labeling(TUNEL)-positive cells in the rhEPO-treated rat brains was far fewer than in the vehicle-treated rat brains. Conclusions: Epo exerts neuroprotective effect against traumatic brain injury via reducing Bax gene expression involved in inhibiting TBI-induced neuronal cell death.	[Liao, Z. B.; Jiang, G. Y.; Tang, Z. H.; Zhi, X. G.; Sun, X. C.; Tang, W. Y.] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Chongqing 400016, Peoples R China; [Wu, M. J.] Chongqing Med Univ, Dept Lab Med, Chongqing 400016, Peoples R China		Liao, ZB (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Chongqing 400016, Peoples R China.	stonebu8@yahoo.com.cn	liao, ZB/ABF-8804-2021	liao, ZB/0000-0003-4591-9689; sun, xiao chuan/0000-0001-6992-332X	National Natural Science Funds of ChinaNational Natural Science Foundation of China (NSFC) [30801182]	This research was supported by the National Natural Science Funds of China (30801182).	Alexander JJ, 2005, J IMMUNOL, V175, P8312, DOI 10.4049/jimmunol.175.12.8312; Bellander BM, 2001, J NEUROTRAUM, V18, P1295, DOI 10.1089/08977150152725605; Casarsa C, 2003, EUR J IMMUNOL, V33, P1260, DOI 10.1002/eji.200323574; Celik M, 2002, P NATL ACAD SCI USA, V99, P2258, DOI 10.1073/pnas.042693799; Chang YS, 2005, PEDIATR RES, V58, P106, DOI 10.1203/01.PDR.0000163616.89767.69; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Chong ZZ, 2003, BRIT J PHARMACOL, V138, P1107, DOI 10.1038/sj.bjp.0705161; Cole DS, 2006, MOL IMMUNOL, V43, P1953, DOI 10.1016/j.molimm.2005.11.015; Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074; Eldadah BA, 2000, J NEUROTRAUM, V17, P811, DOI 10.1089/neu.2000.17.811; Elward K, 2005, J BIOL CHEM, V280, P36342, DOI 10.1074/jbc.M506579200; Faden AI, 2002, CURR OPIN NEUROL, V15, P707, DOI 10.1097/00019052-200212000-00008; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Felderhoff-Mueser U, 2002, NEUROBIOL DIS, V11, P231, DOI 10.1006/nbdi.2002.0521; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Gorio A, 2002, P NATL ACAD SCI USA, V99, P9450, DOI 10.1073/pnas.142287899; Holers VM, 2004, MOL IMMUNOL, V41, P147, DOI 10.1016/j.molimm.2004.03.012; Kang JQ, 2003, MOL PHARMACOL, V64, P557, DOI 10.1124/mol.64.3.557; Knoblach SM, 2004, J CEREBR BLOOD F MET, V24, P1119, DOI 10.1097/01.WCB.0000138664.17682.32; Kyrkanides S, 2001, J NEUROIMMUNOL, V119, P269, DOI 10.1016/S0165-5728(01)00404-0; Leinhase I, 2006, EXP NEUROL, V199, P454, DOI 10.1016/j.expneurol.2006.01.033; Liao ZB, 2008, EUR J NEUROL, V15, P140, DOI 10.1111/j.1468-1331.2007.02013.x; Liu CL, 2004, NEUROSCIENCE, V127, P113, DOI 10.1016/j.neuroscience.2004.03.062; Marciano PG, 2004, J NEUROSCI, V24, P2866, DOI 10.1523/JNEUROSCI.5051-03.2004; McArthur DL, 2004, BRAIN PATHOL, V14, P185, DOI 10.1111/j.1750-3639.2004.tb00052.x; Nataf S, 2000, J IMMUNOL, V165, P5867, DOI 10.4049/jimmunol.165.10.5867; O'Barr SA, 2001, J IMMUNOL, V166, P4154, DOI 10.4049/jimmunol.166.6.4154; Ohlsson M, 2006, NEUROSCI LETT, V394, P179, DOI 10.1016/j.neulet.2005.10.037; Ohlsson M, 2003, J NEUROTRAUM, V20, P895, DOI 10.1089/089771503322385827; Pillay NS, 2005, ANN NY ACAD SCI, V1056, P450, DOI 10.1196/annals.1352.021; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Rancan M, 2003, J CEREBR BLOOD F MET, V23, P1070, DOI 10.1097/01.WCB.0000084250.20114.2C; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Sola A, 2005, PEDIATR RES, V57, P481, DOI 10.1203/01.PDR.0000155760.88664.06; Stahel PF, 2000, J NEUROIMMUNOL, V109, P164, DOI 10.1016/S0165-5728(00)00304-0; Stahel Philip F, 2006, Expert Rev Clin Immunol, V2, P445, DOI 10.1586/1744666X.2.3.445; Stefanis L, 2005, NEUROSCIENTIST, V11, P50, DOI 10.1177/1073858404271087; Sun Y, 2004, J CEREBR BLOOD F MET, V24, P259, DOI 10.1097/01.WCB.0000110049.43905.AC; Thurman JM, 2006, J IMMUNOL, V176, P1305, DOI 10.4049/jimmunol.176.3.1305; Thurman JM, 2005, KIDNEY INT, V67, P524, DOI 10.1111/j.1523-1755.2005.67109.x; Thurman JM, 2003, J IMMUNOL, V170, P1517, DOI 10.4049/jimmunol.170.3.1517; Wei L, 2004, BRAIN RES, V1022, P54, DOI 10.1016/j.brainres.2004.06.080; Williams S, 2001, ACTA NEUROPATHOL, V102, P581, DOI 10.1007/s004010100410; Wong J, 2005, NEUROCRIT CARE, V3, P177, DOI 10.1385/NCC:3:2:177; Xiong ZQ, 2003, J NEUROSCI, V23, P955; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950	48	18	23	1	2	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0028-3886	1998-4022		NEUROL INDIA	Neurol. India	NOV-DEC	2009	57	6					722	728		10.4103/0028-3886.59466			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	561XR	WOS:000275013900006	20139499	Green Submitted			2022-02-06	
J	Shear, DA; Williams, AJ; Sharrow, K; Lu, XCM; Tortella, FC				Shear, Deborah A.; Williams, Anthony J.; Sharrow, Keith; Lu, Xi-Chun M.; Tortella, Frank C.			Neuroprotective profile of dextromethorphan in an experimental model of penetrating ballistic-like brain injury	PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR			English	Article						Penetrating ballistic-like brain injury; PBBI; Traumatic brain injury; TBI; Dextromethorphan; DM; Motor; Cognitive; Novel object recognition; NOR	D-ASPARTATE ANTAGONIST; PREFRONTAL CORTEX; MEDIATED NEUROPROTECTION; CORTICAL-NEURONS; SIGMA-RECEPTORS; RAT MODEL; CALCIUM; DEXTRORPHAN; ATTENTION; ISCHEMIA	Dextromethorphan (DM) has been well-characterized as a neuroprotective agent in experimental models of CNS injury. The goal of this study was to determine the neuroprotective profile of DM in a military-relevant model of penetrating ballistic-like brain injury (PBBI). In an acute (3 day) dose-response study, anesthetized male Sprague-Dawley rats were exposed to a unilateral frontal PBBI with DM (0.156-10 mg/kg) or vehicle delivered as an i.v. bolus from 30 min to 48 h post-injury. In a follow-up (7 day) experiment, the 10-mg/kg bolus injections of DM were administered in conjunction with a 6-h infusion (5 mg/kg/h). DM bolus injections alone produced a dose-dependent improvement in motor recovery on a balance beam task at 3 days post-injury. However, more rapid recovery (24 h) was observed on this task when the bolus injections were combined with the 6-h infusion. Moreover, the DM bolus/infusion treatment regimen resulted in a significant (76%) improvement in cognitive performance in a novel object recognition (NOR) task at 7 days post-injury. Although post-injury administration of DM (all doses) failed to reduce core lesion size, the maximum dose of DM (10 mg/kg) was effective in reducing silver-stained axonal fiber degeneration in the cortical regions adjacent to the injury. Published by Elsevier Inc.	[Shear, Deborah A.; Williams, Anthony J.; Sharrow, Keith; Lu, Xi-Chun M.; Tortella, Frank C.] Walter Reed Army Inst Res, Dept Appl Neurobiol, Silver Spring, MD 21045 USA		Shear, DA (corresponding author), Walter Reed Army Inst Res, MRMC UWI C,Bldg 503-2W14, Silver Spring, MD 20910 USA.	Deborah.Shear@AMEDD.ARMY.MIL	Shear, Deborah/B-3607-2011				BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; BELL RS, 2009, TRAUMA, V65, pS104; CARPENTER CL, 1988, BRAIN RES, V439, P372, DOI 10.1016/0006-8993(88)91497-7; CHOI DW, 1987, BRAIN RES, V403, P333, DOI 10.1016/0006-8993(87)90070-9; D'Esposito M, 2000, EXP BRAIN RES, V133, P3, DOI 10.1007/s002210000395; D'Esposito M, 1999, NEUROPSYCHOLOGIA, V37, P1303, DOI 10.1016/S0028-3932(99)00021-4; Daffner KR, 2000, BRAIN, V123, P927, DOI 10.1093/brain/123.5.927; Daffner KR, 2000, J NEUROL NEUROSUR PS, V68, P18, DOI 10.1136/jnnp.68.1.18; DECOSTER MA, 1995, BRAIN RES, V671, P45, DOI 10.1016/0006-8993(94)01294-R; Godefroy O, 1996, BRAIN COGNITION, V30, P155, DOI 10.1006/brcg.1996.0010; Godefroy O, 1997, NEUROLOGY, V49, P695, DOI 10.1212/WNL.49.3.695; GOLDBERG MP, 1987, NEUROSCI LETT, V80, P11, DOI 10.1016/0304-3940(87)90486-1; Katnik C, 2006, J PHARMACOL EXP THER, V319, P1355, DOI 10.1124/jpet.106.107557; Klette KL, 1997, BRAIN RES, V756, P231, DOI 10.1016/S0006-8993(97)00142-X; Klette KL, 1995, BRAIN RES, V704, P31, DOI 10.1016/0006-8993(95)01103-X; LU XC, 2009, J NEUROTRAUMA; MATSUMOTO RR, 1990, PHARMACOL BIOCHEM BE, V36, P151, DOI 10.1016/0091-3057(90)90141-4; Maurice T, 2001, BRAIN RES REV, V37, P116, DOI 10.1016/S0165-0173(01)00112-6; SCHADEL M, 1995, J CLIN PSYCHOPHARM, V15, P263, DOI 10.1097/00004714-199508000-00005; Senda T, 1996, EUR J PHARMACOL, V315, P1, DOI 10.1016/S0014-2999(96)00572-9; Steinberg GK, 1996, J NEUROSURG, V84, P860, DOI 10.3171/jns.1996.84.5.0860; Tortella FC, 1999, J PHARMACOL EXP THER, V291, P399; TORTELLA FC, 1989, TRENDS PHARMACOL SCI, V10, P501, DOI 10.1016/0165-6147(89)90050-3; WALKER FO, 1989, CLIN NEUROPHARMACOL, V12, P322, DOI 10.1097/00002826-198908000-00010; WALKER JM, 1990, PHARMACOL REV, V42, P355; Werling LL, 2007, NEUROLOGIST, V13, P272, DOI 10.1097/NRL.0b013e3180f60bd8; Williams AJ, 2000, J PHARMACOL EXP THER, V294, P378; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17; Williams AJ, 2006, NEUROSCI LETT, V408, P183, DOI 10.1016/j.neulet.2006.08.086; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828; Zhang HL, 2002, J NEUROPHYSIOL, V87, P2867, DOI 10.1152/jn.2002.87.6.2867; ZHOU GZ, 1991, EUR J PHARM-MOLEC PH, V206, P261, DOI 10.1016/0922-4106(91)90108-T	33	18	18	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0091-3057			PHARMACOL BIOCHEM BE	Pharmacol. Biochem. Behav.	NOV	2009	94	1					56	62		10.1016/j.pbb.2009.07.006			7	Behavioral Sciences; Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Pharmacology & Pharmacy	513ZH	WOS:000271362300009	19619574				2022-02-06	
J	Singh, GD; Maher, GJ; Padilla, RR				Singh, G. Dave; Maher, Gerald J.; Padilla, Ray R.			Customized mandibular orthotics in the prevention of concussion/mild traumatic brain injury in football players: a preliminary study	DENTAL TRAUMATOLOGY			English	Article							PROFESSIONAL FOOTBALL; HIGH-SCHOOL; NECK INJURIES; MOUTHGUARDS; HEAD; STRENGTH; IMPACTS; SPORTS; BITE	Background/Aim: It is accepted that sports mouthguards decrease the incidence of dental injuries in athletes, but the value of oral orthotics in the prevention of concussion/mild traumatic brain injuries in footballers remains contentious. However, previous investigations have primarily studied non-customized mouthguards without dental/temporo-mandibular joint examinations of the subjects. Therefore, the aim of this study is to determine whether the use of a customized mandibular orthotic after temporo-mandibular joint assessment reduces the incidence of concussion/mild traumatic brain injuries in high-school football players. Materials and methods: Using a longitudinal, retrospective design, data were collected from a cohort of football players (n = 28) over three seasons using a questionnaire. The mean age of the sample prior to the use of the customized mandibular orthotic was 17.3 years +/- 1.9. Prior to deployment, dental records and temporo-mandibular joint evaluations were undertaken, as well as neurocognitive assessment, including history of concussion/mild traumatic brain injuries. After establishing optimal jaw position, a customized mandibular orthotic was fabricated to the new spatial relations. Results: The mean age of the sample after three seasons was 19.7 years +/- 2.0. Prior to the use of the customized mandibular orthotic, the mean self-reported incidence of concussion/mild traumatic brain injuries was 2.1 +/- 1.4 concussive events. After the deployment of the customized mandibular orthotic the number of concussive events fell to 0.11 +/- 0.3 with an odds ratio of 38.33 (95% CI 8.2-178.6), P < 0.05. Conclusion: The preliminary results of this study suggest that a customized mandibular orthotic may decrease the incidence of concussion/mild traumatic brain injuries in high- school football athletes, but a comprehensive study is required to confirm these initial findings. Furthermore, additional research is necessary to indicate the possible mode(s) of action of a customized mandibular orthotic in the prevention of concussion/mild traumatic brain injuries.	[Singh, G. Dave] SMILE Fdn, Chatsworth, CA 91311 USA; [Maher, Gerald J.] Mahercor Labs LLC, S Weymouth, MA USA; [Padilla, Ray R.] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA		Singh, GD (corresponding author), SMILE Fdn, 9129 Lurline Ave, Chatsworth, CA 91311 USA.	drsingh@smilefoundation.org					Barbic D, 2005, CLIN J SPORT MED, V15, P294, DOI 10.1097/01.jsm.0000171883.74056.21; Barth J T, 2000, Dent Clin North Am, V44, P67; Benson BW, 1999, JAMA-J AM MED ASSOC, V282, P2328, DOI 10.1001/jama.282.24.2328; Casson IR, 2008, NEUROL CLIN, V26, P217, DOI 10.1016/j.ncl.2007.11.005; Chapman P., 1985, AUST J SCI MED SPORT, V17, P25; Cohenca N, 2007, J AM DENT ASSOC, V138, P1420, DOI 10.14219/jada.archive.2007.0065; dela Cruz GG, 2008, DENT TRAUMATOL, V24, P86, DOI 10.1111/j.1600-9657.2006.00500.x; Dimitroulis G, 1998, BMJ-BRIT MED J, V317, P190, DOI 10.1136/bmj.317.7152.190; FORGIONE AG, 1992, CRANIO, V10, P13, DOI 10.1080/08869634.1992.11677886; FORGIONE AG, 1991, CRANIO, V9, P305, DOI 10.1080/08869634.1991.11678377; Francis K T, 1991, Br J Sports Med, V25, P227; Gelb H, 1996, CRANIO, V14, P320, DOI 10.1080/08869634.1996.11745984; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gusenbauer Albert, 2002, Dent Today, V21, P74; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Knapik JJ, 2007, SPORTS MED, V37, P117, DOI 10.2165/00007256-200737020-00003; Labella CR, 2002, MED SCI SPORT EXER, V34, P41, DOI 10.1097/00005768-200201000-00007; McCrory P, 2001, BRIT J SPORT MED, V35, P81, DOI 10.1136/bjsm.35.2.81; McIntosh AS, 2000, MED SCI SPORT EXER, V32, P1980, DOI 10.1097/00005768-200012000-00002; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Powell JW, 1999, J ATHL TRAINING, V34, P277; Proctor MR, 2000, CLIN SPORT MED, V19, P693, DOI 10.1016/S0278-5919(05)70233-7; Sgan-Cohen HD, 2008, DENT TRAUMATOL, V24, P458, DOI 10.1111/j.1600-9657.2008.00601.x; STENGER JM, 1964, J AM DENT ASSOC, V69, P273, DOI 10.14219/jada.archive.1964.0290; Takeda T, 2005, DENT TRAUMATOL, V21, P134, DOI 10.1111/j.1600-9657.2005.00320.x; TORG JS, 1979, JAMA-J AM MED ASSOC, V241, P1477, DOI 10.1001/jama.241.14.1477; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Wisniewski JF, 2004, DENT TRAUMATOL, V20, P143, DOI 10.1111/j.1600-4469.2004.00259.x; Woodmansey K F, 1999, Gen Dent, V47, P64; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA	33	18	19	1	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469	1600-9657		DENT TRAUMATOL	Dent. Traumatol.	OCT	2009	25	5					515	521		10.1111/j.1600-9657.2009.00808.x			7	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	492ZB	WOS:000269700900012	19614931				2022-02-06	
J	Gunter, TD; Philibert, R; Hollenbeck, N				Gunter, Tracy D.; Philibert, Robert; Hollenbeck, Nancy			Medical and Psychiatric Problems among Men and Women in a Community Corrections Residential Setting	BEHAVIORAL SCIENCES & THE LAW			English	Article							EPIDEMIOLOGIC CATCHMENT-AREA; TRAUMATIC BRAIN-INJURY; HIV RISK BEHAVIORS; PRISON HEALTH; UNITED-STATES; DRUG-USE; DSM-IV; PREVALENCE; DEPENDENCE; DISORDERS	Though the medical and mental health morbidity of incarcerated offenders has been discussed in a number of recent reports, very few data have been published concerning medical and mental health problems facing those on community corrections supervision. In this study of community corrections offenders utilizing residential facilities, we found that frequencies of substance use disorders, other mental health disorders, and medical problems exceeded frequencies found in the community and, in some cases, were higher than frequencies found in incarcerated individuals. Of particular concern were the high frequencies of substance use disorders, traumatic brain injury, anxiety states, suicidal ideation, and prior self-harm. While the level of self-reported medical and mental health service utilization was higher than expected, it appeared low relative to the disease burden reported by this special population. We conclude that concurrent evaluation and treatment of medical and psychiatric problems during the process of community supervision is indicated in this population. Copyright (C) 2009 John Wiley & Sons, Ltd.	[Gunter, Tracy D.; Philibert, Robert] Univ Iowa, Carver Coll Med, Dept Psychiat, Iowa City, IA 52242 USA		Gunter, TD (corresponding author), St Louis Univ, Sch Med, Div Forens Psychiat, Dept Neurol & Psychiat, 1438 S Grand Blvd, St Louis, MO 63104 USA.		Gunter, Tracy/ABD-1754-2020	Gunter, Tracy/0000-0003-2122-8816; Philibert, Robert/0000-0001-7822-4977			Achenbach TM., 2003, MANUAL ASEBA ADULT F; ALLEN JP, 2000, ASSESSING ALCOHOL PR; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Arciniegas DB, 2001, BRAIN INJURY, V15, P649, DOI 10.1080/02699050010019800; Awofeso N, 2008, INT J PRISON HEALTH, V4, P175, DOI 10.1080/17449200802473081; Baillargeon J, 2007, ANN EPIDEMIOL, V17, P808, DOI 10.1016/j.annepidem.2007.04.005; Belenko S, 2004, AIDS EDUC PREV, V16, P367, DOI 10.1521/aeap.16.4.367.40394; Breslau N, 2001, ARCH GEN PSYCHIAT, V58, P810, DOI 10.1001/archpsyc.58.9.810; BUCHOLZ KK, 1994, J STUD ALCOHOL, V55, P149, DOI 10.15288/jsa.1994.55.149; Carcedo RJ, 2008, INT J OFFENDER THER, V52, P641, DOI 10.1177/0306624X07311596; Cashin A, 2008, INT J PRISON HEALTH, V4, P208, DOI 10.1080/17449200802473131; CONDON L, 2006, J COMMUNITY PRACTICE, V79, P19; Condon L, 2007, J CLIN NURS, V16, P1201, DOI 10.1111/j.1365-2702.2007.01799.x; de Viggiani N, 2007, SOCIOL HEALTH ILL, V29, P115, DOI 10.1111/j.1467-9566.2007.00474.x; DeVol R., 2007, UNHEALTHY AM EC BURD; Dyer O, 2008, BRIT MED J, V336, P1210, DOI 10.1136/bmj.39590.660174.DB; FRIESTAD C, 2008, NORD J PSYCH, P1; GLAZE LE, 2008, PROB PAR US 2007 STA; Goodwin RD, 2005, AM J PUBLIC HEALTH, V95, P717, DOI 10.2105/AJPH.2003.019109; Grant BF, 1996, J SUBST ABUSE, V8, P195, DOI 10.1016/S0899-3289(96)90249-7; Grant BF, 1996, AM J PUBLIC HEALTH, V86, P1450, DOI 10.2105/AJPH.86.10.1450; Grant BF, 1996, ALCOHOL CLIN EXP RES, V20, P1481, DOI 10.1111/j.1530-0277.1996.tb01152.x; Gunter TD, 2008, J AM ACAD PSYCHIATRY, V36, P27; HANSER RD, 2009, COMMUNITY CORRECTION; Havens Jennifer R, 2007, J Opioid Manag, V3, P107; Hesselbrock M, 1999, ADDICTION, V94, P1361, DOI 10.1046/j.1360-0443.1999.94913618.x; James D.J., 2006, MENTAL HLTH PROBLEMS; Kanato M, 2008, CURR OPIN PSYCHIATR, V21, P252, DOI 10.1097/YCO.0b013e3282fc985c; KARBERG JC, 2006, SUBSTANCE DEPENDENCE; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; MARUSCHAK L, 2006, MED PROBLEMS JAIL IN; MARUSCHAK LAURA M., 2008, MED PROBLEMS PRISONE; Massoglia M, 2008, J HEALTH SOC BEHAV, V49, P56, DOI 10.1177/002214650804900105; MCLOUGHLIN M, 2006, J COMMUNITY PRACTICE, V79, P178; Messina N, 2006, AM J PUBLIC HEALTH, V96, P1842, DOI 10.2105/AJPH.2005.082016; Metraux S, 2008, PSYCHIAT SERV, V59, P800, DOI 10.1176/appi.ps.59.7.800; MOORE A, 2007, J HEALTH SERV RES PO, V117, P26; Morrell R.F., 1998, J OFFENDER REHABIL, V27, P1, DOI [DOI 10.1300/J076V27N03_01, https://doi.org/10.1300/J076v27n03_01]; MUMOLA CJ, 1999, SUBSTANCE ABUSE TREA; Organization W.H, 2008, GLOBAL BURDEN DIS 20; Oser CB, 2006, AIDS CARE, V18, P339, DOI 10.1080/02652040500200491; Sarapatta M, 1998, BRAIN INJURY, V12, P821, DOI 10.1080/026990598122061; Shepherd J, 2004, J PUBLIC HEALTH, V26, P347, DOI 10.1093/pubmed/fdh169; Shepherd J, 2002, J ROY SOC MED, V95, P539, DOI 10.1258/jrsm.95.11.539; SHEPHERD J, 2004, J PUBLIC HLTH OXFORD, V27, P312; SHEPHERD JP, 2009, J PUBLIC HLTH OXFORD; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Skeem JL, 2006, PSYCHIAT SERV, V57, P333, DOI 10.1176/appi.ps.57.3.333; Skogstad Philip, 2006, Crim Behav Ment Health, V16, P43, DOI 10.1002/cbm.54; Slaughter B, 2003, BRAIN INJURY, V17, P731, DOI 10.1080/0269905031000088649; Steel J, 2007, BRIT J PSYCHIAT, V190, P373, DOI 10.1192/bjp.bp.106.031294; US Department of Health and Human Services, 1999, MENT HLTH REP SURG G; Watson R, 2007, J CLIN NURS, V16, P1195, DOI 10.1111/j.1365-2702.2007.01848.x; Way BB, 2007, J FORENSIC SCI, V52, P965, DOI 10.1111/j.1556-4029.2007.00472.x; Wunsch MJ, 2007, J ADDICT DIS, V26, P15, DOI 10.1300/J069v26n04_03	55	18	18	0	10	JOHN WILEY & SONS LTD	CHICHESTER	THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND	0735-3936			BEHAV SCI LAW	Behav. Sci. Law	SEP-OCT	2009	27	5					695	711		10.1002/bsl.887			17	Psychology, Applied; Law	Social Science Citation Index (SSCI)	Psychology; Government & Law	511BX	WOS:000271140000004	19743513				2022-02-06	
J	Petracca, GM; Jorge, RE; Acion, L; Weintraub, D; Robinson, RG				Petracca, Gustavo M.; Jorge, Ricardo E.; Acion, Laura; Weintraub, Daniel; Robinson, Robert G.			Frequency and Correlates of Involuntary Emotional Expression Disorder in Parkinson's Disease	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							WHITE-MATTER HYPERINTENSITIES; TRAUMATIC BRAIN-INJURY; PATHOLOGICAL LAUGHTER; ALZHEIMERS-DISEASE; RATING-SCALE; DEPRESSION; PREVALENCE; DIAGNOSIS; SCLEROSIS	Involuntary emotional expression disorder (IEED) is a syndrome characterized by involuntary episodes of emotional expression, particularly crying or laughing, that occur in patients with a neurological illness, including neuro-degenerative diseases. The authors assessed the frequency and clinical correlates of IEED among 131 patients with Parkinson's disease. IEED was present in 16.8% of patients overall and in 15.3% of depressed patients. The only clinical correlate of IEED diagnosis was greater severity of Parkinson's disease. The lack of an association between IEED and depression suggests that, in spite of some symptom overlap, the two disorders are distinct neuropsychiatric syndromes in Parkinson's disease. (The Journal of Neuropsychiatry and Clinical Neurosciences 2009; 21:406-412)	[Petracca, Gustavo M.] Inst Neurosci Buenos Aires, Buenos Aires, DF, Argentina; [Jorge, Ricardo E.; Acion, Laura; Robinson, Robert G.] Univ Iowa, Dept Psychiat, Roy C & Lucille A Coll Med, Iowa City, IA 52242 USA; [Weintraub, Daniel] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA		Jorge, RE (corresponding author), 200 Hawkins Dr,W278 GH, Iowa City, IA 52242 USA.	ricardo-jorge@uiowa.edu	Weintraub, Daniel/AAD-8309-2020; Weintraub, Daniel/AAC-5232-2020	Weintraub, Daniel/0000-0003-0633-7168; Acion, Laura/0000-0001-5213-6012			Arciniegas David B, 2005, Am J Geriatr Pharmacother, V3 Suppl A, P4, DOI 10.1016/S1543-5946(05)80031-5; ARCINIEGAS DB, 2005, AM J GERIATR PHAR SA, V3, P16; ARROYO S, 1993, BRAIN, V116, P757, DOI 10.1093/brain/116.4.757; Beyer MK, 2006, MOVEMENT DISORD, V21, P223, DOI 10.1002/mds.20704; Burton EJ, 2006, AM J GERIAT PSYCHIAT, V14, P842, DOI 10.1097/01.JGP.0000236596.56982.1c; Chemerinski E, 1998, J NEUROPSYCH CLIN N, V10, P421, DOI 10.1176/jnp.10.4.421; Cummings JL, 2006, CNS SPECTRUMS, V11, P1; Feinstein A, 1999, MULT SCLER, V5, P69, DOI 10.1177/135245859900500201; FOLSTEIN MF, 1975, J PSYCHIATR RES, V12, P198; GALLAGHER JP, 1989, ACTA NEUROL SCAND, V80, P114, DOI 10.1111/j.1600-0404.1989.tb03851.x; GIBB WRG, 1989, NEUROPATH APPL NEURO, V15, P27, DOI 10.1111/j.1365-2990.1989.tb01147.x; Goetz CG, 2004, MOVEMENT DISORD, V19, P1020, DOI 10.1002/mds.20213; Granger, 1987, FUNCTIONAL INDEPENDE; HACHINSKI V, 1985, ACUTE STROKE; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Martinez-Martin P, 2006, VALUE HEALTH, V9, P386, DOI 10.1111/j.1524-4733.2006.00131.x; MARTINEZMARTIN P, 1994, MOVEMENT DISORD, V9, P76, DOI 10.1002/mds.870090112; MAYBERG HS, 1990, ANN NEUROL, V28, P57, DOI 10.1002/ana.410280111; McCullagh S, 1999, J NEUROL SCI, V169, P43, DOI 10.1016/S0022-510X(99)00214-2; McDonald WA, 2003, BIOL PSYCHIAT, V54, P363, DOI 10.1016/S0006-3223(03)00530-4; Parvizi J, 2001, BRAIN, V124, P1708, DOI 10.1093/brain/124.9.1708; PARVIZI J, 2007, MOV DISORD; PICCINI P, 1995, ARCH NEUROL-CHICAGO, V52, P191, DOI 10.1001/archneur.1995.00540260097023; ROBINSON RG, 1993, AM J PSYCHIAT, V150, P286; ROSS ED, 1981, ARCH GEN PSYCHIAT, V38, P1344; Schapira AHV, 2006, NAT REV DRUG DISCOV, V5, P845, DOI 10.1038/nrd2087; Schiffer R, 2005, J NEUROPSYCH CLIN N, V17, P447, DOI 10.1176/appi.neuropsych.17.4.447; Spitzer R, 1995, STRUCTURED CLIN INTE; STARKSTEIN SE, 1992, J NEUROPSYCH CLIN N, V4, P134; STARKSTEIN SE, 1995, J NEUROL NEUROSUR PS, V59, P55, DOI 10.1136/jnnp.59.1.55; Tateno A, 2004, J NEUROPSYCH CLIN N, V16, P426, DOI 10.1176/appi.neuropsych.16.4.426; Thumler BH, 2003, J NEUROL, V250, P1107, DOI 10.1007/s00415-003-0075-7; Weintraub D, 2005, AM J GERIAT PSYCHIAT, V13, P844, DOI 10.1176/appi.ajgp.13.10.844; Woolley JD, 2004, NEUROLOGY, V63, P1740, DOI 10.1212/01.WNL.0000143054.54412.5B; YUDOFSKY SC, 1986, AM J PSYCHIAT, V143, P35; Zeilig G, 1996, BRAIN INJURY, V10, P591, DOI 10.1080/026990596124160	37	18	18	0	0	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	FAL	2009	21	4					406	412					7	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	526RR	WOS:000272311300007	19996249				2022-02-06	
J	Maruichi, K; Kuroda, S; Chiba, Y; Hokari, M; Shichinohe, H; Hida, K; Iwasaki, Y				Maruichi, Katsuhiko; Kuroda, Satoshi; Chiba, Yasuhiro; Hokari, Masaaki; Shichinohe, Hideo; Hida, Kazutoshi; Iwasaki, Yoshinobu			Transplanted bone marrow stromal cells improves cognitive dysfunction due to diffuse axonal injury in rats	NEUROPATHOLOGY			English	Article						bone marrow stromal cell; cognitive function; differentiation; diffuse axonal injury; neuroprotection; transplantation	TRAUMATIC BRAIN-INJURY; NERVE GROWTH-FACTOR; MICE CEREBRAL INFARCT; CLOSED-HEAD INJURY; SPINAL-CORD-INJURY; GENE-EXPRESSION; IN-VIVO; FUNCTIONAL RECOVERY; EXPERIMENTAL-MODEL; ACID RECEPTOR	Diffuse axonal injury (DAI) often leads to persistent cognitive dysfunction in spite of the lack of gross lesions on MRI. Therefore, this study was aimed to evaluate whether transplanted bone marrow stromal cells (BMSC) can improve DAI-induced cognitive dysfunction or not. The rats were subjected to impact acceleration head injury, using a pneumatic high-velocity impactor. The BMSC were harvested from the mice and were cultured. The BMSC (4.0 x 10(5) cells) or vehicle were stereotactically transplanted into the right striatum at 10 days post-injury. Cognitive function analysis was repeated at 1, 2, and 4 weeks post-injury, using the Morris water maze test. Histological analysis was performed at 2, 8 and 20 weeks post-injury, using double fluorescence immunohistochemistry. Transplanted BMSC were widely distributed in the injured brain and gradually acquired the phenotypes of neurons and astrocytes over 20 weeks. In addition, they significantly improved DAI-induced cognitive dysfunction as early as 2 weeks post-injury, although their processes of neuronal differentiation were not completed at this time point. The findings suggest that the engrafted BMSC may exhibit this early beneficial effect on cognitive function by producing neuroprotective or neurotrophic factors. In conclusion, direct transplantation of BMSC may serve as a novel therapeutic strategy to enhance the recovery from DAI-induced cognitive impairment.	[Kuroda, Satoshi] Hokkaido Univ, Grad Sch Med, Dept Neurosurg, Kita Ku, Sapporo, Hokkaido 0608638, Japan		Kuroda, S (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Neurosurg, Kita Ku, North 15,West 7, Sapporo, Hokkaido 0608638, Japan.	skuroda@med.hokudai.ac.jp	Hokari, Masaaki/G-5395-2012; Shichinohe, Hideo/G-5367-2012		Ministry of Education, Science and Culture of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [17390389, 18390387, 18659411, 19390371]	This study was supported by Grant-in-aid from the Ministry of Education, Science and Culture of Japan (No.17390389, No.18390387, No.18659411 and No.19390371).	ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908; Bakshi A, 2006, EUR J NEUROSCI, V23, P2119, DOI 10.1111/j.1460-9568.2006.04743.x; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Cernak I, 2004, NEUROBIOL DIS, V17, P29, DOI 10.1016/j.nbd.2004.05.011; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chen XG, 2002, J NEUROSCI RES, V69, P687, DOI 10.1002/jnr.10334; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Ding YC, 2001, NEUROL RES, V23, P193, DOI 10.1179/016164101101198334; Gao JL, 2006, EXP NEUROL, V201, P281, DOI 10.1016/j.expneurol.2006.04.039; Gao Q, 2005, NEUROSCIENCE, V136, P123, DOI 10.1016/j.neuroscience.2005.06.091; Garcia R, 2004, BIOCHEM BIOPH RES CO, V316, P753, DOI 10.1016/j.bbrc.2004.02.111; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Hokari M, 2008, J NEUROSCI RES, V86, P1024, DOI 10.1002/jnr.21572; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; Kortesidis A, 2005, BLOOD, V105, P3793, DOI 10.1182/blood-2004-11-4349; Lee JB, 2004, BRAIN RES PROTOC, V14, P37, DOI 10.1016/j.brainresprot.2004.09.004; Lee JB, 2003, NEUROPATHOLOGY, V23, P169, DOI 10.1046/j.1440-1789.2003.00496.x; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Lu DY, 2007, NEUROSURGERY, V61, P596, DOI 10.1227/01.NEU.0000290908.38438.B2; Lu DY, 2002, J NEUROSURG, V97, P935, DOI 10.3171/jns.2002.97.4.0935; Lu DY, 2001, J NEUROTRAUM, V18, P813, DOI 10.1089/089771501316919175; Lu J, 2006, NEUROSCI LETT, V398, P12, DOI 10.1016/j.neulet.2005.12.053; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Mahmood A, 2005, NEUROSURGERY, V57, P1026, DOI 10.1227/01.NEU.0000181369.76323.50; Mahmood A, 2004, NEUROSURGERY, V55, P1185, DOI 10.1227/01.NEU.0000141042.14476.3C; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Mahmood A, 2002, J NEUROTRAUM, V19, P1609, DOI 10.1089/089771502762300265; Mahmood A., 2003, NEUROSURGERY, V53, P702; Mahmood A, 2007, NEUROSURGERY, V61, P206, DOI 10.1227/01.neu.0000279914.37559.de; Mahmood A, 2007, NEUROSURGERY, V60, P546, DOI 10.1227/01.NEU.0000255346.25959.99; MARUICHI K, 2009, NEUROPATHOL IN PRESS; Maxwell WL, 1995, J NEUROCYTOL, V24, P925, DOI 10.1007/BF01215643; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Neuhuber B, 2005, BRAIN RES, V1035, P73, DOI 10.1016/j.brainres.2004.11.055; Philips MF, 2001, J NEUROSURG, V94, P765, DOI 10.3171/jns.2001.94.5.0765; Pike BR, 2000, J NEUROTRAUM, V17, P283, DOI 10.1089/neu.2000.17.283; Pineda JA, 2001, J NEUROTRAUM, V18, P625, DOI 10.1089/089771501750291864; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Seki T, 2003, NEUROSURGERY, V53, P192, DOI 10.1227/01.NEU.0000068988.28788.2C; Seki T, 2002, NEUROSURGERY, V50, P1075, DOI 10.1097/00006123-200205000-00024; Shichinohe H, 2004, BRAIN RES PROTOC, V13, P166, DOI 10.1016/j.brainresprot.2004.04.004; Shichinohe H, 2008, NEUROREHAB NEURAL RE, V22, P447, DOI 10.1177/1545968308315596; Shichinohe H, 2007, BRAIN RES, V1183, P138, DOI 10.1016/j.brainres.2007.08.091; Shichinohe H, 2006, J NUCL MED, V47, P486; Sinson G, 1996, J NEUROSURG, V84, P655, DOI 10.3171/jns.1996.84.4.0655; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Watson DJ, 2003, J NEUROPATH EXP NEUR, V62, P368, DOI 10.1093/jnen/62.4.368; Woodbury D, 2002, J NEUROSCI RES, V69, P908, DOI 10.1002/jnr.10365; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Yamaguchi S, 2006, BRAIN RES, V1087, P15, DOI 10.1016/j.brainres.2006.02.127; Yano S, 2005, BRAIN RES, V1065, P60, DOI 10.1016/j.brainres.2005.10.031; Yano S, 2005, J NEUROTRAUM, V22, P907, DOI 10.1089/neu.2005.22.907; Yano S, 2006, J NEUROTRAUM, V23, P1682, DOI 10.1089/neu.2006.23.1682; Zhong C, 2003, NEUROSCI LETT, V342, P93, DOI 10.1016/S0304-3940(03)00255-6	60	18	19	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-6544	1440-1789		NEUROPATHOLOGY	Neuropathology	AUG	2009	29	4					422	432		10.1111/j.1440-1789.2008.00995.x			11	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	471LY	WOS:000268060400005	19170895				2022-02-06	
J	Puccio, AM; Hoffman, LA; Bayir, H; Zullo, TG; Fischer, M; Darby, J; Alexander, S; Dixon, CE; Okonkwo, DO; Kochanek, PM				Puccio, Ava M.; Hoffman, Leslie A.; Bayir, Huelya; Zullo, Thomas G.; Fischer, Michael; Darby, Joseph; Alexander, Sheila; Dixon, C. Edward; Okonkwo, David O.; Kochanek, Patrick M.			Effect of Short Periods of Normobaric Hyperoxia on Local Brain Tissue Oxygenation and Cerebrospinal Fluid Oxidative Stress Markers in Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						antioxidant reserve; normobaric hyperoxia; oxidative stress; traumatic brain injury	SEVERE HEAD-INJURY; CEREBRAL METABOLISM; IMPROVEMENT	Preliminary evidence suggests local brain tissue oxygenation (PbtO(2)) values of <= 15 mm Hg following severe traumatic brain injury (TBI) represent brain tissue hypoxia. Accordingly, many neurotrauma units attempt to maintain PbtO(2) >= 20 mm Hg to avoid hypoxia. This study tested the impact of a short (2 h) trial of normobaric hyperoxia on measures of oxidative stress. We hypothesized this treatment would positively affect cerebral oxygenation but negatively affect the cellular environment via oxidative stress mechanisms. Cerebrospinal fluid (CSF) was serially assessed in 11 adults (9 male, 2 female), aged 26 +/- 1.8 years with severe TBI (Glasgow Coma Scale score, 6 +/- 1.4) before, during, and after a FiO(2) = 1.0 challenge for markers of oxidative stress, including lipid peroxidation (F-2-isoprostane [ELISA]), protein oxidation (protein sulfhydryl [fluorescence]), and antioxidant defenses (total antioxidant reserve (AOR) [chemiluminescence] and glutathione [fluorescence]). Physiological parameters [PbtO(2), arterial oxygen content (PaO2), intracranial pressure (ICP), mean arterial pressure (MAP), and cerebral perfusion pressure (CPP)] were assessed at the same time points. Mean (+/- SD) PbtO(2) and PaO2 levels significantly changed for each time point. Oxidative stress markers, antioxidant reserve defenses, and ICP, MAP, and CPP did not significantly change for any time period. These preliminary findings suggest that brief periods of normobaric hyperoxia do not produce oxidative stress and/or change antioxidant reserves in CSF. Additional studies are required to examine extended periods of normobaric hyperoxia in a larger sample.	[Puccio, Ava M.; Fischer, Michael; Dixon, C. Edward; Okonkwo, David O.] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15213 USA; [Hoffman, Leslie A.; Zullo, Thomas G.; Alexander, Sheila] Univ Pittsburgh, Dept Acute Tertiary Care, Sch Nursing, Pittsburgh, PA 15213 USA; [Darby, Joseph] Univ Pittsburgh, Dept Pediat & Crit Care Med, Med Ctr, Pittsburgh, PA 15213 USA; [Bayir, Huelya; Kochanek, Patrick M.] Childrens Hosp Pittsburgh, Pittsburgh, PA USA; [Puccio, Ava M.; Dixon, C. Edward; Okonkwo, David O.] Univ Pittsburgh, Brain Trauma Res Ctr, Pittsburgh, PA 15213 USA; [Kochanek, Patrick M.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15213 USA		Puccio, AM (corresponding author), Univ Pittsburgh, Dept Neurol Surg, 200 Lothrop St,B-400 PUH, Pittsburgh, PA 15213 USA.	puccioam@upmc.edu	Kochanek, Patrick M/D-2371-2015	Kochanek, Patrick M/0000-0002-2627-913X	University of Pittsburgh Brain Trauma Research CenterUniversity of Pittsburgh; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [ProNS30318]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS030318, P20NS030318, P50NS030318] Funding Source: NIH RePORTER	This research was supported in part by the University of Pittsburgh Brain Trauma Research Center (NIH ProNS30318 to C. E. D.), Walter Copeland Research Award, and Leslie A. Hoffman Research Award. We thank Keri Feldman-Janesco and Ashley L. Glumac for technical assistance; the nurses and residents at the University of Pittsburgh Medical Center for excellent patient care, and Dr. Valerian Kagan for helpful discussions.	Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; BOGAERT YE, 1994, FREE RADICAL BIO MED, V16, P811, DOI 10.1016/0891-5849(94)90197-X; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Diringer MN, 2007, J NEUROSURG, V106, P526, DOI 10.3171/jns.2007.106.4.526; Hlatky R, 2008, J NEUROSURG, V108, P53, DOI 10.3171/JNS/2008/108/01/0053; Kaindl AM, 2006, CELL DEATH DIFFER, V13, P1097, DOI 10.1038/sj.cdd.4401796; Langmuir VK, 1996, INT J RADIAT ONCOL, V34, P79, DOI 10.1016/0360-3016(95)02077-2; Longhi Luca, 2004, Curr Opin Crit Care, V10, P105, DOI 10.1097/00075198-200404000-00005; Magnoni S, 2003, J NEUROSURG, V98, P952, DOI 10.3171/jns.2003.98.5.0952; Nortje J, 2008, CRIT CARE MED, V36, P273, DOI 10.1097/01.CCM.0000292014.60835.15; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Tolias CM, 2004, J NEUROSURG, V101, P435, DOI 10.3171/jns.2004.101.3.0435; TYURINA YY, 1995, TOXICOL APPL PHARM, V131, P277, DOI 10.1006/taap.1995.1070; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; van Santbrink H, 2003, ACTA NEUROCHIR, V145, P429, DOI 10.1007/s00701-003-0032-3; Vereczki V, 2006, J CEREBR BLOOD F MET, V26, P821, DOI 10.1038/sj.jcbfm.9600234; Wagner AK, 2004, J NEUROTRAUM, V21, P125, DOI 10.1089/089771504322778596; Zenri H, 2004, CRIT CARE MED, V32, P1155, DOI 10.1097/01.CCM.0000126264.00551.C8	18	18	21	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2009	26	8					1241	1249		10.1089/neu.2008.0624			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	479AF	WOS:000268629900007	19505175	Green Published			2022-02-06	
J	Goodrich-Hunsaker, NJ; Gilbert, PE; Hopkins, RO				Goodrich-Hunsaker, Naomi J.; Gilbert, Paul E.; Hopkins, Ramona O.			The Role of the Human Hippocampus in Odor-Place Associative Memory	CHEMICAL SENSES			English	Article						amnesia; associative memory; hippocampus; odor-place paired associate; recognition memory	MEDIAL TEMPORAL-LOBE; MILD COGNITIVE IMPAIRMENT; TRAUMATIC BRAIN INJURY; RECOGNITION MEMORY; ALZHEIMERS-DISEASE; ITEM RECOGNITION; SPATIAL MEMORY; OLFACTORY RECOGNITION; LESIONS; OBJECT	Hippocampal lesions in rodents impair both object-place and odor-place associative memory. Subjects with hippocampal damage have impaired associative memory such as object-place memory. Whereas studies have investigated some types of associative memory, no investigation has specifically examined odor-place associative memory in subjects with well-defined amnesia. It is unknown whether amnesic subjects with hippocampal damage would be impaired on an odor-place associative task. We investigated the effect of hippocampal damage in amnesic subjects with hippocampal atrophy on odor-place associative memory and recognition memory tasks. Amnesic and healthy comparison subjects matched for age and education were tested on an odor-place associative task, an odor recognition task, and a place recognition task. The odor-place associative task required subjects to associate 6 odors with 6 spatial locations on a board. The recognition tasks required subjects to identify the 6 odors and the 6 locations that were presented during the associative task. Amnesic subjects were impaired for odor-place memory and place recognition, but not odor recognition compared with comparison subjects. These results suggest that the human hippocampus is necessary for odor-place associative memory and spatial recognition memory. These data provide support for the idea that odor-place associative memory is mediated by the hippocampus in both humans and rodents, suggesting an evolutionary continuity in cognitive function assigned to the hippocampus.	[Goodrich-Hunsaker, Naomi J.; Hopkins, Ramona O.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Goodrich-Hunsaker, Naomi J.] Brigham Young Univ, Dept Physiol & Dev Biol, Provo, UT 84602 USA; [Gilbert, Paul E.] San Diego State Univ, Dept Psychol, San Diego, CA 92182 USA; [Gilbert, Paul E.] Univ Calif San Diego, San Diego State Univ, Joint Doctoral Program Clin Psychol, San Diego, CA 92120 USA; [Goodrich-Hunsaker, Naomi J.; Hopkins, Ramona O.] Brigham Young Univ, Ctr Neurosci, Provo, UT 84602 USA; [Hopkins, Ramona O.] Latter Day St Hosp, Dept Med, Div Pulm & Crit Care, Salt Lake City, UT 84143 USA; [Hopkins, Ramona O.] Intermt Med Ctr, Dept Med, Div Pulm & Crit Care, Murray, UT 84157 USA		Goodrich-Hunsaker, NJ (corresponding author), Brigham Young Univ, Dept Psychol, 1082 SWKT, Provo, UT 84602 USA.	naomihunsaker@mac.com					Barrash J, 1998, J CLIN EXP NEUROPSYC, V20, P807, DOI 10.1076/jcen.20.6.807.1114; Bigler ED, 2002, AM J NEURORADIOL, V23, P255; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; BLATTER DD, 1995, AM J NEURORADIOL, V16, P241; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Cerf-Ducastel B, 2006, NEUROIMAGE, V31, P386, DOI 10.1016/j.neuroimage.2005.11.009; Chua EF, 2007, HIPPOCAMPUS, V17, P1071, DOI 10.1002/hipo.20340; Crane J, 2005, HIPPOCAMPUS, V15, P216, DOI 10.1002/hipo.20043; Davachi L, 2002, J NEUROPHYSIOL, V88, P982, DOI 10.1152/jn.2002.88.2.982; Davachi L, 2003, P NATL ACAD SCI USA, V100, P2157, DOI 10.1073/pnas.0337195100; Devanand DP, 2000, AM J PSYCHIAT, V157, P1399, DOI 10.1176/appi.ajp.157.9.1399; Di Paola M, 2008, HIPPOCAMPUS, V18, P719, DOI 10.1002/hipo.20432; Djordjevic J, 2008, NEUROBIOL AGING, V29, P693, DOI 10.1016/j.neurobiolaging.2006.11.014; Dudchenko PA, 2000, J NEUROSCI, V20, P2964; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Eichenbaum H, 1998, ANN NY ACAD SCI, V855, P657, DOI 10.1111/j.1749-6632.1998.tb10642.x; Ergorul C, 2004, LEARN MEMORY, V11, P397, DOI 10.1101/lm.73304; ESIRI MM, 1984, J NEUROL NEUROSUR PS, V47, P56, DOI 10.1136/jnnp.47.1.56; Gadian DG, 2000, BRAIN, V123, P499, DOI 10.1093/brain/123.3.499; Gilbert PE, 2008, EXP AGING RES, V34, P437, DOI 10.1080/03610730802271914; Gilbert PE, 2004, J CLIN EXP NEUROPSYC, V26, P779, DOI 10.1080/13803390490509439; Gilbert PE, 2004, NEUROBIOL LEARN MEM, V81, P39, DOI 10.1016/S1074-7427(03)00069-8; Gilbert PE, 2002, BEHAV NEUROSCI, V116, P63, DOI 10.1037//0735-7044.116.1.63; Giovanello KS, 2004, HIPPOCAMPUS, V14, P5; Goh JOS, 2004, J NEUROSCI, V24, P10223, DOI 10.1523/JNEUROSCI.3373-04.2004; Gold JJ, 2005, HIPPOCAMPUS, V15, P79, DOI 10.1002/hipo.20032; Hamilton JM, 1999, J INT NEUROPSYCH SOC, V5, P609, DOI 10.1017/S1355617799577035; Holdstock JS, 2005, HIPPOCAMPUS, V15, P203, DOI 10.1002/hipo.20046; Hopkins R O, 1995, J Int Neuropsychol Soc, V1, P454; Hopkins RO, 2004, NEUROPSYCHOLOGIA, V42, P524, DOI 10.1016/j.neuropsychologia.2003.09.005; Kesner RP, 2000, CURR OPIN NEUROBIOL, V10, P260, DOI 10.1016/S0959-4388(00)00067-2; Kesner RP, 2001, NEUROPSYCHOLOGY, V15, P58, DOI 10.1037/0894-4105.15.1.58; Kessels RPC, 2001, BRAIN RES REV, V35, P295, DOI 10.1016/S0165-0173(01)00058-3; Levy DA, 2004, LEARN MEMORY, V11, P794, DOI 10.1101/lm.82504; Maguire EA, 1997, J NEUROSCI, V17, P7103; Manns JR, 2003, NEURON, V38, P127, DOI 10.1016/S0896-6273(03)00146-6; Manns JR, 2003, NEURON, V37, P171, DOI 10.1016/S0896-6273(02)01147-9; Mayes AR, 2002, HIPPOCAMPUS, V12, P325, DOI 10.1002/hipo.1111; Meltzer JA, 2005, NEUROIMAGE, V24, P384, DOI 10.1016/j.neuroimage.2004.09.001; Meyers JE., 1995, REY COMPLEX FIGURE T; MOBERG PJ, 1987, J CLIN EXP NEUROPSYC, V9, P650, DOI 10.1080/01688638708405208; MURPHY C, 1991, AM J PSYCHOL, V104, P161, DOI 10.2307/1423153; Murphy C, 1997, NEUROPSYCHOLOGY, V11, P126; Murphy C, 2002, JAMA-J AM MED ASSOC, V288, P2307, DOI 10.1001/jama.288.18.2307; Murphy C, 2003, J INT NEUROPSYCH SOC, V9, P459, DOI 10.1017/S1355617703930116; Nordin S, 1998, ANN NY ACAD SCI, V855, P686, DOI 10.1111/j.1749-6632.1998.tb10646.x; Nunn JA, 1999, BRAIN, V122, P47, DOI 10.1093/brain/122.1.47; O'Keefe J, 1998, PHILOS T ROY SOC B, V353, P1333, DOI 10.1098/rstb.1998.0287; O'Reilly RC, 2001, PSYCHOL REV, V108, P311, DOI 10.1037//0033-295X.108.2.311; OTTO T, 1992, HIPPOCAMPUS, V2, P323, DOI 10.1002/hipo.450020310; PRICE JL, 1991, NEUROBIOL AGING, V12, P295, DOI 10.1016/0197-4580(91)90006-6; Rolls ET, 2005, J NEUROPHYSIOL, V94, P833, DOI 10.1152/jn.01063.2004; Squire LR, 2007, NAT REV NEUROSCI, V8, P872, DOI 10.1038/nrn2154; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Stark CEL, 2002, LEARN MEMORY, V9, P238, DOI 10.1101/lm.51802; Turriziani P, 2004, NEUROPSYCHOLOGIA, V42, P426, DOI 10.1016/j.neuropsychologia.2003.10.003; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wilson RS, 2007, ARCH GEN PSYCHIAT, V64, P802, DOI 10.1001/archpsyc.64.7.802	61	18	18	1	7	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X	1464-3553		CHEM SENSES	Chem. Senses	JUL	2009	34	6					513	521		10.1093/chemse/bjp026			9	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	457TE	WOS:000266955500007	19477953				2022-02-06	
J	Farhadi, MR; Becker, M; Stippich, C; Unterberg, AW; Kiening, KL				Farhadi, M. R.; Becker, M.; Stippich, C.; Unterberg, A. W.; Kiening, K. L.			Transorbital penetrating head injury by a toilet brush handle	ACTA NEUROCHIRURGICA			English	Article						Traumatic brain injury; Foreign body; Intraoperative CT		Transorbital penetrating brain injuries are rare lesions without defined therapy standards. A male patient presented at our institution with a toilet brush handle in the right cerebral hemisphere. CT imaging identified the object entering the right orbit and having crossed the right hemisphere in the ventricular plane. After performing a medium-sized craniotomy, the object was removed step-by-step under monitoring with an intraoperative CT scan to ensure no involving major hemorrhage. Transorbital penetrating brain injuries are treated best by utilizing all up-to-date technical developments such as intraoperative CT-scanning to increase the safety in the management of such exceptional lesions with increased risk of immediate life-threatening intracranial bleeding.	[Farhadi, M. R.; Unterberg, A. W.; Kiening, K. L.] Univ Heidelberg, Dept Neurosurg, D-69120 Heidelberg, Germany; [Becker, M.] Univ Heidelberg Hosp, Dept Ophthalmol, Heidelberg, Germany; [Stippich, C.] Univ Heidelberg Hosp, Dept Neuroradiol, Heidelberg, Germany		Farhadi, MR (corresponding author), Univ Heidelberg, Dept Neurosurg, Neuenheimer Feld 400, D-69120 Heidelberg, Germany.	mohammad.farhadi@med.uni-heidelberg.de	Farhadi, Mohammad Reza/AAN-9612-2021	Farhadi, Mohammad Reza/0000-0001-5333-5355			Heininger AD, 2004, ANAESTHESIST, V53, P830, DOI 10.1007/s00101-004-0729-6; Kochanek PM, 2007, J NEUROTRAUM, V24, P1, DOI 10.1089/neu.2006.0209; Lin Hung-Lin, 2007, J Chin Med Assoc, V70, P36; Matsuyama T, 2001, NEUROL MED-CHIR, V41, P345, DOI 10.2176/nmc.41.345	4	18	20	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.	JUN	2009	151	6					685	687		10.1007/s00701-009-0221-9			3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	456AZ	WOS:000266811700019	19255713				2022-02-06	
J	Potts, MB; Rola, R; Claus, CP; Ferriero, DM; Fike, JR; Noble-Haeusslein, LJ				Potts, Matthew B.; Rola, Radoslaw; Claus, Catherine P.; Ferriero, Donna M.; Fike, John R.; Noble-Haeusslein, Linda J.			Glutathione Peroxidase Overexpression Does Not Rescue Impaired Neurogenesis in the Injured Immature Brain	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						traumatic brain injury; dentate gyrus; hippocampus; glutathione peroxidase	CENTRAL-NERVOUS-SYSTEM; DENTATE GYRUS; TRAUMATIC INJURY; SELECTIVE VULNERABILITY; REGIONAL VULNERABILITY; ENHANCED NEUROGENESIS; SUPEROXIDE-DISMUTASE; TRANSGENIC MICE; HEAD TRAUMA; ADULT RATS	Traumatic brain injury (TBI) is a leading cause of disability among young children and is associated with long-term cognitive deficits. These clinical findings have prompted an investigation of the hippocampus in an experimental model of trauma to the developing brain at postnatal day (p21). Previous studies using this model have revealed a progressive loss of neurons in the hippocampus as brain-injured animals mature to young adulthood. Here we determined whether this hippocampal vulnerability is likewise reflected in altered neurogenesis and whether the antioxidant glutathione peroxidase (GPx) modulates neurogenesis during maturation of the injured immature brain. Male transgenic mice that overexpress GPx and wild-type littermates were subjected to controlled cortical impact or sham surgery on p21. At 2 weeks postinjury, the numbers of proliferating cells and immature neurons within the subgranular zone were measured by using Ki-67 and doublecortin, respectively. Bromodeoxyuricline (BrdU) was used to label dividing cells beginning 2 weeks postinjury. Survival (BrdU(+)) and neuronal differentiation (BrdU(+)/NeuN(+)) were then measured 4 weeks later via confocal microscopy. Two-way ANOVA revealed no significant interaction between genotype and injury. Subsequent analysis of the individual effects of injury and genotype, however, showed a significant reduction in subgranular zone proliferation (Ki-67) at 2 weeks postinjury (P = 0.0003) and precursor cell survival (BrdU(+)) at 6 weeks postinjury (P = 0.016) and a trend toward reduced neuronal differentiation (BrdU(+)/NeuN(+)) at 6 weeks postinjury (P = 0.087). Overall, these data demonstrate that traumatic injury to the injured immature brain impairs neurogenesis during maturation and suggest that GPx cannot rescue this reduced neurogenesis. (C) 2009 Wiley-Liss, Inc.	[Potts, Matthew B.; Rola, Radoslaw; Claus, Catherine P.; Fike, John R.; Noble-Haeusslein, Linda J.] Univ Calif San Francisco, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA; [Potts, Matthew B.; Rola, Radoslaw; Claus, Catherine P.; Fike, John R.; Noble-Haeusslein, Linda J.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Ferriero, Donna M.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Ferriero, Donna M.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Noble-Haeusslein, Linda J.] Univ Calif San Francisco, Dept Phys Therapy & Rehabil Sci, San Francisco, CA 94143 USA		Noble-Haeusslein, LJ (corresponding author), 521 Parnassus Ave,Room C-224,UCSF Box 0520, San Francisco, CA 94143 USA.	linda.noble@ucsf.edu	Rola, Radoslaw/AAQ-5587-2021; Rola, Radoslaw/V-6749-2018	Rola, Radoslaw/0000-0003-0613-6593; Rola, Radoslaw/0000-0003-0613-6593	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS050159]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS050159] Funding Source: NIH RePORTER	Contract grant sponsor: NIH; Contract grant number: NS050159	Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; Adelson PD, 1996, J NEUROSURG, V85, P877, DOI 10.3171/jns.1996.85.5.0877; Adelson PD, 2001, J NEUROTRAUM, V18, P967, DOI 10.1089/08977150152693674; Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; Bauer R, 2004, EXP TOXICOL PATHOL, V56, P65, DOI 10.1016/j.etp.2004.04.002; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Benz B, 1999, RESTOR NEUROL NEUROS, V14, P135; Bittigau D, 1999, ANN NEUROL, V45, P724, DOI 10.1002/1531-8249(199906)45:6<724::AID-ANA6>3.0.CO;2-P; Bittigau P, 2004, EXP TOXICOL PATHOL, V56, P83, DOI 10.1016/j.etp.2004.04.006; Braun H, 2002, J NEUROTRAUM, V19, P975, DOI 10.1089/089771502320317122; Card JP, 2005, J NEUROTRAUM, V22, P989, DOI 10.1089/neu.2005.22.989; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Cuppini R, 2002, INT J VITAM NUTR RES, V72, P170, DOI 10.1024/0300-9831.72.3.170; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Ditelberg JS, 1996, PEDIATR RES, V39, P204, DOI 10.1203/00006450-199602000-00003; Emery DL, 2005, J NEUROTRAUM, V22, P978, DOI 10.1089/neu.2005.22.978; Englund U, 2002, DEV BRAIN RES, V134, P123, DOI 10.1016/S0165-3806(01)00330-3; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fan P, 2003, J NEUROTRAUM, V20, P437, DOI 10.1089/089771503765355513; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Gaulke LJ, 2005, MOL BRAIN RES, V141, P138, DOI 10.1016/j.molbrainres.2005.08.011; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; HALL ED, 1993, RES P ARNMD, V71, P81; Herrera DG, 2003, P NATL ACAD SCI USA, V100, P7919, DOI 10.1073/pnas.1230907100; Igarashi T, 2001, EXP NEUROL, V172, P332, DOI 10.1006/exnr.2001.7820; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Levin H S, 1997, J Int Neuropsychol Soc, V3, P598; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Mazzola CA, 2002, CRIT CARE MED, V30, pS393, DOI 10.1097/00003246-200211001-00003; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; MIROCHNITCHENKO O, 1995, P NATL ACAD SCI USA, V92, P8120, DOI 10.1073/pnas.92.18.8120; NAWASHIRO H, 1995, NEUROL RES, V17, P455, DOI 10.1080/01616412.1995.11740363; Nichols NR, 2005, BRAIN RES REV, V48, P287, DOI 10.1016/j.brainresrev.2004.12.019; Nybo T, 2005, ACTA NEUROL SCAND, V112, P338, DOI 10.1111/j.1600-0404.2005.00489.x; Parent JM, 1997, J NEUROSCI, V17, P3727; Picard-Riera N, 2004, J NEUROSCI RES, V76, P223, DOI 10.1002/jnr.20040; Potts Mathew B, 2006, NeuroRx, V3, P143; Pullela R, 2006, DEV NEUROSCI-BASEL, V28, P396, DOI 10.1159/000094166; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Sheldon RA, 2004, PEDIATR RES, V56, P656, DOI 10.1203/01.PDR.0000139413.27864.50; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; TSUROAOYAGI K, 2006, SOC NEUR ABSTR; Yager JY, 1997, NEUROSCI BIOBEHAV R, V21, P167, DOI 10.1016/S0149-7634(96)00006-1; Yoshimura S, 2003, J CLIN INVEST, V112, P1202, DOI 10.1172/JCI200316618; Zhang Q, 2005, NEUROL RES, V27, P552, DOI 10.1179/016164105X25126	52	18	18	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	JUN	2009	87	8					1848	1857		10.1002/jnr.21996			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	437CD	WOS:000265462800012	19170177	Green Accepted			2022-02-06	
J	McCluggage, LK; Voils, SA; Bullock, MR				McCluggage, Lauren K.; Voils, Stacy A.; Bullock, Malcolm Ross			Phenytoin Toxicity Due to Genetic Polymorphism	NEUROCRITICAL CARE			English	Article						Phenytoin; Case report; Phenytoin toxicity; Polymorphism; Traumatic brain injury	INTOXICATION	Patients with traumatic brain injury commonly receive phenytoin for seizure prophylaxis. Due to the non-linear pharmacokinetics of phenytoin and narrow therapeutic window, phenytoin concentrations are monitored to ensure efficacy and prevent toxicity. Because phenytoin is hepatically metabolized, polymorphisms within cytochrome P450 enzymes can affect phenytoin concentrations. We report a case of a 53-year-old Asian female admitted to the neuroscience intensive care unit after suffering a traumatic brain injury. Phenytoin was subsequently administered for seizure prophylaxis. Four days after being initiated on phenytoin, the patient remained lethargic, and phenytoin toxicity was suspected. Lab values revealed a free phenytoin concentration of 4.4 mg/l, and phenytoin was discontinued. Upon further investigation, it was found that the patient was a cytochrome P450 2C9 poor metabolizer. Causes of the patient's toxic phenytoin concentration such as drug interactions, decreased albumin, and lab error were excluded. The cause of her elevated phenytoin concentration was determined to be hepatic polymorphism. This case reveals the clinical significance of genetic polymorphisms and the effect on phenytoin dosage requirements. Because pharmacogenomic testing is expensive and not readily available, routine monitoring of phenytoin concentrations is warranted. Further, established polymorphisms should be documented to prevent toxicity of drugs metabolized by similar pathways.	[Voils, Stacy A.] Virginia Commonwealth Univ Hlth Syst, Dept Pharm Serv, Richmond, VA 23298 USA; [McCluggage, Lauren K.] Univ Sci Philadelphia, Dept Pharm Practice, Philadelphia, PA USA; [McCluggage, Lauren K.] Univ Sci Philadelphia, Pharm Adm, Philadelphia, PA USA; [Bullock, Malcolm Ross] Univ Miami, Miller Sch Med, Dept Neurosurg, Miami, FL 33136 USA		Voils, SA (corresponding author), Virginia Commonwealth Univ Hlth Syst, Dept Pharm Serv, POB 980042, Richmond, VA 23298 USA.	svoils@mcvh-vcu.edu					Citerio G, 2003, NEUROLOGY, V60, P1395, DOI 10.1212/01.WNL.0000058756.61277.17; Hung CC, 2004, THER DRUG MONIT, V26, P534, DOI 10.1097/00007691-200410000-00012; Lardizabal DV, 2004, NEUROLOGY, V62, P161; Lee CR, 2002, PHARMACOGENETICS, V12, P251, DOI 10.1097/00008571-200204000-00010; Ninomiya H, 2000, THER DRUG MONIT, V22, P230, DOI 10.1097/00007691-200004000-00016; Schwarz UI, 2003, EUR J CLIN INVEST, V33, P23, DOI 10.1046/j.1365-2362.33.s2.6.x; van der Weide J, 2001, PHARMACOGENETICS, V11, P287, DOI 10.1097/00008571-200106000-00002; WINTER ME, 1994, BASIC CLIN PHARMACOK, P312	8	18	18	0	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2009	10	2					222	224		10.1007/s12028-008-9165-9			3	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	414XP	WOS:000263898800012	19030785				2022-02-06	
J	Street, D; Burge, S; Quadagno, J				Street, Debra; Burge, Stephanie; Quadagno, Jill			The Effect of Licensure Type on the Policies, Practices, and Resident Composition of Florida Assisted Living Facilities	GERONTOLOGIST			English	Article; Proceedings Paper	59th Annual Meeting of the Gerontological-Society-of-America	NOV 16-20, 2006	Dallas, TX	Gerontol Soc Amer		Long-term care; Residential care; Aging in place; Mental illness; Racial and ethnic minorities	MENTAL-ILLNESS; NURSING-HOMES; QUALITY; DECLINE; APPLES	Purpose: Most assisted living facility (ALF) residents are White widows in their mid- to late 80s who need assistance with activities of daily living (ADLs) because of frailty or cognitive decline. Yet, ALFs also serve younger individuals with physical disabilities, traumatic brain injury, or serious mental illness. We compare Florida ALFs with different licensure profiles by admission-discharge policies and resident population characteristics. Design and Methods: We use state administrative data and facility survey data from the Florida Study of Assisted Living (FSAL) to classify ALFs by licensure type and to determine how licensure influences ALF policies, practices, and resident population profiles. Results: Standard-licensed traditional ALFs primarily serve elderly White women with physical care needs and typically retain residents when their physical health deteriorates. Some ALFs that hold specialty licenses (extended congregate care and limited nursing services) offer extra physical care services and serve an older, more physically frail population with greater physical and cognitive challenges. ALFs with limited mental health (LMH) licenses serve clientele who are more racially and ethnically diverse, younger, and more likely to be men and single. LMH facilities also have a significant proportion of frail elder residents who live alongside these younger residents, including some who exhibit behavioral problems. LMH facilities also employ discharge policies that make it more difficult for frail elderly residents to age in place. implications: These differences by facility type raise important quality of life issues for both the frail elderly individuals and assisted living residents who do not fit the conventional demographic profile.	[Street, Debra] SUNY Buffalo, Dept Sociol, Buffalo, NY 14260 USA; [Burge, Stephanie] Univ Oklahoma, Dept Sociol, Norman, OK 73019 USA; [Quadagno, Jill] Florida State Univ, Dept Sociol, Pepper Inst Aging & Publ Policy, Tallahassee, FL 32306 USA		Street, D (corresponding author), SUNY Buffalo, Dept Sociol, 430 Pk Hall, Buffalo, NY 14260 USA.	dastreet@buffalo.edu					Ball MM, 2004, J GERONTOL B-PSYCHOL, V59, pS202, DOI 10.1093/geronb/59.4.S202; Ball MM, 2000, J APPL GERONTOL, V19, P304, DOI 10.1177/073346480001900304; Bishop CE, 1999, HEALTH AFFAIR, V18, P146, DOI 10.1377/hlthaff.18.4.146; BURBY RJ, 1990, J AM PLANN ASSOC, V56, P324, DOI 10.1080/01944369008975776; Chapin R, 2001, GERONTOLOGIST, V41, P43, DOI 10.1093/geront/41.1.43; Chou SC, 2003, GERONTOLOGIST, V43, P459, DOI 10.1093/geront/43.4.459; COHEN F, 1987, RES AGING, V9, P79, DOI 10.1177/0164027587009001004; *CTR MED MED SERV, 2005, NURS HOM DATA COMP 2; CUMMINGS C, 2004, J MENTAL HLTH AGING, V10, P151; DeJong G, 2002, MILBANK Q, V80, P261, DOI 10.1111/1468-0009.t01-1-00004; Frank J.B., 2002, PARADOX AGING PLACE; Golant SM, 2004, J GERONTOL B-PSYCHOL, V59, pS68, DOI 10.1093/geronb/59.2.S68; Hawes C, 2003, GERONTOLOGIST, V43, P875, DOI 10.1093/geront/43.6.875; Hawes C, 2000, HIGH SERVICE HIGH PR; HAWES C, 1999, NATL STUDY ASSISTED; Hawes C, 2007, GERONTOLOGIST, V47, P40, DOI 10.1093/geront/47.Supplement_1.40; Hedrick S, 2007, GERONTOLOGIST, V47, P365, DOI 10.1093/geront/47.3.365; Hernandez M, 2007, GERONTOLOGIST, V47, P110, DOI 10.1093/geront/47.Supplement_1.110; Heumann LF, 1996, HOUS POLICY DEBATE, V7, P447; Kane RA, 2007, GERONTOLOGIST, V47, P125, DOI 10.1093/geront/47.Supplement_1.125; KELLAM S, 1992, C Q WEEKLY REP, V50, P23; Mechanic D, 2000, PSYCHIATR SERV, V51, P354, DOI 10.1176/appi.ps.51.3.354; MEHDIZADEH S, 2006, WHO STAYS WHO PAYS; Miller N, 2007, SOC SCI MED, V64, P303, DOI 10.1016/j.socscimed.2006.08.036; Mollica R. L., 2005, STATE RESIDENTIAL CA; *NAT CTR ASS LIV, 2008, ASS LIV STAT REG REV; SALMON J, 2004, 30347 USF FLOR POL E; SMITH V, 2004, CONTINUING MED BUDGE; STREET D, 2005, FLORIDA ASSISTED LIV; STREET D, 2004, NURSING HOME ASSISTE; STREET D, 2006, A0507 RC SUNY U BUFF; Street D, 2007, J GERONTOL B-PSYCHOL, V62, pS129, DOI 10.1093/geronb/62.2.S129; Zimmerman S, 2003, GERONTOLOGIST, V43, P107, DOI 10.1093/geront/43.suppl_2.107	33	18	18	0	9	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0016-9013	1758-5341		GERONTOLOGIST	Gerontologist	APR	2009	49	2					211	223		10.1093/geront/gnp022			13	Gerontology	Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Geriatrics & Gerontology	436GI	WOS:000265400300007	19363016	Bronze, Green Published			2022-02-06	
J	Bigler, ED; Brooks, M				Bigler, Erin D.; Brooks, Michael			Traumatic Brain Injury and Forensic Neuropsychology	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						forensic neuropsychology; practice standards; research standards; traumatic brain injury	ASSOCIATION PRACTICE SURVEY; UNITED-STATES; CLINICAL NEUROPSYCHOLOGY; MILD; CONTROVERSIES; ACADEMY; OUTCOMES; ISSUES; NATIONAL-ACADEMY-OF-NEUROPSYCHOLOGY/DIVISION-40; CONCUSSION	As part of a special issue of The Journal of Head Trauma Rehabilitation, forensic neuropsychology is reviewed as it applies to traumatic brain injury (TBI) and other types of acquired brain Injury in which clinical neuropsychologists and rehabilitation psychologists may be asked to render professional opinions about the neurobehavioral effects and outcome of a brain injury. The article introduces and overviews the topic focusing on the process of forensic neuropsychological consultation and practice as it applies to patients with TBI or other types of acquired brain injury. The emphasis is on the application of scientist-practitioner standards as they apply to legal questions about the status of a TBI patient and how best that may be achieved. This article introduces each topic area covered in this special edition.	[Bigler, Erin D.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Bigler, Erin D.] Brigham Young Univ, Dept Neurosci, Provo, UT 84602 USA; [Brooks, Michael] Brigham Young Univ, Univ Accessibil Ctr, Provo, UT 84602 USA; [Bigler, Erin D.] Univ Utah, Dept Psychiat, Salt Lake City, UT USA; [Bigler, Erin D.] Univ Utah, Brain Inst Utah, Salt Lake City, UT USA		Bigler, ED (corresponding author), Brigham Young Univ, Dept Psychol, 1001 SWKT, Provo, UT 84602 USA.	erin_bigler@byu.edu					*AM PSYCH ASS, 2007, COMM PSYCH TESTS ASS; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Bailey CM, 2009, J HEAD TRAUMA REHAB, V24, P123, DOI 10.1097/HTR.0b013e31819c1caa; Baker DB, 2000, AM PSYCHOL, V55, P241, DOI 10.1037/0003-066X.55.2.241; BANDAK FA, 1996, TRAUMATIC BRAIN INJU; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; BIGLER ED, 2006, BRAIN INJURY PROFESS, V3, P8; Bigler ED, 2006, ARCH CLIN NEUROPSYCH, V21, P503, DOI 10.1016/j.acn.2006.03.008; Bigler ED, 2008, ARCH CLIN NEUROPSYCH, V23, P755, DOI 10.1016/j.acn.2008.09.003; Black KL, 2002, J HEAD TRAUMA REHAB, V17, P489, DOI 10.1097/00001199-200212000-00001; Boone K.B., 2007, ASSESSMENT FEIGNED C; Bryant RA, 2001, J CLIN EXP NEUROPSYC, V23, P718, DOI 10.1076/jcen.23.6.718.1024; Buchanan A, 2006, J AM ACAD PSYCHIATRY, V34, P14; Burt RA, 2006, CRIT CARE MED, V34, pS348, DOI 10.1097/01.CCM.0000237270.55658.34; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P997, DOI 10.1016/j.acn.2005.06.003; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Cain DM, 2008, JAMA-J AM MED ASSOC, V299, P2893, DOI 10.1001/jama.299.24.2893; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Coyle PK, 2007, NEUROLOGY, V68, pS3, DOI 10.1212/01.wnl.0000277702.74115.9b; CYNKAR A, 2007, APA MONIT PSYCHOL, V38, P52; Dawson DR, 2007, DISABIL REHABIL, V29, P301, DOI 10.1080/09638280600756687; DeAngelis CD, 2008, JAMA-J AM MED ASSOC, V299, P1833, DOI 10.1001/jama.299.15.1833; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; EDLUND W, 2005, AM ACAD NEUROLOGY CL; Essig SM, 2001, ARCH CLIN NEUROPSYCH, V16, P271, DOI 10.1016/S0887-6177(99)00065-7; Farmer A, 2008, BRIT J PSYCHIAT, V192, P351, DOI 10.1192/bjp.bp.107.038380; Flaro L, 2007, BRAIN INJURY, V21, P373, DOI 10.1080/02699050701311133; Frederick RI, 2009, J HEAD TRAUMA REHAB, V24, P105, DOI 10.1097/HTR.0b013e31819b1210; Garner Bryan A., 1999, BLACKS LAW DICT; Genovese Elizabeth, 2004, Clin Occup Environ Med, V4, P361; Gorwood P, 2008, AM J PSYCHIAT, V165, P731, DOI 10.1176/appi.ajp.2008.07040574; Griffin GAE, 1996, J CONSULT CLIN PSYCH, V64, P1425, DOI 10.1037/0022-006X.64.6.1425; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P158, DOI 10.1097/00001199-200503000-00004; Heilbronner RL, 2004, CLIN NEUROPSYCHOL, V18, P312, DOI 10.1080/13854040490501574; Heilbronner RL, 2007, CLIN NEUROPSYCHOL, V21, P209, DOI 10.1080/13825580601025932; Holloway RG, 2008, NEUROLOGY, V71, P57, DOI 10.1212/01.wnl.0000316319.19159.c3; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Kendler KS, 2008, AM J PSYCHIAT, V165, P695, DOI 10.1176/appi.ajp.2008.07071061; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Larrabee G.J., 2005, FORENSIC NEUROPSYCHO; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larrabee GJ, 2008, ARCH CLIN NEUROPSYCH, V23, P763, DOI 10.1016/j.acn.2008.09.004; Larriviere D, 2008, JAMA-J AM MED ASSOC, V299, P1667, DOI 10.1001/jama.299.14.1667-a; Lee LK, 2007, PEDIATR EMERG CARE, V23, P580, DOI 10.1097/PEC.0b013e31813444ea; Lezak MD, 1976, NEUROPSYCHOLOGICAL A; LoPiccolo CJ, 1999, ANN MED, V31, P166, DOI 10.3109/07853899909115975; Lundin KA, 1999, CLIN NEUROPSYCHOL, V13, P433, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT433; Lynch W, 2004, J HEAD TRAUMA REHAB, V19, P277, DOI 10.1097/00001199-200405000-00008; Martelli MF, 2002, PAIN MANAGEMENT PRAC, P895; Michaels D., 2008, DOUBT IS THEIR PRODU; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; NARAYAN R, 1996, J NEUROTRAUMA; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Pickelsimer EE, 2006, J HEAD TRAUMA REHAB, V21, P491, DOI 10.1097/00001199-200611000-00004; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Psaty BM, 2008, JAMA-J AM MED ASSOC, V299, P1813, DOI 10.1001/jama.299.15.1813; Quill TE, 2005, NEW ENGL J MED, V352, P1630, DOI 10.1056/NEJMp058062; Racette BA, 2006, NEUROLOGY, V67, P2124, DOI 10.1212/01.wnl.0000249306.85048.86; Rondina C, 2005, J HEAD TRAUMA REHAB, V20, P368, DOI 10.1097/00001199-200507000-00008; Ross JS, 2008, JAMA-J AM MED ASSOC, V299, P1800, DOI 10.1001/jama.299.15.1800; Ruff R, 2009, J HEAD TRAUMA REHAB, V24, P131, DOI 10.1097/01.HTR.0000348755.42649.e9; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; Sagsveen MG, 2004, NEUROLOGY, V63, P1555, DOI 10.1212/01.WNL.0000146627.92573.8D; Schnadower D, 2007, CURR OPIN PEDIATR, V19, P258, DOI 10.1097/MOP.0b013e3281084e85; Schwarz L, 2009, J HEAD TRAUMA REHAB, V24, P100, DOI 10.1097/HTR.0b013e31819b0504; Silver JM, 1997, J NEUROPSYCH CLIN N, V9, P102; Standaert CJ, 2007, ARCH PHYS MED REHAB, V88, P1077, DOI 10.1016/j.apmr.2007.06.002; STERN BH, 2007, LITIGATING BRAIN INJ; Sweet JJ, 2006, CLIN NEUROPSYCHOL, V20, P325, DOI 10.1080/13854040600760488; Sweet JJ, 2003, ARCH CLIN NEUROPSYCH, V18, P557, DOI 10.1016/S0887-6177(02)00215-9; Sweet JJ, 2002, CLIN NEUROPSYCHOL, V16, P109, DOI 10.1076/clin.16.2.109.13237; Thurman DJ, 2007, BRAIN INJURY MED PRI, P45; VOISS DV, 1995, NEUROL CLIN, V13, P431, DOI 10.1016/S0733-8619(18)30055-0; Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Williams MA, 2006, NEUROLOGY, V66, P13, DOI 10.1212/01.wnl.0000190568.69950.11; Wood RL, 2009, J HEAD TRAUMA REHAB, V24, P88, DOI 10.1097/HTR.0b013e31819b118a; Zasler N., 2007, BRAIN INJURY MED PRI; [No title captured]	85	18	18	2	22	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2009	24	2					76	87		10.1097/HTR.0b013e31819c2190			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	427WF	WOS:000264809100002	19333063				2022-02-06	
J	Pfleger, CCH; Koch-Henriksen, N; Stenager, E; Flachs, EM; Johansen, C				Pfleger, C. C. H.; Koch-Henriksen, N.; Stenager, E.; Flachs, E. M.; Johansen, C.			Head injury is not a risk factor for multiple sclerosis: a prospective cohort study	MULTIPLE SCLEROSIS JOURNAL			English	Article						craniocerebral trauma; epidemiology; head injury; head trauma; multiple sclerosis; pathogenesis; trauma	TRAUMA; REGISTRY; DENMARK	Background The idea of physical trauma being involved in the causation of multiple sclerosis ( MS) had been discussed since the earliest description of the illness. Despite the ongoing debate, the proposed association between physical and especially head trauma and MS failed to be proved or to be refuted conclusively. Objective To determine whether head trauma is associated with an increased risk of developing MS. Method A cohort of 150,868 subjects, 95,111 men, and 55,757 women registered in the National Danish Patient Registry with hospital admission for cerebral concussion, contusion, or skull fracture between 1977 and 1992, aged under 55, was selected. This trauma cohort was linked with the Danish MS Registry and followed up to the end of 1999 to retrieve subjects who had onset of MS after the year of the head trauma. We calculated the expected number of subjects, who, under a null-hypothesis, would subsequently develop MS, by using population age-, year-, and sex-specific MS-incidence densities from the Danish MS Registry. Results For men and women combined, the observed to expected number of MS cases (possible cases included) with onset after the head injury was 182/193.6 (standardized incidence ratio [SIR], 0.94; 95% CI, 0.81-1.09) and for possible MS excluded, 171/164.7 (SIR, 1.04; 95% CI, 0.89-1.21). In an analysis of a sub-cohort of 16,425 subjects with severe trauma ( contusion, traumatic cerebral hemorrhage, and base or skull fracture), the observed to expected numbers, including possible MS, were 15/15.3 (SIR, 0.98; 95% CI, 0.55-1.62) and with possible MS excluded, 13/12.9 (SIR, 1.01; 95% CI, 0.53-1.73). As for the total group and for any of the subgroups and for men and women separately, none of the SIRs differed statistically significantly from unity. Neither were there any trends, which could be missed by type II errors. Conclusion Head injury of any severity does not affect the risk of acquiring MS later in life. Multiple Sclerosis 2009; 15: 294-298. http://msj.sagepub.com	[Pfleger, C. C. H.; Koch-Henriksen, N.] Arhus Univ Hosp, Dept Neurol, DK-9000 Aalborg, Denmark; [Koch-Henriksen, N.; Stenager, E.; Flachs, E. M.] Danish Multiple Sclerosis Registry, Copenhagen, Denmark; [Stenager, E.] Sonderborg Hosp, Dept Neurol, Sonderborg, Denmark; [Flachs, E. M.] Univ So Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark; [Johansen, C.] Danish Canc Soc, Danish Inst Canc Epidemiol, Copenhagen, Denmark		Pfleger, CCH (corresponding author), Arhus Univ Hosp, Dept Neurol, Ladegaardsgade 5, DK-9000 Aalborg, Denmark.	ccp@rn.dk	Stenager, Egon/AAU-4463-2020; Johansen, Christoffer/AAG-7916-2020; Stenager, Egon/O-2275-2017	Johansen, Christoffer/0000-0002-4384-206X; stenager, egon/0000-0002-4877-5193	Danish Multiple Sclerosis Society; Danish Multiple Sclerosis Registry; Danish Cancer SocietyDanish Cancer Society	The study was indirectly supported by the Danish Multiple Sclerosis Society by funding the maintenance of the Danish Multiple Sclerosis Registry. CJ was supported by the Danish Cancer Society.	ALTER M, 1968, NEUROLOGY, V18, P109, DOI 10.1212/WNL.18.2.109; Goldacre MJ, 2006, J NEUROL NEUROSUR PS, V77, P351, DOI 10.1136/jnnp.2005.077693; Goodin DS, 1999, NEUROLOGY, V52, P1737, DOI 10.1212/WNL.52.9.1737; HOFFMANN J, 1902, DTSCH Z NERVENHEILK, V21, P1; HYLLESTED K, 1956, THESIS COPENHAGEN; Inskip PD, 1998, CANCER CAUSE CONTROL, V9, P109, DOI 10.1023/A:1008861722901; JELLINEK EH, 1994, LANCET, V343, P1053, DOI 10.1016/S0140-6736(94)90178-3; Koch-Henriksen N, 1999, MULT SCLER, V5, P293, DOI 10.1191/135245899678846258; KOCHHENRIKSEN N, 1988, ACTA NEUROL SCAND, V78, P369, DOI 10.1111/j.1600-0404.1988.tb03672.x; KURLAND LEONARD T., 1954, ANN NEW YORK ACAD SCI, V58, P682, DOI 10.1111/j.1749-6632.1954.tb54106.x; KURLAND LT, 1994, ANN NEUROL, V36, pS33, DOI 10.1002/ana.410360711; LAUER K, 1994, NEUROLOGY, V44, P1360, DOI 10.1212/WNL.44.7.1360-a; MCALPINE D, 1952, Q J MED, V21, P135; MENDEL K, 1897, DEUT MED WOCHENSCHR, V7, P97; MILLAR J H, 1954, Ulster Med J, V23, P29; POSER CM, 1994, CLIN NEUROL NEUROSUR, V96, P103, DOI 10.1016/0303-8467(94)90042-6; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; SIVA A, 1993, NEUROLOGY, V43, P1878, DOI 10.1212/WNL.43.10.1878; VONHOESSLIN R, 1934, UEBER MULTIPLE SKLER, P68	19	18	20	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1352-4585	1477-0970		MULT SCLER J	Mult. Scler. J.	MAR	2009	15	3					294	298		10.1177/1352458508099475			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	423AF	WOS:000264468100003	19028828				2022-02-06	
J	Tang, ME; Lobel, DA				Tang, Mary E.; Lobel, Darlene A.			Severe Traumatic Brain Injury: Maximizing Outcomes	MOUNT SINAI JOURNAL OF MEDICINE			English	Article						brain injury; brain mass lesions; brain tissue oxygenation; cerebral perfusion pressures; computed tomography; injury sequelae; secondary injury; seizures; severe injury; traumatic injury	HEAD-INJURY; VENOUS THROMBOEMBOLISM; CEREBRAL EDEMA; UNITED-STATES; MANAGEMENT; PROPHYLAXIS; PRESSURE; INFUSION; PROTOCOL; COMPLICATIONS	Severe traumatic brain injury is one of the leading causes of death and disability in the United States. The initial management of traumatic brain injury involves early resuscitation, computed tomography scanning, and surgical evacuation of mass lesions, when indicated. Recent research suggests that the prevention and treatment of secondary brain injury decrease mortality and improve outcomes. Specifically, treatment should address not only cerebral protection but also prevention of injury to other organ system. To achieve the best outcomes, attention must be focused on optimizing blood pressure and brain tissue oxygenation, maintaining adequate cerebral perfusion pressures, and preventing seizures. In addition, maximizing good outcomes depends on proactively addressing the risk of common sequelae of brain injury, including infection, deep venous thrombosis, and inadequate nutrition. Guidelines developed for the management of severe traumatic brain injury have dramatically improved functional neurological outcomes. Mt Sinai J Med 76:119-128, 2009 (C) 2009 Mount Sinai School of Medicine	[Lobel, Darlene A.] Univ Florida, Dept Neurosurg, Jacksonville, FL USA; [Tang, Mary E.] Univ Florida, Dept Emergency Med, Jacksonville, FL USA		Lobel, DA (corresponding author), Univ Florida, Dept Neurosurg, Jacksonville, FL USA.	darlene.lobel@jax.ufl.edu	Lobel, Darlene/H-4923-2012				Agnelli G, 1998, NEW ENGL J MED, V339, P80, DOI 10.1056/NEJM199807093390204; Ahmed Nasim, 2007, Surg Infect (Larchmt), V8, P343, DOI 10.1089/sur.2006.065; BORZOTTA AP, 1994, J TRAUMA, V37, P459, DOI 10.1097/00005373-199409000-00022; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carlile MC, 2006, J HEAD TRAUMA REHAB, V21, P483, DOI 10.1097/00001199-200611000-00003; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CLIFTON GL, 1986, J NEUROSURG, V64, P895, DOI 10.3171/jns.1986.64.6.0895; Dasic D, 2006, BRIT J NEUROSURG, V20, P296, DOI 10.1080/02688690600999901; DEUTSCHMAN CS, 1986, J NEUROSURG, V64, P89, DOI 10.3171/jns.1986.64.1.0089; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; French JA, 2004, EPILEPSIA, V45, P401, DOI 10.1111/j.0013-9580.2004.06204.x; GOODPASTURE HC, 1977, J NEUROSURG, V47, P228, DOI 10.3171/jns.1977.47.2.0228; HELLING TS, 1988, J TRAUMA, V28, P1575, DOI 10.1097/00005373-198811000-00009; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Jones KE, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E3; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Kakarla UK, 2008, NEUROSURGERY, V63, P162, DOI 10.1227/01.NEU.0000312390.83127.7F; Kang TM, 2002, ANN PHARMACOTHER, V36, P1453; KLEINSCHMIDTDEMASTERS BK, 1981, SCIENCE, V211, P1068, DOI 10.1126/science.7466381; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; Lee TT, 1997, ACTA NEUROCHIR, V139, P1042, DOI 10.1007/BF01411558; LOSSIUS MI, 2008, EPILEPSY CURR, V4, P90; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; Norwood SH, 2002, ARCH SURG-CHICAGO, V137, P696, DOI 10.1001/archsurg.137.6.696; Page RB, 2004, NEUROSURGERY, V54, P143, DOI 10.1227/01.NEU.0000097514.60813.1B; PICKARD JD, 1993, J NEUROL NEUROSUR PS, V56, P845, DOI 10.1136/jnnp.56.8.845; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; Qureshi AI, 1999, J TRAUMA, V47, P659, DOI 10.1097/00005373-199910000-00009; Qureshi AI, 1998, CRIT CARE MED, V26, P440, DOI 10.1097/00003246-199803000-00011; Qureshi AI, 2000, CRIT CARE MED, V28, P3301, DOI 10.1097/00003246-200009000-00032; RAPP RP, 1983, J NEUROSURG, V58, P906, DOI 10.3171/jns.1983.58.6.0906; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sirvent JM, 1997, AM J RESP CRIT CARE, V155, P1729, DOI 10.1164/ajrccm.155.5.9154884; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Sugerman HJ, 1997, J TRAUMA, V43, P741, DOI 10.1097/00005373-199711000-00002; Temkin N R, 1991, Neurosurg Clin N Am, V2, P425; Valadka AB, 2007, NEUROSURGERY, V61, P203, DOI 10.1227/01.NEU.0000255497.26440.01; Wang HC, 2008, J TRAUMA, V64, P883, DOI 10.1097/TA.0b013e31804a7fa4; WOSTER PS, 1990, CLIN PHARMACY, V9, P762; YOUNG B, 1987, J NEUROSURG, V67, P668, DOI 10.3171/jns.1987.67.5.0668; Zhong J, 2003, NEUROL RES, V25, P339, DOI 10.1179/016164103101201661	48	18	20	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0027-2507	1931-7581		MT SINAI J MED	Mt. Sinai J. Med.	MAR-APR	2009	76	2					119	128		10.1002/msj.20106			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	427OE	WOS:000264787800005	19306369				2022-02-06	
J	Zadik, Y; Levin, L				Zadik, Yehuda; Levin, Liran			Does a free-of-charge distribution of boil-and-bite mouthguards to young adult amateur sportsmen affect oral and facial trauma?	DENTAL TRAUMATOLOGY			English	Article							FITTED MOUTHGUARDS; DENTAL TRAUMA; PROTECTION; INJURIES; PREVENTION; CONCUSSION; ISRAEL	The purpose of this retrospective study was to evaluate the compliance effectiveness of free-of-charge distribution of boil-and-bite mouthguards to amateur sportsmen who exercise and play without a formal team, a coach, or regulations. Several infantry units in the Israel Defense Forces distributed maxillary boil-and-bite mouthguards to their recruits. Target companies from these battalions and from similar battalions (comparison group -mouthguards not supplied), were selected. Soldiers were interviewed using a structured questionnaire. Of the 630 male participants, 272 received a mouthguard and 358 served as the comparison group. No differences were found between groups regarding demographic parameters or overall trauma cases. When compliance to a free-of-charge distributed boil-and-bite mouthguard was assessed, 93 (34.2%) participants reported using the mouthguard during sport activities. Compliance was high for martial arts, but low for other sports. Although the number of self-reported sport-related oral/dental trauma cases was similar between mouthguard users and non-users, the users group showed less severe injuries. However, free distribution to young amateur sportsmen does not affect oral and dental trauma unless accompanied by education and motivation.	[Levin, Liran] Tel Aviv Univ, Sch Dent Med, Dept Oral Rehabil, IL-69978 Tel Aviv, Israel; [Levin, Liran] Rambam Med Ctr, Dept Oral & Dent Sci, Unit Periodontol, Haifa, Israel; [Zadik, Yehuda] Israel Def Forces Med Corps, Zrifin Cent Dent Clin, Jerusalem, Israel; [Zadik, Yehuda] Israel Def Forces Med Corps, Ctr Hlth Promot & Prevent Med, Jerusalem, Israel		Levin, L (corresponding author), Tel Aviv Univ, Sch Dent Med, Dept Oral Rehabil, IL-69978 Tel Aviv, Israel.	liranl@post.tau.ac.il	Zadik, Yehuda/H-7242-2019				Bastone EB, 2000, AUST DENT J, V45, P2, DOI 10.1111/j.1834-7819.2000.tb00234.x; Bechor R, 2008, DENT TRAUMATOL, V24, P550, DOI 10.1111/j.1600-9657.2007.00545.x; Cohenca N, 2007, J AM DENT ASSOC, V138, P1121, DOI 10.14219/jada.archive.2007.0326; Finch C, 2005, INJURY PREV, V11, P242, DOI 10.1136/ip.2004.006882; Gardiner D M, 2000, Dent Clin North Am, V44, P53; Gassner R, 2003, J CRANIO MAXILL SURG, V31, P51, DOI 10.1016/S1010-5182(02)00168-3; Holmes C, 2000, BRIT DENT J, V188, P473, DOI 10.1038/sj.bdj.4800514a; KATZ RV, 1979, COMMUNITY DENT ORAL, V7, P30, DOI 10.1111/j.1600-0528.1979.tb01182.x; Knapik JJ, 2007, SPORTS MED, V37, P117, DOI 10.2165/00007256-200737020-00003; Levin L, 2003, DENT TRAUMATOL, V19, P237, DOI 10.1034/j.1600-9657.2003.00196.x; Levin L, 2007, DENT TRAUMATOL, V23, P356, DOI 10.1111/j.1600-9657.2006.00473.x; McCrory P, 2001, BRIT J SPORT MED, V35, P81, DOI 10.1136/bjsm.35.2.81; Patrick DG, 2005, BRIT J SPORT MED, V39, P278, DOI 10.1136/bjsm.2004.012658; PERSSON LG, 1994, SCAND J DENT RES, V102, P367; Ranalli D N, 2000, Dent Clin North Am, V44, P35; RANALLI DN, 1993, J PUBLIC HEALTH DENT, V53, P96, DOI 10.1111/j.1752-7325.1993.tb02682.x; Winters JE, 2001, J ATHL TRAINING, V36, P339	17	18	19	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469	1600-9657		DENT TRAUMATOL	Dent. Traumatol.	FEB	2009	25	1					69	72		10.1111/j.1600-9657.2008.00708.x			4	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	397CN	WOS:000262639700014	19208013				2022-02-06	
J	Czarnik, T; Gawda, R; Kolodziej, W; Latka, D; Sznajd-Weron, K; Weron, R				Czarnik, Tomasz; Gawda, Ryszard; Kolodziej, Waldemar; Latka, Dariusz; Sznajd-Weron, Katarzyna; Weron, Rafal			Associations between intracranial pressure, intraocular pressure and mean arterial pressure in patients with traumatic and non-traumatic brain injuries	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Intracranial pressure; Intraocular pressure; Mean arterial pressure; Ocular tonometry; Correlation; Brain injury	CEREBRAL VASOMOTOR REACTIVITY; NONINVASIVE MEASUREMENT; PERFUSION-PRESSURE; CODMAN MICROSENSOR; SUCCINYLCHOLINE	Introduction: Anatomical proximity of the eye and the intracranial space is a fact but the existence of physiological and pathophysiological relationships between them is elusive. The objective of this study was to explore anatomical and pathophysiological interactions between the eye and the intracranial space and to assess clinical Utility Of intraocular pressure measurement in estimation of intracranial pressure in patients with brain injuries and to discover how haemodynamic instability could influence these interactions. Controversy surrounds the recent literature concerning this problem and the Consensus has not been achieved. Materials and methods: We evaluated the correlation between intracranial pressure and intraocular pressure, intracranial pressure and mean arterial pressure, intraccular pressure and mean arterial pressure in 40 patients with brain injuries initially comatose, admitted to our hospital. All patients required the intracranial pressure monitoring on clinical grounds. Simultaneous recordings of intracranial pressure, intraocular pressure and mean arterial pressure were performed. Results: We calculated both the linear correlation coefficient and the Spearman rank-order correlation coefficient for all three relations, We found significant correlation between intraocular pressure and mean arterial pressure in 63%, of the tested population. When the power of the test was increased, by considering only patients with 11 or more observations, this ratio increased to 76%. However, the correlation between intraocular pressure and intracranial pressure, as well as, between intracranial pressure and mean arterial pressure was not significant. Conclusions: There is no anatomical and pathophysiological basis for the statement that intraocular pressure can be used as an indirect estimator of intracranial pressure. (C) 2008 Elsevier Ltd. All rights reserved.	[Czarnik, Tomasz; Gawda, Ryszard] St Francis Reg Med Ctr, Dept Anaesthesia & Crit Care, PL-45418 Opole, Poland; [Kolodziej, Waldemar; Latka, Dariusz] St Francis Reg Med Ctr, Dept Neurosurg, PL-45418 Opole, Poland; [Sznajd-Weron, Katarzyna] Univ Wroclaw, Inst Theoret Phys, Complex Syst & Nonlinear Dynam Div, PL-50204 Wroclaw, Poland; [Weron, Rafal] Wroclaw Univ Technol, Inst Math & Comp Sci, Hugo Steinhaus Ctr Stochast Methods, PL-50372 Wroclaw, Poland		Czarnik, T (corresponding author), St Francis Reg Med Ctr, Dept Anaesthesia & Crit Care, Aleja Witosa 26, PL-45418 Opole, Poland.	antocz@mp.pl	Weron, Rafal/ABG-6143-2021; Kolodziej, Waldemar/M-6369-2019; Weron, Rafal/D-8778-2013; Gawda, Ryszard/K-2941-2017; Latka, Dariusz/X-2332-2018; Czarnik, Tomasz/W-5602-2019	Weron, Rafal/0000-0003-1619-5239; Kolodziej, Waldemar/0000-0001-6381-152X; Gawda, Ryszard/0000-0001-6060-0751; Latka, Dariusz/0000-0003-3958-2477; Czarnik, Tomasz/0000-0002-6734-978X; Sznajd-Weron, Katarzyna/0000-0002-1851-8508			Bellner J, 2004, SURG NEUROL, V62, P45, DOI 10.1016/j.surneu.2003.12.007; BESSMAN ES, 2004, EMERGENCY MED COMPRE, P132; Carter K, 1999, J GLAUCOMA, V8, P204; Casati A, 1999, J CLIN ANESTH, V11, P216, DOI 10.1016/S0952-8180(99)00029-X; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Czarnik T, 2007, J TRAUMA, V62, P207, DOI 10.1097/01.ta.0000219128.29515.d5; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Firsching R, 1998, LANCET, V351, P523, DOI 10.1016/S0140-6736(05)78717-1; Hayreh SS, 1998, LANCET, V351, P524, DOI 10.1016/S0140-6736(05)78719-5; Hirlinger W K, 1986, Anasth Intensivther Notfallmed, V21, P324, DOI 10.1055/s-2007-1002491; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; *JOINT VENT BRAIN, 2007, GUID MAN SEV TRAUM B; KELLY RE, 1993, ANESTHESIOLOGY, V79, P948, DOI 10.1097/00000542-199311000-00012; Koskinen LOD, 2005, NEUROSURGERY, V56, P693, DOI 10.1227/01.NEU.0000156609.95596.24; LAMB K, 1992, BRIT J ANAESTH, V69, P143, DOI 10.1093/bja/69.2.143; Lane PL, 2000, CAN J SURG, V43, P442; Lang EW, 2003, J NEUROL NEUROSUR PS, V74, P1053, DOI 10.1136/jnnp.74.8.1053; Lashutka MK, 2004, ANN EMERG MED, V43, P585, DOI 10.1016/j.annemergmed.2003.12.006; LAYON AJ, 2004, TXB NEUROINTENSIVE C, P709; LEHMAN RAW, 1972, J NEUROSURG, V36, P60, DOI 10.3171/jns.1972.36.1.0060; Lirng JF, 2003, AM J NEURORADIOL, V24, P700; Marin-Caballos A, 2005, CRIT CARE, V9, pR670, DOI 10.1186/cc3822; MICKEY R, 2004, APPL STAT ANAL VARIA; Moeini HA, 2006, EUR J ANAESTH, V23, P739, DOI 10.1017/S0265021506000536; Motschmann M, 2001, Strabismus, V9, P13, DOI 10.1076/stra.9.1.13.711; Nagdeve NG, 2006, J PEDIAT OPHTH STRAB, V43, P219, DOI 10.3928/01913913-20060701-03; Ng HP, 2000, BRIT J ANAESTH, V85, P785, DOI 10.1093/bja/85.5.785; Querfurth HW, 2004, NEUROCRIT CARE, V1, P183, DOI 10.1385/NCC:1:2:183; Ravi R., 2003, CURR ANAESTH CRIT CA, V14, P229, DOI DOI 10.1016/J.CACC.2003.09.003; Reitsamer HA, 2003, INVEST OPHTH VIS SCI, V44, P3967, DOI 10.1167/iovs.03-0088; Reitsamer HA, 2002, INVEST OPHTH VIS SCI, V43, P3728; Robertson CS, 2001, ANESTHESIOLOGY, V95, P1513, DOI 10.1097/00000542-200112000-00034; Ross N., 2005, CURR ANAESTH CRIT CA, V16, P255; Salman MS, 1997, LANCET, V350, P1367, DOI 10.1016/S0140-6736(05)65138-0; Sheeran P, 2000, LANCET, V355, P899, DOI 10.1016/S0140-6736(99)02768-3; Shimbles S, 2005, ACTA NEUROCHIR SUPPL, V95, P197; Signorini DF, 1998, BRIT J NEUROSURG, V12, P223; STOVER JF, 2005, EUR J TRAUMA, V31, P308; TEBA L, 1993, CRIT CARE MED, V21, P867, DOI 10.1097/00003246-199306000-00014	40	18	19	0	9	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JAN	2009	40	1					33	39		10.1016/j.injury.2008.10.010			7	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	407TA	WOS:000263386000005	19135194				2022-02-06	
J	DeFina, P; Fellus, J; Polito, MZ; Thompson, JWG; Moser, RS; DeLuca, J				DeFina, Philip; Fellus, Jonathan; Polito, Mary Zemyan; Thompson, James W. G.; Moser, Rosemarie Scolaro; DeLuca, John			THE NEW NEUROSCIENCE FRONTIER: PROMOTING NEUROPLASTICITY AND BRAIN REPAIR IN TRAUMATIC BRAIN INJURY	CLINICAL NEUROPSYCHOLOGIST			English	Article						Neuroplasticity; Neuromarkers; Neuromodulation	TRANSCRANIAL MAGNETIC STIMULATION; PLASTICITY	Increased awareness of traumatic brain injury (TBI) in the military, a persistent call for evidence-based treatment, and recent government funding have revealed new research opportunities in neuroscience. This paper describes a relatively new frontier for research: that of the facilitation or enhancement of neuroplasticity and brain repair in TBI using novel treatment protocols. Such protocols, algorithmically introduced, may be tailored to the individual through the matching of neuromarkers with specific interventions. Examples of neuromarkers and interventions employed for the purpose of neuromodulation are reported. Problems with lack of controlled studies and inferring causation in correlational research are noted. Healthy skepticism and open-minded creativity are needed so that we can think in unorthodox ways, create partnerships, harness available knowledge and expertise, and ultimately develop effective treatments.	[DeFina, Philip; Polito, Mary Zemyan; Thompson, James W. G.] IBRF, Edison, NJ 08837 USA; [Fellus, Jonathan] Kessler Inst Rehabil, W Orange, NJ USA; [Moser, Rosemarie Scolaro] RSM Psychol Ctr LLC, Lawrenceville, NJ USA; [DeLuca, John] Kessler Fdn Res Ctr, W Orange, NJ USA		Thompson, JWG (corresponding author), IBRF, 100 Menlo Pk,Suite 412, Edison, NJ 08837 USA.	JThompson@IBRFinc.org					Bacskai BJ, 2002, J CEREBR BLOOD F MET, V22, P1035, DOI 10.1097/00004647-200209000-00001; Boggio PS, 2007, RESTOR NEUROL NEUROS, V25, P123; Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; COLE M, 1979, MAKING MIND PERSONAL; COOPER E, 2008, RIGHT MEDIAN N UNPUB; *DEP DEF, 2009, NEW ER RESP FUND HIG; DINGFELDER SF, 2009, MONITOR PSYCHOL  MAR, P40; Gevensleben H, 2009, J CHILD PSYCHOL PSYC, V50, P780, DOI 10.1111/j.1469-7610.2008.02033.x; Giza CC, 2001, J ATHL TRAINING, V36, P228; GOODMAN A, 2008, NEUROLOGY TODAY; Gordon E, 2007, PERS MED, V4, P201, DOI 10.2217/17410541.4.2.201; HALTER JA, 1995, J NEUROPHYSIOL, V73, P867, DOI 10.1152/jn.1995.73.2.867; Hebb DO, 1949, ORG BEHAV NEUROPSYCH; Hermens DF, 2005, PEDIATR NEUROL, V32, P248, DOI 10.1016/j.pediatrneurol.2004.11.009; Hess G, 1996, J NEUROPHYSIOL, V75, P1765, DOI 10.1152/jn.1996.75.5.1765; HYER R, 2006, MEDSCAPE MED NE 0327; Ilgin N, 1998, Q J NUCL MED, V42, P179; JACOBS KM, 1991, SCIENCE, V251, P944, DOI 10.1126/science.2000496; KUBE C, 2009, SUICIDES CONTINUE AL; Liepert J, 2005, ACT NEUR S, V93, P71; Liepert J, 2003, SUPPL CLIN NEUROPHYS, V56, P368; Mahncke HW, 2006, PROG BRAIN RES, V157, P81, DOI 10.1016/S0079-6123(06)57006-2; McAllister TW, 2009, CLIN NEUROPSYCHOL, V23, P1338, DOI 10.1080/13854040903277289; Ost M, 2006, NEUROLOGY, V67, P1600, DOI 10.1212/01.wnl.0000242732.06714.0f; Pascrell WJ, 2009, CLIN NEUROPSYCHOL, V23, P1281, DOI 10.1080/13854040902939319; Reis J, 2008, J PHYSIOL-LONDON, V586, P325, DOI 10.1113/jphysiol.2007.144824; Rosenzweig MR, 1996, BEHAV BRAIN RES, V78, P57, DOI 10.1016/0166-4328(95)00216-2; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Silvanto J, 2008, BRAIN TOPOGR, V21, P1, DOI 10.1007/s10548-008-0067-0; *ST JOS REG MED CT, 2008, INT C TRAUM BRAIN IN; Tinius T. P., 2000, J NEUROTHER, V4, P27, DOI [DOI 10.1300/J184v04n02_05, 10.1300/J184v04n02_05]; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Whyte J, 2005, ARCH PHYS MED REHAB, V86, P453, DOI 10.1016/j.apmr.2004.05.016; Zielinski K, 2006, ACTA NEUROBIOL EXP, V66, P75; [No title captured]	36	18	20	0	13	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2009	23	8					1391	1399		10.1080/13854040903058978			9	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	524KF	WOS:000272141500009	19882477				2022-02-06	
J	Doorly, MC; Gilchrist, MD				Doorly, M. C.; Gilchrist, M. D.			Three-dimensional multibody dynamics analysis of accidental falls resulting in traumatic brain injury	INTERNATIONAL JOURNAL OF CRASHWORTHINESS			English	Article						brain injury; accident; fall; multibody dynamics modelling	HEAD; RECONSTRUCTION; BIOMECHANICS	Clinical, physical and mechanical details of one of a set of ten real-world accidental falls which resulted in non-fatal head impact injury in the form of various traumatic brain lesions are presented herein. These are analysed and described in depth in this paper, along with the accompanying time profiles of linear and angular velocities of all 10 accident cases, which were predicted using multibody dynamics modelling simulations. It is suggested that these cases could usefully constitute the basis of a database of documented head injury cases that may be of use to the wider research community. As such, these are freely available to those researchers who would wish to use this set of data upon direct request to the authors.	[Doorly, M. C.; Gilchrist, M. D.] Univ Coll Dublin, Sch Elect Elect & Mech Engn, Dublin 2, Ireland		Gilchrist, MD (corresponding author), Univ Coll Dublin, Sch Elect Elect & Mech Engn, Dublin 2, Ireland.	michael.gilchrist@ucd.ie	Gilchrist, Michael D/B-6100-2017	Gilchrist, Michael D/0000-0003-1765-429X			AUER C, 2001, P INT SOC BIOM 18 C; CANTON B, 2003, THESIS U COLL DUBLIN; COLGAN N, 2006, P 7 INT S BIOM BIOM; DOORLY M, 2004, INT C CRASHW SAN FRA; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Doorly M.C., 2007, THESIS U COLL DUBLIN; Doorly MC, 2005, SOLID MECH APPL, V124, P431; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; Gilchrist MD, 2000, COMPUT MECH, V26, P229, DOI 10.1007/s004660000179; Gilchrist MD, 2004, STRAIN, V40, P180, DOI 10.1111/j.1475-1305.2004.00168.x; Gilchrist MD, 2003, KEY ENG MATER, V245-2, P417, DOI 10.4028/www.scientific.net/KEM.245-246.417; Gilchrist MD, 2001, INT J CRASHWORTHINES, V6, P253, DOI 10.1533/cras.2001.0176; GILCHRIST MD, 2005, IMPACT BIOMECHANICS; GILCHRIST MD, 2004, P 6 INT S BIOM BIOM; GILCHRIST MD, 2009, PATHOMECHANICS TISSU, P19; Horgan T, 2005, THESIS U COLL DUBLIN; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; HORGAN TJ, 2003, P IRCOBI C BIOM IMP, P347; HORGAN TJ, 2004, P 6 INT S BIOM BIOM; HORGAN TJ, 2004, INT C CRASHW SAN FRA; Kleiven S, 2003, J NEUROTRAUM, V20, P365, DOI 10.1089/089771503765172327; Neal-Sturgess CE, 2002, P I MECH ENG D-J AUT, V216, P883, DOI 10.1243/095440702321031432; Newman J, 2000, P 44 STAPP CAR CRASH; O'Donoghue D., 1998, IRISH J MED SCI, V167, P263; O'Riordain K, 2003, CLIN BIOMECH, V18, P590, DOI 10.1016/S0268-0033(03)00111-6; ODONOGHUE D, 1999, THESIS U COLL DUBLIN; ORIORDAIN K, 2002, THESIS U COLL DUBLIN; Smyth A, 2005, SOLID MECH APPL, V124, P393; SMYTH A, 2006, P 11 INT INV MET CAG, P369; THOMAS PM, 2002, IRISH J MED SCI, V171, P73; THOMSON R, P 2001 INT RES COUNC; *TNO AUT, 2004, MADYMO 6 2 1; YOGANANDAN N, 1995, J NEUROTRAUM, V12, P659, DOI 10.1089/neu.1995.12.659; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	35	18	18	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1358-8265	1754-2111		INT J CRASHWORTHINES	Int. J. Crashworthiness		2009	14	5					503	509	PII 915135264	10.1080/13588260902826554			7	Engineering, Manufacturing; Engineering, Mechanical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	497IM	WOS:000270052400011		Green Submitted			2022-02-06	
J	Guerreiro, DF; Navarro, R; Silva, M; Carvalho, M; Gois, C				Guerreiro, D. F.; Navarro, R.; Silva, M.; Carvalho, M.; Gois, C.			Psychosis secondary to traumatic brain injury	BRAIN INJURY			English	Article						Head injury; neurobehavioural; neuropsychiatric; psychiatry; psychopharmacology; traumatic brain injury	HEAD TRAUMA; FOLLOW-UP; DISORDERS	Background: Traumatic brain injury (TBI) can result in serious and disabling neuropsychiatric disorders. Method: The authors report a case of a 51-year old male, admitted to the psychiatric ward for acute psychosis and suicidal ideation, probably associated with TBI. After a temporal head trauma he initiated auditory/verbal hallucinations and subsequently developed paranoid delusions. The electroencephalography showed slow bilateral temporal activity and the neuropsychological testing showed several impairments. The patient improved with olanzapine at a dosage of 20 mg daily. Results: This case shows the difficulty of differential diagnosis between schizophrenia and psychotic disorder due to traumatic brain injury. Conclusions: The authors conducted a revision of literature about the diagnosis, epidemiology, clinical aspects, laboratory and structural investigations and the treatment of this condition. Based on this revision work, the authors sketch some recommendations about the work-up that should be done when faced with this diagnostic hypothesis.	[Guerreiro, D. F.; Navarro, R.; Silva, M.; Carvalho, M.; Gois, C.] Hosp Santa Maria, Dept Psychiat, P-1649035 Lisbon, Portugal		Guerreiro, DF (corresponding author), Hosp Santa Maria, Dept Psychiat, Ave Prof Egas Moniz, P-1649035 Lisbon, Portugal.	dfguerreiro@gmail.com	de Carvalho, Mamede/I-6295-2019	de Carvalho, Mamede/0000-0001-7556-0158; Gois, Carlos/0000-0003-4346-4844; Silva, Manuela/0000-0003-1275-0338; Guerreiro, Diogo/0000-0003-3701-9509			ACHTE K, 1991, PSYCHOPATHOLOGY, V24, P309, DOI 10.1159/000284731; ACHTE KA, 1969, ACTA PSYCHIAT SCAND, V45, P1, DOI 10.1111/j.1600-0447.1969.tb06197.x; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; BURG JS, 1996, J CLIN PSYCHOL MED S, V3, P245; DAVISON K, 1983, PSYCHIAT DEV, V1, P1; FEINSTEIN A, 1990, PSYCHOL MED, V20, P793, DOI 10.1017/S0033291700036485; Fujii D, 2002, J NEUROPSYCH CLIN N, V14, P130, DOI 10.1176/appi.neuropsych.14.2.130; Fujii DE, 2001, J NEUROPSYCH CLIN N, V13, P61, DOI 10.1176/appi.neuropsych.13.1.61; Fujii DEM, 1996, NEUROPSY NEUROPSY BE, V9, P133; HILLBOM E, 1960, Acta Psychiatr Scand Suppl, V35, P1; KOUFEN H, 1987, EUR ARCH PSY CLIN N, V237, P2, DOI 10.1007/BF00385660; MCKENNA PJ, 1985, AM J PSYCHIAT, V142, P895; REICHENBERG A, 2008, SCHIZOPHRENIA B; Sachdev P, 2001, PSYCHOL MED, V31, P231, DOI 10.1017/S0033291701003336; Stewart B, 2005, J NEUROPSYCH CLIN N, V17, P243, DOI 10.1176/appi.neuropsych.17.2.243; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; VIOLON A, 1987, ACTA NEUROCHIR, V85, P96, DOI 10.1007/BF01456104; Violon A, 1988, Acta Neurochir Suppl (Wien), V44, P67; WILL RG, 1988, BRIT J PSYCHIAT, V152, P410, DOI 10.1192/bjp.152.3.410	19	18	20	1	8	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2009	23	4					358	361	PII 909310751	10.1080/02699050902800918			4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	425MY	WOS:000264643000011	19274520				2022-02-06	
J	Tippett, WJ; Lee, JH; Zakzanis, KK; Black, SE; Mraz, R; Graham, SJ				Tippett, William J.; Lee, Jang-Han; Zakzanis, Konstantine K.; Black, Sandra E.; Mraz, Richard; Graham, Simon J.			Visually navigating a virtual world with real-world impairments: A study of visually and spatially guided performance in individuals with mild cognitive impairments	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Mild cognitive impairment; Virtual environment; Visually guided performance; Spatial navigation	TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL ASSESSMENT; MEMORY; TASK; REHABILITATION; ENVIRONMENTS; DYSFUNCTION; RESPONSES; DISEASE; MAZE	In recent years, computer technology has evolved such that highly realistic virtual environments (VEs) can be used within a lab setting. Such VEs provide controlled ability to examine behavioral performance across different populations. The primary goal of this investigation was to examine the ability of mild cognitive impaired (MCI) participants to navigate effectively through a realistic, fictional virtual city. A total of 26 healthy control participants (age: 69 7.7 years; Mini-Mental State Examination, MMSE 29) and 8 MCI patients (age: 72 7 years, MMSE 26) were recruited. Both groups exhibited similar spatial-navigation ability. However, the MCI groups' ability to use effective visually guided navigation to traverse the VE was significantly compromised compared to healthy controls; a similar performance reduction was also observed when selecting appropriate paths. Though initially groups appear practically indistinguishable in regard to spatially navigating their way through the VE, these data indicate that careful evaluations of behavior in VEs may provide novel ways to differentiate between populations that have historically displayed relatively subtle differences.	[Tippett, William J.] Sunnybrook Hlth Sci Ctr, Cognit Neurol Res Unit, Div Neurol, Dept Med, Toronto, ON M4N 3M5, Canada; [Tippett, William J.; Black, Sandra E.] LC Campbell Cognit Neurol Res Unit, Toronto, ON, Canada; [Lee, Jang-Han] Chung Ang Univ, Dept Psychol, Seoul 156756, South Korea; [Zakzanis, Konstantine K.] Univ Toronto, Dept Psychol, Scarborough, ON M1C 1A4, Canada; [Tippett, William J.; Black, Sandra E.; Graham, Simon J.] Heart & Stroke Fdn Ctr Stroke Recovery, Toronto, ON, Canada; [Black, Sandra E.; Mraz, Richard; Graham, Simon J.] Univ Toronto, Toronto, ON, Canada; [Zakzanis, Konstantine K.; Graham, Simon J.] Rotman Res Inst, Toronto, ON, Canada		Tippett, WJ (corresponding author), Sunnybrook Hlth Sci Ctr, Cognit Neurol Res Unit, Div Neurol, Dept Med, 2075 Bayview Ave,Roorinm A419, Toronto, ON M4N 3M5, Canada.	bj.tippett@sunnybrook.ca	Black, Sandra E./C-7294-2011	Black, Sandra/0000-0001-7093-8289			Astur RS, 1998, BEHAV BRAIN RES, V93, P185, DOI 10.1016/S0166-4328(98)00019-9; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Broeren J, 2002, CYBERPSYCHOL BEHAV, V5, P207, DOI 10.1089/109493102760147196; Buckwalter J G, 1997, Stud Health Technol Inform, V39, P17; Burgess N, 2006, REV NEUROSCIENCE, V17, P239; Christiansen C, 1998, ARCH PHYS MED REHAB, V79, P888, DOI 10.1016/S0003-9993(98)90083-1; Drzezga A, 2005, PLOS MED, V2, P986, DOI 10.1371/journal.pmed.0020288; GALEA LAM, 1993, PERS INDIV DIFFER, V14, P53, DOI 10.1016/0191-8869(93)90174-2; Gillner S, 1998, J COGNITIVE NEUROSCI, V10, P445, DOI 10.1162/089892998562861; Glantz K, 1997, PRESENCE-TELEOP VIRT, V6, P87, DOI 10.1162/pres.1997.6.1.87; Goude D, 2007, STUD HEALTH TECHNOL, V125, P146; Kahana MJ, 1999, NATURE, V399, P781, DOI 10.1038/21645; KENNEDY RS, 1993, AVIAT SPACE ENVIR MD, V64, P912; KIRASIC KC, 1991, PSYCHOL AGING, V6, P10, DOI 10.1037/0882-7974.6.1.10; Ku JH, 2003, CYBERPSYCHOL BEHAV, V6, P497, DOI 10.1089/109493103769710523; Loewenstein DA, 2004, AM J GERIAT PSYCHIAT, V12, P395, DOI 10.1176/appi.ajgp.12.4.395; Lundberg C, 1997, ALZ DIS ASSOC DIS, V11, P28, DOI 10.1097/00002093-199703000-00006; Maguire EA, 1999, CURR OPIN NEUROBIOL, V9, P171, DOI 10.1016/S0959-4388(99)80023-3; Maguire EA, 1998, J NEUROL NEUROSUR PS, V65, P903, DOI 10.1136/jnnp.65.6.903; McCarthy RA, 1996, J NEUROL NEUROSUR PS, V60, P318, DOI 10.1136/jnnp.60.3.318; Moffat SD, 2001, NEUROBIOL AGING, V22, P787, DOI 10.1016/S0197-4580(01)00251-2; Mraz R, 2003, CYBERPSYCHOL BEHAV, V6, P359, DOI 10.1089/109493103322278736; Nadolne MJ, 2001, J INT NEUROPSYCH SOC, V7, P675, DOI 10.1017/S1355617701766039; Nomura Y, 2005, COGNITIVE BRAIN RES, V25, P624, DOI 10.1016/j.cogbrainres.2005.08.012; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Rose FD, 2005, CYBERPSYCHOL BEHAV, V8, P241, DOI 10.1089/cpb.2005.8.241; Sandstrom NJ, 1998, COGNITIVE BRAIN RES, V6, P351, DOI 10.1016/S0926-6410(98)00002-0; Shechtman Oritz, 2007, Traffic Inj Prev, V8, P78, DOI 10.1080/15389580600994321; Slobounov S, 2006, NEUROSURGERY, V59, P134, DOI 10.1227/01.NEU.0000219197.33182.3F; Walshe D, 2005, CYBERPSYCHOL BEHAV, V8, P532, DOI 10.1089/cpb.2005.8.532; Whitney SL, 2006, CYBERPSYCHOL BEHAV, V9, P152, DOI 10.1089/cpb.2006.9.152; Yan JH, 2006, AGING NEUROPSYCHOL C, V13, P385, DOI 10.1080/138255890969609	32	18	18	0	7	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2009	31	4					447	454	PII 901418728	10.1080/13803390802251360			8	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	435HH	WOS:000265334200007	18686114				2022-02-06	
J	Tortorici, MA; Mu, Y; Kochanek, PM; Xie, W; Poloyac, SM				Tortorici, Michael A.; Mu, Ying; Kochanek, Patrick M.; Xie, Wen; Poloyac, Samuel M.			Moderate hypothermia prevents cardiac arrest-mediated suppression of drug metabolism and induction of interleukin-6 in rats	CRITICAL CARE MEDICINE			English	Article						heart arrest; pharmacology; metabolism; interleukin-6; cytochrome P450; pregnane-X-receptor	PREGNANE-X-RECEPTOR; TRAUMATIC BRAIN-INJURY; MILD THERAPEUTIC HYPOTHERMIA; ACUTE-PHASE RESPONSE; NF-KAPPA-B; PHARMACOKINETIC ALTERATIONS; CYTOCHROME-P-450 ENZYMES; CYP2E1 EXPRESSION; MESSENGER-RNA; HEAD-INJURY	Objective: Therapeutic hypothermia is being clinically used to reduce neurologic deficits after cardiac arrest (CA). Patents receiving hypothermia after CA receive a wide-array of medications. During hypothermia, drug metabolism is markedly reduced. Little, however, is known about the impact of hypothermia on drug metabolism after rewarming. The objective of this study was to examine the effect of CA and hypothermia on the functional regulation of two major drug metabolizing cytochrome P450 (CYP) isoforms. Design: Laboratory investigation. Setting: University pharmacy school and animal research facility. Subjects: Thirty-six male Sprague-Dawley rats. Interventions: Hypothermia was induced via surface cooling in a rat CA model and maintained for 3 hrs. Animals were killed at 5 or 24 hrs and liver was analyzed for hepatic activity and mRNA expression of CYP3A2 and CYP2E1. Plasma interleukin-6 (IL-6) concentrations were determined. The effect of IL-6 on pregnane X receptor-mediated transcription of the rat CYP3A2 promoter was evaluated via luciferase reporter in HepG2 cells. Measurements and Main Results: At 24 hrs after CA a decrease in CYP3A2 and CYP2E1 activity was observed, 55.7% +/- 12.8% and 46.8% +/- 29.7% of control, respectively (p < 0.01). CA decreased CYP3A2 mRNA (p < 0.05), but not CYP2E1 mRNA. Expression of other pregnane X receptor target enzymes and transporter genes were similarly down-regulated. CA also produced an approximately ten-fold increase in plasma IL-6. CA-mediated inhibition of CYP3A2 and CYP2E1 was attenuated by hypothermia, as was the increase in IL-6. Furthermore, IL-6 attenuated pregnane X receptor-mediated transcription of the CYP3A2 promoter. Conclusions. CA produces CYP3A2 down-regulation at 24 hrs, potentially via IL-6 effects on pregnane X receptor-mediated transcription. Also, hypothermia attenuates the CA-mediated down - regulation, thereby normalizing drug metabolism after rewarming. (Crit Care Med 2009; 37:263-269)	[Tortorici, Michael A.; Mu, Ying; Xie, Wen; Poloyac, Samuel M.] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA; [Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Safar Ctr Resuscitat Res, Pittsburgh, PA 15261 USA; [Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Pediat, Childrens Hosp Pittsburgh, Pittsburgh, PA 15261 USA		Tortorici, MA (corresponding author), Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA.	poloyac@pitt.edu	Kochanek, Patrick M/D-2371-2015; Xie, Wen/M-1768-2016	Kochanek, Patrick M/0000-0002-2627-913X; 	National Institute of General Medical Sciences (Primary)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM073031]; National Heart, Lung, and Blood Institute (Secondary)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [S10 RR023461]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS30318 and NS 38087]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S10RR023461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM073031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS030318, R01NS038087, P50NS030318, P20NS030318] Funding Source: NIH RePORTER	Supported, in part, by grant GM073031 from the National Institute of General Medical Sciences (Primary) and the National Heart, Lung, and Blood Institute (Secondary), grant S10 RR023461 from the National Center for Research Resources, grants NS30318 and NS 38087 from National Institute of Neurological Disorders and Stroke.	ABDELRAZZAK Z, 1993, MOL PHARMACOL, V44, P707; Adrie C, 2002, CIRCULATION, V106, P562, DOI 10.1161/01.CIR.0000023891.80661.AD; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Boucher BA, 1998, CLIN PHARMACOKINET, V35, P209, DOI 10.2165/00003088-199835030-00004; Caron E, 2005, J BIOCHEM MOL TOXIC, V19, P368, DOI 10.1002/jbt.20103; Fink Ericka L, 2004, Pediatr Crit Care Med, V5, P139, DOI 10.1097/01.PCC.0000112376.29903.8F; Fukuoka N, 2004, RESUSCITATION, V60, P225, DOI 10.1016/j.resuscitation.2003.09.017; Gu XS, 2006, J BIOL CHEM, V281, P17882, DOI 10.1074/jbc.M601302200; Guluma KZ, 2008, NEUROCRIT CARE, V8, P42, DOI 10.1007/s12028-007-9009-z; Gundersen Y, 2001, ACTA ANAESTH SCAND, V45, P994, DOI 10.1034/j.1399-6576.2001.450812.x; Hakkola J, 2003, J PHARMACOL EXP THER, V304, P1048, DOI 10.1124/jpet.102.041582; Holzer M, 2002, NEW ENGL J MED, V346, P549; Iida Y, 2001, THER DRUG MONIT, V23, P192, DOI 10.1097/00007691-200106000-00002; Kalsotra A, 2003, J NEUROTRAUM, V20, P1339, DOI 10.1089/089771503322686139; KATZ L, 1995, J CEREBR BLOOD F MET, V15, P1032, DOI 10.1038/jcbfm.1995.129; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MCALLISTER RG, 1980, PHARMACOLOGY, V20, P95; MIYATA M, 1995, ARCH BIOCHEM BIOPHYS, V318, P71, DOI 10.1006/abbi.1995.1206; Mu Y, 2005, MOL PHARMACOL, V68, P403, DOI 10.1124/mol.105.013292; Nishida K, 2007, BIOL PHARM BULL, V30, P1763, DOI 10.1248/bpb.30.1763; Oppert M, 1999, INTENS CARE MED, V25, P1386, DOI 10.1007/s001340051086; Pohjanvirta R, 2006, CHEM-BIOL INTERACT, V160, P134, DOI 10.1016/j.cbi.2006.01.001; Poloyac SM, 2004, DRUG METAB DISPOS, V32, P727, DOI 10.1124/dmd.32.7.727; Poloyac SM, 2001, DRUG METAB DISPOS, V29, P296; Rendic S, 2002, DRUG METAB REV, V34, P83, DOI 10.1081/DMR-120001392; Rockich K, 1999, DRUG METAB DISPOS, V27, P1074; Roe AL, 2001, J PHARM PHARMACOL, V53, P1365, DOI 10.1211/0022357011777864; Saini SPS, 2005, HEPATOLOGY, V41, P497, DOI 10.1002/hep.20570; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; SONDERFAN AJ, 1987, ARCH BIOCHEM BIOPHYS, V255, P27, DOI 10.1016/0003-9861(87)90291-8; Tanaka E, 2000, J CLIN PHARM THER, V25, P165; Teng S, 2005, J PHARMACOL EXP THER, V312, P841, DOI 10.1124/jpet.104.076141; TOLER SM, 1993, DRUG METAB DISPOS, V21, P1064; Tortorici MA, 2006, CRIT CARE MED, V34, P785, DOI 10.1097/01.CCM.0000201899.52739.4F; Weisfeldt ML, 2002, JAMA-J AM MED ASSOC, V288, P3035, DOI 10.1001/jama.288.23.3035; Xie W, 2000, NATURE, V406, P435, DOI 10.1038/35019116; Zhao H, 2007, J CEREBR BLOOD F MET, V27, P1879, DOI 10.1038/sj.jcbfm.9600540; Zhou C, 2006, J CLIN INVEST, V116, P2280, DOI 10.1172/JCI26283; Zhou J, 2006, J BIOL CHEM, V281, P15013, DOI 10.1074/jbc.M511116200	40	18	18	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0090-3493			CRIT CARE MED	Crit. Care Med.	JAN	2009	37	1					263	269		10.1097/CCM.0b013e3181931ed3			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	391YK	WOS:000262269900036	19050605	Green Accepted			2022-02-06	
J	Walz, NC; Yeates, KO; Wade, SL; Mark, E				Walz, Nicolay Chertkoff; Yeates, Keith Owen; Wade, Shari L.; Mark, Erin			Social information processing skills in adolescents with traumatic brain injury: Relationship with social competence and behavior problems	JOURNAL OF PEDIATRIC REHABILITATION MEDICINE			English	Article						Traumatic brain injury; adolescence; social; behavioral outcomes	PROBLEM-SOLVING SKILLS; LONG-TERM OUTCOMES; AGGRESSIVE-BEHAVIOR; CHILDREN; ADJUSTMENT; PREVALENCE; MECHANISMS; COGNITION; PATTERNS; EMOTION	Objective: To examine social information processing (SIP) skills, behavior problems, and social competence following adolescent TBI and to determine whether SIP skills were predictive of behavior problems and social competence. Design: Cross-sectional analyses of adolescents with TBI recruited and enrolled in a behavioral treatment study currently in progress. Setting: Two tertiary care children's hospitals with Level 1 trauma centers. Participants: Adolescents aged 11 to 18 years with severe TBI (n = 19) and moderate TBI (n = 24) who were injured up to 24 months prior to recruitment. Assessment of risk factors: TBI severity, race, maternal education, and age at testing. Main outcome measurements: a measure of SIP skills, Child Behavior Checklist (CBCL), Youth Self Report (YSR), and Home and Community Social Behavior Scale (HCSBS). Results: The severe TBI group did not obtain significantly lower scores on the SIP measures than the moderate TBI group. In comparison to adolescents with moderate TBI, those with severe TBI had significantly more parent-reported externalizing behaviors and self-reported weaknesses in social competence. SIP skills were strong predictors of problems and social competence in adolescents with TBI. More specifically, an aggressive SIP style predicted externalizing problems and a passive SIP style predicted internalizing problems. Both passive and aggressive SIP skills were related to social competence and social problems. Conclusions: Adolescents with TBI are at risk for deficits in social and behavioral outcomes. SIP skills are strongly related to behavior problems and social competence in adolescents with TBI. SIP skills, social competence, and behavior problems are important targets for intervention that may be amenable to change and lead to improved functional outcomes following TBI.	[Walz, Nicolay Chertkoff] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Behav Med & Clin Psychol, Cincinnati, OH 45229 USA; [Walz, Nicolay Chertkoff; Wade, Shari L.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Yeates, Keith Owen; Mark, Erin] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Yeates, Keith Owen; Mark, Erin] Nationwide Childrens Hosp, Res Inst, Ctr Biobehav Hlth, Columbus, OH USA; [Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Divison Pediat Rehabil, Cincinnati, OH 45229 USA		Walz, NC (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Behav Med & Clin Psychol, MLC 10006,2800 Winslow Ave, Cincinnati, OH 45229 USA.	nicolay.walz@cchmc.org	Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892	National Institute of Disability and Rehabilitation Research US Department of EducationUS Department of Education [H133G050239]; National Institutes of Health - National Institute of Child Health and Human Development - National Center for Medical Rehabilitation ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23 HD046690]; Trauma Research grant from the State of Ohio Emergency Medical Services	This work was supported by National Institute of Disability and Rehabilitation Research US Department of Education grant #H133G050239 to Shari L. Wade, in part by National Institutes of Health - National Institute of Child Health and Human Development - National Center for Medical Rehabilitation Research grant K23 HD046690 to Nicolay Chertkoff Walz, and by a Trauma Research grant from the State of Ohio Emergency Medical Services. We wish to acknowledge the contributions of Abby Burkhardt, Luke Herren, Paulina Osinska, Robert Tamer, and Kendra Williams in recruitment, as well as data collection, coding, and management.	Achenbach T.M., 1991, MANUAL YOUTH SELF RE; Achenbach TM, 1991, MANUAL CHILD BEHAV C; Andrews TK, 1998, BRAIN INJURY, V12, P133, DOI 10.1080/026990598122755; Blair C, 2002, AM PSYCHOL, V57, P111, DOI 10.1037//0003-066X.57.2.111; Bohnert AM, 1997, DEV NEUROPSYCHOL, V13, P477, DOI 10.1080/87565649709540688; Cole WR, 2008, BRAIN INJURY, V22, P932, DOI 10.1080/02699050802454808; CRICK NR, 1994, PSYCHOL BULL, V115, P74, DOI 10.1037/0033-2909.115.1.74; Crick NR, 1996, CHILD DEV, V67, P993, DOI 10.1111/j.1467-8624.1996.tb01778.x; Dodge K. A., 1990, PERSONALITY SOCIAL P, V53, P1146, DOI DOI 10.1177/0146167290161002; DODGE KA, 1986, MINN SYM CHILD PSYCH, V18, P77; Dodge KA, 2002, PSYCHOL ASSESSMENT, V14, P60, DOI 10.1037//1040-3590.14.1.60; FRANKEL F, 1994, PSYCHOL ASSESSMENT, V6, P249; Ganesalingam K, 2007, J NEUROPSYCHOL, V1, P149, DOI 10.1348/174866407X185300; Godfrey HPD, 2000, APHASIOLOGY, V14, P433, DOI 10.1080/026870300401441; GOODMAN SH, 1995, J ABNORM CHILD PSYCH, V23, P473, DOI 10.1007/BF01447209; Hanten G, 2008, NEUROPSYCHOLOGY, V22, P357, DOI 10.1037/0894-4105.22.3.357; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Lansford JE, 2006, J ABNORM CHILD PSYCH, V34, P715, DOI 10.1007/s10802-006-9057-4; Lemerise EA, 2000, CHILD DEV, V71, P107, DOI 10.1111/1467-8624.00124; Merrell KM., 2002, HOME COMMUNITY SOCIA; Muscara F, 2009, NEUROPSYCHOL REHABIL, V19, P541, DOI 10.1080/09602010802365223; PAPERO PH, 1993, NEUROPSYCHOL REHABIL, V3, P321, DOI 10.1080/09602019308401445; QUIGGLE NL, 1992, CHILD DEV, V63, P1305, DOI 10.1111/j.1467-8624.1992.tb01696.x; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; TEASDALE G, 1974, LANCET, V2, P81; Wade S. L., J PEDIAT PSYCHOL; Wade SL, 2008, J HEAD TRAUMA REHAB, V23, P369, DOI 10.1097/01.HTR.0000341432.67251.48; Warschausky S, 1999, J HEAD TRAUMA REHAB, V14, P373, DOI 10.1097/00001199-199908000-00006; Warschausky S, 1997, Pediatr Rehabil, V1, P77; Wechsler D., 2011, WECHSLER ABBREVIATED; WEISS B, 1992, CHILD DEV, V63, P1321, DOI 10.2307/1131558; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; YEATES KO, 1991, MERRILL PALMER QUART, V37, P369; YEATES KO, 1990, CLIN PSYCHOL REV, V10, P567, DOI 10.1016/0272-7358(90)90097-T	38	18	18	0	5	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1874-5393	1875-8894		J PEDIATR REHAB MED	J. Pediatr. Rehab. Med.		2009	2	4					285	295		10.3233/PRM-2009-0094			11	Pediatrics	Emerging Sources Citation Index (ESCI)	Pediatrics	GY1ER	WOS:000448267700005	21791821				2022-02-06	
J	Williams, GP; Morris, ME				Williams, Gavin P.; Morris, Meg E.			High-level mobility outcomes following acquired brain injury: A preliminary evaluation	BRAIN INJURY			English	Article						Balance; outcome; rehabilitation; therapy; traumatic brain injury	RANDOMIZED CONTROLLED-TRIAL; ASSESSMENT-TOOL HIMAT; CHRONIC STROKE; EXERCISE; GAIT; INDIVIDUALS; CAPACITY; RECOVERY; VALIDITY; PROGRAM	Primary objective: To evaluate the efficacy of a high-level mobility programme for people with acquired brain injury (ABI). Research design: A cohort study which evaluated the efficacy of a high-level mobility programme for people with ABI. Setting: A major rehabilitation hospital. Participants: Twenty-eight people with acquired brain injury. Experimental interventions: A 3 month high-level mobility programme conducted twice weekly consisting of strengthening exercises, pre-running and running drills and agility exercises supplemented with a gym or home exercise programme. Main outcomes and results: The primary outcome measure was the high-level mobility assessment tool (HiMAT). Participants were predominantly male and young (average age 33.2 years, range 16-72 years) with chronic ABI. HiMAT scores for the 28 participants who returned at the 3 month follow-up initially ranged from 6-44 points (mean 20.3). The 3 month follow-up scores ranged from 12-51 points (mean 29.2). The mean HiMAT score change ranged from 2-20 points (mean 8.9). Conclusions: Significant recovery in high-level mobility was achieved during a 3 month running programme. People with chronic ABI may also expect to benefit from retraining high-level mobility. Clinical trials are needed to assess the effectiveness of training programmes for high-level mobility.	[Williams, Gavin P.] Epworth Med Fdn, Melbourne, Vic, Australia; [Williams, Gavin P.] Univ Melbourne, Ctr Hlth Exercise & Sports Med, Melbourne, Vic, Australia; [Morris, Meg E.] Univ Melbourne, Sch Physiotherapy, Melbourne, Vic, Australia		Williams, GP (corresponding author), Epworth Med Fdn, Physiotherapy Dept, 89 Bridge Rd, Richmond, Vic 3121, Australia.	Gavin.Williams@epworth.org.au		Morris, Meg/0000-0002-0114-4175; Williams, Gavin/0000-0003-2758-7473			Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Bateman A, 2001, ARCH PHYS MED REHAB, V82, P174, DOI 10.1053/apmr.2001.19744; Brown TH, 2005, J HEAD TRAUMA REHAB, V20, P402, DOI 10.1097/00001199-200509000-00002; Collen F M, 1991, Int Disabil Stud, V13, P50; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; Duncan P, 2003, STROKE, V34, P2173, DOI 10.1161/01.STR.0000083699.95351.F2; Gardner MB, 1998, PHYS THER, V78, P361, DOI 10.1093/ptj/78.4.361; Gordon WA, 1998, J HEAD TRAUMA REHAB, V13, P58, DOI 10.1097/00001199-199808000-00006; Hillier SL, 1997, BRAIN INJURY, V11, P661; HUNTER M, 1990, PHYS THER, V70, P363, DOI 10.1093/ptj/70.6.363; Jackson D, 2001, CLIN REHABIL, V15, P535, DOI 10.1191/026921501680425252; JANKOWSKI LW, 1990, ARCH PHYS MED REHAB, V71, P500; Katz DI, 2004, ARCH PHYS MED REHAB, V85, P865, DOI 10.1016/j.apmr.2003.11.020; Macko RF, 2005, STROKE, V36, P2206, DOI 10.1161/01.STR.0000181076.91805.89; Miller EW, 2008, PHYS THER, V88, P511, DOI 10.2522/ptj.20050240; Olney SJ, 2006, STROKE, V37, P476, DOI 10.1161/01.STR.0000199061.85897.b7; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Pang MYC, 2006, CLIN REHABIL, V20, P97, DOI 10.1191/0269215506cr926oa; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Regensteiner JG, 1990, J VASC MED BIOL, V2, P142; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; SULLIVAN S J, 1990, Brain Injury, V4, P407, DOI 10.3109/02699059009026194; Swaine BR, 1996, BRAIN INJURY, V10, P347, DOI 10.1080/026990596124368; Williams G, 2006, ARCH PHYS MED REHAB, V87, P437, DOI 10.1016/j.apmr.2005.10.028; Williams G, 2005, BRAIN INJURY, V19, P925, DOI 10.1080/02699050500058687; Williams G, 2004, AM J PHYS MED REHAB, V83, P910, DOI 10.1097/01.PHM.0000146503.25221.1D; Williams GP, 2005, BRAIN INJURY, V19, P833, DOI 10.1080/02699050500058711; Wolman RL, 1994, CLIN REHABIL, V8, P253; Yang YR, 2007, ARCH PHYS MED REHAB, V88, P1236, DOI 10.1016/j.apmr.2007.06.762	29	18	18	0	10	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2009	23	4					307	312	PII 909973890	10.1080/02699050902774170			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	425MY	WOS:000264643000005	19330594				2022-02-06	
J	Stola, A; Perlman, J				Stola, Anita; Perlman, Jeffrey			Post-resuscitation strategies to avoid ongoing injury following intrapartum hypoxia-ischemia	SEMINARS IN FETAL & NEONATAL MEDICINE			English	Article						Hypoglycemia; Hypotension; Modest hypothermia; Neuroprotection; Seizures; Ventilator management	SEVERE INTRAVENTRICULAR HEMORRHAGE; WHOLE-BODY HYPOTHERMIA; BRAIN-INJURY; PERINATAL ASPHYXIA; NEONATAL BRAIN; SELECTIVE HEAD; CONTROLLED TRIAL; NEWBORN-INFANTS; NEURONAL RESCUE; CEREBRAL-PALSY	The interruption of placental. blood flow during labor with redistribution of cardiac output resulting in increased flow to brain, heart, and adrenal glands at the expense of flow to kidney, gut, and skin can result in systemic organ as well as cerebral injury. Thus, post-resuscitation strategies should focus on both the management of potential systemic organ dysfunction and on methods of preventing ongoing brain injury in high-risk infants. General management strategies should include ventilator management to maintain pCO(2) values in the normal range, close attention to blood pressure to avoid hypotension, striving to avoid hypoglycemia, and control of seizures. Modest hypothermia administered within the first 6 hours has been shown to reduce neurodevelopmental deficits and death in those infants at highest-risk infants for developing hypoxic-ischemic brain injury. (C) 2008 Elsevier Ltd. All rights reserved.	[Stola, Anita; Perlman, Jeffrey] Weill Cornell Med Coll, New York, NY 10021 USA		Perlman, J (corresponding author), Weill Cornell Med Coll, New York, NY 10021 USA.	jmp2007@med.cornell.edu					Arvin KL, 2002, ANN NEUROL, V52, P54, DOI 10.1002/ana.10242; Aydin A, 2003, BRAIN DEV-JPN, V25, P494, DOI 10.1016/S0387-7604(03)00039-1; Azzopardi D, 2000, PEDIATRICS, V106, P684, DOI 10.1542/peds.106.4.684; AZZORPARDI D, TOBY TREATMENT PERIN; Benders MJNL, 2006, ARCH DIS CHILD-FETAL, V91, pF163, DOI 10.1136/adc.2005.086652; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bhat MA, 2006, J PEDIATR-US, V149, P180, DOI 10.1016/j.jpeds.2006.03.053; Blackmon LR, 2006, PEDIATRICS, V117, P942, DOI 10.1542/peds.2005-2950; Collins MP, 2001, PEDIATR RES, V50, P712, DOI 10.1203/00006450-200112000-00014; Dingley J, 2006, STROKE, V37, P501, DOI 10.1161/01.STR.0000198867.31134.ac; duPlessis AJ, 1997, CLIN PERINATOL, V24, P627, DOI 10.1016/S0095-5108(18)30162-3; Dzhala V, 2000, ANN NEUROL, V48, P632, DOI 10.1002/1531-8249(200010)48:4<632::AID-ANA10>3.3.CO;2-V; Eicher DJ, 2005, PEDIATR NEUROL, V32, P11, DOI 10.1016/j.pediatrneurol.2004.06.014; Fabres J, 2007, PEDIATRICS, V119, P299, DOI 10.1542/peds.2006-2434; Ferriero DM, 2004, NEW ENGL J MED, V351, P1985, DOI 10.1056/NEJMra041996; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; GOLDBERG RN, 1986, J PEDIATR-US, V109, P851, DOI 10.1016/S0022-3476(86)80713-2; Grow J, 2002, CLIN PERINATOL, V29, P585, DOI 10.1016/S0095-5108(02)00059-3; Gunn AJ, 1997, J CLIN INVEST, V99, P248, DOI 10.1172/JCI119153; Gunn AJ, 1998, PEDIATRICS, V102, P1098, DOI 10.1542/peds.102.5.1098; Gunn AJ, 1998, PEDIATRICS, V102, P885, DOI 10.1542/peds.102.4.885; Halle JN, 1997, BRAIN RES, V759, P309, DOI 10.1016/S0006-8993(97)00364-8; HALLER DG, 1986, SEMIN ONCOL, V13, P2; Hankins GDV, 2002, OBSTET GYNECOL, V99, P688, DOI 10.1016/S0029-7844(02)01959-2; Higgins RD, 2006, J PEDIATR-US, V148, P170, DOI 10.1016/j.jpeds.2005.12.009; Holmes GL, 1998, ANN NEUROL, V44, P845, DOI 10.1002/ana.410440602; Holtzman DM, 1996, ANN NEUROL, V39, P114, DOI 10.1002/ana.410390117; Holzer M, 2002, NEW ENGL J MED, V346, P549; Ichiba H, 2002, PEDIATR INT, V44, P505, DOI 10.1046/j.1442-200X.2002.01610.x; Jenik AG, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.4.e45; Johnston BM, 1996, J CLIN INVEST, V97, P300, DOI 10.1172/JCI118416; Johnston MV, 2001, PEDIATR RES, V49, P735, DOI 10.1203/00006450-200106000-00003; Kaiser JR, 2006, J PERINATOL, V26, P279, DOI 10.1038/sj.jp.7211492; Kumral A, 2003, BIOL NEONATE, V83, P224, DOI 10.1159/000068926; Laptook AR, 2002, CLIN PERINATOL, V29, P623, DOI 10.1016/S0095-5108(02)00057-X; LAPTOOK AR, 1994, PEDIATR RES, V35, P436, DOI 10.1203/00006450-199404000-00010; Laptook AR, 2001, PEDIATRICS, V108, P1103, DOI 10.1542/peds.108.5.1103; LEVENE MI, 1983, ARCH DIS CHILD, V58, P1013, DOI 10.1136/adc.58.12.1013; LEVENE MI, 1987, DEV MED CHILD NEUROL, V29, P311; Liu XH, 1996, PEDIATR RES, V40, P797, DOI 10.1203/00006450-199612000-00004; LOREK A, 1994, PEDIATR RES, V36, P699, DOI 10.1203/00006450-199412000-00003; MARTINANCEL A, 1995, J PEDIATR-US, V127, P786, DOI 10.1016/S0022-3476(95)70174-5; MCINTOSH TK, 1989, BRAIN RES, V482, P252, DOI 10.1016/0006-8993(89)91188-8; Miller SL, 2005, DEV NEUROSCI-BASEL, V27, P200, DOI 10.1159/000085993; MIZRAHI EM, 1989, CLIN PERINATOL, V16, P485, DOI 10.1016/S0095-5108(18)30643-2; NELSON KB, 1995, PEDIATRICS, V95, P263; PALMER C, 1995, CLIN PERINATOL, V22, P481; Peeters-Scholte C, 2003, PEDIATR RES, V54, P516, DOI 10.1203/01.PDR.0000081297.53793.C6; PERLMAN JM, 1989, AM J DIS CHILD, V143, P617, DOI 10.1001/archpedi.1989.02150170119037; RAJU TNK, 1982, MED INSTRUM, V16, P154; Salhab WA, 2004, PEDIATRICS, V114, P361, DOI 10.1542/peds.114.2.361; SCHER MS, 1993, PEDIATRICS, V91, P128; Shah PS, 2007, ARCH PEDIAT ADOL MED, V161, P951, DOI 10.1001/archpedi.161.10.951; Shalak L, 2004, EARLY HUM DEV, V80, P125, DOI 10.1016/j.earlhumdev.2004.06.003; Shankaran S, 2002, PEDIATRICS, V110, P377, DOI 10.1542/peds.110.2.377; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Shimizu K, 2003, NEUROSCI LETT, V346, P41, DOI 10.1016/S0304-3940(03)00558-5; Simbruner G, 1999, INTENS CARE MED, V25, P1111, DOI 10.1007/s001340051020; TAN WKM, 1994, AM J OBSTET GYNECOL, V170, P663, DOI 10.1016/S0002-9378(94)70245-4; Thoresen M, 1996, ARCH DIS CHILD-FETAL, V74, pF3, DOI 10.1136/fn.74.1.F3; Thoresen M, 2000, PEDIATRICS, V106, P92, DOI 10.1542/peds.106.1.92; TSANG RC, 1974, PEDIATRICS, V84, P428; Van Bel F, 1998, PEDIATRICS, V101, P185, DOI 10.1542/peds.101.2.185; Vannucci RC, 1997, PEDIATRICS, V100, P1004, DOI 10.1542/peds.100.6.1004; Volpe J., 2001, NEUROLOGY NEWBORN; Wyatt JS, 2007, PEDIATRICS, V119, P912, DOI 10.1542/peds.2006-2839; Wyckoff MH, 2005, PEDIATRICS, V115, P950, DOI 10.1542/peds.2004-0913; Wyckoff M, 2007, PEDIATR RES, V61, P415, DOI 10.1203/pdr.0b013e3180332c45; YAGER J, 1993, PEDIATR RES, V34, P525, DOI 10.1203/00006450-199310000-00029; Yager JY, 2002, CLIN PERINATOL, V29, P651, DOI 10.1016/S0095-5108(02)00054-4	70	18	18	0	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1744-165X	1878-0946		SEMIN FETAL NEONAT M	Semin. Fetal Neonatal Med.	DEC	2008	13	6					424	431		10.1016/j.siny.2008.04.011			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	373KR	WOS:000260971000010	18501692				2022-02-06	
J	Prigatano, GP; Gray, J				Prigatano, George P.; Gray, Jennifer			Parental Perspectives on Recovery and Social Reintegration After Pediatric Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						children; memory; neuropsychological status; parental judgment; processing speed; recovery; severity of traumatic brain injury; social reintegration	HEAD-INJURY; CHILDREN; REHABILITATION; SCHOOL; OUTCOMES	To determine the validity of parental ratings of their child's overall recovery and social reintegration after pediatric traumatic brain injury (TBI). Setting: Primary care hospital/medical center. Participants: Ninety-nine children aged 6 to 16 years (80 with TBI and 19 orthopedic trauma controls) evaluated as outpatients. Main Outcome Measures: Parental ratings of overall recovery and social reintegration; neuropsychological test performance. Results: Severity of injury correlated with postacute parental ratings of the child's overall recovery (r = -0.498, N = 84, P =.001) and social reintegration (r = -0.507, N = 84, P =.001). A similar correlation was observed between TBI severity and a known "objective" market of recovery (Wechsler Intelligence Scale for Children-III Coding subtest; r = -0.503, N = 84, P =.001). Conclusions: The present findings support the concurrent validity of parental perspectives of a child's overall recovery and social reintegration after pediatric TBI. Incorporating these views may assist in the rehabilitation of children following brain injury. Parental reasons for Judging a child's recovery as may differ as a function of severity of injury.	[Prigatano, George P.; Gray, Jennifer] St Josephs Hosp, Barrow Neurol Inst, Div Neurol, Phoenix, AZ 85013 USA		Prigatano, GP (corresponding author), St Josephs Hosp, Barrow Neurol Inst, Div Neurol, 222 W Thomas Rd,St 315, Phoenix, AZ 85013 USA.	george.prigatano@chw.edu					Achenbach T. M., 1991, CHILD BEHAV CHECKLIS; Aitken ME, 2004, ARCH PHYS MED REHAB, V85, P567, DOI 10.1016/j.apmr.2003.06.018; Als H, 2004, PEDIATRICS, V113, P846, DOI 10.1542/peds.113.4.846; Anderson SW, 2000, DEV NEUROPSYCHOL, V18, P281, DOI 10.1207/S1532694202Anderson; BIRCH HG, 1964, BRAIN DAMAGE CHILDRE; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Braga LW, 2005, BRAIN INJURY, V19, P819, DOI 10.1080/02699050500110165; Catroppa C, 2003, NEUROPSYCHOL REHABIL, V13, P517, DOI 10.1080/09602010343000084; Clark E, 1999, SCHOOL PSYCHOL REV, V28, P242; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Donders J, 2004, J INT NEUROPSYCH SOC, V10, P482, DOI 10.1017/S1355617704104025; Ewing-Cobbs L, 2006, AM J NEURORADIOL, V27, P879; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Farmer JE, 1996, J LEARN DISABIL-US, V29, P532, DOI 10.1177/002221949602900508; Fuld PA, 1981, FULD OBJECT MEMORY E; GLANG A, 1992, J HEAD TRAUMA REHAB, V7, P93; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; Jennett B, 1981, MANAGEMENT HEAD INJU; Johnson SC, 1994, NEUROPSYCHOLOGY, V8, P307, DOI DOI 10.1037/0894-4105.8.3.301; Klonoff PS, 2001, BRAIN INJURY, V15, P413, DOI 10.1080/02699050010005968; Laatsch L, 2007, J HEAD TRAUMA REHAB, V22, P248, DOI 10.1097/01.HTR.0000281841.92720.0a; Levin HS, 2000, NEUROLOGY, V54, P647, DOI 10.1212/WNL.54.3.647; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; Prigatano GP, 2008, CLIN NEUROPSYCHOL, V22, P603, DOI 10.1080/13854040701440501; Prigatano GP, 2007, DEV NEUROPSYCHOL, V32, P757, DOI 10.1080/87565640701539469; Prigatano GP, 2007, BRAIN INJURY, V21, P721, DOI 10.1080/02699050701481605; Prigatano GP, 2006, J HEAD TRAUMA REHAB, V21, P505, DOI 10.1097/00001199-200611000-00005; Prigatano GP, 2003, J INT NEUROPSYCH SOC, V9, P128, DOI 10.1017/S1355617703000134; PRIGATANO GP, 2005, BNI SCREEN HIGHER CE; PRIGATANO GP, 1994, J HEAD TRAUMA REHAB, V9, P81; PRIGATANO GP, 2004, COMMUNITY SCH REINTE, P151; Reitan RM., 1955, MANUAL ADM NEUROPSYC; ROMANO MD, 1974, SCAND J REHABIL MED, V6, P1; RUTTER M, 1983, DEV NEUROPSYCHIATRY, P83; SPSS Inc, 1998, SPSS BAS 8 0 WIND US; STRAUSS A, 1947, PSYCHOPATHOLOGY ED B; Wechsler D., 1991, WISC 3 WECHSLER INTE; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009	41	18	18	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2008	23	6					378	387		10.1097/01.HTR.0000341433.67251.01			10	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	379WZ	WOS:000261428300003	19033830				2022-02-06	
J	Aoyama, N; Lee, SM; Moro, N; Hovda, DA; Sutton, RL				Aoyama, Naoki; Lee, Stefan M.; Moro, Nobuhiro; Hovda, David A.; Sutton, Richard L.			Duration of ATP reduction affects extent of CA1 cell death in rat models of fluid percussion injury combined with secondary ischemia	BRAIN RESEARCH			English	Article						adenosine triphosphate; cell death; hippocampus; rat; secondary ischemia; traumatic brain injury	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; ENERGY PHOSPHATE-METABOLISM; PERMEABILITY TRANSITION; GLUCOSE-UTILIZATION; HEAD-INJURY; MITOCHONDRIAL DYSFUNCTION; HEMORRHAGIC HYPOTENSION; FOREBRAIN ISCHEMIA; PROGNOSTIC VALUE	Secondary ischemia (SI) following traumatic brain injury (TBI) increases damage to the brain in both animals and humans. The current study determined if SI after TBI alters the extent or duration of reduced energy production within the first 24 h post-injury and hippocampal cell loss at one week post-injury. Adult male rats were subjected to sham injury, lateral (LFPI) or central fluid percussion injury (CFPI) only, or to combined LFPI or CFPI with SI. The SI was 8 min of bilateral forebrain ischemia combined with hemorrhagic hypotension, applied at 1 h following FPI. After LFPI alone adenosine triphosphate (ATP) levels within the ipsilateral CA1 were reduced at 2 h (p < 0.05) and subsequently recovered. After LFPI+SI the ATP reductions in CA1 ipsilateral to FP persisted for 24 h (p<0.01). ATP levels in the contralateral CA1 were not affected by LFPI alone or LFPI+SI. After CFPI alone CA1 ATP levels were depressed bilaterally only at 2 h (p<0.05). Similar to the LFPI paradigm, CFPI+SI reduced ATP levels for 24 h (p < 0.01), with bilateral ATP reductions seen after CFPI+SI. Cell counts in the CA1 region at 7 days post-injury revealed no significant neuronal cell loss after LFPI or CFPI alone. Significant neuronal cell loss was present only within the ipsilateral (p<0.001) CA1 after LFPI+SI, but cell loss was bilateral (p<0.001) after CFPI+SI. Thus, SI prolongs ATP reductions induced by LFPI and CFPI within the CA1 region and this SI-induced energy reduction appears to adversely affect regional neuronal viability. (C) 2008 Elsevier B.V. All rights reserved.	[Aoyama, Naoki; Lee, Stefan M.; Moro, Nobuhiro; Hovda, David A.; Sutton, Richard L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; [Aoyama, Naoki; Lee, Stefan M.; Moro, Nobuhiro; Hovda, David A.; Sutton, Richard L.] Univ Calif Los Angeles, David Geffen Sch Med, Brain Injury Res Ctr, Los Angeles, CA 90095 USA; [Hovda, David A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA		Sutton, RL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, 10833 Le Conte Ave,Box 957039, Los Angeles, CA 90095 USA.	rsutton@mednet.ucla.edu			UCLA Brain Injury Research Center; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS27544, NS37363]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS027544, R01NS037363] Funding Source: NIH RePORTER	We wish to thank Monica D. Wong and Sima S. Ghavim for their superb technical assistance. This research was supported by the UCLA Brain Injury Research Center and NIH grants NS27544 and NS37363. The authors have no conflicts of interest to declare.	ARAI H, 1986, METAB BRAIN DIS, V1, P263, DOI 10.1007/BF00999356; Bauman RA, 2000, J NEUROTRAUM, V17, P679, DOI 10.1089/089771500415427; Bedell EA, 2004, J NEUROTRAUM, V21, P1212; Bramlett HM, 1999, J NEUROTRAUM, V16, P1035, DOI 10.1089/neu.1999.16.1035; Bramlett HM, 1999, J NEUROSURG, V91, P653, DOI 10.3171/jns.1999.91.4.0653; Brustovetsky N, 2002, J NEUROCHEM, V80, P207, DOI 10.1046/j.0022-3042.2001.00671.x; Buczek M, 2002, METAB BRAIN DIS, V17, P153, DOI 10.1023/A:1019973921217; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; Cherian L, 1996, J NEUROTRAUM, V13, P371, DOI 10.1089/neu.1996.13.371; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Davis KL, 1998, J NEUROTRAUM, V15, P615, DOI 10.1089/neu.1998.15.615; DeWitt D S, 1995, New Horiz, V3, P376; Dietrich WD, 1998, NEUROSURGERY, V43, P585, DOI 10.1097/00006123-199809000-00105; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; Floyd CL, 2002, J NEUROTRAUM, V19, P303, DOI 10.1089/089771502753594873; Geeraerts T, 2008, INTENS CARE MED, V34, P551, DOI 10.1007/s00134-007-0863-0; Giri BK, 2000, STROKE, V31, P961, DOI 10.1161/01.STR.31.4.961; Gorman LK, 1996, J NEUROTRAUM, V13, P457, DOI 10.1089/neu.1996.13.457; Hata R, 2000, J CEREBR BLOOD F MET, V20, P937, DOI 10.1097/00004647-200006000-00006; Henzler D, 2007, CRIT CARE MED, V35, P1027, DOI 10.1097/01.CCM.0000259526.45894.08; ISHIGE N, 1987, NEUROSURGERY, V20, P854, DOI 10.1227/00006123-198706000-00006; ISHIGE N, 1988, J NEUROSURG, V68, P129, DOI 10.3171/jns.1988.68.1.0129; Jenkins LW, 1999, BRAIN RES, V817, P132, DOI 10.1016/S0006-8993(98)01237-2; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; Jiang DM, 2001, J BIOL CHEM, V276, P47524, DOI 10.1074/jbc.M108834200; Katayama Y, 1997, BRAIN RES, V746, P126, DOI 10.1016/S0006-8993(96)01218-8; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; KOGURE K, 1978, BRAIN RES, V154, P273, DOI 10.1016/0006-8993(78)90700-X; Lee SM, 1999, ANN NY ACAD SCI, V893, P337, DOI 10.1111/j.1749-6632.1999.tb07849.x; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Marklund N, 2006, NEUROCHEM RES, V31, P1085, DOI 10.1007/s11064-006-9120-0; Matsushita Y, 2000, J NEUROTRAUM, V17, P143, DOI 10.1089/neu.2000.17.143; Matsushita Y, 2001, J CEREBR BLOOD F MET, V21, P847, DOI 10.1097/00004647-200107000-00010; Matsushita Y, 2001, CRIT CARE MED, V29, P2060, DOI 10.1097/00003246-200111000-00004; Mautes AEM, 2001, J MOL NEUROSCI, V16, P33, DOI 10.1385/JMN:16:1:33; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; MIES G, 1990, J CEREBR BLOOD F MET, V10, P638, DOI 10.1038/jcbfm.1990.116; MIES G, 1991, J CEREBR BLOOD F MET, V11, P753, DOI 10.1038/jcbfm.1991.132; MIES G, 1999, J CEREB BLOOD FLOW M, V11, P753; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; Osteen CL, 2001, J NEUROTRAUM, V18, P141, DOI 10.1089/08977150150502587; Sanchez-Olmedo JI, 2005, TRANSPL P, V37, P1990, DOI 10.1016/j.transproceed.2005.03.048; Schutz C, 2006, CRIT CARE MED, V34, P492, DOI 10.1097/01.CCM.0000198326.32049.7F; Signoretti S, 2001, J NEUROTRAUM, V18, P977, DOI 10.1089/08977150152693683; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Vagnozzi R, 2005, NEUROSURGERY, V57, P164, DOI 10.1227/01.NEU.0000163413.90259.85; Vagnozzi R, 1999, J NEUROTRAUM, V16, P903, DOI 10.1089/neu.1999.16.903; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Vink R, 2001, J NEUROTRAUM, V18, P839, DOI 10.1089/089771501316919201; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; Yamamoto M, 1999, J NEUROTRAUM, V16, P487, DOI 10.1089/neu.1999.16.487; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289; Zanier ER, 2003, J NEUROTRAUM, V20, P409, DOI 10.1089/089771503765355496	64	18	20	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	SEP 16	2008	1230						310	319		10.1016/j.brainres.2008.07.006			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	359BW	WOS:000259962200033	18657524	Green Accepted			2022-02-06	
J	Beaulieu, C; Wertheimer, JC; Pickett, L; Spierre, L; Schnorbus, T; Healy, W; Palmer, C; Jones, A				Beaulieu, Cynthia; Wertheimer, Jeffrey C.; Pickett, Lee; Spierre, Louise; Schnorbus, Tonya; Healy, Wendy; Palmer, Candace; Jones, Amy			Behavior management on an acute brain injury unit: Evaluating the effectiveness of an interdisciplinary training program	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						agitation; behavior management; crisis intervention; interdisciplinary; rehabilitation; restraints; traumatic brain injury	HEAD-INJURY; AGITATION; REHABILITATION; SCALE; THROMBOSIS; RESTRAINT; PATIENT	Objective: To measure the effect of behavior management training on restraint use and pm medication delivery on an acute inpatient brain injury unit. Setting/participants: Interdisciplinary staff and hospitalized brain injury patients on a 20-bed unit within a freestanding rehabilitation hospital. Intervention: Staff participated in the Nonviolent Crisis Intervention (R) (NCI) program from the Crisis Prevention Institute (R). Main outcome measures: Applied physical restraints and delivered pm medications. Results: Despite comparable patient levels of agitation severity across the duration of the study, the use of physical restraints initially declined and then increased after training. Data collected on pm medication delivery also indicated a trend for an increase in the delivery of select medication categories across time. Conclusion: NCI training resulted in a temporary, short-lived reduction in physical restraint use, but had an inverse effect oil pm medication delivery for select categories of medication. Medication delivery significantly increased over time and restraint use eventually exceeded baseline level. Ramifications of these results are discussed.	[Beaulieu, Cynthia; Pickett, Lee; Spierre, Louise; Schnorbus, Tonya; Palmer, Candace] Brooks Rehabil Hosp, Brain Injury Program, Jacksonville, FL 32216 USA; [Wertheimer, Jeffrey C.] Brooks Behavioral Med, Jacksonville, FL USA; [Healy, Wendy] Brooks Rehabil Fleming Isl, Orange Pk, FL USA		Beaulieu, C (corresponding author), Brooks Rehabil Hosp, Brain Injury Program, 3599 Univ Blvd, Jacksonville, FL 32216 USA.	cynthia.beaulieu@brookshealth.org					Allen MH, 2000, J CLIN PSYCHIAT, V61, P11; ARTIOLAIFORTUNY L, 1980, J NEUROL NEUROSUR PS, V43, P377, DOI 10.1136/jnnp.43.5.377; Beaulieu CL, 1997, ARCH CLIN NEUROPSYCH, V12, P285, DOI 10.1093/arclin/12.4.285a; Bogner JA, 1999, J HEAD TRAUMA REHAB, V14, P91, DOI 10.1097/00001199-199902000-00012; Bogner JA, 2001, AM J PHYS MED REHAB, V80, P636, DOI 10.1097/00002060-200109000-00002; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P320, DOI 10.1016/0003-9993(92)90003-F; Calabro Karen, 2002, Issues Ment Health Nurs, V23, P3, DOI 10.1080/01612840252825446; CORRIGAN JD, 1994, J CLIN EXP NEUROPSYC, V16, P386, DOI 10.1080/01688639408402649; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; DeYoung Sandra, 2002, J Gerontol Nurs, V28, P22; Fugate LP, 1997, ARCH PHYS MED REHAB, V78, P924, DOI 10.1016/S0003-9993(97)90051-4; Gilbert M, 1999, J NURS CARE QUAL, V13, P57, DOI 10.1097/00001786-199906000-00007; Goldstein LB, 2003, BRAIN INJURY, V17, P685, DOI 10.1080/0269905031000107179; GOLDSTEIN LB, 1995, J NEUROL NEUROSUR PS, V58, P753, DOI 10.1136/jnnp.58.6.753; Hem E, 2001, ACTA PSYCHIAT SCAND, V103, P73, DOI 10.1034/j.1600-0447.2001.00082.x; Inouye SK, 1996, JAMA-J AM MED ASSOC, V275, P852, DOI 10.1001/jama.275.11.852; Laursen SB, 2005, ACTA PSYCHIAT SCAND, V111, P324, DOI 10.1111/j.1600-0447.2004.00456.x; Morrison EF, 2003, ARCH PSYCHIAT NURS, V17, P146, DOI 10.1016/S0883-9417(03)00085-2; MURPHY MC, 2002, J AM PSYCHIAT NURSES, V8, pS2; Mysiw WJ, 2006, BRAIN INJURY, V20, P905, DOI 10.1080/02699050600743972; MYSIW WJ, 1988, AM J PHYS MED REHAB, V67, P29, DOI 10.1097/00002060-198802000-00006; MYSIW WJ, 2007, BRAIN INJURY MED PRI, P283; Nott MT, 2006, BRAIN INJURY, V20, P1175, DOI 10.1080/02699050601049114; Petit JR, 2005, PSYCHIAT CLIN N AM, V28, P701, DOI 10.1016/j.psc.2005.05.011; POOLE J, 2005, INT J NURS PRACT, V11, P95; Roth DL, 2002, J GERONTOL B-PSYCHOL, V57, pP461, DOI 10.1093/geronb/57.5.P461; Sherer M, 2005, ARCH PHYS MED REHAB, V86, P896, DOI 10.1016/j.apmr.2004.09.029; Stanislav SW, 2000, BRAIN INJURY, V14, P261; Temple RO, 2007, REHABIL PSYCHOL, V52, P429, DOI 10.1037/0090-5550.52.4.429; Zafonte RD, 1997, ARCH PHYS MED REHAB, V78, P1103, DOI 10.1016/S0003-9993(97)90135-0; Zhu J, 2000, EXP NEUROL, V166, P136, DOI 10.1006/exnr.2000.7484; [No title captured]	32	18	18	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2008	23	5					304	311		10.1097/01.HTR.0000336843.60961.b7			8	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	357GN	WOS:000259834400005	18815507				2022-02-06	
J	Degeneffe, CE; Burcham, CM				Degeneffe, Charles Edmund; Burcham, Christyn M.			Adult Sibling Caregiving for Persons with Traumatic Brain Injury: Predictors of Affective and Instrumental Support	JOURNAL OF REHABILITATION			English	Article							MENTAL-RETARDATION; DISABILITIES; CHILDREN; PARENTS; FUTURE; ROLES	This study investigated the amount and predictors of affective and instrumental caregiving supports provided by a national sample of 233 adult siblings of persons with traumatic brain injury (TBI). Affective support encompasses emotionally-based care such as companionship, encouragement, praise, and intimacy. Instrumental support consists of assistance in performing functional tasks such as completing chores, running errands, handling finances and preparing food. Participants provided significantly more affective than instrumental supports. Hierarchical multiple regression analyses identified predictors of the type of supports the siblings provided. Participants of a different gender than their injured siblings were more likely to provide both instrumental and affective supports. Also, as the age differences increased between the non-injured and injured siblings, participants were more likely to provide affective care. Instrumental support was positively related to age of the non-injured siblings and level of the injured siblings' cognitive-behavioral impairments. Instrumental support was negatively related to geographic distance. Clinical and research implications of these findings are discussed.	[Degeneffe, Charles Edmund] San Diego State Univ, ARPE Interwork Inst, San Diego, CA 92182 USA		Degeneffe, CE (corresponding author), San Diego State Univ, ARPE Interwork Inst, Mail Code 1127,5500 Campanile Dr, San Diego, CA 92182 USA.	cdegenef@mail.sdsu.edu					AKIYAMA H, 1996, J GERONTOL B-PSYCHOL, V51, P374; ALLEN K, 1994, REHABIL PSYCHOL, V39, P29, DOI 10.1037/0090-5550.39.1.29; Cunningham J. M., 2005, HLTH CARE DISABILITY, P475; Degeneffe CE, 2006, REHABIL COUNS BULL, V49, P130, DOI 10.1177/00343552060490030101; Degeneffe CE, 2001, HEALTH SOC WORK, V26, P257, DOI 10.1093/hsw/26.4.257; DEGENEFFE CE, REHABILITAT IN PRESS; Douglas JM, 1996, BRAIN INJURY, V10, P819, DOI 10.1080/026990596123936; Eckstein D., 2000, INDIVIDUAL PSYCHOL, V56, P481; Erdfelder E, 1996, BEHAV RES METH INS C, V28, P1, DOI 10.3758/BF03203630; Gill D. J., 2000, REHABILITATION NURSI, V25, P48, DOI [10.1002/j.2048-7940.2000.tb01862.x, DOI 10.1002/J.2048-7940.2000.TB01862.X]; GREENBERG JS, 1993, GERONTOLOGIST, V33, P542, DOI 10.1093/geront/33.4.542; GRIFFITHS DL, 1994, FAM RELAT, V43, P221, DOI 10.2307/585326; Harland P., 2000, INT J DISABIL DEV ED, V47, P293, DOI [10.1080/713671116, DOI 10.1080/713671116]; HORWITZ AV, 1993, J MARRIAGE FAM, V55, P623, DOI 10.2307/353343; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Krauss MW, 1996, MENT RETARD, V34, P83; Kreutzer JS, 1996, J LEARN DISABIL, V29, P643, DOI 10.1177/002221949602900608; KREUTZER JS, 1992, ARCH PHYS MED REHAB, V73, P771; LOBATO D, 1983, J AUTISM DEV DISORD, V13, P347, DOI 10.1007/BF01531585; MARASCUILO L. A., 1983, MULTIVARIATE STAT SO; MAURER J, 1991, HEAD INJURY FAMILY M, P29; *NIH, 1999, REP NIH CONS DEV C R; Orsillo SM, 1993, J HEAD TRAUMA REHAB, V8, DOI [10.1097/00001199-199303000-00010, DOI 10.1097/00001199-199303000-00010]; Orsmond GI, 2000, AM J MENT RETARD, V105, P486, DOI 10.1352/0895-8017(2000)105<0486:BASOAW>2.0.CO;2; Pruchno RA, 1996, FAM RELAT, V45, P318, DOI 10.2307/585504; SACHS PR, 1991, TREATING FAMILIES BR; SELTZER GB, 1991, FAM RELAT, V40, P310, DOI 10.2307/585017; Seltzer M. M., 1996, AGING FAMILIES ADULT; SELTZER MM, 1989, AM BEHAV SCI, V33, P107, DOI 10.1177/0002764289033001010; Seltzer MM, 1997, FAM RELAT, V46, P395, DOI 10.2307/585099; Smith MJ, 2007, AM J ORTHOPSYCHIAT, V77, P29, DOI 10.1037/0002-9432.77.1.29; SPRIGGS VT, 1998, PROMOTING CULTURAL C, P149; Willer B, 1999, ARCH PHYS MED REHAB, V80, P399, DOI 10.1016/S0003-9993(99)90276-9; ZETLIN AG, 1986, AM J MENT DEF, V91, P217	34	18	18	0	6	NATL REHABILITATION ASSOC-NRA	ALEXANDRIA	633 S WASHINGTON ST, ALEXANDRIA, VA 22314-4109 USA	0022-4154			J REHABIL	J. Rehabil.	JUL-SEP	2008	74	3					10	20					11	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	361NQ	WOS:000260134800002					2022-02-06	
J	Notturno, F; Caporale, CM; De Lauretis, A; Uncini, A				Notturno, Francesca; Caporale, Christina M.; De Lauretis, Angelo; Uncini, Antonino			Glial fibrillary acidic protein: A marker of axonal Guillain-Barre syndrome and outcome	MUSCLE & NERVE			English	Article						axonal GBS; glial fibrillary acidic protein; diagnostic marker; outcome	SCHWANN-CELL PROLIFERATION; INTERMEDIATE-FILAMENTS; MULTIPLE-SCLEROSIS; GFAP EXPRESSION; POLYNEUROPATHY; DEMYELINATION; NEUROPATHY; INJURY; ADULTS; ELISA	Glial fibrillary acid protein (GFAP) is increased in serum and cerebrospinal fluid of patients with dementia, traumatic brain injury, stroke, and multiple sclerosis. To determine whether GFAP is increased in Guillain-Barre syndrome (GBS) we evaluated serum GFAP in 30 controls, 20 patients with acute inflammatory demyelinating neuropathy (AIDP), and 17 with primary axonal GBS. Serum GFAP levels were increased in axonal GBS (median, 0.74) compared with controls (median, 0.41; P < 0.0001) and AIDP (median, 0.58; P = 0.0015). GFAP levels correlated with Hughes grades (serum r = 0.74; P < 0.0001) 6 months after neuropathy onset. Applying the cutoff value in serum of 0.63 to the diagnosis of axonal GBS, we obtained a sensitivity of 76.5% and a specificity of 86%. Thus, serum GFAP levels may be used in GBS as a diagnostic marker of the axonal variant and to predict outcome.	[Notturno, Francesca; Caporale, Christina M.; Uncini, Antonino] Univ G Dannunzio, Dept Human Motor Sci, I-66013 Chieti, Italy; [Notturno, Francesca; Caporale, Christina M.; Uncini, Antonino] Univ G Dannunzio, Neuromuscular Dis Unit, I-66013 Chieti, Italy; [Notturno, Francesca; Caporale, Christina M.; Uncini, Antonino] Fdn Univ G Dannunzio, Inst Aging, Neurol Clin, Osped SS Annunziata, I-66013 Chieti, Italy; [De Lauretis, Angelo] Catholic Univ, Dept Resp Dis, Rome, Italy		Uncini, A (corresponding author), Univ G Dannunzio, Dept Human Motor Sci, Via Dei Vestini, I-66013 Chieti, Italy.	uncini@unich.it		Notturno, Francesca/0000-0002-4191-6619			ASBURY AK, 1990, ANN NEUROL, V27, pS21, DOI 10.1002/ana.410270707; AUTILIOGAMBETTI L, 1982, J NEUROCHEM, V38, P774, DOI 10.1111/j.1471-4159.1982.tb08698.x; BIANCHINI D, 1992, BRAIN RES, V570, P209, DOI 10.1016/0006-8993(92)90583-U; Brisby H, 1999, SPINE, V24, P742, DOI 10.1097/00007632-199904150-00003; Cheng C, 2002, NEUROSCIENCE, V115, P321, DOI 10.1016/S0306-4522(02)00291-9; FEASBY TE, 1986, BRAIN, V109, P1115, DOI 10.1093/brain/109.6.1115; FIELDS KL, 1985, J NEUROIMMUNOL, V8, P311, DOI 10.1016/S0165-5728(85)80070-9; GRIFFIN JW, 1990, J NEUROCYTOL, V19, P367, DOI 10.1007/BF01188405; Hadden RDM, 1998, ANN NEUROL, V44, P780, DOI 10.1002/ana.410440512; Herrmann M, 2000, STROKE, V31, P2670, DOI 10.1161/01.STR.31.11.2670; Ho TW, 1997, NEUROLOGY, V48, P717, DOI 10.1212/WNL.48.3.717; Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9; HUGHES RAC, 1978, LANCET, V2, P750, DOI 10.1016/s0140-6736(78)92644-2; JESSEN KR, 1984, J NEUROCYTOL, V13, P923, DOI 10.1007/BF01148594; JESSEN KR, 1990, DEVELOPMENT, V109, P91; Jessen KR, 1999, TRENDS NEUROSCI, V22, P402, DOI 10.1016/S0166-2236(98)01391-5; Malmestrom C, 2003, NEUROLOGY, V61, P1720, DOI 10.1212/01.WNL.0000098880.19793.B6; MANCARDI GL, 1991, J NEUROL SCI, V102, P177, DOI 10.1016/0022-510X(91)90066-G; MCKHANN GM, 1991, LANCET, V338, P593, DOI 10.1016/0140-6736(91)90606-P; Norgren N, 2004, NEUROLOGY, V63, P1586, DOI 10.1212/01.WNL.0000142988.49341.D1; O'Brien M., 2000, AIDS EXAMINATION PER; Petzold A, 2004, J IMMUNOL METHODS, V287, P169, DOI 10.1016/j.jim.2004.01.015; Petzold A, 2002, BRAIN, V125, P1462, DOI 10.1093/brain/awf165; Quattrini A, 1996, GLIA, V17, P294, DOI 10.1002/(SICI)1098-1136(199608)17:4<294::AID-GLIA4>3.0.CO;2-#; ROSENGREN LE, 1994, J NEUROSCI METH, V51, P197, DOI 10.1016/0165-0270(94)90011-6; TOEWS AD, 1992, J NEUROSCI, V12, P3676; Triolo D, 2006, J CELL SCI, V119, P3981, DOI 10.1242/jcs.03168; van Geel WJA, 2002, CLIN CHIM ACTA, V326, P151, DOI 10.1016/S0009-8981(02)00330-3; van Koningsveld R, 2007, LANCET NEUROL, V6, P589, DOI 10.1016/S1474-4422(07)70130-8; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC	30	18	18	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0148-639X	1097-4598		MUSCLE NERVE	Muscle Nerve	JUL	2008	38	1					899	903		10.1002/mus.20983			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	319MP	WOS:000257168100010	18508349				2022-02-06	
J	Blake, H				Blake, Holly			Caregiver stress in traumatic brain injury	INTERNATIONAL JOURNAL OF THERAPY AND REHABILITATION			English	Article						traumatic brain injury; adults; caregivers; psychosocial outcomes; social support; depression	BLUNT HEAD-INJURY; FAMILY CARERS; PSYCHOLOGICAL DISTRESS; CRITICAL-APPRAISAL; SOCIAL SUPPORT; COPING STYLE; INDIVIDUALS; DEPRESSION; RELATIVES; BURDEN	Aims: Many patients experience physical, behavioural, cognitive and emotional problems following traumatic brain injury (TBI). They may require continuing care for many years, most of which is provided by informal caregivers, such as spouses, parents, or other family members. The caregiving role is associated with a range of adverse effects including anxiety, depression, poor physical health and lowered quality of life. This article explores issues around caregiver stress; highlighting interventions for this group and areas for further research. Methods: Literature exploring the impact of caregiving, its influencing and alleviating factors and interventions for caregivers of people with TBI is discussed, with brief critical analysis of key studies. Findings: Research suggests that caregiver characteristics, coping strategies, their appraisal of the situation and social networks may be associated with the amount of distress experienced. Many caregivers have unmet needs such as respite care and information provision on TBI. Providing information may help to alleviate strain. Community-based family therapies providing education, support and counselling can help to decrease distress and improve aspects of family functioning, although evidence for these is lacking. Conclusions: There is a need for more well-designed, controlled studies evaluating the impact of interventions to alleviate caregiver strain.	[Blake, Holly] Univ Nottingham, Fac Med & Hlth Sci, Queens Med Ctr, Sch Nursing, B Floor,Med Sch, Nottingham NG7 2UH, England		Blake, H (corresponding author), Univ Nottingham, Fac Med & Hlth Sci, Queens Med Ctr, Sch Nursing, B Floor,Med Sch, Nottingham NG7 2UH, England.	Holly.Blake@nottingham.ac.uk	Blake, Holly/B-8855-2008	Blake, Holly/0000-0003-3080-2306			ALLEN K, 1994, REHABIL PSYCHOL, V39, P29, DOI 10.1037/0090-5550.39.1.29; Boschen K, 2007, NEUROREHABILITATION, V22, P19; Bowen A, 2001, BRAIN INJURY, V15, P29, DOI 10.1080/02699050150209101; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; BRUMFITT S, 1994, APHASIOLOGY, V8, P583, DOI 10.1080/02687039408248683; Campbell C H, 1988, Rehabil Nurs, V13, P320; Campbell L, 2007, NEUROREHABILITATION, V22, P325; Chan J, 2007, INT J REHABIL RES, V30, P137, DOI 10.1097/MRR.0b013e32813a2f11; CHWALISZ K, 1992, REHABIL PSYCHOL, V37, P189, DOI 10.1037/h0079103; Critical Reviews and Advisory Group, 1996, CRIT REV ADV GROUP; Davies C, 2000, BRIT J THERAPY REHAB, V7, P521; DeJong G, 1999, ACCESS BRAIN INJURY, P121; Department of Health, 2005, NAT SERV FRAM LONG T; Douglas JM, 2000, BRAIN INJURY, V14, P71, DOI 10.1080/026990500120943; Flanagan DAJ, 1998, BRIT J CLIN PSYCHOL, V37, P431, DOI 10.1111/j.2044-8260.1998.tb01400.x; Fraas M, 2007, BRAIN INJURY, V21, P1267, DOI 10.1080/02699050701721794; FRANK R G, 1990, Brain Injury, V4, P289, DOI 10.3109/02699059009026179; Fyffe C, 1996, Aust J Rural Health, V4, P232, DOI 10.1111/j.1440-1584.1996.tb00216.x; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Hanks RA, 2007, NEUROREHABILITATION, V22, P43; Harris JKJ, 2001, BRAIN INJURY, V15, P223; HOSACK KR, 1995, J HEAD TRAUMA REHAB, V10, P57, DOI 10.1097/00001199-199504000-00007; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; JACOBS HE, 1989, NEUROPSYCHOLOGICAL T, P297; Johnson B P, 1995, J Neurosci Nurs, V27, P113; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; KREUTZER JS, 1992, ARCH PHYS MED REHAB, V73, P771; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; Kuipers P, 2000, J HEAD TRAUMA REHAB, V15, P1275, DOI 10.1097/00001199-200012000-00007; Leathem J, 1996, BRAIN INJURY, V10, P27; LEY P, 1990, COMMUNICATING PATIEN; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P870, DOI 10.1136/jnnp.48.9.870; Machamer J, 2002, J CLIN EXP NEUROPSYC, V24, P420, DOI 10.1076/jcen.24.4.420.1040; MAITZ EA, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199504000-00003; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; McCluskey AE, 2000, BRAIN INJURY, V14, P943, DOI 10.1080/02699050050191896; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; McKinlay WW, 1988, J HEAD TRAUMA REHAB, p[3, 64]; McPherson KM, 2000, INT J REHABIL RES, V23, P295, DOI 10.1097/00004356-200023040-00005; McPherson KM, 2000, DISABIL REHABIL, V22, P683, DOI 10.1080/096382800445489; Minnes P, 2000, BRAIN INJURY, V14, P737; Morris KC, 2001, BRAIN INJURY, V15, P239, DOI 10.1080/02699050010004068; Moules S, 1999, BRAIN INJURY, V13, P983; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; ODDY M, 1995, TRAUMATIC BRAIN INJU, P167; Perlesz A, 1998, INT J REHABIL RES, V21, P339, DOI 10.1097/00004356-199812000-00001; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Public Health Resource Unit, 2007, CRIT APPR SKILLS PRO; Riley GA, 2007, CLIN REHABIL, V21, P82, DOI 10.1177/0269215506071279; Rivera P, 2007, NEUROREHABILITATION, V22, P3; ROMANO MD, 1974, SCAND J REHABIL MED, V6, P1; SACHS PR, 1991, TREATING FAMILIES BR; Sander AM, 1997, BRAIN INJURY, V11, P235, DOI 10.1080/026990597123548; Sinnakaruppan I, 2001, BRAIN INJURY, V15, P653; Sinnakaruppan I, 2001, INT J REHABIL RES, V24, P35, DOI 10.1097/00004356-200103000-00005; Smith MJ, 2006, J HEAD TRAUMA REHAB, V21, P76, DOI 10.1097/00001199-200601000-00008; Tabish A, 2006, INJURY, V37, P410, DOI 10.1016/j.injury.2006.01.039; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TENNANT A, 1995, BRAIN INJURY, V9, P595, DOI 10.3109/02699059509008218; Teri L, 1997, J GERONTOL B-PSYCHOL, V52, pP159, DOI 10.1093/geronb/52B.4.P159; Thomsen I V, 1974, Scand J Rehabil Med, V6, P180; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Toner H, 1987, BRIT J CLIN SOCIAL P, V5, P24; Twibell R S, 1998, Dimens Crit Care Nurs, V17, P100; Tyerman A, 2001, NEUROREHABILITATION; Van Baalen B, 2007, BRAIN INJURY, V21, P925, DOI 10.1080/02699050701553197; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; Watanabe Y, 2001, DISABIL REHABIL, V23, P370; Watanabe Y, 2000, CLIN REHABIL, V14, P172, DOI 10.1191/026921500666833742; Wells R, 2005, BRAIN INJURY, V19, P1105, DOI 10.1080/02699050500150062; Wiles R, 1998, J ADV NURS, V28, P794, DOI 10.1046/j.1365-2648.1998.00709.x; WILLER BS, 1991, ARCH PHYS MED REHAB, V72, P460; Williams J., 1990, J HEAD TRAUMA REHAB, V5, P9, DOI [https://doi.org/10.1097/00001199-199003000-00004, DOI 10.1097/00001199-199003000-00004]; [No title captured]	81	18	20	1	1	MARK ALLEN GROUP	LONDON	ST JUDES CHURCH, DULWICH RD, LONDON, SE24 0PB, ENGLAND	1741-1645	1759-779X		INT J THER REHABIL	Int. J. Ther. Rehabil.	JUN	2008	15	6					263	271		10.12968/ijtr.2008.15.6.29878			9	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	V04QZ	WOS:000213820800008		Green Accepted, Green Submitted			2022-02-06	
J	Dalgic, A; Okay, HO; Gezici, AR; Daglioglu, E; Akdag, R; Ergungor, MF				Dalgic, A.; Okay, H. O.; Gezici, A. R.; Daglioglu, E.; Akdag, R.; Ergungor, M. F.			An effective and less invasive treatment of post-traumatic cerebrospinal fluid fistula: Closed lumbar drainage system	MINIMALLY INVASIVE NEUROSURGERY			English	Article						trauma; cerebrospinal fluid fistula; closed lumbar drainage system; meningitis; treatment	SKULL BASE; SUBARACHNOID CATHETER; MANAGEMENT; PREVENTION; RHINORRHEA; FRACTURES; DIAGNOSIS; LEAK	Cerebrospinal fluid (CSF) leakage may develop when a defect is formed in dural layers by traumatic or iatrogenic processes. Traumatic CSF leakage was encountered in 2 % of head injuries. CSF leakage is an associated feature of 12-30 % of skull base fractures. Numerous treatment modalities are proposed for the management of CSF leaks. A closed lumbar drainage system (CLDS) is recommended as an alternative method to surgery for preventing complications related to leakage. In the present study, we report the clinical details of 46 patients who suffered from rhinorrhea/otorrhea (R/O), three of whom were urgently operated due to other causes like subdural hematoma and tension pneumocephalus. Leakage spontaneously ceased in 26 (60.4%) patients whereas CLDS insertion was found to be necessary in 17 patients. A prophylactic antibiotic regimen was started in the CLDS group and these patients were followed with daily CSF cell counts. Fifteen patients (88.2 %) were successfully treated by CLDS, however meningitis developed in 2 patients (11.7 %). Severe complications like meningitis could be avoided by a simple daily microbiological analysis of CSF.	[Dalgic, A.; Okay, H. O.; Daglioglu, E.; Akdag, R.; Ergungor, M. F.] Ankara Numune Training & Res Hosp, Neurosurg Clin 2, Ankara, Turkey; [Gezici, A. R.] Abant Izzet Baysal Univ, Izzet Baysal Fac Med, Dept Neurosurg, Bolu, Turkey		Dalgic, A (corresponding author), Yenicag Mah Serdar Sok 77-3, TR-06170 Ankara, Turkey.	dalgica@superonline.com	DALGIC, Ali/ABF-9665-2021; Daglioglu, Ergun/AAV-4708-2021	DALGIC, Ali/0000-0003-1000-2811			Acikbas SC, 2002, ACTA NEUROCHIR, V144, P475, DOI 10.1007/s007010200068; Basauri LT, 1999, CRIT REV NEUROSURG, V9, P21, DOI 10.1007/s003290050104; FRIEDMAN AJ, 2000, NEUROSURG FOCUS, V9, P1; Kerr JT, 2005, OTOLARYNG CLIN N AM, V38, P597, DOI 10.1016/j.otc.2005.03.011; Lee TJ, 2004, LARYNGOSCOPE, V114, P1475, DOI 10.1097/00005537-200408000-00029; PIEK J, 2000, NEUROSURG FOCUS, V9, P1; Puzzilli F, 1998, NEUROSURG REV, V21, P237, DOI 10.1007/BF01105778; Raine C, 2005, OTOLARYNG CLIN N AM, V38, P583, DOI 10.1016/j.otc.2005.03.009; Selesnick SH, 2004, OTOL NEUROTOL, V25, P580, DOI 10.1097/00129492-200407000-00027; SHAPIRO SA, 1992, NEUROSURGERY, V30, P241, DOI 10.1227/00006123-199202000-00015; SHEKAR L, 1991, NEUROSURGERY, V28, P882; SNOW RB, 1991, NEUROSURGERY, V28, P880, DOI 10.1227/00006123-199106000-00016; Trotter MI, 2002, ANN ROY COLL SURG, V84, P64; Villalobos T, 1998, CLIN INFECT DIS, V27, P364, DOI 10.1086/514666; VOURCH G, 1963, BRIT J ANAESTH, V35, P118, DOI 10.1093/bja/35.2.118; Yilmazlar S, 2006, NEUROSURG REV, V29, P64, DOI 10.1007/s10143-005-0396-3	16	18	22	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0946-7211			MINIM INVAS NEUROSUR	Minim. Invasive Neurosurg.	JUN	2008	51	3					154	157		10.1055/s-2008-1042437			4	Clinical Neurology; Neuroimaging; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	318UD	WOS:000257117400005	18521786				2022-02-06	
J	Dhandapani, SS; Gupta, A; Vivekanandhan, S; Sharma, BS; Mahapatra, AK				Dhandapani, S. S.; Gupta, Aditya; Vivekanandhan, S.; Sharma, B. S.; Mahapatra, A. K.			Randomized controlled trial of magnesium sulphate in severe closed traumatic brain injury	INDIAN JOURNAL OF NEUROTRAUMA			English	Article						Severe traumatic brain injury; Magnesium sulphate; Pritchard regimen; Outcome		Magnesium decline is likely to play an important role in the pathogenesis of Traumatic Brain Injury (TBI). This study was undertaken to test the therapeutic efficacy and safety of parenterally administered Magnesium sulphate (MgSO4) in patients of severe closed TBI. Adult patients admitted within 12 hours of closed TBI with Glasgow coma score 5 to 8 fulfilling eligibility criteria were randomized to two groups, one group receiving 'standard care' and the other, MgSO4 in addition as per the Pritchard regimen. The outcome measures were Glasgow outcome scale at 3 months and other relevant clinical parameters. Seventy patients were randomized after obtaining informed consent, and 30 in each group remained in the study till 3 months. Favorable outcome was observed in 22 out of 30 patients (73.3%) who had received MgSO 4, as compared with 12 out of 30 (40%) in control group. Univariate analysis revealed an odds ratio (OR) of 4.13 (95% CI 1.39-12.27) and the P value was 0.009. In the logistic regression analysis, the adj. OR was 4.24 (95% CI 1.116.36) and the P value was 0.036. The secondary outcomes analyzed in MgSO4 group showed significant difference with respect to intra-operative brain swelling at the end of surgical decompression and mortality at 1 month. No significant adverse effects were observed. Parenteral MgSO4 appears to have some favorable influence on mortality and intra-operative brain swelling without any significant adverse effects.	[Dhandapani, S. S.; Gupta, Aditya; Sharma, B. S.; Mahapatra, A. K.] All India Inst Med Sci, Neurosci Ctr, Dept Neurosurg, New Delhi, India; [Vivekanandhan, S.] All India Inst Med Sci, Neurosci Ctr, Dept Neurobiochem, New Delhi, India		Gupta, A (corresponding author), AIIMS, Dept Neurosurg, New Delhi 110029, India.		Dhandapani, Sivashanmugam/I-2395-2013	Dhandapani, Sivashanmugam/0000-0002-3497-4255			ANDERSEN BJ, 1992, BRAIN RES, V585, P184, DOI 10.1016/0006-8993(92)91205-S; Bareyre FM, 2000, J NEUROTRAUM, V17, P1029, DOI 10.1089/neu.2000.17.1029; Bareyre FM, 1999, J NEUROCHEM, V73, P271, DOI 10.1046/j.1471-4159.1999.0730271.x; BELFORT MA, 1992, AM J OBSTET GYNECOL, V167, P661, DOI 10.1016/S0002-9378(11)91567-1; BRAAKMAN R, 1980, NEUROSURGERY, V6, P362, DOI 10.1227/00006123-198004000-00002; Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001; Canavero S, 2003, SURG NEUROL, V60, P165, DOI 10.1016/S0090-3019(03)00159-9; CHI OZ, 1990, ARCH INT PHARMACOD T, V304, P196; Duley L, 2002, LANCET, V359, P1877, DOI 10.1016/s0140-6736(02)08778-0; Fox C, 2001, SOUTH MED J, V94, P1195, DOI 10.1097/00007611-200112000-00013; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; Graham DI, 1997, GREENFIELDS NEUROPAT, P197; Heath DL, 1998, J NEUROTRAUM, V15, P183, DOI 10.1089/neu.1998.15.183; Heath DL, 1999, J NEUROSURG, V90, P504, DOI 10.3171/jns.1999.90.3.0504; Heath DL, 1999, J PHARMACOL EXP THER, V288, P180; ISERI LT, 1984, AM HEART J, V108, P188, DOI 10.1016/0002-8703(84)90572-6; JENNETT B, 1975, LANCET, V1, P480; JOHNSON JW, 1990, BIOPHYS J, V57, P1085, DOI 10.1016/S0006-3495(90)82626-6; KURODA Y, 1992, J NEUROSURG, V76, P471, DOI 10.3171/jns.1992.76.3.0471; Lin JY, 2002, LIFE SCI, V71, P803, DOI 10.1016/S0024-3205(02)01738-1; LUCAS MJ, 1995, NEW ENGL J MED, V333, P201, DOI 10.1056/NEJM199507273330401; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; McIntosh TK, 1988, J NEUROTRAUM, V5, P17, DOI 10.1089/neu.1988.5.17; Memon ZI, 1995, SCAND J CLIN LAB INV, V55, P671, DOI 10.3109/00365519509075397; OKIYAMA K, 1995, J NEUROCHEM, V64, P802; Polderman KH, 2000, CRIT CARE MED, V28, P2022, DOI 10.1097/00003246-200006000-00057; PRITCHARD JA, 1984, AM J OBSTET GYNECOL, V148, P951, DOI 10.1016/0002-9378(84)90538-6; Reilly PL, 2001, J CLIN NEUROSCI, V8, P398, DOI 10.1054/jocn.2001.0916; SIBAI BM, 1984, AM J OBSTET GYNECOL, V150, P728, DOI 10.1016/0002-9378(84)90676-8; SMITH DH, 1993, NEUROSCI LETT, V157, P211, DOI 10.1016/0304-3940(93)90739-8; Tandon PN, 2001, NEUROL INDIA, V49, P3; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; van den Bergh WM, 2005, STROKE, V36, P1011, DOI 10.1161/01.STR.0000160801.96998.57; van den Heuvel Corinna, 2004, Clin Calcium, V14, P9; Vanden Veyyer IB, 1994, J MATERN FETAL MED, V3, P9; VINK R, 1987, BIOCHEM BIOPH RES CO, V149, P594, DOI 10.1016/0006-291X(87)90409-8; VINK R, 1988, J BIOL CHEM, V263, P757; Vink R, 2001, CLIN EXP PHARMACOL P, V28, P919, DOI 10.1046/j.1440-1681.2001.03548.x	40	18	18	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0973-0508	2213-3739		INDIAN J NEUROTRAUM	Indian J. Neurotrauma	JUN	2008	5	1					27	33		10.1016/S0973-0508(08)80025-1			7	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V3M0G	WOS:000218378100007					2022-02-06	
J	Asloun, S; Soury, S; Couillet, J; Giroire', JM; Joseph, PA; Mazaux, JM; Azouvi, P				Asloun, Sybille; Soury, Stephane; Couillet, Josette; Giroire', Jean-Michel; Joseph, Pierre-Alain; Mazaux, Jean-Michel; Azouvi, Philippe			Interactions between divided attention and working-memory load in patients with severe traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						traumatic brain injury; executive functions; working memory; divided attention	DUAL-TASK PERFORMANCE; NEURAL BASIS; PREFRONTAL CORTEX; HEAD-INJURY; IMPAIRMENTS; ACTIVATION; COMA	The aim of this study was to assess the relationships between divided-attention deficits and working-memory limitations after severe traumatic brain injury (TBI). Severe TBI patients (n = 43) and controls were given a n-back task of three different load levels, which was performed as a single and a dual task. Patients demonstrated, as expected, a difficulty in dual-task processing and an increased susceptibility to high working-memory load, but dual-task performance and working-memory load did not interact as expected. These results are in accordance with recent findings suggesting that dual-task performance and other working-memory functions represent dissociable although interrelated abilities.	[Asloun, Sybille; Couillet, Josette; Azouvi, Philippe] Hop Raymond Poincare, Dept Phys Med & Rehabil, INSERM, UPMC 731, F-92380 Garches, France; [Asloun, Sybille; Couillet, Josette; Azouvi, Philippe] Univ Versailles, Dept Phys Med & Rehabil, F-78000 Versailles, France; [Soury, Stephane; Giroire', Jean-Michel; Joseph, Pierre-Alain; Mazaux, Jean-Michel] CHU Pellegrin, Dept Phys Med & Rehabil, Bordeaux, France		Azouvi, P (corresponding author), Hop Raymond Poincare, Dept Phys Med & Rehabil, INSERM, UPMC 731, F-92380 Garches, France.	philippe.azouvi@rpc.aphp.fr					Adcock RA, 2000, P NATL ACAD SCI USA, V97, P3567, DOI 10.1073/pnas.060588897; Azouvi P, 2004, NEUROPSYCHOLOGIA, V42, P1260, DOI 10.1016/j.neuropsychologia.2004.01.001; Azouvi P, 1996, J CLIN EXP NEUROPSYC, V18, P317, DOI 10.1080/01688639608408990; Baddeley A, 1998, CURR OPIN NEUROBIOL, V8, P234, DOI 10.1016/S0959-4388(98)80145-1; Baddeley A, 1997, NEUROPSYCHOLOGY, V11, P187, DOI 10.1037/0894-4105.11.2.187; Baddeley A., 2002, PRINCIPLES FRONTAL L, P246, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0016; Baddeley A.D., 1986, WORKING MEMORY; Bennett PC, 2005, J INT NEUROPSYCH SOC, V11, P376, DOI 10.1017/S1355617705050423; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; BROUWER WH, 1989, CORTEX, V25, P219, DOI 10.1016/S0010-9452(89)80038-3; Bublak P, 2000, J CLIN EXP NEUROPSYC, V22, P176, DOI 10.1076/1380-3395(200004)22:2;1-1;FT176; Bunge SA, 2000, P NATL ACAD SCI USA, V97, P3573, DOI 10.1073/pnas.050583797; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Collette F, 2002, NEUROSCI BIOBEHAV R, V26, P105, DOI 10.1016/S0149-7634(01)00063-X; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; GUM T, 1992, PSYCHLAB SOFTWARE; Hart T, 1993, J HEAD TRAUMA REHAB, V8, P1; Klingberg T, 1998, CEREB CORTEX, V8, P593, DOI 10.1093/cercor/8.7.593; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; Leclercq M, 2000, J CLIN EXP NEUROPSYC, V22, P339, DOI 10.1076/1380-3395(200006)22:3;1-V;FT339; Leclercq M, 2002, APPLIED NEUROPSYCHOLOGY OF ATTENTION: THEORY DIAGNOSIS AND REHABILITATION, P257; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Ponsford JL, 1991, NEUROPSYCHOL REHABIL, V1, P241, DOI DOI 10.1080/09602019108402257; Smith EE, 2001, P NATL ACAD SCI USA, V98, P2095, DOI 10.1073/pnas.98.4.2095; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; STABLUM F, 1994, CORTEX, V30, P603, DOI 10.1016/S0010-9452(13)80238-9; TEASDALE G, 1974, LANCET, V2, P81; Vallat-Azouvi C, 2007, J INT NEUROPSYCH SOC, V13, P770, DOI 10.1017/S1355617707070993; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; van Zomeren AH, 1984, CLOSED HEAD INJURY P, P74; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Veltman JC, 1996, NEUROPSYCHOLOGY, V10, P357, DOI 10.1037/0894-4105.10.3.357; Vilkki J, 1996, NEUROPSYCHOLOGIA, V34, P1051, DOI 10.1016/0028-3932(96)00028-0; Wilson BA, 1998, NEUROPSYCHOL REHABIL, V8, P213, DOI 10.1080/713755570; [No title captured]	45	18	18	0	12	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	MAY	2008	30	4					481	490		10.1080/13803390701550144			10	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	303FM	WOS:000256026400009	18415888				2022-02-06	
J	Wright, DW; Clark, PL; Pentz, RD; Hertzberg, V; Kellermann, AL				Wright, David W.; Clark, Pamela L.; Pentz, Rebecca D.; Hertzberg, Vicki; Kellermann, Arthur L.			Enrolling subjects by exception from consent versus proxy consent in trauma care research	ANNALS OF EMERGENCY MEDICINE			English	Article							EMERGENCY RESEARCH CIRCUMSTANCES; ADMINISTRATIONS FINAL RULE; INFORMED-CONSENT; COMMUNITY CONSULTATION; CLINICAL-TRIAL; BRAIN-INJURY; TUSKEGEE SYPHILIS; HEMORRHAGIC-SHOCK; WAIVER; FOOD	Study objective: For clinical research, the consent process plays a critical role in protecting human subjects. In emergency research, proxy consent can impose substantial delays or even render a study infeasible if the intervention involves a highly time-sensitive treatment. The objective of this study is to compare the time required to enroll brain-injured trauma patients in a study with proxy consent versus exception from consent. Methods: We analyzed data from a clinical trial (Progesterone for Traumatic brain injury-Experimental Clinical Treatment-ProTECT) of a promising treatment for acute brain injury that used proxy consent for subject enrollment. Performance metrics using proxy consent (actual study) were compared to assumptions of what would have happened if the study had been conducted with exception from consent (hypothetical study). The total number and monthly rate of enrollees, mean time from injury to initiation of the study treatment, and number of subjects receiving unwanted treatment for any span of time were compared. Results: During the 30-month enrollment period, the actual study accrued 100 consenting subjects (3.3 per month) compared with 122 subjects (4.1 per month) for the hypothetical study. Mean time from injury to initiation of experimental treatment in the actual study was 379.2 standard deviation 118.0 minutes, approximately 6.3 hours, compared with 122 minutes in the hypothetical study. Conclusion: Exception from consent can reduce mean time from injury to initiation of study treatment of trauma patients by 4 hours or more. For a time-critical trauma care intervention, this difference may justify elaborate efforts to comply with the Final Rule.	[Wright, David W.; Clark, Pamela L.; Kellermann, Arthur L.] Emory Univ, Sch Med, Dept Emergency Med, Atlanta, GA 30322 USA; [Hertzberg, Vicki] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Pentz, Rebecca D.] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA		Wright, DW (corresponding author), Emory Univ, Sch Med, Dept Emergency Med, Atlanta, GA 30322 USA.		Wright, David/F-1209-2013	Wright, David/0000-0002-7145-9105	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039097, R34NS055465] Funding Source: NIH RePORTER; NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR000454] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R34 NS055465, 1 RO-1 NS-39097A1] Funding Source: Medline		[Anonymous], 1991, Fed Regist, V56, P28025; [Anonymous], 1996, Fed Regist, V61, P51498; Baren JM, 1999, ACAD EMERG MED, V6, P1210, DOI 10.1111/j.1553-2712.1999.tb00135.x; Biros MH, 2003, ANN EMERG MED, V42, P550, DOI 10.1067/S0196-0644(03)00490-6; BIROS MH, 1995, JAMA-J AM MED ASSOC, V273, P1283, DOI 10.1001/jama.273.16.1283; Biros MH, 1996, ACAD EMERG MED, V3, P101, DOI 10.1111/j.1553-2712.1996.tb03395.x; Biros MH, 1998, ACAD EMERG MED, V5, P359, DOI 10.1111/j.1553-2712.1998.tb02722.x; Biros MH, 1999, ACAD EMERG MED, V6, P1272, DOI 10.1111/j.1553-2712.1999.tb00144.x; Davis Arlene M, 1998, IRB, V20, P1, DOI 10.2307/3563732; Dix ES, 2004, J INVEST MED, V52, P113, DOI 10.1136/jim-52-02-20; Ernst AA, 2005, ACAD EMERG MED, V12, P1050, DOI 10.1197/j.aem.2005.06.015; Gamble VN, 1997, AM J PUBLIC HEALTH, V87, P1773, DOI 10.2105/AJPH.87.11.1773; *I MED, 2006, FUT EM CAR US HLTH S; Kremers MS, 1999, ANN EMERG MED, V33, P224, DOI 10.1016/S0196-0644(99)70399-9; Lewis RJ, 2001, ANN EMERG MED, V38, P397, DOI 10.1067/mem.2001.118223; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; McGee G, 2005, ACAD EMERG MED, V12, P1019, DOI 10.1197/j.aem.2005.07.023; Moler FW, 2004, PEDIATRICS, V114, P859, DOI 10.1542/peds.2004-1458; Mosesso VN, 2004, RESUSCITATION, V61, P29, DOI 10.1016/j.resuscitation.2003.11.016; Pape TLB, 2004, J REHABIL RES DEV, V41, P155, DOI 10.1682/JRRD.2004.02.0155; Prentice Ernest D, 1994, IRB, V16, P16, DOI 10.2307/3563576; Prentice Ernest D, 1993, IRB, V15, P1, DOI 10.2307/3563728; Saver Jeffrey L, 2007, Acad Emerg Med, V14, pe57, DOI 10.1197/j.aem.2006.11.023; SAYRE MR, 2005, NATL EMS RES AGENDA; Schmidt TA, 2003, ANN EMERG MED, V41, P79, DOI 10.1067/mem.2003.17; Shah AN, 2003, ANN EMERG MED, V41, P72, DOI 10.1067/mem.2003.14; Sloan EP, 1999, ACAD EMERG MED, V6, P1203; *US FDA, 2006, 1995S 0158 COMM DISC; Valenzuela TD, 2001, NEW ENGL J MED, V345, P689, DOI 10.1056/NEJM200108303450909; Vincent VN, 2005, ACAD EMERG MED, V12, P1031, DOI 10.1197/j.aem.2005.06.021; White RM, 2002, HASTINGS CENT REP, V32, P4, DOI 10.2307/3528121; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2005, J CLIN PHARMACOL, V45, P640, DOI 10.1177/0091270005276201	33	18	18	0	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0196-0644			ANN EMERG MED	Ann. Emerg. Med.	APR	2008	51	4					355	360		10.1016/j.annemergmed.2007.08.021			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	283PG	WOS:000254648000003	17933428				2022-02-06	
J	Knyazev, GG; Levin, EA; Savostyanov, AN				Knyazev, Gennady G.; Levin, Evgenij A.; Savostyanov, Alexander N.			A failure to stop and attention fluctuations: An evoked oscillations study of the stop-signal paradigm	CLINICAL NEUROPHYSIOLOGY			English	Article						EEG; evoked oscillations; stop-signal task; inhibition; attention	EVENT-RELATED POTENTIALS; INHIBITORY MOTOR CONTROL; TRAUMATIC BRAIN-INJURY; DEFICIT HYPERACTIVITY DISORDER; DEFICIT/HYPERACTIVITY DISORDER; ERP COMPONENTS; RESPONSES; EEG; IMPULSIVITY; CHILDREN	Objective: It is not always clear whether inhibition or attention deficit underlies a failure to stop a prepared motor response. One possible way to approach this question is to resort to measures of evoked oscillations since functional correlates of different frequency oscillations are relatively well understood. Methods: The present study examined event-related oscillations during a stop-signal task in non-clinical adults. In 25% of trials of an auditory discrimination tasks subjects had to refrain from a prepared motor response. Results: In successful stop trials, the Go N2 peaked later and the Stop N2 peaked earlier than in failed stop trials. Relative to successful, failed stop trials were associated with a larger N1-N2 and Go P3, and a smaller Stop P3 in the central and posterior cortical regions. The latter effect was exclusively determined by evoked delta oscillations, whereas all other frequency bands contributed to enhanced responses in failed comparative to successful stop trials. Conclusions: The sum of presented evidence seems to show that success or failure to stop mostly depends on how the subject prepares for the Go and Stop stimuli in advance. If attention is more directed towards the Stop signal, the stopping succeeds, otherwise it fails. Significance: These data may contribute to understanding the cognitive basis of successful and unsuccessful stopping performance. (C) 2007 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.	[Knyazev, Gennady G.; Levin, Evgenij A.; Savostyanov, Alexander N.] Russian Acad Med Sci, State Res Inst Physiol, Siberian Branch, Novosibirsk 630117, Russia		Knyazev, GG (corresponding author), Russian Acad Med Sci, State Res Inst Physiol, Siberian Branch, Timakova St 4, Novosibirsk 630117, Russia.	G.G.Knyazev@iph.ma.nsc.ru	Savostyanov, Alexander N./N-3020-2014; Savostyanov, Alexander Nikolaevich/AAS-6968-2020; Levin, Evgeny A./AAQ-4558-2021; Knyazev, Gennady G/F-6095-2010	Levin, Evgeny A./0000-0002-1338-5881; Knyazev, Gennady G/0000-0002-8628-4678			Avila C, 2004, J ABNORM CHILD PSYCH, V32, P295, DOI 10.1023/B:JACP.0000026143.70832.4b; BASAR E, 1984, INT J NEUROSCI, V24, P1, DOI 10.3109/00207458409079530; BASAREROGLU C, 1992, INT J PSYCHOPHYSIOL, V13, P161, DOI 10.1016/0167-8760(92)90055-G; Bekker EM, 2005, COGNITIVE BRAIN RES, V22, P221, DOI 10.1016/j.cogbrainres.2004.08.011; Bekker EM, 2005, INT J PSYCHOPHYSIOL, V55, P191, DOI 10.1016/j.ijpsycho.2004.07.005; Belleville S, 2007, NEUROPSYCHOLOGY, V21, P458, DOI 10.1037/0894-4105.21.4.458; Brandeis D, 1998, BEHAV BRAIN RES, V94, P111, DOI 10.1016/S0166-4328(97)00174-5; Chamberlain SR, 2007, CURR OPIN PSYCHIATR, V20, P255, DOI 10.1097/yco.0b013e3280ba4989; DEJONG R, 1995, J EXP PSYCHOL HUMAN, V21, P498, DOI 10.1037/0096-1523.21.3.498; DEJONG R, 1990, J EXP PSYCHOL HUMAN, V16, P164, DOI 10.1037/0096-1523.16.1.164; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dimoska A, 2003, BIOL PSYCHIAT, V54, P1345, DOI 10.1016/S0006-3223(03)00703-0; Falkenstein M, 1999, ACTA PSYCHOL, V101, P267, DOI 10.1016/S0001-6918(99)00008-6; Farrow M, 2007, J CLIN EXP NEUROPSYC, V29, P235, DOI 10.1080/13803390600657693; Fell J, 2004, J COGNITIVE NEUROSCI, V16, P1595, DOI 10.1162/0898929042568514; Fuentemilla LI, 2006, NEUROIMAGE, V30, P909, DOI 10.1016/j.neuroimage.2005.10.036; Hummel F, 2002, BRAIN, V125, P404, DOI 10.1093/brain/awf030; INTRILIGATOR J, 1995, INT J PSYCHOPHYSIOL, V20, P59, DOI 10.1016/0167-8760(95)00028-Q; Jonkman LM, 2004, CLIN NEUROPHYSIOL, V115, P1537, DOI 10.1016/j.clinph.2004.01.022; Kenemans JL, 2005, INT J PSYCHOPHYSIOL, V58, P59, DOI 10.1016/j.ijpsycho.2005.03.009; Klimesch W, 2000, NEUROSCI LETT, V284, P97, DOI 10.1016/S0304-3940(00)00985-X; Klimesch W, 1999, COGNITIVE BRAIN RES, V7, P493, DOI 10.1016/S0926-6410(98)00056-1; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Knyazev GG, 2007, NEUROSCI BIOBEHAV R, V31, P377, DOI 10.1016/j.neubiorev.2006.10.004; KOK A, 1986, BIOL PSYCHOL, V23, P21, DOI 10.1016/0301-0511(86)90087-6; Kok A, 2004, PSYCHOPHYSIOLOGY, V41, P9, DOI 10.1046/j.1469-8986.2003.00127.x; Laufs H, 2003, P NATL ACAD SCI USA, V100, P11053, DOI 10.1073/pnas.1831638100; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; LOGAN GD, 1984, J EXP PSYCHOL HUMAN, V10, P276, DOI 10.1037/0096-1523.10.2.276; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; LOGAN GD, INHIBITORY PROCESSES, P189; Makeig S, 2002, SCIENCE, V295, P690, DOI 10.1126/science.1066168; Makinen V, 2005, NEUROIMAGE, V24, P961, DOI 10.1016/j.neuroimage.2004.10.020; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Mur M, 2007, J CLIN PSYCHIAT, V68, P1078, DOI 10.4088/JCP.v68n0715; Naito E, 1996, NEUROPSYCHOLOGIA, V34, P565, DOI 10.1016/0028-3932(95)00140-9; Nieuwenhuis S, 2003, COGN AFFECT BEHAV NE, V3, P17, DOI 10.3758/CABN.3.1.17; Overtoom CCE, 2002, BIOL PSYCHIAT, V51, P668, DOI 10.1016/S0006-3223(01)01290-2; PFEFFERBAUM A, 1985, ELECTROEN CLIN NEURO, V60, P423, DOI 10.1016/0013-4694(85)91017-X; Pfurtscheller G, 2000, CLIN NEUROPHYSIOL, V111, P1873, DOI 10.1016/S1388-2457(00)00428-4; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; PICTON TW, 1992, J CLIN NEUROPHYSIOL, V9, P456, DOI 10.1097/00004691-199210000-00002; Quay HC, 1997, J ABNORM CHILD PSYCH, V25, P7, DOI 10.1023/A:1025799122529; Rodriguez PD, 2007, BEHAV NEUROL, V18, P115, DOI 10.1155/2007/865717; Roschke J, 1997, NEUROPSYCHOBIOLOGY, V35, P108, DOI 10.1159/000119400; SCHACHAR R, 1990, DEV PSYCHOL, V26, P710, DOI 10.1037/0012-1649.26.5.710; Schurmann M, 2001, INT J PSYCHOPHYSIOL, V39, P229, DOI 10.1016/S0167-8760(00)00144-6; Tanji K, 2005, J NEUROSCI, V25, P3287, DOI 10.1523/JNEUROSCI.4948-04.2005; Tannock R, 1998, J CHILD PSYCHOL PSYC, V39, P65, DOI 10.1111/1469-7610.00304; Treitz FH, 2007, AGING NEUROPSYCHOL C, V14, P370, DOI 10.1080/13825580600678442; van Boxtel GJM, 2001, BIOL PSYCHOL, V58, P229, DOI 10.1016/S0301-0511(01)00117-X; Whelan BM, 2007, J HEAD TRAUMA REHAB, V22, P192, DOI 10.1097/01.HTR.0000271120.04405.db; Whitmer AJ, 2007, PSYCHOL SCI, V18, P546, DOI 10.1111/j.1467-9280.2007.01936.x; WOLDORFF MG, 1993, PSYCHOPHYSIOLOGY, V30, P98, DOI 10.1111/j.1469-8986.1993.tb03209.x; WOLDORFF MG, 1991, ELECTROEN CLIN NEURO, V79, P170, DOI 10.1016/0013-4694(91)90136-R	55	18	19	0	17	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	MAR	2008	119	3					556	567		10.1016/j.clinph.2007.11.041			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	277ZN	WOS:000254253300006	18164656				2022-02-06	
J	Lima, RR; Guimaraes-Silva, J; Oliveira, JL; Costa, AMR; Souza-Rodrigues, RD; Dos Santos, CD; Picanco-Diniz, CW; Gomes-Leal, W				Lima, Rafael R.; Guimaraes-Silva, Joanilson; Oliveira, Jorge L.; Costa, Ana Maria R.; Souza-Rodrigues, Renata D.; Dos Santos, Claudia D.; Picanco-Diniz, Cristovam W.; Gomes-Leal, Walace			Diffuse axonal damage, myelin impairment, astrocytosis and inflammatory response following microinjections of NMDA into the rat striatum	INFLAMMATION			English	Article						white matter damage; basal ganglia; excitotoxicity; neutrophils; macrophages	SPINAL-CORD-INJURY; CENTRAL-NERVOUS-SYSTEM; WHITE-MATTER INJURY; VASCULAR MECHANISMS; THERAPEUTIC TARGET; CEREBRAL-ISCHEMIA; HEAD-INJURY; BETA-APP; CNS; MACROPHAGES	White matter damage and inflammatory response are important secondary outcomes after acute neural disorders. Nevertheless, a few studies addressed the temporal outcomes of these pathological events using non-traumatic models of acute brain injury. In the present study, we describe acute inflammatory response and white matter neuropathology between 1 and 7 days after acute excitotoxic striatal damage. Twenty micrometer sections were stained by hematoxylin and eosin technique for gross histopathological analysis and immunolabed for neutrophils (anti-mbs-1), activated macrophages/microglia (anti-ed1), astrocytes (anti-gfap), damaged axons (anti-beta app) and myelin basic protein (MBP). Recruitment peak of neutrophils and macrophages occurred at 1 and 7 days post-nmda injection, respectively. Diffuse damaged axons (beta-app + end-bulbs) were apparent at 7 days, concomitant with progressive myelin impairment and astrocytosis. Further studies using electron microscopy and blockers of inflammatory response and glutamatergic receptors should be performed to confirm and address the mechanisms of white matter damage following an excitotoxic lesion.	[Gomes-Leal, Walace] Univ Lund Hosp, Lund Strateg Res Ctr Stem Cell Biol & Cell Therap, SE-22184 Lund, Sweden; [Gomes-Leal, Walace] Univ Lund Hosp, Wallenberg Neurosci Ctr, Sect Restorat Neurol, Lab Neurogenet Cell Therapy, SE-22184 Lund, Sweden; [Lima, Rafael R.; Guimaraes-Silva, Joanilson; Oliveira, Jorge L.; Costa, Ana Maria R.; Souza-Rodrigues, Renata D.; Dos Santos, Claudia D.; Picanco-Diniz, Cristovam W.; Gomes-Leal, Walace] Fed Univ Para, Dept Morphol, Ctr Biol Sci, Lab Expt Neuroprotect & Neuroregenerat, BR-66075900 Belem, Para, Brazil		Gomes-Leal, W (corresponding author), Univ Lund Hosp, Lund Strateg Res Ctr Stem Cell Biol & Cell Therap, SE-22184 Lund, Sweden.	leal@ufpa.br	Gomes-Leal, Walace/AAO-9171-2021; Diniz, Cristovam W.P./G-1474-2010; Lima, Rafael Rodrigues/M-7726-2019; Souza-Rodrigues, Renata Duarte/AAL-7367-2021	Diniz, Cristovam W.P./0000-0001-6611-6880; Lima, Rafael Rodrigues/0000-0003-1486-4013; 			Anderson CM, 2000, GLIA, V32, P1; Aschner M, 1998, NEUROTOXICOLOGY, V19, P269; Aschner M, 1998, NEUROTOXICOLOGY, V19, P7; AYRES M, 2005, BIOSTAT 4 0; BLIGHT AR, 1994, NEUROSCIENCE, V60, P263, DOI 10.1016/0306-4522(94)90220-8; Bolton SJ, 1998, EXP NEUROL, V154, P231, DOI 10.1006/exnr.1998.6927; Carlson SL, 1998, EXP NEUROL, V151, P77, DOI 10.1006/exnr.1998.6785; Coleman MP, 2002, TRENDS NEUROSCI, V25, P532, DOI 10.1016/S0166-2236(02)02255-5; Dommergues MA, 2003, NEUROSCIENCE, V121, P619, DOI 10.1016/S0306-4522(03)00558-X; Dos Santos CD, 2007, BRAIN RES, V1172, P130, DOI 10.1016/j.brainres.2007.07.037; Esiri MM, 2007, J NEUROIMMUNOL, V184, P4, DOI 10.1016/j.jneuroim.2006.11.013; Frost SB, 2006, BEHAV BRAIN RES, V169, P206, DOI 10.1016/j.bbr.2006.01.014; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Goda M, 2002, J NEUROTRAUM, V19, P1445, DOI 10.1089/089771502320914679; Gomes-Leal W, 2005, BRAIN RES, V1066, P57, DOI 10.1016/j.brainres.2005.10.069; Gomes-Leal W, 2004, EXP NEUROL, V190, P456, DOI 10.1016/j.expneurol.2004.06.028; Hamby AM, 2007, STROKE, V38, P632, DOI 10.1161/01.STR.0000250742.61241.79; Hughes PM, 2003, J NEUROPATH EXP NEUR, V62, P1276, DOI 10.1093/jnen/62.12.1276; Irving EA, 2001, ACTA NEUROPATHOL, V102, P627, DOI 10.1007/s004010100416; Jones TB, 2005, CURR PHARM DESIGN, V11, P1223, DOI 10.2174/1381612053507468; Kanellopoulos GK, 2000, STROKE, V31, P1945, DOI 10.1161/01.STR.31.8.1945; Karadottir R, 2005, NATURE, V438, P1162, DOI 10.1038/nature04302; Knoller N, 2005, J NEUROSURG-SPINE, V3, P173, DOI 10.3171/spi.2005.3.3.0173; Lazarov-Spiegler O, 1998, MOL MED TODAY, V4, P337, DOI 10.1016/S1357-4310(98)01298-2; Li S, 2001, NEUROSCIENCE, V107, P675, DOI 10.1016/S0306-4522(01)00385-2; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Mahapatra RK, 2004, LANCET NEUROL, V3, P736, DOI 10.1016/S1474-4422(04)00936-6; Matute C, 2007, J ANAT, V210, P693, DOI 10.1111/j.1469-7580.2007.00733.x; Matute C, 2006, TRENDS MOL MED, V12, P289, DOI 10.1016/j.molmed.2006.05.004; McKenzie KJ, 1996, ACTA NEUROPATHOL, V92, P608, DOI 10.1007/s004010050568; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Mitsios N, 2006, PATHOBIOLOGY, V73, P159, DOI 10.1159/000096017; Popovich PG, 1999, EXP NEUROL, V158, P351, DOI 10.1006/exnr.1999.7118; Popovich PG, 2001, J NEUROPATH EXP NEUR, V60, P676, DOI 10.1093/jnen/60.7.676; Popovich PG, 2002, J NEUROPATH EXP NEUR, V61, P623, DOI 10.1093/jnen/61.7.623; Rapalino O, 1998, NAT MED, V4, P814, DOI 10.1038/nm0798-814; ROBINSON AP, 1986, IMMUNOLOGY, V57, P239; Rogove AD, 1998, CURR BIOL, V8, P19, DOI 10.1016/S0960-9822(98)70016-8; Schabitz WR, 2000, STROKE, V31, P1709, DOI 10.1161/01.STR.31.7.1709; Schnell L, 1999, EUR J NEUROSCI, V11, P3648, DOI 10.1046/j.1460-9568.1999.00792.x; Schwartz M, 2006, TRENDS NEUROSCI, V29, P68, DOI 10.1016/j.tins.2005.12.005; Stys PK, 2005, J NEUROL SCI, V233, P3, DOI 10.1016/j.jns.2005.03.031; Tator CH, 1997, J NEUROSURG, V86, P483, DOI 10.3171/jns.1997.86.3.0483; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Taylor TN, 1996, STROKE, V27, P1459, DOI 10.1161/01.STR.27.9.1459; Verkhratsky A, 2007, NEUROSCIENTIST, V13, P28, DOI 10.1177/1073858406294270; Yi L, 2005, GLIA, V49, P407, DOI 10.1002/glia.20126; Yoles E, 1998, EXP NEUROL, V153, P1, DOI 10.1006/exnr.1998.6811	49	18	20	0	2	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0360-3997	1573-2576		INFLAMMATION	Inflammation	FEB	2008	31	1					24	35		10.1007/s10753-007-9046-y			12	Cell Biology; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Immunology	260JR	WOS:000253007100003	17899345				2022-02-06	
J	Huttemann, M; Lee, I; Kreipke, CW; Petrov, T				Huttemann, M.; Lee, I.; Kreipke, C. W.; Petrov, T.			Suppression of the inducible form of nitric oxide synthase prior to traumatic brain injury improves cytochrome c oxidase activity and normalizes cellular energy levels	NEUROSCIENCE			English	Article						trauma; mitochondria; iNOS; cytochrome c oxidase; nitric oxide; ATP	EXPRESSION; ENDOTHELIN-1; CALCIUM; OXYGEN; PHOSPHORYLATION; HYPOPERFUSION; RESPIRATION; DYSFUNCTION; METABOLISM; MODEL	We have previously shown that the observed immediate increase in nitric oxide (NO) plays a significant role in the control of the cerebral microcirculation following traumatic brain injury (TBI). However, a second consequence of increased NO production after TBI may be impaired mitochondrial function, due to the fact that NO is a well-known inhibitor of cytochrome c oxidase (CcO). CcO is a key enzyme of the mitochondrial oxidative phosphorylation (OxPhos) machinery, which creates cellular energy in the form of ATP. NO competes with oxygen at the heme a(3)-Cu-B reaction center of CcO. We thus hypothesized that TBI triggers inhibition of CcO, which would in turn lead to a decreased energy production by OxPhos at a time of an elevated energy demand for tissue remodeling. Here we show that TBI as induced by an acceleration weight drop model of diffuse brain injury in rats leads to CcO inhibition and dramatically decreased ATP levels in brain cortex. CcO inhibition can be partially restored by application of iNOS antisense oligonucleotides prior to TBI, which leads to a normalization of ATP levels similar to the controls. We propose that a lack of energy after TBI caused by inhibition of CcO is an important aspect of trauma pathology. (C) 2008 IBRO. Published by Elsevier Ltd. All rights reserved.	[Huttemann, M.; Lee, I.] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA; [Kreipke, C. W.; Petrov, T.] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA		Huttemann, M (corresponding author), Wayne State Univ, Sch Med, Ctr Mol Med & Genet, 540 E Canfield Ave, Detroit, MI 48201 USA.	mhuttema@med.wayne.edu; tpetrov@med.wayne.edu		Huttemann, Maik/0000-0001-6310-7081	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039860] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS39860] Funding Source: Medline		Assreuy Jamil, 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P165; Brookes PS, 2004, MITOCHONDRION, V3, P187, DOI 10.1016/j.mito.2003.10.001; BROWN GC, 1994, FEBS LETT, V356, P295, DOI 10.1016/0014-5793(94)01290-3; Brown GC, 2001, BBA-BIOENERGETICS, V1504, P46, DOI 10.1016/S0005-2728(00)00238-3; Clark RSB, 1996, PEDIATR RES, V39, P784, DOI 10.1203/00006450-199605000-00007; Cuzzocrea S, 2006, CURR PHARM DESIGN, V12, P3551, DOI 10.2174/138161206778343082; Fukumura D, 2006, NAT REV CANCER, V6, P521, DOI 10.1038/nrc1910; Giulivi C, 1998, BIOCHEM J, V332, P673, DOI 10.1042/bj3320673; GORREN AC, 2006, BIOCHIM BIOPHYS ACTA, V1770, P432; Hopper RK, 2006, BIOCHEMISTRY-US, V45, P2524, DOI 10.1021/bi052475e; Iadecola C, 1996, STROKE, V27, P1373, DOI 10.1161/01.STR.27.8.1373; Kadenbach B, 2004, BBA-BIOENERGETICS, V1655, P400, DOI 10.1016/j.bbabio.2003.06.005; Lee I, 2005, J BIOL CHEM, V280, P6094, DOI 10.1074/jbc.M411335200; Lee I, 2002, MOL CELL BIOCHEM, V234, P63, DOI 10.1023/A:1015921513720; Louin G, 2004, J NEUROSCI METH, V138, P73, DOI 10.1016/j.jneumeth.2004.03.010; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Napiwotzki J, 1997, BIOL CHEM, V378, P1013, DOI 10.1515/bchm.1997.378.9.1013; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; Petrov T, 1995, J NEUROSCI RES, V42, P835, DOI 10.1002/jnr.490420612; Petrov T, 2001, NEUROL RES, V23, P139, DOI 10.1179/016164101101198479; Petrov T, 2000, ACTA NEUROPATHOL, V100, P196, DOI 10.1007/s004019900167; Rafols D, 2004, NEUROSCI LETT, V362, P154, DOI 10.1016/j.neulet.2004.03.021; Rafols JA, 2007, NEUROL RES, V29, P348, DOI 10.1179/016164107X204657; Springett RJ, 2003, ADV EXP MED BIOL, V530, P555; Steiner J, 2004, NITRIC OXIDE-BIOL CH, V10, P162, DOI 10.1016/j.niox.2004.03.005; Stepp DW, 2006, CLIN EXP PHARMACOL P, V33, P407, DOI 10.1111/j.1440-1681.2006.04381.x; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Verweij BH, 1997, NEUROL RES, V19, P334, DOI 10.1080/01616412.1997.11740821; WONGRILEY M, 1979, BRAIN RES, V171, P11, DOI 10.1016/0006-8993(79)90728-5; [No title captured]	30	18	19	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	JAN 2	2008	151	1					148	154		10.1016/j.neuroscience.2007.09.029			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	254SR	WOS:000252608800015	18037245				2022-02-06	
J	Dolce, G; Riganello, F; Quintieri, M; Candelieri, A; Conforti, D				Dolce, G.; Riganello, F.; Quintieri, M.; Candelieri, A.; Conforti, D.			Personal Interaction in the Vegetative State A Data-Mining Study	JOURNAL OF PSYCHOPHYSIOLOGY			English	Article						vegetative state; autonomic response; mother's voice; heart rate variability; machine-learning procedures	HEART-RATE-VARIABILITY; TRAUMATIC BRAIN-INJURY; OWN NAME; MOTHERS VOICE; CONSCIOUSNESS; RECOGNITION; RESPONSES; HRV	Background and purpose: Brain processing at varying levels of functional complexity and emotional reactions to relatives are anecdotally reported by the caregivers of patients in a vegetative state. In this study, computer-assisted machine-learning procedures were applied to identify heart rate variability changes or galvanic skin responses to a relative's presence. Methods: The skin conductance (galvanic skin response) and heart beats were continuously recorded in 12 patients in a vegetative state, at rest (baseline) and while approached by a relative (usually the mother; test condition) or by a nonfamiliar person (control condition). The cardiotachogram (the series of consecutive intervals between heart beats) was analyzed in the time and frequency domains by computing the parametric and nonparametric frequency spectra. A machine-learning algorithm was applied to sort out the significant spectral parameter(s). For all patients, each condition (baseline, test, control) was characterized by the values of its spectral parameters, and the association between spectral parameters values and experimental condition was tested (WEKA machine-learning software). Results and comments: A galvanic skin response was obtained in two patients. The machine-learning procedure independently selected the nu_LF spectral parameter and attributed each nu_LF measure to any of the three experimental conditions. 69.4% of attributions were correct (baseline: 58%; test condition: 75%; control. 75%). In seven patients, attribution changed when the subject was approached by the test person; specifically, sequential shifts from baseline to test condition ("the Mom effect") to control condition were identified in four patients (30.0%); the change from test to control was attributed correctly in seven patients (58%). The observation of heart rate changes tentatively attributable to emotional reaction in a vegetative state suggest residual rudimentary personal interaction, consistent with functioning limbic and paralimbic systems after massive brain damage. Machine-learning proved applicable to sort significant measure(s) out of large samples and to control for statistical alpha inflation.	[Dolce, G.; Riganello, F.; Quintieri, M.] S Anna Inst, Intens Care Unit, I-88900 Crotone, Italy		Dolce, G (corresponding author), S Anna Inst, Intens Care Unit, Via Siris 11, I-88900 Crotone, Italy.	giulianodolce@libero.it	/AAI-7627-2021; Conforti, Domenico/D-2734-2011; Riganello, Francesco/N-2615-2014; Riganello, Francesco/AAC-3976-2020	/0000-0003-1431-576X; Conforti, Domenico/0000-0002-4816-4333; Riganello, Francesco/0000-0003-0678-9252; Riganello, Francesco/0000-0003-0678-9252	S. Anna Institute, Crotone; Italian Ministry of University and ResearchMinistry of Education, Universities and Research (MIUR)	This research has been supported by the S. Anna Institute, Crotone, and the University of Calabria under the special project "MIMERICA," funded by the Italian Ministry of University and Research ( 2004-2007). Thanks are due to Professors Leon Sazbon, MD ( University of Tel Aviv, Israel) and Walter G. Sannita, MD ( University of Genova, Genova, Italy, and State University of New York, Stony Brook, NY, USA) for continuing support and valuable advice.	APPELHANS BM, 2007, BIOL PSYCHOL, V12; Appelhans BM, 2006, REV GEN PSYCHOL, V10, P229, DOI 10.1037/1089-2680.10.3.229; Barbieri R, 2002, AM J PHYSIOL-REG I, V283, pR1210, DOI 10.1152/ajpregu.00127.2002; Biswas AK, 2000, CRIT CARE MED, V28, P3907, DOI 10.1097/00003246-200012000-00030; Brown S, 2004, NEUROREPORT, V15, P2033, DOI 10.1097/00001756-200409150-00008; Camm AJ, 1996, CIRCULATION, V93, P1043; Chambers AS, 2002, PSYCHOPHYSIOLOGY, V39, P861, DOI 10.1111/1469-8986.3960861; Coleman MR, 2007, BRAIN, V130, P2494, DOI 10.1093/brain/awm170; Critchley HD, 2005, NEUROIMAGE, V24, P751, DOI 10.1016/j.neuroimage.2004.10.013; Di HB, 2007, NEUROLOGY, V68, P895, DOI 10.1212/01.wnl.0000258544.79024.d0; DOLCE G, 1973, ELECTROEN CLIN NEURO, V34, P647, DOI 10.1016/0013-4694(73)90010-2; Dolce G., 2002, POSTTRAUMATIC VEGETA; Eibe F., 2004, MACHINE LEARNING WEK; Frazier TW, 2004, PSYCHOPHYSIOLOGY, V41, P75, DOI 10.1046/j.1469-8986.2003.00131.x; Hildebrandt H, 1998, EUR ARCH PSY CLIN N, V248, P46, DOI 10.1007/s004060050016; HOLTE RC, 1993, MACH LEARN, V11, P63, DOI 10.1023/A:1022631118932; JENNETT B, 1972, LANCET, V1, P734; Jennett B., 2002, VEGETATIVE STATE; JOHN ER, 2008, LANCET IN PRESS; Kamber, 2006, DATA MINING CONCEPTS; Keren O, 2005, BRAIN INJURY, V19, P605, DOI 10.1080/02699050400024946; King ML, 1997, BRAIN INJURY, V11, P445; Kotchoubey B, 2006, J NEUROL, V253, P1374, DOI 10.1007/s00415-006-0221-0; LAFRANCHI PA, 2003, AM J PHYSIOL-REG I, V283, pR815; Laureys S, 2004, NEUROREHABILITATION, V19, P335; Laureys S, 2004, NEUROLOGY, V63, P916, DOI 10.1212/01.WNL.0000137421.30792.9B; Laureys S, 2000, BRAIN, V123, P1589, DOI 10.1093/brain/123.8.1589; Laureys S, 2007, CONSCIOUS COGN, V16, P722, DOI 10.1016/j.concog.2007.04.004; Lehrer PM, 2003, PSYCHOSOM MED, V65, P796, DOI 10.1097/01.PSY.0000089200.81962.19; Levy DA, 2003, PSYCHOPHYSIOLOGY, V40, P291, DOI 10.1111/1469-8986.00031; Luecken LJ, 2005, PSYCHOSOM MED, V67, P514, DOI 10.1097/01.psy.0000160466.10397.18; Machado C, 2007, CLIN EEG NEUROSCI, V38, P124, DOI 10.1177/155005940703800306; Malpas SC, 2002, AM J PHYSIOL-HEART C, V282, pH6, DOI 10.1152/ajpheart.2002.282.1.H6; Mashin V., 2000, HUMAN PHYSL, V26, P420, DOI DOI 10.1007/BF02760270; MEHLER J, 1978, PERCEPTION, V7, P491, DOI 10.1068/p070491; Mizuno K, 2004, ACTA PAEDIATR, V93, P1640, DOI 10.1080/08035250410023115; Nikki S.R., 2004, PSYCHOL MUSIC, V32, P371; Niskanen JP, 2004, COMPUT METH PROG BIO, V76, P73, DOI 10.1016/j.cmpb.2004.03.004; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Owen AM, 2005, NEUROPSYCHOL REHABIL, V15, P290, DOI 10.1080/09602010443000579; Perrin F, 2006, ARCH NEUROL-CHICAGO, V63, P562, DOI 10.1001/archneur.63.4.562; Purhonen M, 2005, COGNITIVE BRAIN RES, V24, P627, DOI 10.1016/j.cogbrainres.2005.03.012; Qiu J, 2007, LANCET NEUROL, V6, P946, DOI 10.1016/S1474-4422(07)70255-7; Rappaport M, 1991, J Neuropsychiatry Clin Neurosci, V3, P180; REITERO N, 2002, AM J PHYSIOL-REG I, V283, pR1327; RIGANELLO F, 2008, J PSYCHOPHY IN PRESS; Schiff ND, 2002, BRAIN, V125, P1210, DOI 10.1093/brain/awf131; Schwarz G, 1987, Funct Neurol, V2, P149; SOSNOWSKI T, 1991, PSYCHOPHYSIOLOGY, V28, P665, DOI 10.1111/j.1469-8986.1991.tb01011.x; Staffen W, 2006, J NEUROL NEUROSUR PS, V77, P1383, DOI 10.1136/jnnp.2006.095166; Sztajzel J, 2004, SWISS MED WKLY, V134, P514; Urakawa K, 2005, TOHOKU J EXP MED, V206, P213, DOI 10.1620/tjem.206.213; VANBEMMEL JH, 1997, HDB MED INFORM; Wijnen VJM, 2007, CLIN NEUROPHYSIOL, V118, P597, DOI 10.1016/j.clinph.2006.11.020; Witten I., 2005, DATA MINING PRACTICA, Vsecond; Yien HW, 1997, CRIT CARE MED, V25, P258, DOI 10.1097/00003246-199702000-00011	56	18	18	0	3	HOGREFE PUBLISHING CORP	BOSTON	361 NEWBURY ST, 5 FL, BOSTON, MA, UNITED STATES	0269-8803	2151-2124		J PSYCHOPHYSIOL	J. Psychophysiol.		2008	22	3					150	156		10.1027/0269-8803.22.3.150			7	Psychology, Biological; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	468TB	WOS:000267843400005					2022-02-06	
J	Mossberg, KA; Orlander, EE; Norcross, JL				Mossberg, Kurt A.; Orlander, Evelyne E.; Norcross, Julie L.			Cardiorespiratory capacity after weight-supported treadmill training in patients with traumatic brain injury	PHYSICAL THERAPY			English	Article; Proceedings Paper	Annual Conference of the American-Physical-Therapy-Association	JUN 22, 2006	Orlando, FL	Amer Phys Therapy Assoc			SPINAL-CORD-INJURY; OXYGEN-CONSUMPTION; WALKING; REHABILITATION; STROKE; GAIT; INDIVIDUALS; RELIABILITY; RESPONSES; EXERCISE	Background and Purpose The primary goal of body-weight-supported treadmill training (BWSTI) has been to improve the temporal and spatial characteristics of unsupported overground walking; however, little attention has been given to cardiorespiratory adaptations. The purpose of this case report is to describe the effects of BWSTT on cardiorespiratory fitness in 2 patients recovering from severe traumatic brain injury (TBI). Case Description Both patients were involved in motor vehicle accidents and were studied after admission to a postacute residential treatment program. Patient 1 was a 25-year-old man (initial Glasgow Coma Scale [GCS] score=3) who began observation and treatment 3 months after the injury. Patient 2 was an 18-year-old woman (initial GCS=6) who began observation and treatment 1 year after the injury. Outcomes Each patient received 2 to 3 sessions of BWSTT per week. Aerobic capacity was measured while they ambulated on a treadmill without body-weight support before and after BWSTT. Both patients' submaximal and peak responses improved. For patient 1 and patient 2, total treadmill work performed increased 134% and 53%, respectively. Peak oxygen uptake increased 24% for patient 1 and 16% for patient 2. Estimated cardiac stroke volume (oxygen pulse) increased 32% and 26% for patient 1 and patient 2, respectively. Discussion The observations made on these 2 patients suggest that BWSTT has the potential to favorably change cardiorespiratory capacity after TBI.	[Mossberg, Kurt A.; Orlander, Evelyne E.; Norcross, Julie L.] Univ Texas Galveston, Med Branch, Sch Allied Hlth Sci, Dept Phys Therapy, Galveston, TX 77555 USA		Mossberg, KA (corresponding author), Univ Texas Galveston, Med Branch, Sch Allied Hlth Sci, Dept Phys Therapy, 301 Univ Blvd, Galveston, TX 77555 USA.	kmossber@utmb.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD046570] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD046570] Funding Source: Medline		Bateman A, 2001, ARCH PHYS MED REHAB, V82, P174, DOI 10.1053/apmr.2001.19744; Behmran AL, 2000, PHYS THER, V80, P688, DOI 10.1093/ptj/80.7.688; BERG K, 1995, SCAND J REHABIL MED, V27, P27; Brown TH, 2005, J HEAD TRAUMA REHAB, V20, P402, DOI 10.1097/00001199-200509000-00002; Carvalho DCL, 2005, SPINAL CORD, V43, P400, DOI 10.1038/sj.sc.3101730; Danielsson A, 2000, ARCH PHYS MED REHAB, V81, P953, DOI 10.1053/apmr.2000.6283; David D, 2006, ARCH PHYS MED REHAB, V87, P482, DOI 10.1016/j.apmr.2005.11.034; Ditor DS, 2005, SPINAL CORD, V43, P664, DOI 10.1038/sj.sc.3101785; Ditor DS, 2005, J APPL PHYSIOL, V98, P1519, DOI 10.1152/japplphysiol.01004.2004; Dobkin BH, 2003, NEUROREHAB NEURAL RE, V17, P153, DOI 10.1177/0888439003255508; FINCH L, 1986, Physiotherapy Canada, V38, P36; Gazzani F, 1999, SPINAL CORD, V37, P336, DOI 10.1038/sj.sc.3100821; GOLIGHTLY LK, 1985, DRUG INTEL CLIN PHAR, V19, P302, DOI 10.1177/106002808501900414; Hesse Stefan, 2003, Adv Neurol, V92, P423; Israel JF, 2006, PHYS THER, V86, P1466, DOI 10.2522/ptj.20050266; Mossberg KA, 2005, AM J PHYS MED REHAB, V84, P492, DOI 10.1097/01.phm.0000166883.97562.cd; Mossberg KA, 2003, AM J PHYS MED REHAB, V82, P385, DOI 10.1097/01.PHM.0000052589.96202.BE; Mossberg KA, 2002, BRAIN INJURY, V16, P789, DOI 10.1080/02699050210131894; MOSSBERG KA, 2003, BRAIN INJURY, V17, P266; Mossberg KA, 2007, ARCH PHYS MED REHAB, V88, P315, DOI 10.1016/j.apmr.2006.12.006; Nash MS, 2004, J SPINAL CORD MED, V27, P78, DOI 10.1080/10790268.2004.11753734; Noonan V, 2000, PHYS THER REHABIL J, V80, P782, DOI 10.1093/ptj/80.8.782; Pollock ML, 1990, EXERCISE HLTH DIS; Seif-Naraghi AH, 1999, J HEAD TRAUMA REHAB, V14, P146, DOI 10.1097/00001199-199904000-00005; Silver KHC, 2000, NEUROREHAB NEURAL RE, V14, P65, DOI 10.1177/154596830001400108; SVEDENHAG J, 1984, ACTA PHYSIOL SCAND, V120, P77, DOI 10.1111/j.1748-1716.1984.tb07376.x; Visintin M, 1998, STROKE, V29, P1122, DOI 10.1161/01.STR.29.6.1122; Whaley MH, 2006, ACSMS GUIDELINES EXE; Wilson DJ, 2002, BRAIN INJURY, V16, P259, DOI 10.1080/02699050110103922; Wolman RL, 1994, CLIN REHABIL, V8, P253	30	18	18	0	10	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0031-9023	1538-6724		PHYS THER	Phys. Ther.	JAN	2008	88	1					77	87		10.2522/ptj.20070022			11	Orthopedics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Orthopedics; Rehabilitation	253RP	WOS:000252535600011	17940106	Bronze			2022-02-06	
J	Stalnacke, BM; Sojka, P				Stalnacke, Britt-Marie; Sojka, Peter			Repeatedly Heading a Soccer Ball Does Not Increase Serum Levels of S-100B, a Biochemical Marker of Brain Tissue Damage: an Experimental Study	BIOMARKER INSIGHTS			English	Article						S100 proteins; traumatic brain injury; concussion; sport; soccer		Objectives: The aim of the study was to analyse whether the controlled heading of soccer balls elicits increased serum concentrations of a biochemical marker of brain tissue damage S-100B. Methods: Nineteen male soccer players were randomly divided into two groups, A and B. Group A headed a soccer ball falling from 18 m five times, while group B served as controls (no heading). Blood samples were taken before and 0.5 h, 2 h and 4 h after the heading for analysis of S-100B. Results: No statistically significant (p > 0.05) increases in serum concentrations of S-100B were encountered in group A at 0.5 h (0.109 +/- 0.024 mu g/L), 2 h (0.098 +/- 0.026 mu g/L), and 4 h (0.113 +/- 0.035 mu g/L) when the blood samples obtained before and after the heading were compared (0.157 +/- 0.134 mu g/L). No statistically significant difference was found when the serum concentrations of S-100B were compared between groups A and B either before or after heading. Conclusions: Heading a soccer ball dropped from a height of 18 m five times was not found to cause an increase in serum concentrations of S-100B, indicating that the impact was not sufficient to cause biochemically discernible damage of brain tissue.	[Stalnacke, Britt-Marie; Sojka, Peter] Umea Univ, Dept Community Med & Rehabil Rehabil Med, Umea, Sweden		Stalnacke, BM (corresponding author), Umea Univ, Dept Community Med & Rehabil Rehabil Med, Umea Univ Hosp, Bldg 9A, SE-90185 Umea, Sweden.	brittmarie.stalnacke@rehabmed.umu.se			PfizerPfizer	This work was supported by Grants for neuroscience research projects from Pfizer.	Autti T, 1997, LANCET, V349, P1144, DOI 10.1016/S0140-6736(05)63019-X; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Delaney JS, 2001, CLIN J SPORT MED, V11, P234, DOI 10.1097/00042752-200110000-00005; Downs DS, 2002, J SPORT MED PHYS FIT, V42, P103; Elting JW, 2000, J NEUROL SCI, V181, P104, DOI 10.1016/S0022-510X(00)00442-1; GRONWALL D, 1975, LANCET, V2, P995; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; HAGLUND Y, 1993, AM J SPORT MED, V21, P97, DOI 10.1177/036354659302100117; Herrmann M, 2000, J NEUROTRAUM, V17, P113, DOI 10.1089/neu.2000.17.113; Herrmann M, 1999, RESTOR NEUROL NEUROS, V14, P109; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; JENNETT B, 1981, BRIT MED J, V282, P101, DOI 10.1136/bmj.282.6258.101; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; Kapural M, 2002, BRAIN RES, V940, P102, DOI 10.1016/S0006-8993(02)02586-6; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kelly KD, 2001, CLIN J SPORT MED, V11, P77, DOI 10.1097/00042752-200104000-00003; King N, 1997, BRIT J CLIN PSYCHOL, V36, P161, DOI 10.1111/j.2044-8260.1997.tb01405.x; Kirkendall DT, 2001, SPORTS MED, V31, P369, DOI 10.2165/00007256-200131050-00006; Kleindienst A, 2005, J NEUROSURG, V102, P1115, DOI 10.3171/jns.2005.102.6.1115; Kushner DS, 2001, AM FAM PHYSICIAN, V64, P1007; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; Mehnert Michael J, 2005, Pain Physician, V8, P391; *NAT COLL ATHL ASS, 2000, INJ SURV SYST AC YEA; Naunheim RS, 2000, J TRAUMA, V48, P938, DOI 10.1097/00005373-200005000-00020; Otto M, 2000, INT J SPORTS MED, V21, P551, DOI 10.1055/s-2000-8480; Rabadi MH, 2001, CLIN J SPORT MED, V11, P194, DOI 10.1097/00042752-200107000-00011; Rutherford W. H., 1989, MILD HEAD INJURY, P217; SHARMA HS, 1991, NEUROSCI RES, V10, P211; Stalnacke BM, 2006, BRIT J SPORT MED, V40, P313, DOI 10.1136/bjsm.2005.021584; Stalnacke BM, 2005, J REHABIL MED, V37, P300, DOI 10.1080/16501970510032910; Stalnacke BM, 2004, BRAIN INJURY, V18, P899, DOI 10.1080/02699050410001671865; Stalnacke BM, 2003, CLIN J SPORT MED, V13, P292; Tegner Y, 1996, BRIT J SPORT MED, V30, P251, DOI 10.1136/bjsm.30.3.251; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Townend W, 2006, J NEUROTRAUM, V23, P149, DOI 10.1089/neu.2006.23.149; TYSVAER AT, 1989, ACTA NEUROL SCAND, V80, P151, DOI 10.1111/j.1600-0404.1989.tb03858.x; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109; von Wild KRH, 2005, ACTA NEUROCHIR SUPPL, V93, P15; Zetterberg H, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2007.037143	39	18	18	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1177-2719			BIOMARK INSIGHTS	Biomark. Insights		2008	3						87	91					5	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	V30II	WOS:000215555900009	19578497				2022-02-06	
J	Sturzenegger, M; Radanov, BP; Winter, P; Simko, M; Farra, AD; Di Stefano, G				Sturzenegger, M.; Radanov, B. P.; Winter, P.; Simko, M.; Farra, A. D.; Di Stefano, G.			MRI-based brain volumetry in chronic whiplash patients: no evidence for traumatic brain injury	ACTA NEUROLOGICA SCANDINAVICA			English	Article						cognitive complaints; mild traumatic brain injury; VBR; whiplash injury	DIFFUSE AXONAL INJURY; COMMON WHIPLASH; FOLLOW-UP; ATTENTION; DISORDERS; MEMORY	Introduction Cognitive complaints, such as poor concentration and memory deficits, are frequent after whiplash injury and play an important role in disability. The origin of these complaints is discussed controversially. Some authors postulate brain lesions as a consequence of whiplash injuries. Potential diffuse axonal injury (DAI) with subsequent atrophy of the brain and ventricular expansion is of particular interest as focal brain lesions have not been documented so far in whiplash injury. Objective To investigate whether traumatic brain injury can be identified using a magnetic resonance (MR)-based quantitative analysis of normalized ventricle-brain ratios (VBR) in chronic whiplash patients with subjective cognitive impairment that cannot be objectively confirmed by neuropsychological testing. Materials and methods MR examination was performed in 21 patients with whiplash injury and symptom persistence for 9 months on average and in 18 matched healthy controls. Conventional MR imaging (MRI) was used to assess the volumes of grey and white matter and of ventricles. The normalized VBR was calculated. Results The values of normalized VBR did not differ in whiplash patients when compared with that in healthy controls (F = 0.216, P = 0.645). Conclusions This study does not support loss of brain tissue following whiplash injury as measured by VBR. On this basis, traumatic brain injury with subsequent DAI does not seem to be the underlying mechanism for persistent concentration and memory deficits that are subjectively reported but not objectively verifiable as neuropsychological deficits.	[Sturzenegger, M.] Univ Hosp Bern, Dept Neurol, CH-3010 Bern, Switzerland; [Radanov, B. P.] Pain Management & Ctr Medico Legal Affairs, Klin Wilhelm Schulthess, CH-8008 Zurich, Switzerland; [Winter, P.] Univ Bern, Dept Psychol, Bern, Switzerland; [Simko, M.] Lindenhof Spital, Dept Radiol, Bern, Switzerland; [Farra, A. D.] Clin Epilepsy & Neurorehabil, Klin Bethesda, Tschugg, Switzerland; [Di Stefano, G.] Univ Hosp Bern, Dept Psychiat, CH-3010 Bern, Switzerland		Radanov, BP (corresponding author), Pain Management & Ctr Medico Legal Affairs, Klin Wilhelm Schulthess, Lengghalda 2, CH-8008 Zurich, Switzerland.	bogdan.radanov@kws.ch					Alexander MP, 1998, NEUROLOGY, V51, P336, DOI 10.1212/WNL.51.2.336; BIGLER ED, 1992, BRAIN RES BULL, V28, P651, DOI 10.1016/0361-9230(92)90119-I; Bigler ED, 2004, J INT NEUROPSYCH SOC, V10, P442, DOI 10.1017/S1355617704103111; BIGLER ED, 1994, BRAIN INJURY, V8, P231, DOI 10.3109/02699059409150975; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; BLATTER DD, 1995, AM J NEURORADIOL, V16, P241; Blokhorst M, 2002, J CLIN EXP NEUROPSYC, V24, P471, DOI 10.1076/jcen.24.4.471.1042; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Borchgrevink G, 1997, INJURY, V28, P331, DOI 10.1016/S0020-1383(97)00027-2; DISTEFANO G, 1995, ACTA NEUROL SCAND, V91, P346; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; HODGE JR, 1971, PSYCHOSOMATICS, V12, P245; LEVI L, 1990, NEUROSURGERY, V27, P429, DOI 10.1227/00006123-199009000-00015; Obelieniene D, 1999, J NEUROL NEUROSUR PS, V66, P279, DOI 10.1136/jnnp.66.3.279; Radanov BP, 1999, J NEUROL NEUROSUR PS, V66, P485, DOI 10.1136/jnnp.66.4.485; RADANOV BP, 1995, MEDICINE, V74, P281, DOI 10.1097/00005792-199509000-00005; RADANOV BP, 1993, ARCH NEUROL-CHICAGO, V50, P87, DOI 10.1001/archneur.1993.00540010081022; Regard M, 1981, THESIS U VICTORIA CA; Robinson JP, 2007, ARCH PHYS MED REHAB, V88, P774, DOI 10.1016/j.apmr.2007.03.004; Schrader H, 1996, LANCET, V347, P1207, DOI 10.1016/S0140-6736(96)90733-3; SPITZER WO, 1995, SPINE, V20, pS1; Sullivan Michael J L, 2002, Pain Res Manag, V7, P120; Zimmermann P., 1993, DEV ASSESSMENT REHAB, P3	24	18	18	0	1	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	0001-6314			ACTA NEUROL SCAND	Acta Neurol. Scand.	JAN	2008	117	1					49	54		10.1111/j.1600-0404.2007.00939.x			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	240JN	WOS:000251584000007	17949454				2022-02-06	
J	Vagnini, VL; Berry, DTR; Clark, JA; Jiang, Y				Vagnini, Victoria L.; Berry, David T. R.; Clark, Jessica A.; Jiang, Yang			New measures to detect malingered neurocognitive deficit: Applying reaction time and event-related potentials	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						electroencephalography; event-related potential; malingered neurocognitive deficit; memory malingering; traumatic brain injury	COGNITIVE DEFICIT; BRAIN POTENTIALS; NAME AGREEMENT; MEMORY; DECEPTION; FAMILIARITY; AMPLITUDE; AMNESIA; NORMS; TASK	The ability of the Test of Memory Malingering (TOMM), reaction times (RTs), and event-related potentials (ERPs) to detect malingered neurocognitive deficit (MNCD) was examined in 32 normal individuals answering under honest (HON; n = 16) or malingering (MAL; n = 16) instructions as well as in 15 patients with traumatic brain injury (TBI) who answered under honest instructions. Overall, the TOMM was the most effective at classifying groups. However, new accuracy, RT, and ERP measures reached promising hit rates in the range of 71-88%. In particular, the difference in frontal versus posterior ERP obtained during an old-new task was effective at classifying MAL versus TBI (hit rate = 87%).	[Jiang, Yang] Univ Kentucky, Coll Med, Dept Behav Sci, Lexington, KY 40536 USA		Jiang, Y (corresponding author), Univ Kentucky, Coll Med, Dept Behav Sci, Lexington, KY 40536 USA.	yjiang@uky.edu		JIANG, Yang/0000-0003-4589-0097	American Forensic Academy; University of Kentucky; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AG00986]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K01AG000986] Funding Source: NIH RePORTER	The paper is based on V. L. Vagnini's PhD dissertation in partial fulfillment of the requirements for a doctoral degree in clinical psychology from the University of Kentucky. This research was supported in part by the American Forensic Academy for dissertation award funds, the Pilot fund of Behavioral Science Department at the University of Kentucky to VLV, and National Institutes of Health (NIH) Grant AG00986 to YJ.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Cohen J., 1998, STAT POWER ANAL BEHA, V2nd; Cycowicz YM, 1997, J EXP CHILD PSYCHOL, V65, P171, DOI 10.1006/jecp.1996.2356; Ellwanger J, 1996, INT J PSYCHOPHYSIOL, V23, P9, DOI 10.1016/0167-8760(96)00035-9; Ellwanger J, 1999, J CLIN EXP NEUROPSYC, V21, P866, DOI 10.1076/jcen.21.6.866.850; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; Kozel FA, 2005, BIOL PSYCHIAT, V58, P605, DOI 10.1016/j.biopsych.2005.07.040; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Osimani A, 1997, J NEUROL NEUROSUR PS, V62, P617, DOI 10.1136/jnnp.62.6.617; PALLER KA, 1992, J COGNITIVE NEUROSCI, V4, P375, DOI 10.1162/jocn.1992.4.4.375; Polo MD, 2002, NEUROPSYCHOLOGIA, V40, P2350, DOI 10.1016/S0028-3932(02)00127-6; Rees LM, 1998, PSYCHOL ASSESSMENT, V10, P10, DOI 10.1037/1040-3590.10.1.10; Rogers R., 1997, CLIN ASSESSMENT MALI; ROSE FE, 1995, CLIN NEUROPSYCHOL, V9, P124, DOI 10.1080/13854049508401594; Rosenfeld JP, 1999, INT J PSYCHOPHYSIOL, V33, P3, DOI 10.1016/S0167-8760(99)00021-5; Rosenfeld JP, 1996, CLIN NEUROPSYCHOL, V10, P163, DOI 10.1080/13854049608406678; Rosenfeld JP, 1998, INT J PSYCHOPHYSIOL, V28, P233; Rosenfeld JP, 1999, STUD NEUROPSYCHOL DE, P287; RUGG MD, 1993, NEUROPSYCHOLOGIA, V31, P373, DOI 10.1016/0028-3932(93)90161-R; RUGG MD, 1995, NEUROPSYCHOLOGIA, V33, P1131, DOI 10.1016/0028-3932(95)00053-6; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; STRAUSS E, 1994, ARCH CLIN NEUROPSYCH, V9, P483, DOI 10.1016/0887-6177(94)90039-6; Suhr J.A., 2007, ASSESSMENT MALINGERE, P287; Tardif HP, 2000, INT J PSYCHOPHYSIOL, V36, P1, DOI 10.1016/S0167-8760(00)00083-0; Tardif HP, 2002, INT J PSYCHOPHYSIOL, V46, P147, DOI 10.1016/S0167-8760(02)00090-9; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; van Gorp WG, 1999, J CLIN EXP NEUROPSYC, V21, P245; Vickery CD, 2001, ARCH CLIN NEUROPSYCH, V16, P45, DOI 10.1016/S0887-6177(99)00058-X	30	18	18	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2008	30	7					766	776		10.1080/13803390701754746			11	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	345EH	WOS:000258978400004	18608662	Green Accepted			2022-02-06	
J	Reza, MF; Ikoma, K; Ito, T; Ogawa, T; Mano, Y				Reza, Mohammed Faruque; Ikoma, Katsunori; Ito, Takeya; Ogawa, Taro; Mano, Yukio			N200 latency and P300 amplitude in depressed mood post-traumatic brain injury patients	NEUROPSYCHOLOGICAL REHABILITATION			English	Article							EVENT-RELATED POTENTIALS; CLOSED-HEAD-INJURY; EVOKED-POTENTIALS; ANXIETY; POPULATION; DIAGNOSIS; SCALE	In order to examine the independent and combined effects of depressive symptoms and traumatic brain injury on event-related potential (ERP) components, we classified traumatic brain injury (TBI) patients as depressed and non-depressed mood according to their scores on the Zung Self-rating Depression Scale (SDS). Non-depressed mood post-traumatic brain injury patients (NondepTBI, n = 9), depressed mood post-traumatic brain injury patients (DepTBI, n = 26), and normal healthy control subjects (HC, n = 10) were assessed for N100, N200, and P300 latencies and amplitudes by the auditory "oddball paradigm". DepTBI subjects had significantly prolonged N200 latency and low P300 amplitude compared with the NondepTBI and HC groups. A longer P300 latency in the NondepTBI and DepTBI than in the HC groups was found. A prolongation of N200 latency accompanied by low P300 amplitude may be a characteristic of post-traumatic brain injury patients with depressed mood. Prolonged P300 latency may be more closely associated with TBI than with depression, as it was significantly greater in both the DepTBI and NondepTBI, than in the HC group.	[Reza, Mohammed Faruque; Ikoma, Katsunori; Ito, Takeya; Ogawa, Taro; Mano, Yukio] Hokkaido Univ, Grad Sch Med, Dept Phys Med & Rehabil, Sapporo, Hokkaido 0608638, Japan		Ikoma, K (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Phys Med & Rehabil, N15 W7, Sapporo, Hokkaido 0608638, Japan.	ikoma@med.hokudai.ac.jp	Ikoma, Katsunori/D-8158-2012; , Faruque Reza/L-9994-2016	, Faruque Reza/0000-0002-0302-6623			ANDERSON DC, 1984, ARCH NEUROL-CHICAGO, V41, P369, DOI 10.1001/archneur.1984.04050160031011; Baguley IJ, 1997, ARCH PHYS MED REHAB, V78, P1248, DOI 10.1016/S0003-9993(97)90339-7; BARRETT J, 1978, ARCH GEN PSYCHIAT, V35, P741; BRUDER GE, 1991, BIOL PSYCHIAT, V30, P233, DOI 10.1016/0006-3223(91)90108-X; CANT BR, 1986, ELECTROEN CLIN NEURO, V65, P188, DOI 10.1016/0168-5597(86)90053-5; Chida F, 2004, PSYCHIAT CLIN NEUROS, V58, P420, DOI 10.1111/j.1440-1819.2004.01277.x; CYNTHIA MS, 2001, BRAIN INJURY, V15, P561; DOJONGHE JFM, 1989, PSYCHOL REP, V64, P833; Duncan CC, 2005, INT J PSYCHOPHYSIOL, V58, P133, DOI 10.1016/j.ijpsycho.2005.05.011; GANGADHAR BN, 1993, J AFFECT DISORDERS, V28, P57, DOI 10.1016/0165-0327(93)90077-W; GOODIN DS, 1978, PSYCHOPHYSIOLOGY, V15, P360, DOI 10.1111/j.1469-8986.1978.tb01392.x; Hashiro M, 1997, J DERMATOL SCI, V14, P63, DOI 10.1016/S0923-1811(96)00553-1; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; JORGE RE, 1993, J NERVE MENTAL DISOR, V181, P191; Kibiger G, 2003, J PAIN SYMPTOM MANAG, V26, P705, DOI 10.1016/S0885-3924(03)00237-9; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LEVIN HS, 1982, NEUROBEHAVIOURAL CON, P3; Patel Salil H, 2005, Int J Med Sci, V2, P147; Polich J, 1996, PSYCHOPHYSIOLOGY, V33, P334, DOI 10.1111/j.1469-8986.1996.tb01058.x; RUMPL E, 1988, J CLIN NEUROPHYSIOL, V5, P237, DOI 10.1097/00004691-198807000-00002; Sandel ME, 1996, ARCH PHYS MED REHAB, V77, P617, DOI 10.1016/S0003-9993(96)90306-8; SARA G, 1994, J AFFECT DISORDERS, V31, P29, DOI 10.1016/0165-0327(94)90124-4; SQUIRES NK, 1986, EXPT TECHNIQUES HUMA, P386; Urretavizcaya M, 2003, J AFFECT DISORDERS, V74, P293, DOI 10.1016/S0165-0327(02)00016-2; Vandoolaeghe E, 1998, J AFFECT DISORDERS, V48, P105, DOI 10.1016/S0165-0327(97)00165-1; Viggiano MP, 1996, J CLIN EXP NEUROPSYC, V18, P631, DOI 10.1080/01688639608408288; Walters GD, 2001, PERS INDIV DIFFER, V30, P1345, DOI 10.1016/S0191-8869(00)00116-1; ZUNG WWK, 1973, ARCH GEN PSYCHIAT, V29, P328; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008; [No title captured]	31	18	22	0	10	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0960-2011			NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	DEC	2007	17	6					723	734		10.1080/09602010601082441			12	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	246EU	WOS:000251991100004	18030646				2022-02-06	
J	Sharma, V; Babu, PP; Singh, A; Singh, S; Singh, R				Sharma, Varsha; Babu, P. Prakash; Singh, Arun; Singh, Sangeeta; Singh, Rameshwar			Iron-induced experimental cortical seizures: Electroencephalographic mapping of seizure spread in the subcortical brain	SEIZURE-EUROPEAN JOURNAL OF EPILEPSY			English	Article						epilepsy; iron epilepsy; etectroencephalography; multi-unit activity; ethosuximide; mapping of intracerebral epileptic activity	FLUID PERCUSSION INJURY; POSTTRAUMATIC EPILEPSY; RAT HIPPOCAMPUS; ELECTRICAL-STIMULATION; EPILEPTIFORM ACTIVITY; SUPEROXIDE-DISMUTASE; LIPID-PEROXIDATION; ABSENCE EPILEPSY; MODEL; ETHOSUXIMIDE	The iron-induced model of post-traumatic chronic focal epilepsy in rats was studied by depth-electrode mapping to investigate the spread of epileptiform activity into subcortical brain structures after its onset in the cortical epileptic focus. Electrical seizure activity was recorded in the hippocampal CA1 and CA3 areas, amygdata and caudate-putamen, in rats with iron-induced chronic cortical focal epilepsy. These experiments showed that the epileptiform activity with its onset in the cortical focus synchronously propagated into the studied subcortical brain areas. Seizure behaviours seemed to increase in correspondence with the spread of the epileptic electrographic activity in subcortical areas. Comparison of the cortical focus etectroencephalographic and associated muttipte-unit action potential recordings with those from the subcortical structures showed that the occurrence and evolution of the epileptiform activity in the subcortical structures were in parallel with that in the cortical focus. The intracerebral anatomic progression and delineation of seizure spread (mapped by field potential (EEG) and multipte-unit action potentials (MUA) recordings) indicated participation of these regions in the generalization of seizure activity in this model of epilepsy. The seizure-induced activation of the hippocampus appeared to evolve into an epileptic focus independent of the cortical focus. The present study demonstrates the propagation of epileptic activity from the cortical focus into the limbic and basal ganglia regions. Treatment of iron-induced epileptic rats with ethosuximide, an anti-absence drug, resulted in suppression of the epileptiform activity in the cortical focus as well as in the subcortical brain areas. (c) 2007 British Epilepsy Association. Published by Elsevier Ltd. AR rights reserved.	Jawaharlal Nehru Univ, Sch Life Sci, Neurobiol Lab, New Delhi 110067, India; Univ Hyderabad, Dept Biotechnol, Hyderabad 500046, Andhra Pradesh, India; Bareilly Coll, Dept Zool, Bareilly 243001, Uttar Pradesh, India		Sharma, V (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, Neurobiol Lab, 118 & 303, New Delhi 110067, India.	varsha.sharma@gmail.com	Singh, Arun/ABC-5154-2020	Singh, Arun/0000-0003-4273-542X			Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; BABB TL, 1987, ELECTROEN CLIN NEURO, V66, P467, DOI 10.1016/0013-4694(87)90093-9; Baram TZ, 1997, DEV BRAIN RES, V98, P265, DOI 10.1016/S0165-3806(96)00190-3; BARAM TZ, 1992, DENDRON, P39; Benardo LS, 2003, EPILEPSIA, V44, P27, DOI 10.1046/j.1528-1157.44.s10.2.x; Bouilleret V, 2000, BRAIN RES, V852, P255, DOI 10.1016/S0006-8993(99)02092-2; BRAILOWSKY S, 1990, EPILEPSIA, V31, P369, DOI 10.1111/j.1528-1157.1990.tb05490.x; Brunson KL, 1998, DEV BRAIN RES, V111, P119, DOI 10.1016/S0165-3806(98)00130-8; D'Ambrosio R, 2005, BRAIN, V128, P174, DOI 10.1093/brain/awh337; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; de Vasconcelos AP, 1999, BRAIN RES, V838, P110, DOI 10.1016/S0006-8993(99)01729-1; Deransart C, 2003, EPILEPSIA, V44, P1513, DOI 10.1111/j.0013-9580.2003.26603.x; Gruslin E, 1999, BRAIN RES, V835, P290, DOI 10.1016/S0006-8993(99)01605-4; HANDFORTH A, 1995, BRAIN RES REV, V20, P1, DOI 10.1016/0165-0173(94)00003-8; Imao K, 1998, BIOCHEM MOL BIOL INT, V45, P11; JANERO DR, 1989, BIOCHEM PHARMACOL, V38, P4344, DOI 10.1016/0006-2952(89)90537-6; Kandel A, 1996, EPILEPSY RES, V23, P123, DOI 10.1016/0920-1211(95)00097-6; LOSCHER W, 1991, EPILEPSY RES, V8, P79, DOI 10.1016/0920-1211(91)90075-Q; LOTHMAN EW, 1991, CURR OPIN NEUROL NEU, V4, P253; Manning JPA, 2004, NEUROSCIENCE, V123, P5, DOI 10.1016/j.neuroscience.2003.09.026; MEDVEDEV A, 1996, ELECTROENCEPHALGR CL, V92, P157; MORI A, 1990, PAVLOVIAN J BIOL SCI, V25, P54; MORIWAKI A, 1992, ELECTROEN CLIN NEURO, V83, P281, DOI 10.1016/0013-4694(92)90087-X; MORIWAKI A, 1990, NEUROSCI LETT, V110, P72, DOI 10.1016/0304-3940(90)90789-C; PELLEGRINI A, 1989, BRAIN RES, V497, P344, DOI 10.1016/0006-8993(89)90280-1; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Samuelsson C, 2003, EPILEPSY RES, V56, P165, DOI 10.1016/j.eplepsyres.2003.09.004; Samuelsson C, 2000, NEUROSCI LETT, V289, P185, DOI 10.1016/S0304-3940(00)01284-2; SHARMA D, 1993, NEUROBIOL AGING, V14, P319, DOI 10.1016/0197-4580(93)90117-T; Sharma Varsha, 1999, Indian Journal of Experimental Biology, V37, P461; Sharma Varsha, 1999, Indian Journal of Experimental Biology, V37, P468; SILVABARRAT C, 1986, ELECTROEN CLIN NEURO, V64, P455, DOI 10.1016/0013-4694(86)90079-9; SINGH R, 1990, EPILEPSIA, V31, P15, DOI 10.1111/j.1528-1157.1990.tb05354.x; STRINGER JL, 1994, EPILEPSY RES, V19, P229; STRINGER JL, 1994, BRAIN RES, V636, P221, DOI 10.1016/0006-8993(94)91020-0; Talley EM, 2000, MOL BRAIN RES, V75, P159, DOI 10.1016/S0169-328X(99)00307-1; Tian GF, 2005, NAT MED, V11, P973, DOI 10.1038/nm1277; Timofeev I, 2004, NEUROSCIENCE, V123, P299, DOI 10.1016/j.neuroscience.2003.08.051; VERGNES M, 1990, BRAIN RES, V523, P87, DOI 10.1016/0006-8993(90)91638-W; Wiest MC, 2003, NAT NEUROSCI, V6, P913, DOI 10.1038/nn1107; WILLMORE LJ, 1981, NEUROLOGY, V31, P63, DOI 10.1212/WNL.31.1.63; WILLMORE LJ, 1978, ANN NEUROL, V4, P329, DOI 10.1002/ana.410040408; WILLMORE LJ, 1986, BRAIN RES, V382, P422; YOKOI I, 1995, FREE RADICAL BIO MED, V19, P473, DOI 10.1016/0891-5849(95)00050-8	44	18	19	0	3	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	1059-1311	1532-2688		SEIZURE-EUR J EPILEP	Seizure	DEC	2007	16	8					680	690		10.1016/j.seizure.2007.05.012			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	235DF	WOS:000251213000004	17629512	Bronze			2022-02-06	
J	Ozisik, PA; Oruckaptan, H; Geyik, PO; Misirlioglu, M; Sargon, MF; Kilinc, K; Ozgen, T				Ozisik, Pinar Akdemir; Oruckaptan, Hakan; Geyik, Pinar Ozdemir; Misirlioglu, Muge; Sargon, Mustafa F.; Kilinc, Kamer; Ozgen, Tuncalp			Effect of erythropoietin on brain tissue after experimental head trauma in rats	SURGICAL NEUROLOGY			English	Article						brain injury; methylprednisolone; erythropoietin; apoptosis; bcl-2; survivin; electron microscopy; lipid peroxidation	LIPID-PEROXIDATION; TRANSGENIC MICE; INJURY; METHYLPREDNISOLONE; BCL-2; APOPTOSIS; SURVIVIN; EDEMA; BCL-2-DEFICIENT; EXPRESSION	Background: The purpose of this study was to investigate the effect of EPO on LPO, on ultrastructural findings, and on antiapoptotic bcl-2 and survivin gene expressions after TBI. The authors also compared the activity of EPO with that of MPSS. Methods: Wistar rats were divided into 6 groups: sham-operated, control, moderate TBI-alone (300 g/cm), TBI + EPO-treated (1000 IU/kg), TBI + MPSS-treated (30 mg/kg), and TBI + vehicle-treated (0.4 mL albumin solution) groups. Results: Compared with the levels in control and sham-operated animals, LPO was significantly elevated in rats in the trauma-alone group. The administration of EPO and MPSS significantly decreased the LPO levels (P < .05). Trauma also increases the antiapoptotic bcl-2 gene expression significantly at 24 hours postinjury (P < .05), but it has no effect on survivin expression. The EPO and MPSS treatments caused significant elevation in both gene expressions (P < .05). It is also showed that MPSS has more protective effect than EPO on brain ultrastructure, especially on the structure of small- (P < .05) and medium-sized myelinated axons, after TBI. Conclusions: EPO has protective effects after moderate TBI, and this effect seems better than MPSS on antiapoptotic gene expression and LPO. The protection of cerebral subcellular organelles after traumatic injury is more prominent in MPSS-treated animals than EPO-treated animals quantitatively. This experimental study indicates that the benefits of EPO in the management of TBI have promising results and prompts further studies on the difference between EPO and MPSS in histopathological findings at the subcellular level. (C) 2007 Elsevier Inc. All rights reserved.	Hacettepe Univ, Sch Med, Dept Neurosurg, TR-06100 Ankara, Turkey; Hacettepe Univ, Sch Med, Dept Biostat, TR-06100 Ankara, Turkey; Hacettepe Univ, Sch Med, Dept Anat, TR-06100 Ankara, Turkey; Hacettepe Univ, Sch Med, Dept Biochem, TR-06100 Ankara, Turkey		Ozisik, PA (corresponding author), Hacettepe Univ, Sch Med, Dept Neurosurg, TR-06100 Ankara, Turkey.	pozisik@hacettepe.edu.tr; oruckaptan@hacettepe.edu.tr; pozdemir@hacettepe.edu.tr; msargon@hacettepe.edu.tr; kkilinc@hacettepe.edu.tr; tozgen@hacettepe.edu.tr	Sargon, Mustafa F./AAZ-5470-2021	Sargon, Mustafa F./0000-0001-6360-6008; OZISIK, PINAR/0000-0001-5183-8100			Adida C, 1998, AM J PATHOL, V152, P43; ANDERSON DK, 1994, BRAIN RES, V637, P119, DOI 10.1016/0006-8993(94)91224-6; Aoki Y, 2001, J PHARMACOL EXP THER, V296, P306; BanyMohammed FM, 1996, PEDIATR RES, V40, P381, DOI 10.1203/00006450-199609000-00003; BOURKE RS, 1979, NEURAL TRAUMA, P95; Braughler J M, 1986, Cent Nerv Syst Trauma, V3, P153; BRAUGHLER JM, 1982, J NEUROSURG, V56, P838, DOI 10.3171/jns.1982.56.6.0838; Buemi M, 2002, CLIN SCI, V103, P275, DOI 10.1042/cs1030275; Cheung NS, 2000, J NEUROCHEM, V74, P1613, DOI 10.1046/j.1471-4159.2000.0741613.x; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Dogan A, 1999, J NEUROCHEM, V72, P765, DOI 10.1046/j.1471-4159.1999.0720765.x; EID T, 2002, CLIN BREAST CANCER, V3, P109, DOI DOI 10.3816/CBC.2002.S.021; FUJIMOTO S, 1984, SURG NEUROL, V22, P449, DOI 10.1016/0090-3019(84)90301-X; HALL ED, 1993, RES P ARNMD, V71, P81; HALL ED, 1985, J NEUROSURG, V62, P882, DOI 10.3171/jns.1985.62.6.0882; Ildan F, 1995, SURG NEUROL, V44, P573; JELKMANN W, 1992, PHYSIOL REV, V72, P672; Johnson EA, 2004, J NEUROTRAUM, V21, P1183, DOI 10.1089/neu.2004.21.1183; Kalinina O, 1997, NUCLEIC ACIDS RES, V25, P1999, DOI 10.1093/nar/25.10.1999; KIRKALI Z, 1995, J UROLOGY, V154, P1939, DOI 10.1016/S0022-5347(01)66830-7; KIWAK KJ, 1985, J NEUROSURG, V62, P865, DOI 10.3171/jns.1985.62.6.0865; KLEINDIENST A, 13 INT S BRAIN ED C; Kobayashi K, 1999, P NATL ACAD SCI USA, V96, P1457, DOI 10.1073/pnas.96.4.1457; Koc PK, 1999, RES EXP MED, V199, P21, DOI 10.1007/s004330050129; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; Kroemer G, 1997, IMMUNOL TODAY, V18, P44, DOI 10.1016/S0167-5699(97)80014-X; Kumral A, 2004, BEHAV BRAIN RES, V153, P77, DOI 10.1016/j.bbr.2003.11.002; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; Matsuo Y, 2001, STROKE, V32, P2143, DOI 10.1161/hs0901.94259; MEYER JS, 1971, LANCET, V2, P933; Minn AJ, 1997, NATURE, V385, P353, DOI 10.1038/385353a0; MUCHMORE SW, 1999, MOL CELL, V6, P213; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Ohlsson M, 2004, J NEURO-OPHTHALMOL, V24, P11, DOI 10.1097/00041327-200403000-00003; Ozisik K, 2004, AM J TRANSPLANT, V4, P900, DOI 10.1111/j.1600-6143.2004.00448.x; Paydas S, 2003, ANN ONCOL, V14, P1045, DOI 10.1093/annonc/mdg277; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; Shingo T, 2001, J NEUROSCI, V21, P9733, DOI 10.1523/JNEUROSCI.21-24-09733.2001; Simonati A, 1999, MICROSC RES TECHNIQ, V45, P341, DOI 10.1002/(SICI)1097-0029(19990615)45:6<341::AID-JEMT2>3.0.CO;2-U; Tanabe H, 1997, EUR J NEUROSCI, V9, P848, DOI 10.1111/j.1460-9568.1997.tb01434.x; TRON VA, 1995, AM J PATHOL, V146, P643; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Wang L, 2004, STROKE, V35, P1732, DOI 10.1161/01.STR.0000132196.49028.a4; Yamada Y, 2002, NEUROSCIENCE, V114, P165, DOI 10.1016/S0306-4522(02)00210-5	45	18	18	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0090-3019			SURG NEUROL	Surg. Neurol.	NOV	2007	68	5					547	555		10.1016/j.surneu.2007.01.030			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	231QV	WOS:000250965000017	17586022				2022-02-06	
J	Armstead, WM; Vavilala, MS				Armstead, William M.; Vavilala, Monica S.			Adrenomedullin reduces gender-dependent loss of hypotensive cerebrovasodilation after newborn brain injury through activation of ATP-dependent K channels	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						autoregulation; brain injury; cerebral circulation; newborn; signal transduction	CEREBROSPINAL-FLUID; POTASSIUM CHANNELS; UNITED-STATES; CHILDREN; VASODILATION; ARTERIOLES; DILATION; INFANTS; PIGLETS; NO	Cerebrovascular dysregulation during hypotension occurs after fluid percussion brain injury (FPI) in the newborn pig owing to impaired K channel function. This study was designed to ( 1) determine the role of gender and K channel activation in adrenomedullin (ADM) cerebrovasodilation, ( 2) characterize the role of gender in the loss of hypotensive cerebrovasodilation after FPI, and ( 3) determine the role of gender in the ability of exogenous ADM to modulate hypotensive dysregulation after FPI. Lateral FPI ( 2 atm) was induced in newborn male and female newborn pigs ( 1 to 5 days old) equipped with a closed cranial window, n = 6 for each protocol. Adrenomedullin-induced pial artery dilation was significantly greater in female than male piglets and blocked by the KATP channel antagonist glibenclamide, but not by the K-ca channel antagonist iberiotoxin. Cerebrospinal fluid ADM was increased from 3.8 +/- 0.7 to 14.6 +/- 3.0 fmol/ mL after FPI in female but was unchanged in male piglets. Hypotensive pial artery dilation was blunted to a significantly greater degree in male versus female piglets after FPI. Topical pretreatment with a subthreshold vascular concentration of ADM ( 10(-10) mol/ L) before FPI reduced the loss of hypotensive pial artery dilation in both genders, but protection was significantly greater in male versus female piglets. These data show that hypotensive pial artery dilation is impaired after FPI in a gender- dependent manner. By unmasking a genderdependent endogenous protectant, these data suggest novel gender- dependent approaches for clinical intervention in the treatment of perinatal traumatic brain injury.	Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; Univ Washington, Dept Anesthesiol, Seattle, WA 98195 USA; Univ Washington, Dept Pediat & Neurol Surg, Seattle, WA 98195 USA		Armstead, WM (corresponding author), Univ Penn, Dept Anesthesiol & Crit Care, 3620 Hamilton Walk,JM3, Philadelphia, PA 19104 USA.	armsteaw@uphs.upenn.edu					Armstead William M, 2005, Pathophysiology, V12, P5, DOI 10.1016/j.pathophys.2005.01.002; Armstead WM, 1998, AM J PHYSIOL-HEART C, V274, pH1674, DOI 10.1152/ajpheart.1998.274.5.H1674; Armstead WM, 1999, AM J PHYSIOL-HEART C, V277, pH1884; Armstead WM, 1997, BRAIN RES, V768, P177, DOI 10.1016/S0006-8993(97)00641-0; Armstead WM, 1999, BRAIN RES, V816, P158, DOI 10.1016/S0006-8993(98)01146-9; Armstead WM, 1997, STROKE, V28, P2273, DOI 10.1161/01.STR.28.11.2273; Armstead WM, 1996, AM J PHYSIOL-HEART C, V270, pH423, DOI 10.1152/ajpheart.1996.270.2.H423; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Coates BM, 2005, CRIT CARE MED, V33, P2645, DOI 10.1097/01.CCM.0000186417.19199.9B; Du LN, 2004, J BIOL CHEM, V279, P38563, DOI 10.1074/jbc.M405461200; Fan P, 2003, J NEUROTRAUM, V20, P437, DOI 10.1089/089771503765355513; Faraci FM, 1998, PHYSIOL REV, V78, P53, DOI 10.1152/physrev.1998.78.1.53; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; Kanu A, 2006, AM J PHYSIOL-HEART C, V291, pH2409, DOI 10.1152/ajpheart.01368.2005; Lang MG, 1997, STROKE, V28, P181, DOI 10.1161/01.STR.28.1.181; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; NELSON MT, 1993, TRENDS CARDIOVAS MED, V3, P54, DOI 10.1016/1050-1738(93)90037-7; NELSON MT, 1995, AM J PHYSIOL, V268, P799; Robertson CL, 2001, J NEUROTRAUM, V18, P861, DOI 10.1089/089771501750451785; RODRIGUEZ JG, 1990, AM J DIS CHILD, V144, P625, DOI 10.1001/archpedi.1990.02150300019014; Sakai K, 1998, EUR J PHARMACOL, V359, P151, DOI 10.1016/S0014-2999(98)00641-4; Terata K, 2000, AM J PHYSIOL-HEART C, V279, pH2620, DOI 10.1152/ajpheart.2000.279.6.H2620; Tsuji M, 1998, PEDIATR RES, V44, P591, DOI 10.1203/00006450-199810000-00020; Vavilala MS, 2006, DEV NEUROSCI-BASEL, V28, P348, DOI 10.1159/000094161; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; Willis AP, 1999, AM J PHYSIOL-HEART C, V277, pH299, DOI 10.1152/ajpheart.1999.277.1.H299; Willis AP, 2001, AM J PHYSIOL-HEART C, V281, pH2366, DOI 10.1152/ajpheart.2001.281.6.H2366; Xi Q, 2004, AM J PHYSIOL-HEART C, V286, pH610, DOI 10.1152/ajpheart.00782.2003; Zuckerman SL, 1996, AM J PHYSIOL-HEART C, V271, pH535, DOI 10.1152/ajpheart.1996.271.2.H535	31	18	19	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	0271-678X			J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	OCT	2007	27	10					1702	1709		10.1038/sj.jcbfm.9600473			8	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	212GV	WOS:000249583200006	17377515	Bronze			2022-02-06	
J	Sussmann, PS; Zumstein, M; Hahn, F; Dora, C				Sussmann, Patrick S.; Zumstein, Matthias; Hahn, Frederik; Dora, Claudio			The risk of vascular injury to the femoral head when using the posterolateral arthroscopy portal: Cadaveric investigation	ARTHROSCOPY-THE JOURNAL OF ARTHROSCOPIC AND RELATED SURGERY			English	Article						arthroscopy; avascular necrosis; blood supply; complication; hip; portal	HIP ARTHROSCOPY; COMPLICATIONS; ANATOMY	Purpose: The aim was to clarify the relationship between the posterolateral arthroscopy portal to the hip joint and the deep branch of the medial femoral circumflex artery (MFCA) and its terminal divisions. Methods: In 7 fresh fixated human cadavers, the deep femoral arteries were injected with latex. In all specimens, the standard anterior, anterolateral, and posterolateral arthroscopy portals to the central compartment of the hip were established in a standardized procedure as done in our operating room. Subsequently, all specimens underwent surgical dissection to identify the tract of the posterolateral portal, the course of the deep branch of the MFCA, and its terminal divisions. The distance between the portal tract and the deep branch of the MFCA was measured at its shortest point. Results: None of the specimens revealed injury to the deep branch of the MFCA and its terminal divisions; however, I specimen did not reveal filling of the MFCA, and did not allow for accurate measurement. For the remaining 6 specimens, the mean distance of the portal tract to the vessels at the closest point was 10.16 rum (standard deviation, 4.4 mm; range, 5 to 15 mm). In all specimens, the greater trochanter seemed to prevent closer contact between the vessel and the portal tract. Conclusions: As long as the shape of the posterior aspect of the greater trochanter has not been changed by previous surgery, the posterolateral portal to the hip joint can be performed safely with respect to the vital blood supply to the femoral head, because the MFCA is protected by the overhang of the posterior aspect of the greater trochanter, giving a minimum of 3 rum and an average 10 rum of clearance. Clinical Relevance: At the level of the piriformis muscle, the posterolateral portal has a minimum of 3 mm and an average of 10 mm of clearance to the deep branch of the MFCA. As long as the shape of the posterior aspect of the greater trochanter has not been changed, and the skin penetration remains close to this bony margin with direction of the portal toward the joint space, this portal can be performed safely with respect to the vital blood supply to the femoral head.	Univ Zurich, Dept Orthopaed, CH-8008 Zurich, Switzerland; Inselspital Bern, Dept Orthopaed & tRAUMATOL, CH-3010 Bern, Switzerland		Sussmann, PS (corresponding author), Univ Zurich, Dept Orthopaed, Forchstr 340, CH-8008 Zurich, Switzerland.	sussmannp@gmx.net	Zumstein, Matthias/AAV-3268-2020	Zumstein, Matthias/0000-0001-5480-6008			BYRD JWT, 1995, ARTHROSCOPY, V11, P418, DOI 10.1016/0749-8063(95)90193-0; Byrd JWT, 2000, ARTHROSCOPY, V16, P770, DOI 10.1053/jars.2000.7686; Byrd JWT, 2006, ORTHOPADE, V35, P41, DOI 10.1007/s00132-005-0892-8; Clarke MT, 2003, CLIN ORTHOP RELAT R, P84, DOI 10.1097/01.blo.0000043048.84315.af; Dienst M, 2005, ARTHROSCOPY, V21, P1510, DOI 10.1016/j.arthro.2005.09.014; ERIKSSON E, 1982, ORTHOP CLIN N AM, V13, P293; Funke EL, 1996, ARTHROSCOPY, V12, P156, DOI 10.1016/S0749-8063(96)90004-3; Gautier E, 2000, J BONE JOINT SURG BR, V82B, P679, DOI 10.1302/0301-620X.82B5.10426; Griffin DR, 1999, J BONE JOINT SURG BR, V81B, P604, DOI 10.1302/0301-620X.81B4.9102; Guanche CA, 2006, ARTHROSCOPY, V22, P95, DOI 10.1016/j.arthro.2005.10.018; Kelly BT, 2003, AM J SPORT MED, V31, P1020, DOI 10.1177/03635465030310060701; MCCARTHY JC, 1995, ORTHOPEDICS, V18, P753; SEVITT S, 1965, J Bone Joint Surg Br, V47, P560; Thiel W, 2002, ANN ANAT, V184, P267, DOI 10.1016/S0940-9602(02)80121-2	14	18	20	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0749-8063			ARTHROSCOPY	Arthroscopy	OCT	2007	23	10					1112	1115		10.1016/j.arthro.2007.05.014			4	Orthopedics; Sport Sciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences; Surgery	225DY	WOS:000250498500013	17916478				2022-02-06	
J	Berg, P; Westerling, R				Berg, Peter; Westerling, Ragnar			A decrease in both mild and severe bicycle-related head injuries in helmet wearing ages - trend analyses in Sweden	HEALTH PROMOTION INTERNATIONAL			English	Article						bicycle helmet; head injuries; head protection; bicycle-related accidents	TRAUMA CENTER; LEGISLATION; CHILDREN; STRATEGIES; EFFICACY; LAWS	Several international studies point at the efficacy of bicycle helmets in reducing head injuries. In Sweden, observational studies show that from 1988 to 1996 helmet use increased in all categories of cyclists. The objectives of this study were to analyse the trends of bicycle-related head injuries based on their main diagnosis and external cause of injury by different age groups. Our study area was the whole population of Sweden from 1987 to 1996. Outcome evaluation was based on data from the Swedish National Hospital Discharge Register concerning all bicycle-related injuries from 1987 to 1996, which presented 49 758 reported in-patient care. The trends in incidence rates (IRs) were studied with regression analyses. The results show that children under 15 years had the highest IRs. For these children, the IR decreased by 46%. The head injuries in children decreased both in collisions with motor vehicles and in other accidents. Similarly, the IR of concussion and skull fracture decreased. For nonhead injuries, there were no significant changes for children. On the other hand, the incidence of both head and other injuries for adults aged 16-50 years increased. Ages above that showed no significant changes. Our conclusions are that the decrease in IR for bicycle-related head injuries refers to children in ages for whom bicycle helmet use during the period increased. This could not be explained by any general decrease in bicycle-related accidents or by any changes in the distribution of injuries after collision with motor vehicles. The increasing helmet use among younger schoolchildren probably contributed to the decrease in head injuries.	Dept Publ Hlth & Caring Sci & Social Med, SE-75185 Uppsala, Sweden		Berg, P (corresponding author), Dept Publ Hlth & Caring Sci & Social Med, Uppsala Sci Pk, SE-75185 Uppsala, Sweden.	peter.berg@pubcare.uu.se					Attewell RG, 2001, ACCIDENT ANAL PREV, V33, P345, DOI 10.1016/S0001-4575(00)00048-8; Berg P, 2001, Inj Prev, V7, P218, DOI 10.1136/ip.7.3.218; Bostrom L, 2001, J TRAUMA, V50, P900, DOI 10.1097/00005373-200105000-00021; *CENTR ORG TRAFF S, LIIKENNETURVA; Cook A, 2000, BRIT MED J, V321, P1055, DOI 10.1136/bmj.321.7268.1055; Curnow WJ, 2003, ACCIDENT ANAL PREV, V35, P287, DOI 10.1016/S0001-4575(02)00012-X; DANNENBERG AL, 1993, AM J PUBLIC HEALTH, V83, P667, DOI 10.2105/AJPH.83.5.667; Ekman R, 2001, PUBLIC HEALTH, V115, P38, DOI 10.1016/S0033-3506(01)00411-5; Grimard G, 1995, Inj Prev, V1, P21, DOI 10.1136/ip.1.1.21; LeBlanc JC, 2002, CAN MED ASSOC J, V166, P592; Lee BHY, 2005, ACCIDENT ANAL PREV, V37, P93, DOI 10.1016/j.aap.2004.07.001; Linn S, 1998, Inj Prev, V4, P122; MACKNIN ML, 1994, ARCH PEDIAT ADOL MED, V148, P255, DOI 10.1001/archpedi.1994.02170030025005; MCDERMOTT FT, 1993, J TRAUMA, V34, P834, DOI 10.1097/00005373-199306000-00015; MOCK CN, 1995, J TRAUMA, V39, P29, DOI 10.1097/00005373-199507000-00004; NILSSON G, 2003, EVALUATION GOVT 11 P; Nolen S, 2005, HEALTH PROMOT INT, V20, P33, DOI 10.1093/heapro/dah505; Rivara F P, 1999, Inj Prev, V5, P194; Rivara FP, 2000, BRIT MED J, V321, P1035, DOI 10.1136/bmj.321.7268.1035; Robinson DL, 1996, ACCIDENT ANAL PREV, V28, P463, DOI 10.1016/0001-4575(96)00016-4; Shafi S, 1998, J PEDIATR SURG, V33, P317, DOI 10.1016/S0022-3468(98)90454-7; THOMAS S, 1994, BRIT MED J, V308, P173, DOI 10.1136/bmj.308.6922.173; WELANDER G, 2001, J TRAFFIC MED, V29, P20	23	18	18	0	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0957-4824			HEALTH PROMOT INT	Health Promot. Int.	SEP	2007	22	3					191	197		10.1093/heapro/dam020			7	Health Policy & Services; Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	218IJ	WOS:000250008900003	17728326	Bronze			2022-02-06	
J	Ellis, T; McNames, J; Aboy, M				Ellis, Tim; McNames, James; Aboy, Mateo			Pulse morphology visualization and analysis with applications in cardiovascular pressure signals	IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING			English	Article						terms-Arterial blood pressure (ABP); hemodynamics intracranial pressure (ICP); point process; pulse contour analysis; pulse morphology; pulse pressure; traumatic brain injury (TBI)	WAVE-FORM ANALYSIS; CONTINUOUS CARDIAC-OUTPUT; CONTOUR ANALYSIS; ARTERIAL COMPLIANCE; SYSTEMS-ANALYSIS; TRANSMISSION; ALGORITHM; AGE	We present a new analysis and visualization method for studying the functional relationship between the pulse morphology of pressure signals and time or signal metrics such as heart rate, pulse pressure, and means of pressure signals, such as arterial blood pressure and central venous pressure. The pulse morphology is known to contain potentially useful clinical information, but it is difficult to study in the time domain without the aid of a tool such as the method we present here. The primary components of the method are established signal processing techniques, nonparametric regression, and an automatic beat detection algorithm. Some of the insights that can be gained from this are demonstrated through the analysis of intracranial pressure signals acquired from patients with traumatic brain injuries. The analysis indicates the point of transition from low-pressure morphology consisting of three distinct peaks to a high-pressure morphology consisting of a single peak. In addition, we demonstrate how the analysis can reveal distinctions in the relationship between morphology and several signal metrics for different patients.	Portland State Univ, Dept Elect & Comp Engn, Biomed Signal Proc Lab, Portland, OR 97201 USA; Oregon Inst Technol, Elect Engn Technol Dept, Portland, OR 97229 USA; Univ London, London WC1E 7HU, England		Ellis, T (corresponding author), Portland State Univ, Dept Elect & Comp Engn, Biomed Signal Proc Lab, 1900 SW 4th Ave, Portland, OR 97201 USA.	taellis@pdx.edu; mcnames@pdx.edu	Aboy, Mateo/K-4060-2019	Aboy, Mateo/0000-0002-5168-4321			Aboy M, 2005, BLOOD PRESS MONIT, V10, P111, DOI 10.1097/00126097-200506000-00001; Aboy M, 2004, IEEE T BIO-MED ENG, V51, P2198, DOI 10.1109/TBME.2004.834295; Adelson PD, 2003, CRIT CARE MED, V31, pS418, DOI 10.1097/00003246-200306006-00002; Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; AVEZAAT CJJ, 1979, J NEUROL NEUROSUR PS, V42, P687, DOI 10.1136/jnnp.42.8.687; Balestreri L, 2004, HORIZ CANC RES, V2, P1; Balestreri M, 2004, ACTA NEUROCHIR, V146, P131, DOI 10.1007/s00701-003-0187-y; Chaney JC, 2002, CRIT CARE MED, V30, P2338, DOI 10.1097/00003246-200210000-00025; CHOPP M, 1980, J NEUROSURG, V53, P516, DOI 10.3171/jns.1980.53.4.0516; COHN D, 1995, NEW LITERARY HIST, V26, P3, DOI 10.1353/nlh.1995.0004; CONTANT CF, 1995, J NEUROSCI METH, V57, P15, DOI 10.1016/0165-0270(94)00106-Q; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Czosnyka M, 1996, ACTA NEUROCHIR, V138, P531, DOI 10.1007/BF01411173; DOYLE J, 1992, J CLIN MONITOR, V8, P81, DOI 10.1007/BF01618093; Dubin MJ, 1998, NEUROL RES, V20, P533; ELLIS T, 2005, P 27 ANN INT C IEEE, P2880; FOLTZ E L, 1990, Neurological Research, V12, P67; Godje O, 2002, CRIT CARE MED, V30, P52; Godje O, 1999, ANN THORAC SURG, V68, P1532, DOI 10.1016/S0003-4975(99)00956-X; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Linton NWF, 2001, BRIT J ANAESTH, V86, P486, DOI 10.1093/bja/86.4.486; Luerssen T G, 1997, Semin Pediatr Neurol, V4, P146, DOI 10.1016/S1071-9091(97)80033-2; Lundberg N, 1960, ACTA PSYCHIAT NEUR S, V36, P149; McNames J, 2006, IEEE SIGNAL PROC MAG, V23, P82, DOI 10.1109/MSP.2006.1593340; McVeigh GE, 1999, HYPERTENSION, V33, P1392, DOI 10.1161/01.HYP.33.6.1392; McVeigh GE, 2002, CLIN SCI, V102, P51, DOI 10.1042/CS20010191; NORTH B, 1997, HEAD INJURY, P209; Panerai RB, 1998, PHYSIOL MEAS, V19, P305, DOI 10.1088/0967-3334/19/3/001; PIPER IR, 1990, J NEUROSURG, V73, P871, DOI 10.3171/jns.1990.73.6.0871; PORTNOY HD, 1982, J NEUROSURG, V56, P666, DOI 10.3171/jns.1982.56.5.0666; PORTNOY HD, 1981, NEUROSURGERY, V9, P14, DOI 10.1227/00006123-198107000-00004; Resnick LM, 2000, AM J HYPERTENS, V13, P1243, DOI 10.1016/S0895-7061(00)01219-X; Rodig G, 1999, BRIT J ANAESTH, V82, P525; van Lieshout JJ, 2001, BRIT J ANAESTH, V86, P467, DOI 10.1093/bja/86.4.467; Wesseling K H, 1976, Acta Anaesthesiol Belg, V27 suppl, P327	35	18	18	1	9	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9294	1558-2531		IEEE T BIO-MED ENG	IEEE Trans. Biomed. Eng.	SEP	2007	54	9					1552	1559		10.1109/TBME.2007.892918			8	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	204TW	WOS:000249067900002	17867347				2022-02-06	
J	Starling, SP; Sirotnak, AP; Heisler, KW; Ames-Eley, MLB				Starling, Suzanne P.; Sirotnak, Andrew P.; Heisler, Kurt W.; Ames-Eley, Myra L. B.			Inflicted skeletal trauma: The relationship of perpetrators to their victims	CHILD ABUSE & NEGLECT			English	Article						fractures; child abuse; perpetrators	ABUSIVE HEAD TRAUMA; CHILD-ABUSE; FRACTURES; INJURIES; VIOLENCE	Objective: Although inflicted skeletal trauma is a very common presentation of child abuse, little is known about the perpetrators of inflicted skeletal injuries. Studies exist describing perpetrators of inflicted traumatic brain injury, but no study has examined characteristics of perpetrators of inflicted skeletal trauma. Methods: All cases of suspected child physical abuse evaluated by the child abuse evaluation teams at Vanderbilt University Medical Center (January 1996 to August 2000) and at the Children's Hospital at Denver (January 1996 to December 1999) were reviewed for the presence of fractures. All children with inflicted fractures were entered into the study, and demographic data, investigative data, and identity of perpetrators were collected. Results: There were a total of 630 fractures for 194 patients. The median number of fractures per patient was 2, and the maximum was 3 1. Sixty-three percent of children presented with at least one additional abusive injury other than the fracture(s). Perpetrators were identified in 79% of the cases. Nearly 68% of the perpetrators were male; 45% were the biological fathers. The median age of the children abused by males (4.5 months) significantly differed from the median age of those abused by females (10 months) (p =.003). Conclusion: In the cases where a perpetrator of inflicted fractures could be identified, the majority were men, most commonly the biological fathers. Children injured by men were younger than those injured by women. (C) 2007 Elsevier Ltd. All rights reserved.	Childrens Hosp Kings Daughters, Child Abuse Program, Norfolk, VA 23507 USA; Eastern Virginia Med Sch, Dept Pediat, Norfolk, VA 23501 USA; Univ Colorado, Childrens Hosp, Dept Pediat, Sch Med, Denver, CO 80202 USA		Starling, SP (corresponding author), Childrens Hosp Kings Daughters, Child Abuse Program, 935 Redgate Ave, Norfolk, VA 23507 USA.						Brenner RA, 1999, PEDIATRICS, V103, P968, DOI 10.1542/peds.103.5.968; COOPER A, 1988, J TRAUMA, V28, P1483, DOI 10.1097/00005373-198810000-00015; Cramer KE, 1996, PEDIATR CLIN N AM, V43, P1035, DOI 10.1016/S0031-3955(05)70449-1; Eckenrode J, 2000, JAMA-J AM MED ASSOC, V284, P1385, DOI 10.1001/jama.284.11.1385; HYDEN PW, 1992, PEDIATR CLIN N AM, V39, P1053; Kotch JB, 1999, CHILD ABUSE NEGLECT, V23, P305, DOI 10.1016/S0145-2134(99)00003-4; LEVENTHAL JM, 1993, AM J DIS CHILD, V147, P87, DOI 10.1001/archpedi.1993.02160250089028; Loder R T, 1991, J Orthop Trauma, V5, P428, DOI 10.1097/00005131-199112000-00007; Mathew MO, 1998, BRIT MED J, V317, P1117; Starling SP, 2004, ARCH PEDIAT ADOL MED, V158, P454, DOI 10.1001/archpedi.158.5.454; Starling SP, 2000, SOUTHERN MED J, V93, P463; STARLING SP, 1995, PEDIATRICS, V95, P259; WOLFNER GD, 1993, CHILD ABUSE NEGLECT, V17, P197, DOI 10.1016/0145-2134(93)90040-C; WORLOCK P, 1986, BRIT MED J, V293, P100, DOI 10.1136/bmj.293.6539.100	14	18	18	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0145-2134			CHILD ABUSE NEGLECT	Child Abuse Negl.	SEP	2007	31	9					993	999		10.1016/j.chiabu.2007.02.010			7	Family Studies; Psychology, Social; Social Work	Social Science Citation Index (SSCI)	Family Studies; Psychology; Social Work	228QX	WOS:000250745700006	17870159				2022-02-06	
J	Gottshall, KR; Gray, NL; Drake, AI; Tejidor, R; Hoffer, ME; McDonald, EC				Gottshall, Kim R.; Gray, Nicola L.; Drake, Angela I.; Tejidor, Raechel; Hoffer, Michael E.; McDonald, Eric C.			To investigate the influence of acute vestibular impairment following mild traumatic brain injury on subsequent ability to remain on activity duty 12 months later	MILITARY MEDICINE			English	Article							DYNAMIC VISUAL-ACUITY; HEAD-INJURY; MENTAL-DISORDERS; OUTCOME MEASURES; US MILITARY; RETURN; WORK; PERFORMANCE; CONCUSSION; TESTS	The objective of this study was to investigate the relationship between acute vestibular dysfunction as measured by the Dizziness Handicap Inventory and the Dynamic Visual Acuity Test and the ability to remain on active duty status in the U.S. military 1 year after mild traumatic brain injury. This longitudinal prospective study was conducted by the Defense and Veterans Brain Injury Clinic at Marine Corp Base, Camp Pendleton, California. Participants (n = 47, controls = 44) were referrals to the clinic who had sustained a mild traumatic brain injury and were initially seen within 6 days of injury, then weekly for 1 month, and for follow-up 12 months later. The results demonstrated that those on active duty at 12 months were older in age, had more years of service, and had no history of psychiatric illness or apparent secondary gain issues. Acute vestibular dysfunction and demographic and injury variables were not significantly correlated or predictive of work status at 12 months.	Naval Med Ctr, Spatial Orientat Ctr, Dept Otolaryngol, San Diego, CA 92134 USA; Naval Med Ctr, Def & Vet Brain Injury Ctr, Dept Neurosci, San Diego, CA 92134 USA; Naval Med Ctr, Emergency Dept, San Diego, CA 92134 USA		Gottshall, KR (corresponding author), Naval Med Ctr, Spatial Orientat Ctr, Dept Otolaryngol, 34800 Bob Wilson Dr,Suite 200, San Diego, CA 92134 USA.						Abrams D., 1993, J HEAD TRAUMA REHAB, V8, P59; Badke MB, 2004, ARCH PHYS MED REHAB, V85, P227, DOI 10.1016/j.apmr.2003.06.006; Binder LM, 2003, J CLIN EXP NEUROPSYC, V25, P420, DOI 10.1076/jcen.25.3.420.13806; *CDCP, 2003, REPORT C MILD TRAUM; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Cigrang JA, 1998, MIL MED, V163, P834, DOI 10.1093/milmed/163.12.834; Clendaniel RA, 2000, OTOLARYNG CLIN N AM, V33, P519, DOI 10.1016/S0030-6665(05)70225-5; Demer JL, 2001, ANN NY ACAD SCI, V942, P428; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; *DVA, 1991, USERS MANUAL RES, P1; Feinstein A, 2001, MED SCI LAW, V41, P116, DOI 10.1177/002580240104100206; Gottshall K, 2003, LARYNGOSCOPE, V113, P1746, DOI 10.1097/00005537-200310000-00016; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; HEALY GB, 1982, NEW ENGL J MED, V306, P1029, DOI 10.1056/NEJM198204293061705; Herdman SJ, 2001, ARCH OTOLARYNGOL, V127, P1205, DOI 10.1001/archotol.127.10.1205; Herdman SJ, 1998, AM J OTOL, V19, P790; Hoge CW, 2005, AM J PSYCHIAT, V162, P585, DOI 10.1176/appi.ajp.162.3.585; Hoge CW, 2002, AM J PSYCHIAT, V159, P1576, DOI 10.1176/appi.ajp.159.9.1576; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; JONTZ S, 2006, TBI WARTIME AFGHAN I; Kelly JP, 1998, J HEAD TRAUMA REHAB, V13, P53, DOI 10.1097/00001199-199804000-00008; Kelly JP, 1997, NEUROLOGY, V48, P581; KIRTANE MV, 1982, J LARYNGOL OTOL, V96, P521, DOI 10.1017/S0022215100092793; Kisilevski V, 2001, Int Tinnitus J, V7, P118; Lee MH, 1997, AVIAT SPACE ENVIR MD, V68, P111; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Nyabenda A., 2004, Annales de Readaptation et de Medecine Physique, V47, P105; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; RAO N, 1990, Brain Injury, V4, P49, DOI 10.3109/02699059009026148; RAO N, 1992, ARCH PHYS MED REHAB, V73, P911; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; Sosin DM, 1996, BRAIN INJURY, V10, P47; Sylvia FR, 2001, MIL MED, V166, P918, DOI 10.1093/milmed/166.10.918; *TBI STAT DEM GRAN, 2000, J HEAD TRAUMA REHAB, V15, P750; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Vanderploeg RD, 2003, J HEAD TRAUMA REHAB, V18, P148, DOI 10.1097/00001199-200303000-00006; Whitney SL, 2004, OTOL NEUROTOL, V25, P139, DOI 10.1097/00129492-200403000-00010	39	18	18	0	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	AUG	2007	172	8					852	857		10.7205/MILMED.172.8.852			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	201JW	WOS:000248828400012	17803077	hybrid			2022-02-06	
J	West, SL; Luck, RS; Capps, CF				West, Steven L.; Luck, Richard S.; Capps, C. Fred			Physical inaccessibility negatively impacts the treatment participation of persons with disabilities	ADDICTIVE BEHAVIORS			English	Article						persons with disabilities; treatment access; physical accessibility	SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; SUBSTANCE-ABUSE; MISUSE	This research assessed the impact that physical inaccessibility of provider locations has on the substance abuse treatment participation of two groups of persons with disabilities. A random sample of treatment providers in the Mid-Atlantic region were surveyed and asked if they had declined services to persons with spinal cord (SCI) or traumatic brain (TBI) injuries due to the inaccessibility of their practices. Over half of those who had been approached by persons with SCI and nearly half of those approached by persons with TBI were unable to provide services due to physical barriers. The inability to serve such individuals was not related to practice affiliation (public or private) or practice type (hospital based, non-medical residential, or outpatient). These findings support earlier research indicating the treatment participation of persons with disabilities is negatively affected by physical accessibility concerns. (C) 2007 Published by Elsevier Ltd.	Virginia Commonwealth Univ, Dept Rehabil Counseling, Richmond, VA 23298 USA		West, SL (corresponding author), Virginia Commonwealth Univ, Dept Rehabil Counseling, POB 980330, Richmond, VA 23298 USA.	slwest2@vcu.edu					Burgard JF, 2000, J PSYCHOACTIVE DRUGS, V32, P293, DOI 10.1080/02791072.2000.10400452; Cherry L., 1993, SUBSTANCE ABUSE PHYS, P181; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Kolakowsky-Hayner S, 2002, BRAIN INJURY, V16, P583, DOI 10.1080/02699050110119475; McKinley WO, 1999, AM J PHYS MED REHAB, V78, P306, DOI 10.1097/00002060-199907000-00002; MOORE D, 1991, INT J ADDICT, V26, P65, DOI 10.3109/10826089109056240; Nelipovich M, 1998, J VISUAL IMPAIR BLIN, V92, P567, DOI 10.1177/0145482X9809200805; RADNITZ CL, 1995, INT J ADDICT, V30, P1117, DOI 10.3109/10826089509055831; Schaschl S., 1993, SUBSTANCE ABUSE PHYS, P165; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Voss C. P., 2002, TOPICS SPINAL CORD I, V7, P47; Waldrop J., 2003, DISABILITY STATUS 20; West S. L., 2005, 5 ANN NAT COUNC REH; WEST SL, IN PRESS J SUBSTANCE; Westermeyer J, 1996, AM J ADDICTION, V5, P23	15	18	18	0	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4603			ADDICT BEHAV	Addict. Behav.	JUL	2007	32	7					1494	1497		10.1016/j.addbeh.2006.10.009			4	Psychology, Clinical; Substance Abuse	Social Science Citation Index (SSCI)	Psychology; Substance Abuse	171JL	WOS:000246732000017	17258869				2022-02-06	
J	Rao, V; Spiro, JR; Schretlen, DJ; Cascella, NG				Rao, Vani; Spiro, Jennifer R.; Schretlen, David J.; Cascella, Nicola G.			Apathy syndrome after traumatic brain injury compared with deficits in schizophrenia	PSYCHOSOMATICS			English	Article							NEGATIVE SYMPTOMS; NONDEFICIT FORMS; HEAD-INJURY; SCALE; PSYCHOPATHOLOGY; DEPRESSION	The authors compared the severity and clinical profiles of patients with two etiologically different apathy syndromes: apathy after traumatic brain injury (TBI) and deficit schizophrenia (DSS). Patients from both groups were equally apathetic, but those with DSS had more severe anhedonia, blunted affect, and alogia, as measured by the Scale for Assessment of Negative Symptoms. These findings suggest that patients with DSS have a more complex presentation of apathy. Their differences may help to identify anatomical correlates of these apathy syndromes and aid in the design of more effective management strategies for both groups of patients.	Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA		Rao, V (corresponding author), Johns Hopkins Univ Hosp, Div Neuropsychiat & Geriatr Psychiat, 600 N Wolfe St, Baltimore, MD 21287 USA.	vrao@jhmi.edu					Andreasen NC, 1981, SCALE ASSESSMENT NEG; Arango C, 2004, EUR PSYCHIAT, V19, P21, DOI 10.1016/j.eurpsy.2003.10.004; BUCHANAN RW, 1994, ARCH GEN PSYCHIAT, V51, P804; BUCHANAN RW, 1990, AM J PSYCHIAT, V147, P290; Carpenter WT, 1999, BIOL PSYCHIAT, V46, P352, DOI 10.1016/S0006-3223(99)00088-8; CARPENTER WT, 1988, AM J PSYCHIAT, V145, P578; DOODY RS, 1995, J NEUROPSYCH CLIN N, V7, P54; FABREGA H, 1988, COMPR PSYCHIAT, V29, P285, DOI 10.1016/0010-440X(88)90051-X; Finset A, 2000, BRAIN INJURY, V14, P887; First M., 1997, STRUCTURED CLIN INTE; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Galderisi S, 2002, AM J PSYCHIAT, V159, P983, DOI 10.1176/appi.ajp.159.6.983; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Kant R, 1998, BRAIN INJURY, V12, P87, DOI 10.1080/026990598122908; KIRKPATRICK B, 1989, PSYCHIAT RES, V30, P119, DOI 10.1016/0165-1781(89)90153-4; Kopelowicz A, 1997, AM J PSYCHIAT, V154, P424; Levy R, 2006, CEREB CORTEX, V16, P916, DOI 10.1093/cercor/bhj043; Lyketsos CG, 2004, PSYCHOSOMATICS, V45, P247, DOI 10.1176/appi.psy.45.3.247; Mann R. S., 1996, REV PSYCHIAT, V15, P205; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; Marit RS, 2005, J HEAD TRAUMA REHAB, V20, P377, DOI 10.1097/00001199-200507000-00009; Mueser KT, 2004, LANCET, V363, P2063, DOI 10.1016/S0140-6736(04)16458-1; Murphy KJ., 2000, NEUROPSYCHOLOGY EMOT, P340; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Resnick B, 1998, Rehabil Nurs, V23, P141; Spreen O., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI [10.1080/13854048908403285, DOI 10.1080/13854048908403285]; STARKSTEIN SE, 1993, STROKE, V24, P1625, DOI 10.1161/01.STR.24.11.1625; Tattan TMG, 2001, SCHIZOPHRENIA BULL, V27, P149, DOI 10.1093/oxfordjournals.schbul.a006853; TEASDALE G, 1974, LANCET, V2, P81; van Reekum R, 2005, J NEUROPSYCH CLIN N, V17, P7, DOI 10.1176/appi.neuropsych.17.1.7; VANZOMERAN A, 1985, J NEUROL NEUROSURGER, V41, P21; Verstraeten E, 2004, SLEEP MED REV, V8, P257, DOI 10.1016/j.smrv.2004.01.001; Weisman AG, 2000, SCHIZOPHRENIA BULL, V26, P817, DOI 10.1093/oxfordjournals.schbul.a033496	33	18	18	0	4	AMER PSYCHIATRIC PUBLISHING, INC	ARLINGTON	1000 WILSON BOULEVARD, STE 1825, ARLINGTON, VA 22209-3901 USA	0033-3182			PSYCHOSOMATICS	Psychosomatics	JUN	2007	48	3					217	222		10.1176/appi.psy.48.3.217			6	Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry; Psychology	164CN	WOS:000246210400005	17478590				2022-02-06	
J	Testerman, GM; Dacks, LM				Testerman, George M.; Dacks, Laura M.			Multiple self-inflicted nail gun head injury	SOUTHERN MEDICAL JOURNAL			English	Article						brain trauma; penetrating brain injury; self-inflicted injury; nail gun	TRAUMATIC ANEURYSMS; SUICIDE; MANAGEMENT	Penetrating brain injury resulting from nail-gun use is a well-characterized entity, one that is increasing in frequency as nail guns become more powerful and more readily available to the public. We present a case and offer management strategies for a 50-year-old male with two intracranial penetrating nail gun injuries. Nail gun brain injuries are commonly intentionally self-inflicted. Suicide should be considered when straight nails cause wounds to the chest, head, or abdomen. The primary preoperative concern is formation of a traumatic pseudoaneurism, which prompts both preoperative and follow-up cerebral angiography. Surgery for combined intracranial and extracranial injury may require the collaborative expertise of colleagues from the fields of ophthalmology, otolaryngology, and oral maxillofacial surgery. A rational management strategy should permit these patients to be discharged with no additional injury.	E Tennessee State Univ, Coll Med, Wellmont Holston Valley Med Ctr, Dept Surg, Kingsport, TN 37660 USA		Testerman, GM (corresponding author), E Tennessee State Univ, Coll Med, Wellmont Holston Valley Med Ctr, Dept Surg, 134 W Pk Dr, Kingsport, TN 37660 USA.	gmt0@charter.net					AARABI B, 1995, NEUROSURG CLIN N AM, V6, P775; Amirjamshidi A, 1996, J NEUROSURG, V84, P769, DOI 10.3171/jns.1996.84.5.0769; Beaver AC, 1999, AM SURGEON, V65, P1113; GAUL JS, 1987, J HAND SURG-AM, V12A, P966, DOI 10.1016/S0363-5023(87)80266-6; HARRIS T, NAIL GUNS WORK; KENNY N, 1993, J TRAUMA, V35, P943, DOI 10.1097/00005373-199312000-00023; Litvack ZN, 2006, J NEUROSURG, V104, P828, DOI 10.3171/jns.2006.104.5.828; MCCORKELL SJ, 1986, AM J FOREN MED PATH, V7, P192, DOI 10.1097/00000433-198607030-00004; Panourias IG, 2006, CLIN NEUROL NEUROSUR, V108, P490, DOI 10.1016/j.clineuro.2005.01.007; Sahjpaul RL, 2000, CAN J NEUROL SCI, V27, pS55, DOI 10.1017/S0317167100000676; VISWANATHAN R, 1994, SCOT MED J, V39, P83, DOI 10.1177/003693309403900310; Wu W Q, 1975, Surg Neurol, V3, P83	12	18	19	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0038-4348	1541-8243		SOUTH MED J	South.Med.J.	JUN	2007	100	6					608	610		10.1097/SMJ.0b013e3180398e47			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	177PZ	WOS:000247166300013	17591316				2022-02-06	
J	Bentz, K; Molcanyi, M; Riess, P; Elbers, A; Pohl, E; Sachinidis, A; Hescheler, J; Neugebauer, E; Schafer, U				Bentz, Kristine; Molcanyi, Marek; Riess, Peter; Elbers, Andrea; Pohl, Esther; Sachinidis, Agapios; Hescheler, Juergen; Neugebauer, Edmund; Schaefer, Ute			Embryonic stem cells produce neurotrophins in response to cerebral tissue extract: Cell line-dependent differences	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						Sprague-Dawley rats; fluid percussion injury; BDNF; NGF; neurotrophin-3	TRAUMATIC BRAIN-INJURY; MARROW STROMAL CELLS; GROWTH-FACTOR PRODUCTION; FLUID-PERCUSSION MODEL; NEURAL TRANSPLANTATION; SPINAL-CORD; IN-VIVO; PRECURSOR CELLS; MESSENGER-RNAS; RAT	In the present study, we compare the capacity of two different embryonic stem (ES) cell lines to secrete neurotrophins in response to cerebral tissue extract derived from healthy or injured rat brains. The intrinsic capacity of the embryonic cell lines BAC7 (feeder cell-dependent cultivation) to release brain-derived neurotrophic factor (BDNF) or neurotrophin-3 (NT-3) exceeded the release of these factors by CGR8 cells (feeder cell-free growth) by factors of 10 and 4, respectively. Nerve growth factor (NGF) was secreted only by BAC7 cells. Conditioning of cell lines with cerebral tissue extract derived from healthy or fluid percussion-injured rat brains resulted in a significant time-dependent increase in BDNF release in both cell lines. The increase in BDNF release by BAC7 cells was more pronounced when cells were incubated with brain extract derived from injured brain. However, differences in neurotrophin release associated with the origin of brain extract were at no time statistically significant. Neutrophin-3 and NGF release was inhibited when cell lines were exposed to cerebral tissue extract. The magnitude of the response to cerebral tissue extract was dependent on the intrinsic capacity of the cell lines to release neurotrophins. Our results clearly demonstrate significant variations in the intrinsic capability of different stem cell lines to produce neurotrophic factors. Furthermore, a significant modulation of neurotrophic factor release was observed following conditioning of cell lines with tissue extract derived from rat brains. A significant modulation of neurotrophin release dependent on the source of cerebral tissue extract used was not observed. (c) 2007 Wiley-Liss, Inc.	Univ Witten Herdecke, Fac Med, IFOM, Inst Res Operat Med, D-51109 Cologne, Germany; GSF, Natl Res Ctr Environm & Hlth, Inst Dev Genet, Munich, Germany; Univ Cologne, Fac Med, Clin Neurosurg, D-5000 Cologne 41, Germany; Univ Witten Herdecke, Hosp Merheim, Fac Med, Dept Traumat & Orthoped Surg, D-51109 Cologne, Germany; Univ Cologne, Fac Med, Dept Neurophysiol, D-5000 Cologne 41, Germany		Schafer, U (corresponding author), Univ Witten Herdecke, Fac Med, IFOM, Inst Res Operat Med, Ostmerheimerstr 200, D-51109 Cologne, Germany.	u.schaefer@uni-koeln.de	Sachinidis, Agapios/AAD-4178-2020; Sachinidis, Agapios/AAM-7988-2020				Arnhold S, 2000, J NEUROSURG, V93, P1026, DOI 10.3171/jns.2000.93.6.1026; Boockvar JA, 2005, NEUROSURGERY, V56, P163, DOI 10.1227/01.NEU.0000145866.25433.FF; Borlongan CV, 1997, NEUROSCI BIOBEHAV R, V21, P79, DOI 10.1016/0149-7634(95)00063-1; Cao QL, 2002, EXP NEUROL, V177, P349, DOI 10.1006/exnr.2002.7981; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chen Q, 2005, J NEUROSCI RES, V80, P611, DOI 10.1002/jnr.20494; Chen XG, 2002, J NEUROSCI RES, V69, P687, DOI 10.1002/jnr.10334; Chen XG, 2002, NEUROPATHOLOGY, V22, P275, DOI 10.1046/j.1440-1789.2002.00450.x; Davis A E, 2000, Crit Care Nurs Q, V23, P1; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Emery DL, 2005, J NEUROTRAUM, V22, P978, DOI 10.1089/neu.2005.22.978; Giehl KM, 2001, J NEUROSCI, V21, P3492, DOI 10.1523/JNEUROSCI.21-10-03492.2001; Hicks RR, 1999, EXP NEUROL, V160, P469, DOI 10.1006/exnr.1999.7216; Hicks RR, 1997, MOL BRAIN RES, V48, P401, DOI 10.1016/S0169-328X(97)00158-7; Iguchi F, 2003, NEUROREPORT, V14, P77, DOI 10.1097/00001756-200301200-00015; Karchewski LA, 2002, EUR J NEUROSCI, V16, P1449, DOI 10.1046/j.1460-9568.2002.02205.x; Lacza Z, 2003, INT J MOL MED, V12, P153; Lacza Z, 2003, BRAIN RES PROTOC, V11, P145, DOI 10.1016/S1385-299X(03)00039-4; Le Belle JE, 2002, BIODRUGS, V16, P389, DOI 10.2165/00063030-200216060-00001; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Longhi L, 2005, TRANSPL IMMUNOL, V15, P143, DOI 10.1016/j.trim.2005.09.003; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Lu DY, 2002, J NEUROSURG, V97, P935, DOI 10.3171/jns.2002.97.4.0935; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mahmood A., 2003, NEUROSURGERY, V53, P702; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MOCLONYI M, 2007, IN PRESS J NEUROTRAU; Okano H, 2003, SEMIN CELL DEV BIOL, V14, P191, DOI 10.1016/S1084-9521(03)00011-9; Philips MF, 2001, J NEUROSURG, V94, P765, DOI 10.3171/jns.2001.94.5.0765; Ricci-Vitiani L, 2006, NEUROL RES, V28, P488, DOI 10.1179/016164106X115134; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Riess P, 2007, J NEUROTRAUM, V24, P216, DOI 10.1089/neu.2006.0141; ROHWEDEL J, 1994, DEV BIOL, V164, P87, DOI 10.1006/dbio.1994.1182; Saporta S, 1999, NEUROSCIENCE, V91, P519, DOI 10.1016/S0306-4522(98)00610-1; Sinson G, 1996, J NEUROSURG, V84, P655, DOI 10.3171/jns.1996.84.4.0655; Veizovic T, 2001, STROKE, V32, P1012, DOI 10.1161/01.STR.32.4.1012; Watson DJ, 2003, J NEUROPATH EXP NEUR, V62, P368, DOI 10.1093/jnen/62.4.368; Wong G, 2004, EXP NEUROL, V187, P171, DOI 10.1016/j.expneurol.2004.01.009	39	18	19	0	1	WILEY-LISS	HOBOKEN	DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA	0360-4012			J NEUROSCI RES	J. Neurosci. Res.	APR	2007	85	5					1057	1064		10.1002/jnr.21219			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	157NK	WOS:000245726700013	17335079				2022-02-06	
J	Hayden, MG; Jandial, R; Duenas, HA; Mahajan, R; Levy, M				Hayden, M. G.; Jandial, R.; Duenas, H. A.; Mahajan, R.; Levy, M.			Pediatric concussions in sports; a simple and rapid assessment tool for concussive injury in children and adults	CHILDS NERVOUS SYSTEM			English	Article						brain concussion; pediatrics; athletic injuries; clinical protocol; prevention and control		We established a routine protocol for concussion evaluation in athletes for nonmedical personnel. The evaluation, management guidelines, and return-to-play recommendations were summarized with a memorable mnemonic on a convenient handheld card. The ability to remember the return-to-play mnemonic and effectively apply it to corresponding guidelines was evaluated in 194 sports personnel without medical training. The participants were given three clinical scenarios, each including age, pertinent history, sporting event, description of an injury, symptoms, signs, and a brief neurological exam. Subsequently, the subject's ability to recall the return-to-play mnemonic and the Standard Assessment of Concussion, to describe the corresponding guidelines, and to advise return-to-play was evaluated. Our "return-to-play" mnemonic was found to be simple and memorable, allowing for a high recall percentage and accurate evaluation of concussion cases. High intersubject agreement suggests that this method has both standardization and generalization potential.	Univ Calif San Diego, Div Neurosurg, San Diego, CA 92103 USA; Childrens Specialists San Diego, Childrens Hosp San Diego, San Diego, CA 92123 USA		Jandial, R (corresponding author), Univ Calif San Diego, Div Neurosurg, Mailcode 8893200,W Arbor Dr, San Diego, CA 92103 USA.	rahuljandial@hotmail.com		Hayden Gephart, Melanie/0000-0003-2965-9231			Bazarian JJ, 2001, CLIN PEDIATR, V40, P207, DOI 10.1177/000992280104000405; KRAUS JF, 1987, PEDIATRICS, V79, P501; Lazar L, 1997, J PEDIATR SURG, V32, P88, DOI 10.1016/S0022-3468(97)90102-0; Poirier MP, 2000, PEDIATR EMERG CARE, V16, P278, DOI 10.1097/00006565-200008000-00018; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Skokan EG, 2003, AM J EMERG MED, V21, P95, DOI 10.1053/ajem.2003.50032	6	18	18	0	11	SPRINGER	NEW YORK	233 SPRING STREET, NEW YORK, NY 10013 USA	0256-7040			CHILD NERV SYST	Childs Nerv. Syst.	APR	2007	23	4					431	435		10.1007/s00381-006-0277-2			5	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	143UH	WOS:000244750900012	17219233				2022-02-06	
J	Schmitter-Edgecombe, M; Anderson, JW				Schmitter-Edgecombe, Maureen; Anderson, Jonathan W.			Feeling of knowing in episodic memory following moderate to severe closed-head injury	NEUROPSYCHOLOGY			English	Article						traumatic brain injury; memory monitoring; metamemory; metacognition	TRAUMATIC BRAIN-INJURY; TEMPORAL-LOBE EPILEPSY; SELF-AWARENESS; CONFIDENCE JUDGMENTS; METAMEMORY; KNOWLEDGE; ACCURACY; RECALL; ADULTS; FAMILIARITY	The ability to accurately monitor one's memory is a metacognitive process that is important in everyday life. The authors examined episodic memory feeling-of-knowing (FOK) ratings in 21 moderate to severe closed-head injury (CHI) participants (more than 1 year postinjury) and 21 controls. Participants studied 36 critical cue-target word pairs. Following a brief delay, they were asked to recall the target that corresponded to a given cue. Confidence ratings were made for recalled words, and FOK judgments were made for nonrecalled words in terms of the likelihood of recognizing the target word on a subsequent recognition test. CHI participants demonstrated less accurate recall but accurate ability to judge their recall performance (retrospective memory monitoring). They also demonstrated intact FOK judgments when providing binary judgments but demonstrated difficulties making finer discriminations on an ordinal scale (prospective memory monitoring). These findings suggest that memory monitoring is not a unitary construct. It is proposed that CHI participants may display intact memory monitoring when predictions are based on familiarity assessment but not when continued probing for additional episodic information is required.	Washington State Univ, Dept Psychol, Pullman, WA 99164 USA		Schmitter-Edgecombe, M (corresponding author), Washington State Univ, Dept Psychol, Pullman, WA 99164 USA.	schmitter-e@wsu.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS047690-04, R01 NS047690, R01 NS047690-02, R01 NS47690, R01 NS047690-03, R01 NS047690-01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS047690] Funding Source: NIH RePORTER		ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ALLEN C C, 1990, Brain Injury, V4, P7, DOI 10.3109/02699059009026143; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Benton A., 1976, MULTILINGUAL APHASIA; BIEMANCOPLAND S, 1994, PSYCHOL AGING, V9, P287, DOI 10.1037/0882-7974.9.2.287; BOAKE C, 1995, BRAIN INJURY, V9, P273, DOI 10.3109/02699059509008198; Brandt J, 1985, DEV NEUROPSYCHOL, V1, P335, DOI 10.1080/87565648509540319; COSTERMANS J, 1992, J EXP PSYCHOL LEARN, V18, P142, DOI 10.1037/0278-7393.18.1.142; Delis DC, 1987, CALIFORNIA VERBAL LE; Fleming JM, 1996, BRAIN INJURY, V10, P1; GERMAN DJ, 1990, NATL COLL ED TEST AD; Giacino JT, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199810000-00003; HART JT, 1965, J EDUC PSYCHOL, V56, P208, DOI 10.1037/h0022263; Heaton RK, 1981, MANUAL WISCONSIN CAR; Herbert CM, 1989, CLIN REHABIL, V3, P125; JANOWSKY JS, 1989, PSYCHOBIOLOGY, V17, P3; Kennedy MRT, 2004, AM J SPEECH-LANG PAT, V13, P142, DOI 10.1044/1058-0360(2004/015); Kennedy MRT, 2003, J SPEECH LANG HEAR R, V46, P98, DOI 10.1044/1092-4388(2003/008); Kennedy MRT, 2001, BRAIN INJURY, V15, P469, DOI 10.1080/02699050010007380; Kennedy MRT, 2000, J SPEECH LANG HEAR R, V43, P1072, DOI 10.1044/jslhr.4305.1072; Klin CM, 1997, J EXP PSYCHOL LEARN, V23, P1378, DOI 10.1037/0278-7393.23.6.1378; Knight RG, 2005, BRAIN INJURY, V19, P19, DOI 10.1080/02699050410001720022; Koriat A, 1997, J EXP PSYCHOL GEN, V126, P349, DOI 10.1037/0096-3445.126.4.349; KORIAT A, 1993, PSYCHOL REV, V100, P609, DOI 10.1037/0033-295X.100.4.609; Koriat A, 2001, J EXP PSYCHOL LEARN, V27, P34, DOI 10.1037//0278-7393.27.1.34; Koriat A., 2000, OXFORD HDB MEMORY, P333; Lam C S, 1988, Brain Inj, V2, P235, DOI 10.3109/02699058809150947; Leathem JM, 1998, J CLIN EXP NEUROPSYC, V20, P694, DOI 10.1076/jcen.20.5.694.1122; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P1294, DOI 10.1136/jnnp.51.10.1294; Marquie JC, 2000, PSYCHOL AGING, V15, P451, DOI 10.1037//0882-7974.15.3.451; METCALFE J, 1993, PSYCHOL REV, V100, P3, DOI 10.1037/0033-295X.100.1.3; Nelson D. L., 1998, U S FLORIDA WORD ASS; Nelson T.O., 1990, PSYCHOL LEARN MOTIV, V26, P125, DOI [10.1016/s0079-7421(08)60053-5, DOI 10.1016/S0079-7421(08)60053-5]; NELSON TO, 1984, PSYCHOL BULL, V95, P109, DOI 10.1037/0033-2909.95.1.109; Pannu JK, 2005, NEUROPSYCHOL REV, V15, P105, DOI 10.1007/s11065-005-7091-6; Pannu JK, 2005, J INT NEUROPSYCH SOC, V11, P668, DOI 10.1017/S13556177050873; PAPPAS BA, 1992, J GERONTOL, V47, pP159, DOI 10.1093/geronj/47.3.P159; Port A, 2002, BRAIN INJURY, V16, P277, DOI 10.1080/02699050110103274; PREVEY ML, 1988, BRAIN COGNITION, V7, P298, DOI 10.1016/0278-2626(88)90004-8; PREVEY ML, 1991, CORTEX, V27, P81, DOI 10.1016/S0010-9452(13)80270-5; REDER LM, 1987, COGNITIVE PSYCHOL, V19, P90, DOI 10.1016/0010-0285(87)90005-3; REDER LM, 1992, J EXP PSYCHOL LEARN, V18, P435, DOI 10.1037/0278-7393.18.3.435; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Roche NL, 2002, BRAIN INJURY, V16, P931, DOI 10.1080/02699050210138581; Sbordone RJ, 1998, BRAIN INJURY, V12, P505, DOI 10.1080/026990598122467; Schlund MW, 1999, BRAIN INJURY, V13, P375, DOI 10.1080/026990599121566; Schmitter-Edgecombe M, 2005, BRAIN LANG, V94, P331, DOI 10.1016/j.bandl.2005.01.007; Schmitter-Edgecombe M, 2004, BRAIN INJURY, V18, P997, DOI 10.1080/02699050410001719934; Schmitter-Edgecombe M, 2004, NEUROPSYCHOLOGY, V18, P104, DOI 10.1037/0894-4105.18.1.104; Schmitter-Edgecombe M, 2006, NEUROPSYCHOLOGY, V20, P675, DOI 10.1037/0894-4105.20.6.675; SCHNEIBEL RS, 1997, DEV PREFRONTAL CORTE, P241; Schnyer DM, 2005, J COGNITIVE NEUROSCI, V17, P832, DOI 10.1162/0898929053747694; Schnyer DM, 2004, NEUROPSYCHOLOGIA, V42, P957, DOI 10.1016/j.neuropsychologia.2003.11.020; SCHRAW G, 1995, APPL COGNITIVE PSYCH, V9, P321, DOI 10.1002/acp.2350090405; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Smith A., 1991, SYMBOL DIGIT MODALIT; Souchay C, 2004, EXP AGING RES, V30, P179, DOI 10.1080/03610730490274248; Souchay C, 2004, EXP AGING RES, V30, P47, DOI 10.1080/03610730490251478; Souchay C, 2002, NEUROPSYCHOLOGIA, V40, P2386, DOI 10.1016/S0028-3932(02)00075-1; Souchay C, 2000, NEUROPSYCHOLOGY, V14, P299, DOI 10.1037/0894-4105.14.2.299; Souchay C, 2006, J CLIN EXP NEUROPSYC, V28, P828, DOI 10.1080/13803390591000846; *SPSS, 1999, SPSS BAS 9 0 US GUID; SUNDERLAND A, 1983, J VERB LEARN VERB BE, V22, P341, DOI 10.1016/S0022-5371(83)90229-3; TEASDALE G, 1974, LANCET, V2, P81; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WILSON JTL, 1995, J NEUROL NEUROSUR PS, V59, P328, DOI 10.1136/jnnp.59.3.328; Zachary R., 1991, SHIPLEY I LIVING SCA	69	18	19	0	10	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	MAR	2007	21	2					224	234		10.1037/0894-4105.21.2.224			11	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	146YJ	WOS:000244970300008	17402822	Green Accepted			2022-02-06	
J	Earle, SA; de Moya, MA; Zuccarelli, JE; Norenberg, MD; Proctor, KG				Earle, Steven A.; de Moya, Marc A.; Zuccarelli, Jennifer E.; Norenberg, Michael D.; Proctor, Kenneth G.			Cerebrovascular resuscitation after polytrauma and fluid restriction	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article; Proceedings Paper	92nd Annual Clinical Congress of the American-College-of-Surgeons	OCT 08-12, 2006	Chicago, IL	Amer Coll Surg			TRAUMATIC BRAIN-INJURY; OPERATION-IRAQI-FREEDOM; CEREBRAL PERFUSION-PRESSURE; HYDROXYETHYL STARCH; PULMONARY CONTUSION; BISPECTRAL INDEX; BLAST INJURIES; CHEST TRAUMA; CASUALTIES; EXPERIENCE	BACKGROUND: There are few reproducible models of blast injury, so it is difficult to evaluate new or existing therapies. We developed a clinically relevant polytrauma model to test the hypothesis that cerebrovascular resuscitation is optimized when intravenous fluid is restricted. STUDY DESIGN: Anesthetized swine (42 +/- 5 kg, n = 35) received blasts to the head and bilateral chests with captive bolt guns, followed by hypoventilation (4 breaths/min; FiO(2) = 0.21). After 30 minutes, resuscitation was divided into phases to simulate typical prehospital, emergency room, and ICU care. For 30 to 45 minutes, group 1, the control group (n = 5), received 1 L of normal saline (NS). For 45 to 120 minutes additional NS was titrated to mean arterial pressure (MAP) > 60 mmHg. After 120 minutes, mannitol (1g/kg) and phenylephrine were administered to manage cerebral perfusion pressure (CPP) > 70 mmHg, plus additional NS was given to maintain central venous pressure (CVP) > 12 mmHg. In group 2 (n = 5), MAP and CPP targets were the same, but the CVP target was > 8 mmHg. Group 3 (n = 5) received 1 L of NS followed only by CPP management. Group 4 (n = 5) received Hextend (Abbott Laboratories), instead of NS, to the same MAP and CPP targets as group 2. RESULTS: Polytrauma caused 13 deaths in the 35 animals. In survivors, at 30 minutes, MAP was 60 to 65 mmHg, heart rate was > 100 beats/min, PaO2 was < 50 mmHg, and lactate was > 5 mmol/L. In two experiments, no fluid or pressor was administered; the tachycardia and hypotension persisted. The first liter of intravenous fluid partially corrected these variables, and also partially corrected mixed venous O-2, gastric and portal venous O-2, cardiac output, renal blood flow, and urine output. Additional NS (total of 36 +/- 1 mL/kg/h and 17 6 mL/kg/h, in groups 1 and 2, respectively) correlated with increased intracranial pressure to 38 4 mmHg (group 1) and 26 +/- 4 mmHg (group 2) versus 22 +/- 4 mmHg in group 3 (who received 5 +/- 1 mL/kg/h). CPP was maintained only after mannitol and phenylephrine. By 5 hours, brain tissue PO2 was > 20 mmHg in groups 1 and 2, but only 6 +/- 1 mmHg in group 3. In contrast, minimal Hextend (6 3 mL/kg/h) was needed; the corrections in MAP and CPP were immediate and sustained, intracranial pressure was lower (14 +/- 2 mmHg), and brain tissue PO2 was > 20 mmHg. Neuropathologic changes were consistent with traumatic brain injury, but there were no statistically significant differences between groups. CONCLUSIONS: After polytrauma and resuscitation to standard MAP and CPP targets with mannitol and pressor therapy, we concluded that intracranial hypertension was attenuated and brain oxygenation was maintained with intravenous fluid restriction; cerebrovascular resuscitation was optimized with Hextend versus NS; and longer term studies are needed to determine neuropathologic consequences.	Univ Miami, Miller Sch Med, Dewitt Daughtry Family Dept Surg, Div Trauma & Surg Crit Care,Ryder Trauma Ctr, Miami, FL 33136 USA; Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL USA		Proctor, KG (corresponding author), Univ Miami, Miller Sch Med, Dewitt Daughtry Family Dept Surg, Div Trauma & Surg Crit Care,Ryder Trauma Ctr, 1800 NW 10th Ave, Miami, FL 33136 USA.		Proctor, Kenneth/AAA-2199-2022	Proctor, Kenneth/0000-0003-1326-6628			BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; Bilski TR, 2003, J TRAUMA, V54, P814, DOI 10.1097/01.TA.0000046627.87250.1D; BOWEN TE, 1988, NATO HDB, pCH5; *BRAIN TRAUM FDN A, MAN PROGN SEV TRAUM; Butler FK, 2000, MIL MED, V165, P1; Chambers LW, 2005, ARCH SURG-CHICAGO, V140, P26, DOI 10.1001/archsurg.140.1.26; Champion HR, 2003, J TRAUMA, V54, pS13, DOI 10.1097/01.TA.0000057151.02906.27; Crookes BA, 2004, J TRAUMA, V57, P547, DOI 10.1097/01.TA.0000135162.85859.4C; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Desselle WJ, 2001, J TRAUMA, V51, P239, DOI 10.1097/00005373-200108000-00005; Dubick MA, 2003, J TRAUMA, V54, pS43, DOI 10.1097/01.TA.0000064514.42470.3B; Feinstein AJ, 2005, J TRAUMA, V59, P876, DOI 10.1097/01.ta.0000187654.24146.22; Feinstein AJ, 2005, J AM COLL SURGEONS, V201, P536, DOI 10.1016/j.jamcollsurg.2005.05.031; Gan TJ, 1999, ANESTH ANALG, V88, P992, DOI 10.1097/00000539-199905000-00005; Gawande A, 2004, NEW ENGL J MED, V351, P2471, DOI 10.1056/NEJMp048317; Gutierrez de Ceballos J Peral, 2005, Crit Care Med, V33, pS107, DOI 10.1097/01.CCM.0000151072.17826.72; Hayashida M, 2003, BRIT J ANAESTH, V90, P694, DOI 10.1093/bja/aeg107; Holcomb JB, 2003, J TRAUMA, V54, pS46, DOI 10.1097/01.TA.0000051936.91915.A2; Kelly ME, 2003, J TRAUMA, V55, P94, DOI 10.1097/01.TA.0000029042.37577.A6; King DR, 2006, J TRAUMA, V61, P943, DOI 10.1097/01.ta.0000233670.97515.3a; King DR, 2004, SURGERY, V136, P355, DOI 10.1016/j.surg.2004.05.011; Klein Yoram, 2002, Curr Opin Anaesthesiol, V15, P65; Kluger Y, 2004, J AM COLL SURGEONS, V199, P875, DOI 10.1016/j.jamcollsurg.2004.09.003; Krausz MM, 2003, J TRAUMA, V54, pS39, DOI 10.1097/01.TA.0000064506.47688.51; Ling GSF, 2005, NEUROCRIT CARE, V2, P75, DOI 10.1385/NCC:2:1:075; Majde JA, 2003, J TRAUMA, V54, pS100, DOI 10.1097/01.TA.0000064503.24416.F4; Mallonee S, 1996, JAMA-J AM MED ASSOC, V276, P382, DOI 10.1001/jama.276.5.382; Montgomery SP, 2005, J AM COLL SURGEONS, V201, P7, DOI 10.1016/j.jamcollsurg.2005.03.038; Myles PS, 2004, ANESTH ANALG, V98, P706; Nelson TJ, 2006, J AM COLL SURGEONS, V202, P418, DOI 10.1016/j.jamcollsurg.2005.11.011; Nielsen VG, 1997, CRIT CARE MED, V25, P1565, DOI 10.1097/00003246-199709000-00026; NORENBERG MD, 1994, J NEUROPATH EXP NEUR, V53, P213, DOI 10.1097/00005072-199405000-00001; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Panickar KS, 2005, GLIA, V50, P287, DOI 10.1002/glia.20181; Patel TH, 2004, J TRAUMA, V57, P201, DOI 10.1097/01.TA.0000133638.30269.38; Rafie AD, 2004, SHOCK, V22, P262, DOI 10.1097/01.shk.0000135255.59817.8c; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Roche AM, 2004, BRIT J ANAESTH, V92, pA154, DOI 10.1093/bja/aeh502; Rodoplu Ulkumen, 2004, Prehosp Disaster Med, V19, P133; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Ryan J, 2005, NEW ENGL J MED, V353, P543, DOI 10.1056/NEJMp058177; Sanui M, 2006, CRIT CARE MED, V34, P433, DOI 10.1097/01.CCM.0000196206.83534.39; Sondeen JL, 2003, J TRAUMA, V54, pS110, DOI 10.1097/01.TA.0000047220.81795.3D; Wiedermann CJ, 2004, WIEN KLIN WOCHENSCHR, V116, P583, DOI 10.1007/s00508-004-0237-3; Wilkes NJ, 2002, ANESTH ANALG, V94, P538, DOI 10.1097/00000539-200203000-00011; COALITION CASULTIES	46	18	18	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1072-7515	1879-1190		J AM COLL SURGEONS	J. Am. Coll. Surg.	FEB	2007	204	2					261	275		10.1016/j.jamcollsurg.2006.11.014			15	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	135DF	WOS:000244133600009	17254930				2022-02-06	
J	DeHaan, A; Halterman, C; Langan, J; Drew, AS; Osternig, LR; Chou, LS; van Donkelaar, P				DeHaan, Alex; Halterman, Charlene; Langan, Jeanne; Drew, Anthony S.; Osternig, Louis R.; Chou, Li-Shan; van Donkelaar, Paul			Cancelling planned actions following mild traumatic brain injury	NEUROPSYCHOLOGIA			English	Article						mild traumatic brain injury; countermanding saccades; decision-making; executive function	INHIBITORY CONTROL; DEFICITS; ATTENTION; BEHAVIOR; SACCADES; ABILITY	Mild traumatic brain injury (mTBI) leads to a variety of attentional, cognitive, and sensorimotor deficits. An important aspect of behavior that intersects each of these functions is the ability to cancel a planned action. Thus, the purpose of this study was to determine the effects of mTBI on the ability to perform a countermanding saccade task. In this task, participants were asked to generate a saccade to a target appearing in peripheral vision, but to inhibit saccade execution if an auditory stop signal was presented. The delay between the appearance of the peripheral target and the presentation of the auditory stop signal was varied between 0 and 125 ms. We found that the change in the probability of cancelling the saccade as a function of this delay was no different between participants with mTBI tested within 2 days of their injury and matched controls. However, saccadic reaction times and the stop signal reaction time were unexpectedly faster in the participants with mTBI and, furthermore, they inaccurately inhibited saccades during 15% of the trials with no stop signal. Taken together, this data suggests that the ability to cancel planned actions is subtly yet adversely affected by mTBI. (c) 2006 Elsevier Ltd. All rights reserved.	Univ Oregon, Dept Human Physiol, Eugene, OR 97403 USA; Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA		van Donkelaar, P (corresponding author), Univ Oregon, Dept Human Physiol, 122C Esslinger Hall, Eugene, OR 97403 USA.	paulvd@uoregon.edu		Langan, Jeanne/0000-0003-1417-2180			Armstrong IT, 2003, EXP BRAIN RES, V152, P444, DOI 10.1007/s00221-003-1569-3; Aron AR, 2006, J NEUROSCI, V26, P2424, DOI 10.1523/JNEUROSCI.4682-05.2006; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Badcock JC, 2002, PSYCHOL MED, V32, P287, DOI 10.1017/S0033291701005128; Band GPH, 2003, ACTA PSYCHOL, V112, P105, DOI 10.1016/S0001-6918(02)00079-3; Cabel DWJ, 2000, EXP BRAIN RES, V133, P431, DOI 10.1007/s002210000440; CHIKAZOE J, 2005, SOC NEUR ABSTR; Crevits L, 2000, J NEUROL, V247, P179, DOI 10.1007/s004150050559; Curtis CE, 2005, CEREB CORTEX, V15, P1281, DOI 10.1093/cercor/bhi011; DEBEAUMONT L, 2006, UNPUB IMPAIRED CORTI; Fillmore MT, 2002, DRUG ALCOHOL DEPEN, V67, P157, DOI 10.1016/S0376-8716(02)00062-5; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Hanes DP, 1999, VISION RES, V39, P2777, DOI 10.1016/S0042-6989(99)00011-5; Hanisch C, 2006, J NEURAL TRANSM, V113, P671, DOI 10.1007/s00702-005-0344-y; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Kelly JP, 1997, NEUROLOGY, V48, P581; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; McIntire A, 2006, EXP BRAIN RES, V174, P361, DOI 10.1007/s00221-006-0469-8; Mulvihill LE, 1997, J STUD ALCOHOL, V58, P600, DOI 10.15288/jsa.1997.58.600; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Reddi BAJ, 2000, NAT NEUROSCI, V3, P827, DOI 10.1038/77739; Schall JD, 2002, NEURON, V36, P309, DOI 10.1016/S0896-6273(02)00964-9; Schall JD, 2001, NAT REV NEUROSCI, V2, P33, DOI 10.1038/35049054; Schall JD, 2000, PSYCHOL RES-PSYCH FO, V63, P299, DOI 10.1007/s004269900008; van Donkelaar P, 2006, EXERC SPORT SCI REV, V34, P77, DOI 10.1249/00003677-200604000-00007; van Donkelaar P, 2005, BRAIN INJURY, V19, P1031, DOI 10.1080/02699050500110363; Werhahn KJ, 1999, J PHYSIOL-LONDON, V517, P591, DOI 10.1111/j.1469-7793.1999.0591t.x	30	18	18	0	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia		2007	45	2					406	411		10.1016/j.neuropsychologia.2006.06.008			6	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	130XR	WOS:000243832800022	16876828				2022-02-06	
J	Formisano, R; Barba, C; Buzzi, MG; Newcomb-Fernandez, J; Menniti-Ippolito, F; Zafonte, R; Vinicola, V; Spanedda, F				Formisano, R.; Barba, C.; Buzzi, M. G.; Newcomb-Fernandez, J.; Menniti-Ippolito, F.; Zafonte, R.; Vinicola, V.; Spanedda, F.			The impact of prophylactic treatment on post-traumatic epilepsy after severe traumatic brain injury	BRAIN INJURY			English	Article						late post-traumatic epilepsy; severe traumatic brain injury; prophylactic anti-epileptic treatment; cognitive functioning	SEVERE HEAD-INJURIES; PHARMACOLOGICAL PROPHYLAXIS; SEIZURES; PHENYTOIN; PREVENTION; TOPIRAMATE; CARBAMAZEPINE; LAMOTRIGINE; PREDICTORS; RECOVERY	Aim: To assess the incidence of late post-traumatic epilepsy ( PTE) in patients with very severe traumatic brain injury ( TBI) who either received or did not receive anti-epileptic prophylactic treatment. Methods: Two populations were studied: 55 patients retrospectively and 82 subjects prospectively. Results: Ten patients ( 18%) in the first population showed late PTE. Although the incidence was lower in patients who did not receive prophylactic treatment, the difference between the treated and the non-treated group was not statistically significant. Sixty-nine patients in the second group ( 84%) had prophylactic treatment. Twenty-seven patients ( 39%) suffered from late PTE during the 2-year follow-up period and 17 of them ( 63%) showed EEG epileptic abnormalities. No patient who did not receive preventive therapy suffered from late PTE during the observation period. Conclusions: Due to the negative cognitive effects of anti-epileptic drugs, the preliminary results are of considerable interest for the rehabilitation of patients with very severe TBI.	Rehabil Hosp, IRCCS, Santa Lucia Fdn, Rome, Italy; Newcomb Sci LLC, Houston, TX USA; Natl Inst Hlth, Rome, Italy; Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA USA		Formisano, R (corresponding author), IRCCS, Fdn Santa Lucia, V Ardeatina 306, I-00179 Rome, Italy.	r.formisano@hsantalucia.it	Buzzi, Maria Gabriella/K-5468-2016; Barba, Carmen/AAB-7162-2022; barba, carmen/K-4942-2016	Buzzi, Maria Gabriella/0000-0003-1307-8707; barba, carmen/0000-0001-5445-5842			Angeleri F, 1999, EPILEPSIA, V40, P1222, DOI 10.1111/j.1528-1157.1999.tb00850.x; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; ASKAINEN I, 1999, EPILEPSIA, V40, P584; BRICOLO A, 1976, CLIN ELECTROENCEPHAL, V7, P184, DOI 10.1177/155005947600700402; CAVENESS WF, 1979, J NEUROSURG, V50, P545, DOI 10.3171/jns.1979.50.5.0545; Chadwick D, 2000, LANCET, V355, P334, DOI 10.1016/S0140-6736(99)00452-3; COURJON J, 1972, HDB ELECTROENCEPHALO, P8; Courjon J.A., 1969, POST TRAUMATIC EPILE, P215; Dauch WA, 1996, ZBL NEUROCHIR, V57, P190; De Santis A, 1992, Acta Neurochir Suppl (Wien), V55, P64; DIKMEN SS, 1991, JAMA-J AM MED ASSOC, V265, P1271, DOI 10.1001/jama.265.10.1271; EVANS JH, 1962, NEUROLOGY, V12, P665, DOI 10.1212/WNL.12.10.665; Fonseca L C, 1975, Arq Neuropsiquiatr, V33, P318; Formisano R, 2004, ACTA NEUROCHIR, V146, P457, DOI 10.1007/s00701-004-0225-4; Formisano R, 2004, BRAIN INJURY, V18, P103, DOI 10.1080/0269905031000149470; Haltiner AM, 1999, J NEUROSURG, V91, P588, DOI 10.3171/jns.1999.91.4.0588; Haltiner AM, 1997, ARCH PHYS MED REHAB, V78, P835, DOI 10.1016/S0003-9993(97)90196-9; HAUSER WA, 1983, PEDIAT HEAD TRAUMA, P241; Herman ST, 2002, NEUROLOGY, V59, pS21, DOI 10.1212/WNL.59.9_suppl_5.S21; HERNANDEZ TD, 1994, BRAIN RES, V635, P300, DOI 10.1016/0006-8993(94)91451-6; Iudice A, 2000, DRUGS, V59, P1091, DOI 10.2165/00003495-200059050-00005; JENNETT B, 1975, EPILEPSIA, V16, P251, DOI 10.1111/j.1528-1157.1975.tb06055.x; JENNETT B, 1975, EPILEPSY NONMISSILE; JENNETT WB, 1969, LANCET, V1, P1023; Marienne J P, 1979, Acta Neurochir Suppl (Wien), V28, P89; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; Martin R, 1999, NEUROLOGY, V52, P321, DOI 10.1212/WNL.52.2.321; Mazzini L, 2003, EPILEPSIA, V44, P569, DOI 10.1046/j.1528-1157.2003.34902.x; Meador KJ, 2005, NEUROLOGY, V64, P2108, DOI 10.1212/01.WNL.0000165994.46777.BE; MEADOR KJ, 2004, TREATMENT EPILEPSY P, P1215; PAILLAS JE, 1982, B LEGA ITAL EPILEPSI, V39, P11; PENRY JK, 1979, NEUROLOGY, V29, P600; PohlmannEden B, 1997, ACTA NEUROL SCAND, V95, P257, DOI 10.1111/j.1600-0404.1997.tb00206.x; Privitera MD, 2003, ACTA NEUROL SCAND, V107, P165, DOI 10.1034/j.1600-0404.2003.00093.x; RAPPORT RL, 1973, J NEUROSURG, V38, P159, DOI 10.3171/jns.1973.38.2.0159; Schierhout G, 1998, J NEUROL NEUROSUR PS, V64, P108, DOI 10.1136/jnnp.64.1.108; SMITH KR, 1994, ARCH NEUROL-CHICAGO, V51, P653, DOI 10.1001/archneur.1994.00540190029012; TEASDALE TW, 1974, LANCET, V11, P81; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Temkin NR, 2001, EPILEPSIA, V42, P515, DOI 10.1046/j.1528-1157.2001.28900.x; VANWOERKOM TCAM, 1982, EUR NEUROL, V21, P227, DOI 10.1159/000115485; WOHNS RNW, 1979, J NEUROSURG, V51, P507, DOI 10.3171/jns.1979.51.4.0507; Yablon SA, 1998, ARCH PHYS MED REHAB, V79, P594; YOUNG B, 1983, J NEUROSURG, V58, P236, DOI 10.3171/jns.1983.58.2.0236; [No title captured]	47	18	18	0	6	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2007	21	5					499	504		10.1080/02699050701310994			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	175FI	WOS:000246998000006	17522989				2022-02-06	
B	Mahone, EM; Slomine, BS		Hunter, SJ; Donders, J		Mahone, E. Mark; Slomine, Beth S.			Managing dysexecutive disorders	PEDIATRIC NEUROPSYCHOLOGICAL INTERVENTION: A CRITICAL REVIEW OF SCIENCE AND PRACTICE			English	Article; Book Chapter							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; TRAUMATIC BRAIN-INJURY; EXECUTIVE FUNCTIONS; WORKING-MEMORY; YOUNG-CHILDREN; TOURETTE-SYNDROME; PHARMACOLOGICAL-TREATMENT; PRESCHOOL-CHILDREN; HEAD-INJURY		[Mahone, E. Mark; Slomine, Beth S.] Johns Hopkins Univ, Med Ctr, Dept Neuropsychol, Kennedy Krieger Inst, Baltimore, MD 21218 USA		Mahone, EM (corresponding author), Johns Hopkins Univ, Med Ctr, Dept Neuropsychol, Kennedy Krieger Inst, Baltimore, MD 21218 USA.						Anderson V, 1997, Pediatr Rehabil, V1, P63; Barkley RA, 2000, J AM ACAD CHILD PSY, V39, P1064, DOI 10.1097/00004583-200008000-00025; Barnett R, 2001, PSYCHOL MED, V31, P1107, DOI 10.1017/S0033291701004172; Beebe DW, 2004, J INT NEUROPSYCH SOC, V10, P962, DOI 10.1017/S135561770410708X; Beebe DW, 2000, J CLIN EXP NEUROPSYC, V22, P779, DOI 10.1076/jcen.22.6.779.950; Beers SR, 2005, J HEAD TRAUMA REHAB, V20, P450, DOI 10.1097/00001199-200509000-00006; Bernstein J. H., 1996, ISSUES PSYCHOEDUCATI; Bernstein JH, 2000, SCI PRACT NEUROPSYCH, P405; Brocki KC, 2004, DEV NEUROPSYCHOL, V26, P571, DOI 10.1207/s15326942dn2602_3; Burmeister R, 2005, CHILD NEUROPSYCHOL, V11, P265, DOI 10.1080/092970490911324; Butler RW, 2002, J INT NEUROPSYCH SOC, V8, P115, DOI 10.1017/S1355617701020112; Canfield RL, 2004, DEV NEUROPSYCHOL, V26, P513, DOI 10.1207/s15326942dn2601_8; Castellanos FX, 2006, TRENDS COGN SCI, V10, P117, DOI 10.1016/j.tics.2006.01.011; Chronis AM, 2001, COGN BEHAV PRACT, V8, P346, DOI 10.1016/S1077-7229(01)80008-0; Chronis AM, 2006, CLIN PSYCHOL REV, V26, P486, DOI 10.1016/j.cpr.2006.01.002; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; CROWLEY JA, 1991, J PEDIATR PSYCHOL, V16, P611, DOI 10.1093/jpepsy/16.5.611; Cummings DD, 2002, CLIN NEUROPHARMACOL, V25, P325, DOI 10.1097/00002826-200211000-00009; DELIS DC, 2001, DELISKAPLAN EXECUTIV; Denckla MB, 1996, J DEV BEHAV PEDIATR, V17, P114; Denckla MB, 1996, DEV NEUROPSYCHOL, V12, P5, DOI 10.1080/87565649609540637; Dennis M, 1996, DEV NEUROPSYCHOL, V12, P77, DOI 10.1080/87565649609540641; Dodrill CB, 1997, CLIN NEUROPSYCHOL, V11, P1, DOI 10.1080/13854049708407025; Dodrill CB, 1999, CLIN NEUROPSYCHOL, V13, P562, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT562; Durston S, 2003, MENT RETARD DEV D R, V9, P184, DOI 10.1002/mrdd.10079; Espy KA, 2002, CHILD NEUROPSYCHOL, V8, P83, DOI 10.1076/chin.8.2.83.8723; Espy KA, 2004, DEV NEUROPSYCHOL, V26, P379, DOI 10.1207/s15326942dn2601_1; Espy KA, 2001, CLIN NEUROPSYCHOL, V15, P46, DOI 10.1076/clin.15.1.46.1908; Evans DW, 2004, BRAIN COGNITION, V55, P220, DOI 10.1016/s0278-2626(03)00274-4; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; Feeney TJ, 2003, J HEAD TRAUMA REHAB, V18, P33, DOI 10.1097/00001199-200301000-00006; Gassio R, 2005, DEV MED CHILD NEUROL, V47, P443, DOI 10.1017/S0012162205000861; Gioia GA IP, 2000, BEHAV RATING INVENTO; Goldberg MC, 2005, J AUTISM DEV DISORD, V35, P279, DOI 10.1007/s10803-005-3291-4; Griffith EM, 1999, CHILD DEV, V70, P817, DOI 10.1111/1467-8624.00059; Guare R., 2004, EXECUTIVE SKILLS CHI; Gureasko-Moore S, 2006, BEHAV MODIF, V30, P159, DOI 10.1177/0145445503259387; Habboushe DF, 2001, COGN BEHAV PRACT, V8, P123, DOI 10.1016/S1077-7229(01)80018-3; Harris E L, 1995, J Int Neuropsychol Soc, V1, P511; Heilman K. M., 1993, CLIN NEUROPSYCHOLOGY, P279; Heilman K. M., 1994, NIH C ATT MEM EX FUN; HEILMAN KM, 1991, J CHILD NEUROL, V6, pS76, DOI 10.1177/0883073891006001S09; Holmbeck GN, 2003, EVIDENCE-BASED PSYCHOTHERAPIES FOR CHILDREN AND ADOLESCENTS, P21; HOLMES JM, 1987, HDB COGNITIVE SOCIAL, P303; Holmes-Bernstein J., 1990, NEUROPSYCHOLOGY, P311, DOI DOI 10.1385/0-89603-133-0:311; Jensen PS, 1999, ARCH GEN PSYCHIAT, V56, P1073; Jung RE, 2000, CLIN NEUROPSYCHOL, V14, P535, DOI 10.1076/clin.14.4.535.7198; Klingberg T, 2002, J CLIN EXP NEUROPSYC, V24, P781, DOI 10.1076/jcen.24.6.781.8395; Klingberg T, 2005, J AM ACAD CHILD PSY, V44, P177, DOI 10.1097/00004583-200502000-00010; Konrad K, 2000, CHILD NEUROPSYCHOL, V6, P286, DOI 10.1076/chin.6.4.286.3145; Krause KH, 2000, NEUROSCI LETT, V285, P107, DOI 10.1016/S0304-3940(00)01040-5; Mahone E. M., TXB CLIN NE IN PRESS; Mahone E. M., 2001, INSIGHTS SPINA BIFID, V7, p1A; Mahone EM, 2005, DEV NEUROPSYCHOL, V27, P11, DOI 10.1207/s15326942dn2701_2; Mahone EM, 2002, CHILD NEUROPSYCHOL, V8, P258, DOI 10.1076/chin.8.4.258.13510; Mahone EM, 2002, CHILD NEUROPSYCHOL, V8, P52, DOI 10.1076/chin.8.1.52.8719; Mahone EM, 2002, ARCH CLIN NEUROPSYCH, V17, P643, DOI 10.1016/S0887-6177(01)00168-8; Mahone EM, 2001, J INT NEUROPSYCH SOC, V7, P102, DOI 10.1017/S1355617701711101; Marlowe WB, 2000, DEV NEUROPSYCHOL, V18, P445, DOI 10.1207/S1532694209Marlowe; Martinussen R, 2005, J AM ACAD CHILD PSY, V44, P377, DOI 10.1097/01.chi.0000153228.72591.73; Mash E. J., 1998, TREATMENT CHILDHOOD, P3; Mateer CA, 1996, J LEARN DISABIL, V29, P618, DOI 10.1177/002221949602900606; MCEVOY RE, 1993, J CHILD PSYCHOL PSYC, V34, P563, DOI 10.1111/j.1469-7610.1993.tb01036.x; Michel JA, 2005, CHILD NEUROPSYCHOL, V11, P295, DOI 10.1080/092970490911270; Mostofsky SH, 2003, PERCEPT MOTOR SKILL, V97, P1315, DOI 10.2466/PMS.97.8.1315-1331; Nyden A, 2000, EUR CHILD ADOLES PSY, V9, P180, DOI 10.1007/s007870070041; O'Connell ME, 2003, NEUROREHABILITATION, V18, P9; O'Driscoll GA, 2005, BIOL PSYCHIAT, V57, P1452, DOI 10.1016/j.biopsych.2005.02.029; Ozonoff S, 1999, J AUTISM DEV DISORD, V29, P171, DOI 10.1023/A:1023052913110; Pelham W. E., 2004, PSYCHOSOCIAL TREATME, P311; Pelham WE, 2000, J ABNORM CHILD PSYCH, V28, P507, DOI 10.1023/A:1005127030251; Rapport MD, 2001, J CLIN CHILD PSYCHOL, V30, P48, DOI 10.1207/S15374424JCCP3001_6; Reiter A, 2005, DYSLEXIA, V11, P116, DOI 10.1002/dys.289; Riva D, 2005, NEUROL SCI, V26, P263, DOI 10.1007/s10072-005-0469-7; Royall DR, 2002, J NEUROPSYCH CLIN N, V14, P377, DOI 10.1176/appi.neuropsych.14.4.377; RUDEL RG, 1981, B ORTON SOC, V31, P89; Russell EW, 2001, CLIN NEUROPSYCHOL, V15, P423, DOI 10.1076/clin.15.3.423.10267; Slomine BS, 2005, J INT NEUROPSYCH SOC, V11, P645, DOI 10.1017/S1355617705050769; Slusarek M, 2001, J AM ACAD CHILD PSY, V40, P355, DOI 10.1097/00004583-200103000-00016; Snyder MC, 1997, J LEARN DISABIL, V30, P534, DOI 10.1177/002221949703000509; Suzman KB, 1997, J BEHAV THER EXP PSY, V28, P203, DOI 10.1016/S0005-7916(97)00023-2; Thompson PM, 2005, INT REV NEUROBIOL, V67, P285, DOI 10.1016/S0074-7742(05)67009-2; Turner GR, 2004, SCI PRACT NEUROPSYCH, P224; Vance ALA, 2003, AUST NZ J PSYCHIAT, V37, P570, DOI 10.1046/j.1440-1614.2003.01238.x; Vygotsky L. S., 1962, THOUGHT LANGUAGE; Weber P, 2002, PEDIATR NEUROL, V26, P261, DOI 10.1016/S0887-8994(01)00408-8; Willcutt EG, 2005, DEV NEUROPSYCHOL, V27, P35, DOI 10.1207/s15326942dn2701_3; Wilson BA, 2001, J NEUROL NEUROSUR PS, V70, P477, DOI 10.1136/jnnp.70.4.477; Wodka E. L., 2007, J CLIN EXPT NEUROPSY, DOI [10.1080/13803390600678056, DOI 10.1080/13803390600678056]; Wodka E. L., 2007, J INT NEUROPSYCH SOC, V12, P40; Wong G, 2001, WORKING TIME IN COMPARATIVE PERSPECTIVE, VOL I, P1, DOI 10.1079/9780851994567.0001; Yerys BE, 2003, J PEDIAT HEMATOL ONC, V25, P495, DOI 10.1097/00043426-200306000-00014; Ylvisaker M, 2005, J HEAD TRAUMA REHAB, V20, P95, DOI 10.1097/00001199-200501000-00009; Ylvisaker M., 1998, TRAUMATIC BRAIN INJU, P159; ZABEL TA, 2004, CEREBROSPINAL FLUID, V1, pS57; Zelazo PD, 2003, MONOGR SOC RES CHILD, V68, P1, DOI 10.1111/j.0037-976X.2003.00261.x	96	18	18	0	2	CAMBRIDGE UNIV PRESS	CAMBRIDGE	THE PITT BUILDING, TRUMPINGTON ST, CAMBRIDGE CB2 1RP, CAMBS, ENGLAND			978-0-521-87550-9				2007							287	313					27	Clinical Neurology; Psychology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Psychology	BXM34	WOS:000296371600014					2022-02-06	
J	O'Brien, L				O'Brien, Lisa			Achieving a successful and sustainable return to the workforce after ABI: A client-centred approach	BRAIN INJURY			English	Article						acquired brain injury; stroke; vocational rehabilitation; employment; client-centred practice; work	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; COMMUNITY INTEGRATION; PRODUCTIVE WORK; HEAD-INJURY; EMPLOYMENT; REHABILITATION; PREDICTION; WORKPLACE; MODERATE	Primary objective: This paper describes the approach used by the Victorian Acquired Brain Injury ( ABI) specialist team of CRS Australia ( formerly Commonwealth Rehabilitation Service) to facilitate participation in the workforce for its clients. The approach and results achieved are compared and contrasted with other models nationally and internationally. Method and procedures: This two part study involves a survey of the specialist team members regarding use and efficacy of assessment and intervention strategies and data mining of closed case files to identify predictors of sustainable employment outcomes for people with ABI. Main outcomes and results: CRS Australia's results compare favourably with other published results ( 50% achieved a minimum of 13 weeks open employment compared to population estimates of 38-46.5%). Results were achieved with people with mild, moderate and severe injury. Assessments and interventions that correlate with successful employment outcome are described. Conclusions: A client-centred approach, combining specialist ABI expertise, skilled assessment and practical workplace-based interventions results in favourable employment outcome rates.	Monash Univ, Dept Occupat Therapy, Fac Med Nursing & Hlth Sci, Frankston, Vic 3199, Australia		O'Brien, L (corresponding author), Monash Univ, Dept Occupat Therapy, Fac Med Nursing & Hlth Sci, POB 527, Frankston, Vic 3199, Australia.	lisa.obrien@med.monash.edu.au		O'Brien, Lisa/0000-0002-4149-6669			Abreu BC, 1996, AM J OCCUP THER, V50, P417, DOI 10.5014/ajot.50.6.417; BLACKSCHAFFER RM, 1990, ARCH PHYS MED REHAB, V71, P285; Boake C, 2005, NEUROSURGERY, V56, P994, DOI 10.1227/01.NEU.0000158319.38230.C3; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; CHAPMAN B, 1994, SOCIAL SECURITY J, P19; Chapparo C, 1997, OCCUPATIONAL PERFORM, P189; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; *DEP WORK PENS UK, 2004, FRAM VOC REH; Doig E, 2001, BRAIN INJURY, V15, P747, DOI 10.1080/02699050110034343; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Ezzy D, 2001, NARRATING UNEMPLOYME; FEARING V, 2000, INDIVIDUALS CONTEXT; Fleming J, 1999, BRAIN INJURY, V13, P417; Heinemann AW, 2000, REHABIL COUNS BULL, V43, P165, DOI 10.1177/003435520004300307; Hodgkinson A, 2000, J HEAD TRAUMA REHAB, V15, P1208, DOI 10.1097/00001199-200012000-00003; Johansson U, 2006, AM J OCCUP THER, V60, P60, DOI 10.5014/ajot.60.1.60; Johnson R, 1998, NEUROPSYCHOL REHABIL, V8, P61, DOI 10.1080/713755552; Johnston MV, 2005, ARCH PHYS MED REHAB, V86, P735, DOI 10.1016/j.apmr.2004.10.031; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P238, DOI 10.1053/apmr.2003.50097; JUNANKAR PN, 1991, 249 AUSTR NAT U CTR; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Kowalske K, 2000, J HEAD TRAUMA REHAB, V15, P989, DOI 10.1097/00001199-200008000-00003; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; KREUTZER JS, 1990, J HEAD TRAUMA REHAB, V5, P9, DOI DOI 10.1097/00001199-199009000-00005; Law M, 1995, Can J Occup Ther, V62, P250; Leung K L, 2005, Work, V25, P333; Levack W, 2004, DISABIL REHABIL, V26, P290, DOI 10.1080/09638280310001647615; MCCOLL MAH, 2005, 6 WORLD C BRAIN INJ; MCLAUGHLIN E, 2002, EARLY INTERVENTIONS; MCMORDIE W R, 1990, Brain Injury, V4, P57, DOI 10.3109/02699059009026149; Morse P, 1992, CLIN SYNDROMES ADULT, P85; NAIR A, 2006, COCHRANE DB SYST REV, P2, DOI DOI 10.1002/14651858; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Partridge T M, 1996, Work, V7, P63, DOI 10.3233/WOR-1996-7108; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; Powell J, 2002, J NEUROL NEUROSUR PS, V72, P193, DOI 10.1136/jnnp.72.2.193; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; SANDERSON I, 1999, BACK WORK LOCAL ACTI; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; Tate RL, 2004, BRAIN IMPAIR, V5, P81, DOI [DOI 10.1375/BRIM.5.1.81.35408, 10.1375/brim.5.1.81.35408, DOI 10.1375/brim.5.1.81.35408]; TEASDALE G, 1974, LANCET, V2, P81; Tomberg T, 2005, BRAIN INJURY, V19, P1181, DOI 10.1080/02699050500150153; Tyerman R., 1986, CHESSINGTON OCCUPATI; Vandiver VL, 2003, J HEAD TRAUMA REHAB, V18, P457, DOI 10.1097/00001199-200309000-00007; Vestling M, 2003, J REHABIL MED, V35, P127, DOI 10.1080/16501970310010475; Vogenthaler D R, 1989, Brain Inj, V3, P369, DOI 10.3109/02699058909004561; Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001; Wehman P, 2003, ARCH PHYS MED REHAB, V84, P192, DOI 10.1053/apmr.2003.50027; WEHMAN PH, 1995, J HEAD TRAUMA REHAB, V10, P27; WEST MD, 1995, BRAIN INJURY, V9, P301, DOI 10.3109/02699059509008200; West MD, 1996, J VOCATIONAL REHABIL, V7, P143; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107; Wilson BA, 1991, RIVERMEAD BEHAV MEMO; [No title captured]	57	18	18	0	17	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2007	21	5					465	478		10.1080/02699050701315134			14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	175FI	WOS:000246998000003	17522986				2022-02-06	
J	Parish, L; Oddy, M				Parish, Liz; Oddy, Michael			Efficacy of rehabilitation for functional skills more than 10 years after extremely severe brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article							CLOSED-HEAD-INJURY; COGNITIVE REHABILITATION; FOLLOW-UP; MEMORY; ADULTS; RECOVERY	Purpose: To determine whether gains in personal independence can be achieved in individuals 10 or more years after very severe acquired brain injury. Method: Four individuals in a continuing (slow stream) rehabilitation centre were assessed by an occupational therapist (OT) and programmes were designed to help the individual enhance personal independence. Support staff were trained to implement these programmes under the guidance of the OT. Methods described by Giles, Ridley, Dill, and Frye (1997) were used. Pre- and post-training measures were taken as well as follow up measures to assess the durability of such changes. Results: The results demonstrate that it is possible to achieve clinically significant improvements in personal independence many years after very severe acquired brain injury. Conclusions: The findings of this study suggest that personally and clinically significant goals can be achieved 10 or more years after brain injury and there should be continuing effort to improve the circumstances of individuals with acquired brain injury. Such gains can be achieved through consistent application of such programmes by support workers working under the supervision of an occupational therapist.	Brain Injury Rehabil Trust, Burgess Hill RH15 9NP, W Sussex, England		Oddy, M (corresponding author), Brain Injury Rehabil Trust, 32 Market Pl, Burgess Hill RH15 9NP, W Sussex, England.	michael.oddy@birt.co.uk					Baddeley A., 1992, SPEED CAPACITY LANGU; Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; BOND MR, 1976, ACTA NEUROCHIR, V34, P57, DOI 10.1007/BF01405863; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; Chesnut RM, 1999, J HEAD TRAUMA REHAB, V14, P176, DOI 10.1097/00001199-199904000-00007; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1073, DOI 10.1016/j.apmr.2005.01.003; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Eames P, 1996, BRAIN INJURY, V10, P631, DOI 10.1080/026990596124061; Giles GM, 1997, AM J OCCUP THER, V51, P256, DOI 10.5014/ajot.51.4.256; GILES GM, 1999, REHABILITATION SEVER; KIRN TF, 1987, JAMA-J AM MED ASSOC, V257, P3187; Mazaux JM, 1998, DISABIL REHABIL, V20, P435, DOI 10.3109/09638289809166108; McMillan TM, 2004, BRAIN INJURY, V18, P935, DOI 10.1080/02699050410001675915; McMillan TM, 2004, CLIN REHABIL, V18, P132, DOI 10.1191/0269215504cr712oa; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; SBORDONE RJ, 1995, BRAIN INJURY, V9, P285, DOI 10.3109/02699059509008199; Thomsen IV, 1990, NEUROPSYCHOLOGY, V4, P1; THOMSEN IV, 1992, SCAND J REHABIL MED, P142; Timmerman ME, 1999, NEUROPSYCHOLOGIA, V37, P467, DOI 10.1016/S0028-3932(98)00085-2; Warrington E, 1984, RECOGNITION MEMORY T, V1; Watson C, 2001, BRAIN INJURY, V15, P1003, DOI 10.1080/02699050010022662; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Williams WH, 1998, NEUROPSYCHOL REHABIL, V8, P43, DOI 10.1080/713755551; WILSON BA, 1994, NEUROPSYCHOL REHABIL, V4, P307, DOI 10.1080/09602019408401463; Wood RL, 1999, BRAIN INJURY, V13, P69, DOI 10.1080/026990599121746	27	18	19	0	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2007	17	2					230	243		10.1080/09602010600750675			14	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	165IP	WOS:000246298400006	17454695				2022-02-06	
J	Schroeter, ML; Ettrich, B; Schwier, C; Scheid, R; Guthke, T; von Cramon, DY				Schroeter, Matthias L.; Ettrich, Barbara; Schwier, Christiane; Scheid, Rainer; Guthke, Thomas; von Cramon, D. Yves			Diffuse axonal injury due to traumatic brain injury alters inhibition of imitative response tendencies	NEUROPSYCHOLOGIA			English	Article						diffuse axonal injury; executive functions; inhibition; imitation; stroop; traumatic brain injury	NEAR-INFRARED SPECTROSCOPY; MATCHING STROOP TASK; CLOSED-HEAD INJURY; NEUROPSYCHIATRIC INVENTORY; EXECUTIVE DYSFUNCTION; EMOTION RECOGNITION; MIND; INTERFERENCE; NEUROPRAGMATICS; COMMUNICATION	It is well known that traumatic brain injury particularly affects the frontal lobes. Consequently, patients often suffer from executive dysfunction and behavioral disturbances. Accordingly, our study aimed at investigating patients after traumatic brain injury with two tasks involving different functional processes and structural networks supported by the frontal lobes. Two paradigms were applied: the Stroop color-word task and a task in which subjects had to inhibit imitative response tendencies. We selected a patient group solely with diffuse axonal injury, as this type of injury is homogenous and is correlated with cognitive dysfunction more than focal contusions. To evaluate long-term effects most relevant for rehabilitation, we selected a patient group whose brain injuries dated back several years. Our results show that patients with diffuse axonal injury inhibited imitative responses more successfully than control subjects, whereas executive processes examined with the Stroop task were unaltered. Interestingly, impairments were tightly correlated both with the length of the post-traumatic amnesia predicting outcome in traumatic brain injury and with behavioral disturbances. Impairments in the imitation-inhibition task may indicate alterations in an anterior frontomedian neural network even years after traumatic brain injury. (C) 2007 Elsevier Ltd. All rights reserved.	Max Planck Inst Human Cognit & Brain Sci, D-04103 Leipzig, Germany; Univ Leipzig, Day Clin Cognit Neurol, D-04103 Leipzig, Germany; Tech Univ Chemnitz, Inst Psychol, D-09120 Chemnitz, Germany		Schroeter, ML (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Stephanstr 1A, D-04103 Leipzig, Germany.	schroet@cbs.mpg.de					Bara BG, 1997, BRAIN LANG, V59, P7, DOI 10.1006/brln.1997.1812; Bara BG, 2001, BRAIN LANG, V77, P72, DOI 10.1006/brln.2000.2430; Beringer J., 1995, EXPT RUN TIME SYSTEM; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Brass M, 2005, NEUROPSYCHOLOGIA, V43, P89, DOI 10.1016/j.neuropsychologia.2004.06.018; Brass M, 2005, TRENDS COGN SCI, V9, P314, DOI 10.1016/j.tics.2005.05.001; Brass M, 2003, NEUROPSYCHOLOGY, V17, P265, DOI 10.1037/0894-4105.17.2.265; Burgess P, 1996, BEHAV ASSESSMENT DYS; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; DELIS D, 1987, CALIFORNIA VERBAL LE; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Goethals I, 2004, J NEUROTRAUM, V21, P1059, DOI 10.1089/0897715041651051; Gouick J, 2004, TRAUMA, V6, P285, DOI DOI 10.1191/1460408604TA3230A; HAERTING C, 2000, WMS R DTSCH ADAPTATI; Havet-Thomassin V, 2006, BRAIN INJURY, V20, P83, DOI 10.1080/02699050500340655; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; Kilmer RP, 2006, REHABIL PSYCHOL, V51, P232, DOI 10.1037/0090-5550.51.3.232; LHERMITTE F, 1986, ANN NEUROL, V19, P326, DOI 10.1002/ana.410190404; LUCAS JA, 1999, CLIN NEUROPSYCHOLOGY, P243; Luria A.R., 1980, HIGHER CORTICAL FUNC, V2d; MacDonald SWS, 2006, TRENDS NEUROSCI, V29, P474, DOI 10.1016/j.tins.2006.06.011; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; Milders M, 2006, NEUROPSYCHOLOGY, V20, P400, DOI 10.1037/0894-4105.20.4.400; Okamoto T, 2007, EUR J NEUROL, V14, P540, DOI 10.1111/j.1468-1331.2007.01742.x; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Salmond CH, 2005, J NEUROTRAUM, V22, P613, DOI 10.1089/neu.2005.22.613; Salmond CH, 2005, CURR OPIN CRIT CARE, V11, P111, DOI 10.1097/01.ccx.0000155358.31983.37; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Schroeter ML, 2004, NEUROIMAGE, V22, P341, DOI 10.1016/j.neuroimage.2003.12.041; Schroeter ML, 2004, NEUROIMAGE, V23, P1317, DOI 10.1016/j.neuroimage.2004.08.001; Schroeter ML, 2002, HUM BRAIN MAPP, V17, P61, DOI 10.1002/hbm.10052; Spikman JM, 1999, J CLIN EXP NEUROPSYC, V21, P585, DOI 10.1076/jcen.21.5.585.874; Stamatakis EA, 2002, J NUCL MED, V43, P476; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Stuss DT, 2001, NEUROPSYCHOLOGIA, V39, P771, DOI 10.1016/S0028-3932(01)00013-6; Wallesch CW, 2001, J NEUROTRAUM, V18, P11, DOI 10.1089/089771501750055730; Wilson JTL, 2005, ACTA NEUROCHIR SUPPL, V93, P75; WOLFRAM H, 1986, PSYCHOL LEISTUNGSTES; Zimmermann P., 1993, TESTBATTERIE AUFMERK; Zysset S, 2001, NEUROIMAGE, V13, P29, DOI 10.1006/nimg.2000.0665	47	18	19	0	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932			NEUROPSYCHOLOGIA	Neuropsychologia		2007	45	14					3149	3156		10.1016/j.neuropsychologia.2007.07.004			8	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	230DG	WOS:000250855400002	17727901				2022-02-06	
J	Lubsch, L; Habersang, R; Haase, M; Luedtke, S				Lubsch, Lisa; Habersang, Rolf; Haase, Mark; Luedtke, Sherry			Oral baclofen and clonidine for treatment of spasticity in children	JOURNAL OF CHILD NEUROLOGY			English	Article; Proceedings Paper	12th Annual Meeting of the Pediatric-Pharmacy-Advocacy-Group	OCT, 2002	St Petersburg, FL	Pediat Pharm Advocacy Grp			CEREBRAL-PALSY; TRIAL; PHARMACOTHERAPY	Few data exist in the literature to support the use of high dosages of oral baclofen and clonidine that are frequently required to treat children with spasticity. This study was a retrospective chart review of baclofen and clonidine dosages used in children diagnosed with cerebral palsy or traumatic brain injury. The primary objective was to calculate the mean dosages of baclofen and clonidine based on the duration of spasticity postinjury. Secondary objectives included determining correlations between dosage and age, injury type, location of spasticity, comorbid seizures, or concomitant antispasticity medications. Eighty-seven children receiving baclofen and/or clonidine were included in this study. Mean dosages of 40 mg/day (n = 86) and 0.4 mg/day (n = 31) were required for baclofen and clonidine, respectively. The maximum dosage was 240 mg/day for baclofen and 3.6 mg/day for clonidine. Duration postinjury, age, and concomitant antispasticity medications were the most predictive variables for baclofen dosage as a model (r = .522; P = .000). Duration postinjury and location of spasticity were the most predictive variables for clonidine dosage as a model (r = .523; P = .000). The average dosages of baclofen and clonidine used in this population of children with cerebral palsy or traumatic brain injury were similar to those reported in the literature, with higher maximum dosages found in this investigation.	So Illinois Univ, Sch Pharm, Dept Pharm Practice, Edwardsville, IL 62026 USA; Texas Tech Hlth Sci Ctr, Sch Pharm, Dept Pediat, Amarillo, TX USA; Texas Tech Hlth Sci Ctr, Sch Pharm, Dept Pharm Practice, Amarillo, TX USA		Lubsch, L (corresponding author), So Illinois Univ, Sch Pharm, Dept Pharm Practice, Campus Box 2000, Edwardsville, IL 62026 USA.	llubsch@siue.edu					Albright AL, 1996, J CHILD NEUROL, V11, P77, DOI 10.1177/088307389601100202; ASHWORTH B, 1964, PRACTITIONER, V192, P540; DONOVAN WH, 1988, ARCH PHYS MED REHAB, V69, P193; Goldstein EM, 2001, J CHILD NEUROL, V16, P16, DOI 10.1177/088307380101600104; Krach LE, 2001, J CHILD NEUROL, V16, P31, DOI 10.1177/088307380101600106; MILLA PJ, 1977, J INT MED RES, V5, P398; PARZIALE JR, 1993, ORHTOPEDICS, V16, P901; Rapp CE, 2000, ARCH FAM MED, V9, P466, DOI 10.1001/archfami.9.5.466; ROCCHINI AP, 1984, PEDIATR CLIN N AM, V31, P1259; Tilton AH, 2001, J CHILD NEUROL, V16, P66, DOI 10.1177/088307380101600112; WILENS TE, 1994, J AM ACAD CHILD PSY, V33, P424, DOI 10.1097/00004583-199403000-00018; YOUNG RR, 1994, NEUROLOGY, V44, P12	12	18	18	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	DEC	2006	21	12					1090	1092		10.1177/7010.2006.00134			3	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Pediatrics	122DX	WOS:000243207000020	17156708				2022-02-06	
J	Carlile, MC; Yablon, SA; Mysiw, WJ; Frol, AB; Lo, D; Diaz-Arrastia, R				Carlile, Mary C.; Yablon, Stuart A.; Mysiw, W. Jerry; Frol, Alan B.; Lo, David; Diaz-Arrastia, Ramon			Deep venous thrombosis management following traumatic brain injury - A practice survey of the traumatic brain injury model systems	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						deep venous thrombosis; prophylaxis; pulmonary embolism; traumatic brain injury; venous thromboembolism	VEIN THROMBOSIS; THROMBOEMBOLIC DISEASE; PULMONARY-EMBOLISM; REHABILITATION; PROPHYLAXIS; PREVENTION; PREVALENCE; GUIDELINES; DIAGNOSIS; THERAPY	Objective: To determine national patterns of screening, prophylaxis, and treatment of deep venous thrombosis (DVT) following traumatic brain injury (TBI) within the Traumatic Brain Injury Model Systems (TBIMS). Design: e-mail survey instrument. Setting: Multicenter Regional TBIMS. Results: Fifteen of the 16 rehabilitation centers within the TBIMS responded to the survey (94% response rate). Approximately half of these centers routinely screen to detect subclinical DVTs (56% venous duplex ultrasonography, 12% plasma D-dimer) on admission to inpatient rehabilitation. Fifty-six percent of respondents use anticoagulation prophylactically, while 69% use mechanical means for DVT prophylaxis. Eighty fatal pulmonary emboli were reported for TBI patients in 189 practice-years, corresponding to 0.42 fatalities per year of practice. Conclusions: No consensus exists regarding the optimal methods for screening, prevention, or treatment of DVT in TBI patients in the acute rehabilitation setting of the TBIMS. The number of fatal pulmonary emboli reported among these centers emphasizes the need to develop evidence-based clinical practice guidelines for the prevention and treatment of venous thromboembolism in this patient population.	Baylor Inst Rehabil, Dept Phys Med & Rehabil, Dallas, TX 75246 USA; Univ Mississippi, Sch Med, Dept Neurol, Jackson, MS 39216 USA; Univ Mississippi, Sch Med, Dept Neurosurg, Jackson, MS 39216 USA; Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; Univ Texas, SW Med Ctr, Dept Neurol, Dallas, TX 75235 USA		Carlile, MC (corresponding author), Baylor Inst Rehabil, Dept Phys Med & Rehabil, 3505 Gaston Ave, Dallas, TX 75246 USA.	MaryCar@BaylorHealth.edu	Mysiw, Walter/E-3724-2011	Diaz-Arrastia, Ramon/0000-0001-6051-3594			Bates SM, 2004, NEW ENGL J MED, V351, P268, DOI 10.1056/NEJMcp031676; Buller HR, 2004, CHEST, V126, p401S, DOI 10.1378/chest.126.3_suppl.401S; Burke DT, 1999, J HEAD TRAUMA REHAB, V14, P515, DOI 10.1097/00001199-199910000-00015; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P1182, DOI 10.1016/S0003-9993(96)90145-8; Decousus H, 1998, NEW ENGL J MED, V338, P409, DOI 10.1056/NEJM199802123380701; GANDO S, 1992, CRIT CARE MED, V20, P594, DOI 10.1097/00003246-199205000-00009; Geerts WH, 2004, CHEST, V126, p338S, DOI 10.1378/chest.126.3_suppl.338S; Greenfield LJ, 1997, J TRAUMA, V42, P100, DOI 10.1097/00005373-199701000-00017; Hammond FM, 1998, J HEAD TRAUMA REHAB, V13, P36, DOI 10.1097/00001199-199802000-00007; Hirsh J, 2004, CHEST, V126, p172S, DOI 10.1378/chest.126.3_suppl.172S; Kearon C, 1998, ANN INTERN MED, V128, P663, DOI 10.7326/0003-4819-128-8-199804150-00011; LAGERSTEDT CI, 1985, LANCET, V2, P515; Lai JM, 1997, BRAIN INJURY, V11, P331, DOI 10.1080/026990597123485; Meythaler JM, 1996, ARCH PHYS MED REHAB, V77, P1, DOI 10.1016/S0003-9993(96)90210-5; Norwood SH, 2002, ARCH SURG-CHICAGO, V137, P696, DOI 10.1001/archsurg.137.6.696; Rogers FB, 2002, J TRAUMA, V53, P142, DOI 10.1097/00005373-200207000-00032; Sharpe RP, 2002, J TRAUMA, V53, P1048, DOI 10.1097/00005373-200212000-00003; STEIN PD, 1995, CHEST, V108, P978, DOI 10.1378/chest.108.4.978; WRIGHT DJ, 1990, J VASC SURG, V11, P675, DOI 10.1067/mva.1990.18519; Yablon SA, 2004, NEUROLOGY, V63, P485, DOI 10.1212/01.WNL.0000133009.24727.9F; Yablon SA, 2000, AM J PHYS MED REHABI, V79, P204	21	18	19	2	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2006	21	6					483	490		10.1097/00001199-200611000-00003			8	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	109UC	WOS:000242333400003	17122679				2022-02-06	
J	Deja, M; Wolf, S; Weber-Carstens, S; Lehmann, TN; Adler, A; Ruhnke, M; Tintelnot, K				Deja, Maria; Wolf, Steffen; Weber-Carstens, Steffen; Lehmann, Thomas-Nicolas; Adler, Andreas; Ruhnke, Markus; Tintelnot, Kathrin			Gastrointestinal zygomycosis caused by Mucor indicus in a patient with acute traumatic brain injury	MEDICAL MYCOLOGY			English	Article						zygomycosis; gastrointestinal; Mucor indicus; liposomal amphotericin B; trauma	TRANSPLANT RECIPIENT; MUCORMYCOSIS	We report a gastrointestinal infection caused by Mucor indicus in a patient with severe head injuries. Monotherapy with high-dose liposomal amphotericin B successfully eradicated the mucormycosis. Nevertheless, subsequently a hemicolectomy was necessary due to recurrent bleeding from a deep ulcer. Mucor indicus is an uncommon fungal pathogen, typically found in starters used for food fermentation. Reviewing other reports on Mucor indicus infections, primary gastrointestinal manifestations seem to be typical and indicate an oral route of infection.	Robert Koch Inst, D-13353 Berlin, Germany; Univ Med, Dept Anesthesiol & Intens Care Med, Charite, Berlin, Germany; Univ Med, Dept Neurosurg, Charite, Berlin, Germany; Univ Med, Div Hepatol Gastroenterol Endocrinol & Metab, Charite, Berlin, Germany; Univ Med, Dept Med, Div Oncol Hematol, Charite Mitte, Berlin, Germany		Tintelnot, K (corresponding author), Robert Koch Inst, D-13353 Berlin, Germany.	tintelnotk@rki.de	Weber-Carstens, Steffen/A-6401-2009	Weber-Carstens, Steffen/0000-0001-7405-0172			Aboltins CA, 2006, CLIN INFECT DIS, V42, P154, DOI 10.1086/498751; Azadeh B, 2004, HISTOPATHOLOGY, V44, P298, DOI 10.1111/j.1365-2559.2004.01761.x; De Hoog G. S., 2000, ATLAS CLIN FUNGI; Frater JL, 2001, ARCH PATHOL LAB MED, V125, P375; Gil-Lamaignere C, 2005, J INFECT DIS, V191, P1180, DOI 10.1086/428503; JENSEN HE, 1994, VET PATHOL, V31, P28, DOI 10.1177/030098589403100104; Lee AC, 1999, WORLD J MICROB BIOT, V15, P57, DOI 10.1023/A:1008818511497; Martinez EJ, 1997, SOUTH MED J, V90, P341, DOI 10.1097/00007611-199703000-00017; Mata-Essayag S, 2001, INT J DERMATOL, V40, P406, DOI 10.1046/j.1365-4362.2001.01246-3.x; Oliver MR, 1996, CLIN INFECT DIS, V22, P521, DOI 10.1093/clinids/22.3.521; Prabhu RM, 2004, CLIN MICROBIOL INFEC, V10, P31, DOI 10.1111/j.1470-9465.2004.00843.x; Roden MM, 2005, CLIN INFECT DIS, V41, P634, DOI 10.1086/432579; SAMSON RA, 1989, SOC APPL BACTERIOL S, V18; Spellberg B, 2005, CLIN MICROBIOL REV, V18, P556, DOI 10.1128/CMR.18.3.556-569.2005; Stamm B, 2005, HISTOPATHOLOGY, V47, P222, DOI 10.1111/j.1365-2559.2005.02080.x; Sues A, 2005, FEMS YEAST RES, V5, P669, DOI 10.1016/j.femsyr.2004.10.013; TERBORG F, 1990, SCAND J INFECT DIS, V22, P499, DOI 10.3109/00365549009027083; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wolach B, 2001, J NEUROSURG, V94, P706, DOI 10.3171/jns.2001.94.5.0706; Yousef OM, 1999, AM J CLIN PATHOL, V112, P610	20	18	19	0	2	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1369-3786			MED MYCOL	Med. Mycol.	NOV	2006	44	7					683	687		10.1080/13693780600803888			5	Infectious Diseases; Mycology; Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Infectious Diseases; Mycology; Veterinary Sciences	112UE	WOS:000242552000016	17071566	Bronze			2022-02-06	
J	Saniova, B; Drobny, M; Lehotsky, J; Sulaj, M; Schudichova, J				Saniova, B.; Drobny, M.; Lehotsky, J.; Sulaj, M.; Schudichova, J.			Biochemical and clinical improvement of cytotoxic state by amantadine sulphate	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						brain injury; antioxidative state; free oxygen radicals; income and outcome Glasgow Coma Scale; beta-caroten; malondialdehyde		The main idea of the open clinical trial was to compare the income and outcome clinical picture and the evolution of the biochemical markers in the defined intervals in closed head injury group patients. In the group of 32 patients, mean age 40.78 +/- 15.36 years suffering from closed traumatic brain injury the following markers were measured: glycaemia, malondialdehyde (MDA) as marker of lipid peroxidation, beta-caroten, total SH groups as marker of protein oxidation in the following intervals: between the 1st and the 3rd, between the 3rd and the 7th, between the 1st and the 7th day respectively. Glycaemia significantly decreased since the 1st day till the 3rd day (p < 0.05) and since the 1st day till the 7th day (p < 0.05) but it was not significantly changed since the 3rd day till the 7th day (p > 0.05). MDA 1st x MDA 3rd p > 0.05 insignificant change, MDA 1st x MDA 7th p < 0.001-high significant decrease, MDA 3rd x MDA 7th-p < 0.0001-very high significant decrease. Beta-caroten the 1st x beta-caroten the 3rd day was insignificantly changed-p > 0.05, the 3rd x the 7th day beta-caroten increased significantly-p < 0.0002, the 1st day x 7th day beta-caroten significantly increased-p < 0.0001. We examined the SH groups only in nine patients, due to technical problems and SH groups decrease on the 3rd day (p < 0.005). In 18 amantadine sulphate subgroups (randomly selected), there was 5.5% lethality and mean outcome GCS (outGCS) 9.83 +/- 3.8, while lethality of the control subgroup (n=14) was 42.9%, mean outGCS 6.28 +/- 3.5.	Fac Hosp, Jessenius Fac Med, Clin Anaesthesiol & Intens Med, Martin, Slovakia; Fac Hosp, Jessenius Fac Med, Neurol Clin, Martin, Slovakia; Fac Hosp, Jessenius Fac Med, Inst Med Biochem, Martin, Slovakia; Fac Hosp, Jessenius Fac Med, Inst Clin Biochem, Martin, Slovakia		Saniova, B (corresponding author), Fac Hosp, Jessenius Fac Med, Clin Anaesthesiol & Intens Med, Martin, Slovakia.	saniova@lefa.sk	Lehotsky, Jan/X-5951-2018; Saniova, Beata/AAU-5751-2021; Lehotsky, Jan/AAE-3686-2019	Lehotsky, Jan/0000-0002-2408-5745			DROBNY M, 2002, AMANTADIN SULFAT PK, P1; FRYKHOLM P, 2002, CEREBRAL ISCHEMIA ST, P8; Jorg J, 2000, NERVENHEILKUNDE, V19, P521; SCHMIDT WJ, 1996, NERVENHEILKUNDE, V8, P1; STEUBE, 2000, NEUROL REHABIL, V6, P307; Tesoriere L, 2002, FREE RADICAL RES, V36, P89, DOI 10.1080/10715760210163; WALLNOFER H, 1974, MED WELT, V25, P703; Warner DS, 2004, J EXP BIOL, V207, P3221, DOI 10.1242/jeb.01022	8	18	21	0	1	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340			CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	NOV	2006	26	7-8					1475	1482		10.1007/s10571-006-9033-0			8	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	114HO	WOS:000242657500030	16710757				2022-02-06	
J	Zhang, YH; Zhang, HJ; Wu, F; Chen, YH; Ma, XQ; Du, JQ; Zhou, ZL; Li, JY; Nan, FJ; Li, J				Zhang, Ya-Hui; Zhang, Hua-Jie; Wu, Fang; Chen, Yi-Hua; Ma, Xue-Qin; Du, Jun-Qin; Zhou, Zhong-Liang; Li, Jing-Ya; Nan, Fa-Jun; Li, Jia			Isoquinoline-1,3,4-trione and its derivatives attenuate beta-amyloid-induced apoptosis of neuronal cells	FEBS JOURNAL			English	Article						attenuate apoptosis; beta-amyloid; caspase-3 inhibitor; irreversible; neuronal cell	TRAUMATIC BRAIN-INJURY; CASPASE INHIBITOR; PRECURSOR PROTEIN; PEPTIDE; ACTIVATION; CLEAVAGE; POTENT; INVOLVEMENT; SURVIVAL; DISEASE	Caspase-3 is a programmed cell death protease involved in neuronal apoptosis during physiological development and under pathological conditions. It is a promising therapeutic target for treatment of neurodegenerative diseases. We reported previously that isoquinoline-1,3,4-trione and its derivatives inhibit caspase-3. In this report, we validate isoquinoline-1,3,4-trione and its derivatives as potent, selective, irreversible, slow-binding and pan-caspase inhibitors. Furthermore, we show that these inhibitors attenuated apoptosis induced by beta-amyloid(25-35) in PC12 cells and primary neuronal cells.	Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Mat Med, Natl Ctr Drug Screening, Beijing 100864, Peoples R China; E China Normal Univ, Acad Life Sci, Shanghai 200062, Peoples R China		Nan, FJ (corresponding author), 189 Guo Shou Jing Rd, Shanghai 201203, Peoples R China.	fjnan@mail.shcnc.ac.cn; jli@mail.shcnc.ac.cn	Chen, Yihua/A-4323-2013; Du, Junqing/B-7803-2016; Li, Jia/F-9116-2011; Chen, Yihua/O-2743-2019	Chen, Yihua/0000-0003-1733-7980; Du, Junqing/0000-0001-7449-1170; Chen, Yihua/0000-0003-1733-7980			Ayala-Grosso C, 2002, BRAIN PATHOL, V12, P430; Chapman JG, 2002, EUR J PHARMACOL, V456, P59, DOI 10.1016/S0014-2999(02)02484-6; Chen YH, 2006, J MED CHEM, V49, P1613, DOI 10.1021/jm050896o; Cheng Y, 1998, J CLIN INVEST, V101, P1992, DOI 10.1172/JCI2169; Chung CW, 2001, NEUROBIOL DIS, V8, P162, DOI 10.1006/nbdi.2000.0335; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Donkor IO, 2000, CURR MED CHEM, V7, P1171, DOI 10.2174/0929867003374129; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; EARNSHAW WC, 2003, J PHARMACOL EXP THER, V304, P433; Elliott PJ, 2003, J MOL MED, V81, P235, DOI 10.1007/s00109-003-0422-2; Erhardt J, 1999, MOL BIOL CELL, V10, p328A; Garcia-Calvo M, 1998, J BIOL CHEM, V273, P32608, DOI 10.1074/jbc.273.49.32608; Gervais FG, 1999, CELL, V97, P395, DOI 10.1016/S0092-8674(00)80748-5; Guo ZM, 2001, BIOORGAN MED CHEM, V9, P99, DOI 10.1016/S0968-0896(00)00222-4; Hoglen NC, 2004, J PHARMACOL EXP THER, V309, P634, DOI 10.1124/jpet.103.062034; Hotchkiss RS, 2000, NAT IMMUNOL, V1, P496, DOI 10.1038/82741; Kim R, 2001, INT J ONCOL, V18, P1227; Kim TW, 1997, SCIENCE, V277, P373, DOI 10.1126/science.277.5324.373; Krakauer T, 2004, CLIN DIAGN LAB IMMUN, V11, P621, DOI 10.1128/CDLI.11.3.621-624.2004; Lee D, 2000, J BIOL CHEM, V275, P16007, DOI 10.1074/jbc.275.21.16007; Li MW, 2000, SCIENCE, V288, P335, DOI 10.1126/science.288.5464.335; Misiti F, 2005, NEUROCHEM INT, V46, P575, DOI 10.1016/j.neuint.2005.01.001; Natori S, 2003, LIVER TRANSPLANT, V9, P278, DOI 10.1053/jlts.2003.50019; Niikura T, 2002, J NEUROSCI RES, V70, P380, DOI 10.1002/jnr.10354; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Riedout HJ, 2001, HISTOL HISTOPATHOL, V16, P895, DOI 10.14670/HH-16.895; ROBERT AC, 2004, DRUG DISCOVERY GUIDE, P125; Roth KA, 2001, J NEUROPATH EXP NEUR, V60, P829, DOI 10.1093/jnen/60.9.829; Stennicke HR, 1997, J BIOL CHEM, V272, P25719, DOI 10.1074/jbc.272.41.25719; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; van de Craen M, 1999, FEBS LETT, V445, P149, DOI 10.1016/S0014-5793(99)00108-8; Velez-Pardo C, 2002, NEUROTOXICOLOGY, V23, P351, DOI 10.1016/S0161-813X(02)00081-5; Wellington CL, 2000, CLIN GENET, V57, P1, DOI 10.1034/j.1399-0004.2000.570101.x; Wu JC, 1999, METHODS, V17, P320, DOI 10.1006/meth.1999.0746; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Yang W, 2003, BRIT J PHARMACOL, V140, P402, DOI 10.1038/sj.bjp.0705450	36	18	18	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-464X	1742-4658		FEBS J	FEBS J.	NOV	2006	273	21					4842	4852		10.1111/j.1742-4658.2006.05483.x			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	095YJ	WOS:000241343900004	17032354				2022-02-06	
J	Koob, AO; Cirillo, J; Babbs, CF				Koob, Andrew O.; Cirillo, John; Babbs, Charles F.			A novel open field activity detector to determine spatial and temporal movement of laboratory animals after injury and disease	JOURNAL OF NEUROSCIENCE METHODS			English	Article						brain injury; neurological disease; neurodegeneration; head injury; behavior; laboratory animal; open field; exploratory behavior	TRAUMATIC BRAIN-INJURY; RATS; HIPPOCAMPAL; NAVIGATION; BEHAVIOR; SYSTEM; MODEL	The wide range of tests for laboratory animal behavior after neurological injury or disease each have their benefits and detriments. The varied behavior an animal exhibits makes it difficult to decide which test to use. However, a fundamental instinct for the laboratory animal is to explore when placed in a new environment. A way to test exploratory behavior is in the open field. Here, we introduce a simple activity box without the use of video equipment to determine the exploratory movement of a rat after traumatic brain injury. The activity box is an open field and the rat explores its surroundings when placed inside. Four infrared beams were placed in both the X and Y-axis inside the box. Using a novel system to determine which beam the rat breaks, we describe where the rat is in space and time while in the activity box. Other models can show the number of beams broken, but here we elucidate the methods to additionally determine the amount of area explored, the total distance traveled by the rat and percent time exploring. (c) 2006 Elsevier B.V. All rights reserved.	Dartmouth Coll, Hitchcock Med Ctr, Dept Pediat Neurosurg, Lebanon, NH 03756 USA; Purdue Univ, Dept Basic Med Sci, Ctr Paralysis Res, W Lafayette, IN 47907 USA		Koob, AO (corresponding author), Dartmouth Coll, Hitchcock Med Ctr, Dept Pediat Neurosurg, 1 Med Ctr Dr, Lebanon, NH 03756 USA.	Andrew.O.Koob@Dartmouth.EDU					BARR GA, 1983, LIFE SCI, V33, P1341, DOI 10.1016/0024-3205(83)90817-2; Devan BD, 1996, NEUROBIOL LEARN MEM, V66, P305, DOI 10.1006/nlme.1996.0072; DUTRIEUX G, 1978, PHYSIOL BEHAV, V21, P721, DOI 10.1016/0031-9384(78)90010-0; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; GIULIAN D, 1975, PHYSIOL BEHAV, V14, P109, DOI 10.1016/0031-9384(75)90150-X; Koob AO, 2005, J NEUROTRAUM, V22, P1092, DOI 10.1089/neu.2005.22.1092; Marino MJ, 2003, P NATL ACAD SCI USA, V100, P13668, DOI 10.1073/pnas.1835724100; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; O'Connor C, 2003, J NEUROTRAUM, V20, P985, DOI 10.1089/089771503770195830; OLTON DS, 1976, J EXP PSYCHOL-ANIM B, V2, P97, DOI 10.1037/0097-7403.2.2.97; Pickens R., 1971, STIMULUS PROPERTIES, P39, DOI 10.1007/978-1-4757-0788-5_3; ROTH KA, 1979, NEUROSCI BIOBEHAV R, V3, P247, DOI 10.1016/0149-7634(79)90012-5; SCHWARTING RKW, 1993, J NEUROSCI METH, V49, P199, DOI 10.1016/0165-0270(93)90125-B; TOMKINS PT, 1981, PHYSIOL BEHAV, V26, P741, DOI 10.1016/0031-9384(81)90154-2; Vicens P, 2003, PSICOTHEMA, V15, P539; Vink R, 2003, NEUROSCI LETT, V336, P41, DOI 10.1016/S0304-3940(02)01244-2; Whishaw IQ, 1999, MODERN TECHNIQUES NE, P1243; WILLIAMS T, 2004, GNUPLOT 4 0 INTERACT; [No title captured]	20	18	19	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	OCT 30	2006	157	2					330	336		10.1016/j.jneumeth.2006.04.020			7	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	101PU	WOS:000241753600017	16735064	Green Submitted			2022-02-06	
J	Netto, KJ; Burnett, AF				Netto, Kevin J.; Burnett, Angus F.			Neck muscle activation and head postures in common high performance aerial combat maneuvers	AVIATION SPACE AND ENVIRONMENTAL MEDICINE			English	Article						electromyography; neck; cervical; hypergravity; injury	ISOMETRIC CERVICAL STRENGTH; FIGHTER PILOTS; SPINE; MOTION; KINEMATICS; INJURIES; STRAIN; FORCES; RANGE; LOADS	Introduction: Neck injuries are common in high performance combat pilots and have been attributed to high gravitational forces and the non-neutral head postures adopted during aerial combat maneuvers. There is still little known about the pathomechanics of these injuries. Methods: Six Royal Australian Air Force Hawk pilots flew a sortie that included combinations of three +Gz levels (1, 3, and 5) and four head postures (Neutral, Turn, Extension, and Check-6). Surface electromyography from neck and shoulder muscles was recorded in flight. Three-dimensional measures of head postures adopted in flight were estimated postflight with respect to end-range of the cervical spine using an electromagnetic tracking device. Results: Mean muscle activation increased significantly with both increasing +Gz and non-neutral head postures. Check-6 at +5 Gz (mean activation of all muscles = 51% MVIC) elicited significantly greater muscle activation in most muscles when compared with Neutral, Extension, and Turn head postures. High levels of muscle co-contraction were evident in high acceleration and non-neutral head postures. Head kinematics showed Check-6 was closest to end-range in any movement plane (86% ROM in rotation) and produced the greatest magnitude of rotation in other planes. Turn and Extension showed a large magnitude of rotation with reference to end-range in the primary plane of motion but displayed smaller rotations in other planes. Discussion: High levels of neck muscle activation and co-contraction due to high +Gz and head postures close to end range were evident in this study, suggesting the major influence of these factors on the pathomechanics of neck injuries in high performance combat pilots.	Charles Darwin Univ, Sch Sci & Primary Ind, Darwin, NT 0909, Australia; Edith Cowan Univ, Sch Exercise Biomed & Hlth Sci, Joondalup, WA, Australia; Curtin Univ Technol, Sch Phys, Bentley, WA 6102, Australia		Netto, KJ (corresponding author), Charles Darwin Univ, Sch Sci & Primary Ind, Casuarina Campus,Bldg 42-1-65,Ellengowan Dr, Darwin, NT 0909, Australia.	kevin.netto@cdu.edu.au	Netto, Kevin/ABE-1340-2020	Netto, Kevin/0000-0002-3680-3548			Alricsson M, 2004, AVIAT SPACE ENVIR MD, V75, P23; ANDERSEN HT, 1988, AVIAT SPACE ENVIR MD, V59, P356; Ang B, 2005, AVIAT SPACE ENVIR MD, V76, P375; Ariens GAM, 2001, AM J IND MED, V39, P180, DOI 10.1002/1097-0274(200102)39:2<180::AID-AJIM1005>3.0.CO;2-#; Aultman CD, 2004, SPINE, V29, pE304, DOI 10.1097/01.BRS.0000132515.21703.38; Bergman GJD, 2005, SPINE, V30, P650, DOI 10.1097/01.brs.0000155414.03723.3d; Burnett AF, 1998, CLIN BIOMECH, V13, P574, DOI 10.1016/S0268-0033(98)00026-6; Choi H, 2003, MED ENG PHYS, V25, P133, DOI 10.1016/S1350-4533(02)00151-0; Falla D, 2004, MANUAL THER, V9, P125, DOI 10.1016/j.math.2004.05.003; Finsen L, 1998, CLIN BIOMECH, V13, P272, DOI 10.1016/S0268-0033(98)00096-5; Garces GL, 2002, MED SCI SPORT EXER, V34, P464, DOI 10.1097/00005768-200203000-00013; Green NDC, 2004, AVIAT SPACE ENVIR MD, V75, P676; HAMALAINEN O, 1992, AVIAT SPACE ENVIR MD, V63, P709; Hamalainen O, 1999, AVIAT SPACE ENVIR MD, V70, P330; Hendriksen IJM, 1999, AVIAT SPACE ENVIR MD, V70, P1057; Hof AL, 2001, CLIN BIOMECH, V16, P455, DOI 10.1016/S0268-0033(01)00012-2; Jones JA, 2000, MIL MED, V165, P6, DOI 10.1093/milmed/165.1.6; Kumar S, 2002, SPINE, V27, P1044, DOI 10.1097/00007632-200205150-00009; Linton SJ, 2001, SPINE, V26, P778, DOI 10.1097/00007632-200104010-00019; Netto Kevin J, 2006, Work, V26, P123; Newman DG, 1997, AVIAT SPACE ENVIR MD, V68, P732; Oksa J, 1996, AVIAT SPACE ENVIR MD, V67, P1138; PANJABI MM, 1992, J SPINAL DISORD, V5, P383, DOI 10.1097/00002517-199212000-00001; Rugulies R, 2005, SOC SCI MED, V61, P27, DOI 10.1016/j.socscimed.2004.11.042; Seng KY, 2003, AVIAT SPACE ENVIR MD, V74, P164; Sforza C, 2002, CLIN BIOMECH, V17, P611, DOI 10.1016/S0268-0033(02)00071-2; Siegmund GP, 2003, J BIOMECH, V36, P473, DOI 10.1016/S0021-9290(02)00458-X; Sommerich CM, 2000, J ELECTROMYOGR KINES, V10, P377, DOI 10.1016/S1050-6411(00)00033-X; Suryanarayana L, 2005, CLIN BIOMECH, V20, P138, DOI 10.1016/j.clinbiomech.2004.10.003; VANDIJKE GAH, 1993, J BIOMECH, V26, P1017, DOI 10.1016/S0021-9290(05)80001-6	30	18	24	0	1	AEROSPACE MEDICAL ASSOC	ALEXANDRIA	320 S HENRY ST, ALEXANDRIA, VA 22314-3579 USA	0095-6562	1943-4448		AVIAT SPACE ENVIR MD	Aviat. Space Environ. Med.	OCT	2006	77	10					1049	1055					7	Public, Environmental & Occupational Health; Medicine, General & Internal; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; General & Internal Medicine; Sport Sciences	091SQ	WOS:000241049000008	17042250				2022-02-06	
J	Anderson, V; Anderson, D; Anderson, P				Anderson, Vicki; Anderson, Dianne; Anderson, Peter			Comparing attentional skills in children with acquired and developmental central nervous system disorders	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						sustained attention; children; CNS; ADHD; TBI; variability	DEFICIT HYPERACTIVITY DISORDER; TRAUMATIC BRAIN-INJURY; PEDIATRIC HEAD-INJURY; ACUTE LYMPHOBLASTIC-LEUKEMIA; CONTINUOUS PERFORMANCE-TEST; SELECTIVE ATTENTION; NEUROPSYCHOLOGICAL EVALUATION; CRANIAL IRRADIATION; SUSTAINED ATTENTION; EVERYDAY ATTENTION	Attentional impairments in children occur in the context of both developmental and acquired disorders involving the central nervous system (CNS) and may have implications for ongoing development, potentially impeding cognitive, educational, and behavioral functions. Using a continuous performance paradigm (CPT), this study compared attentional profiles of children with developmental and acquired conditions impacting on the CNS: (i) attention deficit-hyperactivity disorder (ADHD: n = 27); (ii) moderate traumatic brain injury (TBI: n = 41); (iii) acute lymphoblastic leukemia (n = 3 1); and (iv) insulin-dependent diabetes mellitus (n = 39). A healthy control group (n = 46) was also examined. Groups were compared on measures of sustained attention, selective attention, and response inhibition. In addition, measures of performance variability and deterioration and processing speed were examined. Results showed that children with ADHD exhibited global and severe attentional impairments in contrast to all other groups. Children with moderate TBI displayed mild attentional difficulties, restricted to selective and sustained attention domains. In conclusion, although CPT parameters differentiated the ADHD group from all others, a disorder-specific profile was not observed.	Royal Childrens Hosp, Dept Psychol, Parkville, Vic 3052, Australia; Univ Melbourne, Dept Psychol, Melbourne, Vic, Australia; Murdoch Childrens Res Inst, Dept Psychol, Melbourne, Vic, Australia		Anderson, V (corresponding author), Royal Childrens Hosp, Dept Psychol, Flemington Rd, Parkville, Vic 3052, Australia.	vicki.anderson@rch.org.au	Anderson, Peter John/O-5302-2019; Anderson, Peter J/B-6839-2015	Anderson, Peter John/0000-0001-7430-868X; Anderson, Peter J/0000-0001-7430-868X			Aman CJ, 1998, DEV PSYCHOL, V34, P956, DOI 10.1037/0012-1649.34.5.956; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Anderson V, 1998, NEUROPSYCHOL REHABIL, V8, P283; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson V, 2001, J CLIN EXP NEUROPSYC, V23, P705, DOI 10.1076/jcen.23.6.705.1015; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Anderson VA, 2004, J CLIN EXP NEUROPSYC, V26, P684, DOI 10.1080/13803390490504344; Anderson VA, 2000, BRIT J CANCER, V82, P255; Aronson M, 1997, DEV MED CHILD NEUROL, V39, P583; AUGUST GJ, 1990, J ABNORM CHILD PSYCH, V18, P29, DOI 10.1007/BF00919454; BARKLEY RA, 1999, HDB DISRUPTIVE BEHAV, P295; BARONCOHEN S, 1995, MOVEMENT ALLIED DISO, P306; BROUWERS P, 1985, J PEDIATR-US, V106, P723, DOI 10.1016/S0022-3476(85)80343-7; CASEY BJ, 1993, J CLIN EXP NEUROPSYC, V15, P933, DOI 10.1080/01688639308402609; Catroppa C, 1999, J INT NEUROPSYCH SOC, V5, P48, DOI 10.1017/S1355617799511077; Catroppa C, 2003, DEV NEUROPSYCHOL, V23, P359, DOI 10.1207/S15326942DN2303_3; Catroppa C, 1999, CHILD NEUROPSYCHOL, V5, P251, DOI 10.1076/0929-7049(199912)05:04;1-R;FT251; COOLEY EL, 1990, DEV NEUROPSYCHOL, V6, P239, DOI 10.1080/87565649009540465; COUSENS P, 1991, J PEDIATR PSYCHOL, V16, P475, DOI 10.1093/jpepsy/16.4.475; Cowan N., 1997, ATTENTION MEMORY; Daniel A., 1983, POWER PRIVILEGE PRES; Dennis M, 1995, TRAUMATIC HEAD INJUR; Dennis M, 1989, CLIN NEUROPSYCHOLOGY, P85; Ewing-Cobbs L, 1998, CHILD NEUROPSYCHOL, V4, P35, DOI 10.1076/chin.4.1.35.3194; GOFF JR, 1980, DEV BEH PEDIAT, V1, P153; GOYETTE CH, 1978, J ABNORM CHILD PSYCH, V6, P221, DOI 10.1007/BF00919127; HAGEN JW, 1990, CHILD DEV, V61, P1714, DOI 10.1111/j.1467-8624.1990.tb03561.x; Heaton SC, 2001, CHILD NEUROPSYCHOL, V7, P251, DOI 10.1076/chin.7.4.251.8736; HOLMES CS, 1990, NEUROPSYCHOLOGICAL B, P122; HOOKS K, 1994, J CLIN CHILD PSYCHOL, V23, P69, DOI 10.1207/s15374424jccp2301_9; James W., 1890, PRINCIPLES PSYCHOL; Johannes S, 2001, ACTA NEUROL SCAND, V104, P36, DOI 10.1034/j.1600-0404.2001.00308.x; KAUFMANN PM, 1993, J CHILD NEUROL, V8, P348, DOI 10.1177/088307389300800410; KINGMA A, 1993, AM J PEDIAT HEMATOL, V15, P231; KLIN A, 1995, SYNDROME NONVERBAL L, P93; Konrad KN, 2000, BRAIN INJURY, V14, P859; Lajoie G., 2005, BRAIN IMPAIR, V6, P21, DOI DOI 10.1375/BRIM.6.1.21.65479; LANE DM, 1982, MERRILL PALMER QUART, V28, P317; LANE DM, 1978, J EXPT CHILD PSYCHOL, V28, P16; Levy F, 1997, J PAEDIATR CHILD H, V33, P384; Manly T, 2001, J CHILD PSYCHOL PSYC, V42, P1065, DOI 10.1111/1469-7610.00806; Manly T, 1999, TEA CH TEST EVERYDAY; McCall AL, 1997, DIABETES SPECTRUM, V10, P25; MCKAY KE, 1994, DEV NEUROPSYCHOL, V10, P121, DOI 10.1080/87565649409540572; MIRSKY A F, 1991, Neuropsychology Review, V2, P109, DOI 10.1007/BF01109051; Mirsky A.F., 1996, ATTENTION MEMORY EXE, P71; Northam EA, 1998, DIABETES CARE, V21, P379, DOI 10.2337/diacare.21.3.379; Northam EA, 2001, DIABETES CARE, V24, P1541, DOI 10.2337/diacare.24.9.1541; PAAKKO E, 1992, CANCER, V70, P2728, DOI 10.1002/1097-0142(19921201)70:11<2728::AID-CNCR2820701126>3.0.CO;2-7; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; PONSFORD J, 1997, J INT NEUROPSYCH SOC, V3, P225; Posner, 1978, CHRONOMETRIC EXPLORA; POSNER M, 1984, NEUROBIOLOGY LEARNIN; REBOK G, 1997, CHILD NEUROPSYCHOL, V3, P47; Reeve WV, 2001, ADOLESCENCE, V36, P749; ROSVOLD HE, 1956, J CONSULT PSYCHOL, V20, P343, DOI 10.1037/h0043220; ROWE JK, 1995, ROWE BEHAV RATING IN; Rubia K, 1999, AM J PSYCHIAT, V156, P891, DOI 10.1176/ajp.156.6.891; Ruff H. A., 1996, ATTENTION EARLY DEV; SATTLER JM, 1988, ASSESSMENT CHILDRENS; Schachar R, 2004, DEV NEUROPSYCHOL, V25, P179, DOI 10.1207/s15326942dn2501&2_10; SEIDEL WT, 1990, J ABNORM CHILD PSYCH, V18, P217, DOI 10.1007/BF00910732; Semrud-Clikeman M, 2000, J AM ACAD CHILD PSY, V39, P477, DOI 10.1097/00004583-200004000-00017; Shallice T, 2002, DEV NEUROPSYCHOL, V21, P43, DOI 10.1207/S15326942DN2101_3; SHEPP BE, 1987, J EXP CHILD PSYCHOL, V43, P159, DOI 10.1016/0022-0965(87)90057-9; Shiffrin, 1988, STEVENS HDB EXPT PSY, V1-2, P739; Sowell ER, 2003, LANCET, V362, P1699, DOI 10.1016/S0140-6736(03)14842-8; Stuss DT, 1995, ANN NY ACAD SCI, V769, P191, DOI 10.1111/j.1749-6632.1995.tb38140.x; TALLROTH G, 1992, METABOLISM, V41, P717, DOI 10.1016/0026-0495(92)90310-7; TAYLOR HM, 1993, PHLEBOLOGY S, V1, P22; THATCHER RW, 1991, DEV NEUROPSYCHOL, V7, P397, DOI 10.1080/87565649109540500; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; VANDERMEERE J, 1988, J ABNORM CHILD PSYCH, V16, P627, DOI 10.1007/BF00913474; Villella S., 2001, CLIN NEUROPSYCHOL, V21, P1; WAINWRIGHTSHARP JA, 1993, J AUTISM DEV DISORD, V23, P1, DOI 10.1007/BF01066415; WATERS KD, 1992, MED PAEDIAT ONCOLOGY, V20; Wechsler D., 1991, MANUAL WECHSLER INTE, V3rd; Wilkinson G.S., 1993, WIDE RANGE ACHIEVEME; Willmott C, 2000, DEV NEUROPSYCHOL, V17, P361, DOI 10.1207/S15326942DN1703_5; Wu KK, 2002, DEV NEUROPSYCHOL, V22, P501, DOI 10.1207/S15326942DN2202_5; Yeates K O, 1995, J Int Neuropsychol Soc, V1, P78; Yeates KO, 1994, NEUROPSYCHOLOGY, V8, P65, DOI 10.1037/0894-4105.8.1.65	83	18	19	0	5	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177			J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JUL	2006	12	4					519	531		10.1017/S135561770606067X			13	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	063DU	WOS:000238997300009	16981604				2022-02-06	
J	Israelsson, C; Lewen, A; Kylberg, A; Usoskin, D; Althini, S; Lindeberg, J; Deng, CX; Fukuda, T; Wang, Y; Kaartinen, V; Mishina, Y; Hillered, L; Ebendal, T				Israelsson, Charlotte; Lewen, Anders; Kylberg, Annika; Usoskin, Dmitry; Althini, Susanna; Lindeberg, Jonas; Deng, Chu-Xia; Fukuda, Tomokazu; Wang, Yun; Kaartinen, Vesa; Mishina, Yuji; Hillered, Lars; Ebendal, Ted			Genetically modified bone morphogenetic protein signalling alters traumatic brain injury-induced gene expression responses in the adult mouse	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						TBI; activin receptor-1; Smad4; CaMKII-Cre; glial fibrillary acidic protein	CENTRAL-NERVOUS-SYSTEM; SERINE/THREONINE KINASE RECEPTORS; MICROTUBULE-ASSOCIATED PROTEIN-2; MESSENGER-RNA; TISSUE INHIBITOR; DENDRITIC GROWTH; MICE; BMP; HIPPOCAMPUS; ISCHEMIA	Three genetic mouse models were examined to define effects of bone morphogenetic protein (BMP) signalling on gene expression in normal and injured adult brain. CaMKII-Cre eliminated the BMP receptor Acvr1 (Alk2) and the common TGF beta superfamily signal mediator Smad4 or activated a constitutively active Acvr1 in postnatal forebrain neurons. All mutants followed mendelian ratios, with no overt phenotypic changes. In situ hybridization demonstrated normal patterns of the dendritic marker MAP2 (Mtap2) throughout cortex despite neuron-specific losses of Acvr1 or Smad4. However, strong up-regulation of Mtap2 transcript in these mice was found by quantitative RT-PCR (qRT-PCR), indicating that Mtap2 is normally suppressed by BMR Traumatic brain injury (TBI) resulted in increases of histone-associated DNA fragments in both control and Smad4-deficient cortex. Several cell-type-specific transcripts known to be involved in injury-related responses were measured by qRT-PCR. Gfap mRNA was strongly upregulated in controls as well as in the loss-of-BMP-signalling mutants. Notably, activated Acvr1 signalling gave significantly lower TBI-induced up-regulations of Gfap and Phox2a mRNA levels, indicating reductions in astroglial and neuronal reactions to injury. Strong impairment in injury-induced Timp1 transcript up-regulation was also seen in these mice. In contrast, osteopontin (Spp1) transcript levels in activated microglia were not reduced by Acvr1 signalling. Altogether, the data suggest that BMP signalling is dispensable in adult cortical neurons but that augmented BMP signalling affects molecular changes associated with neuronal lesions. (c) 2006 Wiley-Liss, Inc.	Uppsala Univ, Dept Neurosci, Biomed Ctr, SE-75123 Uppsala, Sweden; Univ Uppsala Hosp, Uppsala, Sweden; NIDDK, Mammalian Genet Sect, NIH, Bethesda, MD USA; NIEHS, Reprod & Dev Toxicol Lab, Res Triangle Pk, NC 27709 USA; NIDA, NIH, Neurol Protect & Regenerat Sect, Baltimore, MD 21224 USA; Univ So Calif, Childrens Hosp, Dev Biol Program, Los Angeles, CA 90027 USA		Ebendal, T (corresponding author), Uppsala Univ, Dept Neurosci, Biomed Ctr, Box 587, SE-75123 Uppsala, Sweden.	ted.ebendal@neuro.uu.se	deng, chuxia/N-6713-2016; Kaartinen, Vesa/AAU-5396-2021; Lewen, Anders/A-5156-2013; Fukuda, Tomokazu/O-1257-2018	Lewen, Anders/0000-0003-4925-1348; Fukuda, Tomokazu/0000-0001-8456-0483; Kaartinen, Vesa/0000-0002-9432-510X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL074862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR) [R01DE013085] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [Z01DK056012, ZIADK056012, Z01DK056001, ZIADK056001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [Z01ES071003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [ZIADA000443, Z01DA000443, ZIADA000461, Z01DA000461] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL074862] Funding Source: Medline; NIDCR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR) [DE013085] Funding Source: Medline		Althini S, 2004, MOL CELL NEUROSCI, V25, P345, DOI 10.1016/j.mcn.2003.10.015; Angley C, 2003, J NEUROSCI, V23, P260; Bengtsson H, 1995, NEUROREPORT, V7, P113, DOI 10.1097/00001756-199512000-00027; Bengtsson H, 1998, J NEUROSCI RES, V53, P559, DOI 10.1002/(SICI)1097-4547(19980901)53:5<559::AID-JNR6>3.0.CO;2-8; Chang CF, 2002, NEUROPHARMACOLOGY, V43, P418, DOI 10.1016/S0028-3908(02)00092-8; Crocker SJ, 2004, J NEUROSCI RES, V75, P1, DOI 10.1002/jnr.10836; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dudas M, 2004, MECH DEVELOP, V121, P173, DOI 10.1016/j.mod.2003.12.003; Ebendal T, 1998, J NEUROSCI RES, V51, P139, DOI 10.1002/(SICI)1097-4547(19980115)51:2<139::AID-JNR2>3.0.CO;2-E; Folkerts MM, 1998, J NEUROTRAUM, V15, P349, DOI 10.1089/neu.1998.15.349; FUKUDA T, IN PRESS GENESIS; Gardner J, 2003, J NEUROSCI RES, V74, P801, DOI 10.1002/jnr.10835; Gu ZY, 1999, DEVELOPMENT, V126, P2551; Guha U, 2004, DEVELOPMENT, V131, P1175, DOI 10.1242/dev.01013; Hall AK, 2004, J NEUROSCI RES, V76, P1, DOI 10.1002/jnr.20019; Huh JW, 2003, J NEUROTRAUM, V20, P975, DOI 10.1089/089771503770195821; Jaworski DM, 2000, GLIA, V30, P199, DOI 10.1002/(SICI)1098-1136(200004)30:2<199::AID-GLIA9>3.0.CO;2-#; Kaartinen V, 2001, GENESIS, V31, P126, DOI 10.1002/gene.10015; Laurer HL, 1999, CURR OPIN NEUROL, V12, P715, DOI 10.1097/00019052-199912000-00010; Lein PJ, 2002, J NEUROSCI, V22, P10377; Lewen A, 1996, BRAIN RES, V719, P161, DOI 10.1016/0006-8993(96)00081-9; Lewen A, 1997, NEUROREPORT, V8, P475, DOI 10.1097/00001756-199701200-00020; Liu YT, 2001, BRAIN RES, V905, P81, DOI 10.1016/S0006-8993(01)02502-1; Lonn P, 2005, NEUROCHEM RES, V30, P753, DOI 10.1007/s11064-005-6868-6; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Matzilevich DA, 2002, J NEUROSCI RES, V67, P646, DOI 10.1002/jnr.10157; Mehler MF, 1997, TRENDS NEUROSCI, V20, P309, DOI 10.1016/S0166-2236(96)01046-6; Meller R, 2005, J CEREBR BLOOD F MET, V25, P217, DOI 10.1038/sj.jcbfm.9600022; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Mishina Y, 1999, DEV BIOL, V213, P314, DOI 10.1006/dbio.1999.9378; Miyazawa K, 2002, GENES CELLS, V7, P1191, DOI 10.1046/j.1365-2443.2002.00599.x; Nakashima K, 2001, P NATL ACAD SCI USA, V98, P5868, DOI 10.1073/pnas.101109698; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; Noshita N, 2002, NEUROBIOL DIS, V9, P294, DOI 10.1006/nbdi.2002.0482; Rall JM, 2003, NEUROPATH APPL NEURO, V29, P118, DOI 10.1046/j.1365-2990.2003.00439.x; Rivera S, 2002, EUR J NEUROSCI, V15, P19, DOI 10.1046/j.0953-816x.2001.01838.x; Sirard C, 1998, GENE DEV, V12, P107, DOI 10.1101/gad.12.1.107; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Soderstrom S, 1999, J NEUROSCI RES, V56, P482; Soderstrom S, 1996, CELL TISSUE RES, V286, P269, DOI 10.1007/s004410050697; ten Dijke P, 2003, MOL CELL ENDOCRINOL, V211, P105, DOI 10.1016/j.mce.2003.09.016; Teng JL, 2001, J CELL BIOL, V155, P65, DOI 10.1083/jcb.200106025; von Gertten C, 2003, J NEUROSCI RES, V73, P803, DOI 10.1002/jnr.10729; Wang Y, 2001, STROKE, V32, P2170, DOI 10.1161/hs0901.095650; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Withers GS, 2000, EUR J NEUROSCI, V12, P106, DOI 10.1046/j.1460-9568.2000.00889.x; Xu BJ, 2000, NEURON, V26, P233, DOI 10.1016/S0896-6273(00)81153-8; Xu BJ, 2000, J NEUROSCI, V20, P6888, DOI 10.1523/JNEUROSCI.20-18-06888.2000; Yang X, 2002, GENESIS, V32, P80, DOI 10.1002/gene.10029; Yang YQ, 2004, J APPL PHYS, V95, P3667, DOI 10.1063/1.1652250; Zhou YX, 2003, J BIOL CHEM, V278, P42313, DOI 10.1074/jbc.M308287200	51	18	18	0	4	WILEY-LISS	HOBOKEN	DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA	0360-4012			J NEUROSCI RES	J. Neurosci. Res.	JUL	2006	84	1					47	57		10.1002/jnr.20856			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	061UD	WOS:000238897400005	16583403				2022-02-06	
J	Salmond, CH; Menon, DK; Chatfield, DA; Pickard, JD; Sahakian, BJ				Salmond, Claire H.; Menon, David K.; Chatfield, Doris A.; Pickard, John D.; Sahakian, Barbara J.			Cognitive reserve as a resilience factor against depression after moderate/severe head injury	JOURNAL OF NEUROTRAUMA			English	Article						cognitive reserve; depression; head injury	TRAUMATIC BRAIN-INJURY; MAJOR DEPRESSION; MOOD DISORDERS; HIPPOCAMPAL VOLUME; SYMPTOMS; ADULTS; LIFE; CLASSIFICATION; INTELLIGENCE; OUTPATIENTS	Depression is one of the most frequently reported and distressing residual complaints in survivors of head injury. Studies investigating the pattern of neuropathology associated with depression post head injury have found little consistency. One explanation for this is that cognitive reserve "protects" against depression either through more efficient processing or more effective compensation. An alternative explanation is that previous studies have used relatively gross measures of lesion location, and variable inclusion criteria and times between scan and injury. This study explored these possibilities in a cohort of survivors of moderate-severe head injury at least 6 months post-injury. Volunteers completed neuropsychological assessments and structural magnetic resonance imaging (MRI) scans. A significant difference between depressed and non-depressed survivors was found, with higher intelligence associated with lower rates of depression. No significant anatomical differences were found between depressed and non-depressed survivors. These results suggest that premorbid intelligence may provide a resilience factor against depression in head injury survivors.	Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Wolfson Brain Imaging Ctr,Univ Dept Anaesthet, Cambridge CB2 2QQ, England; Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Wolfson Brain Imaging Ctr,Univ Dept Neurosurg, Cambridge CB2 2QQ, England; Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Wolfson Brain Imaging Ctr,Univ Dept Psychiat, Cambridge CB2 2QQ, England		Salmond, CH (corresponding author), Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Wolfson Brain Imaging Ctr,Univ Dept Anaesthet, Cambridge CB2 2QQ, England.	Claire.Salmond@iop.kcl.ac.uk	Sahakian, Barbara/AAW-1198-2020	Sahakian, Barbara/0000-0001-7352-1745	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0001354, G0001237, G0600986, G9439390] Funding Source: Medline; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0001237, G9439390] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0001354B] Funding Source: researchfish		ALOIA MS, 1995, BRAIN INJURY, V9, P575, DOI 10.3109/02699059509008216; Andersson S, 1999, PSYCHOL MED, V29, P447, DOI 10.1017/S0033291798008046; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 1997, NEUROIMAGE, V6, P344, DOI 10.1006/nimg.1997.0299; Babin PR, 2003, BRAIN INJURY, V17, P889, DOI 10.1080/0269905031000088595; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Beck A. T., 1970, DEPRESSION CAUSES TR; Beck AT, 1987, BECK DEPRESSION INVE; BORNSTEIN RA, 1989, J NEUROSURG, V70, P509, DOI 10.3171/jns.1989.70.4.0509; Bowen A, 1999, BRAIN INJURY, V13, P547; Campbell S, 2004, AM J PSYCHIAT, V161, P598, DOI 10.1176/appi.ajp.161.4.598; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Crawford J.R., 1992, HDB NEUROPSYCHOLOGIC, P21; CRAWFORD JR, 1987, BRIT J CLIN PSYCHOL, V26, P313, DOI 10.1111/j.2044-8260.1987.tb01366.x; Deb S, 1999, AM J PSYCHIAT, V156, P374; Drevets WC, 2000, BIOL PSYCHIAT, V48, P813, DOI 10.1016/S0006-3223(00)01020-9; Duncan J, 2000, SCIENCE, V289, P457, DOI 10.1126/science.289.5478.457; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; FORDYCE DJ, 1983, J NEUROL NEUROSUR PS, V46, P620, DOI 10.1136/jnnp.46.7.620; Glenn MB, 2001, BRAIN INJURY, V15, P811, DOI 10.1080/02699050010025777; GomezHernandez R, 1997, ARCH PHYS MED REHAB, V78, P1321, DOI 10.1016/S0003-9993(97)90304-X; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; GREENSPAN L, 1985, J TRAUMA, V25, P60, DOI 10.1097/00005373-198501000-00010; Groom KN, 1998, ARCH CLIN NEUROPSYCH, V13, P695, DOI 10.1016/S0887-6177(98)00005-5; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Isacson D, 2005, EUR PSYCHIAT, V20, P205, DOI 10.1016/j.eurpsy.2004.12.011; JENKINSON C, 1993, AUDITORIUM, V2, P7; JENNETT B, 1981, MANAGEMENT HEAD INJU, P77; JORGE RE, 1993, J NERV MENT DIS, V181, P91, DOI 10.1097/00005053-199302000-00004; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; JORGE RE, 1994, J NEUROSURG, V81, P726, DOI 10.3171/jns.1994.81.5.0726; Lawrence NS, 2004, BIOL PSYCHIAT, V55, P578, DOI 10.1016/j.biopsych.2003.11.017; LISHMAN WA, 1987, ORGANIC PSYCHIATRY, P137; MACNIVEN E, 1993, BRAIN INJURY, V7, P241, DOI 10.3109/02699059309029676; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; Mayes S D, 1989, Brain Inj, V3, P301, DOI 10.3109/02699058909029643; McCleary C, 1998, J CLIN EXP NEUROPSYC, V20, P270, DOI 10.1076/jcen.20.2.270.1172; Nelson H.E., 1982, NATL ADULT READING T; OCarroll R, 1995, NEUROCASE, V1, P83, DOI 10.1080/13554799508402350; Ownsworth TL, 1998, BRAIN INJURY, V12, P735, DOI 10.1080/026990598122133; Powell BD, 2003, ARCH CLIN NEUROPSYCH, V18, P277, DOI 10.1016/S0887-6177(02)00135-X; Pukrop R, 2003, PSYCHIAT RES, V119, P63, DOI 10.1016/S0165-1781(03)00110-0; Richter P, 1998, PSYCHOPATHOLOGY, V31, P160, DOI 10.1159/000066239; Rose D, 2001, EUROPEAN SOCIOECONOM; Rosenberg M, 1989, SOC ADOLESCENT SELF; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; RUTHERFORD WH, 1979, LANCET, V1, P1; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Satz P, 1998, BRAIN INJURY, V12, P537, DOI 10.1080/026990598122313; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P1621, DOI 10.1053/S0003-9993(03)00270-3; Sherman EMS, 2000, BRAIN INJURY, V14, P621; Sliwinski M, 1998, J HEAD TRAUMA REHAB, V13, P40, DOI 10.1097/00001199-199808000-00004; STARKSTEIN SE, 1988, ARCH GEN PSYCHIAT, V45, P247; STARKSTEIN SE, 1987, BRAIN, V110, P1045, DOI 10.1093/brain/110.4.1045; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Tavares JVT, 2003, PSYCHOL MED, V33, P959, DOI 10.1017/S0033291703008432; Trahan DE, 2001, ARCH CLIN NEUROPSYCH, V16, P435, DOI 10.1016/S0887-6177(00)00051-2; Underhill AT, 2003, BRAIN INJURY, V17, P973, DOI 10.1080/0269905031000110418; Vargha-Khadem F, 2003, P NATL ACAD SCI USA, V100, P10055, DOI 10.1073/pnas.1233756100; Varney NR, 1987, NEUROPSYCHOLOGY, V1, P7, DOI 10.1037//0894-4105.1.1.7; Vythilingam M, 2004, BIOL PSYCHIAT, V56, P101, DOI 10.1016/j.biopsych.2004.04.002; Watt KJ, 1999, J NEUROL NEUROSUR PS, V66, P474, DOI 10.1136/jnnp.66.4.474; Zasler ND, 1997, ARCH PHYS MED REHAB, V78, pS12, DOI 10.1016/S0003-9993(97)90150-7; [No title captured]	70	18	20	0	9	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUL	2006	23	7					1049	1058		10.1089/neu.2006.23.1049			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	069UG	WOS:000239473200001	16866618				2022-02-06	
J	Hoffmann, B; Karbe, H; Krusch, C; Muller, B; Pause, M; Prosiegel, M; Puschendorf, W; Schleep, J; Spranger, M; Steube, D; Voss, A				Hoffmann, B.; Karbe, H.; Krusch, C.; Mueller, B.; Pause, M.; Prosiegel, M.; Puschendorf, W.; Schleep, J.; Spranger, M.; Steube, D.; Voss, A.			Early rehabilitation in neurology and neurosurgery: a multicenter study to describe typical impairments and complications define patient characteristics	AKTUELLE NEUROLOGIE			German	Article							SCALE	In nine centers for neurological in-patient rehabilitation in different states within the Federal Republic of Germany, every patient who was admitted and treated in the phase of early rehabilitation was prospectively documented. The aim of this documentation was a general description of the Phase-B-patient group in Germany with demographic and medical data. 1280 patients were included in the study. They were predominantly of male gender (62%) and the median of the age was 65 years. The largest number of these patients were transferred from neurological and/or neurosurgical departments where they were treated for 27 days on average before their discharge and transfer to the rehabilitation centre. On admission to the rehabilitation hospital, 17% of all patients were dependent on artificial respiration. The average patient was rated by the Glasgow Coma Scale (GCS) as being in a light or middle coma status at this time. Patients remained in the rehabilitation center for 57 days on average. During this time recovery depended on diagnosis: Those with a favourable diagnosis e.g. traumatic brain injury (TBI) recovered rather quickly compared to those who where diagnosed with brain hypoxia, who did not show measurable amendments. A discharge from early rehabilitation Phase B to home care was documented in 24.3% of all patients, 33.1% were transferred to further rehabilitation treatment and 23.1% to a nursing home. 6.4% of all documented patients died during the documented study period. For a great number of patients the outcome, as defined by the Glasgow Outcome Scale was estimated as "upper severe diasability" or "lower moderate disability", therefore it is concluded, that the early rehabilitation Phase B is a very effective treatment.	Klinikum Staffelstein, D-96231 Bad Staffelstein, Germany; Clemenshosp, Munster, Germany; Neurol Rehabil Zentrum Godeshohe, Bad Godesberg, Germany; Asklepios Schlossberg Klin, Bad Konig, Germany; Klin Bavaria, Kreischa, Germany; Neurol Krankenhaus, Munich, Germany; Neurol Klin Westend, Bad Wildungen, Germany; Friedehorst Neurol Rehabil Zentrum, Bremen, Germany; Neurol Clin, Bad Neustadt an der Saale, Germany		Pause, M (corresponding author), Klinikum Staffelstein, Kurpk 11, D-96231 Bad Staffelstein, Germany.	Mpause@Schoen-Kliniken.de					Bundesarbeitsgemeinschaft fur Rehabilitation (BAR), 1999, EMPF NEUR REH PAT SC; Chesnut RM, 1998, EVIDENCE REPORT REHA; *FACHPR STAT VERS, 1982, HEUR BAY STAATSM ARB; KEITH RA, 1987, ADV CLIN REHABILITAT, V2, P6; MAHONEY F I, 1965, Md State Med J, V14, P61; Schonle P W, 2001, Rehabilitation (Stuttg), V40, P123; Schonle P W, 1995, Rehabilitation (Stuttg), V34, P69; Stier-Jarmer M, 2002, PHYS MED REHAB KUROR, V12, P260, DOI 10.1055/s-2002-35154; TEASDALE G, 1974, LANCET, V2, P81; Voss A, 1993, SPECTRUM NEUROREHABI, P112; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zieger A, 1998, J ANASTHESIE INTENSI, V1, P220	12	18	18	0	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0302-4350			AKTUEL NEUROL	Aktuelle Neurol.	JUN	2006	33	5					287	296		10.1055/s-2005-915348			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	061BH	WOS:000238845700006					2022-02-06	
J	Schopp, LH; Shigaki, CL; Bounds, TA; Johnstone, B; Stucky, RC; Conway, DL				Schopp, Laura H.; Shigaki, Cheryl L.; Bounds, Thomas A.; Johnstone, Brick; Stucky, Renee C.; Conway, Debbie L.			Outcomes in TBI with violent versus nonviolent etiology in a predominantly rural setting	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; cognition; community integration; function; memory; outcome; rehabilitation; rural; social; violence	TRAUMATIC BRAIN-INJURY; VOCATIONAL OUTCOMES; 1-YEAR	Objective: To evaluate differences in outcome in persons with violent versus nonviolent traumatic brain injury (TBI) etiology. Design: Two-group (violent vs nonviolent) 1-year follow-up study. Setting: Midwestern medical center TBI Model System serving a predominantly rural catchment area. Participants: Forty-five (n = 19 violent TBI etiology; n = 26 nonviolent TBI etiology) inpatients with primary diagnosis of TBI followed up as outpatients I year after injury. Main Outcome Measures: Substance use, income source, employment status, Wechsler Adult Intelligence Scale-Revised (abbreviated version), Logical Memory I and 11 from the Wechsler Memory Scale-Revised, Wide Range Achievement Test-Third Edition Reading subtest, Trail-Making Tests A and B, Rey Auditory Verbal Learning Test, Community Integration Questionnaire, Neurobehavioral Functioning Inventory. Results: Members of the violent group were more likely to be men, of a racial minority, unemployed, and have low income. Substance abuse was common among both groups prior to injury, with significant declines at 1 year. Follow-up also revealed significant group differences in verbal intelligence, social integration, productivity, and source of income, but nonsignificant difference in employment. In all comparisons, more favorable outcomes were found for the nonviolent group. Conclusions: Persons with violent injury etiology have poorer premorbid functioning and are likely to have less favorable outcomes than the general population with TBI. Therefore, persons with violent TBI etiology may require more intensive aftercare programming to promote improved rehabilitation outcomes.	Univ Missouri, Dept Hlth Psychol, Sch Hlth Prof, Columbia, MO 65212 USA; Univ Missouri, Missouri Rehabil Ctr, Mt Vernon, MO USA		Schopp, LH (corresponding author), Univ Missouri, Dept Hlth Psychol, Sch Hlth Prof, DC046-46, Columbia, MO 65212 USA.	schoppL@health.missouri.edu		Johnstone, Brick/0000-0001-8845-9649	PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [H133A980008] Funding Source: Medline		Bogner JA, 2001, ARCH PHYS MED REHAB, V82, P571, DOI 10.1053/apmr.2001.22340; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P255, DOI 10.1053/apmr.2003.50092; Callahan CD, 1997, ARCH CLIN NEUROPSYCH, V12, P133, DOI 10.1016/S0887-6177(96)00029-7; [Centers for Disease Control and Prevention National Center for Injury Prevention and Control], WEBB INJ STAT QUER R; Chwalisz K, 2000, HANDBOOK OF REHABILITATION PSYCHOLOGY, P537, DOI 10.1037/10361-025; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P41, DOI 10.1097/00001199-199508000-00005; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; CREPEAU F, 1993, NEUROPSYCHOL REHABIL, V3, P5; DIKMEN S, 1996, NEUROPSYCHOLOGICAL A, P552; Farmer JE, 2003, J HEAD TRAUMA REHAB, V18, P116, DOI 10.1097/00001199-200303000-00003; FARR SP, 1986, HDB CLIN NEUROPSYCHO, P213; Hanks RA, 2003, ARCH PHYS MED REHAB, V84, P249, DOI 10.1053/apmr.2003.50096; Hanlon RE, 1999, BRAIN INJURY, V13, P873; Harrison-Felix C, 1998, ARCH PHYS MED REHAB, V79, P730, DOI 10.1016/S0003-9993(98)90348-3; Hawkins KA, 2002, ARCH CLIN NEUROPSYCH, V17, P49, DOI 10.1016/S0887-6177(00)00099-8; Johnstone B, 2003, NEUROREHABILITATION, V18, P197; JOHNSTONE B, 1995, BRAIN INJURY, V9, P377, DOI 10.3109/02699059509005777; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P238, DOI 10.1053/apmr.2003.50097; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; KREUTZER J, 1999, NEUROBEHAVIORAL FUNC; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; Machamer JE, 2003, J HEAD TRAUMA REHAB, V18, P387, DOI 10.1097/00001199-200309000-00001; MICHAUD LJ, 1995, J HEAD TRAUMA REHAB, V10, P25, DOI 10.1097/00001199-199510000-00005; Parker RS, 1996, J CLIN PSYCHOL, V52, P32, DOI 10.1002/(SICI)1097-4679(199601)52:1<32::AID-JCLP5>3.3.CO;2-1; REITAN RM, 1986, TRAIM MAKING TEST MA; Schootman M, 1999, BRAIN INJURY, V13, P995; *TRAUM BRAIN INJ M, 2000, TRAUM BRAIN INJ FACT; Wechsler D, 1997, MANUAL WECHSLER MEMO; WILKINSON G, 1993, WRATS WIDE RANGE ACH; Zafonte RD, 1997, BRAIN INJURY, V11, P403	30	18	18	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2006	21	3					213	225		10.1097/00001199-200605000-00002			13	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	044YL	WOS:000237709600002	16717499				2022-02-06	
J	Brandstack, N; Kurki, T; Tenovuo, O; Isoniemi, H				Brandstack, Nina; Kurki, Timo; Tenovuo, Olli; Isoniemi, Heli			MR imaging of head trauma: Visibility of contusions and other intraparenchymal injuries in early and late stage	BRAIN INJURY			English	Article						head trauma; magnetic resonance imaging; contusion; diffuse axonal injury	DIFFUSE AXONAL INJURY; MAGNETIC-RESONANCE SPECTROSCOPY; COMA SCALE SCORE; BRAIN-INJURY; CORPUS-CALLOSUM; COMPUTERIZED-TOMOGRAPHY; QUANTITATIVE-ANALYSIS; DEGENERATIVE CHANGES; CT FINDINGS; MILD	The aim of this study was to investigate the visibility of traumatic brain lesions on conventional magnetic resonance images (MRI) in early and late phase. Thirty-six patients were studied 1 week and 1 year after a traumatic brain injury. A similar MRI technique was used in both studies; T-2-weighted fast or turbo spin echo images, fluid attenuated inversion recovery ( FLAIR) images and T-1-weighted images were used for analysis. The number and extent of contusions and semi-quantitative score of other traumatic intraparenchymal lesions were compared in the early and late phase. Contusions were seen in 18 patients both in acute and 1 year MRI; the number and extent of visible contusions was significantly decreased at 1 year. Other traumatic intraparenchymal lesions were detected in 12 patients in early MRI and in 10 patients in late MRI. The number of visible lesions and the semi-quantitative scores were significantly lower at 1 year. There is a significant decrease in the visibility of both cortical contusions and other intraparenchymal injuries in late MRI studies compared with studies in acute stage using conventional imaging techniques. Thus, early phase MRI is essential for the detection of brain injury at least using conventional imaging techniques.	Turku Univ Hosp, Dept Radiol, FIN-20521 Turku, Finland; Turku Univ Hosp, Dept Neurol, FIN-20521 Turku, Finland		Kurki, T (corresponding author), Turku Univ Hosp, Dept Radiol, Pl 52, FIN-20521 Turku, Finland.	timoji.kurki@pp.inet.fi		Kurki, Timo/0000-0001-5532-3534			Abdel-Dayem HM, 1998, CLIN NUCL MED, V23, P309, DOI 10.1097/00003072-199805000-00009; Anderson CV, 1996, J NEUROTRAUM, V13, P59, DOI 10.1089/neu.1996.13.59; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Ashikaga R, 1997, NEURORADIOLOGY, V39, P239, DOI 10.1007/s002340050401; Azouvi P, 2000, CURR OPIN NEUROL, V13, P665, DOI 10.1097/00019052-200012000-00009; Bagley LJ, 2000, J MAGN RESON IMAGING, V11, P1, DOI 10.1002/(SICI)1522-2586(200001)11:1<1::AID-JMRI1>3.0.CO;2-H; Barzo P, 1997, ACT NEUR S, V70, P115; Besenski N, 2002, EUR RADIOL, V12, P1237, DOI 10.1007/s00330-002-1355-9; BIGLER ED, 1995, ARCH CLIN NEUROPSYCH, V10, P159, DOI 10.1016/0887-6177(94)E0003-8; Bigler ED, 2002, AM J NEURORADIOL, V23, P255; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Bigler Erin D., 1993, Brain Injury, V7, P125, DOI 10.3109/02699059309008166; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; Cecil KM, 1998, J NEUROSURG, V88, P795, DOI 10.3171/jns.1998.88.5.0795; Chan JHM, 2003, NEURORADIOLOGY, V45, P34, DOI 10.1007/s00234-002-0891-y; Chen SHA, 2003, J NEUROL NEUROSUR PS, V74, P326, DOI 10.1136/jnnp.74.3.326; Danielsen ER, 2003, NEURORADIOLOGY, V45, P722, DOI 10.1007/s00234-003-1068-z; DOEZEMA D, 1991, ANN EMERG MED, V20, P1281, DOI 10.1016/S0196-0644(05)81065-0; Fiser SM, 1998, AM SURGEON, V64, P1088; Friedman SD, 1998, AM J NEURORADIOL, V19, P1879; Friedman SD, 1999, NEUROLOGY, V52, P1384, DOI 10.1212/WNL.52.7.1384; FUMEYA H, 1990, ACT NEUR S, V51, P283; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; GALE SD, 1995, J NEUROTRAUM, V12, P151, DOI 10.1089/neu.1995.12.151; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; GENTRY LR, 1988, AM J NEURORADIOL, V9, P101, DOI 10.2214/ajr.150.3.663; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; Gerber DJ, 2004, BRAIN INJURY, V18, P1083, DOI 10.1080/02699050410001672341; Groswasser Z, 2002, BRAIN INJURY, V16, P681, DOI 10.1080/02699050110119835; HADLEY DM, 1988, CLIN RADIOL, V39, P131; Henry-Feugeas MC, 2000, BRAIN INJURY, V14, P597; Himanen L, 2005, BRAIN INJURY, V19, P93, DOI 10.1080/02699050410001720031; Hofman PAM, 2002, J NEUROPSYCH CLIN N, V14, P176, DOI 10.1176/appi.neuropsych.14.2.176; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Holshouser BA, 2005, AM J NEURORADIOL, V26, P1276; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; ICHISE M, 1994, J NUCL MED, V35, P217; JENKINS A, 1986, LANCET, V2, P445; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kant R, 1997, BRAIN INJURY, V11, P115, DOI 10.1080/026990597123700; Le TH, 2005, NEUROSURGERY, V56, P189, DOI 10.1227/01.NEU.0000144846.00569.3A; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; Liu AY, 1999, AM J NEURORADIOL, V20, P1636; LOBATO RD, 1986, J NEUROSURG, V65, P784, DOI 10.3171/jns.1986.65.6.0784; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Marmarou A, 2000, ACT NEUR S, V76, P349; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; McGowan JC, 2000, AM J NEURORADIOL, V21, P875; MCLEAN A, 1984, NEUROSURGERY, V14, P393, DOI 10.1227/00006123-198404000-00001; Mitchener A, 1997, J NEUROL NEUROSUR PS, V62, P633, DOI 10.1136/jnnp.62.6.633; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Naganawa S, 2004, AM J NEURORADIOL, V25, P1553; NEWTON MR, 1992, J NEUROL NEUROSUR PS, V55, P92, DOI 10.1136/jnnp.55.2.92; Ogawa T, 1992, Acta Neurochir Suppl (Wien), V55, P8; ORRISON WW, 1994, AM J NEURORADIOL, V15, P351; Paterakis K, 2000, J TRAUMA, V49, P1071, DOI 10.1097/00005373-200012000-00016; Pierallini A, 2000, NEURORADIOLOGY, V42, P860, DOI 10.1007/s002340000447; PRAYER L, 1993, ACTA RADIOL, V34, P593; Reider-Groswasser II, 2002, BRAIN INJURY, V16, P517, DOI 10.1080/02699050110119141; REIDERGROSWASSER I, 1993, AM J ROENTGENOL, V160, P147, DOI 10.2214/ajr.160.1.8416613; Rugg-Gunn FJ, 2001, J NEUROL NEUROSUR PS, V70, P530, DOI 10.1136/jnnp.70.4.530; Schafer PW, 2004, RADIOLOGY, V233, P58, DOI 10.1148/radiol.2323031173; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; SCHELTENS P, 1993, J NEUROL SCI, V114, P7, DOI 10.1016/0022-510X(93)90041-V; Shanmuganathan K, 2004, AM J NEURORADIOL, V25, P539; Sinson G, 2001, AM J NEURORADIOL, V22, P143; SNOW RB, 1986, NEUROSURGERY, V18, P45, DOI 10.1227/00006123-198601000-00008; Stamatakis EA, 2002, J NUCL MED, V43, P476; Takayama H, 2000, CLIN NEUROL NEUROSUR, V102, P135, DOI 10.1016/S0303-8467(00)00079-2; Thatcher RW, 1997, J NEUROTRAUM, V14, P1, DOI 10.1089/neu.1997.14.1; Tomaiuolo F, 2004, J NEUROL NEUROSUR PS, V75, P1314, DOI 10.1136/jnnp.2003.017046; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; Voller B, 1999, BRAIN INJURY, V13, P821, DOI 10.1080/026990599121214; Voller B, 2001, BRAIN INJURY, V15, P107, DOI 10.1080/026990501458344; Wardlaw JM, 2000, NEURORADIOLOGY, V42, P81, DOI 10.1007/s002340050019; Wilson JTL, 1990, NEUROPSYCHOLOGY, V4, P261, DOI 10.1037/0894-4105.4.4.261; WILSON JTL, 1988, J NEUROL NEUROSUR PS, V51, P391, DOI 10.1136/jnnp.51.3.391; Yanagawa Y, 2000, J TRAUMA, V49, P272, DOI 10.1097/00005373-200008000-00013	85	18	19	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR	2006	20	4					409	416		10.1080/02699050500487951			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	045GN	WOS:000237730700005	16716986				2022-02-06	
J	Iverson, GL; Lange, RT; Viljoen, H; Brink, J				Iverson, GL; Lange, RT; Viljoen, H; Brink, J			WAIS-III General Ability Index in neuropsychiatry and forensic psychiatry inpatient samples	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						intelligence; WAIS-III; psychiatry; assessment	TRAUMATIC BRAIN INJURY; BASE-RATES; INTELLIGENCE; SCORES	The purpose of this study is to examine the WAIS-III General Ability Index (GAI) in a sample of 33 neuropsychiatry inpatients and 47 forensic psychiatry inpatients. The GAI is comprised of the six subtests that form the Verbal Comprehension and the Perceptual Organization Indexes. The GAI, although highly correlated with the FSIQ, was on average 5.3 points higher in the neuropsychiatry sample and 4.2 points higher in the forensic psychiatry sample. The GAI was significantly higher than the Working Memory and the Processing Speed Indexes in both groups. The GAI, a composite measure of verbal and nonverbal intellect, appears to be an appropriate measure for use in day-to-day clinical practice in neuropsychology. To facilitate clinical use, statistically reliable difference scores between the GAI and the WMI and PSI, for the 95% confidence interval, are presented. (c) 2005 National Academy of Neuropsychology. Published by Elsevier Ltd. All rights	Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 2A1, Canada; Forens Psychiat Hosp, Vancouver, BC V6T 2A1, Canada		Iverson, GL (corresponding author), Univ British Columbia, Dept Psychiat, 2255 Wesbrook Mall, Vancouver, BC V6T 2A1, Canada.	giverson@interchange.ubc.ca		Iverson, Grant/0000-0001-7348-9570			Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Fisher D C, 2000, Appl Neuropsychol, V7, P126, DOI 10.1207/S15324826AN0703_2; Hawkins KA, 1998, CLIN NEUROPSYCHOL, V12, P535, DOI 10.1076/clin.12.4.535.7236; Hawkins KA, 2001, J INT NEUROPSYCH SOC, V7, P875, DOI 10.1017/S1355617701777119; Lange RT, 2005, CLIN NEUROPSYCHOL, V19, P73, DOI 10.1080/13854040490888549; LANGE RT, CLIN NEUROPSYCHOLOGI; LANGE RT, J CLIN EXPT NEUROPSY; Martin TA, 2000, REHABIL PSYCHOL, V45, P402, DOI 10.1037/0090-5550.45.4.402; Prifitera A., 1998, WISC 3 CLIN USE INTE, P1, DOI [10.1016/B978-012564930-8/50002-4, DOI 10.1016/B978-012564930-8/50002-4]; *PSYCH CORP, 1997, WAIS III WMS III TEC; Raiford S. E., 2005, WECHSLER INTELLIGENC; Saklofske DH, 2005, CAN J BEHAV SCI, V37, P44, DOI 10.1037/h0087244; SCHOENBERG MR, CLIN NEUROPSYCHOLOGI; SELLERS AH, 1999, WAIS III GEN ABILITI; Tulsky DS, 2001, PSYCHOL ASSESSMENT, V13, P566, DOI 10.1037/1040-3590.13.4.566; Tulsky DS, 2000, CLIN NEUROPSYCHOL, V14, P451, DOI 10.1076/clin.14.4.451.7202; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Weiss L. G., 1999, CANADIAN J SCH PSYCH, V14, P1, DOI [10.1177/082957359901400202, DOI 10.1177/082957359901400202]	18	18	18	0	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JAN	2006	21	1					77	82		10.1016/j.acn.2005.07.007			6	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	006EA	WOS:000234877100007	16162397				2022-02-06	
J	Boden, BP				Boden, BP			Direct catastrophic injury in sports	JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS			English	Article							CERVICAL SPINAL STENOSIS; FOOTBALL PLAYERS; PROFESSIONAL FOOTBALL; AMERICAN FOOTBALL; SOCCER PLAYERS; CHEST IMPACTS; SUDDEN-DEATH; CORD; CONCUSSION; HOCKEY	Catastrophic sports injuries are rare but tragic events. Direct (traumatic) catastrophic injury results from participating in the skills of a sport, such as a collision in football. Football is associated with the greatest number of direct catastrophic injuries for all major team sports in the United States. Pole vaulting, gymnastics, ice hockey, and football have the highest incidence of direct catastrophic injuries for sports in which males participate. In most sports, the rate of catastrophic injury is higher at the collegiate than at the high school level. Cheerleading is associated with the highest number of direct catastrophic injuries for all sports in which females participate. Indirect (nontraumatic) injury is caused by systemic failure as a result of exertion while participating in a sport. Cardiovascular conditions, heat illness, exertional hyponatremia, and dehydration can cause indirect catastrophic injury. Understanding the common mechanisms of injury and prevention strategies for direct catastrophic injuries is critical in caring for athletes.	Orthopaed Ctr, Rockville, MD 20850 USA; Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA		Boden, BP (corresponding author), Orthopaed Ctr, 9711 Med Ctr Dr,201, Rockville, MD 20850 USA.						[Anonymous], 1994, J Am Coll Cardiol, V24, P845; Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Boden BP, 2004, AM J SPORT MED, V32, P1189, DOI 10.1177/0363546503262161; Boden BP, 1998, AM J SPORT MED, V26, P238, DOI 10.1177/03635465980260021301; Boden BP, 2002, AM J SPORT MED, V30, P791, DOI 10.1177/03635465020300060601; Boden BP, 2001, AM J SPORT MED, V29, P50, DOI 10.1177/03635465010290011301; Boden BP, 2003, AM J SPORT MED, V31, P881, DOI 10.1177/03635465030310062501; Cantu RC, 2003, NEUROSURGERY, V52, P846, DOI 10.1227/01.NEU.0000053210.76063.E4; CANTU RC, 1993, MED SCI SPORT EXER, V25, P316; Crisco JJ, 1997, MED SCI SPORT EXER, V29, P26, DOI 10.1097/00005768-199701000-00005; Crisco JJ, 2002, MED SCI SPORT EXER, V34, P1675, DOI 10.1097/00005768-200210000-00021; DeVivo MJ, 1997, SPINAL CORD, V35, P809, DOI 10.1038/sj.sc.3100501; HERZOG RJ, 1991, SPINE, V16, pS178, DOI 10.1097/00007632-199106001-00001; Janda DH, 1998, J TRAUMA, V44, P298, DOI 10.1097/00005373-199802000-00011; JANDA DH, 1995, AM J SPORT MED, V23, P340, DOI 10.1177/036354659502300316; Janda DH., 1992, CLIN J SPORT MED, V2, P172; Kane SM, 2002, AM J SPORT MED, V30, P834, DOI 10.1177/03635465020300061301; MARON BJ, 1995, NEW ENGL J MED, V333, P337, DOI 10.1056/NEJM199508103330602; Maron BJ, 2003, NEW ENGL J MED, V349, P1064, DOI 10.1056/NEJMra022783; Molsa JJ, 1999, INT J SPORTS MED, V20, P64, DOI 10.1055/s-2007-971095; MUELLER FO, 1996, HK SPORT SCI MONOGRA, V8, P1; *NAT FED STAT HIGH, 2001, BAS 2002 RUL BOOK, P14; *NAT SLEEP FDN, 2002, 2002 SLEEP AM POLL, P1; *NCAA, 2002, 2003 BAS RUL INT, P20; ODOR JM, 1990, AM J SPORT MED, V18, P507, DOI 10.1177/036354659001800510; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Strasburger JF, 2002, NEW ENGL J MED, V347, P1248, DOI 10.1056/NEJMicm020053; Stuart MJ, 2002, AM J SPORT MED, V30, P39, DOI 10.1177/03635465020300012001; TORG JS, 1986, J BONE JOINT SURG AM, V68A, P1354, DOI 10.2106/00004623-198668090-00008; Torg JS, 1996, J BONE JOINT SURG AM, V78A, P1308, DOI 10.2106/00004623-199609000-00003; Torg JS, 2002, J BONE JOINT SURG AM, V84A, P112, DOI 10.2106/00004623-200201000-00017; TORG JS, 1994, ORTHOPAEDIC SPORTS M, P417; VIANO DC, 1992, CLIN J SPORT MED, V2, P161	33	18	18	3	14	AMER ACAD ORTHOPAEDIC SURGEONS	ROSEMENT	6300 N RIVER ROAD, ROSEMENT, IL 60018-4262 USA	1067-151X			J AM ACAD ORTHOP SUR	J. Am. Acad. Orthop. Surg.	NOV	2005	13	7					445	454		10.5435/00124635-200511000-00004			10	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	981DQ	WOS:000233068000004	16272269				2022-02-06	
J	Tuli, T; Hachl, O; Rasse, M; Kloss, F; Gassner, R				Tuli, T.; Haechl, O.; Rasse, M.; Kloss, F.; Gassner, R.			Dentoalveolar trauma. Analysis of 4763 patients with 6237 injuries in 10 years	ORAL AND MAXILLOFACIAL SURGERY-HEIDELBERG			German	Article						Epidemiology; Facial injuries; Dentoalveolar trauma; Maxillofacial trauma; Preventive measures		Purpose: The purpose of this study was to evaluate the overall place of dental trauma in facial injuries. This was a retrospective investigation based on the analysis of a large amount of dentoalveolar injuries over a 10-year period. Patients and methods: Between 1991 and 2000, 4763 of 9543 patients suffering from oral and maxillofacial injuries, sustained dentoalveolar trauma. Records of 6237 different dental injury patterns were reviewed according to the five main injury mechanisms: age, sex, type of injury, cause of accident, and frequency of dentoalveolar trauma. They were statistically analyzed using frequency distribution, chi-square test, t-test, Mann-Whitney U test, Kolmogorov-Smirnov test, and logistic regression analysis. Results: Household and play (2117), sports (1533), traffic accidents (438), acts of violence (426), and work-related accidents (201) were noted. A total of 4763 patients had 2988 subluxations, 2356 showed crown fractures, 444 had avulsions, 176 root fractures, 154 intrusions, and 119 patients suffered from concussions. This number of patients accounts for the prevalence of 49.9% for dentoalveolar trauma among all facial injuries. Conclusion: Only the analysis of a large number of injuries reveals the risk of suffering from dentoalveolar trauma. Due to this fact, preventive methods can be recommended and demanded more effectively.	[Tuli, T.; Haechl, O.; Rasse, M.; Kloss, F.; Gassner, R.] Med Univ Innsbruck, Klin Abt Mund Kiefer & Gesichtschirurg, A-6020 Innsbruck, Austria		Tuli, T (corresponding author), Med Univ Innsbruck, Klin Abt Mund Kiefer & Gesichtschirurg, Univ Klin Zahn Mund & Kieferheilkunde, Maximilianstr 10, A-6020 Innsbruck, Austria.	tarkantuli@gmx.at					Andreasen JO, 1994, TXB COLOR ATLAS TRAU; Bastone EB, 2000, AUST DENT J, V45, P2, DOI 10.1111/j.1834-7819.2000.tb00234.x; Blinkhorn FA, 2000, ENDOD DENT TRAUMATOL, V16, P162; Celenk S, 2002, J ENDODONT, V28, P208, DOI 10.1097/00004770-200203000-00016; COOK HE, 1990, J ORAL MAXIL SURG, V48, P574, DOI 10.1016/S0278-2391(10)80469-0; da Silva AC, 2004, DENT TRAUMATOL, V20, P6, DOI 10.1111/j.1600-4469.2004.00212.x; DELATTRE JP, 1995, ENDOD DENT TRAUMATOL, V11, P186; Diab M, 2000, QUINTESSENCE INT, V31, P335; Down KE, 1995, INT J ORAL MAX SURG, V24, P409, DOI 10.1016/S0901-5027(05)80469-2; Ehrenfeld M, 2000, ZAHNARZTLICHE CHIRUR, P61; FRIED I, 1995, J DENT CHILD, V62, P256; Gassner R, 2004, J ORAL MAXIL SURG, V62, P399, DOI 10.1016/j.joms.2003.05.013; Gassner R, 2003, J CRANIO MAXILL SURG, V31, P51, DOI 10.1016/S1010-5182(02)00168-3; Glendor U, 2000, Swed Dent J Suppl, V140, P1; Gomez E, 1996, AM J SPORT MED, V24, P684, DOI 10.1177/036354659602400521; Grimm S, 2004, DENT TRAUMATOL, V20, P134, DOI 10.1111/j.1600-4469.2004.00238.x; Hamilton FA, 1997, BRIT DENT J, V182, P91, DOI 10.1038/sj.bdj.4809313; Hoffmann J, 1999, ENDOD DENT TRAUMATOL, V15, P157; Kaste LM, 1996, J DENT RES, V75, P696, DOI 10.1177/002203459607502S09; McTigue DJ, 2000, PEDIATR CLIN N AM, V47, P1067, DOI 10.1016/S0031-3955(05)70258-3; Pohl Y, 2005, DENT TRAUMATOL, V21, P93, DOI 10.1111/j.1600-9657.2004.00298.x; Rajab LD, 2003, DENT TRAUMATOL, V19, P6, DOI 10.1034/j.1600-9657.2003.00131.x; SAELIM V, 1995, ENDOD DENT TRAUMATOL, V11, P32; SANE J, 1988, MED SCI SPORT EXER, V20, P202, DOI 10.1249/00005768-198820020-00016; Schatz J P, 1994, Schweiz Monatsschr Zahnmed, V104, P843; Tschan Jorg D, 2003, Schweiz Monatsschr Zahnmed, V113, P20; Tuli Tarkan, 2002, General Dentistry, V50, P274; von Arx Thomas, 2005, Schweiz Monatsschr Zahnmed, V115, P133; Wilson S, 1997, PEDIATR EMERG CARE, V13, P12, DOI 10.1097/00006565-199702000-00004; Zeng Yang, 1994, Pediatric Dentistry, V16, P419	30	18	18	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1865-1550	1865-1569		ORAL MAXILLOFAC SURG	Oral Maxillofac. Surg.-Heidelb.	SEP	2005	9	5					324	329		10.1007/s10006-005-0629-1			6	Dentistry, Oral Surgery & Medicine	Emerging Sources Citation Index (ESCI)	Dentistry, Oral Surgery & Medicine	V3B5M	WOS:000218105700008	15995881				2022-02-06	
J	Coimbra, R; Hoyt, DB; Anjaria, DJ; Potenza, BM; Fortlage, D; Hollingsworth-Fridlund, P				Coimbra, R; Hoyt, DB; Anjaria, DJ; Potenza, BM; Fortlage, D; Hollingsworth-Fridlund, P			Reversal of anticoagulation in trauma: A North American survey on clinical practices among trauma surgeons	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	62nd Annual Meeting of the American-Association-for-the-Surgery-of-Trauma	SEP 11-13, 2003	MINNEAPOLIS, MN	Amer Assoc Surg Trauma		trauma; anticoagulation; warfarin; reversal of anticoagulation; fresh frozen plasma; severe head injury; abdominal trauma; chest trauma; survey; anticoagulation; complications; mortality; outcomes	PREINJURY WARFARIN USE; ATRIAL-FIBRILLATION; ELDERLY-PATIENTS; HEAD-INJURY; ANTITHROMBOTIC THERAPY; COMPLICATIONS; RISK; PATIENT; STROKE; IMPACT	Background: Recent studies addressing reversal of anticoagulation in trauma have reported conflicting results. We hypothesized that current clinical practice is variable throughout North America. Methods: We surveyed 100 trauma surgeons to obtain information regarding variability in current clinical practice. Results: Seventy-five of 100 trauma surgeons surveyed responded, and the majority (98.7%) agreed that preinjury anticoagulation poses problems in trauma management that include bleeding, increased complications, and mortality. Nine participants (12.2%) had a protocol addressing reversal of anticoagulation in their institution. Most use fresh frozen plasma based on the type and location of injury, initial international normalized ratio (INR), and targeted INR value. Fresh frozen plasma was consistently used in patients with positive head computed tomographic scans, hemothorax, nonoperative solid organ injury management, pelvic and long bone fractures, and any operative intervention. Practice inconsistencies were found in patients with loss of consciousness and normal head computed tomographic scan, facial and rib fractures, and pulmonary contusion. Significant variability was found in the reversal INR target. One third of participants agreed that anticoagulation could be restarted 5 to 7 days after craniotomy; one sixth would do so within 72 hours and one third would wait 10 or more days. Most agreed that anticoagulation could be restarted 3 days after chest, abdominal, and orthopedic operations. Significant inconsistencies were also observed regarding when to restart anticoagulation in closed head injury patients treated nonoperatively. Conclusion: On the basis of the discrepancies observed in this survey, a clinical trial addressing specific injury location and patterns, INR thresholds, and type of strategy to achieve reversal is warranted, and most would agree to participate.	Univ Calif San Diego, Sch Med, Dept Surg, Div Trauma Surg Crit Care & Burns, San Diego, CA 92103 USA		Coimbra, R (corresponding author), Univ Calif San Diego, Sch Med, Dept Surg, Div Trauma Surg Crit Care & Burns, 200 W Arbor Dr,Suite 8896, San Diego, CA 92103 USA.	rcoimbra@ucsd.edu	Coimbra, Raul/AAP-3019-2020	Coimbra, Raul/0000-0002-3759-6851			Albers GW, 2001, CHEST, V119, p194S, DOI 10.1378/chest.119.1_suppl.194S; FEINBERG WM, 1995, ARCH INTERN MED, V155, P469, DOI 10.1001/archinte.155.5.469; Fihn SD, 1996, ANN INTERN MED, V124, P970, DOI 10.7326/0003-4819-124-11-199606010-00004; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Hart RG, 1999, ANN INTERN MED, V131, P492, DOI 10.7326/0003-4819-131-7-199910050-00003; Karni A, 2001, AM SURGEON, V67, P1098; Kennedy DM, 2000, J TRAUMA, V48, P451, DOI 10.1097/00005373-200003000-00012; Kirsch MJ, 2004, J TRAUMA, V57, P1230, DOI 10.1097/01.TA.0000150839.69648.17; Lavoie A, 2004, J TRAUMA, V56, P802, DOI 10.1097/01.TA.0000066183.02177.AF; Li J, 2001, LANCET, V357, P771, DOI 10.1016/S0140-6736(00)04163-5; Man-Son-Hing M, 2003, ARCH INTERN MED, V163, P1580, DOI 10.1001/archinte.163.13.1580; Man-Son-Hing M, 1999, ARCH INTERN MED, V159, P677, DOI 10.1001/archinte.159.7.677; MATHIESEN T, 1995, ACTA NEUROL SCAND, V91, P208; Mina AA, 2003, J TRAUMA, V54, P842, DOI 10.1097/01.TA.0000063271.05829.15; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; PETTY GW, 1988, ANN NEUROL, V23, P570, DOI 10.1002/ana.410230607; White RH, 1996, ARCH INTERN MED, V156, P1197, DOI 10.1001/archinte.156.11.1197; Wojcik R, 2001, J TRAUMA, V51, P1147, DOI 10.1097/00005373-200112000-00021	18	18	19	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	AUG	2005	59	2					374	381		10.1097/01.ta.000174728.46883.a4			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	014BX	WOS:000235454800025	16294078				2022-02-06	
J	Kim, J; Whyte, J; Hart, T; Vaccaro, M; Polansky, M; Coslett, HB				Kim, J; Whyte, J; Hart, T; Vaccaro, M; Polansky, M; Coslett, HB			Executive function as a predictor of inattentive behavior after traumatic brain injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						brain injuries; attention; neuropsychological tests; cognition; predictive value of tests; ecological validity	FRONTAL-LOBE; HEAD-INJURY; WORKING-MEMORY; PREFRONTAL CORTEX; VISUAL-ATTENTION; METHYLPHENIDATE; DEFICITS; TESTS; REHABILITATION; FLUENCY	Emerging evidence from recent studies using laboratory and naturalistic attention tasks suggests that individuals with traumatic brain injury (TBI) may have a deficit mainly in strategic control of attention. In the present study, we tested the hypothesis that inattentive behavior after TBI could be predicted by performance on psychometric measures of executive function. A group of 37 individuals with moderate to severe TBI were assessed with previously validated naturalistic measures of attention. A battery of neuropsychological tests was also administered to assess various aspects of executive function. Seven measures of executive function and 10 variables reflecting inattentive behavior were combined to form 1 executive and 3 inattentive behavior (TB) composite scores. Three predictors (executive composite, current disability scores, and age) were associated, at the univariate level, with one of the IB composites reflecting frequency and duration of off-task episodes. A stepwise multiple regression procedure indicated that the executive composite was the only significant predictor of the IB composite. Additional post-hoc regression analyses suggested that the relationship was not likely to be mediated by processing speed. The current study supports the hypothesis that executive function, measured by commonly used neuropsychological tests, significantly predicts certain aspects of inattentive behavior in real-world tasks after TBT.	Moss Rehabil Res Inst, Albert Einstein Healthcare Network, Philadelphia, PA 19141 USA; Thomas Jefferson Univ, Jefferson Med Coll, Dept Rehabil Med, Philadelphia, PA 19107 USA; Drexel Univ, Dept Biostat, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Biostat, Philadelphia, PA 19104 USA		Whyte, J (corresponding author), Moss Rehabil Res Inst, Albert Einstein Healthcare Network, 1200 W Tabor Rd,Suite 213, Philadelphia, PA 19141 USA.	jwhyte@einstein.edu	Kim, Junghoon/A-6669-2012; Kim, Junghoon John/I-6702-2019	Kim, Junghoon John/0000-0001-5729-8993; Whyte, John/0000-0002-4381-1474	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R24HD039621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039163] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R24HD39621] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS39163] Funding Source: Medline		ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; Alban JP, 2004, AM J PHYS MED REHAB, V83, P131, DOI 10.1097/01.phm.0000112308.68586.1d; AUERBACH SH, 1986, J HEAD TRAUMA REHAB, V1, P1, DOI DOI 10.1097/00001199-198609000-00004; Baddeley A, 1996, P NATL ACAD SCI USA, V93, P13468, DOI 10.1073/pnas.93.24.13468; Baddeley A, 1998, J INT NEUROPSYCH SOC, V4, P523, DOI 10.1017/S135561779800513X; Bashore TR, 2002, PSYCHOL BULL, V128, P151, DOI 10.1037/0033-2909.128.1.151; Bate AJ, 2001, J CLIN EXP NEUROPSYC, V23, P386, DOI 10.1076/jcen.23.3.386.1190; Bell-McGinty S, 2002, INT J GERIATR PSYCH, V17, P828, DOI 10.1002/gps.646; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; Boyle PA, 2003, AM J GERIAT PSYCHIAT, V11, P214, DOI 10.1176/appi.ajgp.11.2.214; BROWN J, 1958, Q J EXP PSYCHOL, V10, P12, DOI 10.1080/17470215808416249; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Cahn-Weiner DA, 2000, CLIN NEUROPSYCHOL, V14, P187, DOI 10.1076/1385-4046(200005)14:2;1-Z;FT187; Challman TD, 2000, MAYO CLIN PROC, V75, P711; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Downing PE, 2000, PSYCHOL SCI, V11, P467, DOI 10.1111/1467-9280.00290; Duncan J, 1997, COGNITIVE NEUROPSYCH, V14, P713, DOI 10.1080/026432997381420; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Godefroy O, 1996, BRAIN, V119, P191, DOI 10.1093/brain/119.1.191; GRONWALL D, 1987, NEUROBEHAVIORAL RECO, P355; Hamster K., 1983, MULTILINGUAL APHASIA; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; Hart T, 2003, ARCH PHYS MED REHAB, V84, P221, DOI 10.1053/apmr.2003.50023; HART T, 1986, CLIN NEUROPSYCHOLOGY, P21; Heaton PDRK., 1993, WISCONSIN CARD SORTI; KERNS KA, 1996, ECOLOGICAL VALIDITY, P147; Lee GP, 1997, CLIN NEUROPSYCHOL, V11, P59, DOI 10.1080/13854049708407030; LEVINE B, 1995, J CLIN EXP NEUROPSYC, V17, P740, DOI 10.1080/01688639508405164; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; LOKEN WJ, 1995, NEUROPSYCHOLOGY, V9, P592, DOI 10.1037/0894-4105.9.4.592; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; Miller E, 1970, Cortex, V6, P121; Miller EK, 2000, NEUROIMAGE, V11, P447, DOI 10.1006/nimg.2000.0574; MIRSKY A F, 1991, Neuropsychology Review, V2, P109, DOI 10.1007/BF01109051; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; PETERSON LR, 1959, J EXP PSYCHOL, V58, P193, DOI 10.1037/h0049234; PETRIDES M, 1982, NEUROPSYCHOLOGIA, V20, P249, DOI 10.1016/0028-3932(82)90100-2; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Posner, 1986, CHRONOMETRIC EXPLORA; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Pratt J, 2003, J EXP PSYCHOL HUMAN, V29, P835, DOI 10.1037/0096-1523.29.5.835; Randolph C., 1993, NEUROPSYCHOLOGY, V7, P82, DOI [10.1037/0894-4105.7.1.82, DOI 10.1037/0894-4105.7.1.82]; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rapport LJ, 1998, ARCH PHYS MED REHAB, V79, P629, DOI 10.1016/S0003-9993(98)90035-1; REGARD M, 1982, PERCEPT MOTOR SKILL, V55, P839, DOI 10.2466/pms.1982.55.3.839; Reitan R, 1985, HALSTEAD REITAN NEUR; Royall DR, 2002, J NEUROPSYCH CLIN N, V14, P377, DOI 10.1176/appi.neuropsych.14.4.377; Sbordone RJ, 2001, NEUROREHABILITATION, V16, P199; Spikman JM, 2004, J INT NEUROPSYCH SOC, V10, P851, DOI 10.1017/S1355617704106061; Spreen O., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI [10.1080/13854048908403285, DOI 10.1080/13854048908403285]; Stablum F, 1996, CORTEX, V32, P261, DOI 10.1016/S0010-9452(96)80050-5; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Stuss DT, 1994, NEUROPSYCHOLOGY, V8, P316, DOI DOI 10.1037/0894-4105.8.3.316; Trenerry MR, 1989, STROOP NEUROPSYCHOLO; Troyer AK, 2000, J CLIN EXP NEUROPSYC, V22, P370, DOI 10.1076/1380-3395(200006)22:3;1-V;FT370; Van Zomeren A. H., 1981, REACTION TIME ATTENT; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Vriezen ER, 2002, CHILD NEUROPSYCHOL, V8, P296, DOI 10.1076/chin.8.4.296.13505; Wechsler D., 1997, WECHSLER MEMORY SCAL; Whyte J, 2004, AM J PHYS MED REHAB, V83, P401, DOI 10.1097/01.PHM.0000128789.75375.D3; Whyte J, 1997, AM J PHYS MED REHAB, V76, P440, DOI 10.1097/00002060-199711000-00002; Whyte J, 1996, J Int Neuropsychol Soc, V2, P274; Whyte J, 1998, J INT NEUROPSYCH SOC, V4, P127, DOI 10.1017/S1355617798001271; Whyte J, 1997, NEUROPSYCHOLOGIA, V35, P313, DOI 10.1016/S0028-3932(96)00092-9; WHYTE J, 1995, NEUROPSYCHOLOGIA, V33, P797, DOI 10.1016/0028-3932(95)00029-3; Whyte J, 2000, J INT NEUROPSYCH SOC, V6, P1, DOI 10.1017/S1355617700611013; WHYTE J, 1998, REHABILITATION MED P, P1191; WHYTE J, 1998, INT PERSPECTIVES TRA, P154; Wood JN, 2003, NAT REV NEUROSCI, V4, P139, DOI 10.1038/nrn1033; Yantis S, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P73; Zasler ND, 1996, MED REHABILITATION T, P133; [No title captured]	77	18	18	0	11	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JUL	2005	11	4					434	445		10.1017/S1355617705050563			12	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	948UY	WOS:000230742400011	16209424				2022-02-06	
J	Hukkelhoven, CWPM; Steyerberg, EW; Habbema, JDF; Maas, AIR				Hukkelhoven, CWPM; Steyerberg, EW; Habbema, JDF; Maas, AIR			Admission of patients with severe and moderate traumatic brain injury to specialized ICU facilities: a search for triage criteria	INTENSIVE CARE MEDICINE			English	Article						traumatic brain injury; intensive care; patient admission; hematoma; intracranial hypertension; prognosis	HEAD; PREDICTION; EXPERIENCE; MANAGEMENT; REGRESSION; VARIABLES; MORTALITY; SELECTION; REVISION; TREE	Objective: To investigate whether triage for direct admission of patients with traumatic brain injury to a trauma center is facilitated by predicting the risk of potentially removable lesions or raised intracranial pressure (ICP). Design and setting: Cohort study in a level I university trauma center. Patients and participants: A prospective cohort of primarily ( n= 200) and secondarily ( n= 75) referred patients with moderate or severe traumatic brain injury. Measurements and results: Predictive characteristics for the risk of surgically removable lesions and the risk of raised ICP ( repeatedly >= 20 mmHg) were identified and included in prognostic models. These models were validated internally with bootstrapping techniques and externally on a historic sample ( n= 205) regarding discriminative ability (AUC). Among the cohort patients, 67% had raised ICP and 54% had surgically removable lesions. Both outcomes occurred more frequently in patients secondarily referred, but the incidence in patients primarily referred was also high (62% and 33% respectively). No strong predictors of raised ICP were identified. Age and pupillary reactivity were significant predictors of surgically removable lesions. The models discriminated reasonably for surgically removable lesions ( AUC = 0.78 at development and AUC= 0.67 at external validation) but not for raised ICP ( AUC= 0.59 at development and AUC= 0.50 at external validation). Conclusions: It is difficult accurately to identify patients in need of specialized intensive care using baseline characteristics. The high incidence of both outcomes in patients primarily referred support direct admission of more and particularly older patients with severe or moderate brain trauma to level I trauma centers.	Erasmus MC, Dept Neurol Surg, NL-3000 CA Rotterdam, Netherlands; Erasmus MC, Dept Intens Care Med, NL-3000 CA Rotterdam, Netherlands; Erasmus MC, Dept Publ Hlth, Ctr Clin Decis Sci, Rotterdam, Netherlands		Maas, AIR (corresponding author), Erasmus MC, Dept Neurol Surg, POB 2040, NL-3000 CA Rotterdam, Netherlands.	airmaas@erasmusmc.nl	Maas, Andrew IR/C-5584-2013; Steyerberg, Ewout/C-1509-2018	Maas, Andrew IR/0000-0003-1612-1264; Steyerberg, Ewout/0000-0002-7787-0122; Hukkelhoven, Chantal/0000-0002-0015-1883			Altman DG, 2000, STAT MED, V19, P453, DOI 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.3.CO;2-X; Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; ANDREWS PJD, 1990, LANCET, V335, P327, DOI 10.1016/0140-6736(90)90614-B; Bleeker J K, 1993, Ned Tijdschr Geneeskd, V137, P1091; BRAAKMAN R, 1980, NEUROSURGERY, V6, P362, DOI 10.1227/00006123-198004000-00002; Bullock RM, 2000, J NEUROTRAUM, V17, P449; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; CHOI SC, 1991, J NEUROSURG, V75, P251, DOI 10.3171/jns.1991.75.2.0251; Combes P, 1996, INTENS CARE MED, V22, P1391, DOI 10.1007/BF01709556; Efron B., 1993, INTRO BOOTSTRAP; GENTLEMAN D, 1992, INT SURG, V77, P297; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Harrell FE Jr, 2017, REGRESSION MODELING; HUKKELHOVEN C, IN PRESS J NEUROTRAU; Hukkelhoven CWPM, 2002, J NEUROSURG, V97, P549, DOI 10.3171/jns.2002.97.3.0549; LITTLE RJA, 1992, J AM STAT ASSOC, V87, P1227, DOI 10.2307/2290664; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; Sakellaropoulos GC, 1999, METHOD INFORM MED, V38, P37; Schaan M, 2002, J TRAUMA, V52, P667, DOI 10.1097/00005373-200204000-00009; Schreiber MA, 2002, ARCH SURG-CHICAGO, V137, P285, DOI 10.1001/archsurg.137.3.285; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; SMITH JS, 1990, J TRAUMA, V30, P1533, DOI 10.1097/00005373-199012000-00017; *SPOED HULPV, 2004, HAAST SPOED NIET OV; Steyerberg EW, 2000, STAT MED, V19, P1059, DOI 10.1002/(SICI)1097-0258(20000430)19:8<1059::AID-SIM412>3.3.CO;2-S; van Houwelingen HC, 2000, STAT MED, V19, P3401, DOI 10.1002/1097-0258(20001230)19:24<3401::AID-SIM554>3.0.CO;2-2	29	18	18	0	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	JUN	2005	31	6					799	806		10.1007/s00134-005-2628-y			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	932UC	WOS:000229578000008	15834705				2022-02-06	
J	Morris, PG; Wilson, JTL; Dunn, LT; Teasdale, GM				Morris, PG; Wilson, JTL; Dunn, LT; Teasdale, GM			Premorbid intelligence and brain injury	BRITISH JOURNAL OF CLINICAL PSYCHOLOGY			English	Article							CONTEXTUAL-READING-TEST; HEAD-INJURY; DEMOGRAPHIC-VARIABLES; ALZHEIMERS-DISEASE; OLDER PERSONS; ABILITY; DEMENTIA; EQUATION; IQ	Objectives. To determine whether NART scores are associated with severity of brain injury and therefore presumably affected by brain injury. In addition, to compare the Cambridge Contextual Reading Test (CCRT) with injury severity in head-injured individuals. Design and methods. Participants were 55 survivors of traumatic head injury, who completed the NART and the CCRT. The scores on these premorbid measures were then compared with indices of injury severity from their initial neurosurgical admission. Results. The NART was significantly correlated with Glasgow coma scale, with greater severity of injury associated with poorer performance. Poorer NART performance was also significantly more likely amongst those whose injury resulted in coma. The CCRT was preferred by patients, though it was also significantly associated with Glasgow coma scale and presence of coma. Conclusions. The data suggest that performance on both the NART and the CCRT are affected by brain injury severity and thus may underestimate true premorbid ability in these individuals. Similar findings would be likely with the conceptually identical WTAR measure. These measures should be used with appropriate caution and may be usefully supplemented by predictions based on demographic information.	Royal Edinburgh & Associated Hosp, Sect Clin & Hlth Psychol, Edinburgh EH10 5HF, Midlothian, Scotland; Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland; Univ Glasgow, Dept Neurosurg, Glasgow G12 8QQ, Lanark, Scotland		Morris, PG (corresponding author), Royal Edinburgh & Associated Hosp, Sect Clin & Hlth Psychol, Kennedy Tower, Edinburgh EH10 5HF, Midlothian, Scotland.	p.g.morris@ed.ac.uk	Wilson, Lindsay/A-3659-2009; Wilson, Lindsay/O-8883-2019	Wilson, Lindsay/0000-0003-4113-2328; Wilson, Lindsay/0000-0003-4113-2328; Morris, Paul/0000-0001-8467-1669; Dunn, Laurence/0000-0002-8990-4334			Beardsall L, 1998, BRIT J CLIN PSYCHOL, V37, P229, DOI 10.1111/j.2044-8260.1998.tb01297.x; BEARDSALL L, 1994, J CLIN EXP NEUROPSYC, V16, P232, DOI 10.1080/01688639408402634; Conway SC, 1997, BRIT J CLIN PSYCHOL, V36, P623, DOI 10.1111/j.2044-8260.1997.tb01267.x; Crawford JR, 1997, CLIN NEUROPSYCHOL, V11, P192, DOI 10.1080/13854049708407050; CRAWFORD JR, 1988, BRIT J PSYCHIAT, V153, P178, DOI 10.1192/bjp.153.2.178; Crawford JR, 2001, BRIT J CLIN PSYCHOL, V40, P97, DOI 10.1348/014466501163517; CRAWFORD JR, 1990, BRIT J CLIN PSYCHOL, V29, P435, DOI 10.1111/j.2044-8260.1990.tb00908.x; Freeman J, 2001, BRIT J CLIN PSYCHOL, V40, P221, DOI 10.1348/014466501163562; MOSS AR, 1991, BRIT J CLIN PSYCHOL, V30, P179, DOI 10.1111/j.2044-8260.1991.tb00934.x; NEBES RD, 1994, J CLIN EXP NEUROPSYC, V16, P489, DOI 10.1080/01688639408402660; Nebes RD, 1996, BRAIN LANG, V54, P233, DOI 10.1006/brln.1996.0073; NELSON HE, 1975, BRIT J SOC CLIN PSYC, V14, P259, DOI 10.1111/j.2044-8260.1975.tb00178.x; Nelson HE, 1991, REVISED NATL ADULT R; OCarroll R, 1995, NEUROCASE, V1, P83, DOI 10.1080/13554799508402350; Patterson K., 1994, NEUROPSYCHOLOGY, V8, P395, DOI DOI 10.1037/0894-4105.8.3.395; TEASDALE G, 1985, HDB CLIN NEUROLOGY C, P185; TEASDALE GM, 1995, J NEUROL NEUROSUR PS, V58, P526, DOI 10.1136/jnnp.58.5.526; Watt KJ, 1999, J NEUROL NEUROSUR PS, V66, P474, DOI 10.1136/jnnp.66.4.474	18	18	19	0	6	BRITISH PSYCHOLOGICAL SOC	LEICESTER	ST ANDREWS HOUSE, 48 PRINCESS RD EAST, LEICESTER LE1 7DR, LEICS, ENGLAND	0144-6657			BRIT J CLIN PSYCHOL	Br. J. Clin. Psychol.	JUN	2005	44		2				209	214		10.1348/014466505X34174			6	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	937FO	WOS:000229910200005	16004655	Green Submitted			2022-02-06	
J	Sample, PL; Langlois, JA				Sample, PL; Langlois, JA			Linking people with traumatic brain injury to services - Successes and challenges in Colorado	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; craniocerebral trauma; services	SILENT EPIDEMIC; NEEDS; PERCEPTIONS; TBI	People with traumatic brain injury (TBI)-related disability often need services and other types of support to return to productive lives; thus, improving access to available TBI services is a priority for a variety of states' agencies, such as Human Services and Public Health. Although infrastructure and resources vary from state to state, each can benefit by learning about how other states link people with TBI to services. In this report, we summarize Colorado's experience in exploring and developing better ways to link state residents with TBI to services. Recommendations for improving the system of linking people to services in Colorado included the following: (1) expanding the population targeted for linkage to services beyond those who are hospitalized; (2) improving access to information about available services; and (3) increasing the availability of services.	Colorado State Univ, Dept Occupat Therapy, Ft Collins, CO 80523 USA; Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA USA		Sample, PL (corresponding author), Colorado State Univ, Dept Occupat Therapy, 211 Occupat Therapy Bldg, Ft Collins, CO 80523 USA.	psample@cabs.colostate.edu					Brooks CA, 1997, ARCH PHYS MED REHAB, V78, pS26, DOI 10.1016/S0003-9993(97)90152-0; *CDCP, 2003, HEADS BRAIN INJ YOUR; CONNORS S, 2003, GUIDE STATE GOVT BRA; Connors SH, 2001, RESOURCE FACILITATIO; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P1, DOI 10.1097/00001199-200102000-00004; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; Darragh AR, 2001, AM J OCCUP THER, V55, P191, DOI 10.5014/ajot.55.2.191; *GEN ACC OFF, 1998, PUBL GAO HEHS; Heinemann AW, 2002, ARCH PHYS MED REHAB, V83, P1052, DOI 10.1053/apmr.2002.34283; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P196, DOI 10.1097/00001199-200505000-00003; RICH CJ, 1998, THESIS COLORADO STAT; Sample P L, 1995, Occup Ther Health Care, V9, P45, DOI 10.1080/J003v09n01_05; Sample PL, 1998, BRAIN INJURY, V12, P855, DOI 10.1080/026990598122089; Sample PL, 2004, BRAIN INJURY, V18, P1177, DOI 10.1080/02699050410001719925; SAMPLE PL, IN PRESS SUBST USE M; Stuart M, 2004, J HEAD TRAUMA REHAB, V19, P329, DOI 10.1097/00001199-200407000-00007; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; TOMTER H, 2001, THESIS COLORADO STAT; WETHERELL W, 2001, THESIS COLORADO STAT; Whiteneck G, 2001, COLORADO TRAUMATIC B; Zimmerman DE, 2003, J HEALTH PSYCHOL, V8, P119, DOI 10.1177/1359105303008001448	21	18	18	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2005	20	3					270	278		10.1097/00001199-200505000-00009			9	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	926ZZ	WOS:000229163500009	15908826				2022-02-06	
J	Baker, KA; Hagg, T				Baker, KA; Hagg, T			An adult rat spinal cord contusion model of sensory axon degeneration: The estrus cycle or a preconditioning lesion do not affect outcome	JOURNAL OF NEUROTRAUMA			English	Article						anterograde tracing; axonal protection; gracile nucleus; sex hormones; spinal cord injury	DORSAL-ROOT GANGLION; GLOBAL CEREBRAL-ISCHEMIA; ESTROGEN-RECEPTOR-ALPHA; PRIMARY AFFERENT-FIBERS; TRAUMATIC BRAIN-INJURY; TOXIN B-SUBUNIT; NEUROTROPHIC FACTOR; FUNCTIONAL RECOVERY; CHOLERA-TOXIN; WHITE-MATTER	A therapeutic strategy for acute spinal cord injury would be to reduce the progressive degeneration and disconnection of axons from their targets. Here, we describe a model to evaluate degeneration of the ascending sensory projections to the nuclei in the medulla following graded spinal cord contusions in adult female Sprague-Dawley rats. Cholera toxin B (CTB) labeling from the sciatic nerve of naive rats revealed effective labeling of the terminal fibers in the gracile nucleus at 3 days post-injection and a subpopulation of rapidly transporting fibers after 1 day. Seven days after contusions using the Infinite Horizon impactor the area of CTB-labeled terminal fibers had a negative correlation with increasing impact force. Moderate spinal contusions of around 150 kilodyne (kdyn or 0.15 x 10(-3) newton) caused a reduction to 40% in the fiber area which will enable the identification of protective as well as detrimental drugs and post-injury mechanisms. A preconditioning injury of the sciatic nerve reportedly can enhance growth of sensory axons but did not affect the terminal fiber area in the gracile nucleus. Estrogen and progesterone are protective in various systems and could therefore influence experimental outcomes when using females. However, the phase of the estrus cycle at the time of contusion or during the post-injury time did not affect the outcome of the contusion, indicating that female rats may be used without consideration of the estrus cycle. This model can readily be used to evaluate pharmacological agents for protection of sensory axons and pathophysiological mechanisms of their degeneration.	Univ Louisville, Kentucky Spinal Cord Injury Res Ctr, Dept Neurol Surg, Louisville, KY 40292 USA; Univ Louisville, Kentucky Spinal Cord Injury Res Ctr, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA; Univ Louisville, Kentucky Spinal Cord Injury Res Ctr, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA		Hagg, T (corresponding author), Univ Louisville, Kentucky Spinal Cord Injury Res Ctr, Dept Neurol Surg, MDR Bldg 616,511 S Floyd St, Louisville, KY 40292 USA.	theo.hagg@louisville.edu					Agrawal SK, 1997, J NEUROSCI, V17, P1055; BASKIN DS, 1987, NEUROSURGERY, V20, P871, DOI 10.1227/00006123-198706000-00009; Bouyer LJG, 2003, J NEUROPHYSIOL, V90, P3640, DOI 10.1152/jn.00497.2003; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Cafferty WBJ, 2004, J NEUROSCI, V24, P4432, DOI 10.1523/JNEUROSCI.2245-02.2004; Cao QL, 2005, EXP NEUROL, V191, pS3, DOI 10.1016/j.expneurol.2004.08.026; Cervantes M, 2002, ARCH MED RES, V33, P6, DOI 10.1016/S0188-4409(01)00347-2; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Freeman Marc E., 1994, P613; GEORGE EB, 1995, J NEUROSCI, V15, P6445; GIUFFRIDA R, 1992, J COMP NEUROL, V316, P206, DOI 10.1002/cne.903160206; Gonzalez SL, 2004, NEUROSCIENCE, V125, P605, DOI 10.1016/j.neuroscience.2004.02.024; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Hall E D, 1987, Cent Nerv Syst Trauma, V4, P15; HARRY GJ, 1987, J NEUROCHEM, V48, P1529, DOI 10.1111/j.1471-4159.1987.tb05696.x; He Z, 2002, J NEUROL SCI, V193, P79, DOI 10.1016/S0022-510X(01)00648-7; Horsburgh K, 2002, J CEREBR BLOOD F MET, V22, P1189, DOI 10.1097/01.wcb.0000037991.07114.4e; Iannotti C, 2004, EXP NEUROL, V189, P317, DOI 10.1016/j.expneurol.2004.05.033; Inserte J, 2004, CARDIOVASC RES, V64, P105, DOI 10.1016/j.cardiores.2004.06.001; Jones LL, 2003, J NEUROSCI, V23, P9276; Jover T, 2002, J NEUROSCI, V22, P2115, DOI 10.1523/JNEUROSCI.22-06-02115.2002; Kupina NC, 2003, EXP NEUROL, V180, P55, DOI 10.1016/S0014-4886(02)00048-1; Li SX, 2000, J NEUROPHYSIOL, V84, P1116; Li SX, 2000, J NEUROSCI, V20, P1190, DOI 10.1523/JNEUROSCI.20-03-01190.2000; Li WP, 1999, NEUROSCI LETT, V260, P49, DOI 10.1016/S0304-3940(98)00958-6; LITERSKY JM, 1995, J NEUROCHEM, V65, P903; Lu P, 2004, J NEUROSCI, V24, P6402, DOI 10.1523/JNEUROSCI.1492-04.2004; MASLANY S, 1991, BRAIN RES, V564, P56, DOI 10.1016/0006-8993(91)91351-Z; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; MUIR GD, 1995, J NEUROPHYSIOL, V74, P358, DOI 10.1152/jn.1995.74.1.358; MURPHY PG, 1995, J NEUROSCI, V15, P5130; Murphy PG, 2000, EUR J NEUROSCI, V12, P1891, DOI 10.1046/j.1460-9568.2000.00074.x; Murphy SJ, 2002, J CEREBR BLOOD F MET, V22, P1181, DOI 10.1097/01.WCB.0000037990.07114.07; Nashmi R, 1997, J NEUROTRAUM, V14, P151, DOI 10.1089/neu.1997.14.151; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; Nikulina E, 2004, P NATL ACAD SCI USA, V101, P8786, DOI 10.1073/pnas.0402595101; Nilsen J, 2003, P NATL ACAD SCI USA, V100, P2842, DOI 10.1073/pnas.0438041100; Oudega M, 2000, NEUROSCIENCE, V100, P873, DOI 10.1016/S0306-4522(00)00350-X; Oudega M, 1999, BRAIN RES, V818, P431, DOI 10.1016/S0006-8993(98)01314-6; OUDEGA M, 1994, EXP NEUROL, V129, P194, DOI 10.1006/exnr.1994.1161; Oudega M, 1996, EXP NEUROL, V140, P218, DOI 10.1006/exnr.1996.0131; Papka RE, 2002, NEUROSCI LETT, V319, P71, DOI 10.1016/S0304-3940(01)02562-9; Patrone C, 1999, P NATL ACAD SCI USA, V96, P10905, DOI 10.1073/pnas.96.19.10905; PATTERSON JT, 1992, PAIN, V49, P117, DOI 10.1016/0304-3959(92)90197-J; PATTERSON JT, 1989, J COMP NEUROL, V290, P384, DOI 10.1002/cne.902900307; Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; Rau SW, 2003, J NEUROSCI, V23, P11420; RICHARDSON PM, 1987, BRAIN RES, V411, P406, DOI 10.1016/0006-8993(87)91096-1; RICHARDSON PM, 1984, NATURE, V309, P791, DOI 10.1038/309791a0; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Rosen CJ, 1999, J CLIN DENSITOM, V2, P3, DOI 10.1385/JCD:2:1:3; Rosenberg LJ, 1999, J NEUROSCI, V19, P6122, DOI 10.1523/JNEUROSCI.19-14-06122.1999; Sayer FT, 2002, EXP NEUROL, V175, P282, DOI 10.1006/exnr.2002.7901; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Schumacher PA, 2000, J NEUROCHEM, V74, P1646, DOI 10.1046/j.1471-4159.2000.0741646.x; Schwartz G, 2001, J NEUROSURG, V94, P245, DOI 10.3171/spi.2001.94.2.0245; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Shehab SAS, 2003, BRAIN RES, V964, P218, DOI 10.1016/S0006-8993(02)04001-5; Shiraha H, 2002, MOL CELL BIOL, V22, P2716, DOI 10.1128/MCB.22.8.2716-2727.2002; Shughrue PJ, 2003, NEUROSCIENCE, V116, P851, DOI 10.1016/S0306-4522(02)00790-X; Shuman SL, 1997, J NEUROSCI RES, V50, P798, DOI 10.1002/(SICI)1097-4547(19971201)50:5<798::AID-JNR16>3.0.CO;2-Y; Stutzmann JM, 1996, NEUROREPORT, V7, P387, DOI 10.1097/00001756-199601310-00003; Suzer T, 1999, SPINAL CORD, V37, P480, DOI 10.1038/sj.sc.3100874; Suzuki T, 2004, J NEUROTRAUM, V21, P842, DOI 10.1089/0897715041526186; SWETT JE, 1985, J COMP NEUROL, V231, P66, DOI 10.1002/cne.902310106; Taleghany N, 1999, J NEUROSCI RES, V57, P603, DOI 10.1002/(SICI)1097-4547(19990901)57:5<603::AID-JNR3>3.0.CO;2-R; Teng YD, 1997, J NEUROSCI, V17, P4359; Thomas AJ, 1999, SPINE, V24, P2134, DOI 10.1097/00007632-199910150-00013; Tong YG, 1999, J COMP NEUROL, V404, P143; van der Want JJL, 1997, BRAIN RES PROTOC, V1, P269, DOI 10.1016/S1385-299X(96)00042-6; VANHEYNI.WE, 1974, NATURE, V249, P415, DOI 10.1038/249415a0; VANHEYNINGEN S, 1974, SCIENCE, V183, P656, DOI 10.1126/science.183.4125.656; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; YOUNG WF, 1994, J NEUROSURG ANESTH, V6, P122; Yune TY, 2004, J NEUROTRAUM, V21, P293, DOI 10.1089/089771504322972086; Zhou XF, 1999, NEUROSCIENCE, V92, P841, DOI 10.1016/S0306-4522(99)00027-5	79	18	18	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2005	22	4					415	428		10.1089/neu.2005.22.415			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	920YM	WOS:000228731400001	15853460				2022-02-06	
J	Barth, A; Nguyen, LB; Barth, L; Newell, DW				Barth, A; Nguyen, LB; Barth, L; Newell, DW			Glycine-induced neurotoxicity in organotypic hippocampal slice cultures	EXPERIMENTAL BRAIN RESEARCH			English	Article						glycine; NMDA receptor; excitatory amino acid; excitotoxicity; organotypic hippocampal culture	NMDA RECEPTOR CHANNEL; TRANSIENT GLOBAL-ISCHEMIA; EXCITATORY AMINO-ACIDS; TRAUMATIC BRAIN INJURY; GLUTAMATE NEUROTOXICITY; CEREBRAL-ISCHEMIA; RECOGNITION SITE; ASPARTATE; RAT; STROKE	The role of the neutral amino acid glycine in excitotoxic neuronal injury is unclear. Glycine coactivates glutamate N-methyl-D-aspartate (NMDA) receptors by binding to a distinct recognition site on the NR1 subunit. Purely excitatory glycine receptors composed of NR1 and NR3/NR4 NMDA receptor subunits have recently been described, raising the possibility of excitotoxic effects mediated by glycine alone. We have previously shown that exposure to high concentrations of glycine causes extensive neurotoxicity in organotypic hippocampal slice cultures by activation of NMDA receptors. In the present study, we investigated further properties of in vitro glycine-mediated toxicity. Agonists of the glycine recognition site of NMDA receptors (D-serine and D-alanine) did not have any toxic effect in hippocampal cultures, whereas competitive blockade of the glycine site by 7-chlorokynurenic acid was neuroprotective. Stimulation (taurine, beta-alanine) or inhibition (strychnine) of the inhibitory strychnine-sensitive glycine receptors did not produce any neurotoxicity. The toxic effects of high-dose glycine were comparable in extent to those produced by the excitatory amino acid glutamate in our model. When combined with sublethal hypoxia/hypoglycemia, the threshold of glycine toxicity was decreased to less than 1 mM, which corresponds to the range of concentrations of excitatory amino acids measured during in vivo cerebral ischemia. Taken together, these results further support the assumption of an active role of glycine in excitotoxic neuronal injury.	Univ Washington, Sch Med, Dept Neurol Surg, Seattle, WA 98195 USA; Univ Bern, Inselspital, Dept Neurosurg, CH-3010 Bern, Switzerland		Barth, A (corresponding author), Univ Washington, Sch Med, Dept Neurol Surg, Seattle, WA 98195 USA.	alain.barth@insel.ch	mo, qin/O-7877-2014				Albers GW, 1999, STROKE, V30, P508, DOI 10.1161/01.STR.30.3.508; BAKER AJ, 1991, J NEUROCHEM, V57, P1370, DOI 10.1111/j.1471-4159.1991.tb08303.x; Castillo J, 1997, LANCET, V349, P79, DOI 10.1016/S0140-6736(96)04453-4; Castillo J, 1996, STROKE, V27, P1060, DOI 10.1161/01.STR.27.6.1060; Chatterton JE, 2002, NATURE, V415, P793, DOI 10.1038/nature715; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.neuro.13.1.171; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Dingledine R, 1999, PHARMACOL REV, V51, P7; FADDA E, 1988, NEUROPHARMACOLOGY, V27, P1183, DOI 10.1016/0028-3908(88)90015-9; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Foucaud B, 2003, J BIOL CHEM, V278, P24011, DOI 10.1074/jbc.M300219200; GLOBUS MYT, 1991, J NEUROCHEM, V57, P470, DOI 10.1111/j.1471-4159.1991.tb03775.x; GLOBUS MYT, 1991, NEUROSCI LETT, V127, P39, DOI 10.1016/0304-3940(91)90889-2; GRAHAM SH, 1990, NEUROSCI LETT, V110, P124, DOI 10.1016/0304-3940(90)90799-F; Hirai H, 1996, P NATL ACAD SCI USA, V93, P6031, DOI 10.1073/pnas.93.12.6031; HOOD WF, 1990, J NEUROCHEM, V54, P1040, DOI 10.1111/j.1471-4159.1990.tb02355.x; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; KAPLITA PV, 1990, EUR J PHARM-MOLEC PH, V188, P175, DOI 10.1016/0922-4106(90)90053-Z; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; LARSON AA, 1988, J NEUROSCI, V8, P3822; Lees KR, 2000, LANCET, V355, P1949, DOI 10.1016/S0140-6736(00)02326-6; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; MADDEN K, 2002, CURR MED RES OPIN S2, V18, P27; MATSUMOTO K, 1993, J CEREBR BLOOD F MET, V13, P586, DOI 10.1038/jcbfm.1993.76; MCBAIN CJ, 1994, PHYSIOL REV, V74, P723, DOI 10.1152/physrev.1994.74.3.723; MCNAMARA D, 1990, J NEUROSCI, V10, P3970, DOI 10.1523/JNEUROSCI.10-12-03970.1990; MEGURO H, 1992, NATURE, V357, P70, DOI 10.1038/357070a0; MONAHAN JB, 1990, MOL PHARMACOL, V37, P780; Newell DW, 1997, EXP NEUROL, V145, P235, DOI 10.1006/exnr.1997.6463; NEWELL DW, 1995, J NEUROSCI, V15, P7702; NEWELL DW, 1995, BRAIN RES, V675, P38, DOI 10.1016/0006-8993(95)00039-S; Obrenovitch TP, 1997, BRAIN RES, V746, P190, DOI 10.1016/S0006-8993(96)01197-3; OBRENOVITCH TP, 1995, CEREBROVAS BRAIN MET, V7, P1; PACE JR, 1992, NEUROSCI LETT, V141, P97, DOI 10.1016/0304-3940(92)90343-6; PATEL J, 1990, J NEUROCHEM, V54, P849, DOI 10.1111/j.1471-4159.1990.tb02329.x; PERRY TL, 1981, NEUROLOGY, V31, P872, DOI 10.1212/WNL.31.7.872; SANDBERG M, 1986, J NEUROCHEM, V47, P178; Saransaari P, 2001, NEUROCHEM RES, V26, P845, DOI 10.1023/A:1011624421505; SHALABY I, 1989, EUR J PHARMACOL, V160, P309, DOI 10.1016/0014-2999(89)90506-2; Shoham S, 2001, BIOL PSYCHIAT, V49, P876, DOI 10.1016/S0006-3223(00)01046-5; Sierra-Paredes G, 2001, BRAIN RES, V888, P19, DOI 10.1016/S0006-8993(00)02974-7; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Sucher NJ, 1996, TRENDS PHARMACOL SCI, V17, P348, DOI 10.1016/S0165-6147(96)10046-8; THOMSON AM, 1990, PROG NEUROBIOL, V35, P53, DOI 10.1016/0301-0082(90)90040-N; vonEssen C, 1996, J NEUROCHEM, V67, P260; Wallis Roi Ann, 1995, Brain Research, V685, P225, DOI 10.1016/0006-8993(95)00465-3; Waziri R, 1999, SCHIZOPHR RES, V37, P205, DOI 10.1016/S0920-9964(98)00169-8	49	18	19	0	8	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0014-4819	1432-1106		EXP BRAIN RES	Exp. Brain Res.	MAR	2005	161	3					351	357		10.1007/s00221-004-2079-7			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	900TJ	WOS:000227236900011	15490133	Green Published, Green Submitted			2022-02-06	
J	Dharap, SB; Khandkar, AA; Pandey, A; Sharma, AK				Dharap, SB; Khandkar, AA; Pandey, A; Sharma, AK			Repeat CT scan in closed head injury	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						CT scan; serial CT scan; repeat CT scan; head injury; economics	SERIAL COMPUTED-TOMOGRAPHY; EPIDURAL HEMATOMA; MANAGEMENT; UTILITY; TRAUMA	Background: Cranial CT scans are often repeated to observe the progress of an intracranial injury. This prospective observational study analyses the effect of repeat CT scans with the aim of formulating a guideline for their use. Methods: One hundred and seventy-five patients with blunt head injury presenting to the trauma unit and undergoing CT scan were included. Unstable patients with polytrauma were excluded. There was no standard protocol for ordering the repeat cranial. CT scans. This decision was purely based on the discretion of neurosurgeons. Results: CT scan was repeated in 53 (30%) patients. The clinical indications for the repeat CT scan could be grouped into three: (i) clinical deterioration, (ii) failure of improvement, and (iii) as a follow-up scan. Nine underwent surgical intervention based on the repeat CT scan findings. They were associated with clinical deterioration and had a better survival after surgery. In others the repeat CT scan findings did not alter the management. Conclusion: When a head injured patient shows clinical deterioration, it is necessary to repeat the CT scan to pick up a surgically treatable lesion; which is likely in a significant number of patients. Repeat CT scan as a matter of "routine" follow-up when the patient is clinically status-quo or improving, is unlikely to yield any further information necessitating change in treatment. This guideline may be useful in settings where CT scan facility is not easily available or expenditure is an issue. (c) 2004 Elsevier Ltd. All rights reserved.	LTM Med Coll, Dept Surg, Bombay 400022, Maharashtra, India; LTM Med Coll, Dept Neurosurg, Bombay 400022, Maharashtra, India		Dharap, SB (corresponding author), 905 Hrishikesh Apartments,Veer Savarkar Marg, Bombay 400028, Maharashtra, India.	drdharap@hotmail.com	Dharap, Satish/AAE-8565-2020	Dharap, Satish/0000-0002-9304-9617			ASHKENAZI E, 1990, J TRAUMA, V30, P613, DOI 10.1097/00005373-199005000-00015; Chao A, 2001, J TRAUMA, V51, P870, DOI 10.1097/00005373-200111000-00008; COOPER PR, 1979, NEUROSURGERY, V5, P566, DOI 10.1227/00006123-197911000-00004; COPE DN, 1988, ARCH PHYS MED REHAB, V69, P483; Figg RE, 2003, J TRAUMA, V55, P1061, DOI 10.1097/01.TA.0000096712.90133.5C; Gentleman D, 1989, Br J Neurosurg, V3, P367, DOI 10.3109/02688698909002817; KOBAYASHI S, 1983, SURG NEUROL, V20, P25, DOI 10.1016/0090-3019(83)90101-5; MACPHERSON P, 1990, CLIN RADIOL, V42, P85, DOI 10.1016/S0009-9260(05)82072-0; Mandavia DP, 2001, PEDIATR EMERG CARE, V17, P193, DOI 10.1097/00006565-200106000-00011; Muszynski CA, 1999, NEURORADIOLOGY, V41, P875, DOI 10.1007/s002340050859; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; POON WS, 1992, NEUROSURGERY, V30, P681; ROBERSON FC, 1979, SURG NEUROL, V12, P161; Sinson G, 2001, J TRAUMA, V51, P875; SMITH HK, 1991, NEUROSURGERY, V29, P258, DOI 10.1227/00006123-199108000-00016; Sullivan TP, 1999, AM J NEURORADIOL, V20, P107; Tabori U, 2000, CRIT CARE MED, V28, P840, DOI 10.1097/00003246-200003000-00038; YAMAKI T, 1990, ACTA NEUROCHIR, V103, P112, DOI 10.1007/BF01407516	18	18	18	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383			INJURY	Injury-Int. J. Care Inj.	MAR	2005	36	3					412	416		10.1016/j.injury.2004.06.020			5	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	905XP	WOS:000227605000010	15710159				2022-02-06	
J	Narozny, W; Sicko, Z; Kot, J; Stankiewicz, C; Przewozny, T; Kuczkowski, J				Narozny, W; Sicko, Z; Kot, J; Stankiewicz, C; Przewozny, T; Kuczkowski, J			Hyperbaric oxygen therapy in the treatment of complications of irradiation in head and neck area	UNDERSEA AND HYPERBARIC MEDICINE			English	Article							RADIATION; OSTEORADIONECROSIS; RADIONECROSIS; NECROSIS	Background and purpose: We have investigated the treatment results of hyperbaric oxygen (HBO2) to patients with radiation-induced tissue complications. Material and methods: Eight patients (1.4%) from 548 with head and neck cancers treated surgically with post- or preoperative radiotherapy or radiotherapy alone in standard doses who developed postradiation complications (6 patients with laryngeal chondroradionecrosis, 1 patient with osteoradionecrosis of the temporal bone, and 1 patient with soft tissue radionecrosis) are presented. To evaluate radiation reactions occuring in the head and neck region, we used the Chandler grading system for classification of postradiation larynx injuries and SOMA/LENT score for classification of postradiation injuries of mucosa of upper aerodigestive tract. Grades I and II in those grading systems are expected side effects of radiation therapy, thus our cases were all in grades III and IV The HBO2 was performed after failure of the conventional treatment (antibiotics, steroids, topical therapy). The number of HBO2 expositions was from 8 to 39 and the delay to therapy from 2 to 22 months. Results: Symptoms resolved in all treated patients. Six patients with laryngeal chondroradionecrosis had no symptoms after therapy and in three of them after partial laryngectomy the decannulation was performed. In one patient with mucosal radionecrosis after total laryngectomy, the esophageal fistula was closed and in one patient with osteoradionecrosis of the temporal bone, wound debridement followed. Conclusion: The authors' experience supports the increasing clinical evidence that HBO2 is an effective adjunct therapy for treatment of complications of irradiation in head and neck area.	Med Univ Gdansk, ENT Dept, Gdansk, Poland; Med Univ Gdansk, Inst Maritime & Trop Med Gdynia, Natl Ctr Hyperbar Med, Gdansk, Poland		Narozny, W (corresponding author), Med Univ Gdansk, ENT Dept, Gdansk, Poland.		Kot, Jacek/I-5284-2012; Sicko, Zdzislaw/C-2877-2013; Narozny, Waldemar/T-7531-2018	Kot, Jacek/0000-0001-5604-8407; Narozny, Waldemar/0000-0001-5780-1923; Przewozny, Tomasz/0000-0002-4719-9411			Barton S, 2001, CLIN EVIDENCE; CHANDLER JR, 1979, ANN OTO RHINOL LARYN, V88, P509, DOI 10.1177/000348947908800410; Cox JD, 2003, RAD ONCOLOGY RATIONA; Cummins RO, 1998, CIRCULATION, V97, P1654, DOI 10.1161/01.CIR.97.16.1654; DISCHE S, 1986, INT J RADIAT ONCOL, V12, P1335, DOI 10.1016/0360-3016(86)90166-5; Feldmeier JJ, 2002, UNDERSEA HYPERBAR M, V29, P4; FELDMEIER JJ, 1993, UNDERSEA HYPERBAR M, V20, P329; FERGUSON BJ, 1987, ANN OTO RHINOL LARYN, V96, P1; Filntisis GA, 2000, ANN OTO RHINOL LARYN, V109, P554, DOI 10.1177/000348940010900605; FITZGERALD PJ, 1979, ANN OTO RHINOL LARYN, V98, P509; GREENWOOD TW, 1973, BRIT J SURG, V60, P394, DOI 10.1002/bjs.1800600522; HAMPSON NB, 1999, HYPERBARIC OXYGEN TH; HORSMAN MR, 1997, BASIC CLIN RADIOBIOL; Hunter Shannon E, 2003, Curr Opin Otolaryngol Head Neck Surg, V11, P103, DOI 10.1097/00020840-200304000-00007; JAIN KK, 1999, TXB HYPERBARIC MED; KEENE M, 1982, LARYNGOSCOPE, V92, P173; London SD, 1998, LARYNGOSCOPE, V108, P1291, DOI 10.1097/00005537-199809000-00005; MAINOUS EG, 1975, ARCH OTOLARYNGOL, V101, P173; MARRONI A, 2001, P ESTRO ECHM CONS C, P147; MARX RE, 1983, J ORAL MAXIL SURG, V41, P283, DOI 10.1016/0278-2391(83)90294-X; MARX RE, 1987, PROBLEM WOUNDS ROLE, P65; MARX RE, 1999, HYPERBARIC MED PRACT, P665; MAUCH PM, 1994, RAD ONCOLOGY RATIONA; Michaels L., 1984, PATHOLOGY LARYNX; Narozny W, 2001, Otolaryngol Pol, V55, P57; Neovius EB, 1997, HEAD NECK-J SCI SPEC, V19, P315, DOI 10.1002/(SICI)1097-0347(199707)19:4<315::AID-HED10>3.0.CO;2-8; PARK MK, 1994, HYPERBARIC MED PRACT, P141; PASQUIER D, 2001, P ESTRO ECHM CONS C, P21; PAVY JJ, 1995, RADIOTHER ONCOL, V35, P11, DOI 10.1016/0167-8140(95)97448-M; PEREZ CA, 1993, PRINICPLES PRACTICE; ROWLEY H, 1995, J LARYNGOL OTOL, V109, P218, DOI 10.1017/S0022215100129731; Tibbles PM, 1996, NEW ENGL J MED, V334, P1642, DOI 10.1056/NEJM199606203342506; VANKMERKSTEYN JPR, 1996, HDB HYPERBARIC MED, P387	33	18	20	0	1	UNDERSEA & HYPERBARIC MEDICAL SOC INC	DURHAM	21 WEST COLONY PLACE, STE 280, DURHAM, NC 27705 USA	1066-2936			UNDERSEA HYPERBAR M	Undersea Hyperb. Med.	MAR-APR	2005	32	2					103	110					8	Marine & Freshwater Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Marine & Freshwater Biology; Research & Experimental Medicine	921KC	WOS:000228762100005	15926302				2022-02-06	
J	Bell, DA; Strong, AJ				Bell, DA; Strong, AJ			Glucose/insulin infusions in the treatment of subarachnoid haemorrhage: a feasibility study	BRITISH JOURNAL OF NEUROSURGERY			English	Article						glucose; hyperglycaemia; insulin; subarachnoid haemorrhage	INTENSIVE INSULIN THERAPY; FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; PERIINFARCT DEPOLARIZATIONS; MODERATE HYPERGLYCEMIA; SPREADING DEPRESSION; CRITICALLY-ILL; BLOOD-GLUCOSE; ACUTE STROKE; MICRODIALYSIS	Hyperglycaemia following subarachnoid haemorrhage (SAH) is well recognized and has been shown to be associated with a worse prognosis. It is currently unclear whether this is a secondary phenomenon reflecting the magnitude of the stress response or whether it contributes directly to the pathophysiological disturbances within the brain. There is significant experimental work on ischaemic stroke to suggest that hyperglycaemia increases infarct volume. The authors propose that controlling blood glucose following SAH is safe and that it might improve outcome. All patients admitted with SAH were treated with insulin to control plasma glucose with a target range of 5.0 - 7.0 mmol/l. Episodes of hypoglycaemia were recorded. Outcome was assessed at 3 months using the Glasgow Outcome Scale. Fifty-five patients were recruited. 32/3389 (0.94%) of glucose readings fell below 3.5 mmol/l. All were treated with i.v. glucose without evidence of clinical deterioration. Insulin treatment for hyperglycaemia following SAH is feasible and safe. A randomised trial is required to assess any effect on outcome.	Kings Coll Hosp London, Dept Neurosurg, London SE5 9RS, England		Strong, AJ (corresponding author), Kings Coll Hosp London, Dept Neurosurg, Denmark Hill, London SE5 9RS, England.	anthony.strong@kcl.ac.uk		Strong, Anthony/0000-0003-2432-5945			Alberti O, 2000, CLIN NEUROL NEUROSUR, V102, P78, DOI 10.1016/S0303-8467(00)00067-6; Back T, 1996, J CEREBR BLOOD F MET, V16, P202, DOI 10.1097/00004647-199603000-00004; BEREK K, 1991, LANCET, V338, P964; Bernard Claude, 1858, LECONS PHYSL PATHOLO, VI; BESSEY PQ, 1984, ANN SURG, V200, P264, DOI 10.1097/00000658-198409000-00004; BUCKELL M, 1966, J NEUROL NEUROSUR PS, V4, P293; Busch E, 1996, J CEREBR BLOOD F MET, V16, P1090, DOI 10.1097/00004647-199611000-00002; CRUICKSHANK JM, 1974, BRIT HEART J, V36, P697; DECOURTENMYERS G, 1988, STROKE, V19, P623, DOI 10.1161/01.STR.19.5.623; Dreier JP, 2000, J NEUROSURG, V93, P658, DOI 10.3171/jns.2000.93.4.0658; GINSBERG MD, 1980, STROKE, V11, P347, DOI 10.1161/01.STR.11.4.347; GRAY CS, 1987, DIABETIC MED, V4, P237, DOI 10.1111/j.1464-5491.1987.tb00870.x; HAMILTON MG, 1995, J NEUROSURG, V82, P262, DOI 10.3171/jns.1995.82.2.0262; Hopwood SE, 2005, J CEREBR BLOOD F MET, V25, P391, DOI 10.1038/sj.jcbfm.9600050; LANIER WL, 1987, ANESTHESIOLOGY, V66, P39, DOI 10.1097/00000542-198701000-00008; LANZINO G, 1993, J NEUROSURG, V79, P885, DOI 10.3171/jns.1993.79.6.0885; LONGSTRETH WT, 1993, NEUROLOGY, V43, P712, DOI 10.1212/WNL.43.4.712; MALMBERG K, 1995, J AM COLL CARDIOL, V26, P57, DOI 10.1016/0735-1097(95)00126-K; MARSH WR, 1986, J NEUROSURG, V65, P693, DOI 10.3171/jns.1986.65.5.0693; MYERS GMD, 1994, J CEREB BLOOD FLOW M, V14, P227; MYERS RE, 1977, ARCH NEUROL-CHICAGO, V34, P65, DOI 10.1001/archneur.1977.00500140019003; MYERS RE, 1976, J NEUROPATH EXP NEUR, V35, P301, DOI 10.1097/00005072-197605000-00011; MYERS RE, 1976, NEUROLOGY, V26, P345; NEILDWYER G, 1974, J NEUROL SCI, V22, P375, DOI 10.1016/0022-510X(74)90008-2; OPPENHEIMER SM, 1985, BRIT MED J, V291, P1014, DOI 10.1136/bmj.291.6501.1014-a; Parkin MC, 2005, J CEREBR BLOOD F MET, V25, P402, DOI 10.1038/sj.jcbfm.9600051; PEEK KE, 1989, METAB BRAIN DIS, V4, P261, DOI 10.1007/BF00999772; PICKARD JD, 1989, BRIT MED J, V298, P636, DOI 10.1136/bmj.298.6674.636; PULSINELLI WA, 1982, NEUROLOGY, V32, P1239, DOI 10.1212/WNL.32.11.1239; Scott JF, 1999, STROKE, V30, P793, DOI 10.1161/01.STR.30.4.793; SHIMAZU T, 1966, NATURE, V210, P1178, DOI 10.1038/2101178a0; Strong AJ, 2000, STROKE, V31, P214, DOI 10.1161/01.STR.31.1.214; Takano K, 1996, ANN NEUROL, V39, P308, DOI 10.1002/ana.410390307; Van den Berghe G, 2003, CRIT CARE MED, V31, P359, DOI 10.1097/01.CCM.0000045568.12881.10; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; VOLL CL, 1989, STROKE, V20, P646, DOI 10.1161/01.STR.20.5.646; VOLL CL, 1991, J CEREBR BLOOD F MET, V11, P1006, DOI 10.1038/jcbfm.1991.168; Zygun DA, 2004, NEUROSURGERY, V55, P877, DOI 10.1227/01.NEU.0000137658.14906.E4	39	18	19	0	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0268-8697			BRIT J NEUROSURG	Br. J. Neurosurg.	FEB	2005	19	1					21	24		10.1080/02688690500089423			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	933IO	WOS:000229622300003	16147578				2022-02-06	
J	De Monte, VE; Geffen, GM; May, CR; McFarland, K; Heath, P; Neralic, M				De Monte, VE; Geffen, GM; May, CR; McFarland, K; Heath, P; Neralic, M			The acute effects of mild traumatic brain injury on finger tapping with and without word repetition	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							CLOSED-HEAD INJURY; NEUROPSYCHOLOGICAL DEFICITS; STANDARDIZED ASSESSMENT; RAPID SCREEN; SEQUELAE; TASK; TOMOGRAPHY; CONCUSSION; RECOVERY; LESIONS	This study aimed to investigate the acute effects of mild Traumatic Brain Injury (mTBI) on the performance of a finger tapping and word repetition dual task in order to determine working memory impairment in mTBI Sixty-four (50 male, 14 female) right-handed cases of mTBI and 26 (18 male and 8 female) right-handed cases of orthopaedic injuries were tested within 24 hours of injury. Patients with mTBI completed fewer correct taps in 10 seconds than patients with orthopaedic injuries, and female mTBI cases repeated fewer words. The size of the dual task decrement did not vary between groups. When added to a test battery including the Rapid Screen of Concussion (RSC; Comerford, Geffen, May, Medland & Geffen, 2002) and the Digit Symbol Substitution Test,finger tapping speed accounted for 1% of between groups variance and did not improve classification rates of male participants. While the addition of tapping rate did not improve the sensitivity and specificity of the RSC and DSST to mTBI in males, univariate analysis of motor performance in females indicated. that dual task performance might be diagnostic. An increase in female sample Size is warranted. These results confirm the view that there is a generalized slowing of processing ability following mTBI.	Univ Queensland, Sch Med, Cognit Psychophysiol Lab, Brisbane, Qld 4006, Australia; Royal Brisbane Hosp, Dept Emergency Med, Brisbane, Qld 4029, Australia; Univ Queensland, Sch Psychol, Brisbane, Qld, Australia		De Monte, VE (corresponding author), Univ Queensland, Sch Med, Cognit Psychophysiol Lab, Edith Cavell Bldg,Herston Rd, Brisbane, Qld 4006, Australia.	comerf@psy.uq.edu.au					Abdel-Dayem HM, 1998, CLIN NUCL MED, V23, P309, DOI 10.1097/00003072-199805000-00009; Abu-Judeh HH, 1999, NUCL MED COMMUN, V20, P505, DOI 10.1097/00006231-199906000-00003; ADAMS JH, 1980, NEUROPATH APPL NEURO, V6, P319, DOI 10.1111/j.1365-2990.1980.tb00217.x; Adams R. D., 1993, PRINCIPLES NEUROLOGY; ALLEN JW, 1996, MJM, V2, P40; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Arnsten AFT, 1997, J PSYCHOPHARMACOL, V11, P151, DOI 10.1177/026988119701100208; BADCOCK KA, 1988, COMMUNITY HEALTH ST, V12, P428; Baddeley A, 1996, Q J EXP PSYCHOL-A, V49, P5, DOI 10.1080/713755608; Baddeley A, 1998, J INT NEUROPSYCH SOC, V4, P523, DOI 10.1017/S135561779800513X; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Bernstein DM, 2002, J INT NEUROPSYCH SOC, V8, P673, DOI 10.1017/S1355617702801400; BERRYHILL P, 1995, NEUROSURGERY, V37, P392, DOI 10.1227/00006123-199509000-00004; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Blumbergs PC, 1997, HEAD INJURY PATHOPHY, P39; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; BRADSHAW JL, 2001, DEV DISORDERS FRONTO; Chan RCK, 2000, BRAIN INJURY, V14, P227, DOI 10.1080/026990500120709; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Comerford VE, 2002, J CLIN EXP NEUROPSYC, V24, P409, DOI 10.1076/jcen.24.4.409.1044; Cudmore LJ, 2000, BRAIN COGNITION, V44, P86; De Monte VE, 2004, J CLIN EXP NEUROPSYC, V26, P628, DOI 10.1080/13803390490504443; DEMONTE VE, 2003, UNPUB SELECTION APPR; Di Stefano G, 2000, J NEUROL NEUROSUR PS, V69, P210, DOI 10.1136/jnnp.69.2.210; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; DUCKETT S, 1993, MINOR HEAD TRAUMA, P5; Eisenberg H.M., 1989, MILD HEAD INJURY, P133; GABELLA B, 1997, MMWR            0110, P8; Geldmacher DS, 1997, BRAIN INJURY, V11, P59, DOI 10.1080/026990597123818; GENTILINI M, 1989, MILD HEAD INJURY, P163; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; HAALAND KY, 1994, J CLIN EXP NEUROPSYC, V16, P448, DOI 10.1080/01688639408402655; Hillier SL, 1997, BRAIN INJURY, V11, P649; Hills EC, 1998, BRAIN INJURY, V12, P69, DOI 10.1080/026990598122872; HintonBayre AD, 1997, J CLIN EXP NEUROPSYC, V19, P275, DOI 10.1080/01688639708403857; Hovda DA, 1999, SPORTS-RELATED CONCUSSION, P12; JENKINS A, 1986, LANCET, V2, P445; Keller M, 2000, J NEUROL NEUROSUR PS, V68, P761, DOI 10.1136/jnnp.68.6.761; KRAUS JF, 1989, MILD HEAD INJURY, P8; LANGFITT TW, 1987, NEUROBEHAVIOURAL REC, P31; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; Lewine JD, 1999, AM J NEURORADIOL, V20, P857; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Lombardi WJ, 1999, J CLIN EXP NEUROPSYC, V21, P2, DOI 10.1076/jcen.21.1.2.940; Maddocks D, 1996, BRAIN INJURY, V10, P99, DOI 10.1080/026990596124584; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; MCFARLAND K, 1982, NEUROPSYCHOLOGIA, V20, P383, DOI 10.1016/0028-3932(82)90038-0; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; MILNER B, 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI 10.1001/archneur.1963.00460070100010; MURELIUS O, 1991, ACTA NEUROL SCAND, V83, P9; Prigatano GP, 2003, J INT NEUROPSYCH SOC, V9, P128, DOI 10.1017/S1355617703000134; Ruff RM., 1995, RUFF 2 7 SELECTIVE A; SCHNIDER A, 1999, SCI PRACT NEUROPSYCH, P487; Segalowitz SJ, 2001, BRAIN COGNITION, V45, P342, DOI 10.1006/brcg.2000.1263; Stablum F, 1996, CORTEX, V32, P261, DOI 10.1016/S0010-9452(96)80050-5; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; Trenerry MR, 1989, STROOP NEUROPSYCHOLO; TRONCOSO JC, 1996, HEAD INJURY POSTCONC, P46; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; VANZOMEREN AH, 1989, MILD HEAD INJURY, P398; VENDRELL P, 1995, NEUROPSYCHOLOGIA, V33, P341, DOI 10.1016/0028-3932(94)00116-7; Wechsler, 1997, WECHSLER ADULT INTEL; Whitall J, 1996, RES Q EXERCISE SPORT, V67, P349, DOI 10.1080/02701367.1996.10607963; WHITE N, 1995, BRAIN COGNITION, V28, P59, DOI 10.1006/brcg.1995.1033; WHITMAN S, 1984, AM J EPIDEMIOL, V119, P570, DOI 10.1093/oxfordjournals.aje.a113774; Zoccolotti P, 2000, CORTEX, V36, P93, DOI 10.1016/S0010-9452(08)70839-6	72	18	18	0	4	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	FEB	2005	27	2					224	239		10.1080/13803390490515766			16	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	908NP	WOS:000227794000006	15903152				2022-02-06	
J	Fleminger, S; Leigh, E; Eames, P; Langrell, L; Nagraj, R; Logsdail, S				Fleminger, Simon; Leigh, Eleanor; Eames, Peter; Langrell, Lorna; Nagraj, Raj; Logsdail, Steven			HoNOS-ABI: a reliable outcome measure of neuropsychiatric sequelae to brain injury?	PSYCHIATRIC BULLETIN			English	Article								AIMS AND METHOD The Health of the Nation Outcome Scale for Acquired Brain Injury (HoNOS-ABI) is a relatively new outcome measure designed to assess the neuropsychiatric sequelae of brain damage. This study investigated the interrater reliability of this scale. Fifty patients with traumatic brain injury receiving rehabilitation were each rated twice on the HoNOS-ABI, by two different raters. There were 24 raters in total. RESULTS Weighted kappa values ranged from 0.43 to 0.84 and intraclass correlation coefficients from 0.58 to 0.97 for the ten items assessed. This indicated that agreement was moderate to substantial for all items. CLINICAL IMPLICATIONS The scales consistently measured the items of interest across different raters. This indicates that HoNOS-ABI is a reliable outcome measure when applied by different raters in routine clinical practice.	[Fleminger, Simon; Leigh, Eleanor] Maudsley Hosp & Inst Psychiat, Lishman Brain Injury Unit, Denmark Hill, London SE5 8AZ, England; [Eames, Peter] Grafton Manor, Towcester, Northants, England; [Langrell, Lorna] Royal Edinburgh & Associated Hosp, Robert Ferguson Unit, Psychiat, Edinburgh, Midlothian, Scotland; [Nagraj, Raj] St Andrews Hosp, Kemsley Div, Northampton, England; [Logsdail, Steven] Campbell Unit, Milton Keynes, Bucks, England		Fleminger, S (corresponding author), Maudsley Hosp & Inst Psychiat, Lishman Brain Injury Unit, Denmark Hill, London SE5 8AZ, England.	s.fleminger@lop.kcl.ac.uk		Leigh, Eleanor/0000-0003-2756-3770			Brooks R, 2000, AUST NZ J PSYCHIAT, V34, P504, DOI 10.1080/j.1440-1614.2000.00755.x; Coetzer R., 2001, PSYCHIATR BULL, V25, P421, DOI [https://doi.org/10.1192/pb.25.11.421, DOI 10.1192/PB.25.11.421]; Fleminger S, 1999, NEUROPSYCHOL REHABIL, V9, P225, DOI 10.1080/096020199389338; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Orrell M, 1999, BRIT J PSYCHIAT, V174, P409, DOI 10.1192/bjp.174.5.409; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Wing JK, 1998, BRIT J PSYCHIAT, V172, P11, DOI 10.1192/bjp.172.1.11	7	18	18	0	0	ROYAL COLL PSYCHIATRISTS	LONDON	BRITISH JOURNAL OF PSYCHIATRY 17 BELGRAVE SQUARE, LONDON SW1X 8PG, ENGLAND	2053-4868	2053-4876		PSYCHIATR BULL	Psychiatr. Bull.	FEB	2005	29	2					53	55		10.1192/pb.29.2.53			3	Psychiatry	Emerging Sources Citation Index (ESCI)	Psychiatry	V02WD	WOS:000213699000006		hybrid			2022-02-06	
J	Munoz-Sanchez, M; Murillo-Cabezas, F; Cayuela, A; Flores-Cordero, J; Rincon-Ferrari, M; Amaya-Villar, R; Fornelino, A				Munoz-Sanchez, M; Murillo-Cabezas, F; Cayuela, A; Flores-Cordero, J; Rincon-Ferrari, M; Amaya-Villar, R; Fornelino, A			The significance of skull fracture in mild head trauma differs between children and adults	CHILDS NERVOUS SYSTEM			English	Article						pediatric mild head injury; adult mild head injury; skull fracture; Glasgow Coma Scale; abbreviated injury score	COMA-SCALE SCORE; INJURY; CONSCIOUSNESS; EMERGENCY; MANAGEMENT; DIAGNOSIS; CARE	Objective: The objective was to determine whether the age of patients with mild head injury and skull fracture influences the level of risk for acute intracranial injuries. Method: A study was conducted of 156 patients with skull fracture, 60 children (aged <14 years) and 96 adults, detected among 5,097 consecutive patients with mild head injury (Glasgow Coma Scale [GCS] score of 15-14 points) arriving at the Emergency Department of a Level I University Hospital Trauma Center during 1998. Acute intracranial injuries were defined as traumatic brain injuries identified by cranial computed tomography scan, excluding pneumocephalus. Results: Compared with the children, this risk of intracranial injury was 13 times greater in the adults aged 14-54 years and 16 times greater in the over-54-year-olds. Besides age over 14 years (p<0.0001), compound skull fracture (p<0.001), and a GCS score of 14 (p<0.001) were factors significantly associated with intracranial injury in the logistic regression analysis. Conclusions: Skull fracture in mild head injury implies a greater risk of intracranial injury in adults than in children.	Hosp Univ Virgen del Rocio, Dept Crit Care & Emergency, Res Unit, Seville 41013, Spain		Munoz-Sanchez, M (corresponding author), Hosp Univ Virgen del Rocio, Dept Crit Care & Emergency, Res Unit, Avda Manuel Siurot S-N, Seville 41013, Spain.	angeles.munoz.sspa@juntadeandalucia.es	Murillo-Cabezas, Francisco/AAO-3348-2021; Cayuela, Aurelio/C-6698-2012; Cayuela, Aurelio/AAZ-1294-2020; IBIS, NEUROCRITICOS/C-1805-2016	Cayuela, Aurelio/0000-0002-4936-9402; 			*AM ASS AUT MED, 1990, ABBR INJ SCAL AIS 19; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BRUCE S, 2001, J TRAUMA, V51, P231; CULLOTA VP, 1996, NEUROSURGERY, V38, P245; DAVIS RL, 1994, ANN EMERG MED, V24, P640, DOI 10.1016/S0196-0644(94)70273-X; Gomez PA, 1996, BRIT J NEUROSURG, V10, P453, DOI 10.1080/02688699647078; Gruskin KD, 1999, ARCH PEDIAT ADOL MED, V153, P15; Hofman PAM, 2000, J NEUROL NEUROSUR PS, V68, P416, DOI 10.1136/jnnp.68.4.416; Lavelle JM, 1998, ARCH PEDIAT ADOL MED, V152, P1220; Lloyd DA, 1997, LANCET, V349, P821, DOI 10.1016/S0140-6736(96)09356-7; Mandera M, 2000, CHILD NERV SYST, V16, P156, DOI 10.1007/s003810050484; Murgio A, 1999, CHILD NERV SYST, V15, P318, DOI 10.1007/s003810050401; Murgio A, 2001, CHILD NERV SYST, V17, P257, DOI 10.1007/s003810000403; Phillips S, 1996, PEDIATR EMERG CARE, V12, P394, DOI 10.1097/00006565-199612000-00002; SERVADEI F, 1988, SURG NEUROL, V30, P364, DOI 10.1016/0090-3019(88)90199-1; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; Simon B, 2001, J TRAUMA, V51, P231, DOI 10.1097/00005373-200108000-00004; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; TEASDALE G, 1974, LANCET, V2, P81; Wang MY, 2000, NEUROSURGERY, V46, P1093, DOI 10.1097/00006123-200005000-00014	20	18	18	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	FEB	2005	21	2					128	132		10.1007/s00381-004-1036-x			5	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	894NQ	WOS:000226799000010	15338178				2022-02-06	
J	Diamond, AL; Callison, RC; Shokri, J; Cruz-Flores, S; Kinsella, LJ				Diamond, AL; Callison, RC; Shokri, J; Cruz-Flores, S; Kinsella, LJ			Paroxysmal sympathetic storm	NEUROCRITICAL CARE			English	Article						diencephalic seizures; sympathetic storm; autonomic instability; cardiac arrest; hyperthermia	DIENCEPHALIC SEIZURES; EPILEPSY	Introduction: Paroxysmal sympathetic storm (PSS) is a rare syndrome characterized by episodic hypertension, hyperhydrosis, hyperthermia, tachycardia, tachypnea, and extensor posturing. Case reports: This article describes two cases of PSS: one following traumatic brain injury and the other following cardiac arrest. Discussion: The first responded to labetalol, morphine, and codeine, whereas the second responded to labetalol. Conclusion: These observations underscore the importance of central opioid receptors and nonselective P-adrenergic antagonists in modulating catecholamine pathways.	St Louis Univ, Sch Med, Dept Neurol, St Louis, MO 63103 USA; Forest Pk Hosp, Souers Stroke Inst, St Louis, MO 63139 USA; Forest Pk Hosp, Dept Internal Med, St Louis, MO 63139 USA; Forest Pk Hosp, Dept Neurol, Inst Neurosci, St Louis, MO 63139 USA		Kinsella, LJ (corresponding author), Forest Pk Hosp, Dept Neurol, Inst Neurosci, 6125 Clayton Ave,Suite 430, St Louis, MO 63139 USA.	laurence.Kinsella@FPHSTL.com	Cruz-Flores, Salvador/AAR-1233-2020	Cruz-Flores, Salvador/0000-0003-4998-1471			BHIGJEE AI, 1985, J NEUROL SCI, V71, P77, DOI 10.1016/0022-510X(85)90038-3; Boeve BF, 1998, MAYO CLIN PROC, V73, P148; BULLARD DE, 1987, ANN NEUROL, V21, P609, DOI 10.1002/ana.410210617; CARMEL PW, 1985, ACTA NEUROCHIR, V75, P113, DOI 10.1007/BF01406331; DARNELL RB, 1993, NEUROLOGY, V43, P579, DOI 10.1212/WNL.43.3_Part_1.579; Do D, 2000, J NEUROL NEUROSUR PS, V69, P832, DOI 10.1136/jnnp.69.6.832; Graham LN, 2002, CIRCULATION, V106, P793, DOI 10.1161/01.CIR.0000025610.14665.21; Penfield W, 1929, ARCH NEURO PSYCHIATR, V22, P358, DOI 10.1001/archneurpsyc.1929.02220020174010; Penfield W, 1954, EPILEPSY FUNCTIONAL; Ryan JB, 2003, J HEART LUNG TRANSPL, V22, P922, DOI 10.1016/S1053-2498(02)00558-2; SHAPIRO WR, 1969, BRAIN, V92, P423, DOI 10.1093/brain/92.2.423; SOLOMON GE, 1973, J PEDIATR-US, V83, P277, DOI 10.1016/S0022-3476(73)80492-5	12	18	20	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care		2005	2	3					288	291		10.1385/NCC:2:3:288			4	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	955DD	WOS:000231204500008	16159077				2022-02-06	
J	Minns, RA				Minns, R. A.			Shaken baby syndrome: theoretical and evidential controversies	JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH			English	Article						Diagnosis; differential diagnosis; evidence; non accidental head injury; outcome; shaken baby syndrome		Recent controversies have focused on whether shaking can injure the infant brain and if a diagnosis of SBS can be confidently made and distinguished from accidents (short falls) and non-traumatic conditions. This article reviews documented cases, animal, biomechanical, and computer-modelling evidence to support the contention that shaking alone without additional impact results in a rotational brain injury with tearing of cortical emissary veins, parenchymal shearing, cervico-medullary, and hypoxic-ischaemic injury. While the terminology SBS is best avoided because it implies a mechanism in what is usually an unwitnessed injury, a more secure diagnosis of NAHI can be offered, with varying degrees of certainty, based on clinical, imaging, and ophthalmological findings after excluding conditions simulating these features. The type of brain injury (inertial, contact, hypoxic-ischaemic) and the context in which it is sustained, may enable an opinion about whether the mechanism is consistent with either a purely rotational or rotational impact-deceleration injury, compressive, penetrative or other combined mechanism.	[Minns, R. A.] Univ Edinburgh, Royal Hosp Sick Children, 20 Sylvan Pl, Edinburgh EH9 1UW, Midlothian, Scotland; [Minns, R. A.] Univ Edinburgh, Child Life & Hlth, Edinburgh, Midlothian, Scotland		Minns, RA (corresponding author), Univ Edinburgh, Royal Hosp Sick Children, 20 Sylvan Pl, Edinburgh EH9 1UW, Midlothian, Scotland.	Robert.Minns@ed.ac.uk					Abel JM, 1978, P 22 STAPP CAR CRASH; ALEXANDER RC, 1986, J PEDIATR-US, V109, P975, DOI 10.1016/S0022-3476(86)80279-7; Barlow KM, 1999, ACTA PAEDIATR, V88, P734; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; CAFFEY J, 1946, AM J ROENTGENOL, V56, P163; CAFFEY J, 1972, AM J DIS CHILD, V124, P161, DOI 10.1001/archpedi.1972.02110140011001; Carrigan TD, 2000, J ACCID EMERG MED, V17, P138; COHEN RA, 1986, AM J ROENTGENOL, V146, P97, DOI 10.2214/ajr.146.1.97; de San Lazaro C, 2003, ARCH DIS CHILD, V88, P632, DOI 10.1136/adc.88.7.632; Donohoe M, 2003, AM J FOREN MED PATH, V24, P239, DOI 10.1097/01.paf.0000083635.85457.97; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; GOLDSTEIN B, 1993, CRIT CARE MED, V21, P1328, DOI 10.1097/00003246-199309000-00016; GUTHKELCH AN, 1971, BMJ-BRIT MED J, V2, P430, DOI 10.1136/bmj.2.5759.430; Hodgson DC, 2001, ARCH DIS CHILD, V84, P187; Holbourn AHS, 1943, LANCET, V2, P438; JASPAN T, 1992, PEDIATR RADIOL, V22, P237, DOI 10.1007/BF02019848; Jones PA, 2003, BRIT J NEUROSURG, V17, P29, DOI 10.1080/0268869031000093708; King WJ, 2003, CAN MED ASSOC J, V168, P155; Lantz PE, 2004, BRIT MED J, V328, P754, DOI 10.1136/bmj.328.7442.754; Lazoritz S, 1997, CHILD ABUSE NEGLECT, V21, P1009, DOI 10.1016/S0145-2134(97)00061-6; LINDLEY DV, 1953, J R STAT SOC B, V15, P30; Lo T Y M, 2003, Pediatr Rehabil, V6, P47, DOI 10.1080/1363849031000109516; MACKEITH R, 1974, DEV MED CHILD NEUROL, V16, P216; MAY PRA, 1979, ARCH NEUROL-CHICAGO, V36, P370, DOI 10.1001/archneur.1979.00500420080011; Minns RA, 2004, BRIT MED J, V328, P766, DOI 10.1136/bmj.328.7442.766; Minns RA, 2004, SHAKEN BABY SYNDROME; Minns RA, BIOMECHANICAL STUDIE; Morison CN, 2002, THESIS; OMMAYA AK, 1968, J AMER MED ASSOC, V204, P285, DOI 10.1001/jama.204.4.285; OMMAYA AK, 1969, LANCET, V2, P237; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Ommaya AK, 1993, BIOMECHANICS IMPACT, P265; Plunkett J, 2001, AM J FOREN MED PATH, V22, P1, DOI 10.1097/00000433-200103000-00001; Pounder DJ, 1997, AM J FOREN MED PATH, V18, P321, DOI 10.1097/00000433-199712000-00001; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Raghupathi R, 2002, J NEUROTRAUM, V19, P843, DOI 10.1089/08977150260190438; REECE RM, 2003, INFLICTED CHILDHOOD; SATO Y, 1989, RADIOLOGY, V173, P653, DOI 10.1148/radiology.173.3.2813768; Shaver EG, 1996, PEDIATR NEUROSURG, V25, P123, DOI 10.1159/000121109; Thibault KL, 1998, J BIOMECH, V31, P1119, DOI 10.1016/S0021-9290(98)00122-5; Zhou C, 1996, INT IRCOBI C BIOM IM; ZIMMERMAN RA, 1978, RADIOLOGY, V127, P393, DOI 10.1148/127.2.393	44	18	19	0	0	ROYAL COLL PHYSICIANS EDINBURGH	EDINBURGH	9 QUEEN ST, EDINBURGH, EH2 1JQ, ENGLAND	1478-2715	2042-8189		J ROY COLL PHYS EDIN	J. Roy. Coll. Phys. Edinb.		2005	35	1					5	15					11	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	VF5GR	WOS:000443057800002					2022-02-06	
J	Montour-Proulx, I; Braun, CMJ; Daigneault, S; Rouleau, I; Kuehn, S; Begin, J				Montour-Proulx, I; Braun, CMJ; Daigneault, S; Rouleau, I; Kuehn, S; Begin, J			Predictors of intellectual function after a unilateral cortical lesion: Study of 635 patients from infancy to adulthood	JOURNAL OF CHILD NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; PATHOLOGICAL LEFT-HANDEDNESS; FRONTAL-LOBE LESIONS; SEX-DIFFERENCES; HEMIPLEGIC CHILDREN; CEREBRAL ORGANIZATION; LEFT HEMISPHERECTOMY; CHILDHOOD APHASIA; AGE ONE; INTELLIGENCE	This study investigated potential predictors of intellectual outcome in 417 children and 218 adults who had sustained a unilateral cortical lesion. Of these, 295 cases were collected from the scientific literature and 340 from medical records at seven hospitals in Canada. Different sets of predictors emerged for the Wechsler Verbal and Performance IQ values, accounting for differing variances (ie, 12.4% and 20.1%, respectively). The volume of the lesion was the factor that explained the most variance (ie, 4.95% and 11.7%, respectively). Age at lesion onset was significantly and positively correlated with verbal intelligence scores. This variable, considered independently or in interaction with other predictors, did not account for a large portion of the variance explained in intelligence. This refutes the commonly held notion that early onset of the insults results in a better prognosis.	Childrens Hosp Eastern Ontario, Oncol Patient Serv Unit, Ottawa, ON K1H 8L1, Canada; Childrens Hosp Eastern Ontario, Mental Hlth Patient Serv Unit, Ottawa, ON K1H 8L1, Canada; Univ Quebec, Dept Psychol, Montreal, PQ H3C 3P8, Canada; Hop Montreal Enfants, Psychol Serv, Montreal, PQ, Canada		Montour-Proulx, I (corresponding author), Childrens Hosp Eastern Ontario, Oncol Patient Serv Unit, 401 Smyth Rd, Ottawa, ON K1H 8L1, Canada.	montour@cheo.on.ca					Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; ARAM D, CHANGING NERVOUS SYS, P254; ARAM DM, 1988, NEUROPSYCHOLOGIA, V26, P903, DOI 10.1016/0028-3932(88)90058-9; ARAM DM, 1994, NEUROPSYCHOLOGIA, V32, P85, DOI 10.1016/0028-3932(94)90071-X; Aram DM, 1986, DEV NEUROPSYCHOL, V2, P155, DOI 10.1080/87565648609540339; BALLANTYNE AO, 1994, DEV NEUROPSYCHOL, V10, P39, DOI 10.1080/87565649409540565; BANICH MT, 1990, NEUROPSYCHOLOGIA, V28, P35, DOI 10.1016/0028-3932(90)90084-2; BATES E, CHANGING NERVOUS SYS, P214; BESAG FMC, EPILEPSY BEHAV COGNI, P113; BORNSTEIN RA, 1984, J NERV MENT DIS, V172, P707, DOI 10.1097/00005053-198412000-00002; BORNSTEIN RA, 1984, J CONSULT CLIN PSYCH, V52, P604; Braun CMJ, 2002, BEHAV NEUROL, V13, P105, DOI 10.1155/2002/634764; BREEDLOVE SM, 1994, ANNU REV PSYCHOL, V45, P389, DOI 10.1146/annurev.ps.45.020194.002133; CHAGNON M, 1953, MANUAL NORMES ECHELL; Cohen J., 1983, APPL MULTIPLE REGRES; DENNIS M, 1985, J CLIN EXP NEUROPSYC, V7, P526, DOI 10.1080/01688638508401283; DENNIS M, CLIN NEUROPSYCHOLOGY, P89; ESLINGER PJ, 1991, DEV NEUROPSYCHOL, V7, P257, DOI 10.1080/87565649109540493; Filley CM, 1999, NEUROPSY NEUROPSY BE, V12, P156; Gadian DG, 1996, NEUROLOGY, V46, P974, DOI 10.1212/WNL.46.4.974; GOLDENBERG G, 1994, BRAIN LANG, V47, P684, DOI 10.1006/brln.1994.1063; Goodman R, 1996, DEV MED CHILD NEUROL, V38, P881, DOI 10.1111/j.1469-8749.1996.tb15045.x; GRATTAN LM, 1991, DEV NEUROPSYCHOL, V7, P283, DOI 10.1080/87565649109540496; INGLIS J, 1981, SCIENCE, V212, P693, DOI 10.1126/science.7221560; INGLIS J, 1982, CAN J PSYCHOL, V36, P670, DOI 10.1037/h0080670; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; JONESGOTMAN M, 1977, NEUROPSYCHOLOGIA, V15, P653, DOI 10.1016/0028-3932(77)90070-7; Kennard MA, 1938, J NEUROPHYSIOL, V1, P477, DOI 10.1152/jn.1938.1.6.477; KIMURA D, 1983, CAN J PSYCHOL, V37, P19, DOI 10.1037/h0080696; Kleihues P., 1997, PATHOLOGY GENETICS T; Klein B, 2000, NEUROLOGY, V55, P230, DOI 10.1212/WNL.55.2.230; Kuehn SM, 2002, CHILD NERV SYST, V18, P306, DOI 10.1007/s00381-002-0599-7; LANSDELL H, 1969, J COMP PHYSIOL PSYCH, V69, P734, DOI 10.1037/h0028306; LEHR E, PSYCHOLOGICAL MANAGE, P41; LEVINE SC, 1987, DEV MED CHILD NEUROL, V29, P27; LEVY J, HDB BEHAV NEUROBIOLO, V11, P245; LOONEN MCB, 1990, ARCH NEUROL-CHICAGO, V47, P1324, DOI 10.1001/archneur.1990.00530120068012; Mariotti P, 1998, NEUROPSYCHOLOGIA, V36, P1303, DOI 10.1016/S0028-3932(98)00031-1; MCGLONE J, 1977, BRAIN, V100, P775, DOI 10.1093/brain/100.4.775; MCGLONE J, 1978, CORTEX, V14, P122, DOI 10.1016/S0010-9452(78)80015-X; MILNER B, 1982, PHILOS T R SOC B, V298, P211, DOI 10.1098/rstb.1982.0083; MILNER B, ADV NEUROLOGY, V8, P299; Muter V, 1997, NEUROPSYCHOLOGIA, V35, P289, DOI 10.1016/S0028-3932(96)00079-6; NASS R, 1989, BRAIN COGNITION, V9, P258, DOI 10.1016/0278-2626(89)90035-3; NASS RD, 1985, ANN NEUROL, V18, P393; NOVELLY RA, 1986, INT NEUR SOC DENV CO; OGDEN JA, 1988, NEUROPSYCHOLOGIA, V26, P645, DOI 10.1016/0028-3932(88)90001-2; ORSINI DL, 1986, ARCH NEUROL-CHICAGO, V43, P333, DOI 10.1001/archneur.1986.00520040021012; RIS MD, 1994, J CLIN EXP NEUROPSYC, V16, P21, DOI 10.1080/01688639408402615; Riva D, 1997, J NEUROSURG, V86, P207, DOI 10.3171/jns.1997.86.2.0207; RIVA D, 1986, NEUROPSYCHOLOGIA, V24, P423, DOI 10.1016/0028-3932(86)90029-1; SATZ P, 1985, BRAIN COGNITION, V4, P27, DOI 10.1016/0278-2626(85)90052-1; Satz P., 1994, NEUROPSYCHOLOGY, V8, P255, DOI DOI 10.1037/0894-4105.8.2.255; Schretlen D., 1994, PSYCHOL ASSESSMENT, V6, P188; SEGALOWITZ SJ, 1992, DEV NEUROPSYCHOL, V8, P279, DOI 10.1080/87565649209540528; SPAYCAR M, 1995, STEDMANS MED DICT; STJAMESROBERTS I, 1981, BRAIN LANG, V13, P31; STRAUSS E, 1990, NEUROPSYCHOLOGIA, V28, P1221, DOI 10.1016/0028-3932(90)90057-U; Tabachnik B.G., 1996, USING MULTIVARIATE S, V3rd ed.; TEUBER HL, NEUROSCIENCES THIRD, P71; VarghaKhadem F, 1997, BRAIN, V120, P159, DOI 10.1093/brain/120.1.159; VARGHAKHADEM F, 1992, BRAIN, V115, P315, DOI 10.1093/brain/115.1.315; VARGHAKHADEM K, 1994, CHILD NEUROL S, V9, pS67; Verger K, 2000, BRAIN INJURY, V14, P495; WARRINGTON EK, 1986, NEUROPSYCHOLOGIA, V24, P223, DOI 10.1016/0028-3932(86)90055-2; Wechsler D., 1991, MANUAL WECHSLER INTE, VIII; Wechsler D., 1974, MANUAL WECHSLER INTE; Wechsler D, 1967, MANUAL WECHSLER PRES; Wechsler D, 1989, MANUAL WECHSLER PRES; WECHSLER D, 1996, MANUAL CANADIAN SUPP; Wechsler D, 1981, WECHSLER ADULT INTEL; Wechsler D., 1955, MANUAL WECHSLER ADUL; Wechsler David., 1949, MANUAL WECHSLER INTE; WELSH MC, 1991, DEV NEUROPSYCHOL, V7, P131, DOI 10.1080/87565649109540483; Woods B T, 1973, Trans Am Neurol Assoc, V98, P113; WOODS BT, 1978, ANN NEUROL, V3, P273, DOI 10.1002/ana.410030315; WOODS BT, 1980, NEUROPSYCHOLOGIA, V18, P65, DOI 10.1016/0028-3932(80)90084-6	78	18	20	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	DEC	2004	19	12					935	943		10.1177/08830738040190120501			9	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics	914LJ	WOS:000228228800005	15704866				2022-02-06	
J	Gilchrist, MD				Gilchrist, MD			Experimental device for simulating traumatic brain injury resulting from linear accelerations	STRAIN			English	Article						experimental device; impact biomechanics; linear acceleration; tissue damage; traumatic brain injury (TBI)	CONTROLLED CORTICAL IMPACT; FLUID-PERCUSSION MODEL; DIFFUSE AXONAL INJURY; HEAD-INJURY; PRESSURE CHANGES; CONTUSION; BIOMECHANICS; CONCUSSION; RATS; RECONSTRUCTION	Various methods are used to model and analyse traumatic brain injuries (TBI) in human beings. These include volunteer and cadaver experiments, anthropomorphic dummies, physical models, computational models and mathematical models. The pathophysiological response to mechanical impact of the human central nervous system and of in vivo neural tissue, is most realistically analysed using animal models, which provide the best surrogate for the human brain. During non-fatal impacts, a mechanical insult may trigger a cascade of physiological processes, many mediated by neurochemicals within the neural tissue which will, in turn, control the depth and extent of the brain injury. This paper reports the development of a novel experimental device which can apply different linear acceleration impacts directly to in vivo neural tissue in a manner which permits the experimental analysis of non-fatal TBI of varying severity.	Univ Coll Dublin, Dept Mech Engn, Dublin 2, Ireland		Gilchrist, MD (corresponding author), Univ Coll Dublin, Dept Mech Engn, Dublin 2, Ireland.		Gilchrist, Michael D/B-6100-2017	Gilchrist, Michael D/0000-0003-1765-429X			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Adelson PD, 1996, J NEUROSURG, V85, P877, DOI 10.3171/jns.1996.85.5.0877; ANDERSON TE, 1982, J NEUROSCI METH, V6, P327, DOI 10.1016/0165-0270(82)90033-4; BAKAY L, 1977, J NEUROSURG, V47, P525, DOI 10.3171/jns.1977.47.4.0525; Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; BECKMAN DL, 1969, P SOC EXP BIOL MED, V130, P5; Bostrom K, 1986, Acta Neurochir Suppl (Wien), V36, P51; CHERIAN L, 1994, J NEUROTRAUM, V11, P573, DOI 10.1089/neu.1994.11.573; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Gennarelli T A, 1983, Acta Neurochir Suppl (Wien), V32, P1; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; Gilchrist MD, 2000, COMPUT MECH, V26, P229, DOI 10.1007/s004660000179; Gilchrist MD, 2003, KEY ENG MATER, V245-2, P417, DOI 10.4028/www.scientific.net/KEM.245-246.417; Gilchrist MD, 2001, INT J CRASHWORTHINES, V6, P253, DOI 10.1533/cras.2001.0176; Goldman H, 1991, J NEUROTRAUM, V8, P129, DOI 10.1089/neu.1991.8.129; GOLDSMITH W, 1970, BIOMECHANICS ITS FDN, P585; GURDJIAN ES, 1975, SURG GYNECOL OBSTET, V140, P845; HARRIS GF, 1993, J BIOMED ENG, V15, P67, DOI 10.1016/0141-5425(93)90096-H; Holbourn AHS, 1943, LANCET, V2, P438; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; KING AI, 1995, BIOMEDICAL ENG HDB; Koizumi H, 1997, BRAIN RES, V747, P304, DOI 10.1016/S0006-8993(96)01240-1; Krantz K P, 1986, Acta Neurochir Suppl (Wien), V36, P47; LIGHTHALL J W, 1989, Journal of Neurotrauma, V6, P83, DOI 10.1089/neu.1989.6.83; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; LINDGREN S, 1969, ACTA PHYSIOL SCAND, V76, P340, DOI 10.1111/j.1748-1716.1969.tb04477.x; MADSEN FF, 1987, ACTA NEUROCHIR, V88, P65, DOI 10.1007/BF01400517; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mathew P, 1996, J NEUROSURG, V85, P860, DOI 10.3171/jns.1996.85.5.0860; MATHEW P, 1994, ACTA NEUROCHIR, P428; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MURAI II, 1991, P 1 INT NEUROTRAUMA; NILSSON B, 1977, J NEUROSURG, V47, P241, DOI 10.3171/jns.1977.47.2.0241; Nishimoto T, 1998, J BIOMECH ENG-T ASME, V120, P140, DOI 10.1115/1.2834294; O'Riordain K, 2003, CLIN BIOMECH, V18, P590, DOI 10.1016/S0268-0033(03)00111-6; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Park HK, 1999, CRIT REV NEUROSURG, V9, P44, DOI 10.1007/s003290050108; PARKINSON D, 1978, NEUROSURGERY, V3, P176, DOI 10.1227/00006123-197809000-00008; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; PUDENZ RH, 1946, J NEUROSURG, V3, P487, DOI 10.3171/jns.1946.3.6.0487; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Shreiber DI, 1999, NEUROSCI LETT, V259, P5, DOI 10.1016/S0304-3940(98)00853-2; Shreiber DI, 1999, J NEUROPATH EXP NEUR, V58, P153, DOI 10.1097/00005072-199902000-00005; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; SMYTH A, 2003, P 33 ANN NEUROSCI M; SMYTH A, 2004, P 34 ANN NEUROSCI M; Stalhammar D, 1986, Acta Neurochir Suppl (Wien), V36, P33; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; VIANO D, 1988, 881706 SAE, P1070; WEST M, 1982, ELECTROEN CLIN NEURO, V53, P192, DOI 10.1016/0013-4694(82)90023-2; WILBERGER JE, 1990, J TRAUMA, V30, P733, DOI 10.1097/00005373-199006000-00014; YAMAKI T, 1994, J NEUROTRAUM, V11, P613, DOI 10.1089/neu.1994.11.613	58	18	18	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0039-2103	1475-1305		STRAIN	Strain	NOV	2004	40	4					180	192		10.1111/j.1475-1305.2004.00168.x			13	Materials Science, Characterization & Testing	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science	880AM	WOS:000225760700005		Green Submitted			2022-02-06	
J	Brodhun, M; Bauer, R; Patt, S				Brodhun, M; Bauer, R; Patt, S			Potential stem cell therapy and application in neurotrauma	EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY			English	Article; Proceedings Paper	4th International Congress of Pathophysiology	JUN 29-JUL 05, 2002	BUDAPEST, HUNGARY			stem cells; neurotrauma; spinal cord injury	EPIDERMAL-GROWTH-FACTOR; MARROW STROMAL CELLS; TRAUMATIC BRAIN INJURY; BONE-MARROW; SPINAL-CORD; PRECURSOR CELLS; ADULT RATS; IN-VITRO; INTRASTRIATAL TRANSPLANTATION; REPLACEMENT STRATEGIES	Traumatic brain injury results from a sudden and external physical insult to the head, which is often accompanied by motor and cognitive impairment. Neurotrauma is characterized not only by focal abnormalities, but rather by multifocal, or even global structural and functional disturbances of the brain network. The impact initially causes necrotic cell death in the underlying tissue, followed by apoptotic cell death in the surrounding tissue due to multiple subsequent events, such as ischemia. excitotoxicity and altered gene expression. These pathological conditions are associated with high morbidity and mortality. Despite the high medical and economical relevance of neurotrauma there are currently no sufficient treatments. Supplementary therapeutic strategies have to be established. Many types of stem cells have the ability to engraft diffusely and become integral members of structures throughout the host CNS. Intrinsic factors appear to derive spontaneously from stem cells and seem to be capable of neuroprotective and/or neuroregenerative functions. Furthermore stem cells can be readily engineered to express specific genes. Such observations suggest that stem cells might participate in reconstructing the molecular and cellular milieu of traumatized brains. In this paper, the state of stem cell research is reviewed and its possible application in neurotrauma will be discussed. (C) 2004 Elsevier GmbH. All rights reserved.	Univ Jena, Inst Pathol, D-07740 Jena, Germany; Univ Jena, Inst Pathophysiol & Pathobiochem, D-07740 Jena, Germany		Brodhun, M (corresponding author), Univ Jena, Inst Pathol, Bachstr 18, D-07740 Jena, Germany.	michael.brodhun@med.uni-jena.de					Armstrong RJE, 2001, LANCET, V358, P1174, DOI 10.1016/S0140-6736(01)06260-2; Bjorklund A, 2000, NATURE, V405, P892, DOI 10.1038/35016175; Bjorklund A, 2000, NAT NEUROSCI, V3, P537, DOI 10.1038/75705; Blau HM, 2001, CELL, V105, P829, DOI 10.1016/S0092-8674(01)00409-3; Bonilla S, 2001, INT J DEV BIOL, V45, pS67; Brodhun M, 2001, ACTA NEUROPATHOL, V101, P424; Brustle O, 1997, P NATL ACAD SCI USA, V94, P14809, DOI 10.1073/pnas.94.26.14809; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Cao QL, 2002, J NEUROSCI RES, V68, P501, DOI 10.1002/jnr.10240; Castro RF, 2003, SCIENCE, V299; Castro RF, 2002, SCIENCE, V297, P1299, DOI 10.1126/science.297.5585.1299; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Chopp M, 2000, NEUROREPORT, V11, P3001, DOI 10.1097/00001756-200009110-00035; Chung S, 2002, EUR J NEUROSCI, V16, P1829, DOI 10.1046/j.1460-9568.2002.02255.x; del Rio JA, 2002, EUR J NEUROSCI, V15, P1881, DOI 10.1046/j.1460-9568.2002.02027.x; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; Ducray A, 2002, EUR J NEUROSCI, V15, P1907, DOI 10.1046/j.1460-9568.2002.02044.x; Fallon J, 2000, P NATL ACAD SCI USA, V97, P14686, DOI 10.1073/pnas.97.26.14686; FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009; Fuchs E, 2000, CELL, V100, P143, DOI 10.1016/S0092-8674(00)81691-8; Fung KM, 1997, BRAIN RES, V761, P347, DOI 10.1016/S0006-8993(97)00467-8; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gage FH, 1998, NATURE, V392, P18; Gerlach M, 2002, J NEUROL S3, V249, piii33, DOI DOI 10.1007/S00415-002-1307-Y; Gould E, 2002, J NEUROSCI, V22, P619, DOI 10.1523/JNEUROSCI.22-03-00619.2002; Gould E, 1999, BIOL PSYCHIAT, V46, P1472, DOI 10.1016/S0006-3223(99)00247-4; GRAHAM DI, 1997, GREENFIELDS NEUROPAT, P198; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Gu WG, 2000, J CEREBR BLOOD F MET, V20, P1166, DOI 10.1097/00004647-200008000-00002; Hagell P, 1999, BRAIN, V122, P1121, DOI 10.1093/brain/122.6.1121; Hagell P, 2001, J NEUROPATH EXP NEUR, V60, P741, DOI 10.1093/jnen/60.8.741; Hatton J, 2001, CNS DRUGS, V15, P553, DOI 10.2165/00023210-200115070-00005; Hess DC, 2002, STROKE, V33, P1362, DOI 10.1161/01.STR.0000014925.09415.C3; Hynes M, 2000, NEURON, V28, P11, DOI 10.1016/S0896-6273(00)00079-9; Jiang W, 2001, STROKE, V32, P1201, DOI 10.1161/01.STR.32.5.1201; Jin KL, 2002, J NEUROSCI, V22, P5365; Jones LL, 2002, J NEUROSCI, V22, P4611, DOI 10.1523/JNEUROSCI.22-11-04611.2002; Kempermann G, 2002, BIPOLAR DISORD, V4, P17, DOI 10.1034/j.1399-5618.2002.40101.x; Kempermann G, 2002, J NEUROSCI, V22, P635, DOI 10.1523/JNEUROSCI.22-03-00635.2002; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; Kruger GM, 2002, CELL, V110, P399, DOI 10.1016/S0092-8674(02)00899-1; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Legrier ME, 2001, CELL GROWTH DIFFER, V12, P591; Li Y, 2000, J CEREBR BLOOD F MET, V20, P1311, DOI 10.1097/00004647-200009000-00006; Li Y, 2001, NEUROLOGY, V56, P1666, DOI 10.1212/WNL.56.12.1666; Lindvall O, 2001, CLIN CHEM LAB MED, V39, P356, DOI 10.1515/CCLM.2001.056; Ling ZD, 1998, EXP NEUROL, V149, P411, DOI 10.1006/exnr.1998.6715; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; Liu S, 2000, P NATL ACAD SCI USA, V97, P6126, DOI 10.1073/pnas.97.11.6126; Lu DY, 2002, CELL TRANSPLANT, V11, P275; Lu DY, 2001, J NEUROTRAUM, V18, P813, DOI 10.1089/089771501316919175; Lu K, 2002, SPINE, V27, P887, DOI 10.1097/00007632-200204150-00021; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; McDonald JW, 2000, NAT MED, V6, P358, DOI 10.1038/74759; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Modo M, 2002, BRAIN RES, V958, P70, DOI 10.1016/S0006-8993(02)03463-7; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cb.11.110195.000343; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nishino H, 2000, Prog Brain Res, V127, P461; Ohta Y, 2000, ORL-J OTO-RHIN-LARYN, V62, P20, DOI 10.1159/000027710; Palmer TD, 2001, NATURE, V411, P42, DOI 10.1038/35075141; PALMER TD, 1995, MOL CELL NEUROSCI, V6, P474, DOI 10.1006/mcne.1995.1035; Parent JM, 2002, PROG BRAIN RES, V135, P121; Park KI, 1999, J NEUROTRAUM, V16, P675, DOI 10.1089/neu.1999.16.675; Park KI, 2002, GENE THER, V9, P613, DOI 10.1038/sj.gt.3301721; Patt S, 1999, EXP TOXICOL PATHOL, V51, P119, DOI 10.1016/S0940-2993(99)80084-0; PEREIRA RF, 1995, P NATL ACAD SCI USA, V92, P4857, DOI 10.1073/pnas.92.11.4857; Philips MF, 2001, J NEUROSURG, V94, P765, DOI 10.3171/jns.2001.94.5.0765; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Prestoz L, 2001, MOL CELL NEUROSCI, V18, P473, DOI 10.1006/mcne.2001.1037; Rathjen J, 2002, DEVELOPMENT, V129, P2649; Reubinoff BE, 2001, NAT BIOTECHNOL, V19, P1134, DOI 10.1038/nbt1201-1134; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; ROMERORAMOS M, 2002, J NEUROSCI RES, V15, P3999; Savitz SI, 2002, ANN NEUROL, V52, P266, DOI 10.1002/ana.60000; Senior K, 2000, LANCET, V355, P1890, DOI 10.1016/S0140-6736(05)73336-5; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Sharp FR, 2002, DEV BRAIN RES, V134, P23, DOI 10.1016/S0165-3806(01)00286-3; Song HJ, 2002, NAT NEUROSCI, V5, P438, DOI 10.1038/nn844; Svendsen CN, 1996, EXP NEUROL, V137, P376, DOI 10.1006/exnr.1996.0039; Tamaki S, 2002, J NEUROSCI RES, V69, P976, DOI 10.1002/jnr.10412; Tanapat P, 1999, J NEUROSCI, V19, P5792, DOI 10.1523/JNEUROSCI.19-14-05792.1999; Tanapat P, 2001, J COMP NEUROL, V437, P496, DOI 10.1002/cne.1297; Tate MC, 2002, CELL TRANSPLANT, V11, P283; Tatton WG, 1997, J NEURAL TRANSM-SUPP, P245; TERSKIKH A, 2000, HUNTING HEMATOPOIETI, V1, P33; TILL JE, 1964, P NATL ACAD SCI USA, V51, P29, DOI 10.1073/pnas.51.1.29; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; van der Kooy D, 2000, SCIENCE, V287, P1439, DOI 10.1126/science.287.5457.1439; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Vescovi AL, 1999, J NEUROTRAUM, V16, P689, DOI 10.1089/neu.1999.16.689; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Whittemore SR, 1999, J NEUROTRAUM, V16, P667, DOI 10.1089/neu.1999.16.667; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; ZAUNER A, 1995, J NEUROTRAUM, V12, P547, DOI 10.1089/neu.1995.12.547; Zhao LR, 2002, EXP NEUROL, V174, P11, DOI 10.1006/exnr.2001.7853	102	18	23	0	3	ELSEVIER GMBH	MUNICH	HACKERBRUCKE 6, 80335 MUNICH, GERMANY	0940-2993	1618-1433		EXP TOXICOL PATHOL	Exp. Toxicol. Pathol.	OCT	2004	56	1-2					103	112		10.1016/j.etp.2004.04.004			10	Pathology; Toxicology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Pathology; Toxicology	872QF	WOS:000225221900013	15581281				2022-02-06	
J	Bombardier, CH; Stroud, MW; Esselman, PC; Rimmele, CT				Bombardier, CH; Stroud, MW; Esselman, PC; Rimmele, CT			Do preinjury alcohol problems predict poorer rehabilitation progress in persons with spinal cord injury?	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						alcohol-related disorders; health services research; rehabilitation; spinal cord injuries	FUNCTIONAL INDEPENDENCE MEASURE; TRAUMATIC BRAIN INJURY; SUBSTANCE-ABUSE; READINESS	Objective: To determine whether a history of alcohol-related problems is associated with inpatient rehabilitation progress. Design: Cross-sectional cohort survey. Setting: Acute inpatient rehabilitation program in a level I trauma center. Participants: Seventy-six of 104 consecutive patients with spinal cord injury (SCI) who met inclusion criteria and had completed interviews and functional outcome data. Participants were on average 38 years old; 84% were white, and 86% were men. Forty-two percent had tetraplegia and 39% had a history of problem drinking. Interventions: Not applicable. Main Outcome Measures: FIM instrument admission, discharge, and efficiency scores as well as rehabilitation length of stay (LOS). Results: The group with a history of problem drinking had significantly lower FIM admission, discharge, and efficiency scores and longer rehabilitation LOS. After controlling for potential confounding factors, a history of problem drinking accounted for a significant proportion of the variance in FIM efficiency scores. Conclusions: A history of problem drinking may be a risk factor for poorer rehabilitation progress among patients with SCI. They may be more costly to rehabilitate and may be discharged before attaining an adequate level of independence. Despite this, the current rehabilitation prospective payment system does not recognize this common comorbid condition.	Univ Washington, Harborview Med Ctr, Sch Med, Dept Rehabil Med, Seattle, WA 98104 USA; Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; Seattle VA Puget Sound Hlth Care Syst, Seattle, WA USA		Bombardier, CH (corresponding author), Univ Washington, Harborview Med Ctr, Sch Med, Dept Rehabil Med, Box 359740,325 9th Ave, Seattle, WA 98104 USA.	chh@u.washington.edu	Bombardier, Charles H./AAZ-3260-2021	Bombardier, Charles H./0000-0003-4758-6283			BABOR TF, 1987, J STUD ALCOHOL, V48, P410, DOI 10.15288/jsa.1987.48.410; Bombardier CH, 1997, ARCH PHYS MED REHAB, V78, P592, DOI 10.1016/S0003-9993(97)90424-X; Bombardier CH, 1998, ARCH PHYS MED REHAB, V79, P1110, DOI 10.1016/S0003-9993(98)90180-0; CARTER GM, DRU2309J RAND, P210; Elliott TR, 1996, ARCH PHYS MED REHAB, V77, P816, DOI 10.1016/S0003-9993(96)90263-4; Elliott TR, 2002, REHABIL PSYCHOL, V47, P278, DOI 10.1037//0090-5550.47.3.278; Frisbie J H, 1984, J Am Paraplegia Soc, V7, P71; HALT PS, 1992, ARCH NEUROL-CHICAGO, V49, P1178, DOI 10.1001/archneur.1992.00530350096025; HEINEMANN AW, 1995, REHABIL PSYCHOL, V40, P125; HEINEMANN AW, 1988, ARCH PHYS MED REHAB, V69, P619; HEINEMANN AW, 1988, ALCOHOL CLIN EXP RES, V12, P815, DOI 10.1111/j.1530-0277.1988.tb01352.x; HEINEMANN AW, 1989, REHABIL PSYCHOL, V34, P191, DOI 10.1037//0090-5550.34.3.191; Heinemann AW, 1997, ARCH PHYS MED REHAB, V78, P143, DOI 10.1016/S0003-9993(97)90255-0; HUBERTY CJ, 1989, PSYCHOL BULL, V105, P302, DOI 10.1037/0033-2909.105.2.302; Kiwerski J E, 1992, Int J Rehabil Res, V15, P240, DOI 10.1097/00004356-199209000-00008; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; McKinley WO, 1999, AM J PHYS MED REHAB, V78, P306, DOI 10.1097/00002060-199907000-00002; Miller WR, 1997, AM PSYCHOL, V52, P1269, DOI 10.1037/0003-066X.52.12.1269; Mulder RT, 2002, AUST NZ J PSYCHIAT, V36, P44, DOI 10.1046/j.1440-1614.2002.00958.x; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; PROCHASKA JO, 1992, AM PSYCHOL, V47, P1102, DOI 10.1037/0003-066X.47.9.1102; Sander AM, 1997, ARCH PHYS MED REHAB, V78, P138, DOI 10.1016/S0003-9993(97)90254-9; SELZER ML, 1971, AM J PSYCHIAT, V127, P1653, DOI 10.1176/ajp.127.12.1653; SOBELL LC, 1990, BEHAV ASSESS, V12, P77; TATE DG, 1993, AM J PHYS MED REHAB, V72, P192, DOI 10.1097/00002060-199308000-00004; YOUNG ME, 1995, ARCH PHYS MED REHAB, V76, P525, DOI 10.1016/S0003-9993(95)80506-0	26	18	19	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	SEP	2004	85	9					1488	1492		10.1016/j.apmr.2003.10.010			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	852DW	WOS:000223736400017	15375822				2022-02-06	
J	Brener, I; Harman, JS; Kelleher, KJ; Yeates, KO				Brener, I; Harman, JS; Kelleher, KJ; Yeates, KO			Medical costs of mild to moderate traumatic brain injury in children	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						healthcare expenditures; financial burden; traumatic brain injury	ECONOMIC BURDEN; CARE; ASTHMA	Objective: To estimate healthcare expenditures of children with mild to moderate traumatic brain injury (TBI) outside of acute care settings. Design: Data from the 1997-2000 Medical Expenditure Panel Survey were used to produce estimates of expenditures for a natural sample of 196 children with TBI. Results: Expenditures for TBI-related services in children averaged $77.9 million per year. Average per capita expenditure was $1044, of which $166 was for TBI-related services and $878 was for all other health services. Conclusion: Although total costs of TBI in children are high, the average costs are much lower than those previous reports because youth with minor trauma were not included in prior samples.	Columbus Childrens Res Inst, Columbus, OH 43205 USA; Denison Univ, Granville, OH 43023 USA; Univ Florida, Dept Hlth Serv Adm, Gainesville, FL 32611 USA; Ohio State Univ, Dept Pediat, Columbus, OH USA		Kelleher, KJ (corresponding author), Columbus Childrens Res Inst, 700 Childrens Dr, Columbus, OH 43205 USA.	kellebek@pediatrics.obio-state.edu	Yeates, Keith/AAJ-4223-2020; Kelleher, Kelly/E-3361-2011	Yeates, Keith/0000-0001-7680-2892			BROOKS CA, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199508000-00002; Bryant ET, 1993, J HEAD TRAUMA REHAB, V8, P15; Centers for Disease Control and Prevention, NATL CTR INJ PREV CO; Chambers JG, 2003, TOTAL EXPENDITURES S; Chan E, 2002, ARCH PEDIAT ADOL MED, V156, P504, DOI 10.1001/archpedi.156.5.504; COHEN JW, 1997, HLTH AFF MILLWOOD, V22, P129; Edelstein Burton L, 2002, Pediatr Dent, V24, P11; Gergen PJ, 2001, J ALLERGY CLIN IMMUN, V107, pS445, DOI 10.1067/mai.2001.114992; Hwang W, 2001, HEALTH AFFAIR, V20, P267, DOI 10.1377/hlthaff.20.6.267; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P681, DOI 10.1016/0003-9993(93)90024-5; LANGLOIS JA, 2003, CDCP MORB MORBTAL WK, V52, P1; Lehmkuhl L, 1993, J HEAD TRAUMA REHAB, V8, P88; Lozano P, 1999, J ALLERGY CLIN IMMUN, V104, P957, DOI 10.1016/S0091-6749(99)70075-8; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; MILLS RJ, 2001, HLTH INSURANCE COVER, P60; Osberg JS, 1997, BRAIN INJURY, V11, P11; *STAT CORP, 2002, STATACORP STAT STAT; Swigonski N, 2001, CHILD HEALTH CARE, V30, P219, DOI 10.1207/S15326888CHC3003_4; Thompson K, 2001, N C Med J, V62, P376; Yelin E, 2002, EUR RESPIR J, V19, P414, DOI 10.1183/09031936.02.00522001; FAMILY CAREGIVE ALLI	22	18	18	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2004	19	5					405	412		10.1097/00001199-200409000-00005			8	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	858UB	WOS:000224216300005	15597031				2022-02-06	
J	Bush, BA; Novack, TA; Schneider, JJ; Madan, A				Bush, BA; Novack, TA; Schneider, JJ; Madan, A			Depression following traumatic brain injury: The validity of the CES-D as a brief screening device	JOURNAL OF CLINICAL PSYCHOLOGY IN MEDICAL SETTINGS			English	Article						depression; traumatic brain injury; assessment; CES-D	GENDER-DIFFERENCES; SCALE; POSTSTROKE; INVENTORY; ADULTS; MOOD	The validity, reliability, and factor structure of the Center for Epidemiological Studies-Depression Scale (CES-D) was examined with 253 patients seen for neuropsychological evaluation following traumatic brain injury (TBI). All patients completed the CES-D; 31 also completed the Beck Depression Inventory (BDI) and 17 completed the Minnesota Multiphasic Personality Inventory-II (MMPI-II). The CES-D demonstrated good concurrent, construct validity, significantly correlating with the BDI (r=.673, p<.0001) and the MMPI-II ( Depression Scale T scorer=.536, p=.027). The CES-D also demonstrated good internal consistency (coefficient alpha=.8195) and split-half reliability (Spearman-Brown r=.8284). Principal components factor analysis with varimax rotation resulted in a four-factor solution that accounted for 56.01% of the variance. The factor structure differed from the originally reported factor structure, and indicated that somatic difficulties were strongly associated with dysphoric affect in TBI patients. The CES-D is a valid and reliable screening instrument for use with TBI patients.	Univ Alabama, Dept Psychiat & Behav Neurobiol, Birmingham, AL 35294 USA; Univ Alabama, Dept Phys Med & Rehabil, Birmingham, AL USA		Bush, BA (corresponding author), Univ Alabama, Dept Psychiat & Behav Neurobiol, 1530 3rd Ave S,C253, Birmingham, AL 35294 USA.	babush@uab.edu					American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bowen A, 1998, BRAIN INJURY, V12, P177, DOI 10.1080/026990598122656; Busch CR, 1998, NEUROPSYCHOL REV, V8, P95, DOI 10.1023/A:1025661200911; Bush BA, 1999, ARCH CLIN NEUROPSYCH, V14, P123, DOI 10.1093/arclin/14.1.123; CALLAHAN CM, 1994, MED CARE, V32, P341, DOI 10.1097/00005650-199404000-00003; Devins G., 1988, PSYCHOL HEALTH, V2, P139, DOI DOI 10.1080/08870448808400349; GARCIA M, 1989, PSYCHIAT RES, V27, P137, DOI 10.1016/0165-1781(89)90129-7; GUARNACCIA PJ, 1989, SOC SCI MED, V29, P85, DOI 10.1016/0277-9536(89)90131-7; HATHAWAY SR, 1989, MINNESOTA MULTIPHASI, V2; HOLBROOK TL, 1994, J TRAUMA, V36, P74, DOI 10.1097/00005373-199401000-00011; Levin, 1997, Semin Clin Neuropsychiatry, V2, P207; Manson SM, 1991, PSYCHOL ASSESS, V3, P623, DOI [DOI 10.1037/1040-3590.3.4.623, 10.1037/1040-3590.3.4.623]; NOVACK TA, 1984, INT J CLIN NEUROPSYC, V6, P139; Paradiso S, 1998, J NEUROPSYCH CLIN N, V10, P41, DOI 10.1176/jnp.10.1.41; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; ROSS CE, 1984, AM J EPIDEMIOL, V119, P997, DOI 10.1093/oxfordjournals.aje.a113819; Sliwinski M, 1998, J HEAD TRAUMA REHAB, V13, P40, DOI 10.1097/00001199-199808000-00004; STOMMEL M, 1993, PSYCHIAT RES, V49, P239, DOI 10.1016/0165-1781(93)90064-N	20	18	18	0	3	KLUWER ACADEMIC/PLENUM PUBL	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1068-9583			J CLIN PSYCHOL MED S	J. Clin. Psychol. Med. Settings	SEP	2004	11	3					195	201		10.1023/B:JOCS.0000037613.69367.d4			7	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	845GO	WOS:000223230500006					2022-02-06	
J	Dodson, KM; Bridges, MA; Reiter, ER				Dodson, KM; Bridges, MA; Reiter, ER			Endoscopic transnasal management of intracranial foreign bodies	ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY			English	Article							SPHENOID SINUS FOREIGN; PEN INJURY; BRAIN; BODY	Foreign bodies may be introduced into the paranasal sinuses or cranium through a variety of traumatic or iatrogenic events. A variety of open and, more recently, endoscopic approaches have been used for the removal of sinonasal foreign bodies. Intracranial foreign bodies, however, typically require retrieval via a craniotomy approach, which continues to carry significant perioperative risks. We describe the first reported case of an intracranial foreign body removed using the transnasal endoscopic approach with intraoperative image guidance. We discuss the preoperative evaluation required for this approach to be applied safely and successfully in properly selected cases.	Virginia Commonwealth Univ, Med Ctr, Dept Otolaryngol Head & Neck Surg, Richmond, VA 23298 USA		Reiter, ER (corresponding author), Virginia Commonwealth Univ, Med Ctr, Dept Otolaryngol Head & Neck Surg, Box 980146, Richmond, VA 23298 USA.	ejreiter@comcast.net					Alsarraf R, 1998, ARCH OTOLARYNGOL, V124, P1018, DOI 10.1001/archotol.124.9.1018; Bhattacharyya N, 1998, OTOLARYNG HEAD NECK, V118, P687, DOI 10.1016/S0194-5998(98)70244-X; CABANTOG AM, 1994, CAN J NEUROL SCI, V21, P213, DOI 10.1017/S0317167100041184; Davis GA, 2000, J CLIN NEUROSCI, V7, P545, DOI 10.1054/jocn.2000.0692; FOY P, 1980, LANCET, V2, P662; Gonul E, 1997, NEUROSURG REV, V20, P177, DOI 10.1007/BF01105561; LaFrentz JR, 2000, ANN OTO RHINOL LARYN, V109, P119, DOI 10.1177/000348940010900201; LOES DJ, 1987, PEDIATR NEUROL, V3, P44, DOI 10.1016/0887-8994(87)90055-5; Madei W, 1998, DEUT MED WOCHENSCHR, V123, P1139, DOI 10.1055/s-2007-1024136; Mohanty A, 2002, PEDIATR NEUROSURG, V37, P52, DOI 10.1159/000065104; Mori S, 1999, ORL J OTO-RHINO-LARY, V61, P165, DOI 10.1159/000027664; Pagella F, 1999, LARYNGOSCOPE, V109, P339, DOI 10.1097/00005537-199902000-00030; Sharif S, 2000, BRIT J NEUROSURG, V14, P159; Thaler ER, 1999, AM J RHINOL, V13, P303, DOI 10.2500/105065899782102827; Thomas RF, 2002, OTOLARYNG HEAD NECK, V127, P409, DOI 10.1067/mhn.2002.129821	15	18	18	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0886-4470	1538-361X		ARCH OTOLARYNGOL	Arch. Otolaryngol. Head Neck Surg.	AUG	2004	130	8					985	988		10.1001/archotol.130.8.985			4	Otorhinolaryngology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology; Surgery	844DY	WOS:000223138800013	15313871				2022-02-06	
J	Ratanalert, S; Phuenpathom, N; Saeheng, S; Oearsakul, T; Sripairojkul, B; Hirunpat, S				Ratanalert, S; Phuenpathom, N; Saeheng, S; Oearsakul, T; Sripairojkul, B; Hirunpat, S			ICP threshold in CPP management of severe head injury patients	SURGICAL NEUROLOGY			English	Article						intracranial pressure (ICP); threshold; head injury; cerebral perfusion pressure (CPP)	TRAUMATIC BRAIN-INJURY; PRESSURE; ISCHEMIA	BACKGROUND Elevated intracranial pressure (ICP) is significantly associated with high mortality rate in severe head injury (SHI) patients. However, there is no absolute agreement regarding the level at which ICP must be treated. The objective of this study was to compare the outcomes of severe head injury patients treated by setting the ICP threshold at greater than or equal to20 mm Hg or greater than or equal to25 mm Hg. METHODS Treatment protocol in this study consisted of therapeutic maneuvers designed to maximize cerebral profusion pressure (CPP) and control ICP. Twenty-seven patients with severe head injury and intracranial hypertension (ICP greater than or equal to20 mm Hg) were enrolled and fourteen cases were allocated to the group of ICP threshold greater than or equal to25 mm Hg. Six-month clinical outcomes were evaluated using the Glasgow Outcome Score (GOS). RESULTS There were no statistically significant differences in clinical parameters between the groups. Logistic regression identified the presence of basal cisterns on the initial computed tomography (CT) scan as a significant predictor of good outcome. ICP threshold did not influence outcome. CONCLUSIONS This study supported a recommended ICP threshold of 20 to 25 mm Hg in SHI management. However, in cases with an absence of basal cisterns on initial CT scan, the probability of good outcome may be higher using an ICP threshold of greater than or equal to20 mm Hg. (C) 2004 Elsevier Inc. All rights reserved.	Prince Songkla Univ, Fac Med, Dept Surg, Hat Yai 90110, Thailand; Prince Songkla Univ, Fac Med, Dept Radiol, Hat Yai 90110, Thailand		Ratanalert, S (corresponding author), Prince Songkla Univ, Fac Med, Dept Surg, Hat Yai 90110, Thailand.						ALEXANDER E, 1992, SURG NEUROL, V38, P478, DOI 10.1016/0090-3019(92)90124-6; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P559; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Dickinson K, 2000, BMJ-BRIT MED J, V320, P1308, DOI 10.1136/bmj.320.7245.1308; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; JENNETT B, 1975, LANCET, V1, P480; Klein D G, 1999, Crit Care Nurs Clin North Am, V11, P209; LEVIN HS, 1990, HEAD INJURY, P367; Macmillan CSA, 2001, J NEUROL NEUROSUR PS, V70, P101, DOI 10.1136/jnnp.70.1.101; MAPSTONE TB, 1996, CONT NEUROSURG, V18, P1; MARMAROU A, 1991, J NEUROSURG, V75, pS21, DOI 10.3171/sup.1991.75.1s.0s21; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; MILLER JD, 1990, ADV BRAIN RESUSCITAT, P315; Ratanalert S, 2002, BRIT J NEUROSURG, V16, P487, DOI 10.1080/0268869021000030311; ROSNER MJ, 1987, NEUROSURGERY, V21, P147, DOI 10.1227/00006123-198708000-00003; ROSNER MJ, 1984, J NEUROSURG, V60, P312, DOI 10.3171/jns.1984.60.2.0312; SAHUQUILLO J, 1993, ACTA NEUROCHIR, V122, P204, DOI 10.1007/BF01405530; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498	24	18	21	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0090-3019			SURG NEUROL	Surg. Neurol.	MAY	2004	61	5					429	435		10.1016/S0090-3019(03)00579-2			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	818GO	WOS:000221233800007	15120212				2022-02-06	
J	Hang, CH; Shi, JX; Li, JS; Wu, W; Li, WQ; Yin, HX				Hang, Chun-Hua; Shi, Ji-Xin; Li, Jie-Shou; Wu, Wei; Li, Wei-Qin; Yin, Hong-Xia			Levels of vasoactive intestinal peptide, cholecystokinin and calcitonin gene-related peptide in plasma and jejunum of rats following traumatic brain injury and underlying significance in gastrointestinal dysfunction	WORLD JOURNAL OF GASTROENTEROLOGY			English	Article							SPINAL AFFERENTS; NITRIC-OXIDE; CCK; RESPONSES; MUSCLE; CGRP; INHIBITION; MODULATION; ENDOTOXIN; GASTRIN	AIM: To study the alterations of brain-gut peptides following traumatic brain injury (TBI) and to explore the underlying significance of these peptides in the complicated gastrointestinal dysfunction. METHODS: Rat models of focal traumatic brain injury were established by impact insult method, and divided into 6 groups (6 rats each group) including control group with sham operation and TBI groups at postinjury 3, 12, 24, 72 h, and d 7. Blood and proximal jejunum samples were taken at time point of each group and gross observations of gastrointestinal pathology were recorded simultaneously. The levels of vasoactive intestinal peptide (VIP) in plasma, calcitonin gene-related peptide (CGRP) and cholecystokinin (CCK) in both plasma and jejunum were measured by enzyme immunoassay (EIA). Radioimmunoassay (RIA) was used to determine the levels of VIP in jejunum. RESULTS: Gastric distension, delayed gastric emptying and intestinal dilatation with a large amount of yellowish effusion and thin edematous wall were found in TBI rats through 12 h and 72 h, which peaked at postinjury 72 h. As compared with that of control group (247.8 +/- 29.5 ng/L), plasma VIP levels were significantly decreased at postinjury 3, 12 and 24 h (106.7 +/- 34.1 ng/L, 148.7 +/- 22.8 ng/L, 132.8 +/- 21.6 ng/L, respectively), but significantly increased at 72 h (405.0 +/- 29.8 ng/L) and markedly declined on d 7 (130.7 +/- 19.3 ng/L). However, Plasma levels CCK and CGRP were significantly increased through 3 h and 7 d following TBI (126-691% increases), with the peak at 72 h. Compared with control (VIP, 13.6 +/- 1.4 ng/g; CGRP, 70.6 +/- 17.7 ng/g); VIP and CGRP levels in jejunum were significantly increased at 3 h after TBI (VIP, 35.4 +/- 5.0 ng/g; CGRP, 103.8 +/- 22.1 ng/g), and declined gradually at 12 h and 24 h (VIP, 16.5 +/- 1.8 ng/g, 5.5 +/- 1.4 ng/g; CGRP, 34.9 +/- 9.7 ng/g, 18.5 +/- 7.7 ng/g), but were significantly increased again at 72 h (VIP, 48.7 +/- 9.5 ng/g; CGRP, 142.1 +/- 24.3 ng/g), then declined in various degrees on d 7 (VIP, 3.8 +/- 1.1 ng/g; CGRP, 102.5 +/- 18.1 ng/g). The CCK levels in jejunum were found to change in a similar trend as that in plasma with the concentrations of CCK significantly increased following TBI (99-517% increases) and peaked at 72 h. CONCLUSION: Traumatic brain injury can lead to significant changes of brain-gut peptides in both plasma and small intestine, which may be involved in the pathogenesis of complicated gastrointestinal dysfunction.	[Hang, Chun-Hua; Shi, Ji-Xin; Wu, Wei; Yin, Hong-Xia] Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing 210002, Jiangsu Provinc, Peoples R China; [Li, Jie-Shou; Li, Wei-Qin] Nanjing Univ, Sch Med, Jinling Hosp, Res Inst Gen Surg, Nanjing 210002, Jiangsu Provinc, Peoples R China		Hang, CH (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, 305 E Zhongshan Rd, Nanjing 210002, Jiangsu Provinc, Peoples R China.	hang1965@public1.ptt.js.cn	Yin, Hong/AAC-5784-2020		Scientific Research Foundation of the Chinese [01Z011]	Supported by the Scientific Research Foundation of the Chinese PLA Key Medical Programs during the 10<SUP>th</SUP> Five-Year Plan Period, No. 01Z011	BROWN TH, 1989, GASTROINTEST ENDOSC, V35, P37, DOI 10.1016/S0016-5107(89)72683-3; Chen ZY, 2001, SHIJIE HUAREN XIAOHU, V9, P59; Delgado M, 1999, J IMMUNOL, V162, P1200; Du YP, 2001, WORLD J GASTROENTERO, V7, P275; ESPAT NJ, 1995, J SURG RES, V58, P719, DOI 10.1006/jsre.1995.1113; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; FORSTER ER, 1990, AM J PHYSIOL, V258, pG552, DOI 10.1152/ajpgi.1990.258.4.G552; GERNER T, 1979, SCAND J GASTROENTERO, V14, P73, DOI 10.3109/00365527909179848; Grider JR, 1987, GASTROENTEROLOGY, V92, P175, DOI 10.1016/0016-5085(87)90855-9; GRUNDY D, 1995, AM J PHYSIOL-GASTR L, V268, pG355, DOI 10.1152/ajpgi.1995.268.2.G355; Grundy PL, 2001, J NEUROTRAUM, V18, P1373, DOI 10.1089/08977150152725669; Gue M, 1996, SEMIN NEUROL, V16, P235, DOI 10.1055/s-2008-1040980; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; Hayashi K, 1997, REGUL PEPTIDES, V72, P131, DOI 10.1016/S0167-0115(97)01051-3; Higham A, 1997, GUT, V41, P24, DOI 10.1136/gut.41.1.24; JACKSON MD, 1989, ARCH PHYS MED REHAB, V70, P553; JOYCE CD, 1990, SURGERY, V108, P1097; Kao CH, 1998, AM J GASTROENTEROL, V93, P1108; Li LS, 2003, WORLD J GASTROENTERO, V9, P553, DOI 10.3748/wjg.v9.i3.553; Li W, 2000, WORLD J GASTROENTERO, V6, P93, DOI 10.3748/wjg.v6.i1.93; LI Y, 1993, J CLIN INVEST, V92, P418, DOI 10.1172/JCI116583; Ling YL, 2001, WORLD J GASTROENTERO, V7, P667; Mackay LE, 1999, J HEAD TRAUMA REHAB, V14, P435, DOI 10.1097/00001199-199910000-00004; Maggi CA, 1996, REGUL PEPTIDES, V61, P27, DOI 10.1016/0167-0115(95)00133-6; MELEAGROS L, 1994, GUT, V35, P1701, DOI 10.1136/gut.35.12.1701; NORTON JA, 1988, J NEUROSURG, V68, P62, DOI 10.3171/jns.1988.68.1.0062; Onuoha G, 2001, BURNS, V27, P17, DOI 10.1016/S0305-4179(00)00073-5; PATAKY DM, 1990, NEUROSCIENCE, V36, P247, DOI 10.1016/0306-4522(90)90366-C; PEDOTO MJ, 1995, ARCH PHYS MED REHAB, V76, P871, DOI 10.1016/S0003-9993(95)80555-9; PENDLETON RG, 1987, J PHARMACOL EXP THER, V241, P110; Pilitsis JG, 2001, NEUROL RES, V23, P227, DOI 10.1179/016164101101198389; PINCUS DW, 1990, NATURE, V343, P564, DOI 10.1038/343564a0; Rogers RC, 1996, NEUROSCI BIOBEHAV R, V20, P57, DOI 10.1016/0149-7634(95)00040-L; Said SI, 2000, REGUL PEPTIDES, V93, P21, DOI 10.1016/S0167-0115(00)00174-9; SAXE JM, 1994, J TRAUMA, V37, P581, DOI 10.1097/00005373-199410000-00010; Schwartz GJ, 1997, AM J PHYSIOL-REG I, V272, pR1726, DOI 10.1152/ajpregu.1997.272.6.R1726; Shoji E, 1997, DIGEST DIS SCI, V42, P915, DOI 10.1023/A:1018860313674; Tuncel N, 1998, ANN NY ACAD SCI, V865, P309, DOI 10.1111/j.1749-6632.1998.tb11191.x; VARRO A, 1988, NEUROSCIENCE, V26, P927, DOI 10.1016/0306-4522(88)90109-1; WANG X, 1992, CIRC SHOCK, V36, P21; Wang X, 2002, WORLD J GASTROENTERO, V8, P540, DOI 10.3748/wjg.v8.i3.540; Wang X, 1996, BRIT J PHARMACOL, V118, P2164, DOI 10.1111/j.1476-5381.1996.tb15658.x; Wang X, 1999, J NEUROIMMUNOL, V94, P95, DOI 10.1016/S0165-5728(98)00230-6; Xu MY, 1998, WORLD J GASTROENTERO, V4, P524, DOI 10.3748/wjg.v4.i6.524; Yao YL, 2001, WORLD J GASTROENTERO, V7, P399; Zittel TT, 1998, SURGERY, V123, P518, DOI 10.1067/msy.1998.88090; ZITTEL TT, 1994, ANN SURG, V219, P79, DOI 10.1097/00000658-199401000-00013	47	18	20	0	4	BAISHIDENG PUBLISHING GROUP INC	PLEASANTON	8226 REGENCY DR, PLEASANTON, CA 94588 USA	1007-9327	2219-2840		WORLD J GASTROENTERO	World J. Gastroenterol.	MAR 15	2004	10	6					875	880					6	Gastroenterology & Hepatology	Science Citation Index Expanded (SCI-EXPANDED)	Gastroenterology & Hepatology	V19UH	WOS:000208096800022	15040036				2022-02-06	
J	Betts, R; Anagli, J				Betts, R; Anagli, J			The beta- and gamma-CH2 of B27-WT's Leu(11) and Ile(18) side chains play a direct role in calpain inhibitions	BIOCHEMISTRY			English	Article							TERMINAL CONSERVED REGION; CALMODULIN-LIKE DOMAIN; HUMAN CALPASTATIN; FUNCTIONAL DOMAIN; CALCIUM; PROTEASE; PEPTIDE; LOCALIZATION; DEGRADATION; PROTEINASE	Uncontrolled activation of calpain has been linked to tissue damage after neuronal and cardiac ischemias, traumatic spine and brain injuries, and multiple sclerosis and Alzheimer's disease. In vivo, the activity of calpain is regulated by its endogenous inhibitor calpastatin. The pathological role of calpain has been attributed to an imbalance between the activities of the protease and its inhibitor. Thus, it is possible that by reimposing functional control on the protease, the progression of calpain-mediated diseases could be slowed or eliminated. B27-WT is a 27-residue peptide (DPMSSTYIEELGKREVTIPPKYRELLA) derived from calpastatin that was previously shown to be a potent inhibitor of mu- and m-calpain. Recently, we identified two hot spots (Leu(11)-Gly(12) and Thr(17)-Ile(18)-Pro(19)) within which the amino acid residues that are key to B27-WT's bioactivity are clustered. In the work described here, the most critical residues of B27-WT, Leu(11) and Ile(18), were further probed to determine the nature of their interaction with calpain. Our results demonstrate that the side chains of both residues interact with hydrophobic pockets in calpain and that each of these interactions is indispensable for effective inhibition of calpain. Direct interactions involving the beta- and gamma-CH2- of the Leu(11) and Ile(18) side chains, respectively, rather than the degree of side chain branching or hydrophobicity, seemed to play a significant role in the peptide's ability to inhibit calpain. Furthermore, the minimum peptide sequence that still retained the calpain-inhibitory potency of B27-WT was found to be MSSTYIEELGKREVTIPPKYRELL.	Henry Ford Hlth Sci Ctr, Dept Pathol, Detroit, MI 48202 USA; Karmanos Canc Inst, Protease Program, Detroit, MI 48201 USA; Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA		Anagli, J (corresponding author), Henry Ford Hlth Sci Ctr, Dept Pathol, 1 Ford Pl 5D, Detroit, MI 48202 USA.	janagli1@hfhs.org			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [P60AR020557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039075] Funding Source: NIH RePORTER; NIAMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [P60 AR20557] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS39075] Funding Source: Medline		Anagli J, 1996, EUR J BIOCHEM, V241, P948, DOI 10.1111/j.1432-1033.1996.00948.x; Averna M, 2001, BIOCHEM J, V354, P25, DOI 10.1042/0264-6021:3540025; Betts R, 2003, J BIOL CHEM, V278, P7800, DOI 10.1074/jbc.M208350200; CROALL DE, 1994, BIOCHEMISTRY-US, V33, P13223, DOI 10.1021/bi00249a008; De Tullio R, 1999, BIOCHEM J, V343, P467; Hao LY, 2000, BIOCHEM BIOPH RES CO, V279, P756, DOI 10.1006/bbrc.2000.4040; Hosfield CM, 1999, EMBO J, V18, P6880, DOI 10.1093/emboj/18.24.6880; ISHIMA R, 1991, FEBS LETT, V294, P64, DOI 10.1016/0014-5793(91)81344-8; James T, 1998, J NEUROSCI RES, V51, P218, DOI 10.1002/(SICI)1097-4547(19980115)51:2<218::AID-JNR10>3.0.CO;2-4; KAWASAKI H, 1989, J BIOCHEM, V106, P274, DOI 10.1093/oxfordjournals.jbchem.a122844; Lokuta MA, 2003, P NATL ACAD SCI USA, V100, P4006, DOI 10.1073/pnas.0636533100; MA H, 1994, J BIOL CHEM, V269, P24430; MAKI M, 1987, FEBS LETT, V223, P174, DOI 10.1016/0014-5793(87)80531-8; MAKI M, 1989, J BIOL CHEM, V264, P18866; MAKI M, 1988, J BIOL CHEM, V263, P1787; Moldoveanu T, 2002, CELL, V108, P649, DOI 10.1016/S0092-8674(02)00659-1; Molinari M, 1997, J MEMBRANE BIOL, V156, P1, DOI 10.1007/s002329900181; Ono Y, 1998, BIOCHEM BIOPH RES CO, V245, P289, DOI 10.1006/bbrc.1998.8085; Pal GP, 2001, J BIOL CHEM, V276, P47233, DOI 10.1074/jbc.M105149200; Pinton P, 2001, DRUG DEVELOP RES, V52, P558, DOI 10.1002/ddr.1159; PONTREMOLI S, 1986, ANNU REV BIOCHEM, V55, P455, DOI 10.1146/annurev.biochem.55.1.455; Salvesen, 1986, PROTEINASE INHIBITOR, P23; SCHOLLMEYER JE, 1988, SCIENCE, V240, P911, DOI 10.1126/science.2834825; TAKANO E, 1995, FEBS LETT, V362, P93, DOI 10.1016/0014-5793(95)00219-Y; Todd B, 2003, J MOL BIOL, V328, P131, DOI 10.1016/S0022-2836(03)00274-2; UEMORI T, 1990, BIOCHEM BIOPH RES CO, V166, P1485, DOI 10.1016/0006-291X(90)91035-Q; Wang KKW, 1998, ARCH BIOCHEM BIOPHYS, V356, P187, DOI 10.1006/abbi.1998.0748; YANG HQ, 1994, J BIOL CHEM, V269, P18977; YOSHIZAWA T, 1995, FEBS LETT, V358, P101, DOI 10.1016/0014-5793(94)01401-L	29	18	18	0	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0006-2960			BIOCHEMISTRY-US	Biochemistry	MAR 9	2004	43	9					2596	2604		10.1021/bi0359832			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	800QB	WOS:000220041700025	14992597				2022-02-06	
J	Chen, T; Willoughby, KA; Ellis, EF				Chen, T; Willoughby, KA; Ellis, EF			Group I metabotropic receptor antagonism blocks depletion of calcium stores and reduces potentiated capacitative calcium entry in strain-injured neurons and astrocytes	JOURNAL OF NEUROTRAUMA			English	Article						AIDA; mGluR; tissue culture; traumatic brain injury	STRETCH-INDUCED INJURY; TRAUMATIC INJURY; GLUTAMATE RECEPTORS; CORTICAL-NEURONS; ARACHIDONIC-ACID; INFLUX; ACTIVATION; RELEASE; VITRO; CELLS	Antagonism of the group I metabotropic receptor subtype I (mGluR(1)) with (RS)-1-aminoindan-1,5-dicarboxylic acid (AIDA) has been shown to reduce deficits after in vivo or in vitro traumatic brain injury. We have previously demonstrated that AIDA prevents elevation of astrocyte IP3 subsequent to injury-induced activation of mGluRs and phospholipase C. Since IP3 can cause release of intracellular Ca2+ stores we tested the hypothesis that pre- or post-injury treatment with AIDA can affect (1) the depletion of Ca2+ stores which occurs soon after strain injury of cultured neurons and astrocytes and (2) the delayed potentiation of capacitative calcium entry in strain-injured neurons. Astrocyte or neuronal plus glial cultures were grown on Silastic membranes that were subjected to a 50-msec pulse of compressed gas, which caused membrane displacement and biaxial strain (stretch) injury of the adhering cells. Cells were treated 10 min before or immediately after injury with 100 muM AIDA and the intracellular free Ca2+ ([Ca2+](i)) response to thapsigargin, which inhibits the ability of the stores to sequester Ca2+, was measured at 15 min or 3 h after injury. AIDA pre- or post-injury treatment prevented the depletion of intracellular calcium stores at 15 min post-injury in astrocytes and neurons and reduced the potentiated neuronal capacitative calcium influx 3 h after injury. Since Ca2+ and Ca2+ stores influence many factors, including neuronal excitability, plasticity, protein synthesis, and neuronal-glial interactions, prevention of Ca2+ store depletion and subsequent exaggerated capacitative calcium entry may be an important subcellular mechanism by which antagonism of mGluR1 receptors exert an injury-reducing effect. More globally, the results further emphasize the importance of altered signaling and calcium regulatory mechanisms in the immediate and delayed sequelae of traumatic brain injury.	Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA		Ellis, EF (corresponding author), Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, POB 980613, Richmond, VA 23298 USA.	eellis@mail2.vcu.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL057869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS027214] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL 57869] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 27214, NS 07288] Funding Source: Medline		Allen JW, 2001, EXP NEUROL, V169, P449, DOI 10.1006/exnr.2001.7672; AMRUTHESH SC, 1993, J NEUROCHEM, V61, P150, DOI 10.1111/j.1471-4159.1993.tb03550.x; BRORSON JR, 1991, J NEUROSCI, V11, P4024; Chen T, 2003, J NEUROTRAUM, V20, P1126; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Faden AI, 2001, EXP NEUROL, V167, P435, DOI 10.1006/exnr.2000.7577; Floyd CL, 2001, GLIA, V33, P12, DOI 10.1002/1098-1136(20010101)33:1<12::AID-GLIA1002>3.0.CO;2-V; FLOYD CL, 2004, IN PRESS J NEUROTRAU; FLOYD CL, 1999, C J NEUROTRAUMA, V16, P961; Garaschuk O, 1997, J PHYSIOL-LONDON, V502, P13, DOI 10.1111/j.1469-7793.1997.013bl.x; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Lyeth BG, 2001, EXP NEUROL, V169, P191, DOI 10.1006/exnr.2001.7643; McKinney JS, 1996, STROKE, V27, P934, DOI 10.1161/01.STR.27.5.934; Mukhin A, 1996, J NEUROSCI, V16, P6012; POENIE M, 1990, CELL CALCIUM, V2, P85; PUTNEY JW, 1997, CAPACITATIVE CALCIUM; ROE MW, 1990, CELL CALCIUM, V11, P63, DOI 10.1016/0143-4160(90)90060-8; Rzigalinski BA, 1997, J NEUROCHEM, V68, P289; Rzigalinski BA, 1999, J BIOL CHEM, V274, P175, DOI 10.1074/jbc.274.1.175; Rzigalinski BA, 1998, J NEUROCHEM, V70, P2377; Sakaki Y, 1997, J NEUROBIOL, V32, P62, DOI 10.1002/(SICI)1097-4695(199701)32:1<62::AID-NEU6>3.0.CO;2-C; Schoepp DD, 1999, NEUROPHARMACOLOGY, V38, P1431, DOI 10.1016/S0028-3908(99)00092-1; Schreiber D., 1995, P 1995 INT RES C BIO, P233; Verkhratsky A, 2002, EUR J PHARMACOL, V447, P141, DOI 10.1016/S0014-2999(02)01838-1; Weber JT, 2001, J BIOL CHEM, V276, P1800, DOI 10.1074/jbc.M009209200; Weber JT, 1999, CELL CALCIUM, V26, P289, DOI 10.1054/ceca.1999.0082; WILLAN RL, 1990, MULTIPURPOSE TREE SP, V2, P11; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921	28	18	21	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR	2004	21	3					271	281		10.1089/089771504322972068			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	806CI	WOS:000220411600005	15115602				2022-02-06	
J	Petridou, E; Kedikoglou, S; Belechri, M; Ntouvelis, E; Dessypris, N; Trichopoulos, D				Petridou, E; Kedikoglou, S; Belechri, M; Ntouvelis, E; Dessypris, N; Trichopoulos, D			The mosaic of equestrian-related injuries in Greece	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	6th World Conference on Injury Prevention and Control	MAY 12-15, 2002	MONTREAL, CANADA			horse racing; equestrian sport; farm; horse injury; severity; helmet protective devices; injury prevention	TRAUMA; DIAGNOSIS; ANIMALS; HORSES	Background: This study ainis to estimate the burden and describe the profile of equestrian injuries in Greece, where horses, donkeys, and mules are still used in agriculture and where horse riding is a popular leisure activity. Methods: Prospectively collected information on 140,823 injuries reported in the national Emergency Department Injury Surveillance System was examined and 244 equestrian-related injuries that occurred during farming, equestrian sports, or horse racing were analyzed. Results: The estimated countrywide injury incidence for farming and equestrian sports combined was 21 per 100,000 person-years, but it was 160 times higher for horse-racing personnel. Men had higher rates of racing injuries and women had higher rates of equestrian sport injuries. Fractures accounted for 39.0% of injuries in horse racing and 30.5% in farming; head injuries accounted for approximately 50% of injuries among farmers. Farming injuries were more serious, with 25% requiring hospitalization. Analysis through the Barell matrix pointed to the role of spurs in the causation of ankle fractures and dislocations and the likely contribution of helmets in preventing traumatic brain injuries. conclusion: Equestrian-related injuries are a serious but underappreciated health problem and merit targeted prevention efforts for each category affected.	Univ Athens, Sch Med, Dept Hyg & Epidemiol, GR-11527 Athens, Greece; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA		Petridou, E (corresponding author), Univ Athens, Sch Med, Dept Hyg & Epidemiol, 75 Mikras Asias, GR-11527 Athens, Greece.	epetrid@rned.uoa.gr		PETRIDOU, ELENI/0000-0003-3695-3439			[Anonymous], 1996, EUR HOM LEIS SURV SY; Ball DJ, 1998, SPORTS EXERC INJURY, V4, P3; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; BIXBYHAMMETT D, 1990, SPORTS MED, V9, P36, DOI 10.2165/00007256-199009010-00004; Chitnavis JP, 1996, INJURY, V27, P103, DOI 10.1016/0020-1383(95)00176-X; CHRISTEY GL, 1994, J FAM PRACTICE, V39, P148; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; Dessypris N, 2002, J Cancer Epidemiol Prev, V7, P123; Frankel HL, 1998, AM SURGEON, V64, P151; Griffen M, 2002, SOUTHERN MED J, V95, P441, DOI 10.1097/00007611-200204000-00013; GROSSMAN JAI, 1978, JAMA-J AM MED ASSOC, V240, P1881, DOI 10.1001/jama.240.17.1881; Kanis JA, 2002, LANCET, V359, P1929, DOI 10.1016/S0140-6736(02)08761-5; Kriss TC, 1997, J TRAUMA, V43, P97, DOI 10.1097/00005373-199707000-00022; Lloyd R G, 1987, Br J Sports Med, V21, P22; McGhee C N, 1987, Br J Neurosurg, V1, P131, DOI 10.3109/02688698709034348; McLatchie G R, 1979, Br J Sports Med, V13, P29; Norwood S, 2000, J TRAUMA, V48, P740, DOI 10.1097/00005373-200004000-00025; ORNEHULT L, 1989, ACCIDENT ANAL PREV, V21, P377, DOI 10.1016/0001-4575(89)90029-8; Paix BR, 1999, BRIT J SPORT MED, V33, P46, DOI 10.1136/bjsm.33.1.46; PRESS JM, 1995, CLIN J SPORT MED, V5, P236, DOI 10.1097/00042752-199510000-00005; Sorli J M, 2000, Inj Prev, V6, P59, DOI 10.1136/ip.6.1.59; Temes RT, 1997, J TRAUMA, V43, P492, DOI 10.1097/00005373-199709000-00017; Watt GM, 1996, SPORTS MED, V22, P187, DOI 10.2165/00007256-199622030-00005; Whitlock MR, 1999, BRIT J SPORT MED, V33, P212, DOI 10.1136/bjsm.33.3.212	24	18	18	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAR	2004	56	3					643	647		10.1097/01.TA.0000053470.38129.F4			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	808CM	WOS:000220547200035	15128138				2022-02-06	
J	Mezey, E				Mezey, E			On bone marrow stem cells and openmindedness	STEM CELLS AND DEVELOPMENT			English	Article							TRAUMATIC BRAIN INJURY; RAT SPINAL-CORD; STROMAL CELLS; FUNCTIONAL RECOVERY; IN-VIVO; TRANSPLANTATION; DIFFERENTIATION; LIVER; EXPRESSION; FUSION	Several lines of evidence support the concept that pluripotent stem cells reside in the hematopoietic system of adults, but each has been questioned for valid reasons. Thus, the results reported to date after infusion of bone marrow stem cells, may be due to cell fusion, non-physiological de-differentiation and subsequent differentiation to lineages directed by the culture environment, microchimerism, or transdifferentiation. Several authors have suggested complex ways of investigating each of these possibilities, but in no case are any of the suggested protocols complete, nor will they rule out other possible causes of the results observed to date. Determining the nature, origin, and characteristics of adult cells is important and interesting, but the important question at this time is not what happens physiologically, but what we can do with these cells therapeutically. Research addressing therapeutic endpoints now takes a pivotal position in studies of nonembryonic stem cells.	NINDS, NIH, Bethesda, MD 20892 USA		Mezey, E (corresponding author), NINDS, NIH, Bldg 36,Rm 3D-10,9000 Rockville Pike, Bethesda, MD 20892 USA.	mezeye@ninds.nih.gov	Mezey, Eva/A-8105-2008	Mezey, Eva/0000-0002-5907-4691	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR) [ZIADE000714] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR) [Z01DE000714] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [Z01NS002996] Funding Source: NIH RePORTER		AHKONG QF, 1973, NATURE-NEW BIOL, V242, P215, DOI 10.1038/newbio242215a0; Akiyama Y, 2002, J NEUROSCI, V22, P6623; Anderson DJ, 2001, NAT MED, V7, P393, DOI 10.1038/86439; ANTONOV PA, 1990, BIOCHIM BIOPHYS ACTA, V1051, P279, DOI 10.1016/0167-4889(90)90134-Y; Bateman A, 2000, CANCER RES, V60, P1492; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Chen JL, 2001, J NEUROL SCI, V189, P49, DOI 10.1016/S0022-510X(01)00557-3; Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080; Gasser A, 1999, INFECT IMMUN, V67, P395, DOI 10.1128/IAI.67.1.395-402.1999; Guidotti JE, 2003, J BIOL CHEM, V278, P19095, DOI 10.1074/jbc.M300982200; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Hess DC, 2002, STROKE, V33, P1362, DOI 10.1161/01.STR.0000014925.09415.C3; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Li Y, 2000, J CEREBR BLOOD F MET, V20, P1311, DOI 10.1097/00004647-200009000-00006; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Lu DY, 2001, J NEUROTRAUM, V18, P813, DOI 10.1089/089771501316919175; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Mahmood A, 2001, J NEUROSURG, V94, P589, DOI 10.3171/jns.2001.94.4.0589; Mezey E, 2003, SCIENCE, V299; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Mezey E, 2003, P NATL ACAD SCI USA, V100, P1364, DOI 10.1073/pnas.0336479100; Mikkola I, 2002, SCIENCE, V297, P110, DOI 10.1126/science.1067518; OHNOSHOSAKU T, 1984, BIOCHEM BIOPH RES CO, V120, P138, DOI 10.1016/0006-291X(84)91424-4; Okamoto R, 2003, TRENDS MOL MED, V9, P286, DOI 10.1016/S1471-4914(03)00110-2; Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898; REH TA, 1995, SEMIN CELL BIOL, V6, P137, DOI 10.1006/scel.1995.0019; Sasaki M, 2001, GLIA, V35, P26, DOI 10.1002/glia.1067; Spees JL, 2003, P NATL ACAD SCI USA, V100, P2397, DOI 10.1073/pnas.0437997100; Taylor MV, 2002, CURR BIOL, V12, pR224, DOI 10.1016/S0960-9822(02)00757-1; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Tran SD, 2003, LANCET, V361, P1084, DOI 10.1016/S0140-6736(03)12894-2; Vassilopoulos G, 2003, NATURE, V422, P901, DOI 10.1038/nature01539; Wang X, 2002, AM J PATHOL, V161, P565, DOI 10.1016/S0002-9440(10)64212-5; Willing AE, 2003, CELL TRANSPLANT, V12, P449, DOI 10.3727/000000003108746885; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729	36	18	18	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1547-3287	1557-8534		STEM CELLS DEV	Stem Cells Dev.	FEB	2004	13	1					147	152		10.1089/154732804773099344			6	Cell & Tissue Engineering; Hematology; Medicine, Research & Experimental; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Hematology; Research & Experimental Medicine; Transplantation	843CR	WOS:000223053700014	15068702				2022-02-06	
J	Ptak, R; Schnider, A				Ptak, R; Schnider, A			Disorganised memory after right dorsolateral prefrontal damage	NEUROCASE			English	Article							FRONTAL-LOBE DAMAGE; N-BACK TASKS; WORKING-MEMORY; DECISION-MAKING; ACQUIRED SOCIOPATHY; CORTEX; LESIONS; ORGANIZATION; ACTIVATION; DEFICITS	Neurophysiological and functional brain imaging studies suggest the importance of dorsolateral area 9/46 for modality-independent working memory. However, the behavioural manifestations following isolated damage to this area have not been clearly outlined. Here, we describe the dramatic derangement of pragmatic memory after circumscribed lesion of the right area 9/46. A 52 year-old woman had suffered a traumatic brain injury 13 years ago and sought help for what she thought was a severe memory disorder. She regularly missed appointments and had gradually lost all her friends. She had tried different strategies to compensate for her memory problem, such as writing notes on her wrist or using electronic organizers. Intelligence, attention, verbal long-term memory, and executive functions were normal. Furthermore, experimental exploration demonstrated intact time estimation, attribution of memories to ongoing reality, and anticipation of outcomes. However, she failed to rehearse and manipulate information in working memory (n-back task), confirming the findings of functional imaging studies that the mid-dorsolateral prefrontal cortex is involved in mental manipulation of information. This case exemplifies that an isolated lesion of the right area 9/46 may induce severe failure to schedule actions and memory retrieval, a disorder leading to severely disorganised behaviour and disability.	HUG, Serv Reeduc, CH-1211 Geneva 14, Switzerland		Ptak, R (corresponding author), HUG, Serv Reeduc, 26 Av Beau Sejour, CH-1211 Geneva 14, Switzerland.	Radek.Ptak@hcuge.ch	Ptak, Radek/A-8661-2010	Ptak, Radek/0000-0003-4708-9201			Alderman N., 1996, BADS BEHAV ASSESSMEN; Baddeley A., 1990, HUMAN MEMORY; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; Bechara A, 1998, J NEUROSCI, V18, P428; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1999, J NEUROSCI, V19, P5473; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Braver TS, 2001, NEUROIMAGE, V14, P48, DOI 10.1006/nimg.2001.0791; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; Carlson S, 1998, CEREB CORTEX, V8, P743, DOI 10.1093/cercor/8.8.743; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; D'Esposito M, 1998, NEUROIMAGE, V8, P274, DOI 10.1006/nimg.1998.0364; D'Esposito M, 1999, NEUROPSYCHOLOGIA, V37, P1303, DOI 10.1016/S0028-3932(99)00021-4; Damasio A., 1994, DESCARTES ERROR EMOT; Damasio A.R., 1993, CLIN NEUROPSYCHOLOGY, P409; Damasio AR, 1996, PREFRONTAL CORTEX EX, P36, DOI [10.1093/acprof:oso/9780198524410.003.0004, DOI 10.1093/ACPROF:OSO/9780198524410.003.0004]; DELUCA J, 1995, J CLIN EXP NEUROPSYC, V17, P100, DOI 10.1080/13803399508406586; Duncan J, 1996, COGNITIVE PSYCHOL, V30, P257, DOI 10.1006/cogp.1996.0008; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; Fuster JM, 2001, NEURON, V30, P319, DOI 10.1016/S0896-6273(01)00285-9; Goel V, 1997, BRAIN, V120, P1805, DOI 10.1093/brain/120.10.1805; JANOWSKY JS, 1989, NEUROPSYCHOLOGIA, V27, P1043, DOI 10.1016/0028-3932(89)90184-X; Johnson MK, 1997, BRAIN COGNITION, V34, P189, DOI 10.1006/brcg.1997.0873; Kolb B., 1990, FUNDAMENTALS HUMAN N; Kopelman MD, 1997, NEUROPSYCHOLOGIA, V35, P1533, DOI 10.1016/S0028-3932(97)00076-6; LHERMITTE F, 1986, ANN NEUROL, V19, P326, DOI 10.1002/ana.410190404; Manes F, 2002, BRAIN, V125, P624, DOI 10.1093/brain/awf049; Martin I, 2003, BRAIN LANG, V85, P451, DOI 10.1016/S0093-934X(03)00070-1; Martinkauppi S, 2000, CEREB CORTEX, V10, P889, DOI 10.1093/cercor/10.9.889; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MILNER B, 1985, HUM NEUROBIOL, V4, P137; MILNER B, 1991, NEUROPSYCHOLOGIA, V29, P601, DOI 10.1016/0028-3932(91)90013-X; Owen AM, 1999, EUR J NEUROSCI, V11, P567, DOI 10.1046/j.1460-9568.1999.00449.x; Petrides M, 2002, P NATL ACAD SCI USA, V99, P5649, DOI 10.1073/pnas.072092299; Petrides M, 1994, HDB NEUROPSYCHOLOGY, V9, P59; Pochon JB, 2002, P NATL ACAD SCI USA, V99, P5669, DOI 10.1073/pnas.082111099; PRICE BH, 1990, BRAIN, V113, P1383, DOI 10.1093/brain/113.5.1383; Ptak R, 2001, BEHAV NEUROSCI, V115, P993, DOI 10.1037//0735-7044.115.5.993; Ragland JD, 2002, NEUROPSYCHOLOGY, V16, P370, DOI 10.1037//0894-4105.16.3.370; Riesen JM, 2001, J NEUROL, V248, P27, DOI 10.1007/s004150170266; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; Rowe AD, 2001, BRAIN, V124, P600, DOI 10.1093/brain/124.3.600; Rueckert L, 1996, NEUROPSYCHOLOGIA, V34, P953, DOI 10.1016/0028-3932(96)00016-4; Sakai K, 2002, NAT NEUROSCI, V5, P479, DOI 10.1038/nn846; SAVER JL, 1991, NEUROPSYCHOLOGIA, V29, P1241, DOI 10.1016/0028-3932(91)90037-9; Schnider A, 1999, NAT NEUROSCI, V2, P677, DOI 10.1038/10236; Schnider A, 2003, NAT REV NEUROSCI, V4, P662, DOI 10.1038/nrn1179; Schnider A, 1996, BRAIN, V119, P1365, DOI 10.1093/brain/119.4.1365; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; SHALLICE T, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P125; Shallice T., 1998, FRONTAL CORTEX, P22; Shammi P, 1999, BRAIN, V122, P657, DOI 10.1093/brain/122.4.657; SHAW C, 1994, NEUROPSYCHOLOGIA, V32, P857, DOI 10.1016/0028-3932(94)90023-X; Stuss DT, 2001, BRAIN, V124, P279, DOI 10.1093/brain/124.2.279; Wechsler D, 1987, WECHSLER MEMORY SCAL; [No title captured]	58	18	18	0	12	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1355-4794			NEUROCASE	Neurocase	FEB	2004	10	1					52	59		10.1080/13554790490960495			8	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	830GP	WOS:000222110400007	15849160				2022-02-06	
J	Ryan, JP; Atkinson, TM; Dunham, KT				Ryan, JP; Atkinson, TM; Dunham, KT			Sports-related and gender differences on neuropsychological measures of frontal lobe functioning	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						perceptual-motor speed; verbal fluency; sports; gender	SEX-DIFFERENCES; PERFORMANCE; ABILITIES; EXPERTISE; WOMEN	Objective: To determine similarities and differences in the performance of female and male athletes on neuropsychological measures of frontal lobe functioning. Design: A cross-sectional study of male and female college-aged athletes involved in one of the following sports: hockey, basketball, softball, lacrosse, soccer, swimming, and track. Setting: Division III college. Participants: A total of 262 athletes (male, n = 157; female, n 105) participated in the study. Main Outcome Measures: Controlled Oral Word Association (letters F, A, S), Cognitive Assessment System (Planned Codes, Planned Connections, Number Detection), and WAIS-R-NI Vocabulary were administered to all athletes. Results: MANCOVA was performed with gender and sport as fixed factors. Female athletes displayed faster and more accurate performance on perceptual-motor tasks (P < 0.01) and on one condition of a verbal fluency task (P < 0.01) compared with male athletes. Male hockey athletes showed superior perceptual-motor speed and accuracy (P < 0.01) compared with male athletes in the track/swimming group. Evaluators were naive to athletes' gender and sport. Conclusion: Gender- and sport-specific performances on perceptual-motor and verbal fluency tasks were found. Adding cognitive components to base functions eliminates gender- and sports-related distinctions, suggesting that existing differences are related to basic, fundamental skills, which are inherent and practiced within the respective sport. Understanding the differences and similarities across sports and gender on various neurocognitive measures is relevant for determining group differences in studies examining the consequences of mild traumatic brain injury among athletes.	SUNY Coll Plattsburgh, Dept Psychol, Plattsburgh, NY 12901 USA; Univ Virginia, Dept Psychol, Charlottesville, VA 22903 USA		Ryan, JP (corresponding author), SUNY Coll Plattsburgh, Dept Psychol, 101 Broad St, Plattsburgh, NY 12901 USA.	Jeanne.Ryan@Plattsburgh.edu					Adam JJ, 1992, J SPORT SCI, V10, P261, DOI 10.1080/02640419208729925; Bailes JE, 2001, NEUROSURGERY, V48, P26, DOI 10.1097/00006123-200101000-00005; Bird S, 2001, J SPORT SCI, V19, P243, DOI 10.1080/026404101750158295; Caplan P.J., 1997, GENDER DIFFERENCES H; CHANCE JE, 1971, PERCEPT PSYCHOPHYS, V9, P33, DOI 10.3758/BF03213024; CHATTERJEE S, 1995, SOC BIOL, V42, P124; CONNOR JM, 1977, DEV PSYCHOL, V13, P293, DOI 10.1037/0012-1649.13.3.293; COX JS, 1984, AM J SPORT MED, V12, P241, DOI 10.1177/036354658401200315; Dabbs JM, 1998, EVOL HUM BEHAV, V19, P89, DOI 10.1016/S1090-5138(97)00107-4; Das JP, 1997, COGNITIVE ASSESSMENT; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; GARLAND DJ, 1990, PERCEPT MOTOR SKILL, V70, P1299, DOI 10.2466/PMS.70.4.1299-1314; Halpern D, 2000, SEX DIFFERENCES COGN; KIMURA D, 1983, CAN J PSYCHOL, V37, P19, DOI 10.1037/h0080696; Kimura D., 1999, SEX COGNITION; Kioumourtzoglou E, 1998, PERCEPT MOTOR SKILL, V86, P899, DOI 10.2466/pms.1998.86.3.899; LEWIS DA, 1986, SPORTS MED, V3, P357, DOI 10.2165/00007256-198603050-00005; Lezak MD, 1976, NEUROPSYCHOLOGICAL A; Lidor R, 1998, PERCEPT MOTOR SKILL, V86, P279, DOI 10.2466/pms.1998.86.1.279; MAJERES RL, 1988, INTELLIGENCE, V12, P149, DOI 10.1016/0160-2896(88)90013-X; McKeever CK, 2003, APPL NEUROPSYCHOL, V10, P4, DOI 10.1207/S15324826AN1001_2; MCKEEVER WF, 1995, LEARN INDIVID DIFFER, V7, P323, DOI 10.1016/1041-6080(95)90005-5; MCPHERSON SL, 1990, RES Q EXERCISE SPORT, V70, P369; MENDEZ MF, 1995, INT J PSYCHIAT MED, V25, P249, DOI 10.2190/CUMK-THT1-X98M-WB4C; Ripoll H, 1997, J SPORT SCI, V15, P573, DOI 10.1080/026404197367001; Schatz P, 2003, APPL NEUROPSYCHOL, V10, P42, DOI 10.1207/S15324826AN1001_6; Sowell ER, 2001, J NEUROSCI, V21, P8819, DOI 10.1523/JNEUROSCI.21-22-08819.2001; Thein LA, 1996, J ORTHOP SPORT PHYS, V23, P134, DOI 10.2519/jospt.1996.23.2.134; Wechsler, 1997, WECHSLER ADULT INTEL; WEISS EM, 2002, SCIENCE DIRECT   DEC, P15; Wilmore J H, 1979, Can J Appl Sport Sci, V4, P103	31	18	19	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JAN	2004	14	1					18	24		10.1097/00042752-200401000-00004			7	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Physiology; Sport Sciences	943BM	WOS:000230326800004	14712162				2022-02-06	
J	Peasley, MA; Shi, RY				Peasley, MA; Shi, RY			Ischemic insult exacerbates acrolein-induced conduction loss and axonal membrane disruption in guinea pig spinal cord white matter	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						neurotrauma; oxygen-glucose deprivation; reperfusion; membrane; metabolism	AORTIC-ANEURYSM REPAIR; POLYETHYLENE-GLYCOL; LIPID-PEROXIDATION; INJURY; MODEL; GLUTATHIONE; PROTEINS; BRAIN; RAT	Cellular destruction following ischemic insult may be due to secondary injury mechanisms, not the oxygen-glucose deprivation itself We have examined the effect of acrolein, an aldehyde product of lipid peroxidation (LPO) and oxidative stress, on the axons in isolated guinea pig spinal cord white matter following ischemic insult. We have found that acrolein at 50 muM, which is unharmful to spinal cord when applied alone, causes action potential conduction failure and membrane disruption following I to 2 h of exposure when applied during the reperfusion period. Ischemic insult also exacerbates the effect of acrolein at 200 [M. which does inflict functional and anatomical damage when applied alone. Unlike metabolic poisoning, acrolein-mediated damage is not a function of axonal size and does not affect the refractoriness in response to dual and multiple stimuli. These results indicate that spinal cord axons, in addition to experiencing elevated free radicals, are more vulnerable to acrolein attack when the level of oxygen and glucose is low. We conclude that free radicals and lipid peroxidation in general, and acrolein in specific, may play a critical role in cellular destruction and functional loss in such injury. (C) 2003 Elsevier B.V. All rights reserved.	Purdue Univ, Sch Vet Med, Ctr Paralysis Res, Dept Basic Med Sci, W Lafayette, IN 47907 USA		Shi, RY (corresponding author), Purdue Univ, Sch Vet Med, Ctr Paralysis Res, Dept Basic Med Sci, W Lafayette, IN 47907 USA.						ADAMS JD, 1993, FREE RADICAL BIO MED, V15, P187, DOI 10.1016/0891-5849(93)90058-3; ALLEN BT, 1995, VASCULAR SURG THEORY, P1402; Baldwin SA, 1998, J NEUROSURG, V88, P874, DOI 10.3171/jns.1998.88.5.0874; Coselli JS, 1997, ANN THORAC SURG, V63, P28, DOI 10.1016/S0003-4975(96)01029-6; DENNIS KJ, 1990, LIPIDS, V25, P460, DOI 10.1007/BF02538089; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Hall ED, 1996, ADV NEUROL, V71, P247; Kanellopoulos GK, 1997, STROKE, V28, P2532, DOI 10.1161/01.STR.28.12.2532; Kehrer JP, 2000, TOXICOL SCI, V57, P6, DOI 10.1093/toxsci/57.1.6; Lang-Lazdunski L, 2000, EUR J CARDIO-THORAC, V18, P174, DOI 10.1016/S1010-7940(00)00430-9; Lovell MA, 2001, NEUROBIOL AGING, V22, P187, DOI 10.1016/S0197-4580(00)00235-9; Lucas JH, 1998, J NEUROPATH EXP NEUR, V57, P937, DOI 10.1097/00005072-199810000-00006; Lucas JH, 2002, J NEUROTRAUM, V19, P763, DOI 10.1089/08977150260139138; Luo J, 2002, SPINAL CORD, V40, P656, DOI 10.1038/sj.sc.3101363; Nardini M, 2002, TOXICOLOGY, V170, P173, DOI 10.1016/S0300-483X(01)00540-6; Peasley MA, 2002, AM J PHYSIOL-CELL PH, V283, pC980, DOI 10.1152/ajpcell.00591.2001; Safi HJ, 1998, ANN THORAC SURG, V66, P1204, DOI 10.1016/S0003-4975(98)00781-4; SANDLER AN, 1976, J NEUROSURG, V45, P638, DOI 10.3171/jns.1976.45.6.0638; Satoh K, 1999, ANAL BIOCHEM, V270, P323, DOI 10.1006/abio.1999.4073; Shi R, 1999, J NEUROPHYSIOL, V81, P2406, DOI 10.1152/jn.1999.81.5.2406; Shi R, 1997, NEUROSCIENCE, V77, P553, DOI 10.1016/S0306-4522(96)00477-0; Shi R, 2002, NEUROSCIENCE, V115, P337, DOI 10.1016/S0306-4522(02)00457-8; Shi R, 2000, J NEUROCYTOL, V29, P633, DOI 10.1023/A:1010879219775; Shi R, 2002, NEUROSCIENCE, V110, P765, DOI 10.1016/S0306-4522(01)00596-6; Shi R, 1996, J NEUROPHYSIOL, V76, P1572, DOI 10.1152/jn.1996.76.3.1572; Shi R, 2000, NEUROSCIENCE, V98, P157, DOI 10.1016/S0306-4522(00)00096-8; Shi RY, 2000, J NEUROPHYSIOL, V84, P1763, DOI 10.1152/jn.2000.84.4.1763; TOYOKUNI S, 1994, P NATL ACAD SCI USA, V91, P2616, DOI 10.1073/pnas.91.7.2616; White BC, 2000, J NEUROL SCI, V179, P1, DOI 10.1016/S0022-510X(00)00386-5; YOUNG W, 1993, RES P ARNMD, V71, P191; [No title captured]	31	18	20	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X			J NEUROL SCI	J. Neurol. Sci.	DEC 15	2003	216	1					23	32		10.1016/S0022-510X(03)00201-6			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	748DH	WOS:000186846600004	14607299				2022-02-06	
J	Muller, K; Waterloo, K; Romner, B; Wester, K; Ingebrigtsen, T				Muller, K; Waterloo, K; Romner, B; Wester, K; Ingebrigtsen, T			Mild head injuries: Impact of a national strategy for implementation of management guidelines	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						head injury; management; guidelines; implementation; guideline compliance	TRAUMATIC BRAIN-INJURY; COMPUTED-TOMOGRAPHY; HOSPITALS	Background. A national survey in 1996 showed insufficient routines for management of patients with mild head injuries in Norwegian hospitals. Since then, the Scandinavian Guidelines for Management of Mild Head Injuries have been published. Methods. A cross-sectional questionnaire survey of management practice was performed in all 59 hospitals in 2002. We compared the results with figures from 1996 and evaluated guideline compliance. Results. The proportion of noncompliant hospitals was reduced (p = 0.02) from 52% to 31%. The proportion assessing the patient's level of consciousness according to the Glasgow Coma Scale increased (p = 0.001) from 49% to 80%. The proportion requiring a normal computed tomographic scan if a patient with a history of loss of consciousness was to be sent home from the accident and emergency department increased (p < 0.001) from 1 (2%) to 13 (19%). Conclusion. The Scandinavian Guidelines for Management of Mild Head Injuries have had a significant impact on management practice in Norwegian hospitals.	Univ Hosp N Norway, Dept Neurosurg, N-9038 Tromso, Norway; Univ Hosp N Norway, Dept Neurol, N-9038 Tromso, Norway; Univ Bergen, Inst Surg Sci, Bergen, Norway; Haukeland Hosp, Dept Neurosurg, N-5021 Bergen, Norway; Univ Lund Hosp, Dept Neurosurg, S-22185 Lund, Sweden		Ingebrigtsen, T (corresponding author), Univ Hosp N Norway, Dept Neurosurg, N-9038 Tromso, Norway.	tor.ingebrigtsen@unn.no		Ingebrigtsen, Tor/0000-0001-5966-9786			Bellner J, 1999, ACTA NEUROL SCAND, V100, P355; Bero LA, 1998, BMJ-BRIT MED J, V317, P465; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; DAVIS DA, 1995, JAMA-J AM MED ASSOC, V274, P700; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hesdorffer DC, 2002, J TRAUMA, V52, P1202, DOI 10.1097/00005373-200206000-00031; INBEBRIGTSEN T, 2000, TIDSSKR NOR LAEGEFOR, V120, P1985; Ingebrigtsen T, 1996, ACTA NEUROL SCAND, V93, P207; Ingebrigtsen T, 1997, ACTA NEUROL SCAND, V95, P51, DOI 10.1111/j.1600-0404.1997.tb00068.x; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; KLAUBER MR, 1989, NEUROSURGERY, V24, P31, DOI 10.1227/00006123-198901000-00005; Marion DW, 2000, CRIT CARE MED, V28, P16, DOI 10.1097/00003246-200001000-00003; NARAYAN RK, 1995, J NEUROTRAUM, V12, P907, DOI 10.1089/neu.1995.12.907; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; STARMARK JE, 1988, ACTA NEUROCHIR, V91, P12, DOI 10.1007/BF01400521; Stiell IG, 2000, NEW ENGL J MED, V343, P1570; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x	18	18	18	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	DEC	2003	55	6					1029	1034		10.1097/01.TA.0000100371.49160.2A			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	758TL	WOS:000187666200005	14676646				2022-02-06	
J	Schootman, M; Buchman, TG; Lewis, LM				Schootman, M; Buchman, TG; Lewis, LM			National estimates of hospitalization charges for the acute care of traumatic brain injuries	BRAIN INJURY			English	Article							UNITED-STATES; SYSTEM; COSTS	Primary objective: To estimate hospitalization charges for the acute care of traumatic brain injuries ( TBIs) in the US and to identify factors associated with increased charges. Research design: Population-based descriptive study. Methods: The 1996 National Inpatient Sample was used, which contains all-payer data on hospital inpatient stays from 906 hospitals in 19 states. Multivariate linear regression with the log (mean+1) charges as the dependent variable was used to identify factors associated with increased charges. Results: An estimated 254 500 TBIs required hospitalization in 1996 in the US, with $5.4 billion charged to treat these injuries during acute hospitalization. Patient age ( up to 34 years), increasing severity of injury and urban teaching hospitals were associated with higher mean charges in multivariate analysis. Conclusions: Based on hospitalization rates, mean and total charges, segments of the population were identified that are likely candidates for injury prevention interventions.	Washington Univ, Sch Med, Dept Pediat, Div Hlth Behav ARes, St Louis, MO 63108 USA; Washington Univ, Sch Med, Dept Med, Div Hlth Behav ARes, St Louis, MO 63108 USA; Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; Washington Univ, Sch Med, Div Emergency Med, St Louis, MO USA		Schootman, M (corresponding author), Washington Univ, Sch Med, Dept Pediat, Div Hlth Behav ARes, 4444 Forest Pk Pkwy,Box 8504, St Louis, MO 63108 USA.		Schootman, Mario/AAF-3941-2019	Schootman, Mario/0000-0003-1162-8824; Buchman, Timothy/0000-0001-7350-5921			*AG HLTH CAR POL R, 1999, COMP AN HCUP NHDS S, V13; *AG HLTH CAR POL R, 1999, TECHN SUPPL HCUP 3 N; ANNEST JL, 1998, STATES ARE COLLECTIN; [Anonymous], 1998, REH PERS TRAUM BRAIN, P1; Bass RR, 1999, J TRAUMA, V47, pS15, DOI 10.1097/00005373-199909001-00005; *BUR LAB STAT, 2003, CONS PRIC IND CONV F; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P8; Diehr P, 1999, ANNU REV PUBL HEALTH, V20, P125, DOI 10.1146/annurev.publhealth.20.1.125; EASTMAN AB, 1994, J TRAUMA, V36, P835, DOI 10.1097/00005373-199406000-00014; HSIA DC, 1988, NEW ENGL J MED, V318, P352, DOI 10.1056/NEJM198802113180604; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; Kreutzer JS, 2001, BRAIN INJURY, V15, P763, DOI 10.1080/02699050010025786; LEWIN ICF, 1992, COST DISORDERS BRAIN; MACKENZIE EJ, 1990, J TRAUMA, V30, P1096, DOI 10.1097/00005373-199009000-00005; Max W, 1991, J HEAD TRAUMA REHAB, V6, P76; Rogers FB, 1997, J TRAUMA, V43, P65, DOI 10.1097/00005373-199707000-00016; Rutledge R, 1996, J TRAUMA, V40, P1002, DOI 10.1097/00005373-199606000-00025; Schootman M, 2000, BRAIN INJURY, V14, P373; SCHOOTMAN M, 2000, J TRAUMA, V13, P995; SCHOOTMAN M, 1998, FRONTIERS HEAD NECK; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Thurman DJ., 1995, GUIDELINES SURVEILLA	23	18	18	0	3	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	NOV	2003	17	11					983	990		10.1080/0269905031000110427			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	725GE	WOS:000185534800005	14514449				2022-02-06	
J	Babin, PR				Babin, PR			Diagnosing depression in persons with brain injuries: a look at theories, the DSM-IV and depression measures	BRAIN INJURY			English	Article							MOOD DISORDERS; HEAD-INJURIES; SCALE; INVENTORY; INDIVIDUALS; SEQUELAE; DISEASE; MILD	There have been numerous articles published on the incidence of depression after brain injury. Unfortunately, the studies have shown the incidence of depression varies widely depending on multiple factors: definition of 'depression', time of assessment post-injury and type of measure used. It is well known that traumatic brain injury (TBI) sequelae and depressive symptoms overlap, contributing further to measurement error and ultimately epidemiologic report of depression. This paper reviews different theories of depression, the DSM-IV depression diagnoses, the overlap in depression and TBI symptoms and depression measures and how they contribute to possible diagnostic error. This paper also discusses evaluation and treatment considerations when assessing depression in a person with a TBI.	Charlotte Inst Rehabil, Charlotte, NC 28203 USA		Babin, PR (corresponding author), Charlotte Inst Rehabil, 1100 Blythe Blvd, Charlotte, NC 28203 USA.						AKISKAL HS, 1995, COMPREHENSIVE TXB PS, V6, P1067; ALEXOPOULOS GS, 1988, BIOL PSYCHIAT, V23, P271, DOI 10.1016/0006-3223(88)90038-8; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Beck A.T., 1967, DEPRESSION CLIN; BIELIAUSKAS LA, 1993, J CLIN EXP NEUROPSYC, V15, P421, DOI 10.1080/01688639308407232; Bremner JD, 2002, BIOL PSYCHIAT, V51, P273, DOI 10.1016/S0006-3223(01)01336-1; Busch CR, 1998, NEUROPSYCHOL REV, V8, P95, DOI 10.1023/A:1025661200911; BUTCHER JN, 1994, MINNESOTA MULTIPHASI; Coyne J.C., 1986, ESSENTIAL PAPERS DEP; CUMMINGS JL, 1994, PSYCHIAT ANN, V24, P25; Derogatis L. R., 1994, SCL 90 R ADM SCORING, VThird; FEDEROFF JP, 1992, AM J PSYCHIAT, V149, P918; First MB, 1995, STRUCTURED CLIN INTE; *GAL GROUP INC, 2002, GAL ENC PSYCH EM, P1; GASPARRINI WG, 1978, J NEUROL NEUROSUR PS, V41, P470, DOI 10.1136/jnnp.41.5.470; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1967, BRIT J SOC CLIN PSYC, V6, P278; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; JORGE RE, 1993, J NERV MENT DIS, V181, P91, DOI 10.1097/00005053-199302000-00004; KATHOL RG, 1990, PSYCHOSOMATICS, V31, P434, DOI 10.1016/S0033-3182(90)72140-8; KRAMER T, 2002, MEDSCAPE PSYCHOPHARM, P1; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; LOGSDON RG, 1995, J AM GERIATR SOC, V43, P150, DOI 10.1111/j.1532-5415.1995.tb06380.x; Miguel-Hidalgo JJ, 2002, CNS DRUGS, V16, P361, DOI 10.2165/00023210-200216060-00001; PARKER R, 1990, TRAUMATIC BRAIN INJU; Prigatano GP, 1991, AWARENESS DEFICIT BR, P111; Ressler KJ, 1999, BIOL PSYCHIAT, V46, P1219, DOI 10.1016/S0006-3223(99)00127-4; ROBIN L, 1991, PSYCHIAT DISORDERS A; ROBINSON RG, 1986, HOSP PRACT, V21, P83; ROSENBAUM J, 2001, 154 ANN M AM PSYCH A, P1; Rosenstein LD, 1998, NEUROPSYCHOL REV, V8, P109, DOI 10.1023/A:1025628925796; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; RUTHERFORD WH, 1977, LANCET, V1, P1; SADEK N, 2000, MEDSCAPE PSYCHIAT ME, P1; SCHILDKRAUT JJ, 1989, COMPREHENSIVE TXB PS, P868; SELIGMAN ME, 1975, HELOPLESSNESS; SHINAR D, 1986, STROKE, V17, P241, DOI 10.1161/01.STR.17.2.241; Sliwinski M, 1998, J HEAD TRAUMA REHAB, V13, P40, DOI 10.1097/00001199-199808000-00004; SNAITH RP, 1986, BRIT MED J, V292; STARRATT C, 1998, CLIN NEUROPSYCHOLOGY, P613; STEIN DG, 1994, CLIN NEUROPSYCHOLOGY, P9; Stuss D., 1991, AWARENESS DEFICIT BR, P63; Varney NR, 1987, NEUROPSYCHOLOGY, V1, P7, DOI 10.1037//0894-4105.1.1.7; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	46	18	18	2	6	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	OCT	2003	17	10					889	900		10.1080/0269905031000088595			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	719CR	WOS:000185186500007	12963555				2022-02-06	
J	Danielsen, ER; Christensen, PB; Arlien-Soborg, P; Thomsen, C				Danielsen, ER; Christensen, PB; Arlien-Soborg, P; Thomsen, C			Axonal recovery after severe traumatic brain injury demonstrated in vivo by 1H MR spectroscopy	NEURORADIOLOGY			English	Article						diffuse axonal injury; magnetic resonance spectroscopy; N-acetylaspartate	MAGNETIC-RESONANCE SPECTROSCOPY	Proton magnetic resonance spectroscopy (MRS) suggested almost complete axonal recovery 21 months after trauma in a patient with severe diffuse axonal injury. MRS while the patient was comatose showed evidence of severe diffuse axonal injury in occipitoparietal white matter, but occipital grey matter was relatively spared. At 21 months N-acetylaspartate was normal. At 33 months examination showed a Functional Independence Measure of 83 and a Rancho Los Amigos Scale of Cognitive Function of 7-8, a remarkable improvement considering all the initial findings, except those of MRS.	Rigshosp, Dept Neuroradiol, DK-2100 Copenhagen, Denmark; Aarhus Univ Hosp, Dept Neurol, Hammel Neuroctr, DK-8000 Aarhus, Denmark; Rigshosp, Dept Neurol, DK-2100 Copenhagen, Denmark		Danielsen, ER (corresponding author), Rigshosp, Dept Neuroradiol, Sect 3023,Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	erdanielsen@rh.dk		Christensen, Peter Broegger/0000-0002-0046-5727			Brooks WM, 2000, J NEUROTRAUM, V17, P629, DOI 10.1089/089771500415382; Cecil KM, 1998, J NEUROSURG, V88, P795, DOI 10.3171/jns.1998.88.5.0795; CHOE BY, 1995, INVEST RADIOL, V30, P502, DOI 10.1097/00004424-199508000-00008; CHRISTIANSEN P, 1994, ACTA RADIOL, V35, P117; DESTEFANO N, 1995, MAGN RESON MED, V34, P721; EVANS SJJ, 1999, MRI, P1347; Friedman SD, 1999, NEUROLOGY, V52, P1384, DOI 10.1212/WNL.52.7.1384; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; MICHAELIS T, 1993, RADIOLOGY, V187, P219, DOI 10.1148/radiology.187.1.8451417; Ricci B, 1997, NEURORADIOLOGY, V39, P313, DOI 10.1007/s002340050415; Ross BD, 1998, J MAGN RESON IMAGING, V8, P829, DOI 10.1002/jmri.1880080412; Sinson G, 2001, AM J NEURORADIOL, V22, P143; Takanashi J, 1997, J NEUROL SCI, V149, P99, DOI 10.1016/S0022-510X(97)05401-4	13	18	22	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0028-3940	1432-1920		NEURORADIOLOGY	Neuroradiology	OCT	2003	45	10					722	724		10.1007/s00234-003-1068-z			3	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	732AD	WOS:000185917900009	12942218				2022-02-06	
J	Hawley, CA; Maden, A				Hawley, CA; Maden, A			Mentally disordered offenders with a history of previous head injury: are they more difficult to discharge ?	BRAIN INJURY			English	Article							TRAUMATIC BRAIN INJURY; FOLLOW-UP; SCHIZOPHRENIA; RELATIVES	Primary objectives : To identify the incidence of head injury (HI) amongst mentally disordered offenders (MDOs) in UK medium secure units (MSUs) and test the hypothesis that patients with a history of HI are more difficult to discharge than patients without HI. Design, methods and procedures : One hundred and thirteen MDOs being discharged to community settings from five MSUs in England were recruited consecutively between 1 April 1999 and 31 December 2000. Data on previous HI, offending history and discharge planning were collected from clinical casenotes, structured questionnaires and interviews with clinical staff. Main outcomes and results : More patients with HI (57.4%) than patients without HI (47%) had a violent index offence. Risk assessments carried out prior to discharge showed patients with HI to be at greater risk of violence to others and of self-harm than patients without HI ( p less than or equal to 0.05). All but two patients in the HI group were difficult to discharge (43, 95.6%), compared to 52 (82.5%) in the non-HI group. Conclusions : Information on previous HI should be collected on admission to MSUs and considered when planning for discharge.	Univ Warwick, Warwick Business Sch, Ctr Hlth Serv Studies, Coventry CV4 7AL, W Midlands, England; Univ London Imperial Coll Sci Technol & Med, Acad Ctr, Southall, Middx, England		Hawley, CA (corresponding author), Univ Warwick, Warwick Business Sch, Ctr Hlth Serv Studies, Coventry CV4 7AL, W Midlands, England.		Hawley, Carol/AAG-3830-2019; Lorente, Rosa/AAL-5850-2021				Ahmed I, 1998, Semin Clin Neuropsychiatry, V3, P23; BACHYRITA G, 1974, AM J PSYCHIAT, V131, P1015; Bond M. R., 1990, REHABILITATION ADULT, P179; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Cicerone KD, 1996, BRAIN INJURY, V10, P277, DOI 10.1080/026990596124458; GIBBENS TCN, 1959, J MENT SCI, V105, P108, DOI 10.1192/bjp.105.438.108; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Hawley C., 1998, NATL TRAUMATIC BRAIN; Hawley CA, 2001, J NEUROL NEUROSUR PS, V70, P761, DOI 10.1136/jnnp.70.6.761; *HOM OFF DEP HLTH, 1975, CMND6244; KREUTZER J S, 1991, Brain Injury, V5, P177, DOI 10.3109/02699059109008088; KREUTZER JS, 1995, BRAIN INJURY, V9, P757, DOI 10.3109/02699059509008232; LEWIS DO, 1988, AM J PSYCHIAT, V145, P584; LEWIS DO, 1986, AM J PSYCHIAT, V143, P584; MADEN A, 2001, PATHWAYS OUT MEDIUM; Malaspina D, 2001, AM J PSYCHIAT, V158, P440, DOI 10.1176/appi.ajp.158.3.440; Matthews H., 1997, ADV PSYCHIAT TREATME, V3, P154; McAllister, 1998, Semin Clin Neuropsychiatry, V3, P211; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; Miller E, 1999, J FORENSIC PSYCHIATR, V10, P157, DOI 10.1080/09585189908402146; MILLER JD, 1990, REHABILITATION ADULT, P236; Sachdev P, 2001, PSYCHOL MED, V31, P231, DOI 10.1017/S0033291701003336; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128	25	18	18	0	8	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	SEP	2003	17	9					743	758		10.1080/0269905031000089341			16	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	691ML	WOS:000183610000002	12850941	Green Submitted			2022-02-06	
J	Coughlan, MD; Fieggen, AG; Semple, PL; Peter, JC				Coughlan, MD; Fieggen, AG; Semple, PL; Peter, JC			Craniocerebral gunshot injuries in children	CHILDS NERVOUS SYSTEM			English	Article						penetrating head injury; missile injuries; traumatic brain injury	WOUNDS; MANAGEMENT; BRAIN; ADOLESCENTS; HEAD	Introduction. Despite the worldwide increase in the incidence of gunshot injuries, there are few large published series on craniocerebral gunshot injuries in children. Materials and methods. The records of 30 consecutive children who were treated for craniocerebral gunshot injuries at the Red Cross War Memorial Children's Hospital from 1989 to 2002 were reviewed retrospectively. The circumstances of the injury, clinical status, CT findings, complications, and outcome were assessed. Results. The median age was 7 years. Seventy-seven percent of the victims were boys. The majority of the children were injured in the crossfire of civilian violence. The initial management consisted of debridement under local anesthesia in 16 children and neurosurgical procedures under general anesthesia were performed in 14. Sixteen children sustained transhemispheric injuries, 5 bihemispheric injuries, 5 tangential injuries, and 4 transventricular injuries. All 3 children with a GCS <4 died within 72 h of admission. Three of the 7 children with GCS 4-7 died but there were no deaths in those children whose GCS was >7 post-resuscitation. Motor deficits, cranial nerve palsies, and visual field defects were very common. Early post-traumatic seizures were the commonest complication (18%). Conclusion. Children with higher post-resuscitation GCSs fared better than adults in terms of mortality but not necessarily morbidity. As in the case with adults, the GCS after resuscitation is a very good prognostic indicator of mortality.	Univ Cape Town, Sch Child & Adolescent Hlth, Div Pediat Neurosurg, ZA-7700 Rondebosch, South Africa; Red Cross War Mem Childrens Hosp, Inst Child Hlth, ZA-7700 Rondebosch, South Africa		Fieggen, AG (corresponding author), Univ Cape Town, Sch Child & Adolescent Hlth, Div Pediat Neurosurg, Klipfontein Rd, ZA-7700 Rondebosch, South Africa.		Fieggen, Anthony Graham/AAT-6510-2021	Fieggen, Anthony Graham/0000-0001-6541-8377			BARLOW B, 1982, J PEDIATR SURG, V17, P927, DOI 10.1016/S0022-3468(82)80469-7; BRANDVOLD B, 1990, J NEUROSURG, V72, P15, DOI 10.3171/jns.1990.72.1.0015; Bull MJ, 2000, PEDIATRICS, V105, P888; EWINGCOBBS L, 1994, NEUROSURGERY, V35, P225, DOI 10.1227/00006123-199408000-00007; GRAHM TW, 1990, NEUROSURGERY, V27, P696, DOI 10.1227/00006123-199011000-00005; HADDAD FS, 1991, NEUROSURGERY, V28, P1; KAUFMAN HH, 1985, NEUROSURGERY, V16, P754, DOI 10.1227/00006123-198506000-00002; KENNEDY F, 1993, J TRAUMA, V35, P72; LEVY ML, 1993, NEUROSURGERY, V33, P1018; MINER ME, 1990, NEUROSURGERY, V26, P20, DOI 10.1227/00006123-199001000-00002; NAGIB MG, 1986, NEUROSURGERY, V18, P533, DOI 10.1227/00006123-198605000-00003; Semple PL, 2001, S AFR MED J, V91, P141	12	18	19	0	2	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0256-7040			CHILD NERV SYST	Childs Nerv. Syst.	JUN	2003	19	5-6					348	352		10.1007/s00381-003-0736-y			5	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	699ZW	WOS:000184089000016	12768317				2022-02-06	
J	Lee, IK; Yun, BS; Kim, JP; Kim, WG; Ryoo, IJ; Oh, S; Kim, YH; Yoo, ID				Lee, IK; Yun, BS; Kim, JP; Kim, WG; Ryoo, IJ; Oh, S; Kim, YH; Yoo, ID			p-terphenyl curtisians protect cultured neuronal cells against glutamate neurotoxicity via iron chelation	PLANTA MEDICA			English	Article						Paxillus curtisii; Paxillaceae; mushroom; curtisians; glutamate neurotoxicity; iron chelator	HYDROXYL RADICALS; SUPEROXIDE	The hyperactivity of ionotropic glutamate receptors has been implicated in the development of the neuronal cell death seen in many neurodegenerative processes including ischemic stroke, traumatic brain injury, and epilepsy. Thus neuronal protection against glutamate-induced neurotoxicity is considered as an appropriate therapeutic strategy for preventing and treating neurodegenerative diseases. Whilst searching for blockers of glutamate-induced toxicity in mouse cortical cells, we isolated p-terphenyl curtisians A - D from the mushroom Paxillus curtisii. Curtisians protected cortical neurons from glutamate-induced toxicity in a dose-dependent manner. Among the glutamate receptor subtypes, curtisians were found to block NMDA receptor-mediated but not AMPA/kainate-mediated cell death. In addition, we found that curtisians exhibited potent antioxidative activity against iron-mediated oxidative damage which was generated by H2O2 neurotoxocity and lipid peroxidation, but no activity was detected in the superoxide, DPPH and ABTS radical scavenging systems, and in protection of N-18-RE-105 cells subjected to glutamate-induced glutathione depletion. This effect was likely due to the iron chelating properties of curtisians. The iron chelation ability of curtisians was then further investigated on DNA single strand breakage (SSB) induced by the addition of iron and H2O2, and curtisians prevented DNA SSB like the iron chelator desferrioxamine. These results suggest that the neuroprotective action of curtisians is dependent on their ability to chelate iron as well as to block the NMDA receptor, and that in this context curtisians may be useful as neuroprotective agents against neurological disorders which result in neuronal cell death.	Korea Res Inst Biosci & Biotechnol, Lab Antioxidants, Taejon 305600, South Korea; Ewha Womans Univ, Coll Med, Seoul, South Korea; Chungnam Natl Univ, Coll Pharm, Taejon, South Korea		Yoo, ID (corresponding author), Korea Res Inst Biosci & Biotechnol, Lab Antioxidants, POB 115, Taejon 305600, South Korea.	idyoo@kribb.re.kr					CHOI DW, 1985, NEUROSCI LETT, V58, P293, DOI 10.1016/0304-3940(85)90069-2; CHOI DW, 1988, J NEUROSCI, V8, P185; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.neuro.13.1.171; DUGAN LL, 1994, ANN NEUROL, V35, pS17, DOI 10.1002/ana.410350707; GUTTERIDGE JMC, 1979, BIOCHEM J, V184, P469, DOI 10.1042/bj1840469; Kim SR, 2002, BRIT J PHARMACOL, V135, P1281, DOI 10.1038/sj.bjp.0704576; LAFONCAZAL M, 1993, NATURE, V364, P535, DOI 10.1038/364535a0; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; MIYAMOTO M, 1989, J PHARMACOL EXP THER, V250, P1132; NEILANDS JB, 1995, J BIOL CHEM, V270, P26723, DOI 10.1074/jbc.270.45.26723; Palmer C, 1999, J NEUROSCI RES, V56, P60, DOI 10.1002/(SICI)1097-4547(19990401)56:1<60::AID-JNR8>3.0.CO;2-A; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; RISHER M, 2000, ARCH INTERN MED, V160, P3196; Sarco DP, 2000, NEUROSCI LETT, V282, P113, DOI 10.1016/S0304-3940(00)00878-8; Seo SY, 2001, J PHARMACOL EXP THER, V299, P377; STARKE PE, 1985, J BIOL CHEM, V260, P99; Tan SL, 1998, J CELL BIOL, V141, P1423, DOI 10.1083/jcb.141.6.1423; TOYOKUNI S, 1992, J INORG BIOCHEM, V47, P241, DOI 10.1016/0162-0134(92)84069-Y; Xie CS, 2000, FREE RADICAL BIO MED, V28, P665, DOI 10.1016/S0891-5849(99)00268-3; Yun BS, 2000, J ANTIBIOT, V53, P114, DOI 10.7164/antibiotics.53.114	20	18	19	0	5	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0032-0943	1439-0221		PLANTA MED	Planta Med.	JUN	2003	69	6					513	517					5	Plant Sciences; Chemistry, Medicinal; Integrative & Complementary Medicine; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary Medicine	701BA	WOS:000184144600006	12865968				2022-02-06	
J	Sherer, M; Nick, TG; Millis, SR; Novack, TA				Sherer, M; Nick, TG; Millis, SR; Novack, TA			Use of the WCST and the WCST-64 in the assessment of traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							CARD SORTING TEST; DISABILITY RATING-SCALE; HEAD-INJURY; SHORT-FORM; WISCONSIN; PERFORMANCE; RECOVERY; UTILITY	The Wisconsin Card Sorting Test (WCST) has been found to be valid in characterizing cognitive dysfunction in a variety of neurological disorders including traumatic brain injury (TBI). However, the test has been criticized as being too lengthy and frustrating for severely impaired patients. As a result, shortened versions of the WCST have been proposed. The utility of one of these shortened versions, the Wisconsin Card Sorting Test-64 (WCST-64), was examined in 106 persons with TBI. Findings showed strong associations between scores derived from the two tests. WCST scores were predicted from WCST-64 scores with sufficient accuracy for research purposes with adjusted R-squared values ranging from .74 to .87. Using the standard cutpoint of <40T to indicate impairment or normal performance for perseverative responses from each of the two tests, 91 (86%) of 106 subjects received the same classification showing substantial agreement (Kappa statistic 0.71; 95% CI 0.58-0.84). The WCST and the WCST-64 also performed comparably in predicting functional status at discharge from inpatient rehabilitation using the first score from a principal components analysis as a summary measure (both significant with p=.0002). These findings support the use of the WCST-64 in early evaluations of persons with moderate and severe TBI.	Methodist Rehabil Ctr, Neuropsychol Dept, Jackson, MS 39216 USA; Univ Mississippi, Med Ctr, Jackson, MS 39216 USA; Kessler Med Rehabil Res & Educ Corp, W Orange, NJ USA; Univ Med & Dent New Jersey, New Jersey Med Sch, W Orange, NJ 07052 USA; Spain Rehabil Ctr, Birmingham, AL USA; Univ Alabama Birmingham, Birmingham, AL USA		Sherer, M (corresponding author), Methodist Rehabil Ctr, Neuropsychol Dept, 1350 E Woodwrow Wilson, Jackson, MS 39216 USA.	marks@mmrcrehab.org			PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [H133A980010, H133A011403, H133A980035] Funding Source: Medline		ANDERSON SW, 1991, J CLIN EXP NEUROPSYC, V13, P909, DOI 10.1080/01688639108405107; Axelrod BN, 1997, ASSESSMENT, V4, P41, DOI 10.1177/107319119700400105; Axelrod Bradley N, 1992, Clin Neuropsychol, V6, P143, DOI 10.1080/13854049208401851; Boake C, 2001, ARCH PHYS MED REHAB, V82, P761, DOI 10.1053/apmr.2001.23753; CLIFTON GL, 1992, NEUROSURGERY, V31, P975, DOI 10.1227/00006123-199211000-00028; DREWE E A, 1974, Cortex, V10, P159; Ferland MB, 1998, J CLIN EXP NEUROPSYC, V20, P473, DOI 10.1076/jcen.20.4.473.1475; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Graham D.I., 1996, NEUROTRAUMA, P43; Greve KW, 2001, CLIN NEUROPSYCHOL, V15, P228, DOI 10.1076/clin.15.2.228.1901; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Heaton PDRK., 1993, WISCONSIN CARD SORTI; IVERSON GL, 2001, APPL NEUROPSYCHOLOGY, V7, P247; Kongs S. K., 2000, WCST 64 WISCONSIN CA; KREUTZER JS, 1993, J HEAD TRAUMA REHAB, V8, P47; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Little AJ, 1996, J CLIN PSYCHOL, V52, P455, DOI 10.1002/(SICI)1097-4679(199607)52:4<455::AID-JCLP11>3.0.CO;2-F; Milner B., 1964, FRONTAL GRANULAR COR, P313; Najenson T, 1980, Int Rehabil Med, V2, P17; Paolo AM, 1996, J CLIN EXP NEUROPSYC, V18, P892, DOI 10.1080/01688639608408310; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rapport LJ, 1998, ARCH PHYS MED REHAB, V79, P629, DOI 10.1016/S0003-9993(98)90035-1; ROBINSON AL, 1980, J CONSULT CLIN PSYCH, V48, P605, DOI 10.1037/0022-006X.48.5.605; Robinson L J, 1991, Arch Clin Neuropsychol, V6, P27, DOI 10.1016/0887-6177(91)90019-6; Sherer M, 2000, J HEAD TRAUMA REHAB, V15, P767, DOI 10.1097/00001199-200004000-00002; Smith-Seemiller L, 1997, CLIN NEUROPSYCHOL, V11, P421, DOI 10.1080/13854049708400472; Stuss D. T, 1987, NEUROBEHAVIORAL RECO, V166; Trudel TM, 1998, REHABIL PSYCHOL, V43, P267, DOI 10.1037/0090-5550.43.4.267; [No title captured]	30	18	20	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	JUN	2003	25	4					512	520		10.1076/jcen.25.4.512.13877			9	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	683GY	WOS:000183141300007	12911105				2022-02-06	
J	Barrow, IM; Hough, M; Rastatter, MP; Walker, M; Holbert, D; Rotondo, MF				Barrow, IM; Hough, M; Rastatter, MP; Walker, M; Holbert, D; Rotondo, MF			Can within-category naming identify subtle cognitive deficits in the mild traumatic brain-injured patient?	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	15th Annual Meeting of the Eastern-Association-for-the-Surgery-of-Trauma	JAN 16-19, 2002	ORLANDO, FLORIDA	Eastern Assoc Surg Trauma		mild traumatic brain injury (MTBI); category; speed; accuracy; reaction time	CLOSED-HEAD-INJURY; REACTION-TIME; PERCEPTUAL DIFFERENTIATION; ATTENTION DEFICITS; MEMORY; CHILDREN; LESIONS; ACCESS; TASK; PERFORMANCE	Background: This investigation examined the effect of a speeded, computer-controlled task on detecting differences in latency and accuracy of within-category name generation in adults having sustained a mild traumatic brain injury (MTBI). Methods: Twenty-four adults in acute recovery and 24 age-matched controls were instructed to view 72 pictures on a computer monitor, and then name another item be-longing to the same category as the visual stimulus as quickly as possible. Results: The MTBI group demonstrated significantly longer latencies (p < 0.001) and lower accuracy (p < 0.001) than the control group. Both groups displayed similar patterns of response, although the MTBI group produced significantly more perseverative errors (p < 0.001). No significant correlations were found between performance on the Scales of Cognitive Ability for Traumatic Brain Injury and response latency or accuracy. Conclusion: The MTBI group performed the task significantly slower and less accurately than controls. Reaction time measures may prove more sensitive than traditional assessment measures in detecting subtle difficulties.	E Carolina Univ, Sch Allied Hlth Sci, Dept Commun Sci & Disorders, Greenville, NC USA; E Carolina Univ, Dept Surg, Greenville, NC USA		Barrow, IM (corresponding author), 704 Amberline Court, Chesapeake, VA 23322 USA.			Walker, Marianna/0000-0002-6342-9088			ABBOUD H, 1997, SUPERLAB PRO EXPT LA; Adamovich B. B., 1992, SCALES COGNITIVE ABI; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Baddeley A.D., 1994, NEUROPSYCHOLOGY, V8, P485, DOI [10.1037/0894-4105.8.4.485, DOI 10.1037/0894-4105.8.4.485]; Barrow IM, 2000, AM J SPEECH-LANG PAT, V9, P310, DOI 10.1044/1058-0360.0904.310; BIGGS TC, 1990, AM J PSYCHOL, V103, P81, DOI 10.2307/1423260; Blostein PA, 1997, J NEUROTRAUM, V14, P171, DOI 10.1089/neu.1997.14.171; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Brooks J, 1999, J TRAUMA, V46, P159, DOI 10.1097/00005373-199901000-00027; Burgess PW, 1996, NEUROPSYCHOLOGIA, V34, P263, DOI 10.1016/0028-3932(95)00104-2; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Coelho CA, 1996, J SPEECH HEAR RES, V39, pS5, DOI 10.1044/jshr.3905.s5; Collins LF, 1996, ARCH CLIN NEUROPSYCH, V11, P613, DOI 10.1016/0887-6177(97)81255-3; Cycowicz YM, 1997, J EXP CHILD PSYCHOL, V65, P171, DOI 10.1006/jecp.1996.2356; DELL GS, 1992, COGNITION, V42, P287, DOI 10.1016/0010-0277(92)90046-K; Gerlach C, 1999, BRAIN, V122, P2159, DOI 10.1093/brain/122.11.2159; GLASER WR, 1992, COGNITION, V42, P61, DOI 10.1016/0010-0277(92)90040-O; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; HARRINGTON DE, 1993, ARCH PHYS MED REHAB, V74, P579, DOI 10.1016/0003-9993(93)90155-4; Hayden M E, 1997, AAOHN J, V45, P635; HintonBayre AD, 1997, J CLIN EXP NEUROPSYC, V19, P275, DOI 10.1080/01688639708403857; Hough MS, 1997, BRAIN INJURY, V11, P801; Humphreys G. W., 1987, VISUAL OBJECT PROCES; JENKINS A, 1986, LANCET, V2, P445; KAPUR S, 1994, NEUROREPORT, V5, P2193, DOI 10.1097/00001756-199410270-00051; KATZ RT, 1992, AM FAM PHYSICIAN, V46, P1491; Kopelman MD, 1998, NEUROPSYCHOLOGIA, V36, P785, DOI 10.1016/S0028-3932(97)00167-X; LA HEIJ W, 1990, BRIT J PSYCHOL, V81, P511; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LEVELT WJM, 1989, SPEAKING INTENTION A; LloydJones T, 1997, MEM COGNITION, V25, P606, DOI 10.3758/BF03211303; LloydJones TJ, 1997, MEM COGNITION, V25, P18, DOI 10.3758/BF03197282; LordMaes J, 1996, J LEARN DISABIL, V29, P609, DOI 10.1177/002221949602900605; MACFLYNN G, 1984, J NEUROL NEUROSUR PS, V47, P1326, DOI 10.1136/jnnp.47.12.1326; MARTIN N, 1989, J MEM LANG, V28, P462, DOI 10.1016/0749-596X(89)90022-3; Mateer CA, 1996, J LEARN DISABIL, V29, P618, DOI 10.1177/002221949602900606; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; NOVOA OP, 1987, BRAIN LANG, V30, P206, DOI 10.1016/0093-934X(87)90099-X; Paivio A., 1971, IMAGERY VERBAL PROCE; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; Perani D, 1999, NEUROPSYCHOLOGIA, V37, P293, DOI 10.1016/S0028-3932(98)00073-6; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; REEDER KP, 1994, ARCH CLIN NEUROPSYCH, V9, P491, DOI 10.1016/0887-6177(94)90040-X; RICHARDSON JTE, 1984, CORTEX, V20, P413, DOI 10.1016/S0010-9452(84)80009-X; Robinson-Boone KA, 1999, J MED SPEECH-LANG PA, V7, P47; ROSENTHAL M, 1993, ANN EMERG MED, V22, P1048, DOI 10.1016/S0196-0644(05)82749-0; SALMELIN R, 1994, NATURE, V368, P463, DOI 10.1038/368463a0; Segalowitz S J, 1997, J Int Neuropsychol Soc, V3, P95; Snodgrass JG, 1996, BEHAV RES METH INSTR, V28, P516, DOI 10.3758/BF03200540; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Tang YP, 1997, EUR J NEUROSCI, V9, P1720, DOI 10.1111/j.1460-9568.1997.tb01529.x; THEIOS J, 1989, PSYCHOL REV, V96, P5, DOI 10.1037/0033-295X.96.1.5; Timmerman ME, 1999, NEUROPSYCHOLOGIA, V37, P467, DOI 10.1016/S0028-3932(98)00085-2; VITKOVITCH M, 1993, J EXP PSYCHOL LEARN, V19, P243; VITKOVITCH M, 1991, J EXP PSYCHOL LEARN, V17, P664, DOI 10.1037/0278-7393.17.4.664; Wrightson P, 1998, NEW ZEAL MED J, V111, P99; Zahn TP, 1999, J CLIN EXP NEUROPSYC, V21, P352, DOI 10.1076/jcen.21.3.352.924; Zwaagstra R, 1996, J CLIN EXP NEUROPSYC, V18, P383, DOI 10.1080/01688639608408995	59	18	18	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAY	2003	54	5					888	895		10.1097/01.TA.0000057150.60668.7C			8	Critical Care Medicine; Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Surgery	687BN	WOS:000183356100016	12777901				2022-02-06	
J	Durmaz, R; Kanbak, G; Akyuz, F; Isiksoy, S; Yucel, F; Inal, M; Tel, E				Durmaz, R; Kanbak, G; Akyuz, F; Isiksoy, S; Yucel, F; Inal, M; Tel, E			Lazaroid attenuates edema by stabilizing ATPase in the traumatized rat brain	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article							CEREBRAL-ARTERY OCCLUSION; NERVOUS-SYSTEM TRAUMA; LIPID-PEROXIDATION; BARRIER PERMEABILITY; VASCULAR DISRUPTION; INDUCED INHIBITION; INJURY; ISCHEMIA; METHYLPREDNISOLONE; CELLS	Objective: The aim of the present study was to determine the potential therapeutic value of the lazaroid U-83836E on blood brain barrier (BBB) breakdown and edema with respect to the changes in the synaptosomal Na+/K+ and Mg2+/Ca2+- adenosinetriphosphatase (ATPase) activities, tissue malondialdehyde levels and the neuronal viability in the rat brain subjected to cerebral trauma. Methods: Traumatic brain injury (TBI) was introduced by applying a 75 gm. cm force to the right parietal cortex using the weight-drop method. The first set of animals was used for determining time course changes of the synaptosomal Na+/K+ and Mg2+/Ca2+-ATPase and the malondialdehyde levels and were sacrificed 2, 6 and 24h after lesion production. A group of the animals was treated with U-83836E proir to TBI and sacrificed 24h after cerebral injury. A second set of animals was used for evaluating the alterations in BBB disruption and tissue water content and were sacrificed 2, 6 and 24h after lesion production. Two groups of animals were treated with U-83836E and sacrificed after 2 and 24h following TBI. U-83836E was given intraperitoneally thirty minutes before trauma at a dose of 10 mg/kg. Neuronal necrosis was also evaluated in the groups of U-83836E and physiological saline-treated animals. Results: Extravasation of Evans blue into the traumatized hemisphere was maximum at 2h (p<0.001) and returned close to the control levels at 24h after TBI (p>0.05). Edema had developed progressively over time and reached the maximum degree of 2.1 % (p<0.001) at 24 h. U-83836E showed no effect on the BBB breakdown and the tissue water content at 2h and still had no effect on the BBB breakdown after 24h following the trauma (p>0.05), although it reduced edema after 24h (p<0.01). The losses of Na+/K+ and Mg2+/Ca2+-ATPase activities were found as 39.5 % (p<0.00 1) and 29.4 % (p<0.01) of the control value, respectively, and remained at the decreased levels throughout the experiment. Malondialdehyde level continued to increase over time reaching up to 209 % (p<0.001) of the control value 24h after TBI. Both ATPase activities were improved to near control values (p>0.05) by the effect of U-83836E. U-83836E inhibited the increase of lipid peroxidation (p<0.001) and also salvaged neuronal necrosis (p<0.05). Conclusion: U-83836E given prophylactically after cerebral trauma appears to reduce edema, possibly by inhibiting increases in lipid peroxidation and by stabilizing ATPase. Further studies are recommended to verify the similar effects of the brain penetrating lazaroids when they are given after trauma.	Osmangazi Univ, Dept Neurosurg, Fac Med, TR-26480 Eskisehir, Turkey; Osmangazi Univ, Dept Biochem, Fac Med, TR-26480 Eskisehir, Turkey; Osmangazi Univ, Dept Pathol, Fac Med, TR-26480 Eskisehir, Turkey; Osmangazi Univ, Dept Anat, Fac Med, TR-26480 Eskisehir, Turkey		Durmaz, R (corresponding author), Osmangazi Univ, Dept Neurosurg, Fac Med, TR-26480 Eskisehir, Turkey.			YUCEL, FERRUH/0000-0002-1238-1483			Adelson PD, 1998, ACT NEUR S, V71, P104; AUDUS KL, 1991, FREE RADICAL BIO MED, V11, P361, DOI 10.1016/0891-5849(91)90152-S; AUER RN, 1988, ANN NEUROL, V24, P699, DOI 10.1002/ana.410240602; Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Barzo P, 1997, ACT NEUR S, V70, P119; Boldyrev AA, 1997, ANN NY ACAD SCI, V834, P666, DOI 10.1111/j.1749-6632.1997.tb52345.x; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V7, P125, DOI 10.1016/0891-5849(89)90003-8; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V6, P289, DOI 10.1016/0891-5849(89)90056-7; BRAUGHLER JM, 1981, BRAIN RES, V219, P464; CHAN PH, 1985, PROG BRAIN RES, V63, P227; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Demediuk P, 1990, Adv Neurol, V52, P225; Durmaz R, 1999, ACTA NEUROBIOL EXP, V59, P99; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; FUKUDA K, 1995, J NEUROTRAUM, V12, P315, DOI 10.1089/neu.1995.12.315; Hall E D, 1994, Adv Pharmacol, V28, P221, DOI 10.1016/S1054-3589(08)60497-4; Hall ED, 1996, ACT NEUR S, V66, P107; HALL ED, 1988, BRAIN RES, V451, P350, DOI 10.1016/0006-8993(88)90782-2; HALL ED, 1990, STROKE, V21, P83; HALL ED, 1991, J PHARMACOL EXP THER, V258, P688; Ildan F, 1996, ACTA NEUROCHIR, V138, P338, DOI 10.1007/BF01411746; Jamme I, 1997, BRAIN RES, V774, P123, DOI 10.1016/S0006-8993(97)81695-2; Kaplan P, 1997, NEUROCHEM RES, V22, P1523, DOI 10.1023/A:1021918931780; Kimelberg Harold K., 1995, P919; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; KLATZO I, 1994, ACTA NEUROCHIR, P3; LIN SCC, 1982, BRAIN RES, V235, P387, DOI 10.1016/0006-8993(82)91018-6; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MATTEUCCI E, 1994, ENZYME PROTEIN, V48, P105, DOI 10.1159/000474976; Mayhew TM, 1996, J ANAT, V188, P1; MCINTOSH TK, 1990, ACT NEUR S, V51, P329; MOTULSKY HG, 1994, GRAPHPAD; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; OURY TD, 1993, J BIOL CHEM, V268, P15394; PALKOVIT.M, 1971, BRAIN RES, V32, P15, DOI 10.1016/0006-8993(71)90152-1; Parsons JT, 1997, J NEUROCHEM, V68, P1124; SCHNEIDER GH, 1994, ACTA NEUROCHIR, P516; Schoettle R J, 1990, J Neurotrauma, V7, P207, DOI 10.1089/neu.1990.7.207; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; SUN AY, 1971, J NEUROCHEM, V18, P1711, DOI 10.1111/j.1471-4159.1971.tb03745.x; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; Whalen MJ, 1998, ACT NEUR S, V71, P212; YOUNG W, 1988, STROKE, V19, P1013, DOI 10.1161/01.STR.19.8.1013	44	18	18	0	4	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0317-1671	2057-0155		CAN J NEUROL SCI	Can. J. Neurol. Sci.	MAY	2003	30	2					143	149		10.1017/S0317167100053415			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	679CU	WOS:000182903900010	12774954	Bronze			2022-02-06	
J	Redell, JB; Moore, AN; Dash, PK				Redell, JB; Moore, AN; Dash, PK			Expression of the prodynorphin gene after experimental brain injury and its role in behavioral dysfunction	EXPERIMENTAL BIOLOGY AND MEDICINE			English	Article						dynorphin; behavior; hippocampus; brain trauma; kappa receptor	CONTROLLED CORTICAL IMPACT; SPATIAL MEMORY; ENDOGENOUS DYNORPHINS; HIPPOCAMPAL-LESIONS; CEREBRAL-ISCHEMIA; RECEPTOR AGONIST; AXONAL INJURY; RATS; DEFICITS; ANTAGONISTS	Traumatic brain injury (TBI) causes excess release of neurotransmitters, such as glutamate, and increases intracellular calcium levels. Elevated levels of calcium, and perhaps other intracellular second messengers, as a result of TBI can alter the expression of many genes. The protein products of some of these genes may be signals for TBI-associated memory dysfunction. Therefore, identification of genes whose expression is altered after TBI in the hippocampus, a structure in the medial temporal lobe that plays a critical role in memory formation and storage, and elucidation of the role(s) of their protein products may shed light on the molecular mechanisms underlying TBI-elicited memory dysfunction. The prodynorphin gene is expressed in hippocampal granule cells, and its expression has been reported to be enhanced as a result of elevated intracellular calcium. The prodynorphin protein is proteolytically cleaved to generate multiple dynorphin peptides, which can modulate neurotransmitter release through the activation of presynaptic kappa opioid receptors. In this study, we report that 1) TBI transiently increases prodynorphin mRNA in the hippocampus, 2) dynorphin peptide immunoreactivity is enhanced for up to 24 hr after TBI and 3) intracerebroventricular infusion of the K receptor antagonist nor-binaltorphimine (nor-BNI) impairs subsequent performance in a spatial memory task. These results suggest that dynorphin action may serve a beneficial role after TBI.	Univ Texas, Sch Med, Dept Neurobiol & Anat, Vivian L Smith Ctr Neurol Res, Houston, TX 77225 USA; Univ Texas, Sch Med, Dept Neurosurg, Vivian L Smith Ctr Neurol Res, Houston, TX 77225 USA		Dash, PK (corresponding author), Univ Texas, Sch Med, Dept Neurobiol & Anat, Vivian L Smith Ctr Neurol Res, POB 20708, Houston, TX 77225 USA.				NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH049662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS035457] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH49662] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS35457, P50NS3327] Funding Source: Medline		Aronowski J, 1996, J CEREBR BLOOD F MET, V16, P705, DOI 10.1097/00004647-199607000-00022; BIRCH PJ, 1991, BRIT J PHARMACOL, V103, P1819, DOI 10.1111/j.1476-5381.1991.tb09869.x; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Chen ACH, 2002, AM J MED GENET, V114, P429, DOI 10.1002/ajmg.10362; Cheng HYM, 2002, CELL, V108, P31, DOI 10.1016/S0092-8674(01)00629-8; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Craig TA, 2002, J BIOL CHEM, V277, P10955, DOI 10.1074/jbc.M109660200; DASH PK, 1995, J NEUROSCI, V15, P2030, DOI 10.1523/JNEUROSCI.15-03-02030.1995; DIXON CE, 1991, J NEUROSCI METH, V39, P253; DOUGLASS J, 1994, MOL ENDOCRINOL, V8, P333, DOI 10.1210/me.8.3.333; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Fineman I, 2000, J NEUROTRAUM, V17, P739, DOI 10.1089/neu.2000.17.739; Ghosh S, 1997, BRAIN RES, V745, P152, DOI 10.1016/S0006-8993(96)01144-4; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; Long DA, 1996, BRAIN RES, V717, P109, DOI 10.1016/0006-8993(95)01500-0; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Lukoyanov NV, 2000, NEUROSCI LETT, V285, P139, DOI 10.1016/S0304-3940(00)01053-3; Lyeth BG, 2001, EXP NEUROL, V169, P191, DOI 10.1006/exnr.2001.7643; McIntosh T K, 1986, NIDA Res Monogr, V75, P527; MCINTOSH TK, 1994, AM J PHYSIOL, V267, pR665, DOI 10.1152/ajpregu.1994.267.3.R665; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; MEANEY DF, 1994, J NEUROTRAUM, V11, P599, DOI 10.1089/neu.1994.11.599; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; MORRIS BJ, 1995, TRENDS NEUROSCI, V18, P350, DOI 10.1016/0166-2236(95)93927-P; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; OHNO M, 1991, EUR J PHARMACOL, V193, P357, DOI 10.1016/0014-2999(91)90151-F; PERRY DC, 1992, MOL CHEM NEUROPATHOL, V16, P95, DOI 10.1007/BF03159963; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; RUEGG H, 1994, BRAIN RES, V635, P203, DOI 10.1016/0006-8993(94)91440-0; Sandin J, 1998, NEUROSCIENCE, V85, P375, DOI 10.1016/S0306-4522(97)00605-2; SCHENK F, 1985, EXP BRAIN RES, V58, P11; Scoville WB, 2000, J NEUROPSYCH CLIN N, V12, P103; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; TANG AH, 1985, LIFE SCI, V37, P1475, DOI 10.1016/0024-3205(85)90178-X; VINK R, 1991, AM J PHYSIOL, V261, pR1527, DOI 10.1152/ajpregu.1991.261.6.R1527; WAGNER JJ, 1991, J NEUROCHEM, V57, P333, DOI 10.1111/j.1471-4159.1991.tb02132.x; WAGNER JJ, 1993, NATURE, V363, P451, DOI 10.1038/363451a0; WEISSKOPF MG, 1993, NATURE, V365, P188, DOI 10.1038/365188a0; WHISHAW IQ, 1987, BEHAV BRAIN RES, V24, P125, DOI 10.1016/0166-4328(87)90250-6; Zhu J, 2000, EXP NEUROL, V166, P136, DOI 10.1006/exnr.2000.7484	43	18	19	0	1	SOC EXPERIMENTAL BIOLOGY MEDICINE	MAYWOOD	195 WEST SPRING VALLEY AVE, MAYWOOD, NJ 07607-1727 USA	1535-3702			EXP BIOL MED	Exp. Biol. Med.	MAR	2003	228	3					261	269		10.1177/153537020322800304			9	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	654FF	WOS:000181483000004	12626770				2022-02-06	
J	Tinius, TP				Tinius, TP			The Intermediate Visual and Auditory Continuous Performance Test as a neuropsychological measure	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						neuropsychology; CPT; mTBI; ADHD	CLOSED-HEAD-INJURY; REACTION-TIME; SUSTAINED ATTENTION	The Intermediate Visual and Auditory (IVA) Continuous Performance Test (CPT) and Neuropsychological Impairment Scale (NIS) were completed with adults diagnosed with mild traumatic brain injury (mTBI), adults diagnosed with Attention Deficit Hyperactivity Disorder (ADHD), and controls. On the IVACPT, the mTBI and ADHD groups performed significantly lower on the full and secondary scales for attention and response accuracy. For individual scales, the mTBI and ADHD groups showed lower performance on measures of reaction time, inattention, impulsivity, and variability of RT. The mTBI and ADHD groups showed similar patterns of performance on the IVA. On the NIS, the mTBI and ADHD groups reported more neuropsychological symptoms than the control group and the mTBI group reported more neuropsychological symptoms than the ADHD group. The results are discussed in regard to changes in cognitive processing and sustained attention in individuals diagnosed with mTBI and ADHD. (C) 2002 National Academy of Neuropsychology. Published by Elsevier Science Ltd. All rights reserved.	St Cloud State Univ, Dept Psychol, St Cloud, MN 56301 USA		Tinius, TP (corresponding author), St Cloud State Univ, Dept Psychol, 420 7th Ave S, St Cloud, MN 56301 USA.						American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; ARCIA E, 1994, BRAIN INJURY, V8, P395, DOI 10.3109/02699059409150991; Beck A.T., 1967, DEPRESSION CLIN; BURG JS, 1995, BRAIN INJURY, V9, P395, DOI 10.3109/02699059509005779; Collins LF, 1996, ARCH CLIN NEUROPSYCH, V11, P613, DOI 10.1016/0887-6177(97)81255-3; ERRICO AL, 1990, J CONSULT CLIN PSYCH, V1, P45; GENTILINI M, 1989, MILD HEAD INJURY, P163; Gordon M, 1988, INSTRUCTION MANUAL G; Gronwall D, 1989, MILD HEAD INJURY, P153; KLENSCH H, 1973, FORTSCHR NEUROL PSYC, V41, P575; LARRABEE GJ, 1996, ECOLOGICAL VALIDITY, P225; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; LOKEN WJ, 1995, NEUROPSYCHOLOGY, V9, P592, DOI 10.1037/0894-4105.9.4.592; Mild Traumatic Brain Injury Committee, 1993, J HEAD TRAUMA REHAB, V8, P86; Miller E, 1970, Cortex, V6, P121; NORMAN B, 1961, ACTA PSYCHIAT SCAND, V37, P236; O'Donnell W., 1994, NEUROPSYCHOLOGICAL I; PARASURAMAN R, 1991, J CLIN EXP NEUROPSYC, V13, P789, DOI 10.1080/01688639108401090; Rimel R. W., 1981, NEUROSURGERY, V9, P35; ROSVOLD HE, 1956, J CONSULT PSYCHOL, V20, P343, DOI 10.1037/h0043220; Sandford J, 1995, MANUAL INTERMEDIATE; SOLHBERG MM, 1989, INTRO COGNITIVE REHA; Sparrow E, 1999, CONNERS ADULT ADHD R; Spielberger C.D., 1970, TEST MANUAL STATE TR; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); STUSS DT, 1984, PSYCHOL BULL, V95, P3, DOI 10.1037/0033-2909.95.1.3; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Van Zomeren A. H., 1990, NEUROBEHAVIORAL RECO, P225; VANZOMEREN AH, 1978, J NEUROL NEUROSUR PS, V41, P452, DOI 10.1136/jnnp.41.5.452; Wechsler D, 1981, WECHSLER ADULT INTEL; Western SL, 1996, ARCH CLIN NEUROPSYCH, V11, P557, DOI 10.1016/0887-6177(95)00043-7	31	18	22	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAR	2003	18	2					199	214	PII S0887-6177(01)00196-2	10.1016/S0887-6177(01)00196-2			16	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	648LC	WOS:000181152000009	14591471				2022-02-06	
J	O'Neil-Pirozzi, TM; Momose, KJ; Mello, J; Lepak, P; McCabe, M; Connors, JJ; Lisiecki, DJ				O'Neil-Pirozzi, TM; Momose, KJ; Mello, J; Lepak, P; McCabe, M; Connors, JJ; Lisiecki, DJ			Feasibility of swallowing interventions for tracheostomized individuals with severely disordered consciousness following traumatic brain injury	BRAIN INJURY			English	Article							HEAD TRAUMA; ASPIRATION; TRACHEOTOMY	Primary objective: To report the ability of 12 tracheostomized acute rehabilitation hospital inpatients with severely disordered consciousness post-traumatic brain injury (TBI) to participate in an objective swallowing assessment. Research design: Post hoc analysis of data from a larger, prospective blinded comparison study. Methods and procedures: Subjects completed a modified barium swallow (MBS) study. Food/drink and tracheostomy tube management recommendations were made. Main outcomes and results: All subjects participated successfully during an MBS. Post-MBS, 10 subjects began receiving small amounts of food and/or drink. Prior to hospital discharge, all subjects received some food and/or drink and were extubated. Subjects were deemed representative of this patient population and, from a swallowing perspective, other tracheostomized patient populations at the same facility. Conclusions: Clinicians should routinely consider tracheostomized, acute rehabilitation hospital inpatients with severely disordered consciousness post-TBI potential MBS candidates. Implications and continued research needs are discussed.	Northeastern Univ, Boston, MA 02115 USA; Spaulding Rehabil Hosp, Boston, MA USA		O'Neil-Pirozzi, TM (corresponding author), Northeastern Univ, 103 Forsyth Bldg, Boston, MA 02115 USA.	toneilpi@lynx.dac.neu.edu			NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R03DC003848] Funding Source: NIH RePORTER; NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R03 DC 3848] Funding Source: Medline		ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; BONE DK, 1974, ANN THORAC SURG, V18, P30, DOI 10.1016/S0003-4975(10)65714-1; Cherney LR, 1996, SEMIN NEUROL, V16, P349, DOI 10.1055/s-2008-1040993; CURTIS JL, 1997, DEGLUTITION ITS DISO, P99; Field L H, 1989, Brain Inj, V3, P19, DOI 10.3109/02699058909008069; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P36, DOI 10.1097/00001199-199708000-00005; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; GIACINO JT, 1995, ARCH PHYS MED REHAB, V76, P205; Groher Michael E., 1994, Dysphagia, V9, P233, DOI 10.1007/BF00301916; HAGAN C, 1979, REHABILITATION HEAD, P87; Halper AS, 1999, J HEAD TRAUMA REHAB, V14, P486, DOI 10.1097/00001199-199910000-00009; JEAN A, 1979, BRAIN RES, V178, P567, DOI 10.1016/0006-8993(79)90715-7; Keren O, 2001, BRAIN INJURY, V15, P531, DOI 10.1080/02699050010007371; KLINGBEIL GEG, 1988, ARCH PHYS MED REHAB, V69, P493; Langmore S., 2001, ENDOSCOPIC EVALUATIO, P1; LAZARUS C, 1987, ARCH PHYS MED REHAB, V68, P79; Lazarus CL, 1989, J HEAD TRAUMA REHAB, V4, P34; Leder SB, 1999, J HEAD TRAUMA REHAB, V14, P448, DOI 10.1097/00001199-199910000-00005; Leder SB, 2000, LARYNGOSCOPE, V110, P641, DOI 10.1097/00005537-200004000-00019; Linden P., 1993, Dysphagia, V8, P170, DOI 10.1007/BF01354535; LOGEMANN J, 1982, ANN CONV AM SPEECH L; LOGEMANN J A, 1990, Dysphagia, V4, P202, DOI 10.1007/BF02407266; Logemann JA, 1998, EVALUATION TREATMENT; MACKAY L, 1993, DYSPHAGIA, V8, P161; Mackay LE, 1999, ARCH PHYS MED REHAB, V80, P365, DOI 10.1016/S0003-9993(99)90271-X; Mackay LE, 1999, J HEAD TRAUMA REHAB, V14, P435, DOI 10.1097/00001199-199910000-00004; Martin Bonnie J. W., 1994, Dysphagia, V9, P1; MILLER AJ, 1982, PHYSIOL REV, V62, P129, DOI 10.1152/physrev.1982.62.1.129; Miller AJ, 1997, DEGLUTITION ITS DISO, P43; Morgan AS, 1999, J HEAD TRAUMA REHAB, V14, P454, DOI 10.1097/00001199-199910000-00006; ONEILPIROZZI TM, IN PRESS DYSPHAGIA; Piguet O, 1999, BRAIN INJURY, V13, P829, DOI 10.1080/026990599121223; SMITH GJ, 1985, HEAD INJURY REHABILI, P275; SPLAINGARD ML, 1988, ARCH PHYS MED REHAB, V69, P637; TEASDALE G, 1974, LANCET, V2, P81; Whyte J, 1999, REHABILITATION ADULT, P435; Wilson SL, 1996, BRAIN INJURY, V10, P807, DOI 10.1080/026990596123927	37	18	18	1	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2003	17	5					389	399		10.1080/0269905031000070251			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	660MQ	WOS:000181837300003	12745711				2022-02-06	
J	de Freitas, MS; Spohr, TCLS; Benedito, AB; Caetano, MS; Margulis, B; Lopes, UG; Moura-Neto, V				de Freitas, MS; Spohr, TCLS; Benedito, AB; Caetano, MS; Margulis, B; Lopes, UG; Moura-Neto, V			Neurite outgrowth is impaired on HSP70-positive astrocytes through a mechanism that requires NF-kappa B activation	BRAIN RESEARCH			English	Article						astrocyte; GFAP; HSP70; NF-kappa B; TNF-alpha; stress response; neurite outgrowth; reactive astrocyte	TUMOR-NECROSIS-FACTOR; HEAT-SHOCK-PROTEIN; FIBRILLARY ACIDIC PROTEIN; REACTIVE ASTROCYTES; FACTOR-ALPHA; CEREBELLAR ASTROCYTES; TRANSCRIPTION FACTOR; MESSENGER-RNA; BRAIN; INDUCTION	In the adult central nervous system (CNS), prominent reactive astrocytosis is seen in acute traumatic brain injury, neurodegenerative diseases and a variety of viral infections, Reactive astrocytes synthesize a number of factors that could play different roles in neuronal regeneration. In this study, the effects of thermal stress were evaluated on nuclear factor-kappaB (NF-kappaB) activation and proinflammatory cytokine tumor necrosis factor-alpha (TNF-alpha) secretion in primary astrocytic cultures. The ability of HSP70-positive astrocytes to support or inhibit neurite outgrowth was investigated in neuron-astrocyte cocultures. Cultured astrocytes from cerebral cortex of rats were exposed to transient hyperthermia (42 degreesC/30 min) and incubated at 37 degreesC for different periods of recovery. During HSP70 accumulation. astrocytes extended large and thick processes associated to rearrangement of glial fibrillary acidic protein (GFAP) filaments and an increase in protein synthesis and GFAP. suggesting an astrogliosis event, A delay of NF-kappaB activation appeared closely related to TNF-alpha secretion by HSP70-positive astrocytes. These cells demonstrated a functional shift from neurite growth-promoting to non-permissive substrate. We also found that gliotoxin, a specific NF-kappaB inhibitor, partially abrogated the inhibitory ability of reactive astrocytes. These findings may suggest a involvement of NF-kappaB and TNF-alpha in modulating the failure of HSP70-positive astrocytes to provide functional support to neuritic outgrowth. (C) 2002 Elsevier Science B.V. All rights reserved.	Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Ciencias Biomed, Dept Anat, BR-21949900 Rio De Janeiro, Brazil; Univ Estado Rio de Janeiro, Inst Biol, Dept Farmacol, BR-20551030 Rio De Janeiro, Brazil; Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21949900 Rio De Janeiro, Brazil; Russian Acad Sci, Inst Cytol, Dept Cell Cultures, St Petersburg 194064, Russia		Moura-Neto, V (corresponding author), Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Ciencias Biomed, Dept Anat, Ilha Fundao, BR-21949900 Rio De Janeiro, Brazil.		Lopes, Ulisses/N-4416-2013; de Freitas, Marta Sampaio/AAE-8422-2021; Lopes, Ulisses Gazos/T-6634-2019; Spohr, Tania/I-4299-2015; Moura-Neto, VIVALDO/V-9913-2019	Spohr, Tania/0000-0001-8691-5962; Moura-Neto, VIVALDO/0000-0002-6266-043X			BACUERLE PA, 1996, CELL, V87, P13; BOLOVENTA P, 1992, PROG BRAIN RES, V94, P367; BONTHIUS DJ, 1993, BRAIN RES, V618, P83, DOI 10.1016/0006-8993(93)90432-M; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN CR, 1993, J CELL BIOL, V120, P1101, DOI 10.1083/jcb.120.5.1101; BROWN IR, 1989, NEURON, V2, P1559, DOI 10.1016/0896-6273(89)90044-5; Canning DR, 1996, INT J DEV NEUROSCI, V14, P153, DOI 10.1016/0736-5748(96)00004-4; Coelho ALJ, 1999, EXP CELL RES, V251, P379, DOI 10.1006/excr.1999.4583; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; ENG LF, 1994, BRAIN PATHOL, V4, P229, DOI 10.1111/j.1750-3639.1994.tb00838.x; ENG LF, 1996, NEUROCHEM RES, V21, P521; ESPEVIK T, 1986, J IMMUNOL METHODS, V95, P99, DOI 10.1016/0022-1759(86)90322-4; FADEN AI, 1993, CRIT REV NEUROBIOL, V7, P175; Feinstein DL, 1997, NITRIC OXIDE-BIOL CH, V1, P167, DOI 10.1006/niox.1997.0117; Feinstein DL, 1996, J BIOL CHEM, V271, P17724, DOI 10.1074/jbc.271.30.17724; Froes MM, 1999, P NATL ACAD SCI USA, V96, P7541, DOI 10.1073/pnas.96.13.7541; Fujihara SM, 1999, EMBO J, V18, P411, DOI 10.1093/emboj/18.2.411; GAGE FH, 1988, EXP NEUROL, V102, P2, DOI 10.1016/0014-4886(88)90073-8; Garcia-Abreu J, 2000, GLIA, V29, P260, DOI 10.1002/(SICI)1098-1136(20000201)29:3<260::AID-GLIA7>3.0.CO;2-I; GARCIAABREU J, 1995, J NEUROSCI RES, V40, P471, DOI 10.1002/jnr.490400406; GHIRNIKAR RS, 1994, J NEUROSCI RES, V38, P376, DOI 10.1002/jnr.490380403; Gilbert C D, 1993, Curr Opin Neurobiol, V3, P100, DOI 10.1016/0959-4388(93)90042-W; GLABINSKI AR, 1995, INT J DEV NEUROSCI, V13, P153, DOI 10.1016/0736-5748(95)00017-B; Gomes FCA, 1999, GLIA, V26, P97; Gomes FCA, 1999, GLIA, V25, P247, DOI 10.1002/(SICI)1098-1136(19990201)25:3<247::AID-GLIA5>3.3.CO;2-U; Guzhova IV, 1997, CELL STRESS CHAPERON, V2, P132, DOI 10.1379/1466-1268(1997)002<0132:MSPHIW>2.3.CO;2; Han YL, 2001, J CLIN INVEST, V108, P425, DOI 10.1172/JCI12629; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; HATTEN ME, 1991, GLIA, V4, P233, DOI 10.1002/glia.440040215; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lima FRS, 1998, INT J DEV NEUROSCI, V16, P19, DOI 10.1016/S0736-5748(98)00002-1; MA KC, 1994, J NEUROL SCI, V126, P184, DOI 10.1016/0022-510X(94)90271-2; McNaught KSP, 2000, NEUROSCI LETT, V285, P61, DOI 10.1016/S0304-3940(00)00982-4; MERRILL JE, 1992, DEV NEUROSCI-BASEL, V14, P1, DOI 10.1159/000111642; Miyagishi R, 1997, J NEUROIMMUNOL, V77, P17, DOI 10.1016/S0165-5728(97)00040-4; MORIMOTO RI, 1993, SCIENCE, V259, P1409, DOI 10.1126/science.8451637; Nishimura RN, 1996, MOL BRAIN RES, V36, P227, DOI 10.1016/0169-328X(95)00261-P; Nomoto Y, 2001, NEUROSURGERY, V48, P158, DOI 10.1097/00006123-200101000-00027; NORTON WT, 1992, NEUROCHEM RES, V17, P877, DOI 10.1007/BF00993263; NOWAK TS, 1990, J NEUROCHEM, V54, P451, DOI 10.1111/j.1471-4159.1990.tb01893.x; ONeill LAJ, 1997, TRENDS NEUROSCI, V20, P252, DOI 10.1016/S0166-2236(96)01035-1; OTANO IP, 1996, GLIA, V16, P304; Pahl HL, 1996, J EXP MED, V183, P1829, DOI 10.1084/jem.183.4.1829; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; PIKE CJ, 1995, EXP NEUROL, V132, P172, DOI 10.1016/0014-4886(95)90022-5; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; RUDGE JS, 1990, J NEUROSCI, V10, P3594; SATOH J, 1992, BRAIN RES, V573, P37, DOI 10.1016/0006-8993(92)90111-L; SCHWAB ME, 1993, ANNU REV NEUROSCI, V16, P565, DOI 10.1146/annurev.ne.16.030193.003025; Shafer RA, 1997, GLIA, V21, P370, DOI 10.1002/(SICI)1098-1136(199712)21:4<370::AID-GLIA4>3.0.CO;2-7; SHARP FR, 1991, J CEREBR BLOOD F MET, V11, P621, DOI 10.1038/jcbfm.1991.113; Stasiolek M, 2000, J BIOL CHEM, V275, P24847, DOI 10.1074/jbc.M910284199; THANOS D, 1995, CELL, V80, P529, DOI 10.1016/0092-8674(95)90506-5; Trentin AG, 2001, AM J PHYSIOL-ENDOC M, V281, pE1088, DOI 10.1152/ajpendo.2001.281.5.E1088; Trillo-Pazos G, 2000, BRAIN RES, V864, P315, DOI 10.1016/S0006-8993(00)02213-7; UNEY JB, 1988, FEBS LETT, V235, P215, DOI 10.1016/0014-5793(88)81265-1; Wu VW, 1998, J NEUROCHEM, V71, P749; Yuan L, 2000, GLIA, V32, P42, DOI 10.1002/1098-1136(200010)32:1<42::AID-GLIA40>3.0.CO;2-3	59	18	18	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	DEC 27	2002	958	2					359	370	PII S0006-8993(02)03682-X	10.1016/S0006-8993(02)03682-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	630BH	WOS:000180087300016	12470872				2022-02-06	
J	Borgaro, SR; Prigatano, GP				Borgaro, SR; Prigatano, GP			Early cognitive and affective sequelae of traumatic brain injury: A study using the BNI Screen for Higher Cerebral Functions	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						acute rehabilitation; cognitive and affective disturbances; TBI	SEVERE HEAD-INJURY; REHABILITATION; 1-YEAR	Objective: To demonstrate that the Barrow Neurological Institute (BNI) Screen for Higher Cerebral Functions (BNIS) can be used to briefly assess cognitive and affective disturbances during the acute stages after traumatic brain injury (TBI). Design and Outcome Measures: People with TBI were administered the BNIS during the first 60 days after injury and their performance compared to a convenience sample of control subjects used in the standardization of the BNIS. Setting: Inpatient units of a neurological institute and medical center. Subjects: Forty-two individuals with moderate-to-severe TBI and 21 control subjects. Results: Compared to patients with TBI, control subjects performed significantly better on the BNIS total and all subtest scores. TBI patients were best classified by poor performance on measures of affect disturbance and impaired awareness. Stepwise discriminant analysis identified disturbances in memory; awareness, and affect as contributing most to the classification of an individual as having TBI. Conclusions: Both cognitive and affective disturbances can be directly assessed during the early stages after significant TBI. The BNIS can be used for this purpose and help document that TBI specifically affects memory awareness, and affect during its early stages and should be addressed in rehabilitation.	St Josephs Hosp, Barrow Neurol Inst, Phoenix, AZ USA; Ctr Med, Phoenix, AZ USA; St Josephs Hosp, Barrow Neurol Inst, Dept Clin Neuropsychol, Phoenix, AZ 85013 USA		Prigatano, GP (corresponding author), Barrow Neurol Inst, Dept Clin Neuropsychol, 350 W Thomas Rd, Phoenix, AZ 85013 USA.	gprigat@chw.edu					Alexander GE, 1997, AM J PSYCHIAT, V154, P165; BENYISHAY Y, 1990, REHABILITATION ADULT, P393; Boake C, 2001, ARCH PHYS MED REHAB, V82, P761, DOI 10.1053/apmr.2001.23753; CHAPMAN LF, 1959, ARCH NEUROL-CHICAGO, V1, P357, DOI 10.1001/archneur.1959.03840040001001; Clair JS, 1998, J CLIN EXP NEUROPSYC, V20, P320; CROSSON B, 1993, NEUROPSYCHOLOGY, V7, P193, DOI DOI 10.1037/0894-4105.7.2.193; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Evans D A, 1993, Ann Epidemiol, V3, P71; EZRACHI O, 1991, J HEAD TRAUMA REHAB, V0006, P00071, DOI DOI 10.1097/00001199-199109000-00010; JENNETT B, 1974, MANAGEMENT HEAD INJU; Johnson SC, 1994, NEUROPSYCHOLOGY, V8, P307, DOI DOI 10.1037/0894-4105.8.3.301; Levin H. S., 1994, NEUROPSYCHOLOGY, V87, P171, DOI DOI 10.1037/0894-4105.8.2.171; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Mathias JL, 1999, J CLIN EXP NEUROPSYC, V21, P200, DOI 10.1076/jcen.21.2.200.930; McCleary C, 1998, J CLIN EXP NEUROPSYC, V20, P270, DOI 10.1076/jcen.20.2.270.1172; Prigatano G., 2002, CLIN NEUROPSYCHOLOGY; Prigatano G. P., 1991, AWARENESS DEFICIT BR; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Prigatano GP, 1999, ARCH PHYS MED REHAB, V80, P77, DOI 10.1016/S0003-9993(99)90311-8; Prigatano GP, 1998, J HEAD TRAUMA REHAB, V13, P29, DOI 10.1097/00001199-199810000-00005; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Prigatano GP, 1991, AWARENESS DEFICIT BR, P111; Prigatano GP, 1993, BNI Q, V9, P2; RATTOK J, 1992, NEUROPSYCHOLOGIA, V6, P395, DOI DOI 10.1037/0894-4105.6.4.395; Rosenstein LD, 1997, NEUROPSY NEUROPSY BE, V10, P113; Rosenstein LD., 1995, ADM SCORING MANUAL B; Rosenstein LD, 1992, BNI Q, V8, P24; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; SHERER M, 2001, IN PRESS ARCH PHYS M; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; VILKKI J, 1992, NEUROPSYCHOLOGIA, V30, P807, DOI 10.1016/0028-3932(92)90084-Y; WAAS P, 1997, THESIS U WINDSOR ONT; 1975, CIBA FDN S, V34	37	18	18	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	DEC	2002	17	6					526	534		10.1097/00001199-200212000-00004			9	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	617NN	WOS:000179367900004	12802243				2022-02-06	
J	Krautstrunk, M; Scholtes, F; Martin, D; Schoenen, J; Schmitt, AB; Plate, D; Nacimiento, W; Noth, J; Brook, GA				Krautstrunk, M; Scholtes, F; Martin, D; Schoenen, J; Schmitt, AB; Plate, D; Nacimiento, W; Noth, J; Brook, GA			Increased expression of the putative axon growth-repulsive extracellular matrix molecule, keratan sulphate proteoglycan, following traumatic injury of the adult rat spinal cord	ACTA NEUROPATHOLOGICA			English	Article						spinal cord injury; regeneration; proteoglycan; keratan sulphate proteoglycan; extracellular matrix molecules	CENTRAL-NERVOUS-SYSTEM; CHONDROITIN-SULFATE PROTEOGLYCAN; NEURITE OUTGROWTH; INHIBITORY MOLECULES; RAMIFIED MICROGLIA; CELL-ADHESION; BRAIN INJURY; CNS INJURY; REGENERATION; ASTROCYTES	Keratan sulphate proteoglycan (KSPG) is a developmentally regulated barrier molecule, directing axonal growth during central nervous system (CNS) formation. The possible re-expression and functional significance of KSPG in preventing axon regeneration following spinal cord injury (SCI) is poorly understood. In the present investigation, the spatio-temporal expression of KSPG was studied following experimental SCI. There was no indication of sparing of axons at the lesion epicentre following severe compression injury. By 7 days post operation (p.o.) a diffuse increase of KSPG immunoreactivity (KSPG-IR) was observed in the parenchyma surrounding the lesion. This was followed by a delayed (21-28 days p.o.) and largely heterogeneous increase of KSPG-IR in the lesion epicentre, which revealed both cellular and extracellular matrix-like distribution patterns. Although no re-growth of anterogradely labelled corticospinal axons was observed, many 200-kDa neurofilament (NF)-positive axon could be detected growing into the connective tissue scar. This phase of spontaneous axonal re-growth was closely associated with a framework of glial cells (including Schwann cells from damaged local spinal nerve roots) that had migrated into the lesion site. The spontaneous nerve fibre re-growth could be detected in both KSPG-rich and KSPG-poor territories. The present data suggest that the lesion-induced up-regulation of KSPG-IR may have contributed to the lack of corticospinal axon re-growth. However, the lack of any direct spatio-temporal correlation between the distribution of raised KSPG-IR and spontaneous NF-positive axonal regeneration suggests that at least some populations of axons can resist the putative inhibitory effects of this extracellular matrix molecule.	Rhein Westfal TH Aachen, Sch Med, Dept Neurol, D-52057 Aachen, Germany; Univ Liege, Dept Neuroanat, Liege, Belgium; Univ Liege, CHU Sart Tilman, Dept Neurosurg, Liege, Belgium		Brook, GA (corresponding author), Rhein Westfal TH Aachen, Sch Med, Dept Neurol, Pauwelsstr 30, D-52057 Aachen, Germany.	Gary.Brook@RWTH-Aachen.de		MARTIN, Didier/0000-0001-7325-4958			Asher R A, 2001, Prog Brain Res, V132, P611; Asher RA, 2000, J NEUROSCI, V20, P2427; BERTOLOTTO A, 1995, DEV BRAIN RES, V86, P233, DOI 10.1016/0165-3806(95)00030-H; Bertolotto A, 1998, J NEUROIMMUNOL, V85, P69, DOI 10.1016/S0165-5728(97)00251-8; Brook GA, 2000, EUR J NEUROSCI, V12, P3224, DOI 10.1046/j.1460-9568.2000.00228.x; Brook GA, 1998, J NEUROSCI RES, V53, P51, DOI 10.1002/(SICI)1097-4547(19980701)53:1<51::AID-JNR6>3.0.CO;2-I; BROOK GA, 2000, RESTORATIVE NEUROL N, V16, P361; Bunge R P, 1997, Adv Neurol, V72, P305; Calingasan NY, 1996, J NEUROL SCI, V144, P21, DOI 10.1016/S0022-510X(96)00189-X; COLE GJ, 1991, NEURON, V7, P1007, DOI 10.1016/0896-6273(91)90345-Z; Davies SJA, 1997, NATURE, V390, P680, DOI 10.1038/37776; Davies SJA, 1999, J NEUROSCI, V19, P5810, DOI 10.1523/JNEUROSCI.19-14-05810.1999; DIETZ V, 1995, ANN NEUROL, V37, P574, DOI 10.1002/ana.410370506; Dou CL, 1995, J NEUROSCI, V15, P8053; Fernaud-Espinosa I, 1998, J NEUROBIOL, V36, P16, DOI 10.1002/(SICI)1097-4695(199807)36:1<16::AID-NEU2>3.0.CO;2-D; Fitch MT, 1997, EXP NEUROL, V148, P587, DOI 10.1006/exnr.1997.6701; FRISEN J, 1992, P NATL ACAD SCI USA, V89, P11282, DOI 10.1073/pnas.89.23.11282; GIORDANA MT, 1994, NEUROPATH APPL NEURO, V20, P163, DOI 10.1111/j.1365-2990.1994.tb01175.x; Hirsch S, 1999, GLIA, V26, P36, DOI 10.1002/(SICI)1098-1136(199903)26:1<36::AID-GLIA4>3.0.CO;2-C; Jander S, 2000, GLIA, V30, P401, DOI 10.1002/(SICI)1098-1136(200006)30:4<401::AID-GLIA90>3.0.CO;2-6; Jander S, 1996, GLIA, V18, P255, DOI 10.1002/(SICI)1098-1136(199611)18:3<255::AID-GLIA9>3.0.CO;2-Y; Jander S, 1996, AM J PATHOL, V148, P71; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Kakulas B A, 1984, Cent Nerv Syst Trauma, V1, P117; Lander A D, 1993, Curr Opin Neurobiol, V3, P716, DOI 10.1016/0959-4388(93)90143-M; LAYWELL ED, 1991, ANN NY ACAD SCI, V633, P122; LAYWELL ED, 1992, P NATL ACAD SCI USA, V89, P2634, DOI 10.1073/pnas.89.7.2634; Lemons ML, 1999, EXP NEUROL, V160, P51, DOI 10.1006/exnr.1999.7184; LEVINE JM, 1994, J NEUROSCI, V14, P4716; MARGOLIS RK, 1993, EXPERIENTIA, V49, P429, DOI 10.1007/BF01923587; MARTIN D, 1992, J NEUROSCI RES, V32, P539, DOI 10.1002/jnr.490320409; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; MCKEON RJ, 1995, EXP NEUROL, V136, P32, DOI 10.1006/exnr.1995.1081; Moon LDF, 2001, NAT NEUROSCI, V4, P465, DOI 10.1038/87415; PALLINI R, 1988, J NEUROSURG, V68, P124, DOI 10.3171/jns.1988.68.1.0124; Pasterkamp RJ, 1999, MOL CELL NEUROSCI, V13, P143, DOI 10.1006/mcne.1999.0738; Schnell L, 1999, EUR J NEUROSCI, V11, P3648, DOI 10.1046/j.1460-9568.1999.00792.x; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; SMITHTHOMAS LC, 1995, J CELL SCI, V108, P1307; SNOW DM, 1990, DEV BIOL, V138, P359, DOI 10.1016/0012-1606(90)90203-U; SNOW DM, 1990, EXP NEUROL, V109, P111, DOI 10.1016/S0014-4886(05)80013-5; Stichel CC, 1999, EUR J NEUROSCI, V11, P632, DOI 10.1046/j.1460-9568.1999.00466.x; Stichel CC, 1999, NEUROSCIENCE, V93, P321, DOI 10.1016/S0306-4522(99)00112-8	43	18	19	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0001-6322	1432-0533		ACTA NEUROPATHOL	Acta Neuropathol.	DEC	2002	104	6					592	600		10.1007/s00401-002-0589-6			9	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	621EA	WOS:000179574500002	12410380				2022-02-06	
J	Slewa-Younan, S; Green, AM; Baguley, IJ; Felmingham, KL; Haig, AR; Gordon, E				Slewa-Younan, S; Green, AM; Baguley, IJ; Felmingham, KL; Haig, AR; Gordon, E			Is 'gamma' (40 Hz) synchronous activity disturbed in patients with traumatic brain injury?	CLINICAL NEUROPHYSIOLOGY			English	Article						traumatic brain injury; gamma (40 Hz) synchrony; speed of information processing; electroencephalogram	SEVERE HEAD-INJURY; FUNCTIONAL-SIGNIFICANCE; REACTION-TIME; VALIDATION; POTENTIALS; COMPONENT; PARADIGM; TASK	Objectives: The objective of this work is to determine whether Gamma (40 Hz) synchronous activity has disturbed patients with severe traumatic brain injury (TBI). Methods: Using a conventional auditory oddball paradigm, the extent of Gamma synchrony across multiple scalp sites in specific frequency bands as a function of time was examined in 15 patients with severe TBI and 15 age- and sex-matched controls. Averaged Gamma synchrony was analyzed using within and between group multiple analyses of variance with region (left versus right hemisphere, anterior versus posterior region) as the within factor. Results: Compared to controls, subjects with TBI displayed significantly delayed early Gamma latency (from -150 to 150 ms) (F-(1,F-28)=10.28, P<0.003) across All sites in addition to other specific regional disturbances. For late Gamma synchrony, subjects with TBI displayed delayed Gamma latency at the left hemisphere (from 200 to 450 ms) (F-(1,F-28)=8.71, P<0.006) and posterior region (F-(1,F-28)=9.18, P<0.006) in comparison to controls. Conclusions: Impaired integration of spatially distributed brain activity ('40 Hz' electroencephalogram rhythms) may be an important marker of deficits of cortical network binding postulated to be abnormal in people who have survived TBI. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.	Westmead Hosp, Brain Injury Rehabil Serv, Wentworthville, NSW 2145, Australia; Westmead Hosp, Brain Dynam Ctr, Wentworthville, NSW 2145, Australia; Univ Sydney, Dept Psychol Med, Sydney, NSW 2006, Australia		Slewa-Younan, S (corresponding author), Westmead Hosp, Brain Injury Rehabil Serv, POB 533, Wentworthville, NSW 2145, Australia.		Baguley, Ian/AAM-5828-2021; Baguley, Ian J/K-6878-2013	Baguley, Ian J/0000-0001-5650-3705			Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; BasarEroglu C, 1996, INT J PSYCHOPHYSIOL, V24, P101, DOI 10.1016/S0167-8760(96)00051-7; BLOM JL, 1982, ELECTROEN CLIN NEURO, V54, P591, DOI 10.1016/0013-4694(82)90046-3; DUNCANJOHNSON CC, 1982, BIOL PSYCHOL, V14, P1, DOI 10.1016/0301-0511(82)90016-3; Fisher NI, 1993, STAT ANAL CIRCULAR D; Gordon E, 1999, AUST NZ J PSYCHIAT, V33, P187, DOI 10.1046/j.1440-1614.1999.00557.x; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; GUTLING E, 1995, NEUROLOGY, V45, P915, DOI 10.1212/WNL.45.5.915; Haig AR, 1999, CLIN NEUROPHYSIOL, V110, P158, DOI 10.1016/S0013-4694(98)00112-6; Haig AR, 2000, NEUROREPORT, V11, P669, DOI 10.1097/00001756-200003200-00004; Jefferys JGR, 1996, TRENDS NEUROSCI, V19, P202, DOI 10.1016/S0166-2236(96)10023-0; JENNETT B, 1977, LANCET, V1, P878; JOLIOT M, 1994, P NATL ACAD SCI USA, V91, P11748, DOI 10.1073/pnas.91.24.11748; KRIEGER D, 1987, ELECTROEN CLIN NEURO, V67, P222, DOI 10.1016/0013-4694(87)90020-4; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Phillips WA, 1997, BEHAV BRAIN SCI, V20, P657, DOI 10.1017/S0140525X9700160X; PRESS WH, 1992, FOURIER SPECTRAL APP; Revonsuo A, 1997, NEUROREPORT, V8, P3867, DOI 10.1097/00001756-199712220-00006; Sauve K, 1999, CONSCIOUS COGN, V8, P213, DOI 10.1006/ccog.1999.0383; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; Smith, 1973, SYMBOL DIGIT MODALIT; Thornton KE, 1999, BRAIN INJURY, V13, P477, DOI 10.1080/026990599121395; TIITINEN H, 1993, NATURE, V364, P59, DOI 10.1038/364059a0; UNSAL A, 1995, PSYCHOPHYSIOLOGY, V32, P249, DOI 10.1111/j.1469-8986.1995.tb02953.x; van Zomeren AH, 1987, NEUROBEHAVIORAL RECO, P398; VANZOMEREN A, 1994, CLIN NEUROPSYCHOLOGY, P179; Viggiano MP, 1996, J CLIN EXP NEUROPSYC, V18, P631, DOI 10.1080/01688639608408288; Williams LM, 2000, INT J NEUROSCI, V105, P37, DOI 10.3109/00207450009003264	30	18	18	1	3	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	1388-2457			CLIN NEUROPHYSIOL	Clin. Neurophysiol.	OCT	2002	113	10					1640	1646	PII S1388-2457(02)00239-0	10.1016/S1388-2457(02)00239-0			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	607GH	WOS:000178783400015	12350441				2022-02-06	
J	Steinmeier, R; Hofmann, RP; Bauhuf, C; Hubner, U; Fahlbusch, R				Steinmeier, R; Hofmann, RP; Bauhuf, C; Hubner, U; Fahlbusch, R			Continuous cerebral autoregulation monitoring by cross-correlation analysis	JOURNAL OF NEUROTRAUMA			English	Article						cerebral autoregulation; computer algorithm; continuous neuromonitoring; cross-correlation; traumatic brain injury	HEAD-INJURED PATIENTS; BLOOD-FLOW AUTOREGULATION; EXPERIMENTAL SUBARACHNOID HEMORRHAGE; LASER-DOPPLER FLOWMETRY; INTRACRANIAL-PRESSURE; CEREBROVASCULAR RESISTANCE; PHASE RELATIONSHIP; OXYGEN-SATURATION; VELOCITY; DYNAMICS	In order to validate cross-correlation analysis between spontaneous slow oscillations of arterial blood pressure (aBP) and intracranial pressure (ICP) or flow velocity as a means to assess the status of cerebral autoregulation continuously, we compared its results with different autoregulation bedside tests. The second aim was to check the method's stability over longer time periods. aBP, ICP, and flow velocity in the middle cerebral artery (FVMCA) was measured continuously in 13 critically ill comatose patients. Cross-correlation analysis was performed online and offline between aBP and ICP (CC [aBP --> ICP]) and aBP/FVMCA (CC [aBP --> FVMCA]). Three different-autoregulation bedside tests (cuff deflation, transient hyperemic response, orthostatic hypotension) were performed immediately before a 29-min cross-correlation test period. In addition, continuous cross-correlation autoregulation monitoring was performed over multiple hours (in order to analyze for stability and to assess the influence of other factors). Cluster analysis revealed two main clusters. Cluster 1 (indicative for disturbed autoregulation) showed a centroid at t = -0.21 +/- 3.32 sec, r = 0.43 +/- 0.18 for CC [aBP --> ICP], and t = 0 +/- 3.14 sec, r = 0.44 +/- 0.18 for CC [aBP --> FVMCA]. Cluster 2 (indicative for normal autoregulation) revealed a centroid at t = 4.94 +/- 3.74 sec, r = -0.4 +/- 0.16 for CC [aBP --> ICP], and t = 3.38 +/- 4.44 sec, r = -0.38 +/- 0.18 for CC [aBP --> FVMCA]. Comparison between the cross-correlation test results and the bedside tests showed a sensitivity of 44-73% for CC [aBP --> FVMCA], whereas CC [aBP --> ICP] was more specific (60-80%). Long-term monitoring revealed stable cross-correlation tests in about 45% of the measurement time. It is concluded that cross-correlation between aBP, ICP, and FVMCA is a valid means to monitor the autoregulation status continuously, although further improvement of sensitivity and specificity is needed to make it reliable for clinical decision making.	Univ Erlangen Nurnberg, Dept Neurosurg, Erlangen, Germany		Steinmeier, R (corresponding author), Tech Univ Dresden, Univ Klinikum Carl Gustav Carus, Neurochirurg Klin, Fetscherstr 74, D-01307 Dresden, Germany.						AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; BAUHUF C, 1998, ZENTRALBL NEUROCHI S, V59, P118; BIRCH AA, 1995, STROKE, V26, P834, DOI 10.1161/01.STR.26.5.834; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; CZOSNYKA M, 1994, ACTA NEUROCHIR, V126, P113, DOI 10.1007/BF01476419; Czosnyka M, 1996, ACTA NEUROCHIR, V138, P531, DOI 10.1007/BF01411173; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 1998, ACT NEUR S, V71, P74; DAFFERTSHOFER M, 1995, J CLIN ULTRASOUND, V23, P125, DOI 10.1002/jcu.1870230207; DAFFERTSHOFER M, 1991, J NEUROL SCI, V104, P32, DOI 10.1016/0022-510X(91)90212-P; DALEY ML, 1995, IEEE T BIO-MED ENG, V42, P420, DOI 10.1109/10.376137; DIEHL RR, 1995, STROKE, V26, P1801, DOI 10.1161/01.STR.26.10.1801; Diehl RR, 1998, CLIN AUTON RES, V8, P7, DOI 10.1007/BF02267598; DIEHL RR, 1997, NEW TRENDS CEREBRAL, P605; FLORENCE G, 1992, J CEREBR BLOOD F MET, V12, P674, DOI 10.1038/jcbfm.1992.92; FORTUNE JB, 1994, J NEUROSURG, V80, P461, DOI 10.3171/jns.1994.80.3.0461; Giller CA, 1997, NEUROL RES, V19, P634; GILLER CA, 1991, ACTA NEUROCHIR, V108, P7, DOI 10.1007/BF01407660; GILLER CA, 1990, NEUROSURGERY, V27, P362, DOI 10.1227/00006123-199009000-00004; HAUERBERG J, 1993, J NEUROSURG ANESTH, V5, P258; Jorgensen L G, 1995, Acta Physiol Scand Suppl, V625, P1; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; KONTOS HA, 1978, AM J PHYSIOL, V234, P371; Lam JMK, 1997, J NEUROSURG, V86, P438, DOI 10.3171/jns.1997.86.3.0438; Lang E W, 1995, New Horiz, V3, P400; Lang EW, 2001, CRIT CARE MED, V29, P158, DOI 10.1097/00003246-200101000-00031; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; McLaughlin MR, 1996, J NEUROSURG, V85, P871, DOI 10.3171/jns.1996.85.5.0871; NEWELL DW, 1994, STROKE, V25, P793, DOI 10.1161/01.STR.25.4.793; Newell DW, 1996, NEUROSURGERY, V39, P35, DOI 10.1097/00006123-199607000-00008; Nichols JS, 1996, J NEUROTRAUM, V13, P439, DOI 10.1089/neu.1996.13.439; Panerai RB, 1996, IEEE T BIO-MED ENG, V43, P779, DOI 10.1109/10.508541; PIPER IR, 1993, NEUROSURGERY, V32, P805, DOI 10.1227/00006123-199305000-00014; PIPER IR, 1990, J NEUROSURG, V73, P871, DOI 10.3171/jns.1990.73.6.0871; PORTNOY HD, 1982, J NEUROSURG, V56, P666, DOI 10.3171/jns.1982.56.5.0666; RASMUSSEN G, 1992, ACTA NEUROCHIR, V119, P128, DOI 10.1007/BF01541796; Sahuquillo J, 1996, ACTA NEUROCHIR, V138, P435, DOI 10.1007/BF01420306; SHARPLES PM, 1995, J NEUROL NEUROSUR PS, V58, P153, DOI 10.1136/jnnp.58.2.153; Smielewski P, 1997, J NEUROSURG, V86, P773, DOI 10.3171/jns.1997.86.5.0773; Smielewski P, 1996, STROKE, V27, P2197, DOI 10.1161/01.STR.27.12.2197; STEIGER HJ, 1994, NEUROSURGERY, V34, P79; Steinmeier R, 1996, STROKE, V27, P2236, DOI 10.1161/01.STR.27.12.2236; Steinmeier R, 2002, CRIT CARE MED, V30, P1969, DOI 10.1097/00003246-200209000-00004; Strebel S, 1997, SURG NEUROL, V47, P128, DOI 10.1016/S0090-3019(96)00459-4; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014; Zunker P., 1997, NEW TRENDS CEREBRAL, P718; [No title captured]	49	18	18	0	2	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	OCT	2002	19	10					1127	1138		10.1089/08977150260337949			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	605MJ	WOS:000178681400003	12427323				2022-02-06	
J	Zhang, FY; Sprague, SM; Farrokhi, F; Henry, MN; Son, MG; Vollmer, DG				Zhang, FY; Sprague, SM; Farrokhi, F; Henry, MN; Son, MG; Vollmer, DG			Reversal of attenuation of cerebrovascular reactivity to hypercapnia by a nitric oxide donor after controlled cortical impact in a rat model of traumatic brain injury	JOURNAL OF NEUROSURGERY			English	Article						nitric oxide; controlled cortical impact; hypercapnia; cortical spreading depression; rat	CEREBRAL BLOOD-FLOW; CEREBELLAR FASTIGIAL NUCLEUS; FLUID-PERCUSSION INJURY; SEVERE HEAD-INJURY; SPREADING DEPRESSION; AUTO-REGULATION; L-ARGININE; CO2; RESPONSES; REDUCTION	Object. Traumatic brain injury (TBI) attenuates the cerebral vasodilation to hypercapnia. Cortical spreading depression (CSD) also transiently reduces hypercapnic vasodilation. The authors sought to determine whether the CSD elicited by a controlled cortical impact (CCI) injury masks the true effect of TBI on hypercapnic vasodilation, and whether a nitric oxide (NO) donor can reverse the attenuation of hypercapnic vasodilation following CCI Methods, Anesthetized rats underwent moderate CCL Cerebral blood flow was monitored with laser Doppler flowmetry and the response to hypercapnia was determined for injured and sham-injured animals. The effect of the NO donor, S-nitroso-Al-acetylpenicillamine (SNAP), on this response was also assessed. At an uninjured cortical site ipsilateral to the CCI, a single wave of CSD was recorded and the CO2 response at this location was significantly attenuated for up to 30 minutes (seven rats, p < 0.05). At the injured cortex, hypercapnic vasodilation continued to be attenuated for 7 hours. The cerebral vasodilation to CO2 was 37 +/- 5% in injured rats (six) compared with 84 +/- 10%, in the sham-injured group (five rats, p < 0.05). After 30 minutes of topical supetfusion with SNAP, hypercapnic vasodilation was restored to 74 7% (nine rats, p > 0.1 compared with that in the sham-injured group). In contrast, papaverine, an NO-independent vasodilator, failed to reverse the attenuation of the CO2 response to CCI. Conclusions. The authors conclude that CSD elicited by CCI can mask the true effect of TBI on hypercapnic vasodilation for at least 30 minutes. Exogenous NO, but not papaverine, can reverse the attenuation of cerebrovascular reactivity to CO2 caused by TBI. This result supports the hypothesis that NO production is reduced after TBI and that the NO donor has a potential beneficial role in the clinical management of head injury.	Univ Texas, Hlth Sci Ctr, Div Neurosurg, Dept Surg, San Antonio, TX 78229 USA; Univ Texas, Hlth Sci Ctr, Div Crit Care, Dept Pediat, San Antonio, TX 78229 USA		Zhang, FY (corresponding author), Univ Texas, Hlth Sci Ctr, Div Neurosurg, Dept Surg, Mail Code 7843,7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	fangyizhang@hotmail.com					Alagarsamy S, 1998, J NEUROTRAUM, V15, P627, DOI 10.1089/neu.1998.15.627; Armstead WM, 1996, J NEUROSURG, V85, P901, DOI 10.3171/jns.1996.85.5.0901; BRYAN RM, 1995, ANESTH ANALG, V80, P687, DOI 10.1097/00000539-199504000-00007; Busto R, 1997, J NEUROTRAUM, V14, P35, DOI 10.1089/neu.1997.14.35; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Cherian L, 1999, CRIT CARE MED, V27, P2512, DOI 10.1097/00003246-199911000-00031; CHERIAN L, 1994, J NEUROTRAUM, V11, P573, DOI 10.1089/neu.1994.11.573; COLD GE, 1977, ACTA ANAESTH SCAND, V21, P359, DOI 10.1111/j.1399-6576.1977.tb01232.x; Colonna DM, 1997, AM J PHYSIOL-HEART C, V272, pH1315; DeWitt DS, 1997, J NEUROTRAUM, V14, P223, DOI 10.1089/neu.1997.14.223; Dietrich WD, 1996, J CEREBR BLOOD F MET, V16, P481, DOI 10.1097/00004647-199605000-00015; DIXON CE, 1991, J NEUROSCI METH, V39, P253; ENEVOLDSEN EM, 1978, J NEUROSURG, V48, P689, DOI 10.3171/jns.1978.48.5.0689; FABRICIUS M, 1995, AM J PHYSIOL-HEART C, V269, pH23, DOI 10.1152/ajpheart.1995.269.1.H23; FABRICIUS M, 1993, BRAIN RES, V602, P350, DOI 10.1016/0006-8993(93)90701-N; Forbes ML, 1997, J CEREBR BLOOD F MET, V17, P865, DOI 10.1097/00004647-199708000-00005; Gahm C, 2000, NEUROSURGERY, V46, P169, DOI 10.1093/neurosurgery/46.1.169; GOBIET W, 1975, ACTA NEUROCHIR, V32, P13, DOI 10.1007/BF01405899; Golding EM, 1999, AM J PHYSIOL-HEART C, V277, pH1457, DOI 10.1152/ajpheart.1999.277.4.H1457; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; GORJI A, 1907, BRAIN RES BRAIN RES, V38, P33; Hendrich KS, 1999, MAGN RESON MED, V42, P673, DOI 10.1002/(SICI)1522-2594(199910)42:4<673::AID-MRM8>3.0.CO;2-B; IADECOLA C, 1990, J CEREBR BLOOD F MET, V10, P608, DOI 10.1038/jcbfm.1990.112; IADECOLA C, 1994, AM J PHYSIOL, V267, pR228, DOI 10.1152/ajpregu.1994.267.1.R228; IADECOLA C, 1992, AM J PHYSIOL, V263, pR1156, DOI 10.1152/ajpregu.1992.263.5.R1156; Iadecola C, 1996, AM J PHYSIOL-REG I, V271, pR990, DOI 10.1152/ajpregu.1996.271.4.R990; JACOB TD, 1993, J TRAUMA, V35, P590, DOI 10.1097/00005373-199310000-00015; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; LACOMBE P, 1992, EXP NEUROL, V117, P278, DOI 10.1016/0014-4886(92)90137-F; LADECOLA C, 1992, P NATL ACAD SCI USA, V89, P3913; LAURITZEN M, 1984, J CEREBR BLOOD F MET, V4, P546, DOI 10.1038/jcbfm.1984.79; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; LEWELT W, 1982, J NEUROSURG, V56, P332, DOI 10.3171/jns.1982.56.3.0332; Lu YC, 1997, MOL CHEM NEUROPATHOL, V30, P125, DOI 10.1007/BF02815154; Mayevsky A, 1998, ACT NEUR S, V71, P78; Mayevsky A, 1999, ACT NEUR S, V75, P63; Mesenge C, 1996, J NEUROTRAUM, V13, P209, DOI 10.1089/neu.1996.13.209; Nilsson P, 1996, J NEUROTRAUM, V13, P201, DOI 10.1089/neu.1996.13.201; Rao VLR, 1999, J NEUROTRAUM, V16, P865, DOI 10.1089/neu.1999.16.865; Read SJ, 1998, NEUROSCI LETT, V250, P115, DOI 10.1016/S0304-3940(98)00442-X; ROBERTSON CS, 1992, J NEUROL NEUROSUR PS, V55, P594, DOI 10.1136/jnnp.55.7.594; SAUNDERS ML, 1979, J NEUROSURG, V51, P18, DOI 10.3171/jns.1979.51.1.0018; SOMJEN GG, 1992, CAN J PHYSIOL PHARM, V70, pS248, DOI 10.1139/y92-268; Sonn J, 2000, BRAIN RES, V882, P212, DOI 10.1016/S0006-8993(00)02827-4; SUNAMI K, 1989, Neurosurgical Review, V12, P400, DOI 10.1007/BF01790682; Wada K, 1999, J NEUROTRAUM, V16, P203, DOI 10.1089/neu.1999.16.203; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; ZHANG F, 1995, NEUROSCIENCE, V69, P1195, DOI 10.1016/0306-4522(95)00302-Y; ZHANG ZG, 1994, J CEREBR BLOOD F MET, V14, P939, DOI 10.1038/jcbfm.1994.125	52	18	18	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	OCT	2002	97	4					963	969		10.3171/jns.2002.97.4.0963			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	604MY	WOS:000178626400037	12405388				2022-02-06	
J	Peasley, MA; Shi, RY				Peasley, MA; Shi, RY			Resistance of isolated mammalian spinal cord white matter to oxygen-glucose deprivation	AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY			English	Article						axons; neurotrauma; reperfusion; mitochondria; membrane	CNS MYELINATED AXONS; AORTIC-ANEURYSM REPAIR; NERVOUS-SYSTEM; ANOXIC INJURY; BRAIN; MECHANISMS; TRANSPORT; GLUTAMATE; ISCHEMIA; CALCIUM	We found that isolated guinea pig spinal cord white matter is resistant to acute oxygen-glucose deprivation. Sixty minutes of oxygen-glucose deprivation resulted in a 60% reduction of compound action potential (CAP) conductance, and there was a near complete recovery after 60 min reperfusion. Corresponding horseradish peroxidase-exclusion assay showed little axonal membrane damage. To further deprive the axons of metabolic substrate, we added 2 mM sodium cyanide or 2 mM sodium azide, both mitochondrial suppressors, to the ischemic medium, which completely abolished CAP and resulted in a 15 to similar to30% recovery postreperfusion. Both compounds preferentially reduced the conductance of large diameter axons. We suggest the residual ATP in our ischemic model can protect anatomic integrity and physiological functioning of spinal axons following ischemic insult. This further suggests that oxygen-glucose deprivation alone cannot be solely responsible for short-term functional and anatomic damage. The damaging effects of ischemia in vivo may be mediated by factors originating from the gray matter of the cord or other systemic factors; both were largely eliminated in our in vitro white matter preparation.	Purdue Univ, Dept Basic Med Sci, Ctr Paralysis Res, W Lafayette, IN 47907 USA		Shi, RY (corresponding author), Purdue Univ, Sch Vet Med, Ctr Paralysis Res, Dept Med Sci, W Lafayette, IN 47907 USA.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-27073] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R56NS027073, R01NS027073] Funding Source: NIH RePORTER		ALLEN BT, 1995, VASCULAR SURG THEORY, P1402; AMES A, 1992, J NEUROSCI, V12, P840, DOI 10.1523/jneurosci.12-03-00840.1992; ASANO T, 1995, J NEUROTRAUM, V12, P993; BLIGHT AR, 1983, NEUROSCIENCE, V10, P521, DOI 10.1016/0306-4522(83)90150-1; BLIGHT AR, 1986, NEUROSCIENCE, V19, P321, DOI 10.1016/0306-4522(86)90025-4; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Coselli JS, 1997, ANN THORAC SURG, V63, P28, DOI 10.1016/S0003-4975(96)01029-6; ERECINSKA M, 1994, PROG NEUROBIOL, V43, P37, DOI 10.1016/0301-0082(94)90015-9; GARRETT RH, 1999, BIOCHEMISTRY-US, P268; HANSEN AJ, 1985, PHYSIOL REV, V65, P101, DOI 10.1152/physrev.1985.65.1.101; Kandel E.R., 2000, PRINCIPLES NEURAL SC; Kanellopoulos GK, 1997, STROKE, V28, P2532, DOI 10.1161/01.STR.28.12.2532; Lang-Lazdunski L, 2000, EUR J CARDIO-THORAC, V18, P174, DOI 10.1016/S1010-7940(00)00430-9; Leppanen L, 1997, J NEUROPHYSIOL, V78, P2095, DOI 10.1152/jn.1997.78.4.2095; RANSOM BR, 1990, STROKE, V21, P52; RANSOM BR, 1993, RES P ARNMD, V71, P121; Rose CR, 1998, J NEUROSCI, V18, P3554; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; Safi HJ, 1998, ANN THORAC SURG, V66, P1204, DOI 10.1016/S0003-4975(98)00781-4; SANDLER AN, 1976, J NEUROSURG, V45, P638, DOI 10.3171/jns.1976.45.6.0638; SATRAN R, 1988, Stroke, V19, P529; Shi R, 1999, J NEUROPHYSIOL, V81, P2406, DOI 10.1152/jn.1999.81.5.2406; Shi R, 2002, NEUROSCIENCE, V110, P765, DOI 10.1016/S0306-4522(01)00596-6; Shi R, 1996, J NEUROPHYSIOL, V76, P1572, DOI 10.1152/jn.1996.76.3.1572; Shi R, 2000, NEUROSCIENCE, V98, P157, DOI 10.1016/S0306-4522(00)00096-8; SHI R, 2001, J NEUROTRAUM, V18, P1130; Shi RY, 2000, J NEUROPHYSIOL, V84, P1763, DOI 10.1152/jn.2000.84.4.1763; Siegel GJ, 1999, BASIC NEUROCHEMISTRY; Stys PK, 1996, ANN NY ACAD SCI, V779, P366, DOI 10.1111/j.1749-6632.1996.tb44808.x; STYS PK, 1991, ANN NEUROL, V30, P375, DOI 10.1002/ana.410300309; Stys PK, 1998, J CEREBR BLOOD F MET, V18, P2, DOI 10.1097/00004647-199801000-00002; STYS PK, 1990, P NATL ACAD SCI USA, V87, P4212, DOI 10.1073/pnas.87.11.4212; Stys PK, 1998, NEUROREPORT, V9, P447, DOI 10.1097/00001756-199802160-00017; Stys PK, 1998, NEUROSCIENCE, V82, P21; White BC, 2000, J NEUROL SCI, V179, P1, DOI 10.1016/S0022-510X(00)00386-5; YOUNG W, 1993, RES P ARNMD, V71, P191	36	18	18	0	1	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0363-6143			AM J PHYSIOL-CELL PH	Am. J. Physiol.-Cell Physiol.	SEP	2002	283	3					C980	C989		10.1152/ajpcell.00591.2001			10	Cell Biology; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Physiology	586FG	WOS:000177573500032	12176754				2022-02-06	
J	Ter Minassian, A; Dube, L; Guilleux, AM; Wehrmann, N; Ursino, M; Beydon, L				Ter Minassian, A; Dube, L; Guilleux, AM; Wehrmann, N; Ursino, M; Beydon, L			Changes in intracranial pressure and cerebral autoregulation in patients with severe traumatic brain injury	CRITICAL CARE MEDICINE			English	Article						head injury; cerebral autoregulation; intracranial pressure; cerebral perfusion pressure; cerebral blood flow velocity	SEVERE HEAD-INJURY; CARBON-DIOXIDE REACTIVITY; BLOOD-FLOW; TRANSCRANIAL DOPPLER; MATHEMATICAL-MODEL; PERFUSION-PRESSURE; VOLUME; HYPERTENSION; HUMANS; HYPEREMIA	Background. Impaired cerebral autoregulation is frequent after severe traumatic head injury. This could result in intracranial pressure fluctuating passively with the mean arterial pressure. Objective: This study examines the influence of autoregulation on the amplitude and direction of changes in intracranial pressure in patients with severe head injuries during the management of cerebral perfusion pressure. Design: Prospective study. Setting: Neurosurgical intensive care unit Patients: A total of 42 patients with severe head injuries. Interventions. Continuous recording of cerebral blood flow velocity, intracranial pressure, and mean arterial pressure during the start or change of continuous norepinephrine infusion. Measurements and Main Results. Cerebrovascular resistance was calculated from the cerebral perfusion pressure and middle cerebral artery blood flow velocity. The strength of autoregulation index was calculated as the ratio of the percentage of change in cerebrovascular resistance by the percentage of change in cerebral perfusion pressure before and after 121 changes in mean arterial pressure at constant ventilation between day 1 and day 18 after trauma. The strength of autoregulation index varied widely, indicating either preserved or severely perturbed autoregulation during hypotensive or hypertensive challenge in patients with or without intracranial hypertension at the basal state (strength of autoregulation index, 0.51 +/- 0.32 to 0.71 +/- 0.25). The change in intracranial pressure varied linearly with the strength of autoregulation index. There was a clinically significant change in intracranial pressure (greater than or equal to 5 mm Hg) in the same direction as the change in mean arterial pressure in five tracings of three patients. This was caused by the mean arterial pressure dropping below the identified lower limit of autoregulation in three tracings for two patients. It seemed to be caused by a loss of cerebral autoregulation in the remaining two tracings for one patient. Conclusion: Cerebral perfusion pressure-oriented therapy can be a safe way to reduce intracranial pressure, whatever the status of autoregulation, in almost all patients with severe head injuries.	CHU Angers, Dept Anesthesie Reanimat, Angers, France; Univ Studi Bologna, Dipartimento Elettron Systemist & Math, Bologna, Italy		Ter Minassian, A (corresponding author), CHU Angers, Dept Anesthesie Reanimat, Angers, France.			Ursino, Mauro/0000-0002-0911-0308			AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; AUER LM, 1984, CEREBRAL VENOUS SYST, P169; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Barzo P, 1997, ACT NEUR S, V70, P243; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; BOUMA GJ, 1990, J NEUROSURG, V73, P368, DOI 10.3171/jns.1990.73.3.0368; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; ENEVOLDSEN EM, 1978, J NEUROSURG, V48, P689, DOI 10.3171/jns.1978.48.5.0689; GRAY WJ, 1987, J NEUROSURG, V67, P377, DOI 10.3171/jns.1987.67.3.0377; HANDA Y, 1992, J NEUROSURG, V76, P493, DOI 10.3171/jns.1992.76.3.0493; HARDEBO JE, 1990, FERNS FOUND SERIES, V14, P41; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; Kelly DF, 1997, J NEUROSURG, V86, P633, DOI 10.3171/jns.1997.86.4.0633; Kelly DF, 1996, J NEUROSURG, V85, P762, DOI 10.3171/jns.1996.85.5.0762; KONTOS HA, 1978, AM J PHYSIOL, V234, P371; KOSTELJANETZ M, 1986, NEUROSURGERY, V18, P17, DOI 10.1227/00006123-198601000-00004; LARSEN FS, 1994, STROKE, V25, P1985, DOI 10.1161/01.STR.25.10.1985; Lee JH, 2001, J NEUROSURG, V95, P222, DOI 10.3171/jns.2001.95.2.0222; LINDEGAARD KF, 1987, STROKE, V18, P1025, DOI 10.1161/01.STR.18.6.1025; LINDEGAARD KF, 1988, ACTA NEUROCHIR SUPP, V42, P80; MACKENZIE ET, 1979, STROKE, V10, P711, DOI 10.1161/01.STR.10.6.711; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; Marmarou A., 1996, NEUROTRAUMA, P413; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; MCHEDLISHVILI G, 1986, ARTERIAL BEHAV BLOOD, P42; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; NEWELL DW, 1994, STROKE, V25, P793, DOI 10.1161/01.STR.25.4.793; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; OLESEN J, 1972, NEUROLOGY, V22, P978, DOI 10.1212/WNL.22.9.978; PAULSON OB, 1972, NEUROLOGY, V22, P286, DOI 10.1212/WNL.22.3.286; Raichle ME, 1972, STROKE, V3, P566, DOI 10.1161/01.STR.3.5.566; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; ROSNER MJ, 1984, J NEUROSURG, V60, P342; SAKAS DE, 1995, J NEUROSURG, V83, P277, DOI 10.3171/jns.1995.83.2.0277; Steiger HJ, 1996, STROKE, V27, P2048, DOI 10.1161/01.STR.27.11.2048; STREBEL S, 1995, ANESTHESIOLOGY, V83, P66, DOI 10.1097/00000542-199507000-00008; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014; Ursino M, 2000, AM J PHYSIOL-HEART C, V279, pH2439, DOI 10.1152/ajpheart.2000.279.5.H2439; URSINO M, 1991, ANN BIOMED ENG, V19, P15, DOI 10.1007/BF02368459	41	18	18	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0090-3493			CRIT CARE MED	Crit. Care Med.	JUL	2002	30	7					1616	1622		10.1097/00003246-200207000-00036			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573PY	WOS:000176841100036	12130988				2022-02-06	
J	Hanten, G; Zhang, LF; Levin, HS				Hanten, G; Zhang, LF; Levin, HS			Selective learning in children after traumatic brain injury: A preliminary study	CHILD NEUROPSYCHOLOGY			English	Article							CLOSED-HEAD-INJURY; ORBITOFRONTAL CORTEX; VERBAL REHEARSAL; WORKING-MEMORY; WHITE-MATTER; DAMAGE; METACOGNITION; ORGANIZATION; INCENTIVES; RETRIEVAL	Selective learning (SL) is the ability to select items to learn from among other items. it requires the use of the executive processes of metacognitive control and working memory, which are considered to be mediated by the frontal cortex and its circuitry. We studied the efficiency with which verbal items of greater value are selectively learned from among items varying in value in 14 children ages 8-15 years who had sustained severe traumatic brain injury (TBI) and in 39 typically developing age-matched children. We hypothesized that children with TBI would be disproportionately compromised in selective learning efficiency in contrast to memory span when compared to normally developing children. The results supported our hypothesis, as children with TBI performed significantly worse than controls on a measure of selective learning efficiency, but the two groups performed similarly on a measure of word recall within the same task. Furthermore, the effect of TBI on performance was demonstrated to take place at the time of encoding, rather than at retrieval.	Baylor Coll Med, Cognit Neurosci Lab, Dept Phys Med & Rehabil, Houston, TX 77030 USA		Hanten, G (corresponding author), Baylor Coll Med, Cognit Neurosci Lab, Dept Phys Med & Rehabil, 6560 Fannin,Suite 1144, Houston, TX 77030 USA.	ghanten@bcm.tmc.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS21889] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER		Adams JH, 1975, HDB CLIN NEUROLOGY, V23, P35; Anderson V, 1998, BRAIN INJURY, V12, P937, DOI 10.1080/026990598121990; Anderson V A, 1999, Pediatr Rehabil, V3, P159; Anderson VA, 2000, BRAIN INJURY, V14, P679; APPEL LF, 1972, CHILD DEV, V43, P1365, DOI 10.2307/1127522; Baddeley A.D., 1986, WORKING MEMORY; BAUER RH, 1990, J GEN PSYCHOL, V117, P447, DOI 10.1080/00221309.1990.9921150; BAYLIS LL, 1991, EXP BRAIN RES, V86, P617; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; BERRYHILL P, 1995, NEUROSURGERY, V37, P392, DOI 10.1227/00006123-199509000-00004; Bigler E, 1990, TRAUMATIC BRAIN INJU, P13; BJORK RA, 1998, INTENTIONAL FORGETTI; Brown A. L., 1978, CHILDRENS THINKING W, P3; BUTTER CM, 1969, PHYSIOL BEHAV, V4, P163, DOI 10.1016/0031-9384(69)90075-4; BUTTER CM, 1970, J COMP PHYSIOL PSYCH, V72, P132, DOI 10.1037/h0029303; CHAPMAN S, IN PRESS DEV NEUROPS; Cohen J D, 1994, Hum Brain Mapp, V1, P293, DOI 10.1002/hbm.460010407; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; Dennis M, 1996, DEV NEUROPSYCHOL, V12, P77, DOI 10.1080/87565649609540641; DENNIS M, 1905, TRAUMATIC HEAD INJUR, P165; DONDERS J, 1993, BRAIN INJURY, V7, P431, DOI 10.3109/02699059309029686; DUFRESNE A, 1989, J EXP CHILD PSYCHOL, V47, P274, DOI 10.1016/0022-0965(89)90033-7; DUSEK JB, 1978, DEV PSYCHOL, V14, P115, DOI 10.1037/0012-1649.14.1.115; Elliott R, 2000, CEREB CORTEX, V10, P308, DOI 10.1093/cercor/10.3.308; EPSTEIN W, 1969, J EXP PSYCHOL, V82, P168, DOI 10.1037/h0028045; EYSENCK MW, 1982, Q J EXP PSYCHOL-A, V34, P489, DOI 10.1080/14640748208400832; FLAVELL JH, 1966, CHILD DEV, V37, P283, DOI 10.2307/1126804; Francis S, 1999, NEUROREPORT, V10, P453, DOI 10.1097/00001756-199902250-00003; Fuster JM, 1997, ANATOMY PHYSL NEUROP; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; GARRITY LI, 1975, DEV PSYCHOL, V11, P274, DOI 10.1037/h0076563; HAMILTON P, 1974, COGNITIVE PSYCHOL, V6, P61, DOI 10.1016/0010-0285(74)90004-8; Hanten G, 2000, DEV NEUROPSYCHOL, V18, P383, DOI 10.1207/S1532694206Hanten; Hanten G, 1999, DEV NEUROPSYCHOL, V16, P393, DOI 10.1207/S15326942DN1603_23; Hanten G, 2000, J MEM LANG, V43, P335, DOI 10.1006/jmla.2000.2731; HANTEN G, 2000, SELECTIVE LEARNING D; HANTEN G, 1996, UNPUB SELECTIVE REME; HARLEY WF, 1965, PSYCHON SCI, V2, P377, DOI 10.3758/BF03343506; Harnishfeger KK, 1996, J EXP CHILD PSYCHOL, V62, P292, DOI 10.1006/jecp.1996.0032; JANOWSKY JS, 1989, BEHAV NEUROSCI, V103, P548, DOI 10.1037/0735-7044.103.3.548; JONES B, 1972, EXP NEUROL, V36, P362, DOI 10.1016/0014-4886(72)90030-1; KAUFMANN PM, 1993, J CHILD NEUROL, V8, P348, DOI 10.1177/088307389300800410; KEENEY TJ, 1967, CHILD DEV, V38, P953, DOI 10.1111/j.1467-8624.1967.tb04373.x; KENNEDY BA, 1976, CHILD DEV, V47, P566, DOI 10.2307/1128824; Klingberg T, 1999, NEUROREPORT, V10, P2817, DOI 10.1097/00001756-199909090-00022; Konrad KN, 2000, BRAIN INJURY, V14, P859; Koriat A, 1996, PSYCHOL REV, V103, P490, DOI 10.1037/0033-295X.103.3.490; KUNZINGER EL, 1984, J GENET PSYCHOL, V144, P19; LANGFITT TW, 1986, J NEUROSURG, V64, P760, DOI 10.3171/jns.1986.64.5.0760; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; LEVIN HS, 1988, NEUROSURGERY, V22, P1043, DOI 10.1227/00006123-198806010-00012; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; Levin HS, 2000, NEUROLOGY, V54, P647, DOI 10.1212/WNL.54.3.647; LOFTUS GR, 1970, J EXP PSYCHOL, V85, P141, DOI 10.1037/h0029537; Mazzoni G, 1998, METACOGNITION AND COGNITIVE NEUROPSYCHOLOGY, pIX; Metcalfe J., 1994, METACOGNITION KNOWIN; MILLER PH, 1991, J EXP CHILD PSYCHOL, V52, P149, DOI 10.1016/0022-0965(91)90057-Y; OSULLIVAN JT, 1993, J EXP CHILD PSYCHOL, V55, P396, DOI 10.1006/jecp.1993.1022; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P878, DOI 10.1073/pnas.90.3.878; Rogers RD, 1999, J NEUROSCI, V19, P9029, DOI 10.1523/JNEUROSCI.19-20-09029.1999; Rogoff B., 1974, CHILD DEV, V44, P238; Rolls E.T., 1999, BRAIN EMOTION; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; RYDBERG JN, 1994, RADIOLOGY, V193, P173, DOI 10.1148/radiology.193.1.8090888; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; SECHLER E, 1985, THESIS RICE U HOUSTO; Shallice T., 1988, NEUROPSYCHOLOGY MENT; TEASDALE G, 1974, LANCET, V2, P81; Van Zomeren AH., 1994, CLIN NEUROPSYCHOLOGY; Yeates K O, 1995, J Int Neuropsychol Soc, V1, P78	73	18	18	1	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.	JUN	2002	8	2					107	120		10.1076/chin.8.2.107.8729			14	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	651BB	WOS:000181299300005	12638064				2022-02-06	
J	Boswell, JE; McErlean, M; Verdile, VP				Boswell, JE; McErlean, M; Verdile, VP			Prevalence of traumatic brain injury in an ED population	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						traumatic brain injury; injury prevention; emergency medical services; population prevalence	CLOSED-HEAD INJURY; POSTCONCUSSION SYNDROME; MILD; CHILDREN; ADMISSION; TRENDS; COUNTY; DEATH	The objective of this study was to determine prevalence of traumatic brain injury (TBI) in an emergency department (ED) population. Questionnaires were administered to patients in an urban, university, trauma center ED. All respondents provided demographics; patients reporting TBI were asked age at injury, if they experienced loss of consciousness (LOC), mechanism, or if medical attention was sought. Five hundred one patients completed the survey. Forty-one percent reported TBI; 23% had TBI with LOC. Mean age at injury was 21.5 years. Mechanism was evenly distributed among sports, assaults, falls, and motor vehicle crashes (MVC). Medical attention was sought for 61% of injuries. Men were more likely to report TBI (P < .001). Medical attention was more likely if MVC or LOC and less likely in sports-injured patients (all P < .01). Twenty-five percent of patients with TBI sustained repeat injury by the same mechanism. Prevalence of TBI in this population is high. Many occur by mechanisms that potentially are preventable. (Am J Emerg Med 2002;20: 177-180. Copyright 2002, Elsevier Science (USA). All rights reserved.)	Albany Med Coll, Dept Emergency Med MC139, Albany, NY 12208 USA		McErlean, M (corresponding author), Albany Med Coll, Dept Emergency Med MC139, 47 New Scotland Ave, Albany, NY 12208 USA.						ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Buss T F, 1995, Violence Vict, V10, P183; Cantu RC, 1997, CLIN SPORT MED, V16, P531, DOI 10.1016/S0278-5919(05)70038-7; Diamond PT, 1996, BRAIN INJURY, V10, P413, DOI 10.1080/026990596124278; EVANS RW, 1992, NEUROL CLIN, V10, P815, DOI 10.1016/S0733-8619(18)30182-8; FIFE D, 1987, AM J PUBLIC HEALTH, V77, P810, DOI 10.2105/AJPH.77.7.810; FOULKES MA, 1991, J NEUROSURG, V75, pS1, DOI 10.3171/sup.1991.75.1s.00s1; Gabella B, 1997, ANN EPIDEMIOL, V7, P207, DOI 10.1016/S1047-2797(96)00150-0; Gutentag SS, 1998, ASSESSMENT, V5, P263, DOI 10.1177/107319119800500306; HEDGES BE, 1995, AM J PUBLIC HEALTH, V85, P1008, DOI 10.2105/AJPH.85.7.1008; Hinchliffe FJ, 1998, BRAIN INJURY, V12, P369, DOI 10.1080/026990598122502; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Kant R, 1998, BRAIN INJURY, V12, P87, DOI 10.1080/026990598122908; Kibby MY, 1996, BRAIN INJURY, V10, P159, DOI 10.1080/026990596124494; KLAUBER MR, 1981, NEUROSURGERY, V9, P236, DOI 10.1227/00006123-198109000-00003; Kraus Jess F., 1994, P3; LEE ST, 1990, J TRAUMA, V30, P194, DOI 10.1097/00005373-199002000-00010; LYLE DM, 1990, COMMUNITY HEALTH ST, V14, P118; MacKenzie E J, 1989, Md Med J, V38, P725; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; MOSCATO BS, 1994, J NEUROPSYCH CLIN N, V6, P134; Moss NEG, 1996, INJURY, V27, P159, DOI 10.1016/0020-1383(95)00217-0; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Robertson LS, 1996, AM J PUBLIC HEALTH, V86, P31, DOI 10.2105/AJPH.86.1.31; Skelton CE, 1997, SCOT MED J, V42, P40, DOI 10.1177/003693309704200204; SmithSeemiller L, 1997, BRAIN INJURY, V11, P735; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Sosin DM, 1996, BRAIN INJURY, V10, P47; Spatt J, 1997, ACTA NEUROL SCAND, V95, P173, DOI 10.1111/j.1600-0404.1997.tb00091.x; Stablum F, 1996, CORTEX, V32, P261, DOI 10.1016/S0010-9452(96)80050-5; Stewart DP, 1996, ACAD EMERG MED, V3, P21, DOI 10.1111/j.1553-2712.1996.tb03297.x; Teasdale TW, 1997, BRIT MED J, V315, P569; THOMAS S, 1994, BRIT MED J, V308, P173, DOI 10.1136/bmj.308.6922.173; WHITMAN S, 1984, AM J EPIDEMIOL, V119, P570, DOI 10.1093/oxfordjournals.aje.a113774; 1997, MMWR MORB MORTAL WKL, V46, P8	36	18	18	0	3	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0735-6757			AM J EMERG MED	Am. J. Emerg. Med.	MAY	2002	20	3					177	180		10.1053/ajem.2002.32641			4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	549WK	WOS:000175469600008	11992336				2022-02-06	
J	Young, RJ; Destian, S				Young, RJ; Destian, S			Imaging of traumatic intracranial hemorrhage	NEUROIMAGING CLINICS OF NORTH AMERICA			English	Article							ACUTE EPIDURAL HEMATOMA; DIFFUSE AXONAL INJURY; SEVERE HEAD-INJURY; INTRAVENTRICULAR HEMORRHAGE; BRAIN INJURY; SUBARACHNOID HEMORRHAGE; EXTRADURAL HEMATOMAS; COMPUTED-TOMOGRAPHY; FIELD MR; CT	Traumatic intracranial hemorrhage is a leading cause of morbidity and mortality in the United States. CT remains the primary imaging modality for initial evaluation of patients who have sustained head trauma. MR imaging, which has always been important for the evaluation of subacute and chronic head trauma, has been gaining popularity and recognition as an alternative primary imaging modality.	St Lukes Roosevelt Hosp, Dept Radiol, New York, NY 10019 USA; St Vincent Catholic Med Ctr, Dept Radiol, Manhattan Div, New York, NY 10011 USA		Young, RJ (corresponding author), St Lukes Roosevelt Hosp, Dept Radiol, 1000 10th Ave, New York, NY 10019 USA.						Abraszko RA, 1995, BRIT J NEUROSURG, V9, P769, DOI 10.1080/02688699550040747; Atlas SW, 1998, AM J NEURORADIOL, V19, P1471; Bakshi R, 1999, AM J NEURORADIOL, V20, P629; BARKOVICH AJ, 1988, RADIOL CLIN N AM, V26, P801; Blankenberg FG, 1996, RADIOLOGY, V199, P253, DOI 10.1148/radiology.199.1.8633155; *CDCP, 2000, EP TRAUM BRAIN INJ U, P1; CORDOBES F, 1983, J NEUROSURG, V58, P217, DOI 10.3171/jns.1983.58.2.0217; EBISU T, 1989, RADIOLOGY, V171, P449, DOI 10.1148/radiology.171.2.2704810; FUJITSU K, 1988, NEUROSURGERY, V23, P423, DOI 10.1227/00006123-198810000-00003; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; GENTRY LR, 1988, AM J NEURORADIOL, V9, P1129; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; GENTRY LR, 1994, RADIOLOGY, V191, P1; GOMORI JM, 1985, RADIOLOGY, V157, P87, DOI 10.1148/radiology.157.1.4034983; GREENE KA, 1995, J NEUROSURG, V83, P445, DOI 10.3171/jns.1995.83.3.0445; GURDJIAN ES, 1976, J TRAUMA, V16, P35, DOI 10.1097/00005373-197601000-00005; GUTMAN MB, 1992, J NEUROSURG, V77, P9, DOI 10.3171/jns.1992.77.1.0009; GUTMAN MB, 1991, J TRAUMA, V31, P974, DOI 10.1097/00005373-199107000-00016; HAMILTON M, 1992, AM J NEURORADIOL, V13, P853; HAYMAN LA, 1989, AM J ROENTGENOL, V153, P135, DOI 10.2214/ajr.153.1.135; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; ICHISE M, 1994, J NUCL MED, V35, P217; Jones TR, 2001, RADIOLOGY, V219, P750, DOI 10.1148/radiology.219.3.r01jn47750; LEE JP, 1991, J TRAUMA, V31, P376, DOI 10.1097/00005373-199103000-00011; LEROUX PD, 1992, NEUROSURGERY, V31, P678, DOI 10.1227/00006123-199210000-00010; Li J, 2001, LANCET, V357, P771, DOI 10.1016/S0140-6736(00)04163-5; Liang LX, 1999, AM J NEURORADIOL, V20, P1527; Liu AY, 1999, AM J NEURORADIOL, V20, P1636; MARTIN NA, 1995, J NEUROTRAUM, V12, P897, DOI 10.1089/neu.1995.12.897; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; NEW PFJ, 1976, RADIOLOGY, V121, P635, DOI 10.1148/121.3.635; OSBORN AG, 1994, DIAGNOSTIC NEURORADI, P199; Patel R, 2000, METH MOLEC MED, V48, P3; Paterakis K, 2000, J TRAUMA, V49, P1071, DOI 10.1097/00005373-200012000-00016; PETERSEN OF, 1984, NEURORADIOLOGY, V26, P285; POZZATI E, 1986, NEUROSURGERY, V18, P696, DOI 10.1227/00006123-198606000-00003; SAKAI H, 1988, J NEUROSURG, V68, P566, DOI 10.3171/jns.1988.68.4.0566; Singer MB, 1998, RADIOLOGY, V208, P417, DOI 10.1148/radiology.208.2.9680570; SMITH HK, 1991, NEUROSURGERY, V29, P258, DOI 10.1227/00006123-199108000-00016; Sullivan TP, 1999, AM J NEURORADIOL, V20, P107; Thurman DA, 1999, TRAUMATIC BRAIN INJU, P1; *US BUR CENS, 2000, VIT STAT, V63; WILBERGER JE, 1990, NEUROSURGERY, V27, P208, DOI 10.1227/00006123-199008000-00006; ZIMMERMAN RA, 1982, RADIOLOGY, V144, P809, DOI 10.1148/radiology.144.4.7111729; ZIMMERMAN RA, 1999, CRANIAL MRI CT, P435; Zwimpfer TJ, 1997, J NEUROSURG, V86, P433, DOI 10.3171/jns.1997.86.3.0433	46	18	18	0	1	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	1052-5149			NEUROIMAG CLIN N AM	Neuroimaging Clin. N. Am.	MAY	2002	12	2					189	+	PII S1052-5149(02)00003-5	10.1016/S1052-5149(02)00003-5			17	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	609GA	WOS:000178894200004	12391631				2022-02-06	
J	Brooke, SM; McLaughlin, JR; Cortopassi, KM; Sapolsky, RM				Brooke, SM; McLaughlin, JR; Cortopassi, KM; Sapolsky, RM			Effect of GP120 on glutathione peroxidase activity in cortical cultures and the interaction with steroid hormones	JOURNAL OF NEUROCHEMISTRY			English	Article						estrogen; glucocorticoids; glutathione peroxidase; gp120; neurotoxicity; reactive oxygen species	CENTRAL-NERVOUS-SYSTEM; PNEUMOCYSTIS-CARINII PNEUMONIA; MANGANESE SUPEROXIDE-DISMUTASE; ANTIOXIDANT ENZYME-ACTIVITIES; TRAUMATIC BRAIN INJURY; SIMPLEX VIRUS VECTORS; AIDS DEMENTIA COMPLEX; OXIDATIVE STRESS; HIV-1 INFECTION; FOCAL ISCHEMIA	GP120 (the protein component of the HIV viral coat) is neurotoxic and may contribute to the cell loss associated with AIDS-related dementia Previously, it has been shown in rat cortical mixed cultures that gp120 increased the accumulation of hydrogen peroxide and superoxide, two reactive oxygen species (ROS). We new demonstrate that gp120 increased activity of the key antioxidant glutathione peroxidase (GSPx), presumably as a defensive mechanism against the increased ROS load. Both estrogen and glucocorticoids (GCs), the adrenal steroid released during stress, blunted this gp120 effect on GSPx activity. The similar effects of estrogen and of GCs are superficially surprising, given prior demonstrations that GCs exacerbated and estrogens protected against gp120 neurotoxicity. We find that these similar effects of estrogen and GCs on GSPx regulation arose, in fact, from very different routes, which are commensurate with these prior reports. Specifically, estrogen has demonstrated antioxidant properties that may prevent the ROS increase (therefore acting as a neuroprotective agent) and rendered unnecessary the compensatory GSPx increased activity. To verify this we have added H2O2 to estrogen + gp120-treated cells, and GSPx activity was increased. However, with addition of H2O2 to GCs + gp-120-treated cells there was no increase in activity. GCs appeared to decrease enzyme production and or activity and therefore under insult conditions ROS levels rose in the cell resulting in increased neurotoxicity. Overexpression of GSPx enzyme via herpes vector system reversed the GCs-induced loss of enzyme and eliminated the GCs exacerbation of gp120 neurotoxicity.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA		Brooke, SM (corresponding author), Stanford Univ, Dept Biol Sci, Gilbert Bldg,Rm432, Stanford, CA 94305 USA.				NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG00563] Funding Source: Medline		Adamson DC, 1999, MOL MED, V5, P98, DOI 10.1007/BF03402144; Ahlbom E, 2000, P NATL ACAD SCI USA, V97, P14726, DOI 10.1073/pnas.260501697; Azbill RD, 1997, BRAIN RES, V765, P283, DOI 10.1016/S0006-8993(97)00573-8; Bagetta G, 1996, NEUROREPORT, V7, P1722, DOI 10.1097/00001756-199607290-00005; Barks JDE, 1997, NEUROSCIENCE, V76, P397, DOI 10.1016/S0306-4522(96)00373-9; Binienda Z, 1998, NEUROSCI LETT, V251, P173, DOI 10.1016/S0304-3940(98)00539-4; BRENNEMAN DE, 1995, INT J DEV NEUROSCI, V13, P187, DOI 10.1016/0736-5748(95)00014-8; Brooke S, 1997, P NATL ACAD SCI USA, V94, P9457, DOI 10.1073/pnas.94.17.9457; Brooke SM, 2000, BIOL PSYCHIAT, V48, P881, DOI 10.1016/S0006-3223(00)00922-7; Brooke SM, 1999, NEUROSCI LETT, V267, P21, DOI 10.1016/S0304-3940(99)00315-8; Brooke SM, 1998, J NEUROCHEM, V71, P1187, DOI 10.1046/j.1471-4159.1998.71031187.x; Budka H, 1991, BRAIN PATHOL, V1, P163, DOI 10.1111/j.1750-3639.1991.tb00656.x; Candelario-Jalil E, 2001, NEUROSCI RES, V41, P233, DOI 10.1016/S0168-0102(01)00282-6; Corasaniti MT, 1998, BIOCHEM BIOPH RES CO, V246, P686, DOI 10.1006/bbrc.1998.8687; Foga IO, 1997, J ACQ IMMUN DEF SYND, V16, P223, DOI 10.1097/00042560-199712010-00001; FUKUHARA T, 1994, BRAIN RES, V657, P333, DOI 10.1016/0006-8993(94)90987-3; GAGNON S, 1990, NEW ENGL J MED, V323, P1444, DOI 10.1056/NEJM199011223232103; GENDELMAN HE, 1994, J LEUKOCYTE BIOL, V56, P389, DOI 10.1002/jlb.56.3.389; Gonenc S, 2000, NEUROSCI LETT, V289, P107, DOI 10.1016/S0304-3940(00)01272-6; Goss JR, 1997, EXP NEUROL, V146, P291, DOI 10.1006/exnr.1997.6515; Goss JR, 1998, EXP NEUROL, V149, P301, DOI 10.1006/exnr.1997.6712; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; Hansen JM, 2001, FREE RADICAL BIO MED, V30, P1078, DOI 10.1016/S0891-5849(01)00502-0; HO DY, 1995, J NEUROSCI METH, V57, P205, DOI 10.1016/0165-0270(94)00150-F; HO DY, 1994, METHOD CELL BIOL, V43, P191; Howard SA, 1999, EXP NEUROL, V158, P164, DOI 10.1006/exnr.1999.7080; Howard SA, 2001, EXP NEUROL, V168, P385, DOI 10.1006/exnr.2000.7619; LAWRENCE MS, 1995, P NATL ACAD SCI USA, V92, P7247, DOI 10.1073/pnas.92.16.7247; Lee BR, 1999, EXP CELL RES, V248, P430, DOI 10.1006/excr.1999.4409; Lipton SA, 1998, ANNU REV PHARMACOL, V38, P159, DOI 10.1146/annurev.pharmtox.38.1.159; MASLIAH E, 1992, ANN NEUROL, V32, P321, DOI 10.1002/ana.410320304; MATSUYAMA T, 1994, STROKE, V25, P1417, DOI 10.1161/01.STR.25.7.1417; Mattson MP, 1997, J NEUROSCI RES, V49, P681, DOI 10.1002/(SICI)1097-4547(19970915)49:6<681::AID-JNR3>3.0.CO;2-3; Mcewen BS, 1999, ENDOCR REV, V20, P279, DOI 10.1210/er.20.3.279; McIntosh LJ, 1998, BRAIN RES, V791, P215, DOI 10.1016/S0006-8993(98)00104-8; Michaels J, 1988, Immunodefic Rev, V1, P71; MOSCOW JA, 1992, J BIOL CHEM, V267, P5949; Pajovic SB, 1999, GEN PHYSIOL BIOPHYS, V18, P35; Pareja JG, 1998, CHEST, V113, P1215, DOI 10.1378/chest.113.5.1215; Perl A, 2000, ANTIOXID REDOX SIGN, V2, P551, DOI 10.1089/15230860050192323; Pippenger C E, 1998, Methods Mol Biol, V108, P299; PRICE RW, 1988, SCIENCE, V239, P586, DOI 10.1126/science.3277272; Rohrdanz E, 2001, ARCH TOXICOL, V75, P150, DOI 10.1007/s002040000206; Roy M, 2001, BRAIN RES, V901, P12, DOI 10.1016/S0006-8993(01)02034-0; Saksena NK, 1998, B I PASTEUR, V96, P171, DOI 10.1016/S0020-2452(98)80012-2; Sapolsky, 1996, Stress, V1, P1, DOI 10.3109/10253899609001092; Sapolsky RM, 1999, NEUROLOGY, V53, P1922, DOI 10.1212/WNL.53.9.1922; SIES H, 1993, EUR J BIOCHEM, V215, P213, DOI 10.1111/j.1432-1033.1993.tb18025.x; Sokolova T, 2001, NEUROSCI LETT, V297, P129, DOI 10.1016/S0304-3940(00)01689-X; Tabatabaie T, 1996, BIOCHEM BIOPH RES CO, V221, P386, DOI 10.1006/bbrc.1996.0605; Toyoda T, 1997, NEUROREPORT, V8, P847, DOI 10.1097/00001756-199703030-00008; Toyoda T, 1997, NEUROSCI LETT, V235, P29, DOI 10.1016/S0304-3940(97)00707-6; Vergun O, 2001, J PHYSIOL-LONDON, V531, P147, DOI 10.1111/j.1469-7793.2001.0147j.x	53	18	18	0	0	BLACKWELL PUBLISHING LTD	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DG, OXON, ENGLAND	0022-3042			J NEUROCHEM	J. Neurochem.	APR	2002	81	2					277	284		10.1046/j.1471-4159.2002.00825.x			8	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	542TE	WOS:000175059800007	12064474				2022-02-06	
J	Erdogan, E; Gonul, E; Seber, N				Erdogan, E; Gonul, E; Seber, N			Craniocerebral gunshot wounds	NEUROSURGERY QUARTERLY			English	Article						craniocerebral injury; prognostic factor; gunshot wound	INTRACRANIAL BONE FRAGMENTS; MISSILE HEAD WOUNDS; RETROSPECTIVE ANALYSIS; PENETRATING WOUNDS; FOREIGN-BODIES; BRAIN; INJURIES; MANAGEMENT; VIETNAM; TRAUMA	Cranial gunshot wounds frequently produce devastating injuries to central nervous system (CNS) structures. Surgical therapy and primary and secondary debridement, including repair of dural defects and removal of retained intracranial bone and metal fragments, were applied to 374 cranial gunshot wound victims at Gulhane Military Medical School in Turkey from 1992 to 1999. Dural defects were closed primarily or with temporalis fascia, pericranium, and cadaver grafts. Central nervous system infections were mostly observed in cases with cerebrospinal fluid (CSF) fistulas. All patients underwent computed tomography (CT) scans periodically. In 119 of 374 (32%) patients, bone and metal fragments were determined on control CT scans. We also performed angiography in some patients to reveal traumatic vascular pathologic findings. Most of the deaths in this group of patients were attributed to the direct effects of brain injury and occurred within the first month after injury. Fragments retained after the first debridement were followed periodically by CT scan. Surgery was not performed until infection developed. Retained fragments did not increase the infection risk, but high rates of infection did occur in cases with CSF fistulas. The presence of diffuse brain damage, brainstem. injury, CNS infection, or ventricular injury was associated with a poor outcome.	Gulhane Mil Med Acad, Dept Neurosurg, TR-06018 Ankara, Turkey			ersinerdogan@usa.net					AARABI B, 1987, NEUROSURGERY, V20, P610, DOI 10.1227/00006123-198704000-00018; AARABI B, 1989, NEUROSURGERY, V25, P923, DOI 10.1227/00006123-198912000-00011; AARABI B, 1988, NEUROSURGERY, V22, P1056, DOI 10.1227/00006123-198806010-00014; ABE T, 1986, EUR NEUROL, V25, P233, DOI 10.1159/000116013; ACHRAM M, 1980, BRIT J RADIOL, V53, P1144, DOI 10.1259/0007-1285-53-636-1144; ALLEN MB, 1995, ESSENTIALS NEUROSURG, P285; AMATO JJ, 1972, J CARDIOVASC SURG, V13, P147; BARNETT JC, 1955, J NEUROSURG, V12, P34, DOI 10.3171/jns.1955.12.1.0034; Bayston R, 2000, LANCET, V355, P1813, DOI 10.1016/S0140-6736(00)02275-3; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BECKER DP, 1990, NEUROLOGICAL SURG, P2017; BRADLEY WG, 1986, MAGNETIC RESONANCE A; BRANDVOLD B, 1990, J NEUROSURG, V72, P15, DOI 10.3171/jns.1990.72.1.0015; BUTLER EG, 1945, J NEUROSURG, V2, P358, DOI 10.3171/jns.1945.2.4.0358; CAREY ME, 1971, J NEUROSURG, V34, P145, DOI 10.3171/jns.1971.34.2part1.0145; CAREY ME, 1974, J NEUROSURG, V41, P542, DOI 10.3171/jns.1974.41.5.0542; CAVENESS WF, 1979, J NEUROSURG, V50, P545, DOI 10.3171/jns.1979.50.5.0545; CLARK WC, 1986, J NEUROSURG, V65, P9, DOI 10.3171/jns.1986.65.1.0009; COOPER PR, 1979, NEUROSURGERY, V4, P373, DOI 10.1227/00006123-197905000-00001; COPLEY I B, 1991, British Journal of Neurosurgery, V5, P43, DOI 10.3109/02688699108998446; CROCKARD HA, 1977, J NEUROSURG, V46, P776, DOI 10.3171/jns.1977.46.6.0776; CRONE KR, 1986, SURG NEUROL, V25, P276, DOI 10.1016/0090-3019(86)90239-9; Cushing H, 1918, BRIT J SURG, V5, P558; DODGE PR, 1952, J NEUROSURG, V9, P472, DOI 10.3171/jns.1952.9.5.0472; ECKER AD, 1946, J NEUROSURG, V3, P1, DOI 10.3171/jns.1946.3.1.0001; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; ENZMANN DR, 1981, J NEUROSURG, V54, P304, DOI 10.3171/jns.1981.54.3.0304; FREYTAG E, 1963, ARCH PATHOL, V76, P215; FREYTAG E, 1971, PATHOL ANNU, V6, P321; Gean AD, 1994, IMAGING HEAD TRAUMA; Gonul E, 1997, NEUROSURG REV, V20, P177, DOI 10.1007/BF01105561; Gonul E, 1998, OTOLARYNG HEAD NECK, V118, P559, DOI 10.1177/019459989811800421; Gonul E, 1999, MINIM INVAS NEUROSUR, V42, P207, DOI 10.1055/s-2008-1053401; GOODNIGHT SH, 1974, NEW ENGL J MED, V290, P1043, DOI 10.1056/NEJM197405092901903; GURDJIAN ES, 1950, J NEUROSURG, V7, P106, DOI 10.3171/jns.1950.7.2.0106; HADDAD FS, 1978, CAN J SURG, V21, P233; HADDAD FS, 1991, NEUROSURGERY, V28, P1; HAGAN RE, 1971, J NEUROSURG, V34, P132, DOI 10.3171/jns.1971.34.2part1.0132; HAMMON WM, 1971, J NEUROSURG, V34, P142, DOI 10.3171/jns.1971.34.2part1.0142; HAMMON WM, 1971, J NEUROSURG, V34, P127, DOI 10.3171/jns.1971.34.2part1.0127; HANIEH A, 1971, J NEUROSURG, V34, P222, DOI 10.3171/jns.1971.34.2part1.0222; HARDAWAY RM, 1978, J TRAUMA, V18, P635, DOI 10.1097/00005373-197809000-00004; HARSH GR, 1985, NEUROSURGERY, P1670; HAYNES WG, 1945, J NEUROSURG, V2, P365, DOI 10.3171/jns.1945.2.5.0365; HOPKINSON DA, 1967, BRIT J SURG, V54, P344, DOI 10.1002/bjs.1800540507; Horowitz MB, 1999, SURG NEUROL, V51, P31, DOI 10.1016/S0090-3019(98)00029-9; JACOBS GB, 1970, J NEUROSURG, V32, P642, DOI 10.3171/jns.1970.32.6.0642; JENNETT B, 1975, LANCET, V1, P480; Kaufman H H, 1991, Neurosurg Clin N Am, V2, P387; KAUFMAN HH, 1980, NEUROSURGERY, V7, P445, DOI 10.1227/00006123-198011000-00003; KAUFMAN HH, 1986, NEUROSURGERY, V18, P689, DOI 10.1227/00006123-198606000-00002; KIM PE, 1995, NEUROSURG CLIN N AM, V6, P669; KIRKPATRICK JB, 1978, J NEUROSURG, V49, P185, DOI 10.3171/jns.1978.49.2.0185; Kordestani RK, 1997, NEUROSURGERY, V41, P351, DOI 10.1097/00006123-199708000-00003; LEVY ML, 1993, NEUROSURGERY, V32, P532, DOI 10.1227/00006123-199304000-00007; LEVY ML, 1993, NEUROSURGERY, V33, P1018; MATSON DD, 1981, J NEUROSURG, V54, P44; Meirowsky A., 1965, NEUROLOGICAL SURGERY, P103; MEIROWSKY AM, 1982, J NEUROSURG, V57, P617, DOI 10.3171/jns.1982.57.5.0617; MEIROWSKY AM, 1981, J NEUROSURG, V54, P44, DOI 10.3171/jns.1981.54.1.0044; MINER ME, 1986, NEUROSURGERY, V19, P952, DOI 10.1227/00006123-198612000-00009; NINCHOJI T, 1984, ACTA NEUROCHIR, V71, P69, DOI 10.1007/BF01401152; PITLYK PJ, 1970, J NEUROSURG, V33, P19, DOI 10.3171/jns.1970.33.1.0019; RENGACHARY SS, 1994, PRINCIPLES NEUROSURG, P1; RISH BL, 1983, J NEUROSURG, V59, P775, DOI 10.3171/jns.1983.59.5.0775; RISH BL, 1981, NEUROSURGERY, V9, P535, DOI 10.1227/00006123-198111000-00008; RISH BL, 1976, MIL MED, V141, P448, DOI 10.1093/milmed/141.7.448; ROSENWASSER RH, 1991, SURG CLIN N AM, V71, P305; SELDEN BS, 1988, ANN EMERG MED, V17, P247, DOI 10.1016/S0196-0644(88)80117-3; SHERMAN WD, 1980, WESTERN J MED, V132, P99; SHOUNG HM, 1985, ACTA NEUROCHIR, V74, P27, DOI 10.1007/BF01413272; SICCARDI D, 1991, SURG NEUROL, V35, P455, DOI 10.1016/0090-3019(91)90179-D; STRICH SJ, 1961, LANCET, V2, P443; SYKES LN, 1988, J TRAUMA, V28, P618, DOI 10.1097/00005373-198805000-00010; TANAKA T, 1988, J NEUROSURG, V69, P203, DOI 10.3171/jns.1988.69.2.0203; TSAI FY, 1978, J COMPUT ASSIST TOMO, V2, P323, DOI 10.1097/00004728-197807000-00018; TSAI FY, 1984, NEURORADIOLOGY HEAD; UNGER JM, 1990, RADIOLOGY, V175, P175, DOI 10.1148/radiology.175.1.2315477; WALKER AE, 1969, HEAD INJURED MEN 15, P10; WEISS GH, 1982, ARCH NEUROL-CHICAGO, V39, P741, DOI 10.1001/archneur.1982.00510240003001; Woodburne RT, 1978, ESSENTIALS HUMAN ANA; ZIMMERMAN RA, 1978, RADIOLOGY, V127, P393, DOI 10.1148/127.2.393	82	18	19	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-6438	1534-4916		NEUROSURG QUART	Neurosurg. Q.	MAR	2002	12	1					1	18		10.1097/00013414-200203000-00001			18	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	523CX	WOS:000173935500001					2022-02-06	
J	Nishioka, T; Maeda, Y; Tomogane, Y; Nakano, A; Arita, N				Nishioka, T; Maeda, Y; Tomogane, Y; Nakano, A; Arita, N			Unexpected delayed rupture of the vertebral-posterior inferior cerebellar artery aneurysms following closed head injury	ACTA NEUROCHIRURGICA			English	Article						aneurysm; delayed rupture; PICA; repair; trauma	TRAUMATIC ANEURYSM; SUBARACHNOID HEMORRHAGE; CEREBRAL-ARTERIES; BASILAR ARTERY; SECONDARY	Subarachnoid haemorrhage secondary to closed head injury is rarely associated with traumatic aneurysms of the posterior circulation. We report two cases of ruptured vertebral-posterior inferior cerebellar artery (VA-PICA) pseudoaneurysms following closed head injuries. In each case, there was no associated penetrating injury or skull fracture. The first patient was kicked followed by disturbed consciousness. The computerized tomography (CT) scan on admission and cerebral angiography on the 11th day after the trauma revealed a massive subarachnoid haemorrhage (SAH) with pan-ventricular haemorrhage and an aneurysm of the right PICA near its origin. Further ruptures occurred on the 12th, 15th, and 66th day, and he died on the 69th day. The second patient complained of persistent headache and nausea following a fight on the previous day. A CT scan and angiography on the 1st day after the trauma showed posterior fossa SAH with fourth ventricular blood and a tiny protrusion of the left VA-PICA. On the 14th day, repeated angiography revealed a remarkable growth of the aneurysm, followed by the second rupture. The repair of the VA-PICA junction was urgently performed with successful exclusion of the aneurysm. To our knowledge, only eight cases of traumatic aneurysms located at the VA or the PICA near its origin have been reported. When intraventricular blood is found with massive subarachnoid blood or with posterior fossa SAH, this omnious complication should be considered. Traumatic VA-PICA pseudoaneurysms are curable by refined microsurgical techniques, if diagnosed in time.	Ishikiriseiki Hosp, Dept Neurosurg, Higashiosaka, Osaka 5798026, Japan; Hyogo Med Univ, Dept Neurosurg, Nishinomiya, Hyogo, Japan		Nishioka, T (corresponding author), Ishikiriseiki Hosp, Dept Neurosurg, 18-28 Yayoi Cho, Higashiosaka, Osaka 5798026, Japan.						ASARI S, 1977, J NEUROSURG, V46, P795, DOI 10.3171/jns.1977.46.6.0795; BANK WO, 1978, AM J ROENTGENOL, V130, P975, DOI 10.2214/ajr.130.5.975; BENOIT BG, 1973, J NEUROL NEUROSUR PS, V36, P127, DOI 10.1136/jnnp.36.1.127; BOSTROM K, 1992, FORENSIC SCI INT, V53, P61, DOI 10.1016/0379-0738(92)90133-H; BURTON C, 1968, J NEUROSURG, V28, P468, DOI 10.3171/jns.1968.28.5.0468; CASEY ATH, 1994, BRIT J NEUROSURG, V8, P97, DOI 10.3109/02688699409002401; COCKRILL HH, 1977, J NEUROSURG, V46, P377, DOI 10.3171/jns.1977.46.3.0377; CROWELL RM, 1995, SURG MANAGEMENT NEUR, P377; DECK JHN, 1986, ARCH PATHOL LAB MED, V110, P489; DIAL DL, 1937, AM J SURG, V35, P2; DOWLING G, 1988, AM J FOREN MED PATH, V9, P23, DOI 10.1097/00000433-198803000-00007; Drake C G, 1979, Clin Neurosurg, V26, P96; FERRY DJ, 1972, J NEUROSURG, V36, P503, DOI 10.3171/jns.1972.36.4.0503; FLEISCHER A S, 1975, Surgical Neurology, V4, P233; HEROS RC, 1996, NEUROSURGERY, V2, P2357; HOLMES B, 1993, J TRAUMA, V35, P855, DOI 10.1097/00005373-199312000-00009; HUDGINS RJ, 1983, J NEUROSURG, V58, P381, DOI 10.3171/jns.1983.58.3.0381; MCDONALD EJ, 1976, AM J ROENTGENOL, V126, P792, DOI 10.2214/ajr.126.4.792; MEGURO K, 1985, NEUROSURGERY, V16, P666, DOI 10.1227/00006123-198505000-00015; MORARD M, 1991, NEUROSURGERY, V29, P438, DOI 10.1227/00006123-199109000-00018; PARKINSON D, 2000, SCHMIDEK SWEET OPERA, V2, P1296; PAUL GA, 1980, J NEUROSURG, V53, P101, DOI 10.3171/jns.1980.53.1.0101; PIATT JH, 1992, J NEUROSURG, V77, P799, DOI 10.3171/jns.1992.77.5.0799; Proust F, 1997, J NEUROSURG, V87, P950, DOI 10.3171/jns.1997.87.6.0950; QUATTROCCHI KB, 1990, NEUROSURGERY, V27, P476, DOI 10.1227/00006123-199009000-00025; REZAI AR, 1994, SURG NEUROL, V42, P312, DOI 10.1016/0090-3019(94)90399-9; RUMBAUGH CL, 1970, RADIOLOGY, V96, P49, DOI 10.1148/96.1.49; Sahjpaul RL, 1998, J NEUROSURG, V89, P822, DOI 10.3171/jns.1998.89.5.0822; Schuster JM, 1999, NEUROSURGERY, V45, P1465, DOI 10.1097/00006123-199912000-00039; SENEGOR M, 1991, J NEUROSURG, V75, P475, DOI 10.3171/jns.1991.75.3.0475; SHAW CM, 1972, J NEUROL NEUROSUR PS, V35, P247, DOI 10.1136/jnnp.35.2.247; SMITH DR, 1970, J NEUROSURG, V32, P357, DOI 10.3171/jns.1970.32.3.0357; Sure U, 1999, CHILD NERV SYST, V15, P354, DOI 10.1007/s003810050411; WORTZMAN D, 1980, SURG NEUROL, V13, P329; Yasui T, 2000, NEUROSURGERY, V46, P196, DOI 10.1093/neurosurgery/46.1.196	35	18	21	0	0	SPRINGER-VERLAG WIEN	VIENNA	SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.		2002	144	8					839	845		10.1007/s00701-002-0952-3			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	588KU	WOS:000177701300028	12181696				2022-02-06	
J	Ma, JJ; Novikov, LN; Karlsson, K; Kellerth, JO; Wiberg, M				Ma, JJ; Novikov, LN; Karlsson, K; Kellerth, JO; Wiberg, M			Plexus avulsion and spinal cord injury increase the serum concentration of S-100 protein: An experimental study in rats	SCANDINAVIAN JOURNAL OF PLASTIC AND RECONSTRUCTIVE SURGERY AND HAND SURGERY			English	Article						S-100 protein; plexus avulsion; spinal cord injury	NEURON-SPECIFIC ENOLASE; ISCHEMIC STROKE; BRAIN-DAMAGE; SERIAL S-100; HEAD-INJURY; BLOOD; MOTONEURONS; INFARCTION; SURVIVAL; SURGERY	The possibility of using the presence of the glial-cell-derived protein S-100 in serum as a marker for neuronal damage caused by spinal cord injury and plexus avulsion injury was investigated in 144 adult rats. After a spinal cord injury had been induced at the thoracic level or a plexus avulsion injury at the lumbar level, blood samples were taken and analysed for S-100 protein by a monoclonal two-site immunno-luminometric assay. The two types of neurotrauma changed the kinetics of serum S-100 in different ways. After spinal cord injury it rapidly increased and within 72 hours had reached a concentration about 5 times that of the control animals. Three peak concentrations occurred at 3, 12, and 72 hours, respectively, and differed significantly from those of the control group (p < 0.05). After six days the values had returned to normal. After lumbar plexus injury alone there was no significant increase in the concentration of S-100. These results suggest that the concentration of S-100 protein in serum may be used as an early diagnostic tool for detecting neuronal damage caused by spinal cord injury or plexus avulsion associated with damage to the root entry zone.	Univ Umea Hosp, Dept Hand & Plast Surg, SE-90185 Umea, Sweden; Umea Univ, Sect Anat, Dept Integrat Med Biol, Umea, Sweden; Univ Umea Hosp, Dept Clin Chem, S-90185 Umea, Sweden		Wiberg, M (corresponding author), Univ Umea Hosp, Dept Hand & Plast Surg, SE-90185 Umea, Sweden.		Novikov, Lev/I-1983-2012	Novikov, Lev/0000-0001-5520-3890			Beattie MS, 1998, NEUROSCIENTIST, V4, P163, DOI 10.1177/107385849800400312; Birch R, 1998, SURG DISORDERS PERIP, P157; Buttner T, 1997, STROKE, V28, P1961, DOI 10.1161/01.STR.28.10.1961; DONATO R, 1986, CELL CALCIUM, V7, P123, DOI 10.1016/0143-4160(86)90017-5; DUSART I, 1994, EUR J NEUROSCI, V6, P712, DOI 10.1111/j.1460-9568.1994.tb00983.x; Fassbender K, 1997, J NEUROL SCI, V148, P101, DOI 10.1016/S0022-510X(96)05351-8; HARDEMARK HG, 1989, J NEUROSURG, V71, P727, DOI 10.3171/jns.1989.71.5.0727; Ingebrigtsen T, 1996, J NEUROSURG, V85, P945, DOI 10.3171/jns.1996.85.5.0945; Missler U, 1997, STROKE, V28, P1956, DOI 10.1161/01.STR.28.10.1956; Novikov L, 1997, NEUROSCIENCE, V79, P765, DOI 10.1016/S0306-4522(96)00665-3; NOVIKOV L, 1995, NEUROSCI LETT, V200, P45, DOI 10.1016/0304-3940(95)12078-I; PERSSON L, 1988, ACTA NEUROCHIR, V93, P116, DOI 10.1007/BF01402892; USUI A, 1989, CLIN CHEM, V35, P1942; van Dongen EP, 1998, J VASC SURG, V27, P344, DOI 10.1016/S0741-5214(98)70365-9; Wiesmann M, 1997, ACTA NEUROCHIR, V139, P1155, DOI 10.1007/BF01410976; Woertgen C, 1997, ACTA NEUROCHIR, V139, P1161, DOI 10.1007/BF01410977	16	18	19	0	0	TAYLOR & FRANCIS AS	OSLO	CORT ADELERSGT 17, PO BOX 2562, SOLLI, 0202 OSLO, NORWAY	0284-4311			SCAND J PLAST RECONS	Scand. J. Plast. Reconstr. Surg. Hand Surg.	DEC	2001	35	4					355	359					5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	509PE	WOS:000173155800003	11878171				2022-02-06	
J	Horn, P; Vajkoczy, P; Thome, C; Muench, E; Schilling, L; Schmiedek, P				Horn, P; Vajkoczy, P; Thome, C; Muench, E; Schilling, L; Schmiedek, P			Xenon-induced flow activation in patients with cerebral insult who undergo xenon-enhanced CT blood flow studies	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article; Proceedings Paper	5th International Conference on Xenon/CT CBF	SEP, 1999	TOKYO, JAPAN				TRAUMATIC BRAIN INJURY; STABLE XENON; ISOFLURANE; ENDOTHELIUM; INHALATION; HALOTHANE; STIMULATION; TOMOGRAPHY; ANESTHESIA; RELAXATION	BACKGROUND AND PURPOSE: Stable xenon-enhanced CT (Xe-s/CT) has gained wide acceptance in the assessment of regional cerebral blood flow (rCBF) in patients with intracranial abnormalities. The aim of this study was to test whether the contrast medium (ie, Xe-s) itself directly induces relevant changes in rCBF, thereby distorting any valid determination of cerebral perfusion by using Xe-s/CT. METHODS: To characterize the degree and temporal dynamics of Xe-s-induced flow activation, a thermal diffusion (TD)-based microprobe was placed subcortically into the frontal lobe on either hemisphere to assess rCBF (TD-rCBF) continuously in 23 patients (mean age, 55 +/- 18 years) with severe intracranial insult who were undergoing Xe-s/CT. RESULTS: In 35, the Xe-s/CT studies TD-rCBF rose from 25 +/- 17 mL/100 g per minute (range, 5-42 mL/100 g per minute) before Xe-s administration to 28 +/- 21 mL/100 g per minute (range, 6-46 mL/100 g per minute) after arterial Xe-s saturation was reached. Analysis of the flow activation curve showed a logarithmic shape with an increase in TD-rCBF between 3% and 7% within the first 76 seconds of Xe-s wash-in (12% after 190 seconds) and showed no further augmentation until the end of the blood flow study. CONCLUSION: The observed Xe-s-induced rCBF activation, which showed significant interand intraindividual variability, might lead to overestimation of rCBF in patients with severe intracranial insult. The obtained How activation curve provides essential information that may allow subsequent refinement of the methodology, aiming to further minimize the influence of Xe-s-induced rCBF activation on rCBF calculations when using Xe-s/CT technology.	Heidelberg Univ, Dept Neurosurg, Univ Hosp, Fac Clin Med, D-68167 Mannheim, Germany; Heidelberg Univ, Fac Clin Med, Univ Hosp, Dept Anesthesiol & Intens Care, D-6800 Mannheim, Germany		Horn, P (corresponding author), Heidelberg Univ, Dept Neurosurg, Univ Hosp, Fac Clin Med, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany.						ASHWAL S, 1990, J PEDIATR-US, V117, P523, DOI 10.1016/S0022-3476(05)80683-3; BECK T, 1987, AM J PHYSIOL, V252, pH504, DOI 10.1152/ajpheart.1987.252.3.H504; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; BOOMSMA F, 1990, ANAESTHESIA, V45, P273, DOI 10.1111/j.1365-2044.1990.tb14731.x; BROICH K, 1992, CEREBRAL BLOOD FLOW MEASUREMENT WITH STABLE XENON-ENHANCED COMPUTED TOMOGRAPHY, P292; CHRISTENSEN MS, 1967, BRIT J ANAESTH, V39, P927, DOI 10.1093/bja/39.12.927; Cruz J, 1996, CRIT CARE MED, V24, P953, DOI 10.1097/00003246-199606000-00013; CUCCHIARA RF, 1974, ANESTHESIOLOGY, V40, P571, DOI 10.1097/00000542-197406000-00011; CULLEN SC, 1951, SCIENCE, V113, P580, DOI 10.1126/science.113.2942.580; DETTMERS C, 1987, ADV NEUROSURG, V15, P67; FLYNN NM, 1992, ANESTHESIOLOGY, V76, P461, DOI 10.1097/00000542-199203000-00021; GELMAN S, 1984, ANESTH ANALG, V63, P557; GILLER CA, 1990, AM J NEURORADIOL, V11, P177; GUR D, 1985, STROKE, V16, P871, DOI 10.1161/01.STR.16.5.871; Hamberg LM, 1996, AM J NEURORADIOL, V17, P639; HARTMANN A, 1991, STROKE, V22, P182, DOI 10.1161/01.STR.22.2.182; HARTMANN A, 1987, STROKE, V18, P643, DOI 10.1161/01.STR.18.3.643; HOLL K, 1995, QUANTITATIVE CEREBRAL BLOOD FLOW MEASUREMENTS USING STABLE XENON/CT: CLINICAL APPLICATIONS, P41; Horn Peter, 2000, Keio Journal of Medicine, V49, pA161; JENSEN NF, 1992, ANESTHESIOLOGY, V76, P624, DOI 10.1097/00000542-199204000-00021; JUNCK L, 1985, J CEREBR BLOOD F MET, V5, P126, DOI 10.1038/jcbfm.1985.16; Klar E, 1999, MICROVASC RES, V58, P156, DOI 10.1006/mvre.1999.2166; LACHMANN B, 1989, NARKOSEBEATMUNG LOW, P125; LINDER J, 1982, ACTA PHYSIOL SCAND, V114, P379, DOI 10.1111/j.1748-1716.1982.tb06998.x; LOVE JT, 1992, CEREBRAL BLOOD FLOW MEASUREMENT WITH STABLE XENON-ENHANCED COMPUTED TOMOGRAPHY, P282; Marion DW, 1999, CRIT CARE MED, V27, P2063, DOI 10.1097/00003246-199909000-00077; MEIXENSBERGER J, 1993, ACTA NEUROCHIR, P28; MOORE LE, 1994, ANESTHESIOLOGY, V80, P1328, DOI 10.1097/00000542-199406000-00021; Nakamura N, 2000, MAGN RESON IMAGING, V18, P397, DOI 10.1016/S0730-725X(00)00129-6; Obrist WD, 1998, J CEREBR BLOOD F MET, V18, P1192, DOI 10.1097/00004647-199811000-00005; OBRIST WD, 1992, STROKE, V23, P464; OBRIST WD, 1985, J CEREB BLOOD FLOW M, V5, P557; Stippich C, 1999, NEUROSCI LETT, V277, P25, DOI 10.1016/S0304-3940(99)00835-6; TEASDALE G, 1974, LANCET, V2, P81; THOME C, 1999, J CEREB BLOOD FLOW M, V19, pS623; TODD MM, 1984, ANESTHESIOLOGY, V60, P276, DOI 10.1097/00000542-198404000-00002; UELTZEN J, 1992, HIRNDURCHBLUTUNG CER, P35; Vajkoczy P, 2000, J NEUROSURG, V93, P265, DOI 10.3171/jns.2000.93.2.0265; WITT JP, 1991, AM J NEURORADIOL, V12, P973; YONAS H, 1995, QUANTITATIVE CEREBRAL BLOOD FLOW MEASUREMENTS USING STABLE XENON/CT: CLINICAL APPLICATIONS, P1; YOSHIDA K, 1992, ANESTHESIOLOGY, V76, P440, DOI 10.1097/00000542-199203000-00018; Zauner A, 1997, NEUROSURGERY, V41, P1082, DOI 10.1097/00006123-199711000-00011	42	18	24	0	3	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	SEP	2001	22	8					1543	1549					7	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	474QZ	WOS:000171119500016	11559502				2022-02-06	
J	Kishi, Y; Robinson, RG; Kosier, JT				Kishi, Y; Robinson, RG; Kosier, JT			Suicidal ideation among patients during the rehabilitation period after life-threatening physical illness	JOURNAL OF NERVOUS AND MENTAL DISEASE			English	Article							HEALTH-SERVICE NEEDS; PRIMARY-CARE; DEPRESSION; CONSULTATION; CANCER; STROKE	A total of 496 patients were examined for suicidal ideation during the acute hospital period and at 3, 6, 12, and 24 months' follow-up after suffering either stroke, traumatic brain injury, myocardial infarction, or spinal cord injury. A total of 7.3% of patients had suicidal ideation during the in-hospital evaluation (acute-onset suicidal ideation), and 11.3% developed it during the chronic 3 to 24 month rehabilitation period (delayed-onset suicidal ideation). Compared with delayed-onset suicidal patients, acute-onset suicidal patients had more predisposing risk factors (i.e., personal psychiatric history and alcohol abuse/dependence) and less social support (i.e., lower frequency of being married). Both acute and delayed-onset suicidal ideation, however, were strongly associated with the existence of major depression and impaired social functioning. These findings suggest that the detection and appropriate treatment of depressive disorders and social isolation may be the most important factor in preventing suicide both during the acute and chronic period following life-threatening physical illnesses.	Univ Iowa, Coll Med, Dept Psychiat, Iowa City, IA 52242 USA; Chiba Hokusoh Hosp, Nippon Med Sch, Dept Psychiat, Chiba, Japan		Robinson, RG (corresponding author), Univ Iowa, Coll Med, Dept Psychiat, Iowa City, IA 52242 USA.		Robinson, Robert/AAF-6191-2021; Kishi, Yasuhiro/T-4047-2019		NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH052879, R01MH053592] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH53592, MH52879] Funding Source: Medline		Akechi T, 1999, PSYCHIAT CLIN NEUROS, V53, P569, DOI 10.1046/j.1440-1819.1999.00607.x; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Breitbart W, 2000, JAMA-J AM MED ASSOC, V284, P2907, DOI 10.1001/jama.284.22.2907; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; Conwell Y, 2000, J AM GERIATR SOC, V48, P23, DOI 10.1111/j.1532-5415.2000.tb03024.x; FEDOROFF JP, 1991, J AFFECT DISORDERS, V22, P83, DOI 10.1016/0165-0327(91)90088-A; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GUZE SB, 1970, BRIT J PSYCHIAT, V117, P437, DOI 10.1192/bjp.117.539.437; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Haste F, 1998, BRIT J GEN PRACT, V48, P1759; Huyse FJ, 1997, J PSYCHOSOM RES, V43, P233, DOI 10.1016/S0022-3999(97)00011-1; Huyse FJ, 1999, GEN HOSP PSYCHIAT, V21, P39, DOI 10.1016/S0163-8343(98)00057-7; Huyse FJ, 2001, PSYCHOSOMATICS, V42, P5, DOI 10.1176/appi.psy.42.1.5; KATON W, 1994, PSYCHOSOMATICS, V35, P268, DOI 10.1016/S0033-3182(94)71775-8; KATON W, 1995, JAMA-J AM MED ASSOC, V273, P1026, DOI 10.1001/jama.273.13.1026; Kelly B, 1998, PSYCHOSOMATICS, V39, P405, DOI 10.1016/S0033-3182(98)71299-X; KISHI Y, IN PRESS PSYCHOSOMAT; MACKENZIE TB, 1987, INT J PSYCHIAT MED, V17, P3; MILES CP, 1977, J NERV MENT DIS, V164, P231, DOI 10.1097/00005053-197704000-00002; MISSEL JL, 1978, ARCH PHYS MED REHAB, V59, P371; MURPHY GE, 1983, ARCH GEN PSYCHIAT, V40, P342; RABINS PV, 1982, BRIT J PSYCHIAT, V140, P149, DOI 10.1192/bjp.140.2.149; ROBINS E, 1959, AM J PUBLIC HEALTH N, V49, P888, DOI 10.2105/AJPH.49.7.888; ROBINSON RG, 1981, BRAIN LANG, V14, P282, DOI 10.1016/0093-934X(81)90080-8; ROBINSON RG, 1983, COMPR PSYCHIAT, V24, P555, DOI 10.1016/0010-440X(83)90024-X; Starr L B, 1982, Soc Work Res Abstr, V18, P28; Stiefel FC, 1999, GEN HOSP PSYCHIAT, V21, P49, DOI 10.1016/S0163-8343(98)00061-9; Wing J. K., 1974, MEASUREMENT CLASSIFI	28	18	18	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-3018			J NERV MENT DIS	J. Nerv. Ment. Dis.	SEP	2001	189	9					623	628		10.1097/00005053-200109000-00009			6	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	475BH	WOS:000171141400009	11580007				2022-02-06	
J	Shapira, MY; Chelouche, M; Yanai, R; Kaner, C; Szold, A				Shapira, MY; Chelouche, M; Yanai, R; Kaner, C; Szold, A			Tai Chi Chuan practice as a tool for rehabilitation of severe head trauma: 3 case reports	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						art therapy; brain injuries; case report; martial arts; physical therapy; rehabilitation; Tai Chi; therapy	BALANCE; STRENGTH	Rehabilitation after severe head trauma is a complex process that can be long and frustrating, New, more holistic methods for rehabilitation are constantly sought. We present the cases of 3 patients who had severe head injury and whose rehabilitation was facilitated by Tai Chi Chuan (TCC) therapy. TCC therapy should be taught only by a qualified TCC therapist and under close medical supervision.	Hebrew Univ Jerusalem, Dept Bone Marrow Transplant, Hadassah Univ Hosp, Hadassah Med Sch, IL-91120 Jerusalem, Israel; Shalvata Psychiat Hosp, Tel Aviv, Israel; Tel Aviv Sourasky Med Ctr, Dept Surg, Tel Aviv, Israel; Israeli Thai Chi Ctr, Tel Aviv, Israel		Shapira, MY (corresponding author), Hebrew Univ Jerusalem, Dept Bone Marrow Transplant, Hadassah Univ Hosp, Hadassah Med Sch, POB 12000, IL-91120 Jerusalem, Israel.		Szold, Amir/AAS-7223-2020	Szold, Amir/0000-0002-2238-8670			BROWN DR, 1995, MED SCI SPORT EXER, V27, P765; CHANNER KS, 1996, POSTGRAD MED J, V72, P347; Hong YL, 2000, BRIT J SPORT MED, V34, P29, DOI 10.1136/bjsm.34.1.29; Jacobson BH, 1997, PERCEPT MOTOR SKILL, V84, P27, DOI 10.2466/pms.1997.84.1.27; JIN PT, 1992, J PSYCHOSOM RES, V36, P361, DOI 10.1016/0022-3999(92)90072-A; KOH TC, 1982, AM J CHINESE MED, V10, P59, DOI 10.1142/S0192415X82000105; Wolf SL, 1997, PHYS THER, V77, P371, DOI 10.1093/ptj/77.4.371; Wolf SL, 1996, J AM GERIATR SOC, V44, P489, DOI 10.1111/j.1532-5415.1996.tb01432.x; Wolfson L, 1996, J AM GERIATR SOC, V44, P498, DOI 10.1111/j.1532-5415.1996.tb01433.x	9	18	18	0	6	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	SEP	2001	82	9					1283	1285		10.1053/apmr.2001.25152			3	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	470LR	WOS:000170873900023	11552205				2022-02-06	
J	Haley, SM; Dumas, HM; Ludlow, LH				Haley, SM; Dumas, HM; Ludlow, LH			Variation by diagnostic and practice pattern groups in the mobility outcomes of inpatient rehabilitation programs for children and youth	PHYSICAL THERAPY			English	Article						disability; functional limitations; functional mobility assessment; outcomes; pediatrics; physical therapy; rehabilitation	TRAUMATIC BRAIN INJURY; RECOVERY	Background and Purpose. The purpose Of this study was to describe variation in functional mobility outcomes among children and youth with different diagnoses and belonging to groups with different practice patterns from an inpatient pediatric rehabilitation hospital setting. Subjects. A sample of 138 individuals between the ages of I and 22 years ((X) over bar =9.4, SD=5.3) was enrolled. Methods. Physical therapists administered the "Mobility" domain of the Pediatric Evaluation of Disability Inventory at the time of admission and at the time of discharge. Mobility level (combined admission and discharge scores) and amount of change between and within 4 diagnostic groups (traumatic brain injury, non-traumatic brain injury, orthopedic, and neurological) and 5 neuromuscular and musculoskeletal practice pattern groups were calculated, and post hoc analyses were done for specific contrast comparisons. Results. Mobility scores between admission and discharge for all subgroups were different. Practice pattern groups were useful for identifying variations in level of motor performance. Diagnostic groups best described differences in mobility change during inpatient rehabilitation. Discussion and Conclusion. The use of practice patterns as grouping categories may enhance our understanding of variation in clinical outcomes of children during inpatient rehabilitation.	Boston Univ, Sargent Coll Hlth & Rehabil Sci, Ctr Rehabil Effect, Boston, MA 02215 USA; Franciscan Childrens Hosp & Res Ctr, Ctr Excellence Children Special Hlth Care Needs, Boston, MA USA; Boston Coll, Lynch Sch Educ, Chestnut Hill, MA 02167 USA		Haley, SM (corresponding author), Boston Univ, Sargent Coll Hlth & Rehabil Sci, Ctr Rehabil Effect, 635 Commonwealth Ave, Boston, MA 02215 USA.						Bowen JM, 1997, DEV MED CHILD NEUROL, V39, P17; BOYER MG, 1991, INJURY, V22, P315, DOI 10.1016/0020-1383(91)90014-6; Butler C, 1999, DEV MED CHILD NEUROL, V41, P55, DOI 10.1017/S0012162299000110; COSTER WJ, 1994, AM J OCCUP THER, V48, P211, DOI 10.5014/ajot.48.3.211; Dobrzykowski EA, 1997, J REHABILITATION OUT, V1, P8; DUDGEON BJ, 1994, ARCH PHYS MED REHAB, V75, P46; Engelbert R H, 1997, Pediatrics, V99, pE3, DOI 10.1542/peds.99.2.e3; Engelbert RH, 1997, PEDIAT PHYS THER, V9, P18; FELDMAN AB, 1990, PHYS THER, V70, P602, DOI 10.1093/ptj/70.10.602; GLASS GV, 1994, STAT METHODS ED PSYC; HALEY SM, 1990, J HEAD TRAUMA REHAB, V5, P77; HALEY SM, 1997, J REHABILITATION OUT, V1, P61; HALEY SM, MOVEMENT DISORDERS C, V199, P278; HALEY SM, 1992, PEDIAT PHYS THERAPY, V4, P24; HALEY SM, 1992, PEDIAT EVALUATION DI; Haley SM, 1993, PHYS MED REH CLIN N, V4, P529, DOI [10.1016/S1047-9651(18)30568-0, DOI 10.1016/S1047-9651(18)30568-0]; HALEY SM, 1991, PEDIATRIC PHYSICAL T, V3, P177; HAMILITON BB, 1994, PHYS THER, V74, P494, DOI 10.1093/ptj/74.5.494; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; KANE RL, 1994, PHYS THER, V74, P425, DOI 10.1093/ptj/74.5.425; Massey B, 2001, PHYS THER, V81, P9; NAGI SZ, 1976, MILBANK FUND Q, V54, P439, DOI 10.2307/3349677; NAGI SZ, 1991, DISABILITY AM NATL A; *NCMRR, 1992, REP PLAN MED REH RES; Nichols DS., 1996, PEDIATR PHYS THER, V8, P15, DOI DOI 10.1097/00001577-199600810-00004; PALISANO RJ, 2000, PHYSICAL THERAPY CHI, P198; PHILIP PA, 1994, ARCH PHYS MED REHAB, V75, P36; POPE AM, 1991, DISABILITY AM NATL A; Reid DT, 1993, PHYSICAL OCCUPATIONA, V13, P57, DOI [10.1080/J006v13n0404, DOI 10.1080/J006V13N04_04]; SCHYVE PM, 1996, JOINT COMMISSION J Q, V11, pS54; VanderSchaaf PJ, 1997, PEDIATR NEUROL, V16, P306, DOI 10.1016/S0887-8994(97)00025-8; WILKINS D, 1997, ANN ARBOR NEWS   JAN, P1; World Health Organisation (WHO), 1977, MAN INT STAT CLASS D; WRIGHT BD, 1978, BEST TEST DESIGN	35	18	18	0	2	AMER PHYSICAL THERAPY ASSOC	ALEXANDRIA	1111 N FAIRFAX ST, ALEXANDRIA, VA 22314 USA	0031-9023			PHYS THER	Phys. Ther.	AUG	2001	81	8					1425	1436		10.1093/ptj/81.8.1425			12	Orthopedics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Rehabilitation	458VQ	WOS:000170216500004	11509072	Bronze			2022-02-06	
J	Sekiya, T; Tanaka, M; Shimamura, N; Suzuki, S				Sekiya, T; Tanaka, M; Shimamura, N; Suzuki, S			Macrophage invasion into injured cochlear nerve and its modification by methylprednisolone	BRAIN RESEARCH			English	Article						cochlear nerve; macrophage; methylprednisolone; nerve degeneration; nerve regeneration	MYELIN-ASSOCIATED GLYCOPROTEIN; RAT OPTIC-NERVE; SPINAL-CORD; WALLERIAN DEGENERATION; NEURITE GROWTH; MONONUCLEAR PHAGOCYTES; CEREBELLOPONTINE ANGLE; AXONAL REGENERATION; BRAIN MACROPHAGES; MICROGLIA	Post-traumatic invasion of macrophages into the cochlear nerve of the rat and measurement of how their invasion was modified by the administration of methylprednisolone were investigated for the first time by using a reproducible and quantifiable experimental model of cochlear nerve injury. Two weeks after precise cochlear nerve compression, a massive invasion of EDI immunostained macrophages was observed at the compressed portion of the cochlear nerve, and this invasion of macrophages was markedly reduced in the rats to which methylprednisolone had been administered during the pre- and post-compression period. Concomitantly, the residual number of spiral ganglion cells was found to be greater in the compression+methylprednisolone group than in the control compression group. The tissue loss observed in the lesion epicenter was also significantly less in the compression+methylprednisolone group than in the control compression group. The results of our present study demonstrated the effectiveness of methylprednisolone treatment to ameliorate trauma induced cochlear nerve degeneration in the acute phase. However, these results may reflect the sum effects of methylprednisolone on macrophages, including both its beneficial effect by inhibiting the negative aspects of macrophages through attenuating macrophage recruitment to the lesion site, and at the same time an undesirable effect by sacrificing the positive aspects of macrophage function. Moreover, one reservation should be added that the protective effects of steroid to injured cochlear nerve may have operated via a pathway not related to macrophage function. Besides macrophages, various cells and factors participate in the process of CNS injury, and their effects may potentially work either positively or negatively with respect to CNS protection and regeneration at each particular time during the on-going process of CNS injury. Therefore, future investigation in CNS injury should be directed toward understanding such complex mechanisms involved in this process. (C) 2001 Elsevier Science B.V, All rights reserved.	Hirosaki Univ, Sch Med, Dept Neurosurg, Hirosaki, Aomori 0368216, Japan		Sekiya, T (corresponding author), Hirosaki Univ, Sch Med, Dept Neurosurg, 5 Zaifu Cho, Hirosaki, Aomori 0368216, Japan.	seky@cc.hirosaki-u.ac.jp					BAMA BPJ, 1994, J NEUROIMMUNOL, V50, P101; BANATI RB, 1993, GLIA, V7, P111, DOI 10.1002/glia.440070117; BARTHOLDI D, 1995, BRAIN RES, V672, P177, DOI 10.1016/0006-8993(94)01410-J; BENVENISTE EN, 1992, AM J PHYSIOL, V263, pC1, DOI 10.1152/ajpcell.1992.263.1.C1; BIGNAMI A, 1969, BRAIN RES, V13, P444, DOI 10.1016/0006-8993(69)90259-5; Carlson SL, 1998, EXP NEUROL, V151, P77, DOI 10.1006/exnr.1998.6785; CARONI P, 1988, J CELL BIOL, V106, P1281, DOI 10.1083/jcb.106.4.1281; CHAMAK B, 1994, J NEUROSCI RES, V38, P221, DOI 10.1002/jnr.490380213; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; COLTON CA, 1987, FEBS LETT, V223, P284, DOI 10.1016/0014-5793(87)80305-8; DIJKSTRA CD, 1985, IMMUNOLOGY, V54, P589; DINARELLO CA, 1989, ADV IMMUNOL, V44, P153, DOI 10.1016/S0065-2776(08)60642-2; Elkabes S, 1996, J NEUROSCI, V16, P2508; Flavin MP, 1997, EXP NEUROL, V145, P462, DOI 10.1006/exnr.1997.6474; GIULIAN D, 1993, ADV NEUROL, V59, P315; GIULIAN D, 1994, NEUROCHEM INT, V25, P227, DOI 10.1016/0197-0186(94)90066-3; GIULIAN D, 1990, ANN NEUROL, V27, P33, DOI 10.1002/ana.410270107; GUYRE PM, 1988, J STEROID BIOCHEM, V30, P89, DOI 10.1016/0022-4731(88)90080-5; Hayashi Mito, 1997, Acta Anatomica Nipponica, V72, P209; Klusman I, 1997, BRAIN RES, V762, P173, DOI 10.1016/S0006-8993(97)00381-8; LAWSON LJ, 1994, J NEUROCYTOL, V23, P729, DOI 10.1007/BF01268086; LazarovSpiegler O, 1996, FASEB J, V10, P1296, DOI 10.1096/fasebj.10.11.8836043; LING EA, 1978, J ANAT, V126, P111; Marchant A, 1996, CLIN EXP IMMUNOL, V106, P91, DOI 10.1046/j.1365-2249.1996.d01-799.x; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; NATHAN CF, 1987, J CLIN INVEST, V79, P319, DOI 10.1172/JCI112815; Oudega M, 1999, EUR J NEUROSCI, V11, P2453, DOI 10.1046/j.1460-9568.1999.00666.x; Pavelko KD, 1998, J NEUROSCI, V18, P2498; PESHEVA P, 1989, J CELL BIOL, V109, P1765, DOI 10.1083/jcb.109.4.1765; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; SEKIYA T, 1987, NEUROSURGERY, V21, P631, DOI 10.1227/00006123-198711000-00005; SEKIYA T, 1985, J NEUROSURG, V63, P598, DOI 10.3171/jns.1985.63.4.0598; Sekiya T, 2001, HEARING RES, V151, P125, DOI 10.1016/S0378-5955(00)00219-7; Sekiya T, 2000, EXP NEUROL, V161, P490, DOI 10.1006/exnr.1999.7280; STOLL G, 1989, J NEUROSCI, V9, P2327; Streit WJ, 1996, NEUROTOXICOLOGY, V17, P671; Tang S, 1997, MOL CELL NEUROSCI, V9, P333, DOI 10.1006/mcne.1997.0633; THERY C, 1991, EUR J NEUROSCI, V3, P1155, DOI 10.1111/j.1460-9568.1991.tb00050.x	38	18	18	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUN 29	2001	905	1-2					152	160		10.1016/S0006-8993(01)02523-9			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	452RY	WOS:000169873600018	11423090				2022-02-06	
J	Basso, D; Bisiacchi, PS; Cotelli, M; Farinello, C				Basso, D; Bisiacchi, PS; Cotelli, M; Farinello, C			Planning times during traveling salesman's problem: Differences between closed head injury and normal subjects	BRAIN AND COGNITION			English	Article; Proceedings Paper	11th Annual Meeting on Theoretical and Experimental Neuropsychology	JUN 15-17, 2000	MONTREAL, CANADA	Univ Quebec, Montreal, Minist Rech, Sci & Technol, Quebec, Med Res Council, Ottawa			SPATIAL DECISIONS; PERFORMANCE	We studied planning behavior in a group of normal subjects and a group of closed head injury patients (CHI). A computerized version of the traveling salesman's problem was used as a visuospatial planning ability task. The program collected measurements of partial times, number of moves, and number of skipped subgoals. These measures allow us to calculate a "planning index" of subjects' planning ability. Results show that CHI patients present limitations in thr planning process due to the lack of ongoing planning, (C) 2001 Academic Press.	Univ Padua, Dept Gen Psychol, Padua, Italy; Spedali Civili Brescia, I-25125 Brescia, Italy; Opsed Civile San Bortolo, Vicenza, Italy		Basso, D (corresponding author), Univ Padua, Dept Gen Psychol, Padua, Italy.		Basso, Demis/Q-4782-2017; Cotelli, Maria/K-1355-2016; BISIACCHI, PATRIZIA/B-8976-2008	Basso, Demis/0000-0002-4595-3513; Cotelli, Maria/0000-0003-3208-3798; BISIACCHI, PATRIZIA/0000-0003-2760-8000			BASSO D, 1999, C NAZ SEZ PSIC SPER; Bisiacchi PS, 1998, BRAIN COGNITION, V37, P113; BISIACCHI PS, 1999, RES PERCEPTION, P179; CADWALLADER M, 1975, ECON GEOGR, V51, P339, DOI 10.2307/142918; Cohen G., 1989, MEMORY REAL WORLD; DUNCAN J, 1986, COGNITIVE NEUROPSYCH, V3, P271, DOI 10.1080/02643298608253360; GARLING T, 1994, EUR J COGN PSYCHOL, V6, P399, DOI 10.1080/09541449408406522; GARLING T, 1989, J ENVIRON PSYCHOL, V9, P269, DOI 10.1016/S0272-4944(89)80009-X; HAYES-ROTH B, 1979, Cognitive Science, V3, P275, DOI 10.1207/s15516709cog0304_1; HIRTLE SC, 1992, GEOFORUM, V23, P227, DOI 10.1016/0016-7185(92)90019-Z; MacGregor JN, 1996, PERCEPT PSYCHOPHYS, V58, P527, DOI 10.3758/BF03213088; VILKKI J, 1991, CORTEX, V27, P203, DOI 10.1016/S0010-9452(13)80124-4	12	18	18	0	5	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0278-2626			BRAIN COGNITION	Brain Cogn.	JUN-JUL	2001	46	1-2					38	42		10.1016/S0278-2626(01)80029-4			5	Neurosciences; Psychology, Experimental	Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	436JT	WOS:000168933300027	11527359				2022-02-06	
J	Choi, SC; Bullock, R				Choi, SC; Bullock, R			Design and statistical issues in multicenter trials of severe head injury	NEUROLOGICAL RESEARCH			English	Article						head injury; randomised clinical trials; Glasgow coma scale; therapy	CLINICAL-TRIALS	Multicenter clinical trials are the most powerful agent to evaluate new therapies in medicine, but have failed to impact traumatic brain injury, in which at least 20 such trials have been performed, without a positive result. Such trials need to be carefully planned, with a run-in period to ensure center compliance. Stratification, careful monitoring, adequate sample size, interim analysis and adequate numbers of patients per center are all vital requirements for a useful outcome in such trials.	Virginia Commonwealth Univ, Med Coll Virginia, Richmond, VA 23298 USA		Bullock, R (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Richmond, VA 23298 USA.						BRACKEN MB, 2001, IN PRESS NEUROSURGER; Choi S C, 1998, J Biopharm Stat, V8, P367, DOI 10.1080/10543409808835246; Choi SC, 1998, J NEUROTRAUM, V15, P771, DOI 10.1089/neu.1998.15.771; Doppenberg EMR, 1997, J NEUROTRAUM, V14, P71, DOI 10.1089/neu.1997.14.71; EDERER P, 1975, AM J EPIDEMIOL, V102, P111; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; SYLVESTER RJ, 1981, NEW ENGL J MED, V305, P852, DOI 10.1056/NEJM198110083051503; WHITEHEAD J, 1983, BIOMETRICS, V39, P227, DOI 10.2307/2530822	8	18	19	0	0	FOREFRONT PUBL GROUP	WILTON	C/O MARY J RAWLINS, 5 RIVER RD, STE 113, WILTON, CT 06897 USA	0161-6412			NEUROL RES	Neurol. Res.	MAR-APR	2001	23	2-3					190	192		10.1179/016164101101198325			3	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	422DX	WOS:000168104200011	11320598				2022-02-06	
J	Perron, AD; Brady, WJ; Huff, JS				Perron, AD; Brady, WJ; Huff, JS			Concussive convulsions: Emergency department assessment and management of a frequently misunderstood entity	ACADEMIC EMERGENCY MEDICINE			English	Article						concussion; concussive convulsion; brain injury; head injury; posttraumatic epilepsy	TRAUMATIC BRAIN INJURY; POSTTRAUMATIC SEIZURES; HEAD-INJURY; POPULATION; EPILEPSY; SPORT	Immediate concussive convulsions are an unusual but dramatic sequela to head injuries. Previously believed to be an epileptic phenomenon, they are now thought to be a brief traumatic functional decerebration that results from loss of cortical inhibition. With concussive convulsions generally occurring within seconds of head impact and lasting up to several minutes, patients are initially in a tonic phase, followed by a clonic convulsion. A postictal phase is generally brief if it occurs at all with these episodes. Patients with isolated concussive convulsions have no evidence of structural brain injury as assessed with neuroimaging studies or physical examination. Neuropsychological testing often demonstrates transient cortical dysfunction consistent with the concussive episode. The long-term outcome for patients with isolated concussive convulsion is universally good, with no long-term neurologic sequelae and no increased incidence of early or late posttraumatic epilepsy. Emergency department management should focus on evaluation of the associated concussive injury. The concussive convulsion requires no specific therapy, and antiepileptic medication is not indicated.	Univ Virginia Hlth Syst, Dept Emergency Med, Charlottesville, VA 22908 USA		Perron, AD (corresponding author), Univ Virginia Hlth Syst, Dept Emergency Med, Box 800699, Charlottesville, VA 22908 USA.						ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; BECKER DP, 1990, NEUROLOGICAL SURG, P2017; BINDER LM, 1988, J CLIN EXP NEUROPSYC, V8, P23; Biros MH., 1998, EMERGENCY MED CONCEP, P416; BORCZUK P, 1990, EMERG MED CLIN N AM, P563; Chadwick D, 2000, LANCET, V355, P334, DOI 10.1016/S0140-6736(99)00452-3; Chadwick D, 1997, BRIT MED J, V314, P1283; Dalmady-Israel Christina, 1993, Brain Injury, V7, P263, DOI 10.3109/02699059309029679; DALY CC, 1986, RES VET SCI, V41, P353, DOI 10.1016/S0034-5288(18)30629-5; DALY CC, 1987, BRIT VET J, V143, P574, DOI 10.1016/0007-1935(87)90049-2; EVANS RW, 1992, NEUROL CLIN, V10, P815, DOI 10.1016/S0733-8619(18)30182-8; FRANKOWSKI RF, 1985, CENTRAL NERVOUS SYST; GASTAUT H, 1957, LANCET, V2, P1018; GRANDIN T, 1980, INT J STUD ANIM PROB, V1, P242; GRANDIN T, 1994, J AM VET MED ASSOC, V204, P1354; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; LIN JTY, 1982, ANN NEUROL, V11, P525, DOI 10.1002/ana.410110513; McCrory PR, 2000, NEUROLOGY, V54, P1488, DOI 10.1212/WNL.54.7.1488; McCrory PR, 1997, BRIT MED J, V314, P171, DOI 10.1136/bmj.314.7075.171; McCrory PR, 1998, SPORTS MED, V25, P131, DOI 10.2165/00007256-199825020-00005; PENFIELD W, 1945, RES PUBL ASSOC RES N, V24, P620; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; SASAKI M, 1987, Brain and Nerve (Tokyo), V39, P983; STEIN SC, 1993, ANN EMERG MED, V22, P1193, DOI 10.1016/S0196-0644(05)80989-8; STEPHENSON JBP, 1990, FITS FAINTS, P112; WALKER AE, 1989, SURG NEUROL, V32, P235, DOI 10.1016/0090-3019(89)90185-7; WOLFDIETER R, 1989, METAB BRAIN DIS, V4, P3, DOI 10.1007/BF00999487	29	18	18	0	2	HANLEY & BELFUS INC	PHILADELPHIA	210 S 13TH ST, PHILADELPHIA, PA 19107 USA	1069-6563			ACAD EMERG MED	Acad. Emerg. Med.	MAR	2001	8	3					296	298		10.1111/j.1553-2712.2001.tb01312.x			3	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	408UA	WOS:000167345000017	11229957	Bronze			2022-02-06	
J	Poloyac, SM; Perez, A; Scheff, S; Blouin, RA				Poloyac, SM; Perez, A; Scheff, S; Blouin, RA			Tissue-specific alterations in the 6-hydroxylation of chlorzoxazone following traumatic brain injury in the rat	DRUG METABOLISM AND DISPOSITION			English	Article							ACUTE-PHASE RESPONSE; CYTOCHROME-P450; NEUROTRAUMA; EXPRESSION; PHARMACOKINETICS; METABOLISM; PHENYTOIN; ENZYMES	Interest in the non-neuronal alterations following traumatic brain injury (TBI) has led to research evaluating hepatic metabolism following injury. Several models of injury demonstrate tissue-specific alterations in cytochrome P450 activity. This study examined tissue-specific alterations in cytochrome P450-mediated hydroxylation in the rat model of TBI. Male Sprague-Dawley rats received anesthesia alone, craniotomy, or craniotomy plus TBI. Rats were sacrificed at 24 and 48 h. Liver, kidney, and brain cortex microsomes were isolated. Total liver P450 content, 6-hydroxychlorzoxazone formation rate, and CYP2E1 protein were evaluated. In liver microsomes, spectral P450 was decreased to 86 +/- 5% (p < 0.05) of control at 24 h following injury, and 6-hydroxychlorzoxazone formation rate decreased to 74 +/- 18% of control (p < 0.05) at 48 h following injury. In kidney microsomes, 6-hydroxychlorzoxazone formation rate was increased to 154% of control (p < 0.01) 24 h following injury. 6-Hydroxychlorzoxazone formation rate was unaffected by TBI in brain cortical microsomes. The CYP2E1 inhibitor, 4-methylpyrazole, inhibited the formation of 6-hydroxychlorzoxazone in brain, kidney, and liver microsomes. These data demonstrate that tissue-specific alterations in 6-hydroxychlorzoxazone formation rate occur following TBI.	Univ Kentucky, Coll Pharm, Div Pharmaceut Sci, Lexington, KY USA; Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; Univ Puerto Rico, Sch Pharm, San Juan, PR 00936 USA		Poloyac, SM (corresponding author), Univ Pittsburgh, Dept Pharmaceut Sci, 1014 Salk Hall,3500 Terrace St, Pittsburgh, PA 15261 USA.		Perez, Alex/AAX-5145-2020		NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS39828] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039828] Funding Source: NIH RePORTER		Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; BOUCHER BA, 1991, CLIN PHARMACOL THER, V50, P487, DOI 10.1038/clpt.1991.173; GRIFFETH LK, 1984, DRUG METAB DISPOS, V12, P588; Hanioka N, 1997, ARCH TOXICOL, V72, P9, DOI 10.1007/s002040050462; HEINEMEYER G, 1986, THER DRUG MONIT, V8, P145, DOI 10.1097/00007691-198606000-00003; LOWRY OH, 1951, J BIOL CHEM, V193, P265; McKindley DS, 1997, J CLIN PHARMACOL, V37, P129, DOI 10.1002/j.1552-4604.1997.tb04771.x; OMARA NB, 1995, CRIT CARE MED, V23, P1418, DOI 10.1097/00003246-199508000-00017; OMURA T, 1964, J BIOL CHEM, V239, P2379; Renton KW, 2000, J PHARMACOL EXP THER, V294, P524; Rockich K, 1999, DRUG METAB DISPOS, V27, P1074; Sewer MB, 1996, DRUG METAB DISPOS, V24, P401; Sewer MB, 1997, J PHARMACOL EXP THER, V280, P1445; Tindberg N, 1996, J NEUROCHEM, V67, P2066, DOI 10.1046/j.1471-4159.1996.67052066.x; TOLER SM, 1993, DRUG METAB DISPOS, V21, P1064	15	18	18	0	1	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0090-9556			DRUG METAB DISPOS	Drug Metab. Dispos.	MAR	2001	29	3					296	298					3	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	402KC	WOS:000166985300014	11181498				2022-02-06	
J	Von Wild, K; Terwey, S				Von Wild, K; Terwey, S			Diagnostic confusion in mild traumatic brain injury (MTBI). Lessons from clinical practice and EFNS - Inquiry	BRAIN INJURY			English	Article								A 1997 inquiry of 130 neurosurgeons throughout Germany, dealing with diagnosis and therapy of patients with mild traumatic brain injury showed a mainly inhomogeneous picture. The European Federation of Neurological Societies inquiry form 'Management of Patients with Mild Head Injury' was sent on behalf of the German Society of Neurological Surgeons to every leading neurosurgeon in Germany, of whom only 74 (57%) answered. The diagnosis 'mild brain injury' is used by 63%, `commotio cerebri' by 49%, and 'brain concussion' by 4% of the institutions. GCS is used for classification by 60%, PTA 48%, retrograde amnesia by 50%, and LOC by 63% of institutions. Guidelines are used in 78%. Diagnostic x-ray of the skull is used in 77%, cervical spine in 62%, CT in 66%, MRT in 7%; and routine EEG in 35%. Fourteen per cent of the patients are not admitted; home observation is used in 45% of institutions, full bedrest in 19%, working pause in 48%, pain medication in 27%, control in 51%. Seperate guidelines for children in 54% of those departments.	Univ Munster, Dept Neurosurg, Clemenshosp, Teaching Hosp, D-48153 Munster, Germany; Univ Munster, Div Early Neurotraumatol Rehabil, Clemenshosp, Teaching Hosp, D-48153 Munster, Germany		Von Wild, K (corresponding author), Univ Munster, Dept Neurosurg, Clemenshosp, Teaching Hosp, Duesbergweg 124, D-48153 Munster, Germany.						Borczuk Pierre, 1997, Emergency Medicine Clinics of North America, V15, P563, DOI 10.1016/S0733-8627(05)70318-7; JACOBIC G, 1966, EUROPEAN J PAEDIAT, V55, P673; KIBBY MY, 1996, BRAIN INJURY, V10, P156; Murshid WR, 1998, ACTA NEUROCHIR, V140, P56, DOI 10.1007/s007010050058; ROZENTHAL M, 1993, ANN EMERG MED, V22, P1048; SNOEK JW, 1989, MILD HEAD INJURY, P102; TORNEI G, 1996, J NEUROSURGERY SCI, V40, P11	7	18	18	0	3	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	MAR	2001	15	3					273	277					5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	407ZM	WOS:000167302100007	11260775				2022-02-06	
J	Zwienenberg, M; Muizelaar, JP				Zwienenberg, M; Muizelaar, JP			Cerebral perfusion and blood flow in neurotrauma	NEUROLOGICAL RESEARCH			English	Article						cerebral blood flow; cerebral blood volume; cerebral metabolism; ischemia; autoregulation; CO2-reactivity	SEVERE HEAD-INJURY; EXPERIMENTAL SUBARACHNOID HEMORRHAGE; ENDOTHELIN-RECEPTOR-ANTAGONIST; TRAUMATIC BRAIN INJURY; INTRACRANIAL-PRESSURE; ISCHEMIC BRAIN; PROLONGED HYPERVENTILATION; AGGRESSIVE TREATMENT; COMATOSE PATIENTS; AUTO-REGULATION	Post-traumatic cerebral ischemia is associated with a poor prognosis. Optimization of cerebral perfusion and blood flow thus plays a key role in contemporary head injury management However, understanding of the pathophysiology of severe head injury is required for optimal patient management. This article explains the relationships between cerebral blood flow and metabolism and summarizes the current understanding of how these parameters can be helpful in the treatment of patients with severe head injuries.	Univ Calif Davis, Dept Neurol Surg, Sacramento, CA 95817 USA		Muizelaar, JP (corresponding author), Univ Calif Davis, Dept Neurol Surg, 4860 Y St,Suite 3740, Sacramento, CA 95817 USA.	j.paul.muizelaar@ucdmc.ucdavis.edu					ASTRUP J, 1982, J NEUROSURG, V56, P482, DOI 10.3171/jns.1982.56.4.0482; BOUMA G, 1993, THESIS U AMSTERDAM; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BRUCE DA, 1973, J NEUROSURG, V38, P131, DOI 10.3171/jns.1973.38.2.0131; BURKE AM, 1981, J NEUROSURG, V55, P550, DOI 10.3171/jns.1981.55.4.0550; Caner HH, 1996, J NEUROSURG, V85, P917, DOI 10.3171/jns.1996.85.5.0917; Chesnut R M, 1991, Neurosurg Clin N Am, V2, P267; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; COLLINS JG, 1990, VITAL HLTH STAT, V10, P175; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; EKSTEDT J, 1978, J NEUROL NEUROSUR PS, V41, P345, DOI 10.1136/jnnp.41.4.345; ERB DE, 1988, ACTA NEUROPATHOL, V76, P347, DOI 10.1007/BF00686971; FIESCHI C, 1974, J NEUROL NEUROSUR PS, V37, P1378, DOI 10.1136/jnnp.37.12.1378; Fukuda T, 1998, NEUROSURGERY, V43, P1040, DOI 10.1097/00006123-199811000-00022; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; GRAHAM DI, 1988, J CLIN PATHOL, V41, P34, DOI 10.1136/jcp.41.1.34; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; HIROSE H, 1995, EUR J PHARMACOL, V277, P77, DOI 10.1016/0014-2999(95)00070-2; HIROSE H, 1995, EUR J PHARMACOL, V284, P335, DOI 10.1016/0014-2999(95)00446-R; HOVDA DA, 1992, J NEUROTRAUM, V9, pS47; HUDAK ML, 1989, AM J PHYSIOL, V257, pH912, DOI 10.1152/ajpheart.1989.257.3.H912; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kellie George, 1824, Trans Med Chir Soc Edinb, V1, P84; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; KONTOS HA, 1977, STROKE, V8, P358, DOI 10.1161/01.STR.8.3.358; KORITOS HA, 1978, AM J PHYSIOL, V234, pH371; Lee JH, 1997, J NEUROSURG, V87, P221, DOI 10.3171/jns.1997.87.2.0221; Lindegaard K F, 1988, Acta Neurochir Suppl (Wien), V42, P81; MACPHERS.P, 1973, J NEUROL NEUROSUR PS, V36, P1069, DOI 10.1136/jnnp.36.6.1069; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; MARMAROU A, 1978, J NEUROSURG, V48, P332, DOI 10.3171/jns.1978.48.3.0332; MARSHALL LF, 1978, J NEUROSURG, V48, P560, DOI 10.3171/jns.1978.48.4.0560; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; MARSHALL LF, 1979, J NEUROSURG, V50, P26, DOI 10.3171/jns.1979.50.1.0026; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; MARTIN NA, 1995, J NEUROTRAUM, V12, P897, DOI 10.1089/neu.1995.12.897; McGraw CP, 1989, INTRACRANIAL PRESSUR, P839; Monro A., 1783, OBSERVATIONS STRUCTU; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; MUIZELAAR JP, 1984, J NEUROSURG, V61, P700, DOI 10.3171/jns.1984.61.4.0700; MUIZELAAR JP, 1983, J NEUROSURG, V59, P822, DOI 10.3171/jns.1983.59.5.0822; MUIZELAAR JP, 1989, J NEUROSURG, V71, P72, DOI 10.3171/jns.1989.71.1.0072; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; MUIZELAAR JP, 1988, J NEUROSURG, V69, P923, DOI 10.3171/jns.1988.69.6.0923; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; Pierre LN, 1999, STROKE, V30, P638, DOI 10.1161/01.STR.30.3.638; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; ROUX S, 1995, NEUROSURGERY, V37, P78, DOI 10.1227/00006123-199507000-00012; SEIFERT V, 1995, J NEUROSURG, V82, P55, DOI 10.3171/jns.1995.82.1.0055; SHAPIRO K, 1980, ANN NEUROL, V7, P508, DOI 10.1002/ana.410070603; SIESJO BK, 1984, J NEUROSURG, V60, P883, DOI 10.3171/jns.1984.60.5.0883; Skippen P, 1997, CRIT CARE MED, V25, P1402, DOI 10.1097/00003246-199708000-00031; Sobey CG, 1998, CLIN EXP PHARMACOL P, V25, P867, DOI 10.1111/j.1440-1681.1998.tb02337.x; TEASDALE G, 1974, LANCET, V2, P81; WARD JD, 1985, J NEUROSURG, V62, P383, DOI 10.3171/jns.1985.62.3.0383; Zimmermann M, 1997, J Neurosurg Sci, V41, P139; Zimmermann M, 1996, NEUROSURGERY, V38, P115, DOI 10.1097/00006123-199601000-00028; Zimmermann M, 1996, ZBL NEUROCHIR, V57, P143; Zimmermann M, 1998, NEUROSURGERY, V43, P863, DOI 10.1097/00006123-199810000-00083; ZUCCARELLO M, 1995, AM J PHYSIOL-HEART C, V269, pH1009	64	18	19	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	MAR-APR	2001	23	2-3					167	174		10.1179/016164101101198505			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	422DX	WOS:000168104200008	11320595				2022-02-06	
J	Brors, M; Schafers, M; Schick, B; Dazert, S; Draf, W; Kahle, G				Brors, M; Schafers, M; Schick, B; Dazert, S; Draf, W; Kahle, G			Sigmoid and transverse sinus thrombosis after closed head injury presenting with unilateral hearing loss	NEURORADIOLOGY			English	Article; Proceedings Paper	4th European-Skull-Base-Society Congress	MAY 19-22, 1999	NURNBERG, GERMANY	European Skull Base Soc		Sigmoid sinus thrombosis; head injury; magnetic resonance imaging; magnetic resonance angiography		Sinus thrombosis has rarely been associated with closed head injury; more often, thrombosis of the sigmoid or transverse sinus is caused by otogenic inflammations or tumours, or occurs during pregnancy. Symptoms are frequently vague, while untreated thrombus progression may be fatal due to venous congestion and infarction. We report a 32-year-old man presenting with right hearing loss, tinnitus and headache 2 days after a closed head injury. Neurological examination showed no additional abnormality. The EEG showed focal bifrontal slowing. CT revealed a fracture of the occipital bone. MRI and MRA demonstrated complete thrombosis of the right sigmoid and transverse sinuses. After 2 weeks of intravenous heparin therapy followed by warfarin, the patient's hearing improved and MRI and MRA showed complete recanalisation of the sigmoid and transverse sinuses. Venous sinus thrombosis can be an undetected sequel to head injury. Appropriate imaging studies should be carried out to enable therapy to be started as soon as possible.	Univ Hosp Wurzburg, Dept Otorhinolaryngol Head & Neck Surg, D-97080 Wurzburg, Germany; Klinikum Fulda, Dept Ear Nose & Throat Dis Head Neck & Facial Pla, Fulda, Germany; Univ Hosp Wurzburg, Dept Neurol, Wurzburg, Germany; Univ Hosp Wurzburg, Dept Otorhinolaryngol Head & Neck Surg, Wurzburg, Germany; Hosp Fulda, Dept Radiol, Fulda, Germany		Brors, M (corresponding author), Univ Hosp Wurzburg, Dept Otorhinolaryngol Head & Neck Surg, Josef-Schneider Str 12, D-97080 Wurzburg, Germany.	dominik.brors@mail.uni-wuerzburg.de					BJORNEBRINK J, 1976, ANGIOLOGY, V27, P688, DOI 10.1177/000331977602701203; DAVELLA D, 1984, J NEUROSURG, V61, P1129, DOI 10.3171/jns.1984.61.6.1129; HULCELLE PJ, 1989, NEURORADIOLOGY, V31, P217, DOI 10.1007/BF00344346; KAPP J, 1985, NEUROSURGERY, P1300; KINAL M, 1967, J NEUROSURG, V27, P215; Kuether TA, 1998, NEUROSURGERY, V42, P1163, DOI 10.1097/00006123-199805000-00129; LENZ RP, 1984, LARYNGOSCOPE, V94, P1451; Luerssen T G, 1991, Neurosurg Clin N Am, V2, P399; MAS JL, 1990, STROKE, V21, P1350, DOI 10.1161/01.STR.21.9.1350; NISSEN A J, 1980, American Journal of Otology, V2, P164; Ochagavia AR, 1996, LANCET, V347, P1564, DOI 10.1016/S0140-6736(96)90721-7; SCOTT JA, 1988, J NEUROSURG, V68, P284, DOI 10.3171/jns.1988.68.2.0284; TAHA JM, 1993, NEUROSURGERY, V32, P541, DOI 10.1227/00006123-199304000-00008; TSURUDA JS, 1991, AM J NEURORADIOL, V12, P481; VIRAPONGSE C, 1987, RADIOLOGY, V162, P779, DOI 10.1148/radiology.162.3.3809494	15	18	20	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0028-3940			NEURORADIOLOGY	Neuroradiology	FEB	2001	43	2					144	146		10.1007/PL00006045			3	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	401CY	WOS:000166910600006	11326560				2022-02-06	
J	Bowen, A; Tennant, A; Neumann, V; Chamberlain, MA				Bowen, A; Tennant, A; Neumann, V; Chamberlain, MA			Neuropsychological rehabilitation for traumatic brain injury: do carers benefit?	BRAIN INJURY			English	Article							HEAD-INJURY	This study evaluated the effectiveness of a new rehabilitation service, compared with existing services, for carers of people with traumatic brain injury (TBI). Subjects were 96 adult carers of people consecutively admitted to two local hospitals. They were assigned to one of three groups: Early new service (pre-discharge); Late new service (post-discharge); or a Control condition (existing services only). Individual randomization was not possible and randomization by hospital site was rejected because of demographic and clinical differences between sites. Group assignment was determined by a pre-specified timetable which alternated between hospitals. Two outcomes were compared at 6 months post-injury: carers' emotional distress and how well-informed they felt about TBI and available resources. Analyses adjusting for potential confounding factors confirmed a clinically plausible superior outcome for both intervention groups compared to the control group. However, these differences did not obtain statistical significance (p greater than or equal to 0.01). Several reasons for these findings are discussed, including the novelty of the new service and methodological issues such as statistical power. Longer term follow-up studies are required as psychological sequelae and, therefore, the need for intervention is known to increase with time and may not be most apparent during the first 6 months.	Univ Leeds, Rheumatol & Rehabil Res Unit, Leeds, W Yorkshire, England		Bowen, A (corresponding author), Hope Hosp, Stroke Assoc, Therapy Res Unit, 1st Floor Clin Sci Bldg,Eccles Old Rd, Salford M6 8HD, Lancs, England.		Bowen, Audrey/K-5544-2012	Bowen, Audrey/0000-0003-4075-1215			Bowen A, 1999, NEUROREHABILITATION, V13, P147; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; COPE DN, 1995, BRAIN INJURY, V9, P649, DOI 10.3109/02699059509008224; Coughlan AK, 1988, CLIN REHABIL, V2, P207, DOI DOI 10.1177/026921558800200305; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; MCMORDIE W R, 1991, Brain Injury, V5, P43, DOI 10.3109/02699059108998510; *MED DIS SOC WORK, 1988, MAN TRAUM BRAIN INJ	9	18	20	0	5	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JAN	2001	15	1					29	38		10.1080/02699050150209101			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	384UF	WOS:000165963600003	11201312				2022-02-06	
J	Ratzliff, ADH; Soltesz, I				Ratzliff, ADH; Soltesz, I			Differential immunoreactivity for alpha-actinin-2, an N-methyl-D-aspartate-receptor/actin binding protein, in hippocampal interneurons	NEUROSCIENCE			English	Article						dentate gyrus; cytoskeleton; development; hippocampus; NPY; trauma	RAT DENTATE GYRUS; TRAUMATIC BRAIN INJURY; LONG-TERM POTENTIATION; POSTNATAL MURINE HIPPOCAMPUS; MESSENGER-RNA EXPRESSION; NEUROPEPTIDE-Y; ALPHA-ACTININ; NMDA RECEPTOR; GRANULE CELLS; AMPA RECEPTORS	Recent studies have demonstrated that hippocampal interneurons possess distinct cytoskeletal and cell-signaling proteins in comparison to hippocampal principal cells; however, little is known about the differences in the actin cytoskeleton between these two populations. This study examined the immunoreactivity of alpha -actinin-2, an actin binding/N-methyl-D-aspartate-receptor linking protein, in the rat hippocampal formation using double-labelling immunofluorescence. Alpha-actinin-2 immunoreactivity is seen throughout the hippocampus with heavy labeling observed in the dendrites of granule cells, in CA2 pyramidal cells and in presumed interneuronal somata throughout the dentate gyrus and CA1. All the cells with heavy somatic a-actinin-2 immunoreactivity in the dentate gyrus and CA1 were GABAergic interneurons labeled by glutamate decarboxylase (99%). Examination of the neurochemical marker content of the alpha -actinin-2 immunoreactive interneurons revealed that the majority of this population was neuropeptide-Y-positive and a minority was positive for calretinin. Fluid percussion head trauma did not result in significant alterations of alpha -actinin-2 immunoreactivity in hippocampal interneurons. The developmental profile of alpha -actinin-2 immunoreactivity showed the presence of alpha -actinin-2 in the hippocampus at P1, labeling of interneurons by P7 and the adult staining pattern seen by P21. This study demonstrates that principal cells and interneurons are differentially immunoreactive for alpha -actinin-2, and that alpha -actinin-2 staining is restricted to a subpopulation of interneurons. Each of the three classes of cytoskeletal elements have been shown to be differentially expressed in hippocampal interneurons and principal cells, suggesting that the cytoskeleton is a defining feature of neuronal populations. Additionally, the limited expression of alpha -actinin-2 could have important functional implications in N-methyl-D-aspartate receptor localization and modulation. (C) 2001 IBRO. Published by Elsevier Science Ltd. All rights reserved.	Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA		Ratzliff, ADH (corresponding author), Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA.	adehaasj@uci.edu		Ratzliff, Anna/0000-0002-6654-8007	NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32 GM08620] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS35915] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R37NS035915, R29NS035915, R01NS035915] Funding Source: NIH RePORTER		Acsady L, 1997, J COMP NEUROL, V378, P320; ALLEN YS, 1983, SCIENCE, V221, P877, DOI 10.1126/science.6136091; Allison DW, 1998, J NEUROSCI, V18, P2423; BAIMBRIDGE KG, 1982, BRAIN RES, V245, P223, DOI 10.1016/0006-8993(82)90804-6; BAYER SA, 1980, J COMP NEUROL, V190, P87, DOI 10.1002/cne.901900107; BENARI Y, 1988, NEUROSCI LETT, V94, P88, DOI 10.1016/0304-3940(88)90275-3; BenAri Y, 1997, TRENDS NEUROSCI, V20, P523, DOI 10.1016/S0166-2236(97)01147-8; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; BLANCHARD A, 1989, J MUSCLE RES CELL M, V10, P280, DOI 10.1007/BF01758424; BUCHAN AMJ, 1988, PEPTIDES, V9, P333, DOI 10.1016/0196-9781(88)90269-0; BUHL EH, 1994, J NEUROPHYSIOL, V71, P1289, DOI 10.1152/jn.1994.71.4.1289; Charton JP, 1999, BRAIN RES, V816, P609, DOI 10.1016/S0006-8993(98)01243-8; CHERUBINI E, 1991, TRENDS NEUROSCI, V14, P515, DOI 10.1016/0166-2236(91)90003-D; DELLER T, 1990, J COMP NEUROL, V300, P433, DOI 10.1002/cne.903000312; DEQUIDT ME, 1986, NEUROSCIENCE, V18, P545, DOI 10.1016/0306-4522(86)90057-6; Djinovic-Carugo K, 1999, CELL, V98, P537, DOI 10.1016/S0092-8674(00)81981-9; Dupuy ST, 1996, J NEUROSCI, V16, P6919; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; GULYAS AI, 1992, NEUROSCIENCE, V48, P1, DOI 10.1016/0306-4522(92)90334-X; Gulyas AI, 1996, J NEUROSCI, V16, P3397; GULYAS AI, 1990, NEUROSCIENCE, V37, P31, DOI 10.1016/0306-4522(90)90189-B; HALASY K, 1993, EUR J NEUROSCI, V5, P411, DOI 10.1111/j.1460-9568.1993.tb00508.x; HAN ZS, 1993, EUR J NEUROSCI, V5, P395, DOI 10.1111/j.1460-9568.1993.tb00507.x; Hollrigel GS, 1998, J NEUROPHYSIOL, V80, P2340, DOI 10.1152/jn.1998.80.5.2340; KAUFMAN DL, 1991, J NEUROCHEM, V56, P720, DOI 10.1111/j.1471-4159.1991.tb08211.x; Kim CH, 1999, J NEUROSCI, V19, P4314; Klapstein GJ, 1997, J NEUROPHYSIOL, V78, P1651, DOI 10.1152/jn.1997.78.3.1651; KOHLER C, 1987, NEUROSCI LETT, V78, P1, DOI 10.1016/0304-3940(87)90551-9; KOHLER C, 1986, J COMP NEUROL, V244, P384, DOI 10.1002/cne.902440310; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; Krupp JJ, 1999, J NEUROSCI, V19, P1165; Leranth C, 1996, NEUROSCIENCE, V70, P631, DOI 10.1016/S0306-4522(96)83003-X; LERANTH C, 1992, EPILEPSY RES, P49; Liu XB, 1997, NEUROREPORT, V8, P1475, DOI 10.1097/00001756-199704140-00030; Liu XB, 1996, P NATL ACAD SCI USA, V93, P7332, DOI 10.1073/pnas.93.14.7332; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; LUBBERS K, 1985, NEUROSCI LETT, V62, P317, DOI 10.1016/0304-3940(85)90568-3; LUBBERS K, 1988, ANAT EMBRYOL, V178, P119, DOI 10.1007/BF02463645; MACCAFERRI G, 1995, NEURON, V15, P137, DOI 10.1016/0896-6273(95)90071-3; Martinez A, 1999, J COMP NEUROL, V404, P438, DOI 10.1002/(SICI)1096-9861(19990222)404:4<438::AID-CNE2>3.0.CO;2-K; Matus A, 1999, CURR OPIN NEUROBIOL, V9, P561, DOI 10.1016/S0959-4388(99)00018-5; MCBAIN CJ, 1993, J PHYSIOL-LONDON, V462, P373, DOI 10.1113/jphysiol.1993.sp019560; McBain CJ, 1997, CAN J PHYSIOL PHARM, V75, P488, DOI 10.1139/cjpp-75-5-488; McBain CJ, 1999, TRENDS NEUROSCI, V22, P228, DOI 10.1016/S0166-2236(98)01347-2; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MODY I, 1994, TRENDS NEUROSCI, V17, P517, DOI 10.1016/0166-2236(94)90155-4; MORRISETT RA, 1990, DEV BRAIN RES, V56, P257, DOI 10.1016/0165-3806(90)90090-L; MORROW JS, 1989, J CELL BIOL, V108, P455, DOI 10.1083/jcb.108.2.455; NITSCH R, 1992, P NATL ACAD SCI USA, V89, P5197, DOI 10.1073/pnas.89.11.5197; PAVALKO FM, 1991, BIOCHEM SOC T, V19, P1065, DOI 10.1042/bst0191065; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; PETRALIA RS, 1994, J NEUROSCI, V14, P667; Pinkstaff JK, 1998, MOL BRAIN RES, V55, P265, DOI 10.1016/S0169-328X(98)00007-2; Qian J, 1997, J NEUROSCI, V17, P8169; Rao A, 1998, J NEUROSCI, V18, P1217; Ratzliff AD, 2000, HIPPOCAMPUS, V10, P162; Redrobe JP, 1999, BRAIN RES, V848, P153, DOI 10.1016/S0006-8993(99)02119-8; ROSENMUND C, 1993, NEURON, V10, P805, DOI 10.1016/0896-6273(93)90197-Y; Ross ST, 2000, J NEUROPHYSIOL, V83, P2916, DOI 10.1152/jn.2000.83.5.2916; Santhakumar V, 2000, J PHYSIOL-LONDON, V524, P117, DOI 10.1111/j.1469-7793.2000.00117.x; SCHLESSINGER AR, 1975, J COMP NEUROL, V159, P149, DOI 10.1002/cne.901590202; Schwarzer C, 1996, BRAIN RES REV, V22, P27; SERESS L, 1993, NEUROSCIENCE, V55, P775, DOI 10.1016/0306-4522(93)90441-H; Sik A, 1998, P NATL ACAD SCI USA, V95, P3245, DOI 10.1073/pnas.95.6.3245; Sloviter R S, 1991, Hippocampus, V1, P41, DOI 10.1002/hipo.450010106; SORIANO E, 1989, J COMP NEUROL, V281, P603, DOI 10.1002/cne.902810409; SORIANO E, 1994, J COMP NEUROL, V342, P571, DOI 10.1002/cne.903420406; SPERK G, 1992, NEUROSCIENCE, V50, P831, DOI 10.1016/0306-4522(92)90207-I; SRINIVASAN Y, 1988, NATURE, V333, P177, DOI 10.1038/333177a0; SUPER H, 1994, J COMP NEUROL, V344, P101, DOI 10.1002/cne.903440108; Tamamaki N, 1999, J COMP NEUROL, V411, P257; Toth Z, 1997, J NEUROSCI, V17, P8106; van Rossum D, 1999, TRENDS NEUROSCI, V22, P290, DOI 10.1016/S0166-2236(99)01404-6; Vezzani A, 1999, TRENDS NEUROSCI, V22, P25, DOI 10.1016/S0166-2236(98)01284-3; Wechsler A, 1998, EMBO J, V17, P3931, DOI 10.1093/emboj/17.14.3931; Whittaker E, 1999, BRAIN RES, V827, P229, DOI 10.1016/S0006-8993(99)01302-5; WINSKY L, 1989, P NATL ACAD SCI USA, V86, P10139, DOI 10.1073/pnas.86.24.10139; Wintergerst ES, 1996, NEUROSCI LETT, V209, P173, DOI 10.1016/0304-3940(96)12643-4; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0; Wyszynski M, 1998, J NEUROSCI, V18, P1383; ZAFIROV S, 1994, J COMP NEUROL, V345, P472, DOI 10.1002/cne.903450312; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921; Zhang S, 1998, NEURON, V21, P443, DOI 10.1016/S0896-6273(00)80553-X; Zhang WD, 1999, J NEUROSCI, V19, P96, DOI 10.1523/JNEUROSCI.19-01-00096.1999	85	18	18	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience		2001	103	2					337	349		10.1016/S0306-4522(01)00013-6			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	414ZD	WOS:000167695300005	11246149				2022-02-06	
J	Stover, JF; Beyer, TF; Unterberg, AW				Stover, JF; Beyer, TF; Unterberg, AW			Riluzole reduces brain swelling and contusion volume in rats following controlled cortical impact injury	JOURNAL OF NEUROTRAUMA			English	Article						brain edema; cell swelling; cerebrospinal fluid; glutamate; hypoxanthine; taurine; traumatic brain injury	NEUROPROTECTIVE AGENT RILUZOLE; FOCAL CEREBRAL-ISCHEMIA; EXTRACELLULAR GLUTAMATE; TAURINE; RELEASE; EDEMA; NMDA; ACCUMULATION; HIPPOCAMPUS; ANTAGONISM	Modulation of the glutamatergic and excitotoxic pathway may attenuate secondary damage following traumatic brain injury by reducing presynaptic glutamate release and blocking sodium channels in their inactivated state. The aim of the present study was to investigate the neuroprotective potential of riluzole in traumatic brain-injured rats. A left temporoparietal contusion was induced in 70 male Sprague-Dawley rats (controlled cortical impact injury). Riluzole (8 mg/kg body weight) was given 30 min, and 6, 24, and 30 h after trauma, while control rats received physiological saline. Experiments were performed at two different degrees of trauma severity as defined by penetration depth of the impactor rod (1 vs. 1.5 mm) with the aim of investigating impact of severity of tissue damage on the neuroprotective potential of riluzole. At 48 h after trauma, brains were removed to determine hemispheric swelling and water content and to assess cortical contusion volume. Before brain removal cisternal cerebrospinal fluid (CSF) was collected in all rats to determine the effects of riluzole on substances associated with edema formation. For this, the excitatory transmitter glutamate, the volume-regulatory amino acid taurine, and the ATP-degradation product hypoxanthine were analyzed by high-performance liquid chromatography. Overall, the degree of tissue damage seems to influence the neuroprotective potential of riluzole. In rats with a less severe trauma (l-mm penetration depth), hemispheric swelling, cerebral water content of the traumatized hemisphere and cortical contusion volume were significantly reduced under riluzole compared to controls (p < 0.05). In rats with a more severe trauma (1.5-mm penetration depth), the neuroprotective effect of riluzole failed to reach statistical significance. Following trauma, CSF glutamate, taurine, and hypoxanthine levels were significantly increased compared to nontraumatized rats (p < 0.001). However, these neurochemical parameters as measured in cisternal CSF failed to reflect trauma-dependent increases in severity of tissue damage and did not reveal riluzole-mediated neuroprotection. Under the present study design, riluzole significantly reduced brain edema formation and contusion volume in rats subjected to a mild focal cortical contusion.	Virchow Med Ctr, Charite, Dept Neurosurg, D-13353 Berlin, Germany		Stover, JF (corresponding author), Virchow Med Ctr, Charite, Dept Neurosurg, Augustenburger Pl 01, D-13353 Berlin, Germany.	john.stover@charite.de					Bareyre F, 1997, J NEUROTRAUM, V14, P839, DOI 10.1089/neu.1997.14.839; Baskaya MK, 2000, J NEUROTRAUM, V17, P93, DOI 10.1089/neu.2000.17.93; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; Bell MJ, 1998, J NEUROTRAUM, V15, P163, DOI 10.1089/neu.1998.15.163; BENOIT E, 1991, PFLUG ARCH EUR J PHY, V419, P603, DOI 10.1007/BF00370302; Bezard E, 1998, EUR J PHARMACOL, V356, P101, DOI 10.1016/S0014-2999(98)00537-8; BOIREAU A, 1994, NEUROREPORT, V5, P2157, DOI 10.1097/00001756-199410270-00042; Bryson HM, 1996, DRUGS, V52, P549, DOI 10.2165/00003495-199652040-00010; BULLOCK R, 1991, J NEUROSURG, V74, P794, DOI 10.3171/jns.1991.74.5.0794; Centonze D, 1998, NEUROPHARMACOLOGY, V37, P1063, DOI 10.1016/S0028-3908(98)00081-1; CHERAMY A, 1992, NEUROSCI LETT, V147, P209, DOI 10.1016/0304-3940(92)90597-Z; DEBONO MW, 1993, EUR J PHARMACOL, V235, P283, DOI 10.1016/0014-2999(93)90147-A; Doble A., 1997, REV CONTEMP PHARMACO, V8, P213; Guyot MC, 1997, NEUROSCIENCE, V81, P141, DOI 10.1016/S0306-4522(97)00192-9; HAGBERG H, 1986, NEUROSCI LETT, V68, P311, DOI 10.1016/0304-3940(86)90508-2; HEBERT T, 1994, MOL PHARMACOL, V45, P1055; HUBERT JP, 1994, BRIT J PHARMACOL, V113, P261, DOI 10.1111/j.1476-5381.1994.tb16203.x; Kanthasamy AG, 1999, J PHARMACOL EXP THER, V288, P1340; KAWAMATA T, 1995, BRAIN RES, V674, P196, DOI 10.1016/0006-8993(94)01444-M; Kroppenstedt SN, 1998, J NEUROTRAUM, V15, P191, DOI 10.1089/neu.1998.15.191; Kwon JY, 1998, ANESTH ANALG, V86, P128, DOI 10.1097/00000539-199801000-00026; MAGNUSSON KR, 1991, BRAIN RES, V549, P1, DOI 10.1016/0006-8993(91)90592-J; MALGOURIS C, 1989, J NEUROSCI, V9, P3720; MARTIN D, 1993, EUR J PHARMACOL, V250, P473, DOI 10.1016/0014-2999(93)90037-I; McIntosh TK, 1996, J NEUROTRAUM, V13, P767, DOI 10.1089/neu.1996.13.767; McIntosh TK, 1996, LAB INVEST, V74, P315; MENENDEZ N, 1989, NEUROSCI LETT, V102, P64, DOI 10.1016/0304-3940(89)90308-X; Mottet I, 1997, MAGN RESON MATER PHY, V5, P185, DOI 10.1007/BF02594581; Obrenovitch TP, 1997, PROG NEUROBIOL, V51, P39, DOI 10.1016/S0301-0082(96)00049-4; ONeill MJ, 1997, EUR J PHARMACOL, V332, P121, DOI 10.1016/S0014-2999(97)01074-1; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; PASANTESMORALES H, 1990, GLIA, V3, P427, DOI 10.1002/glia.440030514; Pratt J, 1999, NEUROSCI LETT, V272, P143, DOI 10.1016/S0304-3940(99)00005-1; Rao VLR, 1998, J NEUROCHEM, V70, P2020; SAMUEL D, 1992, FUND CLIN PHARMACOL, V6, P177, DOI 10.1111/j.1472-8206.1992.tb00109.x; SARANSAARI P, 1991, NEUROSCIENCE, V45, P451, DOI 10.1016/0306-4522(91)90240-O; Stover JF, 2000, J NEUROSURG, V92, P853, DOI 10.3171/jns.2000.92.5.0853; Stover JF, 1999, CRIT CARE MED, V27, P1351, DOI 10.1097/00003246-199907000-00028; Stover JF, 1999, J NEUROTRAUM, V16, P135, DOI 10.1089/neu.1999.16.135; Stutzmann JM, 1996, NEUROREPORT, V7, P387, DOI 10.1097/00001756-199601310-00003; TABER KH, 1986, BRAIN RES, V386, P113, DOI 10.1016/0006-8993(86)90147-2; Unterberg AW, 1997, ACT NEUR S, V70, P106; Urenjak J, 1996, PHARMACOL REV, V48, P21; Wahl F, 1997, BRAIN RES, V756, P247, DOI 10.1016/S0006-8993(97)00144-3; WAHL F, 1993, EUR J PHARMACOL, V230, P209, DOI 10.1016/0014-2999(93)90804-Q; Zhang C, 1998, J NEUROSCI RES, V52, P342, DOI 10.1002/(SICI)1097-4547(19980501)52:3<342::AID-JNR10>3.0.CO;2-8; Zona C, 1998, NEUROSCIENCE, V85, P931, DOI 10.1016/S0306-4522(97)00604-0	47	18	21	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC	2000	17	12					1171	1178		10.1089/neu.2000.17.1171			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	379MB	WOS:000165644900005	11186230				2022-02-06	
J	Stowe, CD; Lee, KR; Storgion, SA; Phelps, SJ				Stowe, CD; Lee, KR; Storgion, SA; Phelps, SJ			Altered phenytoin pharmacokinetics in children with severe, acute traumatic brain injury	JOURNAL OF CLINICAL PHARMACOLOGY			English	Article							ACUTE-PHASE RESPONSE; MICHAELIS-MENTEN PHARMACOKINETICS; OXIDATIVE DRUG-METABOLISM; DIETARY-PROTEIN; CYTOCHROME-P-450 ENZYMES; THEOPHYLLINE METABOLISM; PEDIATRIC-PATIENTS; HUMAN HEPATOCYTES; PRIMARY CULTURE; CARBOHYDRATE	The purpose of this study was to determine if phenytoin protein binding and metabolism rt ere altered in prepubescent pediatric patients within the first 10 days following severe, acute traumatic brain injury. Patients (n = 10) received phenytoin loading doses (15-20 mg/kg) follow ed by a maintenance regimen (7 mg/kg/day) initiated within 12 hours of the loading dose. Phenytoin serum concentrations were measured serially on days 1, 2, 3, 5, 7 9, and 10 at 1, 6, and 12 hours. Time-invariant and time-variant Michaelis-Menten pharmacokinetic models were fit to the unbound phenytoin concentration-time data (ADAPT II(TM)). Albumin concentrations significantly decreased over time (p < 0.001) and were predictive of the phenytoin binding ratio (r(2) = 0.373, p < 0.0001). The time-variant model provided a superior fit of th e data in 7 patients with no difference between models in 3 pa tien ts. Rapid inhibition of metabolism (Vmax(baseline) = 2.82 +/- 2.35 mg/kg/day) was observed initially following injury. This was followed by induction of metabolism as reflected by a Vmax(induced) of 20.79 +/- 13.71 mg/kg/day, which was approximately twofold higher than reported values for nonstressed children. Children with severe, acute neurotrauma were found to have markedly altered protein binding and phenytoin metabolism. (C)2000 the American College of Clinical Pharmacology.	Univ Arkansas Med Sci, Little Rock, AR 72205 USA; Arkansas Childrens Hosp, Little Rock, AR 72202 USA; Univ Tennessee, Memphis, TN USA		Stowe, CD (corresponding author), PharmD,800 Marshall St,Mailslot 304, Little Rock, AR 72202 USA.						ABDELRAZZAK Z, 1993, MOL PHARMACOL, V44, P707; ANDERSON KE, 1979, CLIN PHARMACOL THER, V26, P493, DOI 10.1002/cpt1979264493; ANDERSON KE, 1984, J CLIN ENDOCR METAB, V59, P103, DOI 10.1210/jcem-59-1-103; BAHALOMARA N, 1995, CRIT CARE MED, V23, P1418; BAUER LA, 1983, CLIN PHARMACOKINET, V8, P545, DOI 10.2165/00003088-198308060-00006; BEAL SL, 1983, J PHARMACOKINET BIOP, V11, P641, DOI 10.1007/BF01059062; BOUCHER BA, 1988, CLIN PHARMACOL THER, V44, P675, DOI 10.1038/clpt.1988.211; BOUCHER BA, 1991, CLIN PHARMACOL THER, V50, P487, DOI 10.1038/clpt.1991.173; BOUCHER BA, 1987, CLIN PHARMACY, V6, P881; CHIBA K, 1980, J PEDIATR-US, V96, P479; DARGENIO DZ, 1979, COMPUT PROG BIOMED, V9, P115, DOI 10.1016/0010-468X(79)90025-4; FAGAN TC, 1987, CLIN PHARMACOL THER, V41, P402, DOI 10.1038/clpt.1987.48; FELDMAN CH, 1980, PEDIATRICS, V66, P956; GRIEBEL ML, 1990, CRIT CARE MED, V18, P385, DOI 10.1097/00003246-199004000-00007; GRIFFETH LK, 1983, DRUG METAB DISPOS, V11, P517; GRIFFETH LK, 1984, DRUG METAB DISPOS, V12, P582; HEINRICH PC, 1990, BIOCHEM J, V265, P621, DOI 10.1042/bj2650621; KAPPAS A, 1976, CLIN PHARMACOL THER, V20, P643; KRISHNASWAMY K, 1984, BRIT J CLIN PHARMACO, V17, P139, DOI 10.1111/j.1365-2125.1984.tb02328.x; LACKNER TE, 1991, PHARMACOTHERAPY, V11, P344; LANDAW EM, 1984, AM J PHYSIOL, V246, pR665, DOI 10.1152/ajpregu.1984.246.5.R665; Markowsky SJ, 1996, ANN PHARMACOTHER, V30, P443, DOI 10.1177/106002809603000501; MCCLAIN CJ, 1988, J NEUROSURG, V69, P386, DOI 10.3171/jns.1988.69.3.0386; McKindley DS, 1997, J CLIN PHARMACOL, V37, P129, DOI 10.1002/j.1552-4604.1997.tb04771.x; MUNTANERELAT J, 1995, HEPATOLOGY, V22, P1143; PANTUCK EJ, 1984, ANESTHESIOLOGY, V60, P534, DOI 10.1097/00000542-198406000-00002; Taketomo CK., 1999, PEDIAT DOSAGE HDB, V6; THOMPSON PJ, 1983, BRIT J CLIN PHARMACO, V16, P267, DOI 10.1111/j.1365-2125.1983.tb02160.x; TOLER SM, 1993, DRUG METAB DISPOS, V21, P1064; YOSHIDA N, 1993, CRIT CARE MED, V21, P1514, DOI 10.1097/00003246-199310000-00020; YOUNG AB, 1988, J NEUROSURG, V69, P375, DOI 10.3171/jns.1988.69.3.0375	31	18	18	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0091-2700			J CLIN PHARMACOL	J. Clin. Pharmacol.	DEC	2000	40	12	2				1452	1461					10	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	374MZ	WOS:000165350100006	11185666				2022-02-06	
J	Banik, NL; Matzelle, D; Terry, E; Gantt-Wilford, G; Hogan, EL				Banik, NL; Matzelle, D; Terry, E; Gantt-Wilford, G; Hogan, EL			Inhibition of proteolysis by a cyclooxygenase inhibitor, indomethacin	NEUROCHEMICAL RESEARCH			English	Article						calpain; cyclooxygenase; free radicals; inhibitor; anti-inflammatory	SPINAL-CORD INJURY; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; CYTOSKELETAL PROTEIN-DEGRADATION; TRAUMATIC BRAIN INJURY; ALZHEIMERS-DISEASE; CALPAIN-I; NEUROFILAMENT PROTEINS; CATHEPSIN-D; RAT-BRAIN; ACTIVATION	The effect of indomethacin, a non-steroidal anti-inflammatory drug upon purified calpain has been studied. Also, its effects upon Ca2+-mediated degradation of cytoskeletal proteins (neurofilament) in spinal cord homogenate has been investigated. A dose-dependent inhibition of purified calpain activity was observed. A 50% inhibition of C-14-caseinolytic activity was obtained with less than 1.1 mM of indomethacin while the activity was completely inhibited at 3.3 mM concentration. The inhibitory effect of ketorlac, another non-steroidal anti-inflammatory drug, upon calpain was weaker than that of indomethacin. The degradation of myelin basic protein (MBP) by cathepsin B, a lysosomal cysteine protease, was significantly inhibited by indomethacin. It also inhibited the Ca2+-mediated degradation of neurofilament protein (NFP) in spinal cord homogenate. The extent of NFP degradation was analyzed by SDS-PAGE and the inhibition shown by indomethacin was weaker than that observed with leupeptin and the calpain inhibitor E64-d. The inhibitory effect of indomethacin on the activity of multicatalytic proteinase complex was negligible. These results suggest that indomethacin, a non-steroidal anti-inflammatory drug and cyclooxygenase inhibitor also inhibits proteinases, including cathepsin B and calpain.	Med Univ S Carolina, Dept Neurol, Charleston, SC 29425 USA		Banik, NL (corresponding author), Med Univ S Carolina, Dept Neurol, Charleston, SC 29425 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038146, R01NS031622] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-38146, NS-31622] Funding Source: Medline		BANAYSCHWARTZ M, 1987, NEUROCHEM RES, V12, P361, DOI 10.1007/BF00993246; Banik Naren L., 1992, P571; Banik NL, 1997, BRAIN RES, V748, P205, DOI 10.1016/S0006-8993(96)01302-9; Banik NL, 1998, ANN NY ACAD SCI, V844, P131, DOI 10.1111/j.1749-6632.1998.tb08228.x; Banik NL, 1997, BRAIN RES, V752, P301, DOI 10.1016/S0006-8993(96)01488-6; BANIK NL, 1999, NEUR M MIAM BEACH FL; Bartus RT, 1997, NEUROSCIENTIST, V3, P314, DOI 10.1177/107385849700300513; Beasley TC, 1998, DEV BRAIN RES, V105, P125, DOI 10.1016/S0165-3806(97)00179-X; BRACKEN MB, 1990, NEW ENGL J MED, V67, P1575; BRAUGHLER JM, 1984, J NEUROSURG, V61, P290, DOI 10.3171/jns.1984.61.2.0290; CHAN PH, 1985, PROG BRAIN RES, V63, P227; CHOU CHJ, 1978, J NEUROCHEM, V30, P745, DOI 10.1111/j.1471-4159.1978.tb10780.x; COMPSTON A, 1988, ARCH NEUROL-CHICAGO, V45, P669, DOI 10.1001/archneur.1988.00520300089025; HALL ED, 1994, ANN NY ACAD SCI, V738, P15; HALL ED, 1992, J NEUROSURG, V76, P13, DOI 10.3171/jns.1992.76.1.0013; HAMAKUBO T, 1986, J NEUROSCI, V6, P3103, DOI 10.1523/jneurosci.06-11-03103.1986; HSU CY, 1989, ANN NY ACAD SCI, V559, P282; James T, 1998, J NEUROSCI RES, V51, P218, DOI 10.1002/(SICI)1097-4547(19980115)51:2<218::AID-JNR10>3.0.CO;2-4; Kampfl A, 1996, J NEUROCHEM, V67, P1575; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LUCAS J, 1992, NEUROCHEM RES, V17, P1261, DOI 10.1007/BF00968410; MEHDI S, 1991, TRENDS BIOCHEM SCI, V16, P150, DOI 10.1016/0968-0004(91)90058-4; NIXON RA, 1984, J NEUROCHEM, V43, P507, DOI 10.1111/j.1471-4159.1984.tb00928.x; Nogawa S, 1997, J NEUROSCI, V17, P2746; Pasinetti GM, 1998, J NEUROSCI RES, V54, P1; Posmantur R, 1997, NEUROSCIENCE, V77, P875, DOI 10.1016/S0306-4522(96)00483-6; Ray SK, 1999, BRAIN RES, V829, P18, DOI 10.1016/S0006-8993(99)01290-1; RICH JB, 1995, NEUROLOGY, V45, P51, DOI 10.1212/WNL.45.1.51; ROGERS J, 1993, NEUROLOGY, V43, P1609, DOI 10.1212/WNL.43.8.1609; Saatman KE, 1996, J NEUROPATH EXP NEUR, V55, P850, DOI 10.1097/00005072-199607000-00010; SAITO KI, 1993, P NATL ACAD SCI USA, V90, P2628, DOI 10.1073/pnas.90.7.2628; Shields DC, 1998, EXP EYE RES, V67, P403, DOI 10.1006/exer.1998.0537; Shields DC, 1999, J NEUROSCI RES, V55, P533, DOI 10.1002/(SICI)1097-4547(19990301)55:5<533::AID-JNR1>3.0.CO;2-8; SIMAN R, 1985, BRAIN RES, V347, P399, DOI 10.1016/0006-8993(85)90208-2; Singh IN, 1997, NEUROSCI LETT, V222, P5, DOI 10.1016/S0304-3940(97)13327-4; SMITH WL, 1995, SEMIN NEPHROL, V15, P179; Springer JE, 1997, J NEUROCHEM, V69, P1592, DOI 10.1046/j.1471-4159.1997.69041592.x; STRACHER A, 1978, SCIENCE, V200, P50, DOI 10.1126/science.635570; TAMAI M, 1986, J PHARMACOBIO-DYNAM, V9, P672, DOI 10.1248/bpb1978.9.672; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TSUJINAKA T, 1988, BIOCHEM BIOPH RES CO, V153, P1201, DOI 10.1016/S0006-291X(88)81355-X	41	18	19	0	1	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	NOV	2000	25	11					1509	1515		10.1023/A:1007684311023			7	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	369DF	WOS:000090156000008	11071371				2022-02-06	
J	Puig, N; Davalos, A; Adan, J; Piulats, J; Martinez, JM; Castillo, J				Puig, N; Davalos, A; Adan, J; Piulats, J; Martinez, JM; Castillo, J			Serum amino acid levels after permanent middle cerebral artery occlusion in the rat	CEREBROVASCULAR DISEASES			English	Article						excitotoxicity; glutamate; glycine; ischemia; cerebral; amino acids	TRANSIENT GLOBAL-ISCHEMIA; GAMMA-AMINOBUTYRIC-ACID; TRAUMATIC BRAIN INJURY; INVIVO MICRODIALYSIS; EXTRACELLULAR CONCENTRATIONS; GERBIL HIPPOCAMPUS; IN-VIVO; INTRACEREBRAL MICRODIALYSIS; GLUTAMATE NEUROTOXICITY; SYNAPTIC TRANSMISSION	Background and Purpose: High levels of glutamate in plasma and cerebrospinal fluid (CSF) have been demonstrated in patients with acute ischemic stroke. Whereas this glutamate increase in CSF is only evidenced during the first 6 h in stable ischemic stroke, it is sustained for 24 h in progressing stroke. The aim of this investigation was to study the evolution of serum glutamate levels after stroke in a rat model of permanent cerebral artery occlusion. Methods: Glutamate, glycine, aspartate, taurine and tryptophan were measured by high-performance liquid chromatography from serum samples taken before and at different times after permanent middle cerebral artery occlusion (MCAO) and from sham-operated rats. Results:After MCAO, a 3-fold increase in glutamate and a 2-fold increase in glycine and aspartate were observed in rat serum. The onset of this amino acid increase began 4-6 h after ischemic induction, reached peak values at 8-24 h and returned to preischemic values by 48-72 h. Serum concentrations of taurine and tryptophan were not modified after MCAO. Sham-operated rats did not exhibit changes of basal amino acid concentrations in serum. Conclusions: The serum excitatory amino acid profile in this experimental model confirms that the early detection of increased concentrations of glutamate and glycine at systemic circulation observed in patients with acute stroke is a consequence of the cerebral ischemic process. Copyright (C) 2000 S. Karger AG. Basel.	Univ Santiago Compostela, Hosp Clin Univ Santiago, Dept Neurol, E-15705 Santiago De Compostela, Spain; Merck Farma & Quim SA, Dept Pharmacol, Lab Bioinvestigat, Barcelona, Spain; Hosp Doctor Josep Trueta, Neurol Sect, Girona, Spain		Puig, N (corresponding author), Univ Santiago Compostela, Hosp Clin Univ Santiago, Dept Neurol, E-15705 Santiago De Compostela, Spain.			Castillo, Jose/0000-0002-6685-3001; Puig Calvo, Nuria/0000-0001-8235-4934			BAKER AJ, 1991, J NEUROCHEM, V57, P1370, DOI 10.1111/j.1471-4159.1991.tb08303.x; BAKER AJ, 1993, J NEUROSURG, V79, P369, DOI 10.3171/jns.1993.79.3.0369; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; BENVENISTE H, 1991, CEREBROVAS BRAIN MET, V3, P213; Berger C, 1999, STROKE, V30, P460, DOI 10.1161/01.STR.30.2.460; BULLOCK R, 1995, STROKE, V26, P2187, DOI 10.1161/01.STR.26.11.2187; Castillo J, 1997, LANCET, V349, P79, DOI 10.1016/S0140-6736(96)04453-4; Castillo J, 1996, STROKE, V27, P1060, DOI 10.1161/01.STR.27.6.1060; CHOI DW, 1987, J NEUROSCI, V7, P357; CHOI KT, 1994, BRAIN RES, V642, P104; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; Davalos A, 1997, STROKE, V28, P708, DOI 10.1161/01.STR.28.4.708; DAVSON H, 1967, PHYSL CEREBROSPINAL; FAROOQUI AA, 1994, J NEUROSCI RES, V38, P6, DOI 10.1002/jnr.490380103; GEMBA T, 1992, NEUROSCI LETT, V135, P184, DOI 10.1016/0304-3940(92)90432-7; GLOBUS MYT, 1991, J NEUROCHEM, V57, P470, DOI 10.1111/j.1471-4159.1991.tb03775.x; GLOBUS MYT, 1990, STROKE, V21, P43; GORDON KE, 1991, STROKE, V22, P928, DOI 10.1161/01.STR.22.7.928; GREENAMYRE JT, 1994, NEUROLOGY, V44, P7; Herz RCG, 1996, BRAIN RES, V715, P163, DOI 10.1016/0006-8993(95)01572-8; HOSSMANN KA, 1994, PHARMACOLOGY OF CEREBRAL ISCHEMIA 1994, P239; Kahn RA, 1997, ANESTH ANALG, V84, P997, DOI 10.1097/00000539-199705000-00009; KATSUKI H, 1995, PROG NEUROBIOL, V46, P607, DOI 10.1016/0301-0082(95)00016-O; MARTINEZ F, 1993, HEADACHE, V33, P324, DOI 10.1111/j.1526-4610.1993.hed3306324.x; Matsumoto K, 1996, J CEREBR BLOOD F MET, V16, P114, DOI 10.1097/00004647-199601000-00014; MATSUMOTO K, 1993, J CEREBR BLOOD F MET, V13, P586, DOI 10.1038/jcbfm.1993.76; MATSUMOTO K, 1991, BRAIN RES, V543, P236, DOI 10.1016/0006-8993(91)90033-R; MITANI A, 1990, BRAIN RES BULL, V25, P319, DOI 10.1016/0361-9230(90)90077-D; MITANI A, 1994, J NEUROCHEM, V63, P2152; MITANI A, 1991, NEUROSCIENCE, V42, P661, DOI 10.1016/0306-4522(91)90035-M; MIYASHITA K, 1994, NEUROREPORT, V5, P945, DOI 10.1097/00001756-199404000-00023; MONTALBETTI L, 1995, NEUROSCI LETT, V192, P153, DOI 10.1016/0304-3940(95)11632-7; MUIR KW, 1995, STROKE, V26, P503, DOI 10.1161/01.STR.26.3.503; MYSEROS R, 1995, ANN NY ACAD SCI, V765, P262; NAKATA N, 1994, BRAIN RES BULL, V35, P247, DOI 10.1016/0361-9230(94)90130-9; NAKATA N, 1993, STROKE, V24, P458, DOI 10.1161/01.STR.24.3.458; OJA SS, 1978, TAURINE NEUROLOGICAL, P181; OLNEY JW, 1986, NEUROSCI LETT, V65, P65, DOI 10.1016/0304-3940(86)90121-7; Owen AJ, 1997, BRAIN RES, V770, P115, DOI 10.1016/S0006-8993(97)00789-0; PHILLIS JW, 1978, TAURINE NEUROLOGICAL, P289; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; ROTHMAN SM, 1985, J NEUROPHYSIOL, V54, P701, DOI 10.1152/jn.1985.54.3.701; SHIBANOKI S, 1993, J NEUROCHEM, V61, P1698, DOI 10.1111/j.1471-4159.1993.tb09806.x; SHIROTANI T, 1995, STROKE, V26, P878, DOI 10.1161/01.STR.26.5.878; SILVERSTEIN FS, 1991, PEDIATR RES, V30, P587, DOI 10.1203/00006450-199112000-00021; SPACKMAN DH, 1958, ANAL CHEM, V30, P1190, DOI 10.1021/ac60139a006; TAKAGI K, 1993, J CEREBR BLOOD F MET, V13, P575, DOI 10.1038/jcbfm.1993.75; TAMURA A, 1981, J CEREBR BLOOD F MET, V1, P53, DOI 10.1038/jcbfm.1981.6; TURNELL DC, 1982, CLIN CHEM, V28, P527; UCHIYAMATSUYUKI Y, 1994, J NEUROCHEM, V62, P1074; VONLUBITZ DKJE, 1992, EUR J PHARMACOL, V219, P153, DOI 10.1016/0014-2999(92)90594-T; WAHL F, 1994, J NEUROCHEM, V63, P1003; YOUNG RSK, 1992, EXP NEUROL, V117, P204, DOI 10.1016/0014-4886(92)90128-D	55	18	22	1	3	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-9770	1421-9786		CEREBROVASC DIS	Cerebrovasc. Dis.	NOV-DEC	2000	10	6					449	454		10.1159/000016106			6	Clinical Neurology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Cardiovascular System & Cardiology	373ND	WOS:000165294800006	11070375				2022-02-06	
J	Golding, EM; Steenberg, ML; Johnson, TD; Bryan, RM				Golding, EM; Steenberg, ML; Johnson, TD; Bryan, RM			The effects of potassium on the rat middle cerebral artery	BRAIN RESEARCH			English	Article						cerebral arteries; inward rectifier K+ channels; nitric oxide; osmolality	EXTRACELLULAR POTASSIUM; SMOOTH-MUSCLE; ASTROCYTE ENDFEET; BRAIN INJURY; BLOOD-FLOW; CIRCULATION; K+; CALCIUM; ENDOTHELIUM; ARTERIOLES	After traumatic brain injury, extracellular K+ in brain can dramatically increase. We studied the effects of increased K+ on the isolated pressurized rat middle cerebral artery (MCA). MCAs (200-250 mum OD) were isolated, cannulated with glass micropipettes, and pressurized. K+ was increased in the extraluminal bath using three paradigms: (1) isotonic K+ (Ki,,) where increases in Kt were offset by decreases in Na+, (2) hypertonic K+ (K-hyper) where K+ was increased without a concomitant adjustment of Na+, and (3) K-suc, a solution using K-iso but with the addition of sucrose to obtain a hypertonic solution. Increases in K+ in the extraluminal bath produced significant dilations (approximately 20%) at 21 mM K+ in all three groups (K-iso, K-hyper, and K-suc). With the K-hyper and K-suc groups, the magnitude of the dilation diminished with further increases in K+. L-NAME (10(-5) M), an inhibitor of nitric oxide synthase, had no effect on the response of the K-hyper and K-suc groups at 21 mM but significantly enhanced constrictions of the MCAs above 40 mM K+ compared to the control. The K-iso group was not affected by L-NAME at any K+ concentration and showed profound constrictions above 40 mM K+. We conclude that changes in the K+ concentration and osmolality of the extracellular fluid may have profound effects on the cerebral vasculature. (C) 2000 Elsevier Science B.V. All rights reserved.	Baylor Coll Med, Dept Anesthesiol, Houston, TX 77030 USA		Golding, EM (corresponding author), Baylor Coll Med, Dept Anesthesiol, Houston, TX 77030 USA.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01 NS 27616] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS027616] Funding Source: NIH RePORTER		ASTRUP J, 1980, BRAIN RES, V199, P161, DOI 10.1016/0006-8993(80)90238-3; AYDIN F, 1991, STROKE, V22, P1592, DOI 10.1161/01.STR.22.12.1592; Beny JL, 1999, NEWS PHYSIOL SCI, V14, P68; BETZ E, 1976, IONIC ACTIONS VASCUL, P75; Bryan RM, 1996, ANESTHESIOLOGY, V85, P82, DOI 10.1097/00000542-199607000-00012; BRYAN RM, 1995, AM J PHYSIOL-HEART C, V269, pH1171; BUSIJA DW, 1984, REV PHYSIOL BIOCH P, V101, P161, DOI 10.1007/BFb0027696; DAHL E, 1973, Z ZELLFORSCH MIK ANA, V145, P577, DOI 10.1007/BF00306725; Dora KA, 1997, P NATL ACAD SCI USA, V94, P6529, DOI 10.1073/pnas.94.12.6529; EDWARDS FR, 1988, J PHYSIOL-LONDON, V404, P455, DOI 10.1113/jphysiol.1988.sp017299; FARACI FM, 1992, PHARMACOL THERAPEUT, V56, P1, DOI 10.1016/0163-7258(92)90035-X; FARACI FM, 1993, NEUROSURGERY, V33, P648, DOI 10.1227/00006123-199310000-00014; HANSEN AJ, 1978, ACTA PHYSIOL SCAND, V102, P324, DOI 10.1111/j.1748-1716.1978.tb06079.x; HOGESTATT ED, 1984, J PHARMACOL EXP THER, V228, P187; HOGESTATT ED, 1983, ACTA PHYSIOL SCAND, V117, P49, DOI 10.1111/j.1748-1716.1983.tb07178.x; HOVDA DA, 1992, J NEUROTRAUM, V9, pS47; Johnson TD, 1998, AM J PHYSIOL-REG I, V274, pR541; Katayama Y, 1998, ACT NEUR S, V71, P289; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KNABE U, 1972, VASCULAR SMOOTH MUSC, P83; Knot HJ, 1996, J PHYSIOL-LONDON, V492, P419, DOI 10.1113/jphysiol.1996.sp021318; KUFFER SW, 1984, NEURON BRAIN SINAUER; KUSCHINSKY W, 1972, CIRC RES, V31, P240, DOI 10.1161/01.RES.31.2.240; LITTLE TL, 1995, AM J PHYSIOL-HEART C, V268, pH729, DOI 10.1152/ajpheart.1995.268.2.H729; LITTLE TL, 1995, CIRC RES, V76, P498, DOI 10.1161/01.RES.76.3.498; Marrelli SP, 1998, STROKE, V29, P1469, DOI 10.1161/01.STR.29.7.1469; MCCARRON JG, 1990, AM J PHYSIOL, V259, pH902, DOI 10.1152/ajpheart.1990.259.3.H902; MCCULLOCH J, 1982, PFLUG ARCH EUR J PHY, V393, P95, DOI 10.1007/BF00582399; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; NEWMAN EA, 1986, SCIENCE, V233, P453, DOI 10.1126/science.3726539; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; OSOL G, 1991, CIRC RES, V68, P359, DOI 10.1161/01.RES.68.2.359; PAULSON OB, 1987, SCIENCE, V237, P896, DOI 10.1126/science.3616619; QUAYLE JM, 1993, AM J PHYSIOL, V265, pC1363, DOI 10.1152/ajpcell.1993.265.5.C1363; RYMAN T, 1989, ACTA PHYSIOL SCAND, V136, P151, DOI 10.1111/j.1748-1716.1989.tb08647.x; SPAGNOLI LG, 1982, EXPERIENTIA, V38, P124, DOI 10.1007/BF01944566; SYKOVA E, 1983, PROG BIOPHYS MOL BIO, V42, P135, DOI 10.1016/0079-6107(83)90006-8; TAKAHASHI H, 1981, J NEUROSURG, V55, P708, DOI 10.3171/jns.1981.55.5.0708; TODA N, 1974, AM J PHYSIOL, V227, P1206, DOI 10.1152/ajplegacy.1974.227.5.1206; VARON S S, 1979, Neurosciences Research Program Bulletin, V17, P1; VINALL PE, 1987, STROKE, V18, P92, DOI 10.1161/01.STR.18.1.92; VINALL PE, 1987, BLOOD VESSELS, V24, P51; YONAS H, 1984, J COMPUT ASSIST TOMO, V8, P990, DOI 10.1097/00004728-198410000-00038; YOUNG W, 1986, BRAIN RES, V365, P42, DOI 10.1016/0006-8993(86)90720-1; [No title captured]	45	18	18	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	OCT 13	2000	880	1-2					159	166		10.1016/S0006-8993(00)02793-1			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	365MT	WOS:000089955600017	11033000				2022-02-06	
J	Fujimura, M; Morita-Fujimura, Y; Noshita, N; Yoshimoto, T; Chan, PH				Fujimura, M; Morita-Fujimura, Y; Noshita, N; Yoshimoto, T; Chan, PH			Reduction of the DNA base excision repair protein, XRCC1, may contribute to DNA fragmentation after cold injury-induced brain trauma in mice	BRAIN RESEARCH			English	Article						DNA base excision repair; XRCC1; apoptosis; cold injury; traumatic brain injury	FOCAL CEREBRAL-ISCHEMIA; MITOCHONDRIAL CYTOCHROME-C; STRAND BREAK REPAIR; POLY(ADP-RIBOSE) POLYMERASE; SUPEROXIDE-DISMUTASE; NEURONAL APOPTOSIS; EARLY DECREASE; LIGASE-III; GENE XRCC1; APURINIC/APYRIMIDINIC ENDONUCLEASE	The X-ray repair cross-complementing group 1 (XRCC1) protein plays a central role in the DNA base excision repair pathway by interacting with DNA ligase III and DNA polymerase beta. The present study examined the protein expression of XRCC1 and DNA fragmentation before and after cold injury-induced brain trauma (CIBT) in mice, in which apoptosis is assumed to participate. Immunohistochemistry showed the nuclear expression of XRCC1 in the entire region of the control brains. Fifteen minutes after CIBT, nuclear immunoreactivity was predominantly decreased in the inner boundary of the lesion, followed by a significant reduction of XRCC1 in the entire lesion 4 h after CIBT. A characteristic 70-kDa band was detected in the non-traumatic area, and was markedly decreased after CIBT as shown by Western blot analysis. DNA fragmentation was also observed after CIBT, and double staining with XRCC1 immunohistochemistry and terminal deoxynucleotidyl transferase-mediated uridine 5'-triphosphate-biotin nick end labeling showed a spatial relationship between XRCC1 loss and DNA fragmentation 24 h after CIBT. These data indicate that early decrease of XRCC1 and failure of the DNA repair mechanism may contribute to DNA-damaged neuronal cell death after CIBT. (C) 2000 Elsevier Science B.V. All rights reserved.	Stanford Univ, Neurosurg Labs, Sch Med, Dept Neurosurg, Palo Alto, CA 94304 USA; Stanford Univ, Sch Med, Dept Neurol & Neurosurg Sci, Palo Alto, CA 94304 USA; Stanford Univ, Sch Med, Neurosci Program, Palo Alto, CA 94304 USA; Tohoku Univ, Sch Med, Dept Neurosurg, Sendai, Miyagi 980, Japan		Chan, PH (corresponding author), Stanford Univ, Neurosurg Labs, Sch Med, Dept Neurosurg, 701B Welch Rd,148, Palo Alto, CA 94304 USA.		fujimura, yuiko/M-7393-2013; Morita-fujimura, Yuiko/N-4804-2014		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS025372, R01NS036147, P01NS014543, P50NS014543] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS25372, NS14543, NS36147] Funding Source: Medline		Caldecott KW, 1996, NUCLEIC ACIDS RES, V24, P4387, DOI 10.1093/nar/24.22.4387; Cappelli E, 1997, J BIOL CHEM, V272, P23970, DOI 10.1074/jbc.272.38.23970; CHAN PH, 1991, ANN NEUROL, V29, P482, DOI 10.1002/ana.410290506; Chopp M, 1996, STROKE, V27, P363, DOI 10.1161/01.STR.27.3.363; Conti AC, 1998, J NEUROSCI, V18, P5663; Eliasson MJL, 1997, NAT MED, V3, P1089, DOI 10.1038/nm1097-1089; Fujimura M, 1998, J CEREBR BLOOD F MET, V18, P1239, DOI 10.1097/00004647-199811000-00010; Fujimura M, 1999, STROKE, V30, P2456, DOI 10.1161/01.STR.30.11.2456; Fujimura M, 1999, J CEREBR BLOOD F MET, V19, P495, DOI 10.1097/00004647-199905000-00003; Fujimura M, 1999, STROKE, V30, P2408, DOI 10.1161/01.STR.30.11.2408; Fujimura M, 1999, J NEUROSCI, V19, P3414; Kawase M, 1999, STROKE, V30, P441, DOI 10.1161/01.STR.30.2.441; Kubota Y, 1996, EMBO J, V15, P6662, DOI 10.1002/j.1460-2075.1996.tb01056.x; Liu PK, 1996, J NEUROSCI, V16, P6795; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; Morita-Fujimura Y, 1999, NEUROSCI LETT, V267, P201, DOI 10.1016/S0304-3940(99)00327-4; Morita-Fujimura Y, 1999, J CEREBR BLOOD F MET, V19, P634, DOI 10.1097/00004647-199906000-00006; Morita-Fujimura Y, 1999, NEUROSCIENCE, V93, P1465, DOI 10.1016/S0306-4522(99)00231-6; Murakami K, 1997, NEUROSCIENCE, V81, P231, DOI 10.1016/S0306-4522(97)00197-8; Nash RA, 1997, BIOCHEMISTRY-US, V36, P5207, DOI 10.1021/bi962281m; Shen NR, 1998, NUCLEIC ACIDS RES, V26, P1032, DOI 10.1093/nar/26.4.1032; THOMPSON LH, 1990, MOL CELL BIOL, V10, P6160, DOI 10.1128/MCB.10.12.6160; TOMINAGA T, 1992, NEUROSCI LETT, V139, P265, DOI 10.1016/0304-3940(92)90568-R; Whalen MJ, 1999, J CEREBR BLOOD F MET, V19, P835, DOI 10.1097/00004647-199908000-00002; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; YOO HY, 1992, BIOCHEM BIOPH RES CO, V186, P900, DOI 10.1016/0006-291X(92)90831-5; ZHANG J, 1994, SCIENCE, V263, P687, DOI 10.1126/science.8080500; ZHOU ZQ, 1995, MUTAT RES LETT, V348, P111, DOI 10.1016/0165-7992(95)00053-4	29	18	18	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	JUN 30	2000	869	1-2					105	111		10.1016/S0006-8993(00)02375-1			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	330YY	WOS:000087990300013	10865064				2022-02-06	
J	Cornish, R; Blumbergs, PC; Manavis, J; Scott, G; Jones, NR; Reilly, PL				Cornish, R; Blumbergs, PC; Manavis, J; Scott, G; Jones, NR; Reilly, PL			Topography and severity of axonal injury in human spinal cord trauma using amyloid precursor protein as a marker of axonal injury	SPINE			English	Article						amyloid precursor protein (APP); axonal injury; quantitation; spinal cord trauma	CLOSED-HEAD INJURY; BETA-APP; DAMAGE; BRAIN; RAT; IMMUNOREACTIVITY; PATHOPHYSIOLOGY; UBIQUITIN; DISEASE; MILD	Study Design. Axonal injury was examined in 18 human cases of acute spinal cord compression using amyloid precursor protein as a marker of Al. Objectives. To topographically map and semiquantitate axonal injury in spinal cord compression of sufficient severity to produce para- or quadriplegia. Summary of Background Data, Amyloid precursor protein is carried along the axon by fast axoplasmic transport and has been extensively used as a marker of traumatic axonal injury. Methods. The study group comprised 18 cases of spinal cord compression (17 due to fracture dislocation of the vertebral column and 1 iatrogenic compression from Harrington rods) and two normal control. All the cords were examined according to a standard protocol, and at least 10 segmental levels were immunostained using a monoclonal antibody to amyloid precursor protein and immunopositive Al was semiquantited using a grading system to provide the axonal injury severity score (AISS). The focal injury at the site of cord compression (haemorrhage, haemorrhagic necrosis, ischaemic necrosis) was also semiquantitated to provide the focal injury area score (FIAS). Al occurring around the site of focal compression (focal axonal injury severity score or FAISS) was distinguished from Al distant to the focal injury (nonfocal axonal injury severity score or NFAISS). Results. All 18 cases showed widespread amyloid precursor protein immunoreactive axonal injury and the AISS ranged from 28 to 60%. In all cases, the FAISS was greater than the NFAISS and there was a statistically significant relationship between the AISS and the FIAS. Conclusion. Acute spinal cord compression of sufficient severity to produce permanent paralysis causes widespread axonal damage that is maximal at the site of compression but also present throughout the length of the cord in segments far distant from the site of the focal injury.	Inst Med & Vet Sci, Neuropathol Lab, Adelaide, SA 5000, Australia; Royal Adelaide Hosp, Dept Neurosurg, Adelaide, SA 5000, Australia; Univ Adelaide, Adelaide, SA, Australia		Blumbergs, PC (corresponding author), Inst Med & Vet Sci, Neuropathol Lab, POB 14,Rundle Mall, Adelaide, SA 5000, Australia.			Reilly, Peter/0000-0003-3173-0666			AbouHamden A, 1997, J NEUROTRAUM, V14, P699, DOI 10.1089/neu.1997.14.699; Ahlgren S, 1996, ACTA NEUROPATHOL, V92, P49, DOI 10.1007/s004010050488; Blumbergs PC, 1998, J CLIN NEUROSCI, V5, P123, DOI 10.1016/S0967-5868(98)90026-1; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; BUNGE RP, 1993, ADV NEUROL, V59, P75; COCHRAN E, 1991, AM J PATHOL, V139, P485; Croul S E, 1997, Adv Neurol, V72, P317; FERREIRA A, 1993, J NEUROSCI, V13, P3112; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; GULTEKIN SH, 1994, ARCH PATHOL LAB MED, V118, P168; Hayes KC, 1997, J NEUROTRAUM, V14, P235, DOI 10.1089/neu.1997.14.235; KAKULAS B, 1985, RECENT ACHIEVEMENTS, V1, P163; Kakulas B A, 1984, Cent Nerv Syst Trauma, V1, P117; KAKULAS BA, 1992, HDB CLIN NEUROLOGY, V17, P21; KAWARABAYASHI T, 1991, BRAIN RES, V563, P334, DOI 10.1016/0006-8993(91)91558-I; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; KRAUS JF, 1985, CENTRAL NERVOUS SYST, P313; LI GL, 1995, J NEUROTRAUM, V12, P269, DOI 10.1089/neu.1995.12.269; McKenzie KJ, 1996, ACTA NEUROPATHOL, V92, P608, DOI 10.1007/s004010050568; NAKAMURA Y, 1992, NEUROSCI LETT, V136, P95, DOI 10.1016/0304-3940(92)90656-R; Olsson Y, 1996, NEUROPATH APPL NEURO, V22, P518, DOI 10.1111/j.1365-2990.1996.tb01129.x; OTSUKA N, 1991, BRAIN RES, V568, P335, DOI 10.1016/0006-8993(91)91422-W; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V88, P433; STEPHENSON DT, 1992, BRAIN RES, V593, P128, DOI 10.1016/0006-8993(92)91274-I; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V15, P49; SUENAGA T, 1994, ACTA NEUROPATHOL, V87, P450; TATOR CH, 1995, BRAIN PATHOL, V5, P407, DOI 10.1111/j.1750-3639.1995.tb00619.x; WALSH J, 1987, QUADCARE, V1, P1; YEO JD, 1994, MOD MED AUST, V37, P36	32	18	18	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0362-2436			SPINE	SPINE	MAY 15	2000	25	10					1227	1233		10.1097/00007632-200005150-00005			7	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	316AY	WOS:000087146200004	10806498				2022-02-06	
J	Masson, F				Masson, F			Epidemiology of severe brain injuries.	ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION			French	Article						head trauma	GLASGOW-COMA-SCALE; MOTORCYCLE-HELMET-USE; SEVERE HEAD-INJURIES; PREVENTION STRATEGIES; TRAUMA CENTERS; POPULATION; MORTALITY; CALIFORNIA; DEATH; DISABILITY	Head injuries (HI) are one of the most common causes of death, morbidity and disabilities in young adults. Epidemiological studies allow a quantitative estimation in terms of incidence and a qualitative estimate for the identification of risk factors in specific populations. These estimates may enable appropriate prevention programs. Estimates of annual incidence rates depend on territories, periods and methodological tools. Annual rates for hospitalized patients are found between 150 and 300/100000 inhabitants. Severity of HI can be assessed by the Glasgow Coma Scale (GCS), the Abbreviated Injury Scale (AIS) or the Post-Traumatic Amnesia duration. Annual incidences of severe HI will depend on the selected score: around 25/100000 inhabitants for cerebral trauma with intracranial injuries, around 9/100000 for the most severe Hi, with an AIS maximum of 5 with coma. The male: female ratio increases with degree of severity. Traffic accidents were the most frequent cause of HI. Many patients have associated injuries, worsening the outcome. Some risk factors are considered. Preventive measures are mainly conducted for traffic accidents, and include speed limit and regulations on helmet or seat belt use. Results of these mesures are analysed. (C) 2000 Editions scientifiques et medicales Elsevier SAS.	Hop Pellegrin, Dept Anesthesie Reanimat 1, F-33076 Bordeaux, France		Masson, F (corresponding author), Hop Pellegrin, Dept Anesthesie Reanimat 1, Pl Amelie Raba Leon, F-33076 Bordeaux, France.						ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Buechler CM, 1998, J TRAUMA, V45, P429, DOI 10.1097/00005373-199809000-00001; CAYTEN C G, 1982, Critical Care Quarterly, V5, P79; Close J, 1999, LANCET, V353, P93, DOI 10.1016/S0140-6736(98)06119-4; *COMM INJ SCAL, 1990, ABBR INJ SCAL AIS; DACEY R, 1991, J TRAUMA, V31, P217, DOI 10.1097/00005373-199131020-00011; Engberg Aase, 1995, Acta Neurologica Scandinavica, V92, P1; Foulkes MA, 1991, J NEUROSURG S, V75, P8, DOI 10.3171/sup.1991.75.1s.00s8; GENNARELLI TA, 1989, J TRAUMA, V29, P1193, DOI 10.1097/00005373-198909000-00002; HADDON W, 1972, J TRAUM, V12, P193, DOI 10.1097/00005373-197203000-00002; JAGGER J, 1987, NEUROSURGERY, V20, P815, DOI 10.1227/00006123-198705000-00028; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; JENNETT B, 1981, BRIT MED J, V282, P101, DOI 10.1136/bmj.282.6258.101; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; JOHNSON RM, 1995, J TRAUMA, V38, P876, DOI 10.1097/00005373-199506000-00008; KLAUBER MR, 1989, NEUROSURGERY, V24, P31, DOI 10.1227/00006123-198901000-00005; KLAUBER MR, 1985, J NEUROSURG, V62, P528, DOI 10.3171/jns.1985.62.4.0528; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; KRAUS JF, 1994, JAMA-J AM MED ASSOC, V272, P1506, DOI 10.1001/jama.272.19.1506; KRAUS JF, 1995, J NEUROTRAUM, V12, P873, DOI 10.1089/neu.1995.12.873; LAVECCHIA C, 1994, SOZ PRAVENTIV MED, V39, P150, DOI 10.1007/BF01299659; Lenfant F, 1997, ANN FR ANESTH, V16, P239, DOI 10.1016/S0750-7658(97)86408-8; Masson F, 1997, J CLIN EPIDEMIOL, V50, P595, DOI 10.1016/S0895-4356(97)00012-7; MASSON F, 1998, ANN FR ANESTH, V17, P921; MCKENZIE EJ, 1989, MARYLAND MED J, V38, P725; MCKENZIE EJ, 1988, J TRAUMA, V28, P281; MENEGAZZI JJ, 1993, J TRAUMA, V34, P46, DOI 10.1097/00005373-199301000-00008; Meyer AA, 1998, J TRAUMA, V44, P1, DOI 10.1097/00005373-199801000-00001; MOCK CN, 1995, J TRAUMA, V39, P29, DOI 10.1097/00005373-199507000-00004; MORRIS K, 1993, INJURY, V24, P369, DOI 10.1016/0020-1383(93)90097-P; Moss NEG, 1996, INJURY, V27, P159, DOI 10.1016/0020-1383(95)00217-0; Prasad K, 1996, J CLIN EPIDEMIOL, V49, P755, DOI 10.1016/0895-4356(96)00013-3; ROSS SE, 1992, ACCIDENT ANAL PREV, V24, P181, DOI 10.1016/0001-4575(92)90035-H; Rowland J, 1996, AM J PUBLIC HEALTH, V86, P41, DOI 10.2105/AJPH.86.1.41; RUNE V, 1970, ACTA PAEDIATR SC   S, V209, P1; SALMI R, 1989, ACCIDENT ANAL PREV, V6, P589; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; SERVADEI F, 1988, ITAL J NEUROL SCI, V9, P449, DOI 10.1007/BF02337162; SHACKFORD SR, 1993, ARCH SURG-CHICAGO, V128, P571, DOI 10.1001/archsurg.1993.01420170107016; SOSIN DM, 1989, JAMA-J AM MED ASSOC, V262, P2251, DOI 10.1001/jama.262.16.2251; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; TEASDALE G, 1974, LANCET, V2, P81; TIRET L, 1986, INT J EPIDEMIOL, V19, P133; VIANO DC, 1995, J TRAUMA, V38, P538, DOI 10.1097/00005373-199504000-00013; WALTERS KA, 1992, ARCH EMERG MED, V10, P29; WHITMAN S, 1984, AM J EPIDEMIOL, V119, P570, DOI 10.1093/oxfordjournals.aje.a113774; WILSON JTL, 1994, J NEUROL NEUROSUR PS, V57, P198, DOI 10.1136/jnnp.57.2.198	48	18	18	0	2	EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS CEDEX 15	23 RUE LINOIS, 75724 PARIS CEDEX 15, FRANCE	0750-7658			ANN FR ANESTH	Ann. Fr. Anest. Reanim.	APR	2000	19	4					261	269					9	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	313GX	WOS:000086992900008	10836112				2022-02-06	
J	Georgievski, AB				Georgievski, AB			Rehabilitation in the community	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article								The Project applied rehabilitation in community (RIC) in Zagreb, Croatia as a model of care with the aim of maximizing physical and mental abilities in a persons' own life environment as well as social integration. From September 96 to June 98, 785 patients with primary physical disablement were admitted: 80% with musculoskeletal conditions, and 20% with traumatic brain or spinal injury, stroke, multiple sclerosis, amputation or rheumatoid arthritis. They were residents of Trnje community (55%), Zagreb area (40%) and Croatia area (5%). Mean age was 44 years (men 39, women 48, range 7-76); 52% of patients were women and 17% were recent war wounded. The RIC programme focused on training for physical condition, activities of daily living, preservation of energy and instructions on self-rehabilitation measures, application of aids, and psychosocial consultation. Patients' families were actively involved. Educational activities involved 1100 participants and RIC was promoted by 182 health and social care agencies, humanitarian organizations, the Church, Red Cross, the University and public. The Project demonstrated that primary health care nurse, social worker, and peer counsellor joined to rehabilitation professionals were able to develop interdisciplinary teamwork and to confirm their roles as CBR workers.	Univ Zagreb, Sveti Duh Gen Hosp, HR-10002 Zagreb, Croatia		Georgievski, AB (corresponding author), Univ Zagreb, Sveti Duh Gen Hosp, 64 Sveti Duh St, HR-10002 Zagreb, Croatia.						AITKEN C, 1987, INT DISABILITY STUDI, V9, P55; Clarke A K, 1987, Int Disabil Stud, V9, P18; *DIS MAN INF SYST, 1995, MIDT REP INF SYST WO; Eldar R, 1997, DISABIL REHABIL, V19, P547, DOI 10.3109/09638289709166048; ELDAR R, 2000, IN PRESS DISABILITY; Eldar Reuben, 1993, Croatian Medical Journal, V34, P21; FINDLEY TW, 1987, MED CARE, V25, P753, DOI 10.1097/00005650-198708000-00008; GRANGER CV, 1973, PHYSICAL MED REHABIL, V4, P596; Hermanova H, 1987, Int Disabil Stud, V9, P61; Heruti RJ, 1995, AM J PHYS MED REHAB, V74, P466, DOI 10.1097/00002060-199511000-00017; Kosuta D, 1996, Acta Med Croatica, V50, P53; PEAT M, 1991, CLIN REHABIL, V5, P161; PEAT M, 1997, COMMUNITY BASED REHA; ROKSANDICTOMEK S, 1996, SOME HLTH STAT RELAT; Symington D C, 1994, Int J Rehabil Res, V17, P1, DOI 10.1097/00004356-199403000-00001; *WHO EURO CONS STA, 1992, WHO EURO CONS STAT R	16	18	19	1	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0342-5282			INT J REHABIL RES	Int. J. Rehabil. Res.	MAR	2000	23	1					1	6					6	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	305HJ	WOS:000086533100001	10826120				2022-02-06	
J	Newman, SJ; Bond, B; Crook, B; Darker, J; Edge, C; Maycox, PR				Newman, SJ; Bond, B; Crook, B; Darker, J; Edge, C; Maycox, PR			Neuron-specific localisation of the TR3 death receptor in Alzheimer's disease	BRAIN RESEARCH			English	Article						death receptor; Alzheimer's disease; TR3; lymphocyte; apoptosis; antibody	DOMAIN-CONTAINING RECEPTOR; ISCHEMIC BRAIN INJURY; NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; TNF RECEPTOR; CEREBRAL-ISCHEMIA; CELL-DEATH; APOPTOSIS; PROTEIN; LOCALIZATION	Death receptors are associated with the homeostatic and pathologic induction of cell death. TR3 is a recently characterised member of the death receptor family that is expressed in the adult brain, In order to establish the role of TR3 in acute CNS disease and chronic neurodegeneration, we analysed brain regions from Alzheimer's disease (AD), stroke and neurotrauma patients, using a novel anti-peptide antibody generated to an exposed epitope in the extracellular domain of the receptor. We show a statistically significant increase in TR3 protein levels in AD brain samples but not in stroke, neurotrauma or control samples. The increase observed for TR3 was specific to neurons in regions associated with AD pathology. This is the first report describing the neuron-specific regulation of a death receptor in chronic disease and may indicate that a TR3 receptor-mediated signalling pathway is involved in AD-associated neuronal loss. (C) 2000 Elsevier Science B.V. All rights reserved.	SmithKline Beecham Pharmaceut, Dept Neurosci Res, Harlow CM19 5AW, Essex, England; SmithKline Beecham Pharmaceut, Dept Analyt Sci, Harlow CM19 5AW, Essex, England; SmithKline Beecham Pharmaceut, Dept Computat & Struct Sci, Harlow CM19 5AW, Essex, England; SmithKline Beecham Pharmaceut, Dept Stat Sci, Harlow CM19 5AW, Essex, England		Maycox, PR (corresponding author), SmithKline Beecham Pharmaceut, Dept Neurosci Res, 3rd Ave, Harlow CM19 5AW, Essex, England.						Ashkenazi A, 1999, CURR OPIN CELL BIOL, V11, P255, DOI 10.1016/S0955-0674(99)80034-9; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; BANNER DW, 1993, CELL, V73, P431, DOI 10.1016/0092-8674(93)90132-A; Barone FC, 1997, STROKE, V28, P1233, DOI 10.1161/01.STR.28.6.1233; Bodmer JL, 1997, IMMUNITY, V6, P79, DOI 10.1016/S1074-7613(00)80244-7; Botchkina GI, 1997, MOL MED, V3, P765, DOI 10.1007/BF03401714; BRAAK H, 1990, J NEUROPATH EXP NEUR, V49, P215, DOI 10.1097/00005072-199005000-00003; BRAAK H, 1992, NEUROSCI RES, V15, P6, DOI 10.1016/0168-0102(92)90014-4; Bruce AJ, 1996, NAT MED, V2, P788, DOI 10.1038/nm0796-788; Chen J, 1998, J NEUROSCI, V18, P4914; Chinnaiyan AM, 1996, SCIENCE, V274, P990, DOI 10.1126/science.274.5289.990; CONLON I, 1999, SIZE CONTROL ANIMAL, V96, P235; CUEVAS EC, 1994, J CLIN PATHOL, V47, P448, DOI 10.1136/jcp.47.5.448; ECK MJ, 1989, J BIOL CHEM, V264, P17595; Ellerby LM, 1999, J BIOL CHEM, V274, P8730, DOI 10.1074/jbc.274.13.8730; Gentleman SM, 1997, NEUROREPORT, V8, P1519, DOI 10.1097/00001756-199704140-00039; Gervais FG, 1999, CELL, V97, P395, DOI 10.1016/S0092-8674(00)80748-5; HARRISON DC, IN PRESS TR3 DEATH R; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; Kaltschmidt B, 1997, P NATL ACAD SCI USA, V94, P2642, DOI 10.1073/pnas.94.6.2642; Kitson J, 1996, NATURE, V384, P372, DOI 10.1038/384372a0; LINNIK MD, 1995, MOL BRAIN RES, V32, P116, DOI 10.1016/0169-328X(95)00069-5; Marsters SA, 1996, CURR BIOL, V6, P1669, DOI 10.1016/S0960-9822(02)70791-4; Martin-Villalba A, 1999, J NEUROSCI, V19, P3809; MATSUYAMA T, 1995, MOL BRAIN RES, V34, P166, DOI 10.1016/0169-328X(95)00162-L; MCGEER PL, 1992, J NEUROSCI RES, V31, P428, DOI 10.1002/jnr.490310305; Muzio M, 1998, J BIOL CHEM, V273, P2926, DOI 10.1074/jbc.273.5.2926; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Namura S, 1998, J NEUROSCI, V18, P3659; NISHIMURA T, 1995, BRAIN RES, V695, P137, DOI 10.1016/0006-8993(95)00699-Q; Ona VO, 1999, NATURE, V399, P263, DOI 10.1038/20446; Orlinick JR, 1998, CELL SIGNAL, V10, P543, DOI 10.1016/S0898-6568(98)00018-7; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Pan GH, 1998, FEBS LETT, V431, P351, DOI 10.1016/S0014-5793(98)00791-1; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Pettmann B, 1998, NEURON, V20, P633, DOI 10.1016/S0896-6273(00)81004-1; Pitti RM, 1998, NATURE, V396, P699, DOI 10.1038/25387; Screaton GR, 1997, P NATL ACAD SCI USA, V94, P4615, DOI 10.1073/pnas.94.9.4615; Siegel S., 1956, NONPARAMETRIC STAT B, pXVII, 312; Stennicke HR, 1998, J BIOL CHEM, V273, P27084, DOI 10.1074/jbc.273.42.27084; Tan KB, 1997, GENE, V204, P35, DOI 10.1016/S0378-1119(97)00509-X; TARTAGLIA LA, 1993, CELL, V74, P845, DOI 10.1016/0092-8674(93)90464-2; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; WOOD JA, 1993, BRAIN RES, V629, P245, DOI 10.1016/0006-8993(93)91327-O; Xia MQ, 1999, J NEUROVIROL, V5, P32, DOI 10.3109/13550289909029743; 0869179	47	18	19	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	FEB 28	2000	857	1-2					131	140		10.1016/S0006-8993(99)02417-8			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	290BV	WOS:000085657200014	10700560				2022-02-06	
J	Henry, PT; Rajshekhar, V				Henry, PT; Rajshekhar, V			Post-traumatic malignant glioma: case report and review of the literature	BRITISH JOURNAL OF NEUROSURGERY			English	Article						brain tumour; head injury	LOS-ANGELES COUNTY; MENINGIOMAS	Posttraumatic gliomas have been described, but in none of these has there been documented evidence of absence of tumour at the time of the injury. We report a case of post-traumatic malignant glioma with radiological evidence of only a contusion prior to the development of the tumour.	Christian Med Coll & Hosp, Dept Neurol Sci, Vellore 632004, Tamil Nadu, India		Rajshekhar, V (corresponding author), Christian Med Coll & Hosp, Dept Neurol Sci, Vellore 632004, Tamil Nadu, India.	vraj@neuro.cmc.ernet.in					ANNEGERS JF, 1979, NEUROSURGERY, V4, P203, DOI 10.1227/00006123-197903000-00001; BEHREND RC, 1974, HDB CLIN NEUROLOGY, V16, P78; CHOI NW, 1968, NEUROLOGY, V18, P306; DIEZEL P, 1949, Frankf Z Pathol, V60, P316; FINKEMEYER H, 1956, Zentralbl Neurochir, V16, P318; Hallervorden J, 1948, NERVENARZT, V19, P163; HEYCK H, MONATS SCHR PSYCHIAT, V128, P180; LUDWIN SK, 1984, NATURE, V308, P274, DOI 10.1038/308274a0; MANUELIDIS EE, 1972, PATHOLOGY NERVOUS SY, V3, P2917; Manuelidis EE., 1972, PATHOLOGY NERVOUS SY, V2, P2237; MORANTZ RA, 1978, NEUROSURGERY, V3, P181, DOI 10.1227/00006123-197809000-00009; Parker HL, 1931, J AMER MED ASSOC, V97, P0535, DOI 10.1001/jama.1931.02730080027008; PEREZDIAZ C, 1985, SURG NEUROL, V24, P581, DOI 10.1016/0090-3019(85)90278-2; PRESTONMARTIN S, 1980, JNCI-J NATL CANCER I, V65, P67; PRESTONMARTIN S, 1983, J NATL CANCER I, V70, P863; SCHEID P, 1938, FRANKFURT Z PATHOL, V51, P446; Zulch KJ, 1974, HDB CLIN NEUROLOGY, V16, P31	17	18	19	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	FEB	2000	14	1					64	67					4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	298KT	WOS:000086138700016	10884891				2022-02-06	
J	Savitsky, EA; Votey, SR				Savitsky, EA; Votey, SR			Current controversies in the management of minor pediatric head injuries	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						pediatric; minor head injury; management; head trauma; cranial computed tomography	TRAUMATIC BRAIN INJURY; COMPUTED TOMOGRAPHIC SCANS; DEPRESSED SKULL FRACTURES; ACUTE SUBDURAL-HEMATOMA; POSTTRAUMATIC SEIZURES; NEUROLOGIC EXAMINATION; INTRACRANIAL HEMATOMA; EXTRADURAL HEMATOMA; CLINICAL PREDICTORS; CHILDREN	Each year hundreds of thousands of children receive care in emergency departments after head injury. Minor head injuries account for a majority of these injuries. The prevalence, morbidity, and costs associated with pediatric minor head injuries make it an important topic. We review the management of pediatric minor head injury, emphasizing current areas of controversy, including criteria for neuroimaging, indications for hospitalization, the role of anticonvulsant therapy, and the long-term neurobehavioral sequelae of pediatric minor head injury. Copyright (C) 2000 by W.B. Saunders Company.	Univ Calif Los Angeles, Sch Med, Los Angeles, CA 90024 USA		Savitsky, EA (corresponding author), Univ Calif Los Angeles, Sch Med, 924 Westwood Blvd,Suite 300, Los Angeles, CA 90024 USA.						ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Bijur PE, 1996, J DEV BEHAV PEDIATR, V17, P143, DOI 10.1097/00004703-199606000-00001; BONADIO WA, 1989, AM J DIS CHILD, V143, P194, DOI 10.1001/archpedi.1989.02150140084025; BRICOLO AP, 1984, NEUROSURGERY, V14, P8, DOI 10.1227/00006123-198401000-00003; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; CASEY R, 1986, PEDIATRICS, V78, P497; CEVIKER N, 1995, ACTA NEUROCHIR, V133, P116, DOI 10.1007/BF01420061; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; CROCE MA, 1994, J TRAUMA, V36, P820, DOI 10.1097/00005373-199406000-00012; Dalmady-Israel Christina, 1993, Brain Injury, V7, P263, DOI 10.3109/02699059309029679; DAVIES RL, 1995, PEDIATRICS, V95, P345; DAVIS RL, 1994, ANN EMERG MED, V24, P640, DOI 10.1016/S0196-0644(94)70273-X; DIETRICH AM, 1993, ANN EMERG MED, V22, P1535, DOI 10.1016/S0196-0644(05)81254-5; DOEZEMA D, 1991, ANN EMERG MED, V20, P1281, DOI 10.1016/S0196-0644(05)81065-0; DUHAIME AC, 1992, PEDIATRICS, V90, P179; FAY GC, 1993, ARCH PHYS MED REHAB, V74, P895; FEUERMAN T, 1988, NEUROSURGERY, V22, P449, DOI 10.1227/00006123-198803000-00001; Greenes DS, 1997, ANN EMERG MED, V30, P253, DOI 10.1016/S0196-0644(97)70158-6; GROVEDAHL DL, 1995, PEDIATR EMERG CARE, V95, P345; GULBRANDSEN GB, 1984, J CLIN NEUROPSYCHOL, V6, P257, DOI 10.1080/01688638408401217; HAHN YS, 1993, PEDIATR NEUROSURG, V19, P135, DOI 10.1159/000120718; HAHN YS, 1988, NEUROSURGERY, V22, P864, DOI 10.1227/00006123-198805000-00008; HAHN YS, 1988, CHILD NERV SYST, V4, P34; HENDRICK E, 1963, CLIN NEUROSURG, V11, P46; HENNES H, 1988, AM J DIS CHILD, V142, P1045, DOI 10.1001/archpedi.1988.02150100039021; JORDAN BD, 1990, JAMA-J AM MED ASSOC, V263, P1670, DOI 10.1001/jama.263.12.1670; KELLY AB, 1988, AM J NEURORADIOL, V9, P699; Kibby MY, 1996, BRAIN INJURY, V10, P159, DOI 10.1080/026990596124494; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; LEE ST, 1995, ACTA NEUROCHIR, V135, P136, DOI 10.1007/BF02187757; LENDE RA, 1961, J NEUROSURG, V18, P479, DOI 10.3171/jns.1961.18.4.0479; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; LEWIS RJ, 1993, ANN EMERG MED, V22, P1114, DOI 10.1016/S0196-0644(05)80974-6; LIVINGSTON DH, 1991, AM SURGEON, V57, P14; Miller J D, 1988, Brain Inj, V2, P83, DOI 10.3109/02699058809150934; MILLER JD, 1990, NEUROSURGERY, V27, P669, DOI 10.1227/00006123-199011000-00001; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; MILLER JD, 1969, LANCET, P991; MISES J, 1970, EPILEPSIA, V11, P37, DOI 10.1111/j.1528-1157.1970.tb03864.x; MITCHELL KA, 1994, J PEDIATR SURG, V29, P851, DOI 10.1016/0022-3468(94)90001-9; MUHONEN MG, 1995, SURG NEUROL, V43, P367, DOI 10.1016/0090-3019(95)80066-P; NAIMURRAHMAN, 1994, BRIT J NEUROSURG, V8, P667, DOI 10.3109/02688699409101180; PATERNITI S, 1994, ACTA NEUROCHIR, V131, P207, DOI 10.1007/BF01808614; PIETRZAK M, 1991, AM J EMERG MED, V9, P153, DOI 10.1016/0735-6757(91)90179-N; PITTS L, 1991, ANN EMERG MED, V20, P1386; POHMANNEDEN B, 1997, ACTA NEUROL SCAND, V95, P257; POLISSAR NL, 1994, BRAIN INJURY, V8, P249, DOI 10.3109/02699059409150977; RAIMONDI AJ, 1984, CHILD BRAIN, V11, P12; RAMUNDO ML, 1995, PEDIATR EMERG CARE, V11, P1, DOI 10.1097/00006565-199502000-00001; RIVARA F, 1987, PEDIATRICS, V80, P579; Roddy SP, 1998, PEDIATRICS, V101, P575, DOI 10.1542/peds.101.4.575; RODRIGUEZ JG, 1990, AM J DIS CHILD, V144, P627; ROS S P, 1989, Pediatric Emergency Care, V5, P216, DOI 10.1097/00006565-198912000-00003; Saab M, 1996, J ACCID EMERG MED, V13, P208; SAINSBURY CPQ, 1984, ARCH DIS CHILD, V59, P858; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Schunk JE, 1996, PEDIATR EMERG CARE, V12, P160, DOI 10.1097/00006565-199606000-00004; SCHYNOLL W, 1993, AM J EMERG MED, V11, P321, DOI 10.1016/0735-6757(93)90160-D; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Servadei F, 1988, Brain Inj, V2, P87, DOI 10.3109/02699058809150935; SHACKFORD SR, 1992, J TRAUMA, V33, P385, DOI 10.1097/00005373-199209000-00009; SNOW RB, 1986, NEUROSURGERY, V18, P45, DOI 10.1227/00006123-198601000-00008; STEIN SC, 1991, ANN EMERG MED, V20, P1286, DOI 10.1016/S0196-0644(05)81066-2; STEIN SC, 1990, NEUROSURGERY, V26, P638, DOI 10.1227/00006123-199004000-00012; STEIN SC, 1992, J TRAUMA, V33, P11, DOI 10.1097/00005373-199207000-00003; STEINBOK P, 1987, J NEUROSURG, V66, P506, DOI 10.3171/jns.1987.66.4.0506; TEASDALE GM, 1990, BRIT MED J, V300, P363, DOI 10.1136/bmj.300.6721.363; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; TEPAS JJ, 1990, J PEDIATR SURG, V25, P92, DOI 10.1016/S0022-3468(05)80170-8; VANDENHEEVER CM, 1989, J NEUROSURG, V71, P186, DOI 10.3171/jns.1989.71.2.0186; Wheeler DS, 1997, PEDIATRICS, V100, P1033, DOI 10.1542/peds.100.6.1033	73	18	18	0	3	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0735-6757			AM J EMERG MED	Am. J. Emerg. Med.	JAN	2000	18	1					96	101		10.1016/S0735-6757(00)90060-3			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	278QB	WOS:000084999500023	10674544				2022-02-06	
J	Vajragupta, O; Toasaksiri, S; Boonyarat, C; Wongkrajang, Y; Peungvicha, P; Watanabe, H; Boonchoong, P				Vajragupta, O; Toasaksiri, S; Boonyarat, C; Wongkrajang, Y; Peungvicha, P; Watanabe, H; Boonchoong, P			Chroman amide and nicotinyl amide derivatives: Inhibition of lipid peroxidation and protection against head trauma	FREE RADICAL RESEARCH			English	Article						antioxidant; trolox; cerebroprotective radical scavenger; brain trauma; anoxia; antioxidative vitamins; QSAR; ESR	NERVOUS-SYSTEM TRAUMA; FREE-RADICALS; REPERFUSION INJURY; CEREBRAL-ISCHEMIA; ATHEROSCLEROSIS; DOPAMINE; AGENTS; BRAIN; METHAMPHETAMINE; ACIDS	A series of chroman amide and nicotinyl amide derivatives was designed and synthesized for the treatment of traumatic and ischemic CNS injury. Five compounds were significantly more potent inhibitors of lipid peroxidation in vitro than the reference antioxidant, trolox (p < 0.01). Quantitative structure activity studies demonstrated that the inhibitory action was related to the ability to donate electrons, charge on hydroxy group and E-LUMO, to scavenging radicals and to the lipophilicity log P, which determines penetration of membrane lipids. ESR study indicated the ability of 12 to scavenge the hydroxyl radicals. The most promising compound, [(3,4-dihydro-6-hydroxy2,5,7,8-tetramethyl-2H-1-benzopyran-2yl) carbonyl](aminoethyl) indole (12), inhibited ex vivo lipid peroxidation in a head injury model and showed potent in vivo neuroprotective efficacy. Improvement of neurological recovery within 1 h of injury (grip test score) by as much as 200% was observed together with significant anti-anoxia activity. Compound 12 was a potent antagonist of methamphetamine-induced hypermotility resulting from dopamine release in the mouse brain. These results support the importance of cerebroprotective radical-scavenging agents for the treatment of traumatic injury and anoxia as well as provide additional evidence for the role of oxygen radicals and dopamine in brain damage.	Mahidol Univ, Dept Pharmaceut Chem, Bangkok 10400, Thailand; Mahidol Univ, Fac Pharm, Dept Physiol, Bangkok 10400, Thailand; Toyama Med & Pharmaceut Univ, Res Inst Oriental Med, Sugitani, Toyama 93001, Japan		Vajragupta, O (corresponding author), Mahidol Univ, Dept Pharmaceut Chem, 447 Sri Ayudhya Rd, Bangkok 10400, Thailand.		vajragupta, opa/R-6616-2019; Vajragupta, Opa/AAU-8700-2021	Vajragupta, Opa/0000-0003-3313-0621; Boonyarat, Chantana/0000-0003-4065-6090			AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; BOLLI R, 1991, CARDIOVASC DRUG THER, V5, P249, DOI 10.1007/BF00054747; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V6, P289, DOI 10.1016/0891-5849(89)90056-7; CADET JL, 1994, J NEUROCHEM, V62, P380; CLEMENS JA, 1988, LIFE SCI, V42, P707, DOI 10.1016/0024-3205(88)90463-8; FRAISSE L, 1993, J MED CHEM, V36, P1465, DOI 10.1021/jm00062a020; GRISAR JM, 1995, J MED CHEM, V38, P453, DOI 10.1021/jm00003a008; GROSS H, 1968, TETRAHEDRON, V24, P6935, DOI 10.1016/S0040-4020(01)96807-3; GUTTERIDGE J M C, 1990, Analytical Proceedings, V27, P219; Hall E D, 1986, Cent Nerv Syst Trauma, V3, P281; HALL ED, 1989, FREE RADICAL BIO MED, V6, P303, DOI 10.1016/0891-5849(89)90057-9; HALLIWELL B, 1989, BRIT J EXP PATHOL, V70, P737; JACOBSEN EJ, 1990, J MED CHEM, V33, P1145, DOI 10.1021/jm00166a010; JACOBSEN EJ, 1992, J MED CHEM, V35, P4465; KATO K, 1988, J MED CHEM, V31, P793, DOI 10.1021/jm00399a019; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; KuehmCaubere C, 1997, J MED CHEM, V40, P1201, DOI 10.1021/jm960542k; NIHRO Y, 1991, J MED CHEM, V34, P2152, DOI 10.1021/jm00111a034; Ohkawa S, 1997, J MED CHEM, V40, P559, DOI 10.1021/jm960411j; OHKUBO M, 1995, CHEM PHARM BULL, V43, P947; OLIVER CN, 1990, P NATL ACAD SCI USA, V87, P5144, DOI 10.1073/pnas.87.13.5144; OSHIRO Y, 1991, J MED CHEM, V34, P2014, DOI 10.1021/jm00111a014; PANETTA JA, 1994, ANN NY ACAD SCI, V723, P239, DOI 10.1111/j.1749-6632.1994.tb36730.x; PIOTROWSKI JJ, 1990, LIFE SCI, V46, P715, DOI 10.1016/0024-3205(90)90077-5; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; ROUSSEAU EJ, 1992, FREE RADICAL BIO MED, V13, P407, DOI 10.1016/0891-5849(92)90183-H; SCHMIDT CJ, 1985, J PHARMACOL EXP THER, V233, P539; STOCKS J, 1974, CLIN SCI MOL MED, V47, P215, DOI 10.1042/cs0470215; VAJRAGUPTA O, 1988, J SCI SOC THAILAND, V14, P51; YAMAMOTO M, 1993, RES COMMUN CHEM PATH, V81, P221	30	18	19	1	4	HARWOOD ACAD PUBL GMBH	READING	C/O STBS LTD, PO BOX 90, READING, BERKS, ENGLAND RG1 8JL	1071-5762			FREE RADICAL RES	Free Radic. Res.		2000	32	2					145	155		10.1080/10715760000300151			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	276HG	WOS:000084871500005	10653485				2022-02-06	
J	Meyer, P; Legros, C; Orliaguet, G				Meyer, P; Legros, C; Orliaguet, G			Critical care management of neurotrauma in children: new trends and perspectives	CHILDS NERVOUS SYSTEM			English	Article; Proceedings Paper	World Conference on Pediatric Neurosurgery, 2000 AD	NOV 27-DEC 04, 1999	MARTINIQUE			pediatrics; head injury; cerebral monitoring; critical care; therapeutic hyperventilation; cerebral metabolic rate of oxygen	TRAUMATIC BRAIN INJURY; CEREBRAL BLOOD-FLOW; SEVERE HEAD-INJURY; INTRACRANIAL-PRESSURE; PEDIATRIC TRAUMA; ENDOTRACHEAL INTUBATION; HYPERVENTILATION; HYPERTENSION; HYPOTENSION; OXYGENATION	Secondary brain lesions resulting from cerebral metabolic and hemodynamic reactions can be prevented by neurocritical care management. It must be initiated as soon as possible, ideally in a prehospital setting. Tracheal intubation, controlled ventilation and hemodynamic stabilization are the prerequisites. Beside intracranial and cerebral perfusion pressure, monitoring must evaluate the coupling between cerebral metabolic demand and blood flow. Jugular bulb oximetry is the most reliable approach to global cerebral coupling. Transcranial Doppler evaluates cerebral blood flow indirectly and noninvasively. Technological developments have led to local metabolic evaluation that does not yet have any clinical relevance. Therapeutic developments are more a new approach to the use of old drugs. Controlled hyperventilation, mannitol and, more recently, hypertonic saline solutions, used for restoring cerebral metabolic coupling, are the foundations of treatment. Thiopental, revisited as a vasoconstrictive agent, the "Lund" vasoconstrictive approach with anti-hypertensive drugs and cerebral vasoconstrictors, must be further evaluated in children, as must therapeutic hypothermia. Finally, what we probably need for the immediate future is a noninvasive and easily reproducible method of monitoring cerebral metabolic coupling that will allow precise therapeutic adaptation of multimodal therapy to the individual needs of the child.	Hop Necker Enfants Malad, Dept Anesthesie Reanimat Pediat, F-75743 Paris 15, France		Meyer, P (corresponding author), Hop Necker Enfants Malad, Dept Anesthesie Reanimat Pediat, 149 Rue Sevres, F-75743 Paris 15, France.	philippe.meyer@nck.ap-hop-paris.fr	Meyer, Philippe/ABE-4242-2020	Meyer, Philippe/0000-0002-3829-6631; Orliaguet, Gilles/0000-0003-0930-2251			Alderson P, 1997, BRIT MED J, V314, P1855, DOI 10.1136/bmj.314.7098.1855; ALDRICH EF, 1992, J NEUROSURG, V76, P450, DOI 10.3171/jns.1992.76.3.0450; BLANOT S, 1995, BRIT J ANAESTH, V74, pA334; Boswell W C, 1995, Air Med J, V14, P125, DOI 10.1016/1067-991X(95)90513-8; Brownstein D, 1996, ANN EMERG MED, V28, P34, DOI 10.1016/S0196-0644(96)70136-1; Chesnut RM, 1998, J TRAUMA, V44, P958, DOI 10.1097/00005373-199806000-00003; Cruz J, 1996, J NEUROSURG, V85, P758, DOI 10.3171/jns.1996.85.5.0758; CRUZ J, 1990, J NEUROSURG, V73, P725, DOI 10.3171/jns.1990.73.5.0725; CRUZ J, 1992, J TRAUMA, V32, P629, DOI 10.1097/00005373-199205000-00015; CZONIKA M, 1997, NEUROSURGERY, V41, P11; DellaCorte F, 1997, ACTA NEUROCHIR, V139, P636; Eker C, 1998, CRIT CARE MED, V26, P1881, DOI 10.1097/00003246-199811000-00033; FISHER B, 1992, J NEUROSURG ANESTH, V4, P4, DOI 10.1097/00008506-199201000-00002; Furnival RA, 1996, PEDIATRICS, V98, P56; Giroux JD, 1993, REAN SOINS INTENS ME, V9, P35; HARTWELL RC, 1993, NEUROSURGERY, V32, P444, DOI 10.1227/00006123-199303000-00017; Kelly DF, 1996, J NEUROSURG, V85, P762, DOI 10.3171/jns.1996.85.5.0762; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; MEYER P, 1994, JEUR, V4, P193; Meyer PG, 1999, PAEDIATR ANAESTH, V9, P373, DOI 10.1046/j.1460-9592.1999.00391.x; MEYER PG, 1994, INT ANESTHESIOL CLIN, V32, P149; MEYER PG, 1999, IN PRESS PAEDIAT ANA; MICHAUD LJ, 1991, J TRAUMA, V31, P1356, DOI 10.1097/00005373-199110000-00007; MOESCHLER O, 1995, ANN FR ANESTH, V14, P114, DOI 10.1016/S0750-7658(05)80159-5; MOULTON C, 1994, LANCET, V343, P1261, DOI 10.1016/S0140-6736(94)92155-5; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; NAKAYAMA DK, 1990, ANN SURG, V211, P218, DOI 10.1097/00000658-199002000-00015; NAKAYAMA DK, 1992, ANN SURG, V216, P205, DOI 10.1097/00000658-199208000-00011; Newell DW, 1996, NEUROSURGERY, V39, P35, DOI 10.1097/00006123-199607000-00008; Orliaguet GA, 1997, ANESTH ANALG, V85, P1218; Orliaguet GA, 1998, ANESTH ANALG, V87, P537, DOI 10.1097/00000539-199809000-00006; PFENNINGER J, 1993, INTENS CARE MED, V19, P243, DOI 10.1007/BF01690543; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; SANKER P, 1991, CHILD NERV SYST, V7, P391, DOI 10.1007/BF00304204; SHACKFORD SR, 1992, J NEUROSURG, V76, P91, DOI 10.3171/jns.1992.76.1.0091; SHARPLES PM, 1990, BRIT MED J, V300, P87, DOI 10.1136/bmj.300.6717.87; SIMMA B, 1998, CRIT CARE MED, V8, P1161; STEIGER HJ, 1994, NEUROSURGERY, V34, P79; Suominen P, 1998, J PEDIATR SURG, V33, P1388, DOI 10.1016/S0022-3468(98)90014-8; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; ZORNOW MH, 1987, ANESTHESIOLOGY, V67, P936, DOI 10.1097/00000542-198712000-00010	42	18	18	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	NOV	1999	15	11-12					732	739		10.1007/s003810050462			8	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Neurosciences & Neurology; Pediatrics; Surgery	258WM	WOS:000083862700014	10603014				2022-02-06	
J	Wissel, J; Muller, J; Heinen, F; Mall, V; Sojer, M; Ebersbach, G; Poewe, W				Wissel, J; Muller, J; Heinen, F; Mall, V; Sojer, M; Ebersbach, G; Poewe, W			Safety and tolerance of a single dose of botulinum toxin type A in patients with local spasticity-associated problems: A prospective open multicenter study comprising 204 patients	WIENER KLINISCHE WOCHENSCHRIFT			German	Article						spasticity; botulinum toxin type A; rehabilitation; pain	PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; MUSCLE; PARALLEL	High dose oral anti-spastic medication is effective in the treatment of spasticity but has the disadvantage of frequent systemic side effects such as drowsiness and general weakness. Therefore, neurolytic and chemodenervation procedures are further therapeutic options, especially in cases of local spasticity. Apart from phenol blocks with the risk of persisting painful dysesthesia, botulinum toxin type A (BtxA) appears to be a safe and effective treatment. In 204 patients (mean age, 41.5 years [range 3-91 years]) with acute (n = 29, mean duration of disease 2.9 months [range, 1-6 months]) and chronic (n = 175, mean duration of disease 111 months [range, 7-500 months]) spasticity due to stroke, traumatic brain and spinal injury and other lesions of the upper motor neuron, the effects of single-dose BtxA treatment were studied. An overall dose of 181.2 units [range, 15-600 units] of BtxA (Botox(R)) was injected in a mean of 3.3 [1-14] muscles per patient. Results were assessed using a modified Rating of Response to BtxA (RRB, Brin et al. 1995). The RRB includes a pre- and post BtxA assessment of the severity of spasticity-associated problems (patient's self-assessment), a rating of the current percentage of normal function in the region of the body selected for BtxA and a global rating of changes induced by BtxA. 191 (93.6%) patients demonstrated improvement over a mean of 7.7 weeks [1-36]; no deterioration was observed. Mean overall severity and function improved significantly (p < 0.001). No systemic or severe side effects were registered. Only in 5.9% of the patients were mild (n = 10) or moderate (n = 2) reversible adverse events reported. We conclude that BtxA injections are safe and effective in the treatment of local spasticity.	Univ Innsbruck, Neurol Klin, A-6020 Innsbruck, Austria; Univ Freiburg, Kinderklin, Abt Neuropadiat & Muskelerkrankungen, D-7800 Freiburg, Germany		Wissel, J (corresponding author), Univ Innsbruck, Neurol Klin, Anichstr 35, A-6020 Innsbruck, Austria.	Joerg.Wissel@uibk.ac.at	Heinen, Florian/B-6594-2015	Heinen, Florian/0000-0002-3872-6136; Ebersbach, Georg/0000-0003-3403-6987			BERGER W, 1984, J NEUROL NEUROSUR PS, V47, P1029, DOI 10.1136/jnnp.47.9.1029; BOHANNON RW, 1987, PHYS THER, V67, P659, DOI 10.1093/ptj/67.5.659; Brin MF, 1995, TREATMENT MOVEMENT D, P183; Emre M., 1993, SPASTICITY MECH MANA, P372; GRAZKO MA, 1995, NEUROLOGY, V45, P712, DOI 10.1212/WNL.45.4.712; Heinen F, 1997, NEUROPEDIATRICS, V28, P307, DOI 10.1055/s-2007-973721; Hesse S, 1998, CLIN REHABIL, V12, P381, DOI 10.1191/026921598668275996; HESSE S, 1994, J NEUROL NEUROSUR PS, V57, P1321, DOI 10.1136/jnnp.57.11.1321; HUFSCHMIDT A, 1985, J NEUROL NEUROSUR PS, V48, P676, DOI 10.1136/jnnp.48.7.676; JANKOVIC J, 1991, NEW ENGL J MED, V324, P1186, DOI 10.1056/nejm199104253241707; Lance J.W., 1980, SPASTICITY DISORDERE, P485; MEMIN B, 1992, REV NEUROL, V148, P212; Odergren T, 1998, J NEUROL NEUROSUR PS, V64, P6, DOI 10.1136/jnnp.64.1.6; Reiter F, 1996, J NEUROL REHABIL, V10, P47; Rosales RL, 1996, MUSCLE NERVE, V19, P488, DOI 10.1002/(SICI)1097-4598(199604)19:4<488::AID-MUS9>3.0.CO;2-8; Sampaio C, 1997, MOVEMENT DISORD, V12, P1013, DOI 10.1002/mds.870120627; Schnider P, 1999, WIEN KLIN WOCHENSCHR, V111, P59; Simpson DM, 1996, NEUROLOGY, V46, P1306, DOI 10.1212/WNL.46.5.1306; SNOW BJ, 1990, ANN NEUROL, V28, P512, DOI 10.1002/ana.410280407; *SPAST STUD GROUP, 1997, MUSCLE NERVE       S, V6, P208; Wissel J, 1999, NEUROPEDIATRICS, V30, P120, DOI 10.1055/s-2007-973475	21	18	19	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0043-5325	1613-7671		WIEN KLIN WOCHENSCHR	Wien. Klin. Wochen.	OCT 29	1999	111	20					837	842					6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	261EP	WOS:000083996300003	10586488				2022-02-06	
J	Spitzfaden, AC; Jimenez, DF; Tobias, JD				Spitzfaden, AC; Jimenez, DF; Tobias, JD			Propofol for sedation and control of intracranial pressure in children	PEDIATRIC NEUROSURGERY			English	Article						propofol; intracranial pressure; traumatic brain injury	INTENSIVE-CARE UNIT; TRAUMATIC BRAIN INJURY; SEVERE HEAD-INJURY; INTRAVENOUS ANESTHETICS; PROLONGED SEDATION; METABOLIC-ACIDOSIS; INFUSION; MIDAZOLAM; PATIENT	Following central nervous system insults, control of intracranial pressure may lessen the incidence of morbidity and mortality. Therapies to control intracranial pressure include osmolar agents, prevention of and control of seizures, drainage of cerebrospinal fluid, hypothermia, and barbiturates. Control of agitation and excessive patient movement are additional components in the management of ICP. Although opioids and benzodiazepines are generally effective, in a small subset of patients, alternative agents may be necessary. The authors present 2 children with increased ICP in whom propofol was used to provide sedation and control ICP. The use of propofol in this setting and its possible applications in the children with increased ICP are discussed. Copyright (C) 2000 S. Karger AG, Basel.	Univ Missouri, Dept Child Hlth Anesthesiol, Columbia, MO 65211 USA; Univ Missouri, Dept Neurosurg, Columbia, MO 65211 USA		Tobias, JD (corresponding author), Univ Missouri, Dept Child Hlth, Hlth Sci Ctr M658, 1 Hosp Dr, Columbia, MO 65212 USA.	Joseph_Tobias@muccmail.missouri.edu					BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BELLER JP, 1988, BRIT J ANAESTH, V61, P583, DOI 10.1093/bja/61.5.583; Bray RJ, 1998, PAEDIATR ANAESTH, V8, P491; BRUSSEL T, 1989, ANESTH ANALG, V69, P35; BULLOCK R, 1993, ACTA NEUROCHIR, P113; EGAN TD, 1991, ANESTH ANALG, V73, P818; FARLING PA, 1989, ANAESTHESIA, V44, P222, DOI 10.1111/j.1365-2044.1989.tb11228.x; FINLEY GA, 1993, CAN J ANAESTH, V40, P863, DOI 10.1007/BF03009258; GOTTARDIS M, 1989, BRIT J ANAESTH, V62, P393, DOI 10.1093/bja/62.4.393; Hanna JP, 1998, NEUROLOGY, V50, P301, DOI 10.1212/WNL.50.1.301; HARRIS CE, 1990, ANAESTHESIA, V45, P366, DOI 10.1111/j.1365-2044.1990.tb14777.x; Herregods L, 1988, Anaesthesia, V43 Suppl, P107, DOI 10.1111/j.1365-2044.1988.tb09089.x; Hertzog JH, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.3.e30; LAXENAIRE MC, 1992, ANESTHESIOLOGY, V77, P275, DOI 10.1097/00000542-199208000-00009; Lowenstein DH, 1998, NEW ENGL J MED, V338, P970, DOI 10.1056/NEJM199804023381407; Mangez J F, 1987, Ann Fr Anesth Reanim, V6, P336, DOI 10.1016/S0750-7658(87)80055-2; Marion DW, 1997, J INTENSIVE CARE MED, V12, P239, DOI 10.1177/088506669701200504; MATTA BF, 1995, BRIT J ANAESTH, V74, P159, DOI 10.1093/bja/74.2.159; MERGAERT C, 1991, EUR J ANAESTH, V8, P324; Nimkoff L, 1997, J CRIT CARE, V12, P132, DOI 10.1016/S0883-9441(97)90042-3; PARKE TJ, 1992, BRIT MED J, V305, P613, DOI 10.1136/bmj.305.6854.613; PINAUD M, 1990, ANESTHESIOLOGY, V73, P404, DOI 10.1097/00000542-199009000-00007; RAVUSSIN P, 1988, ANAESTHESIA S, V43, P107; Sanchez-Izquierdo-Riera JA, 1998, ANESTH ANALG, V86, P1219, DOI 10.1097/00000539-199806000-00016; SEBEL PS, 1989, ANESTHESIOLOGY, V71, P260, DOI 10.1097/00000542-198908000-00015; SLADEN RN, 1995, CRIT CARE MED, V23, P423, DOI 10.1097/00003246-199503000-00001; SOSIS MB, 1993, ANESTH ANALG, V77, P766; STEWART L, 1994, ACTA NEUROCHIR, P544; STRICKLAND RA, 1995, CRIT CARE MED, V23, P405, DOI 10.1097/00003246-199502000-00029; Thakker JC, 1997, CRIT CARE MED, V25, P1396, DOI 10.1097/00003246-199708000-00030; TOBIAS JD, IN PRESS CRIT CARE M; TROTTER C, 1992, ANAESTHESIA, V47, P340, DOI 10.1111/j.1365-2044.1992.tb02178.x; VALENTE JF, 1994, CRIT CARE MED, V22, P710, DOI 10.1097/00003246-199404000-00030; VANHEMELRIJCK J, 1990, ANESTH ANALG, V71, P49; Watts ADJ, 1998, ANESTH ANALG, V87, P564, DOI 10.1097/00000539-199809000-00012; WEIGHTMAN WM, 1992, ANAESTHESIA, V47, P500, DOI 10.1111/j.1365-2044.1992.tb02275.x; Yamaguchi S, 1999, CAN J ANAESTH, V46, P593, DOI 10.1007/BF03013553; 1990, MMWR, V39, P426	38	18	18	0	2	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291	1423-0305		PEDIATR NEUROSURG	Pediatr. Neurosurg.	OCT	1999	31	4					194	200		10.1159/000028861			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	280QF	WOS:000085112900006	10705929				2022-02-06	
J	Vajramani, GV; Chandramouli, BA; Jayakumar, PN; Kolluri, S				Vajramani, GV; Chandramouli, BA; Jayakumar, PN; Kolluri, S			Evaluation of posttraumatic vasospasm, hyperaemia, and autoregulation by transcranial colour-coded duplex sonography	BRITISH JOURNAL OF NEUROSURGERY			English	Article						autroregulation; posttraumatic hyperaemia; posttraumatic vasospasm; severe head injury; transcranial Doppler	CEREBRAL BLOOD-FLOW; SEVERE HEAD-INJURY; TRAUMATIC BRAIN INJURY; DOPPLER ULTRASOUND; INTRACRANIAL HYPERTENSION; ANGIOGRAPHIC FINDINGS; PERFUSION-PRESSURE; VELOCITY; HYPEREMIA; ULTRASONOGRAPHY	Serial transcranial colour-coded duplex sonography (TCCS) was performed on 24: adult patients with severe head injury (GCS 8 or less). Flow velocities were obtained from the middle cerebral artery (MCA) and extracranial internal carotid artery (EICA). An autoregulation study was done using the transient hyperaemic response test, evidence of vasospasm (V-MCA greater than 100 cm/s and Lindegaard ratio more than 3) was found in nine patients (37%). Two of these developed non-contusion-related infarction and two others contusion-related infarction. This was significant (p < 0.05). Vasospasm started around day 2, reaching maximum around day 4 and persisting until the second week. Vasospasm was significantly associated with a poor outcome (p < 0.05). There was no correlation between the extent of SAH as seen on CT and vasospasm. Evidence of hyperaemia were observed in two patients (8%) and impaired autoregulation in seven patients (29%). Impaired autoregulation was significantly associated with development of hyperaemia (p < 0.05). TCCS studies permit a non-invasive evaluation of cerebral haemodynamics that will help in the management of head injured patients.	Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bangalore 29, Karnataka, India; Natl Inst Mental Hlth & Neurosci, Dept Neuroradiol, Bangalore 29, Karnataka, India		Chandramouli, BA (corresponding author), Natl Inst Mental Hlth & Neurosci, Dept Neurosurg, Bangalore 29, Karnataka, India.		VAJRAMANI, Girish/AAP-6731-2021; VAJRAMANI, Girish/AAS-3937-2021				AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; CHAN KH, 1992, J NEUROSURG, V77, P55, DOI 10.3171/jns.1992.77.1.0055; CHAN KH, 1992, SURG NEUROL, V38, P433, DOI 10.1016/0090-3019(92)90111-Y; CHAN KH, 1992, NEUROSURGERY, V30, P697; COLD GE, 1978, ACTA ANAESTH SCAND, V22, P249, DOI 10.1111/j.1399-6576.1978.tb01299.x; COLD GE, 1980, ACTA ANAESTH SCAND, V24, P245, DOI 10.1111/j.1399-6576.1980.tb01544.x; COMPTON J S, 1990, British Journal of Neurosurgery, V4, P9, DOI 10.3109/02688699009000676; CZOSNYKA M, 1993, ACTA NEUROCHIR, V121, P159, DOI 10.1007/BF01809269; ENEVOLDSEN EM, 1978, J NEUROSURG, V48, P689, DOI 10.3171/jns.1978.48.5.0689; FIESCHI C, 1974, J NEUROL NEUROSUR PS, V37, P1378, DOI 10.1136/jnnp.37.12.1378; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; GILLER CA, 1991, ACTA NEUROCHIR, V108, P7, DOI 10.1007/BF01407660; GORAJ B, 1993, RADIOLOGY, V188, P137, DOI 10.1148/radiology.188.1.8511287; ITO U, 1986, ACTA NEUROCHIR, V79, P120, DOI 10.1007/BF01407455; Kelly DF, 1996, J NEUROSURG, V85, P762, DOI 10.3171/jns.1996.85.5.0762; LASSEN NA, 1966, LANCET, V2, P1113, DOI 10.1016/S0140-6736(66)92199-4; Lee JH, 1997, J NEUROSURG, V87, P221, DOI 10.3171/jns.1997.87.2.0221; LINDEGAARD KF, 1989, ACTA NEUROCHIR, V100, P12, DOI 10.1007/BF01405268; MACPHERSON P, 1978, J NEUROL NEUROSUR PS, V41, P122, DOI 10.1136/jnnp.41.2.122; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; MUTTAQIN Z, 1993, ACTA NEUROCHIR, V123, P76, DOI 10.1007/BF01476289; NEWELL DW, 1995, NEUROSONOLOGY, P189; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; OBRIST WD, 1979, J NEUROSURG, V51, P292, DOI 10.3171/jns.1979.51.3.0292; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; PASQUALIN A, 1984, NEUROSURGERY, V15, P855, DOI 10.1227/00006123-198412000-00015; PAULSON OB, 1972, NEUROLOGY, V22, P286, DOI 10.1212/WNL.22.3.286; ROZSA L, 1989, NEUROSURG REV, V12, P133, DOI 10.1007/BF01741486; SANDER D, 1993, J NEUROL SCI, V119, P1, DOI 10.1016/0022-510X(93)90185-2; Smielewski P, 1997, J NEUROSURG, V86, P773, DOI 10.3171/jns.1997.86.5.0773; Smielewski P, 1996, STROKE, V27, P2197, DOI 10.1161/01.STR.27.12.2197; STEIGER HJ, 1994, NEUROSURGERY, V34, P79; WEBER M, 1990, NEUROSURGERY, V27, P106, DOI 10.1227/00006123-199007000-00015; ZANE CJ, 1992, J NEUROSURG, V76, pA399; ZURYNSKI YA, 1995, J NEUROL SCI, V134, P41, DOI 10.1016/0022-510X(95)00178-X; ZURYNSKI YA, 1995, J NEUROL SCI, V134, P33, DOI 10.1016/0022-510X(95)00172-9	42	18	18	0	0	CARFAX PUBLISHING	BASINGSTOKE	RANKINE RD, BASINGSTOKE RG24 8PR, HANTS, ENGLAND	0268-8697			BRIT J NEUROSURG	Br. J. Neurosurg.	OCT	1999	13	5					468	473		10.1080/02688699943277			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	242VC	WOS:000082961500006	10627777				2022-02-06	
J	Watt, S; Shores, EA; Kinoshita, S				Watt, S; Shores, EA; Kinoshita, S			Effects of reducing attentional resources on implicit and explicit memory after severe traumatic brain injury	NEUROPSYCHOLOGY			English	Article							CLOSED-HEAD-INJURY; DIVIDED ATTENTION; PERFORMANCE; TESTS; AMNESIA; WORDS	Implicit and explicit memory were examined in individuals with severe traumatic brain injury (TBI) under conditions of full and divided attention. Participants included 12 individuals with severe TBI and 12 matched controls. In Experiment 1, participants carried out an implicit test of word-stem completion and an explicit test of cued recall. Results demonstrated that TBI participants exhibited impaired explicit memory but preserved implicit memory. In Experiment 2, a significant reduction in the explicit memory performance of both TBI and control participants, as well as a significant decrease in the implicit memory performance of TBI participants, was achieved by reducing attentional resources at encoding. These results indicated that performance on an implicit task of word-stem completion may require the availability of additional attentional resources that are not preserved after severe TBI.	Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia		Watt, S (corresponding author), Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia.			Kinoshita, Sachiko/0000-0002-5288-2485; Shores, Edwin A/0000-0003-1553-5131			AURENBACH SH, 1986, J HEAD TRAUMA REHAB, V1, P1; Baayen RH., 1993, CELEX LEXICAL DATABA; BADDELEY A, 1993, BRIT J CLIN PSYCHOL, V32, P55, DOI 10.1111/j.2044-8260.1993.tb01027.x; Baddeley A., 1992, SPEED CAPACITY LANGU; Berg EA, 1948, J GEN PSYCHOL, V39, P15, DOI 10.1080/00221309.1948.9918159; CHAPMAN LJ, 1994, DEV REV, V14, P159, DOI 10.1006/drev.1994.1007; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; EICH E, 1984, MEM COGNITION, V12, P105, DOI 10.3758/BF03198423; Fahy JF., 1993, NEUROPSYCHOLOGY, V7, P136, DOI [10.1037/0894-4105.7.2.136, DOI 10.1037/0894-4105.7.2.136]; FELVUS J, 1989, ACER PSYCHOL TEST B, V2, P20; GRABRIELI JDE, 1996, M PSYCH SOC CHIC IL; GRAF P, 1984, J VERB LEARN VERB BE, V23, P553, DOI 10.1016/S0022-5371(84)90346-3; GRAF P, 1985, J EXP PSYCHOL LEARN, V11, P386, DOI 10.1037/0278-7393.11.2.386; GRAF P, 1985, J EXP PSYCHOL LEARN, V11, P501, DOI 10.1037/0278-7393.11.3.501; GRAF P, 1984, J EXP PSYCHOL LEARN, V10, P164, DOI 10.1037/0278-7393.10.1.164; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; Hart T, 1993, J HEAD TRAUMA REHAB, V8, P1; HIRST W, 1982, PSYCHOL BULL, V91, P435, DOI 10.1037/0033-2909.91.3.435; JERNIGAN TL, 1993, NEUROPSYCHOLOGY, V7, P14, DOI DOI 10.1037/0894-4105.7.1.14; KING MG, 1986, ACER B PSYCHOL, V39, P3; KREUTZER JS, 1993, J HEAD TRAUMA REHAB, V8, P47; LEVIN HS, 1992, NEUROPSYCHOLOGY MEMO, P291; Mulligan NW, 1996, MEM COGNITION, V24, P453, DOI 10.3758/BF03200934; Mulligan NW, 1997, MEM COGNITION, V25, P11, DOI 10.3758/BF03197281; MUTTER SA, 1990, COGNITIVE NEUROPSYCH, V7, P329, DOI 10.1080/02643299008253447; NISSEN M, 1986, J HEAD TRAUMA REHAB, V1, P13; Parkin A. J., 1993, NEUROPSYCHOLOGY AMNE; Parkin A. J., 1990, EUROPEAN J COGNITIVE, V2, P71, DOI [DOI 10.1080/09541449008406198, 10.1080/09541449008406198]; PARKIN AJ, 1990, MEM COGNITION, V18, P507, DOI 10.3758/BF03198483; ROEDIGER HL, 1990, AM PSYCHOL, V45, P1043, DOI 10.1037/0003-066X.45.9.1043; Ruff RM, 1996, ARCH CLIN NEUROPSYCH, V11, P329, DOI 10.1016/0887-6177(95)00033-X; RUFF RM, 1988, J CLIN EXPT NEUROPSY, V11, P539; Schacter D.L., 1988, THOUGHT LANGUAGE, P242; SCHACTER DL, 1986, J CLIN EXP NEUROPSYC, V8, P727, DOI 10.1080/01688638608405192; SCHACTER DL, 1987, J EXP PSYCHOL LEARN, V13, P501, DOI 10.1037/0278-7393.13.3.501; SCHACTER DL, 1977, CORTEX, V13, P150, DOI 10.1016/S0010-9452(77)80006-3; SchmitterEdgecombe M, 1996, NEUROPSYCHOLOGY, V10, P155; SHIMAMURA AP, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P173; Shimamura Arthur P., 1993, P265; Shum D, 1996, J HEAD TRAUMA REHAB, V11, P43, DOI 10.1097/00001199-199604000-00005; SMITH ME, 1990, J EXP PSYCHOL LEARN, V16, P1033, DOI 10.1037/0278-7393.16.6.1033; STRATTON MC, 1994, BRAIN INJURY, V8, P631, DOI 10.3109/02699059409151016; Wechsler D, 1981, WECHSLER ADULT INTEL; WILSON JTL, 1992, J HEAD TRAUMA REHAB, V7, P29; Winocur G, 1996, NEUROPSYCHOLOGY, V10, P57, DOI 10.1037/0894-4105.10.1.57; [No title captured]	46	18	18	0	1	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105			NEUROPSYCHOLOGY	Neuropsychology	JUL	1999	13	3					338	349		10.1037/0894-4105.13.3.338			12	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	221TH	WOS:000081742100002	10447296				2022-02-06	
J	Horne, LT; Blue, BA				Horne, LT; Blue, BA			Intraarticular heterotopic ossification in the knee following intramedullary nailing of the fractured femur using a retrograde method	JOURNAL OF ORTHOPAEDIC TRAUMA			English	Article						retrograde intramedullary rod; heterotopic ossification; femur fracture; knee	HIP-ARTHROPLASTY; REPLACEMENT; IBUPROFEN	The cases of a forty-five-year-old woman and a twenty-year-old man who developed severe intraarticular and periarticular heterotopic ossification around the knee following intramedullary nailing of a femur fracture using a retrograde technique. The association of musculoskeletal heterotopic ossification with closed head injuries seems well established and can occur in and around the knee following retrograde intramedullary nailing. This complication may occur more often than has been reported.	Univ S Carolina, Sch Med, Dept Orthopaed Surg, Columbia, SC 29203 USA		Blue, BA (corresponding author), Univ S Carolina, Sch Med, Dept Orthopaed Surg, 2 Richland Med Pk,Suite 404, Columbia, SC 29203 USA.						AHRENGART L, 1994, ACTA ORTHOP SCAND, V65, P139, DOI 10.3109/17453679408995421; BRUMBACK RJ, 1992, J BONE JOINT SURG AM, V74A, P106, DOI 10.2106/00004623-199274010-00013; BRUMBACK RJ, 1990, J BONE JOINT SURG AM, V72A, P1067, DOI 10.2106/00004623-199072070-00017; ELMSTEDT E, 1985, ACTA ORTHOP SCAND, V56, P25, DOI 10.3109/17453678508992973; FIROOZBAKHSH K, 1995, J ORTHOP TRAUMA, V9, P152, DOI 10.1097/00005131-199504000-00011; FREEMAN PA, 1973, CLIN ORTHOP RELAT R, P224; Gebuhr P, 1996, ACTA ORTHOP SCAND, V67, P29, DOI 10.3109/17453679608995604; GEBUHR P, 1991, ACTA ORTHOP SCAND, V62, P226, DOI 10.3109/17453679108993597; GOSSELIN RA, 1993, J TRAUMA, V34, P161, DOI 10.1097/00005373-199301000-00033; HARRIS LJ, 1980, J BONE JOINT SURG AM, V62, P1185, DOI 10.2106/00004623-198062070-00021; Letournel E, 1993, FRACTURES ACETABULUM; MARKS PH, 1988, J TRAUMA, V28, P1207, DOI 10.1097/00005373-198808000-00012; MOED BR, 1994, J BONE JOINT SURG BR, V76B, P895, DOI 10.1302/0301-620X.76B6.7983114; Moore T J, 1993, J Orthop Trauma, V7, P11, DOI 10.1097/00005131-199302000-00003; NOLLEN AJG, 1993, ACTA ORTHOP SCAND, V64, P185, DOI 10.3109/17453679308994567; PATTERSON BM, 1995, J TRAUMA, V38, P38, DOI 10.1097/00005373-199501000-00012; ROSENDAHL S, 1977, ACTA ORTHOP SCAND, V48, P400, DOI 10.3109/17453677708992016; SANDERS R, 1993, J ORTHOP TRAUMA, V7, P293, DOI 10.1097/00005131-199308000-00001; STEINBERG GG, 1993, J ORTHOP TRAUMA, V7, P536, DOI 10.1097/00005131-199312000-00009; Tornetta P 3rd, 1992, J Orthop Trauma, V6, P113; WLODARSKI KH, 1991, CLIN ORTHOP RELAT R, P8	21	18	18	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0890-5339			J ORTHOP TRAUMA	J. Orthop. Trauma	JUN-JUL	1999	13	5					385	388		10.1097/00005131-199906000-00013			4	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	207LQ	WOS:000080938700013	10406709				2022-02-06	
J	Curtiss, S; de Bode, S				Curtiss, S; de Bode, S			Age and etiology as predictors of language outcome following hemispherectomy	DEVELOPMENTAL NEUROSCIENCE			English	Article						hemispherectomy; language; language development; plasticity; linguistic outcomes	CLOSED HEAD-INJURY; INFANTILE HEMIPLEGICS; NARRATIVE DISCOURSE; BRAIN INJURY; CHILDREN; HEMIDECORTICATION; COMPREHENSION; EPILEPSY; MEMORY; SPEECH	We report on the effects of etiology and age on the linguistic outcomes in a large pediatric hemispherectomy population. Four populations were considered separately: cortical dysplasia (multilobar involvement), Rasmussen's encephalitis, infarction as a primary etiology and, fourth, children who failed to develop language, regardless of etiology. We argue against the 'the-earlier-the-better' hypothesis and propose our own hypothesis that weds maturational factors to etiological factors to predict language outcomes following pervasive brain insult. The implications of our 'critical impact point' hypothesis are discussed. Copyright (C) 1999 S.Karger AG, Basel.	Univ Calif Los Angeles, Dept Linguist, Neurolinguist Lab, Los Angeles, CA 90095 USA		Curtiss, S (corresponding author), Univ Calif Los Angeles, Dept Linguist, Neurolinguist Lab, 405 Hilgard Ave, Los Angeles, CA 90095 USA.	scurtiss@ucla.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS28383] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS028383, P50NS028383] Funding Source: NIH RePORTER		Anderson V, 1997, J Int Neuropsychol Soc, V3, P147; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; ARAM D, 1992, DEV NEUROPSYCHOL, V8, P171; BATES E, 1992, HDB NEUROPSYCHOLOGY, V6; CAPLAN R, 1989, J AM ACAD CHILD ADOL, V28, P208; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; COHEN M, 1992, BRAIN COGNITION, V20, P315, DOI 10.1016/0278-2626(92)90024-G; CURTISS S, 1999, UNPUB BRAIN LANG; CURTISS S, 1997, 4 ANN SOC COGN NEUR; CURTISS S, 1997, P 21 ANN BOST U C LA, P103; CURTISS S, 1998, BOST U C LANG DEV BO; DAY P, 1979, BRAIN LANG, V10, P287; DEBODE S, 1999, P 23 BOST U C LANG D; DEBODE S, 1998, P 22 BOST U C LANG D, V1, P150; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; DENNIS M, 1980, BRAIN LANG, V10, P287, DOI 10.1016/0093-934X(80)90058-9; DENNIS M, 1975, BRAIN LANG, V2, P472, DOI 10.1016/S0093-934X(75)80084-8; Dennis M, 1989, CLIN NEUROPSYCHOLOGY, P89; DENNIS M, 1980, BIOL STUDIES MENTAL, P159; Duchowny M, 1996, ANN NEUROL, V40, P31, DOI 10.1002/ana.410400108; FENSON L, 1990, MACARTHUR COMMUNICAT; GALLAGHER T, 1996, 3 D ULTRASONIC FETAL; GORDON N, 1996, DEV MED CHILD NEUROL, V38, P133; HELMSTAEDTER C, 1994, BRAIN, V117, P729, DOI 10.1093/brain/117.4.729; HEMPHILL L, 1994, J COMMUN DISORD, V27, P107, DOI 10.1016/0021-9924(94)90037-X; Kennard MA, 1940, ARCH NEURO PSYCHIATR, V44, P377, DOI 10.1001/archneurpsyc.1940.02280080137008; KINSBOURNE M, 1974, HEMISPHERIC DISCONNE, P34; Kolb B, 1998, ANNU REV PSYCHOL, V49, P43, DOI 10.1146/annurev.psych.49.1.43; KOLB B, 1990, CEREBRAL CORTEX RAT, P537; LECOURS A, 1985, NEONATE COGNITION; Locke JL, 1997, BRAIN LANG, V58, P265, DOI 10.1006/brln.1997.1791; Mills Debra L., 1994, P427; Ogden JA, 1996, NEUROPSYCHOLOGIA, V34, P905, DOI 10.1016/0028-3932(96)00005-X; OLEARY DS, 1983, J NERV MENT DIS, V171, P624, DOI 10.1097/00005053-198310000-00006; Peacock WJ, 1996, CHILD NERV SYST, V12, P376, DOI 10.1007/BF00395089; RIVA D, 1986, NEUROPSYCHOLOGIA, V24, P423, DOI 10.1016/0028-3932(86)90029-1; ROSSI PG, 1996, DYSPLASIAS CEREBRAL; Segalowitz S. J, 1988, BRAIN LATERALIZATION; Stark RE, 1997, BRAIN LANG, V60, P222, DOI 10.1006/brln.1997.1800; Stark RE, 1995, BRAIN LANG, V51, P406, DOI 10.1006/brln.1995.1068; STILES J, 1993, HUMAN BEHAV DEV BRAI, P643; STRAUSS E, 1983, BRAIN LANG, V20, P1, DOI 10.1016/0093-934X(83)90027-5; THAL DJ, 1991, BRAIN LANG, V40, P491, DOI 10.1016/0093-934X(91)90145-Q; VarghaKhadem F, 1997, BRAIN, V120, P159, DOI 10.1093/brain/120.1.159; VARGHAKHADEM F, 1992, ADV EXP MED BIOL, V325, P137; VARGHAKHADEM F, 1991, BRAIN, V114, P473, DOI 10.1093/brain/114.1.473; WITELSON S, 1985, LANGUAGE FUNCTION BR	47	18	19	0	8	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0378-5866			DEV NEUROSCI-BASEL	Dev. Neurosci.	MAY-OCT	1999	21	3-5					174	181		10.1159/000017396			8	Developmental Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Neurosciences & Neurology	262GM	WOS:000084057600003	10575240				2022-02-06	
J	Lafuente, JV; Cervos-Navarro, J				Lafuente, JV; Cervos-Navarro, J			Craniocerebral trauma induces hemorheological disturbances	JOURNAL OF NEUROTRAUMA			English	Article						fibrinolysis; hemorheology; microthrombi; traumatic brain injury	DISSEMINATED INTRAVASCULAR COAGULATION; HEAD-INJURY; ENDOTHELIAL-CELLS; BRAIN; MICROTHROMBI; ADHESION; ISCHEMIA; INVIVO; MODELS	Several mechanisms are involved in the development of secondary ischemic brain damage, including microthrombi formation, which is thought to play a prominent role. Ninety-four autopsy cases were macro- and microscopically examined by specific staining for fibrin, 74 of which showed cortical contusion after a craniocerebral trauma, Twenty cases with no neurological pathology were used as controls, Traumatic cases comprised 52 males and 22 females, with a mean age of 48 years; most cases died in the first 48 h, The total number of fibrinous microthrombi in a slice of each hemisphere was determined. The mean number of microthrombi found in contused hemisphere was 152 (37-283), with 88 in the contralateral hemisphere (21-139) as compared to 13 (0-27) in control cases, Differences were statistically significant. Globular microthrombi or "shock bodies" (2-60 mu diameter) were present in five cases. Enhanced presence of microthrombi in contused brain areas, higher incidence in young people, an increase in the amount of microthrombi up to the 9th day after injury and involvement of the contralateral hemisphere free of contusion foci were all demonstrated, Microthrombi would therefore seem to be one of the central secondary events after brain trauma to bear in mind when designing treatment strategies.	Univ Int Catalunya, Inst Neurol & Gerontol Sci, Barcelona 08017, Spain; Univ Basque Country, Dept Neurosci, Leioa, Spain		Cervos-Navarro, J (corresponding author), Univ Int Catalunya, Inst Neurol & Gerontol Sci, C Inmaculada 22, Barcelona 08017, Spain.		Lafuente, Jose-Vicente/O-6395-2014	Lafuente, Jose-Vicente/0000-0001-7246-0987			ANDERSON M L, 1990, Neurological Research, V12, P195; ARGENBRIGHT LW, 1992, J CLIN INVEST, V89, P259, DOI 10.1172/JCI115570; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; FADEN AI, 1992, AM J PHYSIOL, V263, pR909, DOI 10.1152/ajpregu.1992.263.4.R909; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; Graham DI, 1997, GREENFIELDS NEUROPAT, P197; HALLENBECK JM, 1994, ACTA NEUROCHIR, P233; Heye N, 1996, STROKE, V27, P431, DOI 10.1161/01.STR.27.3.431; HEYE N, 1992, ACTA NEUROL SCAND, V86, P450, DOI 10.1111/j.1600-0404.1992.tb05122.x; HUBER A, 1993, INT J LEGAL MED, V106, P152, DOI 10.1007/BF01225238; JAFFE EA, 1973, J CLIN INVEST, V52, P2757, DOI 10.1172/JCI107471; JANIGRO D, 1994, CIRC RES, V75, P528, DOI 10.1161/01.RES.75.3.528; KAUFMAN HH, 1984, NEUROSURGERY, V15, P34, DOI 10.1227/00006123-198407000-00008; LADEWIG P, 1938, Z MIKROSKOP TECHNIK, V55, P215; Lafuente JV, 1998, REV NEUROLOGIA, V26, P224, DOI 10.33588/rn.26150.981062; Lafuente JV, 1999, NEUROPATHOLOGY, V19, P28, DOI 10.1046/j.1440-1789.1999.00204.x; LEESTMA JE, 1988, FORENSIC NEUROPATHOL, P157; Maeda T, 1997, ACT NEUR S, V70, P102; MANLOW A, 1992, J NEUROPATH EXP NEUR, V51, P298, DOI 10.1097/00005072-199205000-00008; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; Mendoza L, 1998, J CELL PHYSIOL, V174, P322; MENTER DG, 1987, CLIN EXP METASTAS, V5, P65, DOI 10.1007/BF00116627; MINER ME, 1982, J PEDIATR-US, V100, P687, DOI 10.1016/S0022-3476(82)80565-9; ORFEO T, 1994, J TRAUMA, V37, P347, DOI 10.1097/00005373-199409000-00003	25	18	18	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	1999	16	5					425	430		10.1089/neu.1999.16.425			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	200WC	WOS:000080562200008	10369562				2022-02-06	
J	Sweet, JJ; Suchy, Y; Leahy, B; Abramowitz, C; Nowinski, CJ				Sweet, JJ; Suchy, Y; Leahy, B; Abramowitz, C; Nowinski, CJ			Normative clinical relationships between orientation and memory: Age as an important moderator variable	CLINICAL NEUROPSYCHOLOGIST			English	Article							MINI-MENTAL-STATE; CONFIRMATORY FACTOR-ANALYSIS; CLOSED-HEAD-INJURY; ALZHEIMERS-DISEASE; SCALE; DISORIENTATION; PERFORMANCE; DIAGNOSIS; DEMENTIA; ADULTS	The present study examined the relationship between memory and orientation to time, place, and personal and general information, as moderated by age, education, and simple attentional ability. A heterogeneous sample of 312 clinical referrals was divided into four groups, according to delayed memory functioning. Patients with globally good, globally poor, poor visual, and poor auditory memory were at differential risk of being disoriented, with the globally poor memory patients having the greatest risk. Overall, poorly oriented patients were older and less educated, with worse recall of digits backward. Discriminant Function Analysis selected visual and auditory memory and age as predictors of orientation. Normative tables stratified by age and memory performance are presented.	Northwestern Univ, Evanston Hosp, Sch Med, Evanston, IL 60201 USA; IIT, Chicago, IL 60616 USA; Finch Univ Hlth Sci Chicago Med Sch, N Chicago, IL 60064 USA; Northwestern Univ, Sch Med, Evanston, IL 60208 USA		Sweet, JJ (corresponding author), Evanston NW Healthcare, Neuropsychol Serv, 2650 Ridge Ave, Evanston, IL 60201 USA.	j-sweet@nwu.edu		Suchy, Yana/0000-0001-6513-565X			BACHRACH H, 1974, J CLIN PSYCHOL, V30, P58, DOI 10.1002/1097-4679(197401)30:1<58::AID-JCLP2270300115>3.0.CO;2-4; BENTON A L, 1981, Journal of Clinical Neuropsychology, V3, P33, DOI 10.1080/01688638108403111; BENTON AL, 1964, J NERV MENT DIS, V139, P110, DOI 10.1097/00005053-196408000-00003; Brooker AE, 1997, PERCEPT MOTOR SKILL, V84, P131; BROOKS DN, 1976, J NEUROL NEUROSUR PS, V39, P593, DOI 10.1136/jnnp.39.6.593; BROTCHIE J, 1985, BRIT J PSYCHIAT, V147, P692, DOI 10.1192/bjp.147.6.692; DANIEL WF, 1987, CORTEX, V23, P169, DOI 10.1016/S0010-9452(87)80030-8; DESMOND DW, 1994, J NEUROL, V241, P585, DOI 10.1007/BF00920621; ELWOOD RW, 1991, CLIN NEUROPSYCHOL, V5, P329; FEINSTEIN AR, 1970, CLIN EPIDEMIOLOGY AR; Ferrario E, 1998, ARCH GERONTOL GERIAT, P175; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GUILMETTE TJ, 1995, NEUROPSY NEUROPSY BE, V8, P20; HIGH WM, 1990, J CLIN EXP NEUROPSYC, V12, P703, DOI 10.1080/01688639008401013; Hopp GA, 1997, J CLIN PSYCHOL, V53, P673, DOI 10.1002/(SICI)1097-4679(199711)53:7<673::AID-JCLP5>3.3.CO;2-8; Ishizaki J, 1998, J GERONTOL B-PSYCHOL, V53, pP359, DOI 10.1093/geronb/53B.6.P359; KEARCOLWELL JJ, 1973, BRIT J SOC CLIN PSYC, V12, P384, DOI 10.1111/j.2044-8260.1973.tb00085.x; LARRABEE GJ, 1983, J CLIN NEUROPSYCHOL, V5, P159, DOI 10.1080/01688638308401162; Leonberger FT, 1991, CLIN NEUROPSYCHOL, V5, P83, DOI DOI 10.1080/13854049108401845; MARGOLIS RB, 1984, J CLIN PSYCHOL, V40, P1442, DOI 10.1002/1097-4679(198411)40:6<1442::AID-JCLP2270400630>3.0.CO;2-Y; Mattis S, 1988, DEMENTIA RATING SCAL; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Meiran N, 1996, ARCH NEUROL-CHICAGO, V53, P1043, DOI 10.1001/archneur.1996.00550100129022; NATELSON BH, 1979, ARCH NEUROL-CHICAGO, V36, P444, DOI 10.1001/archneur.1979.00500430074014; PRIGATANO GP, 1977, J CLIN PSYCHOL, V33, P772, DOI 10.1002/1097-4679(197707)33:3<772::AID-JCLP2270330337>3.0.CO;2-Q; ROTH DL, 1990, J CLIN EXP NEUROPSYC, V12, P834; Schnider A, 1996, BRAIN, V119, P1627, DOI 10.1093/brain/119.5.1627; SKILBECK C E, 1980, Journal of Clinical Neuropsychology, V2, P293, DOI 10.1080/01688638008403801; Small BJ, 1997, J GERONTOL A-BIOL, V52, pM299, DOI 10.1093/gerona/52A.5.M299; VARNEY NR, 1991, NEUROPSYCHOLOGY, V5, P13; WANG PL, 1975, ARCH PHYS MED REHAB, V56, P517; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D., 1997, WECHSLER MEMORY SCAL; WOODARD JL, 1993, J CLIN EXP NEUROPSYC, V15, P968, DOI 10.1080/01688639308402611; ZAGAR R, 1984, J CLIN PSYCHOL, V40, P1466, DOI 10.1002/1097-4679(198411)40:6<1466::AID-JCLP2270400635>3.0.CO;2-5; [No title captured], DOI DOI 10.1080/13854048808520093	36	18	18	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		1999	13	4					495	508		10.1076/1385-4046(199911)13:04;1-Y;FT495			14	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	310PP	WOS:000086836800014	10806463				2022-02-06	
J	Adams, VI; Carrubba, C				Adams, VI; Carrubba, C			The Abbreviated Injury Scale - Application to autopsy data	AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY			English	Article						Abbreviated Injury Scale; AIS; autopsy, statistics and numerical data; injury scaling; Injury Severity Scale; ISS; trauma severity indices	SEVERITY SCORE; TRAUMA; CARE	Twenty autopsy reports, comprising 1 fall, 1 cutting, 1 burn, 1 drowning, 1 strangulation, 3 gunshot wound, and 13 traffic fatalities, were scored by the Abbreviated Injury Scale (AIS) and the Injury Severity Score (ISS). The codes were adequate for wounds of skin and long bones, and for most wounds of viscera. The autopsy descriptions were more detailed than the coding criteria for craniocerebral, cervicovertebral and muscular trauma, and less detailed for thoracoabdominal visceral, and long bone trauma. Lung contusions and rib fractures received scores that seemed unduly high, possibly reflecting the greater sensitivity of autopsy diagnosis over clinical diagnosis for these lesions. Complete hinge fractures of the skull base scored 4 (severe), which does not reflect the almost universally lethal nature of the accompanying cerebral concussion, which was itself not codeable. AIS scores were low and did not seem to reflect the lethal outcome when the lethal mechanism was purely physiologic and without a striking morphologic derangement, as in instances of cerebral or cardiac concussion, compression of the neck, occlusive airway hemorrhage, and visceral herniation into an adjacent body cavity. The scores were similarly low when therapy was delayed or adverse. Low AIS and ISS scores ina fatality from blunt or penetrating trauma may be useful retrospective clues to the presence of purely physiologic death mechanisms or therapeutic problems.	Univ S Florida, Hillsborough Cty Med Examiner Dept, Tampa, FL USA		Adams, VI (corresponding author), 401 S Morgan St, Tampa, FL 33602 USA.						Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; CHAMPION HR, 1995, J TRAUMA, V38, P94, DOI 10.1097/00005373-199501000-00024; CHAMPION HR, 1990, J TRAUMA, V30, P1356, DOI 10.1097/00005373-199011000-00008; Friedman Z, 1996, AM J FOREN MED PATH, V17, P233, DOI 10.1097/00000433-199609000-00011; Garber BG, 1996, J TRAUMA, V40, P733, DOI 10.1097/00005373-199605000-00008; Linn Shai, 1995, Annals of Epidemiology, V5, P440, DOI 10.1016/1047-2797(95)00059-3; LONG WB, 1994, J TRAUMA, V36, P499, DOI 10.1097/00005373-199404000-00007; PRUITT RD, 1974, MAYO CLIN PROC, V49, P627; Stewart TC, 1995, J TRAUMA, V39, P1036, DOI 10.1097/00005373-199512000-00003	10	18	19	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA	0195-7910			AM J FOREN MED PATH	Am. J. Forensic Med. Pathol.	SEP	1998	19	3					246	251		10.1097/00000433-199809000-00009			6	Medicine, Legal; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine; Pathology	120UM	WOS:000075975800009	9760090				2022-02-06	
J	Santos, ME; Castro-Caldas, A; De Sousa, L				Santos, ME; Castro-Caldas, A; De Sousa, L			Spontaneous complaints of long-term traumatic brain injured subjects and their close relatives	BRAIN INJURY			English	Article							SEVERE HEAD-INJURY	Long-term consequences of head injury for patients and families are not well known, given the complexity of variables that have to be studied. Subject's self-experience is one of these less studied aspects. The purpose of this study is to examine the spontaneous complaints of long-term brain injured adult subjects to be compared to the impression of their relatives. A total of 18 chronic head trauma subjects were studied more than 6 years after injury together with a relative, usually a mother or wife. At the beginning of the interview the participants were asked to freely refer their present complaints. In general, relatives referred more complaints about the injured subjects than the injured subjects referred about themselves. This occurred in several domains: somatic, physical, cognitive and behavioural. Memory problems were highly reported by both groups. Somatic complaints were more frequently reported by patients and behavioural problems were more often reported by relatives. Mothers and wives had different profiles of responses. Mothers' opinions were identical to those of their TBI sons in all domains. These different results must be taken into consideration so that the real needs of patients and relatives can be addressed.	Hosp Santa Maria, Ctr Estudos Egas Moniz, Lab Estud Linguagem, P-1600 Lisboa, Portugal; Univ Porto, ICBAS, Porto, Portugal		Santos, ME (corresponding author), Hosp Santa Maria, Ctr Estudos Egas Moniz, Lab Estud Linguagem, P-1600 Lisboa, Portugal.		de Sousa, Liliana/K-9756-2014; Castro-Caldas, Alexandre/M-4156-2013	de Sousa, Liliana/0000-0001-6656-4595; Castro-Caldas, Alexandre/0000-0002-9148-3719; Santos, Maria Emilia/0000-0002-7575-4435			Brooks DN, 1994, EVALUATION TRAUMATIS; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Florian V, 1989, Brain Inj, V3, P219, DOI 10.3109/02699058909029637; HENDRYX PM, 1989, ARCH PHYS MED REHAB, V70, P526; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kay Thomas, 1994, P533; KREUTZER JS, 1992, ARCH PHYS MED REHAB, V73, P771; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; MOORE A D, 1992, Brain Injury, V6, P89, DOI 10.3109/02699059209008129; Thomsen I V, 1989, Brain Inj, V3, P157, DOI 10.3109/02699058909004547; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; WILLER BS, 1991, ARCH PHYS MED REHAB, V72, P460	14	18	19	0	1	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	SEP	1998	12	9					759	767		10.1080/026990598122151			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	117ET	WOS:000075768500004	9755367				2022-02-06	
J	Smith, SL; Hall, ED				Smith, SL; Hall, ED			Tirilazad widens the therapeutic window for riluzole-induced attenuation of progressive cortical degeneration in an infant rat model of the shaken baby syndrome	JOURNAL OF NEUROTRAUMA			English	Article						cortical degeneration; cortical hemorrhaging; riluzole; shaken baby syndrome; tirilazad mesylate	EXPERIMENTAL SUBARACHNOID HEMORRHAGE; FOCAL CEREBRAL-ISCHEMIA; NONGLUCOCORTICOID 21-AMINOSTEROID U74006F; TRAUMA-INDUCED NEURODEGENERATION; EXCITATORY AMINO-ACIDS; METHYL-D-ASPARTATE; BRAIN INJURY; LIPID-PEROXIDATION; BARRIER DISRUPTION; HEAD-INJURY	Our infant rat model of traumatic subarchnoid hemorrhage combines violent shaking and hypoxia to produce subdural hemorrhaging and progressive cortical degeneration similar to that seen in victims of the shaken baby syndrome. Anesthetized, 6-day-old male rats were subjected to one episode of shaking under hypoxic conditions. Brain histologies revealed moderate-to-severe cortical hemorrhaging at 48 h postinjury and progressive cortical degeneration, as indicated by a 15.3% and 20.2% reduction in cortical wet weight, at 7 and 14 days postinjury, respectively. The purpose of the present study was to assess the effects of two antioxidant lipid peroxidation inhibitors (tirilazad mesylate and PNU-101033E), and the glutamate release inhibitor (riluzole), upon the brain pathology seen in this model. A significant, 54.3-75.3%, reduction in cortical hemorrhaging was observed in rats that were treated with a total of three doses of tirilazad (10 mg/kg, i.p.): 10 min before or 5-30 min after injury, and again at 2 and 24 h postinjury (p < 0.01 vs. vehicle). However, treatment with tirilazad or the more potent, brain-penetrating pyrrolopyrimidine, PNU-101033E (10 min before plus 2, 24, 48, and 72 h after), did not attenuate the progressive cortical degeneration typically seen at 14 days postinjury. These results suggest that free radicals play an important role in the pathophysiology of secondary brain hemorrhaging due to shaking + hypoxia, but may not be critical in the mediation of the subsequent neurodegeneration. Rather, glutamate neurotoxicity may be a key factor here. This is suggested by our observation that the glutamate release inhibitor, riluzole, significantly reduced cortical degeneration when it was administered up to 1 h postinjury in the present model. Specifically, the cortical wet weights of rats treated with 8 mg/kg riluzole (i.p.) 10 min before or 1 h after shaking + hypoxia (and again at 24 h postinjury) were 95.3% and 97.4% of noninjured controls, respectively, at 14 days postinjury (p < 0.02 vs. vehicle). Riluzole treatment beyond 1 h (e.g., 2 or 4 h postinjury) did not reduce the neurodegeneration. Lastly, we attempted to demonstrate that the therapeutic window for riluzole-induced attenuation of cortical degeneration could be extended beyond 1 h through the use of combination therapy. In this experiment, rat pups were treated with 10 mg/kg tirilazad (i.p.) at 30 min postinjury followed by 8 mg/kg riluzole (i.p.) at 4 and 24 h postinjury. At 14 days postinjury, the cortical wet weights of these rats were 94.5% of noninjured controls, thus demonstrating significant neuroprotection (p < 0.05 vs, vehicle) and a widening of the therapeutic window from 1 to 4 h in length. These results suggest that early attenuation of free radical-induced lipid peroxidation may slow down the biochemical cascade of events related to glutamate-induced excitotoxicity and, in doing so, prolong the time during which a glutamate release inhibitor, such as riluzole, is effective.	Pharmacia & Upjohn Inc, CNS Dis Res, Kalamazoo, MI 49001 USA		Smith, SL (corresponding author), Pharmacia & Upjohn Inc, CNS Dis Res, 301 Henrietta St 7251-209-4, Kalamazoo, MI 49001 USA.		Hall, Edward D/F-8930-2013				Bagenholm R, 1996, PEDIATR RES, V40, P399, DOI 10.1203/00006450-199609000-00006; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; DIETRICH WD, 1992, ACTA NEUROPATHOL, V84, P621, DOI 10.1007/BF00227739; Doble A, 1996, NEUROLOGY, V47, pS233, DOI 10.1212/WNL.47.6_Suppl_4.233S; Du C, 1996, J NEUROTRAUM, V13, P215, DOI 10.1089/neu.1996.13.215; DUHAIME AC, 1992, PEDIATRICS, V90, P179; DUHAIME AC, 1996, NEUROLOGICAL SURG CO, V3, P1777; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FLECK TJ, 1995, J NEUROTRAUM, V12, P968; GILLAND E, 1994, DEV BRAIN RES, V83, P79, DOI 10.1016/0165-3806(94)90181-3; GRAFE MR, 1994, BRAIN RES, V653, P161, DOI 10.1016/0006-8993(94)90385-9; HAGBERG H, 1994, BIOL NEONATE, V66, P205; HALL E D, 1989, Journal of Neurotrauma, V6, P169, DOI 10.1089/neu.1989.6.169; Hall ED, 1996, ACT NEUR S, V66, P107; HALL ED, 1988, J NEUROSURG, V68, P462, DOI 10.3171/jns.1988.68.3.0462; HALL ED, 1988, BRAIN RES, V451, P350, DOI 10.1016/0006-8993(88)90782-2; Hall ED, 1996, EUR J ANAESTH, V13, P279, DOI 10.1046/j.1365-2346.1996.00980.x; HALL ED, 1988, STROKE, V19, P997, DOI 10.1161/01.STR.19.8.997; HALL ED, 1988, EXP NEUROL, V102, P244, DOI 10.1016/0014-4886(88)90100-8; HALL ED, 1993, J NEUROCHEM, V60, P588, DOI 10.1111/j.1471-4159.1993.tb03189.x; HALL ED, 1997, HDB SYNTHETIC ANTIOX, P261; Hall ED, 1993, IRON CENTRAL NERVOUS, P173; IKONOMIDOU C, 1989, J NEUROSCI, V9, P2809; Ikonomidou C, 1996, PEDIATR RES, V39, P1020, DOI 10.1203/00006450-199606000-00015; Ikonomidou C, 1996, METAB BRAIN DIS, V11, P125, DOI 10.1007/BF02069500; KANAMARU K, 1991, J NEUROSURG, V74, P454, DOI 10.3171/jns.1991.74.3.0454; KOENIG H, 1992, BRAIN RES, V588, P297, DOI 10.1016/0006-8993(92)91589-7; MALGOURIS C, 1989, J NEUROSCI, V9, P3720; Mathew P, 1996, J NEUROTRAUM, V13, P465, DOI 10.1089/neu.1996.13.465; MCDONALD JW, 1990, BRAIN RES REV, V15, P41, DOI 10.1016/0165-0173(90)90011-C; MCINTOSH TK, 1990, J NEUROCHEM, V55, P1170, DOI 10.1111/j.1471-4159.1990.tb03122.x; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; McIntosh TK, 1996, J NEUROTRAUM, V13, P767, DOI 10.1089/neu.1996.13.767; MUNNS PL, 1995, FREE RADICAL BIO MED, V18, P467, DOI 10.1016/0891-5849(94)00163-E; NAKAGOMI T, 1987, J NEUROSURG, V66, P915, DOI 10.3171/jns.1987.66.6.0915; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; PELLEGRINIGIAMPIETRO DE, 1990, J NEUROSCI, V10, P1035, DOI 10.1523/jneurosci.10-03-01035.1990; Povlishock John T., 1993, P185; PRATT J, 1992, NEUROSCI LETT, V140, P225, DOI 10.1016/0304-3940(92)90108-J; ROHN TT, 1993, BIOCHEM PHARMACOL, V46, P525, DOI 10.1016/0006-2952(93)90530-A; SASAKI T, 1986, NEUROSURGERY, V19, P177, DOI 10.1227/00006123-198608000-00002; SASAKI T, 1985, J NEUROSURG, V63, P433, DOI 10.3171/jns.1985.63.3.0433; SCHMIDT I, 1987, CAN J PHYSIOL PHARM, V65, P1355, DOI 10.1139/y87-214; Smith SL, 1998, J NEUROTRAUM, V15, P693, DOI 10.1089/neu.1998.15.693; Smith SL, 1996, J NEUROSURG, V84, P229, DOI 10.3171/jns.1996.84.2.0229; SMITH SL, 1994, J NEUROTRAUM, V11, P393, DOI 10.1089/neu.1994.11.393; SPAIDE RF, 1990, AM FAM PHYSICIAN, V41, P1145; Taylor BM, 1996, J PHARMACOL EXP THER, V276, P1224; VOLLMER DG, 1989, SURG NEUROL, V31, P190, DOI 10.1016/0090-3019(89)90115-8; WAHL F, 1993, EUR J PHARMACOL, V230, P209, DOI 10.1016/0014-2999(93)90804-Q; WAHL F, 1996, J NEUROTRAUM, V13, P627; YANG GY, 1994, NEUROSURGERY, V34, P339, DOI 10.1227/00006123-199402000-00018; ZUCCARELLO M, 1989, STROKE, V20, P367, DOI 10.1161/01.STR.20.3.367	54	18	20	0	0	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	SEP	1998	15	9					707	719		10.1089/neu.1998.15.707			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	118ZT	WOS:000075871400006	9753218				2022-02-06	
J	Yamaki, T; Murakami, N; Iwamoto, Y; Sakakibara, T; Kobori, N; Ueda, S; Uwahodo, Y; Kikuchi, T				Yamaki, T; Murakami, N; Iwamoto, Y; Sakakibara, T; Kobori, N; Ueda, S; Uwahodo, Y; Kikuchi, T			Cognitive dysfunction and histological findings in rats with chronic-stage contusion and diffuse axonal injury	BRAIN RESEARCH PROTOCOLS			English	Article						behavioral neurobiology; traumatic brain injury; cortical contusion; diffuse axonal injury; Morris water maze	TRAUMATIC BRAIN INJURY; CONTROLLED CORTICAL IMPACT; DEFICITS; LESION; MODEL	The Morris water maze (MWM) technique is well known as a prominent method of evaluating learning acquisition and memory retention impairments in rats. We previously reported on a modified fluid percussion device that is able to consistently produce experimental cortical contusion (CC) and diffuse axonal injury (DAI) in separate groups of rats. The purpose of the present protocol is to evaluate the differences in learning acquisition and memory retention impairments between these two types of injured rats in the chronic stage using the MWM technique. CC and DAT rats are respectively induced by lateral and midline fluid percussion. We also compare the histological differences between these two different types of traumatic brain injury. The results show statistically significant differences in learning acquisition impairment between the sham and CC rats and between the sham and DAI rats. However, a difference in memory retention impairment was expected to be seen only between the sham and DAI rats. Histologically, the loss of CA3 pyramidal cells in the hippocampus was observed ipsilaterally in the CC and bilaterally in DAI. Neuronal cell loss was observed in bilaterally in layer II of the entorhinal cortex in DAI, but not in CC. (C) 1998 Elsevier Science B.V. All rights reserved.	Kyoto Prefectural Univ Med, Dept Neurosurg, Kamigyo Ku, Kyoto 602, Japan; Otsuka Pharmaceut Co Ltd, Tokushima Inst New Drug Res 3, Tokushima 77101, Japan		Yamaki, T (corresponding author), Kyoto Prefectural Univ Med, Dept Neurosurg, Kamigyo Ku, Kyoto 602, Japan.						Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; DIXON CE, 1994, J NEUROTRAUM, V11, P275, DOI 10.1089/neu.1994.11.275; ERB DE, 1988, ACTA NEUROPATHOL, V76, P347, DOI 10.1007/BF00686971; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; IWAMOTO Y, 1994, LIFE SCI, V55, P1651, DOI 10.1016/0024-3205(94)00332-7; IWAMOTO Y, IN PRESS NEUROSURGER; LIU SL, 1994, J NEUROTRAUM, V11, P73, DOI 10.1089/neu.1994.11.73; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; MURAKAMI N, 1993, ADV NEUROTRAUMA RES, V5, P42; PELLEGRINO LJ, 1975, STEREOTAXIC ATLAS RA; PHILLIPS LL, 1994, J NEUROTRAUM, V11, P641, DOI 10.1089/neu.1994.11.641; REIDERGROSWASSER I, 1993, AM J ROENTGENOL, V160, P147, DOI 10.2214/ajr.160.1.8416613; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; YAMAKI T, 1994, J NEUROTRAUM, V11, P613, DOI 10.1089/neu.1994.11.613; Yamaki T, 1997, BRAIN RES, V752, P151, DOI 10.1016/S0006-8993(96)01469-2	19	18	18	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1385-299X			BRAIN RES PROTOC	Brain Res. Protoc.	SEP	1998	3	1					100	106		10.1016/S1385-299X(98)00030-0			7	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	134TU	WOS:000076760200015	9767137				2022-02-06	
J	Ferland, MB; Ramsay, J; Engeland, C; O'Hara, P				Ferland, MB; Ramsay, J; Engeland, C; O'Hara, P			Comparison of the performance of normal individuals and survivors of traumatic brain injury on repeat administrations of the Wisconsin Card Sorting Test	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							FRONTAL-LOBE DAMAGE; AGE; SEX	Repeat administrations of the Wisconsin Card Sorting Test (WCST) are a common clinical practice to assess changes in cognitive functions of individuals recovering from traumatic brain injury (TBI). Yet, little is even known about the performance of healthy individuals on repeat administrations of the test. The present study compared the effects of repeat administration of the WCST in normal individuals and survivors of traumatic brain injury. Normal participants were administered the WCST twice, with a 5-month interval between testings and the findings were compared to the data from patients with TBI tested twice. Normal controls only modestly improved their performance on repeat testing. In constrast, using a reliability of change (RC) index, TBI survivors demonstrated clinically meaningful gains in performance.	Sisters Charity Ottawa Hlth Serv, Dept Res, Ottawa, ON K1R 7A5, Canada; Univ Toronto, Dept Human Dev & Appl Psychol, Toronto, ON, Canada; Royal Ottawa Hosp, Neurophysiol Res Lab, Ottawa, ON K1Z 7K4, Canada		Ferland, MB (corresponding author), Sisters Charity Ottawa Hlth Serv, Dept Res, St Vincent Pavil,60 Cambridge St N, Ottawa, ON K1R 7A5, Canada.	mferland@scohs.on.ca					ANDERSON SW, 1991, J CLIN EXP NEUROPSYC, V13, P909, DOI 10.1080/01688639108405107; Berg EA, 1948, J GEN PSYCHOL, V39, P15, DOI 10.1080/00221309.1948.9918159; BOONE KB, 1993, J CLIN PSYCHOL, V49, P54, DOI 10.1002/1097-4679(199301)49:1<54::AID-JCLP2270490108>3.0.CO;2-6; DREWE E A, 1974, Cortex, V10, P159; Esposito G, 1996, J NUCL MED, V37, P559; GRAFMAN J, 1990, PERCEPT MOTOR SKILL, V71, P1120, DOI 10.2466/PMS.71.7.1120-1122; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; Gualtari CT, 1991, BRAIN INJURY, V5, P219; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Heaton RK, 1981, MANUAL WISCONSIN CAR; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; JANOWSKY JS, 1989, BEHAV NEUROSCI, V103, P548, DOI 10.1037/0735-7044.103.3.548; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; MILNER B, 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI 10.1001/archneur.1963.00460070100010; ROBINSON AL, 1980, J CONSULT CLIN PSYCH, V48, P605, DOI 10.1037/0022-006X.48.5.605; Spreen O, 1991, COMPENDIUM NEUROPSYC; Stuss D. T., 1992, J HEAD TRAUMA REHAB, V7, P40; YEUDALL LT, 1986, J CLIN PSYCHOL, V42, P918, DOI 10.1002/1097-4679(198611)42:6<918::AID-JCLP2270420617>3.0.CO;2-Y; [No title captured]	19	18	19	0	2	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	AUG	1998	20	4					473	482		10.1076/jcen.20.4.473.1475			10	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	153JY	WOS:000077831000005	9892051				2022-02-06	
J	Johnstone, B; Childers, MK; Hoerner, J				Johnstone, B; Childers, MK; Hoerner, J			The effects of normal ageing on neuropsychological functioning following traumatic brain injury	BRAIN INJURY			English	Article							HEAD-INJURY; ALZHEIMERS-DISEASE; DEMENTIA; ONSET	Increasing age is associated with greater absolute neuropsychological impairment (e.g. slower processing speed, diminished memory), although it is unclear if older individuals with traumatic brain injury (TBI) show greater relative impairment than younger individuals with TBI. The current study evaluated the effects of normal ageing on TBI by using age-based normative data to calculate indices of relative decline from pre-morbid levels (expressed as z-deficit scores) for different age groups (20-39 years, 40-59 years, 60+ years). The sample included 279 individuals with TBI between the ages of 20 and 65 who were assessed in a department of rehabilitation neuropsychology laboratory over a 4-year period. Spearman correlations and ANOVAs did not show age-related differences in relative memory, attention or speed of processing abilities, although results did indicate that increasing age is associated with relatively less impairment in intelligence. The results suggest that the greater neuropsychological impairment noted in older individuals with TBI is most likely related to normal ageing. The importance of considering both absolute and relative degrees of impairment is discussed.	Univ Missouri, Sch Med, Dept Phys Med & Rehabil, Columbia, MO 65212 USA		Johnstone, B (corresponding author), Univ Missouri, Sch Med, Dept Phys Med & Rehabil, 1 Hosp Dr, Columbia, MO 65212 USA.			Johnstone, Brick/0000-0001-8845-9649; Childers, Martin/0000-0003-4754-0883			ADLER A, 1945, ARCH NEURO PSYCHIATR, V53, P34, DOI 10.1001/archneurpsyc.1945.02300010044003; ALEXANDER MP, 1928, PSYCHIAT ASPECTS NEU, V2, P219; BORNSTEIN RA, 1985, J CLIN PSYCHOL, V41, P651, DOI 10.1002/1097-4679(198509)41:5<651::AID-JCLP2270410511>3.0.CO;2-C; CHANDRA V, 1987, NEUROLOGY, V37, P1295, DOI 10.1212/WNL.37.8.1295; COFFEY E, 1992, BRIT NEUR ASS ANN M; Diamond PT, 1996, BRAIN INJURY, V10, P413, DOI 10.1080/026990596124278; FOGEL, 1994, NEUROPSYCHIATRY TRAU, P413; HAMM RJ, 1991, J NEUROSURG, V75, P916, DOI 10.3171/jns.1991.75.6.0916; HERNESNIEMI J, 1979, ACTA NEUROCHIR, V49, P67, DOI 10.1007/BF01809175; HORTON AM, 1992, PERCEPT MOTOR SKILL, V75, P257, DOI 10.2466/PMS.75.4.257-258; Hung C C, 1991, J Formos Med Assoc, V90, P1227; Jastak S., 1984, WRAT R WIDE RANGE AC; Johnstone B, 1996, J Int Neuropsychol Soc, V2, P282; JOHNSTONE B, 1995, BRAIN INJURY, V9, P377, DOI 10.3109/02699059509005777; Levin HS., 1982, NEUROBEHAVIORAL CONS; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MEIER U, 1991, ZBL CHIR, V116, P845; Miller JR, 1989, MILD MODERATE HEAD I, P125; MORTIMER JA, 1985, NEUROLOGY, V35, P264, DOI 10.1212/WNL.35.2.264; MOULTON RJ, 1992, CAN J SURG, V35, P35; NEE LE, 1987, NEUROLOGY, V37, P359, DOI 10.1212/WNL.37.3.359; PENTLAND B, 1986, AGE AGEING, V15, P193, DOI 10.1093/ageing/15.4.193; RAKIER A, 1995, BRAIN INJURY, V9, P187, DOI 10.3109/02699059509008191; Reitan R, 1985, HALSTEAD REITAN NEUR; SULLIVAN P, 1987, JAMA-J AM MED ASSOC, V257, P2289, DOI 10.1001/jama.1987.03390170045014; TEASDALE TW, 1982, HEAD INJURY BASIC CL, P213; Vollmer DG, 1991, J NEUROSURG S, V75, P37; Wechsler D, 1987, MANUAL WECHSLER MEMO; Wechsler D, 1981, WECHSLER ADULT INTEL; Wilkinson G. S, 1993, WRAT 3 WIDE RANGE AC	30	18	19	0	0	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUL	1998	12	7					569	576		10.1080/026990598122331			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	ZX249	WOS:000074495200003	9653520				2022-02-06	
J	Stover, JF; Lenzlinger, PM; Stocker, R; Morganti-Kossmann, MC; Imhof, HG; Trentz, O; Kossmann, T				Stover, JF; Lenzlinger, PM; Stocker, R; Morganti-Kossmann, MC; Imhof, HG; Trentz, O; Kossmann, T			Thiopental in CSF and serum correlates with prolonged loss of cortical activity	EUROPEAN NEUROLOGY			English	Article						thiopental; traumatic brain injury; drug kinetics; drug monitoring; barbiturate coma; electroencephalogram	EXCITATORY AMINO-ACIDS; TRAUMATIC BRAIN INJURY; SEVERE HEAD-INJURY; PHARMACOKINETICS	Barbiturate coma is initiated in brain-injured patients whenever elevated intracranial pressure remains unresponsive to other therapeutical strategies. However, barbiturates alter cortical activity resulting in difficulties in clinical evaluation. Therefore, we investigated the impact of long-term thiopental administration on responsiveness to exteroceptive stimuli in relation to pharmacokinetics of thiopental in CSF and serum. Long-term infusion increases thiopental levels which remain elevated for 6 and 9 days in CSF and serum, respectively, after termination of its administration. Prolonged unresponsiveness to exteroceptive stimuli correlates with persisting thiopental in CSF and serum. Thus, quantitative analysis of thiopental in serum becomes indispensable in predicting the length of drug-induced neurological impairment and in avoiding misinterpretation of the neurological status.	Univ Zurich, Div Trauma Surg, Dept Surg, Sch Med, CH-8091 Zurich, Switzerland; Univ Zurich, Div Surg Res, Dept Surg, Sch Med, CH-8091 Zurich, Switzerland; Univ Zurich Hosp, Sch Med, Dept Neurosurg, CH-8091 Zurich, Switzerland		Stover, JF (corresponding author), Univ Zurich, Div Trauma Surg, Dept Surg, Sch Med, Ramistr 100, CH-8091 Zurich, Switzerland.		Lenzlinger, Philipp/A-3822-2008	Morganti-Kossmann, Cristina/0000-0002-0807-2063			AIREY IL, 1982, ANAESTHESIA, V37, P328, DOI 10.1111/j.1365-2044.1982.tb01110.x; ALTMAYER P, 1987, METHOD FIND EXP CLIN, V9, P817; BAKER AJ, 1993, J NEUROSURG, V79, P369, DOI 10.3171/jns.1993.79.3.0369; BONDY SC, 1993, FREE RADICAL BIO MED, V14, P633, DOI 10.1016/0891-5849(93)90144-J; BRODIE BB, 1952, FED PROC, V11, P632; DONEGAN JH, 1985, AM J PHYSIOL, V249, pH421, DOI 10.1152/ajpheart.1985.249.2.H421; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GRUHL H, 1984, J CLIN CHEM CLIN BIO, V22, P385; HUDSON RJ, 1983, ANESTHESIOLOGY, V59, P215; JENNETT B, 1975, LANCET, V1, P480; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; LUNDAR T, 1983, CRIT CARE MED, V11, P559, DOI 10.1097/00003246-198307000-00017; MICHENFE.JD, 1974, ANESTHESIOLOGY, V41, P231, DOI 10.1097/00000542-197409000-00004; MILLER JD, 1971, BRAIN RES, V34, P411; NORDBY HK, 1984, ACTA NEUROCHIR, V72, P157, DOI 10.1007/BF01406868; PRICE HL, 1960, ANESTHESIOLOGY, V21, P40, DOI 10.1097/00000542-196001000-00008; SCHALEN W, 1992, ACTA NEUROCHIR, V117, P153, DOI 10.1007/BF01400613; SELMAN WR, 1981, SURG NEUROL, V15, P9, DOI 10.1016/S0090-3019(81)80081-X; SHERWIN AL, 1988, EPILEPSY RES, V2, P281, DOI 10.1016/0920-1211(88)90035-6; STANSKI DR, 1980, ANESTHESIOLOGY, V53, P169, DOI 10.1097/00000542-198008000-00012; STOCKER R, 1995, INTEGRATED APPROACH, P196; SUTTON LN, 1987, J NEUROSURG, V67, P381, DOI 10.3171/jns.1987.67.3.0381; TURCANT A, 1985, ANESTHESIOLOGY, V63, P50, DOI 10.1097/00000542-198507000-00007; TWYMAN RE, 1989, ANN NEUROL, V25, P213, DOI 10.1002/ana.410250302; WOOD M, 1990, DRUGS ANESTHESIA PHA, P178	26	18	19	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0014-3022			EUR NEUROL	Eur. Neurol.		1998	39	4					223	228		10.1159/000007938			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZR376	WOS:000073968500006	9635473	Green Accepted			2022-02-06	
J	Bogner, JA; Corrigan, JD; Spafford, DE; LambHart, GL				Bogner, JA; Corrigan, JD; Spafford, DE; LambHart, GL			Integrating substance abuse treatment and vocational rehabilitation after traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article								Objective: To describe and evaluate a resource and service coordination model for integrating substance abuse treatment and vocational rehabilitation following brain injury. Design: Retrospective study, consecutive sample. Setting: Community-based treatment. Subjects: Seventy-two clients who received services from the TBI Network. Only subjects that had received a comprehensive assessment, agreed to a treatment plan, and had been monitored fcr at least 1 year after initiation of the plan were included in the sample. Main Outcome Measures: Substance use and productivity, as measured by the Quantity-Frequency-Variability Index, General Health;md History Questionnaire, Addiction Severity Index, and the Employability Rating Scale. Results: Pre-and postcomparisons showed significantly better vocational status and greater Likelihood of abstinence from alcohol and other drugs after the intervention. Investigation of a priori hypotheses regarding mediating variables was limited by sample size and selection biases. Time after injury was not associated with positive outcomes, though a trend was evident for decreased substance use among those referred within 3 months after injury. The engagement of a community team was associated with decreased substance use but not greater productivity. Results are discussed in terms of possible ingredients for replication of this approach in other settings.	TBI NETWORK,COLUMBUS,OH; OHIO STATE UNIV,OHIO VALLEY CTR BRAIN INJURY PREVENT & REHABIL,DEPT PHYS MED & REHABIL,COLUMBUS,OH 43210				Corrigan, John D./E-2921-2011				Ashery R S, 1994, J Case Manag, V3, P179; Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; Blackerby W.F., 1990, J HEAD TRAUMA REHAB, V5, P47; CALLAHAN D, 1968, Q J STUD ALCOHOL, V29, P130; CORRIGAN JD, 1995, BRAIN INJURY, V9, P221, DOI 10.3109/02699059509008195; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P29; Girard D, 1996, BRAIN INJURY, V10, P663, DOI 10.1080/026990596124089; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; KAY T, 1993, COMMUNITY BASED EMPL, P29; Kreutzer J., 1987, GEN HLTH HIST QUESTI; Kreutzer JS, 1996, J HEAD TRAUMA REHAB, V11, P58, DOI 10.1097/00001199-199610000-00006; LANGLEY MJ, 1992, NEUROREHABILITATION, V2, P52; LANGLEY MJ, 1991, ADV BRAIN INJURY REH; Marmarou A., 1990, J HEAD TRAUMA REHAB, V5, P21, DOI [10.1097/00001199-199009000-00006, DOI 10.1097/00001199-199009000-00006]; McLellan AT., 1990, ADDICTION SEVERITY I, V5th; Miller WR, 1991, MOTIVATIONAL INTERVI; *NAT HEAD INJ F, 1988, SUBST AB TASK FORC W; PROCHASKA JO, 1992, AM PSYCHOL, V47, P1102, DOI 10.1037/0003-066X.47.9.1102; Ridgely M S, 1994, J Case Manag, V3, P132; Sander AM, 1997, ARCH PHYS MED REHAB, V78, P138, DOI 10.1016/S0003-9993(97)90254-9; SPARADEO FR, 1992, NEUROREHABILITATION, V2, P65; SPARADEO FR, 1993, STAFF DEV CLIN INTER; Willenbring M L, 1994, J Case Manag, V3, P150; [No title captured], DOI DOI 10.1037/0894-4105.7.3.296	25	18	18	0	5	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	OCT	1997	12	5					57	71		10.1097/00001199-199710000-00006			15	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	YA515	WOS:A1997YA51500006					2022-02-06	
J	Krauss, JK; Jankovic, J				Krauss, JK; Jankovic, J			Tics secondary to craniocerebral trauma	MOVEMENT DISORDERS			English	Article						head injury; movement disorder; tics; Tourette's syndrome	POSTTRAUMATIC MOVEMENT-DISORDERS; TOURETTE SYNDROME; HEAD TRAUMA; DYSTONIA; GILLES	We describe three adult patients who presented with multifocal motor and vocal tics secondary to craniocerebral trauma. In one case, the tics were accompanied by marked obsessive-compulsive behavior. All patients were involved in motor vehicle accidents resulting in closed craniocerebral trauma, The latency of onset between head trauma and the movement disorder varied between 1 day and a few months. Magnetic resonance imaging, which was performed in all three patients, did not detect any structural lesions of the basal ganglia or the brainstem. Extensive bifrontal leukoencephalopathy was found in one patient who suffered severe head trauma.	BAYLOR COLL MED, DEPT NEUROL, HOUSTON, TX 77030 USA; BAYLOR COLL MED, DEPT NEUROSURG, HOUSTON, TX 77030 USA								COMINGS DE, 1990, J CLIN PSYCHIAT, V51, P463; CURRAN TG, 1995, HDB TREMOR DISORDERS, P411; ERIKSSON B, 1969, BRIT J PSYCHIAT, V115, P351, DOI 10.1192/bjp.115.520.351; Fahn S, 1982, Adv Neurol, V35, P349; GAUL JJ, 1994, MOVEMENT DISORD, V9, P121; GOETZ CG, 1992, NEUROL CLIN, V10, P907, DOI 10.1016/S0733-8619(18)30187-7; JANKOVIC J, 1994, MOVEMENT DISORD, V9, P347, DOI 10.1002/mds.870090315; Jankovic J, 1997, NEUROL CLIN, V15, P267, DOI 10.1016/S0733-8619(05)70311-X; Jankovic J, 1997, NEUROLOGY, V48, P358, DOI 10.1212/WNL.48.2.358; JANKOVIC J, 1994, NEUROLOGY, V44, P2006, DOI 10.1212/WNL.44.11.2006; JANKOVIC J, 1993, HDB TOURETTES SYNDRO, P167; JANKOVIC J, 1987, MOVEMENT DISORD, V2, P383; JANKOVIC J, 1993, CURR NEUROL, V13, P209; KLEMPEL K, 1974, S AFR MED J, V48, P1379; KOLLER WC, 1989, MOVEMENT DISORD, V4, P20, DOI 10.1002/mds.870040106; Kraus J, 1996, NEUROTRAUMA, P13; KRAUSS JK, 1992, MOVEMENT DISORD, V7, P263, DOI 10.1002/mds.870070313; KRAUSS JK, 1995, NEUROL RES, V17, P409, DOI 10.1080/01616412.1995.11740353; KRAUSS JK, 1997, IN PRESS MOV DISORD; KRAUSS JK, 1997, IN PRESS NEUROLOGY; Kumar R, 1997, NEUROL CLIN, V15, P309, DOI 10.1016/S0733-8619(05)70315-7; LANG AE, 1992, ADV NEUROL, V58, P25; LECKMAN JF, 1992, ADV NEUROL, V58, P15; LEE MS, 1994, NEUROLOGY, V44, P1374, DOI 10.1212/WNL.44.8.1374; RICHARDSON EP, 1982, G DELATOURETTE SYNDR, P83; ROBERTSON M, 1990, J NEUROL NEUROSUR PS, V53, P691, DOI 10.1136/jnnp.53.8.691; SACKS OW, 1982, GILLES TOURETTE SYND, P89; Siemers E, 1990, Mov Disord, V5, P183; SINGER C, 1989, MOVEMENT DISORD, V4, P342, DOI 10.1002/mds.870040409; Singer HS, 1997, NEUROL CLIN, V15, P357, DOI 10.1016/S0733-8619(05)70318-2; SINGER HS, 1991, ANN NEUROL, V30, P558, DOI 10.1002/ana.410300408; TALAIRAC.J, 1973, ELECTROEN CLIN NEURO, V34, P45, DOI 10.1016/0013-4694(73)90149-1; TRIMBLE MR, 1987, MOVEMENT DISORD, V2, P106	33	18	19	0	1	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0885-3185			MOVEMENT DISORD	Mov. Disord.	SEP	1997	12	5					776	782		10.1002/mds.870120527			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	XX028	WOS:A1997XX02800026	9380066				2022-02-06	
J	Cummings, RS; Shurland, AT; Prodoehl, JA; Moody, K; Sherk, HH				Cummings, RS; Shurland, AT; Prodoehl, JA; Moody, K; Sherk, HH			Injuries in the sport of luge - Epidemiology and analysis	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article							SKI	We undertook this study to determine the types and frequency of injuries sustained in the sport of luge. Before this study, no data were available in the medical literature on luge injuries. We performed a retrospective analysis between the years 1985 and 1992 using data obtained from the athlete injury and illness report forms at the US Training Center Sports Medicine Clinic in Lake Placid, New York. During the 7 years examined, 1043 athletes took 57, 244 track runs and sustained 407 injuries. The risk of sustaining an injury was 0.39 per person per year, and the risk of an injury causing the loss of more than 1 day of practice was 0.04 per person per year. Contusions were the major injury (51%), followed by strains (27%). Strains of the neck muscles and contusions of extremities, especially the hands, were characteristic injuries sustained by athletes. The most serious injuries were concussions (2%) and fractures (3%). Crashes were responsible for 64% of injuries. Luge appears to be a relatively safe sport with injury rates comparable with recreational alpine skiing.	UNIV PENN, SCH MED, PHILADELPHIA, PA 19104 USA; US OLYMP COMM, SPORTS MED CLIN, LAKE PLACID, NY USA		Cummings, RS (corresponding author), MED COLL PENN & HAHNEMANN UNIV, DEPT ORTHOPAED SURG, 3300 HENRY AVE, PHILADELPHIA, PA 19118 USA.						BACKX FJG, 1991, AM J SPORT MED, V19, P124, DOI 10.1177/036354659101900206; BJORNSTIG U, 1986, SCAND J SOC MED, V14, P83; BOYLE JJ, 1985, SKIING TRAUMA SAFETY, P411; ELMQUIST LG, 1994, SPORTS INJURIES MECH, P481; Garrick J G, 1979, Am J Sports Med, V7, P245, DOI 10.1177/036354657900700408; HERKOWITZ HN, 1978, J TRAUMA, V18, P806, DOI 10.1097/00005373-197812000-00004; REID DC, 1989, SPORTS MED, V7, P393, DOI 10.2165/00007256-198907060-00004; Rogowski P, 1978, SPORT LUGE; Shealy JE, 1989, SKIING TRAUMA SAFETY, P75; THOMPSON N, 1987, AM J SPORTS MED, V15, pS97; WARME WJ, 1995, AM J SPORT MED, V23, P597, DOI 10.1177/036354659502300514; WEBSTER K, 1985, AM J SPORTS MED, V13, P124; WRIGHT JR, 1991, AM J SPORT MED, V19, P615, DOI 10.1177/036354659101900611; YOUNG LR, 1991, AM SOC TEST MATER, P125, DOI 10.1520/STP17637S	14	18	18	1	9	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465			AM J SPORT MED	Am. J. Sports Med.	JUL-AUG	1997	25	4					508	513		10.1177/036354659702500414			6	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	XM181	WOS:A1997XM18100014	9240985				2022-02-06	
J	Armstrong, C				Armstrong, C			Selective versus sustained attention: A continuous performance test revisited	CLINICAL NEUROPSYCHOLOGIST			English	Article							EVENT-RELATED POTENTIALS; CLOSED-HEAD-INJURY; MULTIPLE-SCLEROSIS; ALZHEIMERS-DISEASE; DEMENTIA; CHILDREN; TASK; AGE; DEFICITS; BRAIN	The selective-set paradigm has dominated the measurement of visual selective attention in cognitive neuroscience. Previous auditory selective attention tests, the continuous performance tests (CPT), actually measure sustained attention, while auditory filtering paradigms require ''bottom-up'' perceptual processing. The development of the Auditory Selective Attention Test (ASAT) was based on selective-set theory. An age effect was found in subjects between 19-94 years of age who were over age 60. The probability foils were effective in discriminating impairment in four adult neurological groups (dementia, mild head injury, multiple sclerosis, learning disability). Impairment in discrimination (omission errors) but not response bias suggests that the ASAT requires cognitive search as defined by selective-set theory, which differentiates it from CPT and filtering paradigms. Associations with cognitive complexity and working memory are posited.			Armstrong, C (corresponding author), UNIV PENN,SCH MED,DEPT NEUROL,3 GATES,3400 SPRUCE ST,PHILADELPHIA,PA 19104, USA.						ALBERT MS, 1988, GERIATRIC NEUROPSYCH, P33; ALEXANDER DA, 1973, PSYCHOL REP, V32, P229, DOI 10.2466/pr0.1973.32.1.229; Armstrong C, 1996, NEUROPSYCHOLOGIA, V34, P853, DOI 10.1016/0028-3932(95)00171-9; Baddeley A.D., 1986, WORKING MEMORY; Benton AL, 1974, REVISED VISUAL RETEN; BROADBENT DE, 1970, ATTENTION CONT THEOR, P51; BROUWER WH, 1985, CORTEX, V21, P111, DOI 10.1016/S0010-9452(85)80019-8; COYLE S, 1991, EXP AGING RES, V17, P103, DOI 10.1080/03610739108253889; DIXON WJ, 1988, BMDP STATISTICAL SOF; DONALD MW, 1981, CAN J PSYCHOL, V35, P175, DOI 10.1037/h0081153; ESPOSITO RU, 1984, MEMORY CONSOLIDATION, P15; FISCHER P, 1990, NEUROLOGY, V40, P387; GAUTHIER L, 1989, INT J CLIN NEUROPSYC, V11, P49; GIESSER BS, 1992, ELECTROEN CLIN NEURO, V82, P320, DOI 10.1016/0013-4694(92)90002-Y; GRADY CL, 1989, ARCH NEUROL-CHICAGO, V46, P317, DOI 10.1001/archneur.1989.00520390083021; GRIMSLEY G, 1956, EMPLOYEE APTITUDE SU; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Halperin J., 1991, PSYCHOL ASSESSMENT J, V3, P603, DOI [10.1037/1040-3590.3.4.603, DOI 10.1037/1040-3590.3.4.603]; HALPERIN JM, 1991, INT J NEUROSCI, V58, P171, DOI 10.3109/00207459108985433; HALPERIN JM, 1988, J AM ACAD CHILD PSY, V27, P326, DOI 10.1097/00004583-198805000-00010; HALPERIN JM, 1990, J ABNORM CHILD PSYCH, V18, P437, DOI 10.1007/BF00917645; HEATON R, 1985, J CONSULT CLIN PSYCH, V53, P101; Heaton R.K., 1981, WISCONSIN CARD SORTI; JAMES L, 1989, INT J PSYCHOPHYSIOL, V8, P61, DOI 10.1016/0167-8760(89)90020-2; Kachigan S.K., 1986, STAT ANAL; Kahneman D, 1984, VARIETIES ATTENTION, V1, P29; KIRBY JR, 1984, J PSYCHOEDUCATIONAL, V0002, P00009, DOI DOI 10.1177/073428298400200102; KREMEN WS, 1992, J NERV MENT DIS, V180, P89, DOI 10.1097/00005053-199202000-00004; KUTAS M, 1984, HDB COGNITIVE NEUROS, P387; LAIDLAW TM, 1993, INT J CLIN EXPT HYPN, V16, P97; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mesulam M. M., 1985, PRINCIPLES BEHAV NEU, P71; MIRSKY AF, 1987, ENVIRON HEALTH PERSP, V74, P191, DOI 10.2307/3430449; MIRSKY AF, 1965, ELECTROEN CLIN NEURO, V18, P334, DOI 10.1016/0013-4694(65)90053-2; MIRSKY AF, 1962, ELECTROEN CLIN NEURO, V14, P1, DOI 10.1016/0013-4694(62)90002-0; MONEY J, 1976, STANDARDIZED ROAD MA; NAATANEN R, 1990, BEHAV BRAIN SCI, V13, P201, DOI 10.1017/S0140525X00078407; Newcombe F., 1969, MISSILE WOUNDS BRAIN; NISSEU MJ, 1981, ANN C AM AG ASS CHIC; Osterrieth P., 1944, ARCH PSYCHOLOGIE, V30, P206; PARASURAMAN R, 1991, HUM FACTORS, V33, P539, DOI 10.1177/001872089103300506; PARASURAMAN R, 1992, BRAIN, V115, P711, DOI 10.1093/brain/115.3.711; PARASURAMAN R, 1991, J CLIN EXP NEUROPSYC, V13, P789, DOI 10.1080/01688639108401090; Parasuraman R., 1993, NEUROPSYCHOLOGY, V7, P242, DOI [10.1037/0894-4105.7.3.242, DOI 10.1037/0894-4105.7.3.242]; POLICH J, 1990, ELECTROEN CLIN NEURO, V77, P179, DOI 10.1016/0168-5597(90)90036-D; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; PRIOR M, 1985, J CHILD PSYCHOL PSYC, V26, P289, DOI 10.1111/j.1469-7610.1985.tb02267.x; Rey A., 1964, EXAMEN CLIN PSYCHOL; RITTER W, 1968, ELECTROEN CLIN NEURO, V25, P550, DOI 10.1016/0013-4694(68)90234-4; ROSVOLD HE, 1956, J CONSULT PSYCHOL, V20, P343, DOI 10.1037/h0043220; RUCH FR, 1963, EMPLOYEE APTITUDE SU; Russell E. W., 1970, ASSESSMENT BRAIN DAM; SAHAKIAN BJ, 1990, NEUROPSYCHOLOGIA, V28, P1197, DOI 10.1016/0028-3932(90)90055-S; SANDRONI P, 1992, ARCH NEUROL-CHICAGO, V49, P517, DOI 10.1001/archneur.1992.00530290105019; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Smith A., 1982, SYMBOL DIGIT MODALIT; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Spreen O., 1977, NEUROSENSORY CTR COM, VRev; SUNDERLAND T, 1987, ARCH GEN PSYCHIAT, V44, P418; TARNOWSKI KJ, 1986, J ABNORM PSYCHOL, V95, P341, DOI 10.1037/0021-843X.95.4.341; VANDERMEERE J, 1989, J ABNORM CHILD PSYCH, V17, P409, DOI 10.1007/BF00915035; Vanier M, 1990, NEUROPSYCHOLOGY, V4, P87, DOI 10.1037/0894-4105.4.2.87; Wechsler D, 1987, MEMORY SCALE REVISED; WICKENS CD, 1987, PSYCHOL AGING, V2, P70, DOI 10.1037/0882-7974.2.1.70; WOODS DL, 1986, NEUROLOGY, V36, P212, DOI 10.1212/WNL.36.2.212; [No title captured]	70	18	18	2	8	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	0920-1637			CLIN NEUROPSYCHOL	Clin. Neuropsychol.	FEB	1997	11	1					18	33		10.1080/13854049708407026			16	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	WK256	WOS:A1997WK25600002					2022-02-06	
J	Zink, BJ; Maio, RF; Chen, B				Zink, BJ; Maio, RF; Chen, B			Alcohol, central nervous system injury, and time to death in fatal motor vehicle crashes	ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH			English	Article						alcohol; brain injury; motor vehicle crashes; trauma	TRAUMATIC BRAIN INJURY; HOSPITAL COURSE; ETHANOL; INTOXICATION; ABUSE	Objectives: Motor vehicle crash (MVC) studies have found that alcohol (ALC) is associated with increased mortality and decreased time to death (TTD). Clinical and experimental data suggest that ALC potentiates central nervous system injury (CNSI). We hypothesize that ALC-intoxicated, MVC fatalities with CNSI are more likely to die in the immediate postinjury period than are sober victims with CNSI. Methods: Design-A retrospective cohort of 401 MVC fatalities from four Michigan counties for the time period 1985 to 1991 was studied. Measurements-Medical examiner records were reviewed to determine age, blood alcohol concentration (BAC), and TTD. Injury severity was calculated with the Abbreviated Injury Scale (1985 version). Anatomical profile scores and G scores were also calculated and used to identify CNSI subjects. Analysis-chi(2) and Student's t test were used, and odds ratios with 0.95 confidence intervals (CIs) were calculated. Results: ALC(+) cases (BAC greater than or equal to 100 mg/dl) (n = 99) were significantly younger and more frequently had TTD < 1 hr than ALC(-) cases (n = 233): odds ratio 1.62 [0.95 CI (1.02 to 2.56)]. Overall, CNSI cases (n = 297) were significantly younger and had fewer thoracic injuries, but did not have significantly shorter TTD, compared with non-CNSI cases. However, ALC(+) CNSI cases (n = 77) were over twice as likely to have TTD < 1 hr {odds ratio 2.04 [0.95 CI (1.13 to 3.70)]}. For ALC(+) isolated CNSI cases, the odds ratio for TTD < 1 hr, compared with nonisolated CNSI cases was 8.25 (0.95; CI 0.66 to 102.5). Injury Severity Score, anatomical profile, and G scores were not significantly different for ALC(+) CNSI cases, compared with ALC(-) CNSI cases, whether isolated or nonisolated. Conclusions: These data suggest that alcohol intoxication is associated with increased frequency of early death in MVC victims with CNSI, despite there being no detectable difference in anatomical injury scoring.			Zink, BJ (corresponding author), UNIV MICHIGAN,DEPT SURG,SECT EMERGENCY MED,TC B1354,1500 E MED CTR DR,ANN ARBOR,MI 48109, USA.						ALBIN MS, 1986, CRIT CARE MED, V14, P841, DOI 10.1097/00003246-198610000-00001; ANDA RF, 1988, JAMA-J AM MED ASSOC, V260, P2529, DOI 10.1001/jama.260.17.2529; Becker DP, 1989, TXB HEAD INJURY, P1; CHEN B, 1995, J TRAUMA, V38, P228, DOI 10.1097/00005373-199502000-00014; COPES WS, 1990, J TRAUMA, V30, P1200, DOI 10.1097/00005373-199010000-00003; EVANS L, 1993, J STUD ALCOHOL, V54, P441, DOI 10.15288/jsa.1993.54.441; FELL JC, 1990, 34 ANN P ASS ADV AUT, P69; FLAMM ES, 1977, J NEUROSURG, V46, P328, DOI 10.3171/jns.1977.46.3.0328; FRANCO CD, 1988, J NATL MED ASSOC, V80, P63; GENTILE NT, 1993, ANN EMERG MED, V22, P1028, DOI 10.1016/S0196-0644(05)82746-5; GURNEY JG, 1992, J TRAUMA, V33, P709, DOI 10.1097/00005373-199211000-00020; HALT PS, 1992, ARCH NEUROL-CHICAGO, V49, P1178, DOI 10.1001/archneur.1992.00530350096025; HUTH JF, 1983, J TRAUMA, V23, P494, DOI 10.1097/00005373-198306000-00009; JURKOVICH GJ, 1993, JAMA-J AM MED ASSOC, V270, P51, DOI 10.1001/jama.270.1.51; KIM HJ, 1989, J NEUROSURG, V71, P565, DOI 10.3171/jns.1989.71.4.0565; KRAUS JF, 1989, AM J PUBLIC HEALTH, V79, P294, DOI 10.2105/AJPH.79.3.294; MILLER JD, 1991, J NEUROL SCI, V103, pS33; RONTY H, 1993, EUR J CLIN INVEST, V23, P182, DOI 10.1111/j.1365-2362.1993.tb00759.x; SELIGMAN ML, 1978, LIPIDS, V12, P946; SHANLEY BC, 1993, RES MONOGRAPH US DEP, V22, P299; STEWART JR, 1988, 32 ANN P ASS ADV AUT, P319; WALLER PF, 1986, JAMA-J AM MED ASSOC, V256, P1461, DOI 10.1001/jama.256.11.1461; WARD RE, 1982, AM J SURG, V144, P153, DOI 10.1016/0002-9610(82)90617-1; Zink B J, 1994, Acad Emerg Med, V1, P171; ZINK BJ, 1988, ANN EMERG MED, V17, P15, DOI 10.1016/S0196-0644(88)80496-7; ZINK BJ, 1995, J NEUROSURG, V82, P822, DOI 10.3171/jns.1995.82.5.0822; ZINK BJ, 1993, J NEUROTRAUM, V10, P275, DOI 10.1089/neu.1993.10.275; 1992, MMWR-MORBID MORTAL W, V41, P893	28	18	18	0	1	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0145-6008			ALCOHOL CLIN EXP RES	Alcoholism (NY)	DEC	1996	20	9					1518	1522		10.1111/j.1530-0277.1996.tb01693.x			5	Substance Abuse	Science Citation Index Expanded (SCI-EXPANDED)	Substance Abuse	VZ863	WOS:A1996VZ86300004	8986197	Green Published			2022-02-06	
J	Shum, DKY; Chau, CH				Shum, DKY; Chau, CH			Changes in glycosaminoglycans during regeneration of post-crush sciatic nerves of adult guinea pigs	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						neural glycosaminoglycans; post-crush sciatic nerve; regeneration	CHONDROITIN-SULFATE PROTEOGLYCAN; CELL-ADHESION MOLECULES; GOLDFISH OPTIC-NERVE; NEURITE OUTGROWTH; SCHWANN-CELLS; EXTRACELLULAR-MATRIX; HYALURONIC-ACID; AXONAL-TRANSPORT; BRAIN; RAT	The glycosaminoglycans of sciatic nerves recovering from crush-injury were studied in adult guinea pigs and compared with those of non-injured mature neural tissues, The glycosaminoglycans were recovered from the 1,900 g supernatant and pellet of the tissue homogenates and assayed for hexuronate contents and susceptibilities to hyaluronidase, chondroitinase ABC, and nitrous acid, In the normal brain and central nerve tracts, the glycosoaminoglycans were distributed both in the supernatant and pellet fractions; the brain showed a predominance of chondroitin sulphates but the tracts showed a predominance of heparan sulphates, Twice as much glycosaminoglycans were found in normal sciatic nerves, only in the pellet fraction and with heparan sulphate predominant, In the 2 weeks post-crush, progressive increase in hexuronate was observed, due mainly to additional chondroitin sulphate forms in the supernatant; the pellet fraction in the same period was however similar to the untreated controls in relative abundance of glycosaminoglycan classes and hexuronate content, At 4 weeks post-crush, although the total hexuronate returned to the control level, a significant proportion of glycosaminoglycans remained in the supernatant fraction, Evidence is thus provided for the need to modulate the glycosaminoglycan expression pattern in adult neural tissue to allow post-traumatic tissue remodelling and axonal regrowth. (C) 1996 Wiley-Liss, Inc.			Shum, DKY (corresponding author), UNIV HONG KONG,DEPT BIOCHEM,FAC MED,5 SASSOON RD,HONG KONG,HONG KONG.		Shum, Daisy/C-4393-2009; Chau, Chi Ho/C-4221-2009				ACHESON A, 1991, NEURON, V7, P265, DOI 10.1016/0896-6273(91)90265-2; BERTOLOTTO A, 1991, J NEUROSCI RES, V29, P225, DOI 10.1002/jnr.490290213; BICKNESE AR, 1994, J NEUROSCI, V14, P3500; BIGNAMI A, 1993, ANAT EMBRYOL, V188, P419; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; BRAUNEWELL KH, 1995, EUR J NEUROSCI, V7, P792, DOI 10.1111/j.1460-9568.1995.tb00682.x; BRAUNEWELL KH, 1995, EUR J NEUROSCI, V7, P804; BRITTIS PA, 1994, P NATL ACAD SCI USA, V91, P7539, DOI 10.1073/pnas.91.16.7539; BRITTIS PA, 1992, SCIENCE, V255, P733, DOI 10.1126/science.1738848; BROWN MC, 1991, NEURON, V6, P359, DOI 10.1016/0896-6273(91)90245-U; CAREY DJ, 1986, J BIOL CHEM, V261, P7518; CAREY DJ, 1993, EXP CELL RES, V208, P10, DOI 10.1006/excr.1993.1217; CAREY DJ, 1990, J CELL BIOL, V111, P2053, DOI 10.1083/jcb.111.5.2053; CAREY DJ, 1994, J CELL BIOL, V124, P161, DOI 10.1083/jcb.124.1.161; COUGHLIN C, 1989, BRAIN RES, V493, P326, DOI 10.1016/0006-8993(89)91167-0; Dou CL, 1995, J NEUROSCI, V15, P8053; DOW KE, 1994, EXP NEUROL, V126, P129, DOI 10.1006/exnr.1994.1049; FRIEDLANDER DR, 1994, J CELL BIOL, V125, P669, DOI 10.1083/jcb.125.3.669; FUXE K, 1994, BRAIN RES, V636, P131, DOI 10.1016/0006-8993(94)90187-2; GHIRNIKAR RS, 1995, GLIA, V14, P145, DOI 10.1002/glia.440140209; GRUMET M, 1994, J BIOL CHEM, V269, P12142; HANEMANN CO, 1993, J HISTOCHEM CYTOCHEM, V41, P1383, DOI 10.1177/41.9.8354878; Hennig A., 1992, Cellular and Molecular Biology (Noisy-Le-Grand), V38, P585; IIJIMA N, 1991, J NEUROCHEM, V56, P706, DOI 10.1111/j.1471-4159.1991.tb08207.x; LAFONT F, 1992, DEVELOPMENT, V114, P17; LEE YC, 1961, ARCH BIOCHEM BIOPHYS, V93, P292, DOI 10.1016/0003-9861(61)90265-X; LEVINE JM, 1994, J NEUROSCI, V14, P4716; MAEDA N, 1995, NEUROSCIENCE, V67, P23, DOI 10.1016/0306-4522(94)00069-H; MARGOLIS RK, 1993, EXPERIENTIA, V49, P429, DOI 10.1007/BF01923587; MAUREL P, 1994, P NATL ACAD SCI USA, V91, P2512, DOI 10.1073/pnas.91.7.2512; NEWTON DJ, 1974, ANAL BIOCHEM, V62, P268, DOI 10.1016/0003-2697(74)90386-8; OOHIRA A, 1991, J NEUROSCI, V11, P822; PERIDES G, 1990, BRAIN RES, V512, P309, DOI 10.1016/0006-8993(90)90642-O; PERRY VH, 1987, J EXP MED, V165, P1218, DOI 10.1084/jem.165.4.1218; PINDZOLA RR, 1993, DEV BIOL, V156, P34, DOI 10.1006/dbio.1993.1057; RAULO E, 1994, J BIOL CHEM, V269, P12999; RIPELLINO JA, 1988, J CELL BIOL, V106, P845, DOI 10.1083/jcb.106.3.845; SAITO H, 1968, J BIOL CHEM, V243, P1536; SALZER JL, 1980, J CELL BIOL, V84, P739, DOI 10.1083/jcb.84.3.739; Schachner M., 1990, SEMIN NEUROSCI, V2, P497; SCOTT J. E., 1960, METHODS BIOCHEM ANAL, V8, P145; SILBERT JE, 1993, BIOCHEM J, V296, P119, DOI 10.1042/bj2960119; SNOW DM, 1992, J NEUROBIOL, V23, P322, DOI 10.1002/neu.480230311; TAN SS, 1987, P NATL ACAD SCI USA, V84, P7977, DOI 10.1073/pnas.84.22.7977; TONA A, 1993, J HISTOCHEM CYTOCHEM, V41, P593, DOI 10.1177/41.4.8450198	45	18	19	0	0	WILEY-LISS	NEW YORK	DIV JOHN WILEY & SONS INC 605 THIRD AVE, NEW YORK, NY 10158-0012	0360-4012			J NEUROSCI RES	J. Neurosci. Res.	NOV 15	1996	46	4					465	476		10.1002/(SICI)1097-4547(19961115)46:4<465::AID-JNR8>3.0.CO;2-E			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VV519	WOS:A1996VV51900008	8950706				2022-02-06	
J	Zafonte, RD; Hammond, FM; Mann, NR; Wood, DL; Millis, SR; Black, KL				Zafonte, RD; Hammond, FM; Mann, NR; Wood, DL; Millis, SR; Black, KL			Revised trauma score - An additive predictor of disability following traumatic brain injury?	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						revised trauma score; trauma scores; trauma; head injury; outcome; disability; hypoxic-ischemic injury	SEVERE HEAD-INJURY; RATING-SCALE; COMA; RECOVERY; INSULTS	Recent studies have clarified the role of hypoxic-ischemic damage as a secondary factor in traumatic brain injury (TBI). Many trauma centers are now consistently using the Revised Trauma Score (Glasgow Coma Scale, systolic blood pressure, and respiratory rate) to assist with triage of multitrauma patients. This study investigated the predictive power of the Revised Trauma Score (RTS) instead of the Glasgow Coma Scale (GCS) in determination of disability as measured by the Disability Rating Scale (DRS). Data were obtained as part of the National institute for Disability and Rehabilitation Research TBI Model Systems database on 501 patients receiving acute medical care and inpatient rehabilitation within a coordinated neurotrauma program for treatment of TBI. initial RTS and GCS were obtained on admission to the emergency department, along with the lowest CCS measured in the first 24 h. Analysis of initial RTS and GCS demonstrated modest, but statistically significant Pearson's correlations with DRS at rehabilitation admission (-0.18 and -0.25, respectively) and discharge (-0.22 and -0.24, respectively). Lowest GCS within the first 24 h postinjury also failed to show a strong relationship with DRS at rehabilitation admission (-0.28) and discharge (-0.24). Multiple regression analysis performed on RTS subsets for systolic blood pressure and respiratory rate did not reveal an added predictive value. Although RTS may be important in emergency triage For its ability to predict mortality, this study indicates its limited usefulness in prediction of disability.	WAYNE STATE UNIV,SCH MED,DETROIT,MI		Zafonte, RD (corresponding author), REHABIL INST MICHIGAN,SERV PHYS,261 MACK AVE,DETROIT,MI 48201, USA.						BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHOI SC, 1983, J NEUROSURG, V59, P294, DOI 10.3171/jns.1983.59.2.0294; Dahmer E., 1993, J HEAD TRAUMA REHAB, V8, P12, DOI [10.1097/00001199-199308020-00004, DOI 10.1097/00001199-199308020-00004]; FLEMING JM, 1994, ARCH PHYS MED REHAB, V75, P156; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; JENNETT B, 1975, LANCET, V1, P480; KOHI YM, 1984, INJURY, V16, P25, DOI 10.1016/0020-1383(84)90110-4; MACIVER IN, 1958, LANCET, V1, P390; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; PRICE DJE, 1972, INJURY-BR J ACCIDENT, V3, P218, DOI 10.1016/0020-1383(72)90104-0; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; ROBERTSON C, 1973, ACTA NEUROCHIR WIEN, V59, pS98; TEASDALE G, 1974, LANCET, V2, P81	19	18	18	2	3	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	NOV-DEC	1996	75	6					456	460		10.1097/00002060-199611000-00011			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	WA783	WOS:A1996WA78300009	8985110				2022-02-06	
J	Dall, JT; Harmon, RL; Quinn, CM				Dall, JT; Harmon, RL; Quinn, CM			Use of clonidine for treatment of spasticity arising from various forms of brain injury: A case series	BRAIN INJURY			English	Article							SPINAL SPASTICITY; CORD	Spasticity may occur as a result of different types of brain injury. The experience with six patients, aged 17-73 years, treated with clonidine for spasticity due to brain injuries of various causes is presented. These cases include a patient with traumatic brain injury, three patients with intracranial haemorrhage, a patient with a right basal ganglia stroke 3 years prior to a left subdural haematoma associated with a fall, and a patient with cerebral palsy. To varying degrees for each patient, clonidine was effective in reducing extremity hypertonicity. A possible mechanism of action is discussed. These case findings suggest clonidine may be useful in the management of spasticity associated with various forms of brain injury, and that formal studies of clonidine for this application appear warranted.	MED COLL OHIO,DEPT PHYS MED & REHABIL,TOLEDO,OH 43699								BOYESON MG, 1994, ARCH NEUROL-CHICAGO, V51, P405, DOI 10.1001/archneur.1994.00540160107014; Dall J T, 1995, J Stroke Cerebrovasc Dis, V5, P78, DOI 10.1016/S1052-3057(10)80350-7; DONOVAN WH, 1988, ARCH PHYS MED REHAB, V69, P193; GLENN MB, 1990, PRCTICAL MANAGEMENT, P296; Glenn MB, 1986, J HEAD TRAUMA REHAB, V1, P71; GOLDSTEIN LB, 1990, STROKE, V21, P179; GOLDSTEIN LB, 1990, BRAIN RES, V508, P305, DOI 10.1016/0006-8993(90)90413-6; GOLDSTEIN LB, 1990, J NEURO REHAB, V4, P137; KATZ RT, 1988, AM J PHYS MED REHAB, V67, P108, DOI 10.1097/00002060-198806000-00004; KATZ RT, 1992, ARCH PHYS MED REHAB, V73, P339, DOI 10.1016/0003-9993(92)90007-J; MAYNARD FM, 1986, PARAPLEGIA, V24, P175, DOI 10.1038/sc.1986.24; MILANOV IG, 1992, ACTA NEUROL SCAND, V85, P305; NAFTCHI NE, 1982, SCIENCE, V217, P1042, DOI 10.1126/science.6126002; NANCE PW, 1989, PARAPLEGIA, V27, P296, DOI 10.1038/sc.1989.44; Robinson K. M., 1990, PRACTICAL MANAGEMENT, P201; SANDFORD PR, 1992, AM J PHYS MED REHAB, V71, P301, DOI 10.1097/00002060-199210000-00010; STEVENS J, 1986, ARCH PHYSICAL MED RE, V67, P666; TREMBLAY LE, 1986, NEUROPHARMACOLOGY, V25, P41, DOI 10.1016/0028-3908(86)90056-0; TUCKMAN J, 1982, SPINAL CORD INJURY, P133; UNNERSTALL JR, 1984, BRAIN RES REV, V319, P69; YABLON SA, 1993, AM J PHYS MED REHAB, V72, P154, DOI 10.1097/00002060-199306000-00009	21	18	19	0	0	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	JUN	1996	10	6					453	458					6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	UR327	WOS:A1996UR32700005	8816098				2022-02-06	
J	Di, X; Harpold, T; Watson, JC; Bullock, MR				Di, X; Harpold, T; Watson, JC; Bullock, MR			Excitotoxic damage in neurotrauma: Fact or fiction	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						secondary brain injury; excitatory amino acid; glutamate antagonist; ischemia; extracellular fluid	ACUTE SUBDURAL-HEMATOMA; TRAUMATIC BRAIN INJURY; COMPETITIVE NMDA ANTAGONIST; FOCAL CEREBRAL-ISCHEMIA; CORTICAL CELL-CULTURE; GLUTAMATE NEUROTOXICITY; HEAD-INJURY; RECEPTOR; CAT; RAT	Secondary brain injury is a well-demonstrated contributor to the morbidity and mortality of severe head injury. At least ten new compounds which antagonize the effects of glutamate in the brain are currently undergoing clinical evaluation as putative protectants against this secondary injury. None have yet shown clear benefit in humans. It is accepted that excitatory amino acids, glutamate in particular, have 'neurotoxic' effects on the brain, especially when present in excessive amounts. Whether or not this excitatory amino acid toxicity represents the major pathway for secondary damage is disputed. In the laboratory, over 300 studies have now demonstrated the ability of glutamate antagonist drugs of various types to prevent ischemic and post-traumatic acute brain damage. The magnitude and consistency of protection afforded by this group of compounds exceeds that which has ever been shown with any other mechanisms. Laboratory studies using in vitro neuronal models have implicated glutamate as a promoter of ionic flux and calcium entry across the cell membrane, which may then initiate astrocytic swelling and neuronal necrosis. In vivo animal models of brain trauma and ischemia have demonstrated glutamate release and potassium efflux into the extracellular fluid (ECF). Outcome in these models is improved, as assessed by both histopathology and behavioral studies, when glutamate antagonists are used. Additionally, presynaptic glutamate blockade in animal models such as middle cerebral artery (MCA) occlusion and subdural hematoma, creates reduction in lesion size which is paralleled by reduced glutamate production. In bridging the gap between the laboratory and the patient care setting, human microdialysis studies have shown massive release of excitatory amino acids into the ECF after severe head injury. Early studies with N-methyl-D-aspartate (NMDA) antagonists in head injured humans have demonstrated a reduction of intracranial pressure and an improvement in cerebral perfusion. Future studies are needed to examine further the value of protection from excitatory amino acid induced injury.			Di, X (corresponding author), VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, DEPT NEUROSURG, BOX 631, MCV STN, RICHMOND, VA 23298 USA.						ADAMS JH, 1983, ACTA NEUROCHIR, V32, pS15; ALEXANDER MJ, 1994, ACTA NEUROCHIR, P479; BENVENISTE H, 1991, CEREBROVAS BRAIN MET, V3, P213; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; BULLOCK MR, 1995, INTRACRANIAL PRESURE, V10, P64; BULLOCK MR, 1994, INTRACRANIAL PRESSUR, V9, P238; BULLOCK MR, 1994, INTRACRANIAL PRESSUR, V9, P264; BULLOCK R, 1992, J NEUROTRAUM, V9, pS443; BULLOCK R, 1994, J CEREBR BLOOD F MET, V14, P466, DOI 10.1038/jcbfm.1994.57; BULLOCK R, 1990, J CEREBR BLOOD F MET, V10, P668, DOI 10.1038/jcbfm.1990.120; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; CHEN M, 1991, ANN NEUROL, V30, P62, DOI 10.1002/ana.410300112; CHEN MH, 1991, J NEUROSURG, V74, P944, DOI 10.3171/jns.1991.74.6.0944; CHOI DW, 1988, J NEUROSCI, V8, P185; CHOI DW, 1987, J NEUROSCI, V7, P357; COLLINS RC, 1989, ANN INTERN MED, V110, P992, DOI 10.7326/0003-4819-110-12-992; ERB DE, 1988, ACTA NEUROPATHOL, V76, P347, DOI 10.1007/BF00686971; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FUJISAWA H, 1993, BRAIN RES, V629, P73, DOI 10.1016/0006-8993(93)90483-4; GARTHWAITE G, 1989, NEUROSCI LETT, V99, P113, DOI 10.1016/0304-3940(89)90274-7; GOLDBERG MP, 1987, J PHARMACOL EXP THER, V243, P784; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; GRAHAM SH, 1993, J CEREBR BLOOD F MET, V13, P88, DOI 10.1038/jcbfm.1993.11; GROTTA J, 1995, STROKE, V26, P602, DOI 10.1161/01.STR.26.4.602; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; HOSSMAN KA, 1992, BRAIN PATHOL, V4, P23; HOVDA DA, 1990, ACT NEUR S, V51, P331; HOVDA DA, 1992, J NEUROTRAUMA; HUMPHREYS RP, 1990, CHILD NERV SYST, V6, P139, DOI 10.1007/BF00308490; INGLIS F, 1992, J NEUROTRAUM, V9, P75, DOI 10.1089/neu.1992.9.75; Kakarieka A., 1995, Journal of Neurotrauma, V12, P375; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; KLUN B, 1984, ACTA NEUROCHIR, V71, P171, DOI 10.1007/BF01401312; KOTAPA M, 1992, J NEUROL NEUROSURG P; KURODA Y, 1994, NEUROSURGERY, V35, P106, DOI 10.1227/00006123-199407000-00016; LYETH B G, 1989, Society for Neuroscience Abstracts, V15, P1113; LYETH BG, 1991, NEUROREHABILITATION, P50; MACPHERSON P, 1978, J NEUROL NEUROSUR PS, V41, P122, DOI 10.1136/jnnp.41.2.122; MAXWELL WL, 1994, ACTA NEUROCHIR WIEN, V60, P122; MCINTOSH TK, 1990, J NEUROCHEM, V55, P1170, DOI 10.1111/j.1471-4159.1990.tb03122.x; MELDRUM BS, 1992, BRAIN RES, V593, P1, DOI 10.1016/0006-8993(92)91254-C; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; MILLER LP, 1990, BRAIN RES, V526, P103, DOI 10.1016/0006-8993(90)90254-9; PARK CK, 1988, ANN NEUROL, V24, P543, DOI 10.1002/ana.410240411; PERSSON L, 1992, J NEUROSURG, V76, P72, DOI 10.3171/jns.1992.76.1.0072; Povlishock J T, 1985, Cent Nerv Syst Trauma, V2, P285; POVLISHOCK JT, 1985, LAB INVEST, V52, P540; ROSENBERG PA, 1989, NEUROSCI LETT, V103, P162, DOI 10.1016/0304-3940(89)90569-7; ROTHMAN SM, 1987, TRENDS NEUROSCI, V10, P299, DOI 10.1016/0166-2236(87)90177-9; SCHRODER ML, 1994, J NEUROSURG, V80, P324, DOI 10.3171/jns.1994.80.2.0324; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; SHIMADA N, 1989, J CEREBR BLOOD F MET, V9, P603, DOI 10.1038/jcbfm.1989.86	55	18	18	0	0	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.	JUN	1996	9	4					231	241					11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UU331	WOS:A1996UU33100007	21551912				2022-02-06	
J	Wiley, JL; Compton, AD; Pike, BR; Temple, MD; McElderry, JW; Hamm, RJ				Wiley, JL; Compton, AD; Pike, BR; Temple, MD; McElderry, JW; Hamm, RJ			Reduced sensorimotor reactivity following traumatic brain injury in rats	BRAIN RESEARCH			English	Article						startle; reflex function; sensory system; traumatic brain injury	ACOUSTIC STARTLE; PREPULSE INHIBITION; SEQUELAE; LESIONS; REFLEX	The present study examined sensorimotor reactivity in rats following traumatic brain injury (TBI). Moderate injury was induced with midline fluid percussion in some of the rats. Others received identical surgery, but were not injured (sham-injured rats), or received neither surgery nor injury (naive rats). All rats were evaluated in acoustic and/or tactile startle procedures. At 8 days post-injury, the sensorimotor reactivity of TBI rats to acoustic stimuli was severely reduced compared to that of sham-injured rats. This TBI-induced deficit was enduring (> 30 days). In a separate experiment, greater sensorimotor reactivity was observed with tactile (vs. acoustic) stimulation in both TBI and naive rats, although startle amplitudes for the TBI rats were lower than control levels for both types of stimuli. These results suggest that sensorimotor reactivity is altered by TBI and that the startle procedure is a promising method for investigation of information processing alterations following TBI.	UNIV RICHMOND, DEPT PSYCHOL, RICHMOND, VA 23173 USA; VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, DEPT PSYCHOL, RICHMOND, VA 23298 USA		Wiley, JL (corresponding author), VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, DEPT PHARMACOL & TOXICOL, POB 980613, RICHMOND, VA 23298 USA.			Wiley, Jenny/0000-0001-8489-2947	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-12587] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS012587, P50NS012587] Funding Source: NIH RePORTER		BRAFF D, 1978, PSYCHOPHYSIOLOGY, V15, P339, DOI 10.1111/j.1469-8986.1978.tb01390.x; CAINE SB, 1992, PHARMACOL BIOCHEM BE, V43, P1201, DOI 10.1016/0091-3057(92)90503-8; COOVER GD, 1971, PHYSIOL BEHAV, V7, P727, DOI 10.1016/0031-9384(71)90140-5; DAVIS M, 1977, J COMP PHYSIOL PSYCH, V91, P549, DOI 10.1037/h0077345; DAVIS M, 1982, J NEUROSCI, V2, P791; DAVIS M, 1980, NEUROSCI BIOBEHAV R, V4, P241, DOI 10.1016/0149-7634(80)90016-0; Davis M., 1984, P287; DEWITT DS, 1989, J CEREB BLOOD FLO S1, V9, pS93; DIXON CE, 1994, J NEUROTRAUM, V11, P275, DOI 10.1089/neu.1994.11.275; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; GEYER MA, 1990, BRAIN RES BULL, V25, P485, DOI 10.1016/0361-9230(90)90241-Q; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; HAMM RJ, 1995, CENTRAL NERVOUS SYST, P307; Hamm RJ, 1994, NEUROBIOLOGY CENTRAL, P86; HAMMOND GR, 1973, PHYSIOL BEHAV, V10, P239, DOI 10.1016/0031-9384(73)90304-1; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; HOFFMAN HS, 1980, PSYCHOL REV, V87, P175, DOI 10.1037/0033-295X.87.2.175; KATZ RT, 1992, AM FAM PHYSICIAN, V46, P1491; KODSI MH, 1994, BRAIN RES, V643, P59, DOI 10.1016/0006-8993(94)90008-6; LINGENHOHL K, 1994, J NEUROSCI, V14, P1176, DOI 10.1523/JNEUROSCI.14-03-01176.1994; LYETH BG, 1994, BRAIN RES, V640, P240, DOI 10.1016/0006-8993(94)91879-1; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; SWERDLOW NR, 1993, BEHAV NEUROSCI, V107, P104, DOI 10.1037/0735-7044.107.1.104; TAYLOR BK, 1991, PHYSIOL BEHAV, V49, P527, DOI 10.1016/0031-9384(91)90275-S; WHYTE J, 1994, AM J PHYS MED REHAB, V73, P2; WILEY JL, 1995, J NEUROTRAUM, V12, P992; [No title captured]	29	18	19	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	APR 15	1996	716	1-2					47	52		10.1016/0006-8993(96)00045-5			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UM083	WOS:A1996UM08300006	8738219				2022-02-06	
J	Meyer, MA				Meyer, MA			Evaluating brain death with positron emission tomography: Case report on dynamic imaging of F-18-fluorodeoxyglucose activity after intravenous bolus injection	JOURNAL OF NEUROIMAGING			English	Article							CEREBRAL BLOOD-FLOW; GLUCOSE-UTILIZATION	A dynamic positron emission tomography (PET) study of the head was performed over 1 hour after the intravenous bolus administration of F-18-fluorodeoxyglucose (F-18-FDG) to a 18-year-old patient with the clinical diagnosis of brain death. This dynamic PET study was performed on the seventh day after a severe posttraumatic closed-head injury. No intracerebral uptake or retention of tracer was noted, consistent with a diffuse absence of brain metabolism. A small amount of tracer was noted to slowly rise over time within the sagittal sinus, indicating that visualization of sagittal sinuses on technetium 99m-diethylenetriaminepentaacetic acid planar images could provide a falsely negative scintigraphic evaluation for the presence of brain death. It is concluded that PET FDG imaging may be a useful technique in evaluating patients for brain death.	UNIV TENNESSEE,MED CTR,BIOMED IMAGING CTR,KNOXVILLE,TN								ALTMAN DI, 1987, PEDIATR RES, V21, pA487; BLACKLOCK JB, 1987, J NEUROSURG, V67, P71, DOI 10.3171/jns.1987.67.1.0071; GOODMAN JM, 1985, NEUROSURGERY, V16, P492, DOI 10.1227/00006123-198504000-00010; LAURIN NR, 1989, J NUCL MED, V30, P1627; LEE VW, 1987, J NUCL MED, V28, P1279; LEVY DE, 1987, ANN NEUROL, V22, P673, DOI 10.1002/ana.410220602; MEDLOCK MD, 1993, J NEUROSURG, V79, P752, DOI 10.3171/jns.1993.79.5.0752; MEYER MA, 1994, J NEUROSURG, V81, P644; Momose T, 1992, Kaku Igaku, V29, P1139; Sandler M. P., 1995, Journal of Nuclear Medicine, V36, p35P; Tsuchida T, 1993, Kaku Igaku, V30, P663	11	18	18	0	0	LITTLE BROWN CO	BOSTON	34 BEACON STREET, BOSTON, MA 02108-1493	1051-2284			J NEUROIMAGING	J. Neuroimaging	APR	1996	6	2					117	119		10.1111/jon199662117			3	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	UG268	WOS:A1996UG26800011	8634485				2022-02-06	
J	Porter, MD; Fricker, PA				Porter, MD; Fricker, PA			Controlled prospective neuropsychological assessment of active experienced amateur boxers	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						active; amateur boxing; chronic traumatic encephalopathy; neuropsychological tests; prospective; screening	CHRONIC BRAIN-DAMAGE; MINOR HEAD-INJURY; BOXING LEAD	Objective: To use a practical battery of eight neuropsychological tests for the detection of an association between amateur boxing and chronic traumatic encephalopathy. Design: A controlled prospective neuropsychological study over a 15-18-month period. Setting: Dublin, Ireland. March 1992 to September 1993. Participants: Twenty experienced actively competing amateur boxers and 20 controls matched for age and socioeconomic status. Interventions: Participation in competitive amateur boxing and training. Main outcome measures: Absolute scores, and changes in scores, in the neuropsychological tests. Results: At the end of the study period, the boxers performed significantly better then the controls in both the Trail-Making Tests A and B (TMT-A, TMT-B), whereas the control group's scores for the Finger Tapping Tests (FTT) were significantly higher than those of the boxers. The boxer's scores for the dominant-hand FTT showed a significant deterioration, but there was no association between this change and boxing exposure. Conclusions: There was no evidence of neuropsychological impairment in the boxers as compared with socioeconomically, educationally and age-matched controls, and there was no association between boxing exposure and performances in any of the neuropsychological tests used. There is accumulating evidence that amateur boxing is not associated with chronic traumatic encephalopathy but longer term prospective studies are needed.			Porter, MD (corresponding author), AUSTRALIAN INST SPORT,DEPT SPORTS MED,POB 176,BELCONNEN,ACT 2616,AUSTRALIA.						ADAMS JH, 1992, AIBA J, V25, P26; *BRIT MED ASS, 1984 BRIT MED ASS BO; BROOKS N, 1987, J NEUROL NEUROSUR PS, V50, P997, DOI 10.1136/jnnp.50.8.997; BUTLER RJ, 1993, J NEUROL NEUROSUR PS, V56, P1055, DOI 10.1136/jnnp.56.10.1055; CARLSSON GS, 1987, J NEUROSURG, V67, P197, DOI 10.3171/jns.1987.67.2.0197; CASSON IR, 1984, JAMA-J AM MED ASSOC, V251, P2663, DOI 10.1001/jama.251.20.2663; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; DREW RH, 1986, J CLIN PSYCHOL, V42, P520, DOI 10.1002/1097-4679(198605)42:3<520::AID-JCLP2270420319>3.0.CO;2-6; Gennarelli T A, 1983, Acta Neurochir Suppl (Wien), V32, P1; GENNARELLI TA, 1982, ATHLETIC INJURIES HE; GRONWALL D, 1975, LANCET, V2, P995; HAGLUND Y, 1990, ACTA NEUROL SCAND, V82, P353; HAGLUND Y, 1990, ACTA NEUROL SCAND, V82, P245; HAGLUND Y, 1990, ACTA NEUROL SCAND, V82, P297; HARVEY PKP, 1974, LANCET, V19, P928; INGLIS J, 1959, BRAIN, P440; JANE JA, 1985, J NEUROSURG, V62, P96, DOI 10.3171/jns.1985.62.1.0096; JOHNSON J, 1969, BRIT J PSYCHIAT, V115, P45, DOI 10.1192/bjp.115.518.45; JORDAN BD, 1988, J NATL MED ASSOC, V80, P407; KASTE M, 1982, LANCET, V2, P1186; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1987, J NEUROSURG, V67, P657, DOI 10.3171/jns.1987.67.5.0657; Lewis R, 1979, MANUAL REPEATABLE CO; MALISZEWSKI M, 1990, SPORT PSYCHOL, V4, P55; MCLATCHIE G, 1987, J NEUROL NEUROSUR PS, V50, P96, DOI 10.1136/jnnp.50.1.96; MURELIUS O, 1991, ACTA NEUROL SCAND, V83, P9; PORTER MD, 1993, THESIS DUBLIN U; Roberts AH, 1969, BRAIN DAMAGE BOXERS; ROSS RJ, 1987, CLIN SPORT MED, V6, P41; ROSS RJ, 1983, JAMA-J AM MED ASSOC, V249, P211, DOI 10.1001/jama.249.2.211; RUSSELL EW, 1975, J CONSULT CLIN PSYCH, V43, P800, DOI 10.1037/0022-006X.43.6.800; SCHMIDTOLSEN S, 1990, AM J SPORT MED, V18, P98, DOI 10.1177/036354659001800117; SCHWARTZ ML, 1986, J NEUROSURG, V64, P248, DOI 10.3171/jns.1986.64.2.0248; Sironi V A, 1982, J Neurosurg Sci, V26, P165; Spreen O, 1991, COMPENDIUM NEUROPSYC; STEWART WF, 1994, IABA MAGAZINE    APR, P3; THOMASSEN A, 1979, ACTA NEUROL SCAND, V60, P352, DOI 10.1111/j.1600-0404.1979.tb07661.x; WECHSLER D, 1971, WECHSLER ADULT INTEL	38	18	18	1	4	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	1050-642X			CLIN J SPORT MED	Clin. J. Sport Med.	APR	1996	6	2					90	96		10.1097/00042752-199604000-00005			7	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	UC180	WOS:A1996UC18000005	8673582				2022-02-06	
J	Golding, EM; Dobson, GP; Golding, RM				Golding, EM; Dobson, GP; Golding, RM			A critical assessment of noise-induced errors in P-31 MRS: Application to the measurement of free intracellular magnesium in vivo	MAGNETIC RESONANCE IN MEDICINE			English	Article						phosphorus magnetic resonance spectroscopy; magnesium; fluid percussion brain injury	TRAUMATIC BRAIN INJURY; FREE MG-2+; RATS; NMR; RECOVERY; INVIVO; ATP	Phosphorus magnetic resonance spectroscopy (P-31 MRS) is a noninvasive technique that has been used to estimate free intracellular magnesium concentration (free [Mg2+]). Free [Mg2+] is computed from the chemical shift separation between the alpha- and beta-phosphate resonances of ATP. The current study was undertaken to critically assess the influence of noise effects in estimating free [Mg2+] in rat brain subjected to moderate parasagittal fluid percussion-induced injury. We show that contrary to published data, free [Mg2+] does not significantly change for up to 4 h after moderate trauma in different rat strains and using different surface coils, Before injury, free [Mg2+] = 0.56 +/- 0.11 (mean +/- SD, n = 36) and 4 h post-trauma, free [Mg2+] = 0.56 +/- 0.28. Our results suggest that explanations for this discrepancy comprise errors of chemical shift assignments accompanying low signal-to-noise ratios and the method of analysis employed, Indeed, the authors propose that spectra of beta-ATP signal-to-noise ratio less than 5:1 will produce significant noise-induced errors. We conclude that without knowledge of the inherent errors in P-31 MRS spectroscopy and appropriate statistical analysis, caution should be exercised in calculating free [Mg2+] and using these changes as a basis for proposing pharmacotherapeutic interventions.			Golding, EM (corresponding author), JAMES COOK UNIV N QUEENSLAND,SCH MOLEC SCI,DEPT PHYSIOL & PHARMACOL,TOWNSVILLE,QLD 4811,AUSTRALIA.						Altura B. M., 1992, Magnesium and Trace Elements, V10, P122; ALTURA BM, 1983, SCIENCE, V220, P331, DOI 10.1126/science.6836278; COHN M, 1962, J BIOL CHEM, V237, P176; DOBSON GP, 1992, NMR BIOMED, V5, P20, DOI 10.1002/nbm.1940050105; EMERSON CS, 1992, NEUROREPORT, V11; FITTS RH, 1994, PHYSIOL REV, V74, P49, DOI 10.1152/physrev.1994.74.1.49; Galland L, 1991, Magnes Trace Elem, V10, P287; GOLDING EM, 1995, MAGNET RESON MED, V33, P467, DOI 10.1002/mrm.1910330403; GUPTA RK, 1978, J BIOL CHEM, V253, P6172; HALVORSON HR, 1992, NMR BIOMED, V5, P53, DOI 10.1002/nbm.1940050202; HELPERN JA, 1993, NEUROLOGY, V43, P1577, DOI 10.1212/WNL.43.8.1577; ILES RA, 1985, BIOCHEM J, V229, P141, DOI 10.1042/bj2290141; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McIntosh TK, 1988, J NEUROTRAUM, V5, P17, DOI 10.1089/neu.1988.5.17; VINK R, 1991, AM J PHYSIOL, V261, pR1527, DOI 10.1152/ajpregu.1991.261.6.R1527; VINK R, 1988, BRAIN RES, V460, P184, DOI 10.1016/0006-8993(88)91221-8; VINK R, 1987, BIOCHEM BIOPH RES CO, V149, P594, DOI 10.1016/0006-291X(87)90409-8; VINK R, 1990, J NEUROSCI, V10, P3524; VINK R, 1988, J BIOL CHEM, V263, P757; VINK R, 1988, MAGNET RESON MED, V6, P37, DOI 10.1002/mrm.1910060105; WHITE JR, 1993, ANN PHARMACOTHER, V27, P775, DOI 10.1177/106002809302700619; WILLIAMS GD, 1995, MAGNET RESON MED, V33, P853, DOI 10.1002/mrm.1910330618; [No title captured]	23	18	18	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0740-3194			MAGNET RESON MED	Magn.Reson.Med.	FEB	1996	35	2					174	185		10.1002/mrm.1910350208			12	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	TT422	WOS:A1996TT42200007	8622581				2022-02-06	
J	Iwamoto, Y; Yang, K; Clifton, GL; Hayes, RL				Iwamoto, Y; Yang, K; Clifton, GL; Hayes, RL			Liposome-mediated BDNF cDNA transfer in intact and injured rat brain	NEUROREPORT			English	Article						gene transfer; liposome; BDNF; cDNA; traumatic brain injury; in vivo; rat	INVIVO GENE-TRANSFER; VECTOR; CELLS; MODEL; RNA	WE examined the temporal profile of the expression of brain-derived neurotrophic factor (BDNF) cDNA containing a viral promoter following the injection of liposome cDNA complexes into the intact and traumatically injured rat brain. In situ hybridization and PCR confirmed the presence of injected BDNF cDNA for at least 6 days after injection. A similar profile of BDNF cDNA was observed when it was injected following cortical impact injury. mRNA was also localized around the injection areas. These results suggest that liposome-mediated delivery of neurotrophin cDNA may be a practical gene transfer method for treating traumatic brain injury.	UNIV TEXAS, HLTH SCI CTR, DEPT NEUROSURG, HOUSTON, TX 77030 USA						NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021458, P01NS031998] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS21458, P01 NS31998] Funding Source: Medline		BARINAGA M, 1994, SCIENCE, V264, P772, DOI 10.1126/science.8171331; BARINAGA M, 1994, SCIENCE, V264, P773; CHENG B, 1994, BRAIN RES, V640, P56, DOI 10.1016/0006-8993(94)91857-0; CULVER KW, 1992, SCIENCE, V256, P1550, DOI 10.1126/science.1317968; DAVIDSON BL, 1993, NAT GENET, V3, P219, DOI 10.1038/ng0393-219; DIXON CE, 1991, J NEUROSCI METH, V39, P253; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; FINK DJ, 1992, HUM GENE THER, V3, P11, DOI 10.1089/hum.1992.3.1-11; FRIEDMAN B, 1995, J NEUROSCI, V15, P1044; GIORDANO T, 1992, MOL BRAIN RES, V16, P239, DOI 10.1016/0169-328X(92)90231-Y; HAYES RL, 1995, NEUROSCI LETT, V191, P121, DOI 10.1016/0304-3940(95)11561-X; HUG P, 1991, BIOCHIM BIOPHYS ACTA, V1097, P1, DOI 10.1016/0925-4439(91)90016-3; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; KATO K, 1994, MOL BRAIN RES, V25, P359, DOI 10.1016/0169-328X(94)90173-2; LASALLE GL, 1993, SCIENCE, V259, P988, DOI 10.1126/science.8382374; MACGREGOR GR, 1989, NUCLEIC ACIDS RES, V17, P2365, DOI 10.1093/nar/17.6.2365; NABEL EG, 1992, HUM GENE THER, V3, P649, DOI 10.1089/hum.1992.3.6-649; NAKAO N, 1995, EXP NEUROL, V131, P1, DOI 10.1016/0014-4886(95)90002-0; ROESSLER BJ, 1994, NEUROSCI LETT, V167, P5, DOI 10.1016/0304-3940(94)91015-4; SIMMONS DM, 1989, J HISTOTECHNOL, V12, P169; WHITSON JS, 1995, IN PRESS BRAIN RES; YANG K, 1994, NEUROSCI LETT, V182, P287, DOI 10.1016/0304-3940(94)90818-4; YANG K, 1994, BRAIN RES, V664, P141, DOI 10.1016/0006-8993(94)91964-X; YANG K, 1994, NEUROSCI LETT, V182, P291, DOI 10.1016/0304-3940(94)90819-2; YANG K, 1995, IN PRESS J NEUROSCI	25	18	18	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	JAN 31	1996	7	2					609	612		10.1097/00001756-199601310-00056			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UC299	WOS:A1996UC29900056	8730841				2022-02-06	
J	PERSINGER, MA				PERSINGER, MA			NEUROPSYCHOLOGICA PRINCIPIA BREVITA - AN APPLICATION TO TRAUMATIC (ACQUIRED) BRAIN INJURY	PSYCHOLOGICAL REPORTS			English	Article							HEAD-INJURY; RECEPTORS; SCHIZOPHRENIA; INTERNEURONS; EPILEPSY	The concepts and discoveries of modern neuroscience now challenge many of the presumptions that influence diagnostic decisions within neurology, psychiatry, and clinical neuropsychology. Many of these presumptions are derived from archaic bivariate models such as the mind-body argument, organic-functional dichotomy, and single lesion-single behavior causality. Thirteen basic principles which may be useful for inferring more reliable and accurate relationships between microstructural function and clinical manifestations are developed.			PERSINGER, MA (corresponding author), LAURENTIAN UNIV,DEPT PSYCHOL,CLIN NEUROPSYCHOL LAB,RAMSEY LAKE RD,SUDBURY,ON P3E 2C6,CANADA.						American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; ANDERSEN AR, 1990, COMPREHENSIVE EPILEP, P375; ANDREASEN NC, 1988, SCIENCE, V239, P1381, DOI 10.1126/science.3279509; ARDILA A, 1988, INT J NEUROSCI, V39, P235, DOI 10.3109/00207458808985710; ARNSTEN AFT, 1985, SCIENCE, V230, P1273, DOI 10.1126/science.2999977; BANCAUD J, 1994, BRAIN, V117, P71, DOI 10.1093/brain/117.1.71; BARNES CA, 1994, TRENDS NEUROSCI, V17, P13, DOI 10.1016/0166-2236(94)90029-9; BEKENSTEIN JW, 1993, SCIENCE, V259, P97, DOI 10.1126/science.8093417; BIGLER ED, 1992, BRAIN RES BULL, V28, P651, DOI 10.1016/0361-9230(92)90119-I; BIZIERE K, 1985, NEURAL MODULATION IM, P81; Carmichael L, 1926, PSYCHOL REV, V33, P51, DOI 10.1037/h0074309; CHUGANI HT, 1986, SCIENCE, V237, P840; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Cummings J, 1985, CLIN NEUROPSYCHIATRY; Delorey Timothy M., 1994, P389; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GEDYE A, 1989, J AM GERIATR SOC, V37, P970, DOI 10.1111/j.1532-5415.1989.tb07283.x; GOLDSTEIN JA, 1993, CHRONIC FATIGUE SYND; JARVIS PE, 1984, HALSTEAD REITAN TEST; JIBIKI I, 1994, NEUROSCI BIOBEHAV R, V18, P281, DOI 10.1016/0149-7634(94)90030-2; Levin H. S., 1987, NEUROBEHAVIORAL RECO, P318; MICHELSON HB, 1991, SCIENCE, V253, P1420, DOI 10.1126/science.1654594; MILLER L, 1993, PSYCHOTHERAPY BRAIN; MOORE RY, 1993, NEUROSCI LETT, V150, P112, DOI 10.1016/0304-3940(93)90120-A; NITSCH RM, 1992, SCIENCE, V258, P304, DOI 10.1126/science.1411529; ODER W, 1992, J NEUROL NEUROSUR PS, V55, P475, DOI 10.1136/jnnp.55.6.475; PARKER R, 1990, TRAUMATIC BRAIN INJU; Pawlik G, 1989, NEUROPSYCHOLOGICAL F, P65; PERSINGER MA, 1994, PHYSIOL BEHAV, V56, P225, DOI 10.1016/0031-9384(94)90188-0; PERSINGER MA, 1994, PSYCHOL REP, V75, P1059, DOI 10.2466/pr0.1994.75.3.1059; PERSINGER MA, 1993, PSYCHOL REP, V72, P1059, DOI 10.2466/pr0.1993.72.3c.1059; PERSINGER MA, 1971, THESIS U MANITOBA; PHELPS ME, 1985, SCIENCE, V228, P799, DOI 10.1126/science.2860723; POKRAS RS, 1994, MED HYPOTHESES, V42, P253, DOI 10.1016/0306-9877(94)90126-0; REILA AR, 1990, COMPREHENSIVE EPILEP, P359; REIMAN EM, 1984, NATURE, V316, P683; ROBERTS GW, 1990, NEUROPATH APPL NEURO, V16, P3, DOI 10.1111/j.1365-2990.1990.tb00927.x; SLOVITER RS, 1987, SCIENCE, V235, P73, DOI 10.1126/science.2879352; TERRY RD, 1988, AGING BRAIN, P109; WEILAND NG, 1990, ENDOCRINOLOGY, V126, P2392, DOI 10.1210/endo-126-5-2392; [No title captured]	41	18	18	0	1	PSYCHOLOGICAL REPORTS	MISSOULA	P O BOX 9229, MISSOULA, MT 59807	0033-2941			PSYCHOL REP	Psychol. Rep.	DEC	1995	77	3	1				707	724		10.2466/pr0.1995.77.3.707			18	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	TJ037	WOS:A1995TJ03700001	8559908				2022-02-06	
J	MURR, R; SCHURER, L				MURR, R; SCHURER, L			CORRELATION OF JUGULAR VENOUS OXYGEN-SATURATION TO SPONTANEOUS FLUCTUATIONS OF CEREBRAL PERFUSION-PRESSURE IN PATIENTS WITH SEVERE HEAD-INJURY	NEUROLOGICAL RESEARCH			English	Article						AUTOREGULATION; CEREBRAL PERFUSION PRESSURE; JUGULAR VENOUS OXYGEN SATURATION; OXIMETRY; TRAUMATIC BRAIN INJURY	BLOOD-FLOW; BRAIN INJURY; INTRACRANIAL HYPERTENSION; AUTO-REGULATION; METABOLISM; AUTOREGULATION; CIRCULATION; MANNITOL	Continuous measurements of mean arterial pressure (MAP), ICP, and jugular venous oxygen saturation (SjO(2)) were performed in 11 patients with severe head injury (GCS 3-7) to assess the dependence of SjO(2) from the cerebral perfusion pressure (CPP) trying to establish an indirect measure of cerebrovascular autoregulation. Changes in CPP resulting from spontaneous fluctuations in MAP or ICP induced highly significant alterations in SjO(2) in the range of 0.14-0.56% SjO(2) mmHg(-1) CPP in all patients and all periods after trauma. The analysis of the distribution of the SjO(2):CPP-ratios showed the highest frequency of values in the range of 0.0-0.25% SjO(2) mmHg(-1) CPP in 9 of the 11 patients. Within the first 2 days after trauma, a more pronounced dependency of SjO(2) from changes in CPP was found, but this was not statistically significant. No predictable relationship of the SjO(2):CPP-ratio to the level of ICP could be demonstrated in the patients. Because changes in SjO(2) induced by alterations in CPP were found in all patients and throughout the acute phase of severe head injury, these changes more probably reflect physiological alterations in CBF with varying perfusion pressure rather than impaired autoregulation after head trauma. Although assessment of cerebral autoregulation by estimation of the SjO(2):CPP-ratio offers new possibilities for monitoring of these patients, the high frequency of erroneous readings or irregular fluctuations of the SjO(2)-signal from the fibreoptic catheter limits the usefulness of the SjO(2)-dependency from CPP for practical use in the intensive care unit.	UNIV HEIDELBERG,KLINIKUM MANNHEIM,DEPT NEUROSURG,MANNHEIM,GERMANY		MURR, R (corresponding author), UNIV MUNICH,KLINIKUM GROSSHADERN,INST ANAESTHESIOL,MARCHIONINISTR 15,D-81366 MUNICH,GERMANY.						AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; AOYAGI M, 1975, J NEUROSURG, V43, P689, DOI 10.3171/jns.1975.43.6.0689; BAUMBACH GL, 1985, AM J PHYSIOL, V249, pH629, DOI 10.1152/ajpheart.1985.249.3.H629; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; CHAN KH, 1993, NEUROSURGERY, V32, P547, DOI 10.1227/00006123-199304000-00009; CRUZ J, 1990, J NEUROSURG, V73, P725, DOI 10.3171/jns.1990.73.5.0725; ENEVOLDSEN EM, 1978, J NEUROSURG, V48, P689, DOI 10.3171/jns.1978.48.5.0689; FORTUNE JB, 1994, J NEUROSURG, V80, P461, DOI 10.3171/jns.1994.80.3.0461; HERNANDEZPEREZ MJ, 1976, AM J PHYSIOL, V231, P929, DOI 10.1152/ajplegacy.1976.231.3.929; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; JAMES IM, 1969, CIRC RES, V25, P77, DOI 10.1161/01.RES.25.1.77; LASSEN NA, 1959, PHYSIOL REV, V39, P183, DOI 10.1152/physrev.1959.39.2.183; MUIZELAAR JP, 1984, J NEUROSURG, V61, P700, DOI 10.3171/jns.1984.61.4.0700; MURR R, 1993, J NEUROTRAUMA S1, V10, pS2555; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; PRICE DJ, 1993, INTRACRANIAL PRESSUR, V8, P61; ROBERTSON CS, 1992, J NEUROL NEUROSUR PS, V55, P594, DOI 10.1136/jnnp.55.7.594; STRANDGAARD S, 1976, STROKE, V7, P287, DOI 10.1161/01.STR.7.3.287; THEODORSSONNORH.E, 1986, COMPUT METH PROG BIO, V23, P57	20	18	20	0	0	FOREFRONT PUBL GROUP	LONDON	MONOMARK HOUSE 27 OLD GLOUCESTER STREET, LONDON, ENGLAND WC1N 3XX	0161-6412			NEUROL RES	Neurol. Res.	OCT	1995	17	5					329	333		10.1080/01616412.1995.11740338			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TA934	WOS:A1995TA93400002	8584122				2022-02-06	
J	MILDERS, MV; BERG, IJ; DEELMAN, BG				MILDERS, MV; BERG, IJ; DEELMAN, BG			4-YEAR FOLLOW-UP OF A CONTROLLED MEMORY TRAINING STUDY IN CLOSED-HEAD INJURED PATIENTS	NEUROPSYCHOLOGICAL REHABILITATION			English	Article							TRAUMATIC BRAIN INJURY; COGNITIVE REHABILITATION; REMEDIATION; STRATEGIES	In a controlled group study Berg, Koning-Haanstra, and Deelman (1991) compared the effects of memory strategy training with the effects of drill and practice training and no treatment in severely head injured patients. Four months after training the group in the strategy condition performed significantly better on three memory tests than the patient groups in the other two conditions. Four years following this last evaluation, 31 of the 38 patients from the original training study were retested on the same memory tests. Thirteen normal subjects, who had already served as normal controls in the training study, were also retested. In contrast to the results four years earlier, memory performance was the same for all three patient groups. The level of performance of the patients was still well below the level of the normal controls. One reason for the disappearance of the advantage of the strategy group over the other two patient groups, was the drop-out of patients with relatively poor memory scores on the previous evaluation. A second reason was the improvement in memory performance relative to the previous evaluation found in the drill and practice and the no-treatment groups.	UNIV GRONINGEN,DEPT NEUROPSYCHOL,9713 EZ GRONINGEN,NETHERLANDS								BENEDICT RHB, 1989, CLIN PSYCHOL REV, V9, P605; Berg IJ, 1991, NEUROPSYCHOL REHABIL, V1, P97, DOI DOI 10.1080/09602019108401384; CROSSON B, 1984, J CLIN NEUROPSYCHOL, V6, P287, DOI 10.1080/01688638408401219; DEELMAN BG, 1990, TRAUMATIC BRAIN INJU; FRANZEN M D, 1991, Neuropsychology Review, V2, P29, DOI 10.1007/BF01108846; FREEMAN M R, 1992, Brain Injury, V6, P65, DOI 10.3109/02699059209008124; GODFREY HPD, 1985, J CONSULT CLIN PSYCH, V53, P555, DOI 10.1037/0022-006X.53.4.555; GODLSTEIN G, 1988, CLIN NEUROPSYCHOLOGI, V2, P251; LEVIN HS, 1990, ARCH NEUROL-CHICAGO, V47, P223, DOI 10.1001/archneur.1990.00530020131027; MILLER E, 1992, BRIT J PSYCHIAT, V160, P1, DOI 10.1192/bjp.160.1.1; Prigatano G. P., 1993, NEUROPSYCHOL REHABIL, V3, P53; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; ROBERTSON IH, 1993, CURR OPIN NEUROL, V6, P756, DOI 10.1097/00019052-199310000-00013; Ruff R. M., 1989, J HEAD TRAUMA REHAB, V4, P20, DOI [10.1097/00001199-198909000-00006, DOI 10.1097/00001199-198909000-00006]; Ryan T V, 1988, Arch Clin Neuropsychol, V3, P165, DOI 10.1016/0887-6177(88)90061-3; SCHACTER DL, 1985, J CLIN EXP NEUROPSYC, V7, P79, DOI 10.1080/01688638508401243; TATE RL, 1991, J NERV MENT DIS, V179, P117, DOI 10.1097/00005053-199103000-00001; VOLPE BT, 1990, ARCH NEUROL-CHICAGO, V47, P220, DOI 10.1001/archneur.1990.00530020128026; WILSON B, 1992, J NEUROL NEUROSUR PS, V55, P177, DOI 10.1136/jnnp.55.3.177; WILSON BA, 1991, NEUROPSYCHOL REHABIL, V1, P117, DOI DOI 10.1080/09602019108401386; [No title captured]	21	18	18	0	2	LAWRENCE ERLBAUM ASSOC LTD	HOVE	27 PALMEIRA MANSIONS CHURCH RD, HOVE, E SUSSEX, ENGLAND BN3 2FA	0960-2011			NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	SEP	1995	5	3					223	238		10.1080/09602019508401468			16	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	RG859	WOS:A1995RG85900002					2022-02-06	
J	MAIER, DL; KALB, RG; STELZNER, DJ				MAIER, DL; KALB, RG; STELZNER, DJ			NMDA ANTAGONISM DURING DEVELOPMENT EXTENDS SPARING OF HINDLIMB FUNCTION TO OLDER SPINALLY TRANSECTED RATS	DEVELOPMENTAL BRAIN RESEARCH			English	Article						NMDA RECEPTOR; MK-801; SPINAL CORD; DEVELOPMENTAL PLASTICITY; CRITICAL PERIOD; RECOVERY OF FUNCTION	EXCITATORY AMINO-ACIDS; ACTIVITY-DEPENDENT DEVELOPMENT; TRAUMATIC BRAIN INJURY; LONG-TERM POTENTIATION; POSTNATAL-DEVELOPMENT; CORTICOSPINAL TRACT; CORD TRANSECTION; MOTOR NEURONS; RECEPTORS; GROWTH	Hindlimb weight support and bipedal stepping occur after spinal cord transection in neonatal rats (birth to 12 days of age) while the same lesion in 15-day and older animals results in permanent loss of these responses. Some compensatory change in lumbar spinal circuitry must occur after spinal transection in young animals subserving these hindlimb behaviors. In contrast, animals just a few days older are incapable of such compensatory responses. We have examined the hypothesis that neural activity leads to the postnatal loss of plasticity in spinal circuitry. We find that antagonism of the N-methyl-D-aspartate (NMDA) subtype of glutamate receptor with MK-801 in young animals extends the sparing of hindlimb function after spinal transection to older animals. This effect is not due to a non-specific depression of all exciatory drive to motor neurons since Ia to motor neuron synaptic transmission through non-NMDA receptors is preserved during MK-801 treatment. Acute administration of MK-801 at the time of spinal transection or chronic administration of MK-801 after postnatal day 17 has no effect on recovery of hindlimb function after spinal transection. These results highlight the importance of NMDA receptor activation in spinal circuit maturation.	SUNY HLTH SCI CTR,DEPT ANAT & CELL BIOL,SYRACUSE,NY 13210; YALE UNIV,SCH MED,DEPT NEUROL,NEW HAVEN,CT 06510						NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1F32NS09235, NS14096, NS29837] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS014096, F32NS009235, R01NS029837] Funding Source: NIH RePORTER		ALTMAN J, 1975, ANIM BEHAV, V23, P896, DOI 10.1016/0003-3472(75)90114-1; CARONI P, 1992, J NEUROSCI, V12, P3849; CLINE HT, 1987, P NATL ACAD SCI USA, V84, P4342, DOI 10.1073/pnas.84.12.4342; COMMISSIONG JW, 1989, EXP BRAIN RES, V78, P597; CUMMINGS JP, 1984, EXP NEUROL, V83, P155, DOI 10.1016/0014-4886(84)90054-2; CURFS MHJM, 1993, DEVELOPMENT, V117, P535; DONATELLE JM, 1977, J COMP NEUROL, V175, P207, DOI 10.1002/cne.901750205; FADEN AI, 1988, ANN NEUROL, V23, P623, DOI 10.1002/ana.410230618; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GILBERT M, 1979, J COMP NEUROL, V184, P821, DOI 10.1002/cne.901840413; GOLDBERGER ME, 1986, DEV PLASTICITY MAMMA, P363; GRIDNAU AAM, 1986, ANAT EMBRYOL, V175, P101; JAHR CE, 1986, J PHYSIOL-LONDON, V370, P515, DOI 10.1113/jphysiol.1986.sp015948; KALB RG, 1994, DEV BIOL, V162, P539, DOI 10.1006/dbio.1994.1107; KALB RG, 1992, P NATL ACAD SCI USA, V89, P8502, DOI 10.1073/pnas.89.18.8502; KALB RG, 1992, BRAIN RES REV, V17, P283, DOI 10.1016/0165-0173(92)90020-M; KALB RG, 1988, J NEUROSCI, V8, P2350; KALB RG, 1990, SCIENCE, V250, P294, DOI 10.1126/science.2145629; KIMURA J, 1983, ELECTRODIAGNOSIS DIS; KLEINSCHMIDT A, 1987, SCIENCE, V238, P355, DOI 10.1126/science.2443978; KUANG RZ, 1990, J COMP NEUROL, V292, P585, DOI 10.1002/cne.902920408; LEONG SK, 1984, J COMP NEUROL, V228, P18; MAIER DL, 1993, SOC NEUR ABSTR; MAIER DL, 1993, SEC INT BEHAV NEUROS; MCDONALD JW, 1990, BRAIN RES REV, V15, P41, DOI 10.1016/0165-0173(90)90011-C; NICOLL RA, 1988, NEURON, V1, P97, DOI 10.1016/0896-6273(88)90193-6; PANTER SS, 1992, NEUROSCI LETT, V136, P165, DOI 10.1016/0304-3940(92)90040-E; PANTER SS, 1990, ANN NEUROL, V27, P96, DOI 10.1002/ana.410270115; RAUSCHECKER JP, 1987, NATURE, V326, P183, DOI 10.1038/326183a0; SCHERER WJ, 1989, J NEUROSCI, V9, P3837; SCHMIDT JT, 1990, J NEUROSCI, V10, P233; SCHNEIDER GE, 1979, NEUROPSYCHOLOGIA, V17, P557, DOI 10.1016/0028-3932(79)90033-2; SCHREYER DJ, 1982, NEUROSCIENCE, V7, P1837, DOI 10.1016/0306-4522(82)90001-X; SIMON DK, 1992, P NATL ACAD SCI USA, V89, P10593, DOI 10.1073/pnas.89.22.10593; STANFIELD BB, 1992, PROG NEUROBIOL, V38, P169, DOI 10.1016/0301-0082(92)90039-H; STELZNER DJ, 1971, EXP NEUROL, V31, P337, DOI 10.1016/0014-4886(71)90237-8; STELZNER DJ, 1991, RES NEUROL, V5, P419; STELZNER DJ, 1988, CURRENT ISSUES NEURA, P343; STELZNER DJ, 1986, DEV PLASTICITY MAMMA, P81; STELZNER DJ, 1986, DEV NEUROPSYCHOBIOLO, P241; THORNE B, 1980, INTRO STATISTICS PSY; TINCO M, 1993, J NEUROPHYSIOL, V70, P403; WEBER ED, 1980, BRAIN RES, V185, P17, DOI 10.1016/0006-8993(80)90667-8; WEBER ED, 1977, BRAIN RES, V125, P241, DOI 10.1016/0006-8993(77)90618-7	44	18	19	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-3806			DEV BRAIN RES	Dev. Brain Res.	JUL 14	1995	87	2					135	144		10.1016/0165-3806(95)00065-L			10	Developmental Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Neurosciences & Neurology	RL550	WOS:A1995RL55000005	7586495				2022-02-06	
J	BATES, L; REDMAN, S; BROWN, W; HANCOCK, L				BATES, L; REDMAN, S; BROWN, W; HANCOCK, L			DOMESTIC VIOLENCE EXPERIENCED BY WOMEN ATTENDING AN ACCIDENT AND EMERGENCY DEPARTMENT	AUSTRALIAN JOURNAL OF PUBLIC HEALTH			English	Article							VICTIMS	The aim of the study was to establish the extent and severity of domestic violence experienced by women attending the accident and emergency department of a large teaching hospital in Newcastle. The data were collected over a five-week period in 1992. All women between 17 and 80 years, attending the emergency or ambulatory areas between 8 a.m. and midnight, were asked to complete a confidential structured interview. A total of 401 women participated in the study, representing 82 per cent of eligible women approached. Each participant was asked if she had ever been physically hurt by someone close to her. Questions were asked to determine the relationship to the perpetrator, the type and cause of injury, treatment necessary and help sought Seven (1.7 per cent, 95 per cent confidence interval (CI) 0.46 to 3.02) of the women surveyed were attending the hospital as a direct result of an incident of domestic violence, and 100 women (25 per cent, CI 21 to 29) had experienced domestic violence at some time. Bruising, fractures and cuts were the most common forms of injury, with the most common locations being the head, face and chest. Weapons, such as guns and knives, were used in 20 per cent of the incidents. A considerable number of the women (68 per cent) did not seek help at the time of their injuries. As a substantial proportion of women have experienced domestic violence in their lives, accident and emergency workers should receive training in recognising and assisting victims of domestic violence.	HUNTER CTR HLTH ADVANCEMENT,NEWCASTLE,NSW,AUSTRALIA				Brown, Wendy J/A-1553-2016; Parkinson, Lynne/C-1949-2008	Brown, Wendy J/0000-0001-9093-4509; Parkinson, Lynne/0000-0001-9433-9555			*CANB PUBL POL RES, 1988, DOM VIOL ATT SURV; CUTHBERT M, 1991, AUSTR VIOL CONT PERS; DEVERY C, 1992, EOMSTIC VIOLENCE NSW; Dobash R.E., 1979, VIOLENCE WIVES CASE; GOLDBERG WG, 1984, JAMA-J AM MED ASSOC, V251, P3259, DOI 10.1001/jama.251.24.3259; MATKA E, 1991, CRIME JUSTICE B, V12; MCLEER SV, 1989, AM J PUBLIC HEALTH, V79, P65, DOI 10.2105/AJPH.79.1.65; Mugford J., 1989, VIOLENCE TODAY; MULLEN PE, 1988, LANCET          0416, P841; National Committee on Violence against Women, 1992, NAT STRAT VIOL WOM; *NSW BUR CRIM STAT, 1987, CRIM JUST B, V5; *NSW DOM VIOL COMM, 1991, NSW DOM VIOL STRAT P; *QUEENSL DOM VIOL, 1988, THES WALLS, P117; RANDALL T, 1990, JAMA-J AM MED ASSOC, V264, P940, DOI 10.1001/jama.264.8.940; ROBERTS G, 1989, VIOLENCE TODAY; ROBERTS GL, 1993, MED J AUSTRALIA, V159, P307, DOI 10.5694/j.1326-5377.1993.tb137866.x; SCUTT J, 1990, CONNEXIONS, V10, P7; WIDOM CS, 1992, 2ND NAT C VIOL CANB	18	18	18	0	2	PUBLIC HEALTH ASSOC	CANBERRA	GPO BOX 2204 ATTN:FIONA BRAY, CANBERRA 2601, AUSTRALIA	1035-7319			AUST J PUBLIC HEALTH	Aust. J. Public Health	JUN	1995	19	3					293	299					7	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	RH041	WOS:A1995RH04100016	7626680				2022-02-06	
J	MITCHELL, HL; FRISELLA, WA; BROOKER, RW; YOON, KW				MITCHELL, HL; FRISELLA, WA; BROOKER, RW; YOON, KW			ATTENUATION OF TRAUMATIC CELL-DEATH BY AN ADENOSINE A(1) AGONIST IN RAT HIPPOCAMPAL CELLS	NEUROSURGERY			English	Article						ADENOSINE; CELL DEATH; GLUTAMATE; ISCHEMIA; TRAUMA	SYNAPTIC TRANSMISSION; NEURONAL INJURY; BRAIN INJURY; AMINO-ACIDS; RECEPTORS; CURRENTS; INVITRO	IN A RAT hippocampal cell culture, we studied the mechanism of adenosine-mediated neuroprotection in traumatic injury to neurons. When the processes and bodies of cells in culture were mechanically disrupted, neurons that were located at a distance from the damage site died. This secondary neuronal death is at least partially mediated by glutamate, because MK801, a specific N-methyl-D-aspartate glutamate channel blocker, diminished the toxic effect. Furthermore, cyclopentyl adenosine, a specific A(1) adenosine receptor agonist that specifically attenuates synaptic release at the excitatory terminal, also blocked this trauma-mediated cell death. The dissemination of neurotoxicity from cell injury implies a release of a toxin by the dying cells. Consistent with this hypothesis, we found that neurotoxicity could be transferred to an uninjured neuronal culture by applying extracellular solution of the damaged culture to the healthy undamaged culture, as long as the fluid was transferred within 5 minutes. However, the glutamate concentrations in this medium were never higher than 20 nmol/L, suggesting that glutamate is not mediating the soluble and transferable toxicity. Consistent with this observation, the transferable neurotoxicity was not blocked by MK801 but was effectively blocked by cyclopentyl adenosine. Our observations suggest that traumatic cell death in culture is mediated by multiple mechanisms, including glutamate excitotoxicity.	ST LOUIS UNIV,DEPT PHARMACOL & PHYSIOL SCI,DIV NEUROSURG,ST LOUIS,MO 63131; ST LOUIS UNIV,INST SURG RES,DEPT SURG,ST LOUIS,MO 63131						NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS01547] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08NS001547] Funding Source: NIH RePORTER		BOWMER CJ, 1989, TRENDS PHARMACOL SCI, V10, P339, DOI 10.1016/0165-6147(89)90001-1; DOLPHIN AC, 1986, J PHYSIOL-LONDON, V373, P47, DOI 10.1113/jphysiol.1986.sp016034; DUNWIDDIE TV, 1985, INT REV NEUROBIOL, V27, P63, DOI 10.1016/S0074-7742(08)60556-5; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GOLDBERG MP, 1987, J PHARMACOL EXP THER, V243, P784; Kurbat J. M., 1993, Society for Neuroscience Abstracts, V19, P1661; MATTSON MP, 1994, J NEUROTRAUM, V11, P3, DOI 10.1089/neu.1994.11.3; MILLER LP, 1992, J NEUROTRAUM, V9, pS563; PARK TS, 1991, DEV BRAIN RES, V61, P73, DOI 10.1016/0165-3806(91)90115-Y; PARK TS, 1987, J CEREBR BLOOD F MET, V7, P178, DOI 10.1038/jcbfm.1987.41; PHILLIS JW, 1991, J NEUROCHEM, V56, P644, DOI 10.1111/j.1471-4159.1991.tb08198.x; PINARD E, 1989, BRAIN RES, V481, P124, DOI 10.1016/0006-8993(89)90492-7; RUDOLPHI KA, 1992, TRENDS PHARMACOL SCI, V13, P439, DOI 10.1016/0165-6147(92)90141-R; SCANZIANI M, 1992, NEURON, V9, P919, DOI 10.1016/0896-6273(92)90244-8; SCHOLZ KP, 1991, J PHYSIOL-LONDON, V435, P373, DOI 10.1113/jphysiol.1991.sp018515; SHOEMAKER JD, 1991, J CHROMATOGR-BIOMED, V562, P125, DOI 10.1016/0378-4347(91)80571-S; STRATTON KR, 1989, BRAIN RES, V494, P359, DOI 10.1016/0006-8993(89)90604-5; STURM CD, 1993, J NEUROSURG, V79, P111, DOI 10.3171/jns.1993.79.1.0111; TECOMA ES, 1989, NEURON, V2, P1541, DOI 10.1016/0896-6273(89)90042-1; THOMPSON SM, 1992, J PHYSIOL-LONDON, V451, P347, DOI 10.1113/jphysiol.1992.sp019168; TRUSSELL LO, 1985, P NATL ACAD SCI USA, V82, P4857, DOI 10.1073/pnas.82.14.4857; YAMADA KA, 1989, J NEUROSCI, V9, P3230; YOON KW, 1991, J NEUROSCI, V11, P1375	23	18	18	0	1	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0148-396X			NEUROSURGERY	Neurosurgery	MAY	1995	36	5					1003	1007		10.1227/00006123-199505000-00017			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	QV351	WOS:A1995QV35100057	7791963				2022-02-06	
J	ALQURAINY, IA				ALQURAINY, IA			CONVERGENCE INSUFFICIENCY AND FAILURE OF ACCOMMODATION FOLLOWING MIDFACIAL TRAUMA	BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY			English	Article								A prospective evaluation of patients who had sustained midfacial trauma was carried out in order to determine the prevalence of impaired convergence and accommodation and to establish the risk factors for such defects. Of 52 patients in this study, 11 suffered accommodation and/or convergence disturbances. They included 6 males (17% of the male population) and 5 females (29% of the female population). Nine of these 11 patients sustained their injuries due to alleged assaults (24.3% of all assaulted patients) and 2 following simple falls (25% of all fall victims). Five patients complained of double vision for near (5/11=45.5%) and another 4 had blurred vision and/or difficulty with reading (4/11=36.4%). The remaining two were asymptomatic. Six patients were randomly selected to receive orthoptic exercises/treatment while the other five were monitored for signs of spontaneous recovery. Within six months of injury/surgery, 83% of the treated patients (n=5) and 80% of the non-treated patients (n=4) recovered to within the normal values of accommodation and convergence. No significant statistical relationship was found between the incidence of accommodation and/or convergence failure, and the cause or the type of fracture sustained. It may, however, be related to the severity of both the impact and the associated closed head trauma.			ALQURAINY, IA (corresponding author), ROYAL EYE INFIRM,ASPLEY RD,PLYMOUTH PL4 6PL,DEVON,ENGLAND.						ALQURAINY IA, 1991, BRIT J ORAL MAX SURG, V29, P291; BRINKLEY JR, 1983, ANN OPHTHALMOL, V15, P826; CANDLER RG, 1945, T OPHTHAL SOC UK, V65, P57; COOPER J, 1978, J AM OPTOM ASSOC, V49, P673; Cross AG, 1945, T OPHTHAL SOC UK, V65, P20; DAVIES C E, 1956, Am Orthopt J, V6, P124; DODEN W, 1965, KLIN MBL AUGENHEILK, V146, P845; Duane A., 1922, AM J OPHTHALMOL, V5, P865, DOI [10.1016/S0002-9394(22)90793-7, DOI 10.1016/S0002-9394(22)90793-7]; DUKEELDER S, 1972, SYSTEM OPHTHALMOLO 1, V14, P710; Franceschetti A, 1943, SCHWEIZ ARCH NEUROL, V50, P267; HENDERSON D, 1973, UNPUB CLASSIFICATION; JAMPOLSKY A, 1971, T AM OPHTHAL SOC, V68, P730; KROHEL GB, 1986, ANN OPHTHALMOL, V18, P101; Matsuzaki H, 1964, Nippon Ganka Gakkai Zasshi, V68, P569; MEIN J, 1986, DIAGNOSIS MANAGEMENT, P119; RASKIND R H, 1976, American Orthoptic Journal, V26, P53; VANNOORDEN GK, 1985, BINOCULAR VISION OCU, P380	17	18	18	0	5	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH, MIDLOTHIAN, SCOTLAND EH1 3AF	0266-4356			BRIT J ORAL MAX SURG	Br. J. Oral Maxillofac. Surg.	APR	1995	33	2					71	75		10.1016/0266-4356(95)90203-1			5	Dentistry, Oral Surgery & Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine; Surgery	QR213	WOS:A1995QR21300002	7772590				2022-02-06	
J	HERNANDEZ, TD; WARNER, LA				HERNANDEZ, TD; WARNER, LA			KINDLED SEIZURES DURING A CRITICAL POSTLESION PERIOD EXERT A LASTING IMPACT ON BEHAVIORAL RECOVERY	BRAIN RESEARCH			English	Article						AMYGDALA KINDLING; ANTEROMEDIAL CORTEX LESION; SOMATOSENSORY ASYMMETRY; RECOVERY OF FUNCTION; KINDLED SEIZURE STAGE; NEUROLOGICAL MODEL	MORRIS WATER MAZE; POSTTRAUMATIC SEIZURES; TRAUMATIC EPILEPSY; GLUCOSE-UTILIZATION; CORTICAL INJURY; SPATIAL MEMORY; BRAIN-DAMAGE; HEAD-INJURY; RATS; PHENYTOIN	The present study was undertaken to assess the effects of amygdala kindling on behavioral recovery following unilateral frontal cortex damage in rats. Daily electrical stimulation of the amygdala began 48 h after lesion and continued until all animals had a single Stage 5 seizure. When amygdala kindled seizure activity ratable as Stage 0 occurred within the first 6 days after lesion, animals recovered from somatosensory asymmetries in approximately 3 weeks. In contrast, kindled animals that experienced Stage 1 seizure activity within the first 6 days after lesion failed to recover from somatosensory deficits in 4 months of testing. Differences in rate of recovery could not be accounted for by lesion size or placement. These data support the notion that not only is there a 'critical period' after brain damage during which the recovery process is vulnerable to seizure activity, but the type of kindled seizure that is experienced during that time ultimately determines how recovery is affected.			HERNANDEZ, TD (corresponding author), UNIV COLORADO,DEPT PSYCHOL,CAMPUS BOX 345,BOULDER,CO 80309, USA.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-30595] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R29NS030595] Funding Source: NIH RePORTER		ACKERMANN RF, 1989, EXP NEUROL, V104, P73, DOI 10.1016/0014-4886(89)90011-3; ADLER MW, 1969, EPILEPSIA, V10, P263, DOI 10.1111/j.1528-1157.1969.tb03847.x; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; BARTH TM, 1990, BEHAV BRAIN RES, V39, P73, DOI 10.1016/0166-4328(90)90122-U; BECKER A, 1992, BEHAV NEURAL BIOL, V57, P37, DOI 10.1016/0163-1047(92)90735-M; BELDHUIS HJA, 1992, HIPPOCAMPUS, V2, P397, DOI 10.1002/hipo.450020407; BOYESON MG, 1985, EXP NEUROL, V89, P479, DOI 10.1016/0014-4886(85)90107-4; BRAILOWSKI S, 1986, BRAIN RES, V363, P322; BRAILOWSKY S, 1986, BRAIN RES, V376, P71, DOI 10.1016/0006-8993(86)90900-5; CAVENESS WF, 1979, J NEUROSURG, V50, P545, DOI 10.3171/jns.1979.50.5.0545; COOPER RM, 1984, EXP NEUROL, V86, P261, DOI 10.1016/0014-4886(84)90185-7; CORCORAN ME, 1976, KINDLING, P215; CRISOSTOMO EA, 1988, ANN NEUROL, V23, P94, DOI 10.1002/ana.410230117; DAUTH GW, 1985, ANN NEUROL, V17, P431, DOI 10.1002/ana.410170503; Dietz M A, 1991, J Stroke Cerebrovasc Dis, V1, P37, DOI 10.1016/S1052-3057(11)80018-2; DIKMEN SS, 1991, JAMA-J AM MED ASSOC, V265, P1271, DOI 10.1001/jama.265.10.1271; DUELL RM, 1984, ANN NEUROL, V15, P521; ENGEL J, 1978, ANN NEUROL, V3, P538, DOI 10.1002/ana.410030615; FEASEYTRUGER KJ, 1993, NEUROSCI LETT, V151, P25, DOI 10.1016/0304-3940(93)90036-K; Feeney D M, 1987, Brain Inj, V1, P27, DOI 10.3109/02699058709034441; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; FEENEY DM, 1979, ARCH NEUROL-CHICAGO, V36, P8, DOI 10.1001/archneur.1979.00500370038005; FEENEY DM, 1985, PHYSIOL PSYCHOL, V13, P197; FEENEY DM, 1991, J NEUROL REHABIL, V5, P113; GILMAN S, 1987, ANN NEUROL, V22, P370, DOI 10.1002/ana.410220314; GLASSMAN RB, 1976, BEHAV BIOL, V17, P333, DOI 10.1016/S0091-6773(76)90688-X; GODDARD GV, 1969, EXP NEUROL, V25, P295, DOI 10.1016/0014-4886(69)90128-9; GOLDSTEIN IB, 1991, J NEUROL REHAB, V5, P129; GOLDSTEIN LB, 1993, J NEURAL TRANSP PLAS, V4, P175, DOI 10.1155/NP.1993.175; Guidice M A, 1987, Brain Inj, V1, P61; HAUSER WA, 1984, NEUROLOGY, V34, P746, DOI 10.1212/WNL.34.6.746; Hernandez T D, 1990, Restor Neurol Neurosci, V1, P323, DOI 10.3233/RNN-1990-1503; HERNANDEZ TD, 1989, BRAIN RES, V487, P89, DOI 10.1016/0006-8993(89)90943-8; HERNANDEZ TD, 1988, EXP NEUROL, V102, P318, DOI 10.1016/0014-4886(88)90226-9; HERNANDEZ TD, 1994, BRAIN RES, V635, P300, DOI 10.1016/0006-8993(94)91451-6; HERNANDEZ TD, 1989, CEREBROVASC DIS, P327; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; HOVDA DA, 1987, EXP NEUROL, V97, P391, DOI 10.1016/0014-4886(87)90099-9; JENNETT B, 1973, LANCET, V2, P652; JENNETT B, 1974, J NEUROSURG, V41, P208, DOI 10.3171/jns.1974.41.2.0208; JENNETT WB, 1969, LANCET, V1, P1023; KEMPINSKY WH, 1958, ARCH NEURO PSYCHIATR, V79, P376, DOI 10.1001/archneurpsyc.1958.02340040020002; KLINE AE, 1994, PHARMACOL BIOCHEM BE, V48, P773, DOI 10.1016/0091-3057(94)90345-X; KNOWLTON BJ, 1989, BEHAV NEUROSCI, V103, P1144, DOI 10.1037/0735-7044.103.5.1144; KUHL DA, 1990, DICP ANN PHARMAC, V24, P277, DOI 10.1177/106002809002400314; MASON CR, 1972, EPILEPSIA, V13, P663, DOI 10.1111/j.1528-1157.1972.tb04401.x; MCINTYRE DC, 1979, PHYSIOL BEHAV, V23, P855, DOI 10.1016/0031-9384(79)90190-2; MCNAMARA RK, 1992, BEHAV BRAIN RES, V50, P167, DOI 10.1016/S0166-4328(05)80298-0; MCNAMARA RK, 1993, HIPPOCAMPUS, V3, P149, DOI 10.1002/hipo.450030207; MEYER JS, 1970, ARCH NEUROL-CHICAGO, V23, P241, DOI 10.1001/archneur.1970.00480270051007; NAMBA H, 1989, BRAIN RES, V486, P221, DOI 10.1016/0006-8993(89)90508-8; PAPPIUS HM, 1989, PROG NEURO-PSYCHOPH, V13, P353, DOI 10.1016/0278-5846(89)90124-3; PARENTI ML, 1980, ITAL J NEUROL SCI, V4, P225; Paxinos G, 1986, RAT BRAIN STEREOTAXI; PEELE DB, 1992, BEHAV BRAIN RES, V48, P65, DOI 10.1016/S0166-4328(05)80140-8; PETERSON SL, 1982, PROG NEUROBIOL, V19, P237, DOI 10.1016/0301-0082(82)90008-9; RACINE R, 1979, BRAIN RES BULL, V4, P1, DOI 10.1016/0361-9230(79)90050-9; RAPPORT RL, 1973, J NEUROSURG, V38, P159, DOI 10.3171/jns.1973.38.2.0159; ROSE FD, 1987, BEHAV BRAIN RES, V24, P195, DOI 10.1016/0166-4328(87)90057-X; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; SCHALLERT T, 1984, BEHAV NEUROSCI, V98, P518; SCHALLERT T, 1986, BRAIN RES, V379, P104, DOI 10.1016/0006-8993(86)90261-1; SCHWARTZ AS, 1979, BRAIN, V102, P669, DOI 10.1093/brain/102.4.669; SERVIT Z, 1981, EPILEPSIA, V22, P315, DOI 10.1111/j.1528-1157.1981.tb04115.x; TEMKIN NR, 1990, NEW ENGL J MED, V323, P487; VONMONAKOW C, 1969, MOODS STATES MIND, P27; Ward Arthur A., 1942, YALE JOUR BIOL AND MED, V15, P189; WATSON CW, 1945, J NEUROPHYSIOL, V8, P221; WOHNS RNW, 1979, J NEUROSURG, V51, P507, DOI 10.3171/jns.1979.51.4.0507; YABLON SA, 1993, ARCH PHYS MED REHAB, V74, P983; YOUNG B, 1983, J NEUROSURG, V58, P231, DOI 10.3171/jns.1983.58.2.0231	71	18	18	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	MAR 6	1995	673	2					208	216		10.1016/0006-8993(94)01415-E			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	QK714	WOS:A1995QK71400005	7606434				2022-02-06	
J	FRASER, RT; WEHMAN, P				FRASER, RT; WEHMAN, P			TRAUMATIC BRAIN INJURY REHABILITATION - ISSUES IN VOCATIONAL OUTCOME	NEUROREHABILITATION			English	Article						TRAUMATIC BRAIN INJURY; VOCATIONAL REHABILITATION OUTCOME	CLOSED-HEAD-INJURY; WORK; RETURN	Since the population with a traumatic brain injury is principally young with many years of potential future earning capacity, understanding the issues affecting the vocational outlook for this group is critical. This article overviews the research to date on vocational outcome, emphasizing newly developed multivariate prediction models and encouraging a focus on actually examining the effects of different vocational interventions. The reasons for the variability in current study findings are reviewed with a framework proposed for more meaningful future research on the vocational rehabilitation process for this disability group. It is only through utilization of more standard intake and outcome variables and manipulation of interventions within this more standardized context that efficient and effective vocational rehabilitation for these survivors will be understood.	UNIV WASHINGTON,HARBORVIEW MED CTR,DEPT REHABIL MED,SEATTLE,WA 98104; VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PHYS MED & REHABIL,RICHMOND,VA 23284; VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT SPECIAL EDUC,RICHMOND,VA 23284		FRASER, RT (corresponding author), UNIV WASHINGTON,HARBORVIEW MED CTR,DEPT NEUROL SURG,ZA-05,SEATTLE,WA 98104, USA.						Abrams D., 1993, J HEAD TRAUMA REHAB, V8, P59; Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; BENNETT P, 1990, 9TH ANN S NAT HEAD I; CREPEAU F, 1993, NEUROPSYCHOL REHABIL, V3, P5; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; ELLERD DA, 1990, VOCATIONAL REHABILIT, P105; FRASER R, 1988, REHABIL COUNS BULL, V31, P276; FRASER R, 1990, SUMMARY NIDRR STUDIE; FRASER RT, 1994, TOP LANG DISORD, V15, P55, DOI 10.1097/00011363-199411000-00006; GODFREY HPD, 1993, NEW ZEAL MED J, V106, P301; HAFFEY W, 1989, REHAB PSYCHOL, V2, P147; KAPLAN SP, 1990, REHABIL COUNS BULL, V34, P16; KAY T, 1984, PUBLICATION, V1851; MCMORDIE W R, 1990, Brain Injury, V4, P57, DOI 10.3109/02699059009026149; MEYERSON L, 1979, REHAB PSYCHOL, V26, P228; NOVACK AT, 1988, 65TH ANN C AM C REH; ODDY M, 1980, J NEUROL NEUROSUR PS, V43, P798, DOI 10.1136/jnnp.43.9.798; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; PRIGATANO GP, 1994, J HEAD TRAUMA REHAB, V9, P91, DOI DOI 10.1097/00001199-199403000-00011; RAO N, 1992, ARCH PHYS MED REHAB, V73, P911; Rosenthal R., 1994, METAANALYTIC PROCEDU; SCHWAB K, 1993, NEUROLOGY, V43, P96; STAPLETON M, 1989, COGNITIVE REHABILITA, V7, P18; U.S. Department of Labor, 1991, DICT OCC TITL; WEHMAN P, 1995, IN PRESS J HEAD TRAU; WEHMAN P, 1992, ADA MANDATE SOCIAL C; [No title captured]	27	18	18	0	5	ELSEVIER SCI PUBL IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	1053-8135			NEUROREHABILITATION	Neurorehabilitation	FEB	1995	5	1					39	48		10.1016/1053-8135(94)00103-2			10	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RJ879	WOS:A1995RJ87900004	24525458				2022-02-06	
J	NIDA, TY; BIROS, MH; PHELEY, AM; BERGMAN, TA; ROCKSWOLD, GL				NIDA, TY; BIROS, MH; PHELEY, AM; BERGMAN, TA; ROCKSWOLD, GL			EFFECT OF HYPOXIA OR HYPERBARIC-OXYGEN ON CEREBRAL EDEMA FOLLOWING MODERATE FLUID PERCUSSION OR CORTICAL IMPACT INJURY IN RATS	JOURNAL OF NEUROTRAUMA			English	Article							TRAUMATIC BRAIN INJURY; INTRACRANIAL-PRESSURE; MODEL	This study was designed to evaluate the production of cerebral edema [as measured by tissue specific gravity (SpG)] following moderate fluid percussion (FP) and cortical impact (CI) injury in rodents. To determine the effects of a secondary systemic insult, hypoxia (13% oxygen for 30 min) was added to some experimental groups immediately after head injury. To determine the effects of hyperbaric oxygen (HBO) on injured cortical tissue, additional animal groups were exposed to HBO (1.5 atm, for 60 min), beginning 4 h after head trauma. Both injury models produced equal amounts of tissue edema at the site of injury (mean SpG +/- SEM = 1.035 +/- 0.001), when measured 6 h posttrauma. There was no significant edema at the tissue sites immediately adjacent to the trauma sites. The addition of hypoxia to either injury system did not increase edema formation beyond that produced by injury alone. HBO reduced the water content of the trauma site in animals that had received FP, but not in animals receiving CI. We conclude that with the injury parameters used in this protocol, both FP and CI appear to produce focal cerebral edema at the site of trauma. Hypoxia does not worsen edema. HBO appears to reduce edema produced by FP, but not by CI.	HENNEPIN CTY MED CTR,DEPT EMERGENCY MED,MINNEAPOLIS,MN 55415; UNIV MINNESOTA HOSP & CLIN,DEPT NEUROSURG,MINNEAPOLIS,MN; HENNEPIN CTY MED CTR,DEPT MED,MINNEAPOLIS,MN 55415; HENNEPIN CTY MED CTR,DEPT SURG,DIV NEUROSURG,MINNEAPOLIS,MN 55415						ONROffice of Naval Research [P2ONS30322-01] Funding Source: Medline		BIROS MH, 1990, ANN EMERG MED, V19, P201; BIROS MH, 1991, ANN EMERG MED, V20, P194; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; DIXON C E, 1988, Journal of Neurotrauma, V5, P91, DOI 10.1089/neu.1988.5.91; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HAYAKAWA T, 1971, NEUROL NEUROSURG PSY, V34, P580; HOLBACH KH, 1977, J NEUROL, V217, P17, DOI 10.1007/BF00316313; ISHIGE N, 1987, J CEREBR BLOOD F MET, V7, P759, DOI 10.1038/jcbfm.1987.131; KAWAMURA S, 1990, J HYPERBARIC MED, V5, P111; LAMBERTSEN CJ, 1953, J APPL PHYSIOL, V5, P471, DOI 10.1152/jappl.1953.5.9.471; LIGHTHALL J W, 1989, Journal of Neurotrauma, V6, P83, DOI 10.1089/neu.1989.6.83; LIGHTHALL J W, 1990, Journal of Neurotrauma, V7, P65, DOI 10.1089/neu.1990.7.65; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; LINDGREN STEN, 1965, BIOPHYSIK, V2, P320; MARMAROU A, 1982, J NEUROSURG, V56, P246, DOI 10.3171/jns.1982.56.2.0246; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MILLER JD, 1970, J NEUROSURG, V33, P287, DOI 10.3171/jns.1970.33.3.0287; NODA Y, 1983, J NEUROCHEM, V40, P1329, DOI 10.1111/j.1471-4159.1983.tb13574.x; PFENNINGER EG, 1989, J NEUROSURG, V70, P774, DOI 10.3171/jns.1989.70.5.0774; REITAN JA, 1990, STROKE, V21, P119, DOI 10.1161/01.STR.21.1.119; ROCKSWOLD GL, 1992, J NEUROSURG, V76, P929, DOI 10.3171/jns.1992.76.6.0929; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; SUKOFF MH, 1982, NEUROSURGERY, V10, P29, DOI 10.1227/00006123-198201000-00006; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; ZALESKA MM, 1985, NEUROCHEM RES, V10, P397, DOI 10.1007/BF00964608	27	18	22	0	1	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	FEB	1995	12	1					77	85		10.1089/neu.1995.12.77			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	QN638	WOS:A1995QN63800006	7783234				2022-02-06	
J	BOHNEN, NJ; WIJNEN, G; TWIJNSTRA, A; VANZUTPHEN, W; JOLLES, J				BOHNEN, NJ; WIJNEN, G; TWIJNSTRA, A; VANZUTPHEN, W; JOLLES, J			THE CONSTELLATION OF LATE POSTTRAUMATIC SYMPTOMS OF MILD HEAD-INJURY PATIENTS	JOURNAL OF NEUROLOGIC REHABILITATION			English	Article						MILD HEAD INJURY; POSTCONCUSSIVE COMPLAINTS	POSTCONCUSSIONAL SYMPTOMS; CONCUSSION	A questionnaire based investigation was carried out in patients with mild head injury (MHI) one to five years after the injury. A heterogeneous item pool was used in order to study the interrelationships between traditional postconcussive complaints and more emotional and vegetative complaints. A three-factor model of residual subjective and psycho logical complaints was identified in the patient population (N = 231). This model contained a dysthymic factor, a vegetative/bodily complaints factor, and a cognitive performance factor. A factor analysis in a matched non-concussed population (N = 231) revealed a rather different pattern. Although symptoms in both the patient and control group were non-specific in nature, patients reported significantly more severe symptoms compared with control persons.	UNIV LIMBURG,DEPT NEUROPSYCHOL & PSYCHOBIOL,6200 MD MAASTRICHT,NETHERLANDS; UNIV LIMBURG HOSP,DEPT NEUROL,MAASTRICHT,NETHERLANDS; UNIV LIMBURG,DEPT GEN PRACTICE MED,6200 MD MAASTRICHT,NETHERLANDS								Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; BOHNEN N, 1992, J NERV MENT DIS, V180, P683, DOI 10.1097/00005053-199211000-00002; BOHNEN N, 1993, NEUROPSY NEUROPSY BE, V6, P193; BOHNEN N, 1995, IN PRESS BRAIN INJUR; BOHNEN N, 1992, INT J NEUROSCI, V64, P95; CAVENESS WF, 1966, HEAD INJURY C P, P209; Denker P., 1944, NY STATE J MED, V44, P379; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; EDNA TH, 1987, ACTA NEUROCHIR, V86, P12, DOI 10.1007/BF01419498; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; GRONWALL D, 1974, LANCET, V2, P605; HINKELDEY N S, 1990, Brain Injury, V4, P115, DOI 10.3109/02699059009026157; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; MACFLYNN G, 1984, J NEUROL NEUROSUR PS, V47, P1326, DOI 10.1136/jnnp.47.12.1326; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P211; VERHAGE R, 1964, THESIS ASSEN NETHERL; 1985, SAS USERS GUIDE STAT	21	18	19	0	0	DEMOS PUBLICATIONS	NEW YORK	386 PARK AVE S STE 201, NEW YORK, NY 10016-8804	0888-4390			J NEUROL REHABIL	J. Neurol. Rehabil.		1995	9	1					33	39					7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	TF487	WOS:A1995TF48700005					2022-02-06	
J	FARMER, JE; PETERSON, L				FARMER, JE; PETERSON, L			PEDIATRIC TRAUMATIC BRAIN INJURY - PROMOTING SUCCESSFUL SCHOOL REENTRY	SCHOOL PSYCHOLOGY REVIEW			English	Article							CLOSED-HEAD-INJURY; CHILDREN; ADOLESCENTS; SEVERITY; COHORT; SEQUELAE; MILD	This article reviews physical, cognitive, and behavioral characteristics, of traumatic brain injury (TBI) that can place a child at risk for poor school adjustment. It proposes an ecological approach to school-based assessment and intervention that considers not only the nature of the child's brain injury, but also developmental factors and the quality of the school environment. Key issues for school success are discussed, including early identification of the child with TBI, neuropsychological assessment, multidisciplinary collaboration, individualized programming, and interventions aimed at modifying the environment to provide needed supports.	UNIV MISSOURI,SCH MED,COLUMBIA,MO 65211								ACHENBACH TM, 1983, MANUAL CHILD BEHAVIO; ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; Begali V., 1992, HEAD INJURY CHILDREN; Bigler E. D., 1990, TRAUMATIC BRAIN INJU; BOYER MG, 1991, INJURY, V22, P315, DOI 10.1016/0020-1383(91)90014-6; BRUCE DA, 1989, PEDIATR ANN, V18, P482, DOI 10.3928/0090-4481-19890801-07; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; COIE JD, 1993, AM PSYCHOL, V48, P1013, DOI 10.1037/0003-066X.48.10.1013; CROWLEY JA, 1991, J PEDIATR PSYCHOL, V16, P611, DOI 10.1093/jpepsy/16.5.611; DALBY PR, 1991, DEV NEUROPSYCHOL, V7, P35, DOI 10.1080/87565649109540476; DELIS DC, 1993, CALIFORNIA VERBAL LE; DEPOMPEI R, 1991, J HEAD TRAUMA REHABI, V6, P1; DORONZO JF, 1990, PSYCHOL MANAGEMENT T, P207; Ewing-Cobbs L, 1990, TRAUMATIC BRAIN INJU, P107; FAY GC, 1993, ARCH PHYS MED REHAB, V74, P895; FEAGENS LD, 1992, EMOTION COGNITION HL, P165; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; FLETCHER JM, 1988, HDB PEDIATRIC PSYCHO, P258; GOLDSTEIN FC, 1990, TRAUMATIC BRAIN INJU, P51; HAGEN C, 1981, RANCHO AMIGOS LEVELS; HANSON SL, 1992, PHYSICAL MED REHABIL, V6, P483; HARRINGTON DE, 1990, REHABILITATION ADULT, P476; HOPEWELL CA, 1990, COGNITIVE REHABILITA, P229; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; Jorgensen C., 1992, NATURAL SUPPORTS SCH, P179; KAUFMANN PM, 1993, J CHILD NEUROL, V8, P348, DOI 10.1177/088307389300800410; Lash M, 1993, NeuroRehabilitation, V3, P13, DOI 10.3233/NRE-1993-3304; Lehr E., 1990, COMMUNITY INTEGRATIO, P301; Lehr E, 1990, PSYCHOL MANAGEMENT T; Levin H. S., 1994, NEUROPSYCHOLOGY, V87, P171, DOI DOI 10.1037/0894-4105.8.2.171; LEVIN HS, 1988, NEUROSURGERY, V22, P1043, DOI 10.1227/00006123-198806010-00012; MATEER CA, 1991, DEV NEUROPSYCHOL, V7, P359, DOI 10.1080/87565649109540498; MCKEE WT, 1990, HDB SCH PSYCHOL, P821; MICHAUD LJ, 1993, ARCH PHYS MED REHAB, V74, P368; MIDGLEY C, 1989, J EDUC PSYCHOL, V81, P247, DOI 10.1037/0022-0663.81.2.247; *NAT HEAD INJ F, 1980, SIL EP; Nisbet J., 1992, NATURAL SUPPORTS SCH; POLLOCK E, 1993, TEACHERS GUIDE MANAG; Reitan R. M., 1992, NEUROPSYCHOLOGICAL E; Reynolds C.R., 1994, TEST MEMORY LEARNING; Rifkinson-Mann Stephanie, 1993, Contemporary Neurosurgery, V15, P1; Ringle-Bartels J, 1993, NeuroRehabilitation, V3, P26, DOI 10.3233/NRE-1993-3305; RIVARA JB, 1993, ARCH PHYS MED REHAB, V74, P1047, DOI 10.1016/0003-9993(93)90060-N; ROSENTHAL M, 1990, REHABILITATION ADULT; Savage R. C., 1994, ED DIMENSIONS ACQUIR; SAVAGE RC, 1991, J HEAD TRAUMA REHAB, V6, P1; Sheslow D., 1990, WIDE RANGE ASSESSMEN; SLOMKA GT, 1993, HDB CHILD ADOLESCENT, P208; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; Spreen O, 1991, COMPENDIUM NEUROPSYC; TEASDALE G, 1974, LANCET, V2, P81; TELZROW CF, 1991, J HEAD TRAUMA REHAB, V6, P23; TEPAS JJ, 1990, J PEDIATR SURG, V25, P92, DOI 10.1016/S0022-3468(05)80170-8; *VIRG DEP ED, 1992, GUID ED SERV STUD TR; WAALAND PK, 1993, RETURNING SCH FOLLOW; Weber A. M., 1990, J HEAD TRAUMA REHABI, V5, P73, DOI [10.1097/00001199-199003000-00012, DOI 10.1097/00001199-199003000-00012]; Wechsler D., 1974, WECHSLER INTELLIGENC; WEST M, 1992, LIFE CLASSROOM TRANS, P395; YLVISAKER M, 1993, NEUROPSYCHOL REHABIL, V3, P367, DOI 10.1080/09602019308401447; Ylvisaker M, 1991, J HEAD TRAUMA REHAB, V6, P10, DOI DOI 10.1097/00001199-199103000-00006; Ylvisaker Mark, 1993, Seminars in Speech and Language, V14, P74, DOI 10.1055/s-2008-1064160; Ylvisaker Mark, 1992, Seminars in Speech and Language, V13, P308, DOI 10.1055/s-2008-1064205	64	18	18	0	3	NATL ASSN SCHOOL PSYCHOL	HARRISONBURG	JAMES MADISON UNIV DEPT PSYCHOL, HARRISONBURG, VA 22807	0279-6015			SCHOOL PSYCHOL REV	Sch. Psychol. Rev.		1995	24	2					230	243					14	Psychology, Educational	Social Science Citation Index (SSCI)	Psychology	RP664	WOS:A1995RP66400010					2022-02-06	
J	Talamonti, G; Fontana, RA; Versari, PP; Villa, F; DAliberti, GA; Car, P; Collice, M				Talamonti, G; Fontana, RA; Versari, PP; Villa, F; DAliberti, GA; Car, P; Collice, M			Delayed complications of ethmoid fractures: A ''growing fracture'' phenomenon	ACTA NEUROCHIRURGICA			English	Article						head injury; meningitis; rhinorrhea; skull fracture	CEREBROSPINAL-FLUID RHINORRHEA; LEPTOMENINGEAL CYST; HEAD-INJURY; MANAGEMENT; MENINGITIS; TRAUMA; FOSSA	Delayed complications of ethmoid fractures are considered relatively rare. However, meningitis, recurrence of previously ceased cerebrospinal fluid rhinorrhea and delayed onset of cerebrospinal fluid rhinorrhea are possible even years after trauma. We report 10 consecutive patients with delayed complications of ethmoid fractures, whom we treated over the past 11 years. All patients had previously sustained a closed head injury and had remained anosmic. Variously after trauma (ranging from 2 months to 31 years), these patients were re-admitted because of meningitis (6 cases), recurrence of previously ceased cerebrospinal fluid rhinorrhea (3 cases), and delayed onset of cerebrospinal fluid rhinorrhea (1 case). In all cases the delayed complications were associated with relatively large defects of the ethmoid bone. These bone lesions were now evident even in those patients whose radiological assessments had been normal after trauma. All patients underwent a successful surgical repair and remained well during the follow-up. We discuss the possibility that delayed complications of ethmoid fractures are due to a mechanism like that of ''growing fractures'' in children.			Talamonti, G (corresponding author), OSPED NIGUARDA CA GRANDA,DEPT NEUROSURG,PIAZZA OSPED MAGGIORE 3,I-20162 MILAN,ITALY.		D'Aliberti, Giuseppe Antonio/AAS-3059-2020; Talamonti, Giuseppe/AAC-2760-2019	Talamonti, Giuseppe/0000-0002-9164-3292			ABERNETHY LJ, 1989, CLIN RADIOL, V40, P531, DOI 10.1016/S0009-9260(89)80278-8; BRAWLEY BW, 1967, J NEUROSURG, V26, P57, DOI 10.3171/jns.1967.26.1part1.0057; BYRNE JV, 1992, NEURORADIOLOGY, V34, P528, DOI 10.1007/BF00598968; Cairns H., 1937, J LARYNG, V52, P589, DOI 10.1017/S0022215100043991; COMOY J, 1986, J NEURORADIOLOGY, V13, P248; COOK PG, 1988, CLIN RADIOL, V39, P214; COSTA H, 1993, BRIT J PLAST SURG, V46, P503, DOI 10.1016/0007-1226(93)90225-Z; DAGI TF, 1983, AM J EMERG MED, V3, P295; DAGI TF, 1988, OPERATIVE NEUROSURGI, P57; Dandy WE, 1944, ARCH SURG-CHICAGO, V49, P75, DOI 10.1001/archsurg.1944.01230020080001; DYKE CG, 1937, NELSONS LOOSE LEAF M, P185; FARRELL VJ, 1993, SURG NEUROL, V37, P378; HALLIDAY AL, 1990, NEUROSURGERY, V26, P150, DOI 10.1227/00006123-199001000-00025; JEFFERSON A, 1972, BRIT J SURG, V59, P585, DOI 10.1002/bjs.1800590802; KOONSMAN M, 1992, AM J SURG, V164, P487, DOI 10.1016/S0002-9610(05)81186-9; KRAUS H, 1962, J Int Coll Surg, V38, P372; LEECH PJ, 1973, LANCET, V1, P1013; Lewin W, 1964, Clin Neurosurg, V12, P237; LEWIN W, 1954, BRIT J SURG, V42, P1, DOI 10.1002/bjs.18004217102; MACGEE EE, 1970, J NEUROSURG, V33, P312, DOI 10.3171/jns.1970.33.3.0312; MINCY JE, 1966, J TRAUM, V6, P618, DOI 10.1097/00005373-196609000-00007; PAPPAS DG, 1993, CLIN INFECT DIS, V17, P364, DOI 10.1093/clinids/17.3.364; PARK JI, 1983, LARYNGOSCOPE, V93, P1294; PRERE J, 1986, J NEURORADIOLOGY, V13, P278; RAHIMIZADEH A, 1986, NEUROSURGERY, V18, P386; RUSSELL T, 1984, NEUROSURGERY, V15, P705, DOI 10.1227/00006123-198411000-00013; SOULE AB, 1946, ARCH NEURO PSYCHIATR, V55, P382, DOI 10.1001/archneurpsyc.1946.02300150086006; SPETZLER RF, 1990, CLIN NEUROSURG, P2269; STEWART BT, 1992, AUST NZ J SURG, V62, P818, DOI 10.1111/j.1445-2197.1992.tb06927.x; TAVERAS JM, 1953, J NEUROSURG, V10, P233, DOI 10.3171/jns.1953.10.3.0233; WESTMORE GA, 1982, BRIT J SURG, V69, P489, DOI 10.1002/bjs.1800690821	31	18	20	0	0	SPRINGER-VERLAG WIEN	VIENNA	SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.		1995	137	3-4					164	173		10.1007/BF02187189			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	TL370	WOS:A1995TL37000014	8789657				2022-02-06	
J	WOOD, DMG; BIGLER, ED				WOOD, DMG; BIGLER, ED			DIENCEPHALIC CHANGES IN TRAUMATIC BRAIN INJURY - RELATIONSHIP TO SENSORY PERCEPTUAL FUNCTION	BRAIN RESEARCH BULLETIN			English	Article						DIENCEPHALON; SENSORY-PERCEPTUAL ABILITY; 3RD-VENTRICLE; INTERNAL CAPSULE; TRAUMATIC BRAIN INJURY	MIDDLE CEREBRAL-ARTERY; CLOSED HEAD-INJURY; DEGENERATION; ATROPHY; NEURONS; NUCLEUS; INFARCTION; THALAMUS; ISCHEMIA; RATS	Magnetic resonance (MR) imaging scans of 33 traumatically brain-injured (TBI) patients were compared quantitatively to MR scans of controls matched for age and gender. Quantitative estimates of thalamic, internal capsule, and third ventricle morphology were obtained in each TBI patient. Comparisons were made to normal control subjects and revealed significant reduction in thalamic volume with corresponding increase in third ventricle. Measurements of internal capsule reflected nonsignificant changes. Significant correlations were observed between sensory-perceptual functioning, as measured by the Reitan-Klove Sensory-Perceptual Exam, and thalamic volume in TBI patients. A decrease in thalamic volume was associated with an increase in sensory-perceptual errors.	BRIGHAM YOUNG UNIV,DEPT PSYCHOL,PROVO,UT 84602; LATTER DAY ST HOSP,SALT LAKE CITY,UT 84143								ANDERSON CV, 1994, BRAIN INJURY, V8, P565, DOI 10.3109/02699059409151008; Bigler E D, 1987, Arch Clin Neuropsychol, V2, P293, DOI 10.1016/0887-6177(87)90017-5; Bigler E. D., 1990, TRAUMATIC BRAIN INJU; BIGLER ED, 1992, ARCH CLIN NEUROPSYCH, V7, P449, DOI 10.1016/0887-6177(92)90158-J; BIGLER ED, 1994, BRAIN INJURY, V8, P231, DOI 10.3109/02699059409150975; BIGLER ED, 1992, BRAIN INJURY, V7, P125; BLATTER DD, AJNR, V16, P241; CULLUM CM, 1986, J CLIN EXP NEUROPSYC, V8, P437, DOI 10.1080/01688638608401333; DALPAN GJ, 1992, NEUROLOGY, V42, P2125, DOI 10.1212/WNL.42.11.2125; Duvernoy H. M., 1991, HUMAN BRAIN SURFACE; EAGLESON KL, 1992, EXP NEUROL, V116, P156, DOI 10.1016/0014-4886(92)90163-K; FUJIE W, 1990, STROKE, V21, P1485, DOI 10.1161/01.STR.21.10.1485; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; GALE SD, 1994, NEUROPSY NEUROPSY BE, V7, P160; Gean AD, 1994, IMAGING HEAD TRAUMA; Gilman S., 1992, CLIN NEUROANATOMY NE; GONZALES CF, 1993, MINOR HEAD TRAUMA AS, P33; HANYU H, 1991, Brain and Nerve (Tokyo), V43, P255; IIZUKA H, 1990, STROKE, V21, P790, DOI 10.1161/01.STR.21.5.790; JESSELL TM, 1991, PRINCIPLES NEURAL SC, P258; Johnson SC, 1994, NEUROPSYCHOLOGY, V8, P307, DOI DOI 10.1037/0894-4105.8.3.301; Jones E.G., 1985, THALAMUS; KUCHARCZYK J, 1994, MAGNETIC RESONANCE N; LEVIN HS, 1981, ARCH NEUROL-CHICAGO, V38, P623, DOI 10.1001/archneur.1981.00510100051007; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; RASBAND W, 1993, IMAGE 1 52 COMPUTER; REIDERGROSWASSE.I, 1992, AJR, V160, P147; Reitan RM, 1985, HALSTEADREITAN NEURO; ROBB RA, 1990, NATO ASI SER, P333; Roberts M, 1970, ATLAS HUMAN BRAIN SE; ROSS DT, 1993, J NEUROTRAUM, V10, P151, DOI 10.1089/neu.1993.10.151; ROSS DT, 1990, NEUROSCIENCE, V35, P525, DOI 10.1016/0306-4522(90)90327-Z; ROSS DT, 1989, BRAIN RES, V501, P129, DOI 10.1016/0006-8993(89)91034-2; SHENTON ME, 1992, NEW ENGL J MED, V327, P604, DOI 10.1056/NEJM199208273270905; STEWART MG, 1992, QUANTITATIVE METHODS; TAGUOHI J, 1989, Brain and Nerve (Tokyo), V41, P813; TAMURA A, 1991, STROKE, V22, P615, DOI 10.1161/01.STR.22.5.615; TEASDALE E, 1984, J NEUROL NEUROSUR PS, V47, P600, DOI 10.1136/jnnp.47.6.600; YAMADA K, 1991, J CEREBR BLOOD F MET, V11, P472, DOI 10.1038/jcbfm.1991.90; YAMADA K, 1992, Neurological Research, V14, P267	40	18	18	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0361-9230			BRAIN RES BULL	Brain Res. Bull.		1995	38	6					545	549		10.1016/0361-9230(95)02026-0			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	TF570	WOS:A1995TF57000005	8590076				2022-02-06	
J	THEODOROS, DG; MURDOCH, BE				THEODOROS, DG; MURDOCH, BE			LARYNGEAL DYSFUNCTION IN DYSARTHRIC SPEAKERS FOLLOWING SEVERE CLOSED-HEAD INJURY	BRAIN INJURY			English	Article							VOICE QUALITY; DYSPHONIA; APHONIA; SPEECH	The laryngeal function of 19 severely closed head-injured subjects with a perceptible dysarthria was assessed using electrolaryngography and a computerized airflow/air pressure analysis system (Aerophone II). Variables measured included parameters of the Lx waveform (Fo, duty cycle and closing time) as well as aerodynamic parameters such as subglottal pressure, glottal resistance, average phonatory sound pressure level, phonatory flow rate and ad/abduction rate. Values were compared to those recorded from a non-neurologically impaired control group matched for age and sex, and correlated with the findings of a perceptual speech analysis. The findings are discussed in relation to the effects of a severe closed-head injury on laryngeal function. The clinical implications of the findings for the assessment and treatment of vocal dysfunction in head-injured subjects are also discussed.	UNIV QUEENSLAND,DEPT SPEECH & HEARING,MOTOR SPEECH RES UNIT,ST LUCIA,QLD 4072,AUSTRALIA				Theodoros, Deborah/F-1362-2010; Murdoch, Bruce E/C-1397-2012				ARONSON AE, 1968, J SPEECH HEAR DISORD, V33, P203, DOI 10.1044/jshd.3303.203; Aronson AE., 1980, CLIN VOICE DISORDERS; Baken R., 1987, CLIN MEASUREMENT SPE, P197; BASSICH CJ, 1986, J SPEECH HEAR DISORD, V51, P125, DOI 10.1044/jshd.5102.125; BLAUSTEIN S, 1983, J COMMUN DISORD, V16, P157, DOI 10.1016/0021-9924(83)90046-1; Boone DR, 1977, VOICE VOICE THERAPY; Brown J.R., 1975, MOTOR SPEECH DISORDE; COLTON RH, 1991, J VOICE, V4, P10; FEX S, 1992, J VOICE, V6, P155, DOI 10.1016/S0892-1997(05)80130-4; FROKJAERJENSEN B, 1989, C INT ASS LOG PHON P; GREENE MCL, 1972, VOICE ITS DISORDERS; HANSON DG, 1983, ANN OTO RHINOL LARYN, V92, P413, DOI 10.1177/000348948309200501; HANSON DG, 1991, OTOLARYNGOLOGIC CLIN, P1035; HARTMAN DE, 1984, ANN OTO RHINOL LARYN, V93, P57, DOI 10.1177/000348948409300114; HARTMANN E, 1984, J COMMUN DISORD, V17, P425, DOI 10.1016/0021-9924(84)90004-2; HILLMAN RE, 1989, J SPEECH HEAR RES, V32, P373, DOI 10.1044/jshr.3202.373; Holmberg E, 1980, J ACOUST SOC AM, V68, pS101; HOLMBERG E B, 1989, Journal of Voice, V3, P294, DOI 10.1016/S0892-1997(89)80051-7; HOLMBERG EB, 1988, J ACOUST SOC AM, V84, P511, DOI 10.1121/1.396829; HOODIN RB, 1989, FOLIA PHONIATR, V41, P249, DOI 10.1159/000265976; IISSHIKI N, 1965, FOLIA PHONIATR, V17, P92; KEARNS KP, 1988, J SPEECH HEAR RES, V31, P131, DOI 10.1044/jshr.3101.131; KENT RD, 1982, BRAIN LANG, V15, P259, DOI 10.1016/0093-934X(82)90060-8; KITZING P, 1982, FOLIA PHONIATR, V34, P216, DOI 10.1159/000265653; LABLANCE G R, 1991, Ear Nose and Throat Journal, V70, P691; Ludlow C., 1983, CLIN DYSARTHRIA, P121; Murdoch Bruce E., 1990, AUSTR J HUMAN COMMUN, V18, P83; ORLIKOFF R F, 1992, Seminars in Speech and Language, V13, P25, DOI 10.1055/s-2008-1064184; Prater R. J., 1984, MANUAL VOICE THERAPY; Ramig L.O., 1992, INTELLIGIBILITY SPEE, P119, DOI DOI 10.1075/SSPCL.1.05RAM; SAPIR S, 1985, BRIT J DISORD COMMUN, V20, P289; SCHOLEFIELD JA, 1987, BRIT J DISORD COMMUN, V22, P167; Schutte H K, 1986, Acta Otorhinolaryngol Belg, V40, P344; SCHUTTE HK, 1980, EFFICIENCY VOICE; SMITHERAN JR, 1981, J SPEECH HEAR DISORD, V46, P138, DOI 10.1044/jshd.4602.138; THEODOROS DG, 1994, BRAIN INJURY, V8, P101, DOI 10.3109/02699059409150963; VOGEL M, 1982, FOLIA PHONIATR, V34, P150, DOI 10.1159/000265644; VONCRAMON D, 1981, NEUROPSYCHOLOGIA, V19, P801, DOI 10.1016/0028-3932(81)90092-0; VONLEDEN H, 1968, ANN NY ACAD SCI, V155, P56; ZYSKI JB, 1987, J COMMUN DISORD, V204, P367; [No title captured]	41	18	18	0	1	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	NOV-DEC	1994	8	8					667	684		10.3109/02699059409151021			18	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	PT049	WOS:A1994PT04900003	7849686				2022-02-06	
J	TAKEHARA, S; TANAKA, T; UEMURA, K; SHINOHARA, Y; YAMAMOTO, T; TOKUYAMA, T; SATOH, A				TAKEHARA, S; TANAKA, T; UEMURA, K; SHINOHARA, Y; YAMAMOTO, T; TOKUYAMA, T; SATOH, A			OPTIC-NERVE INJURY DEMONSTRATED BY MRI WITH STIR SEQUENCES	NEURORADIOLOGY			English	Article						OPTIC NERVE INJURY; MAGNETIC RESONANCE IMAGING; SHORT INVERSION TIME INVERSION RECOVERY SEQUENCE		We studied nine patients with optic nerve injury associated with closed head trauma by magnetic resonance imaging (MRI) with short inversion time inversion recovery (STIR) sequences on 11 occasions from 4 days to 14 years after the injury: three studies were within 17 days and eight over 4 months to 14 years. MRI revealed abnormal high signal in 10 of the 11 injured nerves. MRI 4 days after the injury showed no abnormality.	HAMAMATSU UNIV SCH MED, DEPT NEUROSURG, SHIZUOKA, JAPAN; SHIDA GEN HOSP FUJIEDA, DEPT NEUROSURG, SHIZUOKA, JAPAN; FUJINOMIYA CITY GEN HOSP, DEPT NEUROSURG, SHIZUOKA, JAPAN		TAKEHARA, S (corresponding author), YAIZU MUNICIPAL HOSP, DEPT NEUROSURG, 100 DOUBARA, YAIZU SHIZUOKA 425, JAPAN.						ATLAS SW, 1988, AM J NEURORADIOL, V9, P969; BYDDER GM, 1985, J COMPUT ASSIST TOMO, V9, P659, DOI 10.1097/00004728-198507010-00002; DANIELS DL, 1986, AM J NEURORADIOL, V7, P249; JOHNSON G, 1987, NEURORADIOLOGY, V29, P238, DOI 10.1007/BF00451760; KLINE LB, 1984, NEUROSURGERY, V14, P756, DOI 10.1227/00006123-198406000-00021; Kojima S, 1990, No To Shinkei, V42, P1191; MILLER DH, 1988, NEUROLOGY, V38, P175, DOI 10.1212/WNL.38.2.175; SIMON J, 1988, AM J NEURORADIOL, V9, P961; TAKEHARA S, 1992, PROG COMPUT IMAG, V14, P56	9	18	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0028-3940			NEURORADIOLOGY	Neuroradiology	OCT	1994	36	7					512	514		10.1007/BF00593510			3	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	PL580	WOS:A1994PL58000004	7845573				2022-02-06	
J	SILVER, JK; LUX, WE				SILVER, JK; LUX, WE			EARLY-ONSET DYSTONIA FOLLOWING TRAUMATIC BRAIN INJURY	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							HEMIDYSTONIA; THERAPY		NATL REHABIL HOSP,BRAIN INJURY PROGRAM,102 IRVING ST NW,WASHINGTON,DC 20010				Silver, Julie K/AAE-7163-2019	Silver, Julie K./0000-0001-9711-0713			ANDREW J, 1983, BRAIN, V106, P981, DOI 10.1093/brain/106.4.981; Brin M F, 1988, Adv Neurol, V50, P599; DEMIERRE B, 1983, J NEUROL NEUROSUR PS, V46, P404, DOI 10.1136/jnnp.46.5.404; Elston J S, 1988, Adv Neurol, V50, P579; FAHN S, 1984, NEUROL CLIN, V2, P541, DOI 10.1016/S0733-8619(18)31090-9; Fahn S, 1976, Adv Neurol, V14, P1; FAHN S, 1984, NEUROL CLIN, V2, P555, DOI 10.1016/S0733-8619(18)31091-0; FAHN S, 1983, NEUROLOGY, V33, P1255, DOI 10.1212/WNL.33.10.1255; HAN JS, 1984, RADIOLOGY, V150, P71, DOI 10.1148/radiology.150.1.6689790; HUANG G-S, 1992, Kaohsiung Journal of Medical Sciences, V8, P108; JABBARI B, 1992, MOVEMENT DISORD, V7, P78, DOI 10.1002/mds.870070116; KRUASS JK, 1992, MOV DIS, V7, P263; Marsden C D, 1976, Adv Neurol, V14, P259; MARSDEN CD, 1985, BRAIN, V108, P463, DOI 10.1093/brain/108.2.463; MAURO AJ, 1980, TRANSCRIPTS AM NEURO, P229; PETTIGREW LC, 1985, J NEUROL NEUROSUR PS, V48, P650, DOI 10.1136/jnnp.48.7.650; Tanner C M, 1988, Adv Neurol, V50, P557; Teravainen H, 1988, Adv Neurol, V50, P571; YOSHIMURA DM, 1992, NEUROLOGY, V42, P627, DOI 10.1212/WNL.42.3.627	19	18	19	0	1	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	1994	75	8					885	888		10.1016/0003-9993(94)90113-9			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	PB621	WOS:A1994PB62100008	8053795				2022-02-06	
J	PRIOER, M; KINSELLA, G; SAWYER, M; BRYAN, D; ANDERSON, V				PRIOER, M; KINSELLA, G; SAWYER, M; BRYAN, D; ANDERSON, V			COGNITIVE AND PSYCHOSOCIAL OUTCOME AFTER HEAD-INJURY IN CHILDREN	AUSTRALIAN PSYCHOLOGIST			English	Article							EMOTIONAL-PROBLEMS; COMMUNITY; BEHAVIOR; ADOLESCENTS; ADJUSTMENT; SEQUELAE; TRAUMA	Neuropsychological and psychosocial assessment of 58 Victorian and South Australian school-aged children who sustained a closed head injury was carried out immediately postinjury and at 6 months follow-up. For those children whose head injury was defined as mild (length of coma less than 1 hour) outcome on all variables was good at both time points. Children with moderate to severe injury (length of coma greater than 1 hour) had lower WISC-R IQ scores at both time points and were particularly poor on reading and spelling measures. There was no improvement over time on the academic measures. Family and parental functioning was in the normative range and, although some children showed a clinical level of behaviour problems, there was no consistency in their clinical status over time nor across parent and teacher informants. Our results suggest that there are no particular concerns for the long-term outcome of mildly head-injured children but that cognitive and school learning problems for moderate to severely head-injured children puts them at continuing risk.	ADELAIDE CHILDRENS HOSP INC,ADELAIDE,SA 5006,AUSTRALIA		PRIOER, M (corresponding author), LA TROBE UNIV,DEPT PSYCHOL,BUNDOORA,VIC 3083,AUSTRALIA.		Kinsella, Glynda/O-6347-2017	Kinsella, Glynda/0000-0002-5859-0934			ACHANBACH TM, 1986, MANUAL TEAHCERS REPO; ACHENBACH TM, 1987, PSYCHOL BULL, V101, P213, DOI 10.1037/0033-2909.101.2.213; ACHENBACH TM, 1983, MANUAL CHILD BEHAVIO; ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; BIJUR PE, 1986, AM J DIS CHILD, V140, P487, DOI 10.1001/archpedi.1986.02140190097036; Bond M R, 1975, Ciba Found Symp, P141; BRINK JD, 1980, J PEDIATR-US, V97, P721, DOI 10.1016/S0022-3476(80)80253-8; BROOKS N, 1984, CLOSED HEAD INJURY P; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; BURNS S, 1990, THESIS LA TROBE U; BURVILL PW, 1983, AUST NZ J PSYCHIAT, V17, P237, DOI 10.3109/00048678309161279; CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; DONDERS J, 1992, J ABNORM CHILD PSYCH, V20, P233, DOI 10.1007/BF00916690; EWINGCOBBS L, 1987, J LEARN DISABIL, V20, P526, DOI 10.1177/002221948702000904; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; FORRESTER G, 1990, CLIN NEUROPSYCHOLOGI, V5, P345; HENSLEY VR, 1988, AUST PSYCHOL, V23, P371, DOI 10.1080/00050068808255619; JOHNSTON C, 1984, DEV MED CHILD NEUROL, V26, P588; JONES D, 1987, THESIS LA TROBE U; KYRIOS M, 1988, THESIS LA TROBE U; Levin H S, 1991, Neurosurg Clin N Am, V2, P457; MAHONEY WJ, 1983, PEDIATRICS, V71, P756; MORSE S, 1987, P AUSTR SOC BRAIN IM, P46; PELCO L, 1992, Brain Injury, V6, P29, DOI 10.3109/02699059209008119; PRIOR M, 1993, J AM ACAD CHILD PSY, V32, P291, DOI 10.1097/00004583-199303000-00009; PRIOR M, 1985, HYPERACTIVITY DIAGNO; RUTTER M, 1981, AM J PSYCHIAT, V138, P1533; SAWYER MG, 1988, J MARITAL FAM THER, V14, P287, DOI 10.1111/j.1752-0606.1988.tb00748.x; SAWYER MG, 1992, J CHILD PSYCHOL PSYC, V33, P441, DOI 10.1111/j.1469-7610.1992.tb00878.x; Slater E.J., 1989, J ADOLESCENT RES, V4, P371; TELZROW CF, 1987, J LEARN DISABIL, V20, P536, DOI 10.1177/002221948702000905; VERHULST FC, 1989, J CHILD PSYCHOL PSYC, V30, P123, DOI 10.1111/j.1469-7610.1989.tb00772.x; WERNER E, 1982, VULNERABLE BUT INVIN; WILLSHIRE D, 1992, THESIS LA TROBE U	34	18	18	0	3	AUSTRALIAN PSYCHOLOGICAL SOC	CARLTON	1 GRATTAN STREET, CARLTON VICTORIA 3053, AUSTRALIA	0005-0067			AUST PSYCHOL	Aust. Psychol.	JUL	1994	29	2					116	123		10.1080/00050069408257334			8	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	PK594	WOS:A1994PK59400007					2022-02-06	
J	WEHMAN, P; KREGEL, J; WEST, M; CIFU, D				WEHMAN, P; KREGEL, J; WEST, M; CIFU, D			RETURN TO WORK FOR PATIENTS WITH TRAUMATIC BRAIN INJURY - ANALYSIS OF COSTS	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article								This brief report describes staff time commitment and program cost outcomes for a return to work program of supported employment for persons with brain injuries. The mean cost of providing services was $10,198 for the first year of service (median, $6,942). Clients achieved job stabilization after an average of 18 wk of time-limited job coaching services, during which they received mean intervention time of 245.7 h (median, 219) at a cost of $7,789. A mean of 2.24 h/wk of extended services intervention was required to maintain clients in employment for the remainder of the first year of service, at a mean weekly cost of $71.01. Results are compared with findings reported in a previous study using a smaller sample.			WEHMAN, P (corresponding author), VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,CTR REHABIL RES & TRAINING,1314 W MAIN ST,BOX 2011,RICHMOND,VA 23298, USA.			Cifu, David/0000-0003-1600-9387			Abrams D., 1993, J HEAD TRAUMA REHAB, V8, P59; Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; KAY T, 1986, ANNOTATED BIBL RES V; Kregel J, 1994, NeuroRehabilitation, V4, P1, DOI 10.3233/NRE-1994-4103; WEHMAN P, 1992, SUPPORTED EMPLOYMENT; Wehman Paul, 1993, Brain Injury, V7, P31, DOI 10.3109/02699059309008154; WEHMAN PH, 1990, ARCH PHYS MED REHAB, V71, P1047; WEST M, 1991, ARCH PHYS MED REHAB, V72, P127	8	18	18	0	2	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	JUL-AUG	1994	73	4					280	282		10.1097/00002060-199407000-00010			3	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	PB254	WOS:A1994PB25400010	8043251				2022-02-06	
J	GOODMAN, JC				GOODMAN, JC			PATHOLOGICAL-CHANGES IN MILD HEAD-INJURY	SEMINARS IN NEUROLOGY			English	Article							DIFFUSE AXONAL INJURY; TRAUMATIC BRAIN INJURY; DAMAGE; IMPACT; MODEL; HEMATOMA; ASSAULT; COMA; RAT	Physical injury of the brain constitutes a major cause of loss of life and productivity. Populations at highest risk for such injuries include children, men in late adolescence and early adult life, and the elderly. Head injuries most commonly result from assaults, vehicular accidents, and falls. The neuropathology of severe injury has been described extensively and constitutes much of the lore of clinical neurosurgery, forensic neuropathology, and critical care neurology.1 The neuropathology of mild head injury is much less well explored, reflecting the low mortality of these injuries. Experimental head injury models originally developed to facilitate research in severe trauma have proven valuable in understanding the neurobiologic basis of the numerous and debilitating symptoms that follow mild head injury and have focused attention on diffuse axonal injury (DAI) as the primary neuropathologic mechanism underlying these symptoms.2 This review sequentially covers experimental models of head injury, neuropathology of human head trauma, with a detailed discussion of DAI, and ends with a discussion of the regenerative response to head injury and possible role of neuroplasticity in the genesis of post-traumatic symptomatology.	BAYLOR COLL MED, DEPT NEUROSURG, HOUSTON, TX 77030 USA; BAYLOR COLL MED, DEPT NEUROL, HOUSTON, TX 77030 USA		GOODMAN, JC (corresponding author), BAYLOR COLL MED, DEPT PATHOL, 1 BAYLOR PLAZA, HOUSTON, TX 77030 USA.						ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ADAMS JH, 1989, SCOT MED J, V34, P399, DOI 10.1177/003693308903400106; AMMONS AM, 1990, NURS CLIN N AM, V25, P23; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; CROOKS DA, 1991, J PATHOL, V165, P5, DOI 10.1002/path.1711650103; CROOKS DA, 1991, NEUROPATH APPL NEURO, V17, P407, DOI 10.1111/j.1365-2990.1991.tb00740.x; CROOKS DA, 1991, NEUROPATH APPL NEURO, V17, P421, DOI 10.1111/j.1365-2990.1991.tb00742.x; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; ERB DE, 1991, EXP BRAIN RES, V83, P253; Gennarelli T A, 1993, Acta Neurochir Suppl (Wien), V57, P49; GENNARELLI TA, 1989, J NEUROSURG, V71, P244, DOI 10.3171/jns.1989.71.2.0244; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENNARELLI TA, 1993, J EMERG MED, V1, P5; Graham D I, 1988, Prog Clin Biol Res, V264, P159; Graham D I, 1993, Acta Neurochir Suppl (Wien), V57, P41; GRAHAM DI, 1988, J CLIN PATHOL, V41, P34, DOI 10.1136/jcp.41.1.34; GRAHAM DI, 1992, J CLIN PATHOL, V45, P840, DOI 10.1136/jcp.45.9.840; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; HAINES DE, 1993, NEUROSURGERY, V32, P111, DOI 10.1227/00006123-199301000-00017; IMAJO T, 1992, AM J FOREN MED PATH, V13, P169; IMAJO T, 1987, AM J FOREN MED PATH, V8, P217, DOI 10.1097/00000433-198708030-00004; KIRKPATRICK JB, 1988, FORENSIC NEUROPATHOL, P276; KOBAYASHI S, 1989, Neurosurgical Review, V12, P451, DOI 10.1007/BF01790690; LEESTMA JE, 1988, FORENSIC NEUROPATHOL, P184; LEESTMA JE, 1988, FORENSIC NEUROPATHOL, P1; LEVI L, 1990, NEUROSURGERY, V27, P429, DOI 10.1227/00006123-199009000-00015; LEVIN HS, 1989, MILD HEAD INJURY, P1; LIGHTHALL J W, 1989, Journal of Neurotrauma, V6, P83, DOI 10.1089/neu.1989.6.83; LIGHTHALL J W, 1990, Journal of Neurotrauma, V7, P65, DOI 10.1089/neu.1990.7.65; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; LUCAS JH, 1992, J NEUROTRAUM, V9, P117, DOI 10.1089/neu.1992.9.117; MAXWELL WL, 1991, J NEUROCYTOL, V20, P157, DOI 10.1007/BF01186989; NAKAZAWA S, 1989, Neurological Surgery, V17, P247; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Onaya M, 1991, No To Shinkei, V43, P283; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; PARKER JR, 1990, ANN CLIN LAB SCI, V20, P220; PEERLESS SJ, 1967, CAN MED ASSOC J, V96, P577; Pilz P, 1983, Acta Neurochir Suppl (Wien), V32, P119; POTAPOV AA, 1990, ZH VOPR NEIROKHIR, V2, P3; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; POVLISHOCK JT, 1986, ACTA NEUROPATHOL, V70, P53, DOI 10.1007/BF00689514; POVLISHOCK JT, 1990, ADV NEUROTRAUMA RES, V2, P1; RODDA RA, 1987, CLIN NEUROPATHOL, V6, P179; SAHUQUILLO J, 1989, ACTA NEUROCHIR, V101, P149, DOI 10.1007/BF01410531; SAHUQUILLOBARRIS J, 1988, J NEUROSURG, V68, P894, DOI 10.3171/jns.1988.68.6.0894; SGANZERLA EP, 1989, CHILD NERV SYST, V5, P168, DOI 10.1007/BF00272121; Shigemori M, 1992, Acta Neurochir Suppl (Wien), V55, P37; SHIGEMORI M, 1991, NEUROL MED CHIR TOKY, V314, P390; SHIMURA T, 1988, Neurological Surgery, V16, P647; Shumway-Cook A, 1990, J HEAD TRAUMA REHAB, V5, P51, DOI DOI 10.1097/00001199-199012000-00007; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; TOMINAGA I, 1991, REV NEUROL-FRANCE, V147, P658; TUOHIMAA P, 1978, ACTA OTO-LARYNGOL, P7; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; YAGHMAI A, 1992, J NEUROPATH EXP NEUR, V51, P158, DOI 10.1097/00005072-199203000-00006; YAMAKI T, 1992, ACTA NEUROCHIR, V119, P153, DOI 10.1007/BF01541800; ZIMMERMAN RA, 1978, RADIOLOGY, V127, P393, DOI 10.1148/127.2.393	64	18	18	0	1	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.	MAR	1994	14	1					19	24		10.1055/s-2008-1041054			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	NE151	WOS:A1994NE15100005	8029556				2022-02-06	
J	MURSHID, WR				MURSHID, WR			ROLE OF SKULL RADIOGRAPHY IN THE INITIAL EVALUATION OF MINOR HEAD-INJURY - A RETROSPECTIVE STUDY	ACTA NEUROCHIRURGICA			English	Article						HEAD INJURY; SKULL FRACTURE; SKULL RADIOGRAPHY	TRAUMA; ADMISSION	The use of skull radiography in the initial evaluation of minor head injured patients is controversial. In an attempt to evaluate its benefits, a retrospective study of 566 cases subjected to skull radiography following close minor head trauma (Glasgow Coma Scale 13-15), is presented. A skull fracture (linear vault, depressed or base of skull) was present in 64 (11 %) cases. Only three (5 %) who were found to have a skull fracture on skull radiography developed an intracranial injury which required surgery. Intracranial injuries developed in 19 (3 %) cases and were followed by surgery in six (32 %). All, except for one case, had a decreased level of consciousness and a Glasgow Coma Scale less than 15, few had focal neurological deficits. Management had not been altered by the results of skull radiography in any of the cases. We concluded that skull radiographs are unnecessary for the decision process in closed minor head injury because management decisions are based primarily on a careful neurological examination, When intracranial injuries are a concern, a CT scan should be obtained.			MURSHID, WR (corresponding author), KING SAUD UNIV, KING KHALID UNIV HOSP, DEPT SURG 37, DIV NEUROSURG, POB 7805, RIYADH 11472, SAUDI ARABIA.						BELL RS, 1971, NEW ENGL J MED, V284, P236, DOI 10.1056/NEJM197102042840504; BRIGGS M, 1984, BRIT MED J, V288, P983; COOPER PR, 1983, NEUROSURGERY, V13, P136, DOI 10.1227/00006123-198308000-00005; DACEY RG, 1986, J NEUROSURG, V65, P203, DOI 10.3171/jns.1986.65.2.0203; FEUERMAN T, 1988, NEUROSURGERY, V22, P449, DOI 10.1227/00006123-198803000-00001; JENNETT B, 1980, CLIN RADIOL, V31, P463, DOI 10.1016/S0009-9260(80)80195-4; MASTERS SJ, 1987, NEW ENGL J MED, V316, P84, DOI 10.1056/NEJM198701083160205; MENDELOW AD, 1982, BRIT MED J, V285, P1530, DOI 10.1136/bmj.285.6354.1530; PHILLIPS LA, 1979, NEUROSURGERY, V4, P580, DOI 10.1227/00006123-197906000-00017; ROBERTS CJ, 1983, LANCET, V1, P115; ROBERTS CJ, 1981, LANCET, V2, P791; ROSENTHAL BW, 1989, J PEDIATR-US, V115, P346, DOI 10.1016/S0022-3476(89)80830-3; Vollmer D G, 1991, Neurosurg Clin N Am, V2, P437; ZIMMERMAN RA, 1978, RADIOLOGY, V127, P393, DOI 10.1148/127.2.393	14	18	19	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.		1994	129	1-2					11	14		10.1007/BF01400866			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	NY476	WOS:A1994NY47600003	7998489				2022-02-06	
J	LEVIN, HS				LEVIN, HS			HEAD TRAUMA	CURRENT OPINION IN NEUROLOGY			English	Article							BRAIN INJURY; BLOOD-FLOW; SEVERITY; CHILDREN; DEFICITS; SPECT; MILD	Progress in research includes studies concerning the pathophysiology and outcome of pediatric head injury, the pathology of the hippocampus in fatal injury, and the use of multivariate statistics to predict outcome in survivors. Recent research has confirmed and extended findings regarding the differential effects of closed head injury, depending on the age of the individual. These studies indicate that the consequences of head injury are more severe in older adults and in children younger than 2 years. Neuroimaging findings include evidence for delayed brain injury as a major cause of mortality and disability. Functional brain imaging provides evidence for cerebral dysfunction that is not appreciated by structural brain imaging techniques and may have a stronger relationship to neurobehavioral sequelae. The neurobehavioral sequelae frequently implicate frontal dysfunction, even in the absence of structural findings on computed tomography or magnetic resonance imaging. Studies of mild head injury have expanded our knowledge concerning the pathogenesis of postconcussional symptoms, including a preinjury vulnerability based on recent life events. Persistent postconcussional symptoms after mild head injury are frequently associated with emotional disturbance of clinical proportions.			LEVIN, HS (corresponding author), UNIV MARYLAND,DIV NEUROSURG,ROOM N12E27,22 S GREENE ST,BALTIMORE,MD 21201, USA.						ALDRICH EF, 1992, SURG NEUROL, V38, P418, DOI 10.1016/0090-3019(92)90109-Z; BOHNEN N, 1992, NEUROSURGERY, V30, P692, DOI 10.1097/00006123-199205000-00007; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P320, DOI 10.1016/0003-9993(92)90003-F; CHAN KH, 1992, J NEUROL NEUROSUR PS, V55, P787, DOI 10.1136/jnnp.55.9.787; CHAPLIN D, 1993, ARCH PHYS MED REHAB, V74, P161; COHEN M, 1992, J NEUROL NEUROSUR PS, V55, P313, DOI 10.1136/jnnp.55.4.313; DUHAIME AC, 1992, PEDIATRICS, V90, P179; ELIASJONES AC, 1992, ARCH DIS CHILD, V67, P1430, DOI 10.1136/adc.67.12.1430; FENTON G, 1993, BRIT J PSYCHIAT, V162, P493, DOI 10.1192/bjp.162.4.493; GOLDENBERG G, 1992, J NEUROL NEUROSUR PS, V55, P362, DOI 10.1136/jnnp.55.5.362; GUTMAN MB, 1992, J NEUROSURG, V77, P9, DOI 10.3171/jns.1992.77.1.0009; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; JERET JS, 1993, NEUROSURGERY, V32, P9, DOI 10.1227/00006123-199301000-00002; KOTAPKA MJ, 1992, ACTA NEUROPATHOL, V83, P530, DOI 10.1007/BF00310031; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; MacPherson Valerie, 1992, Brain Injury, V6, P489, DOI 10.3109/02699059209008146; MAZZUCCHI A, 1992, J NEUROL, V239, P256; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; ODER W, 1992, J NEUROL NEUROSUR PS, V55, P475, DOI 10.1136/jnnp.55.6.475; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; SCHMITTEREDGECOMBE ME, 1992, J CLIN EXP NEUROPSYC, V14, P717, DOI 10.1080/01688639208402858; SCHWAB K, 1993, NEUROLOGY, V43, P95, DOI 10.1212/WNL.43.1_Part_1.95; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; VILKKI J, 1992, NEUROPSYCHOLOGIA, V30, P807, DOI 10.1016/0028-3932(92)90084-Y; WILSON J T L, 1992, Brain Injury, V6, P391, DOI 10.3109/02699059209008135	26	18	18	0	0	RAPID SCIENCE PUBLISHERS	LONDON	2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8NH	1350-7540			CURR OPIN NEUROL	Curr. Opin. Neurol.	DEC	1993	6	6					841	846		10.1097/00019052-199312000-00003			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MJ016	WOS:A1993MJ01600003	8293157				2022-02-06	
J	ROSENTHAL, M				ROSENTHAL, M			MILD TRAUMATIC BRAIN INJURY SYNDROME	ANNALS OF EMERGENCY MEDICINE			English	Article; Proceedings Paper	SYMP ON NEUROTRAUMA : CONCEPTS, CURRENT PRACTICE AND EMERGING THERAPIES	JUN 11-12, 1992	DEARBORN, MI	WAYNE STATE UNIV SCH MED, DEPT EMERGENCY MED		TRAUMA; BRAIN INJURY		The mild post-traumatic brain injury syndrome has continued to pose clinical management problems for medical specialists from the emergency physician to the family practitioner. The contribution of preinjury medical and psychosocial factors, along with the concomitant risk of litigation, complicates the diagnostic task. This review examines selected aspects of this problem, including definition and classification, pathophysiology, symptom constellation, medicolegal pitfalls, diagnostic procedures, and treatment recommendations. Practitioners need to be particularly alert to the optimal strategies for emergency department management to prevent ''mild'' injuries from becoming major disabilities.			ROSENTHAL, M (corresponding author), REHABIL INST MICHIGAN,261 MACK BLVD,DETROIT,MI 48201, USA.							0	18	18	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0196-0644			ANN EMERG MED	Ann. Emerg. Med.	JUN	1993	22	6					1048	1051		10.1016/S0196-0644(05)82749-0			4	Emergency Medicine	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	LE338	WOS:A1993LE33800015	8503524				2022-02-06	
J	PHILLIS, JW; PERKINS, LM; OREGAN, MH				PHILLIS, JW; PERKINS, LM; OREGAN, MH			POTASSIUM-EVOKED EFFLUX OF TRANSMITTER AMINO-ACIDS AND PURINES FROM RAT CEREBRAL-CORTEX	BRAIN RESEARCH BULLETIN			English	Article						GLUTAMATE; ASPARTATE; GABA; ADENOSINE; INOSINE; CORTEX; RELEASE; POTASSIUM	GAMMA-AMINOBUTYRIC ACID; INHIBITORY SYNAPTIC TRANSMISSION; HIPPOCAMPAL SLICES; BRAIN SYNAPTOSOMES; GLUTAMATE RELEASE; ISCHEMIC BRAIN; INVIVO RELEASE; ADENOSINE; ASPARTATE; HYPOXIA	Repeated applications of elevated K+ (50 or 75 mM) in cerebral cortical cup superfusates was used to evoke an efflux of gamma-aminobutyric acid (GABA), glutamate, aspartate, glycine, adenosine. and inosine from the in vivo rat cerebral cortex. K+ (50 mM) significantly elevated GABA levels in cup superfusates but had little effect on the efflux of glutamate, aspartate, glycine, adenosine, or inosine. K+ (75 mM) significantly enhanced the efflux of GABA, aspartate, adenosine, and inosine and caused nonsignificant increases in glutamate and glycine efflux. The adenosine A1 receptor agonist N6-cyclopentyladenosine (CPA), applied in cup superfusates at a concentration of 10(-10) M had no effect on either basal or K+-evoked release of any of the amino acids or purines measured. At 10(-6) M CPA significantly enhanced aspartate release, and depressed GABA efflux. The selective A2 adenosine receptor agonist 2-p(2-carboxyethyl) phenethylamino-5'-N-ethyl-carboxamidoadenosine (CGS 21680) (10(-8) M) was without effect on either basal, or K+-evoked, efflux of amino acids or purines. The enhancement of aspartate (an excitotoxic amino acid) efflux by higher concentrations of CPA is likely due to activation of adenosine A2b receptors. This observation may be of relevance when selecting adenosinergic agents to treat ischemic or traumatic brain injuries. Overall, the results suggest that effects of adenosine receptor agonists on K+-evoked efflux of transmitter amino acids from the in vivo rat cerebral cortex may not be comparable to those observed with in vitro preparations.			PHILLIS, JW (corresponding author), WAYNE STATE UNIV, SCH MED, DEPT PHYSIOL, 540 E CANFIELD, DETROIT, MI 48201 USA.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS26912] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS026912] Funding Source: NIH RePORTER		ANDINE P, 1991, J NEUROCHEM, V57, P222, DOI 10.1111/j.1471-4159.1991.tb02119.x; ARVIN B, 1989, BRIT J PHARMACOL, V98, P225, DOI 10.1111/j.1476-5381.1989.tb16886.x; ASTRUP J, 1980, BRAIN RES, V199, P161, DOI 10.1016/0006-8993(80)90238-3; AUER RN, 1988, ANN NEUROL, V24, P699, DOI 10.1002/ana.410240602; BURKE SP, 1988, J NEUROCHEM, V51, P1541, DOI 10.1111/j.1471-4159.1988.tb01123.x; CLARK RM, 1976, J PHYSIOL-LONDON, V262, P383, DOI 10.1113/jphysiol.1976.sp011600; CORRADETTI R, 1984, EUR J PHARMACOL, V104, P19, DOI 10.1016/0014-2999(84)90364-9; DOLPHIN AC, 1983, NEUROSCI LETT, V43, P49, DOI 10.1016/0304-3940(83)90127-1; EVANS MC, 1987, NEUROSCI LETT, V83, P287, DOI 10.1016/0304-3940(87)90101-7; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FASTBOM J, 1985, ACTA PHYSIOL SCAND, V125, P121, DOI 10.1111/j.1748-1716.1985.tb07698.x; FREDHOLM BB, 1988, TRENDS PHARMACOL SCI, V9, P130, DOI 10.1016/0165-6147(88)90194-0; GARRITSEN A, 1989, BIOCHEM PHARMACOL, V38, P693, DOI 10.1016/0006-2952(89)90218-9; GLOBUS MYT, 1988, J NEUROCHEM, V51, P1455, DOI 10.1111/j.1471-4159.1988.tb01111.x; GONCALVES ML, 1991, J NEUROCHEM, V56, P1769; GRIFFITH NC, 1991, EPILEPSIA, V32, P767, DOI 10.1111/j.1528-1157.1991.tb05532.x; HAGBERG H, 1985, J CEREBR BLOOD F MET, V5, P413, DOI 10.1038/jcbfm.1985.56; HOLLINS C, 1980, BRIT J PHARMACOL, V69, P107, DOI 10.1111/j.1476-5381.1980.tb10888.x; JHAMANDAS K, 1980, CAN J PHYSIOL PHARM, V58, P1262, DOI 10.1139/y80-193; KAMIYA H, 1991, SYNAPSE, V8, P229, DOI 10.1002/syn.890080309; LAMBERT NA, 1991, NEUROSCI LETT, V122, P50, DOI 10.1016/0304-3940(91)90190-5; LEHMANN A, 1985, BRAIN RES, V359, P147, DOI 10.1016/0006-8993(85)91422-2; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; MICHAELIS ML, 1988, BRAIN RES, V473, P249, DOI 10.1016/0006-8993(88)90854-2; MORONI F, 1981, N-S ARCH PHARMACOL, V316, P235, DOI 10.1007/BF00505655; NICHOLLS DG, 1989, J NEUROCHEM, V52, P331, DOI 10.1111/j.1471-4159.1989.tb09126.x; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; OREGAN MH, 1992, NEUROSCI LETT, V138, P169, DOI 10.1016/0304-3940(92)90498-V; OREGAN MH, 1992, BRAIN RES, V582, P22, DOI 10.1016/0006-8993(92)90312-W; PHILLIS JW, 1989, BRAIN RES, V504, P121, DOI 10.1016/0006-8993(89)91606-5; PHILLIS JW, 1988, J CEREBR BLOOD F MET, V8, P733, DOI 10.1038/jcbfm.1988.121; PHILLIS JW, 1991, J NEUROCHEM, V56, P644, DOI 10.1111/j.1471-4159.1991.tb08198.x; PHILLIS JW, 1987, J CEREBR BLOOD F MET, V7, P679, DOI 10.1038/jcbfm.1987.122; PHILLIS JW, 1989, NEUROSCI LETT, V106, P147, DOI 10.1016/0304-3940(89)90217-6; PHILLIS JW, 1991, INT J PURINE PYRIMID, V2, P41; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; SHINOZUKA K, 1985, EUR J PHARMACOL, V113, P417, DOI 10.1016/0014-2999(85)90090-1; SIMPSON RE, 1992, J NEUROCHEM, V58, P1683, DOI 10.1111/j.1471-4159.1992.tb10041.x; TERRIAN DM, 1989, J NEUROCHEM, V53, P1390, DOI 10.1111/j.1471-4159.1989.tb08529.x; VANWYLEN DGL, 1986, J CEREBR BLOOD F MET, V6, P522, DOI 10.1038/jcbfm.1986.97; VONLUBITZ DKEJ, 1989, NEUROSCIENCE, V30, P451, DOI 10.1016/0306-4522(89)90265-0; YOON KW, 1991, J NEUROSCI, V11, P1375	42	18	18	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.		1993	31	5					547	552		10.1016/0361-9230(93)90122-R			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KX863	WOS:A1993KX86300016	8098653				2022-02-06	
J	RUIJS, MBM; KEYSER, A; GABREELS, FJM				RUIJS, MBM; KEYSER, A; GABREELS, FJM			ASSESSMENT OF POSTTRAUMATIC AMNESIA IN YOUNG-CHILDREN	DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY			English	Article							SEVERE HEAD-INJURY; PRACTICAL SCALE; COMA SCALE; SEQUELAE; MEMORY	To assess the duration of post-traumatic amnesia (PTA) in children, a new procedure is described, derived from a method described previously for adults. The procedure was tested on 70 healthy children between 3.5 and 10 years of age, then applied in a longitudinal prospective study of 54 children with brain damage resulting from closed head-injury. The procedure consistently measured PTA in children of various ages. The duration of PTA was found to be as good a prognostic indicator for the occurrence of long-term residual sequelae as is duration of coma.	CATHOLIC UNIV NIJMEGEN,ST RADBOUD HOSP,DEPT CHILD NEUROL,6500 HB NIJMEGEN,NETHERLANDS		RUIJS, MBM (corresponding author), CATHOLIC UNIV NIJMEGEN,ST RADBOUD HOSP,INST NEUROL,POB 9101,6500 HB NIJMEGEN,NETHERLANDS.						ARTIOLA I, 1980, J NEUROL NEUROSUR PS, V43, P377; BRAAKMAN R, 1980, NEUROSURGERY, V6, P362, DOI 10.1227/00006123-198004000-00002; BROOKS DN, 1974, J NEUROL NEUROSUR PS, V37, P794, DOI 10.1136/jnnp.37.7.794; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; EVANS CD, 1977, INJURY, V8, P80; HANNAY HJ, 1979, CORTEX, V15, P269, DOI 10.1016/S0010-9452(79)80031-3; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1976, J NEUROL NEUROSUR PS, V39, P647, DOI 10.1136/jnnp.39.7.647; JENNETT B, 1976, LANCET, V1, P1031; LEVATI A, 1982, J NEUROSURG, V57, P779, DOI 10.3171/jns.1982.57.6.0779; LEVIN HS, 1979, CHILD BRAIN, V5, P281; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LEVIN HS, 1983, PAEDIATRIC HEAD TRAU; MINDERHOUD JM, 1984, TRAUMATISCHE HERSENL; REILLY PL, 1988, CHILD NERV SYST, V4, P30; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; RUTTER M, 1980, PSYCHOL MED, V10, P633, DOI 10.1017/S0033291700054933; SCHACTER DL, 1977, CORTEX, V13, P150, DOI 10.1016/S0010-9452(77)80006-3; SIMPSON D, 1982, LANCET, V2, P450; SISLER G, 1975, CAN PSYCHIAT ASSOC J, V20, P333, DOI 10.1177/070674377502000502; TEASDALE G, 1974, LANCET, V2, P81; TODOROW S, 1975, SCAND J REHABIL MED, V7, P93; WINOGRON HW, 1984, J CLIN NEUROPSYCHOL, V6, P269, DOI 10.1080/01688638408401218; YOUNG B, 1981, J NEUROSURG, V54, P300, DOI 10.3171/jns.1981.54.3.0300; [No title captured]	26	18	19	0	2	CAMBRIDGE UNIV PRESS	NEW YORK	40 WEST 20TH STREET, NEW YORK, NY 10011-4211	0012-1622			DEV MED CHILD NEUROL	Dev. Med. Child Neurol.	OCT	1992	34	10					885	892					8	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics	JN729	WOS:A1992JN72900006	1397728				2022-02-06	
J	RATHBONE, D; JOHNSON, G; LETTS, M				RATHBONE, D; JOHNSON, G; LETTS, M			SPINAL-CORD CONCUSSION IN PEDIATRIC ATHLETES	JOURNAL OF PEDIATRIC ORTHOPAEDICS			English	Article						SPINAL CORD CONCUSSION; SPINAL STENOSIS; TRANSIENT QUADRAPARESIS		Children with a narrowed canal secondary to spinal stenosis or congenital malformation may be predisposed to spinal cord concussion when the canal is further narrowed in hyperflexion or hyperextension. Review of the medical records of the Winnipeg and Ottawa Children's Hospitals disclosed 12 children who had been treated for transient sensory or motor loss after a spinal injury. Measurements of the spinal canal were compared with standard normal measurements, and the spinal canal width was expressed as a percentage of the vertebral width (the Torg ratio). This study shows that narrowing of the spinal canal is an inconsistent predisposing factor to spinal cord concussion in children. A poor correlation between the Torg ratio and comparison with a series of normal control canal widths was noted.	CHILDRENS HOSP EASTERN ONTARIO,DEPT SURG,401 SMYTH RD,OTTAWA K1H 8L1,ONTARIO,CANADA									0	18	18	0	0	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0271-6798			J PEDIATR ORTHOPED	J. Pediatr. Orthop.	SEP-OCT	1992	12	5					616	620					5	Orthopedics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Pediatrics	JJ224	WOS:A1992JJ22400010	1517422				2022-02-06	
J	CRUZ, J; GENNARELLI, TA; ALVES, WM				CRUZ, J; GENNARELLI, TA; ALVES, WM			CONTINUOUS MONITORING OF CEREBRAL OXYGENATION IN ACUTE BRAIN INJURY - MULTIVARIATE ASSESSMENT OF SEVERE INTRACRANIAL PLATEAU WAVE - CASE-REPORT	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article							HEAD-INJURY; PRESSURE; MANNITOL	A case of acute closed brain trauma is presented in which, for the first time, a full spectrum of multivariate physiologic abnormalities was clearly documented in association with a severe posttraumatic intracranial "plateau" wave and clinical signs of tentorial herniation. Prompt therapeutic measures proved effective, ultimately contributing to a favorable outcome.	UNIV PENN,SCH MED,DIV NEUROSURG,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,CTR HEAD INJURY,PHILADELPHIA,PA 19104								BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BROWN FD, 1979, J NEUROSURG, V50, P423, DOI 10.3171/jns.1979.50.4.0423; BRUCE DA, 1973, J NEUROSURG, V38, P131, DOI 10.3171/jns.1973.38.2.0131; Cruz J, 1988, Acta Neurochir Suppl (Wien), V42, P35; CRUZ J, 1991, NEUROSURGERY, V29, P743, DOI 10.1227/00006123-199111000-00017; CRUZ J, 1985, CRIT CARE MED, V13, P284, DOI 10.1097/00003246-198504000-00047; CRUZ J, 1990, J NEUROSURG, V73, P725, DOI 10.3171/jns.1990.73.5.0725; CRUZ J, 1984, Society for Neuroscience Abstracts, V10, P542; CRUZ J, 1986, NEUROTRAUMA TREATMEN, P55; LUNDBERG N, 1965, J NEUROSURG, V22, P581, DOI 10.3171/jns.1965.22.6.0581; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; MILLER JD, 1983, INTRACRANIAL PRESSUR, P45; TEASDALE G, 1974, LANCET, V2, P81	13	18	18	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAR	1992	32	3					401	403		10.1097/00005373-199203000-00020			3	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	HM904	WOS:A1992HM90400020	1548731				2022-02-06	
J	YUAN, XQ; WADE, CE				YUAN, XQ; WADE, CE			INFLUENCES OF TRAUMATIC BRAIN INJURY ON THE OUTCOMES OF DELAYED AND REPEATED HEMORRHAGES	CIRCULATORY SHOCK			English	Article						FLUID PERCUSSION; HEAD INJURY; HEMORRHAGIC SHOCK; RAT; HEMODYNAMIC RECOVERY	FLUID-PERCUSSION MODEL; SEVERE HEAD-INJURY; INTRAVASCULAR COAGULATION; SHOCK; CATECHOLAMINES; COMPLICATIONS; SURGERY; RAT	Effects of traumatic brain injury (fluid percussion) on outcomes of hemorrhage, either delayed (70.5 min after the injury) or repeated (0.5 min after injury, then followed by a delayed hemorrhage), were examined in 4 groups of 10 anesthetized rats. Comparisons were made for delayed hemorrhage following sham injury (A1) vs. injury (A2) and for repeated hemorrhage following sham injury (B1) vs. injury (B2). No significant differences were observed in MAP, CI, HR, SVI, SVRI, and CVP between groups A1 and A2. Hemodynamic recovery was significantly better in B1 than B2 at 70 min after the initial hemorrhage. The respective values of MAP and CI for the groups B1 and B2 at 70 min were 65 +/- 3 vs. 56 +/- 4 mmHg and 220 +/- 15 vs. 182 +/- 15 ml/min/kg. Brain trauma did not affect survival rate (90 vs. 100%) following delayed hemorrhage, but significantly worsened the outcome of repeated hemorrhage. The 130 min survival rates for groups B1 and B2 were 50% and 10% (P = 0.08), respectively; their survival curves were significantly different (P = 0.02). Our data indicate that brain trauma has greater impact on responses to immediate hemorrhage than delayed hemorrhage, suggesting that traumatic brain injury may have a time-dependent effect on the response to hemorrhage.	LETTERMAN ARMY INST RES, DIV MIL TRAUMA RES, SAN FRANCISCO, CA 94129 USA		YUAN, XQ (corresponding author), CARE OF BRUTTIG SP, LETTERMAN ARMY INST RES, DIV MIL TRAUMA RES, SAN FRANCISCO, CA 94129 USA.						Altman PL, 1974, BIOL DATA BOOK, VIII; ANDREWS BT, 1987, SURG NEUROL, V28, P419, DOI 10.1016/0090-3019(87)90223-0; BROWN RB, 1988, CRIT CARE MED, V16, P1171, DOI 10.1097/00003246-198812000-00001; CARLSON TA, 1989, JAMA-J AM MED ASSOC, V261, P1943, DOI 10.1001/jama.261.13.1943; CHAN KH, 1989, NEUROSURGERY, V25, P378, DOI 10.1227/00006123-198909000-00010; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; CLIFTON GL, 1983, J NEUROSURG, V59, P447, DOI 10.3171/jns.1983.59.3.0447; DEMIRJIAN Z, 1974, CLIN ORTHOP RELAT R, P174; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; EDELSON RJ, 1989, AM SURGEON, V55, P488; EGAN EL, 1974, MAYO CLIN PROC, V49, P658; FELICIANO DV, 1989, SURG CLIN N AM, V69, P273; FEUERSTEIN G, 1984, AM J PHYSIOL, V246, pR551, DOI 10.1152/ajpregu.1984.246.4.R551; FRIEDMAN NJ, 1969, ARCH INTERN MED, V124, P341, DOI 10.1001/archinte.124.3.341; GOODNIGHT SH, 1974, NEW ENGL J MED, V290, P1043, DOI 10.1056/NEJM197405092901903; GUNDRY SR, 1989, AM SURGEON, V55, P162; HANNON JP, 1989, CIRC SHOCK, V29, P205; JONES SB, 1990, CIRC SHOCK, V30, P51; LEVEEN HH, 1974, ANN SURG, V180, P580, DOI 10.1097/00000658-197410000-00023; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McIntosh TK, 1988, J NEUROTRAUM, V5, P17, DOI 10.1089/neu.1988.5.17; MCLEOD AA, 1982, BRIT HEART J, V47, P221; MILLEN JE, 1980, J APPL PHYSIOL, V49, P856, DOI 10.1152/jappl.1980.49.5.856; MULCARE RJ, 1976, SURG GYNECOL OBSTET, V143, P730; NISHIMURA N, 1984, RESUSCITATION, V12, P175, DOI 10.1016/0300-9572(84)90003-0; OLSON JD, 1989, NEUROSURGERY, V24, P825, DOI 10.1227/00006123-198906000-00007; PAPA MZ, 1984, AM J SURG, V147, P378, DOI 10.1016/0002-9610(84)90171-5; PEDOWITZ RA, 1989, J TRAUMA, V29, P219, DOI 10.1097/00005373-198902000-00012; POPP AJ, 1982, J SURG RES, V32, P416, DOI 10.1016/0022-4804(82)90121-4; RAYMOND RM, 1990, CIRC SHOCK, V30, P27; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; SAIFI J, 1990, ARCH SURG-CHICAGO, V125, P119; VANDERSANDE JJ, 1978, J NEUROSURG, V49, P357, DOI 10.3171/jns.1978.49.3.0357; WADE CE, 1989, CIRC SHOCK, V29, P193; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289; YUAN XQ, 1991, IN PRESS J NEUROSURG	37	18	18	0	0	WILEY-LISS	HOBOKEN	DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA	0092-6213			CIRC SHOCK	Circ. Shock	DEC	1991	35	4					231	236					6	Cardiac & Cardiovascular Systems	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	GV218	WOS:A1991GV21800006	1777959				2022-02-06	
J	LAM, CS; PRIDDY, DA; JOHNSON, P				LAM, CS; PRIDDY, DA; JOHNSON, P			NEUROPSYCHOLOGICAL INDICATORS OF EMPLOYABILITY FOLLOWING TRAUMATIC BRAIN INJURY	REHABILITATION COUNSELING BULLETIN			English	Article									INST PHYS MED & REHABIL,PEORIA,IL; NEW MEDICO REHABIL CTR WISCONSIN,WATERFORD,WI		LAM, CS (corresponding author), IIT,DEPT PSYCHOL,CHICAGO,IL 60616, USA.						Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; BROOKS N, 1987, BRAIN INJURY, V5, P5; Burke W H, 1988, Brain Inj, V2, P313, DOI 10.3109/02699058809150902; DIKMEN S, 1980, J NERV MENT DIS, V168, P236, DOI 10.1097/00005053-198004000-00008; FRASER R, 1988, REHABIL COUNS BULL, V31, P276; GILCHRIST E, 1979, ARCH NEUROL-CHICAGO, V36, P355, DOI 10.1001/archneur.1979.00500420065008; HEATON RK, 1978, J NERV MENT DIS, V166, P408, DOI 10.1097/00005053-197806000-00004; HUMPHREY M, 1980, INJURY, V12, P107, DOI 10.1016/0020-1383(80)90133-3; MORRIS J, 1982, AM PSYCHOL ASS WASH; NEWMAN OS, 1978, BRAIN INJURY, V46, P635; VARNEY NR, 1988, J CLIN EXP NEUROPSYC, V10, P250, DOI 10.1080/01688638808408239	11	18	18	0	0	AMER COUNSELING ASSOC	ALEXANDRIA	5999 STEVENSON AVE, ALEXANDRIA, VA 22304-3300	0034-3552			REHABIL COUNS BULL	Rehabil. Couns. Bull.	SEP	1991	35	1					68	74					7	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	GB357	WOS:A1991GB35700005					2022-02-06	
J	ALHADY, MRA; SHEHATA, O; ELMOUSLY, M; SALLAM, FS				ALHADY, MRA; SHEHATA, O; ELMOUSLY, M; SALLAM, FS			AUDIOLOGICAL FINDINGS FOLLOWING HEAD TRAUMA	JOURNAL OF LARYNGOLOGY AND OTOLOGY			English	Article							BRAIN-STEM RESPONSE; EVOKED-POTENTIALS; INJURIES	Traumatic head injury is the principal cause of death and serious physical disability in adolescents and young adult. Hearing loss is a common sequela of head trauma. The results of pure tone and auditory brainstem response (ABR) assessment of minor head injury revealed that 20 per cent of these cases showed impairment of hearing including both conductive and sensorineural hearing loss mostly in the high frequencies loss. ABR findings showed a significant difference of absolute wave V latency and interwave (III-V) latencies at repetition rate 11.1 click/sec., and a highly significant difference at a repetition rate of 51.1 click/sec., compared with the control group. In severe head injury, conductive hearing loss was found in only one case, in which a longitudinal fracture of the temporal bone was identified radiologically. No ABR could be recorded at a repetition rate of 11.1 click/sec. in either ear of this case; this patient died a few days later. Three cases were found with a mixed sensorineural hearing loss; one of them showed a longitudinal fracture radiologically. ABR findings in two cases showed prolongation of wave V and I-V interwave latencies, and the third case showed absence of ABR recording. In comatose patients, an ABR grading system is a more sensitive index of brainstem dysfunction than the simple division of normal versus abnormal ABR waves and interwave latencies. Presence or prolongation of wave V and interwave latency I-V even in one ear is of good prognostic value in the comatosed patient.			ALHADY, MRA (corresponding author), AL ZAHRAA UNIV HOSP,98 MOHAMED FARID ST,CAIRO,EGYPT.						BRAAKMANN R, 1980, NEUROSURGERY, V6, P360; DALY DM, 1977, ELECTROEN CLIN NEURO, V43, P151, DOI 10.1016/0013-4694(77)90123-7; ELWANY S, 1988, J LARYNGOL OTOL, V102, P755, DOI 10.1017/S0022215100106383; GERLING IJ, 1983, ANN OTO RHINOL LARYN, V92, P119, DOI 10.1177/000348948309200204; GROS JC, 1967, SOUTHERN MED J, V60, P705, DOI 10.1097/00007611-196707000-00006; HALL JW, 1983, OTOLARYNG HEAD NECK, V91, P50, DOI 10.1177/019459988309100110; HALL JW, 1982, LARYNGOSCOPE, V92, P833; MAJOEN S, 1983, ACTA OTOLARYNGOLOGIC, V95, P131; MONTGOMERY A, 1984, LANCET, V1, P1011; Nelson J R, 1979, Adv Neurol, V22, P107; OTTAVIANI F, 1986, ELECTROENCEPHALOGRAP, V62, P196; ROWE MJ, 1980, ARCH NEUROL-CHICAGO, V37, P679, DOI 10.1001/archneur.1980.00500600027002; SCHOENHUBER R, 1987, ARCH NEUROL-CHICAGO, V44, P1181, DOI 10.1001/archneur.1987.00520230061015; SOLIMAN SM, 1976, AIN SHAMS MED J, V27, P273; TEASDALE G, 1974, LANCET, V2, P81	15	18	19	0	0	HEADLEY BROTHERS LTD	ASHFORD	INVICTA PRESS, ASHFORD, KENT, ENGLAND TN24 8HH	0022-2151			J LARYNGOL OTOL	J. Laryngol. Otol.	DEC	1990	104	12					927	936		10.1017/S0022215100114410			10	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	EU344	WOS:A1990EU34400001	2280144				2022-02-06	
J	SPEED, WG				SPEED, WG			CLOSED HEAD-INJURY SEQUELAE - CHANGING CONCEPTS	HEADACHE			English	Article									JOHNS HOPKINS UNIV,SCH MED,BALTIMORE,MD 21205								BECKER RF, 1945, FED PROC, V4, P6; COOMBE A, 1831, OBSERVATIONS MENTAL; de Morsier G, 1943, SCHWEIZ ARCH NEUROL, V50, P161; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; GROAT R, 1950, J NEUROPATH EXP NEUR, V9, P150, DOI 10.1097/00005072-195004000-00003; Holbourn AHS, 1943, LANCET, V2, P438; KELLY R, 1975, Forensic Science, V6, P17, DOI 10.1016/0300-9432(75)90219-8; KELLY R, 1981, J ROY SOC MED, V74, P275, DOI 10.1177/014107688107400407; Kelly R., 1972, PAHLAVI MED J, V3, P530; MILLER H, 1961, BRIT MED J, V1, P919, DOI 10.1136/bmj.1.5230.919; MILLER H, 1961, BRIT MED J, V1, P992, DOI 10.1136/bmj.1.5231.992; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; PUDENZ RH, 1946, J NEUROSURG, V3, P487, DOI 10.3171/jns.1946.3.6.0487; VEITH I, HYSTERIA HIST DISEAS; Windle W. F., 1944, SURG GYNECOL AND OBSTET, V79, P561; WINDLE WF, 1945, ANAT REC, V93, P201, DOI 10.1002/ar.1090930210; [No title captured]; [No title captured]	19	18	20	0	0	AMER ASSOC STUDY HEADACHE	WOODBURY	875 KINGS HIGHWAY, STE 200, WOODBURY, NJ 08096	0017-8748			HEADACHE	Headache	NOV	1989	29	10					643	647		10.1111/j.1526-4610.1989.hed2910643.x			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CG305	WOS:A1989CG30500004	2693407				2022-02-06	
J	HARIRI, RJ; GHAJAR, JBG; POMERANTZ, KB; HAJJAR, DP; GIANNUZZI, RF; TOMICH, E; ANDREWS, DW; PATTERSON, RH				HARIRI, RJ; GHAJAR, JBG; POMERANTZ, KB; HAJJAR, DP; GIANNUZZI, RF; TOMICH, E; ANDREWS, DW; PATTERSON, RH			HUMAN GLIAL-CELL PRODUCTION OF LIPOXYGENASE-GENERATED EICOSANOIDS - A POTENTIAL ROLE IN THE PATHO-PHYSIOLOGY OF VASCULAR CHANGES FOLLOWING TRAUMATIC BRAIN INJURY	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article									CORNELL UNIV, MED CTR, DEPT SURG, NEW YORK, NY 10021 USA; CORNELL UNIV, MED CTR, DEPT PATHOL, VAC BIOL LAB, NEW YORK, NY 10021 USA; CORNELL UNIV, MED CTR, DIV NEUROSURG, AITKEN NEUROSURG LAB, NEW YORK, NY 10021 USA					Pomerantz, Kenneth/0000-0001-9443-5301			BACH MK, 1982, ANNU REV MICROBIOL, V36, P371, DOI 10.1146/annurev.mi.36.100182.002103; BLACK KL, 1985, ANN NEUROL, V18, P349, DOI 10.1002/ana.410180313; BLACK KL, 1986, ANN NEUROL, V19, P592, DOI 10.1002/ana.410190613; CHEN TR, 1977, EXP CELL RES, V104, P255, DOI 10.1016/0014-4827(77)90089-1; DEMBINSKAKIEC A, 1984, EUR J PHARMACOL, V99, P57, DOI 10.1016/0014-2999(84)90431-X; DEMPSEY RJ, 1986, J NEUROSURG, V64, P118, DOI 10.3171/jns.1986.64.1.0118; FEINMARK SJ, 1988, ANN NY ACAD SCI, V524, P122; HENKE DC, 1984, ANAL BIOCHEM, V140, P87, DOI 10.1016/0003-2697(84)90137-4; KENNEDY PGE, 1986, BRAIN, V109, P1261, DOI 10.1093/brain/109.6.1261; KIWAK KJ, 1985, J NEUROSURG, V62, P865, DOI 10.3171/jns.1985.62.6.0865; LINDGREN JA, 1984, P NATL ACAD SCI-BIOL, V81, P6212, DOI 10.1073/pnas.81.19.6212; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MOSKOWITZ MA, 1984, SCIENCE, V224, P886, DOI 10.1126/science.6719118; PIOMELLI D, 1987, J PHARMACOL EXP THER, V241, P763; POMERANTZ KB, 1984, CIRC RES, V54, P554, DOI 10.1161/01.RES.54.5.554; POWELL WS, 1982, METHOD ENZYMOL, V86, P467; TAGARI P, 1983, PROSTA LEUKOTR MED, V11, P281, DOI 10.1016/0262-1746(83)90041-0; WOLFE LS, 1982, J NEUROCHEM, V38, P1, DOI 10.1111/j.1471-4159.1982.tb10847.x	18	18	19	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	SEP	1989	29	9					1203	1210		10.1097/00005373-198909000-00003			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	AQ652	WOS:A1989AQ65200003	2504938				2022-02-06	
J	TREXLER, LE; ZAPPALA, G				TREXLER, LE; ZAPPALA, G			NEUROPATHOLOGICAL DETERMINANTS OF ACQUIRED ATTENTION DISORDERS IN TRAUMATIC BRAIN INJURY	BRAIN AND COGNITION			English	Article									CTR NEUROPSYCHOL REHABIL,INDIANAPOLIS,IN								ALEXANDER MP, 1982, PSYCHIATRIC ASPECTS, V2, P219; Blumer D., 1975, PSYCHIAT ASPECTS NEU, P151; BRICOLO A, 1980, J NEUROSURG, V52, P625, DOI 10.3171/jns.1980.52.5.0625; GENNARELLI TA, 1986, J HEAD TRAUMA REHAB, V1, P23; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; GROSS Y, 1982, COGNITIVE REHABILITA, P99; Jennett B, 1981, MANAGEMENT HEAD INJU; KAPLAN E, 1978, UNPUB BOSTON VERSION; KAPLAN E, 1980, UNPUB BOSTON VISUAL; LEVIN HS, 1985, STATUS REPORT CENTRA, P281; MANDLEBERG IA, 1975, J NEUROL NEUROSUR PS, V38, P1121, DOI 10.1136/jnnp.38.11.1121; MILNER B, 1971, BRIT MED BULL, V27, P272, DOI 10.1093/oxfordjournals.bmb.a070866; NAUTA WJH, 1971, J PSYCHIAT RES, V8, P167, DOI 10.1016/0022-3956(71)90017-3; PAPANICOLAOU AC, 1985, P EUROPEAN M INT NEU; SARA SJ, 1985, MEMORY DYSFUNCTIONS, V44; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; STUSS DT, 1984, PSYCHOL BULL, V95, P3, DOI 10.1037/0033-2909.95.1.3; STUSS DT, 1983, LOCALIZATION NEUROPS, P429; TREXLER LE, UNPUB COMPUTER TASKS; van Zomeren AH, 1984, CLOSED HEAD INJURY P, P74; VANZOMEREN AH, 1978, J NEUROL NEUROSUR PS, V41, P452, DOI 10.1136/jnnp.41.5.452; Walsh K. W., 1978, NEUROPSYCHOLOGY CLIN	22	18	19	0	2	ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495	0278-2626			BRAIN COGNITION	Brain Cogn.	DEC	1988	8	3					291	302		10.1016/0278-2626(88)90056-5			12	Neurosciences; Psychology, Experimental	Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	R4757	WOS:A1988R475700002	3214587				2022-02-06	
J	MARTIN, DA				MARTIN, DA			CHILDREN AND ADOLESCENTS WITH TRAUMATIC BRAIN INJURY - IMPACT ON THE FAMILY	JOURNAL OF LEARNING DISABILITIES			English	Article									UNIV TEXAS,SCH NURSING,AUSTIN,TX 78712								BLACHER J, 1984, SEVERELY HANDICAPPED; BLAZYCK S, 1983, SOCIAL WORK HLTH CAR, V80, P55; BOND MR, 1983, REHABILITATION HEAD, P209; Bristol MM, 1984, SEVERELY HANDICAPPED, V91-141; CHADWICK O, 1985, DEV MED CHILD NEUROL, V27, P69; DARLING RB, 1982, CHILDREN ARE DIFFERE; DEATON AV, 1987, J LEARN DISABIL, V20, P581, DOI 10.1177/002221948702001003; DEMYER M, 1983, AUTISM ADOLESCENTS A, P75; DROTAR D, 1975, PEDIATRICS, V56, P710; EIBEN CF, 1984, ARCH PHYS MED REHAB, V65, P168; Elkins T E, 1986, Issues Law Med, V1, P419; EWINGCOBBS L, 1987, J LEARN DISABIL, V20, P526, DOI 10.1177/002221948702000904; FEATHERSTONE MA, 1980, DIFFERENCE FAMILY; Figley, 1983, STRESS FAMILY, P5; FISHER JM, 1985, SEMIN NEUROL, V5, P197, DOI 10.1055/s-2008-1041516; FRANKOWSKI RF, 1985, INJURED CHILD, P20; Gallagher J, 1981, J DIVISION EARLY CHI, V3, P3; GOLDSTEIN FC, 1987, J LEARN DISABIL, V20, P518, DOI 10.1177/002221948702000903; Hill R., 1949, FAMILIES STRESS ADJU; Hills R., 1958, SOCIAL CASEWORK, V49, P139; HOLADAY B, 1984, NURS CLIN N AM, V19, P361; KLAUS MH, 1982, PARENT INFANT BONDIN; LIEBERMAN M, 1979, SELF HELP GROUPS COP; MCCUBBIN H, 1979, J MARRIAGE FAMILY, V42, P237; McCubbin H.I., 1982, FAMILY STRESS COPING; McCubbin M, 1984, West J Nurs Res, V6, P407, DOI 10.1177/019394598400600404; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; *NAT HEAD INJ FDN, 1985, ED MAN WHAT ED NEED; NEVIN RS, 1979, NATIONAL COUNCIL FAM; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; OLSHANKY S, 1970, COUNSELING PARENTS M; Panting A, 1972, REHABILITATION, V38, P33; PATTERSON JM, 1985, FAM RELAT, V34, P79, DOI 10.2307/583760; PRIGATANO GP, 1987, J LEARN DISABIL-US, V20, P603, DOI 10.1177/002221948702001006; Pueschel S M, 1986, Issues Law Med, V2, P171; ROSENTHAL M, 1986, NEUROPSYCHOLOGY HDB, P325; SIMEONSSON RJ, 1981, CHILD CARE HLTH DEV, V7, P153, DOI 10.1111/j.1365-2214.1981.tb00833.x; SOLNIT AJ, 1961, PSYCHOANAL STUD CHIL, V16, P523, DOI 10.1080/00797308.1961.11823222; Turk D. C., 1985, HLTH ILLNESS FAMILIE, P1	39	18	18	0	1	PRO-ED INC	AUSTIN	8700 SHOAL CREEK BLVD, AUSTIN, TX 78757-6897	0022-2194			J LEARN DISABIL	J. Learn. Disabil.	OCT	1988	21	8					464	470		10.1177/002221948802100803			7	Education, Special; Rehabilitation	Social Science Citation Index (SSCI)	Education & Educational Research; Rehabilitation	Q4889	WOS:A1988Q488900011	3053950				2022-02-06	
J	LINDSAY, JR; ZAJTCHUK, J				LINDSAY, JR; ZAJTCHUK, J			FOWLER, E.P. MEMORIAL LECTURE - CONCUSSION OF INNER EAR	ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY			English	Article																	BRUNNER H, 1928, HDB NEUROLOGIE OHR 1, V2, P305; Fischer J, 1943, INNER EAR; KIMURA R, 1956, Ann Otol Rhinol Laryngol, V65, P620; LINDSAY JR, UNPUBLISHED MATERIAL; Manasse P, 1924, BEITR Z ANAT PHYSIOL, V21, P230; NAGER FR, 1907, Z OHRENHEILK, V101, P217; SCHUKNECHT HF, 1951, ANN OTO RHINOL LARYN, V60, P273, DOI 10.1177/000348945106000201; Stenger P, 1909, ARCH OHRENH, V79, P43; STEURER O, HNDB SPEZ PATH ANAT, V12, P451; Theodore E, 1910, Z OHRENHEILKD, V61, P299; VOS O, 1933, ARCH OHRRN NASEN KEH, P137; Wittmaack K., 1932, ARCH F OHRENH, V131, P59; WITTMAACK K, HNDB SPEZ PATH ANAT, V12, pC290; [No title captured]	14	18	18	1	1	ANNALS PUBL CO	ST LOUIS	4507 LACLEDE AVE, ST LOUIS, MO 63108	0003-4894			ANN OTO RHINOL LARYN	Ann. Otol. Rhinol. Laryngol.		1970	79	4					699	&		10.1177/000348947007900403			0	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	H1275	WOS:A1970H127500002	5316676				2022-02-06	
J	Hassin, GB				Hassin, GB			Concussion of the spinal cord - A case with the clinical picture of amyotrophic lateral sclerosis	ARCHIVES OF NEUROLOGY AND PSYCHIATRY			English	Article									Illinois State Psychopath Inst, Chicago, IL USA								ASTWAZATUOW M, 1911, DTSCH Z NERVENH, V42, P352; BICKELES, 1895, OBERSTEINER ARB, V3, P102; BICKELES G, 1895, I WIENER U, V3, P102; BING R, 1905, ARCH PSYCHIAT, V39, P75; BRUCE A, 1897, M S J, V1, P41; CLAUDE H, 1915, B MEM SOC MED HOP P, V39, P680; CLAUDE H, 1915, ANN MED, V2, P479; DUMENIL L, 1885, ARCH NEUROL-CHICAGO, V9, P1; ERB W, 1897, DTSCH Z NERVENH, V1, P122; ERB W, 1912, DTSCH Z NERVENH, V45, P1; ERB W, 1910, DTSCH Z NERVENH, V38, P261; ERICHSEN JE, 1883, CONCUSSION SPINE, P5; FICKLER, 1905, DTSCH Z NERVENHEILK, V29, P1; Finkelnburg R, 1914, DEUT MED WOCHENSCHR, V40, P2057, DOI 10.1055/s-0029-1190830; Giese O, 1904, DEUT MED WOCHENSCHR, V30, P1348; GOLDBERG L, 1898, BERLIN KLIN WCHNSCHR, V35, P263; GUSSENBAUER C, 1893, PRAGER MED WOCHENSCH, V18, P496; GUSSENBAUER C, 1893, PRAG MED WCHNSCHR, V18, P485; HARTMANN F, 1900, JB PSYCHIAT NEUROL, V19, P380; Hassin GB, 1922, ARCH NEURO PSYCHIATR, V7, P613, DOI 10.1001/archneurpsyc.1922.02190110064007; HASSIN GB, 1917, MED REC, V91, P228; HELLBACH H, 1909, DTSCH Z NERVENH, V37, P321; HENNEBERG, 1915, BERLIN KLIN WCHNSCHR, V52, P859; Holmes G., 1909, REV NEUROL PSYCHIAT, V7, P693; JACOB, 1912, NISSL ALZHEIMER ARB, V5, P182; JACOB A, 1912, NISSL ALZHEIMERS ARB, V5, P1; JACOB A, 1919, Z NEUROL PSYCHIAT, V51, P247; JOFFROY A, 1890, ARCH MED EXP ANAT PA, V2, P434; KIENBOCK R, 1899, WIEN MED PRESSE, V40, P1926; Kirchgasser G., 1897, DTSCH Z NERVENH, V11, P406; Kocher T, 1896, MITT GRENZGEB MED CH, V1, P481; LHERMITTE J, 1917, ANN MED, V4, P295; LHERMITTE J, 1915, B MEM SOC MED HOP P, V39, P680; Licen E, 1917, MON PSYCHIATR NEUROL, V42, P86; MARIE P, 1893, SEMAINE MED, V13, P533; MARIE P, 1894, SEMAINE MED, V14, P17; MOTT F, 1888, BRAIN, V10, P478; OBERSTEINER H, 1879, WIEN MED JB; REDLICH E, 1917, JB PSYCHIAT NEUROL, V38, P103; ROUSSY, 1917, ANN MED, V4, P458; ROUSSY G, 1920, ANN MED, V8, P335; SARBO A, 1913, DTSCH Z NERVENH, V46, P43; SCHMAUS H, 1890, VIRCHOWS ARCH PATH A, V122, P326; SCHMAUS H, 1890, VIRCHOWS ARCH PATH A, V122, P470; SEIFFER W, 1902, CHARITE ANN, V27, P542; Thorburn W, 1887, BRAIN, V9, P510, DOI [10.1093/brain/9.4.510, DOI 10.1093/BRAIN/9.4.510]; WESTPHAL, 1896, ARCH PSYCHIAT, V28, P554	47	18	18	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0096-6754			ARCH NEURO PSYCHIATR		AUG	1923	10	2					194	211		10.1001/archneurpsyc.1923.02190260055004			18	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Psychiatry	V23SJ	WOS:000201602500004					2022-02-06	
J	Okonkwo, DO; Puffer, RC; Puccio, AM; Yuh, EL; Yue, JK; Diaz-Arrastia, R; Korley, FK; Wang, KKW; Sun, XY; Taylor, SR; Mukherjee, P; Markowitz, AJ; Jain, S; Manley, GT				Okonkwo, David O.; Puffer, Ross C.; Puccio, Ava M.; Yuh, Esther L.; Yue, John K.; Diaz-Arrastia, Ramon; Korley, Frederick K.; Wang, Kevin K. W.; Sun, Xiaoying; Taylor, Sabrina R.; Mukherjee, Pratik; Markowitz, Amy J.; Jain, Sonia; Manley, Geoffrey T.		Transforming Res Clinical	Point-of-Care Platform Blood Biomarker Testing of Glial Fibrillary Acidic Protein versus S100 Calcium-Binding Protein B for Prediction of Traumatic Brain Injuries: A Transforming Research and Clinical Knowledge in Traumatic Brain Injury Study	JOURNAL OF NEUROTRAUMA			English	Article						biomarkers; glial fibrillary acidic protein; S100 calcium-binding protein B; traumatic brain injury	COMMON DATA ELEMENTS; DECISION-MAKING; DIAGNOSIS; GFAP	Glial fibrillary acidic protein (GFAP) is cleared by the Food and Drug Administration (FDA) to determine need for head computed tomography (CT) within 12 h after mild traumatic brain injury (TBI) (Glasgow Coma Score [GCS] 13-15); S100 calcium-binding protein B (S100B) serves this function in Europe. This phase 1 biomarker cohort analysis of the multi-center, observational Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) study compares GFAP's diagnostic performance, measured on a rapid point-of-care platform, against protein S100B to predict intracranial abnormalities on CT within 24 h post-injury across the spectrum of TBI (GCS 3-15). Head CT scan performed in TBI subjects and blood was collected for all consenting subjects presenting to 18 United States level 1 trauma centers. Plasma was analyzed on a point-of-care device prototype assay for GFAP and serum was analyzed for S100B. In 1359 patients with TBI (GCS 3-15), mean (standard deviation [SD]) age = 40.1 (17.0) years; 68% were male. Plasma GFAP levels were significantly higher in CT+ TBI subjects (median = 1358 pg/mL, interquartile range [IQR]: 472-3803) than in CT- TBI subjects (median = 116 pg/mL, IQR: 26-397) or orthopedic trauma controls (n = 122; median = 13 pg/mL, IQR: 7-20),p < 0.001. Serum S100B levels were likewise higher in CT+ TBI subjects (median = 0.17 mu g/L, IQR: 0.09-0.38) than in CT- TBI subjects (median = 0.10 mu g/L, IQR: 0.06-0.18),p < 0.001. Receiver operating characteristic curves were generated for prediction of intracranial injury on admission CT scan; area under the curve (AUC) for GFAP was significantly higher than for S100B in the same cohort (GFAP AUC - 0.85, 95% confidence interval [CI] 0.83-0.87; S100B AUC - 0.67, 95% CI 0.64-0.70;p < 0.001). GFAP, measured on a point-of-care platform prototype assay, has high discriminative ability to predict intracranial abnormalities on CT scan in patients with TBI across the full injury spectrum of GCS 3-15 through 24 h post-injury. GFAP substantially outperforms S100B.	[Okonkwo, David O.; Puffer, Ross C.; Puccio, Ava M.] Univ Pittsburgh, Dept Neurol Surg, Med Ctr, 200 Lothrop St,Suite B-400, Pittsburgh, PA 15213 USA; [Puffer, Ross C.] Mayo Clin, Dept Neurol Surg, Rochester, MN USA; [Yuh, Esther L.; Mukherjee, Pratik] Univ Calif San Francisco, Dept Radiol, San Francisco, CA USA; [Yue, John K.; Taylor, Sabrina R.; Markowitz, Amy J.; Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Yuh, Esther L.; Yue, John K.; Taylor, Sabrina R.; Mukherjee, Pratik; Markowitz, Amy J.; Manley, Geoffrey T.] Univ Calif San Francisco, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA; [Yuh, Esther L.; Yue, John K.; Taylor, Sabrina R.; Mukherjee, Pratik; Markowitz, Amy J.; Manley, Geoffrey T.] Zuckerberg San Francisco Gen Hosp & Trauma Ctr, San Francisco, CA USA; [Diaz-Arrastia, Ramon] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Korley, Frederick K.] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA; [Wang, Kevin K. W.] Univ Florida, Dept Psychiat, McKnight Brain Inst, Gainesville, FL 32611 USA; [Wang, Kevin K. W.] Univ Florida, Dept Neurosci, McKnight Brain Inst, Gainesville, FL 32610 USA; [Sun, Xiaoying; Jain, Sonia] Univ Calif San Diego, Dept Family Med & Publ Hlth, San Diego, CA 92103 USA		Okonkwo, DO (corresponding author), Univ Pittsburgh, Dept Neurol Surg, Med Ctr, 200 Lothrop St,Suite B-400, Pittsburgh, PA 15213 USA.; Markowitz, AJ (corresponding author), Univ Calif San Francisco, Brain & Spinal Injury Ctr, Zuckerberg San Francisco Gen Hosp & Trauma Ctr, 1001 Potrero Ave,Room 101,Box 0899, San Francisco, CA 94143 USA.	okonkwodo@upmc.edu; amymarkowitz@gmail.com		Ferguson, Adam/0000-0001-7102-1608	National Institute of Neurological Disorders (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1RC2NS069409-01, 3RC2NS069409-02S1, 5RC2NS069409-02, 1U01NS086090-01, 3U01NS086090-02S1, 3U01NS086090-02S2, 3U01NS086090-03S1, 5U01NS086090-02, 5U01NS086090-03]; US Department of Defense (DOD)United States Department of Defense [W81XWH-13-1-0441]; US DODUnited States Department of Defense [W81XWH-14-2-0176]; One Mind	This work was supported by the following grants: National Institute of Neurological Disorders (NINDS) 1RC2NS069409-01, 3RC2NS069409-02S1, 5RC2NS069409-02, 1U01NS086090-01, 3U01NS086090-02S1, 3U01NS086090-02S2, 3U01NS086090-03S1, 5U01NS086090-02, and 5U01NS086090-03; US Department of Defense (DOD) W81XWH-13-1-0441, and US DOD W81XWH-14-2-0176. In-kind support for blinded analyses of GFAP and S100 was provided by Abbott Laboratories. Patient travel and stipend expenses were supported by One Mind (Staglin Family and Gen. Peter Chiarelli).	Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Calcagnile O, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0723-z; Centers for Disease Control and Prevention, 2016, RAT TBI REL EM DEP V; Clinical and Laboratory Standards Institute, EVALUATION DETECTION; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009; Duhaime AC, 2010, ARCH PHYS MED REHAB, V91, P1661, DOI 10.1016/j.apmr.2010.07.238; HAIMOTO H, 1987, LAB INVEST, V57, P489; Hunink MGM, 2005, RADIOLOGY, V235, P375, DOI 10.1148/radiol.2352040727; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Korley FK, 2016, J HEAD TRAUMA REHAB, V31, P379, DOI 10.1097/HTR.0000000000000187; Lee YB, 2000, BRAIN RES, V864, P220, DOI 10.1016/S0006-8993(00)02180-6; Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; McMahon PJ, 2015, J NEUROTRAUM, V32, P527, DOI 10.1089/neu.2014.3635; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Posti J.P., 2017, J NEUROTRAUMA; Reichlin T, 2009, NEW ENGL J MED, V361, P858, DOI 10.1056/NEJMoa0900428; Ruan S, 2009, J NEUROTRAUM, V26, P1655, DOI 10.1089/neu.2009-0928; Smits M, 2010, RADIOLOGY, V254, P532, DOI 10.1148/radiol.2541081672; Steiner J, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-2; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; Thelin EP, 2017, ACTA NEUROCHIR, V159, P209, DOI 10.1007/s00701-016-3046-3; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Whyte J, 2010, ARCH PHYS MED REHAB, V91, P1692, DOI 10.1016/j.apmr.2010.06.031; Yue JK, 2019, LANCET NEUROL, V18, P953, DOI 10.1016/S1474-4422(19)30282-0; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	28	17	17	1	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2020	37	23					2460	2467		10.1089/neu.2020.7140		SEP 2020	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	PC0XQ	WOS:000570776900001	32854584	Green Published, Bronze			2022-02-06	
J	Eagle, SR; Puligilla, A; Fazio-Sumrok, V; Kegel, N; Collins, MW; Kontos, AP				Eagle, Shawn R.; Puligilla, Anish; Fazio-Sumrok, Vanessa; Kegel, Nathan; Collins, Michael W.; Kontos, Anthony P.			Association of time to initial clinic visit with prolonged recovery in pediatric patients with concussion	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						concussion; mild traumatic brain injury; early intervention; recovery; trauma	SPORT-RELATED CONCUSSION; MOTOR SCREENING VOMS; SYMPTOMS; CHILDREN; REST	OBJECTIVE No studies to date have investigated the role of early clinical care in time to recovery from concussion in a pediatric population. The purpose of this study was to investigate the role of clinic presentation timing (<= 7 days [early] compared to 8-20 days [late] from injury) in concussion assessment performance and risk for prolonged recovery (> 30 days) in pediatric concussion. METHODS This study is a retrospective cross-sectional study from a concussion clinic between April 2016 and January 2019, including 218 children and adolescents with diagnosed concussion, separated based on clinic presentation timing following injury: early (<= 7 days) and late (8-20 days). Outcomes were recovery time, Postconcussion Symptom Scale (PCSS), Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT), Vestibular/Ocular Motor Screen (VOMS), and demographics, medical history, and injury information. A general linear model and chi-square analyses were used to assess differences between early and late presentation, along with logistic regression, to predict prolonged recovery (> 30 days). RESULTS Those with early presentation reported higher symptoms on VOMS subtests (79%-85%) compared to those with late presentation (61%-78%), with the exception of near-point of convergence distance and visual motion sensitivity (VMS). The strongest predictor of prolonged recovery was number of days to first clinic visit (OR 9.8). Positive VMS (OR 5.18), history of headache/migraine (OR 4.02), and PCSS score (OR 1.04) were also predictive of prolonged recovery. CONCLUSIONS Despite patients in the early presentation group presenting with more positive VOMS scores, the early presentation group recovered sooner than patients in the late presentation group. Even after controlling for vestibular dysfunction, history of headache or migraine, and total symptom severity, days to first visit remained the most robust predictor of recovery > 30 days. These findings suggest that early, specialized medical care and intervention for children and adolescents with recent concussion is associated with normal recovery time. Clinicians should educate children and parents on the potential importance of early treatment to improve the odds of positive outcomes following concussion.	Univ Pittsburgh, Dept Orthopaed Surg, Pittsburgh, PA 15260 USA; UPMC Sports Med Concuss Program, Pittsburgh, PA USA		Eagle, SR (corresponding author), Univ Pittsburgh, Sch Med, Pittsburgh, PA 15260 USA.	seagle@pitt.edu	Eagle, Shawn/ABG-1388-2020	Eagle, Shawn/0000-0001-6767-1042			Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Chrisman SPD, 2019, JAMA PEDIATR, V173, P315, DOI 10.1001/jamapediatrics.2018.5281; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Faul M, 2010, TRAUMATIC BRAIN INJU; Giza CC, 2018, JAMA NEUROL, V75, P399, DOI 10.1001/jamaneurol.2018.0006; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Kontos AP, 2020, JAMA NEUROL, V77, P435, DOI 10.1001/jamaneurol.2019.4552; Kontos AP, 2018, MIL MED, V183, P333, DOI 10.1093/milmed/usx172; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Master CL, 2018, CLIN J SPORT MED, V28, P139, DOI 10.1097/JSM.0000000000000507; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Ono KE, 2016, AM J SPORT MED, V44, P748, DOI 10.1177/0363546515617746; Reynolds E, 2016, APPL NEUROPSYCH-CHIL, V5, P283, DOI 10.1080/21622965.2015.1057637; Sandel N, 2017, SPORT EXERC PERFORM, V6, P304, DOI 10.1037/spy0000098; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Scopaz KA, 2013, SPORTS HEALTH, V5, P537, DOI 10.1177/1941738112473059; Sufrinko A, 2018, J HEAD TRAUMA REHAB, V33, P7, DOI 10.1097/HTR.0000000000000315; Sufrinko AM, 2019, CLIN J SPORT MED, V29, P318, DOI 10.1097/JSM.0000000000000528; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	28	17	17	1	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	AUG	2020	26	2					165	170		10.3171/2020.2.PEDS2025			6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	NZ5UA	WOS:000577169500009	32330895	Bronze			2022-02-06	
J	Bailey, ZS; Nilson, E; Bates, JA; Oyalowo, A; Hockey, KS; Sajja, VSSS; Thorpe, C; Rogers, H; Dunn, B; Frey, AS; Billings, MJ; Sholar, CA; Hermundstad, A; Kumar, C; VandeVord, PJ; Rzigalinski, BA				Bailey, Zachary S.; Nilson, Eric; Bates, John A.; Oyalowo, Adewole; Hockey, Kevin S.; Sajja, Venkata Siva Sai Sujith; Thorpe, Chevon; Rogers, Heidi; Dunn, Bryce; Frey, Aaron S.; Billings, Marc J.; Sholar, Christopher A.; Hermundstad, Amy; Kumar, Challa; VandeVord, Pamela J.; Rzigalinski, Beverly A.			Cerium Oxide Nanoparticles Improve Outcome after In Vitro and In Vivo Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						cerium oxide; nanoparticles; oxidative stress; traumatic brain injury	OXIDATIVE STRESS; SUPEROXIDE-PRODUCTION; NITRIC-OXIDE; MODEL; NEUROPROTECTION; IMPAIRMENT; RADICALS; DEFICITS; MEMORY; CELLS	Mild traumatic brain injury results in aberrant free radical generation, which is associated with oxidative stress, secondary injury signaling cascades, mitochondrial dysfunction, and poor functional outcome. Pharmacological targeting of free radicals with antioxidants has been examined as an approach to treatment, but has met with limited success in clinical trials. Conventional antioxidants that are currently available scavenge a single free radical before they are destroyed in the process. Here, we report for the first time that a novel regenerative cerium oxide nanoparticle antioxidant reduces neuronal death and calcium dysregulation after in vitro trauma. Further, using an in vivo model of mild lateral fluid percussion brain injury in the rat, we report that cerium oxide nanoparticles also preserve endogenous antioxidant systems, decrease macromolecular free radical damage, and improve cognitive function. Taken together, our results demonstrate that cerium oxide nanoparticles are a novel nanopharmaceutical with potential for mitigating neuropathological effects of mild traumatic brain injury and modifying the course of recovery.	[Bailey, Zachary S.; Oyalowo, Adewole; Sajja, Venkata Siva Sai Sujith; Dunn, Bryce; Hermundstad, Amy; VandeVord, Pamela J.] Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA USA; [Nilson, Eric; Bates, John A.; Hockey, Kevin S.; Thorpe, Chevon; Rogers, Heidi; Frey, Aaron S.; Billings, Marc J.; Sholar, Christopher A.; Rzigalinski, Beverly A.] Edward Via Coll Osteopath Med, Dept Pharmacol, Res 2 Bldg,1861 Pratt Dr, Blacksburg, VA 24060 USA; [Kumar, Challa] Harvard Univ, Rowland Inst Sci, Integrated Mesoscale Architectures Sustainable Ca, Cambridge, MA 02138 USA		Rzigalinski, BA (corresponding author), Edward Via Coll Osteopath Med, Dept Pharmacol, Res 2 Bldg,1861 Pratt Dr, Blacksburg, VA 24060 USA.	brzigali@vcom.vt.edu	Nanozymes, Nanozymes/D-8197-2019; Sajja, Sujith/I-5289-2019	Sajja, Sujith/0000-0002-1992-9501; Dunn, Bryce/0000-0002-4399-1516; Oyalowo, Adewole/0000-0003-0342-6683; Thorpe, Chevon/0000-0003-4328-7876			Aggleton JP, 2010, BEHAV NEUROSCI, V124, P55, DOI 10.1037/a0018320; Ahmed SM, 2000, J NEUROCHEM, V74, P1951, DOI 10.1046/j.1471-4159.2000.0741951.x; Andrievsky GV, 2009, FREE RADICAL BIO MED, V47, P786, DOI 10.1016/j.freeradbiomed.2009.06.016; Aneggi E, 2006, J ALLOY COMPD, V408, P1096, DOI 10.1016/j.jallcom.2004.12.113; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438; BAKER MA, 1990, ANAL BIOCHEM, V190, P360, DOI 10.1016/0003-2697(90)90208-Q; Brahmajothi MV, 2014, ANTIOXID REDOX SIGN, V21, P1823, DOI 10.1089/ars.2013.5664; Celardo I, 2011, ACS NANO, V5, P4537, DOI 10.1021/nn200126a; Celardo I, 2011, NANOSCALE, V3, P1411, DOI 10.1039/c0nr00875c; Chan PH, 2001, J CEREBR BLOOD F MET, V21, P2, DOI 10.1097/00004647-200101000-00002; Ciofani G, 2013, PHARM RES-DORDR, V30, P2133, DOI 10.1007/s11095-013-1071-y; Cuzzocrea S, 2000, BRAIN RES, V875, P96, DOI 10.1016/S0006-8993(00)02582-8; Das M, 2007, BIOMATERIALS, V28, P1918, DOI 10.1016/j.biomaterials.2006.11.036; Ennaceur A, 2010, BEHAV BRAIN RES, V215, P244, DOI 10.1016/j.bbr.2009.12.036; Estevez AY, 2011, FREE RADICAL BIO MED, V51, P1155, DOI 10.1016/j.freeradbiomed.2011.06.006; Frey A., 2014, CERIUM OXIDE NANOPAR; Gaskin S, 2010, BEHAV PROCESS, V83, P61, DOI 10.1016/j.beproc.2009.10.003; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Griesbach GS, 2014, J NEUROTRAUM, V31, P674, DOI 10.1089/neu.2013.3151; Hu GH, 2003, J NEUROSURG, V98, P393, DOI 10.3171/jns.2003.98.2.0393; Hylin MJ, 2013, J NEUROTRAUM, V30, P702, DOI 10.1089/neu.2012.2630; Ischiropoulos H, 1998, ARCH BIOCHEM BIOPHYS, V356, P1, DOI 10.1006/abbi.1998.0755; JOHANSSON LH, 1988, ANAL BIOCHEM, V174, P331, DOI 10.1016/0003-2697(88)90554-4; Jortner B.S., 2015, SOC TOX ANN M; Kannan, 2000, Pathophysiology, V7, P153, DOI 10.1016/S0928-4680(00)00053-5; Kohl M, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.080402; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; LAFONCAZAL M, 1993, NATURE, V364, P535, DOI 10.1038/364535a0; Li Y, 2016, ENVIRON TOXICOL PHAR, V44, P25, DOI 10.1016/j.etap.2016.04.004; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARKLUND S, 1980, ACTA PHYSIOL SCAND, P19; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Polak P, 2015, NANOMED-NANOTECHNOL, V11, P1467, DOI 10.1016/j.nano.2015.03.005; Pratico D, 2002, ARCH NEUROL-CHICAGO, V59, P972, DOI 10.1001/archneur.59.6.972; Reger ML, 2009, DEV PSYCHOBIOL, V51, P672, DOI 10.1002/dev.20402; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Rzigalinski B.A., 2011, NANOMEDICINE HLTH DI, P100; Rzigalinski BA, 1998, J NEUROCHEM, V70, P2377; Rzigalinski BA, 2006, NANOMEDICINE-UK, V1, P399, DOI 10.2217/17435889.1.4.399; Saito I, 1998, NEUROSURGERY, V42, P269, DOI 10.1097/00006123-199802000-00038; Sajja VSSS, 2014, MOL CELL NEUROSCI, V59, P119, DOI 10.1016/j.mcn.2014.02.004; Schreiber D., 1995, P 1995 INT RES C BIO, P233; Schubert D, 2006, BIOCHEM BIOPH RES CO, V342, P86, DOI 10.1016/j.bbrc.2006.01.129; Singh N, 2007, ANN NY ACAD SCI, V1122, P219, DOI 10.1196/annals.1403.015; SMITH SL, 1994, J NEUROTRAUM, V11, P393, DOI 10.1089/neu.1994.11.393; Titus DJ, 2015, EXP NEUROL, V263, P254, DOI 10.1016/j.expneurol.2014.10.020; Tsai YY, 2007, NANOMEDICINE-UK, V2, P325, DOI 10.2217/17435889.2.3.325; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Walkey C, 2015, ENVIRON SCI-NANO, V2, P33, DOI 10.1039/c4en00138a; Weber JT, 2001, J BIOL CHEM, V276, P1800, DOI 10.1074/jbc.M009209200; Weber JT, 1999, CELL CALCIUM, V26, P289, DOI 10.1054/ceca.1999.0082; Whiting M, 2009, J NEUROTRAUM, V26, pA101; Whiting MD, 2006, J NEUROTRAUM, V23, P1529, DOI 10.1089/neu.2006.23.1529; Xiang JY, 2016, ACS APPL MATER INTER, V8, P4489, DOI 10.1021/acsami.6b00158; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921	56	17	19	5	23	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 15	2020	37	12					1452	1462		10.1089/neu.2016.4644			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	LT4XN	WOS:000537075800008	27733104	Green Published, Green Submitted, hybrid			2022-02-06	
J	Hajiaghamemar, M; Wu, TT; Panzer, MB; Margulies, SS				Hajiaghamemar, Marzieh; Wu, Taotao; Panzer, Matthew B.; Margulies, Susan S.			Embedded axonal fiber tracts improve finite element model predictions of traumatic brain injury	BIOMECHANICS AND MODELING IN MECHANOBIOLOGY			English	Article						Multi-scale finite element modeling; Axonal injury prediction; Diffusion tensor imaging; Tractography; Axonal tract network	HEAD ROTATIONS; IN-VITRO; STRAIN; STRETCH; DAMAGE; TISSUE; VERIFICATION; COMPUTATION; SENSITIVITY; VALIDATION	With the growing rate of traumatic brain injury (TBI), there is an increasing interest in validated tools to predict and prevent brain injuries. Finite element models (FEM) are valuable tools to estimate tissue responses, predict probability of TBI, and guide the development of safety equipment. In this study, we developed and validated an anisotropic pig brain multi-scale FEM by explicitly embedding the axonal tract structures and utilized the model to simulate experimental TBI in piglets undergoing dynamic head rotations. Binary logistic regression, survival analysis with Weibull distribution, and receiver operating characteristic curve analysis, coupled with repeated k-fold cross-validation technique, were used to examine 12 FEM-derived metrics related to axonal/brain tissue strain and strain rate for predicting the presence or absence of traumatic axonal injury (TAI). All 12 metrics performed well in predicting of TAI with prediction accuracy rate of 73-90%. The axonal-based metrics outperformed their rival brain tissue-based metrics in predicting TAI. The best predictors of TAI were maximum axonal strain times strain rate (MASxSR) and its corresponding optimal fraction-based metric (AF-MASxSR(7.5)) that represents the fraction of axonal fibers exceeding MASxSR of 7.5 s(-1). The thresholds compare favorably with tissue tolerances found in in-vitro/in-vivo measurements in the literature. In addition, the damaged volume fractions (DVF) predicted using the axonal-based metrics, especially MASxSR (DVF = 0.05-4.5%), were closer to the actual DVF obtained from histopathology (AIV = 0.02-1.65%) in comparison with the DVF predicted using the brain-related metrics (DVF = 0.11-41.2%). The methods and the results from this study can be used to improve model prediction of TBI in humans.	[Hajiaghamemar, Marzieh; Margulies, Susan S.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, UA Whitaker Bldg,313 Ferst Dr, Atlanta, GA 30332 USA; [Hajiaghamemar, Marzieh; Margulies, Susan S.] Emory Univ, UA Whitaker Bldg,313 Ferst Dr, Atlanta, GA 30332 USA; [Wu, Taotao; Panzer, Matthew B.] Univ Virginia, Dept Mech & Aerosp Engn, 4040 Lewis & Clark Dr, Charlottesville, VA 22911 USA		Hajiaghamemar, M (corresponding author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, UA Whitaker Bldg,313 Ferst Dr, Atlanta, GA 30332 USA.; Hajiaghamemar, M (corresponding author), Emory Univ, UA Whitaker Bldg,313 Ferst Dr, Atlanta, GA 30332 USA.	memar@gatech.edu	Lang, Steven/AAE-8102-2021	Lang, Steven/0000-0003-1669-9146; Hajiaghamemar, Marzieh/0000-0002-0232-2447	NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS097549, R56NS055951] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R56 NS055951, R01 NS097549] Funding Source: Medline		Anderson Andrew E., 2007, Computer Methods in Biomechanics and Biomedical Engineering, V10, P171, DOI 10.1080/10255840601160484; Arbogast KB, 1999, J BIOMECH, V32, P865, DOI 10.1016/S0021-9290(99)00042-1; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bain AC, 2001, J NEUROTRAUM, V18, P499, DOI 10.1089/089771501300227305; Bandak FA, 1994, SAE T, P1708; Bar-Kochba E, 2016, SCI REP-UK, V6, DOI 10.1038/srep30550; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Caragea C, 2007, PROCEEDINGS OF THE 7TH IEEE INTERNATIONAL SYMPOSIUM ON BIOINFORMATICS AND BIOENGINEERING, VOLS I AND II, P320; Cater HL, 2006, J BIOMECH, V39, P2810, DOI 10.1016/j.jbiomech.2005.09.023; Chatelin Simon, 2013, Journal of Biorheology, V27, P26, DOI 10.1007/s12573-012-0055-6; Chatelin S, 2011, J MECH BEHAV BIOMED, V4, P1905, DOI 10.1016/j.jmbbm.2011.06.007; Cloots RJH, 2012, J MECH BEHAV BIOMED, V5, P41, DOI 10.1016/j.jmbbm.2011.09.012; Coats B, 2012, INT J DEV NEUROSCI, V30, P191, DOI 10.1016/j.ijdevneu.2011.12.009; Colgan NC, 2010, PROG BIOPHYS MOL BIO, V103, P304, DOI 10.1016/j.pbiomolbio.2010.09.008; Control CfD Prevention, 2015, REP C TRAUM BRAIN IN, P1; Cullen DK, 2007, BRAIN RES, V1158, P103, DOI 10.1016/j.brainres.2007.04.070; Duda JT, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00046; Elkin B.S., 2007, SAE TECHNICAL PAPER; Feng Y, 2013, J MECH BEHAV BIOMED, V23, P117, DOI 10.1016/j.jmbbm.2013.04.007; Fung Y.C., 2013, BIOMECHANICS MECH PR; GALBRAITH JA, 1993, J BIOMECH ENG-T ASME, V115, P13, DOI 10.1115/1.2895464; Ganpule S, 2017, J NEUROTRAUM, V34, P2154, DOI 10.1089/neu.2016.4744; Garimella HT, 2019, ANN BIOMED ENG, V47, P1889, DOI 10.1007/s10439-018-02166-0; Garimella HT, 2017, INT J NUMER METH BIO, V33, DOI 10.1002/cnm.2823; Gasser TC, 2006, J R SOC INTERFACE, V3, P15, DOI 10.1098/rsif.2005.0073; Giordano C, 2014, J BIOMECH, V47, P1052, DOI 10.1016/j.jbiomech.2013.12.036; Giordano C, 2014, SAE TECHNICAL PAPER; Giordano C, 2017, BIOMECH MODEL MECHAN, V16, P1269, DOI 10.1007/s10237-017-0887-5; Giordano C, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0914; Guruprakash DK, 2011, EFFECTS STRAIN STRAI; Hajiaghamemar M, 2019, INT J LEGAL MED, V133, P847, DOI 10.1007/s00414-018-1918-1; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ibrahim NG, 2010, J NEUROTRAUM, V27, P1021, DOI 10.1089/neu.2009.1212; Ibrahim NG, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000956; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; King AI, 2003, IRCOBI C LISB PORT; Kleiven S., 2007, SAE TECHNICAL PAPER; KWAN MK, 1992, ACTA ORTHOP SCAND, V63, P267, DOI 10.3109/17453679209154780; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; Maltese MR, 2016, COMPUT METHOD BIOMEC, V19, P1618, DOI 10.1080/10255842.2016.1176153; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Margulies SS, 2015, BRAIN PATHOL, V25, P289, DOI 10.1111/bpa.12247; Mittlbock M, 1999, COMPUT METH PROG BIO, V58, P17; Morrison B, 2000, J BIOMECH ENG-T ASME, V122, P224, DOI 10.1115/1.429650; Naim MY, 2010, DEV NEUROSCI-BASEL, V32, P466, DOI 10.1159/000322448; Nakadate H, 2017, SAE TECHNICAL PAPER; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; Ning XG, 2006, J BIOMECH ENG-T ASME, V128, P925, DOI 10.1115/1.2354208; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Petitjean A., 2011, SAE TECHNICAL PAPER; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Rashid B, 2014, J MECH BEHAV BIOMED, V33, P43, DOI 10.1016/j.jmbbm.2012.07.015; Sahoo D, 2016, ACCIDENT ANAL PREV, V92, P53, DOI 10.1016/j.aap.2016.03.013; Sahoo D, 2014, J MECH BEHAV BIOMED, V33, P24, DOI 10.1016/j.jmbbm.2013.08.022; Sanchez EJ, 2019, CLIN BIOMECH, V64, P82, DOI 10.1016/j.clinbiomech.2018.02.019; Shi R, 2006, J NEUROPHYSIOL, V95, P3384, DOI 10.1152/jn.00350.2005; Singh A, 2006, SAE TECHNICAL PAPER; Singh A, 2017, BRAIN INJURY, V31, P1387, DOI 10.1080/02699052.2017.1321781; Singh A, 2009, J NEUROTRAUM, V26, P627, DOI 10.1089/neu.2008.0621; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Smith DH, 1999, J NEUROSCI, V19, P4263; Sullivan S, 2015, BIOMECH MODEL MECHAN, V14, P877, DOI 10.1007/s10237-014-0643-z; Takhounts EG, 2003, SAE TECHNICAL PAPER; Tamura A, 2007, SAE TECHNICAL PAPER; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Untaroiu C., 2007, P 20 INT TECHN C ENH; Wright RM, 2013, J NEUROTRAUM, V30, P102, DOI 10.1089/neu.2012.2418; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Wu TT, 2019, ANN BIOMED ENG, V47, P1908, DOI 10.1007/s10439-019-02239-8; Yadav S, 2016, INT CONF ADV COMPU, P78, DOI 10.1109/IACC.2016.25; Zhao W, 2017, BIOMECH MODEL MECHAN, V16, P1709, DOI 10.1007/s10237-017-0915-5	72	17	17	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-7959	1617-7940		BIOMECH MODEL MECHAN	Biomech. Model. Mechanobiol.	JUN	2020	19	3					1109	1130		10.1007/s10237-019-01273-8			22	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	LK5AX	WOS:000530879100022	31811417	Green Published, hybrid			2022-02-06	
J	Keret, O; Hoang, TD; Xia, F; Rosen, HJ; Yaffe, K				Keret, Ophir; Hoang, Tina D.; Xia, Feng; Rosen, Howard J.; Yaffe, Kristine			Association of Late-Onset Unprovoked Seizures of Unknown Etiology With the Risk of Developing Dementia in Older Veterans	JAMA NEUROLOGY			English	Article							DIAGNOSED EPILEPTIC SEIZURES; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; EEG ALTERATIONS; POPULATION; MODEL	Importance The incidence of unprovoked seizures and epilepsy increases considerably in late life, with approximately one-third of seizures being of unknown etiology. While individuals with dementia have a high risk of developing unprovoked seizures, it is unknown whether older adults with late-onset unprovoked seizures of unknown etiology (LOSU) are at risk of developing dementia. Objective To determine whether incident LOSU is associated with a higher risk of dementia among older US veterans. Design, Setting, and Participants This retrospective multicenter cohort study was conducted using data from US Veterans Health Administration medical centers from October 2001 to September 2015. Data were generated from all veteran inpatient and outpatient encounters that occurred within Veterans Health Administration facilities. A random sample of 941 524 veterans 55 years and older was generated. A total of 649 262 veterans previously diagnosed (using International Classification of Diseases, Ninth Revision, Clinical Modification codes) with dementia, unprovoked seizures, epilepsy, and conditions that could lead to seizures (brain tumors, trauma, infections, stroke, and neurotoxin exposure) as well as veterans without follow-up data were excluded. Data were analyzed from October 2018 to July 2019. Exposures Late-onset unprovoked seizures of unknown etiology were defined as a new diagnosis of epilepsy or unprovoked seizures without a diagnosis of a secondary cause for seizures. Incident LOSU was assessed during a 5-year baseline period. Main Outcomes and Measures Veterans were assessed for incident dementia diagnosis during an outcome period. Fine-Gray proportional hazards models were used to determine whether LOSU was associated with greater risk of incident dementia. Models were adjusted for demographic variables, cardiovascular risk factors, depression, and traumatic brain injury. Results Of the 292 262 included veterans, 282 628 (96.7%) were male, and the mean (SD) age was 73.0 [8.8] years. During the baseline period, 2166 veterans developed LOSU. The mean (SD) follow-up after LOSU was 6.1 (2.9) years. After multivariable adjustment, veterans with LOSU had greater risk of dementia compared with veterans without seizures (hazard ratio, 1.89; 95% CI, 1.62-2.20). A sensitivity analysis imposing a 2-year lag between incident LOSU and dementia diagnosis led to similar results. Conclusions and Relevance These findings suggest LOSU in older veterans is associated with a 2-fold risk of developing dementia. While seizures are commonly thought to occur in late stages of dementia, these findings suggest unexplained seizures in older adults may be a first sign of neurodegenerative disease.	[Keret, Ophir; Rosen, Howard J.; Yaffe, Kristine] Univ Calif San Francisco, Global Brain Hlth Inst, San Francisco, CA 94158 USA; [Hoang, Tina D.; Xia, Feng; Yaffe, Kristine] San Francisco Vet Affairs Hlth Care Syst, San Francisco, CA USA; [Hoang, Tina D.; Xia, Feng; Yaffe, Kristine] Vet Hlth Res Inst, Northern Calif Inst Res & Educ, San Francisco, CA USA; [Rosen, Howard J.; Yaffe, Kristine] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94158 USA		Keret, O (corresponding author), Univ Calif San Francisco, Global Brain Hlth Inst, Sandler Neurosci Ctr, 675 Nelson Rising Ln,Ste 190, San Francisco, CA 94158 USA.	ophir.keret@gbhi.org		Keret, Ophir/0000-0002-9964-7888	US Department of DefenseUnited States Department of Defense [W81XWH-12-PHTBI-CENC]; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K24 AG031155]; Sierra Pacific VISN Mental Illness Research, Education, and Clinical Centers	This research was supported by grant W81XWH-12-PHTBI-CENC from the US Department of Defense (Dr Yaffe), grant K24 AG031155 from the National Institute on Aging (Dr Yaffe), and the Sierra Pacific VISN Mental Illness Research, Education, and Clinical Centers (Dr Yaffe).	Acharya JN, 2014, ANN INDIAN ACAD NEUR, V17, pS18, DOI 10.4103/0972-2327.128645; Appel S, 2015, ACTA NEUROL SCAND, V131, P152, DOI 10.1111/ane.12304; Beghi E, 2019, LANCET NEUROL, V18, P357, DOI 10.1016/S1474-4422(18)30454-X; Breteler MMB, 1995, AM J EPIDEMIOL, V142, P1300, DOI 10.1093/oxfordjournals.aje.a117597; BROE GA, 1990, NEUROLOGY, V40, P1698, DOI 10.1212/WNL.40.11.1698; Carter MD, 2007, J NEUROL SCI, V252, P169, DOI 10.1016/j.jns.2006.11.004; Chang TE, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003056; Cheng CH, 2015, EPILEPSY RES, V115, P63, DOI 10.1016/j.eplepsyres.2015.05.009; Costa C, 2019, NEUROBIOL AGING, V73, P61, DOI 10.1016/j.neurobiolaging.2018.09.006; Cretin B, 2016, J ALZHEIMERS DIS, V52, P1125, DOI 10.3233/JAD-150096; DiFrancesco JC, 2017, J ALZHEIMERS DIS, V60, P1267, DOI 10.3233/JAD-170392; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Giussani G, 2016, EPILEPSY BEHAV, V55, P30, DOI 10.1016/j.yebeh.2015.11.021; Giussani G, 2014, EPILEPSIA, V55, P1526, DOI 10.1111/epi.12748; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; Hesdorffer DC, 1996, NEUROLOGY, V46, P727, DOI 10.1212/WNL.46.3.727; HOFMAN A, 1989, NEUROLOGY, V39, P1589, DOI 10.1212/WNL.39.12.1589; Imfeld P, 2013, EPILEPSIA, V54, P700, DOI 10.1111/epi.12045; Jack CR, 2018, ALZHEIMERS DEMENT, V14, P535, DOI 10.1016/j.jalz.2018.02.018; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jette N, 2010, EPILEPSIA, V51, P62, DOI 10.1111/j.1528-1167.2009.02201.x; Kim HT, 2007, CLIN CANCER RES, V13, P559, DOI 10.1158/1078-0432.CCR-06-1210; KOKMEN E, 1991, NEUROLOGY, V41, P1393, DOI 10.1212/WNL.41.9.1393; LOISEAU J, 1990, ANN NEUROL, V27, P232, DOI 10.1002/ana.410270304; MACKENZIE IRA, 1994, ACTA NEUROPATHOL, V87, P504; Mendez M F, 1994, J Geriatr Psychiatry Neurol, V7, P230; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Palop JJ, 2009, ARCH NEUROL-CHICAGO, V66, P435, DOI 10.1001/archneurol.2009.15; Pitkanen A, 2016, LANCET NEUROL, V15, P185, DOI 10.1016/S1474-4422(15)00248-3; Ponomareva NV, 2008, NEUROBIOL AGING, V29, P819, DOI 10.1016/j.neurobiolaging.2006.12.019; Ponomareva NV, 2003, NEUROPSYCHOBIOLOGY, V48, P152, DOI 10.1159/000073633; Ramsay RE, 2004, NEUROLOGY, V62, pS24, DOI 10.1212/WNL.62.5_suppl_2.S24; SANDER JWAS, 1990, LANCET, V336, P1267, DOI 10.1016/0140-6736(90)92959-L; Sarkis RA, 2016, J NEUROPSYCH CLIN N, V28, P56, DOI 10.1176/appi.neuropsych.15060143; Scarmeas N, 2009, ARCH NEUROL-CHICAGO, V66, P992, DOI 10.1001/archneurol.2009.130; SHALAT SL, 1987, NEUROLOGY, V37, P1630, DOI 10.1212/WNL.37.10.1630; Sohn Min-Woong, 2006, Popul Health Metr, V4, P2, DOI 10.1186/1478-7954-4-2; Stefanidou M, 2017, SEIZURE-EUR J EPILEP, V47, P105, DOI 10.1016/j.seizure.2017.03.009; Stephen LJ, 2000, LANCET, V355, P1441, DOI 10.1016/S0140-6736(00)02149-8; Tai XY, 2016, BRAIN, V139, P2441, DOI 10.1093/brain/aww187; Tarlov E, ASCERTAINING VETERAN; Tchalla AE, 2011, EPILEPSIA, V52, P2203, DOI 10.1111/j.1528-1167.2011.03320.x; Thom M, 2011, BRAIN, V134, P2969, DOI 10.1093/brain/awr209; US Department of Veterans Affairs, 2016, VHA DEM STEER COMM R; VOLICER L, 1995, DEMENTIA, V6, P258, DOI 10.1159/000106956; Vossel KA, 2013, JAMA NEUROL, V70, P1158, DOI 10.1001/jamaneurol.2013.136	46	17	17	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6149	2168-6157		JAMA NEUROL	JAMA Neurol.	JUN	2020	77	6					710	715		10.1001/jamaneurol.2020.0187			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MA8CR	WOS:000542138800009	32150220	Green Published			2022-02-06	
J	Wang, JY; Deng, JH; Li, YB; Yuan, H; Xu, M				Wang, Jiayu; Deng, Jiahao; Li, Yunbo; Yuan, Huan; Xu, Ming			ZnO nanocrystal-coated MoS2 nanosheets with enhanced ultraviolet light gas sensitive activity studied by surface photovoltage technique	CERAMICS INTERNATIONAL			English	Article						ZnO; MoS2; Surface photovoltage; Gas sensors	NANOWIRE HETEROJUNCTIONS; NO2; PHOTOLUMINESCENCE; HETEROSTRUCTURES; PERFORMANCE; OXIDE; BULK	In this paper, ZnO nanocrystals and MoS2/ZnO composites were fabricated by a simple sol-gel method and ultrasonic concussion. Several characterization techniques including XRD, TEM, XPS, Raman spectroscopy and surface photovoltage were employed to explore the samples. The doping of MoS2 nanosheet into the ZnO nanocrystal composites was studied for its effect on NO2 gas-sensitivity under UV irradiation at room temperature. Compared to gas sensors developed from pure ZnO, those developed from ZnO/MoS2 exhibited higher sensitivity with a reversible response. Surface photovoltage results suggest that these desirable sensing features can be attributed to MoS2/ZnO heterojunctions and an abundance of diffusion channels which reduce the energy barrier to promote ready transference and target gas adsorption/desorption. These results offer new opportunities to fabricate composite materials for gas sensors.	[Wang, Jiayu; Deng, Jiahao; Li, Yunbo; Yuan, Huan; Xu, Ming] Southwest Minzu Univ, Sch Elect & Informat Engn, Key Lab Informat Mat Sichuan Prov, Chengdu 610041, Peoples R China		Yuan, H; Xu, M (corresponding author), Southwest Minzu Univ, Sch Elect & Informat Engn, Key Lab Informat Mat Sichuan Prov, Chengdu 610041, Peoples R China.	yuanhuanwill@126.com; hsuming_2001@aliyun.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [61901401, 61701050]; Training Program of Innovation and Entrepreneurship for Undergraduates, Southwest Minzu University [S201910656171]	This work is supported by the National Natural Science Foundation of China (Grant No. 61901401, 61701050) and Training Program of Innovation and Entrepreneurship for Undergraduates, Southwest Minzu University (Grant No. S201910656171).	Bae SH, 2019, NAT MATER, V18, P550, DOI 10.1038/s41563-019-0335-2; Cho SY, 2015, ACS NANO, V9, P9314, DOI 10.1021/acsnano.5b04504; Cui SM, 2015, SMALL, V11, P2305, DOI 10.1002/smll.201402923; Donarelli M, 2013, CHEM PHYS LETT, V588, P198, DOI 10.1016/j.cplett.2013.10.034; Gribchenkova NA, 2019, J ALLOY COMPD, V778, P77, DOI 10.1016/j.jallcom.2018.11.136; Kasipandi S, 2019, ADV MATER, V31, DOI 10.1002/adma.201803390; Late DJ, 2012, ADV FUNCT MATER, V22, P1894, DOI 10.1002/adfm.201102913; Li H, 2012, ADV FUNCT MATER, V22, P1385, DOI 10.1002/adfm.201102111; Li X, 2020, MATER LETT, V262, DOI 10.1016/j.matlet.2019.127148; Liu S, 2014, SENSOR ACTUAT B-CHEM, V202, P272, DOI 10.1016/j.snb.2014.05.086; Mak KF, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.136805; Manjon FJ, 2005, J APPL PHYS, V97, DOI 10.1063/1.1856222; Radisavljevic B, 2011, NAT NANOTECHNOL, V6, P147, DOI [10.1038/nnano.2010.279, 10.1038/NNANO.2010.279]; Rudakova AV, 2019, J PHYS CHEM C, V123, P8884, DOI 10.1021/acs.jpcc.8b12125; Saravanan A, 2019, SENSOR ACTUAT B-CHEM, V292, P70, DOI 10.1016/j.snb.2019.04.108; Splendiani A, 2010, NANO LETT, V10, P1271, DOI 10.1021/nl903868w; Tong ZF, 2018, MATER LETT, V217, P296, DOI 10.1016/j.matlet.2018.01.083; Xu M, 2020, J PHYS D APPL PHYS, V53, DOI 10.1088/1361-6463/ab4bfd; Yan HH, 2016, J ALLOY COMPD, V662, P118, DOI 10.1016/j.jallcom.2015.12.066; Yang XL, 2019, SENSOR ACTUAT B-CHEM, V281, P415, DOI 10.1016/j.snb.2018.10.138; Yuan HY, 2019, ADV MATER, V31, DOI 10.1002/adma.201807161; Yuan H, 2019, APPL SURF SCI, V496, DOI 10.1016/j.apsusc.2019.07.253; Yuan H, 2019, CERAM INT, V45, P16694, DOI 10.1016/j.ceramint.2019.05.136; Zhao SF, 2018, APPL SURF SCI, V456, P808, DOI 10.1016/j.apsusc.2018.06.103; Zhao SF, 2018, RSC ADV, V8, P11070, DOI 10.1039/c7ra13484c; Zhou Y, 2018, APPL PHYS LETT, V113, DOI 10.1063/1.5042061; Zhou Y, 2018, J MATER CHEM A, V6, P10286, DOI 10.1039/c8ta02679c	27	17	18	10	58	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0272-8842	1873-3956		CERAM INT	Ceram. Int.	JUN 1	2020	46	8	A				11427	11431		10.1016/j.ceramint.2020.01.157			5	Materials Science, Ceramics	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science	LH0LS	WOS:000528481900177					2022-02-06	
J	Libeson, L; Downing, M; Ross, P; Ponsford, J				Libeson, Lauren; Downing, Marina; Ross, Pamela; Ponsford, Jennie			The experience of return to work in individuals with traumatic brain injury (TBI): A qualitative study	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; vocational rehabilitation; employment; return to work	VOCATIONAL-REHABILITATION; EMPLOYMENT; STABILITY; INTEGRATION; OUTCOMES; PEOPLE; MEMORY; MILD; LIFE	Traumatic Brain Injury (TBI) is a leading cause of disability in young people, with return to work (RTW) a major goal of recovery. This qualitative study aimed to understand the RTW experience of individuals with TBI who received comprehensive vocational rehabilitation, and to identify facilitating and limiting factors in the RTW process. Semi-structured interviews were conducted with 15 individuals (mean age = 47.33 years) approximately 4.5 years post-injury, of whom 14 had moderate to severe TBI. Twelve individuals had successfully returned to work. Thematic analysis of transcribed interviews identified three key factors affecting RTW: client, work and rehabilitation factors. Across these factors, 12 themes reported to be critical to the success or failure of the RTW programme were identified. Client themes included social support, cognitive difficulties and motivation, with RTW too early associated with unfavourable outcomes. Work themes included work modifications, employer support and financial incentives. Rehabilitation themes included the RTW programme, the role of the vocational occupational therapist and work preparation. These key factors were reported to have impacted the RTW outcome, comprising three further themes: work satisfaction, future vocational outlook, and quality of life. Consideration of these factors can inform vocational rehabilitation programmes, potentially improving employment outcomes following TBI.	[Libeson, Lauren; Downing, Marina; Ponsford, Jennie] Monash Univ, Sch Psychol Sci, Melbourne, Vic, Australia; [Downing, Marina; Ponsford, Jennie] Monash Epworth Rehabil Res Ctr, Dept Rehabil Psychol & Psychotherapy, Melbourne, Vic, Australia; [Ross, Pamela] Epworth Healthcare, Richmond, Australia		Ponsford, J (corresponding author), Monash Univ, Sch Psychol Sci, Clayton, Vic 3800, Australia.	jennie.ponsford@monash.edu	Downing, Marina/AAX-2380-2020; Ponsford, Jennie/H-8341-2014	Downing, Marina/0000-0002-3126-6632; Libeson, Lauren/0000-0003-4648-4023; Ponsford, Jennie/0000-0003-0430-125X	Epworth Research Institute by a Feasibility grant	This work was supported by Epworth Research Institute by a Feasibility grant.	Agency for Clinical Innovation, 2016, INV VOC PROGR OUTC P; Almeida OP, 2015, INT J GERIATR PSYCH, V30, P1215, DOI 10.1002/gps.4276; Andelic N, 2012, BRAIN INJURY, V26, P261, DOI 10.3109/02699052.2012.654589; Barbour RS, 2001, BMJ-BRIT MED J, V322, P1115, DOI 10.1136/bmj.322.7294.1115; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Braun V., 2013, SUCCESSFUL QUALITATI; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Bush EJ, 2016, BRAIN INJURY, V30, P422, DOI 10.3109/02699052.2015.1131849; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Colantonio A, 2016, ARCH PHYS MED REHAB, V97, pS1, DOI 10.1016/j.apmr.2015.12.002; Creswell J., 2009, RES DESIGN, V3rd; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; Donker-Cools BHPM, 2018, DISABIL REHABIL, V40, P185, DOI 10.1080/09638288.2016.1250118; Economics A., 2009, EC COST SPINAL CORD, P31; Ellingsen KL., 2009, INT J DISABIL MANAG, V4, P1, DOI DOI 10.1375/JDMR.4.1.1; Fadyl JK, 2009, J HEAD TRAUMA REHAB, V24, P195, DOI 10.1097/HTR.0b013e3181a0d458; Forslund MV, 2013, J REHABIL MED, V45, P801, DOI 10.2340/16501977-1168; Gagnon A, 2016, DISABIL REHABIL, V38, P433, DOI 10.3109/09638288.2015.1044035; Gilworth G, 2008, J REHABIL MED, V40, P334, DOI 10.2340/16501977-0169; Gilworth G, 2006, BRAIN INJURY, V20, P835, DOI 10.1080/02699050600832221; Gollaher K, 1998, BRAIN INJURY, V12, P255, DOI 10.1080/026990598122557; Goverover Y, 2010, AM J OCCUP THER, V64, P540, DOI 10.5014/ajot.2010.09020; Graham CW., 2016, CAMPBELL SYST REV, V12, P6; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hart T, 2006, J HEAD TRAUMA REHAB, V21, P467, DOI 10.1097/00001199-200611000-00002; Hooson JM, 2013, NEUROPSYCHOL REHABIL, V23, P19, DOI 10.1080/09602011.2012.713314; Jourdan C, 2013, BRAIN INJURY, V27, P1000, DOI 10.3109/02699052.2013.794971; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Levack W, 2004, DISABIL REHABIL, V26, P290, DOI 10.1080/09638280310001647615; Liaset IF, 2016, SCAND J OCCUP THER, V23, P446, DOI 10.3109/11038128.2016.1152294; Little Deborah M, 2015, Handb Clin Neurol, V131, P465, DOI 10.1016/B978-0-444-62627-1.00027-5; Machamer J, 2005, J INT NEUROPSYCH SOC, V11, P807, DOI 10.1017/S135561770505099X; Malec JF, 2000, ARCH PHYS MED REHAB, V81, P1007, DOI 10.1053/apmr.2000.6980; Materne M, 2017, WORK, V56, P125, DOI 10.3233/WOR-162468; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; Mcrae P, 2016, AUST J REHABIL COUNS, V22, P76, DOI 10.1017/jrc.2016.14; Mitrushina M, 2019, NEUROPSYCHOL REHABIL, V29, P1313, DOI 10.1080/09602011.2017.1395746; Moller Claire-Lynn, 2017, S. Afr. j. occup. ther., V47, P17, DOI 10.17159/2310-3833/2017/v47n3a4; Murphy L, 2006, BRAIN INJURY, V20, P1119, DOI 10.1080/02699050600664335; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Phillips J., 2014, ADV CLIN NEUROSCIENC, V14, P1473; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P321, DOI 10.1097/HTR.0000000000000072; Ponsford JL, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000033; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Rassovsky Y, 2015, J CLIN EXP NEUROPSYC, V37, P354, DOI 10.1080/13803395.2015.1015498; Ruddle Jean Jean, 2011, SOCIAL CARE NEURODIS, V2, P200, DOI [10.1108/20420911111188452, DOI 10.1108/20420911111188452]; Ryan G. W., 2003, FIELD METHOD, V15, P85, DOI [10.1177/1525-822X02239569, DOI 10.1177/1525822X02239569, 10.1177/1525822X02239569]; SANDELOWSKI M, 1995, RES NURS HEALTH, V18, P371, DOI 10.1002/nur.4770180411; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Soo CA, 2007, BRAIN IMPAIR, V8, P101, DOI DOI 10.1375/BRIM.8.2.101; Stergiou-Kita M, 2012, DISABIL REHABIL, V34, P179, DOI 10.3109/09638288.2011.591881; Stergiou-Kita M, 2011, J OCCUP REHABIL, V21, P374, DOI 10.1007/s10926-010-9282-0; Tam S, 2015, BRAIN INJURY, V29, P813, DOI 10.3109/02699052.2015.1005134; van Velzen JM, 2011, DISABIL REHABIL, V33, P2237, DOI 10.3109/09638288.2011.563821; Viera AJ, 2005, FAM MED, V37, P360; Williams MW, 2014, REHABIL PSYCHOL, V59, P298, DOI 10.1037/a0037164	56	17	17	0	12	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	MAR 15	2020	30	3					412	429		10.1080/09602011.2018.1470987			18	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	MB2FW	WOS:000542421300003	29745289				2022-02-06	
J	Lindblad, C; Nelson, DW; Zeiler, FA; Ercole, A; Ghatan, PH; von Horn, H; Risling, M; Svensson, M; Agoston, DV; Bellander, BM; Thelin, EP				Lindblad, Caroline; Nelson, David W.; Zeiler, Frederick A.; Ercole, Ari; Ghatan, Per Hamid; von Horn, Henrik; Risling, Marten; Svensson, Mikael; Agoston, Denes, V; Bellander, Bo-Michael; Thelin, Eric Peter			Influence of Blood-Brain Barrier Integrity on Brain Protein Biomarker Clearance in Severe Traumatic Brain Injury: A Longitudinal Prospective Study	JOURNAL OF NEUROTRAUMA			English	Article						albumin quotient; BBB; NSE; S100B; TBI	NEURON-SPECIFIC ENOLASE; CEREBROSPINAL-FLUID; SERUM S100B; SECONDARY INSULTS; POSSIBLE MARKER; HEAD-INJURY; CSF; PREDICTION; CLASSIFICATION; CONSCIOUSNESS	Brain protein biomarker clearance to blood in traumatic brain injury (TBI) is not fully understood. The aim of this study was to analyze the effect that a disrupted blood-brain barrier (BBB) had on biomarker clearance. Seventeen severe TBI patients admitted to Karolinska University Hospital were prospectively included. Cerebrospinal fluid (CSF) and blood concentrations of S100 calcium binding protein B (S100B) and neuron-specific enolase (NSE) were analyzed every 6-12 h for similar to 1 week. Blood and CSF albumin were analyzed every 12-24 h, and BBB integrity was assessed using the CSF:blood albumin quotient (Q(A)). We found that time-dependent changes in the CSF and blood levels of the two biomarkers were similar, but that the correlation between the biomarkers and Q(A) was lower for NSE (rho = 0.444) than for S100B (rho = 0.668). Because data were longitudinal, we also conducted cross correlation analyses, which indicated a directional flow and lag-time of biomarkers from CSF to blood. For S100B, this lag-time could be ascribed to BBB integrity, whereas for NSE it could not. Upon inferential modelling, using generalized least square estimation (S100B) or linear mixed models (NSE), Q(A) (p = 0.045), time from trauma (p < 0.001), time from trauma(2) (p = 0.023), and CSF biomarker levels (p = 0.008) were independent predictors of S100B in blood. In contrast, for NSE, only time from trauma was significant (p < 0.001). These findings are novel and important, but must be carefully interpreted because of different characteristics between the two proteins. Nonetheless, we present the first data that indicate that S100B and NSE are cleared differently from the central nervous system, and that both the disrupted BBB and additional alternative pathways, such as the recently described glymphatic system, may play a role. This is of importance both for clinicians aiming to utilize these biomarkers and for the pathophysiological understanding of brain protein clearance, but warrants further examination.	[Lindblad, Caroline; Ghatan, Per Hamid; Svensson, Mikael; Bellander, Bo-Michael; Thelin, Eric Peter] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [von Horn, Henrik] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Risling, Marten; Agoston, Denes, V] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Svensson, Mikael; Bellander, Bo-Michael] Karolinska Inst, Dept Neurosurg, Stockholm, Sweden; [Nelson, David W.] Karolinska Inst, Dept Physiol & Pharmacol, Sect Perioperat Med & Intens Care, Stockholm, Sweden; [von Horn, Henrik] Karolinska Inst, Div Clin Chem, Stockholm, Sweden; [Thelin, Eric Peter] Karolinska Inst, Theme Neuro, Stockholm, Sweden; [Zeiler, Frederick A.] Univ Manitoba, Dept Surg, Sect Neurosurg, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Dept Human Anat & Cell Sci, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Fac Engn, Biomed Engn, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Ctr Aging, Winnipeg, MB, Canada; [Zeiler, Frederick A.; Ercole, Ari] Univ Cambridge, Dept Med, Div Anaesthesia, Cambridge, England; [Thelin, Eric Peter] Univ Cambridge, Div Neurosurg, Dept Clin Neurosci, Cambridge, England; [Agoston, Denes, V] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD USA		Lindblad, C (corresponding author), Karolinska Univ Sjukhuset Solna, Tema Neuro, Forskargrp Svensson, J5 20, SE-17176 Stockholm, Sweden.	caroline.lindblad@ki.se	Ercole, Ari/B-6288-2009; Lindblad, Caroline/AAJ-7911-2021; Thelin, Eric Peter/K-2144-2012	Ercole, Ari/0000-0001-8350-8093; Lindblad, Caroline/0000-0003-4952-8597; Thelin, Eric Peter/0000-0002-2338-4364; Zeiler, Frederick/0000-0003-1737-0510; Nelson, David/0000-0003-2530-8207	Karolinska Institute Funds Clinical Scientist Training Programme, Research Internship, Karolinska Institutet Resebidrag [K825715022, K825715052, K825715703]; Swedish Society for Medical Research [SLS-816961]; Swedish Armed Forces Research and Development Fund [AT.9221010]; Stockholm County ALF [20180572]; University of Manitoba VicePresident Research and International (VPRI) Research Investment Fund (RIF); University of Manitoba Rudy Falk ClinicianScientist Professorship; Health Sciences Centre Foundation in Winnipeg; University of Manitoba Centre on Aging Fellowship; Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [432061]; National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [RO3NS114335]	This work was supported by several funding sources. C.L. received salary funding and travel grants from the Karolinska Institute Funds Clinical Scientist Training Programme, Research Internship, Karolinska Institutet Resebidrag (grant numbers K825715022, K825715052, and K825715703). C.L. and E.P.T. received travel grants and salary from the Swedish Society for Medical Research Travel Grant and Post-Doctoral Scholarship (grant numbers SLS-816961, N/A). Equipment was purchased using the Swedish Armed Forces Research and Development Fund (grant number AT.9221010) obtained by M.R.; and Stockholm County ALF (grant number 20180572), obtained by B.M.B. F.A.Z. receives research support from the University of Manitoba VicePresident Research and International (VPRI) Research Investment Fund (RIF), the University of Manitoba Rudy Falk ClinicianScientist Professorship, the Health Sciences Centre Foundation in Winnipeg, the University of Manitoba Centre on Aging Fellowship, the Canadian Institutes of Health Research (CIHR) (432061), and the National Institute of Neurological Disorders and Stroke (NINDS) (RO3NS114335). None of the other authors received funding. The funders did not participate in study design, data acquisition, data analysis/interpretation, manuscript compilation, or submission decision.	Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; [Anonymous], KLIN SEM KUL 24SJU A; [Anonymous], KLIN KEM KUL 24SJU S; [Anonymous], 2008, BMJ-BRIT MED J, V336, P425, DOI DOI 10.1136/bmj.39461.643438.25; [Anonymous], KLIN KEM KUL 24SJU A; Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290; Bakdash JZ, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00456; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bellander BM, 2011, ACTA NEUROCHIR, V153, P90, DOI 10.1007/s00701-010-0737-z; Blyth BJ, 2011, J NEUROTRAUM, V28, P2453, DOI 10.1089/neu.2010.1653; Blyth BJ, 2009, J NEUROTRAUM, V26, P1497, DOI 10.1089/neu.2008-0738; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Correale J, 1998, NEUROLOGY, V50, P1388, DOI 10.1212/WNL.50.5.1388; Dadas A, 2016, FLUIDS BARRIERS CNS, V13, DOI 10.1186/s12987-016-0045-y; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Eide PK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25666-4; Field A., 2012, DISCOVERING STAT USI; Goyal A, 2013, J NEUROTRAUM, V30, P946, DOI 10.1089/neu.2012.2579; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Hyndman RJ, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i03; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Isgro MA, 2015, ADV EXP MED BIOL, V867, P125, DOI 10.1007/978-94-017-7215-0_9; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; JENNETT B, 1975, LANCET, V1, P480; Johanson CE, 2011, METHODS MOL BIOL, V686, P101, DOI 10.1007/978-1-60761-938-3_4; Johnsson P, 2000, ANN THORAC SURG, V69, P750, DOI 10.1016/S0003-4975(99)01393-4; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; KAISER E, 1989, CLIN CHIM ACTA, V183, P13, DOI 10.1016/0009-8981(89)90268-4; Kanner AA, 2003, CANCER, V97, P2806, DOI 10.1002/cncr.11409; Kapural M, 2002, BRAIN RES, V940, P102, DOI 10.1016/S0006-8993(02)02586-6; Kawata K, 2016, NEUROSCI BIOBEHAV R, V68, P460, DOI 10.1016/j.neubiorev.2016.05.009; Kleindienst Andrea, 2010, Cardiovasc Psychiatry Neurol, V2010, P801295, DOI 10.1155/2010/801295; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Liddelow SA, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-2; Lindblad C, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00015; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Marchi N, 2003, RESTOR NEUROL NEUROS, V21, P109; Marchi N, 2003, J NEUROSCI, V23, P1949; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Martens P, 1998, STROKE, V29, P2363, DOI 10.1161/01.STR.29.11.2363; Muller K, 2006, CLIN CHEM LAB MED, V44, P1111, DOI 10.1515/CCLM.2006.211; Nag S, 2011, METHODS MOL BIOL, V686, P1, DOI 10.1007/978-1-60761-938-3; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Petzold A, 2003, BRAIN RES BULL, V61, P281, DOI 10.1016/S0361-9230(03)00091-1; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; R Core Team, 2018, STATS PACK LANG ENV; Reiber H, 2003, RESTOR NEUROL NEUROS, V21, P79; Ringstad G, 2017, BRAIN, V140, P2691, DOI 10.1093/brain/awx191; Sarrafzadeh AS, 2001, CRIT CARE MED, V29, P1116, DOI 10.1097/00003246-200106000-00004; Saw MM, 2014, NEUROCRIT CARE, V20, P209, DOI 10.1007/s12028-013-9933-z; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Smit LHM, 2005, INT J BIOL MARKER, V20, P34, DOI 10.1177/172460080502000106; Steiner J, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-2; TEASDALE G, 1974, LANCET, V2, P81; Thelin E, 2019, J NEUROTRAUM, V36, P2850, DOI 10.1089/neu.2019.6375; Thelin EP, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00159; Thelin EP, 2014, NEUROCRIT CARE, V20, P217, DOI 10.1007/s12028-013-9916-0; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00300; Thelin EP, 2017, ACTA NEUROCHIR, V159, P209, DOI 10.1007/s00701-016-3046-3; Thelin EP, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1450-y; Thelin EP, 2013, J NEUROTRAUM, V30, P519, DOI 10.1089/neu.2012.2553; TIBBLING G, 1977, SCAND J CLIN LAB INV, V37, P385, DOI 10.3109/00365517709091496; Tierney Nicholas, 2015, GGPLOT YOUR MISSING; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; West B., 2015, LINEAR MIXED MODELS; Wickham H., 2019, J OPEN SOURCE SOFTW, V4, P1686, DOI [10.21105/joss.01686, DOI 10.21105/JOSS.01686]; Winter C, 2015, NEUROL RES, V37, P599, DOI 10.1179/1743132815Y.0000000018	72	17	19	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 15	2020	37	12					1381	1391		10.1089/neu.2019.6741		MAR 2020	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	LT4XN	WOS:000524988900001	32013731	hybrid, Green Published, Green Submitted			2022-02-06	
J	Sigurdardottir, S; Andelic, N; Wehling, E; Anke, A; Skandsen, T; Holthe, OO; Manskow, US; Roe, C				Sigurdardottir, Solrun; Andelic, Nada; Wehling, Eike; Anke, Audny; Skandsen, Toril; Holthe, Oyvor Oistensen; Manskow, Unn Sollid; Roe, Cecilie			Return to work after severe traumatic brain injury: a national study with a one-year follow-up of neurocognitive and behavioural outcomes	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						TBI; Employment; Outcome assessment; Behaviour; Neuropsychological; Executive functions	QUALITY-OF-LIFE; EXECUTIVE FUNCTION; POSTTRAUMATIC AMNESIA; DEPRESSION SCALE; RATING INVENTORY; HOSPITAL ANXIETY; SELF-AWARENESS; HEAD-INJURY; EMPLOYMENT; REHABILITATION	The objectives were to investigate the frequency of return-to-work (RTW) one year after severe traumatic brain injury (sTBI: Glasgow Coma Scale, GCS 3-8) and to identify which demographic and injury-related characteristics and neurocognitive factors are associated with RTW. This study is part of a prospective national study on sTBI conducted in all four Norwegian Trauma Referral Centres, including patients aged >15 years over a period of three years (n = 378). For the purpose of this study, only pre-employed individuals of working age (16 to 67 years) were investigated for RTW (n = 143), and of these, 104 participants underwent neuropsychological testing. Measures of acute injury severity, neuropsychological composite scores (Memory, Processing Speed, Executive Functions) at the one-year follow-up, and the Behaviour Rating Inventory of Executive Functions (patient- and relative reports) were explored as predictors of RTW. The frequency of RTW was 54.5%. Multivariate logistic regression analyses identified younger age, shorter length of stay in intensive care, better Processing Speed scores, and lower levels of metacognitive difficulties as rated by relatives as significant predictors of RTW. Findings support the importance of neuropsychological measures in predicting long-term RTW and highlight the need to address neurocognitive and behavioural difficulties to improve RTW after sTBI.	[Sigurdardottir, Solrun] Sunnaas Rehabil Hosp, Dept Res, Bjornemyrveien 11, N-1450 Nesoddtangen, Norway; [Sigurdardottir, Solrun; Andelic, Nada; Roe, Cecilie] Univ Oslo, Fac Med, Inst Hlth & Soc, Res Ctr Habilitat & Rehabil Models & Serv CHARM, POB 1130 Blindern, N-0318 Oslo, Norway; [Andelic, Nada; Holthe, Oyvor Oistensen; Roe, Cecilie] Oslo Univ Hosp, Div Clin Neurosci, Dept Phys Med & Rehabil, Oslo, Norway; [Wehling, Eike] Haukeland Hosp, Dept Phys Med & Rehabil, Bergen, Norway; [Anke, Audny; Manskow, Unn Sollid] Univ Hosp North Norway, Dept Rehabil, Tromso, Norway; [Anke, Audny] Univ Tromso, Arctic Univ Norway, Dept Clin Med, Tromso, Norway; [Skandsen, Toril] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Phys Med & Rehabil, Trondheim, Norway; [Skandsen, Toril] Norwegian Univ Sci & Technol NTNU, Dept Neuromed & Movement Sci, Fac Med & Heath Sci, Trondheim, Norway; [Manskow, Unn Sollid] Univ Tromso, Fac Hlth Sci, Dept Hlth & Care Sci, Tromso, Norway		Sigurdardottir, S (corresponding author), Sunnaas Rehabil Hosp, Dept Res, Bjornemyrveien 11, N-1450 Nesoddtangen, Norway.; Sigurdardottir, S (corresponding author), Univ Oslo, Fac Med, Inst Hlth & Soc, Res Ctr Habilitat & Rehabil Models & Serv CHARM, POB 1130 Blindern, N-0318 Oslo, Norway.	solrun.sigurdardottir@sunnaas.no		Anke, Audny/0000-0002-2491-2560; Andelic, Nada/0000-0002-3719-4406	Research Council of NorwayResearch Council of Norway [209748]	This study was supported by The Research Council of Norway, Grant number 185267, and The Research Council of Norway, Project number 209748.	Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Andelic N, 2012, BRAIN INJURY, V26, P261, DOI 10.3109/02699052.2012.654589; Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Anke A, 2015, J HEAD TRAUMA REHAB, V30, pE38, DOI 10.1097/HTR.0000000000000080; Arango-Lasprilla JC, 2009, PM&R, V1, P41, DOI 10.1016/j.pmrj.2008.07.001; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL REV 19; Atchison TB, 2004, CLIN NEUROPSYCHOL, V18, P249, DOI 10.1080/13854040490501475; Avesani R, 2005, BRAIN INJURY, V19, P933, DOI 10.1080/02699050400002371; Azouvi P, 2016, J HEAD TRAUMA REHAB, V31, pE10, DOI 10.1097/HTR.0000000000000169; Azouvi P, 2015, NEUROPSYCHOL REHABIL, V25, P864, DOI 10.1080/09602011.2014.990907; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Boake C, 2001, ARCH PHYS MED REHAB, V82, P761, DOI 10.1053/apmr.2001.23753; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Cattelani R, 2002, BRAIN INJURY, V16, P51, DOI 10.1080/02699050110088821; Cattran CJ, 2011, BRAIN INJURY, V25, P1035, DOI 10.3109/02699052.2011.607787; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cuthbert JP, 2015, ARCH PHYS MED REHAB, V96, P2128, DOI 10.1016/j.apmr.2015.07.020; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Doctor JN, 2005, J INT NEUROPSYCH SOC, V11, P747, DOI 10.1017/S1355617705050836; Donders J, 2015, J HEAD TRAUMA REHAB, V30, pE30, DOI 10.1097/HTR.0000000000000120; Duggan MC, 2017, J CRIT CARE, V37, P72, DOI 10.1016/j.jcrc.2016.08.023; Finnanger TG, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/329241; Finnanger TG, 2013, BRAIN INJURY, V27, P1606, DOI 10.3109/02699052.2013.831127; Flashman LA, 2002, NEUROREHABILITATION, V17, P285; Forslund MV, 2014, BRAIN INJURY, V28, P980, DOI 10.3109/02699052.2014.888770; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Gioia GA, 2005, PSYCHOL ASSESS RESOU; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS51, DOI 10.1016/j.apmr.2008.09.552; Hanks RA, 2016, CLIN NEUROPSYCHOL, V30, P1074, DOI 10.1080/13854046.2016.1194479; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P333, DOI 10.1097/00001199-200507000-00005; Jourdan C, 2013, BRAIN INJURY, V27, P1000, DOI 10.3109/02699052.2013.794971; Kalechstein AD, 2003, J CLIN EXP NEUROPSYC, V25, P1186, DOI 10.1076/jcen.25.8.1186.16723; Kelley E, 2014, J HEAD TRAUMA REHAB, V29, P147, DOI 10.1097/HTR.0b013e31826db6b9; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Kompier MAJ, 2006, SCAND J WORK ENV HEA, V32, P421, DOI 10.5271/sjweh.1048; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lovstad M, 2016, J INT NEUROPSYCH SOC, V22, P682, DOI 10.1017/S135561771600031X; Lovstad M, 2012, BRAIN INJURY, V26, P1586, DOI 10.3109/02699052.2012.698787; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Machamer J, 2005, J INT NEUROPSYCH SOC, V11, P807, DOI 10.1017/S135561770505099X; Matheson L, 2010, WORK, V36, P413, DOI 10.3233/WOR-2010-1043; Meyers JE., 1995, REY COMPLEX FIGURE T; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; Odgaard L, 2017, J HEAD TRAUMA REHAB, V32, pE57, DOI 10.1097/HTR.0000000000000239; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Pallant JF, 2007, BRIT J CLIN PSYCHOL, V46, P1, DOI 10.1348/014466506X96931; Ponsford JL, 2016, J NEUROTRAUM, V33, P997, DOI 10.1089/neu.2015.4025; Ponsford JL, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000033; Rao V, 2008, J NEUROPSYCH CLIN N, V20, P118, DOI 10.1176/jnp.2008.20.1.118; Roe C, 2013, J REHABIL MED, V45, P734, DOI 10.2340/16501977-1198; Ruet A, 2018, DISABIL REHABIL, V40, P2200, DOI 10.1080/09638288.2017.1327992; Sabaz M, 2014, J HEAD TRAUMA REHAB, V29, pE19, DOI 10.1097/HTR.0b013e31828dc590; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Schonberger M, 2011, J NEUROL NEUROSUR PS, V82, P936, DOI 10.1136/jnnp.2010.210021; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Sherer M, 2002, CLIN NEUROPSYCHOL, V16, P157, DOI 10.1076/clin.16.2.157.13238; Sigurdardottir S, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000039; Sigurdardottir S, 2013, J REHABIL MED, V45, P808, DOI 10.2340/16501977-1156; Skandsen T, 2008, CLIN REHABIL, V22, P653, DOI 10.1177/0269215508089067; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Sveen U, 2016, EUR J PHYS REHAB MED, V52, P650; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; van Velzen JM, 2009, BRAIN INJURY, V23, P385, DOI 10.1080/02699050902838165; Waid-Ebbs JK, 2012, BRAIN INJURY, V26, P1646, DOI 10.3109/02699052.2012.700087; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Whelan-Goodinson R, 2010, J HEAD TRAUMA REHAB, V25, P320, DOI 10.1097/HTR.0b013e3181c8f8e7; Whelan-Goodinson R, 2008, J REHABIL MED, V40, P850, DOI 10.2340/16501977-0271; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Williams MW, 2013, CLIN NEUROPSYCHOL, V27, P356, DOI 10.1080/13854046.2013.765507	77	17	17	0	11	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	FEB 7	2020	30	2					281	297		10.1080/09602011.2018.1462719			17	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	KQ4EM	WOS:000516877900008	29667477				2022-02-06	
J	Mangat, HS; Wu, X; Gerber, LM; Schwarz, JT; Fakhar, M; Murthy, SB; Stieg, PE; Ghajar, J; Hartl, R				Mangat, Halinder S.; Wu, Xian; Gerber, Linda M.; Schwarz, Justin T.; Fakhar, Malik; Murthy, Santosh B.; Stieg, Philip E.; Ghajar, Jamshid; Hartl, Roger			Hypertonic Saline is Superior to Mannitol for the Combined Effect on Intracranial Pressure and Cerebral Perfusion Pressure Burdens in Patients With Severe Traumatic Brain Injury	NEUROSURGERY			English	Article						Cerebral perfusion pressure; Hypertonic saline; Intracranial pressure; Mannitol; Traumatic brain injury	HEAD-INJURY; SODIUM-CHLORIDE; BLOOD-FLOW; HYPERTENSION; ICP; RESUSCITATION; GUIDELINES; MANAGEMENT	BACKGROUND Hypertonic saline (HTS) and mannitol are effective in reducing intracranial pressure (ICP) after severe traumatic brain injury (TBI). However, their simultaneous effect on the cerebral perfusion pressure (CPP) and ICP has not been studied rigorously. OBJECTIVE To determine the difference in effects of HTS and mannitol on the combined burden of high ICP and low CPP in patients with severe TBI. METHODS We performed a case-control study using prospectively collected data from the New York State TBI-trac (R) database (Brain Trauma Foundation, New York, New York). Patients who received only 1 hyperosmotic agent, either mannitol or HTS for raised ICP, were included. Patients in the 2 groups were matched (1:1 and 1:2) for factors associated with 2-wk mortality: age, Glasgow Coma Scale score, pupillary reactivity, hypotension, abnormal computed tomography scans, and craniotomy. Primary endpoint was the combined burden of ICPhigh (> 25 mm Hg) and CPPlow (< 60 mm Hg). RESULTS There were 25 matched pairs for 1:1 comparison and 24 HTS patients matched to 48 mannitol patients in 1:2 comparisons. Cumulative median osmolar doses in the 2 groups were similar. In patients treated with HTS compared to mannitol, total number of days (0.6 0.8 vs 2.4 +/- 2.3 d, P < .01), percentage of days with (8.8 +/- 10.6 vs 28.1 +/- 26.9%, P < .01), and the total duration of ICPhigh + CPPlow (11.12 +/- 14.11 vs 30.56 +/- 31.89 h, P = .01) were significantly lower. These results were replicated in the 1:2 match comparisons. CONCLUSION HTS bolus therapy appears to be superior to mannitol in reduction of the combined burden of intracranial hypertension and associated hypoperfusion in severe TBI patients.	[Mangat, Halinder S.; Fakhar, Malik; Murthy, Santosh B.] Weill Cornell Med, Dept Neurol, New York, NY 10065 USA; [Mangat, Halinder S.; Schwarz, Justin T.; Stieg, Philip E.; Hartl, Roger] Weill Cornell Med, Dept Neurol Surg, Weill Cornell Brain & Spine Inst, New York, NY 10065 USA; [Wu, Xian; Gerber, Linda M.] Weill Cornell Med, Dept Healthcare Policy & Res, New York, NY 10065 USA; [Schwarz, Justin T.] NewYork Presbyterian Hosp, New York, NY USA; [Ghajar, Jamshid] Stanford Univ, Dept Neurol Surg, Palo Alto, CA 94304 USA; [Ghajar, Jamshid] Brain Trauma Fdn, New York, NY USA		Mangat, HS (corresponding author), Weill Cornell Med, Dept Neurol, Div Stroke & Crit Care, 525 East 68 St,F-610, New York, NY 10065 USA.	hsm9001@med.cornell.edu	Mangat, HALINDER/AAN-9153-2020; Murthy, Santosh/ABA-2883-2020	Mangat, HALINDER/0000-0003-3426-2001; Murthy, Santosh/0000-0002-4950-0992	New York State Department of Health; Brain Trauma Foundation; New York-Presbyterian Hospital TBI fund	The authors thank the New York State Department of Health, the Brain Trauma Foundation and the New York-Presbyterian Hospital TBI fund for their financial support.	Asehnoune K, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1918-4; Bentsen G, 2006, CRIT CARE MED, V34, P2912, DOI 10.1097/01.CCM.0000245665.46789.7C; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock M Ross, 2006, Neurosurgery, V58, pS7; BURKE AM, 1981, J NEUROSURG, V55, P550, DOI 10.3171/jns.1981.55.4.0550; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cohen J., 2013, STAT POWER ANAL BEHA; Cottenceau V, 2011, J NEUROTRAUM, V28, P2003, DOI 10.1089/neu.2011.1929; DEFELIPPE J, 1980, LANCET, V2, P1002; Eskandari R, 2013, J NEUROSURG, V119, P338, DOI 10.3171/2013.4.JNS121541; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Francony G, 2008, CRIT CARE MED, V36, P795, DOI 10.1097/CCM.0B013E3181643B41; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Hartl R, 1997, ACT NEUR S, V70, P126; Hartl R, 1997, ACT NEUR S, V70, P40; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; JAMES HE, 1980, ACTA NEUROCHIR, V51, P161, DOI 10.1007/BF01406742; Kahraman S, 2010, J TRAUMA, V69, P110, DOI 10.1097/TA.0b013e3181c99853; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Koenig MA, 2008, NEUROLOGY, V70, P1023, DOI 10.1212/01.wnl.0000304042.05557.60; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Mangat HS, 2015, J NEUROSURG, V122, P202, DOI 10.3171/2014.10.JNS132545; Marion DW, 2006, NEUROSURGERY, V58, P655; Mortazavi MM, 2012, J NEUROSURG, V116, P210, DOI 10.3171/2011.7.JNS102142; MUIZELAAR JP, 1984, J NEUROSURG, V61, P700, DOI 10.3171/jns.1984.61.4.0700; MUIZELAAR JP, 1983, J NEUROSURG, V59, P822, DOI 10.3171/jns.1983.59.5.0822; NATH F, 1986, J NEUROSURG, V65, P41, DOI 10.3171/jns.1986.65.1.0041; Oddo M, 2009, J NEUROL NEUROSUR PS, V80, P916, DOI 10.1136/jnnp.2008.156596; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Rockswold GL, 2009, NEUROSURGERY, V65, P1035, DOI 10.1227/01.NEU.0000359533.16214.04; Roquilly A, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-018035; ROSENBAUM PR, 1989, J AM STAT ASSOC, V84, P1024, DOI 10.2307/2290079; Schatzmann C, 1998, ACT NEUR S, V71, P31; Shackford SR, 1998, J TRAUMA, V44, P50, DOI 10.1097/00005373-199801000-00004; Sheth KN, 2013, NEUROCRIT CARE, V18, P26, DOI 10.1007/s12028-012-9780-3; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; Wakai A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001049.pub5; Ware ML, 2005, NEUROSURGERY, V57, P727, DOI 10.1227/01.NEU.0000175726.08903.OA; WILLERSON JT, 1975, CIRCULATION, V51, P1095, DOI 10.1161/01.CIR.51.6.1095; WISNER DH, 1990, J TRAUMA, V30, P75, DOI 10.1097/00005373-199001000-00011; WORTHLEY LIG, 1988, J NEUROSURG, V68, P478, DOI 10.3171/jns.1988.68.3.0478	42	17	17	1	6	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	FEB	2020	86	2					221	229		10.1093/neuros/nyz046			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	KN8UY	WOS:000515122000058	30877299	Green Published			2022-02-06	
J	Wu, JC; He, JC; Tian, XC; Zhong, JJ; Li, H; Sun, XC				Wu, Jingchuan; He, Junchi; Tian, Xiaocui; Zhong, Jianjun; Li, Hui; Sun, Xiaochuan			Activation of the Hedgehog Pathway Promotes Recovery of Neurological Function After Traumatic Brain Injury by Protecting the Neurovascular Unit	TRANSLATIONAL STROKE RESEARCH			English	Article						Hedgehog pathway; Traumatic brain injury; Neurovascular unit; Blood-brain barrier; Oxygen-glucose deprivation; Inflammation	SONIC-HEDGEHOG; RESVERATROL; STROKE; PROLIFERATION; ANGIOGENESIS; IMPROVES; EDEMA; CELLS; MODEL	The homeostasis of the neurovascular unit (NVU) is disrupted after traumatic brain injury (TBI), and therapeutic strategies targeting the NVU would likely improve neurological outcomes after TBI. Sonic Hedgehog (Shh), which is an endogenous activator of the Hedgehog pathway, promotes brain repair in various injuries. In this study, the controlled cortical impact (CCI) was used to establish a moderate TBI model in adult male Sprague-Dawley rats (250-300 g), and the NVU was reconstructed in vitro from the blood-brain barrier (BBB) and neurons to investigate the effects of exogenous Shh protein on TBI. The modified neurological severity scores (mNSS) and Morris water maze tests were used to evaluate the effect of Shh on neurological function after TBI. The effect of Shh on the NVU in vivo was evaluated by detecting the degrees of cerebral edema and neuronal apoptosis. The integrity and permeability of the BBB, the level of inflammatory factors, and the expression of apoptotic proteins were detected to explore the effect of exogenous Shh on the NVU in vitro. The results showed that exogenous Shh reduced cerebral edema and neuronal apoptosis and promoted neurological recovery after TBI in rats. In vitro experiments showed that Shh-induced activation of the Hedgehog pathway promoted stability of the NVU by reducing damage to the tight junction structure and inhibiting the release of inflammatory factors and neuron apoptosis. Based on these results, the Shh-induced activation of the Hedgehog pathway might be a new promising treatment for TBI.	[Wu, Jingchuan] Wuhan Brain Hosp, Dept Neurosurg, Gen Hosp YangTze River Shipping, Wuhan 430014, Hubei, Peoples R China; [Wu, Jingchuan; He, Junchi; Zhong, Jianjun; Li, Hui; Sun, Xiaochuan] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Chongqing 400016, Peoples R China; [Tian, Xiaocui] Chongqing Med Univ, Coll Pharm, Chongqing Key Lab Biochem & Mol Pharmacol, Chongqing 400016, Peoples R China		Sun, XC (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Chongqing 400016, Peoples R China.	sunxch1445@qq.com	Wu, Jingchuan/AAV-7799-2020; 风, 张/AAR-1410-2020	Wu, Jingchuan/0000-0002-1213-4888; 	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571159]; National Natural Science Foundation for Youth of ChinaNational Natural Science Foundation of China (NSFC) [81801230]; Health Commission of Wuhan Municipality scientific research Funding [WX19Q17]; Health Commission of Hubei Province scientific research project [WJ2019H364]	This work was supported by grants from the National Natural Science Foundation of China (No. 81571159), and National Natural Science Foundation for Youth of China (No. 81801230), and Health Commission of Wuhan Municipality scientific research Funding (No. WX19Q17), and Health Commission of Hubei Province scientific research project (No. WJ2019H364).	Anthonymuthu TS, 2018, FREE RADICAL BIO MED, V124, P493, DOI 10.1016/j.freeradbiomed.2018.06.031; Badaut J, 2014, TRANSL STROKE RES, V5, P394, DOI 10.1007/s12975-013-0304-z; Brilha S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16250-3; Cao F, 2016, J NEUROTRAUM, V33, P175, DOI 10.1089/neu.2015.3887; Chai C, 2018, CNS NEUROSCI THER, V24, P369, DOI 10.1111/cns.12785; Chen J, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.490; Cheng W, 2015, CELL PHYSIOL BIOCHEM, V35, P2019, DOI 10.1159/000374009; Darwazeh R, 2018, WORLD NEUROSURG, V116, pE329, DOI 10.1016/j.wneu.2018.04.202; Ferent J, 2015, NEUROSCIENTIST, V21, P356, DOI 10.1177/1073858414531457; Ge XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06718; He QW, 2013, MOL NEUROBIOL, V47, P976, DOI 10.1007/s12035-013-8396-8; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Huang ZJ, 2016, J NEUROCHEM, V136, P1017, DOI 10.1111/jnc.13491; Hui Z, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1579-5; Hung YH, 2016, MOL NEUROBIOL, V53, P793, DOI 10.1007/s12035-014-9046-5; Jin YM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124657; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; Liang M, 2018, EUR REV MED PHARMACO, V22, P6809, DOI 10.26355/eurrev_201810_16148; Liu S, 2019, BASIC CLIN PHARMACOL, V124, P660, DOI 10.1111/bcpt.13186; Liu Z, 2012, CELL MOL NEUROBIOL, V32, P191, DOI 10.1007/s10571-011-9746-6; Ma XX, 2017, NEUROREPORT, V28, P141, DOI 10.1097/WNR.0000000000000725; Mierzwa AJ, 2014, ASN NEURO, V6, DOI 10.1177/1759091414551782; Papatriantafyllou M, 2012, NAT REV IMMUNOL, V12, DOI 10.1038/nri3143; Placzek M, 2018, INT J DEV BIOL, V62, P225, DOI 10.1387/ijdb.170293jb; Pop V, 2011, TRANSL STROKE RES, V2, P533, DOI 10.1007/s12975-011-0126-9; Powers SA, 2019, J SEX MED, V16, P27, DOI 10.1016/j.jsxm.2018.11.010; Rong HT, 2018, BRAIN RES, V1694, P104, DOI 10.1016/j.brainres.2018.05.015; Salvador E, 2018, METHODS MOL BIOL, V1717, P219, DOI 10.1007/978-1-4939-7526-6_17; Schwedt TJ, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00615; Shao S, 2017, MOL MED REP, V16, P1269, DOI 10.3892/mmr.2017.6751; Tang FR, 2017, CELL PHYSIOL BIOCHEM, V43, P852, DOI 10.1159/000481611; Tian XC, 2016, J NEUROCHEM, V139, P757, DOI 10.1111/jnc.13833; Wang L, 2007, J BIOL CHEM, V282, P32462, DOI 10.1074/jbc.M706880200; Wang NY, 2018, MOL MED REP, V17, P3891, DOI 10.3892/mmr.2017.8341; Wang YJ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0110024, 10.1371/journal.pone.0096339, 10.1371/journal.pone.0085234, 10.1371/journal.pone.0108223]; Xia YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068891; Yu PP, 2017, MOL NEUROBIOL, V54, P212, DOI 10.1007/s12035-015-9639-7; Zhang JH, 2012, NAT REV NEUROL, V8, P711, DOI 10.1038/nrneurol.2012.210; Zhang L, 2013, STROKE, V44, P1965, DOI 10.1161/STROKEAHA.111.000831; Zhang YP, 2014, TRANSL STROKE RES, V5, P454, DOI 10.1007/s12975-014-0327-0; Zhong JJ, 2017, NEUROSCIENCE, V343, P434, DOI 10.1016/j.neuroscience.2016.05.033	41	17	18	3	14	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1868-4483	1868-601X		TRANSL STROKE RES	Transl. Stroke Res.	AUG	2020	11	4					720	733		10.1007/s12975-019-00771-2		JAN 2020	14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MG9XF	WOS:000505374600001	31898187				2022-02-06	
J	Hernandez, ML; Chatlos, T; Gorse, KM; Lafrenaye, AD				Hernandez, Martina L.; Chatlos, Todd; Gorse, Karen M.; Lafrenaye, Audrey D.			Neuronal Membrane Disruption Occurs Late Following Diffuse Brain Trauma in Rats and Involves a Subpopulation of NeuN Negative Cortical Neurons	FRONTIERS IN NEUROLOGY			English	Article						diffuse traumatic brain injury; membrane disruption; NeuN neuronal nuclei; mechanoporation; rat-brain	FLUID-PERCUSSION MODEL; PLASMALEMMA PERMEABILITY; INTRACRANIAL-PRESSURE; MECHANICAL STRETCH; AXONAL INJURY; IN-VITRO; MARKER; CALCIUM; IMPACT; IMMUNOREACTIVITY	The repercussions of traumatic brain injury (TBI) endure years following the initial insult and involve chronic impairments/disabilities. Studies indicate that these morbidities stem from diffuse pathologies, however, knowledge regarding TBI-mediated diffuse pathologies, and in particular, diffuse neuronal membrane disruption, is limited. Membrane disruption has been shown to occur acutely following injury, primarily within neurons, however, the progression of TBI-induced membrane disruption remains undefined. Therefore, the current study investigated this pathology over a longer temporal profile from 6 h to 4 w following diffuse TBI induced using the central fluid percussion injury (CFPI) model in rats. To visualize membrane disruption, animals received an intracerebroventricular infusion of tagged cell-impermeable dextran 2 h prior to experimental endpoints at 6 h, 1 d, 3 d, 1 w, 2 w, or 4 w post-CFPI. The percentage of total neurons demonstrating dextran uptake, indicative of membrane disruption, was quantified within the lateral neocortex layers V and VI from 6 h to 4 w post-injury. We found that membrane disruption displayed a biphasic pattern, where nearly half of the neurons were membrane disrupted sub-acutely, from 6 h to 3 d post-TBI. At 1 w the membrane disrupted population was dramatically reduced to levels indistinguishable from sham controls. However, by 2 and 4 w following CFPI, approximately half of the neurons analyzed displayed membrane disruption. Moreover, our data revealed that a subset of these late membrane disrupted neurons were NeuN negative (NeuN-). Correlative western blot analyses, however, revealed no difference in NeuN protein expression in the lateral neocortex at any time following injury. Furthermore, the NeuN- membrane disrupted neurons did not co-label with traditional markers of astrocytes, microglia, oligodendrocytes, or NG2 cells. Immunohistochemistry against NeuN, paired with a hematoxylin and eosin counter-stain, was performed to quantify the possibility of overall NeuN+ neuronal loss following CFPI. A NeuN- population was observed consistently in both sham and injured animals regardless of time post-injury. These data suggest that there is a consistent subpopulation of NeuN- neurons within the lateral neocortex regardless of injury and that these NeuN- neurons are potentially more vulnerable to late membrane disruption. Better understanding of membrane disruption could provide insight into the mechanisms of diffuse pathology and lead to the discovery of novel treatments for TBI.	[Hernandez, Martina L.; Gorse, Karen M.; Lafrenaye, Audrey D.] Virginia Commonwealth Univ, Anat & Neurobiol, Richmond, VA 23284 USA; [Chatlos, Todd] Univ Calif Davis, Dept Neurol, Davis, CA 95616 USA		Lafrenaye, AD (corresponding author), Virginia Commonwealth Univ, Anat & Neurobiol, Richmond, VA 23284 USA.	audrey.lafrenaye@vcuhealth.org			NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R01NS096143]; NIH-NINDS CenterUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5P30NS047463]	This work was supported by the NINDS grant 1R01NS096143. Microscopy was performed at the VCU Department of Anatomy and Neurobiology Microscopy Facility, supported, in part, with funding from NIH-NINDS Center core grant 5P30NS047463.	Abu Hamdeh S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25060-0; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Cannon JR, 2009, NEUROSCI LETT, V464, P14, DOI 10.1016/j.neulet.2009.08.023; Choo AM, 2007, J NEUROSURG-SPINE, V6, P255, DOI 10.3171/spi.2007.6.3.255; Cullen DK, 2011, J NEUROTRAUM, V28, P2219, DOI 10.1089/neu.2011.1841; Darlot F, 2017, EUR J NEUROSCI, V46, P2729, DOI 10.1111/ejn.13737; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Farkas O, 2006, J NEUROSCI, V26, P3130, DOI 10.1523/JNEUROSCI.5119-05.2006; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; Geddes DM, 2003, EXP NEUROL, V184, P420, DOI 10.1016/S0014-4886(03)00254-1; Giannaris EL, 2012, J COMP NEUROL, V520, P3492, DOI 10.1002/cne.23101; Gorse KM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00778; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Hahn YK, 2015, CURR HIV RES, V13, P10, DOI 10.2174/1570162X13666150311163733; Halford J, 2017, J CEREBR BLOOD F MET, V37, P3278, DOI 10.1177/0271678X17724681; Jacko M, 2018, NEURON, V97, P853, DOI 10.1016/j.neuron.2018.01.020; Kilinc D, 2008, EXP NEUROL, V212, P422, DOI 10.1016/j.expneurol.2008.04.025; Kim KK, 2013, J CELL BIOL, V200, P443, DOI 10.1083/jcb.201206146; Kim KK, 2009, J BIOL CHEM, V284, P31052, DOI 10.1074/jbc.M109.052969; Lafrenaye AD, 2014, J CEREBR BLOOD F MET, V34, P1628, DOI 10.1038/jcbfm.2014.122; Lafrenaye AD, 2012, J CEREBR BLOOD F MET, V32, P1919, DOI 10.1038/jcbfm.2012.95; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LaPlaca MC, 1997, J NEUROTRAUM, V14, P355, DOI 10.1089/neu.1997.14.355; LaPlaca MC, 1998, J NEUROSCI RES, V52, P220, DOI 10.1002/(SICI)1097-4547(19980415)52:2<220::AID-JNR10>3.0.CO;2-B; LaPlaca MC, 2019, CLIN BIOMECH, V64, P2, DOI 10.1016/j.clinbiomech.2018.05.016; LaPlaca MC, 2009, IEEE ENG MED BIO, P1113, DOI 10.1109/IEMBS.2009.5334457; LaPlaca MC, 2010, J BIOMECH, V43, P71, DOI 10.1016/j.jbiomech.2009.09.011; Lavezzi AM, 2013, J NEUROL SCI, V329, P45, DOI 10.1016/j.jns.2013.03.012; Levine J, 2016, GLIA, V64, P668, DOI 10.1002/glia.22953; Lifshitz J, 2007, J NEUROPATH EXP NEUR, V66, P218, DOI 10.1097/01.jnen.0000248558.75950.4d; Lusardi TA, 2004, J NEUROTRAUM, V21, P61, DOI 10.1089/089771504772695959; Macovei A, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00596; Mbye LH, 2012, J CEREBR BLOOD F MET, V32, P515, DOI 10.1038/jcbfm.2011.158; McNeil PL, 2003, ANNU REV CELL DEV BI, V19, P697, DOI 10.1146/annurev.cellbio.19.111301.140101; McPhail LT, 2004, EXP NEUROL, V185, P182, DOI 10.1016/j.expneurol.2003.10.001; Morin LP, 2011, BRAIN RES, V1421, P44, DOI 10.1016/j.brainres.2011.09.015; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; Sedmak G, 2019, J ANAT, V235, P626, DOI 10.1111/joa.13018; Singleton RH, 2004, J NEUROSCI, V24, P3543, DOI 10.1523/JNEUROSCI.5048-03.2004; Sugawara T, 2002, J NEUROTRAUM, V19, P85, DOI 10.1089/089771502753460268; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thomas TC, 2018, BEHAV BRAIN RES, V340, P137, DOI 10.1016/j.bbr.2016.12.038; Unal-Cevik I, 2004, BRAIN RES, V1015, P169, DOI 10.1016/j.brainres.2004.04.032; Weyer A, 2003, J NEUROSCI RES, V73, P400, DOI 10.1002/jnr.10655; Whalen MJ, 2008, J CEREBR BLOOD F MET, V28, P490, DOI 10.1038/sj.jcbfm.9600544; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Witcher KG, 2018, GLIA, V66, P2719, DOI 10.1002/glia.23523; Wolf HK, 1996, J HISTOCHEM CYTOCHEM, V44, P1167, DOI 10.1177/44.10.8813082; Zhu XX, 2012, STROKE, V43, P524, DOI 10.1161/STROKEAHA.111.635672; ZIMATKIN SM, 2017, NEUROSCI BEHAV PHYSL, V47, P122, DOI DOI 10.1007/S11055-016-0374-Y	52	17	17	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	NOV 22	2019	10								1238	10.3389/fneur.2019.01238			13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JT9BB	WOS:000501275600001	31824411	gold, Green Published			2022-02-06	
J	Koziakova, M; Harris, K; Edge, CJ; Franks, NP; White, IL; Dickinson, R				Koziakova, Mariia; Harris, Katie; Edge, Christopher J.; Franks, Nicholas P.; White, Ian L.; Dickinson, Robert			Noble gas neuroprotection: xenon and argon protect against hypoxic-ischaemic injury in rat hippocampus in vitro via distinct mechanisms	BRITISH JOURNAL OF ANAESTHESIA			English	Article						acute brain injury; carbon monoxide poisoning; hypoxic-ischaemic encephalopathy; out-of-hospital cardiac arrest; neuroprotection; noble gases; stroke	D-ASPARTATE RECEPTOR; HOSPITAL CARDIAC-ARREST; TRAUMATIC BRAIN-INJURY; BYPASS GRAFT-SURGERY; COMPETITIVE-INHIBITION; SLICE CULTURES; INHALED XENON; ORGANOTYPIC CULTURES; GLUCOSE DEPRIVATION; SYSTEMATIC ANALYSIS	Background: Noble gases may provide novel treatments for neurological injuries such as ischaemic and traumatic brain injury. Few studies have evaluated the complete series of noble gases under identical conditions in the same model. Methods: We used an in vitro model of hypoxia-ischaemia to evaluate the neuroprotective properties of the series of noble gases, helium, neon, argon, krypton, and xenon. Organotypic hippocampal brain slices from mice were subjected to oxygen-glucose deprivation, and injury was quantified using propidium iodide fluorescence. Results: Both xenon and argon were equally effective neuroprotectants, with 0.5 atm of xenon or argon reducing injury by 96% (P<0.0001), whereas helium, neon, and krypton were devoid of any protective effect. Neuroprotection by xenon, but not argon, was reversed by elevated glycine. Conclusions: Xenon and argon are equally effective as neuroprotectants against hypoxia-ischaemia in vitro, with both gases preventing injury development. Although xenon's neuroprotective effect may be mediated by inhibition of the N-methyl-D-aspartate receptor at the glycine site, argon acts via a different mechanism. These findings may have important implications for their clinical use as neuroprotectants.	[Koziakova, Mariia; Harris, Katie; Dickinson, Robert] Imperial Coll London, Dept Surg & Canc, Anaesthet Pain Med & Intens Care Sect, London, England; [Edge, Christopher J.; Franks, Nicholas P.] Imperial Coll London, Dept Life Sci, London, England; [Edge, Christopher J.] Royal Berkshire Hosp NHS Fdn Trust, Dept Anaesthet, London Rd, Reading, Berks, England; [White, Ian L.] St Peters Hosp, Dept Anaesthet, Chertsey, England; [Dickinson, Robert] Imperial Coll London, Royal British Leg Ctr Blast Injury Studies, Dept Bioengn, London, England		Dickinson, R (corresponding author), Imperial Coll London, Dept Surg & Canc, Anaesthet Pain Med & Intens Care Sect, London, England.; Dickinson, R (corresponding author), Imperial Coll London, Royal British Leg Ctr Blast Injury Studies, Dept Bioengn, London, England.	r.dickinson@imperial.ac.uk		Franks, Nicholas/0000-0003-4874-4212	St Peter's Hospital, Chertsey, UK; Medical Research Council, London, UKUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/N027736/1, MC_PC_13064]; Gas Safety Trust, London, UK; British Journal of Anaesthesia/Royal College of Anaesthetists, London UK; Royal Centre for Defence Medicine, Birmingham, UK; Royal British Legion Centre for Blast Injury Studies, Imperial College London, UK; European Society for Anaesthesiology; Imperial College LondonGeneral Electric; Westminster Medical School Research Trust, London, UK; Royal British Legion; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_PC_13064, MR/N027736/1] Funding Source: UKRI	St Peter's Hospital, Chertsey, UK. Medical Research Council, London, UK (MR/N027736/1; MC_PC_13064). The Gas Safety Trust, London, UK. British Journal of Anaesthesia/Royal College of Anaesthetists, London UK. Royal Centre for Defence Medicine, Birmingham, UK, Royal British Legion Centre for Blast Injury Studies, Imperial College London, UK. The European Society for Anaesthesiology. MK was recipient of a Rector's PhD Studentship from Imperial College London. KH was the recipient of a PhD studentship from the Westminster Medical School Research Trust, London, UK. We acknowledge funding from The Royal British Legion.	Armstrong SP, 2012, ANESTHESIOLOGY, V117, P38, DOI 10.1097/ALN.0b013e31825ada2e; Arola O, 2017, J AM COLL CARDIOL, V70, P2652, DOI 10.1016/j.jacc.2017.09.1088; Azzopardi D, 2016, LANCET NEUROL, V15, P145, DOI 10.1016/S1474-4422(15)00347-6; Azzopardi D, 2013, ARCH DIS CHILD-FETAL, V98, pF437, DOI 10.1136/archdischild-2013-303786; BAHR BA, 1995, J NEUROSCI RES, V42, P294, DOI 10.1002/jnr.490420303; Banks P, 2010, ANESTHESIOLOGY, V112, P614, DOI 10.1097/ALN.0b013e3181cea398; Bantel C, 2010, ANESTHESIOLOGY, V112, P623, DOI 10.1097/ALN.0b013e3181cf894a; Bartsch T, 2015, J CEREBR BLOOD F MET, V35, P1836, DOI 10.1038/jcbfm.2015.137; Campos-Pires R, 2019, BRIT J ANAESTH, V123, P60, DOI 10.1016/j.bja.2019.02.032; Campos-Pires R, 2018, JOVE-J VIS EXP, DOI 10.3791/58400; Campos-Pires R, 2018, J NEUROTRAUM, V35, P1037, DOI 10.1089/neu.2017.5360; Campos-Pires R, 2016, CRIT CARE MED, V44, P1456, DOI 10.1097/CCM.0000000000001680; Chakkarapani E, 2010, ANN NEUROL, V68, P330, DOI 10.1002/ana.22016; Coburn M, 2018, BRIT J ANAESTH, V120, P127, DOI 10.1016/j.bja.2017.11.015; Coburn M, 2008, CRIT CARE MED, V36, P588, DOI 10.1097/01.CCM.0B013E3181611F8A6; Coburn M, 2012, EUR J ANAESTH, V29, P549, DOI 10.1097/EJA.0b013e328357bfdd; Colebourn CL, 2007, ANAESTHESIA, V62, P34, DOI 10.1111/j.1365-2044.2006.04897.x; Crain SM, 1998, METHODS, V16, P228, DOI 10.1006/meth.1998.0681; David HN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030934; David HN, 2009, J CEREBR BLOOD F MET, V29, P1159, DOI 10.1038/jcbfm.2009.40; de Sousa SLM, 2000, ANESTHESIOLOGY, V92, P1055, DOI 10.1097/00000542-200004000-00024; Dickinson R, 2007, ANESTHESIOLOGY, V107, P756, DOI 10.1097/01.anes.0000287061.77674.71; Dickinson R, 2010, CRIT CARE, V14, DOI 10.1186/cc9051; Dingley J, 2014, PEDIATRICS, V133, P809, DOI 10.1542/peds.2013-0787; Dworzynski K, 2015, CLIN MED, V15, P461, DOI 10.7861/clinmedicine.15-5-461; Elsersy H, 2006, ANESTHESIOLOGY, V105, P81, DOI 10.1097/00000542-200607000-00016; Fahlenkamp AV, 2014, MED GAS RES, V4, DOI 10.1186/2045-9912-4-11; Fahlenkamp AV, 2012, EUR J PHARMACOL, V674, P104, DOI 10.1016/j.ejphar.2011.10.045; Finley M, 2004, BRAIN RES, V1001, P125, DOI 10.1016/j.brainres.2003.12.009; Franks NP, 1998, NATURE, V396, P324, DOI 10.1038/24525; Frantseva MV, 2002, J CEREBR BLOOD F MET, V22, P453, DOI 10.1097/00004647-200204000-00009; Gardner AJ, 2018, BRIT J ANAESTH, V120, P453, DOI 10.1016/j.bja.2017.10.017; GOLDBERG MP, 1993, J NEUROSCI, V13, P3510; GOLDBERG WJ, 1986, J NEUROSCI, V6, P3144; Gray JJ, 2005, ANESTHESIOLOGY, V102, P606, DOI 10.1097/00000542-200503000-00020; Grune F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171962; Gruss M, 2004, MOL PHARMACOL, V65, P443, DOI 10.1124/mol.65.2.443; Harris K, 2013, ANESTHESIOLOGY, V119, P1137, DOI 10.1097/ALN.0b013e3182a2a265; Hollig A, 2016, CRIT CARE MED, V44, pE520, DOI 10.1097/CCM.0000000000001561; Hoellig A, 2014, INT J MOL SCI, V15, P18175, DOI 10.3390/ijms151018175; Hofland J, 2017, ANESTHESIOLOGY, V127, P918, DOI 10.1097/ALN.0000000000001873; James SL, 2018, LANCET, V392, P1789, DOI [10.1016/S0140-6736(18)32279-7, 10.1016/s0140-6736(18)32279-7]; Jawad N, 2009, NEUROSCI LETT, V460, P232, DOI 10.1016/j.neulet.2009.05.069; Laitio R, 2016, JAMA-J AM MED ASSOC, V315, P1120, DOI 10.1001/jama.2016.1933; Liet JM, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006915.pub3; Liu JJ, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2493-7; Lockwood GG, 2006, ANESTHESIOLOGY, V104, P458, DOI 10.1097/00000542-200603000-00012; Loetscher PD, 2009, CRIT CARE, V13, DOI 10.1186/cc8214; MACKLIS JD, 1990, J NEUROSCI METH, V31, P43, DOI 10.1016/0165-0270(90)90007-3; Maze M, 2016, CAN J ANESTH, V63, P212, DOI 10.1007/s12630-015-0507-8; Montero M, 2007, BRAIN RES, V1177, P124, DOI 10.1016/j.brainres.2007.08.038; Moraa I, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006822.pub5; Noraberg J, 1999, BRAIN RES PROTOC, V3, P278, DOI 10.1016/S1385-299X(98)00050-6; Noraberg J, 2005, CNS NEUROL DISORD-DR, V4, P435, DOI 10.2174/1568007054546108; Pan Y, 2007, EXP NEUROL, V205, P587, DOI 10.1016/j.expneurol.2007.03.023; Rodrigo G, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002884.pub2; Roth GA, 2018, LANCET, V392, P1736, DOI 10.1016/s0140-6736(18)32203-7; ROTHMAN S, 1984, J NEUROSCI, V4, P1884; Rytter A, 2003, J CEREBR BLOOD F MET, V23, P23, DOI 10.1097/01.WCB.0000034361.37277.1B; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Sullivan BL, 2002, ANESTHESIOLOGY, V96, P189, DOI 10.1097/00000542-200201000-00033; Thrift AG, 2017, INT J STROKE, V12, P13, DOI 10.1177/1747493016676285; Ulbrich F, 2015, J NEUROCHEM, V134, P717, DOI 10.1111/jnc.13115; VORNOV JJ, 1991, EXP NEUROL, V114, P11, DOI 10.1016/0014-4886(91)90079-R; White IL, 2005, BRIT J ANAESTH, V94, P784, DOI 10.1093/bja/aei126; Zhao HL, 2016, ONCOTARGET, V7, P25640, DOI 10.18632/oncotarget.8241; Zhao HL, 2016, ANESTHESIOLOGY, V125, P180, DOI 10.1097/ALN.0000000000001128; Zhuang L, 2012, CRIT CARE MED, V40, P1724, DOI 10.1097/CCM.0b013e3182452164	69	17	20	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0007-0912	1471-6771		BRIT J ANAESTH	Br. J. Anaesth.	NOV	2019	123	5					601	609		10.1016/j.bja.2019.07.010			9	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	JD4NR	WOS:000489956100020	31470983	Green Published, hybrid			2022-02-06	
J	Pergakis, M; Badjatia, N; Chaturvedi, S; Cronin, CA; Kimberly, WT; Sheth, KN; Simard, JM				Pergakis, Melissa; Badjatia, Neeraj; Chaturvedi, Seemant; Cronin, Carolyn A.; Kimberly, W. Taylor; Sheth, Kevin N.; Simard, J. Marc			BIIB093 (IV glibenclamide): an investigational compound for the prevention and treatment of severe cerebral edema	EXPERT OPINION ON INVESTIGATIONAL DRUGS			English	Article						Glibenclamide; BIIB093; SUR1-TRPM4; large hemispheric infarction; stroke; traumatic brain injury; contusion; cerebral edema	SULFONYLUREA RECEPTOR 1; NONSELECTIVE CATION CHANNEL; TRAUMATIC BRAIN-INJURY; POTENTIAL MELASTATIN 4; K-ATP CHANNELS; INTRAVENOUS GLYBURIDE; DECOMPRESSIVE CRANIECTOMY; REACTIVE ASTROCYTES; ARTERY TERRITORY; VASOGENIC EDEMA	Introduction: Brain swelling due to edema formation is a major cause of neurological deterioration and death in patients with large hemispheric infarction (LHI) and severe traumatic brain injury (TBI), especially contusion-TBI. Preclinical studies have shown that SUR1-TRPM4 channels play a critical role in edema formation and brain swelling in LHI and TBI. Glibenclamide, a sulfonylurea drug and potent inhibitor of SUR1-TRPM4, was reformulated for intravenous injection, known as BIIB093. Areas covered: We discuss the findings from Phase 2 clinical trials of BIIB093 in patients with LHI (GAMES-Pilot and GAMES-RP) and from a small Phase 2 clinical trial in patients with TBI. For the GAMES trials, we review data on objective biological variables, adjudicated edema-related endpoints, functional outcomes, and mortality which, despite missing the primary endpoint, supported the initiation of a Phase 3 trial in LHI (CHARM). For the TBI trial, we review data on MRI measures of edema and the initiation of a Phase 2 trial in contusion-TBI (ASTRAL). Expert opinion: Emerging clinical data show that BIIB093 has the potential to transform our management of patients with LHI, contusion-TBI and other conditions in which swelling leads to neurological deterioration and death.	[Pergakis, Melissa; Badjatia, Neeraj; Chaturvedi, Seemant; Cronin, Carolyn A.] Univ Maryland, Dept Neurol, Sch Med, Baltimore, MD 21201 USA; [Kimberly, W. Taylor] Massachusetts Gen Hosp, Div Neurocrit Care, Boston, MA 02114 USA; [Kimberly, W. Taylor] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA; [Sheth, Kevin N.] Yale Univ, Sch Med, Dept Neurol, Div Neurocrit Care, New Haven, CT 06510 USA; [Simard, J. Marc] Univ Maryland, Dept Neurosurg, Sch Med, 22 S Greene St,Suite S12D, Baltimore, MD 21201 USA		Simard, JM (corresponding author), Univ Maryland, Dept Neurosurg, Sch Med, 22 S Greene St,Suite S12D, Baltimore, MD 21201 USA.	msimard@som.umaryland.edu	Badjatia, Neeraj/AAS-4855-2021	Badjatia, Neeraj/0000-0003-1509-9034	National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS105503]; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS060801, R01NS102589, R01NS105633, R01NS099209, U01NS106513, U24NS107136, U24NS107215, R03NS112859, R01NR018335]; AHAAmerican Heart Association [AHA 17CSA 33550004]; Department of Veterans AffairsUS Department of Veterans Affairs [I01BX002889]; Department of DefenseUnited States Department of Defense [SCI170199]; National Heart, Lung and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL082517]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL082517] Funding Source: NIH RePORTER	This paper was not funded. N Badjatia is supported by a grant from the National Institute of Neurological Disorders and Stroke (NINDS) (R01NS105503). WT Kimberly is supported by grants from NINDS (R01NS099209) and AHA (AHA 17CSA 33550004). KN Sheth is supported by grants from NINDS (U01NS106513; U24NS107136; U24NS107215; R03NS112859; R01NR018335). JM Simard is supported by grants from the Department of Veterans Affairs (I01BX002889), the Department of Defense (SCI170199), the National Heart, Lung and Blood Institute (R01HL082517) and the NINDS (R01NS060801; R01NS102589; R01NS105633).	Battey TWK, 2014, STROKE, V45, P3643, DOI 10.1161/STROKEAHA.114.006884; Bemeur C, 2016, METAB BRAIN DIS, V31, P1249, DOI 10.1007/s11011-016-9843-9; Castro L, 2019, J NEUROTRAUM, V36, P165, DOI 10.1089/neu.2017.5619; Chen MK, 2003, J NEUROSCI, V23, P8568; Chen MK, 2001, J NEUROSCI, V21, P6512, DOI 10.1523/JNEUROSCI.21-17-06512.2001; Das S, 2019, WORLD NEUROSURG, V123, P8, DOI 10.1016/j.wneu.2018.11.176; Davis SM, 2008, LANCET NEUROL, V7, P299, DOI 10.1016/S1474-4422(08)70044-9; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Eisenberg HM, 2020, J NEUROTRAUM, V37, P185, DOI 10.1089/neu.2019.6538; Ekker MS, 2019, NEUROLOGY, V92, pE2444, DOI 10.1212/WNL.0000000000007533; Gerzanich V, 2019, J NEUROTRAUM, V36, P1060, DOI 10.1089/neu.2018.5986; Gerzanich V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195526; Gerzanich V, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0953-z; Hacke W, 1996, ARCH NEUROL-CHICAGO, V53, P309, DOI 10.1001/archneur.1996.00550040037012; Hayman EG, 2017, NEUROCRIT CARE, V26, P301, DOI 10.1007/s12028-016-0354-7; Heinsius T, 1998, NEUROLOGY, V50, P341, DOI 10.1212/WNL.50.2.341; Hosier H, 2015, J NEUROTRAUM, V32, P1633, DOI 10.1089/neu.2015.3892; Huang KB, 2018, NEUROCRIT CARE, V29, P128, DOI 10.1007/s12028-018-0505-0; Huang KB, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003465; Huang KB, 2015, CRIT CARE MED, V43, pE341, DOI 10.1097/CCM.0000000000001093; Iaccarino C, 2018, J NEUROSURG SCI, V62, P535, DOI 10.23736/S0390-5616.18.04532-0; Jayakumar AR, 2014, TRANSL STROKE RES, V5, P28, DOI 10.1007/s12975-014-0328-z; Jha RM, 2018, J NEUROTRAUM, V35, P2125, DOI 10.1089/neu.2016.4696; Jha Ruchira M, 2017, Crit Care Med, V45, pe255, DOI 10.1097/CCM.0000000000002079; Jiang B, 2017, TRANSL STROKE RES, V8, P183, DOI 10.1007/s12975-016-0506-2; Kampondeni Samuel D, 2018, Surg Neurol Int, V9, P53, DOI 10.4103/sni.sni_297_17; Kasner SE, 2001, STROKE, V32, P2117, DOI 10.1161/hs0901.095719; Kimberly WT, 2018, NEUROLOGY, V91, pE2163, DOI 10.1212/WNL.0000000000006618; Kimberly WT, 2014, NEUROCRIT CARE, V20, P193, DOI 10.1007/s12028-013-9917-z; King ZA, 2018, DRUG DES DEV THER, V12, P2539, DOI 10.2147/DDDT.S150043; Kochanek PM, 2018, MIL MED, V183, P303, DOI 10.1093/milmed/usx184; Kurland DB, 2015, NEUROCRIT CARE, V23, P292, DOI 10.1007/s12028-015-0144-7; Lahmann C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134476; Makar TK, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0432-3; MARBLE A, 1971, DRUGS, V1, P109, DOI 10.2165/00003495-197101020-00001; Martinez-Valverde T, 2015, J NEUROTRAUM, V32, P1478, DOI 10.1089/neu.2014.3706; Mehta RI, 2015, J NEUROPATH EXP NEUR, V74, P835, DOI 10.1097/NEN.0000000000000223; Mehta RI, 2013, J NEUROPATH EXP NEUR, V72, P871, DOI 10.1097/NEN.0b013e3182a32e40; Montaner J, 2001, STROKE, V32, P1759, DOI 10.1161/01.STR.32.8.1759; Mukherjee D, 2011, WORLD NEUROSURG, V76, pS85, DOI 10.1016/j.wneu.2011.07.023; Nakayama S, 2018, NEUROCRIT CARE, V29, P119, DOI 10.1007/s12028-017-0479-3; NEDERGAARD M, 1991, AM J PHYSIOL, V260, pR581, DOI 10.1152/ajpregu.1991.260.3.R581; Patel AD, 2010, J NEUROPATH EXP NEUR, V69, P1177, DOI 10.1097/NEN.0b013e3181fbf6d6; Radermecker RP, 2010, DIABETES METAB, V36, pS94, DOI 10.1016/S1262-3636(10)70474-2; Roth P, 2010, CURR OPIN NEUROL, V23, P597, DOI 10.1097/WCO.0b013e32833e5a5d; Schattling B, 2012, NAT MED, V18, P1805, DOI 10.1038/nm.3015; Seino S, 2003, J DIABETES COMPLICAT, V17, P2, DOI 10.1016/S1056-8727(02)00274-X; Sheth KN, 2018, STROKE, V49, P1457, DOI 10.1161/STROKEAHA.117.020365; Sheth KN, 2016, LANCET NEUROL, V15, P1160, DOI 10.1016/S1474-4422(16)30196-X; Sheth KN, 2014, NEUROCRIT CARE, V21, P43, DOI 10.1007/s12028-014-9970-2; Sheth KN, 2014, STROKE, V45, P281, DOI 10.1161/STROKEAHA.113.003352; Simard JM, 2007, J CLIN INVEST, V117, P2105, DOI 10.1172/JCI32041; Simard JM, 2014, NEUROCRIT CARE, V20, P319, DOI 10.1007/s12028-013-9923-1; Simard JM, 2012, PFLUG ARCH EUR J PHY, V464, P573, DOI 10.1007/s00424-012-1166-z; Simard JM, 2012, ANN NY ACAD SCI, V1268, P95, DOI 10.1111/j.1749-6632.2012.06705.x; Simard JM, 2012, J CEREBR BLOOD F MET, V32, P1699, DOI 10.1038/jcbfm.2012.91; Simard JM, 2012, TRANSL STROKE RES, V3, P286, DOI 10.1007/s12975-012-0149-x; Simard JM, 2012, EXP NEUROL, V233, P829, DOI 10.1016/j.expneurol.2011.11.048; Simard JM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000522; Simard JM, 2010, STROKE, V41, P531, DOI 10.1161/STROKEAHA.109.572644; Simard JM, 2009, J NEUROTRAUM, V26, P2257, DOI 10.1089/neu.2009.1021; Simard JM, 2009, J CEREBR BLOOD F MET, V29, P317, DOI 10.1038/jcbfm.2008.120; Simard JM, 2009, STROKE, V40, P604, DOI 10.1161/STROKEAHA.108.522409; Simard JM, 2006, NAT MED, V12, P433, DOI 10.1038/nm1390; Simard PF, 2011, TRANSL STROKE RES, V2, P227, DOI 10.1007/s12975-011-0070-8; Szeto V, 2018, ACTA PHARMACOL SIN, V39, P683, DOI 10.1038/aps.2018.10; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thomalla G, 2010, ANN NEUROL, V68, P435, DOI 10.1002/ana.22125; Thompson EM, 2013, NEOPLASIA, V15, P535, DOI 10.1593/neo.13164; Tinker A, 2018, COMPR PHYSIOL, V8, P1463, DOI 10.1002/cphy.c170048; Tosun C, 2013, STROKE, V44, P3522, DOI 10.1161/STROKEAHA.113.002904; Tosun C, 2013, BRAIN SCI, V3, P215, DOI 10.3390/brainsci3010215; Tsaousi GG, 2018, J NEUROSURG SCI; Urday S, 2015, NAT REV NEUROL, V11, P111, DOI 10.1038/nrneurol.2014.264; Vorasayan P, 2019, STROKE, V50; Wali B, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/460909; Wijdicks EFM, 2014, STROKE, V45, P1222, DOI 10.1161/01.str.0000441965.15164.d6; Woo SK, 2013, J BIOL CHEM, V288, P36409, DOI 10.1074/jbc.M113.530584; Woo SK, 2013, J BIOL CHEM, V288, P3655, DOI 10.1074/jbc.M112.428219; Woo SK, 2012, J CEREBR BLOOD F MET, V32, P525, DOI 10.1038/jcbfm.2011.159; Xu ZM, 2017, J NEUROTRAUM, V34, P925, DOI 10.1089/neu.2016.4491; Zhang GS, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/3578702; Zweckberger K, 2014, NEUROSCIENCE, V272, P199, DOI 10.1016/j.neuroscience.2014.04.040	83	17	17	1	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1354-3784	1744-7658		EXPERT OPIN INV DRUG	Expert Opin. Investig. Drugs	DEC 2	2019	28	12					1031	1040		10.1080/13543784.2019.1681967		OCT 2019	10	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	PH8WY	WOS:000492116200001	31623469	Green Accepted			2022-02-06	
J	Sun, YX; Bai, LJ; Niu, X; Wang, ZN; Yin, B; Bai, GH; Zhang, DB; Gan, SQ; Sun, CZ; Wang, S; Zhu, F; Zhang, M				Sun, Yingxiang; Bai, Lijun; Niu, Xuan; Wang, Zhuonan; Yin, Bo; Bai, Guanghui; Zhang, Danbin; Gan, Shuoqiu; Sun, Chuanzhu; Wang, Shan; Zhu, Feng; Zhang, Ming			Elevated Serum Levels of Inflammation-Related Cytokines in Mild Traumatic Brain Injury Are Associated With Cognitive Performance	FRONTIERS IN NEUROLOGY			English	Article						inflammation-related cytokines; post-concussion symptoms; cognitive performance; mild traumatic brain injury; follow-up	WHITE-MATTER; MEMORY; PROFILES; INTERLEUKIN-1-BETA; NEUROINFLAMMATION; NEUROPROTECTION; ACTIVATION; SYMPTOMS; DISEASE	Mild traumatic brain injury (mTBI) is the most common neurological insult and leads to long-lasting cognitive impairments. The immune system modulates brain functions and plays a key role in cognitive deficits, however, the relationship between TBI-induced changes in inflammation-related cytokine levels and cognitive consequences is unclear. This was investigated in the present study in two cohorts of individuals within 1 week of mTBI (n = 52, n = 43) and 54 matched healthy control subjects. Patients with mTBI were also followed up at 1 and 3 months post-injury. Measures included cognitive assessments and a 9-plex panel of serum cytokines including interleukin (IL)-1 beta, IL-4, IL-6, IL-8, IL-10, IL-12, chemokine ligand 2 (CCL2), interferon-gamma (IFN-gamma), and tumor necrosis factor-alpha (TNF-alpha). The contribution of cytokine levels to cognitive function was evaluated by multivariate linear regression analysis. The results showed that serum levels of IL-1 beta, IL-6, and CCL2 were acutely elevated in mTBI patients relative to controls; CCL2 level was remained high over 3 months whereas IL-1 beta and IL-6 levels were declined by 3 months post-injury. A high level of CCL2 was associated with greater severity of post-concussion symptoms (which survived in the multiple testing correction); elevated IL-1 beta was associated with worse working memory in acute phase (which failed in correction); and acute high CCL2 level predicted higher information processing speed at 3 months post-injury (which failed in correction). Thus, acute serum cytokine levels are useful for evaluating post-concussion symptoms and predicting cognitive outcome in participants with mTBI.	[Sun, Yingxiang; Niu, Xuan; Wang, Zhuonan; Gan, Shuoqiu; Zhang, Ming] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Med Imaging, Xian, Shaanxi, Peoples R China; [Bai, Lijun; Gan, Shuoqiu; Sun, Chuanzhu; Wang, Shan] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Dept Biomed Engn, Key Lab Biomed Informat Engn,Minist Educ, Xian, Shaanxi, Peoples R China; [Yin, Bo] Wenzhou Med Univ, Affiliated Hosp 2, Dept Neurosurg, Wenzhou, Peoples R China; [Yin, Bo; Bai, Guanghui; Zhang, Danbin] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Peoples R China; [Bai, Guanghui; Zhang, Danbin] Wenzhou Med Univ, Affiliated Hosp 2, Dept Radiol, Wenzhou, Peoples R China; [Zhu, Feng] Xi An Jiao Tong Univ, Affiliated Hosp 1, Ctr Translat Med, Xian, Shaanxi, Peoples R China		Zhang, M (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Med Imaging, Xian, Shaanxi, Peoples R China.; Bai, LJ (corresponding author), Xi An Jiao Tong Univ, Sch Life Sci & Technol, Dept Biomed Engn, Key Lab Biomed Informat Engn,Minist Educ, Xian, Shaanxi, Peoples R China.; Zhu, F (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Ctr Translat Med, Xian, Shaanxi, Peoples R China.	bailijun@xjtu.edu.cn; zhufeng0714@163.com; zhangming01@mail.xjtu.edu.cn	Wang, Zhuonan/E-3691-2017; Niu, Xuan/AAD-7351-2022; Bai, Lijun/C-5119-2015	Wang, Zhuonan/0000-0002-5745-4340; Bai, Lijun/0000-0001-8790-5424	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571752, 81771914, 81871331, 81571640]; Zhejiang Natural Science FoundationNatural Science Foundation of Zhejiang Province [LY15H090016]; Wenzhou Municipal Sci-Tech Bureau [Y20140577]; Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [xjj2018229, xzy022019045]	This research was supported by the National Natural Science Foundation of China (grant nos. 81571752, 81771914, 81871331, 81571752, and 81571640); Zhejiang Natural Science Foundation (grant nos. LY15H090016); Wenzhou Municipal Sci-Tech Bureau (grant no. Y20140577); and the Fundamental Research Funds for the Central Universities (grant nos. xjj2018229 and xzy022019045).	Amor S, 2014, IMMUNOLOGY, V142, P151, DOI 10.1111/imm.12233; Arfanakis K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073107; Arisi GM, 2014, EPILEPSY BEHAV, V38, P43, DOI 10.1016/j.yebeh.2014.01.017; ARNETT JA, 1995, PSYCHOL ASSESSMENT, V7, P220; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Briones TL, 2014, BRAIN BEHAV IMMUN, V35, P23, DOI 10.1016/j.bbi.2013.07.175; Chiaretti A, 2005, CHILD NERV SYST, V21, P185, DOI 10.1007/s00381-004-1032-1; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Correia LCL, 2010, CLIN CHIM ACTA, V411, P540, DOI 10.1016/j.cca.2010.01.011; Deary IJ, 2002, NATURE, V418, P932, DOI 10.1038/418932a; Eisenberger NI, 2010, BRAIN BEHAV IMMUN, V24, P558, DOI 10.1016/j.bbi.2009.12.009; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Finnoff JT, 2011, PM&R, V3, pS452, DOI 10.1016/j.pmrj.2011.07.014; Goshen I, 2007, PSYCHONEUROENDOCRINO, V32, P1106, DOI 10.1016/j.psyneuen.2007.09.004; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Harman-Smith YE, 2013, J CLIN EXP NEUROPSYC, V35, P785, DOI 10.1080/13803395.2013.824554; Hoseth EZ, 2016, ACTA PSYCHIAT SCAND, V133, P53, DOI 10.1111/acps.12467; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Joy S, 2004, ARCH CLIN NEUROPSYCH, V19, P759, DOI 10.1016/j.acn.2003.09.009; Juengst SB, 2015, J HEAD TRAUMA REHAB, V30, P207, DOI 10.1097/HTR.0000000000000031; Kim YS, 2017, PSYCHOGERIATRICS, V17, P224, DOI 10.1111/psyg.12218; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kochunov P, 2017, JAMA PSYCHIAT, V74, P958, DOI 10.1001/jamapsychiatry.2017.2228; Kulesh A, 2018, J STROKE CEREBROVASC, V27, P1752, DOI 10.1016/j.jstrokecerebrovasdis.2018.02.004; Kumar RG, 2016, BRAIN BEHAV IMMUN, V53, P183, DOI 10.1016/j.bbi.2015.12.008; Kumar RG, 2015, J HEAD TRAUMA REHAB, V30, P369, DOI 10.1097/HTR.0000000000000067; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Lyon DE, 2016, J NEUROIMMUNOL, V301, P74, DOI 10.1016/j.jneuroim.2016.11.002; Maruta J, 2010, ANN NY ACAD SCI, V1208, P58, DOI 10.1111/j.1749-6632.2010.05695.x; Mayer CL, 2013, HEADACHE, V53, P1523, DOI 10.1111/head.12173; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Morris GP, 2013, NEUROBIOL LEARN MEM, V105, P40, DOI 10.1016/j.nlm.2013.07.002; Murray KN, 2013, MOL CELL NEUROSCI, V53, P14, DOI 10.1016/j.mcn.2012.09.004; Mustafa T, 2013, ADV PHARMACOL, V68, P445, DOI 10.1016/B978-0-12-411512-5.00021-X; Nilsson LG, 2006, NEUROPSYCHOLOGY, V20, P645, DOI 10.1037/0894-4105.20.6.645; Petrone AB, 2017, NEUROREHABILITATION, V40, P501, DOI 10.3233/NRE-171437; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rathbone ATL, 2015, BRAIN BEHAV IMMUN, V46, P1, DOI 10.1016/j.bbi.2015.02.009; Russo MV, 2018, NAT IMMUNOL, V19, P442, DOI 10.1038/s41590-018-0086-2; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Santarsieri M, 2015, BRAIN BEHAV IMMUN, V45, P15, DOI 10.1016/j.bbi.2014.09.003; Schnabel RB, 2009, CIRC-CARDIOVASC GENE, V2, P229, DOI 10.1161/CIRCGENETICS.108.804245; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P459, DOI 10.1038/jcbfm.2009.240; Singh K, 2016, EXP NEUROL, V275, P427, DOI 10.1016/j.expneurol.2015.07.016; Stalnacke BM, 2007, J REHABIL MED, V39, P405, DOI 10.2340/16501977-0057; Su SH, 2014, BRAIN BEHAV IMMUN, V38, P111, DOI 10.1016/j.bbi.2014.01.009; Tasci A, 2003, NEUROL RES, V25, P871, DOI 10.1179/016164103771953998; Theadom A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191655; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yirmiya R, 2011, BRAIN BEHAV IMMUN, V25, P181, DOI 10.1016/j.bbi.2010.10.015	53	17	18	2	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	OCT 23	2019	10								1120	10.3389/fneur.2019.01120			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	JK2IO	WOS:000494670900001	31708858	Green Published, gold			2022-02-06	
J	Maggio, MG; Torrisi, M; Buda, A; De Luca, R; Piazzitta, D; Cannavo, A; Leo, A; Milardi, D; Manuli, A; Calabro, RS				Maggio, Maria Grazia; Torrisi, Michele; Buda, Antonio; De Luca, Rosaria; Piazzitta, Denise; Cannavo, Antonio; Leo, Antonio; Milardi, Demetrio; Manuli, Alfredo; Calabro, Rocco Salvatore			Effects of robotic neurorehabilitation through lokomat plus virtual reality on cognitive function in patients with traumatic brain injury: A retrospective case-control study	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						Cognitive rehabilitation; Lokomat; traumatic brain injury; virtual reality	REHABILITATION; RECOVERY; STROKE; TREADMILL; PEOPLE	Background: Traumatic brain injury (TBI) is a clinical condition characterized by damage due to a mechanical physical event, which has a devastating impact on both the patient and his/her family. The purpose of this study is to evaluate the effects of robotic neurorehabilitation using Lokomat with virtual reality (VR) on attention processes and executive functions in patients with TBI. Materials and Methods: This is a retrospective case-control study. Fifty-six TBI patients have been included in the analysis, using an electronic recovery data system. The enrolled patients were divided into two groups: the experimental group (LPG) underwent rehabilitation training with Lokomat Pro, equipped with a VR screen, whereas the control group (LNG) performed rehabilitation training using Lokomat Nanos, without VR. The two groups matched for age, sex, education, brain lesions, interval from TBI. The rehabilitation protocol consisted of a total of 40 training sessions. Results: LPG and LNG had a significant improvement in mood and in the perception of physical well-being. However, only the LPG had a significant improvement in global cognitive, executive and attention functions. Furthermore, LPG presented a significant enhancement of the quality of life, with regard to the perception of the mental and physical state. Conclusion: Our study supports the idea that Lokomat is a useful tool in the rehabilitation of patients with TBI; in particular, the integration of the VR device can implement the cognitive and behavioral functions of TBI patients, enhancing also their physical and mental well-being.	[Maggio, Maria Grazia; Torrisi, Michele; Buda, Antonio; De Luca, Rosaria; Piazzitta, Denise; Cannavo, Antonio; Leo, Antonio; Milardi, Demetrio; Manuli, Alfredo; Calabro, Rocco Salvatore] IRCCS Ctr Neurolesi Bonino Pulejo, SS 113, I-98124 Messina, Italy; [Milardi, Demetrio] Univ Messina, Dept Biomed Dent Sci & Morphol & Funct Images, Messina, Italy		Calabro, RS (corresponding author), IRCCS Ctr Neurolesi Bonino Pulejo, SS 113, I-98124 Messina, Italy.	salbro77@tiscali.it	MILARDI, DEMETRIO/AAD-7793-2019; Leo, Antonino/K-7529-2016; Milardi, Demetrio/J-6587-2016; Calabro, Rocco S/K-7520-2016; Manuli, Alfredo/ABF-3128-2020; Leo, Antonino/ABI-7198-2020; Maggio, Maria Grazia/ABA-1852-2020	MILARDI, DEMETRIO/0000-0001-7311-2757; Leo, Antonino/0000-0003-4163-5830; Milardi, Demetrio/0000-0001-7311-2757; Manuli, Alfredo/0000-0002-4030-1399; Leo, Antonino/0000-0003-4163-5830; /0000-0003-0757-2389			Aida J, 2018, NEUROREHABILITATION, V42, P441, DOI 10.3233/NRE-172361; Banz R, 2008, PHYS THER, V88, P1135, DOI 10.2522/ptj.20070203; Bergmann J, 2018, EUR J PHYS REHAB MED, V54, P397, DOI 10.23736/S1973-9087.17.04735-9; Calabro RS, 2015, INT J REHABIL RES, V38, P219, DOI 10.1097/MRR.0000000000000114; Calabro RS, 2017, J NEUROENG REHABIL, V14, DOI 10.1186/s12984-017-0268-4; Calabro RS, 2017, J NEUROL SCI, V377, P25, DOI 10.1016/j.jns.2017.03.047; Calabro RS, 2016, NEUROL SCI, V37, P503, DOI 10.1007/s10072-016-2474-4; Calabro RS, 2015, AGING CLIN EXP RES, V27, P935, DOI 10.1007/s40520-015-0343-2; Calabro RS, 2014, FUNCT NEUROL, V29, P139, DOI 10.11138/FNeur/2014.29.2.139; D'Arcy RCN, 2016, J HEAD TRAUMA REHAB, V31, pE50, DOI 10.1097/HTR.0000000000000185; De Luca R, 2017, INT J NEUROSCI, V17, p20171403915, DOI 10.1080/00207454; Duschau-Wicke A, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-43; Esquenazi A, 2017, PM&R, V9, P839, DOI 10.1016/j.pmrj.2016.12.010; Furnari A, 2017, INT J NEUROSCI, V127, P996, DOI 10.1080/00207454.2017.1288623; Hussain S, 2012, MED ENG PHYS, V34, P1448, DOI 10.1016/j.medengphy.2012.02.003; Latella D, 2018, J CLIN NEUROSCI, V58, P1, DOI 10.1016/j.jocn.2018.09.030; Lopez-Samaniego L, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13121176; Maggio MG, 2019, J NATL MED ASSOC, V111, P457, DOI 10.1016/j.jnma.2019.01.003; Maggio MG, 2019, J NEUROSCI NURS, V51, P101, DOI 10.1097/JNN.0000000000000423; Maggio MG, 2019, J CLIN NEUROSCI, V61, P1, DOI 10.1016/j.jocn.2018.12.020; Maggio MG, 2018, J GERIATR PSYCH NEUR, V31, P312, DOI 10.1177/0891988718807973; Maggio MG, 2018, APPL NURS RES, V41, P11, DOI 10.1016/j.apnr.2018.03.005; Morone G, 2012, STROKE, V43, P1140, DOI 10.1161/STROKEAHA.111.638148; Rizzo A, 2011, STUD HEALTH TECHNOL, V163, P510, DOI 10.3233/978-1-60750-706-2-510; Rizzolatti G, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0420; Robitaille N, 2017, DISABIL REHABIL-ASSI, V12, P758, DOI 10.1080/17483107.2016.1229048; Saatian Mohamadreza, 2018, Bull Emerg Trauma, V6, P45, DOI 10.29252/beat-060107; Sale A, 2009, TRENDS NEUROSCI, V32, P233, DOI 10.1016/j.tins.2008.12.004; See J, 2013, NEUROREHAB NEURAL RE, V27, P732, DOI 10.1177/1545968313491000; Ucar DE, 2014, NEUROREHABILITATION, V34, P447, DOI 10.3233/NRE-141054; Veerbeek JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087987; Wang YX, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.719; Wilson BA, 2013, S AFR J PSYCHOL, V43, P267, DOI 10.1177/0081246313494156; Zanier ER, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00345; Zengin-Metli D, 2018, J BACK MUSCULOSKELET, V31, P1059, DOI 10.3233/BMR-171015	35	17	19	2	17	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0020-7454	1563-5279		INT J NEUROSCI	Int. J. Neurosci.	FEB 1	2020	130	2					117	123		10.1080/00207454.2019.1664519		OCT 2019	7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	KA6CS	WOS:000490726100001	31590592				2022-02-06	
J	Lecca, D; Bader, M; Tweedie, D; Hoffman, AF; Jung, YJ; Hsueh, SC; Hoffer, BJ; Becker, RE; Pick, CG; Lupica, CR; Greig, NH				Lecca, Daniela; Bader, Miaad; Tweedie, David; Hoffman, Alexander F.; Jung, Yoo Jin; Hsueh, Shin-Chang; Hoffer, Barry J.; Becker, Robert E.; Pick, Chaim G.; Lupica, Carl R.; Greig, Nigel H.			(-)-Phenserine and the prevention of pre-programmed cell death and neuroinflammation in mild traumatic brain injury and Alzheimer's disease challenged mice	NEUROBIOLOGY OF DISEASE			English	Article						(-)-Phenserine; Traumatic brain injury; Alzheimer's disease; Neurodegeneration; Neuroinflammation; TNF-alpha; Synaptic proteins; Long term potentiation; Cognitive impairment; Therapeutic intervention	LONG-TERM POTENTIATION; SYNAPTIC PROTEINS; TNF-ALPHA; GENE-EXPRESSION; ANIMAL-MODELS; PATHOPHYSIOLOGY; SYNAPTOPHYSIN; CONSEQUENCES; MICROGLIA; MEMORY	Mild traumatic brain injury (mTBI) is a risk factor for neurodegenerative disorders, such as Alzheimer's disease (AD) and Parkinson's disease (PD). TBI-derived neuropathologies are promoted by inflammatory processes: chronic microgliosis and release of pro-inflammatory cytokines that further promote neuronal dysfunction and loss. Herein, we evaluated the effect on pre-programmed cell death/neuroinflammation/synaptic integrity and function of (-)-Phenserine tartrate (Phen), an agent originally developed for AD. This was studied at two clinically translatable doses (2.5 and 5.0 mg/kg, BID), in a weight drop (concussive) mTBI model in wild type (WT) and AD APP/PSEN1 transgenic mice. Phen mitigated mTBI-induced cognitive impairment, assessed by Novel Object Recognition and Y-maze behavioral paradigms, in WT mice. Phen fully abated mTBI-induced neurodegeneration, evaluated by counting Fluoro-Jade C-positive (FJC +) cells, in hippocampus and cortex of WT mice. In APP/PSEN1 mice, degenerating cell counts were consistently greater across all experimental groups vs. WT mice. mTBI elevated FJC + cell counts vs. the APP/PSEN1 control (sham) group, and Phen similarly mitigated this. Anti-inflammatory effects on microglial activation (IBA1-immunoreactivity (IR)) and the pro inflammatory cytokine TNF-alpha were evaluated. mTBI increased IBA1-IR and TNF-alpha/IBA1 colocalization vs. sham, both in WT and APP/PSEN1 mice. Phen decreased IBA1-IR throughout hippocampi and cortices of WT mice, and in cortices of AD mice. Phen, likewise, reduced levels of IBA1/TNF-alpha-IR colocalization volume across all areas in WT animals, with a similar trend in APP/PSEN1 mice. Actions on astrocyte activation by mTBI were followed by evaluating GFAP, and were similarly mitigated by Phen. Synaptic density was evaluated by quantifying PSD95 + dendritic spines and Synaptophysin (Syn)-IR. Both were significantly reduced in mTBI vs. sham in both WT and APP/PSEN1 mice. Phen fully reversed the PSD-95 + spine loss in WT and Syn-IR decrease in both WT and APP/PSEN1 mice. To associate immunohistochemical changes in synaptic markers with function, hippocampal long term potentiation (LTP) was induced in WT mice. LTP was impaired by mTBI, and this impairment was mitigated by Phen. In synopsis, clinically translatable doses of Phen ameliorated mTBI-mediated pre-programmed cell death/neuroinflammation/synaptic dysfunction in WT mice, consistent with fully mitigating mTBI-induced cognitive impairments. Phen additionally demonstrated positive actions in the more pathologic brain microenvironment of AD mice, further supporting consideration of its repurposing as a treatment for mTBI.	[Lecca, Daniela; Tweedie, David; Jung, Yoo Jin; Becker, Robert E.; Greig, Nigel H.] NIA, Translat Gerontol Branch, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Bader, Miaad; Pick, Chaim G.] Tel Aviv Univ, Sackler Sch Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel; [Hoffman, Alexander F.; Lupica, Carl R.] NIDA, Electrophysiol Res Sect, Cellular Neurobiol Res Branch, Intramural Res Program,NIH, Baltimore, MD 21224 USA; [Hsueh, Shin-Chang; Hoffer, Barry J.] Case Western Reserve Univ, Sch Med, Dept Neurosurg, Cleveland, OH 44106 USA; [Becker, Robert E.] Aristea Translat Med Corp, Park City, UT 84098 USA; [Pick, Chaim G.] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Pick, Chaim G.] Tel Aviv Univ, Ctr Biol Addict Dis, IL-69978 Tel Aviv, Israel		Greig, NH (corresponding author), NIA, Translat Gerontol Branch, Intramural Res Program, NIH, Baltimore, MD 21224 USA.	Greign@grc.nia.nih.gov	Lupica, Carl/AAY-3193-2021; Hoffman, Alexander F/H-3035-2012	Lupica, Carl/0000-0002-5375-3263; Hoffman, Alexander F/0000-0002-2676-0628	Intramural Research Program of the National Institute on Aging, National Institutes of Health, USA; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AG057028]; MOST [106-2917-1-038-001]; Ari and Regine Aprijaskis Fund, at Tel-Aviv University, Tel-Aviv, Israel; Dr. Miriam and Sheldon G. Adelson Chair for the Biology of Addictive Diseases, Tel-Aviv University, Tel-Aviv, Israel; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R56AG057028, ZIAAG000311] Funding Source: NIH RePORTER	This research was supported in part by (i) the Intramural Research Program of the National Institute on Aging, National Institutes of Health, USA, (ii) NIH grant AG057028 to BJH, (iii) MOST 106-2917-1-038-001, and (iv) the Ari and Regine Aprijaskis Fund, at Tel-Aviv University, and the Dr. Miriam and Sheldon G. Adelson Chair for the Biology of Addictive Diseases, Tel-Aviv University, Tel-Aviv, Israel to CGP.	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Anderson WW, 2007, J NEUROSCI METH, V162, P346, DOI 10.1016/j.jneumeth.2006.12.018; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Bader M, 2019, NEUROBIOL DIS, V124, P439, DOI 10.1016/j.nbd.2018.11.023; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; Baratz R, 2011, J NEUROCHEM, V118, P1032, DOI 10.1111/j.1471-4159.2011.07377.x; Baratz R, 2010, J NEUROTRAUM, V27, P555, DOI 10.1089/neu.2009.0891; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Becker RE, 2019, J ALZHEIMERS DIS, V68, P489, DOI 10.3233/JAD-181300; Ben Shimon M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188524; Bereczki E, 2016, ALZHEIMERS DEMENT, V12, P1149, DOI 10.1016/j.jalz.2016.04.005; Bickford PC, 2017, EXP GERONTOL, V94, P4, DOI 10.1016/j.exger.2017.01.027; Cambon K, 2000, NEUROSCIENCE, V97, P685, DOI 10.1016/S0306-4522(00)00065-8; Caplan HW, 2017, J NEUROSCI RES, V95, P509, DOI 10.1002/jnr.23854; CDER U, 2005, GUID IND EST MAX SAF; Chang CF, 2017, BRAIN RES, V1677, P118, DOI 10.1016/j.brainres.2017.09.015; Chen W, 2014, PLOS ONE, V9; Chen YH, 2011, STROKE, V42, P2733, DOI 10.1161/STROKEAHA.111.620112; Chen Yuan-Hao, 2018, Oncotarget, V9, P11515, DOI 10.18632/oncotarget.23923; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Craft JM, 2005, EXPERT OPIN THER TAR, V9, P887, DOI 10.1517/14728222.9.5.887; D'Amelio M, 2011, NAT NEUROSCI, V14, P69, DOI 10.1038/nn.2709; d'Avila JC, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1059-y; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; DELLU F, 1992, BRAIN RES, V588, P132, DOI 10.1016/0006-8993(92)91352-F; Deselms H, 2016, J NEUROSCI METH, V272, P69, DOI 10.1016/j.jneumeth.2016.02.002; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Dixon KJ, 2017, PHYS MED REH CLIN N, V28, P215, DOI 10.1016/j.pmr.2016.12.001; Edut S, 2011, PSYCHOPHARMACOLOGY, V214, P877, DOI 10.1007/s00213-010-2098-y; Ehrlich I, 2007, P NATL ACAD SCI USA, V104, P4176, DOI 10.1073/pnas.0609307104; Fann JR, 2018, LANCET PSYCHIAT, V5, P424, DOI 10.1016/S2215-0366(18)30065-8; Feng Y, 2016, MOL MED REP, V13, P5248, DOI 10.3892/mmr.2016.5201; FEUERSTEIN GZ, 1994, CEREBROVAS BRAIN MET, V6, P341; Fine SM, 1996, J BIOL CHEM, V271, P15303, DOI 10.1074/jbc.271.26.15303; Frankola KA, 2011, CNS NEUROL DISORD-DR, V10, P391; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Glushakova OY, 2018, J NEUROTRAUM, V35, P157, DOI 10.1089/neu.2017.4999; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Greig NH, 2000, ACTA NEUROL SCAND, V102, P74, DOI 10.1034/j.1600-0404.2000.00311.x; Greig Nigel H., 2005, Current Alzheimer Research, V2, P275; Greig NH, 2014, ALZHEIMERS DEMENT, V10, pS62, DOI 10.1016/j.jalz.2013.12.011; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Hawryluk GWJ, 2016, NEUROSURG CLIN N AM, V27, P375, DOI 10.1016/j.nec.2016.05.002; HEINONEN O, 1995, NEUROSCIENCE, V64, P375, DOI 10.1016/0306-4522(94)00422-2; Hoffer BJ, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0377-1; Hsueh SC, 2019, CELL TRANSPLANT, V28, P1183, DOI 10.1177/0963689719854693; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Janowitz T, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000330; Joo H, 2019, PLANTA MED, V85, P231, DOI 10.1055/a-0753-0400; Kadir A, 2008, ANN NEUROL, V63, P621, DOI 10.1002/ana.21345; Kirkley KS, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0871-0; Kobeissy, 2015, BRAIN NEUROTRAUMA MO; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kwon SE, 2011, NEURON, V70, P847, DOI 10.1016/j.neuron.2011.04.001; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LaPlaca MC, 2007, PROG BRAIN RES, V161, P13, DOI 10.1016/S0079-6123(06)61002-9; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lilja AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054887; Liu BJ, 2017, BRAIN RES, V1672, P18, DOI 10.1016/j.brainres.2017.07.008; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Lynch NJ, 2004, MOL IMMUNOL, V40, P709, DOI 10.1016/j.molimm.2003.08.009; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marchetti C, 2011, REV NEUROSCIENCE, V22, P373, DOI 10.1515/RNS.2011.035; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; Merlo L, 2014, J NEUROTRAUM, V31, P1375, DOI 10.1089/neu.2014.3385; Messier C, 1997, NEUROBIOL LEARN MEM, V67, P172, DOI 10.1006/nlme.1996.3755; Meyer D, 2014, NEURON, V82, P430, DOI 10.1016/j.neuron.2014.02.031; Mollayeva T, 2018, NAT REV NEUROL, V14, P712, DOI 10.1038/s41582-018-0091-y; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Morris RGM, 2003, PHILOS T ROY SOC B, V358, P643, DOI 10.1098/rstb.2002.1230; Nicoll RA, 2017, NEURON, V93, P281, DOI 10.1016/j.neuron.2016.12.015; Nordberg A, 2015, J ALZHEIMERS DIS, V47, P691, DOI 10.3233/JAD-132474; Nudo RJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00887; Ogoshi F, 2005, EXP NEUROL, V193, P384, DOI 10.1016/j.expneurol.2004.12.026; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Paxinos G., 2012, PAXINOS FRANKLINS MO; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; Prins ML, 2012, INT J DEV NEUROSCI, V30, P185, DOI 10.1016/j.ijdevneu.2011.05.009; Przekwas A, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00002; Rachmany L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03792-9; Rizzo FR, 2018, NEURAL PLAST, V2018, DOI 10.1155/2018/8430123; Ruff RL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000312; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shohami E, 1996, J CEREBR BLOOD F MET, V16, P378, DOI 10.1097/00004647-199605000-00004; Stein DG, 2019, NEUROPHARMACOLOGY, V147, P66, DOI 10.1016/j.neuropharm.2018.04.006; Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005; Su Y, 2014, NEUROSCIENCE, V266, P56, DOI 10.1016/j.neuroscience.2014.02.006; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Swinney DC, 2013, CLIN PHARMACOL THER, V93, P299, DOI 10.1038/clpt.2012.236; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tashlykov V, 2009, J MOL NEUROSCI, V37, P16, DOI 10.1007/s12031-008-9094-2; Tashlykov V, 2007, BRAIN RES, V1130, P197, DOI 10.1016/j.brainres.2006.10.032; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; TEASDALE G, 1974, LANCET, V2, P81; Tsai MC, 2015, J NEUROIMMUNE PHARM, V10, P45, DOI 10.1007/s11481-014-9570-0; Tweedie D, 2016, J NEUROSCI METH, V272, P4, DOI 10.1016/j.jneumeth.2016.02.003; Tweedie D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156493; Tweedie D, 2013, NEUROBIOL DIS, V54, P1, DOI 10.1016/j.nbd.2013.02.006; Tweedie D, 2013, EXP NEUROL, V239, P170, DOI 10.1016/j.expneurol.2012.10.001; Valtorta F, 2004, BIOESSAYS, V26, P445, DOI 10.1002/bies.20012; Vitarbo EA, 2004, NEUROSURGERY, V55, P416, DOI 10.1227/01.NEU.0000130036.52521.2C; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Wen ZJ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/4296075; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140; Winblad B, 2010, J ALZHEIMERS DIS, V22, P1201, DOI 10.3233/JAD-2010-101311; Winston CN, 2013, J NEUROTRAUM, V30, P1966, DOI 10.1089/neu.2013.2960; Witcher KG, 2018, GLIA, V66, P2719, DOI 10.1002/glia.23523; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yang LY, 2016, NEUROBIOL DIS, V96, P216, DOI 10.1016/j.nbd.2016.08.012; Zhang B, 2008, BRAIN RES, V1226, P181, DOI 10.1016/j.brainres.2008.05.085	120	17	17	2	11	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	OCT	2019	130								104528	10.1016/j.nbd.2019.104528			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IR6QY	WOS:000481565000036	31295555	Green Accepted			2022-02-06	
J	Morse, LR; Biering-Soerensen, F; Carbone, LD; Cervinka, T; Cirnigliaro, CM; Johnston, TE; Liu, N; Tro, KL; Weaver, FM; Shuhart, C; Craven, BC				Morse, Leslie R.; Biering-Soerensen, Fin; Carbone, Laura D.; Cervinka, Tomas; Cirnigliaro, Christopher M.; Johnston, Therese E.; Liu, Nan; Tro, Karen L.; Weaver, Frances M.; Shuhart, Christopher; Craven, Beverley C.			Bone Mineral Density Testing in Spinal Cord Injury: 2019 ISCD Official Position	JOURNAL OF CLINICAL DENSITOMETRY			English	Article; Proceedings Paper	International-Society-of-Clinical-Densitometry (ISCD) Position Development Conference (PDC)	MAR 20-23, 2019	Kuala Lumpur, MALAYSIA	Int Soc Clin Densitometry		Dual-energy X-ray absorptiometry; guidelines; official positions; spinal cord injury	FUNCTIONAL ELECTRICAL-STIMULATION; X-RAY ABSORPTIOMETRY; WHOLE-BODY VIBRATION; QUANTITATIVE COMPUTED-TOMOGRAPHY; ACTIVITY-BASED THERAPY; CYCLING PROGRAM; PROXIMAL TIBIA; BIOCHEMICAL MARKERS; MUSCLE STIMULATION; PHYSICAL-ACTIVITY	Spinal cord injury (SCI) causes rapid osteoporosis that is most severe below the level of injury. More than half of those with motor complete SCI will experience an osteoporotic fracture at some point following their injury, with most fractures occurring at the distal femur and proximal tibia. These fractures have devastating consequences, including delayed union or nonunion, cellulitis, skin breakdown, lower extremity amputation, and premature death. Maintaining skeletal integrity and preventing fractures is imperative following SCI to fully benefit from future advances in paralysis cure research and robotic-exoskeletons, brain computer interfaces and other evolving technologies. Clinical care has been previously limited by the lack of consensus derived guidelines or standards regarding dual-energy X-ray absorptiometry-based diagnosis of osteoporosis, fracture risk prediction, or monitoring response to therapies. The International Society of Clinical Densitometry convened a task force to establish Official Positions for bone density assessment by dual-energy X-ray absorptiometry in individuals with SCI of traumatic or nontraumatic etiology. This task force conducted a series of systematic reviews to guide the development of evidence-based position statements that were reviewed by an expert panel at the 2019 Position Development Conference in Kuala Lumpur, Malaysia. The resulting the International Society of Clinical Densitometry Official Positions are intended to inform clinical care and guide the diagnosis of osteoporosis as well as fracture risk management of osteoporosis following SCI.	[Morse, Leslie R.] Univ Minnesota, Sch Med, Dept Rehabil Med, 500 Boynton Hlth Serv Bridge 410 Church St SE, Minneapolis, MN 55455 USA; [Biering-Soerensen, Fin] Univ Copenhagen, Rigshosp, Neurosci Ctr, Clin Spinal Cord Injuries, Copenhagen, Denmark; [Carbone, Laura D.] Charlie Norwood Vet Affairs Med Ctr, Augusta, GA USA; [Carbone, Laura D.] Augusta Univ, Med Coll Georgia, Dept Med, Augusta, GA USA; [Cervinka, Tomas] Satakunta Univ Appl Sci, Fac Hlth & Welf, Dept Physiotherapy & Rehabil, Pori, Finland; [Cirnigliaro, Christopher M.] Natl Ctr Med Consequences Spinal Cord Injury, James J Peters Vet Affairs Med Ctr, Dept Vet Affairs, Rehabil Res & Dev Serv, Bronx, NY USA; [Johnston, Therese E.] Thomas Jefferson Univ, Jefferson Coll Rehabil Sci, Dept Phys Therapy, Philadelphia, PA 19107 USA; [Liu, Nan] Peking Univ, Hosp 3, Dept Rehabil Med, Beijing, Peoples R China; [Liu, Nan] Peking Univ, Hosp 3, Osteoporosis & Metab Bone Dis Ctr, Beijing, Peoples R China; [Tro, Karen L.] Worcester Polytech Inst, Dept Biomed Engn, Worcester, MA USA; [Weaver, Frances M.] Hines VA Hosp, Ctr Innovat Complex Chron Healthcare CINCCH, Hlth Serv Res & Dev, Dept Vet Affairs, Hines, IL USA; [Weaver, Frances M.] Loyola Univ, Stritch Sch Med, Dept Publ Hlth Sci, Maywood, IL 60153 USA; [Shuhart, Christopher] Swedish Med Grp, Swedish Bone Hlth & Osteoporosis Ctr, Seattle, WA USA; [Craven, Beverley C.] Univ Toronto, Univ Hlth Network, Neural Engn & Therapeut Team, KITE Res Inst,Dept Med, Toronto, ON, Canada		Morse, LR (corresponding author), Univ Minnesota, Sch Med, Dept Rehabil Med, 500 Boynton Hlth Serv Bridge 410 Church St SE, Minneapolis, MN 55455 USA.	morsel@umn.edu	Morse, Leslie/AAU-5608-2020; Cervinka, Tomas/AAG-2239-2021; Troy, Karen L/AAH-1184-2019; Craven, Beverley/D-5001-2015	Cervinka, Tomas/0000-0002-9345-4233; Troy, Karen L/0000-0002-8135-0066; Craven, Beverley/0000-0001-8234-6803; Johnston, Therese/0000-0002-2644-166X	US Department of Defense (DOD)United States Department of Defense [SC150092]	We would like to acknowledge the Spinal Cord Injury Research Evidence (scireproject.com) team, Vancouver, Canada and Maureen Pakosh, Librarian from University Health Network, Toronto, Canada for their assistance with the literature search and article identification. This work was funded in part by the US Department of Defense (DOD) Grant #SC150092 (Carbone). The views expressed in this article are those of the authors and do not necessarily reflect those of the Department of Veterans Affairs or the United States Government.	Abderhalden L, 2017, OSTEOPOROSIS INT, V28, P925, DOI 10.1007/s00198-016-3841-y; Alekna V, 2008, SPINAL CORD, V46, P727, DOI 10.1038/sc.2008.36; Alizadeh-Meghrazi M, 2014, J SPINAL CORD MED, V37, P525, DOI 10.1179/2045772314Y.0000000242; Alizadeh-Meghrazi M, 2012, PM&R, V4, P963, DOI 10.1016/j.pmrj.2012.08.012; Angeli CA, 2018, NEW ENGL J MED, V379, P1244, DOI 10.1056/NEJMoa1803588; Arija-Blazquez A, 2014, J SPINAL CORD MED, V37, P299, DOI 10.1179/2045772313Y.0000000142; Arija-Blazquez A, 2013, EUR J APPL PHYSIOL, V113, P89, DOI 10.1007/s00421-012-2416-7; Ashe MC, 2010, J SPINAL CORD MED, V33, P68, DOI 10.1080/10790268.2010.11689676; Asselin P, 2015, J REHABIL RES DEV, V52, P147, DOI 10.1682/JRRD.2014.02.0060; Astorino TA, 2013, EUR J APPL PHYSIOL, V113, P3027, DOI 10.1007/s00421-013-2738-0; Baim S, 2008, J CLIN DENSITOM, V11, P75, DOI 10.1016/j.jocd.2007.12.007; Bauman WA, 2009, SPINAL CORD, V47, P628, DOI 10.1038/sc.2008.169; Bauman WA, 2005, J REHABIL RES DEV, V42, P625, DOI 10.1682/JRRD.2004.11.0145; Bauman WA, 1999, OSTEOPOROSIS INT, V10, P123, DOI 10.1007/s001980050206; Bauman WA, 2005, J REHABIL RES DEV, V42, P305, DOI 10.1682/JRRD.2004.05.0062; Bauman WA, 2015, J BONE MINER METAB, V33, P410, DOI 10.1007/s00774-014-0602-x; Bauman WA, 2010, J SPINAL CORD MED, V33, P214, DOI 10.1080/10790268.2010.11689698; BeDell KK, 1996, AM J PHYS MED REHAB, V75, P29, DOI 10.1097/00002060-199601000-00008; Belanger M, 2000, ARCH PHYS MED REHAB, V81, P1090, DOI 10.1053/apmr.2000.7170; Ben M, 2005, AUST J PHYSIOTHER, V51, P251, DOI 10.1016/S0004-9514(05)70006-4; BIERINGSORENSEN F, 1990, EUR J CLIN INVEST, V20, P330, DOI 10.1111/j.1365-2362.1990.tb01865.x; Bittar CK, 2011, AM J PHYS MED REHAB, V90, P477, DOI 10.1097/PHM.0b013e31821a7386; Bloomfield SA, 1996, BONE, V19, P61, DOI 10.1016/8756-3282(96)00109-3; Broholm B, 2005, SPINAL CORD, V43, P674, DOI 10.1038/sj.sc.3101788; Carvalho DCL, 2006, BRAZ J MED BIOL RES, V39, P1357, DOI 10.1590/S0100-879X2006001000012; Chain A, 2012, EUR J APPL PHYSIOL, V112, P3179, DOI 10.1007/s00421-011-2303-7; Chen SC, 2005, DISABIL REHABIL, V27, P1337, DOI 10.1080/09638280500164032; Chen Y, 2006, SPINAL CORD, V44, P82, DOI 10.1038/sj.sc.3101818; Chow YW, 1996, SPINAL CORD, V34, P736, DOI 10.1038/sc.1996.134; Clark JM, 2007, SPINAL CORD, V45, P78, DOI 10.1038/sj.sc.3101929; Clasey JL, 2004, ARCH PHYS MED REHAB, V85, P59, DOI 10.1016/S0003-9993(03)00358-7; Craven BC, 2017, J SPINAL CORD MED, V40, P748, DOI 10.1080/10790268.2017.1368961; de Brito CMM, 2005, SPINAL CORD, V43, P341, DOI 10.1038/sj.sc.3101725; de Paleville DGLT, 2019, J SPINAL CORD MED, V42, P32, DOI 10.1080/10790268.2018.1449373; de Zepetnek JOT, 2015, ARCH PHYS MED REHAB, V96, P1566, DOI 10.1016/j.apmr.2015.05.019; Deley G, 2017, J SPINAL CORD MED, V40, P107, DOI 10.1080/10790268.2015.1117192; Dionyssiotis Y, 2008, J CLIN DENSITOM, V11, P437, DOI 10.1016/j.jocd.2008.04.006; Dolbow DR, 2014, SPINAL CORD, V52, pS3, DOI 10.1038/sc.2014.40; Dolbow DR, 2012, SPINAL CORD, V50, P170, DOI 10.1038/sc.2011.115; Dolbow DR, 2018, J SPINAL CORD MED, V41, P248, DOI 10.1080/10790268.2017.1367358; Dolbow DR, 2017, J SPINAL CORD MED, V40, P485, DOI 10.1080/10790268.2016.1234750; Dolbow DR, 2012, J SPINAL CORD MED, V35, P182, DOI 10.1179/2045772312Y.0000000007; Edwards WB, 2018, J BONE MINER RES, V33, P1729, DOI 10.1002/jbmr.3525; Edwards WB, 2014, J BONE MINER RES, V29, P2074, DOI 10.1002/jbmr.2227; Fattal C, 2020, J SPINAL CORD MED, V43, P402, DOI 10.1080/10790268.2018.1490098; Fattal C, 2011, ARCH PHYS MED REHAB, V92, P59, DOI 10.1016/j.apmr.2010.09.019; Filippo TRM, 2015, SPINAL CORD, V53, P875, DOI 10.1038/sc.2015.27; Forrest GF, 2008, J SPINAL CORD MED, V31, P509, DOI 10.1080/10790268.2008.11753646; FOURNIER A, 1984, ORTHOPEDICS, V7, P1129, DOI 10.3928/0147-7447-19840701-07; Franco JC, 1999, J REHABIL RES DEV, V36, P207; Gagnon DH, 2018, J NEUROENG REHABIL, V15, DOI 10.1186/s12984-018-0354-2; Garland DE, 2004, J SPINAL CORD MED, V27, P202, DOI 10.1080/10790268.2004.11753748; Garland DE, 2004, J SPINAL CORD MED, V27, P207, DOI 10.1080/10790268.2004.11753749; GARLAND DE, 1992, J ORTHOPAED RES, V10, P371, DOI 10.1002/jor.1100100309; Garland DE, 2001, J BONE JOINT SURG AM, V83A, P1195, DOI 10.2106/00004623-200108000-00009; GARLAND DE, 2001, TOP SPINAL CORD INJ, V6, P47, DOI DOI 10.1310/5W45-0L5B-8C7B-C93T; Garland DE, 2008, J SPINAL CORD MED, V31, P543, DOI 10.1080/10790268.2008.11753650; Gaspar AP, 2012, J OSTEOPOROS, V2012, DOI 10.1155/2012/519754; Gaspar AP, 2014, J CLIN ENDOCR METAB, V99, P4649, DOI 10.1210/jc.2014-2165; Giangregorio LM, 2016, OSTEOPOROSIS INT, V27, P2433, DOI 10.1007/s00198-016-3572-0; Giangregorio LM, 2005, SPINAL CORD, V43, P649, DOI 10.1038/sj.sc.3101774; Giangregorio LM, 2005, J CLIN DENSITOM, V8, P347, DOI 10.1385/JCD:8:3:347; Giangregorio LM, 2004, SPINAL CORD, V42, P141, DOI 10.1038/sj.sc.3101570; Giangregorio LM, 2006, APPL PHYSIOL NUTR ME, V31, P283, DOI 10.1139/H05-036; Gifre L, 2016, OSTEOPOROSIS INT, V27, P405, DOI 10.1007/s00198-015-3333-5; Gifre L, 2015, J BONE MINER RES, V30, P1014, DOI 10.1002/jbmr.2423; Goenka S, 2018, SPINAL CORD, V56, P1207, DOI 10.1038/s41393-018-0195-7; Goktepe AS, 2008, J SPINAL CORD MED, V31, P197, DOI 10.1080/10790268.2008.11760712; Goktepe AS, 2004, AM J PHYS MED REHAB, V83, P279, DOI 10.1097/01.PHM.0000118036.20170.6C; Gordon KE, 2013, PM&R, V5, P663, DOI 10.1016/j.pmrj.2013.03.032; Gorgey AS, 2017, TOP SPINAL CORD INJ, V23, P245, DOI 10.1310/sci16-00025; Gorgey AS, 2017, J SPINAL CORD MED, V40, P439, DOI 10.1080/10790268.2016.1229397; Gorgey AS, 2016, J SPINAL CORD MED, V39, P699, DOI 10.1080/10790268.2016.1157970; Gorgey AS, 2016, J SPINAL CORD MED, V39, P99, DOI 10.1179/2045772314Y.0000000293; Gorgey AS, 2012, J SPINAL CORD MED, V35, P107, DOI 10.1179/204577212X13309481546619; Gorgey AS, 2012, MED SCI SPORT EXER, V44, P165, DOI 10.1249/MSS.0b013e31822672aa; Gorla JI, 2016, ARCH PHYS MED REHAB, V97, P92, DOI 10.1016/j.apmr.2015.09.007; Gorman PH, 2014, SPINAL CORD, V52, P287, DOI 10.1038/sc.2014.6; Gorman PH, 2016, J SPINAL CORD MED, V39, P32, DOI 10.1179/2045772314Y.0000000281; Griffin L, 2009, J ELECTROMYOGR KINES, V19, P614, DOI 10.1016/j.jelekin.2008.03.002; Groah SL, 2010, PM&R, V2, P1080, DOI 10.1016/j.pmrj.2010.08.003; Guimaraes JA, 2017, EUR J TRANSL MYOL, V27, P272, DOI 10.4081/ejtm.2017.7169; Hammond ER, 2014, ARCH PHYS MED REHAB, V95, P2342, DOI 10.1016/j.apmr.2014.07.395; Hartkopp A, 1998, ARCH PHYS MED REHAB, V79, P1133, DOI 10.1016/S0003-9993(98)90184-8; Hjeltnes N, 1997, AM J PHYSIOL-REG I, V273, pR1072, DOI 10.1152/ajpregu.1997.273.3.R1072; INGRAM RR, 1989, PARAPLEGIA, V27, P133, DOI 10.1038/sc.1989.20; Javidan AN, 2014, J SPINAL CORD MED, V37, P744, DOI 10.1179/2045772313Y.0000000192; Johnston TE, 2016, ARCH PHYS MED REHAB, V97, P1413, DOI 10.1016/j.apmr.2015.11.014; Johnston Therese E, 2015, Top Spinal Cord Inj Rehabil, V21, P275, DOI 10.1310/sci2104-275; Jones LM, 2002, SPINAL CORD, V40, P230, DOI 10.1038/sj.sc.3101286; Jones LM, 1998, SPINAL CORD, V36, P637, DOI 10.1038/sj.sc.3100664; Karelis AD, 2017, J REHABIL MED, V49, P84, DOI 10.2340/16501977-2173; Kaya K, 2006, J SPINAL CORD MED, V29, P396, DOI 10.1080/10790268.2006.11753888; Khan I, 2017, RAWAL MED J, V42, P95; Kiratli BJ, 2000, J REHABIL RES DEV, V37, P225; Kirshblum S C, 2014, Top Spinal Cord Inj Rehabil, V20, P81, DOI 10.1310/sci2002-81; Kostovski E, 2015, CALCIFIED TISSUE INT, V96, P145, DOI 10.1007/s00223-014-9947-3; KUNKEL CF, 1993, ARCH PHYS MED REHAB, V74, P73; Lai CH, 2010, J REHABIL MED, V42, P150, DOI 10.2340/16501977-0499; Lala D, 2014, OSTEOPOROSIS INT, V25, P177, DOI 10.1007/s00198-013-2419-1; Lazo MG, 2001, SPINAL CORD, V39, P208, DOI 10.1038/sj.sc.3101139; Lester Robert M, 2018, Spinal Cord Ser Cases, V4, P36, DOI 10.1038/s41394-018-0053-z; Levis S, 1998, ARTHRITIS RHEUM-US, V41, P577, DOI 10.1002/1529-0131(199804)41:4<577::AID-ART4>3.0.CO;2-7; Lichy AM, 2012, J REHABIL RES DEV, V49, P221, DOI 10.1682/JRRD.2011.03.0048; Liu CC, 2000, OSTEOPOROSIS INT, V11, P889, DOI 10.1007/s001980070049; Lobos S, 2018, J CLIN DENSITOM, V21, P338, DOI 10.1016/j.jocd.2017.05.006; Lobos S, 2019, J CLIN DENSITOM, V22, P249, DOI 10.1016/j.jocd.2018.04.002; Maimoun L, 2002, METABOLISM, V51, P958, DOI [10.1053/meta.2002.34013, 10.1053/meta2002.34013]; Mc Cormack K., 2010, PHYSIOTHER PRACT RES, V31, P30; McPherson JG, 2014, SPINAL CORD, V52, P821, DOI 10.1038/sc.2014.122; Melchiorri G, 2007, FUNCT NEUROL, V22, P151; Menendez H, 2016, SPINAL CORD, V54, P1169, DOI 10.1038/sc.2016.60; Miller LE, 2016, MED DEVICES-EVID RES, V9, DOI 10.2147/MDER.S103102; Miyahara K, 2008, J BONE MINER METAB, V26, P101, DOI 10.1007/s00774-007-0789-1; Mohr T, 1997, CALCIFIED TISSUE INT, V61, P22, DOI 10.1007/s002239900286; Morse LR, 2016, OSTEOPOROSIS INT, V27, P3503, DOI 10.1007/s00198-016-3678-4; Morse LR, 2009, ARCH PHYS MED REHAB, V90, P827, DOI 10.1016/j.apmr.2008.12.004; Nance PW, 1999, ARCH PHYS MED REHAB, V80, P243, DOI 10.1016/S0003-9993(99)90133-8; NASH MS, 1994, AM J PHYS MED REHAB, V73, P184, DOI 10.1097/00002060-199406000-00007; NeedhamShropshire BM, 1997, ARCH PHYS MED REHAB, V78, P799, DOI 10.1016/S0003-9993(97)90190-8; Paker N, 2007, NEUROSCIENCES, V12, P232; Pearson EG, 1997, ARCH PHYS MED REHAB, V78, P269, DOI 10.1016/S0003-9993(97)90032-0; Peppler WT, 2017, SPINAL CORD, V55, P483, DOI 10.1038/sc.2016.170; PETROFSKY JS, 1992, J NEUROL ORTH MED S, V13, P249; Phonthee S, 2013, PHYS THER, V93, P1061, DOI 10.2522/ptj.20120467; Platz T, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8459018; RAGNARSSON KT, 1981, ARCH PHYS MED REHAB, V62, P418; Reiter AL, 2007, EUR SPINE J, V16, P771, DOI 10.1007/s00586-006-0163-3; RIGGS BL, 1992, NEW ENGL J MED, V327, P620; Roberts D, 1998, J CLIN ENDOCR METAB, V83, P415, DOI 10.1210/jc.83.2.415; Roop S, 2014, J ORTHOP TRAUMA REHA, V18, P2, DOI 10.1016/j.jotr.2013.12.006; Rushton DN, 1998, SPINAL CORD, V36, P303, DOI 10.1038/sj.sc.3100635; Ryan TE, 2013, ARCH PHYS MED REHAB, V94, P2166, DOI 10.1016/j.apmr.2013.06.016; Sabo D, 2001, ARCH ORTHOP TRAUM SU, V121, P75, DOI 10.1007/s004020000162; Schnitzer TJ, 2016, PM&R, V8, P833, DOI 10.1016/j.pmrj.2016.01.012; Schnitzer TJ, 2012, PM&R, V4, P748, DOI 10.1016/j.pmrj.2012.05.011; Shields RK, 2007, NEUROREHAB NEURAL RE, V21, P169, DOI 10.1177/1545968306293447; Shields RK, 2006, SPINE, V31, P548, DOI 10.1097/01.brs.0000201303.49308.a8; Shields RK, 2005, ARCH PHYS MED REHAB, V86, P1969, DOI 10.1016/j.apmr.2005.06.001; Shojaei H, 2006, J SPINAL DISORD TECH, V19, P114, DOI 10.1097/01.bsd.0000194689.95674.c1; Singh R, 2014, INDIAN J ORTHOP, V48, P168, DOI 10.4103/0019-5413.128760; SLOAN KE, 1994, PARAPLEGIA, V32, P407, DOI 10.1038/sc.1994.67; Solomonow M, 1997, ORTHOPEDICS, V20, P315, DOI 10.3928/0147-7447-19970401-08; Spadone R, 2003, SPINAL CORD, V41, P97, DOI 10.1038/sj.sc.3101420; Szollar SM, 1998, AM J PHYS MED REHAB, V77, P28, DOI 10.1097/00002060-199801000-00005; Szollar SM, 1997, SPINAL CORD, V35, P223, DOI 10.1038/sj.sc.3100401; Szollar SM, 1997, SPINAL CORD, V35, P374, DOI 10.1038/sj.sc.3100394; Tan CO, 2014, OSTEOPOROSIS INT, V25, P2599, DOI 10.1007/s00198-014-2786-2; Tanabe S, 2017, NEUROREHABILITATION, V41, P85, DOI 10.3233/NRE-171460; Tawashy Amira E, 2008, J Neurol Phys Ther, V32, P164, DOI 10.1097/NPT.0b013e31818de56f; THOUMIE P, 1995, PARAPLEGIA, V33, P654, DOI 10.1038/sc.1995.137; Triolo RJ, 1996, ARCH PHYS MED REHAB, V77, P1119, DOI 10.1016/S0003-9993(96)90133-1; Tsuzuku S, 1999, SPINAL CORD, V37, P358, DOI 10.1038/sj.sc.3100835; Valayer-Chaleat E, 1998, SPINAL CORD, V36, P593, DOI 10.1038/sj.sc.3100639; Varghese S.M., 2016, CRIT REV PHYS REHAB, V28, P85, DOI [10.1615/CritRevPhysRehabilMed.2016018768, DOI 10.1615/CritRevPhysRehabilMed.2016018768]; Vik Lene C, 2017, Spinal Cord Ser Cases, V3, P17099, DOI 10.1038/s41394-017-0033-8; Vlychou M, 2003, DISABIL REHABIL, V25, P324, DOI 10.1080/0963828021000043770; Wang YC, 2010, SPINE, V35, P958, DOI 10.1097/BRS.0b013e3181bc9dc9; Warden SJ, 2002, OSTEOPOROSIS INT, V13, P586, DOI 10.1007/s001980200077; West CR, 2015, AM J PHYS MED REHAB, V94, pE102, DOI 10.1097/PHM.0000000000000358; Wilbanks SR, 2016, J SPINAL CORD MED, V39, P645, DOI 10.1179/2045772315Y.0000000052; Wood DE, 2001, SPINAL CORD, V39, P145, DOI 10.1038/sj.sc.3101125; Wuermser LA, 2015, J SPINAL CORD MED, V38, P178, DOI 10.1179/2045772313Y.0000000191; Yang Ajax, 2015, Top Spinal Cord Inj Rehabil, V21, P100, DOI 10.1310/sci2102-100; Yilmaz B, 2007, ARCH PHYS MED REHAB, V88, P758, DOI 10.1016/j.apmr.2007.02.037; Zehnder Y, 2004, OSTEOPOROSIS INT, V15, P180, DOI 10.1007/s00198-003-1529-6	166	17	18	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1094-6950	1559-0747		J CLIN DENSITOM	J. Clin. Densitom.	OCT-DEC	2019	22	4					554	566		10.1016/j.jocd.2019.07.012			13	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Endocrinology & Metabolism	JV2IP	WOS:000502192600010	31501005	Bronze			2022-02-06	
J	Snider, SB; Bodien, YG; Bianciardi, M; Brown, EN; Wu, O; Edlow, BL				Snider, Samuel B.; Bodien, Yelena G.; Bianciardi, Marta; Brown, Emery N.; Wu, Ona; Edlow, Brian L.			Disruption of the ascending arousal network in acute traumatic disorders of consciousness	NEUROLOGY			English	Article							AXONAL INJURY; COMA; IMMEDIATE; SYSTEM; DAMAGE	Objective To determine whether ascending arousal network (AAn) connectivity is reduced in patients presenting with traumatic coma. Methods We performed high-angular-resolution diffusion imaging in 16 patients with acute severe traumatic brain injury who were comatose on admission and in 16 matched controls. We used probabilistic tractography to measure the connectivity probability (CP) of AAn axonal pathways linking the brainstem tegmentum to the hypothalamus, thalamus, and basal forebrain. To assess the spatial specificity of CP differences between patients and controls, we also measured CP within 4 subcortical pathways outside the AAn. Results Compared to controls, patients showed a reduction in AAn pathways connecting the brainstem tegmentum to a region of interest encompassing the hypothalamus, thalamus, and basal forebrain. When each pathway was examined individually, brainstem-hypothalamus and brainstem-thalamus CPs, but not brainstem-forebrain CP, were significantly reduced in patients. Only 1 subcortical pathway outside the AAn showed reduced CP in patients. Conclusions We provide initial evidence for the reduced integrity of axonal pathways linking the brainstem tegmentum to the hypothalamus and thalamus in patients presenting with traumatic coma. Our findings support current conceptual models of coma as being caused by subcortical AAn injury. AAn connectivity mapping provides an opportunity to advance the study of human coma and consciousness.	[Snider, Samuel B.; Bodien, Yelena G.; Edlow, Brian L.] Massachusetts Gen Hosp, Dept Neurol, Ctr Neurotechnol & Neurorecovery, Boston, MA 02114 USA; [Brown, Emery N.] Massachusetts Gen Hosp, Dept Anesthesiol, Boston, MA 02114 USA; [Bodien, Yelena G.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Charlestown, MA USA; [Bianciardi, Marta; Wu, Ona; Edlow, Brian L.] Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA; Harvard Med Sch, Charlestown, MA USA; [Brown, Emery N.] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Brown, Emery N.] Harvard Mit Div Hlth Sci & Technol, Cambridge, MA USA		Edlow, BL (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Ctr Neurotechnol & Neurorecovery, Boston, MA 02114 USA.; Edlow, BL (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA.	bedlow@mgh.harvard.edu		Bodien, Yelena/0000-0003-4858-2903	NIH National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS094538]; NIH National Institute of Biomedical Imaging and BioengineeringUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [K01EB019474]; NIH National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P01GM118269, R01GM104948]; American Academy of Neurology/American Brain Foundation; James S. McDonnell Foundation; Rappaport Foundation; Tiny Blue Dot Foundation; National Institute on Disability, Independent Living and Rehabilitation Research, Administration for Community Living [90DP0039]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [K01EB019474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS094538] Funding Source: NIH RePORTER	This study was supported by the NIH National Institute of Neurological Disorders and Stroke (K23NS094538), NIH National Institute of Biomedical Imaging and Bioengineering (K01EB019474), NIH National Institute of General Medical Sciences (P01GM118269, R01GM104948), American Academy of Neurology/American Brain Foundation, James S. McDonnell Foundation, Rappaport Foundation, Tiny Blue Dot Foundation, and National Institute on Disability, Independent Living and Rehabilitation Research, Administration for Community Living (90DP0039, Spaulding-Harvard TBI Model System).	Ding SL, 2016, J COMP NEUROL, V524, P3127, DOI 10.1002/cne.24080; Edlow BL, 2017, BRAIN, V140, P2399, DOI 10.1093/brain/awx176; Edlow BL, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-015-0525-8; Edlow BL, 2013, J NEUROPATH EXP NEUR, V72, P505, DOI 10.1097/NEN.0b013e3182945bf6; Edlow BL, 2012, J NEUROPATH EXP NEUR, V71, P531, DOI 10.1097/NEN.0b013e3182588293; Fuller P, 2011, J COMP NEUROL, V519, P933, DOI 10.1002/cne.22559; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Kuypers H., 1958, RETICULAR FORMATION, P3; LINDSLEY DB, 1949, ELECTROEN CLIN NEURO, V1, P475, DOI 10.1016/0013-4694(49)90221-7; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; MITCHELL DE, 1973, LANCET, V2, P215; Parvizi J, 2003, BRAIN, V126, P1524, DOI 10.1093/brain/awg166; Rosenblum WI, 2015, J NEUROPATH EXP NEUR, V74, P198, DOI 10.1097/NEN.0000000000000170; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; VOYTKO ML, 1994, J NEUROSCI, V14, P167; Weiss N, 2008, J NEUROL, V255, P217, DOI 10.1007/s00415-008-0658-4	17	17	18	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	SEP 24	2019	93	13					E1281	E1287		10.1212/WNL.0000000000008163			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KK2VG	WOS:000512605300006	31484715	Green Published			2022-02-06	
J	Dreyer, NA; Mack, CD; Anderson, RB; Wojtys, EM; Hershman, EB; Sills, A				Dreyer, Nancy A.; Mack, Christina D.; Anderson, Robert B.; Wojtys, Edward M.; Hershman, Elliott B.; Sills, Allen			Lessons on Data Collection and Curation From the NFL Injury Surveillance Program	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						football; data curation; epidemiology surveillance; electronic health records	NATIONAL FOOTBALL LEAGUE; PLAYING SURFACES; HEALTH-CARE	Background: "Research-ready" evidence platforms that link sports data with anonymized electronic health records (EHRs) or other data are important tools for evaluating injury occurrence in response to changes in games, training, rules, and other factors. While there is agreement that high-quality data are essential, there is little evidence to guide data curation. Hypothesis: We hypothesized that an EHR used in the course of clinical care and curated for research readiness can provide a robust evidence platform. Our purpose was to describe the data curation used for active injury surveillance by the National Football League (NFL). Study Design: Dynamic cohort study. Methods: Players provide informed consent for research activities through the collective bargaining process. A league-wide EHR is used to record injuries that come to the attention of the teams' athletic trainers and physicians, NFL medical spotters, or unaffiliated neurotrauma consultants. Information about football activities and injuries are linkable by player, setting, and event to other sports-related data, including game statistics and game-day stadium quality measures, using a unique player identification designed to protect player privacy. Ongoing data curation is used to review data completeness and accuracy and is adjusted over time in response to findings. Results: The core data curation activities include monthly injury summaries to team staff, queries to resolve incomplete reporting, and periodic external checks. Experiences derived from producing more than 100 reports per year on diverse topics are used to update coding training and related guidance documents in response to missing data or inconsistent coding that is observed. Roughly 20% more injuries were recorded for the same "reportable" injuries after switching from targeted reporting to an EHR. Conclusion: Research-ready databases need systematic curation for quality and completeness, along with related action plans. More injuries were reported through EHR than through targeted reporting.	[Dreyer, Nancy A.] IQVIA, Real World & Analyt Solut, Ctr Adv Evidence Generat, 201 Broadway,5th Floor, Cambridge, MA 02139 USA; [Mack, Christina D.] IQVIA, Real World & Analyt Solut, Ctr Adv Evidence Generat, Res Triangle Pk, NC USA; [Anderson, Robert B.] OrthoCarolina, Foot & Ankle Inst, Charlotte, NC USA; [Anderson, Robert B.] Titletown Sports Med, Sports Foot Ankle, Green Bay, WI USA; [Wojtys, Edward M.] Univ Michigan, Dept Orthopaed Surg, MedSport, Ann Arbor, MI 48109 USA; [Hershman, Elliott B.] North Shore LIJ Healthcare Syst, North Shore LIJ Orthopaed Inst, Lenox Hill Hosp, Dept Orthopaed Surg, New York, NY USA; [Sills, Allen] Natl Football League, New York, NY USA		Dreyer, NA (corresponding author), IQVIA, Real World & Analyt Solut, Ctr Adv Evidence Generat, 201 Broadway,5th Floor, Cambridge, MA 02139 USA.	nancy.dreyer@iqvia.com	Hershman, Elliott/ABD-6856-2021		NFL	N.A.D. and C.D.M. are employed by IQVIA; R.B.A. received consulting fees from Amniox, Artelon, Arthrex, Bioventus, DJO, Wright Medical, and Zimmer Biomet, and royalties from Arthrex, Biomet, Wright Medical, and Zimmer Biomet; E.M.W. received travel payments from the National Football League (NFL) and AOSSM and payments from the NFL and NIAMS/KAI, he also serves as editor in chief for Sports Health; E.B.H. received consulting fees and royalties from Active Implants Corp and royalties from Zimmer Biomet; and A.S. is employed by the NFL. This research program was funded by the NFL and approved by the National Football League Players Association under a collectively bargained agreement pertaining to NFL player research. The authors assert that these results are presented clearly, honestly, and without fabrication, falsification, or inappropriate data manipulation.	Califf RM, 2017, JAMA-J AM MED ASSOC, V317, P693, DOI 10.1001/jama.2017.0410; Califf RM, 2016, NEW ENGL J MED, V375, P2395, DOI 10.1056/NEJMsb1610128; Daniel G, 2018, WHITE PAPER CHARACTE; Dreyer NA, 2018, THER INNOV REGUL SCI, V52, P362, DOI 10.1177/2168479018763591; Dreyer NA, 2016, CURR MED RES OPIN, V32, P1697, DOI 10.1080/03007995.2016.1203768; Gliklich RE., 2018, 21 CENTURY PATIENT R; Hershman EB, 2012, AM J SPORT MED, V40, P2200, DOI 10.1177/0363546512458888; Jacobs JJ, 2013, J BONE JOINT SURG AM, V95A, P1629, DOI [10.2106/JBJS.M.00137, 10.2106/JBJS.L.01370]; Leavy MB, 2014, REGISTRIES EVALUATIN, V3rd; Lessley DJ, 2018, AM J SPORT MED, V46, P3502, DOI 10.1177/0363546518804498; Mack CD, 2019, AM J SPORT MED, V47, P189, DOI 10.1177/0363546518808499; Matava MJ, 2016, J KNEE SURG, V29, P370, DOI 10.1055/s-0036-1584313; Miksad RA, 2018, CLIN PHARMACOL THER, V103, P202, DOI 10.1002/cpt.946; POWELL JW, 1992, AM J SPORT MED, V20, P686, DOI 10.1177/036354659202000609; Sherman RE, 2016, NEW ENGL J MED, V375, P2293, DOI 10.1056/NEJMsb1609216; US Food and Drug Administration, 2018, US EL HLTH REC DAT C; US Food Drug Administration, US REAL WORLD EV SUP	17	17	17	0	15	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	SEP	2019	11	5					440	445		10.1177/1941738119854759			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	IT6GH	WOS:000482968400008	31265352	Green Published			2022-02-06	
J	Siwicka-Gieroba, D; Malodobry, K; Biernawska, J; Robba, C; Bohatyrewicz, R; Rola, R; Dabrowski, W				Siwicka-Gieroba, Dorota; Malodobry, Katarzyna; Biernawska, Jowita; Robba, Chiara; Bohatyrewicz, Romuald; Rola, Radoslaw; Dabrowski, Wojciech			The Neutrophil/Lymphocyte Count Ratio Predicts Mortality in Severe Traumatic Brain Injury Patients	JOURNAL OF CLINICAL MEDICINE			English	Article						Neutrophil-lymphocyte count ratio; traumatic brain injury; Extended Glasgow Outcome Score; diffuse axonal injury; cerebral edema	INFLAMMATORY RESPONSE; DYSFUNCTION; DISRUPTION; NEUTROPHIL; BIOMARKERS; MANAGEMENT; MODEL	Introduction: Neutrophil-lymphocyte count ratio (NLCR) is a simple and low-cost marker of inflammatory response. NLCR has shown to be a sensitive marker of clinical severity in inflammatory-related tissue injury, and high value of NLCR is associated with poor outcome in traumatic brain injured (TBI) patients. The purpose of this study was to retrospectively analyze NLCR and its association with outcome in a cohort of TBI patients in relation to the type of brain injury. Methods: Adult patients admitted for isolated TBI with Glasgow Coma Score lower than eight were included in the study. NLCR was calculated as the ratio between the absolute neutrophil and lymphocyte count immediately after admission to the hospital, and for six consecutive days after admission to the intensive care unit (ICU). Brain injuries were classified according to neuroradiological findings at the admission computed tomography (CT) as DAI-patients with severe diffuse axonal injury; CE-patients with hemispheric or focal cerebral edema; ICH-patients with intracerebral hemorrhage; S-EH/SAH-patients with subdural and/or epidural hematoma/subarachnoid hemorrhage. Results: NLCR was calculated in 144 patients. Admission NLCR was significantly higher in the non-survivors than in those who survived at 28 days (p < 0.05) from admission. Persisting high NLCR value was associated with poor outcome, and admission NLCR higher than 15.63 was a predictor of 28-day mortality. The highest NLCR value at admission was observed in patients with DAI compared with other brain injuries (p < 0.001). Concussions: NLCR can be a useful marker for predicting outcome in TBI patients. Further studies are warranted to confirm these results.	[Siwicka-Gieroba, Dorota; Dabrowski, Wojciech] Med Univ Lublin, Dept Anaesthesiol & Intens Care, PL-20954 Lublin, Poland; [Malodobry, Katarzyna] Univ Rzeszow, Fac Med, PL-35959 Rzeszow, Poland; [Biernawska, Jowita; Bohatyrewicz, Romuald] Pomeranian Univ Szczecin, Dept Anaesthesiol & Intens Care, PL-71252 Szczecin, Poland; [Robba, Chiara] IRCCS Oncol & Neurosci, Policlin San Martino, Dept Anaesthesia & Intens Care, I-16100 Genoa, Italy; [Rola, Radoslaw] Med Univ Lublin, Dept Neurosurg Paediat Neurosurg, PL-20954 Lublin, Poland		Siwicka-Gieroba, D (corresponding author), Med Univ Lublin, Dept Anaesthesiol & Intens Care, PL-20954 Lublin, Poland.	dsiw@wp.pl; katarzyna.malodobry112@o2.pl; lisienko@wp.pl; kiarobba@gmail.com; romuald.bohatyrewicz@pum.edu.pl; rola.radoslaw@gmail.com; w.dabrowski5@yahoo.com	Bohatyrewicz, Romuald/L-8280-2018; Robba, Chiara/AAS-7421-2020; Dabrowski, Wojciech/AAN-8425-2020; Rola, Radoslaw/AAQ-5587-2021	Bohatyrewicz, Romuald/0000-0003-1914-826X; Dabrowski, Wojciech/0000-0003-0449-2375; Rola, Radoslaw/0000-0003-0613-6593; Siwicka-Gieroba, Dorota/0000-0002-1001-0080	 [DS 352]	This research was founded with Medical University Grant (DS 352) and received no external funding.	Ackland GL, 2019, BRIT J ANAESTH, V122, P180, DOI 10.1016/j.bja.2018.09.002; Al Nimer F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132177; Al-Mufti F, 2019, J NEUROINTERV SURG, V11, P1135, DOI 10.1136/neurintsurg-2019-014759; Bansal Mayank, 2018, Asian J Neurosurg, V13, P348, DOI 10.4103/ajns.AJNS_229_16; Bogoslovsky T, 2016, DIAGNOSTICS, V6, DOI 10.3390/diagnostics6040037; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chen JG, 2019, NEUROCRIT CARE, V30, P334, DOI 10.1007/s12028-018-0622-9; Chen WQ, 2018, J HEAD TRAUMA REHAB, V33, pE53, DOI 10.1097/HTR.0000000000000320; Corbett JM, 2020, J NEUROSURG, V132, P545, DOI 10.3171/2018.10.JNS182293; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Dal-Pizzol F, 2013, MOL NEUROBIOL, V48, P62, DOI 10.1007/s12035-013-8433-7; Dejonckheere E, 2011, DRUG DISCOV TODAY, V16, P762, DOI 10.1016/j.drudis.2011.06.009; Ekmark-Lewen S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-44; Frati A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122600; Ganau Laura, 2018, Medicines (Basel), V5, DOI 10.3390/medicines5010022; Ganau Mario, 2018, Medicines (Basel), V5, DOI 10.3390/medicines5010019; Gubari MIM, 2019, MEDICINA-LITHUANIA, V55, DOI 10.3390/medicina55080486; Guilfoyle MR, 2015, J NEUROTRAUM, V32, P1553, DOI 10.1089/neu.2014.3764; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Herbert JP, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7070092; Holmin S, 1998, NEUROSURGERY, V42, P291, DOI 10.1097/00006123-199802000-00047; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Joice SL, 2009, BRAIN RES, V1298, P13, DOI 10.1016/j.brainres.2009.08.076; Kotfis K, 2019, J CLIN MED, V8, DOI 10.3390/jcm8071075; Liao YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068963; Lin Y, 2013, INT J MED SCI, V10, P515, DOI 10.7150/ijms.5423; Liu YWY, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1173-x; Loane D, 2014, NEUROTHERAPEUTICS, V11, P857, DOI 10.1007/s13311-014-0298-6; McGirt MJ, 2003, J NEUROSURG, V98, P1222, DOI 10.3171/jns.2003.98.6.1222; Nwachuku EL, 2016, CLIN NEUROL NEUROSUR, V149, P1, DOI 10.1016/j.clineuro.2016.06.009; Ponomarev ED, 2007, J NEUROSCI, V27, P10714, DOI 10.1523/JNEUROSCI.1922-07.2007; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Roxburgh CSD, 2010, FUTURE ONCOL, V6, P149, DOI [10.2217/fon.09.136, 10.2217/FON.09.136]; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shetty AK, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00232; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; Subramanian A., 2012, BRAIN INJURY PATHOGE; Turner RJ, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00056; Volpi PC, 2018, BMC EMERG MED, V18, DOI 10.1186/s12873-018-0197-y; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Winkler EA, 2016, NEUROSURG CLIN N AM, V27, P473, DOI 10.1016/j.nec.2016.05.008; Wofford KL, 2017, EXP NEUROL, V290, P85, DOI 10.1016/j.expneurol.2017.01.004; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Yeoh S, 2013, ANN BIOMED ENG, V41, P2206, DOI 10.1007/s10439-013-0805-7; Zadora P, 2015, NEUROL NEUROCHIR POL, V49, P41, DOI 10.1016/j.pjnns.2014.12.006; Zhang J, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008624; Zhao JL, 2019, WORLD NEUROSURG, V124, pE411, DOI 10.1016/j.wneu.2018.12.107	51	17	17	0	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	SEP	2019	8	9							1453	10.3390/jcm8091453			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JC3NA	WOS:000489184200187	31547411	gold, Green Published			2022-02-06	
J	Unnikrishnan, G; Mao, H; Sundaramurthy, A; Bell, ED; Yeoh, S; Monson, K; Reifman, J				Unnikrishnan, Ginu; Mao, Haojie; Sundaramurthy, Aravind; Bell, E. David; Yeoh, Stewart; Monson, Kenneth; Reifman, Jaques			A 3-D Rat Brain Model for Blast-Wave Exposure: Effects of Brain Vasculature and Material Properties	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Rat cerebral vasculature; High-strain-rate material properties; Shock tube; Blast overpressure	TRAUMATIC BRAIN; INJURY; RESPONSES	Exposure to blast waves is suspected to cause primary traumatic brain injury. However, existing finite-element (FE) models of the rat head lack the necessary fidelity to characterize the biomechanical responses in the brain due to blast exposure. They neglect to represent the cerebral vasculature, which increases brain stiffness, and lack the appropriate brain material properties characteristic of high strain rates observed in blast exposures. To address these limitations, we developed a high-fidelity three-dimensional FE model of a rat head. We explicitly represented the rat's cerebral vasculature and used high-strain-rate material properties of the rat brain. For a range of blast overpressures (100 to 230 kPa) the brain-pressure predictions matched experimental results and largely overlapped with and tracked the incident pressure-time profile. Incorporating the vasculature decreased the average peak strain in the cerebrum, cerebellum, and brainstem by 17, 33, and 18%, respectively. When compared with our model based on rat-brain properties, the use of human-brain properties in the FE model led to a three-fold reduction in the strain predictions. For simulations of blast exposure in rats, our findings suggest that representing cerebral vasculature and species-specific brain properties has a considerable influence in the resulting brain strain but not the pressure predictions.	[Unnikrishnan, Ginu; Mao, Haojie; Sundaramurthy, Aravind; Reifman, Jaques] US Army Med Res & Mat Command, Dept Def Biotechnol High Performance Comp Softwar, Telemed & Adv Technol Res Ctr, MCMR TT, 504 Scott St, Ft Detrick, MD 21702 USA; [Unnikrishnan, Ginu; Mao, Haojie; Sundaramurthy, Aravind] Henry M Jackson Fdn Adv Mil Med Inc HJF, 6720A Rockledge Dr, Bethesda, MD 20817 USA; [Bell, E. David; Yeoh, Stewart; Monson, Kenneth] Univ Utah, Dept Bioengn, 36 S Wasatch Dr, Salt Lake City, UT 84112 USA; [Monson, Kenneth] Univ Utah, Dept Mech Engn, 1495 E 100 S 1550 MEK, Salt Lake City, UT 84112 USA		Reifman, J (corresponding author), US Army Med Res & Mat Command, Dept Def Biotechnol High Performance Comp Softwar, Telemed & Adv Technol Res Ctr, MCMR TT, 504 Scott St, Ft Detrick, MD 21702 USA.	jaques.reifman.civ@mail.mil	Lang, Steven/AAE-8102-2021; Sundaramurthy, Aravind/O-2047-2019	Lang, Steven/0000-0003-1669-9146; Sundaramurthy, Aravind/0000-0002-0359-8680	U.S. Army Medical Research and Materiel Command (Ft. Detrick, MD)U.S. Army Medical Research & Materiel Command (USAMRMC); U.S. DoD Defense Health Program by the Military Operational Medicine Research Program (Ft. Detrick, MD)	Funding provided by the U.S. Army Medical Research and Materiel Command (Ft. Detrick, MD) and the U.S. DoD Defense Health Program, managed by the Military Operational Medicine Research Program (Ft. Detrick, MD).	Bell ED, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4039625; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Cloots RJH, 2012, J MECH BEHAV BIOMED, V5, P41, DOI 10.1016/j.jmbbm.2011.09.012; Fievisohn E, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4038710; Garimella HT, 2017, INT J NUMER METH BIO, V33, DOI 10.1002/cnm.2823; Haslach HW, 2017, J MECH BEHAV BIOMED, V68, P88, DOI 10.1016/j.jmbbm.2017.01.036; Ho J, 2007, J BIOMECH, V40, P3006, DOI 10.1016/j.jbiomech.2007.02.011; Hua Y, 2015, COMPUT MATH METHOD M, V1-8, P2015; Keenan MA, 2010, J NUCL MED, V51, P471, DOI 10.2967/jnumed.109.070532; MacManus DB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13727-z; Mao HJ, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4031765; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Rakesh V, 2014, J APPL PHYSIOL, V117, P1278, DOI 10.1152/japplphysiol.00614.2014; Rakesh V, 2013, J APPL PHYSIOL, V115, P1822, DOI 10.1152/japplphysiol.00589.2013; Skotak M, 2013, J NEUROTRAUM, V30, P1147, DOI 10.1089/neu.2012.2652; Stewart SK, 2019, J ROY ARMY MED CORPS, V165, P18, DOI 10.1136/jramc-2018-000942; Sundaramurthy A, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4039823; Sundaramurthy A, 2012, J NEUROTRAUM, V29, P2352, DOI 10.1089/neu.2012.2413; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Taylor PA, 2014, BRAIN INJURY, V28, P879, DOI 10.3109/02699052.2014.888478; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006; Zhang Liying, 2002, Stapp Car Crash J, V46, P145; Zhu F, 2013, INT J NUMER METH BIO, V29, P392, DOI 10.1002/cnm.2518; Zhu Feng, 2010, Stapp Car Crash J, V54, P211	26	17	17	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	SEP	2019	47	9			SI		2033	2044		10.1007/s10439-019-02277-2			12	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	JD1MH	WOS:000489738300015	31054004	hybrid, Green Published			2022-02-06	
J	Elder, GA; Ehrlich, ME; Gandy, S				Elder, Gregory A.; Ehrlich, Michelle E.; Gandy, Sam			Relationship of traumatic brain injury to chronic mental health problems and dementia in military veterans	NEUROSCIENCE LETTERS			English	Article						Alzheimer's disease; Blast; Chronic traumatic encephalopathy; Dementia; Inflammation; Microglia; Post-traumatic stress disorder; Traumatic brain injury; TYROBP/DAP12; TREM2	DISORDER-RELATED TRAITS; ALZHEIMERS-DISEASE; BLAST EXPOSURE; TREM2 DEFICIENCY; AMYLOID-BETA; MOUSE MODEL; MICROGLIAL RESPONSE; APOLIPOPROTEIN-E; SERVICE MEMBERS; HEAD-INJURY	Traumatic brain injury (TBI) is an unfortunately common event in military life. The conflicts in Iraq and Afghanistan have increased public awareness of TBI in the military. Certain injury mechanisms are relatively unique to the military, the most prominent being blast exposure. Blast-related mild TBI (mTBI) has been of particular concern in the most recent veterans although controversy remains concerning separation of the postconcussion syndrome associated with mTBI from post-traumatic stress disorder. TBI is also a risk factor for the development of neurodegenerative diseases including chronic traumatic encephalopathy (CTE) and Alzheimer's disease (AD). AD, TBI, and CTE are all associated with chronic inflammation. Genome wide association studies (GWAS) have identified multiple genetic loci associated with AD that implicate inflammation and - in particular microglia - as key modulators of the AD- and TBI-related degenerative processes. At the molecular level, recent studies have identified TREM2 and TYROBP/DAP12 as components of a key molecular hub linking inflammation and microglia to the pathophysiology of AD and possibly TBI. Evidence concerning the relationship of TBI to chronic mental health problems and dementia is reviewed in the context of its relevance to military veterans.	[Elder, Gregory A.] Vet Affairs Med Ctr, Neurol Serv, James J Peters Dept, 130 West Kingsbridge Rd, Bronx, NY 10468 USA; [Elder, Gregory A.; Ehrlich, Michelle E.; Gandy, Sam] Icahn Sch Med Mt Sinai, Dept Neurol, One Gustave Levy Pl, New York, NY 10029 USA; [Elder, Gregory A.; Gandy, Sam] Icahn Sch Med Mt Sinai, Dept Psychiat, One Gustave Levy Pl, New York, NY 10029 USA; [Elder, Gregory A.; Ehrlich, Michelle E.; Gandy, Sam] Icahn Sch Med Mt Sinai, Mt Sinai Alzheimers Dis Res Ctr, New York, NY 10029 USA; [Elder, Gregory A.; Ehrlich, Michelle E.; Gandy, Sam] Icahn Sch Med Mt Sinai, Ronald M Loeb Ctr Alzheimers Dis, New York, NY 10029 USA; [Gandy, Sam] Vet Affairs Med Ctr, Res & Dev Serv, James J Peters Dept, 130 West Kingsbridge Rd, Bronx, NY 10468 USA; [Ehrlich, Michelle E.] Icahn Sch Med Mt Sinai, Dept Pediat, One Gustave Levy Pl, New York, NY 10029 USA; [Gandy, Sam] Icahn Sch Med Mt Sinai, NFL Neurol Care Ctr, New York, NY 10029 USA		Elder, GA (corresponding author), James J Peters VA Med Ctr, Neurol Serv 3E16, 130 West Kingsbridge Rd, Bronx, NY 10468 USA.	gregory.elder@va.gov		Elder, Gregory/0000-0001-7035-8380	United States Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research and Development ServiceUS Department of Veterans Affairs [1IO1RX000179, 1I01RX000996, 1I01RX000684, 1I01RX001705, 1I21RX002876, 1I01RX002660, 1I01BX004067, 1I21RX003019]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P50 AG005138]; Alzheimer's Drug Discovery Foundation	The authors have received research support from the United States Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research and Development Service Awards 1IO1RX000179, 1I01RX000996, 1I01RX000684, 1I01RX001705, 1I21RX002876, 1I01RX002660, 1I01BX004067, 1I21RX003019 and by NIH grant P50 AG005138. SG has received support from the Alzheimer's Drug Discovery Foundation.	Audrain M, 2018, MOL PSYCHIAT; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Bochicchio GV, 2008, AM SURGEON, V74, P267; Brenner LA, 2013, J HEAD TRAUMA REHAB, V28, P21, DOI 10.1097/HTR.0b013e31827df0b5; Brickell TA, 2014, MIL MED, V179, P839, DOI 10.7205/MILMED-D-14-00016; Carr W, 2016, MIL MED, V181, P28, DOI 10.7205/MILMED-D-15-00137; Castranio EL, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0569-2; Castranio EL, 2017, NEUROBIOL DIS, V105, P1, DOI 10.1016/j.nbd.2017.05.006; Chapman JC, 2014, ALZHEIMERS DEMENT, V10, pS97, DOI 10.1016/j.jalz.2014.04.012; Chase RP, 2015, J HEAD TRAUMA REHAB, V30, pE57, DOI 10.1097/HTR.0000000000000061; Cheng QW, 2018, J BIOL CHEM, V293, P12620, DOI 10.1074/jbc.RA118.001848; Colonna M, 2016, NAT REV NEUROSCI, V17, P201, DOI 10.1038/nrn.2016.7; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; De Gasperi Rita, 2012, Front Neurol, V3, P177, DOI 10.3389/fneur.2012.00177; Defense and Veterans Brain Injury Center, 2018, DOD WORLDW NUMB TBI; DeKosky ST, 2007, ARCH NEUROL-CHICAGO, V64, P541, DOI 10.1001/archneur.64.4.541; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; DePalma R.G., 2015, BRAIN NEUROTRAUMA MO, P5; Dreer LE, 2018, CURR OPIN PSYCHOL, V22, P73, DOI 10.1016/j.copsyc.2017.08.030; Effgen GB, 2016, J NEUROTRAUM, V33, P1901, DOI 10.1089/neu.2015.4327; Elali A, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00072; Elder GA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00269; Elder GA, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0591-8; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Engel C., 2019, P FIND EXP REC 7 DEP; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Falcon B, 2019, NATURE, V568, P420, DOI 10.1038/s41586-019-1026-5; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Gandy S, 2005, J CLIN INVEST, V115, P1121, DOI 10.1172/JCI200525100; Gandy S, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-37; Gardner R. C., 2015, MOL CELL NEUROSCI; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gill J, 2018, BRAIN INJURY, V32, P1277, DOI 10.1080/02699052.2018.1471738; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Goodrich JA, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0395-3; Gubata ME, 2014, J HEAD TRAUMA REHAB, V29, P65, DOI 10.1097/HTR.0b013e318295f590; Hansen DV, 2018, J CELL BIOL, V217, P459, DOI 10.1083/jcb.201709069; HaureMirande J. V., 2018, MOL PSYCHIAT; Hayes JP, 2017, BRAIN, V140, P813, DOI 10.1093/brain/aww344; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Huber BR, 2016, NEUROSCIENCE, V319, P206, DOI 10.1016/j.neuroscience.2016.01.022; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Jay TR, 2017, J NEUROSCI, V37, P637, DOI [10.1523/JNEUROSCI.2110-16.2017, 10.1523/JNEUROSCI.2110-16.2016]; Jay TR, 2015, J EXP MED, V212, P287, DOI 10.1084/jem.20142322; Jiang T, 2015, NEUROBIOL AGING, V36, P3176, DOI 10.1016/j.neurobiolaging.2015.08.019; Jiang T, 2014, NEUROPSYCHOPHARMACOL, V39, P2949, DOI 10.1038/npp.2014.164; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Jones E, 2007, AM J PSYCHIAT, V164, P1641, DOI 10.1176/appi.ajp.2007.07071180; Jorge RE, 2014, PSYCHIAT CLIN N AM, V37, P13, DOI 10.1016/j.psc.2013.11.005; Kallakuri S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169239; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kokiko-Cochran ON, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00672; Korvatska O, 2015, JAMA NEUROL, V72, P920, DOI 10.1001/jamaneurol.2015.0979; Kraus A, 2019, ACTA NEUROPATHOL, V137, P585, DOI 10.1007/s00401-018-1947-3; Kucherov Y, 2012, J APPL PHYS, V112, DOI 10.1063/1.4765727; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; Lawrence D. W., 2015, BRAIN INJURY, P1; Lenz KM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00698; Leyns CEG, 2017, P NATL ACAD SCI USA, V114, P11524, DOI 10.1073/pnas.1710311114; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Lu YJ, 2015, NEUROL SCI, V36, P1881, DOI 10.1007/s10072-015-2274-2; Maroon JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117338; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McAllister TW, 2009, CLIN NEUROPSYCHOL, V23, P1338, DOI 10.1080/13854040903277289; McKee AC, 2018, HAND CLINIC, V158, P297, DOI 10.1016/B978-0-444-63954-7.00028-8; McKee AC, 2016, NEUROSURG CLIN N AM, V27, P529, DOI 10.1016/j.nec.2016.05.009; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mohamed AZ, 2019, EUR J NUCL MED MOL I, V46, P1139, DOI 10.1007/s00259-018-4241-7; Muller N, 2014, NEUROIMMUNOMODULAT, V21, P123, DOI 10.1159/000356540; National Research Council, 2008, GULF WAR HLTH, V7; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Newcombe EA, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1313-3; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Perez-Garcia G, 2019, NEUROPHARMACOLOGY, V145, P220, DOI 10.1016/j.neuropharm.2018.09.023; Perez-Garcia G, 2018, BEHAV BRAIN RES, V340, P117, DOI 10.1016/j.bbr.2016.09.061; Perez-Garcia G, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00176; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Pierce JES, 1996, J NEUROSCI, V16, P1083; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Puntambekar SS, 2018, BRAIN BEHAV IMMUN, V71, P9, DOI 10.1016/j.bbi.2018.03.033; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Reisman Miriam, 2016, P T, V41, P623; Saber M, 2017, J NEUROTRAUM, V34, P423, DOI 10.1089/neu.2016.4401; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Sharrock AE, 2018, INJURY; Sibener L, 2014, ALZHEIMERS DEMENT, V10, pS105, DOI 10.1016/j.jalz.2014.04.011; Sosa MAG, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-018-0647-5; Sosa MAG, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0483-z; Sosa MAG, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-67; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Toklu HZ, 2018, BEHAV BRAIN RES, V340, P14, DOI 10.1016/j.bbr.2017.04.025; Ulrich JD, 2017, NEURON, V94, P237, DOI 10.1016/j.neuron.2017.02.042; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Veitch DP, 2013, CURR ALZHEIMER RES, V10, P907, DOI 10.2174/15672050113109990142; Vincent AS, 2014, ALZHEIMERS DEMENT, V10, pS174, DOI 10.1016/j.jalz.2014.04.006; Wang YM, 2016, J EXP MED, V213, P667, DOI 10.1084/jem.20151948; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Wieck A, 2014, NEUROIMMUNOMODULAT, V21, P145, DOI 10.1159/000356552; Williams WH, 2018, LANCET PSYCHIAT, V5, P836, DOI 10.1016/S2215-0366(18)30062-2; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9; Wyss-Coray T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006346; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu LY, 2016, EXP NEUROL, V277, P268, DOI 10.1016/j.expneurol.2016.01.010; Yeh FL, 2016, NEURON, V91, P328, DOI 10.1016/j.neuron.2016.06.015; Younger D., 2018, MOL NEUROBIOL; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; Zhao YJ, 2018, NEURON, V97, P1023, DOI 10.1016/j.neuron.2018.01.031; Zheng HH, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00395	124	17	17	0	16	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	AUG 10	2019	707								134294	10.1016/j.neulet.2019.134294			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	IY0PG	WOS:000486094600033	31141716				2022-02-06	
J	Han, D; Zhou, YD				Han, Dong; Zhou, Yidong			YY1-induced upregulation of lncRNA NEAT1 contributes to OGD/R injury-induced inflammatory response in cerebral microglial cells via Wnt/beta-catenin signaling pathway	IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL			English	Article						YY1; lncRNA NEAT1; OGD; R injury; Microglial cells; Wnt; beta-catenin signaling pathway	NONCODING RNA NEAT1; TRAUMATIC BRAIN-INJURY; CANCER PROGRESSION; ISCHEMIC-STROKE; IN-VITRO; KAPPA-B; EXPRESSION; ACTIVATION; MECHANISMS; APOPTOSIS	Stroke can lead to the serious long-term neurological disability. The dysregulation of long non-coding RNAs (lncRNAs) has been proven to be a pivotal factor for the progression of ischemic stroke. However, it is largely unknown whether lncRNAs regulated the OGD/R injury of cerebral microglial cells. In this study, we designed experiments to reveal the role of lncRNA Nuclear Enriched Abundant Transcript 1 (NEAT1) in the OGD/R injury of microglial cells. We found that NEAT1 contributed to the OGD/R injury and neuroinflammation damage in microglial cells. Moreover, the molecular mechanism involved in the NEAT1-mediated OGD/R injury. Mechanism investigation revealed that NEAT1 was upregulated by the transcription factor YY1. Moreover, Western blot analysis suggested that NEAT1 enhance the protein levels of core factors of Wnt/beta-catenin signaling pathway, indicating that NEAT1 contributed to the activation of Wnt/beta-catenin signaling pathway. Rescue assays were carried out in the microglial cells treated with OGD/R. The results showed that NEAT1 regulated the OGD/R injury and neuroinflammation damage via Wnt/beta-catenin signaling pathway. In conclusion, our findings suggested that YY1-induced upregulation of NEAT1 contributed to the OGD/R injury and neuroinflammation damage of microglial cells via Wnt/beta-catenin signaling pathway.	[Han, Dong; Zhou, Yidong] Ningbo First Hosp, Dept Neurol, Ningbo 315010, Zhejiang, Peoples R China		Han, D (corresponding author), Ningbo First Hosp, Dept Neurol, Ningbo 315010, Zhejiang, Peoples R China.	DongHan3389@163.com					AGBOR LN, 2018, FASEB J S, V32; Baizabal-Aguirre VM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01396; Battistelli C, 2019, CELL DEATH DIFFER, V26, P890, DOI 10.1038/s41418-018-0170-z; Carniglia L, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/5048616; Chakravarty D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6383; Chen Q, 2018, CLIN CANCER RES, V24, P684, DOI 10.1158/1078-0432.CCR-17-0605; Chen XX, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0962-6; Cheng L, 2018, BIOCHEM BIOPH RES CO, V495, P1890, DOI 10.1016/j.bbrc.2017.12.058; Choudhry H, 2015, ONCOGENE, V34, P4482, DOI 10.1038/onc.2014.378; Donnan GA, 2008, LANCET NEUROL, V7, P981, DOI 10.1016/S1474-4422(08)70230-8; Fancy SPJ, 2014, NAT NEUROSCI, V17, P506, DOI 10.1038/nn.3676; Gandhy SU, 2015, ONCOTARGET, V6, P26359, DOI 10.18632/oncotarget.4560; Gong W, 2016, ONCOTARGET, V7, P62208, DOI 10.18632/oncotarget.11403; Gu DM, 2015, BIOCHEM BIOPH RES CO, V457, P391, DOI 10.1016/j.bbrc.2015.01.002; Guo F, 2018, J CELL MOL MED, V22, P5062, DOI 10.1111/jcmm.13790; Hu ZP, 2016, BRAIN RES, V1644, P15, DOI 10.1016/j.brainres.2016.05.012; Huang MD, 2017, MOL THER, V25, P1014, DOI 10.1016/j.ymthe.2017.01.017; Huang W, 2017, INT IMMUNOPHARMACOL, V47, P134, DOI 10.1016/j.intimp.2017.03.030; Jang J.B., 2017, TANG, V7, pe14, DOI DOI 10.1038/srep41612; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Jiang L, 2018, BIOMED PHARMACOTHER, V107, P24, DOI 10.1016/j.biopha.2018.07.142; Jin R, 2013, J CARDIOVASC TRANSL, V6, P834, DOI 10.1007/s12265-013-9508-6; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Kiernan EA, 2016, J PHYSIOL-LONDON, V594, P1563, DOI 10.1113/JP271502; Knauss JL, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0840-2; Lakhan SE, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-97; Li GY, 2018, THERANOSTICS, V8, P2846, DOI 10.7150/thno.23463; Li RP, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao2387; Li WJ, 2017, J CLIN INVEST, V127, P3427, DOI 10.1172/JCI94233; Li X, 2018, CANCER RES, V78, P4138, DOI 10.1158/0008-5472.CAN-18-0688; Li Z, 2016, TUMOR BIOL, V37, P673, DOI 10.1007/s13277-015-3843-y; Liu F, 2017, ONCOTARGET, V8, P62927, DOI 10.18632/oncotarget.17757; Liu HT, 2018, CANCER RES, V78, P5877, DOI 10.1158/0008-5472.CAN-18-1011; Liu J, 2017, MOL NEUROBIOL, V54, P8179, DOI 10.1007/s12035-016-0270-z; Louro R, 2009, GENOMICS, V93, P291, DOI 10.1016/j.ygeno.2008.11.009; Lu ZL, 2018, CANCER LETT, V432, P156, DOI 10.1016/j.canlet.2018.06.013; Mehta SL, 2015, J NEUROSCI, V35, P16443, DOI 10.1523/JNEUROSCI.2943-15.2015; Micieli G, 2009, VASC HEALTH RISK MAN, V5, P397; Peng JH, 2017, SCI REP-UK, V7, DOI 10.1038/srep46577; Piccin D, 2011, STEM CELLS, V29, P528, DOI 10.1002/stem.589; Ponjavic J, 2007, GENOME RES, V17, P556, DOI 10.1101/gr.6036807; Ponting CP, 2010, HUM MOL GENET, V19, pR162, DOI 10.1093/hmg/ddq362; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Qi FZ, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0420-4; Qiu CW, 2018, EXP NEUROL, V309, P44, DOI 10.1016/j.expneurol.2018.07.011; Saura J, 2003, GLIA, V44, P183, DOI 10.1002/glia.10274; Suo T, 2018, BIOMED PHARMACOTHER, V108, P783, DOI 10.1016/j.biopha.2018.09.046; Taiana E, 2019, HAEMATOLOGICA, V104, pE72, DOI 10.3324/haematol.2018.201301; Tulsulkar J, 2017, BRAIN RES, V1662, P1, DOI 10.1016/j.brainres.2017.02.006; Wang CF, 2017, J NEUROTRAUM, V34, P2100, DOI 10.1089/neu.2016.4642; Wang JR, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00329; Wang X, 2016, J HEPATOL, V64, P1283, DOI 10.1016/j.jhep.2016.01.019; Wang YJ, 2017, ONCOTARGET, V8, P70156, DOI 10.18632/oncotarget.19596; White BD, 2010, STEM CELLS, V28, P297, DOI 10.1002/stem.268; Zeng CW, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0884-z; Zhang FF, 2016, J AUTOIMMUN, V75, P96, DOI 10.1016/j.jaut.2016.07.012; Zhang M, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0656-7; Zhang Q, 2013, MBIO, V4, DOI 10.1128/mBio.00596-12; Zhong JJ, 2017, BRAIN BEHAV IMMUN, V65, P183, DOI 10.1016/j.bbi.2017.05.001	59	17	17	2	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1071-2690	1543-706X		IN VITRO CELL DEV-AN	In Vitro Cell. Dev. Biol.-Anim.	AUG	2019	55	7					501	511		10.1007/s11626-019-00375-y			11	Cell Biology; Developmental Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Developmental Biology	IM3JC	WOS:000477888500004	31286366				2022-02-06	
J	Porras, DC; Sharon, H; Inzelberg, R; Ziv-Ner, Y; Zeilig, G; Plotnik, M				Porras, Desiderio Cano; Sharon, Hadar; Inzelberg, Rivka; Ziv-Ner, Yitzhak; Zeilig, Gabriel; Plotnik, Meir			Advanced virtual reality-based rehabilitation of balance and gait in clinical practice	THERAPEUTIC ADVANCES IN CHRONIC DISEASE			English	Article						posture; walking; virtual reality; Parkinson's disease; stroke; multiple sclerosis; brain injury; rehabilitation	OLDER-ADULTS; PHYSICAL-THERAPY; BRAIN-INJURY; VALIDATION; EXERCISE; STROKE; HEALTH	Background: Extensive research shows that virtual reality (VR) enhances motor learning and has advantages in balance and gait rehabilitation of neurological patients. There is still uncertainty, however, as for the practicality and efficacy of VR in long-term clinical routine. The objective of this study was to report on 3 years of clinical practice conducting VR-based rehabilitation of balance and gait in a large medical center. Methods: This retrospective study systematically analyzed clinical records of patients who received VR-based rehabilitation in a large rehabilitation center during 3 years. We evaluated the effect of VR-based rehabilitation treatments on balance and gait, cognitive dual-task load, patient's balance confidence (ABC-scale) and perception of suitability. Patients were either neurological patients, allocated to five groups: Parkinson's disease (PD), poststroke (PS), multiple sclerosis, traumatic brain injury, and 'other conditions', or non-neurological patients. Results: Records of 167 patients were analyzed. The availability of multiple VR systems and environments contributed to highly personalized interventions that tailored specific deficits with therapeutic goals. VR-based rehabilitation significantly improved balance and gait (measured by 10-Meter Walk Test, Timed-Up-and-Go, Berg Balance Scale, and Mini BESTest). Patients with PD and PS decreased dual-task cost while walking. Patients increased balance confidence and deemed VR suitable for rehabilitation. Conclusions: Our results suggest that VR-based rehabilitation is practicable and effective in clinical routine. Functional measures of balance and gait show significant improvements following VR-based interventions. Clinical approaches should exploit VR advantages for promoting motor learning and motivation. This study serves to aid transition to long-term clinical implementation of VR.	[Porras, Desiderio Cano; Sharon, Hadar; Inzelberg, Rivka; Plotnik, Meir] Sheba Med Ctr, Ctr Adv Technol Rehabil, Derech Sheba 2, IL-52621 Tel Hashomer, Israel; [Plotnik, Meir] Tel Aviv Univ, Dept Physiol & Pharmacol, Sackler Fac Med, Tel Aviv, Israel; [Inzelberg, Rivka; Plotnik, Meir] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Porras, Desiderio Cano] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Porras, Desiderio Cano] European Unions Horizons 2020 Res & Innovat Progr, Percept & Act Complex Environm, Marie Curie Int Training Network, Tel Aviv, Israel; [Inzelberg, Rivka] Tel Aviv Univ, Sackler Fac Med, Dept Neurol & Neurosurg, Tel Aviv, Israel; [Inzelberg, Rivka] Weizmann Inst Sci, Dept Appl Math & Comp Sci, Rehovot, Israel; [Ziv-Ner, Yitzhak] Sheba Med Ctr, Dept Orthoped Rehabil, Tel Hashomer, Israel; [Zeilig, Gabriel] Sheba Med Ctr, Dept Neurol Rehabil, Tel Hashomer, Israel; [Zeilig, Gabriel] Tel Aviv Univ, Sackler Fac Med, Dept Phys & Rehabil Med, Tel Aviv, Israel		Plotnik, M (corresponding author), Sheba Med Ctr, Ctr Adv Technol Rehabil, Derech Sheba 2, IL-52621 Tel Hashomer, Israel.; Plotnik, M (corresponding author), Tel Aviv Univ, Dept Physiol & Pharmacol, Sackler Fac Med, Tel Aviv, Israel.; Plotnik, M (corresponding author), Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel.	meir.plotnik@sheba.health.gov	Porras, Desiderio Cano/D-2661-2014	Porras, Desiderio Cano/0000-0002-2436-0102	European UnionEuropean Commission [642961]; Israel Science FoundationIsrael Science Foundation [1657-16]; Israel Ministry of Science Technology and Space grant [3-12072]; international training network Perception and Action in Complex Environments (PACE)	The author(s) disclosed receipt of the following financial support for the research, authorship, and publication of this article: The international training network Perception and Action in Complex Environments (PACE) supported this study, in part. The PACE Project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 642961. This study was also supported in part by the Israel Science Foundation grant #1657-16, and the Israel Ministry of Science Technology and Space grant #3-12072.	Adusumilli G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198178; Belchior P, 2012, ACT ADAPT AGING, V36, P269, DOI 10.1080/01924788.2012.702307; BERG KO, 1992, CAN J PUBLIC HEALTH, V83, pS7; Bohannon RW, 1997, AGE AGEING, V26, P15, DOI 10.1093/ageing/26.1.15; Darekar A, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0035-3; Diehr PH, 2013, J GERONTOL A-BIOL, V68, P1059, DOI 10.1093/gerona/glt038; Dite W, 2002, ARCH PHYS MED REHAB, V83, P1566, DOI 10.1053/apmr.2002.35469; Faria AL, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0204-z; Fritz NE, 2015, J NEUROL PHYS THER, V39, P142, DOI 10.1097/NPT.0000000000000090; Gil-Gomez JA, 2013, INT CONF PER COMP, P335, DOI 10.4108/icst.pervasivehealth.2013.252216; Greenwald BD, 2001, J HEAD TRAUMA REHAB, V16, P238, DOI 10.1097/00001199-200106000-00003; Hoogeboom TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038031; Huang YZ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/1941980; Kalron A, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0124-y; Kasser SL, 2015, DISABIL REHABIL, V37, P2238, DOI 10.3109/09638288.2015.1019008; Kenyon Robert V, 2004, J Neuroeng Rehabil, V1, P13, DOI 10.1186/1743-0003-1-13; Keshner EA, 2017, J VESTIBUL RES-EQUIL, V27, P1, DOI 10.3233/VES-170610; King LA, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/375419; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); Lawrence AB., 1990, FLOW PSYCHOL OPTIMAL; Levac D, 2011, PHYS THER, V91, P689, DOI 10.2522/ptj.20100415; Levac DE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168311; Levin MF, 2015, PHYS THER, V95, P415, DOI 10.2522/ptj.20130579; Lozano-Quilis JA, 2014, JMIR SERIOUS GAMES, V2, P43, DOI 10.2196/games.2933; Massano J, 2012, COLD SPRING HARB PER, V2012; MCDOWD JM, 1986, J GERONTOL, V41, P764, DOI 10.1093/geronj/41.6.764; Michael KM, 2005, ARCH PHYS MED REHAB, V86, P1552, DOI 10.1016/j.apmr.2004.12.026; Nilsagard YE, 2013, MULT SCLER J, V19, P209, DOI 10.1177/1352458512450088; O'Neil O, 2018, PM&R, V10, pS198, DOI 10.1016/j.pmrj.2018.08.375; Papegaaij S, 2017, CISC VIS NETW IND GL; Perez-Marcos D, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02120; Persson CU, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-83; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Porras DC, 2018, NEUROLOGY, V90, P1017, DOI 10.1212/WNL.0000000000005603; POWELL LE, 1995, J GERONTOL A-BIOL, V50, pM28, DOI 10.1093/gerona/50A.1.M28; Riva Giuseppe, 2004, J Neuroeng Rehabil, V1, P9, DOI 10.1186/1743-0003-1-9; Shema SR, 2014, PHYS THER, V94, P1319, DOI 10.2522/ptj.20130305; Skjaeret N, 2016, INT J MED INFORM, V85, P1, DOI 10.1016/j.ijmedinf.2015.10.008; Slaboda JC, 2009, IEEE ENG MED BIO, P1147, DOI 10.1109/IEMBS.2009.5333916; Stucki G, 2007, J REHABIL MED, V39, P279, DOI 10.2340/16501977-0041; You SH, 2005, STROKE, V36, P1166, DOI 10.1161/01.STR.0000162715.43417.91; Yu Y, 2019, J MOTOR BEHAV, V7, P1	42	17	18	3	23	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	2040-6223	2040-6231		THER ADV CHRONIC DIS	Ther. Adv. Chronic Dis.	AUG	2019	10								2040622319868379	10.1177/2040622319868379			16	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pharmacology & Pharmacy	IS8FM	WOS:000482385100001	31489154	gold, Green Published			2022-02-06	
J	De Luca, R; Maggio, MG; Maresca, G; Latella, D; Cannavo, A; Sciarrone, F; Lo Voi, E; Accorinti, M; Bramanti, P; Calabro, RS				De Luca, Rosaria; Maggio, Maria Grazia; Maresca, Giuseppa; Latella, Desiree; Cannavo, Antonino; Sciarrone, Francesca; Lo Voi, Emanuele; Accorinti, Maria; Bramanti, Placido; Calabro, Rocco Salvatore			Improving Cognitive Function after Traumatic Brain Injury: A Clinical Trial on the Potential Use of the Semi-Immersive Virtual Reality	BEHAVIOURAL NEUROLOGY			English	Article							REHABILITATION; MILD; ENVIRONMENTS	Traumatic brain injury (TBI) is the most common cause of long-term disability and death among young adults, and it represents an enormous socioeconomic and healthcare burden. Our purpose is to evaluate the effects of a virtual reality training with BTs-Nirvana (BTs-N) on the recovery of cognitive functions in TBI subjects, using the interactive semi-immersive program. One hundred patients with TBI were enrolled in this study and randomized into either the Traditional Cognitive Rehabilitation Group (TCRG: n=50) or the Virtual Reality Training Group (VRTG: n=50). The VRTG underwent a VRT with BTs-N, whereas the TCRG received a standard cognitive treatment. Each treatment session lasted 60 minutes and was repeated three times a week for 8 weeks. All of the patients were evaluated by a specific psychometric battery before (T0) and immediately (T1) after the end of the training. VRTG and TCRG had a significant improvement in cognitive functioning and in mood, but only VRTG presented with a significant increase in cognitive flexibility and shifting skills and in selective attention. In conclusion, our results suggest that VR may be a useful and effective approach for the rehabilitation of patients with TBI, leading to better cognitive and behavioral outcomes.	[De Luca, Rosaria; Maggio, Maria Grazia; Maresca, Giuseppa; Latella, Desiree; Cannavo, Antonino; Sciarrone, Francesca; Lo Voi, Emanuele; Accorinti, Maria; Bramanti, Placido; Calabro, Rocco Salvatore] IRCCS Ctr Neurolesi Bonino Pulejo, Messina, Italy		Calabro, RS (corresponding author), IRCCS Ctr Neurolesi Bonino Pulejo, Messina, Italy.	salbro77@tiscali.it	Calabro, Rocco S/K-7520-2016; Accorinti, Maria/AAB-1119-2021; Bramanti, Placido/K-5117-2016; Maggio, Maria Grazia/ABA-1852-2020; Maresca, Giusy/AAB-2242-2021; Voi, Emanuele Lo/AAK-6304-2020	Voi, Emanuele Lo/0000-0003-0755-042X; Bramanti, Placido/0000-0003-0394-8166; calabro, rocco salvatore/0000-0002-8566-3166; /0000-0003-0757-2389			Aida J, 2018, NEUROREHABILITATION, V42, P441, DOI 10.3233/NRE-172361; Barman A, 2016, INDIAN J PSYCHOL MED, V38, P172, DOI 10.4103/0253-7176.183086; Calabro RS, 2017, J NEUROENG REHABIL, V14, DOI 10.1186/s12984-017-0268-4; Chen SHA, 1997, BRAIN INJURY, V11, P197; Dahdah MN, 2017, NEUROREHABILITATION, V41, P721, DOI 10.3233/NRE-172183; De Luca R, 2018, J STROKE CEREBROVASC, V27, P1055, DOI 10.1016/j.jstrokecerebrovasdis.2017.11.008; De Luca R, 2018, INT J NEUROSCI, V128, P791, DOI 10.1080/00207454.2017.1403915; Doniger Glen M, 2018, Alzheimers Dement (N Y), V4, P118, DOI 10.1016/j.trci.2018.02.005; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Dvorkin AY, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-92; Galetto V, 2017, NEUROREHAB NEURAL RE, V31, P800, DOI 10.1177/1545968317723748; Hackenberg K, 2016, NERVENARZT, V87, P203, DOI 10.1007/s00115-015-0051-3; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Iaccarino C, 2018, J NEUROSURG SCI, V62, P535, DOI 10.23736/S0390-5616.18.04532-0; Inzaghi M. G., 2010, TEST WEIGL MANUALE; Jacoby M, 2013, IEEE T NEUR SYS REH, V21, P182, DOI 10.1109/TNSRE.2012.2235184; Latella D, 2018, J CLIN NEUROSCI, V58, P1, DOI 10.1016/j.jocn.2018.09.030; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maggio MG, 2018, PSYCHOGERIATRICS, V18, P427, DOI 10.1111/psyg.12333; Maggio MG, 2019, J NEUROSCI NURS, V51, P101, DOI 10.1097/JNN.0000000000000423; Maggio MG, 2019, J CLIN NEUROSCI, V61, P1, DOI 10.1016/j.jocn.2018.12.020; Maggio MG, 2018, J GERIATR PSYCH NEUR, V31, P312, DOI 10.1177/0891988718807973; Maggio MG, 2018, APPL NURS RES, V41, P11, DOI 10.1016/j.apnr.2018.03.005; Manivannan S, 2019, J HEAD TRAUMA REHAB, V34, pE52, DOI 10.1097/HTR.0000000000000412; Maresca G, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000013559; Martinez-Moreno JM, 2016, METHOD INFORM MED, V55, P50, DOI 10.3414/ME15-01-0050; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Pietrzak E, 2014, GAMES HEALTH J, V3, P202, DOI 10.1089/g4h.2014.0013; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Robitaille N, 2017, DISABIL REHABIL-ASSI, V12, P758, DOI 10.1080/17483107.2016.1229048; Russo M, 2018, INT J REHABIL RES, V41, P166, DOI 10.1097/MRR.0000000000000270; Sale A, 2009, TRENDS NEUROSCI, V32, P233, DOI 10.1016/j.tins.2008.12.004; Spinnler H., 1987, ITAL J NEUROL SCI, V6, P8; Werner JK, 2015, CURR OPIN NEUROL, V28, P565, DOI 10.1097/WCO.0000000000000265; Yamamoto S, 2018, CURR OPIN NEUROL, V31, P672, DOI 10.1097/WCO.0000000000000624	37	17	17	2	8	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	0953-4180	1875-8584		BEHAV NEUROL	Behav. Neurol.	JUL 30	2019	2019								9268179	10.1155/2019/9268179			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	IS5GE	WOS:000482179700001	31481980	Green Published, Green Submitted, gold			2022-02-06	
J	Frankel, M; Fan, LQ; Yeatts, SD; Jeromin, A; Vos, PE; Wagner, AK; Wolf, BJ; Pauls, Q; Lunney, M; Merck, LH; Hall, CL; Palesch, YY; Silbergleit, R; Wright, DW				Frankel, Michael; Fan, Liqiong; Yeatts, Sharon D.; Jeromin, Andreas; Vos, Pieter E.; Wagner, Amy K.; Wolf, Bethany J.; Pauls, Qi; Lunney, Michael; Merck, Lisa H.; Hall, Casey L.; Palesch, Yuko Y.; Silbergleit, Robert; Wright, David W.			Association of Very Early Serum Levels of S100B, Glial Fibrillary Acidic Protein, Ubiquitin C-terminal Hydrolase-L1, and Spectrin Breakdown Product with Outcome in ProTECT III	JOURNAL OF NEUROTRAUMA			English	Article						biomarker; GFAP; S100B; traumatic brain injury; UCH-L1	TRAUMATIC BRAIN-INJURY; PREDICTION; BIOMARKERS; GFAP; MANAGEMENT; DIAGNOSIS; MARKERS; DAMAGE	Rapid risk-stratification of patients with acute traumatic brain injury (TBI) would inform management decisions and prognostication. The objective of this serum biomarker study (Biomarkers of Injury and Outcome [BIO]-Progesterone for Traumatic Brain Injury, Experimental Clinical Treatment [ProTECT]) was to test the hypothesis that serum biomarkers of structural brain injury, measured at a single, very early time-point, add value beyond relevant clinical covariates when predicting unfavorable outcome 6 months after moderate-to-severe acute TBI. BIO-ProTECT utilized prospectively collected samples obtained from subjects with moderate-to-severe TBI enrolled in the ProTECT III clinical trial of progesterone. Serum samples were obtained within 4 h after injury. Glial fibrillary acidic protein (GFAP), S100B, alpha II-spectrin breakdown product of molecular weight 150 (SBDP150), and ubiquitin C-terminal hydrolase-L1 (UCH-L1) were measured. The association between log-transformed biomarker levels and poor outcome, defined by a Glasgow Outcome Scale-Extended (GOS-E) score of 1-4 at 6 months post-injury, were estimated via logistic regression. Prognostic models and a biomarker risk score were developed using bootstrapping techniques. Of 882 ProTECT III subjects, samples were available for 566. Each biomarker was associated with 6-month GOS-E (p < 0.001). Compared with a model containing baseline patient variables/characteristics, inclusion of S100B and GFAP significantly improved prognostic capacity (p <= 0.05 both comparisons); conversely, UCH-L1 and SBDP did not. A final predictive model incorporating baseline patient variables/characteristics and biomarker data (S100B and GFAP) had the best prognostic capability (area under the curve [AUC] = 0.85, 95% confidence interval [CI]: CI 0.81-0.89). Very early measurements of brain-specific biomarkers are independently associated with 6-month outcome after moderate-to-severe TBI and enhance outcome prediction.	[Frankel, Michael; Hall, Casey L.] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30303 USA; [Frankel, Michael; Hall, Casey L.; Wright, David W.] Grady Hosp, Atlanta, GA USA; [Wright, David W.] Emory Univ, Sch Med, Dept Emergency Med, Atlanta, GA 30303 USA; [Fan, Liqiong] Novartis Inst Biomed Res, Cambridge, MA USA; [Yeatts, Sharon D.; Wolf, Bethany J.; Pauls, Qi; Palesch, Yuko Y.] Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA; [Jeromin, Andreas] Quanterix Corp, Lexington, MA USA; [Vos, Pieter E.] Slingeland Hosp Doetinchem, Dept Neurol, Doetinchem, Netherlands; [Wagner, Amy K.] Univ Pittsburgh, Dept Phys Med & Rehabil & Neurosci, Pittsburgh, PA USA; [Lunney, Michael] Piedmont Heart Inst, Atlanta, GA USA; [Merck, Lisa H.] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Div Emergency Neurosci & Crit Care Res, Providence, RI 02903 USA; [Silbergleit, Robert] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA		Frankel, M (corresponding author), Emory Univ, Grady Hosp, Sch Med, Dept Neurol, 80 Jesse Hill Jr Dr SE, Atlanta, GA 30303 USA.	mfranke@emory.edu		Wolf, Bethany/0000-0002-7124-5158	National Institutes of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R01NS071867]; National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS062778, 5U10NS059032, U01NS056975, R01 NS071867]; National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000454]; Emory Emergency Neurosciences Laboratory in the Department of Emergency Medicine, Emory School of Medicine, and Grady Memorial Hospital; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U10NS059032] Funding Source: NIH RePORTER	This study received funding from the National Institutes of Neurological Disorders and Stroke 1R01NS071867 (PI: Michael Frankel, Emory University). It was partially supported by grants from the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NS062778, 5U10NS059032, and U01NS056975, R01 NS071867) and the National Center for Advancing Translational Sciences of the National Institutes of Health (UL1TR000454), and by the Emory Emergency Neurosciences Laboratory in the Department of Emergency Medicine, Emory School of Medicine, and Grady Memorial Hospital.	BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 1984, CLASSIFICATION REGRE; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cartier AE, 2009, J NEUROSCI, V29, P7857, DOI 10.1523/JNEUROSCI.1817-09.2009; EFRON B, 1983, J AM STAT ASSOC, V78, P316, DOI 10.2307/2288636; Freund Y., 1999, JAPANESE SOC ART INT, V14, P1612; Goyal A, 2013, J NEUROTRAUM, V30, P946, DOI 10.1089/neu.2012.2579; Hergenroeder GW, 2008, MOL DIAGN THER, V12, P345, DOI 10.2165/1250444-200812060-00002; Herrmann M, 2000, J NEUROTRAUM, V17, P113, DOI 10.1089/neu.2000.17.113; Huh GY, 2001, NEUROSCI LETT, V316, P41, DOI 10.1016/S0304-3940(01)02371-0; ISOBE T, 1984, J NEUROCHEM, V43, P1494, DOI 10.1111/j.1471-4159.1984.tb05415.x; Liedtke W, 1996, NEURON, V17, P607, DOI 10.1016/S0896-6273(00)80194-4; Liu MC, 2010, EUR J NEUROSCI, V31, P722, DOI 10.1111/j.1460-9568.2010.07097.x; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Meier TB, 2017, J NEUROTRAUM, V34, P3134, DOI 10.1089/neu.2017.5046; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Mondello S, 2011, EXPERT REV MOL DIAGN, V11, P65, DOI 10.1586/ERM.10.104; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; National Center for Health Statistics, 2002, NAT HOSP AMB MED CAR; Papa L, 2015, NEUROCRIT CARE, V22, P52, DOI 10.1007/s12028-014-0028-2; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Pelinka LE, 2004, J TRAUMA, V57, P1006, DOI 10.1097/01.TA.0000108998.48026.C3; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; RIEDERER BM, 1986, J CELL BIOL, V102, P2088, DOI 10.1083/jcb.102.6.2088; Sattar Abdus, 2012, J Biom Biostat, VSuppl 3, DOI 10.4172/2155-6180.S3-002; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Tsimikas JV, 2012, COMPUT STAT DATA AN, V56, P1854, DOI 10.1016/j.csda.2011.11.010; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Wagner Amy K, 2013, Pathophysiology, V20, P39, DOI 10.1016/j.pathophys.2012.02.007; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Zomzely-Neurath C.E., 1980, PROTEINS NERVOUS SYS, P1	37	17	18	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2019	36	20					2863	2871		10.1089/neu.2018.5809		JUL 2019	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	JC0JD	WOS:000476347400001	30794101	Green Published			2022-02-06	
J	Berke, DS; Kline, NK; Wachen, JS; McLean, CP; Yarvis, JS; Mintz, J; Young-McCaughan, S; Petersong, AL; Foa, E; Resick, PA; Litz, BT				Berke, Danielle S.; Kline, Nora K.; Wachen, Jennifer Schuster; McLean, Carmen P.; Yarvis, Jeffrey S.; Mintz, Jim; Young-McCaughan, Stacey; Petersong, Alan L.; Foa, Edna; Resick, Patricia A.; Litz, Brett T.		STRONG STAR Consortium	Predictors of attendance and dropout in three randomized controlled trials of PTSD treatment for active duty service members	BEHAVIOUR RESEARCH AND THERAPY			English	Article						PTSD; Clinical trial; Attendance; Dropout; Active duty service members	POSTTRAUMATIC-STRESS-DISORDER; COGNITIVE-PROCESSING THERAPY; TRAUMATIC BRAIN-INJURY; MENTAL-HEALTH-CARE; PROLONGED EXPOSURE; PSYCHOMETRIC PROPERTIES; CLINICAL-SIGNIFICANCE; IDENTIFICATION TEST; BEHAVIORAL THERAPY; SELF-REPORT	Dropout from first-line posttraumatic stress disorder (PTSD) treatments is a significant problem. We reported rates and predictors of attendance and dropout in three clinical trials of evidence-based PTSD treatments in military service members (N = 557). Service members attended 81.0% of treatment sessions and 30.7% dropped out. Individually delivered treatment was associated with greater attendance rates (beta = 0.23, p < .001) than group therapy; trauma-focused treatments were associated with higher dropout (beta = 0.19, p < .001) than Present-Centered Therapy. Age was a significant predictor of session attendance (beta = 0.17, p < .001) and drop out (beta = -0.23, p < .001). History of traumatic brain injury (TBI) predicted lower attendance rates (beta = -0.26, p < .001) and greater dropout (beta = 0.19, p < .001). Regardless of treatment type or format, patients who did not drop out were more likely to experience clinically significant gains (d = 0.49, p < .001). Results demonstrate that dropout from PTSD treatments in these trials was significantly associated with treatment outcome and suggest that strategies are needed to mitigate dropout, particularly in group and trauma-focused therapies, and among younger service members and those with TBI.	[Berke, Danielle S.; Kline, Nora K.; Litz, Brett T.] VA Boston Healthcare Syst, Massachusetts Vet Epidemiol Res & Informat Ctr, Boston, MA USA; [Berke, Danielle S.; Wachen, Jennifer Schuster; Litz, Brett T.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Wachen, Jennifer Schuster] VA Boston Healthcare Syst, Natl Ctr, PTSD, Boston, MA USA; [McLean, Carmen P.] VA Palo Alto Healthcare Syst, PTSD, Natl Ctr, Menlo Pk, CA USA; [McLean, Carmen P.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Yarvis, Jeffrey S.] Carl R Darnall Army Med Ctr, Ft Hood, TX USA; [Mintz, Jim; Young-McCaughan, Stacey; Petersong, Alan L.] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA; [Mintz, Jim] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA; [Petersong, Alan L.] South Texas Vet Hlth Care Syst, Res & Dev Serv, San Antonio, TX USA; [Petersong, Alan L.] Univ Texas San Antonio, Dept Psychol, San Antonio, TX USA; [Foa, Edna] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA; [Resick, Patricia A.] Duke Univ, Med Ctr, Durham, NC USA; [Litz, Brett T.] Boston Univ, Dept Psychol & Brain Sci, Boston, MA 02215 USA; [Berke, Danielle S.] CUNY Hunter Coll, New York, NY 10021 USA; [Kline, Nora K.] Clark Univ, Worcester, MA 01610 USA; [Yarvis, Jeffrey S.] 21st Combat Support Hosp, Ft Hood, TX USA		Berke, DS (corresponding author), VA Healthcare Syst, 150 South Huntington Ave, Boston, MA 02130 USA.	db2800@hunter.cuny.edu; nkline@clarku.edu; jennifer.wachen@va.gov; carmen.mclean4@va.gov; jeffrey.s.yarvis.mil@mail.mil; mintz@uthscsa.edu; youngs1@uthscsa.edu; petersona3@uthscsa.edu; foa@pennmedicine.upenn.edu; patricia.resick@duke.edu; brett.litz@va.gov		McLean, Carmen/0000-0003-4322-9318	U.S. Department of Defense through the U.S. Army Medical Research and Materiel Command, Congressionally Directed Medical Research Programs, Psychological Health and Traumatic Brain Injury Research Program [W81XWH-08-02-109, W81XWH-08-02-0111, W81XWH-08-02-0114, W81XWH-08-02-0116]	This work was supported by the U.S. Department of Defense through the U.S. Army Medical Research and Materiel Command, Congressionally Directed Medical Research Programs, Psychological Health and Traumatic Brain Injury Research Program awards W81XWH-08-02-109 (Alan Peterson), W81XWH-08-02-0111 (Edna Foa), W81XWH-08-02-0114 (Brett Litz), and W81XWH-08-02-0116 (Patricia Resick).	Babor T.F., 2001, AUDIT THE ALCOHOL US; Barnes J.B, 2019, MIL MED, V184, pe218, DOI [10.1093/milmed/usy226, DOI 10.1093/MILMED/USY226, https://doi.org/10.1093/milmed/usy226]; Bauer S, 2004, J PERS ASSESS, V82, P60, DOI 10.1207/s15327752jpa8201_11; Beck A., 1996, MANUAL BDI 2; Bovin MJ, 2016, PSYCHOL ASSESSMENT, V28, P1379, DOI 10.1037/pas0000254; Bradley R, 2005, AM J PSYCHIAT, V162, P214, DOI 10.1176/appi.ajp.162.2.214; Cabin R.J., 2000, B ECOLOGICAL SOC AM, V81, P246; Chard KM, 2010, J TRAUMA STRESS, V23, P25, DOI 10.1002/jts.20500; Clinical Data Interchange Standards Consortium, 2011, CDISC IND COLL GROUP; Compas BE, 2015, J CONSULT CLIN PSYCH, V83, P541, DOI 10.1037/a0039053; Davis JJ, 2013, REHABIL PSYCHOL, V58, P36, DOI 10.1037/a0031525; Department of Veterans Affairs, 2017, VA DOD CLIN PRACT GU; Devilly GJ, 2000, J BEHAV THER EXP PSY, V31, P73, DOI 10.1016/S0005-7916(00)00012-4; Ehlers A, 2013, BEHAV RES THER, V51, P742, DOI 10.1016/j.brat.2013.08.006; Foa EB, 1999, J CONSULT CLIN PSYCH, V67, P194, DOI 10.1037/0022-006X.67.2.194; Foa EB, 2002, J CONSULT CLIN PSYCH, V70, P1022, DOI 10.1037//0022-006X.70.4.1022; Foa EB, 2018, JAMA-J AM MED ASSOC, V319, P354, DOI 10.1001/jama.2017.21242; Galovski TE, 2012, J CONSULT CLIN PSYCH, V80, P968, DOI 10.1037/a0030600; Garcia HA, 2011, PSYCHOL SERV, V8, P1, DOI 10.1037/a0022705; Geiser C., 2013, DATA ANAL MPLUS; Gros DF, 2011, BEHAV THER, V42, P276, DOI 10.1016/j.beth.2010.07.005; Hembree EA, 2003, J TRAUMA STRESS, V16, P555, DOI 10.1023/B:JOTS.0000004078.93012.7d; Hoge CW, 2017, JAMA PSYCHIAT, V74, P13, DOI 10.1001/jamapsychiatry.2016.2740; Hoge CW, 2014, PSYCHIAT SERV, V65, P997, DOI 10.1176/appi.ps.201300307; Imel ZE, 2013, J CONSULT CLIN PSYCH, V81, P394, DOI 10.1037/a0031474; Interagency Taskforce on Military and Veterans Mental Health, 2013, NAT RES ACT PLAN RES; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Jeffreys MD, 2014, J ANXIETY DISORD, V28, P108, DOI 10.1016/j.janxdis.2013.04.010; Kehle-Forbes SM, 2016, PSYCHOL TRAUMA-US, V8, P107, DOI 10.1037/tra0000065; Kim PY, 2010, PSYCHIAT SERV, V61, P582, DOI 10.1176/ps.2010.61.6.582; Kok BC, 2012, J NERV MENT DIS, V200, P444, DOI 10.1097/NMD.0b013e3182532312; Lambert M. J, 2011, PSYCHOTHERAPY RELATI; Luke D.A., 2004, MULTILEVEL MODELING, VVol. 143; Martinovich Z, 1996, PSYCHOTHER RES, V6, P124, DOI 10.1080/10503309612331331648; Mott JM, 2014, J TRAUMA STRESS, V27, P265, DOI 10.1002/jts.21927; Najavits Lisa M, 2015, F1000Prime Rep, V7, P43, DOI 10.12703/P7-43; Palmer GA, 2014, MIL MED, V179, P879, DOI 10.7205/MILMED-D-14-00048; Price M, 2015, DEPRESS ANXIETY, V32, P392, DOI 10.1002/da.22354; Reinert DF, 2007, ALCOHOL CLIN EXP RES, V31, P185, DOI 10.1111/j.1530-0277.2006.00295.x; Resick PA, 2002, J CONSULT CLIN PSYCH, V70, P867, DOI 10.1037//0022-006X.70.4.867; Resick PA, 2017, JAMA PSYCHIAT, V74, P28, DOI 10.1001/jamapsychiatry.2016.2729; Resick PA, 2015, J CONSULT CLIN PSYCH, V83, P1058, DOI 10.1037/ccp0000016; Rizvi SL, 2009, BEHAV RES THER, V47, P737, DOI 10.1016/j.brat.2009.06.003; Sareen J, 2007, ARCH GEN PSYCHIAT, V64, P843, DOI 10.1001/archpsyc.64.7.843; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schnurr PP, 2003, ARCH GEN PSYCHIAT, V60, P481, DOI 10.1001/archpsyc.60.5.481; Scholten J, 2017, BRAIN INJURY, V31, P1246, DOI 10.1080/02699052.2016.1274780; Schottenbauer MA, 2008, PSYCHIATRY, V71, P134, DOI 10.1521/psyc.2008.71.2.134; Schwab KA, 2006, NEUROLOGY, V66, pA235; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Sloan DM, 2013, PSYCHOL TRAUMA-US, V5, P176, DOI 10.1037/a0026291; Society of Clinical Psychology, 2012, PRES CTR THER POSTTR; Steenkamp MM, 2015, JAMA-J AM MED ASSOC, V314, P489, DOI 10.1001/jama.2015.8370; Sterba SK, 2017, PSYCHOTHER RES, V27, P425, DOI 10.1080/10503307.2015.1114688; Szafranski DD, 2017, J ANXIETY DISORD, V47, P91, DOI 10.1016/j.janxdis.2017.01.002; Szafranski DD, 2014, PSYCHIATRY, V77, P263, DOI 10.1521/psyc.2014.77.3.263; Taylor S, 2003, J CONSULT CLIN PSYCH, V71, P330, DOI 10.1037/0022-006X.71.2.330; Tuerk PW, 2013, PSYCHOL SERV, V10, P401, DOI 10.1037/a0030549; van Minnen A, 2002, J TRAUMA STRESS, V15, P359, DOI 10.1023/A:1020177023209; van Minnen A, 2002, BEHAV RES THER, V40, P439, DOI 10.1016/S0005-7967(01)00024-9; van Minnen A, 2006, J TRAUMA STRESS, V19, P427, DOI 10.1002/jts.20146; Watts BV, 2013, J CLIN PSYCHIAT, V74, pE541, DOI 10.4088/JCP.12r08225; Weathers F. W., 1993, 9 ANN M INT SOC TRAU; Wright KM, 2009, PSYCHOL SERV, V6, P108, DOI 10.1037/a0012620; Zandberg LJ, 2016, BEHAV RES THER, V80, P1, DOI 10.1016/j.brat.2016.02.005; Zayfert C, 2005, J TRAUMA STRESS, V18, P637, DOI 10.1002/jts.20072	66	17	19	2	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0005-7967	1873-622X		BEHAV RES THER	Behav. Res. Ther.	JUL	2019	118						7	17		10.1016/j.brat.2019.03.003			11	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	ID5TJ	WOS:000471738600002	30933748				2022-02-06	
J	Rashno, M; Sarkaki, A; Farbood, Y; Rashno, M; Khorsandi, L; Naseri, MKG; Dianat, M				Rashno, Masome; Sarkaki, Alireza; Farbood, Yaghoob; Rashno, Mohammad; Khorsandi, Layasadat; Naseri, Mohammad Kazem Gharib; Dianat, Mahin			Therapeutic effects of chrysin in a rat model of traumatic brain injury: A behavioral, biochemical, and histological study	LIFE SCIENCES			English	Article						Traumatic brain injury; Chrysin; Learning and memory; Motor coordination; Oxidative stress; Apoptosis	MILD HEAD-INJURY; OXIDATIVE STRESS; DEFICITS; APOPTOSIS; ACID; PATHOPHYSIOLOGY; NANOPARTICLES	Aims: Oxidative stress and apoptosis have major roles in the progression of traumatic brain injury (TBI)-associated motor and cognitive deficits. The present study was aimed to elucidate the putative effects of chrysin, a natural flavonoid compound, against TBI-induced motor and cognitive dysfunctions and possible involved mechanisms. Main methods: Chrysin (25, 50 or 100 mg/kg) was orally administered to rats starting immediately following TBI induction by Marmarou's weight-drop technique and continuously for 3 or 14 days. Neurological functions, motor coordination, learning and memory performances, histological changes, cell apoptosis, expression of pro-and anti-apoptotic proteins, and oxidative status were assayed at scheduled time points after experimental TBI. Key findings: The results indicated that treatment with chrysin improved learning and memory disabilities in passive avoidance task, and ameliorated motor coordination impairment in rotarod test after TBI. These beneficial effects were accompanied by increased the concentrations of superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), glutathione (GSH), decreased malondialdehyde (MDA) content, prevented neuronal loss, diminished apoptotic index, elevated the expression of anti-apoptotic Bcl-2 protein, and reduced the expression of pro-apoptotic Bax protein in the cerebral cortex and hippocampus tissues. Significance: Our findings suggest that both anti-oxidative and anti-apoptotic properties of chrysin (especially in the dose of 100 mg/kg) are possible mechanisms that improve cognitive/motor deficits and prevent neuronal cell death after TBI.	[Rashno, Masome; Sarkaki, Alireza; Farbood, Yaghoob; Naseri, Mohammad Kazem Gharib; Dianat, Mahin] Ahvaz Jundishapur Univ Med Sci, Fac Med, Physiol Res Ctr, Dept Physiol, Ahvaz, Iran; [Rashno, Mohammad] Ahvaz Jundishapur Univ Med Sci, Fac Med, Dept Immunol, Ahvaz, Iran; [Rashno, Mohammad; Khorsandi, Layasadat] Ahvaz Jundishapur Univ Med Sci, Cellular & Mol Res Ctr, Ahvaz, Iran		Sarkaki, A (corresponding author), Ahvaz Jundishapur Univ Med Sci, Physiol Res Ctr, Farvardin Blvd,Box 45, Ahvaz 6135715794, Iran.	sarkaki_a@ajums.ac.ir	Farbood, Yaghoob/M-3076-2017; Khorsandi, Layasadat/R-3901-2017; Rashno, Masome/AAW-6382-2020	Farbood, Yaghoob/0000-0002-6390-0079; Khorsandi, Layasadat/0000-0002-3391-3055; Rashno, Masome/0000-0002-1290-3499; rashno, mohammad/0000-0001-5473-1384	Ahvaz Physiology Research Center - Ahvaz Jundishapur University of Medical Sciences (Iran) [APRC-9605]	This article was extracted as a part of Masome Rashno's Ph.D. thesis. This work was supported by a grant (APRC-9605) from Ahvaz Physiology Research Center, funded by the Vice Chancellor of Research, Ahvaz Jundishapur University of Medical Sciences (Iran).	Aishwarya V., 2015, INT J PHARMACOGN PHY, V7, P224; Anand KV, 2011, TOXICOL IND HEALTH, V27, P923, DOI 10.1177/0748233711399324; Anitha T. A., 2014, Biomedicine & Preventive Nutrition, V4, P511; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BOHNEN N, 1994, BRAIN INJURY, V8, P701, DOI 10.3109/02699059409151024; Chang C, 2018, INT J HUM-COMPUT ST, V117, P4, DOI 10.1016/j.ijhcs.2018.02.006; Farbood Y, 2015, LIFE SCI, V124, P120, DOI 10.1016/j.lfs.2015.01.013; Garbarino VR, 2015, ARCH BIOCHEM BIOPHYS, V576, P8, DOI 10.1016/j.abb.2015.01.029; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; He HF, 2018, DRUG DES DEV THER, V12, P629, DOI 10.2147/DDDT.S158313; Huang YN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19654-x; HUMAYUN MS, 1989, NUCL MED COMMUN, V10, P335, DOI 10.1097/00006231-198905000-00004; Ignowski E, 2018, FREE RADICAL BIO MED, V124, P328, DOI 10.1016/j.freeradbiomed.2018.06.026; Kandhare AD, 2014, J NAT MED-TOKYO, V68, P586, DOI 10.1007/s11418-014-0840-1; Khoshnam SE, 2018, LIFE SCI, V211, P126, DOI 10.1016/j.lfs.2018.08.065; Kroemer G, 1997, NAT MED, V3, P614, DOI 10.1038/nm0697-614; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007868; Leeds PR, 2014, ACS CHEM NEUROSCI, V5, P422, DOI 10.1021/cn500040g; Malkesman O, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00157; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Miotto EC, 2010, ARQ NEURO-PSIQUIAT, V68, P862, DOI 10.1590/S0004-282X2010000600006; Nagababu E, 2003, BBA-GEN SUBJECTS, V1620, P211, DOI 10.1016/S0304-4165(02)00537-8; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Orazizadeh M, 2014, CHEM-BIOL INTERACT, V220, P214, DOI 10.1016/j.cbi.2014.07.001; Pawlak A, 2018, BIOORG MED CHEM LETT, V28, P1171, DOI 10.1016/j.bmcl.2018.03.006; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; Tabatabaei SRF, 2017, BIOMED PHARMACOTHER, V96, P279, DOI 10.1016/j.biopha.2017.09.146; Thangarajan S, 2016, BIOMED PHARMACOTHER, V84, P514, DOI 10.1016/j.biopha.2016.09.070; Vedagiri A, 2016, NEUROPEPTIDES, V58, P111, DOI 10.1016/j.npep.2016.03.002; Wyllie AH, 1997, BRIT MED BULL, V53, P451; Xiao J, 2014, NEUROSCIENCE, V262, P156, DOI 10.1016/j.neuroscience.2014.01.004; Zeinali M, 2017, BIOMED PHARMACOTHER, V92, P998, DOI 10.1016/j.biopha.2017.06.003; Zink BJ, 2010, PSYCHIAT CLIN N AM, V33, P741, DOI 10.1016/j.psc.2010.08.005; 2002, NEUROIMAGING CLIN N, V12, P175; 1993, J NEUROPHYSIOL, V70, P733; 2014, INT J MOL SCI, V15, P1227, DOI DOI 10.3390/IJMS150712270; 2015, PHARM BIOCH BEHAV, V134, P22, DOI DOI 10.1016/J.PBB.2015.04.010; 2014, IRAN BIOMED J, V18, P101, DOI DOI 10.6091/IBJ.12912.2013; 2004, PROG NEUROPSYCHOPHAR, V28, P771, DOI DOI 10.1016/J.PNPBP.2004.05.023; 2006, INT J DEV NEUROSCI, V24, P357, DOI DOI 10.1016/J.IJDEVNEU.2006.08.003; 2012, J SAFETY RES, V43, P299, DOI DOI 10.1016/J.JSR.2012.08.011; 1999, J NEUROL NEUROSURG P, V66, P207; 2017, EXP THER MED, V13, P2247, DOI DOI 10.3892/ETM.2017.4283; 2014, BIOCHEM PHARMACOL, V89, P503, DOI DOI 10.1016/J.BCP.2014.03.016; 2010, PHYSIOL BEHAV, V101, P660, DOI DOI 10.1016/J.PHYSBEH.2010.09.021; 2013, NAT REV NEUROL, V9, P222, DOI DOI 10.1038/NRNEUROL.2013.33; 2010, J NEUROTRAUM, V27, P1585, DOI DOI 10.1089/NEU.2010.1298; 2004, J NEUROTRAUMA, V21, P1712; 2018, CHEM-BIOL INTERACT, V279, P111, DOI DOI 10.1016/J.CBI.2017.10.019; 2014, INT J MOL SCI, V15, P1216, DOI DOI 10.3390/IJMS15011216; 2014, J EXERC REHABIL, V10, P148, DOI DOI 10.12965/JER.140109; 1990, CANC RES, V50, P7057; 2005, LEARN MEMORY, V12, P375, DOI DOI 10.1101/LM.81905; 2007, ANN ACAD MED SINGAP, V36, P31; 2004, SURGERY, V136, P355, DOI DOI 10.1016/J.SURG.2004.05.011; 2010, NEUROTHERAPEUTICS, V7, P3; 2010, NAT REV NEUROL, V6, P393, DOI DOI 10.1038/NRNEUROL.2010.74; 2015, CAN J PHYSL PHARM, V93, P687, DOI DOI 10.1139/CJPP-2014-0546; 2012, EUR J PHARMACOL, V680, P41, DOI DOI 10.1016/J.EJPHAR.2012.01.025; 2009, MUTAT RES-GEN TOX EN, V674, P137, DOI DOI 10.1016/J.MRGENTOX.2008.09.015; 2008, NEUROPSYCHOLOGY, V22, P618, DOI DOI 10.1037/0894-4105.22.5.618; 2016, J ETHNOPHARMACOL, V185, P87, DOI DOI 10.1016/J.JEP.2016.03.018; 2016, J AGR FOOD CHEM, V64, P5324, DOI DOI 10.1021/ACS.JAFC.6B01707; 2010, TRENDS PHARMACOL SCI, V31, P596, DOI DOI 10.1016/J.TIPS.2010.09.005; 2010, NEUROSCI LETT, V485, P143, DOI DOI 10.1016/J.NEULET.2010.08.064; 2014, INT J MOL SCI, V15, P2091, DOI DOI 10.3390/IJMS151120913; 2006, FREE RADIC BIOL MED, V41, P1694, DOI DOI 10.1016/J.FREERADBIOMED.2006.09.002; 2004, BIOL TRACE ELEM RES, V101, P73; 2019, LIFE SCI, V225, P8, DOI DOI 10.1016/J.LFS.2019.03.078	72	17	17	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0024-3205	1879-0631		LIFE SCI	Life Sci.	JUL 1	2019	228						285	294		10.1016/j.lfs.2019.05.007			10	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine; Pharmacology & Pharmacy	HY5RO	WOS:000468185400032	31063733				2022-02-06	
J	Sufrinko, AM; Kegel, NE; Mucha, A; Collins, MW; Kontos, AP				Sufrinko, Alicia M.; Kegel, Nathan E.; Mucha, Anne; Collins, Michael W.; Kontos, Anthony P.			History of High Motion Sickness Susceptibility Predicts Vestibular Dysfunction Following Sport/Recreation-Related Concussion	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; motion sickness susceptibility; neurocognitive; vestibular; ocular motor	POSTTRAUMATIC MIGRAINE; BASE-LINE; RELIABILITY; IMPACT; SYSTEM; DISORDERS; CONSTRUCT; RECOVERY; VALIDITY; BATTERY	Objective: To compare vestibular dysfunction at 1 to 10 and 11 to 20 days following sport/recreation-related concussion (SRC) in athletes with and without history of motion sickness susceptibility. Secondary aims of this study were to investigate differences in neurocognitive performance and affective symptoms in these groups. Design: Cross-sectional. Setting: Concussion Specialty Clinic. Participants: One hundred twenty-four adolescents and adults (82 males, 42 females) aged 14 to 26 (16.3 +/- 62.10) years, diagnosed with SRC in the past 10 (4.56 +/- 2.54) days; 47 participants composed the sample for quartile analyses. Independent Variable: Motion sickness susceptibility questionnaire short form score. Main Outcome Measures: Computerized neurocognitive test scores, vestibular/oculomotor screening scores (VOMS), and symptom factor scores from a standardized concussion symptom inventory. Results: There was no association between history of motion sickness susceptibility and VOMS scores (above or below clinical cutoff) at 1 to 10 days after injury, although at 11 to 20 days after injury there was an association between high motion sickness susceptibility and symptoms above clinical cutoff on 5 of the 6 VOMS items (P values 0.01-0.04). The high motion sickness group had more affective symptoms on the symptom inventory than the no motion sickness group (P=0.002) at 1 to 10 days after injury. Groups did not differ on computerized neurocognitive testing (P = 0.11). Conclusion: Athletes with a preexisting history of motion sensitivity may exhibit more prolonged vestibular dysfunction following SRC, and may experience more affective symptoms early in recovery.	[Sufrinko, Alicia M.; Kegel, Nathan E.; Collins, Michael W.; Kontos, Anthony P.] Univ Pittsburgh, Med Ctr, Dept Orthopaed Surg, UPMC Sports Med Concuss Program, Pittsburgh, PA USA; [Mucha, Anne] UPMC Ctr Rehabil Serv, Pittsburgh, PA USA		Sufrinko, AM (corresponding author), UPMC Ctr Sports Med, 3200 South Water St, Pittsburgh, PA 15203 USA.	sufrinkoam@upmc.edu					Alhilali LM, 2014, RADIOLOGY, V272, P224, DOI 10.1148/radiol.14132670; Allen BJ, 2011, BRAIN INJURY, V25, P179, DOI 10.3109/02699052.2010.541897; Anzalone AJ, 2016, AM J SPORTS MED, V45, P36; Chen YC, 2013, GAIT POSTURE, V38, P795, DOI 10.1016/j.gaitpost.2013.03.023; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Cullen KE, 2012, TRENDS NEUROSCI, V35, P185, DOI 10.1016/j.tins.2011.12.001; Elbin R, 2015, PERSPECT NEUROPHYSIO, V25, P4, DOI DOI 10.1044/NNSLD25.1.4; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Furman JM, 2011, J HEADACHE PAIN, V12, P81, DOI 10.1007/s10194-010-0250-z; Golding JF, 2006, PERS INDIV DIFFER, V41, P237, DOI 10.1016/j.paid.2006.01.012; Golding JF, 2015, CURR OPIN NEUROL, V28, P83, DOI 10.1097/WCO.0000000000000163; Gurvich C, 2013, BRAIN RES, V1537, P244, DOI 10.1016/j.brainres.2013.08.058; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Jeong SH, 2010, J NEUROL, V257, P905, DOI 10.1007/s00415-009-5435-5; Kolev OI, 2016, FUNCT NEUROL, V31, P75; Kontos AP, 2016, AM J SPORT MED, V44, P1400, DOI 10.1177/0363546516632754; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Maerlender A, 2010, CLIN NEUROPSYCHOL, V24, P1309, DOI 10.1080/13854046.2010.516072; Mast FW, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00044; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Miller JR, 2007, AM J SPORT MED, V35, P1284, DOI 10.1177/0363546507300261; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Rajagopalan Archana, 2017, J Nat Sci Biol Med, V8, P11, DOI 10.4103/0976-9668.198350; Saman Yougan, 2012, Front Neurol, V3, P116, DOI 10.3389/fneur.2012.00116; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Scopaz KA, 2013, SPORTS HEALTH, V5, P537, DOI 10.1177/1941738112473059; Smith PF, 2017, CURR OPIN NEUROL, V30, P84, DOI 10.1097/WCO.0000000000000403; Sufrinko A, 2018, J HEAD TRAUMA REHAB, V33, P7, DOI 10.1097/HTR.0000000000000315; Yorke AM, 2017, SPORTS HEALTH, V9, P174, DOI 10.1177/1941738116678411	36	17	18	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JUL	2019	29	4					318	323		10.1097/JSM.0000000000000528			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Physiology; Sport Sciences	IQ4RL	WOS:000480737900012	31241535				2022-02-06	
J	Zhang, M; Teng, CH; Wu, FF; Ge, LY; Xiao, J; Zhang, HY; Chen, DQ				Zhang, Man; Teng, Chen-Huai; Wu, Fang-Fang; Ge, Li-Yun; Xiao, Jian; Zhang, Hong-Yu; Chen, Da-Qing			Edaravone attenuates traumatic brain injury through anti-inflammatory and anti-oxidative modulation	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						traumatic brain injury; edaravone; oxidative stress; inflammatory response	OXIDATIVE STRESS; ACTIVATION; EXPRESSION; PATHWAY; NEUROINFLAMMATION; NEUROPROTECTION; CONSEQUENCES; APOPTOSIS; RESPONSES; MODELS	Traumatic brain injury (TBI) is among the leading causes of irreversible neurological damage and death worldwide. The aim of the present study was to investigate whether edaravone (EDA) had a neuroprotective effect on TBI as well as to identify the potential mechanism. Results demonstrated that EDA suppressed inflammatory and oxidative responses in mice following TBI. This was evidenced by a reduction in glutathione peroxidase, interleukin 6, tumor necrosis factor-alpha and hydrogen peroxide levels, in addition to an increase in hemeoxygenase-1, quinone oxidoreductase 1 and superoxide dismutase levels, thereby mitigating neurofunctional deficits, cell apoptosis and structural damage. EDA prevented the transfer of NF-kappa B protein from the cytoplasm to the nucleus, whilst promoting the expression of nuclear factor erythroid 2-related factor 2 (Nrf2) protein in mice following TBI. These results indicated that EDA exerted neuroprotective effects, including impeding neurofunctional deficits, cell apoptosis and structural damage, in mice with TBI, potentially via suppression of NF-kappa B-mediated inflammatory activation and promotion of the Nrf2 antioxidant pathway.	[Zhang, Man; Teng, Chen-Huai; Wu, Fang-Fang; Chen, Da-Qing] Wenzhou Med Univ, Affiliated Hosp 2, Dept Emergency, 109 Xueyuan West Rd, Wenzhou 325000, Zhejiang, Peoples R China; [Zhang, Man; Teng, Chen-Huai; Wu, Fang-Fang; Chen, Da-Qing] Wenzhou Med Univ, Yuying Childrens Hosp, 109 Xueyuan West Rd, Wenzhou 325000, Zhejiang, Peoples R China; [Ge, Li-Yun; Xiao, Jian; Zhang, Hong-Yu] Wenzhou Med Univ, Sch Pharmaceut Sci, Mol Pharmacol Res Ctr, Wenzhou 325000, Zhejiang, Peoples R China		Chen, DQ (corresponding author), Wenzhou Med Univ, Affiliated Hosp 2, Dept Emergency, 109 Xueyuan West Rd, Wenzhou 325000, Zhejiang, Peoples R China.; Chen, DQ (corresponding author), Wenzhou Med Univ, Yuying Childrens Hosp, 109 Xueyuan West Rd, Wenzhou 325000, Zhejiang, Peoples R China.	cdq1965@126.com			Zhejiang Provincial Natural Science Funding [LY19H150001]; Project of Wenzhou Science and Technology Bureau [Y20160155, Y20170234]	Funding was provided by the Zhejiang Provincial Natural Science Funding (grant no. LY19H150001) and Project of Wenzhou Science and Technology Bureau (grant nos. Y20160155 and Y20170234).	Bedi SS, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1122-8; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Chen XQ, 2018, J MOL NEUROSCI, V64, P117, DOI 10.1007/s12031-017-0998-6; Chiazza F, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/804659; Choi YK, 2016, NAT MED, V22, P1335, DOI 10.1038/nm.4188; Delbary-Gossart S, 2016, BRAIN, V139, P1762, DOI 10.1093/brain/aww074; Fabrizio FP, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/2492063; Fujiwara N, 2016, NEUROSCI LETT, V633, P7, DOI 10.1016/j.neulet.2016.08.048; Gao YY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0939-5; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Higashi Y, 2014, J NEUROTRAUM, V31, P1689, DOI 10.1089/neu.2014.3331; Ishii T, 2001, ONCOGENE, V20, P1900, DOI 10.1038/sj.onc.1204267; Jami MS, 2015, NEUROCHEM INT, V90, P134, DOI 10.1016/j.neuint.2015.07.024; Kumar A, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0819-4; Lei S, 2014, ASN NEURO, V6, DOI 10.1177/1759091414558417; Li Z, 2016, ACTA PHARMACOL SIN, V37, P1298, DOI 10.1038/aps.2016.71; Liu YL, 2017, J NEUROTRAUM, V34, P2119, DOI 10.1089/neu.2016.4764; Liu ZW, 2017, NEUROCHEM RES, V42, P1375, DOI 10.1007/s11064-017-2186-z; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Lu J, 2013, P NATL ACAD SCI USA, V110, P10747, DOI 10.1073/pnas.1308950110; Mayeux JP, 2015, BEHAV BRAIN RES, V279, P22, DOI 10.1016/j.bbr.2014.10.053; Pan H, 2011, NEUROCHEM RES, V36, P2434, DOI 10.1007/s11064-011-0571-6; Rowe RK, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1200-y; Scott G, 2018, BRAIN, V141, P459, DOI 10.1093/brain/awx339; Tian AY, 2017, EXP THER MED, V14, P355, DOI 10.3892/etm.2017.4489; Vomund S, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122772; Wang GH, 2011, J NEUROTRAUM, V28, P2123, DOI 10.1089/neu.2011.1939; Wang ZX, 2016, MOL NEUROBIOL, V53, P1905, DOI 10.1007/s12035-015-9143-0; Yang L, 2017, METAB BRAIN DIS, V32, P1395, DOI 10.1007/s11011-017-9991-6; Zhang WW, 2017, DRUG DES DEV THER, V11, P3019, DOI 10.2147/DDDT.S144807; Zhou SS, 2013, NEUROTOXICOLOGY, V38, P136, DOI 10.1016/j.neuro.2013.07.007	33	17	17	0	2	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	JUL	2019	18	1					467	474		10.3892/etm.2019.7632			8	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	IK5DN	WOS:000476606000057	31281440	Green Published, gold, Green Submitted			2022-02-06	
J	Schroeder, RW; Olsen, DH; Martin, PK				Schroeder, Ryan W.; Olsen, Daniel H.; Martin, Phillip K.			Classification accuracy rates of four TOMM validity indices when examined independently and jointly	CLINICAL NEUROPSYCHOLOGIST			English	Article						TOMM; test of memory malingering; performance validity; sensitivity; specificity	ADVANCED CLINICAL SOLUTIONS; ALBANY CONSISTENCY INDEX; MEMORY MALINGERING TOMM; TRAUMATIC BRAIN-INJURY; TRIAL 1; DIGIT SPAN; PERFORMANCE; VALIDATION; INDICATORS; BELIEFS	Objective: This study investigated sensitivity and specificity rates of four Test of Memory Malingering (TOMM) indices (Trial 1, Trial 2, Retention, and Albany Consistency Index (ACI)) and examined how classification accuracy rates change when utilizing these indices in various combinations. Method: A sample of 202 neuropsychological outpatients was utilized. Patients were categorized as valid performers if they passed all criterion performance validity tests (PVTs) and were determined to be invalid performers if they failed two or more criterion PVTs. Classification accuracy statistics were obtained for individual TOMM indices as well as combinations of TOMM indices. Results: When using only Trial 1 as a validity indicator, the TOMM identified 57% of invalidly performing individuals. When all TOMM indices were examined, the ACI demonstrated the highest sensitivity value (63%) but it also demonstrated the lowest specificity value (91%). Allowing for failure of any of the four TOMM indices provided the best overall sensitivity value (67%) while maintaining adequate specificity (90%). Finally, it was determined that failure of three or more TOMM validity indices resulted in a specificity rate of 97% and failure of four of more TOMM validity indices resulted in a specificity rate of 98%. Conclusions: Classification accuracy of TOMM validity indices are discussed in relation to positive and negative predictive values. Results suggest that clinicians can examine all four TOMM validity indices concurrently, particularly in settings where high base rates of invalidity occur.	[Schroeder, Ryan W.; Olsen, Daniel H.; Martin, Phillip K.] Univ Kansas, Sch Med Wichita, Dept Psychiat & Behav Sci, 1010 N Kansas St, Wichita, KS 67214 USA		Schroeder, RW (corresponding author), Univ Kansas, Sch Med Wichita, Dept Psychiat & Behav Sci, 1010 N Kansas St, Wichita, KS 67214 USA.	rschroeder2@kumc.edu					[Anonymous], 2009, ADV CLIN SOL ADM SCO; Berthelson L, 2013, BRAIN INJURY, V27, P909, DOI 10.3109/02699052.2013.793400; Boone K. B., 2002, DOT COUNTING TEST MA; Boone K.B., 2013, CLIN PRACTICE FORENS; Buddin WH, 2014, CLIN NEUROPSYCHOL, V28, P525, DOI 10.1080/13854046.2014.906658; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P1278, DOI 10.1080/13854046.2014.975844; Davis JJ, 2012, ARCH CLIN NEUROPSYCH, V27, P706, DOI 10.1093/arclin/acs078; Dean AC, 2008, CLIN NEUROPSYCHOL, V22, P705, DOI 10.1080/13854040701440493; Dean AC, 2009, CLIN NEUROPSYCHOL, V23, P133, DOI 10.1080/13854040701819050; Denning JH, 2012, ARCH CLIN NEUROPSYCH, V27, P417, DOI 10.1093/arclin/acs044; Erdodi LA, 2014, PSYCHOL INJ LAW, V7, P255, DOI 10.1007/s12207-014-9197-8; Fazio RL, 2017, CLIN NEUROPSYCHOL, V31, P251, DOI 10.1080/13854046.2016.1213316; Green P, 2011, APPL NEUROPSYCHOL, V18, P18, DOI 10.1080/09084282.2010.523365; Greve KW, 2006, J CLIN EXP NEUROPSYC, V28, P1176, DOI 10.1080/13803390500263550; Greve KW, 2009, CLIN NEUROPSYCHOL, V23, P1250, DOI 10.1080/13854040902828272; Gunner JH, 2012, ARCH CLIN NEUROPSYCH, V27, P1, DOI 10.1093/arclin/acr089; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Hosmer DW, 2000, WILEY PS TX, V2nd, P147; Jones A, 2013, CLIN NEUROPSYCHOL, V27, P1043, DOI 10.1080/13854046.2013.804949; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larrabee GJ, 2014, ARCH CLIN NEUROPSYCH, V29, P364, DOI 10.1093/arclin/acu019; Marshall P, 2010, CLIN NEUROPSYCHOL, V24, P1204, DOI 10.1080/13854046.2010.514290; Martin PK, 2018, ASSESSMENT, V25, P640, DOI 10.1177/1073191116656796; Martin PK, 2017, CLIN NEUROPSYCHOL, V31, P829, DOI 10.1080/13854046.2017.1284265; Martin PK, 2015, CLIN NEUROPSYCHOL, V29, P741, DOI 10.1080/13854046.2015.1087597; Meyers J E, 2001, Appl Neuropsychol, V8, P234, DOI 10.1207/09084280152829084; Meyers JE, 2003, ARCH CLIN NEUROPSYCH, V18, P261, DOI 10.1016/S0887-6177(02)00136-1; Meyers JE, 2011, ARCH CLIN NEUROPSYCH, V26, P8, DOI 10.1093/arclin/acq083; Miller JB, 2011, CLIN NEUROPSYCHOL, V25, P160, DOI 10.1080/13854046.2010.533197; O'Bryant SE, 2007, CLIN NEUROPSYCHOL, V21, P511, DOI 10.1080/13854040600611368; Odland AP, 2015, PSYCHOL INJ LAW, V8, P46, DOI 10.1007/s12207-015-9216-4; Olsen DH, 2019, CLIN NEUROPSYCHOL, V33, P732, DOI 10.1080/13854046.2018.1501096; Proto DA, 2014, ARCH CLIN NEUROPSYCH, V29, P614, DOI 10.1093/arclin/acu044; Schroeder RW, 2013, ARCH CLIN NEUROPSYCH, V28, P21, DOI 10.1093/arclin/acs094; Schroeder RW, 2019, CLIN NEUROPSYCHOL, V33, P466, DOI 10.1080/13854046.2018.1484517; Schroeder RW, 2016, CLIN NEUROPSYCHOL, V30, P515, DOI 10.1080/13854046.2016.1177118; Schroeder RW, 2012, ASSESSMENT, V19, P21, DOI 10.1177/1073191111428764; Schroeder RW, 2011, CLIN NEUROPSYCHOL, V25, P437, DOI 10.1080/13854046.2011.556668; Schroeder RW, 2010, CLIN NEUROPSYCHOL, V24, P326, DOI 10.1080/13854040903369441; Silk-Eglit GM, 2015, APPL NEUROPSYCH-ADUL, V22, P335, DOI 10.1080/23279095.2014.938809; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682	44	17	17	1	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	NOV 17	2019	33	8			SI		1373	1387		10.1080/13854046.2019.1619839		JUN 2019	15	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	JH1IM	WOS:000478424100001	31130071				2022-02-06	
J	Cousin, CA; Rouse, CA; Duenas, VH; Dixon, WE				Cousin, Christian A.; Rouse, Courtney A.; Duenas, Victor H.; Dixon, Warren E.			Controlling the Cadence and Admittance of a Functional Electrical Stimulation Cycle	IEEE TRANSACTIONS ON NEURAL SYSTEMS AND REHABILITATION ENGINEERING			English	Article						Functional electrical stimulation (FES); rehabilitation robot; Lyapunov; admittance; passivity	AUTOMATIC-CONTROL	For an individual suffering from a neurological condition, such as spinal cord injury, traumatic brain injury, or stroke, motorized functional electrical stimulation (FES) cycling is a rehabilitation strategy, which offers numerous health benefits. Motorized FES cycling is an example of physical human-robot interaction in which both systems must be controlled; the human is actuated by applying neuromuscular electrical stimulation to the large leg muscle groups, and the cycle is actuated through its onboard electric motor. While the rider is stimulated using a robust sliding-mode controller, the cycle utilizes an admittance controller to preserve rider safety. The admittance controller is shown to be passive with respect to the rider, and the cadence controller is shown to be globally exponentially stable through a Lyapunov-like switched systems stability analysis. Experiments are conducted on three able-bodied participants and four participants with neurological conditions (NCs) to demonstrate the efficacy of the developed controller and investigate the effect of manipulating individual admittance parameters. Results demonstrate an average admittance cadence error of -0.06 +/- 1.47 RPM for able-bodied participants and -0.02 +/- 0.93 RPM for participants with NCs.	[Cousin, Christian A.; Rouse, Courtney A.; Dixon, Warren E.] Univ Florida, Dept Mech & Aerosp Engn, Gainesville, FL 32611 USA; [Duenas, Victor H.] Syracuse Univ, Dept Mech & Aerosp Engn, Syracuse, NY 13244 USA		Cousin, CA (corresponding author), Univ Florida, Dept Mech & Aerosp Engn, Gainesville, FL 32611 USA.	ccousin@ufl.edu; courtneyarouse@ufl.edu; vhduenas@syr.edu; wdixon@ufl.edu	Dixon, Warren/F-5238-2015	Dixon, Warren/0000-0002-5091-181X; Cousin, Christian/0000-0003-1845-9541	NSFNational Science Foundation (NSF) [DGE-1842473]	This work was supported in part by the NSF under Award DGE-1842473,	Ambrosini E, 2012, IEEE T NEUR SYS REH, V20, P320, DOI 10.1109/TNSRE.2012.2191574; Anaya F, 2018, INT J INTELL ROBOT, V2, P1, DOI 10.1007/s41315-017-0042-6; Belanger M, 2000, ARCH PHYS MED REHAB, V81, P1090, DOI 10.1053/apmr.2000.7170; Bellman MJ, 2017, IEEE T AUTOM SCI ENG, V14, P1225, DOI 10.1109/TASE.2016.2527716; Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI 10.1161/CIR.0000000000000485; Berkelmans R., 2008, J AUTOM CONTROL, V18, P73; Coste CA, 2018, ARTIF ORGANS, V42, P336, DOI 10.1111/aor.13139; Cousin CA, 2018, P ASME DYN SYST CON; Cousin CA, 2019, IFAC PAPERSONLINE, V51, P272, DOI 10.1016/j.ifacol.2019.01.040; Cousin CA, 2018, IEEE DECIS CONTR P, P6470, DOI 10.1109/CDC.2018.8618685; Duenas V. H., IEEE T CONTROL SYST; Duenas VH, 2018, P AMER CONTR CONF, P3726, DOI 10.23919/ACC.2018.8431421; Duffell LD, 2008, MUSCLE NERVE, V38, P1304, DOI 10.1002/mus.21060; Farhoud A, 2014, IEEE T NEUR SYS REH, V22, P533, DOI 10.1109/TNSRE.2013.2296334; Ferrarin M, 2001, IEEE T NEUR SYS REH, V9, P245, DOI 10.1109/7333.948452; Filippov A.F., 1964, AM MATH SOC TRANSL 2, V42, P354, DOI DOI 10.1090/TRANS2/042/13; Fornusek C, 2004, J REHABIL MED, V36, P232, DOI 10.1080/16501970410029843; Fujinaka T, 2000, IEEE IJCNN, P345, DOI 10.1109/IJCNN.2000.860795; Herrnstadt G, 2016, IEEE-ASME T MECH, V21, P2108, DOI 10.1109/TMECH.2016.2555811; HOGAN N, 1985, J DYN SYST-T ASME, V107, P1, DOI 10.1115/1.3140702; Hunt KJ, 2004, IEEE T NEUR SYS REH, V12, P89, DOI 10.1109/TNSRE.2003.819955; Jamwal PK, 2016, IEEE T IND ELECTRON, V63, P3638, DOI 10.1109/TIE.2016.2521600; Khalil Hassan K., 2002, NONLINEAR SYSTEMS; Killingsworth NJ, 2006, IEEE CONTR SYST MAG, V26, P70, DOI 10.1109/MCS.2006.1580155; Krebs Hermano Igo, 2015, Curr Phys Med Rehabil Rep, V3, P243; Laubacher M, 2019, J NEUROENG REHABIL, V16, DOI 10.1186/s12984-018-0471-y; Lee H, 2016, IEEE INT CONF ROBOT, P3069, DOI 10.1109/ICRA.2016.7487472; Li YA, 2014, IEEE T CONTR SYST T, V22, P1422, DOI 10.1109/TCST.2013.2286194; Liberzon D., 2003, SYS CON FDN; Lor?a A., 2005, CONTROL ROBOT MANIPU; Marchal-Crespo L, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-20; Mohr T, 1997, CALCIFIED TISSUE INT, V61, P22, DOI 10.1007/s002239900286; Nagata Fusaomi, 2007, IEEE International Symposium on Computational Intelligence in Robotics and Automation, 2007, P196; Ott C, 2010, IEEE INT CONF ROBOT, P554, DOI 10.1109/ROBOT.2010.5509861; Paden B. E., 1986, Proceedings of the 25th IEEE Conference on Decision and Control (Cat. No.86CH2344-0), P578; Popovic DB, 2014, J ELECTROMYOGR KINES, V24, P795, DOI 10.1016/j.jelekin.2014.09.008; Ranatunga I, 2017, IEEE T CONTR SYST T, V25, P278, DOI 10.1109/TCST.2016.2523901; Rouse CA, 2018, P AMER CONTR CONF, P4558, DOI 10.23919/ACC.2018.8431044; Sharma N, 2009, IEEE T NEUR SYS REH, V17, P576, DOI 10.1109/TNSRE.2009.2023294; Stefanovic N, 2007, CONTROL ENG PRACT, V15, P1107, DOI 10.1016/j.conengprac.2007.01.010; Szecsi J, 2014, MED ENG PHYS, V36, P484, DOI 10.1016/j.medengphy.2013.09.010; Tee KP, 2010, IEEE INT CONF ROBOT, P5181, DOI 10.1109/ROBOT.2010.5509874; Van Soest AJ, 2005, MED SCI SPORT EXER, V37, P797, DOI 10.1249/01.MSS.0000161802.52243.95; Wu QC, 2018, IEEE T SYST MAN CY-S, V48, P1005, DOI 10.1109/TSMC.2017.2771227	44	17	17	1	11	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1534-4320	1558-0210		IEEE T NEUR SYS REH	IEEE Trans. Neural Syst. Rehabil. Eng.	JUN	2019	27	6					1181	1192		10.1109/TNSRE.2019.2914579			12	Engineering, Biomedical; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Rehabilitation	IC6ZG	WOS:000471121000008	31059451	hybrid			2022-02-06	
J	Jha, RM; Desai, SM; Zusman, BE; Koleck, TA; Puccio, AM; Okonkwo, DO; Park, SY; Shutter, LA; Kochanek, PM; Conley, YP				Jha, Ruchira M.; Desai, Shashvat M.; Zusman, Benjamin E.; Koleck, Theresa A.; Puccio, Ava M.; Okonkwo, David O.; Park, Seo-Young; Shutter, Lori A.; Kochanek, Patrick M.; Conley, Yvette P.			Downstream TRPM4 Polymorphisms Are Associated with Intracranial Hypertension and Statistically Interact with ABCC8 Polymorphisms in a Prospective Cohort of Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						ABCC8; SUR1; cerebral edema; SNPs; TBI; TRPM4	SINGLE NUCLEOTIDE POLYMORPHISMS; SULFONYLUREA RECEPTOR 1; CEREBRAL EDEMA; DOUBLE-BLIND; GLIBENCLAMIDE; PRESSURE; VISUALIZATION; DISABILITY; GLYBURIDE; MORTALITY	Sulfonylurea-receptor-1(SUR1) and its associated transient-receptor-potential cation channel subfamily-M (TRPM4) channel are key contributors to cerebral edema and intracranial hypertension in traumatic brain injury (TBI) and other neurological disorders. Channel inhibition by glyburide is clinically promising. ABCC8 (encoding SUR1) single-nucleotide polymorphisms (SNPs) are reported as predictors of raised intracranial pressure (ICP). This project evaluated whether TRPM4 SNPs predicted ICP and TBI outcome. DNA was extracted from 435 consecutively enrolled severe TBI patients. Without a priori selection, all 11 TRPM4 SNPs available on the multiplex platform (Illumina:Human-Core-Exome v1.0) were genotyped spanning the 25 exon gene. A total of 385 patients were analyzed after quality control. Outcomes included ICP and 6 month Glasgow Outcome Scale (GOS) score. Proxy SNPs, spatial modeling, and functional predictions were determined using established software programs. rs8104571 (intron-20) and rs150391806 (exon-24) were predictors of ICP. rs8104571 heterozygotes predicted higher average ICP (beta = 10.3 mm Hg, p = 0.00000029), peak ICP (beta = 19.6 mm Hg, p = 0.0007), and proportion ICP >25 mm Hg (beta = 0.16 p = 0.004). rs150391806 heterozygotes had higher mean (beta = 7.2 mm Hg, p = 0.042) and peak (beta = 28.9 mm Hg, p = 0.0015) ICPs. rs8104571, rs150391806, and 34 associated proxy SNPs in linkage-disequilibrium clustered downstream. This region encodes TRPM4's channel pore and a region postulated to juxtapose SUR1 sequences encoded by an ABCC8 DNA segment containing previously identified relevant SNPs. There was an interaction effect on ICP between rs8104571 and a cluster of predictive ABCC8 SNPs (rs2237982, rs2283261, rs11024286). Although not significant in univariable or a basic multivariable model, in an expanded model additionally accounting for injury pattern, computed tomographic (CT) appearance, and intracranial hypertension, heterozygous rs8104571 was associated with favorable 6 month GOS (odds ratio [OR] = 16.7, p = 0.007951). This trend persisted in a survivor-only subcohort (OR = 20.67, p = 0.0168). In this cohort, two TRPM4 SNPs predicted increased ICP with large effect sizes. Both clustered downstream, spanning a region encoding the channel pore and interacting with SUR1. If validated, this may guide risk stratification and eventually inform treatment-responder classification for SUR1-TRPM4 inhibition in TBI. Larger studies are warranted.	[Jha, Ruchira M.; Shutter, Lori A.; Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15261 USA; [Jha, Ruchira M.; Desai, Shashvat M.; Shutter, Lori A.] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA; [Jha, Ruchira M.; Zusman, Benjamin E.; Puccio, Ava M.; Okonkwo, David O.; Shutter, Lori A.] Univ Pittsburgh, Sch Med, Dept Neurosurg, Pittsburgh, PA 15261 USA; [Park, Seo-Young] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15261 USA; [Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Anesthesia, Pittsburgh, PA 15261 USA; [Jha, Ruchira M.; Kochanek, Patrick M.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15261 USA; [Jha, Ruchira M.; Kochanek, Patrick M.; Conley, Yvette P.] Univ Pittsburgh, Sch Med, Clin & Translat Sci Inst, Pittsburgh, PA 15261 USA; [Park, Seo-Young] Univ Pittsburgh, Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Conley, Yvette P.] Univ Pittsburgh, Sch Nursing, Pittsburgh, PA 15261 USA; [Conley, Yvette P.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Kochanek, Patrick M.] Univ Pittsburgh, Dept Pediat, Pittsburgh, PA 15261 USA; [Koleck, Theresa A.] Columbia Univ, Sch Nursing, New York, NY USA; [Kochanek, Patrick M.] Univ Pittsburgh, Med Ctr, Childrens Hosp Pittsburgh, Pittsburgh, PA 15261 USA		Jha, RM (corresponding author), Univ Pittsburgh, 3550 Terrace St,Scaife Hall, Pittsburgh, PA 15261 USA.	jharm3@upmc.edu	Shutter, Lori A/G-2957-2013	Conley, Yvette/0000-0002-1784-6067; Shutter, Lori/0000-0002-1390-0628	National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS101036]; NIH/NINRUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R00 NR013176, T32NR007969, R01NR013342]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P50 NS30318]; NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R01NS087978-01]; University of Pittsburgh Physicians Foundation Award; University of Pittsburgh School of Medicine Dean's Faculty Advancement Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS101036, R01NS087978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [T32NR007969, R00NR013176] Funding Source: NIH RePORTER	The authors are grateful to funding from following grants: National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS) K23NS101036 (R.M.J.), NIH/NINR R00 NR013176 (A.M.P.), NIH P50 NS30318 (D.O.O.), NIH/NINR T32NR007969 (T.A.K.), NIH/NINDS 1R01NS087978-01 (P.M.K.), NIH/NINR R01NR013342 (Y.P.C.), University of Pittsburgh Physicians Foundation Award (R.M.J.), and University of Pittsburgh School of Medicine Dean's Faculty Advancement Award (R.M.J.).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Autzen HE, 2018, SCIENCE, V359, P228, DOI 10.1126/science.aar4510; Badri S, 2012, INTENS CARE MED, V38, P1800, DOI 10.1007/s00134-012-2655-4; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bomba L, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1212-4; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Castro L, 2019, J NEUROTRAUM, V36, P165, DOI 10.1089/neu.2017.5619; Chesnut R, 2014, NEUROCRIT CARE, V21, P64, DOI 10.1007/s12028-014-0048-y; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Czosnyka M, 2006, ACTA NEUROCHIR SUPPL, V96, P114; Dardiotis E, 2014, J NEUROTRAUM, V31, P1920, DOI 10.1089/neu.2014.3347; Earley S, 2013, PFLUG ARCH EUR J PHY, V465, P1223, DOI 10.1007/s00424-013-1250-z; Gorse KM, 2018, J NEUROTRAUM, V35, P1694, DOI 10.1089/neu.2017.5275; Jha R, 2015, J NEUROTRAUM, V32, pA119; Jha RM, 2018, J NEUROTRAUM, V35, P2125, DOI 10.1089/neu.2016.4696; Jha RM, 2018, CRIT CARE MED, V46, P1792, DOI 10.1097/CCM.0000000000003361; Jha RM, 2017, LANCET NEUROL, V16, P578, DOI 10.1016/S1474-4422(17)30225-9; Jha RM, 2017, NEUROCRIT CARE, V26, P213, DOI 10.1007/s12028-016-0309-z; Jha Ruchira M, 2017, Crit Care Med, V45, pe255, DOI 10.1097/CCM.0000000000002079; Jha RM, 2018, J NEUROL NEUROSUR PS, V89, P1152, DOI 10.1136/jnnp-2017-317741; Khalili H, 2017, WORLD NEUROSURG, V101, P130, DOI 10.1016/j.wneu.2017.01.103; Kimberly WT, 2014, NEUROCRIT CARE, V20, P193, DOI 10.1007/s12028-013-9917-z; Laird MD, 2014, GLIA, V62, P26, DOI 10.1002/glia.22581; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; LEVIN HS, 1991, NEUROSURGERY, V28, P196, DOI 10.1227/00006123-199102000-00004; Li NN, 2017, CELL, V168, P101, DOI 10.1016/j.cell.2016.12.028; Liang FY, 2015, NEUROSCI LETT, V598, P29, DOI 10.1016/j.neulet.2015.05.006; Lin ZZ, 2017, NEUROPHARMACOLOGY, V121, P1, DOI 10.1016/j.neuropharm.2017.04.016; Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936; Lu YC, 2010, ATHEROSCLEROSIS, V213, P200, DOI 10.1016/j.atherosclerosis.2010.08.053; Machiela MJ, 2015, BIOINFORMATICS, V31, P3555, DOI 10.1093/bioinformatics/btv402; Mall T, 2016, BIOINFORMATICS, V32, P2499, DOI 10.1093/bioinformatics/btw068; Martinez-Valverde T, 2015, J NEUROTRAUM, V32, P1478, DOI 10.1089/neu.2014.3706; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; Nishimura J, 2014, NEW ENGL J MED, V370, P632, DOI 10.1056/NEJMoa1311084; Nissen SE, 2018, JAMA CARDIOL, V3, P401, DOI 10.1001/jamacardio.2018.0569; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Osier ND, 2017, J NEUROTRAUM, V34, P86, DOI 10.1089/neu.2015.4343; Parolo S, 2017, GENES NUTR, V12, DOI 10.1186/s12263-017-0579-x; Patel AD, 2010, J NEUROPATH EXP NEUR, V69, P1177, DOI 10.1097/NEN.0b013e3181fbf6d6; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Schwamm LH, 2014, NEW ENGL J MED, V371, P2522, DOI 10.1056/NEJMe1412951; Shah S, 2016, SEMIN NEUROL, V36, P502, DOI 10.1055/s-0036-1592109; Sheth KN, 2016, LANCET NEUROL, V15, P1160, DOI 10.1016/S1474-4422(16)30196-X; Shuldiner AR, 2009, JAMA-J AM MED ASSOC, V302, P849, DOI 10.1001/jama.2009.1232; Simard JM, 2012, J CEREBR BLOOD F MET, V32, P1699, DOI 10.1038/jcbfm.2012.91; Simard JM, 2009, J NEUROTRAUM, V26, P2257, DOI 10.1089/neu.2009.1021; Stallmeyer B, 2012, HUM MUTAT, V33, P109, DOI 10.1002/humu.21599; Stenson PD, 2017, HUM GENET, V136, P665, DOI 10.1007/s00439-017-1779-6; Stokum JA, 2016, J CEREBR BLOOD F MET, V36, P513, DOI 10.1177/0271678X15617172; Struchen MA, 2001, J NEUROTRAUM, V18, P115, DOI 10.1089/08977150150502569; Tisherman SA, 2015, ANN SURG, V261, P586, DOI 10.1097/SLA.0000000000000837; Winkler EA, 2017, J CLIN NEUROSCI, V35, P109, DOI 10.1016/j.jocn.2016.09.017; Winkler EA, 2016, NEUROGENETICS, V17, P31, DOI 10.1007/s10048-015-0467-8; Woo SK, 2013, J BIOL CHEM, V288, P3655, DOI 10.1074/jbc.M112.428219; Xu ZM, 2017, J NEUROTRAUM, V34, P925, DOI 10.1089/neu.2016.4491; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Yue JK, 2017, NEUROGENETICS, V18, P29, DOI 10.1007/s10048-016-0500-6; Yue JK, 2015, NEUROGENETICS, V16, P169, DOI 10.1007/s10048-015-0437-1; Yue ZC, 2015, AM J PHYSIOL-HEART C, V308, pH157, DOI 10.1152/ajpheart.00457.2014; Zweckberger K, 2014, NEUROSCIENCE, V272, P199, DOI 10.1016/j.neuroscience.2014.04.040	67	17	17	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2019	36	11					1804	1817		10.1089/neu.2018.6124			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IB1EQ	WOS:000470007600011	30484364	Green Published			2022-02-06	
J	Kelly, KM; Kiderman, A; Akhavan, S; Quigley, MR; Snell, ED; Happ, E; Synowiec, AS; Miller, ER; Bauer, MA; Oakes, LP; Eydelman, Y; Gallagher, CW; Dinehart, T; Schroeder, JH; Ashmore, RC				Kelly, Kevin M.; Kiderman, Alex; Akhavan, Sam; Quigley, Matthew R.; Snell, Edward D.; Happ, Erik; Synowiec, Andrea S.; Miller, Eric R.; Bauer, Melissa A.; Oakes, Liza P.; Eydelman, Yakov; Gallagher, Charles W.; Dinehart, Thomas; Schroeder, John Howison; Ashmore, Robin C.			Oculomotor, Vestibular, and Reaction Time Effects of Sports-Related Concussion: Video-Oculography in Assessing Sports-Related Concussion	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						concussion; oculomotor; optokinetic; OVRT; reaction time; smooth pursuit; vestibular; video-oculography	TRAUMATIC BRAIN-INJURY; EYE-MOVEMENTS; SMOOTH-PURSUIT; HEAD-INJURY; MILD; DEFICITS; RECOVERY; IMPACT; RELIABILITY; PERFORMANCE	Objective: The purpose of the study was to test the ability of oculomotor, vestibular, and reaction time (OVRT) metrics to serve as a concussion assessment or diagnostic tool for general clinical use. Setting and Participants: Patients with concussion were high school-aged athletes clinically diagnosed in a hospital setting with a sports-related concussion (n = 50). Control subjects were previously recruited male and female high school student athletes from 3 local high schools (n = 170). Design: Video-oculography was used to acquire eye movement metrics during OVRT tasks, combined with other measures. Measures were compared between groups, and a subset was incorporated into linear regression models that could serve as indicators of concussion. Measures: The OVRT test battery included multiple metrics of saccades, smooth pursuit tracking, nystagmoid movements, vestibular function, and reaction time latencies. Results: Some OVRT metrics were significantly different between groups. Linear regression models distinguished control subjects from concussion subjects with high accuracy. Metrics included changes in smooth pursuit tracking, increased reaction time and reduced saccade velocity in a complex motor task, and decreased optokinetic nystagmus (OKN) gain. In addition, optokinetic gain was reduced and more variable in subjects assessed 22 or more days after injury. Conclusion: These results indicate that OVRT tests can be used as a reliable adjunctive tool in the assessment of concussion and that OKN results appear to be associated with a prolonged expression of concussion symptoms.	[Kelly, Kevin M.; Synowiec, Andrea S.; Miller, Eric R.] Allegheny Gen Hosp, Dept Neurol, 940 South Tower,320 E North Ave, Pittsburgh, PA 15212 USA; [Akhavan, Sam; Snell, Edward D.; Bauer, Melissa A.] Allegheny Gen Hosp, Dept Orthopaed Surg, Pittsburgh, PA 15212 USA; [Happ, Erik] Allegheny Gen Hosp, Dept Ophthalmol, Pittsburgh, PA 15212 USA; [Quigley, Matthew R.] Univ Pittsburgh, Med Ctr, Dept Neurosurg, Erie, PA USA; [Kiderman, Alex; Oakes, Liza P.; Eydelman, Yakov; Gallagher, Charles W.; Dinehart, Thomas; Schroeder, John Howison; Ashmore, Robin C.] Neuro Kinet Inc, Pittsburgh, PA USA		Kelly, KM (corresponding author), Allegheny Gen Hosp, Dept Neurol, 940 South Tower,320 E North Ave, Pittsburgh, PA 15212 USA.	kevin.kelly@ahn.org			Department of DefenseUnited States Department of Defense [81XWH-12-C-0205]; US Department of the Treasury, Internal Revenue Service Qualifying Therapeutic Discovery Project [21.013]	A.K., Y.E., J.H.S., and R.C.A. are employees of and financial stakeholders in Neuro Kinetics, Inc (NKI), a for-profit, privately held company, and manufacturer of the equipment used in this study. C.W.G. and L.P.O. were former employees of NKI, and T.D. was temporarily employed by NKI for this project. K.M.K. and M.R.Q. received salary support from Department of Defense Rapid Innovation Fund Contract 81XWH-12-C-0205 by a subcontract to Allegheny General Hospital from NKI. K.M.K., S.A., M.R.Q., E.D.S., E.H., A.S.S., E.R.M., and M.A.B. used the equipment lent by NKI, for the conduct of the study, which was supported in part by US Department of the Treasury, Internal Revenue Service Qualifying Therapeutic Discovery Project Credit Grant 21.013 to NKI, and by the Department of Defense Rapid Innovation Fund Contract 81XWH-12-C-0205 awarded to NKI under which Allegheny General Hospital was subcontracted.	BAHILL A T, 1975, Mathematical Biosciences, V24, P191, DOI 10.1016/0025-5564(75)90075-9; Balaban C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162168; Casto K. L., 2012, AUDITORY VESTIBULAR; Cifu DX, 2015, J HEAD TRAUMA REHAB, V30, P21, DOI 10.1097/HTR.0000000000000036; Coldren RL, 2010, MIL MED, V175, P477, DOI 10.7205/MILMED-D-09-00258; Contreras R, 2008, J BIOL PHYS, V34, P381, DOI 10.1007/s10867-008-9092-1; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Crevits L, 2000, J NEUROL, V247, P179, DOI 10.1007/s004150050559; DiCesare CA, 2017, BEHAV RES METHODS, V49, P258, DOI 10.3758/s13428-015-0693-x; Drew AS, 2007, NEUROSCI LETT, V417, P61, DOI 10.1016/j.neulet.2007.02.038; GLASS I, 1995, BRAIN INJURY, V9, P769, DOI 10.3109/02699059509008233; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Heitger MH, 2007, J NEUROL SCI, V253, P34, DOI 10.1016/j.jns.2006.11.007; Heitger MH, 2006, BRAIN INJURY, V20, P807, DOI 10.1080/02699050600676354; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Heitger MH, 2005, BRAIN INJURY, V19, P109, DOI 10.1080/02699050410001720095; Heitger MH, 2004, BRAIN, V127, P575, DOI 10.1093/brain/awh066; Heitger MH, 2002, PROG BRAIN RES, V140, P433; Hetherington CR, 1996, BRAIN INJURY, V10, P473, DOI 10.1080/026990596124197; Hoffer ME, 2017, LARYNGOSCOPE INVEST, V2, P157, DOI 10.1002/lio2.74; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Jacobson G, 2008, BALANCE FUNCTION ASS; Jagoda AS, 2002, ANN EMERG MED, V40, P231, DOI [10.1067/mem.2002.125782, 10.1016/j.jen.2008.12.010]; Johnson B, 2015, NEUROLOGY, V85, P1163, DOI 10.1212/WNL.0000000000001968; Johnson B, 2015, BRAIN IMAGING BEHAV, V9, P564, DOI 10.1007/s11682-014-9316-x; Kontos AP, 2016, AM J SPORT MED, V44, P1400, DOI 10.1177/0363546516632754; Krauzlis RJ, 2004, J NEUROPHYSIOL, V91, P591, DOI 10.1152/jn.00801.2003; Laborey M, 2014, J HEAD TRAUMA REHAB, V29, pE28, DOI 10.1097/HTR.0b013e318280f896; LYNCH JC, 1994, EXP BRAIN RES, V100, P181; Maruta J, 2010, ANN NY ACAD SCI, V1208, P58, DOI 10.1111/j.1749-6632.2010.05695.x; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Ono K, 2007, NEUROL MED-CHIR, V47, P291, DOI 10.2176/nmc.47.291; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; Samadani U, 2015, J NEUROTRAUM, V32, P548, DOI 10.1089/neu.2014.3687; Segalowitz S J, 1997, J Int Neuropsychol Soc, V3, P95; Shepard NT, 1996, PRACTICAL MANAGEMENT; Stuss DT, 1994, NEUROPSYCHOLOGY, V8, P316, DOI DOI 10.1037/0894-4105.8.3.316; Suh M, 2006, NEUROSCI LETT, V410, P203, DOI 10.1016/j.neulet.2006.10.001; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074; Szymanowicz D, 2012, J REHABIL RES DEV, V49, P1083, DOI 10.1682/JRRD.2010.07.0129; Tyler CW, 2015, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00282; Wright WG, 2017, J VESTIBUL RES-EQUIL, V27, P27, DOI 10.3233/VES-170607	43	17	17	3	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2019	34	3			SI		176	188		10.1097/HTR.0000000000000437			13	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IH1KG	WOS:000474249100014	30234848	Green Published, hybrid			2022-02-06	
J	Kisala, PA; Boulton, AJ; Cohen, ML; Slavin, MD; Jette, AM; Charlifue, S; Hanks, R; Mulcahey, MJ; Cella, D; Tulsky, DS				Kisala, Pamela A.; Boulton, Aaron J.; Cohen, Matthew L.; Slavin, Mary D.; Jette, Alan M.; Charlifue, Susan; Hanks, Robin; Mulcahey, M. J.; Cella, David; Tulsky, David S.			Interviewer-Versus Self-Administration of PROMIS (R) Measures for Adults With Traumatic Injury	HEALTH PSYCHOLOGY			English	Article						spinal cord injury; traumatic brain injury; patient outcomes assessment; PROMIS (R); mode of administration	PATIENT-REPORTED OUTCOMES; QUALITY-OF-LIFE; ITEM RESPONSE THEORY; SPINAL-CORD-INJURY; NEUROLOGICAL DISORDERS; IMPACT; BANKS; BIAS; CRITERIA; DIF	Objective: To assess differential item functioning and observed mean differences across two modes of administration for PROMIS (R) measure scores in a sample of adults with traumatic injury. Method: Items from 7 PROMIS (R) adult measures (v1.0 Physical Function, Fatigue, Pain Interference, Anger, Anxiety, and Depression and v2.0 Social Health-Emotional Support) were administered as fixed-length short forms in random order to a cross-sectional sample. Participants were randomly assigned to interviewer-administered (phone or in-person) or self-administered (via the Assessment Center website) conditions. The research was conducted at 5 medical rehabilitation institutions across the U.S. Participants included 277 adults with spinal cord injury (n = 148) or traumatic brain injury (n = 129). Results: DIF analyses indicated that all items were invariant to mode of administration. There was no significant effect of mode of administration for the majority of PROMIS (R) measures tested. Regarding observed scores, there were small but significant effects of mode of administration on the Emotional Support and Depression measures, with participants in the interview condition reporting better support/fewer symptoms. Conclusions: PROMIS (R) instruments demonstrated measurement equivalence across interviewer-administered and self-administered conditions. These findings are particularly important for research or clinical applications where administration of PROMIS (R) measures by independent web- or tablet-based administration is not ideal, for example with individuals with physical or cognitive disabilities or with individuals who lack computer and/or Internet access. PROMIS (R) v1.0 Depression and PROMIS (R) v2.0 Emotional Support scores displayed a tendency toward social desirability that should be considered when these measures are interviewer-administered.	[Kisala, Pamela A.; Boulton, Aaron J.] Univ Delaware, Ctr Hlth Assessment Res & Translat, Coll Hlth Sci, Newark, DE 19713 USA; [Cohen, Matthew L.] Univ Delaware, Dept Commun Sci & Disorders, Coll Hlth Sci, Newark, DE 19713 USA; [Slavin, Mary D.] Boston Univ, Dept Hlth Law Policy & Management, Sch Publ Hlth, Boston, MA 02215 USA; [Jette, Alan M.] Massachusetts Gen Hosp, Inst Hlth Profess, Boston, MA 02114 USA; [Charlifue, Susan] Craig Hosp, Englewood, CO USA; [Hanks, Robin] Wayne State Univ, Dept Phys Med & Rehabil, Sch Med, Detroit, MI 48202 USA; [Mulcahey, M. J.] Thomas Jefferson Univ, Dept Occupat Therapy, Coll Hlth Profess, Philadelphia, PA 19107 USA; [Cella, David] Northwestern Univ, Dept Med Social Sci, Feinberg Sch Med, Evanston, IL 60208 USA; [Tulsky, David S.] Univ Delaware, Ctr Hlth Assessment Res & Translat, Dept Phys Therapy, Coll Hlth Sci, Newark, DE 19713 USA; [Tulsky, David S.] Univ Delaware, Dept Psychol & Brain Sci, Newark, DE 19713 USA		Kisala, PA (corresponding author), Univ Delaware, Ctr Hlth Assessment Res & Translat, 540 South Coll Ave, Newark, DE 19713 USA.	pkisala@udel.edu	Cohen, Mathew/W-3982-2019	mulcahey, MJ/0000-0002-0837-714X; Cohen, Matthew/0000-0001-9609-2461; Tulsky, David/0000-0002-4335-4509; Kisala, Pamela/0000-0003-3234-795X	National Institutes of Health (NIH) Common Fund Initiative (Northwestern University) [U54AR057951, U01AR052177, U54AR057943]; National Institutes of Health (NIH) Common Fund Initiative (American Institutes for Research) [U54AR057926]; National Institutes of Health (NIH) Common Fund Initiative (State University of New York, Stony Brook) [U01AR057948, U01AR052170]; National Institutes of Health (NIH) Common Fund Initiative (University of Washington, Seattle) [U01AR057954, U01AR052171]; National Institutes of Health (NIH) Common Fund Initiative (University of North Carolina, Chapel Hill) [U01AR052181]; National Institutes of Health (NIH) Common Fund Initiative (Children's Hospital of Philadelphia) [U01AR057956]; National Institutes of Health (NIH) Common Fund Initiative (Stanford University) [U01AR052158]; National Institutes of Health (NIH) Common Fund Initiative (Boston University) [U01AR057929]; National Institutes of Health (NIH) Common Fund Initiative (University of California, Los Angeles) [U01AR057936]; National Institutes of Health (NIH) Common Fund Initiative (University of Pittsburgh) [U01AR052155]; National Institutes of Health (NIH) Common Fund Initiative (Georgetown University) [U01AR057971]; National Institutes of Health (NIH) Common Fund Initiative (Children's Hospital Medical Center, Cincinnati) [U01AR057940]; National Institutes of Health (NIH) Common Fund Initiative (University of Maryland, Baltimore) [U01AR057967]; National Institutes of Health (NIH) Common Fund Initiative (Duke University) [U01AR052186]; National Institute of General Medical Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U54-GM104941]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U54GM104941] Funding Source: NIH RePORTER	All authors have contributed significantly to the design, analysis and writing of this article. The contents represent original work and have not been published elsewhere. No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit upon the authors or upon any organization with which the authors are associated. PROMIS (R) was funded with cooperative agreements from the National Institutes of Health (NIH) Common Fund Initiative (Northwestern University, PI: David Cella, U54AR057951, U01AR052177; Northwestern University, PI: Richard C. Gershon, U54AR057943; American Institutes for Research, PI: Susan (San) D. Keller, U54AR057926; State University of New York, Stony Brook, PIs: Joan E. Broderick, and Arthur A. Stone, U01AR057948, U01AR052170; University of Washington, Seattle, PIs: Heidi M. Crane, Paul K. Crane, and Donald L. Patrick, U01AR057954; University of Washington, Seattle, PI: Dagmar Amtmann, U01AR052171; University of North Carolina, Chapel Hill, PIs: Harry A. Guess, Darren A. DeWalt, U01AR052181; Children's Hospital of Philadelphia, PI: Christopher B. Forrest, U01AR057956; Stanford University, PI: James F. Fries, U01AR052158; Boston University, PIs: Alan Jette, Stephen M. Haley, and David Scott Tulsky (University of Michigan, Ann Arbor), U01AR057929; University of California, Los Angeles, PIs: Dinesh Khanna (University of Michigan, Ann Arbor) and Brennan Spiegel, U01AR057936; University of Pittsburgh, PI: Paul A. Pilkonis, U01AR052155; Georgetown University, PIs: Carol. M. Moinpour, (Fred Hutchinson Cancer Research Center, Seattle) and Arnold L. Potosky, U01AR057971; Children's Hospital Medical Center, Cincinnati, PI: Esi M. Morgan DeWitt, U01AR057940; University of Maryland, Baltimore, PI: Lisa M. Shulman, U01AR057967; and Duke University, PI: Kevin P. Weinfurt, U01AR052186). NIH Science Officers on this project have included Deborah Ader, Vanessa Ameen, Susan Czajkowski, Basil Eldadah, Lawrence Fine, Lawrence Fox, Lynne Haverkos, Thomas Hilton, Laura Lee Johnson, Michael Kozak, Peter Lyster, Donald Mattison, Claudia Moy, Louis Quatrano, Bryce Reeve, William Riley, Peter Scheidt, Ashley Wilder Smith, Susana Serrate-Sztein, William Phillip Tonkins, Ellen Werner, Tisha Wiley, and James Witter. The contents of this article use data developed under PROMIS (R). These contents do not necessarily represent an endorsement by the U.S. Federal Government or PROMIS (R). See www.nihpromis.org for additional information on the PROMIS (R) initiative. We would also like to acknowledge an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number U54-GM104941 (PI: Binder-Macleod), which provided salary support for Cohen. Authors have no financial disclosures related to this project.	Baylor C, 2011, AM J SPEECH-LANG PAT, V20, P243, DOI 10.1044/1058-0360(2011/10-0079); Bingham CO, 2016, QUAL LIFE RES, V25, P2109, DOI 10.1007/s11136-016-1246-1; Bjorner JB, 2014, QUAL LIFE RES, V23, P217, DOI 10.1007/s11136-013-0451-4; Bjorner JB, 2014, J CLIN EPIDEMIOL, V67, P108, DOI 10.1016/j.jclinepi.2013.07.016; Bjorner JB, 2007, QUAL LIFE RES, V16, P95, DOI 10.1007/s11136-007-9168-6; Cella D, 2007, QUAL LIFE RES, V16, P133, DOI 10.1007/s11136-007-9204-6; Cella D, 2011, ARCH PHYS MED REHAB, V92, pS28, DOI 10.1016/j.apmr.2011.01.025; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Choi SW, 2011, J STAT SOFTW, V39, P1; Cook KF, 2009, QUAL LIFE RES, V18, P447, DOI 10.1007/s11136-009-9464-4; Fayers PM, 2016, QUALITY LIFE; Frank L, 2014, JAMA-J AM MED ASSOC, V312, P1513, DOI 10.1001/jama.2014.11100; Gershon RC, 2013, NEUROLOGY, V80, pS2, DOI 10.1212/WNL.0b013e3182872e5f; Gershon RC, 2012, QUAL LIFE RES, V21, P475, DOI 10.1007/s11136-011-9958-8; Grinnon ST, 2012, CLIN TRIALS, V9, P322, DOI 10.1177/1740774512438980; Hahn EA, 2004, PSYCHO-ONCOLOGY, V13, P86, DOI 10.1002/pon.719; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hays RD, 2000, MED CARE, V38, P28; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jodoin MG, 2001, APPL MEAS EDUC, V14, P329, DOI 10.1207/S15324818AME1404_2; Jones RN., 2016, PSYCHOL TEST ASSESS, V58, P371; MCHORNEY CA, 1994, MED CARE, V32, P551, DOI 10.1097/00005650-199406000-00002; Muthen L.K., 2012, MPLUS USERS GUIDE, V7; NEDERHOF AJ, 1985, EUR J SOC PSYCHOL, V15, P263, DOI 10.1002/ejsp.2420150303; Reise SP, 2013, EDUC PSYCHOL MEAS, V73, P5, DOI 10.1177/0013164412449831; Rutherford C, 2016, QUAL LIFE RES, V25, P559, DOI 10.1007/s11136-015-1110-8; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Samejima F., 1969, PSYCHOMETRIC MONOGRA; Scott NW, 2009, J CLIN EPIDEMIOL, V62, P288, DOI 10.1016/j.jclinepi.2008.06.003; Sherer M, 2017, J HEAD TRAUMA REHAB, V32, P125, DOI 10.1097/HTR.0000000000000207; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; Tulsky DS, 2015, J SPINAL CORD MED, V38, P257, DOI [10.1179/2045772315Y.0000000023, 10.1179/2045772315Y.0000000035]; Tulsky DS, 2012, ARCH PHYS MED REHAB, V93, P1722, DOI 10.1016/j.apmr.2012.05.007; US Food and Drug Administration (FDA), 2006, GUID IND PAT REP OUT; Wagner LI, 2015, CANCER-AM CANCER SOC, V121, P927, DOI 10.1002/cncr.29104; Wang M, 2017, QUAL LIFE RES, V26, P2973, DOI 10.1007/s11136-017-1640-3; Weaver KE, 2012, CANCER EPIDEM BIOMAR, V21, P2108, DOI 10.1158/1055-9965.EPI-12-0740; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Witter JP, 2016, RHEUM DIS CLIN N AM, V42, P377, DOI 10.1016/j.rdc.2016.01.007; Yu C. Y, 2002, EVALUATING CUTOFF CR, V30	40	17	17	0	4	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0278-6133	1930-7810		HEALTH PSYCHOL	Health Psychol.	MAY	2019	38	5			SI		435	444		10.1037/hea0000685			10	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	HW6BH	WOS:000466772600013	31045427	Bronze, Green Accepted			2022-02-06	
J	Kreitzer, N; Ancona, R; McCullumsmith, C; Kurowski, BG; Foreman, B; Ngwenya, LB; Adeoye, O				Kreitzer, Natalie; Ancona, Rachel; McCullumsmith, Cheryl; Kurowski, Brad G.; Foreman, Brandon; Ngwenya, Laura B.; Adeoye, Opeolu			The Effect of Antidepressants on Depression After Traumatic Brain Injury: A Meta-analysis	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						antidepressant; depression; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; COGNITIVE-BEHAVIORAL THERAPY; LONG-TERM DISABILITY; MAJOR DEPRESSION; HEAD-INJURY; UNITED-STATES; MOOD DISORDERS; DOUBLE-BLIND; SERTRALINE; PLACEBO	Objective: Following traumatic brain injury (TBI), depressive symptoms are common and may influence recovery. We performed a meta-analysis to estimate the benefit of antidepressants following TBI and compare the estimated effects between antidepressants and placebo. Participants: Multiple databases were searched to find prospective pharmacological treatment studies of major depressive disorder (MDD) in adults following TBI. Main Measures: Effect sizes for antidepressant medications in patients with TBI were calculated for within-subjects designs that examined change from baseline after receiving medical treatment and treatment/placebo designs that examined the differences between the antidepressants and placebo groups. Design: A random-effects model was used for both analyses. Results: Of 1028 titles screened, 11 were included. Pooled estimates showed nonsignificant difference in reduction of depression scores between medications and placebo (standardized mean difference of 5 trials = -0.3; 95% CI, -0.6 to 0.0; I-2 = 17%), and a significant reduction in depression scores for individuals after pharmacotherapy (mean change = -11.2; 95% CI, -14.7 to -7.6 on the Hamilton Depression Scale; I-2 = 87%). Conclusions: This meta-analysis found no significant benefit of antidepressant over placebo in the treatment of MDD following TBI. Pooled estimates showed a high degree of bias and heterogeneity. Prospective studies on the impact of antidepressants in well-defined cohorts of TBI patients are warranted.	[Kreitzer, Natalie; Foreman, Brandon; Adeoye, Opeolu] Univ Cincinnati, Div Neurocrit Care, Cincinnati, OH 45267 USA; [Kreitzer, Natalie; Ancona, Rachel; Adeoye, Opeolu] Univ Cincinnati, Dept Emergency Med, Cincinnati, OH 45267 USA; [McCullumsmith, Cheryl] Univ Cincinnati, Dept Psychiat, Cincinnati, OH 45267 USA; [Kurowski, Brad G.] Univ Cincinnati, Dept Pediat, Cincinnati, OH 45267 USA; [Kurowski, Brad G.] Univ Cincinnati, Dept Phys Med & Rehabil, Cincinnati, OH 45267 USA; [Foreman, Brandon; Ngwenya, Laura B.] Univ Cincinnati, Dept Neurol & Rehabil Med, Cincinnati, OH 45267 USA; [Ngwenya, Laura B.] Univ Cincinnati, Dept Neurosurg, Cincinnati, OH 45267 USA		Kreitzer, N (corresponding author), Univ Cincinnati, Med Sci Bldg,Room 1513,231 Albert Sabin Dr, Cincinnati, OH 45267 USA.	kreitzne@ucmail.uc.edu		Ngwenya, Laura/0000-0001-7103-971X	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32 NS047996] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32NS047996] Funding Source: NIH RePORTER		Ansari Ahmed, 2014, Asian J Neurosurg, V9, P182, DOI 10.4103/1793-5482.146597; Ashman TA, 2009, ARCH PHYS MED REHAB, V90, P733, DOI 10.1016/j.apmr.2008.11.005; Bailey NW, 2014, BIOL PSYCHOL, V99, P115, DOI 10.1016/j.biopsycho.2014.03.008; Bedard M, 2014, J HEAD TRAUMA REHAB, V29, pE13, DOI 10.1097/HTR.0b013e3182a615a0; Blakey SM, 2018, J PAIN, V19, P797, DOI 10.1016/j.jpain.2018.02.012; BREMNER JD, 1995, J CLIN PSYCHIAT, V56, P519; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Chen CH, 2008, NEUROPSYCHOPHARMACOL, V33, P1909, DOI 10.1038/sj.npp.1301593; DINAN TG, 1992, ACTA PSYCHIAT SCAND, V85, P292, DOI 10.1111/j.1600-0447.1992.tb01472.x; Dyer JR, 2016, J HEAD TRAUMA REHAB, V31, P225, DOI 10.1097/HTR.0000000000000177; Entsuah R, 2002, J PSYCHIATR RES, V36, P437, DOI 10.1016/S0022-3956(02)00024-9; Failla MD, 2016, NEUROREHAB NEURAL RE, V30, P419, DOI 10.1177/1545968315600525; Failla MD, 2013, BRAIN INJURY, V27, P696, DOI 10.3109/02699052.2013.775481; Fann JR, 2017, J HEAD TRAUMA REHAB, V32, P332, DOI 10.1097/HTR.0000000000000322; Fann JR, 2015, JAMA PSYCHIAT, V72, P247, DOI 10.1001/jamapsychiatry.2014.2482; Fann JR, 2015, J NEUROTRAUM, V32, P45, DOI 10.1089/neu.2014.3423; Fann JR, 2000, J NEUROPSYCH CLIN N, V12, P226, DOI 10.1176/appi.neuropsych.12.2.226; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Haagsma JA, 2015, J NEUROTRAUM, V32, P853, DOI 10.1089/neu.2013.3283; Han K, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00231; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Horsfield SA, 2002, INT J PSYCHIAT MED, V32, P337, DOI 10.2190/KQ48-XT0L-2H14-5UMV; Hudak A, 2011, PSYCHIAT RES-NEUROIM, V191, P160, DOI 10.1016/j.pscychresns.2010.10.003; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; Jorge RE, 2007, BIOL PSYCHIAT, V62, P332, DOI 10.1016/j.biopsych.2006.07.024; Juengst SB, 2017, EPILEPSY BEHAV, V73, P240, DOI 10.1016/j.yebeh.2017.06.001; Juengst SB, 2015, J HEAD TRAUMA REHAB, V30, P207, DOI 10.1097/HTR.0000000000000031; Kaplan GB, 2010, BEHAV PHARMACOL, V21, P427, DOI 10.1097/FBP.0b013e32833d8bc9; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P79, DOI 10.1097/HTR.0000000000000238; Lee H, 2005, HUM PSYCHOPHARM CLIN, V20, P97, DOI 10.1002/hup.668; Liberati A, 2009, ANN INTERN MED, V151, pW65, DOI 10.7326/0003-4819-151-4-200908180-00136; Luby JL, 2017, JAMA PEDIATR, V171, P1168, DOI [10.1001/jamapediatrics.2017.3009, 10.1001/jamapediatri]; Lydiard RB, 1997, J CLIN PSYCHIAT, V58, P484, DOI 10.4088/JCP.v58n1104; Maas AIR, 2008, ACTA NEUROCHIR SUPPL, V101, P119; Maller JJ, 2014, BEHAV BRAIN RES, V271, P147, DOI 10.1016/j.bbr.2014.05.047; Maller JJ, 2014, HUM BRAIN MAPP, V35, P227, DOI 10.1002/hbm.22171; Marquez-Romero JM, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-77; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Newburn G, 1999, BRAIN INJURY, V13, P637; Osborn AJ, 2014, NEUROSCI BIOBEHAV R, V47, P1, DOI 10.1016/j.neubiorev.2014.07.007; Pagulayan KF, 2008, ARCH PHYS MED REHAB, V89, P1887, DOI 10.1016/j.apmr.2008.03.019; Pettinati H. M., 2015, FOCUS, V13, P356; Ponsford J, 2016, PSYCHOL MED, V46, P1079, DOI 10.1017/S0033291715002640; Rao V, LEXAPRO TREATMENT TR; Rao V, 2012, J NEUROPSYCH CLIN N, V24, P309, DOI 10.1176/appi.neuropsych.11080188; Rapoport MJ, 2008, J PSYCHOPHARMACOL, V22, P860, DOI 10.1177/0269881107083845; RStudio Team, 2015, RSTUDIO INT DEV ENV; Rutherford BR, 2012, J PSYCHIATR RES, V46, P697, DOI 10.1016/j.jpsychires.2012.02.008; Salter KL, 2016, J HEAD TRAUMA REHAB, V31, pE21, DOI 10.1097/HTR.0000000000000193; SARAN AS, 1985, J CLIN PSYCHIAT, V46, P335; Schonberger M, 2011, BRAIN INJURY, V25, P543, DOI 10.3109/02699052.2011.565013; Seel RT, 2010, J HEAD TRAUMA REHAB, V25, P99, DOI 10.1097/HTR.0b013e3181ce3966; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sepehry AA, 2012, DRUG AGING, V29, P793, DOI 10.1007/s40266-012-0012-5; SILVER JM, 1990, J CLIN PSYCHIAT, V51, P33; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; VECHT CJ, 1975, ARCH NEUROL-CHICAGO, V32, P792, DOI 10.1001/archneur.1975.00490540036004; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	64	17	17	3	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2019	34	3			SI		E47	E54		10.1097/HTR.0000000000000439			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IH1KG	WOS:000474249100006	30169440	Green Accepted			2022-02-06	
J	Register-Mihalik, JK; Cameron, KL; Kay, MC; Kerr, ZY; Peck, KY; Houston, MN; Linnan, LA; Hennink-Kaminski, H; Gildner, P; Svoboda, SJ; Marshall, SW				Register-Mihalik, Johna K.; Cameron, Kenneth L.; Kay, Melissa C.; Kerr, Zachary Y.; Peck, Karen Y.; Houston, Megan N.; Linnan, Laura A.; Hennink-Kaminski, Heidi; Gildner, Paula; Svoboda, Steven J.; Marshall, Stephen W.			Determinants of intention to disclose concussion symptoms in a population of US military cadets	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Educational targets; Traumatic brain injury; Injury prevention; Military cadets	SCHOOL; EDUCATION; SPORT; METAANALYSIS; KNOWLEDGE; BEHAVIOR; PLAYERS; NORMS	Objectives: Non-disclosure of concussion complicates concussion management, but almost nothing is known about non-disclosure in military settings. This study describes concussion disclosure-related knowledge, attitudes, perceived social norms, perceived control, and intention. Additionally, the study identifies determinants of high intention to disclose concussion symptoms. Design: Cross sectional survey. Methods: First-year service academy cadets completed a cross-sectional survey to assess perceptions of concussion disclosure. Independent variables included: gender, race, ethnicity, high school athlete status, NCAA athlete status, previous concussion history, previous concussion education, socioeconomic proxy, concussion-related knowledge, attitudes about concussion, perceived social norms (perceived peer/organizational support and actions), and perceived control over disclosure. Log-binomial regression was used to identify determinants of high intention to disclose concussion symptoms. Results: A total of 972 first-year military service academy cadets completed the survey [85% response; age = 18.4 +/- 0.9 y]. In the simple models, previous concussion history was associated with lower intention to disclose concussion symptoms. High perceived control over disclosure, higher concussion knowledge, more favorable attitudes and social norms about concussion were associated with high intention to disclose. In the multivariable model, a 10% shift towards more favorable perceived social norms (PR = 1.28; p < 0.001) and attitudes (PR = 1.07; p = 0.05) about concussion were associated with high intention to disclose concussion symptoms. High perceived control over disclosure was associated with high intention to disclose concussion symptoms (PR = 1.39; p = 0.08). Conclusions: Concussion-related perceived social norms, attitudes, and perceived control are associated with intention to disclose. Organizationally appropriate intervention strategies can be developed from these data. (C) 2018 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Register-Mihalik, Johna K.; Kay, Melissa C.; Kerr, Zachary Y.] Univ North Carolina Chapel Hill, Dept Exercise & Sport Sci, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC 27515 USA; [Register-Mihalik, Johna K.; Kerr, Zachary Y.; Gildner, Paula; Marshall, Stephen W.] Univ North Carolina Chapel Hill, Injury Prevent Res Ctr, Chapel Hill, NC USA; [Cameron, Kenneth L.; Peck, Karen Y.; Houston, Megan N.; Svoboda, Steven J.] Keller Army Hosp, West Point, NY USA; [Kay, Melissa C.] Univ North Carolina Chapel Hill, Curriculum Human Movement Sci, Chapel Hill, NC USA; [Linnan, Laura A.] Univ North Carolina Chapel Hill, Dept Hlth Behav, Curriculum Human Movement Sci, Chapel Hill, NC USA; [Hennink-Kaminski, Heidi] Univ North Carolina Chapel Hill, Sch Media & Journalism, Curriculum Human Movement Sci, Chapel Hill, NC USA; [Marshall, Stephen W.] Univ North Carolina Chapel Hill, Curriculum Human Movement Sci, Dept Epidemiol, Chapel Hill, NC USA		Register-Mihalik, JK (corresponding author), Univ North Carolina Chapel Hill, Dept Exercise & Sport Sci, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC 27515 USA.	johnakay@email.unc.edu		Kerr, Zachary/0000-0003-1423-1259; Kossman, Melissa/0000-0001-6653-1363; Cameron, Kenneth/0000-0002-6276-4482	NCAA-DOD Mind Matters Research Challenge Award; National Center for Injury Prevention and Control, Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE002479]	This study was mainly funded by a NCAA-DOD Mind Matters Research Challenge Award. Dr. Marshall and the UNC IPRC are partly supported by an Injury Control Research Center award R49CE002479 from the National Center for Injury Prevention and Control, Centers for Disease Control and Prevention.	Ajzen, 2002, CONSTRUCTION THEORY; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Bagozzi RP, 2002, SOC PSYCHOL QUART, V65, P226, DOI 10.2307/3090121; Beachy G, 2014, J ATHL TRAINING, V49, P493, DOI 10.4085/1062-6050-49.2.19; Chase RP, 2015, J HEAD TRAUMA REHAB, V30, pE57, DOI 10.1097/HTR.0000000000000061; Fedor A, 2015, APPL NEUROPSYCH-ADUL, V22, P108, DOI 10.1080/23279095.2013.860604; Fishbein M., 2010, PREDICTING CHANGING, DOI DOI 10.4324/9780203838020; Hoge CW, 2016, AM J PSYCHIAT, V173, P334, DOI 10.1176/appi.ajp.2015.15040553; Kerr ZY, 2018, AM J SPORT MED, V46, P22, DOI 10.1177/0363546517728264; Kroshus E, 2016, HEALTH EDUC BEHAV, V43, P182, DOI 10.1177/1090198115599380; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2015, ANN BEHAV MED, V49, P95, DOI 10.1007/s12160-014-9636-5; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McEachan R, 2016, ANN BEHAV MED, V50, P592, DOI 10.1007/s12160-016-9798-4; Montano D.E., 2015, HLTH BEHAV THEORY RE, V5th, P95; Register-Mihalik J, 2017, J ATHL TRAINING, V52, P195, DOI 10.4085/1062-6050-51.12.02; Register-Mihalik JK, 2017, CLIN J SPORT MED, V27, P321, DOI 10.1097/JSM.0000000000000349; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Rivis A, 2003, CURR PSYCHOL, V22, P218, DOI 10.1007/s12144-003-1018-2; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Sniehotta FF, 2014, HEALTH PSYCHOL REV, V8, P1, DOI 10.1080/17437199.2013.869710; Triandis H C, 1980, Nebr Symp Motiv, V27, P195; TRIANDIS HC, 1988, J PERS SOC PSYCHOL, V54, P323, DOI 10.1037/0022-3514.54.2.323; Webb TL, 2006, PSYCHOL BULL, V132, P249, DOI 10.1037/0033-2909.132.2.249; 2016, AM J SPORTS MED, V44, P220, DOI DOI 10.1177/0363546515612082	29	17	17	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	MAY	2019	22	5					509	515		10.1016/j.jsams.2018.11.003			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	HY6RB	WOS:000468256300004	30551922				2022-02-06	
J	Riley, E; Mitko, A; Stumps, A; Robinson, M; Milberg, W; McGlinchey, R; Esterman, M; DeGutis, J				Riley, Elizabeth; Mitko, Alex; Stumps, Anna; Robinson, Meghan; Milberg, William; McGlinchey, Regina; Esterman, Michael; DeGutis, Joseph			Clinically Significant Cognitive Dysfunction in OEF/OIF/OND Veterans: Prevalence and Clinical Associations	NEUROPSYCHOLOGY			English	Article						cognitive dysfunction; trauma exposure; OEF/OIF/OND Veterans; PTSD; alcohol consumption	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; METABOLIC SYNDROME; PSYCHOLOGICAL SYMPTOMS; PTSD; PERFORMANCE; MEMORY; DEPRESSION; RECOVERY; DISTRESS	Objective: Cognitive performance in trauma-exposed populations, such as combat Veterans, has been shown to be worse than in nonexposed peers. However, cognitive performance has typically been within the normal range (within 1 SD of normative mean), and the prevalence of clinically significant cognitive dysfunction (i.e., performance more than 1 SD below the mean on multiple measures in a domain) in younger adults with trauma exposure remains unknown. The objective of our study was to measure this. Method: We applied Diagnostic and Statistical Manual of Mental Disorders (5th ed.; DSM-5) cutoffs for clinically significant cognitive dysfunction (>1 SD below the mean in multiple measures within a domain) in the domains of memory, executive function, and attention to a sample of combat-exposed Operation Enduring Freedom/Operation Iraqi Freedom/Operation New Dawn (OEF/OIF/OND; N = 368, mean age = 31.7 years, 90% men) Veterans. We then compared psychiatric, physiological, and neural measures, as well as functional outcomes, between those with and without cognitive dysfunction. Results: Veterans with cognitive dysfunction (n = 129, 35.1%) had lower premorbid reading ability and more severe psychological distress, including increased anxiety, depression, posttraumatic stress disorder (PTSD), sleep difficulties, pain, and alcohol consumption. Those with cognitive dysfunction also had worse functional outcomes, with mild but significant disability. In contrast, we found associations between outcome and age, traumatic brain injury, physiological and neural measures to be weak or not significant. Conclusions: Together, this suggests that premorbid abilities and trauma-related psychological symptoms contribute significantly to cognitive dysfunction in OEF/OIF/OND Veterans, and that neurological insult and aging may play less of a role. Cognitive dysfunction may be at least partially ameliorated by treating trauma-related symptoms. General Scientific Summary In this study, we examined the psychological, physical and neurological health profiles of returning OEF/OIF/OND Veterans who had significant cognitive dysfunction. Though we did not find any evidence of physical or neural decline in those with cognitive dysfunction, we did find that those with cognitive dysfunction suffered from more intense psychological distress (posttraumatic stress disorder, depression, anxiety, sleep difficulties, pain) than those without. Our results suggest that cognitive dysfunction in younger returning Veterans might be ameliorated with appropriate treatment for psychological distress conditions.	[Riley, Elizabeth] Cornell Univ, Dept Human Dev, Sch Human Ecol, 162 Human Ecol Bldg, Ithaca, NY 14850 USA; [Mitko, Alex; Stumps, Anna; Robinson, Meghan; Milberg, William; McGlinchey, Regina; Esterman, Michael; DeGutis, Joseph] VA Boston Healthcare Syst, Translat Res Ctr TBI & Stress Disorders TRACTS, VA RR&D TBI Ctr Excellence, Boston, MA USA; [Milberg, William; McGlinchey, Regina; DeGutis, Joseph] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA; [Esterman, Michael] Boston Univ, Dept Psychiat, Sch Med, Boston, MA 02215 USA		Riley, E (corresponding author), Cornell Univ, Dept Human Dev, Sch Human Ecol, 162 Human Ecol Bldg, Ithaca, NY 14850 USA.	er482@cornell.edu			U.S. Department of Veteran Affairs through the VA Boston Translational Research Center for TBI and Stress Disorders (TRACTS), a VA Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence [B9254-C]; Department of Veterans Affairs Clinical Sciences Research and DevelopmentUS Department of Veterans Affairs [1IK2CX000706-01A2]; Veterans AffairsUS Department of Veterans Affairs [I01CX001653, IK2CX000706] Funding Source: NIH RePORTER	This work was supported by the U.S. Department of Veteran Affairs through the VA Boston Translational Research Center for TBI and Stress Disorders (TRACTS), a VA Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence (B9254-C), and a Career Development award from the Department of Veterans Affairs Clinical Sciences Research and Development (1IK2CX000706-01A2) to M.S.E. We thank the Veterans for their patience and diligence in participating in this intensive study.	Altena E, 2008, J SLEEP RES, V17, P335, DOI 10.1111/j.1365-2869.2008.00671.x; Amick MM, 2013, J INT NEUROPSYCH SOC, V19, P792, DOI 10.1017/S1355617713000544; [Anonymous], 2013, DIAGN STAT MAN MENT, DOI 10.1176/appi.books.9780890425596; Aupperle RL, 2012, NEUROPHARMACOLOGY, V62, P686, DOI 10.1016/j.neuropharm.2011.02.008; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birns J, 2006, J HYPERTENS, V24, P1907, DOI 10.1097/01.hjh.0000244934.81180.16; Borsari B, 2017, AM J ORTHOPSYCHIAT, V87, P166, DOI 10.1037/ort0000199; Brady KT, 1999, ALCOHOL RES HEALTH, V23, P263; Brady KT, 2005, AM J PSYCHIAT, V162, P1483, DOI 10.1176/appi.ajp.162.8.1483; Brandes D, 2002, PSYCHIAT RES, V110, P231, DOI 10.1016/S0165-1781(02)00125-7; Breslau N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065391; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Clark AL, 2014, CLIN NEUROPSYCHOL, V28, P802, DOI 10.1080/13854046.2014.904928; Croall ID, 2014, NEUROLOGY, V83, P494, DOI 10.1212/WNL.0000000000000666; DeGutis J, 2018, BEHAV SLEEP MED, V16, P38, DOI 10.1080/15402002.2016.1173550; DeGutis J, 2015, J INT NEUROPSYCH SOC, V21, P342, DOI 10.1017/S1355617715000235; Delis D., 2001, D KEFS EXAMINERS TEC; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Esterman M, 2013, J INT NEUROPSYCH SOC, V19, P835, DOI 10.1017/S135561771300057X; First M.B., 1999, STRUCTURED CLIN INTE; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Gilbertson MW, 2001, J TRAUMA STRESS, V14, P413, DOI 10.1023/A:1011181305501; Gomez-Pinilla Fernando, 2011, Nutrition and Health (Bicester), V20, P165; Grande LJ, 2018, J INT NEUROPSYCH SOC, V24, P466, DOI 10.1017/S1355617717001242; Green A, 2010, ALCOHOL CLIN EXP RES, V34, P443, DOI 10.1111/j.1530-0277.2009.01108.x; Green P., 2004, MANUAL MED SYMPTOM V; Hayes JP, 2017, BRAIN, V140, P813, DOI 10.1093/brain/aww344; Henry GK, 2005, CLIN NEUROPSYCHOL, V19, P121, DOI 10.1080/13854040490516604; Holdnack JA, 2017, ARCH CLIN NEUROPSYCH, V32, P574, DOI 10.1093/arclin/acx032; Houston RJ, 2014, ADDICT BEHAV, V39, P345, DOI 10.1016/j.addbeh.2013.09.032; Jak AJ, 2009, AM J GERIAT PSYCHIAT, V17, P368, DOI 10.1097/JGP.0b013e31819431d5; Jeste DV, 2016, AM J GERIAT PSYCHIAT, V24, P987, DOI 10.1016/j.jagp.2016.08.009; Kalechstein AD, 2003, J CLIN EXP NEUROPSYC, V25, P1186, DOI 10.1076/jcen.25.8.1186.16723; Kubany ES, 2000, PSYCHOL ASSESSMENT, V12, P210, DOI 10.1037//1040-3590.12.2.210; Levine AB, 2014, CARDIOLOGY, V127, P1, DOI 10.1159/000354910; Levkovitz Y, 2002, BRAIN RES BULL, V58, P345, DOI 10.1016/S0361-9230(01)00780-8; Lindemer ER, 2013, NEUROIMAGE-CLIN, V2, P601, DOI 10.1016/j.nicl.2013.04.009; Lippa SM, 2018, ARCH CLIN NEUROPSYCH, V33, P606, DOI 10.1093/arclin/acx098; Lohr JB, 2015, AM J GERIAT PSYCHIAT, V23, P709, DOI 10.1016/j.jagp.2015.04.001; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Mander BA, 2010, J NEUROSCI, V30, P2686, DOI 10.1523/JNEUROSCI.4010-09.2010; Marx BP, 2009, J INT NEUROPSYCH SOC, V15, P840, DOI 10.1017/S1355617709990488; McGlinchey RE, 2017, INT J METH PSYCH RES, V26, DOI 10.1002/mpr.1556; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; Neietlisbach G., 2009, J AGGRESSION MALTREA, V18, P382, DOI [10.1080/10926770902881489, DOI 10.1080/10926770902881489]; Oldenburg C, 2016, BRAIN INJURY, V30, P146, DOI 10.3109/02699052.2015.1089598; ONeil ME, 2013, COMPLICATIONS MILD T, DOI [10.1017/S135561771300146X, DOI 10.1017/S135561771300146X]; Polak AR, 2012, J AFFECT DISORDERS, V141, P11, DOI 10.1016/j.jad.2012.01.001; Poole VN, 2016, NEUROPSYCHOLOGIA, V86, P176, DOI 10.1016/j.neuropsychologia.2016.04.023; Qureshi SU, 2011, J NEUROPSYCH CLIN N, V23, P16, DOI 10.1176/appi.neuropsych.23.1.16; Reppermund S, 2011, INT J GERIATR PSYCH, V26, P843, DOI 10.1002/gps.2612; Ressler KJ, 2004, ARCH GEN PSYCHIAT, V61, P1136, DOI 10.1001/archpsyc.61.11.1136; RICHARDSON JS, 1994, INT CLIN PSYCHOPHARM, V9, P35, DOI 10.1097/00004850-199400910-00006; Robinson ME, 2017, J NEUROTRAUM, V34, pS53, DOI 10.1089/neu.2016.4709; Rodriguez P, 2012, J REHABIL RES DEV, V49, P649, DOI 10.1682/JRRD.2011.09.0162; Sannibale C, 2013, ADDICTION, V108, P1397, DOI 10.1111/add.12167; Schulte MHJ, 2014, CLIN PSYCHOL REV, V34, P531, DOI 10.1016/j.cpr.2014.08.002; SELZER ML, 1975, J STUD ALCOHOL, V36, P117, DOI 10.15288/jsa.1975.36.117; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Sofuoglu M, 2013, NEUROPHARMACOLOGY, V64, P452, DOI 10.1016/j.neuropharm.2012.06.021; Spielberg JM, 2017, HUM BRAIN MAPP, V38, P3249, DOI 10.1002/hbm.23587; Stavro K, 2013, ADDICT BIOL, V18, P203, DOI 10.1111/j.1369-1600.2011.00418.x; STETZ MC, 2007, AVIATION SPACE ENV M, V78, pB25; Stricker NH, 2017, J CLIN EXP NEUROPSYC, V39, P768, DOI 10.1080/13803395.2016.1264575; Stricker NH, 2016, AM J ALZHEIMERS DIS, V31, P68, DOI 10.1177/1533317515578257; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; Sutherland K, 2007, BEHAV RES THER, V45, P2915, DOI 10.1016/j.brat.2007.08.009; Swick D, 2012, J INT NEUROPSYCH SOC, V18, P917, DOI 10.1017/S1355617712000458; Taylor VH, 2007, OBES REV, V8, P409, DOI 10.1111/j.1467-789X.2007.00401.x; Trivedi MH, 2014, J AFFECT DISORDERS, V152, P19, DOI 10.1016/j.jad.2013.09.012; Trotter BB, 2015, BRAIN, V138, P2278, DOI 10.1093/brain/awv139; Ullman SE, 2005, J STUD ALCOHOL, V66, P610, DOI 10.15288/jsa.2005.66.610; US Department of Veterans Affairs, 2017, AN VA HLTH CAR UT OP; Ustun TB., 2010, MEASURING HLTH DISAB, P90; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Vasterling JJ, 2006, JAMA-J AM MED ASSOC, V296, P519, DOI 10.1001/jama.296.5.519; Vasterling JJ, 2002, NEUROPSYCHOLOGY, V16, P5, DOI 10.1037//0894-4105.16.1.5; Vincent AS, 2014, ALZHEIMERS DEMENT, V10, pS174, DOI 10.1016/j.jalz.2014.04.006; Weathers FW, 2018, PSYCHOL ASSESSMENT, V30, P383, DOI 10.1037/pas0000486; Wechsler D., 2008, WECHSLER ADULT INTEL; Wilson RS, 2007, NEUROLOGY, V68, P2085, DOI 10.1212/01.wnl.0000264930.97061.82; Wilson RS, 2005, PSYCHONEUROENDOCRINO, V30, P11, DOI 10.1016/j.psyneuen.2004.04.005; Wilson RS, 2003, NEUROLOGY, V61, P1479, DOI 10.1212/01.WNL.0000096167.56734.59; Wolf EJ, 2016, PSYCHOL MED, V46, P2215, DOI 10.1017/S0033291716000817; Wolf EJ, 2016, BIOL PSYCHIAT, V80, P363, DOI 10.1016/j.biopsych.2015.11.023; Wolf EJ, 2016, PSYCHONEUROENDOCRINO, V63, P155, DOI 10.1016/j.psyneuen.2015.09.020; Woods SP, 2006, ARCH CLIN NEUROPSYCH, V21, P413, DOI 10.1016/j.acn.2006.06.002; Xu W., 2017, ALZHEIMERS DEMENTI S, V13, pP521, DOI [10.1016/j.jalz.2017.06.603, DOI 10.1016/J.JALZ.2017.06.603]; Yaffe K, 2007, ALZ DIS ASSOC DIS, V21, P167, DOI 10.1097/WAD.0b013e318065bfd6	92	17	17	0	1	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	MAY	2019	33	4					534	546		10.1037/neu0000529			13	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	HV6RI	WOS:000466110100009	30945914				2022-02-06	
J	Wu, FF; Xu, K; Liu, L; Zhang, KR; Xia, LL; Zhang, M; Teng, CH; Tong, HY; He, YF; Xue, YJ; Zhang, HY; Chen, DQ; Hu, AP				Wu, Fangfang; Xu, Ke; Liu, Lei; Zhang, Kairui; Xia, Leilei; Zhang, Man; Teng, Chenhuai; Tong, Heyan; He, Yifang; Xue, Yujie; Zhang, Hongyu; Chen, Daqing; Hu, Aiping			Vitamin B-12 Enhances Nerve Repair and Improves Functional Recovery After Traumatic Brain Injury by Inhibiting ER Stress-Induced Neuron Injury	FRONTIERS IN PHARMACOLOGY			English	Article						vitamin B-12; traumatic brain injury; endoplasmic reticulum stress; microtubule; myelin	REGENERATION; NEUROINFLAMMATION; MECHANISMS; APOPTOSIS; RATS; TAU	Traumatic brain injury (TBI) is one of the most common causes of neurological damage in young human populations. Vitamin B-12 has been reported to promote axon growth of neuronal cells after peripheral nerve injury, which is currently used for the treatment of peripheral nerve damage in the clinical trial. Thus, we hypothesized that TBI can be attenuated by vitaminB(12) treatment through its beneficial role on axon regeneration after nerve injury. To confirm it, the biological function of vitaminB(12) was characterized using hematoxylin and eosin (H&E) staining, Luxol fast blue (LFB) staining, western blot analysis, and immunohistochemistry staining. The results showed that the neurological functional recovery was improved in the VitaminB(12)-treated group after TBI, which may be due to downregulation of the endoplasmic reticulum stress-related apoptosis signaling pathway. Moreover, the microtubule stabilization, remyelination and myelin reparation were rescued by vitamin B-12, which was consistent with the treatment of 4-phenylbutyric acid (4-PBA), an endoplasmic reticulum stress inhibitor. The study suggests that vitamin B-12 may be useful as a novel neuroprotective drug for TBI.	[Wu, Fangfang; Liu, Lei; Zhang, Kairui; Zhang, Man; Teng, Chenhuai; Chen, Daqing; Hu, Aiping] Wenzhou Med Univ, Affiliated Hosp 2, Dept Emergency, Wenzhou, Peoples R China; [Wu, Fangfang; Liu, Lei; Zhang, Kairui; Zhang, Man; Teng, Chenhuai; Chen, Daqing; Hu, Aiping] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Peoples R China; [Wu, Fangfang; Tong, Heyan; He, Yifang; Xue, Yujie; Zhang, Hongyu; Hu, Aiping] Wenzhou Med Univ, Sch Pharmaceut Sci, Wenzhou, Peoples R China; [Xu, Ke] Wenzhou Univ, Inst Life Sci, Wenzhou, Peoples R China; [Xia, Leilei] Wenzhou Med Univ, Clin Inst 3, Wenzhou Peoples Hosp, Dept Emergency, Wenzhou, Peoples R China		Chen, DQ; Hu, AP (corresponding author), Wenzhou Med Univ, Affiliated Hosp 2, Dept Emergency, Wenzhou, Peoples R China.; Chen, DQ; Hu, AP (corresponding author), Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Peoples R China.; Hu, AP (corresponding author), Wenzhou Med Univ, Sch Pharmaceut Sci, Wenzhou, Peoples R China.	cdq1965@126.com; hap@wmu.edu.cn		liu, lei/0000-0001-5680-1040; Wu, Fangfang/0000-0002-1888-4516	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81802251, 80217111]; Zhejiang Provincial Natural Science Foundation of ChinaNatural Science Foundation of Zhejiang Province [LQ18H150003, LY19H150001]	This work was supported by research grants from the National Natural Science Foundation of China (81802251, 80217111), and Zhejiang Provincial Natural Science Foundation of China under grant nos. LQ18H150003 and LY19H150001.	Abu-Rub M, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8060111; Armstrong RC, 2016, NEUROPHARMACOLOGY, V110, P654, DOI 10.1016/j.neuropharm.2015.04.029; Brunden KR, 2017, NEUROBIOL DIS, V105, P328, DOI 10.1016/j.nbd.2016.12.021; Cantuti-Castelvetri L, 2018, SCIENCE, V359, P684, DOI 10.1126/science.aan4183; Chan W, 2018, AM J PATHOL, V188, P160, DOI 10.1016/j.ajpath.2017.08.032; Chen CH, 2015, J MED ULTRASOUND, V23, P104, DOI 10.1016/j.jmu.2015.02.001; Chuckowree JA, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00223; Field MS, 2018, ANNU REV NUTR, V38, P219, DOI 10.1146/annurev-nutr-071714-034441; Figlia G, 2018, GLIA, V66, P693, DOI 10.1002/glia.23273; Fink E. L, 2012, PEDIAT CRITICAL CARE, P643, DOI [10.1007/978-0-85729-923-9_31, DOI 10.1007/978-0-85729-923-9_31]; Gao YY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0939-5; Ghemrawi R, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.69; Grober U, 2013, NUTRIENTS, V5, P5031, DOI 10.3390/nu5125031; He ZL, 2017, AM J TRANSL RES, V9, P1075; Hobbenaghi R, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-123; Hood KN, 2018, J NEUROSCI, V38, P2372, DOI 10.1523/JNEUROSCI.1756-17.2018; Hughes D, 2019, FEBS J, V286, P342, DOI 10.1111/febs.14422; Kapitein LC, 2015, NEURON, V87, P492, DOI 10.1016/j.neuron.2015.05.046; Katz PS, 2015, J NEUROTRAUM, V32, P297, DOI 10.1089/neu.2014.3508; Li JW, 2018, J NEUROTRAUM, V35, P548, DOI 10.1089/neu.2017.5205; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Ma MW, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0150-7; Mayer CL, 2013, HEADACHE, V53, P1523, DOI 10.1111/head.12173; Murillo B, 2018, DEV NEUROBIOL, V78, P952, DOI 10.1002/dneu.22602; Nishimoto Shunsuke, 2015, Front Cell Neurosci, V9, P298, DOI 10.3389/fncel.2015.00298; Nogales E, 2000, ANNU REV BIOCHEM, V69, P277, DOI 10.1146/annurev.biochem.69.1.277; O'Donovan KJ, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00486; Okada K, 2010, EXP NEUROL, V222, P191, DOI 10.1016/j.expneurol.2009.12.017; Rathod R, 2016, NEUROSCIENCE, V339, P376, DOI 10.1016/j.neuroscience.2016.10.018; Roussel BD, 2013, LANCET NEUROL, V12, P105, DOI 10.1016/S1474-4422(12)70238-7; Rubenstein R, 2017, JAMA NEUROL, V74, P1063, DOI 10.1001/jamaneurol.2017.0655; Sengottuvel Vetrivel, 2011, Commun Integr Biol, V4, P391, DOI 10.4161/cib.4.4.15552; Stassart RM, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00467; Sukocheva OA, 2001, BLOOD CELL MOL DIS, V27, P812, DOI 10.1006/bcmd.2001.0450; Sun D, 2014, NEURAL REGEN RES, V9, P688, DOI 10.4103/1673-5374.131567; Sun HZ, 2012, ARCH MED SCI, V8, P924, DOI 10.5114/aoms.2012.31623; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Takei Y, 2000, J CELL BIOL, V150, P989, DOI 10.1083/jcb.150.5.989; Tan HP, 2018, NEURAL REGEN RES, V13, P827, DOI 10.4103/1673-5374.232477; Tsai Yien Che, 2010, Genes Cancer, V1, P764; Wieloch T, 2006, CURR OPIN NEUROBIOL, V16, P258, DOI 10.1016/j.conb.2006.05.011; Wu YF, 2018, P NATL ACAD SCI USA, V115, pE2762, DOI 10.1073/pnas.1716439115; Xie YX, 2016, SCI REP-UK, V6, DOI 10.1038/srep38832; Zhang J, 2015, J FORENSIC SCI, V60, P759, DOI 10.1111/1556-4029.12743; Zhang Y, 2017, MOL NEUROBIOL, V54, P2659, DOI 10.1007/s12035-016-9851-0	45	17	17	0	9	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1663-9812			FRONT PHARMACOL	Front. Pharmacol.	APR 24	2019	10								406	10.3389/fphar.2019.00406			12	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	HU9XJ	WOS:000465647300001	31105562	Green Published, gold			2022-02-06	
J	Carlozzi, NE; Ianni, PA; Tulsky, DS; Brickell, TA; Lange, RT; French, LM; Cella, D; Kallen, MA; Miner, JA; Kratz, AL				Carlozzi, Noelle E.; Ianni, Phillip A.; Tulsky, David S.; Brickell, Tracey A.; Lange, Rael T.; French, Louis M.; Cella, David; Kallen, Michael A.; Miner, Jennifer A.; Kratz, Anna L.			Understanding Health-Related Quality of Life in Caregivers of Civilians and Service Members/Veterans With Traumatic Brain Injury: Establishing the Reliability and Validity of PROMIS Fatigue and Sleep Disturbance Item Banks	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Caregiver; Fatigue; Patient reported outcome measures; Psychometrics; Rehabilitation; Sleep; Traumatic brain injury	PORTLAND ADAPTABILITY INVENTORY; ZARIT-BURDEN-INTERVIEW; FAMILY CAREGIVERS; INFORMAL CAREGIVERS; CONSTRUCT-VALIDITY; OUTCOME MEASURES; HEAD-INJURY; TIME-COURSE; RECOVERY; VALIDATION	Objective: To examine the reliability and validity of Patient-Reported Outcomes Measurement Information System (PROMIS) measures of sleep disturbance and fatigue in traumatic brain injury (TBI) caregivers and to determine the severity of fatigue and sleep disturbance in these caregivers. Design: Cross-sectional survey data collected through an online data capture platform. Setting: A total of 4 rehabilitation hospitals and Walter Reed National Military Medical Center. Participants: Caregivers (N=560) of civilians (n =344) and service member/veterans (SMVs) (n =216) with TBI. Intervention: Not applicable. Main Outcome Measures: PROMIS sleep and fatigue measures administered as both computerized adaptive tests (CATS) and 4-item short forms (SFs). Results: For both samples, floor and ceiling effects for the PROMIS measures were low (<11%), internal consistency was very good (all alpha >= 0.80), and test-retest reliability was acceptable (all r >= 0.70 except for the fatigue CAT in the SMV sample r= 0.63). Convergent validity was supported by moderate correlations between the PROMIS and related measures. Discriminant validity was supported by low correlations between PROMIS measures and measures of dissimilar constructs. PROMIS scores indicated significantly worse sleep and fatigue for those caring for someone with high levels versus low levels of impairment. Conclusions: Findings support the reliability and validity of the PROMIS CAT and SF measures of sleep disturbance and fatigue in caregivers of civilians and SMVs with TBI. (C) 2018 by the American Congress of Rehabilitation Medicine	[Carlozzi, Noelle E.; Ianni, Phillip A.; Miner, Jennifer A.; Kratz, Anna L.] Univ Michigan, Dept Phys Med & Rehabil, North Campus Res Complex,2800 Plymouth Rd, Ann Arbor, MI 48109 USA; [Tulsky, David S.] Univ Delaware, Dept Psychol & Brain Sci, Ctr Assessment Res & Translat, Newark, DE USA; [Brickell, Tracey A.; Lange, Rael T.; French, Louis M.] Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bethesda, MD USA; [Brickell, Tracey A.; Lange, Rael T.; French, Louis M.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Brickell, Tracey A.; French, Louis M.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Lange, Rael T.] Univ British Columbia, Vancouver, BC, Canada; [Cella, David; Kallen, Michael A.] Northwestern Univ, Feinberg Sch Med, Dept Med Social Sci, Chicago, IL 60611 USA		Carlozzi, NE (corresponding author), Univ Michigan, Dept Phys Med & Rehabil, North Campus Res Complex,2800 Plymouth Rd, Ann Arbor, MI 48109 USA.	carlozzi@med.umich.edu	french, louis/AAB-2083-2020	Tulsky, David/0000-0002-4335-4509; french, louis/0000-0002-9451-0604	National Institutes of Health National Institute of Nursing ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR); National Center for Advancing Translational SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000433]; Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000433, UL1TR002240] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR013658] Funding Source: NIH RePORTER	Supported by the National Institutes of Health National Institute of Nursing Research (grant no. R01NR013658), the National Center for Advancing Translational Sciences (grant no. UL1TR000433), and the Defense and Veterans Brain Injury Center.	Al-Rawashdeh SY, 2016, J CARDIOVASC NURS, V31, pE21, DOI 10.1097/JCN.0000000000000348; Amtmann D, 2018, DISABIL HEALTH J, V11, P99, DOI 10.1016/j.dhjo.2017.04.008; Andresen EM, 2000, ARCH PHYS MED REHAB, V81, pS15, DOI 10.1053/apmr.2000.20619; [Anonymous], DOD WORLDW NUMB TBI; Bayen E, 2016, J HEAD TRAUMA REHAB, V31, pE59, DOI 10.1097/HTR.0000000000000079; Berger Ann M, 2005, Oncol Nurs Forum, V32, pE98, DOI 10.1188/05.ONF.E98-E126; Bohac DL, 1997, BRAIN INJURY, V11, P469, DOI 10.1080/713802185; Burns Anthony S, 2012, Handb Clin Neurol, V109, P47, DOI 10.1016/B978-0-444-52137-8.00003-6; Buysse DJ, 2010, SLEEP, V33, P781, DOI 10.1093/sleep/33.6.781; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS1, DOI 10.1016/j.apmr.2018.08.175; Carlozzi NE, 2016, J REHABIL RES DEV, V53, P669, DOI 10.1682/JRRD.2015.07.0136; Carlozzi NE, 2015, ARCH PHYS MED REHAB, V96, P105, DOI 10.1016/j.apmr.2014.08.021; Castriotta RJ, 2011, CNS DRUGS, V25, P175, DOI 10.2165/11584870-000000000-00000; Castro CM, 2009, BEHAV SLEEP MED, V7, P164, DOI 10.1080/15402000902976713; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Cohen J., 2013, STAT POWER ANAL BEHA; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Cramer D., 2004, SAGE DICT STAT; Davis LC, 2009, J HEAD TRAUMA REHAB, V24, P145, DOI 10.1097/HTR.0b013e3181a0b291; Degeneffe CE, 2011, REHABIL PSYCHOL, V56, P243, DOI 10.1037/a0024465; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; DeVellis R.F., 2017, SCALE DEV THEORY APP; DeVellis RF, 2006, MED CARE, V44, pS50, DOI 10.1097/01.mlr.0000245426.10853.30; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; DIKMEN S, 1983, ARCH NEUROL-CHICAGO, V40, P333, DOI 10.1001/archneur.1983.04050060033004; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Dillahunt-Aspillaga C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082896; DITUNNO JF, 1992, ARCH PHYS MED REHAB, V73, P431; ENRIGHT RB, 1987, EMPLOYED CAREGIVERS; Ergh TC, 2003, J CLIN EXP NEUROPSYC, V25, P1090, DOI 10.1076/jcen.25.8.1090.16735; Feeny D, 2005, J CLIN EPIDEMIOL, V58, P138, DOI 10.1016/j.jclinepi.2004.08.005; Fletcher BAS, 2008, ONCOL NURS FORUM, V35, P187, DOI 10.1188/08.ONF.E23-E44; Fonareva I, 2011, J GERIATR PSYCH NEUR, V24, P50, DOI 10.1177/0891988710397548; Fortune DG, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01368; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Hays RD, 1995, USERS MANUAL MED OUT; Heaton R. K., 2004, REVISED COMPREHENSIV; Hebert R, 2000, CAN J AGING, V19, P494, DOI 10.1017/S0714980800012484; Hoofien D, 2001, BRAIN INJURY, V15, P189; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; Jensen RE, 2017, J CLIN ONCOL, V35, P1913, DOI 10.1200/JCO.2016.71.4410; Jensen RE, 2017, CANCER-AM CANCER SOC, V123, P327, DOI 10.1002/cncr.30354; Johnson JA, 2004, QUAL LIFE RES, V13, P449, DOI 10.1023/B:QURE.0000018494.72748.cf; JORGENSEN HS, 1995, ARCH PHYS MED REHAB, V76, P406, DOI 10.1016/S0003-9993(95)80568-0; JORGENSEN HS, 1995, ARCH PHYS MED REHAB, V76, P399, DOI 10.1016/S0003-9993(95)80567-2; Jumisko E, 2007, J FAM NURS, V13, P353, DOI 10.1177/1074840707303842; Kean J, 2011, J NEUROTRAUM, V28, P745, DOI 10.1089/neu.2010.1573; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; Kozloff R., 1987, J HEAD TRAUMA REHAB, V2, P14, DOI [DOI 10.1097/00001199-198709000-00004, 10.1097/00001199-198709000-00004]; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; Lange RT, 2014, ARCH CLIN NEUROPSYCH, V29, P329, DOI 10.1093/arclin/acu013; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LAWTON MP, 1989, J GERONTOL, V44, pP61, DOI 10.1093/geronj/44.3.P61; Lee K.A., PATHOPHYSIOLOGICAL P, P363; Lester P, 2010, J AM ACAD CHILD PSY, V49, P310, DOI 10.1016/j.jaac.2010.01.003; Leung YW, 2016, CANCER-AM CANCER SOC, V122, P2906, DOI 10.1002/cncr.30134; Liu S, 2017, J CLIN NURS, V26, P1291, DOI 10.1111/jocn.13601; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; Maddigan SL, 2004, QUAL LIFE RES, V13, P435, DOI 10.1023/B:QURE.0000018497.06539.8f; Malec J, CTR OUTCOME MEASUREM; Malec JF, 2012, ARCH PHYS MED REHAB, V93, P2271, DOI 10.1016/j.apmr.2012.06.013; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Mansfield AJ, 2010, NEW ENGL J MED, V362, P101, DOI 10.1056/NEJMoa0900177; Manskow US, 2015, J HEAD TRAUMA REHAB, V30, P411, DOI 10.1097/HTR.0000000000000085; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Mazlan M, 2016, DISABIL REHABIL, V38, P2198, DOI 10.3109/09638288.2015.1123307; McCurry SM, 2007, SLEEP MED REV, V11, P143, DOI 10.1016/j.smrv.2006.09.002; Musil CM, 2002, WESTERN J NURS RES, V24, P815, DOI 10.1177/019394502762477004; Nagaraja V, 2018, QUAL LIFE RES, V27, P755, DOI 10.1007/s11136-017-1709-z; National Alliance for Caregiving, 2010, CAR VET SERV HOM REP; Panting A, 1972, REHABILITATION, V38, P33; Peng HL, 2013, PERSPECT PSYCHIATR C, V49, P135, DOI 10.1111/ppc.12005; PETERS L C, 1990, Brain Injury, V4, P39, DOI 10.3109/02699059009026147; Pollak C P, 1991, J Geriatr Psychiatry Neurol, V4, P204, DOI 10.1177/089198879100400405; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Purvis TE, 2017, SPINE, V42, pE1357, DOI 10.1097/BRS.0000000000002347; Purvis TE, 1976, SPINE PHILA PA 1976; Quach CW, 2016, QUAL LIFE RES, V25, P2811, DOI 10.1007/s11136-016-1325-3; Ruff RL, 2009, J REHABIL RES DEV, V46, P1071, DOI 10.1682/JRRD.2009.05.0062; Saban KL, 2016, J REHABIL RES DEV, V53, P681, DOI 10.1682/JRRD.2015.07.0143; Sander A. M., 2005, REHABILITATION TRAUM, P156; Sander AM, 2003, ARCH PHYS MED REHAB, V84, P197, DOI 10.1053/apmr.2003.50105; Sander AM, 2013, BRAIN IMPAIR, V14, P113, DOI 10.1017/BrImp.2013.12; Schreiner AS, 2006, AGING MENT HEALTH, V10, P107, DOI 10.1080/13607860500312142; Schulz R, 1997, ANN BEHAV MED, V19, P110, DOI 10.1007/BF02883327; Selim A, 2009, QUAL LIFE RES, V18, P43, DOI 10.1007/s11136-008-9418-2; Seng BK, 2010, ANN ACAD MED SINGAP, V39, P758; Smith MC, 1997, J AM GERIATR SOC, V45, P194, DOI 10.1111/j.1532-5415.1997.tb04506.x; Struchen MA, 2002, J HEAD TRAUMA REHAB, V17, P132, DOI 10.1097/00001199-200204000-00005; Taft CT, 2008, J CONSULT CLIN PSYCH, V76, P648, DOI 10.1037/a0012576; Victorson D, 2016, J ALTERN COMPLEM MED, V22, P778, DOI 10.1089/acm.2015.0121; Vitaliano PP, 2003, PSYCHOL BULL, V129, P946, DOI 10.1037/0033-2909.129.6.946; Waters R L, 1998, J Spinal Cord Med, V21, P195; WATERS RL, 1993, ARCH PHYS MED REHAB, V74, P242; WATERS RL, 1992, ARCH PHYS MED REHAB, V73, P784; WATERS RL, 1994, ARCH PHYS MED REHAB, V75, P67; Whalen KJ, 2009, JBI DATABASE SYSTEMA, V7, P1373; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183; Yu L, 2012, BEHAV SLEEP MED, V10, P6, DOI 10.1080/15402002.2012.636266; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649	108	17	17	0	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	APR	2019	100	4		1			S102	S109		10.1016/j.apmr.2018.05.020			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	HR2FV	WOS:000462951900012	29932884	Green Accepted			2022-02-06	
J	Yang, LX; Yang, LK; Zhu, J; Chen, JH; Wang, YH; Xiong, K				Yang, Li-Xiang; Yang, Li-Kun; Zhu, Jie; Chen, Jun-Hui; Wang, Yu-Hai; Xiong, Kun			Expression signatures of long non-coding RNA and mRNA in human traumatic brain injury	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; human traumatic brain injuries; long noncoding RNA; messenger RNA; GO analysis; real-time quantitative polymerase chain reaction; biomarkers; microarray analysis; biological processes; medical informatics; neural regeneration	PROFILE ANALYSIS; IN-VITRO; S100A12; LNCRNA; MICE; APOPTOSIS; BIOMARKER; PROTECTS; PROMOTES; INVASION	Long non-coding RNAs (lncRNAs) play a key role in craniocerebral disease, although their expression profiles in human traumatic brain injury are still unclear. In this regard, in this study, we examined brain injury tissue from three patients of the 101st Hospital of the People's Liberation Army, China (specifically, a 36-year-old male, a 52-year-old female, and a 49-year-old female), who were diagnosed with traumatic brain injury and underwent brain contusion removal surgery. Tissue surrounding the brain contusion in the three patients was used as control tissue to observe expression characteristics of lncRNAs and mRNAs in human traumatic brain injury tissue. Volcano plot filtering identified 99 lncRNAs and 63 mRNAs differentially expressed in frontotemporal tissue of the two groups (P < 0.05, fold change > 1.2). Microarray analysis showed that 43 lncRNAs were up-regulated and 56 lncRNAs were down-regulated. Meanwhile, 59 mRNAs were up-regulated and 4 mRNAs were down-regulated. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses revealed 27 signaling pathways associated with target genes and, in particular, legionellosis and influenza A signaling pathways. Subsequently, a lncRNA-gene network was generated, which showed an absolute correlation coefficient value > 0.99 for 12 lncRNA-mRNA pairs. Finally, quantitative real-time polymerase chain reaction confirmed different expression of the five most up-regulated mRNAs within the two groups, which was consistent with the microarray results. In summary, our results show that expression profiles of mRNAs and lncRNAs are significantly different between human traumatic brain injury tissue and surrounding tissue, providing novel insight regarding lncRNAs' involvement in human traumatic brain injury. All participants provided informed consent.	[Yang, Li-Xiang; Yang, Li-Kun; Zhu, Jie; Chen, Jun-Hui; Wang, Yu-Hai] 101st Hosp Peoples Liberat Army, Dept Neurosurg, Wuxi, Jiangsu, Peoples R China; [Xiong, Kun] Cent S Univ, Sch Basic Med Sci, Dept Anat & Neurobiol, Changsha, Hunan, Peoples R China		Wang, YH (corresponding author), 101st Hosp Peoples Liberat Army, Dept Neurosurg, Wuxi, Jiangsu, Peoples R China.; Xiong, K (corresponding author), Cent S Univ, Sch Basic Med Sci, Dept Anat & Neurobiol, Changsha, Hunan, Peoples R China.	wangyuhai101@126.com; xiongkun2001@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571939, 81601719, 81772134]; Key Research and Development Program of Hunan Province of China [2018SK2091]; Wu Jie-Ping Medical Foundation of the Minister of Health of China [320.6750.14118]; Teacher Research Foundation of Central South University of China [2014JSJJ026]	This study was supported by the National Natural Science Foundation of China, No. 81571939 (to KX), 81601719 (to JZ) and 81772134 (to KX); the Key Research and Development Program of Hunan Province of China, No. 2018SK2091 (to KX); the Wu Jie-Ping Medical Foundation of the Minister of Health of China, No. 320.6750.14118 (to KX); and the Teacher Research Foundation of Central South University of China, No. 2014JSJJ026 (to KX).	Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Berrocal-Almanza LC, 2016, SCI REP-UK, V6, DOI 10.1038/srep31798; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chen AJW, 2010, NEURON, V66, P11, DOI 10.1016/j.neuron.2010.04.004; Chen G, 2013, NUCLEIC ACIDS RES, V41, pD983, DOI 10.1093/nar/gks1099; Chen RJ, 2016, NEUROSCIENCE, V319, P123, DOI 10.1016/j.neuroscience.2016.01.033; Chi P, 2007, GENE DEV, V21, P1747, DOI 10.1101/gad.1563007; Chowdhary VR, 2015, J IMMUNOL, V195, P4660, DOI 10.4049/jimmunol.1501073; D'haene E, 2016, SCI REP-UK, V6, DOI 10.1038/srep28396; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI [10.1016/j.febslet.2007.05.039, 10.1016/j.febsiet.2007.05.039]; Dharap A, 2012, STROKE, V43, P2800, DOI 10.1161/STROKEAHA.112.669465; Dorosh A, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-42; Eroglu B, 2014, J NEUROCHEM, V130, P626, DOI 10.1111/jnc.12781; Fancy SPJ, 2014, NAT NEUROSCI, V17, P506, DOI 10.1038/nn.3676; Feng MJ, 2018, CLIN CHIM ACTA, V480, P84, DOI 10.1016/j.cca.2018.01.044; Fuchs T, 2002, GENOMICS, V80, P295, DOI 10.1006/geno.2002.6830; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Giera S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7121; Guo Q, 2017, ONCOL REP, V37, P1114, DOI 10.3892/or.2016.5312; Han ZL, 2014, BRAIN RES, V1582, P12, DOI 10.1016/j.brainres.2014.07.045; Harris MA, 2006, NUCLEIC ACIDS RES, V34, pD322, DOI 10.1093/nar/gkj021; Hirschi R, 2017, NEURAL REGEN RES, V12, P1801, DOI 10.4103/1673-5374.219037; Holloway RG, 2010, NEW ENGL J MED, V362, P1757, DOI 10.1056/NEJMp0907808; Jiang BC, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0047-9; Jiang H, 2017, APMIS, V125, P773, DOI 10.1111/apm.12721; Jiang YZ, 2014, CELL BIOCHEM BIOPHYS, V69, P461, DOI 10.1007/s12013-014-9818-6; Kan EM, 2012, BRAIN RES BULL, V87, P359, DOI 10.1016/j.brainresbull.2012.01.007; Kim AR, 2017, MOL IMMUNOL, V91, P218, DOI 10.1016/j.molimm.2017.09.009; Kinouchi T, 2017, CANCER SCI, V108, P2495, DOI 10.1111/cas.13414; Li Y, 2016, TUMOR BIOL, V37, P13091, DOI 10.1007/s13277-016-5227-3; Liu X, 2017, ZHONGGUO ZUZHI GONGC, V21, P4709; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Long YC, 2017, SCI ADV, V3, DOI 10.1126/sciadv.aao2110; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Qu WR, 2016, NEURAL REGEN RES, V11, P248, DOI 10.4103/1673-5374.177732; Quan ZZ, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00175; Roberts TC, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0507; Rockhill CM, 2012, J NEUROTRAUM, V29, P1038, DOI 10.1089/neu.2010.1562; Salmaso N, 2014, NAT NEUROSCI, V17, P341, DOI 10.1038/nn.3604; Shi W, 2011, NEUROCHEM RES, V36, P375, DOI 10.1007/s11064-010-0332-y; Shi ZH, 2015, CELL PHYSIOL BIOCHEM, V36, P542, DOI 10.1159/000430119; Shojo H, 2010, NEUROSCIENCE, V171, P1273, DOI 10.1016/j.neuroscience.2010.10.018; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Suarez-Calvet X, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1383-0; Tan L, 2013, MOL NEUROBIOL, V47, P382, DOI 10.1007/s12035-012-8359-5; Twiss JL, 2016, NEURAL REGEN RES, V11, P1365, DOI 10.4103/1673-5374.191193; Volders PJ, 2013, NUCLEIC ACIDS RES, V41, pD246, DOI 10.1093/nar/gks915; Wang SC, 2018, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00425; Wang Z, 2018, J CELL PHYSIOL, V233, P4864, DOI 10.1002/jcp.26294; Wegleiter K, 2014, EXP NEUROL, V261, P501, DOI 10.1016/j.expneurol.2014.07.022; Xiong K, 2017, TOXICOL IN VITRO, V44, P1, DOI 10.1016/j.tiv.2017.06.009; Yan Y, 2015, J CANCER RES CLIN, V141, P827, DOI 10.1007/s00432-014-1861-6; Yoon JH, 2013, J MOL BIOL, V425, P3723, DOI 10.1016/j.jmb.2012.11.024; Yu G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042377; Zhao JL, 2017, J INVEST DERMATOL, V137, P650, DOI 10.1016/j.jid.2016.10.040; Zhong JJ, 2016, BRAIN RES, V1646, P589, DOI 10.1016/j.brainres.2016.07.002	57	17	18	1	15	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	APR	2019	14	4					632	641	PMID 30632503	10.4103/1673-5374.247467			10	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	HH7LW	WOS:000455913300016	30632503	Green Published, gold			2022-02-06	
J	Zhao, WB; Wang, S; Qin, TY; Wang, WZ				Zhao, Wenbo; Wang, Shuai; Qin, Tingyu; Wang, Wenzhan			Arbutin attenuates hydrogen peroxide-induced oxidative injury through regulation of microRNA-29a in retinal ganglion cells	BIOMEDICINE & PHARMACOTHERAPY			English	Article						Optic nerve injury; Oxidative injury; Arbutin; microRNA-29a; MEK/ERK; p38MAPK	INDUCED APOPTOSIS; STRESS; PROTECTS; DAMAGE; ACTIVATION; H2O2; NEUROPROTECTION; ASSOCIATION; MECHANISMS; EYE	Background: Optic nerve injury is a severe complication of traumatic brain injury, which may lead to permanent and potentially loss of vision. Arbutin (ARB) is a natural hydroquinone glycoside, has been widely utilized to treat pigmented disorders. However, the role of ARB in optic nerve injury is still unclear. The study attempted to explore the effect of ARB on H2O2-induced oxidative injury in RGCs. Methods: RGCs were treated with different concentrations of H2O2 to construct a cell oxidative injury model. Subsequently, the effects of ARB on these injured cells were examined through testing cell viability, apoptosis and their associated factors. MicroRNA-29a (miR-29a) inhibitor was transfected into RGCs, and the regulatory effect of miR-29a inhibition on H2O2-injured cells was detected. Further, the important signaling pathways of MEK/ERK and p38MAPK were determined to uncover the underlying mechanism. Results: We firstly used H2O2 to induce RGCs injury, and subsequent experiments found that ARB significantly alleviated H2O2-induced cell injury in RGCs by promoting cell viability, reducing apoptosis, and regulating the protein levels of cell growth-associated factors. Increasing expression of miR-29a was observed in ARB and H2O2 treated cells. Moreover, miR-29a inhibition significantly abrogated the protective effect of ARB on H2O2-injured RGCs. NRAS was predicated as a direct target gene of miR-29a. Mechanistically, ARB blocked MEK/ERK and p38MAPK pathways by up-regulating miR-29a. Conclusions: These data demonstrated that ARB protected RGCs against oxidative injury induced by H2O2 through blocking MEK/ERK and p38MAPK signaling pathways by up-regulation of miR-29a.	[Zhao, Wenbo; Wang, Shuai; Qin, Tingyu; Wang, Wenzhan] Zhengzhou Univ, Affiliated Hosp 1, Dept Ophthalmol, 1 Jianshe East Rd, Zhengzhou 450052, Henan, Peoples R China		Wang, WZ (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Ophthalmol, 1 Jianshe East Rd, Zhengzhou 450052, Henan, Peoples R China.	wangwenzhan123@sina.com					Abreu CA, 2017, HISTOL HISTOPATHOL, V32, P253, DOI 10.14670/HH-11-788; Alireza M, 2017, WORLD NEUROSURG, V97, DOI 10.1016/j.wneu.2016.10.083; Altomare E, 1997, EUR J CLIN INVEST, V27, P141, DOI 10.1046/j.1365-2362.1997.780629.x; Arfuzir NNN, 2016, NEUROSCIENCE, V325, P153, DOI 10.1016/j.neuroscience.2016.03.041; Azeem AAA, 2009, BRATISL MED J, V110, P678; [别曼 Bie Man], 2012, [中国病理生理杂志, Chinese Journal of Pathophysiology], V28, P1091; Blanc A, 2003, INT J MOL MED, V11, P229; Bull ND, 2012, EXP NEUROL, V236, P34, DOI 10.1016/j.expneurol.2012.03.021; Busetto GM, 2014, BMC UROL, V14, DOI 10.1186/1471-2490-14-53; Chen LW, 2016, J GLAUCOMA, V25, pE569, DOI 10.1097/IJG.0000000000000395; Dahlmann-Noor AH, 2010, DRUG DISCOV TODAY, V15, P287, DOI 10.1016/j.drudis.2010.02.007; [Dong Qin 董钦], 2005, [哈尔滨医科大学学报, The Journal of Harbin Medical College], V39, P142; Gebeshuber CA, 2009, EMBO REP, V10, P400, DOI 10.1038/embor.2009.9; Han YC, 2010, J EXP MED, V207, P475, DOI 10.1084/jem.20090831; Hou RW, 2016, SCI CHINA LIFE SCI, V59, P495, DOI 10.1007/s11427-016-5022-9; Jensen R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189980; Jia WC, 2014, EUR REV MED PHARMACO, V18, P2191; Kang KA, 2010, INT J MOL SCI, V11, P4348, DOI 10.3390/ijms11114348; Kong N, 2014, BMC MOL BIOL, V15, DOI 10.1186/s12867-014-0025-1; Kruk J, 2016, MINI-REV MED CHEM, V16, P241, DOI 10.2174/1389557516666151120114605; Kumar KJS, 2013, FOOD CHEM TOXICOL, V59, P55, DOI 10.1016/j.fct.2013.04.055; LI DD, 2017, MEDICINE, V96, DOI DOI 10.1097/MD.0000000000008523; Liu JJ, 2013, J COSMET SCI, V64, P9; Liu YP, 2011, NEURAL REGEN RES, V6, P2100, DOI 10.3969/j.issn.1673-5374.2011.27.003; Lv BC, 2016, INT J MOL MED, V37, P225, DOI 10.3892/ijmm.2015.2418; Ma XF, 2017, PEPTIDES, V92, P1, DOI 10.1016/j.peptides.2017.04.008; Marler KJ, 2014, J NEUROSCI, V34, P969, DOI 10.1523/JNEUROSCI.1910-13.2014; McMonnies C, 2018, J OPTOM, V11, P3, DOI 10.1016/j.optom.2017.06.002; Mi XS, 2013, J INTEGR MED-JIM, V11, P233, DOI 10.3736/jintegrmed2013037; Mirshahvalad S, 2016, JUNDISHAPUR J NAT PH, V11, DOI 10.17795/jjnpp.33392; Muniz FWMG, 2015, ARCH ORAL BIOL, V60, P1203, DOI 10.1016/j.archoralbio.2015.05.007; Nakajima M, 1998, PIGM CELL RES, V11, P12, DOI 10.1111/j.1600-0749.1998.tb00705.x; Numata T, 2016, CONTACT DERMATITIS, V75, P187, DOI 10.1111/cod.12594; Ozler A, 2014, CENT EUR J IMMUNOL, V39, P198, DOI 10.5114/ceji.2014.43723; Pinter R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010021; Ruan JW, 2018, BIOCHEM BIOPH RES CO, V503, P607, DOI 10.1016/j.bbrc.2018.06.048; Shao Y, 2015, J MOL NEUROSCI, V56, P461, DOI 10.1007/s12031-015-0522-9; Tanito M, 2016, SCI REP-UK, V6, DOI 10.1038/srep25792; Velez G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193250; Wang CM, 2018, INT J IMMUNOPATH PH, V32, DOI 10.1177/2058738418785739; Wang S, 2018, BMC OPHTHALMOL, V18, DOI 10.1186/s12886-018-0766-6; Yamamoto N, 2013, INT J ONCOL, V43, P1855, DOI 10.3892/ijo.2013.2145; Zheng Y, 2010, MOL VIS, V16, P1467	43	17	17	1	5	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0753-3322	1950-6007		BIOMED PHARMACOTHER	Biomed. Pharmacother.	APR	2019	112								108729	10.1016/j.biopha.2019.108729			8	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	HP1TD	WOS:000461449400118	30970524	gold			2022-02-06	
J	Forslund, MV; Perrin, PB; Roe, C; Sigurdardottir, S; Hellstrom, T; Berntsen, SA; Lu, J; Arango-Lasprilla, JC; Andelic, N				Forslund, Marit, V; Perrin, Paul B.; Roe, Cecilie; Sigurdardottir, Solrun; Hellstrom, Torgeir; Berntsen, Svein A.; Lu, Juan; Carlos Arango-Lasprilla, Juan; Andelic, Nada			Global Outcome Trajectories up to 10 Years After Moderate to Severe Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						brain injury; outcome assessment; GOSE; prospective studies; rehabilitation	QUALITY-OF-LIFE; 1ST 5 YEARS; FOLLOW-UP; HEAD-INJURY; GENDER-DIFFERENCES; PHYSICAL HEALTH; MODEL SYSTEMS; YOUNG-PEOPLE; DISABILITY; STABILITY	Aims: Based on important predictors, global functional outcome after traumatic brain injury (TBI) may vary significantly over time. This study sought to: (1) describe changes in the Glasgow Outcome Scale-Extended (GOSE) score in survivors of moderate to severe TBI, (2) examine longitudinal GOSE trajectories up to 10 years after injury, and (3) investigate predictors of these trajectories based on socio-demographic and injury characteristics. Methods: Socio-demographic and injury characteristics of 97 TBI survivors aged 16-55 years were recorded at baseline. GOSE was used as a measure of TBI-related global outcome and assessed at 1-, 2-, 5-, and 10-year follow-ups. Hierarchical linear models were used to examine global outcomes over time and whether those outcomes could be predicted by: time, time*time, sex, age, partner relationship status, education, employment pre-injury, occupation, cause of injury, acute Glasgow Coma Scale score, length of post-traumatic amnesia (PTA), CT findings, and Injury Severity Score (ISS), as well as the interactions between each of the significant predictors and time*time. Results: Between 5- and 10-year follow-ups, 37% had deteriorated, 7% had improved, and 56% showed no change in global outcome. Better GOSE trajectories were predicted by male gender (p = 0.013), younger age (p = 0.012), employment at admission (p = 0.012), white collar occupation (p = 0.014), and shorter PTA length (p = 0.001). The time*time*occupation type interaction effect (p = 0.001) identified different trajectory slopes between survivors in white and blue collar occupations. The time*time*PTA interaction effect (p = 0.023) identified a more marked increase and subsequent decrease in functional level among survivors with longer PTA duration. Conclusion: A larger proportion of survivors experienced deterioration in GOSE scores over time, supporting the concept of TBI as a chronic health condition. Younger age, pre-injury employment, and shorter PTA duration are important prognostic factors for better long-term global outcomes, supporting the existing literature, whereas male gender and white collar occupation are vaguer as prognostic factors. This information suggests that more intensive and tailored rehabilitation programs may be required to counteract a negative global outcome development in survivors with predicted worse outcome and to meet their long-term changing needs.	[Forslund, Marit, V; Roe, Cecilie; Hellstrom, Torgeir; Andelic, Nada] Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway; [Perrin, Paul B.] Virginia Commonwealth Univ, Dept Psychol, Box 2018, Richmond, VA 23284 USA; [Roe, Cecilie] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway; [Sigurdardottir, Solrun] Sunnaas Rehabil Hosp, Dept Res, Nesoddtangen, Norway; [Berntsen, Svein A.] Sorlandet Hosp, Dept Phys Med & Rehabil, Kristiansand, Norway; [Lu, Juan] Virginia Commonwealth Univ, Div Epidemiobgy, Dept Family Med & Populat Hlth, Richmond, VA USA; [Lu, Juan; Andelic, Nada] Univ Oslo, Fac Med, Inst Hlth & Soc, Res Ctr Habilitat & Rehabil Models & Serv CHARM, Oslo, Norway; [Carlos Arango-Lasprilla, Juan] Basque Fdn Sci, Ikerbasque, Bilbao, Spain; [Carlos Arango-Lasprilla, Juan] Cruces Univ Hosp Barakaldo, BioCruces Hlth Res Inst, Baracaldo, Spain		Forslund, MV (corresponding author), Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway.	mavfor@ous-hf.no	Hellstrom, Torgeir/AAY-6043-2021; Hellstrom, Torgeir/AAW-4301-2021	Hellstrom, Torgeir/0000-0003-0831-3274; Andelic, Nada/0000-0002-3719-4406; Lu, Juan/0000-0002-5389-7603	Department of Physical Medicine and Rehabilitation, Oslo University Hospital; The Institute of Health and Society, CHARM (Research Centre for Habilitation and Rehabilitation Models and Services), Faculty of Medicine, University of Oslo; Research Council of NorwayResearch Council of Norway	The authors would like to thank the patients for their participation. Special thanks to Nini Hammergren for assistance with patient registration, and Tone Jerstad, neuroradiologist, for the CT assessments. This study was funded by the Department of Physical Medicine and Rehabilitation, Oslo University Hospital, The Institute of Health and Society, CHARM (Research Centre for Habilitation and Rehabilitation Models and Services), Faculty of Medicine, University of Oslo and The Research Council of Norway.	Andelic N, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.1018; Andelic N, 2016, J NEUROTRAUM, V33, P95, DOI 10.1089/neu.2014.3844; Andelic N, 2015, J NEUROL, V262, P523, DOI 10.1007/s00415-014-7595-1; Andelic N, 2014, PM&R, V6, P1013, DOI 10.1016/j.pmrj.2014.05.005; Andelic N, 2012, BRAIN INJURY, V26, P261, DOI 10.3109/02699052.2012.654589; Andelic N, 2010, DISABIL REHABIL, V32, P1122, DOI 10.3109/09638280903410722; Andersson E, 2017, ACTA ANAESTH SCAND, V61, P502, DOI 10.1111/aas.12880; Anke A, 2015, J HEAD TRAUMA REHAB, V30, pE38, DOI 10.1097/HTR.0000000000000080; Arango-Lasprilla JC, 2010, J HEAD TRAUMA REHAB, V25, P128, DOI 10.1097/HTR.0b013e3181d36ca3; Arango-Lasprilla JC, 2009, PM&R, V1, P41, DOI 10.1016/j.pmrj.2008.07.001; Azouvi P, 2016, BRAIN INJURY, V30, P1665, DOI 10.1080/02699052.2016.1201593; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bonow RH, 2018, WORLD NEUROSURG, V111, pE82, DOI 10.1016/j.wneu.2017.11.171; Connelly J, 2006, DISABIL REHABIL, V28, P629, DOI 10.1080/09638280500276513; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Dams-O'Connor K, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000073; Deguise E, 2008, J HEAD TRAUMA REHAB, V23, P294, DOI 10.1097/01.HTR.0000336842.53338.f4; Einarsen CE, 2018, WORLD NEUROSURG, V114, pE1199, DOI 10.1016/j.wneu.2018.03.176; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Forslund MV, 2013, ACTA NEUROL SCAND, V128, P220, DOI 10.1111/ane.12130; Forslund MV, 2017, BRAIN INJURY, V31, P329, DOI 10.1080/02699052.2016.1255778; Forslund MV, 2014, NEUROREHABILITATION, V34, P781, DOI 10.3233/NRE-141084; Forslund MV, 2014, BRAIN INJURY, V28, P980, DOI 10.3109/02699052.2014.888770; Forslund MV, 2013, J REHABIL MED, V45, P801, DOI 10.2340/16501977-1168; Gautschi OP, 2013, CLIN NEUROL NEUROSUR, V115, P2482, DOI 10.1016/j.clineuro.2013.09.038; Grauwmeijer E, 2017, J NEUROTRAUM, V34, P2575, DOI 10.1089/neu.2016.4846; Haller CS, 2017, BRAIN INJURY, V31, P319, DOI 10.1080/02699052.2016.1255777; Hammond FM, 2010, EUR J PHYS REHAB MED, V46, P545; Howe EI, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01051; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jourdan C, 2013, BRAIN INJURY, V27, P1000, DOI 10.3109/02699052.2013.794971; Jourdan C, 2017, J HEAD TRAUMA REHAB, V32, pE26, DOI 10.1097/HTR.0000000000000276; Kosty JA, 2013, NEUROL RES, V35, P277, DOI 10.1179/1743132813Y.0000000168; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lu J, 2018, J NEUROTRAUM, V35, P1596, DOI 10.1089/neu.2017.5299; Maas AI, 2010, ARCH PHYS MED REHAB, V91, P1641, DOI 10.1016/j.apmr.2010.07.232; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; McMillan TM, 2012, J NEUROL NEUROSUR PS, V83, P1086, DOI 10.1136/jnnp-2012-302746; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P2486, DOI 10.1016/j.apmr.2013.06.021; Roe C, 2012, J NEUROL RES, V2, P134, DOI DOI 10.4021/JNR133W; Shafi S, 2007, J TRAUMA, V63, P1263, DOI 10.1097/TA.0b013e31815b8f00; Sigurdardottir S, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000039; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; TEASDALE G, 1974, LANCET, V2, P81; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Wright DW, 2014, ACAD EMERG MED, V21, P1414, DOI 10.1111/acem.12532; Zelnick LR, 2014, J NEUROTRAUM, V31, P1029, DOI 10.1089/neu.2013.3122	59	17	17	4	7	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAR 14	2019	10								219	10.3389/fneur.2019.00219			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HP5DZ	WOS:000461698400001	30923511	Green Published, gold			2022-02-06	
J	Olby, NJ; Lim, JH; Wagner, N; Zidan, N; Early, PJ; Mariani, CL; Munana, KR; Laber, E				Olby, Natasha J.; Lim, Ji-Hey; Wagner, Nikki; Zidan, Natalia; Early, Peter J.; Mariani, Christopher L.; Munana, Karen R.; Laber, Eric			Time course and prognostic value of serum GFAP, pNFH, and S100 beta concentrations in dogs with complete spinal cord injury because of intervertebral disc extrusion	JOURNAL OF VETERINARY INTERNAL MEDICINE			English	Article						biomarker; intervertebral disc disease; myelomalacia; prognosis	TRAUMATIC BRAIN-INJURY; FLUID INFLAMMATORY CYTOKINES; SUBUNIT NF-H; CEREBROSPINAL-FLUID; STRUCTURAL BIOMARKERS; PAIN PERCEPTION; PROTEIN; SEVERITY; RECOVERY; ASSOCIATION	Background: A noninvasive biomarker is needed to predict recovery from severe spinal cord injury (SCI) because of thoracolumbar intervertebral disc extrusion (TL-IVDE). Proteins released from neural and glial cells can be detected in the blood and show promise as prognostic tools, but their concentration is influenced by time after injury. Hypothesis/Objectives: Serum concentrations of glial fibrillary acidic protein (GFAP), phosphorylated neurofilament heavy chain (pNFH), and S100 beta will follow different time courses; measurement of combinations of these proteins will predict outcome. Animals: Thirty-one dogs with TL-IVDE causing paralysis with no pain perception. Methods: Prospective study. Serum samples were taken at presentation and intervals over 56 days and banked at -80 degrees C. Glial fibrillary acidic protein, pNFH, and 5100 beta concentrations were measured using ELISA tests and plotted against time from onset of nonambulatory status. Outcome was established at 6 months. The association between biomarker concentration and outcome was examined using logistic regression, receiver operator characteristics curve analysis, and model development. Results: Thirty-one dogs participated, 3/31 (10%) developed progressive myelomalacia and 19/31 (62%) recovered ambulation. Glial fibrillary acidic protein and S100 beta concentrations rose for the first 1 to 3 days, and were undetectable by 14 and 28 days, respectively. Phosphorylated neurofilament heavy chain concentrations peaked at 14 days and were detectable at 56 days. Glial fibrillary acidic protein concentrations in the first 72 hours after onset of nonambulatory status predicted recovery with an accuracy of 76.7%-89% depending on sample timing. Conclusions and Clinical Importance: Serum GFAP concentrations can be used to predict outcome in clinically complete SCI. A rapid inexpensive bedside test is needed.	[Olby, Natasha J.; Zidan, Natalia; Early, Peter J.; Mariani, Christopher L.; Munana, Karen R.] North Carolina State Univ, Coll Vet Med, Dept Clin Sci, 1060 William Moore Dr, Raleigh, NC 27607 USA; [Olby, Natasha J.; Zidan, Natalia; Early, Peter J.; Mariani, Christopher L.; Munana, Karen R.] North Carolina State Univ, Comparat Med Inst, Raleigh, NC 27695 USA; [Lim, Ji-Hey] Univ Missouri, Coll Vet Med, Dept Vet Med & Surg, Columbia, MO 65211 USA; [Wagner, Nikki] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA; [Laber, Eric] North Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA		Olby, NJ (corresponding author), North Carolina State Univ, Coll Vet Med, Dept Clin Sci, 1060 William Moore Dr, Raleigh, NC 27607 USA.	njolby@ncsu.edu		Lim, Ji-Hey/0000-0001-6922-3155; Munana, Karen/0000-0001-9592-6276; Olby, Natasha/0000-0003-1349-3484	Congressionally Directed Medical Research ProgramsUnited States Department of Defense [W81XWH-11-1-0772]; Assisi Animal Health; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P01CA142538] Funding Source: NIH RePORTER	Assisi Animal Health; Congressionally Directed Medical Research Programs, Grant/Award Number: W81XWH-11-1-0772	Aikawa T, 2014, VET SURG, V43, P301, DOI 10.1111/j.1532-950X.2014.12102.x; Aikawa T, 2012, JAVMA-J AM VET MED A, V241, P1617, DOI 10.2460/javma.241.12.1617; Chamisha Y, 2015, RES VET SCI, V100, P189, DOI 10.1016/j.rvsc.2015.03.017; De Risio L, 2008, JAVMA-J AM VET MED A, V233, P129, DOI 10.2460/javma.233.1.129; Ferreira AJA, 2002, J SMALL ANIM PRACT, V43, P158, DOI 10.1111/j.1748-5827.2002.tb00049.x; Guez M, 2003, J NEUROTRAUM, V20, P853, DOI 10.1089/089771503322385782; Hastie T., 2009, ELEMENTS STAT LEARNI, P389, DOI [10.1007/978-0-387-84858-7_11, DOI 10.1007/978-0-387-84858-7_11]; Hayakawa K, 2012, SPINAL CORD, V50, P493, DOI 10.1038/sc.2011.184; Ito D, 2005, JAVMA-J AM VET MED A, V227, P1454, DOI 10.2460/javma.2005.227.1454; Jeffery ND, 2013, J VET INTERN MED, V27, P1318, DOI 10.1111/jvim.12183; Jeffery ND, 2016, JAVMA-J AM VET MED A, V248, P386, DOI 10.2460/javma.248.4.386; Kuhle J, 2015, J NEUROL NEUROSUR PS, V86, P273, DOI 10.1136/jnnp-2013-307454; Kwon BK, 2011, CLIN CHEM LAB MED, V49, P425, DOI 10.1515/CCLM.2011.068; Kwon BK, 2010, J NEUROTRAUM, V27, P669, DOI 10.1089/neu.2009.1080; Levine GJ, 2010, J VET INTERN MED, V24, P890, DOI 10.1111/j.1939-1676.2010.0531.x; Levine JM, 2009, J VET INTERN MED, V23, P1220, DOI 10.1111/j.1939-1676.2009.0393.x; Lewis MJ, 2018, J NEUROTRAUM, V35, P500, DOI 10.1089/neu.2017.5255; Lewis MJ, 2017, J NEUROTRAUM, V34, P2994, DOI 10.1089/neu.2017.5012; Ma JJ, 2001, SCAND J PLAST RECONS, V35, P355; McMahill BG, 2015, STEM CELL REV REP, V11, P180, DOI 10.1007/s12015-014-9553-9; Mercier E, 2013, BMJ-BRIT MED J, V346, P1757; Mercier E, 2018, J NEUROTRAUM, V35, P609, DOI 10.1089/neu.2017.5013; Moore SA, 2017, J NEUROTRAUM, V34, P2007, DOI 10.1089/neu.2016.4745; Nishida H, 2014, VET CLIN N AM-SMALL, V44, P1187, DOI 10.1016/j.cvsm.2014.07.014; Nishida H, 2014, VET SURG, V43, P289, DOI 10.1111/j.1532-950X.2014.12144.x; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Olby N, 2004, J NEUROTRAUM, V21, P49, DOI 10.1089/089771504772695940; Olby N, 2003, J AM VET MED ASSOC, V222, P762, DOI 10.2460/javma.2003.222.762; Olby NJ, 1999, J NEUROTRAUM, V16, P1215, DOI 10.1089/neu.1999.16.1215; Oris C, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2018-0037; Papa L, 2015, J NEUROTRAUM, V32, P661, DOI 10.1089/neu.2014.3655; Pouw MH, 2014, SPINAL CORD, V52, P428, DOI 10.1038/sc.2014.26; Ripley B., 1996, PATTERN RECOGN; Rodrigues LF, 2018, MOL NEUROBIOL, V12, P1; Roerig A, 2013, VET J, V197, P253, DOI 10.1016/j.tvjl.2013.02.005; Sato Y, 2013, J VET MED SCI, V75, P949, DOI 10.1292/jvms.12-0483; Shaw G, 2005, BIOCHEM BIOPH RES CO, V336, P1268, DOI 10.1016/j.bbrc.2005.08.252; Singh Ajai, 2017, Int J Crit Illn Inj Sci, V7, P212, DOI 10.4103/IJCIIS.IJCIIS_73_16; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; Taylor AR, 2014, J NEUROTRAUM, V31, P1561, DOI 10.1089/neu.2014.3405; Thelin EP, 2017, ACTA NEUROCHIR, V159, P1; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Wolf H, 2014, SPINE J, V14, P2918, DOI 10.1016/j.spinee.2014.04.027; Yang Z, 2018, MOL NEUROBIOL, V55, P1; Yokobori S, 2015, WORLD NEUROSURG, V83, P867, DOI 10.1016/j.wneu.2013.03.012	45	17	18	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0891-6640	1939-1676		J VET INTERN MED	J. Vet. Intern. Med.	MAR-APR	2019	33	2					726	734		10.1111/jvim.15439			9	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	HS4MR	WOS:000463838000045	30758078	gold, Green Published			2022-02-06	
J	Xue, M; Zhang, XW; Liu, F; Chang, W; Xie, JF; Xu, JY; Yang, Y; Qiu, HB				Xue, Ming; Zhang, Xiwen; Liu, Feng; Chang, Wei; Xie, Jianfeng; Xu, Jingyuan; Yang, Yi; Qiu, Haibo			Effects of chloride content of intravenous crystalloid solutions in critically ill adult patients: a meta-analysis with trial sequential analysis of randomized trials	ANNALS OF INTENSIVE CARE			English	Article						Lactated Ringers; Plasma-Lyte 148; 0.9% Saline; Critically ill patients; In-hospital mortality; Renal outcome	ACUTE KIDNEY INJURY; LACTATED RINGERS SOLUTION; PLASMA-LYTE 148; FLUID RESUSCITATION; INTENSIVE-CARE; BALANCED CRYSTALLOIDS; NORMAL SALINE; MANAGEMENT; MULTICENTER; ACIDOSIS	Intravenous crystalloid solutions are administered commonly for critically ill patients. We performed this meta-analysis of randomized trials with trial sequential analysis (TSA) to evaluate effects of chloride content of intravenous crystalloid solutions on clinical outcomes among critically ill adult patients. Electronic databases were searched up to June 1, 2018, for randomized trials of use of balanced crystalloids versus 0.9% saline solutions in critically ill adult patients. The outcome variables included mortality, renal outcomes, serum content alterations and organ function. Subgroup analysis was conducted according to patient settings, types or volume of crystalloid fluid, or among sepsis versus non-sepsis, TBI versus non-TBI or subpopulations by the categories of baseline kidney function. Random errors were evaluated by trial sequential analysis. Eight studies with 19,301 patients were analyzed. A trend of in-hospital survival benefit with no statistical difference could be observed with balanced crystalloids compared with 0.9% saline (RR 0.92, 95% CI 0.85-1.0, p = 0.06). The use of balanced crystalloid solutions was associated with longer RRT-free days (SMD 0.09, 95% CI 0.06-0.12, p < 0.001), less risk of increase in serum concentrations of chloride (SMD - 1.23, 95% CI - 1.59 to - 0.87, p < 0.001) and sodium (SMD - 1.28, 95% CI - 1.65 to - 0.92, p < 0.001), less risk of decline in serum base deficit (SMD - 0.58, 95% CI - 0.98 to - 0.18, p = 0.004), longer ventilator-free days (SMD 0.08, 95% CI 0.05-0.11, p < 0.001) and vasopressor-free days (SMD 0.04, 95% CI 0.00-0.07, p = 0.02). Subgroup analysis showed that balanced crystalloid solutions were associated with a reduced in-hospital mortality rate among septic patients (RR 0.86, 95% CI 0.75-0.98; p = 0.02) and non-traumatic brain injury patients (RR 0.90, 95% CI 0.82-0.99, p = 0.02), while the TSA results indicated a larger sample size is still in need. Limited evidence supported statistical survival benefit with balanced crystalloid solutions, while it benefited in reducing organ support duration and fluctuations in serum electrolyte and base excess and was associated with decreased in-hospital mortality in subpopulation with sepsis and non-TBI. Large-scale rigorous randomized trials with better designs are needed to provide robust evidence for clinical management. Trial registration The protocol for this meta-analysis was registered on PROSPERO: International prospective register of systematic reviews (CRD42018102661), <ExternalRef><RefSource>https://www.crd.york.ac.uk/prospero/#recordDetails</RefSource><RefTarget Address="https://www.crd.york.ac.uk/prospero/#recordDetails" TargetType="URL" /></ExternalRef>.	[Xue, Ming; Zhang, Xiwen; Liu, Feng; Chang, Wei; Xie, Jianfeng; Xu, Jingyuan; Yang, Yi; Qiu, Haibo] Southeast Univ, Sch Med, Zhongda Hosp, Dept Crit Care Med, Nanjing 210009, Jiangsu, Peoples R China		Qiu, HB (corresponding author), Southeast Univ, Sch Med, Zhongda Hosp, Dept Crit Care Med, Nanjing 210009, Jiangsu, Peoples R China.	haiboq2000@163.com	Qiu, Haibo/AAS-9047-2021	Qiu, Haibo/0000-0001-8589-4717	Jiangsu Provincial Key Medical Discipline [ZDXKA2016025]; National Natural Science Foundations of ChinaNational Natural Science Foundation of China (NSFC) [81601723]; Jiangsu Provincial Key Research and Development program [SBE2018750279]	Dr. Haibo Qiu received grant support from Jiangsu Provincial Key Medical Discipline (Grant No. ZDXKA2016025) and the National Natural Science Foundations of China (Grants 81571874). Dr. Yi Yang received grant support from Jiangsu Provincial Key Research and Development program (Grant No. SBE2018750279). Dr. Jianfeng Xie received grant support from the National Natural Science Foundations of China (Grant No. 81601723). The funding sources had no role in study design and conduct, the data collection, analysis and management or manuscript review and approval.	Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Awad S, 2008, CLIN NUTR, V27, P179, DOI 10.1016/j.clnu.2008.01.008; Boer C, 2018, BRIT J ANAESTH, V120, P384, DOI 10.1016/j.bja.2017.10.022; Brok J, 2009, INT J EPIDEMIOL, V38, P287, DOI 10.1093/ije/dyn188; Chowdhury AH, 2012, ANN SURG, V256, P18, DOI 10.1097/SLA.0b013e318256be72; Ertmer C, 2014, CRIT CARE, V18, DOI 10.1186/cc13764; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Fliser D, 2012, NEPHROL DIAL TRANSPL, V27, P4263, DOI 10.1093/ndt/gfs375; Hammond NE, 2017, CRIT CARE RESUSC, V19, P239; Hartmann AF, 1932, J CLIN INVEST, V11, P327, DOI 10.1172/JCI100414; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Huang LL, 2018, INT J SURG, V51, P1, DOI 10.1016/j.ijsu.2018.01.003; Kawano-Dourado L, 2018, ANESTH ANALG, V126, P513, DOI 10.1213/ANE.0000000000002641; Lobo DN, 2014, KIDNEY INT, V86, P1096, DOI 10.1038/ki.2014.105; Mendes PV, 2017, SHOCK, V47, P30, DOI 10.1097/SHK.0000000000000697; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Rhodes A, 2017, INTENS CARE MED, V43, P304, DOI 10.1007/s00134-017-4683-6; Ringer S, 1882, J Physiol, V3, P195; Rochwerg B, 2014, ANN INTERN MED, V161, P347, DOI 10.7326/M14-0178; Semler MW, 2018, NEW ENGL J MED, V378, P829, DOI 10.1056/NEJMoa1711584; Semler MW, 2017, AM J RESP CRIT CARE, V195, P1362, DOI 10.1164/rccm.201607-1345OC; Takil A, 2002, ANESTH ANALG, V95, P294, DOI 10.1213/01.ANE.0000020188.49502.39; Thorlund K, 2009, INT J EPIDEMIOL, V38, P276, DOI 10.1093/ije/dyn179; Torlund K, 2011, USER MANUAL TRIAL SE, P1; Van Zyl DG, 2012, QJM-INT J MED, V105, P337, DOI 10.1093/qjmed/hcr226; Verma B, 2016, CRIT CARE RESUSC, V18, P205; Waters JH, 2001, ANESTH ANALG, V93, P817, DOI 10.1097/00000539-200110000-00004; Wetterslev J, 2008, J CLIN EPIDEMIOL, V61, P64, DOI 10.1016/j.jclinepi.2007.03.013; Winters ME, 2017, J EMERG MED, V53, P928, DOI 10.1016/j.jemermed.2017.08.093; Young JB, 2014, ANN SURG, V259, P255, DOI 10.1097/SLA.0b013e318295feba; Young P, 2015, JAMA-J AM MED ASSOC, V314, P1701, DOI 10.1001/jama.2015.12334; Yunos NM, 2012, JAMA-J AM MED ASSOC, V308, P1566, DOI 10.1001/jama.2012.13356; Zampieri FG, 2017, CRIT CARE RESUSC, V19, P175; Zayed YZM, 2018, J INTENSIVE CARE, V6, DOI 10.1186/s40560-018-0320-x	35	17	19	0	6	SPRINGEROPEN	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	2110-5820			ANN INTENSIVE CARE	Ann. Intensive Care	FEB 13	2019	9								30	10.1186/s13613-019-0506-y			16	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HL7PY	WOS:000458934700001	30758680	Green Published, gold			2022-02-06	
J	Daar, DA; Abdou, SA; Cohen, JM; Wilson, SC; Levine, JP				Daar, David A.; Abdou, Salma A.; Cohen, Joshua M.; Wilson, Stelios C.; Levine, Jamie P.			Is the Medial Sural Artery Perforator Flap a New Workhorse Flap? A Systematic Review and Meta-Analysis	PLASTIC AND RECONSTRUCTIVE SURGERY			English	Article; Proceedings Paper	Senior Resident's Conference of the American-Society-of-Plastic-Surgeons / Plastic Surgery The Meeting	SEP 28-OCT 01, 2018	Chicago, IL	Amer Soc Plast Surg			RADIAL FOREARM FLAP; ANTEROLATERAL THIGH FLAP; DONOR SITE MORBIDITY; INTRAORAL RECONSTRUCTION; LOWER-EXTREMITY; HEAD; COMPLICATIONS; EXPERIENCE; DEFECTS; ANATOMY	Background: The medial sural artery perforator flap offers thin, pliable tissue with a relatively long pedicle and low donor-site morbidity. This study explores the characteristics and uses of the medial sural artery perforator flap along with postoperative outcomes and complications. Methods: A systematic literature review was performed using PubMed, Embase, and Cochrane Central Register of Controlled Trials to identify all cases of medial sural artery perforator flap reconstruction. Descriptive and meta-analyses were performed on pooled outcomes. Multivariate logistic regression identified factors associated with increased complication rates. Results: Thirty-five studies encompassing 526 medial sural artery perforator flaps were included for analysis. The most common reasons for surgery were oncologic (47.6 percent) and traumatic injuries (31.8 percent). The oral cavity was the most common recipient location (45.5 percent). Average flap dimensions were 6.0 +/- 2.3 cm x 9.8 +/- 3.6 cm, with an average pedicle length of 10.1 +/- 6.6 cm. Meta-analysis revealed an overall complication rate of 14.3 percent (Q value = 22.16; p = 0.877; I-2= -39.9). Use of chimeric medial sural artery perforator flaps was associated with significantly higher rates of complications (OR, 3.92; p = 0.039; 95 percent CI, 1.10 to 13.89). The majority of flap donor sites were closed primarily (68 percent) versus 32 percent that were covered with split-thickness skin grafts. A flap width greater than 5.75 cm had an odds ratio of 5.3 (95 percent CI, 1.3 to 21.8; p = 0.014) of having a donor-site complication if closed primarily. Conclusions: The medial sural artery perforator flap offers thin, pliable tissue with a relatively long pedicle and has minimal donor-site morbidity when the donor site is managed appropriately. As such, it should be considered a workhorse flap for both head and neck and extremity reconstruction.	[Daar, David A.; Abdou, Salma A.; Cohen, Joshua M.; Wilson, Stelios C.; Levine, Jamie P.] NYU, Sch Med, Hansjorg Wyss Dept Plast Surg, 305 East 33rd St, New York, NY 10016 USA		Levine, JP (corresponding author), NYU, Sch Med, Hansjorg Wyss Dept Plast Surg, 305 East 33rd St, New York, NY 10016 USA.	jamie.levine@nyulangone.org	Cohen, Joshua/AAA-5910-2019	Cohen, Joshua/0000-0002-0845-5160			Achal KS, 2011, J CRANIO MAXILL SURG, V39, P111, DOI 10.1016/j.jcms.2010.05.007; Alkureishi LWT, 2003, BRIT J PLAST SURG, V56, P401, DOI 10.1016/S0007-1226(03)00125-5; Avery CME, 2001, INT J ORAL MAX SURG, V30, P37, DOI 10.1054/ijom.2000.0016; BAEK SM, 1983, PLAST RECONSTR SURG, V71, P354, DOI 10.1097/00006534-198303000-00012; BARDSLEY AF, 1990, PLAST RECONSTR SURG, V86, P287, DOI 10.1097/00006534-199008000-00014; Bekara F, 2018, MICROSURG, V38, P109, DOI 10.1002/micr.30047; Camaioni A, 2008, ACTA OTORHINOLARYNGO, V28, P7; Cavadas PC, 2001, PLAST RECONSTR SURG, V108, P1609, DOI 10.1097/00006534-200111000-00027; Chalmers RL, 2016, J PLAST RECONSTR AES, V69, P687, DOI 10.1016/j.bjps.2016.01.005; Chen CH, 2005, ORAL ONCOL, V41, P602, DOI 10.1016/j.oraloncology.2005.01.010; Chen SL, 2008, ANN PLAS SURG, V61, P274, DOI 10.1097/SAP.0b013e318157a1a0; Choi JW, 2013, J RECONSTR MICROSURG, V29, P437, DOI 10.1055/s-0033-1343959; Dusseldorp JR, 2014, J PLAST RECONSTR AES, V67, P1267, DOI [10.1016/j.bjps.2014.05.016, 10.1016/j.bjps.2014.04.013]; Foissac R, 2017, OTOLARYNG HEAD NECK, V156, P822, DOI 10.1177/0194599817691931; GOTTLIEB LJ, 1994, PLAST RECONSTR SURG, V93, P1503, DOI 10.1097/00006534-199406000-00027; Hallock GG, 2014, J RECONSTR MICROSURG, V30, P187, DOI 10.1055/s-0033-1357276; Haughey BH, 2002, ARCH OTOLARYNGOL, V128, P1388, DOI 10.1001/archotol.128.12.1388; He Y, 2014, J ORAL MAXIL SURG, V72, P2351, DOI 10.1016/j.joms.2014.05.019; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hoffmann J, 1998, J CRANIO MAXILL SURG, V26, P255, DOI 10.1016/S1010-5182(98)80022-X; Hung SY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171570; Ives M, 2015, J PLAST RECONSTR AES, V68, P853, DOI 10.1016/j.bjps.2015.02.001; Kao HK, 2010, PLAST RECONSTR SURG, V125, P1135, DOI 10.1097/PRS.0b013e3181d180ac; Kao HK, 2009, PLAST RECONSTR SURG, V124, P1125, DOI 10.1097/PRS.0b013e3181b457cf; Kesting MR, 2011, ANN SURG ONCOL, V18, P1988, DOI 10.1245/s10434-011-1584-8; Kim H, 2015, CLIN EXP OTORHINOLAR, V8, P167, DOI 10.3342/ceo.2015.8.2.167; Knott PD, 2016, HEAD NECK-J SCI SPEC, V38, pE945, DOI 10.1002/hed.24131; KOSHIMA I, 1989, BRIT J PLAST SURG, V42, P645, DOI 10.1016/0007-1226(89)90075-1; Kosutic D, 2012, J PLAST RECONSTR AES, V65, P1530, DOI 10.1016/j.bjps.2012.04.045; Lin CH, 2011, J TRAUMA, V70, P736, DOI 10.1097/TA.0b013e318203179e; Lutz BS, 1999, PLAST RECONSTR SURG, V103, P132, DOI 10.1097/00006534-199901000-00021; Murray RC, 2011, MICROSURG, V31, P104, DOI 10.1002/micr.20833; Nugent M, 2015, BRIT J ORAL MAX SURG, V53, P461, DOI 10.1016/j.bjoms.2015.02.023; Richardson D, 1997, PLAST RECONSTR SURG, V99, P109, DOI 10.1097/00006534-199701000-00017; Ross GL, 2003, BRIT J PLAST SURG, V56, P409, DOI 10.1016/S0007-1226(03)00126-7; Sanati-Mehrizy P, 2016, J CRANIOFAC SURG, V27, P1956, DOI 10.1097/SCS.0000000000003026; Sharabi SE, 2010, ANN PLAS SURG, V65, P555, DOI 10.1097/SAP.0b013e3181cbfebc; Sims JR, 2018, AM J OTOLARYNG, V39, P116, DOI 10.1016/j.amjoto.2017.12.012; Song CT, 2018, J RECONSTR MICROSURG, V34, DOI 10.1055/s-0038-1636939; Song XM, 2015, J RECONSTR MICROSURG, V31, P319, DOI 10.1055/s-0035-1544180; SONG YG, 1984, BRIT J PLAST SURG, V37, P149, DOI 10.1016/0007-1226(84)90002-X; SOUTAR DS, 1986, PLAST RECONSTR SURG, V78, P1; Sullivan D, 2011, PLAST RECONSTR SURG, V128, P311, DOI 10.1097/PRS.0b013e3182195826; Taghinia A.H., 2017, FLAPS RECONSTRUCTIVE, VVolume 47, P525; TAYLOR GI, 1987, BRIT J PLAST SURG, V40, P113, DOI 10.1016/0007-1226(87)90185-8; Toyserkani NM, 2015, EUR J PLAST SURG, V38, P391, DOI 10.1007/s00238-015-1110-5; URKEN ML, 1994, ARCH OTOLARYNGOL, V120, P589; Wang X, 2013, PLAST RECONSTR SURG, V131, P95, DOI 10.1097/PRS.0b013e3182729e3c; Wolff KD, 2011, J RECONSTR MICROSURG, V27, P225, DOI 10.1055/s-0031-1275485; Wong AK, 2015, MICROSURG, V35, P6, DOI 10.1002/micr.22223; Wong MZ, 2012, J RECONSTR MICROSURG, V28, P555, DOI 10.1055/s-0032-1315778; Wu JCW, 2016, PLAST RECONSTR SURG, V137, P257, DOI 10.1097/PRS.0000000000001880; Xie RG, 2007, J HAND SURG-EUR VOL, V32E, P512, DOI 10.1016/j.jhse.2007.05.010; Xie XT, 2012, ANN PLAS SURG, V68, P105, DOI 10.1097/SAP.0b013e31821190e6; Xiong LY, 2016, MICROSURG, V36, P511, DOI 10.1002/micr.30020; Zhao WQ, 2016, J ORAL MAXIL SURG, V74, P1063, DOI 10.1016/j.joms.2015.11.011	56	17	19	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0032-1052	1529-4242		PLAST RECONSTR SURG	Plast. Reconstr. Surg.	FEB	2019	143	2					393E	403E		10.1097/PRS.0000000000005204			11	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	IH6AE	WOS:000474573800017	30531631				2022-02-06	
J	Hong, J; Kim, S; Lin, PC				Hong, Jaewoo; Kim, Soohyun; Lin, P. Charles			Interleukin-33 and ST2 Signaling in Tumor Microenvironment	JOURNAL OF INTERFERON AND CYTOKINE RESEARCH			English	Article						tumorigenesis; interleukin-33; ST2; cancer; tumor microenvironment	RECEPTOR ACCESSORY PROTEIN; INNATE LYMPHOID-CELLS; HEPATOCELLULAR-CARCINOMA; IL-33 RECEPTOR; CYTOKINE PRODUCTION; ALLERGIC INFLAMMATION; HUMAN BASOPHILS; POOR-PROGNOSIS; UP-REGULATION; IMMUNE	Interleukin-33 (IL-33) is one of the members of the IL-1 family of cytokines and a ligand of ST2 and IL-1 receptor accessory protein (IL-1RAcP) that is known to affect Th2 inflammatory response with partial effects on Th1 responses. This cytokine is released by epithelial and smooth muscle cells of the airway system during their injury by several environmental stimuli, such as allergens, viruses, helminths, and pollutants. IL-33 is an alarmin that acts as an endogenous danger signal, and it has been known to affect various types of cells, such as mast cells, basophils, eosinophils, T cells, and specific subsets of innate lymphoid cells (ILCs). In recent findings, this cytokine is believed to have a critical role in several types of cancers, such as lung cancer, liver cancer, and head and neck squamous cell cancer. The expression of IL-33/ST2 in cancer tissues shows a close association with tumor growth and tumor progression in several types of cancer, suggesting the IL-33/ST2 pathway as a potential target for therapy.	[Hong, Jaewoo; Lin, P. Charles] NCI, Canc & Inflammat Program, Ctr Canc Res, Frederick, MD 21702 USA; [Kim, Soohyun] Konkuk Univ, Dept Biomed Sci & Technol, Lab Cytokine Immunol, Seoul 05029, South Korea		Hong, J; Lin, PC (corresponding author), NCI, Canc & Inflammat Program, Ctr Canc Res, Frederick, MD 21702 USA.; Kim, S (corresponding author), Konkuk Univ, Dept Biomed Sci & Technol, Lab Cytokine Immunol, Seoul 05029, South Korea.	jaewoo.hong@nih.gov; soohyun@konkuk.ac.kr; p.lin@nih.gov			Intramural Research Program of the Center for Cancer Research, National Cancer Institute, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI); National Research Foundation of KoreaNational Research Foundation of Korea [NRF-2015R1A2A2A01003472, NRF-2014M3A6A4075058, NRF-2015R1A2A1A15051472]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [ZIABC011390] Funding Source: NIH RePORTER	J.H. and P.C.L. are supported by the Intramural Research Program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health. S.K. was supported by the National Research Foundation of Korea Grants NRF-2015R1A2A2A01003472, -2014M3A6A4075058, and -2015R1A2A1A15051472.	Akimoto M, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.418; Ali S, 2007, P NATL ACAD SCI USA, V104, P18660, DOI 10.1073/pnas.0705939104; Allakhverdi Z, 2009, J ALLERGY CLIN IMMUN, V123, P472, DOI 10.1016/j.jaci.2008.10.022; Allakhverdi Z, 2007, J IMMUNOL, V179, P2051, DOI 10.4049/jimmunol.179.4.2051; Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Bae S, 2012, J BIOL CHEM, V287, P8205, DOI 10.1074/jbc.M111.295055; Baekkevold ES, 2003, AM J PATHOL, V163, P69, DOI 10.1016/S0002-9440(10)63631-0; Barlow JL, 2012, J ALLERGY CLIN IMMUN, V129, P191, DOI 10.1016/j.jaci.2011.09.041; Barlow JL, 2011, J LEUKOCYTE BIOL, V90, P867, DOI 10.1189/jlb.0311160; Bartemes KR, 2012, J IMMUNOL, V188, P1503, DOI 10.4049/jimmunol.1102832; Baumann C, 2015, P NATL ACAD SCI USA, V112, P4056, DOI 10.1073/pnas.1418549112; Bonilla WV, 2012, SCIENCE, V335, P984, DOI 10.1126/science.1215418; Bourgeois E, 2009, EUR J IMMUNOL, V39, P1046, DOI 10.1002/eji.200838575; Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; Brickshawana A, 2011, J IMMUNOL, V187, P5795, DOI 10.4049/jimmunol.1102242; Brunner SM, 2015, HEPATOLOGY, V61, P1957, DOI 10.1002/hep.27728; Bulek K, 2009, J IMMUNOL, V182, P2601, DOI 10.4049/jimmunol.0802729; Byers DE, 2013, J CLIN INVEST, V123, P3967, DOI 10.1172/JCI65570; Candido J, 2013, J CLIN IMMUNOL, V33, pS79, DOI 10.1007/s10875-012-9847-0; Carcas Lauren Peirce, 2014, J Carcinog, V13, P14, DOI 10.4103/1477-3163.146506; Carrega P, 2016, IMMUNOL LETT, V179, P29, DOI 10.1016/j.imlet.2016.06.003; Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104; Cayrol C, 2009, P NATL ACAD SCI USA, V106, P9021, DOI 10.1073/pnas.0812690106; Chackerian AA, 2007, J IMMUNOL, V179, P2551, DOI 10.4049/jimmunol.179.4.2551; Chan WL, 2001, J IMMUNOL, V167, P1238, DOI 10.4049/jimmunol.167.3.1238; Chen SF, 2013, J PATHOL, V231, P180, DOI 10.1002/path.4226; Chen Z, 2014, NAT REV CANCER, V14, P535, DOI 10.1038/nrc3775; Cherry WB, 2008, J ALLERGY CLIN IMMUN, V121, P1484, DOI 10.1016/j.jaci.2008.04.005; Chow JYS, 2010, CELL MOL IMMUNOL, V7, P26, DOI 10.1038/cmi.2009.106; Chu DK, 2013, J ALLERGY CLIN IMMUN, V131, P187, DOI 10.1016/j.jaci.2012.08.002; Cui GL, 2015, CANCER IMMUNOL IMMUN, V64, P181, DOI 10.1007/s00262-014-1624-x; Dinarello CA, 1998, ANN NY ACAD SCI, V856, P1, DOI 10.1111/j.1749-6632.1998.tb08307.x; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Drube S, 2010, BLOOD, V115, P3899, DOI 10.1182/blood-2009-10-247411; Espinassous Q, 2009, J IMMUNOL, V183, P1446, DOI 10.4049/jimmunol.0803067; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Fox JG, 2007, J CLIN INVEST, V117, P60, DOI 10.1172/JCI30111; Funakoshi-Tago M, 2008, CELL SIGNAL, V20, P1679, DOI 10.1016/j.cellsig.2008.05.013; Funakoshi-Tago M, 2011, CELL SIGNAL, V23, P363, DOI 10.1016/j.cellsig.2010.10.006; Gao XM, 2015, 2015 10TH INTERNATIONAL CONFERENCE ON P2P, PARALLEL, GRID, CLOUD AND INTERNET COMPUTING (3PGCIC), P194, DOI 10.1109/3PGCIC.2015.13; Grivennikov SI, 2016, GASTROENTEROLOGY, V150, P808, DOI 10.1053/j.gastro.2016.02.062; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Ha CT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109249; Haenuki Y, 2012, J ALLERGY CLIN IMMUN, V130, P184, DOI 10.1016/j.jaci.2012.02.013; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hayakawa M, 2009, BIOCHEM BIOPH RES CO, V387, P218, DOI 10.1016/j.bbrc.2009.07.018; Ho LH, 2007, J LEUKOCYTE BIOL, V82, P1481, DOI 10.1189/jlb.0407200; Hong J, 2011, J BIOL CHEM, V286, P20078, DOI 10.1074/jbc.M111.219089; Hoshino K, 1999, J EXP MED, V190, P1541, DOI 10.1084/jem.190.10.1541; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Iikura M, 2007, LAB INVEST, V87, P971, DOI 10.1038/labinvest.3700663; Ikutani M, 2012, J IMMUNOL, V188, P703, DOI 10.4049/jimmunol.1101270; Ishikawa K, 2014, AURIS NASUS LARYNX, V41, P552, DOI 10.1016/j.anl.2014.08.007; Ivashkiv LB, 2008, NAT REV IMMUNOL, V8, P816, DOI 10.1038/nri2396; Jiang XG, 2014, MOL CELL ENDOCRINOL, V382, P673, DOI 10.1016/j.mce.2013.06.003; Joshi AD, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-52; Jovanovic I, 2011, EUR J IMMUNOL, V41, P1902, DOI 10.1002/eji.201141417; Jovanovic IP, 2014, INT J CANCER, V134, P1669, DOI 10.1002/ijc.28481; Kaieda S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047252; Kim HR, 2010, J ALLERGY CLIN IMMUN, V126, P880, DOI 10.1016/j.jaci.2010.06.038; Kim JY, 2015, ONCOGENE, V34, P4928, DOI 10.1038/onc.2014.418; Kobayashi S, 2005, GASTROENTEROLOGY, V128, P2054, DOI 10.1053/j.gastro.2005.03.010; Komai-Koma M, 2007, EUR J IMMUNOL, V37, P2779, DOI 10.1002/eji.200737547; Komai-Koma M, 2011, J IMMUNOL, V186, P2584, DOI 10.4049/jimmunol.1002103; Koyasu S, 2011, IMMUNOLOGY, V132, P475, DOI 10.1111/j.1365-2567.2011.03413.x; Koyasu S, 2011, CURR OPIN ALLERGY CL, V11, P109, DOI 10.1097/ACI.0b013e3283448808; Kurowska-Stolarska M, 2008, J IMMUNOL, V181, P4780, DOI 10.4049/jimmunol.181.7.4780; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Lefrancais E, 2012, P NATL ACAD SCI USA, V109, P1673, DOI 10.1073/pnas.1115884109; Li J, 2014, J CLIN INVEST, V124, P3241, DOI 10.1172/JCI73742; Liang HE, 2012, NAT IMMUNOL, V13, P58, DOI 10.1038/ni.2182; Liew FY, 2010, NAT REV IMMUNOL, V10, P103, DOI 10.1038/nri2692; Liew FY, 2016, NAT REV IMMUNOL, V16, P676, DOI 10.1038/nri.2016.95; Liu J, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00141; Liu XJ, 2014, BIOCHEM BIOPH RES CO, V453, P486, DOI 10.1016/j.bbrc.2014.09.106; Louten J, 2011, INT IMMUNOL, V23, P307, DOI 10.1093/intimm/dxr006; Lu BF, 2016, J MOL MED, V94, P535, DOI 10.1007/s00109-016-1397-0; Lu X, 2007, J MAMMARY GLAND BIOL, V12, P153, DOI 10.1007/s10911-007-9047-3; Luthi AU, 2009, IMMUNITY, V31, P84, DOI 10.1016/j.immuni.2009.05.007; Mager LF, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00096; Makrinioti H, 2014, LANCET RESP MED, V2, P226, DOI 10.1016/S2213-2600(13)70261-3; Malik A, 2016, J CLIN INVEST, V126, P4469, DOI 10.1172/JCI88625; Maywald RL, 2015, P NATL ACAD SCI USA, V112, pE2487, DOI 10.1073/pnas.1422445112; Mertz KD, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1062966; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1038/ni.2131, 10.1031/ni.2131]; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; Mun SH, 2010, CELL MOL LIFE SCI, V67, P3883, DOI 10.1007/s00018-010-0410-y; Na HJ, 2012, CYTOKINE, V57, P169, DOI 10.1016/j.cyto.2011.10.007; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; O'Donnell C, 2016, BRIT J CANCER, V114, P37, DOI 10.1038/bjc.2015.433; Oboki Keisuke, 2010, Allergology International, V59, P143, DOI 10.2332/allergolint.10-RAI-0186; Ohno T, 2012, ALLERGY, V67, P1203, DOI 10.1111/all.12004; Ohno T, 2009, J IMMUNOL, V183, P7890, DOI 10.4049/jimmunol.0802449; Onda H, 1999, J CEREBR BLOOD F MET, V19, P1279, DOI 10.1097/00004647-199911000-00013; Palmer G, 2008, CYTOKINE, V42, P358, DOI 10.1016/j.cyto.2008.03.008; Palmer G, 2011, NAT REV RHEUMATOL, V7, P321, DOI 10.1038/nrrheum.2011.53; Pecaric-Petkovic T, 2009, BLOOD, V113, P1526, DOI 10.1182/blood-2008-05-157818; Peek RM, 2006, J PATHOL, V208, P233, DOI 10.1002/path.1868; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Raza A, 2014, WORLD J GASTROENTERO, V20, P4115, DOI 10.3748/wjg.v20.i15.4115; Robles AI, 2016, GASTROENTEROLOGY, V150, P931, DOI 10.1053/j.gastro.2015.12.036; Roussel L, 2008, EMBO REP, V9, P1006, DOI 10.1038/embor.2008.145; Saenz SA, 2010, TRENDS IMMUNOL, V31, P407, DOI 10.1016/j.it.2010.09.001; Sanada S, 2007, J CLIN INVEST, V117, P1538, DOI 10.1172/JCI30634; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Smith DE, 2010, CLIN EXP ALLERGY, V40, P200, DOI 10.1111/j.1365-2222.2009.03384.x; Smith DE, 2011, J LEUKOCYTE BIOL, V89, P383, DOI 10.1189/jlb.0810470; Smithgall MD, 2008, INT IMMUNOL, V20, P1019, DOI 10.1093/intimm/dxn060; Stolarski B, 2010, J IMMUNOL, V185, P3472, DOI 10.4049/jimmunol.1000730; Su Z, 2013, MUCOSAL IMMUNOL, V6, P921, DOI 10.1038/mi.2012.130; Suzukawa M, 2008, J IMMUNOL, V181, P5981, DOI 10.4049/jimmunol.181.9.5981; Suzukawa M, 2008, LAB INVEST, V88, P1245, DOI 10.1038/labinvest.2008.82; Tago K, 2001, BIOCHEM BIOPH RES CO, V285, P1377, DOI 10.1006/bbrc.2001.5306; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Talabot-Ayer D, 2009, J BIOL CHEM, V284, P19420, DOI 10.1074/jbc.M901744200; Tan WL, 2016, LANCET ONCOL, V17, pE347, DOI 10.1016/S1470-2045(16)30123-1; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Trajkovic V, 2004, CYTOKINE GROWTH F R, V15, P87, DOI 10.1016/j.cytogfr.2004.02.004; Tyson GL, 2011, HEPATOLOGY, V54, P173, DOI 10.1002/hep.24351; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Waller LP, 2015, WORLD J HEPATOL, V7, P2648, DOI 10.4254/wjh.v7.i26.2648; Wang CH, 2016, BIOCHEM BIOPH RES CO, V479, P461, DOI 10.1016/j.bbrc.2016.09.081; Wasmer MH, 2017, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00682; Wehbe H, 2006, CANCER RES, V66, P10517, DOI 10.1158/0008-5472.CAN-06-2130; Werman A, 2004, P NATL ACAD SCI USA, V101, P2434, DOI 10.1073/pnas.0308705101; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133; Wu CW, 2018, CELL PHYSIOL BIOCHEM, V47, P191, DOI 10.1159/000489766; Wysocka M, 2008, ANAL BIOCHEM, V378, P208, DOI 10.1016/j.ab.2008.04.003; Yagami A, 2010, J IMMUNOL, V185, P5743, DOI 10.4049/jimmunol.0903818; Yamada D, 2015, HEPATOLOGY, V61, P1627, DOI 10.1002/hep.27687; Yang ZP, 2015, DIS MARKERS, V2015, P1, DOI 10.1155/2015/516895; Yndestad A, 2010, INT J BIOCHEM CELL B, V42, P263, DOI 10.1016/j.biocel.2009.10.021; Zhang P, 2012, J INT MED RES, V40, P1654, DOI 10.1177/030006051204000504; Zhang Y, 2017, MOL CARCINOGEN, V56, P272, DOI 10.1002/mc.22491	138	17	19	1	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1079-9907	1557-7465		J INTERF CYTOK RES	J. Interferon Cytokine Res.	JAN 1	2019	39	1			SI		61	71		10.1089/jir.2018.0044			11	Biochemistry & Molecular Biology; Cell Biology; Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Immunology	HR3AT	WOS:000463009500007	30256696	Green Published			2022-02-06	
J	Nagakannan, P; Islam, MI; Karimi-Abdolrezaee, S; Eftekharpour, E				Nagakannan, Pandian; Islam, Md Imamul; Karimi-Abdolrezaee, Soheila; Eftekharpour, Eftekhar			Inhibition of VDAC1 Protects Against Glutamate-Induced Oxytosis and Mitochondrial Fragmentation in Hippocampal HT22 Cells	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Glutamate toxicity; Ferroptosis; Caspase-independent apoptosis; Oxidative stress; AIF; DIDS	OXIDATIVE STRESS; N-TERMINUS; DEATH; APOPTOSIS; RELEASE; AIF; OLIGOMERIZATION; DEGRADATION; NEUROTRANSMITTER; GLIOTRANSMISSION	The involvement of glutamate in neuronal cell death in neurodegenerative diseases and neurotrauma is mediated through excitotoxicity or oxytosis. The latter process induces oxidative stress via glutamate-mediated inhibition of cysteine transporter xCT, leading to depletion of the cellular glutathione pool. Mitochondrial damage, loss of mitochondrial membrane potential (MMP), and depletion of energy metabolites have been shown in this process. The Voltage-Dependent Anion Channel-1 (VDAC1) is one of the main components of the mitochondrial outer membrane and plays a gatekeeping role in mitochondria-cytoplasm transport of metabolites. In this study, we explored the possible participation of VDAC-1 in the pathophysiology of oxytosis. Administration of glutamate in HT22 cells that lack the glutamate ionotropic receptors induced an upregulation and oligomerization of VDAC1. This was associated with an increase in ROS and loss of cell survival. Glutamate-mediated oxytosis in this model also decreased MMP and promoted ATP depletion, resulting in translocation of cytochrome c (cyt C) and apoptosis inducing factor (AIF) from mitochondria into the cytosol. This was also accompanied by cleavage of AIF to form truncated AIF. Inhibition of VDAC1 oligomerization using 4,4-Diisothiocyanatostilbene-2,2-disulfonate (DIDS), significantly improved the cell survival, decreased the ROS levels, improved mitochondrial functions, and decreased the mitochondrial damage. Notably, DIDS also inhibited the mitochondrial fragmentation caused by glutamate, indicating the active role of VDAC1 oligomerization in the process of mitochondrial fragmentation in oxytosis. These results suggest a critical role for VDAC1 in mitochondrial fragmentation and its potential therapeutic value against glutamate-mediated oxidative neurotoxicity.	[Nagakannan, Pandian; Islam, Md Imamul; Karimi-Abdolrezaee, Soheila; Eftekharpour, Eftekhar] Univ Manitoba, Dept Physiol & Pathophysiol, Regenerat Med Program, Winnipeg, MB, Canada; [Nagakannan, Pandian; Islam, Md Imamul; Karimi-Abdolrezaee, Soheila; Eftekharpour, Eftekhar] Univ Manitoba, Spinal Cord Res Ctr, Winnipeg, MB, Canada		Eftekharpour, E (corresponding author), Univ Manitoba, Dept Physiol & Pathophysiol, Regenerat Med Program, Winnipeg, MB, Canada.; Eftekharpour, E (corresponding author), Univ Manitoba, Spinal Cord Res Ctr, Winnipeg, MB, Canada.	eftekhar@umanitoba.ca		Islam, Md Imamul/0000-0002-3126-5453; Eftekharpour, Eftekhar/0000-0002-2849-3754; Pandian, Nagakannan/0000-0002-6791-0661; Karimi-Abdolrezaee, Soheila/0000-0002-0683-2663	Health Sciences Centre Foundation; Paralyzed Veterans of America	Funding was provided by Health Sciences Centre Foundation and Paralyzed Veterans of America.	Abu-Hamad S, 2009, J CELL SCI, V122, P1906, DOI 10.1242/jcs.040188; Ben-Hail D, 2016, BBA-MOL CELL RES, V1863, P1612, DOI 10.1016/j.bbamcr.2016.04.002; Chaanine AH, 2013, CIRC-HEART FAIL, V6, P572, DOI 10.1161/CIRCHEARTFAILURE.112.000200; Daugas E, 2000, FASEB J, V14, P729, DOI 10.1096/fasebj.14.5.729; De Pinto V, 2016, BBA-BIOENERGETICS, V1857, P1219, DOI 10.1016/j.bbabio.2016.02.020; DeHart DN, 2018, BIOCHEM PHARMACOL, V148, P155, DOI 10.1016/j.bcp.2017.12.022; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Edison N, 2017, CELL REP, V21, P442, DOI 10.1016/j.celrep.2017.09.052; FONNUM F, 1984, J NEUROCHEM, V42, P1, DOI 10.1111/j.1471-4159.1984.tb09689.x; Fukui M, 2009, EUR J PHARMACOL, V617, P1, DOI 10.1016/j.ejphar.2009.06.059; Geula S, 2012, BIOCHEM J, V444, P475, DOI 10.1042/BJ20112079; Itoh K, 2013, TRENDS CELL BIOL, V23, P64, DOI 10.1016/j.tcb.2012.10.006; Kang YY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4672; Keinan N, 2013, BBA-MOL CELL RES, V1833, P1745, DOI 10.1016/j.bbamcr.2013.03.017; Keinan N, 2010, MOL CELL BIOL, V30, P5698, DOI 10.1128/MCB.00165-10; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Landshamer S, 2008, CELL DEATH DIFFER, V15, P1553, DOI 10.1038/cdd.2008.78; Lewerenz J, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00214; Lewerenz J, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00469; Liu ZY, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-015-0188-y; Maher P, 2018, CELL CALCIUM, V70, P47, DOI 10.1016/j.ceca.2017.05.007; Malia TJ, 2007, BIOCHEMISTRY-US, V46, P514, DOI 10.1021/bi061577h; Manczak M, 2012, HUM MOL GENET, V21, P5131, DOI 10.1093/hmg/dds360; McCommis KS, 2012, BBA-BIOMEMBRANES, V1818, P1444, DOI 10.1016/j.bbamem.2011.10.025; Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036; Nagakannan P, 2016, FREE RADICAL BIO MED, V101, P53, DOI 10.1016/j.freeradbiomed.2016.09.026; Neitemeier S, 2017, REDOX BIOL, V12, P558, DOI 10.1016/j.redox.2017.03.007; OLNEY JW, 1969, SCIENCE, V164, P719, DOI 10.1126/science.164.3880.719; Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614; Pamenter ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060804; Polster BM, 2005, J BIOL CHEM, V280, P6447, DOI 10.1074/jbc.M413269200; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Reddy PH, 2013, BBA-MOL BASIS DIS, V1832, P67, DOI 10.1016/j.bbadis.2012.09.003; Sahlender DA, 2014, BIOL SCI, V369, DOI 10.1098/rstb.2013.0592; Sanderson TH, 2015, MOL CELL NEUROSCI, V64, P116, DOI 10.1016/j.mcn.2014.12.007; Santello M, 2012, ADV EXP MED BIOL, V970, P307, DOI 10.1007/978-3-7091-0932-8_14; Savtchouk I, 2018, J NEUROSCI, V38, P14, DOI 10.1523/JNEUROSCI.0017-17.2017; Shoshan-Barmatz V, 2018, PHARMACOL RES, V131, P87, DOI 10.1016/j.phrs.2018.03.010; Shoshan-Barmatz V, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00060; Shoshan-Barmatz V, 2010, BBA-BIOENERGETICS, V1797, P1281, DOI 10.1016/j.bbabio.2010.03.003; Shoshan-Barmatz V, 2009, BBA-BIOENERGETICS, V1787, P421, DOI 10.1016/j.bbabio.2008.11.009; Shoshan-Barmatzt V, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00164; Su B, 2010, BBA-MOL BASIS DIS, V1802, P135, DOI 10.1016/j.bbadis.2009.09.013; Tan Shirlee, 2001, Current Topics in Medicinal Chemistry, V1, P497, DOI 10.2174/1568026013394741; Twig G, 2011, ANTIOXID REDOX SIGN, V14, P1939, DOI 10.1089/ars.2010.3779; van Leyen K, 2005, J NEUROCHEM, V92, P824, DOI 10.1111/j.1471-4159.2004.02915.x; Voronina SG, 2004, J BIOL CHEM, V279, P27327, DOI 10.1074/jbc.M311698200; Zhou Y, 2014, J NEURAL TRANSM, V121, P799, DOI 10.1007/s00702-014-1180-8	48	17	18	4	33	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	JAN	2019	39	1					73	85		10.1007/s10571-018-0634-1			13	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	HG8CY	WOS:000455226200005	30421242				2022-02-06	
J	Rytter, HM; Westenbaek, K; Henriksen, H; Christiansen, P; Humle, F				Rytter, Hana Mala; Westenbaek, Klaus; Henriksen, Henriette; Christiansen, Peter; Humle, Frank			Specialized interdisciplinary rehabilitation reduces persistent post-concussive symptoms: a randomized clinical trial	BRAIN INJURY			English	Article						Concussion; persistent post-concussive symptoms; PCS; rehabilitation; interdisciplinary team	TRAUMATIC BRAIN-INJURY; COGNITIVE-BEHAVIORAL PREVENTION; MINOR HEAD-INJURY; GOOD OLD DAYS; POSTCONCUSSION-SYNDROME; NEUROPSYCHOLOGICAL REHABILITATION; ACTIVE REHABILITATION; FATIGUE; ETIOLOGY; EXERCISE	Objective: To compare the effectiveness of a specialized, interdisciplinary rehabilitation (S-REHAB) with standard care (STAND) for people with persistent post-concussive symptoms (PPCS > 6month).Design: Randomized controlled trial.Participants: Eighty-nine adults.Interventions: 22-week programme combining individual and group-based neuropsychological treatment with exercise therapy and physiotherapeutic coaching (S-REHAB), and the usual treatment offered by the public municipality services (STAND).Outcome Measures: The Rivermead Postconcussion Symptoms Questionnaire (RPSQ) (primary), The Headache Impact Test (HIT-6), Major Depression Inventory (MDI), Multidimensional Fatigue Inventory (MFI-20) and The Short Form (36) Health Survey (SF-36); all collected at baseline, post-treatment, and at 6-month follow-up.Results: The S-REHAB group showed a significant reduction in symptoms measured by RPSQ compared to the STAND immediately post-treatment (effect size [ES]=0.28) and at follow-up (ES=0.26). The S-REHAB groups also showed significant improvements regarding HIT-6 post-treatment (ES=0.38) and at follow-up (ES=0.68), MFI-20 - dimension mental fatigue' post-treatment (ES=0.42), MFI-20 - dimension reduced activities' at follow-up (ES=0.74) and SF-36 - dimension social functioning' post-treatment (ES=0.31).Conclusions: The S-REHAB is more effective than the STAND in reducing the PPCS affecting physical, cognitive and emotional domains. This symptom reduction was associated with experienced improvement in social functioning, increased levels of activity, a decrease in mental fatigue and increased life satisfaction.	[Rytter, Hana Mala] Univ Copenhagen, Dept Psychol, Copenhagen, Denmark; [Rytter, Hana Mala] Bispebjerg Hosp, Dept Neurol, Copenhagen, Denmark; [Westenbaek, Klaus; Henriksen, Henriette; Christiansen, Peter; Humle, Frank] Ctr Rehabil Brain Injury, Copenhagen, Denmark		Rytter, HM (corresponding author), Univ Copenhagen, Dept Psychol, Ctr Integrat Cognit Neurosci, Oester Farimagsgade 2A, DK-1353 Copenhagen K, Denmark.	hana.mala@psy.ku.dk		Rytter, Hana Mala/0000-0002-2910-372X	Foundation for Prevention and Maintenance, Denmark	This work was supported by the Foundation for Prevention and Maintenance, Denmark	Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; Andersson EE, 2007, ACTA NEUROCHIR, V149, P151, DOI 10.1007/s00701-006-1082-0; [Anonymous], 2012, LABOUR MARKET INSURA; Azulay J, 2013, J HEAD TRAUMA REHAB, V28, P323, DOI 10.1097/HTR.0b013e318250ebda; Baker JG, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/705309; Bech P, 2001, J AFFECT DISORDERS, V66, P159, DOI 10.1016/S0165-0327(00)00309-8; BECKER BJ, 1988, BRIT J MATH STAT PSY, V41, P257, DOI 10.1111/j.2044-8317.1988.tb00901.x; Belanger HG, 2013, CLIN NEUROPSYCHOL, V27, P159, DOI 10.1080/13854046.2012.758780; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergersen K, 2017, BRAIN INJURY, V31, P279, DOI 10.1080/02699052.2016.1255779; Bjorner JB, 1998, J CLIN EPIDEMIOL, V51, P991, DOI 10.1016/S0895-4356(98)00091-2; Bjorner JB, 1998, J CLIN EPIDEMIOL, V51, P1001, DOI 10.1016/S0895-4356(98)00092-4; Burke MJ, 2015, BRAIN INJURY, V29, P300, DOI 10.3109/02699052.2014.974673; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cicerone KD, 1996, BRAIN INJURY, V10, P277, DOI 10.1080/026990596124458; Clarke LA, 2012, BRAIN INJURY, V26, P298, DOI 10.3109/02699052.2012.654588; Cooper DB, 2015, BRAIN IMAGING BEHAV, V9, P403, DOI 10.1007/s11682-015-9440-2; Edmed SL, 2012, APPL NEUROPSYCH-ADUL, V19, P164, DOI 10.1080/09084282.2011.643961; Elbin RJ, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0320-7; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00136; Gagnon I, 2016, SCAND J MED SCI SPOR, V26, P299, DOI 10.1111/sms.12441; Gatzounis R, 2012, CURR PAIN HEADACHE R, V16, P117, DOI 10.1007/s11916-012-0247-1; Ghaffar O, 2006, J PSYCHOSOM RES, V61, P153, DOI 10.1016/j.jpsychores.2005.07.018; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Goranson TE, 2003, BRAIN INJURY, V17, P759, DOI 10.1080/0269905031000088513; Grabowski P, 2017, PHYS THER SPORT, V23, P22, DOI 10.1016/j.ptsp.2016.06.001; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Hinkle J L, 1986, J Neurosci Nurs, V18, P268; Ho MR, 1997, ARCH CLIN NEUROPSYCH, V12, P1; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Johansson J, 2017, CLIN EXP OPTOM, V100, P234, DOI 10.1111/cxo.12458; Josefsson T, 2014, SCAND J MED SCI SPOR, V24, P259, DOI 10.1111/sms.12050; Junn C, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0519-7; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kristman VL, 2010, OPEN OCCUP HLTH SAF, V2, P1, DOI [10.2174/1876216601002010001, DOI 10.2174/1876216601002010001]; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P79, DOI 10.1097/HTR.0000000000000238; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Leddy JJ, 2016, PHYS MED REH CLIN N, V27, P437, DOI 10.1016/j.pmr.2015.12.003; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Leininger S, 2014, J HEAD TRAUMA REHAB, V29, P109, DOI 10.1097/HTR.0b013e3182860506; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; McCauley SR, 2008, J CLIN EXP NEUROPSYC, V30, P360, DOI 10.1080/13803390701416635; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, NAT REV NEUROL, V9, P361, DOI 10.1038/nrneurol.2013.88; McDonnell MN, 2011, ARCH PHYS MED REHAB, V92, P1044, DOI 10.1016/j.apmr.2011.01.021; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Meeus M, 2007, CLIN RHEUMATOL, V26, P465, DOI 10.1007/s10067-006-0433-9; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; Nachit-Ouinekh F, 2005, EUR J NEUROL, V12, P189, DOI 10.1111/j.1468-1331.2004.00934.x; Nolin P, 2006, BRAIN INJURY, V20, P1147, DOI 10.1080/02699050601049247; Paniak C, 2000, BRAIN INJURY, V14, P219; Pinner M., 2003, KONSENSUSRAPPORT COM, P1; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Rivara FP, 2014, JAMA-J AM MED ASSOC, V311, P239, DOI 10.1001/jama.2013.282985; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Sawchyn JM, 2000, ARCH CLIN NEUROPSYCH, V15, P1, DOI 10.1016/S0887-6177(98)00041-9; Schwartzman RJ, 2001, ARCH NEUROL-CHICAGO, V58, P1547, DOI 10.1001/archneur.58.10.1547; Silverberg ND, 2018, J NEUROTRAUM, V35, P1864, DOI 10.1089/neu.2018.5662; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P313, DOI 10.1097/HTR.0b013e3182915cb5; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; Sullivan K, 2011, J HEAD TRAUMA REHAB, V26, P170, DOI 10.1097/HTR.0b013e3181e47f95; Sullivan KA, 2018, J NEUROTRAUM, V35, P195, DOI 10.1089/neu.2016.4958; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Waljas M, 2014, J HEAD TRAUMA REHAB, V29, P443, DOI 10.1097/HTR.0000000000000002; Watt T, 2000, J EPIDEMIOL COMMUN H, V54, P827, DOI 10.1136/jech.54.11.827; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Wijenberg MLM, 2017, BRAIN INJURY, V31, P1597, DOI 10.1080/02699052.2017.1366551; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; Wogensen E, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/830871; Wood RL, 2011, BRAIN INJURY, V25, P1296, DOI 10.3109/02699052.2011.624569; Woodrome SE, 2011, J INT NEUROPSYCH SOC, V17, P317, DOI 10.1017/S1355617710001700	87	17	17	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2019	33	3					266	281		10.1080/02699052.2018.1552022			16	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HM7DB	WOS:000459636400002	30500267				2022-02-06	
J	Vukovic, AA; Hanson, HR; Murphy, SL; Mercurio, D; Sheedy, CA; Arnold, DH				Vukovic, Adam A.; Hanson, Holly R.; Murphy, Shelley L.; Mercurio, Danielle; Sheedy, Craig A.; Arnold, Donald H.			Apneic oxygenation reduces hypoxemia during endotracheal intubation in the pediatric emergency department	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						Hypoxia; Pediatric; Intubation; Apneic oxygenation	RAPID-SEQUENCE INTUBATION; TRAUMATIC BRAIN-INJURY; NASAL CANNULA OXYGEN; OXYHEMOGLOBIN DESATURATION; TRACHEAL INTUBATION; CONTROLLED-TRIAL; HYPOXIA; CARE; IMPACT; MILD	Background: Apneic oxygenation (AO) has been evaluated in adult patients as a means of reducing hypoxemia during endotracheal intubation (ETI). While less studied in pediatric patients, its practice has been largely adopted. Objective: Determine association between AO and hypoxemia in pediatric patients undergoing ETI. Methods: Observational study at an urban, tertiary children's hospital emergency department. Pediatric patients undergoing ETI were examined during eras without (January 2011-June 2011) and with (August 2014-March 2017) apneic oxygenation. The primary outcome was hypoxemia, defined as pulse oximetry (SpO(2)) < 90%. The chi(2) and Wilcoxon rank-sum tests examined differences between cohorts. Multivariable regression models examined adjusted associations between covariates and hypoxemia. Results: 149 patients were included. Cohorts were similar except for greater incidence of altered mental status in those receiving AO (26% vs. 7%, p = 0.03). Nearly 50% of the pre-AO cohort experienced hypoxemia during ETI, versus <25% in the AO cohort. Median [IQR] lowest SpO(2) during ETI was 93 (69, 99) for pre-AO and 100 [95, 100] for the AO cohort (p < 0.001). In a multivariable logistic regression model, hypoxemia during ETI was associated with AO (aOR 0.3, 95% confidence interval [CI] 0.1-0.8), increased age (for 1 year, aOR 0.8,95% CI 0.7-1.0), lowest SpO(2) before ETI (for 1% increase, aOR 0.9. 95% CI 0.8-1.0), and each additional intubation attempt (aOR 4.0, 95% CI 22-72). Conclusions: Apneic oxygenation is an easily-applied intervention associated with decreases in hypoxemia during pediatric ETI. Nearly 50% of children not receiving AO experienced hypoxemia. (C) 2018 Elsevier Inc. All rights reserved.	[Vukovic, Adam A.; Hanson, Holly R.; Murphy, Shelley L.; Mercurio, Danielle; Arnold, Donald H.] Vanderbilt Univ, Dept Pediat, Div Pediat Emergency Med, Med Ctr, 2200 Childrens Way Suite 025, Nashville, TN 37232 USA; [Sheedy, Craig A.] Vanderbilt Univ, Med Ctr, Dept Emergency Med, 1313 21st Ave South,703 Oxford House, Nashville, TN 37232 USA; [Arnold, Donald H.] Vanderbilt Univ, Sch Med, Div Pulm Med, Dept Pediat, 2200 Childrens Way, Nashville, TN 37232 USA; [Arnold, Donald H.] Vanderbilt Univ, Sch Med, Ctr Asthma Res, 2200 Childrens Way, Nashville, TN 37232 USA		Vukovic, AA (corresponding author), Monroe Caren Jr Childrens Hosp Vanderbilt, Div Pediat Emergency Med, 2200 Childrens Way,Suite 1025, Nashville, TN 37232 USA.	Adam.a.vukovic@vanderbilt.edu			NCATS/NIH (Vanderbilt CTSA) [UL1 TR000445]	This research was supported by UL1 TR000445 from NCATS/NIH (Vanderbilt CTSA).	Brown CA., 2017, WALLS MANUAL EMERGEN; Caputo N, 2017, ACAD EMERG MED, V24, P1387, DOI 10.1111/acem.13274; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; Davis DP, 2009, J NEUROTRAUM, V26, P2217, DOI 10.1089/neu.2009.0940; Davis DP, 2004, J TRAUMA, V57, P1, DOI 10.1097/01.TA.0000135503.71684.C8; Dyett JF, 2015, ANAESTH INTENS CARE, V43, P577, DOI 10.1177/0310057X1504300505; Silva LOJE, 2017, ANN EMERG MED, V70, P483, DOI 10.1016/j.annemergmed.2017.05.001; Feng JF, 2012, J NEUROTRAUM, V29, P1167, DOI 10.1089/neu.2011.1867; FRUMIN MJ, 1959, ANESTHESIOLOGY, V20, P789, DOI 10.1097/00000542-195911000-00007; Harvey A, 2012, J TRAUMA ACUTE CARE, V72, P497, DOI 10.1097/TA.0b013e31821f84be; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; Humberg A, 2016, DEUT MED WOCHENSCHR, V141, P1409, DOI 10.1055/s-0042-113304; Jaber S, 2010, INTENS CARE MED, V36, P248, DOI 10.1007/s00134-009-1717-8; Kerrey BT, 2015, BMJ QUAL SAF, V24, P709, DOI 10.1136/bmjqs-2014-003713; Lee JH, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0593-y; Long E, 2014, PEDIATR ANESTH, V24, P1204, DOI 10.1111/pan.12490; Mayo Paul H, 2011, J Intensive Care Med, V26, P50, DOI 10.1177/0885066610384070; McSwain NE, 2004, J TRAUMA, V57, P8; Miguel-Montanes R, 2015, CRIT CARE MED, V43, P574, DOI 10.1097/CCM.0000000000000743; Mittiga MR, 2013, ANN EMERG MED, V61, P263, DOI 10.1016/j.annemergmed.2012.06.021; Nishisaki A, 2012, RESP CARE, V57, P1121, DOI 10.4187/respcare.01472; Pavlov I, 2017, AM J EMERG MED, V35, P1184, DOI 10.1016/j.ajem.2017.06.029; Ramachandran SK, 2010, J CLIN ANESTH, V22, P164, DOI 10.1016/j.jclinane.2009.05.006; Rinderknecht AS, 2017, ACAD EMERG MED, V24, P411, DOI 10.1111/acem.13145; Rinderknecht AS, 2015, ACAD EMERG MED, V22, P431, DOI 10.1111/acem.12633; Russotto V, 2017, J CRIT CARE, V41, P98, DOI 10.1016/j.jcrc.2017.05.003; Sakles JC, 2016, INTERN EMERG MED, V11, P983, DOI 10.1007/s11739-016-1396-8; Sakles JC, 2016, ACAD EMERG MED, V23, P703, DOI 10.1111/acem.12931; Semler MW, 2016, AM J RESP CRIT CARE, V193, P273, DOI 10.1164/rccm.201507-1294OC; Vourc'h M, 2015, INTENS CARE MED, V41, P1538, DOI 10.1007/s00134-015-3796-z; Weingart SD, 2012, ANN EMERG MED, V59, P165, DOI 10.1016/j.annemergmed.2011.10.002; Wimalasena Y, 2015, ANN EMERG MED, V65, P371, DOI 10.1016/j.annemergmed.2014.11.014; Yan EB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-147; Yang SH, 2013, SHOCK, V40, P471, DOI 10.1097/SHK.0000000000000037	35	17	17	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	JAN	2019	37	1					27	32		10.1016/j.ajem.2018.04.039			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	HB8AP	WOS:000451306000005	29699900				2022-02-06	
J	Zhao, HY; Liu, Y; Zeng, J; Li, DD; Huang, YH				Zhao, Hongyi; Liu, Yu; Zeng, Jing; Li, Dandan; Huang, Yonghua			Troxerutin cerebroprotein hydrolysate injection ameliorates neurovascular injury induced by traumatic brain injury - via endothelial nitric oxide synthase pathway regulation	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						Endothelial nitric oxide synthase; neurovascular unit; traumatic brain injury; troxerutin	INDUCED COGNITIVE DEFICITS; NEURAL APOPTOSIS; OXIDATIVE DAMAGE; MEMORY DEFICITS; RUTIN; UNIT; DYSFUNCTION; STRESS; MODEL; MITOCHONDRIA	Background: Neurovascular dysfunction caused by traumatic brain injury (TBI) is characterized by cerebralvascular damage, blood-brain barrier (BBB) breakdown, brain edema, etc. This study was designed to assess the protective role of 5 days troxerutin cerebroprotein hydrolysate (TCH) injection treatment against TBI, as well as the potential mechanism. Methods: The weight-drop model of TBI in male Sprague-Dawley rats was chosen to induce TBI model, rats either with TCH or a vehicle via intraperitoneal injection were examined 3 days after TBI. Results: TCH resulted in alleviation of neurological deficits, reduction of infarct volume, improvement of regional cerebral blood flow (rCBF), amelioration of neuronal death, astrocyte proliferation, endothelial cell loss, and BBB dysintegrity. These effects of TCH treatment against TBI were through endothelial nitric oxide synthase (eNOS) coupling/decoupling status adjustment, which not only increased nitric oxide (NO) level, but also decreased peroxynitrate level expression. Conclusions: All the results indicated that TCH injection has multifaceted protective effects of neurovascular unit (NVU) against TBI via eNOS pathway regulation.	[Zhao, Hongyi; Zeng, Jing; Li, Dandan; Huang, Yonghua] Army Gen Hosp PLA, Dept Neurol, 5 Nanmencang Dongsishitiao St, Beijing 100700, Peoples R China; [Zhao, Hongyi; Liu, Yu] 261 Hosp PLA, Dept Neurol, Beijing, Peoples R China		Huang, YH (corresponding author), Army Gen Hosp PLA, Dept Neurol, 5 Nanmencang Dongsishitiao St, Beijing 100700, Peoples R China.	huangyonghua2017@126.com					Agrawal R, 2015, BBA-MOL BASIS DIS, V1852, P862, DOI 10.1016/j.bbadis.2015.01.018; Alluri H, 2015, METAB BRAIN DIS, V30, P1093, DOI 10.1007/s11011-015-9651-7; Bouzat P, 2013, CRIT CARE MED, V41, P1316, DOI 10.1097/CCM.0b013e31827ca64e; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; Dong SY, 2013, NEURAL REGEN RES, V8, P3193, DOI 10.3969/j.issn.1673-5374.2013.34.003; Du H, 2010, P NATL ACAD SCI USA, V107, P18670, DOI 10.1073/pnas.1006586107; Feeney DM, 2011, BRAIN RES, V211, P66; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gu XH, 2016, BEHAV BRAIN RES, V311, P309, DOI 10.1016/j.bbr.2016.05.052; Gupta R, 2003, PHARMACOL RES, V48, P209, DOI 10.1016/S1043-6618(03)00102-6; Hall ED, 2012, EXP NEUROL, V238, P176, DOI 10.1016/j.expneurol.2012.08.024; Jang JW, 2014, J NEUROL SCI, V339, P75, DOI 10.1016/j.jns.2014.01.024; Jullienne A, 2013, FUTUR NEUROL, V8, P677, DOI 10.2217/FNL.13.55; Khan MM, 2009, BRAIN RES, V1292, P123, DOI 10.1016/j.brainres.2009.07.026; Khan M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-78; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Kim H, 2005, PHARM RES-DORDR, V22, P1499, DOI 10.1007/s11095-005-6250-z; Kumar A, 2014, J SURG RES, V188, P268, DOI 10.1016/j.jss.2013.12.028; Lan R, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/459467; Lo EH, 2009, STROKE, V40, pS2, DOI 10.1161/STROKEAHA.108.534404; Lok J, 2015, CNS NEUROSCI THER, V21, P304, DOI 10.1111/cns.12359; Lu J, 2013, J IMMUNOL, V190, P3466, DOI 10.4049/jimmunol.1202862; Lu J, 2011, BRAIN, V134, P783, DOI 10.1093/brain/awq376; Lu J, 2010, BRAIN PATHOL, V20, P952, DOI 10.1111/j.1750-3639.2010.00397.x; Machawal L, 2014, PHARMACOL REP, V66, P15, DOI 10.1016/j.pharep.2013.08.001; Mellou F, 2006, PROCESS BIOCHEM, V41, P2029, DOI 10.1016/j.procbio.2006.05.002; Meng XE, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15016933; Rochette L, 2013, PHARMACOL THERAPEUT, V140, P239, DOI 10.1016/j.pharmthera.2013.07.004; Tao XG, 2017, CHINESE MED J-PEKING, V130, P187, DOI 10.4103/0366-6999.198001; Thal SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050752; Ugusman A, 2014, SCI WORLD J, DOI 10.1155/2014/169370; Voigt C, 2012, NEUROPATH APPL NEURO, V38, P354, DOI 10.1111/j.1365-2990.2011.01211.x; Wang XY, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091476; Wei WT, 2015, NEUROCHEM INT, V87, P85, DOI 10.1016/j.neuint.2015.06.003; Yemisci M, 2009, NAT MED, V15, P1031, DOI 10.1038/nm.2022; Zhai XF, 2016, NEUROIMMUNOMODULAT, V23, P179, DOI 10.1159/000448716; Zhang J, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1184-z; Zhao HY, 2016, NEUROREPORT, V27, P916, DOI 10.1097/WNR.0000000000000631; Zhao Z, 2015, CELL, V163, P1064, DOI 10.1016/j.cell.2015.10.067; Zhu W, 2008, NEUROCHEM INT, V52, P1086, DOI 10.1016/j.neuint.2007.11.005; Zhuang Z, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-47	42	17	18	2	17	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0020-7454	1563-5279		INT J NEUROSCI	Int. J. Neurosci.	DEC 2	2018	128	12					1118	1127		10.1080/00207454.2018.1486828			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HL2UL	WOS:000458562800003	29883225				2022-02-06	
J	Azizian, H; Khaksari, M; Karam, GA; Esmailidehaj, M; Farhadi, Z				Azizian, Hossein; Khaksari, Mohammad; Karam, Gholamreza Asadi; Esmailidehaj, Mansour; Farhadi, Zeinab			Cardioprotective and anti-inflammatory effects of G-protein coupled receptor 30 (GPR30) on postmenopausal type 2 diabetic rats	BIOMEDICINE & PHARMACOTHERAPY			English	Article						Diabetes; 17-beta estradiol; G1; G15; Cardiovascular; GPR30	HIGH-FAT DIET; TRAUMATIC BRAIN-INJURY; ESTROGEN-RECEPTORS; INSULIN-RESISTANCE; ANGIOTENSIN-II; CARDIOMYOCYTE APOPTOSIS; METABOLIC SYNDROME; BLOOD-PRESSURE; GPER FUNCTION; GLUCOSE	Diabetic cardiomyopathy is the most common chronic disease in postmenopausal women, but the mechanism(s) is unclear. G-protein coupled receptor 30 (GPR30) is one of the receptors that binds to 17-beta Estradiol (E2). To date, there is little information on GPR30 and its expression in postmenopausal type 2 diabetes (T2D) in the heart. The current study hypothesized that GPR30 mediated cardioprotective effects of E2 in ovariectomized diabetic rats. Female ovariectomized diabetic rats were divided in nine groups: Control, Vehicle, Diabetes, Proestrous, Non-proestrous, E-2, E2+Vehicle, E2+G15, and G1. G15 is a GPR30 antagonist, while G1 is an agonist of GPR30. T2D was induced by high fat diet and streptozotocin. E2, G1 and G15 were administrated for four weeks after establishment of T2D. Results showed that mean arterial pressure, fasting blood glucose and HOMA-IR in diabetic and vehicle groups were alleviated by E2 and G1, while salutary effects of E2 were inhibited by G15. Furthermore, E2 and G1 improved cardiac weight, atherogenic and cardiovascular risk indices; meanwhile G15 exacerbated cardiac weight and atherogenic indices. Also, diabetes increased cardiac levels of tumor necrosis factor-alpha and interleukin 6 and E2 only decreased interleukin 6. Significant decrement in the level of interleukin 10, and GPR30 protein were observed in diabetic group, whereas E2 and G1 increased the cardiac levels of interleukin 10, and GPR30 protein. Our study suggested that beneficial and anti-inflammatory effects of E2 on diabetic cardiomyopathy are probably mediated via non-genomic E2 pathways.	[Azizian, Hossein; Farhadi, Zeinab] Kerman Univ Med Sci, Dept Physiol, Fac Med, Kerman, Iran; [Azizian, Hossein; Esmailidehaj, Mansour] Shahid Sadoughi Univ Med Sci, Dept Physiol, Fac Med, Yazd, Iran; [Khaksari, Mohammad] Kerman Univ Med Sci, Endocrinol & Metab Res Ctr, Kerman, Iran; [Khaksari, Mohammad] Kerman Univ Med Sci, Physiol Res Ctr, Kerman, Iran; [Karam, Gholamreza Asadi] Kerman Univ Med Sci, Dept Biochem, Kerman, Iran; [Karam, Gholamreza Asadi] Kerman Univ Med Sci, Metab & Endocrinol Res Ctr, Kerman, Iran		Khaksari, M (corresponding author), Kerman Univ Med Sci, Endocrinol & Metab Res Ctr, Kerman, Iran.; Khaksari, M (corresponding author), Kerman Univ Med Sci, Physiol Res Ctr, Kerman, Iran.	mkhaksari@kmu.ac.ir	Esmailidehaj, Mansour/AAQ-5643-2021; Azizian, Hossein/AAA-9554-2020; Haddad, Mohammad Khaksari/AAB-9025-2019; Asadikaram, Gholamreza/AAG-4437-2021	Esmailidehaj, Mansour/0000-0001-6869-0966; Haddad, Mohammad Khaksari/0000-0003-0770-4281; Asadikaram, Gholamreza/0000-0002-9100-0756	 [95/105]	This study was a part of Ph.D. thesis of Hossein Azizian (Grant No. 95/105), we thank Mr. Y. Masoumi-Ardakani, Mr. P. Ghotbi and Mr. M. Gohargazi for their cooperation in this study.	Afrazi S, 2014, J STEROID BIOCHEM, V139, P98, DOI 10.1016/j.jsbmb.2013.10.010; Al-Rasheed NM, 2016, DRUG DES DEV THER, V10, P2095, DOI 10.2147/DDDT.S109287; Antony PJ, 2017, BIOMED PHARMACOTHER, V88, P1098, DOI 10.1016/j.biopha.2017.01.170; Apaijai N, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20170886; Bansal S, 2018, MOL CELL ENDOCRINOL, V460, P152, DOI 10.1016/j.mce.2017.07.017; Bansal S, 2014, GEN COMP ENDOCR, V206, P51, DOI 10.1016/j.ygcen.2014.06.013; Barouch LA, 2006, CIRC RES, V98, P119, DOI 10.1161/01.RES.0000199348.10580.1d; Barton M, 2013, J CARDIOVASC PHARM, V62, P22, DOI 10.1097/FJC.0b013e31829709d4; Bell DSH, 2003, DIABETES CARE, V26, P2433, DOI 10.2337/diacare.26.8.2433; Berry B, 1997, BEHAV NEUROSCI, V111, P267, DOI 10.1037/0735-7044.111.2.267; Bhandari U, 2015, INDIAN J MED RES, V142, P598, DOI 10.4103/0971-5916.171290; Blasko E, 2009, J NEUROIMMUNOL, V214, P67, DOI 10.1016/j.jneuroim.2009.06.023; Brower GL, 2003, MOL CELL BIOCHEM, V251, P89, DOI 10.1023/A:1025438000942; Brunsing RL, 2011, IMMUNOLOGY, V134, P93, DOI 10.1111/j.1365-2567.2011.03471.x; Bryzgalova G, 2008, AM J PHYSIOL-ENDOC M, V295, pE904, DOI 10.1152/ajpendo.90248.2008; Chen Z, 1999, J CLIN INVEST, V103, P401, DOI 10.1172/JCI5347; Cheng S, 2010, CIRCULATION, V122, P570, DOI 10.1161/CIRCULATIONAHA.110.937821; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; Domenighetti AA, 2007, J MOL CELL CARDIOL, V42, P63, DOI 10.1016/j.yjmcc.2006.09.019; Ferder L, 2006, CURR HYPERTENS REP, V8, P191, DOI 10.1007/s11906-006-0050-7; Fielitz J, 2004, J MOL MED, V82, P809, DOI 10.1007/s00109-004-0606-4; Galipeau D, 2002, AM J PHYSIOL-HEART C, V283, pH2478, DOI 10.1152/ajpheart.00243.2002; Gillies G. E., 2010, PHARMACOL REV; GRAY P, 1982, PHYSIOL BEHAV, V29, P287, DOI 10.1016/0031-9384(82)90017-8; Gunson MJ, 2009, AM J ORTHOD DENTOFAC, V136, P772, DOI 10.1016/j.ajodo.2009.07.011; Guo R, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/430791; Haas E, 2009, CIRC RES, V104, P288, DOI 10.1161/CIRCRESAHA.108.190892; He JH, 2015, PEPTIDES, V64, P49, DOI 10.1016/j.peptides.2014.12.012; Holmes A, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/307285; Hotamisligil GS, 1999, J INTERN MED, V245, P621, DOI 10.1046/j.1365-2796.1999.00490.x; Iozzo P, 2002, DIABETES, V51, P3020, DOI 10.2337/diabetes.51.10.3020; Jessup JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015433; Joukar S, 2012, EXCLI J, V11, P480; Kanaya AM, 2003, ANN INTERN MED, V138, P1, DOI 10.7326/0003-4819-138-1-200301070-00005; KANNEL WB, 1979, CIRCULATION, V59, P8, DOI 10.1161/01.CIR.59.1.8; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kawasaki T, 2008, MOL IMMUNOL, V45, P376, DOI 10.1016/j.molimm.2007.06.148; Khaksari M, 2015, INT IMMUNOPHARMACOL, V28, P279, DOI 10.1016/j.intimp.2015.05.046; Khaksari M, 2015, BRAIN RES, V1618, P1, DOI 10.1016/j.brainres.2015.05.017; Khaksari M, 2013, CAN J PHYSIOL PHARM, V91, P700, DOI 10.1139/cjpp-2012-0359; Khaksari M, 2011, CAN J PHYSIOL PHARM, V89, P31, DOI [10.1139/Y10-103, 10.1139/y10-103]; Kumar R, 2012, AM J PHYSIOL-REG I, V302, pR510, DOI 10.1152/ajpregu.00512.2011; Lastra G, 2014, ENDOCRIN METAB CLIN, V43, P103, DOI 10.1016/j.ecl.2013.09.005; Lindsey SH, 2009, ENDOCRINOLOGY, V150, P3753, DOI 10.1210/en.2008-1664; Litwak SA, 2014, ENDOCRINOLOGY, V155, P4447, DOI 10.1210/en.2014-1342; Liu L, 2016, AM J PHYSIOL-HEART C, V310, pH953, DOI 10.1152/ajpheart.00631.2015; Lontchi-Yimagou E, 2013, CURR DIABETES REP, V13, P435, DOI 10.1007/s11892-013-0375-y; Maghool F, 2013, BRAIN RES, V1497, P61, DOI 10.1016/j.brainres.2012.12.014; Mahmoodzadeh S, 2010, CARDIOVASC RES, V85, P719, DOI 10.1093/cvr/cvp350; MANDL AM, 1951, J EXP BIOL, V28, P585; MANDL AM, 1951, J EXP BIOL, V28, P576; Martensson UEA, 2009, ENDOCRINOLOGY, V150, P687, DOI 10.1210/en.2008-0623; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meoli L, 2014, GENE, V540, P210, DOI 10.1016/j.gene.2014.02.036; Meyer MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079245; Mikkola TS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063347; Muruganandan S, 2005, J ETHNOPHARMACOL, V97, P497, DOI 10.1016/j.jep.2004.12.010; Nordell VL, 2003, NEUROBIOL AGING, V24, P733, DOI 10.1016/S0197-4580(02)00193-8; O'Donnell E, 2014, AM J PHYSIOL-REG I, V307, pR498, DOI 10.1152/ajpregu.00182.2014; OBERHOLZER A, 2000, CRIT CARE MED S, V28; Packer C. Subah, 2007, ESTROGEN PROTECTION; Pfeilschifter J, 2002, ENDOCR REV, V23, P90, DOI 10.1210/er.23.1.90; Prossnitz ER, 2015, J STEROID BIOCHEM, V153, P114, DOI 10.1016/j.jsbmb.2015.06.014; Prossnitz ER, 2014, MOL CELL ENDOCRINOL, V389, P71, DOI 10.1016/j.mce.2014.02.002; Putnam K, 2012, AM J PHYSIOL-HEART C, V302, pH1219, DOI 10.1152/ajpheart.00796.2011; Rahman MM, 2017, BIOMED PHARMACOTHER, V92, P606, DOI 10.1016/j.biopha.2017.05.035; Recchiuti A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00298; Reichelt ME, 2013, AM J PHYSIOL-HEART C, V305, pH779, DOI 10.1152/ajpheart.00141.2013; Reimer AE, 2018, NEUROPHARMACOLOGY, V131, P104, DOI 10.1016/j.neuropharm.2017.12.015; Resanovic I, 2013, HORM METAB RES, V45, P701, DOI 10.1055/s-0033-1343478; Ribas V, 2010, AM J PHYSIOL-ENDOC M, V298, pE304, DOI 10.1152/ajpendo.00504.2009; Rubanyi GM, 1997, J CLIN INVEST, V99, P2429, DOI 10.1172/JCI119426; Salpeter SR, 2006, DIABETES OBES METAB, V8, P538, DOI 10.1111/j.1463-1326.2005.00545.x; Sharma G, 2018, J STEROID BIOCHEM, V176, P31, DOI 10.1016/j.jsbmb.2017.02.012; Singh VP, 2008, DIABETES, V57, P3297, DOI 10.2337/db08-0805; Sivasinprasasn S, 2016, MENOPAUSE, V23, P894, DOI 10.1097/GME.0000000000000640; Srinivasan K, 2004, METHOD FIND EXP CLIN, V26, P327, DOI 10.1358/mf.2004.26.5.831322; Tawfik SH, 2015, BIOCHEM RES INT, V2015, DOI 10.1155/2015/567945; Tiano JP, 2012, NAT REV ENDOCRINOL, V8, P342, DOI 10.1038/nrendo.2011.242; Tuttle HA, 2004, J DIABETES COMPLICAT, V18, P343, DOI 10.1016/S1056-8727(03)00088-6; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Wang H, 2012, CARDIOVASC RES, V94, P96, DOI 10.1093/cvr/cvs090; Weng Y, 2014, J ETHNOPHARMACOL, V152, P553, DOI 10.1016/j.jep.2014.02.001; Xu Y, 2003, CARDIOVASC RES, V57, P388, DOI 10.1016/S0008-6363(02)00705-8; Yang LF, 2015, BBA-MOL BASIS DIS, V1852, P209, DOI 10.1016/j.bbadis.2014.05.006; Yang LS, 2006, MOL IMMUNOL, V43, P357, DOI 10.1016/j.molimm.2005.02.012; Yang SL, 2006, AM J PHYSIOL-HEART C, V291, pH2807, DOI 10.1152/ajpheart.00195.2006; Yates MA, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-20	88	17	17	2	6	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0753-3322	1950-6007		BIOMED PHARMACOTHER	Biomed. Pharmacother.	DEC	2018	108						153	164		10.1016/j.biopha.2018.09.028			12	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	HA2UZ	WOS:000450101800020	30218860	hybrid			2022-02-06	
J	Estraneo, A; Loreto, V; Masotta, O; Pascarella, A; Trojano, L				Estraneo, Anna; Loreto, Vincenzo; Masotta, Orsola; Pascarella, Angelo; Trojano, Luigi			Do Medical Complications Impact Long-Term Outcomes in Prolonged Disorders of Consciousness?	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Complications; Minimally conscious state; Outcome; Rehabilitation; Vegetative state	COMA RECOVERY SCALE; TRAUMATIC BRAIN-INJURY; INPATIENT REHABILITATION; NATURAL-HISTORY; COMORBIDITIES; ASSOCIATION; DEFINITION; MORTALITY; RESPONSIVENESS; MULTICENTER	Objective: To investigate medical complications (MCs) occurring within 6 months postinjury in brain-injured patients with prolonged disorders of consciousness (DoC) and to evaluate impact of MC on mortality and long-term clinical outcomes. Design: Prospective observational cohort study. Setting: Rehabilitation unit for acquired DoC. Participants: Patients (N=194) with DoC (142 in vegetative state [VS], 52 in minimally conscious state; traumatic etiology 43, anoxic 69, vascular 82) consecutively admitted to a neurorehabilitation unit within 1-3 months postonset. Interventions: Not applicable. Main Outcome Measures: Mortality and improvements in clinical diagnosis and functional disability level (assessed by Coma Recovery Scale Revised [CRS-R] and Disability Rating Scale) at 12, 24, and 36 months postonset. Results: Within 6 months postinjury, 188 of 194 patients (>95%) developed at least 1 MC and 142 of them (73%) showed at least 1 severe MC. Respiratory and musculoskeletal-cutaneous MCs were the most frequent, followed by endocrino-metabolic abnormalities. Follow-up, complete in 189 of 194 patients, showed that male sex and endocrine-metabolic MCs were associated with higher risk of mortality at all timepoints. Old age, anoxic etiology, lower CRS-R total scores, and diagnosis of VS at study entry predicted no clinical and functional improvements at most timepoints; however, epilepsy predicted no improvement in diagnosis at 24 months postonset only. Conclusions: MCs are very frequent in patients with DoC within at least 6 months after brain injury, regardless of clinical diagnosis, etiology, and age. Endocrino-metabolic MCs are independent predictors of mortality at all timepoints; however,epilepsy predicted poor long-term outcome. Occurrence and severity of MCs in patients with DoC call for long-term appropriate levels of care after the postacute phase. (C) 2018 by the American Congress of Rehabilitation Medicine.	[Estraneo, Anna; Loreto, Vincenzo; Masotta, Orsola; Pascarella, Angelo; Trojano, Luigi] IRCCS Maugeri ICS, Neurorehabil Unit, Via Bagni Vecchi 1, I-82037 Telese Terme, BN, Italy; [Estraneo, Anna; Loreto, Vincenzo; Masotta, Orsola; Pascarella, Angelo; Trojano, Luigi] IRCCS Maugeri ICS, Res Lab Disorder Consciousness, Via Bagni Vecchi 1, I-82037 Telese Terme, BN, Italy; [Trojano, Luigi] Univ Campania Luigi Vanvitelli, Dept Psychol, Neuropsychol Lab, Caserta, Italy		Estraneo, A (corresponding author), IRCCS Maugeri ICS, Neurorehabil Unit, Via Bagni Vecchi 1, I-82037 Telese Terme, BN, Italy.; Estraneo, A (corresponding author), IRCCS Maugeri ICS, Res Lab Disorder Consciousness, Via Bagni Vecchi 1, I-82037 Telese Terme, BN, Italy.	anna.estraneo@icsmaugeri.it	Trojano, Luigi/F-2396-2016; Pascarella, Angelo/A-9813-2016; estraneo, anna/K-5409-2016	Trojano, Luigi/0000-0002-0328-9642; Pascarella, Angelo/0000-0002-0085-9494; estraneo, anna/0000-0001-6646-5626	IRCCS Maugeri ICS	Supported by IRCCS Maugeri ICS.	ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Baguley IJ, 2014, J NEUROTRAUM, V31, P1515, DOI 10.1089/neu.2013.3301; Baltazar GA, 2015, AM SURGEON, V81, pE61; Bargellesi S, 2018, CLIN REHABIL, V32, P255, DOI 10.1177/0269215517723161; Bernat JL, 2010, NEUROLOGY, V75, P206, DOI 10.1212/WNL.0b013e3181e8e960; Cheng PC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002332; Estraneo A, 2015, EUR J PHYS REHAB MED, V51, P627; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Estraneo A, 2015, CLIN REHABIL, V29, P803, DOI 10.1177/0269215514556002; Estraneo A, 2014, ARCH PHYS MED REHAB, V95, P711, DOI 10.1016/j.apmr.2013.11.004; Estraneo A, 2013, NEUROLOGY, V80, P464, DOI 10.1212/WNL.0b013e31827f0f31; Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550; Formisano R, 2017, NEUROL SCI, V38, P181, DOI 10.1007/s10072-016-2724-5; Ganesh S, 2013, ARCH PHYS MED REHAB, V94, P1899, DOI 10.1016/j.apmr.2012.12.026; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Greenwald BD, 2015, J NEUROTRAUM, V32, P1883, DOI 10.1089/neu.2014.3454; Hansen TS, 2008, ARCH PHYS MED REHAB, V89, P2114, DOI 10.1016/j.apmr.2008.04.013; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Hazeldine J, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00235; Kalmar K, 2005, NEUROPSYCHOL REHABIL, V15, P454, DOI 10.1080/09602010443000425; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Lanzillo B, 2016, EUR J PHYS REHAB MED, V52, P263; Laureys S., 2018, COMA DISORDERS CONSC, P17, DOI 10.1007/978-3-319-55964-3; Librizzi L, 2012, ANN NEUROL, V72, P82, DOI 10.1002/ana.23567; LINN BS, 1968, J AM GERIATR SOC, V16, P622, DOI 10.1111/j.1532-5415.1968.tb02103.x; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; Majerus S, 2005, PROG BRAIN RES, V150, P397, DOI 10.1016/S0079-6123(05)50028-1; Menard S.W., 1995, APPL LOGISTIC REGRES; Montalcini T, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0660-4; Moretta P, 2014, CLIN REHABIL, V28, P717, DOI 10.1177/0269215514521826; MYERS RH, 1990, CLASS MOD REGR APPL; Pagani M, 2014, J NEUROL, V261, P1144, DOI 10.1007/s00415-014-7309-8; Pascarella A, 2016, J NEUROL, V263, P2048, DOI 10.1007/s00415-016-8232-y; Pistoia F, 2015, J NEUROTRAUM, V32, P682, DOI 10.1089/neu.2014.3659; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rau CS, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13121203; Romaniello C, 2016, AM J MED SCI, V351, P563, DOI 10.1016/j.amjms.2016.01.024; Sattin D, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.740; Seel RT, 2013, ARCH PHYS MED REHAB, V94, P1908, DOI 10.1016/j.apmr.2012.11.052; Steppacher I, 2014, ANN CLIN TRANSL NEUR, V1, P401, DOI 10.1002/acn3.63; Thibaut A, 2015, EUR J PHYS REHAB MED, V51, P389; Tritos NA, 2015, ENDOCR PRACT, V21, P823, DOI 10.4158/EP14567.DSCR; Wannez S, 2018, NEUROPSYCHOL REHABIL, V28, P1350, DOI 10.1080/09602011.2017.1310656; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1851, DOI 10.1016/j.apmr.2013.07.003; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1877, DOI 10.1016/j.apmr.2012.12.027	45	17	18	1	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	DEC	2018	99	12					2523	2531		10.1016/j.apmr.2018.04.024			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	HE2MW	WOS:000453113200014	29807003				2022-02-06	
J	Pijet, B; Stefaniuk, M; Kostrzewska-Ksiezyk, A; Tsilibary, PE; Tzinia, A; Kaczmarek, L				Pijet, Barbara; Stefaniuk, Marzena; Kostrzewska-Ksiezyk, Agnieszka; Tsilibary, Photini-Effie; Tzinia, Athina; Kaczmarek, Leszek			Elevation of MMP-9 Levels Promotes Epileptogenesis After Traumatic Brain Injury	MOLECULAR NEUROBIOLOGY			English	Article						Traumatic brain injury; Controlled cortical impact; Matrix metalloproteinase-9 (MMP-9); Extracellular matrix (ECM); Epileptogenesis; Posttraumatic epilepsy	CONTROLLED CORTICAL IMPACT; POSTTRAUMATIC EPILEPSY; MATRIX METALLOPROTEINASES; ELECTRICAL-STIMULATION; MATRIX-METALLOPROTEINASE-9; MICE; INHIBITORS; SEIZURE; RATS; HIPPOCAMPUS	Posttraumatic epilepsy (PTE) is a recurrent seizure disorder that often develops secondary to traumatic brain injury (TBI) that is caused by an external mechanical force. Recent evidence shows that the brain extracellular matrix plays a major role in the remodeling of neuronal connections after injury. One of the proteases that is presumably responsible for this process is matrix metalloproteinase-9 (MMP-9). The levels of MMP-9 are elevated in rodent brain tissue and human blood samples after TBI. However, no studies have described the influence of MMP-9 on the development of PTE. The present study used controlled cortical impact (CCI) as a mouse model of TBI. We examined the detailed kinetics of MMP-9 levels for 1month after TBI and observed two peaks after injury (30min and 6h after injury). We tested the hypothesis that high levels of MMP-9 predispose individuals to the development of PTE, and MMP-9 inhibition would protect against PTE. We used transgenic animals with either MMP-9 knockout or MMP-9 overexpression. MMP-9 overexpression increased the number of mice that exhibited TBI-induced spontaneous seizures, and MMP-9 knockout decreased the appearance of seizures. We also evaluated changes in responsiveness to a single dose of the chemoconvulsant pentylenetetrazol. MMP-9-overexpressing mice exhibited a significantly shorter latency between pentylenetetrazol administration and the first epileptiform spike. MMP-9 knockout mice exhibited the opposite response profile. Finally, we found that the occurrence of PTE was correlated with the size of the lesion after injury. Overall, our data emphasize the contribution of MMP-9 to TBI-induced structural and physiological alterations in brain circuitry that may lead to the development of PTE.	[Pijet, Barbara; Stefaniuk, Marzena; Kostrzewska-Ksiezyk, Agnieszka; Kaczmarek, Leszek] Nencki Inst Expt Biol, Neurobiol Lab, Dept Mol & Cellular Neurobiol, Pasteura 3, PL-02093 Warsaw, Poland; [Tsilibary, Photini-Effie] Univ Minnesota, Dept Neurosci, Minneapolis, MN 55405 USA; [Tsilibary, Photini-Effie] Brain Sci Ctr, Minneapolis, MN 55417 USA; [Tzinia, Athina] NCSR Demokritos, Lab Cell & Matrix Pathobiol, Inst Biosci & Applicat, Athens 15310, Greece		Pijet, B; Kaczmarek, L (corresponding author), Nencki Inst Expt Biol, Neurobiol Lab, Dept Mol & Cellular Neurobiol, Pasteura 3, PL-02093 Warsaw, Poland.	b.pijet@nencki.gov.pl; m.stefaniuk@nencki.gov.pl; a.kostrzewska@nencki.gov.pl; tsili001@umn.edu; atzin@bio.demokritos.gr; l.kaczmarek@nencki.gov.pl	Pijet, Barbara/B-6559-2019; Kaczmarek, Leszek/B-6171-2008	Pijet, Barbara/0000-0002-9268-5208; Kaczmarek, Leszek/0000-0002-7207-3490; Kostrzewska-Ksiezyk, Agnieszka/0000-0002-0033-4321	National Center of Research and Development (NCBiR) [NEURON/09/13, PBS/A8/36/2015]	This study was supported by National Center of Research and Development (NCBiR) grants (ERA-NET Neuron grant no. NEURON/09/13 and PBS/A8/36/2015).	Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; Buckmaster PS, 2012, JASPERS BASIC MECH E, DOI [10.1093/med/9780199746545.003.0032, DOI 10.1093/MED/9780199746545.003.0032]; Chen W, 2017, NEUROPSYCH DIS TREAT, V13, P2301, DOI 10.2147/NDT.S141486; Czlonkowska A, 2011, J NEUROIMMUNOL, V231, P78, DOI 10.1016/j.jneuroim.2010.09.020; Dyhrfjeld-Johnsen J, 2007, J NEUROPHYSIOL, V97, P1566, DOI 10.1152/jn.00950.2006; Dziembowska M, 2012, J NEUROSCI, V32, P14538, DOI 10.1523/JNEUROSCI.6028-11.2012; Dzwonek J, 2004, FEBS LETT, V567, P129, DOI 10.1016/j.febslet.2004.03.070; Fragkouli A, 2012, J NEUROCHEM, V121, P239, DOI 10.1111/j.1471-4159.2011.07637.x; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Hayashi T, 2009, BRAIN RES, V1280, P172, DOI 10.1016/j.brainres.2009.05.040; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Huntley GW, 2012, NAT REV NEUROSCI, V13, P743, DOI 10.1038/nrn3320; Jain S, 2011, N-S ARCH PHARMACOL, V383, P385, DOI 10.1007/s00210-011-0606-1; Kim GW, 2009, NEUROBIOL DIS, V36, P169, DOI 10.1016/j.nbd.2009.07.008; Kim YH, 2012, J BIOL CHEM, V287, P38957, DOI 10.1074/jbc.M112.357863; Klein M, 1996, J NERV MENT DIS, V184, P459, DOI 10.1097/00005053-199608000-00002; Konopka A, 2013, EPILEPSY RES, V104, P45, DOI 10.1016/j.eplepsyres.2012.09.018; Kowluru RA, 2011, DIABETES, V60, P3023, DOI 10.2337/db11-0816; Kuzniewska B, 2016, MOL NEUROBIOL, V53, P1478, DOI 10.1007/s12035-014-9089-7; LEMOS T, 1995, EXP BRAIN RES, V102, P423; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; Lukasiuk K, 2011, EPILEPSY RES, V96, P191, DOI 10.1016/j.eplepsyres.2011.08.002; Miszczuk D, 2016, MOL NEUROBIOL, V53, P7010, DOI 10.1007/s12035-015-9578-3; Mizoguchi H, 2011, J NEUROSCI, V31, P12963, DOI 10.1523/JNEUROSCI.3118-11.2011; NADLER JV, 1980, BRAIN RES, V182, P1; Nissinen J, 2000, EPILEPSY RES, V38, P177, DOI 10.1016/S0920-1211(99)00088-1; Pitkanen A, 2012, JASPERS BASIC MECH E, P1; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rivera S, 2010, J NEUROSCI, V30, P15337, DOI 10.1523/JNEUROSCI.3467-10.2010; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; Semple BD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143386; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Stute J, 2003, J PROTEIN CHEM, V22, P509, DOI 10.1023/B:JOPC.0000005499.51466.50; Suehiro E, 2004, J NEUROTRAUM, V21, P1706, DOI 10.1089/0897715042664957; Suenaga N, 2008, J NEUROL SCI, V266, P126, DOI 10.1016/j.jns.2007.09.011; Szklarczyk A, 2002, J NEUROSCI, V22, P920, DOI 10.1523/JNEUROSCI.22-03-00920.2002; Takacs E, 2010, NEUROCHEM INT, V56, P799, DOI 10.1016/j.neuint.2010.03.003; Truettner JS, 2005, J CEREBR BLOOD F MET, V25, P1505, DOI 10.1038/sj.jcbfm.9600150; Vafadari B, 2016, J NEUROCHEM, V139, P91, DOI 10.1111/jnc.13415; Vajtr D, 2009, PHYSIOL RES, V58, P263, DOI 10.33549/physiolres.931253; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Wilczynski GM, 2008, J CELL BIOL, V180, P1021, DOI 10.1083/jcb.200708213; Zimowska M, 2013, BIOL CELL, V105, P334, DOI 10.1111/boc.201300020	44	17	19	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	DEC	2018	55	12					9294	9306		10.1007/s12035-018-1061-5			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GY3VF	WOS:000448483400037	29667129	Green Published, hybrid			2022-02-06	
J	Schneider, KJ; Meeuwisse, WH; Palacios-Derflingher, L; Emery, CA				Schneider, Kathryn J.; Meeuwisse, Willem H.; Palacios-Derflingher, Luz; Emery, Carolyn A.			Changes in Measures of Cervical Spine Function, Vestibulo-ocular Reflex, Dynamic Balance, and Divided Attention Following Sport-Related Concussion in Elite Youth Ice Hockey Players	JOURNAL OF ORTHOPAEDIC & SPORTS PHYSICAL THERAPY			English	Article						cervical spine; concussion; dynamic visual acuity; ice hockey; vestibular; youth	RISK-FACTORS; VISUAL-ACUITY; NECK PAIN; CLINICAL-TEST; RATING-SCALE; NUMERIC PAIN; INJURY; REHABILITATION; RELIABILITY; IMPLEMENTATION	BACKGROUND: Concussion is a commonly occurring injury. The extent to which the cervical spine, vestibulo-ocular reflex (VOR), dynamic balance, and divided attention are affected following concussion is not well understood. OBJECTIVES: To evaluate acute changes in measures of (1) cervical spine function, (2) VOR function, (3) dynamic balance, and (4) tasks of divided attention in elite youth ice hockey players following a sport-related concussion. METHODS: In this prospective cohort study, elite 13- to 17-year-old ice hockey players completed cervical spine measures (cervical flexor endurance test, head perturbation test, anterolateral strength, cervical flexion rotation test, joint position error), VOR function tests (head thrust test, dynamic visual acuity [clinical and computerized]), dynamic balance tests (Functional Gait Assessment), and divided-attention tasks (walking-while-talking test) both in the preseason and following concussion. RESULTS: At least 1 test was completed by 69 of 97 (71%) players (a maximum of 55 for any 1 test) at both preseason and immediately following concussion (median, 4 days post concussion). After Bonferroni corrections (alpha = .00625), using Wilcoxon signed-rank tests, cervical spine measures were significantly worse following concussion compared to baseline (cervical flexor endurance test: z = -5.20, P<.001; anterolateral neck strength: z(left) = -5.36, P<.001 and z(right) = -5.45, P<.001; and head perturbation test: z = -4.36, P<.001). Time taken to complete a complex task of divided attention relative to normal walking speed was faster (improved) compared to the preseason (z = -2.59, P<.01). There was no change in VOR or dynamic balance following concussion. CONCLUSION: Measures of cervical spine function and divided attention were altered following concussion. However, tests of VOR and dynamic balance were not significantly different from baseline. Future research to evaluate the mechanism underlying these changes is warranted.	[Schneider, Kathryn J.; Meeuwisse, Willem H.; Palacios-Derflingher, Luz; Emery, Carolyn A.] Univ Calgary, Fac Kinesiol, Sport Injury Prevent Res Ctr, Calgary, AB, Canada; [Schneider, Kathryn J.] Univ Calgary, Cumming Sch Med, Hotchkiss Brain Inst, Calgary, AB, Canada; [Schneider, Kathryn J.; Emery, Carolyn A.] Univ Calgary, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada; [Palacios-Derflingher, Luz; Emery, Carolyn A.] Univ Calgary, Cumming Sch Med, Dept Community Hlth Sci, Calgary, AB, Canada		Schneider, KJ (corresponding author), Univ Calgary, Sport Injury Prevent Res Ctr, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	kjschnei@ucalgary.ca	Emery, Carolyn/AAI-2761-2020	Schneider, Kathryn/0000-0002-5951-5899			Armstrong B, 2008, SPORTS MED, V38, P101, DOI 10.2165/00007256-200838020-00002; Badke MB, 2004, ARCH PHYS MED REHAB, V85, P227, DOI 10.1016/j.apmr.2003.06.006; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Bogduk N, 2009, LANCET NEUROL, V8, P959, DOI 10.1016/S1474-4422(09)70209-1; Childs JD, 2005, SPINE, V30, P1331, DOI 10.1097/01.brs.0000164099.92112.29; Cleland JA, 2008, ARCH PHYS MED REHAB, V89, P69, DOI 10.1016/j.apmr.2007.08.126; Dannenbaum E, 2005, J OTOLARYNGOL, V34, P13, DOI 10.2310/7070.2005.03105; Dannenbaum E, 2009, OTOL NEUROTOL, V30, P368, DOI 10.1097/MAO.0b013e31819bda35; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Edmondston SJ, 2008, J MANIP PHYSIOL THER, V31, P348, DOI 10.1016/j.jmpt.2008.04.010; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Emery C, 2009, CLIN J SPORT MED, V19, P245; Emery CA, 2009, PAED CHILD HEALT-CAN, V14, P439, DOI 10.1093/pch/14.7.439; Emery CA, 2005, AM J SPORT MED, V33, P1882, DOI 10.1177/0363546505279576; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Emery CA, 2010, INJURY PREV, V16, P113, DOI 10.1136/ip.2009.022764; Feddermann-Demont N, 2017, BRIT J SPORT MED, V51, P903, DOI 10.1136/bjsports-2016-097403; Herdman SJ, 1998, AM J OTOL, V19, P790; Herdman SJ, 2007, VESTIBULAR REHABILIT; Hyndman D, 2004, J NEUROL NEUROSUR PS, V75, P994, DOI 10.1136/jnnp.2003.016014; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; Kristjansson E, 2009, J ORTHOP SPORT PHYS, V39, P364, DOI 10.2519/jospt.2009.2834; Kumbhare DA, 2005, DISABIL REHABIL, V27, P801, DOI 10.1080/09638280400020615; Makdissi M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097470; McCrory P, 2017, BRIT J SPORT MED, V51, P877, DOI 10.1136/bjsports-2016-097393; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meeuwisse WH, 1998, CLIN J SPORT MED, V8, P164, DOI 10.1097/00042752-199807000-00003; Metcalfe S, 2006, J MAN MANIP THER, V14, P152, DOI 10.1179/106698106790835687; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Ogince M, 2007, MANUAL THER, V12, P256, DOI 10.1016/j.math.2006.06.016; Olson LE, 2006, J MANIP PHYSIOL THER, V29, P134, DOI 10.1016/j.jmpt.2005.12.009; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; REVEL M, 1991, ARCH PHYS MED REHAB, V72, P288; REVEL M, 1994, ARCH PHYS MED REHAB, V75, P895, DOI 10.1016/0003-9993(94)90115-5; Scherer M, 2008, J VESTIBUL RES-EQUIL, V18, P147; Schneider KJ, 2021, CLIN J SPORT MED, V31, P70, DOI 10.1097/JSM.0000000000000673; Schneider KJ, 2016, J ORTHOP SPORT PHYS, V46, P613, DOI 10.2519/jospt.2016.0607; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Schneider KJ, 2013, CLIN J SPORT MED, V23, P267, DOI 10.1097/JSM.0b013e318281f09f; SCHNEIDER KJ, 2017, BRIT J SPORT MED, V51; Schneider KJ, 2017, BRIT J SPORT MED, V51, pA50, DOI [10.1136/bjsports-2016-097270.130, DOI 10.1136/BJSPORTS-2016-097270.130]; Schubert MC, 2004, PHYS THER, V84, P151, DOI 10.1093/ptj/84.2.151; TRELEAVEN J, 1994, CEPHALALGIA, V14, P273, DOI 10.1046/j.1468-2982.1994.1404273.x; Wrisley DM, 2004, PHYS THER, V84, P906, DOI 10.1093/ptj/84.10.906; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	46	17	17	2	16	J O S P T	ALEXANDRIA	1111 NORTH FAIRFAX ST, STE 100, ALEXANDRIA, VA 22314-1436 USA	0190-6011	1938-1344		J ORTHOP SPORT PHYS	J. Orthop. Sports Phys. Ther.	DEC	2018	48	12					974	982		10.2519/jospt.2018.8258			9	Orthopedics; Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Rehabilitation; Sport Sciences	HC4JF	WOS:000451768700010	30053794				2022-02-06	
J	Walt, GS; Burris, HM; Brady, CB; Spencer, KR; Alvarez, VE; Huber, BR; Guilderson, L; Rauf, NA; Collins, D; Singh, T; Mathias, R; Averill, JG; Walker, SE; Robey, I; McKee, AC; Kowall, NW; Stein, TD				Walt, Gabriel S.; Burris, Hannah M.; Brady, Christopher B.; Spencer, Keith R.; Alvarez, Victor E.; Huber, Bertrand R.; Guilderson, Latease; Rauf, Nazifa Abdul; Collins, Derek; Singh, Tarnjit; Mathias, Rebecca; Averill, James G.; Walker, Sean E.; Robey, Ian; McKee, Ann C.; Kowall, Neil W.; Stein, Thor D.			Chronic Traumatic Encephalopathy Within an Amyotrophic Lateral Sclerosis Brain Bank Cohort	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article						Amyotrophic lateral sclerosis; Chronic traumatic encephalopathy; Military veterans; Motor neuron degeneration; Motor neuron disease; Traumatic brain injury	FUNCTIONAL RATING-SCALE; ALSFRS-R; NEUROPATHOLOGIC ASSESSMENT; DISEASE PROGRESSION; NATIONAL INSTITUTE; ALZHEIMERS-DISEASE; NERVOUS-SYSTEM; HEAD-INJURY; PATHOLOGY; DIAGNOSIS	Chronic traumatic encephalopathy (CTE) is a progressive neurodegenerative disorder linked to repetitive head impacts and has been associated with amyotrophic lateral sclerosis (ALS), a fatal, degenerative neuromuscular disorder. The Department of Veterans Affairs Biorepository Brain Bank (VABBB) is a tissue repository that collects antemortem disease progression data and postmortem central nervous system tissue from veterans with ALS. We set out to determine the frequency of co-morbid ALS and CTE in the VABBB cohort and to characterize the clinical, genetic, and pathological distinctions between participants with ALS only and those with both ALS and CTE (ALS+CTE). Of 155 participants, 9 (5.8%) had neuropathologically confirmed ALS+CTE. Participants with ALS+CTE were more likely to have a history of traumatic brain injury (p < 0.001), served during the first Persian Gulf War (p < 0.05), and to have more severe tau pathology within the frontal cortex and spinal cord (p < 0.05). The most common exposures to head impacts included contact sports (n = 5) and military service (n = 2). Clinically, participants with ALSthornCTE were more likely to have bulbar onset ALS (p = 0.006), behavioral changes (p = 0.002), and/or mood changes (p < 0.001). Overall, compared with ALS in isolation, comorbid ALS+CTE is associated with a history of TBI and has a distinct clinical and pathological presentation.	[Walt, Gabriel S.; Burris, Hannah M.; Brady, Christopher B.; Spencer, Keith R.; Alvarez, Victor E.; Huber, Bertrand R.; Guilderson, Latease; Rauf, Nazifa Abdul; Collins, Derek; Singh, Tarnjit; Mathias, Rebecca; McKee, Ann C.; Kowall, Neil W.; Stein, Thor D.] VA Boston Healthcare Syst, Boston, MA USA; [Huber, Bertrand R.] VA Boston Healthcare Syst, Natl Ctr PTSD, Boston, MA USA; [Brady, Christopher B.; Alvarez, Victor E.; Huber, Bertrand R.; Mathias, Rebecca; McKee, Ann C.; Kowall, Neil W.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Brady, Christopher B.] Harvard Med Sch, Brigham & Womens Hosp, Div Aging, Boston, MA USA; [Alvarez, Victor E.; Huber, Bertrand R.; McKee, Ann C.; Kowall, Neil W.; Stein, Thor D.] Boston Univ, Sch Med, Alzheimers Dis & CTE Ctr, Boston, MA 02118 USA; [Alvarez, Victor E.; Huber, Bertrand R.; McKee, Ann C.; Stein, Thor D.] Dept Vet Affairs Med Ctr, Bedford, MA USA; [Averill, James G.; Walker, Sean E.; Robey, Ian] Southern Arizona VA Healthcare Syst, Tucson, AZ USA; [McKee, Ann C.; Stein, Thor D.] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA		Stein, TD (corresponding author), VA Boston Healthcare Syst, Dept Pathol & Lab Med, 150 S Huntington Ave, Boston, MA 02130 USA.	thor.stein@va.gov	Brady, Christopher/U-6532-2019	Brady, Christopher/0000-0002-6095-6480	Department of Veterans Affairs, Veterans Health Administration, Veterans Affairs Biorepository [BX002466]; Clinical Sciences Research and Development Merit Award [I01-CX001038]; National Center for PTSD; National Institute of AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [RF1AG054156, R56AG057768]; National Institute of Aging Boston University AD Center [P30AG13846, 0572063345-5]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG013846, RF1AG054156] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX003063, I01CX001038, I01BX002466] Funding Source: NIH RePORTER	This work was supported by the Department of Veterans Affairs, Veterans Health Administration, Veterans Affairs Biorepository (BX002466); Clinical Sciences Research and Development Merit Award (I01-CX001038); National Center for PTSD; National Institute of Aging (RF1AG054156, R56AG057768); National Institute of Aging Boston University AD Center (P30AG13846; supplement 0572063345-5).	Adams JW, 2018, J NEUROPATH EXP NEUR, V77, P757, DOI 10.1093/jnen/nly065; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Bigio EH, 2008, J NEUROPATH EXP NEUR, V67, P635, DOI 10.1097/NEN.0b013e31817d751c; Blauwendraat C, 2017, NEUROBIOL AGING, V57, DOI 10.1016/j.neurobiolaging.2017.05.009; BRAAK H, 1993, EUR NEUROL, V33, P403, DOI 10.1159/000116984; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2008, NEUROLOGY, V70, P1916, DOI 10.1212/01.wnl.0000312279.49272.9f; Brady CB, 2013, AMYOTROPH LAT SCL FR, V14, P591, DOI 10.3109/21678421.2013.822516; Brettschneider J, 2013, ANN NEUROL, V74, P20, DOI 10.1002/ana.23937; BROWNELL B, 1970, J NEUROL NEUROSUR PS, V33, P338, DOI 10.1136/jnnp.33.3.338; Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; Cedarbaum JM, 1997, J NEUROL SCI, V152, pS1, DOI 10.1016/S0022-510X(97)00237-2; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; Chio A, 2005, BRAIN, V128, P472, DOI 10.1093/brain/awh373; Chio A, 2009, AMYOTROPH LATERAL SC, V10, P310, DOI 10.3109/17482960802566824; Daneshvar DH, 2015, MOL CELL NEUROSCI, V66, P81, DOI 10.1016/j.mcn.2015.03.007; Del Tredici K, 2002, J NEUROPATH EXP NEUR, V61, P413, DOI 10.1093/jnen/61.5.413; Fournier CN, 2015, NEUROLOGY, V84, P1788, DOI 10.1212/WNL.0000000000001522; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Greenfield J.G., 2008, GREENFIELDS NEUROPAT; Kaufmann P, 2007, AMYOTROPH LATERAL SC, V8, P42, DOI 10.1080/17482960600888156; Keene CD, 2018, ACTA NEUROPATHOL, V135, P303, DOI 10.1007/s00401-017-1801-z; Kehyayan V, 2014, CAN J NEUROL SCI, V41, P246, DOI 10.1017/S0317167100016656; Kimura F, 2006, NEUROLOGY, V66, P265, DOI 10.1212/01.wnl.0000194316.91908.8a; Koga S, 2016, J NEUROPATH EXP NEUR, V75, P963, DOI 10.1093/jnen/nlw073; Kollewe K, 2008, J NEUROL SCI, V275, P69, DOI 10.1016/j.jns.2008.07.016; Labra J, 2016, J NEUROL NEUROSUR PS, V87, P628, DOI 10.1136/jnnp-2015-310998; Ling HL, 2015, ACTA NEUROPATHOL, V130, P891, DOI 10.1007/s00401-015-1496-y; Logroscino G, 2010, J NEUROL NEUROSUR PS, V81, P385, DOI 10.1136/jnnp.2009.183525; Mackenzie IRA, 2010, ACTA NEUROPATHOL, V119, P1, DOI 10.1007/s00401-009-0612-2; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McKeith IG, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P417; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; Moszczynski AJ, 2018, NEUROLOGY, V90, pE380, DOI 10.1212/WNL.0000000000004899; Newell KL, 1999, J NEUROPATH EXP NEUR, V58, P1147, DOI 10.1097/00005072-199911000-00004; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Saberi S, 2015, NEUROL CLIN, V33, P855, DOI 10.1016/j.ncl.2015.07.012; Schmidt S, 2010, J NEUROL SCI, V291, P22, DOI 10.1016/j.jns.2010.01.011; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Strong MJ, 2017, AMYOTROPH LAT SCL FR, V18, P153, DOI 10.1080/21678421.2016.1267768; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791; Tiryaki Ezgi, 2014, Continuum (Minneap Minn), V20, P1185, DOI 10.1212/01.CON.0000455886.14298.a4; Weisskopf MG, 2015, EPIDEMIOLOGY, V26, P831, DOI 10.1097/EDE.0000000000000376	51	17	17	0	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-3069	1554-6578		J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	DEC	2018	77	12					1091	1100		10.1093/jnen/nly092			10	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	HI8AA	WOS:000456676400004	30299493	Green Published, hybrid			2022-02-06	
J	Huang, CH; Lin, CW; Lee, YC; Huang, CY; Huang, RY; Tai, YC; Wang, KW; Yang, SN; Sun, YT; Wang, HK				Huang, Chi-Hsien; Lin, Chi-Wei; Lee, Yi-Che; Huang, Chih-Yuan; Huang, Ru-Yi; Tai, Yi-Cheng; Wang, Kuo-Wei; Yang, San-Nan; Sun, Yuan-Ting; Wang, Hao-kuang			Is traumatic brain injury a risk factor for neurodegeneration? A meta-analysis of population-based studies	BMC NEUROLOGY			English	Article						TBI; Dementia; Neurodegeneration; Meta-analysis	HEAD-INJURY; ALZHEIMERS-DISEASE; FRONTOTEMPORAL DEMENTIA; ONSET; EXPOSURE	BackgroundTo determine the association of prior traumatic brain injury (TBI) with subsequent diagnosis of neurodegeneration disease.MethodsAll studies from 1980 to 2016 reporting TBI as a risk factor for diagnoses of interest were identified by searching PubMed, Embase, study references, and review articles. The data and study design were assessed by 2 investigators independently. A meta-analysis was performed by RevMan 5.3.ResultsThere were 18 studies comprising 3,263,207 patients. Meta-analysis revealed a significant association of prior TBI with subsequent dementia. The pooled odds ratio (OR) for TBI on development of dementia, FTD and TDP-43 associated disease were 1.93 (95% CI 1.47-2.55, p<0.001), 4.44 (95% CI 3.86-5.10, p<0.001), and 2.97 (95% CI 1.35-6.53, p<0.001). However, analyses of individual diagnoses found no evidence that the risk of Alzheimer's disease, and Parkinson's disease in individuals with previous TBI compared to those without TBI.ConclusionsHistory of TBI is not associated with the development of subsequent neurodegeneration disease. Care must be taken in extrapolating from these results because no suitable criteria define post TBI neurodegenerative processes. Therefore, further research in this area is needed to confirm these questions and uncover the link between TBI and neurodegeneration disease.	[Huang, Chi-Hsien; Lin, Chi-Wei; Huang, Ru-Yi] I Shou Univ, E Da Hosp, Dept Family Med, Kaohsiung, Taiwan; [Huang, Chi-Hsien; Lin, Chi-Wei; Lee, Yi-Che; Huang, Ru-Yi; Wang, Kuo-Wei; Yang, San-Nan; Wang, Hao-kuang] I Shou Univ, Sch Med Int Students, Kaohsiung, Taiwan; [Lee, Yi-Che] I Shou Univ, E Da Hosp, Dept Nephrol, Kaohsiung, Taiwan; [Huang, Chih-Yuan] Natl Cheng Kung Univ Hosp, Dept Surg, Neurosurg Serv, Tainan, Taiwan; [Tai, Yi-Cheng] I Shou Univ, E Da Hosp, Dept Neurol, Kaohsiung, Taiwan; [Wang, Kuo-Wei; Wang, Hao-kuang] I Shou Univ, E Da Hosp, Dept Neurosurg, 1 Yida Rd, Kaohsiung 82445, Taiwan; [Sun, Yuan-Ting] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Neurol, Tainan, Taiwan		Wang, HK (corresponding author), I Shou Univ, Sch Med Int Students, Kaohsiung, Taiwan.; Wang, HK (corresponding author), I Shou Univ, E Da Hosp, Dept Neurosurg, 1 Yida Rd, Kaohsiung 82445, Taiwan.	ed103520@edah.org.tw; ed101393@gmail.com		Wang, Hao-Kuang/0000-0002-1928-7502	Center for Database Research, E-DA HEALTHCARE GROUP	This study was supported by Center for Database Research, E-DA HEALTHCARE GROUP.	Abner EL, 2014, DEMENT GERIATR COGN, V37, P294, DOI 10.1159/000355478; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Barthelemy EJ, 2016, WORLD NEUROSURG, V88, P411, DOI 10.1016/j.wneu.2015.12.044; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; Daneshvar DH, 2015, MOL CELL NEUROSCI, V66, P81, DOI 10.1016/j.mcn.2015.03.007; Ferrari R, 2011, CURR ALZHEIMER RES, V8, P273, DOI 10.2174/156720511795563700; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; FRATIGLIONI L, 1993, ANN NEUROL, V33, P258, DOI 10.1002/ana.410330306; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Kalkonde YV, 2012, ALZHEIMERS DEMENT, V8, P204, DOI 10.1016/j.jalz.2011.03.011; Launer LJ, 1999, NEUROLOGY, V52, P78, DOI 10.1212/WNL.52.1.78; Lee PC, 2012, NEUROLOGY, V79, P2061, DOI 10.1212/WNL.0b013e3182749f28; Levy G, 2002, MOVEMENT DISORD, V17, P250, DOI 10.1002/mds.10086; Luukinen H, 2008, ACTA NEUROL SCAND, V118, P153, DOI 10.1111/j.1600-0404.2008.00994.x; Luukinen H, 2005, EUR J NEUROL, V12, P86, DOI 10.1111/j.1468-1331.2004.00953.x; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mehta KM, 1999, NEUROLOGY, V53, P1959, DOI 10.1212/WNL.53.9.1959; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Ojo JO, 2016, EXP NEUROL, V275, P389, DOI 10.1016/j.expneurol.2015.06.003; Perrine K, 2017, WORLD NEUROSURG; Perry DC, 2015, J NEUROSURG, P1; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rapoport M, 2008, J NEUROPSYCH CLIN N, V20, P68, DOI 10.1176/jnp.2008.20.1.68; RASMUSSON DX, 1995, BRAIN INJURY, V9, P213, DOI 10.3109/02699059509008194; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Rugbjerg K, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2494; Savica R, 2012, MAYO CLIN PROC, V87, P335, DOI 10.1016/j.mayocp.2011.12.016; Schmidt S, 2010, J NEUROL SCI, V291, P22, DOI 10.1016/j.jns.2010.01.011; Spangenberg S, 2009, PARKINSONISM RELAT D, V15, P12, DOI 10.1016/j.parkreldis.2008.02.004; Sundstrom A, 2007, INT PSYCHOGERIATR, V19, P159, DOI 10.1017/S1041610206003498; Tanner CM, 2014, ALZHEIMERS DEMENT, V10, pS213, DOI 10.1016/j.jalz.2014.04.014; Taylor KM, 2015, PARKINSONISM RELAT D; Turner MR, 2010, J NEUROL SCI, V288, P45, DOI 10.1016/j.jns.2009.10.010; Wang HK, 2015, NEUROSCIENCE, V300, P94, DOI 10.1016/j.neuroscience.2015.05.013; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633; Washington PM, 2016, EXP NEUROL, V275, P381, DOI 10.1016/j.expneurol.2015.06.015; WILLIAMS DB, 1991, NEUROLOGY, V41, P1554, DOI 10.1212/WNL.41.10.1554; Zhang BF, 2015, WORLD NEUROSURG, V83, P567, DOI 10.1016/j.wneu.2014.12.010	42	17	17	1	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2377			BMC NEUROL	BMC Neurol.	NOV 5	2018	18								184	10.1186/s12883-018-1187-0			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GZ3DL	WOS:000449267200001	30396335	gold, Green Published			2022-02-06	
J	Chao, HL; Anthonymuthu, TS; Kenny, EM; Amoscato, AA; Cole, LK; Hatch, GM; Ji, J; Kagan, VE; Bayir, H				Chao, Honglu; Anthonymuthu, Tamil S.; Kenny, Elizabeth M.; Amoscato, Andrew A.; Cole, Laura K.; Hatch, Grant M.; Ji, Jing; Kagan, Valerian E.; Bayir, Hulya			Disentangling oxidation/hydrolysis reactions of brain mitochondrial cardiolipins in pathogenesis of traumatic injury	JCI INSIGHT			English	Article							PHOSPHOLIPASE A(2)GAMMA IPLA(2)GAMMA; BARTH-SYNDROME; CYTOCHROME-C; OXIDATIVE LIPIDOMICS; APOPTOSIS; ROTENONE; A(2); SPECIFICITY; DYSFUNCTION; DAMAGE	Mechanical injury to the brain triggers multiple biochemical events whose specific contributions to the pathogenesis define clinical manifestations and the overall outcome. Among many factors, mitochondrial injury has recently attracted much attention due to the importance of the organelle for bioenergetics as well as intra- and extracellular signaling and cell death. Assuming the essentiality of a mitochondria-unique phospholipid, cardiolipin (CL), for the structural and functional organization of mitochondria, here we applied global (phospho) lipidomics and redox lipidomics to reveal and identify CL modifications during controlled cortical impact (CCI). We revealed 2 major pathways activated in the CCI-injured brain as time-specific responses: early accumulation of oxidized CL (CLox) products was followed by hydrolytic reactions yielding monolyso-CLs (mCLs) and free fatty acids. To quantitatively assess possible specific roles of peroxidation and hydrolysis of mitochondrial CL, we performed comparative studies of CL modifications using an animal model of Barth syndrome where deficiency of CL reacylation (Tafazzin [Taz] deficiency) was associated exclusively with the accumulation of mCLs (but not CLox). By comparing the in vitro and in vivo results with genetic manipulation of major CL-, CLox-, and mCL-metabolizing enzymes, calcium-independent phospholipase A(2)gamma and Taz, we concluded that the 2 processes - CL oxidation and CL hydrolysis - act as mutually synergistically enhancing components of the pathogenic mechanism of mitochondrial injury in traumatic brain injury. This emphasizes the need for combined therapeutic approaches preventing the formation of both CLox and mCL.	[Chao, Honglu; Anthonymuthu, Tamil S.; Kenny, Elizabeth M.; Ji, Jing; Bayir, Hulya] Univ Pittsburgh, Childrens Hosp Pittsburgh, Safar Ctr Resuscitat Res, Med Ctr, Pittsburgh, PA 15213 USA; [Chao, Honglu; Anthonymuthu, Tamil S.; Kenny, Elizabeth M.; Ji, Jing; Bayir, Hulya] Univ Pittsburgh, Childrens Hosp Pittsburgh, Neurosci Inst, Med Ctr, Pittsburgh, PA 15213 USA; [Chao, Honglu; Anthonymuthu, Tamil S.; Kenny, Elizabeth M.; Ji, Jing; Bayir, Hulya] Univ Pittsburgh, Med Ctr, Dept Crit Care Med, Pittsburgh, PA USA; [Chao, Honglu; Ji, Jing] Nanjing Med Univ, Dept Neurosurg, Affiliated Hosp 1, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China; [Amoscato, Andrew A.; Kagan, Valerian E.] Univ Pittsburgh, Ctr Free Rad & Antioxidant Hlth, Dept Environm & Occupat Hlth, Pittsburgh, PA USA; [Cole, Laura K.; Hatch, Grant M.; Bayir, Hulya] Univ Manitoba, Childrens Hosp, Fac Hlth Sci, Dept Pharmacol & Therapeut,Res Inst Manitoba, Winnipeg, MB, Canada; [Kagan, Valerian E.] IM Sechenov Moscow State Med Univ, Inst Regenerat Med, Lab Nav Redox Lipid, Moscow, Russia		Ji, J (corresponding author), Nanjing Med Univ, Dept Neurosurg, Affiliated Hosp 1, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China.; Kagan, VE (corresponding author), Dept Environm & Occupat Hlth, Publ Hlth Bldg,130 De Soto St, Pittsburgh, PA 15261 USA.; Bayir, H (corresponding author), Univ Pittsburgh, Dept Crit Care Med, John G Rangos Res Ctr, 6th Floor,4401 Penn Ave, Pittsburgh, PA 15224 USA.	jijing@njmu.edu.cn; kagan@pitt.edu; bayihx@ccm.upmc.edu	Anthonymuthu, Tamil/I-5534-2019	Kagan, Valerian E./0000-0002-7245-1885	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HL114453, AI068021, NS076511, NS061817, NS084604, CA165065]; Human Frontier Science ProgramHuman Frontier Science Program [HFSP-RGP0013/2014]; Heart and Stroke Foundation of CanadaHeart & Stroke Foundation of Canada; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471269]; Jiangsu Province's Natural Science FoundationNatural Science Foundation of Jiangsu Province [BK20160047]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Barth Syndrome Foundation Canada/USA; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA165065] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [P01HL114453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [U19AI068021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS076511, R01NS061817, R01NS084604] Funding Source: NIH RePORTER	We thank Henry Alexander and Jessie Lewis for technical support in the CCI experiments. This work was supported by the NIH (HL114453, AI068021, NS076511, NS061817, NS084604, and CA165065), Human Frontier Science Program (HFSP-RGP0013/2014), Heart and Stroke Foundation of Canada, Barth Syndrome Foundation Canada/USA, National Natural Science Foundation of China (81471269), Jiangsu Province's Natural Science Foundation (BK20160047), and Jiangsu Province and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). GMH is the Canada Research Chair in Molecular Cardiolipin Metabolism.	Acehan D, 2011, J BIOL CHEM, V286, P899, DOI 10.1074/jbc.M110.171439; Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; ADES LC, 1993, AM J MED GENET, V45, P327, DOI 10.1002/ajmg.1320450309; Aprikyan AA, 2013, BRIT J HAEMATOL, V161, P330, DOI 10.1111/bjh.12271; Balasubramanian K, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa6179; Bayir H, 2007, ANN NEUROL, V62, P154, DOI 10.1002/ana.21168; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Buland JR, 2016, AM J PHYSIOL-LUNG C, V311, pL303, DOI 10.1152/ajplung.00038.2016; Chakraborty K, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13944; Chen M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177171; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006; CHRISTODOULOU J, 1994, AM J MED GENET, V50, P255, DOI 10.1002/ajmg.1320500309; Chu CT, 2013, NAT CELL BIOL, V15, P1197, DOI 10.1038/ncb2837; Claypool SM, 2012, TRENDS BIOCHEM SCI, V37, P32, DOI 10.1016/j.tibs.2011.09.003; Claypool SM, 2011, J CELL BIOL, V192, P447, DOI 10.1083/jcb.201008177; Crimi M, 2011, BBA-MOL CELL RES, V1813, P551, DOI 10.1016/j.bbamcr.2010.09.014; Esposti MD, 2003, CELL DEATH DIFFER, V10, P1300, DOI 10.1038/sj.cdd.4401306; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Girgis F, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00008; Houtkooper RH, 2009, BBA-BIOMEMBRANES, V1788, P2003, DOI 10.1016/j.bbamem.2009.07.009; Ji J, 2015, J CEREBR BLOOD F MET, V35, P319, DOI 10.1038/jcbfm.2014.204; Ji J, 2012, NAT NEUROSCI, V15, P1407, DOI 10.1038/nn.3195; Ji J, 2012, J NEUROTRAUM, V29, P776, DOI 10.1089/neu.2010.1602; Kagan VE, 2015, ANTIOXID REDOX SIGN, V22, P1667, DOI 10.1089/ars.2014.6219; Kagan VE, 2014, CHEM PHYS LIPIDS, V179, P64, DOI 10.1016/j.chemphyslip.2013.11.010; Kagan VE, 2009, ADV DRUG DELIVER REV, V61, P1375, DOI 10.1016/j.addr.2009.06.008; Kagan VE, 2009, FREE RADICAL BIO MED, V46, P1439, DOI 10.1016/j.freeradbiomed.2009.03.004; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kagan VE, 2004, FREE RADICAL BIO MED, V37, P1963, DOI 10.1016/j.freeradbiomed.2004.08.016; Kiebish MA, 2013, J LIPID RES, V54, P1312, DOI 10.1194/jlr.M034728; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Liu NK, 2014, ANN NEUROL, V75, P644, DOI 10.1002/ana.24134; Lu YW, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00003; Mancuso DJ, 2003, J BIOL CHEM, V278, P22231, DOI 10.1074/jbc.C300033200; Moon SH, 2012, J BIOL CHEM, V287, P29837, DOI 10.1074/jbc.M112.373654; Moon SH, 2012, J BIOL CHEM, V287, P14880, DOI 10.1074/jbc.M111.336776; Moon Y, 2005, J NEUROCHEM, V93, P1199, DOI 10.1111/j.1471-4159.2005.03112.x; Murakami M, 2005, J BIOL CHEM, V280, P14028, DOI 10.1074/jbc.M413766200; O'Neill LAJ, 2013, CELL METAB, V18, P610, DOI 10.1016/j.cmet.2013.10.013; Osier N, 2016, METHODS MOL BIOL, V1462, P177, DOI 10.1007/978-1-4939-3816-2_11; Paradies G, 2014, BBA-BIOENERGETICS, V1837, P408, DOI 10.1016/j.bbabio.2013.10.006; Ren MD, 2014, PROG LIPID RES, V55, P1, DOI 10.1016/j.plipres.2014.04.001; Saric A, 2016, FRONT GENET, V6, DOI 10.3389/fgene.2015.00359; Schlame M, 2006, FEBS LETT, V580, P5450, DOI 10.1016/j.febslet.2006.07.022; Schlame M, 2017, J BIOL CHEM, V292, P5499, DOI 10.1074/jbc.M116.769182; Schlame M, 2012, NAT CHEM BIOL, V8, P862, DOI 10.1038/NCHEMBIO.1064; Schlame M, 2009, BBA-BIOMEMBRANES, V1788, P2080, DOI 10.1016/j.bbamem.2009.04.019; Schlattner U, 2014, CHEM PHYS LIPIDS, V179, P32, DOI 10.1016/j.chemphyslip.2013.12.008; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schug ZT, 2009, BBA-BIOMEMBRANES, V1788, P2022, DOI 10.1016/j.bbamem.2009.05.004; Sedlak E, 1999, BIOCHEMISTRY-US, V38, P14966, DOI 10.1021/bi9914053; Shellington DK, 2011, CRIT CARE MED, V39, P494, DOI 10.1097/CCM.0b013e318206b1fa; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Sparvero LJ, 2016, J NEUROCHEM, V139, P659, DOI 10.1111/jnc.13840; Taylor WA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048628; Taylor WA, 2009, J BIOL CHEM, V284, P30360, DOI 10.1074/jbc.M109.048322; Testa CM, 2005, MOL BRAIN RES, V134, P109, DOI 10.1016/j.molbrainres.2004.11.007; Tyurin VA, 2012, BIOCHEMISTRY-US, V51, P9736, DOI 10.1021/bi301024e; Tyurina YY, 2017, ACS CHEM BIOL, V12, P265, DOI 10.1021/acschembio.6b00995; Tyurina YY, 2014, NAT CHEM, V6, P542, DOI [10.1038/nchem.1924, 10.1038/NCHEM.1924]; Tyurina YY, 2014, CHEM PHYS LIPIDS, V179, P3, DOI 10.1016/j.chemphyslip.2013.12.003; Tyurina YY, 2013, MOL NUTR FOOD RES, V57, P1410, DOI 10.1002/mnfr.201200801; Wang LY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132638; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Xu Y, 2003, J BIOL CHEM, V278, P51380, DOI 10.1074/jbc.M307382200; Xu Y, 2006, J BIOL CHEM, V281, P39217, DOI 10.1074/jbc.M606100200; Ye CQ, 2016, J BIOENERG BIOMEMBR, V48, P113, DOI 10.1007/s10863-014-9591-7	70	17	17	0	4	AMER SOC CLINICAL INVESTIGATION INC	ANN ARBOR	2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA	2379-3708			JCI INSIGHT	JCI Insight	NOV 2	2018	3	21							e97677	10.1172/jci.insight.97677			15	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	GZ2OG	WOS:000449225900022	30385716	Green Published, gold			2022-02-06	
J	Dijkers, MP; Marwitz, JH; Harrison-Felix, C				Dijkers, Marcel P.; Marwitz, Jennifer H.; Harrison-Felix, Cynthia			Thirty Years of National Institute on Disability, Independent Living, and Rehabilitation Research Traumatic Brain Injury Model Systems Center ResearchAn Update	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injuries; delivery of healthcare; history of medicine; integrated healthcare delivery; rehabilitation; translational medical research; traumatic brain injuries; US government research support	INPATIENT REHABILITATION; LIFE EXPECTANCY; TBI; VETERANS; OUTCOMES; SERVICE; HEALTH; VA; REPRESENTATIVENESS; REHOSPITALIZATION	The Traumatic Brain Injury Model Systems Center (TBIMSC) program was established by the National Institute on Disability, Independent Living, and Rehabilitation Research in 1987, with the goal of conducting research to improve the care and outcomes for individuals with moderate-to-severe traumatic brain injury (TBI). This article provides an update on TBIMSC research program activities since 2010 when a similar article was published. It includes (1) discussion of TBIMSC program management and infrastructure; (2) detail on the management, data quality, access, use, and knowledge translation of the TBIMSC National Database, with more than 16 000 participants with follow-up out to 25 years postinjury to date; (3) an overview of the TBIMSC site-specific studies and collaborative module research; (4) highlights of several collaborative initiatives between the TBIMSCs and other federal, advocacy, and research stakeholders; (5) an overview of the vast knowledge translation occurring through the TBIMSC program; and (6) discussion of issues that impact on the data collection methods for and contents of the TBIMSC National Database. On the occasion of the 30th anniversary of the TBIMSC program, this article highlights many of the accomplishments of this well-established, multicenter TBI research consortium.	[Dijkers, Marcel P.] Icahn Sch Med Mt Sinai, Dept Rehabil Med, One Gustave P Levy Pl, New York, NY 10029 USA; [Marwitz, Jennifer H.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23284 USA; [Harrison-Felix, Cynthia] Craig Hosp, Res Dept, Englewood, CO USA; [Harrison-Felix, Cynthia] Univ Colorado, Dept Phys Med & Rehabil, Denver, CO 80202 USA		Dijkers, MP (corresponding author), Icahn Sch Med Mt Sinai, Dept Rehabil Med, One Gustave P Levy Pl, New York, NY 10029 USA.	marcel.dijkers@mssm.edu			National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90DPTB0005, 90DPTB0007, 90DPTB0009, 90DP0084]	The contents of this publication were developed under grants from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) (grant numbers 90DPTB0005, 90DPTB0007, 90DPTB0009, and 90DP0084). NIDILRR is part of the Administration for Community Living (ACL), US Department of Health and Human Services (HHS). The contents of this publication do not necessarily represent the policies of NIDILRR, ACL, or HHS, and you should not assume endorsement by the Federal Government. The authors acknowledge Cindy Cai, PhD, Cate Miller, PhD, and Risa Nakase-Richardson, PhD, who provided some of the information presented here, and Flora Hammond, MD, and DrMiller, who critically reviewed a draft version.	Bogner JA, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000291; Centers for Disease Control and Prevention, MOD SEV TRAUM BRAIN; Corrigan JA, 2008, ARCH PHYS MED REHAB, V89, P912, DOI 10.1016/j.apmr.2007.12.027; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Corrigan JD, 2012, ARCH PHYS MED REHAB, V93, P1350, DOI 10.1016/j.apmr.2012.04.028; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P160, DOI 10.1097/HTR.0000000000000090; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P122, DOI 10.1097/HTR.0000000000000012; Cuthbert JP, 2012, J HEAD TRAUMA REHAB, V27, pE15, DOI 10.1097/HTR.0b013e31826da983; Dams-O'Connor K, 2017, J HEAD TRAUMA REHAB, V32, P147, DOI 10.1097/HTR.0000000000000263; Dams-O'Connor K, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000073; Department of Defense Department of Veterans Affairs Department of Health and Human Services & Department of Education, 2013, NAT RES ACT PLAN; Dijkers MP, 2010, J HEAD TRAUMA REHAB, V25, P81, DOI 10.1097/HTR.0b013e3181cd3528; Dillahunt-Aspillaga C, 2017, J HEAD TRAUMA REHAB, V32, P271, DOI 10.1097/HTR.0000000000000275; Dreer LE, 2018, CURR OPIN PSYCHOL, V22, P73, DOI 10.1016/j.copsyc.2017.08.030; Farrell-Carnahan L, 2015, BRAIN INJURY, V29, P1400, DOI 10.3109/02699052.2015.1063161; Federal Interagency Traumatic Brain Injury Research (FITBIR), FED INT TRAUM BRAIN; Harrison-Felix C, 2015, J NEUROTRAUM, V32, P1893, DOI 10.1089/neu.2014.3353; Harrison-Felix C, 2012, J HEAD TRAUMA REHAB, V27, pE69, DOI 10.1097/HTR.0b013e3182738010; Hart T, 2010, J HEAD TRAUMA REHAB, V25, P339, DOI 10.1097/HTR.0b013e3181c7e60b; Hicks R, 2013, J NEUROTRAUM, V30, P1852, DOI 10.1089/neu.2013.2938; Kesinger MR, 2016, ARCH PHYS MED REHAB, V97, P1301, DOI 10.1016/j.apmr.2016.02.017; Kesinger MR, 2017, AM J PHYS MED REHAB, V96, P17, DOI 10.1097/PHM.0000000000000513; Kowalski RG, 2017, STROKE, V48, P1802, DOI 10.1161/STROKEAHA.117.017327; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Lamberty GJ, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829a64d1; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McAllister Thomas W, 2015, Handb Clin Neurol, V128, P723, DOI 10.1016/B978-0-444-63521-1.00045-5; McGarity S, 2017, J HEAD TRAUMA REHAB, V32, P34, DOI 10.1097/HTR.0000000000000242; Model Systems Knowledge Translation Center, LIV TRAUM BRAIN INJ; Nakase-Richardson R, 2017, J HEAD TRAUMA REHAB, V32, P221, DOI 10.1097/HTR.0000000000000334; National Institute of Neurological Disorders and Stroke, TRAUM BRAIN INJ STAN; Obama B., 2012, EXECUTIVE ORDER IMPR; Ritter AC, 2016, EPILEPSIA, V57, P1503, DOI 10.1111/epi.13470; Stevens LF, 2017, J HEAD TRAUMA REHAB, V32, P234, DOI 10.1097/HTR.0000000000000324; Thomas JP, 1988, J HEAD TRAUMA REHAB, V3, P1; Tran J, 2017, J HEAD TRAUMA REHAB, V32, P264, DOI 10.1097/HTR.0000000000000296; Traumatic Brain Injury National Data and Statistical Center, TRAUM BRAIN INJ MOD; Traumatic Brain Injury National Data and Statistical Center, NAT DAT STAT CTR TRA; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Whiteneck G. G., ONE 5 YEAR OUTCOMES; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1855, DOI 10.1016/j.apmr.2012.10.041	44	17	17	1	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2018	33	6					363	374		10.1097/HTR.0000000000000454			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HB2QK	WOS:000450886600011	30395041	Bronze, Green Accepted			2022-02-06	
J	Hogberg, U; Andersson, J; Squier, W; Hogberg, G; Fellman, V; Thiblin, I; Wester, K				Hogberg, Ulf; Andersson, Jacob; Squier, Waney; Hogberg, Goren; Fellman, Vineta; Thiblin, Ingemar; Wester, Knut			Epidemiology of subdural haemorrhage during infancy: A population-based register study	PLOS ONE			English	Article							BENIGN EXTERNAL HYDROCEPHALUS; TRAUMATIC BRAIN-INJURY; INTRACRANIAL HEMORRHAGE; SUBARACHNOID SPACES; FLUID COLLECTION; YOUNG-CHILDREN; HEMATOMA; ENLARGEMENT; COMPLICATIONS; PREVALENCE	Objectives To analyse subdural haemorrhage (SDH) during infancy in Sweden by incidence, SDH category, diagnostic distribution, age, co-morbidity, mortality, and maternal and perinatal risk factors; and its association with accidents and diagnosis of abuse. Methods A Swedish population-based register study comprising infants born between 1997 and 2014, 0-1 years of age, diagnosed with SDH-diagnoses according to the (International Classification of Diseases, 10th version (ICD10), retrieved from the National Patient Register and linked to the Medical Birth Register and the Death Cause Register. Outcome measures were: 1) Incidence and distribution, 2) co-morbidity, 3) fall accidents by SDH category, 4) risk factors for all SDHs in the two age groups, 0-6 and 7-365 days, and for ICD10 SDH subgroups: S06.5 (traumatic SDH), I62.0 (acute nontraumatic), SDH and abuse diagnosis. Results Incidence of SDH was 16.5 per 100 000 infants (n = 306). Median age was 2.5 months. For infants older than one week, the median age was 3.5 months. Case fatality was 6.5%. Male sex was overrepresented for all SDH subgroups. Accidental falls were reported in 1/3 of the cases. One-fourth occurred within 0-6 days, having a perinatal risk profile. For infants aged 7-365 days, acute nontraumatic SDH was associated with multiple birth, preterm birth, and small-for-gestational age. Fourteen percent also had an abuse diagnosis, having increased odds of being born preterm, and being small-for-gestational age. Conclusions The incidence was in the range previously reported. SDH among newborns was associated with difficult birth and neonatal morbidity. Acute nontraumatic SDH and SDH with abuse diagnosis had similar perinatal risk profiles. The increased odds for acute nontraumatic SDH in twins, preterm births, neonatal convulsions or small-for-gestational age indicate a perinatal vulnerability for SDH beyond 1st week of life. The association between prematurity/small-for-gestational age and abuse diagnosis is intriguing and not easily understood.	[Hogberg, Ulf] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Andersson, Jacob; Thiblin, Ingemar] Uppsala Univ, Dept Surg Sci, Forens Med, Uppsala, Sweden; [Squier, Waney] Univ Oxford, John Radcliffe Hosp, Dept Neuropathol, Oxford, England; [Hogberg, Goren] Karolinska Inst, Child & Adolescent Psychiat Unit, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Fellman, Vineta] Lund Univ, Dept Clin Sci, Pediat, Lund, Sweden; [Fellman, Vineta] Univ Helsinki, Childrens Hosp, Helsinki, Finland; [Fellman, Vineta] Folkhalsan Res Ctr, Helsinki, Finland; [Wester, Knut] Univ Bergen, Dept Clin Med, Bergen, Norway; [Wester, Knut] Haukeland Hosp, Dept Neurosurg, Bergen, Norway		Hogberg, U (corresponding author), Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden.	ulf.hogberg@kbh.uu.se		Wester, Knut/0000-0001-8489-3931; Hogberg, Ulf/0000-0002-2121-7511; Andersson, Jacob/0000-0001-8266-1926			Arbogast KB, 2005, PEDIATRICS, V116, P180, DOI 10.1542/peds.2004-2671; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; Coats B, 2008, J NEUROSURG-PEDIATR, V2, P321, DOI 10.3171/PED.2008.2.11.321; Dlamini N, 2010, NEUROSURG CLIN N AM, V21, P511, DOI 10.1016/j.nec.2010.03.006; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Elinder G, 2018, ACTA PAEDIATR, V107, P3, DOI 10.1111/apa.14473; Gabaeff SC, 2013, LEGAL MED-TOKYO, V15, P177, DOI 10.1016/j.legalmed.2012.12.003; Ghosh PS, 2011, CLIN PEDIATR, V50, P897, DOI 10.1177/0009922811406435; Gilbert R, 2012, LANCET, V379, P758, DOI 10.1016/S0140-6736(11)61087-8; Gout A, 1997, ARCH PEDIATRIE, V4, P983, DOI 10.1016/S0929-693X(97)86096-4; GUTHKELCH AN, 1953, BMJ-BRIT MED J, V1, P233, DOI 10.1136/bmj.1.4804.233; Hellbusch LC, 2007, J NEUROSURG, V107, P119, DOI 10.3171/PED-07/08/119; Hobbs C, 2005, ARCH DIS CHILD, V90, P952, DOI 10.1136/adc.2003.037739; Hogberg U, 2018, EUR J PUBLIC HEALTH, V28, P641, DOI 10.1093/eurpub/cky062; Ingraham FD, 1944, J PEDIATR-US, V24, P1, DOI 10.1016/S0022-3476(44)80138-X; Jayawant S, 1998, BMJ-BRIT MED J, V317, P1558, DOI 10.1136/bmj.317.7172.1558; KAPILA A, 1982, RADIOLOGY, V142, P669, DOI 10.1148/radiology.142.3.6977789; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kelly P, 2014, PEDIATRICS, V134, pE773, DOI 10.1542/peds.2013-3903; Larionov SN, 2008, CHILD NERV SYST, V24, P437, DOI 10.1007/s00381-007-0496-1; Lee HC, 2018, CHILD NERV SYST, V34, P235, DOI 10.1007/s00381-017-3583-y; Looney CB, 2007, RADIOLOGY, V242, P535, DOI 10.1148/radiol.2422060133; Lorente-Pozo S, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00063; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; McNeely PD, 2006, AM J NEURORADIOL, V27, P1725; Medina LS, 2001, AM J NEURORADIOL, V22, P564; Miller D, 2015, AM J FOREN MED PATH, V36, P111, DOI 10.1097/PAF.0000000000000152; Miller R, 2010, AM J FOREN MED PATH, V31, P165, DOI 10.1097/PAF.0b013e3181d96a8e; Minkowitz B, 2017, J PEDIATR ORTHOPED, V37, P23, DOI 10.1097/BPO.0000000000000587; Minns RA, 2005, ARCH DIS CHILD, V90, P883, DOI 10.1136/adc.2004.060657; MORI K, 1993, CHILD NERV SYST, V9, P282, DOI 10.1007/BF00306274; Myhre MC, 2007, ACTA PAEDIATR, V96, P1159, DOI 10.1111/j.1651-2227.2007.00356.x; PARENT AD, 1992, PEDIATR NEUROSURG, V18, P266, DOI 10.1159/000120674; Piatt J H Jr, 1999, Neurosurg Focus, V7, pe4; Ravid S, 2003, PEDIATR NEUROL, V28, P139, DOI 10.1016/S0887-8994(02)00500-3; Rooks VJ, 2008, AM J NEURORADIOL, V29, P1082, DOI 10.3174/ajnr.A1004; Scheimberg I, 2013, PEDIATR DEVEL PATHOL, V16, P149, DOI 10.2350/12-08-1232-OA.1; Squier W, 2016, DEV MED CHILD NEUROL, V58, P1223, DOI 10.1111/dmcn.13202; Squier W, 2009, FORENSIC SCI INT, V187, P6, DOI 10.1016/j.forsciint.2009.02.005; Swedish National Board of Health and Welfare, 2016, HLTH REG STOCKH; Swedish National Board of Health and Welfare, 2016, SWED PAT REG; Swedish National Board of Health and Welfare, 2003, RES REP EPC, P112; Tavani F, 2003, NEURORADIOLOGY, V45, P253, DOI 10.1007/s00234-003-0946-8; TILL K, 1968, BRIT MED J, V3, P400, DOI 10.1136/bmj.3.5615.400; Torres-Cuevas I, 2017, REDOX BIOL, V12, P674, DOI 10.1016/j.redox.2017.03.011; Tucker J, 2016, J NEUROSURG-PEDIATR, V18, P16, DOI 10.3171/2015.12.PEDS15600; Vinchon M, 2010, CHILD NERV SYST, V26, P1195, DOI 10.1007/s00381-010-1105-2; Wiig US, 2017, PEDIATR NEUROL, V73, P36, DOI 10.1016/j.pediatrneurol.2017.04.018; Wittschieber D, 2015, AM J NEURORADIOL, V36, P432, DOI 10.3174/ajnr.A3989; World Health Organization, 1992, INT CLASS DIS; Zahl SM, 2011, NEUROSURG REV, V34, P417, DOI 10.1007/s10143-011-0327-4	52	17	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0206340	10.1371/journal.pone.0206340			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GY7VH	WOS:000448823700102	30379890	Green Published, gold, Green Submitted			2022-02-06	
J	Arevalo-Martin, A; Grassner, L; Garcia-Ovejero, D; Paniagua-Tonja, B; Barroso-Garcia, G; Arandilla, AG; Mach, O; Turrero, A; Vargas, E; Alcobendas, M; Rosell, C; Alcaraz, MA; Ceruelo, S; Casado, R; Talavera, F; Palazon, R; Sanchez-Blanco, N; Maier, D; Esclarin, A; Molina-Holgado, E				Arevalo-Martin, Angel; Grassner, Lukas; Garcia-Ovejero, Daniel; Paniagua-Tonja, Beatriz; Barroso-Garcia, Gemma; Arandilla, Alba G.; Mach, Orpheus; Turrero, Angela; Vargas, Eduardo; Alcobendas, Monica; Rosell, Carmen; Alcaraz, Maria A.; Ceruelo, Silvia; Casado, Rosa; Talavera, Francisco; Palazon, Ramiro; Sanchez-Blanco, Nuria; Maier, Doris; Esclarin, Ana; Molina-Holgado, Eduardo			Elevated Autoantibodies in Subacute Human Spinal Cord Injury Are Naturally Occurring Antibodies	FRONTIERS IN IMMUNOLOGY			English	Article						spinal cord injury; neurotrauma; natural autoantibodies; proteomics; autoimmunity	INTRAVENOUS IMMUNOGLOBULIN; PROTEIN; ANTIGENS; AUTOIMMUNITY; REPERTOIRE; AUTOREACTIVITY; CYCLOPHILIN; CYTOSCAPE; MORTALITY; CYTOKINES	Spinal cord injury (SCI) results in long-term neurological and systemic consequences, including antibody-mediated autoimmunity, which has been related to impaired functional recovery. Here we show that autoantibodies that increase at the subacute phase of human SCI, 1 month after lesion, are already present in healthy subjects and directed against non-native proteins rarely present in the normal spinal cord. The increase of these autoantibodies is a fast phenomenon-their levels are already elevated before 5 days after lesion-characteristic of secondary immune responses, further supporting their origin as natural antibodies. By proteomics studies we have identified that the increased autoantibodies are directed against 16 different nervous system and systemic self-antigens related to changes known to occur after SCI, including alterations in neural cell cytoskeleton, metabolism and bone remodeling. Overall, in the context of previous studies, our results offer an explanation to why autoimmunity develops after SCI and identify novel targets involved in SCI pathology that warrant further investigation.	[Arevalo-Martin, Angel; Garcia-Ovejero, Daniel; Paniagua-Tonja, Beatriz; Turrero, Angela; Molina-Holgado, Eduardo] SESCAM, Hosp Nacl Paraplej, Lab Neuroinflammat, Toledo, Spain; [Grassner, Lukas; Mach, Orpheus; Maier, Doris] Trauma Ctr, Ctr Spinal Cord Injuries, Murnau, Germany; [Grassner, Lukas] Trauma Ctr, Dept Neurosurg, Murnau, Germany; [Grassner, Lukas] Paracelsus Med Univ, Inst Mol Regenerat Med, Spinal Cord Injury & Tissue Regenerat Ctr Salzbur, Salzburg, Austria; [Barroso-Garcia, Gemma; Arandilla, Alba G.] SESCAM, Hosp Nacl Paraplej, Prote Core Facil, Toledo, Spain; [Vargas, Eduardo; Alcobendas, Monica; Alcaraz, Maria A.; Ceruelo, Silvia; Casado, Rosa; Talavera, Francisco; Palazon, Ramiro; Esclarin, Ana] SESCAM, Hosp Nacl Paraplej, Dept Phys Rehabil, Toledo, Spain; [Rosell, Carmen] SESCAM, Hosp Nacl Paraplej, Dept Occupat Hlth, Toledo, Spain; [Sanchez-Blanco, Nuria] SESCAM, Hosp Nacl Paraplej, Intens Care Unit, Toledo, Spain		Arevalo-Martin, A (corresponding author), SESCAM, Hosp Nacl Paraplej, Lab Neuroinflammat, Toledo, Spain.	aarevalom@sescam.jccm.es	Palazon-Garcia, Ramiro/ABG-1590-2020; Molina-Holgado, Eduardo/C-2714-2008; Talavera-Diaz, Francisco/Z-5217-2019; Arevalo-Martin, Angel/A-5376-2011; Garcia-Ovejero, Daniel/H-9090-2019	Palazon-Garcia, Ramiro/0000-0001-5668-3822; Molina-Holgado, Eduardo/0000-0001-6693-1682; Garcia-Ovejero, Daniel/0000-0002-7479-5104; Arevalo-Martin, Angel/0000-0002-0549-6098; Barroso Garcia, Gemma/0000-0003-3200-8659	Fundacion Mutua Madrilena in 2014 Call for Proposals	This study was funded by Fundacion Mutua Madrilena in 2014 Call for Proposals.	Abu-Shakra M, 2007, ISRAEL MED ASSOC J, V9, P748; Aito S, 2007, SPINAL CORD, V45, P292, DOI 10.1038/sj.sc.3101944; Ankeny DP, 2006, J NEUROCHEM, V99, P1073, DOI 10.1111/j.1471-4159.2006.04147.x; Ankeny DP, 2009, J CLIN INVEST, V119, P2990, DOI 10.1172/JCI39780; Moro-Garcia MA, 2012, AGE, V34, P479, DOI 10.1007/s11357-011-9240-6; Appel R.D., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571, DOI 10.1385/1592598900]; Arevalo-Martin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049057; Avrameas S, 2007, J AUTOIMMUN, V29, P213, DOI 10.1016/j.jaut.2007.07.010; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Benjamini Y, 2001, ANN STAT, V29, P1165; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; BJELLQVIST B, 1993, ELECTROPHORESIS, V14, P1023, DOI 10.1002/elps.11501401163; Bracchi-Ricard V, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0574-y; Brennan FH, 2016, ANN CLIN TRANSL NEUR, V3, P495, DOI 10.1002/acn3.318; Brommer B, 2016, BRAIN, V139, P692, DOI 10.1093/brain/awv375; Chou MY, 2009, J CLIN INVEST, V119, P1335, DOI 10.1172/JCI36800; COHEN IR, 1986, IMMUNOL TODAY, V7, P363, DOI 10.1016/0167-5699(86)90026-5; Cohen IR, 2007, J AUTOIMMUN, V29, P246, DOI 10.1016/j.jaut.2007.07.016; Dahm L, 2014, ANN NEUROL, V76, P82, DOI 10.1002/ana.24189; Davies AL, 2007, ARCH PHYS MED REHAB, V88, P1384, DOI 10.1016/j.apmr.2007.08.004; DIGHIERO G, 1986, ANN NY ACAD SCI, V475, P135, DOI 10.1111/j.1749-6632.1986.tb20863.x; Fiskesund R, 2010, STROKE, V41, P607, DOI 10.1161/STROKEAHA.109.558742; Hadrup SR, 2006, J IMMUNOL, V176, P2645, DOI 10.4049/jimmunol.176.4.2645; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; Hayes KC, 2002, J NEUROTRAUM, V19, P753, DOI 10.1089/08977150260139129; Held KS, 2010, EXP NEUROL, V226, P242, DOI 10.1016/j.expneurol.2010.08.036; Hergenroeder GW, 2018, J NEUROTRAUM, V35, P2530, DOI 10.1089/neu.2018.5675; Hergenroeder GW, 2016, NEUROREPORT, V27, P90, DOI 10.1097/WNR.0000000000000502; Hong CW, 2014, FEBS LETT, V588, P350, DOI 10.1016/j.febslet.2013.10.025; Ibarra A, 2000, NEUROSCIENCE, V96, P3, DOI 10.1016/S0306-4522(99)00541-2; Kaveri SV, 2012, AUTOIMMUN REV, V11, P792, DOI 10.1016/j.autrev.2012.02.006; Keyes LR, 2012, J GEN VIROL, V93, P722, DOI 10.1099/vir.0.037309-0; Kidd JG, 1942, J EXP MED, V76, P557, DOI 10.1084/jem.76.6.557; Levin EC, 2010, BRAIN RES, V1345, P221, DOI 10.1016/j.brainres.2010.05.038; Lucin KM, 2007, EXP NEUROL, V207, P75, DOI 10.1016/j.expneurol.2007.05.019; Lutz HU, 2007, J AUTOIMMUN, V29, P287, DOI 10.1016/j.jaut.2007.07.007; Madi A, 2009, P NATL ACAD SCI USA, V106, P14484, DOI 10.1073/pnas.0901528106; Merbl Y, 2007, J CLIN INVEST, V117, P712, DOI 10.1172/JCI29943; MIZRACHI Y, 1983, PARAPLEGIA, V21, P287, DOI 10.1038/sc.1983.48; Monroe MB, 1998, AM J CLIN NUTR, V68, P1223, DOI 10.1093/ajcn/68.6.1223; MOUTHON L, 1995, J IMMUNOL, V154, P5769; Nagele EP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060726; Narang A, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0894-6; Nataf S, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00582; Oropallo MA, 2012, J IMMUNOL, V188, P5257, DOI 10.4049/jimmunol.1101934; Palmers I, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0713-5; Pavlicek D, 2017, IMMUN AGEING, V14, DOI 10.1186/s12979-017-0103-6; Poletaev AB, 2000, AUTOIMMUNITY, V32, P33, DOI 10.3109/08916930008995985; Quintana FJ, 2006, LUPUS, V15, P428, DOI 10.1191/0961203306lu2328oa; Quintana FJ, 2006, J NEUROIMMUNOL, V174, P1, DOI 10.1016/j.jneuroim.2006.02.003; R Core Team, 2017, R LANG ENV STAT COMP; Riegger T, 2009, NEUROSCIENCE, V158, P1194, DOI 10.1016/j.neuroscience.2008.08.021; Riegger T, 2007, EUR J NEUROSCI, V25, P1743, DOI 10.1111/j.1460-9568.2007.05447.x; RStudio Team, 2016, RSTUDIO INT DEV R; Sali AD, 2015, CLIN TRANSL IMMUNOL, V4, DOI 10.1038/cti.2015.18; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schwab JM, 2014, EXP NEUROL, V258, P121, DOI 10.1016/j.expneurol.2014.04.023; Schwartz-Albiez R, 2009, CLIN EXP IMMUNOL, V158, P43, DOI [10.1111/j.1365-2249.2009.04026.X, 10.1111/j.1365-2249.2009.04026.x]; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Siegrist C.-A., 2013, VACCINES, P14, DOI DOI 10.1016/B978-1-4557-0090-5.00004-5; Thietje R, 2011, J SPINAL CORD MED, V34, P482, DOI 10.1179/2045772311Y.0000000022; Ulndreaj A, 2017, J NEUROTRAUM, V34, P1209, DOI 10.1089/neu.2016.4498; Zajarias-Fainsod D, 2012, EUR SPINE J, V21, P964, DOI 10.1007/s00586-011-2060-7; Zelenay S, 2007, J AUTOIMMUN, V29, P229, DOI 10.1016/j.jaut.2007.07.011; Zerche M, 2015, STROKE, V46, P1180, DOI 10.1161/STROKEAHA.114.008323	66	17	17	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-3224			FRONT IMMUNOL	Front. Immunol.	OCT 11	2018	9								2365	10.3389/fimmu.2018.02365			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GW6FE	WOS:000447045400001	30364218	gold, Green Published			2022-02-06	
J	Cipriano, A; Pecori, A; Bionda, AE; Bardini, M; Frassi, F; Leoli, F; Lami, V; Ghiadoni, L; Santini, M				Cipriano, Alessandro; Pecori, Alessio; Bionda, Alessandra Eugenia; Bardini, Michele; Frassi, Francesca; Leoli, Francesco; Lami, Valentina; Ghiadoni, Lorenzo; Santini, Massimo			Intracranial hemorrhage in anticoagulated patients with mild traumatic brain injury: significant differences between direct oral anticoagulants and vitamin K antagonists	INTERNAL AND EMERGENCY MEDICINE			English	Article; Proceedings Paper	National Meeting of the Italian-Society-of-Emergency-Medicine	NOV 19, 2016	Napoli, ITALY	Italian Soc Emergency Med		Mild traumatic brain injury; Anticoagulation; Direct oral anticoagulants; Intracranialhemorrhage	MINOR HEAD-INJURY; PREINJURY WARFARIN USE; ATRIAL-FIBRILLATION; TASK-FORCE; METAANALYSIS; RISK; DABIGATRAN; OUTCOMES; MORTALITY; EFFICACY	Prognosis after mild traumatic brain injury (MTBI) on oral anticoagulant therapy (OAT) is uncertain. We evaluated the rate of immediate and delayed traumatic intracranial hemorrhage (ICH) comparing vitamin K antagonists (VKAs) to direct oral anticoagulants (DOACs) and the safety of a clinical management protocol. In this single-center prospective observational study, we enrolled 220 patients on OAT with MTBI. After a first negative CT scan, asymptomatic patients underwent a close neurological observation; if neurologically stable, they were discharged without a second CT scan and followed up for 1month. Out of the 220 patients, 206 met the inclusion criteria. 23 of them (11.2%) had a positive first CT scan for ICH. Only 1 (0.5%, 95% CI 0.0-1.4%) died because of ICH; no one required neurosurgical intervention. The observed prevalence rate of immediate ICH resulted statistically higher in VKAs-treated patients compared to those treated with DOACs (15.7 vs. 4.7%, RR 3.34, 95% CI 1.18-9.46, P<0.05). In the 1-month follow-up, 5 out of the 183 patients with a negative CT scan were lost. Out of the remaining 178 patients, only 3 showed a delayed ICH (1.7%, 95% CI 0.0-3.6%), 1of them died (0.6%, 95% CI 0.5-1.7%) and the others did not require neurosurgical intervention. DOACs resulted safer than VKAs also in the setting of MTBI. In our observation, the rate of delayed hemorrhage was relatively low. Patients presenting with a negative first CT scan and without neurological deterioration could be safely discharged after a short period of in-ward observation with a low rate of complications and without a second CT scan.	[Cipriano, Alessandro; Pecori, Alessio; Bionda, Alessandra Eugenia; Bardini, Michele; Frassi, Francesca; Leoli, Francesco; Lami, Valentina; Santini, Massimo] Azienda Osped Univ Pisana, UO Med Urgenza & Pronto Soccorso, Emergency Dept, Nuovo Santa Chiara Hosp, Pisa, Italy; [Ghiadoni, Lorenzo] Azienda Osped Univ Pisana, UO Med Urgenza Univ, Nuovo Santa Chiara Hosp, Emergency Dept, Pisa, Italy		Cipriano, A (corresponding author), Azienda Osped Univ Pisana, UO Med Urgenza & Pronto Soccorso, Emergency Dept, Nuovo Santa Chiara Hosp, Pisa, Italy.	a.cipriano@ao-pisa.toscana.it; a.pecori91@hotmail.it; a.e.bionda@gmail.com; michelebardini@tin.it; frassifrancesca@gmail.com; burgundioleoli@gmail.com; valentina.lami@gmail.com; lorenzo.ghiadoni@med.unipi.it; ma.santini@ao-pisa.toscana.it	Ghiadoni, Lorenzo/AAC-5176-2022; Cipriano, Alessandro/ABG-8127-2020	Ghiadoni, Lorenzo/0000-0002-7399-2720; Cipriano, Alessandro/0000-0001-7085-3621			Akhter M, 2018, INTERN EMERG MED, V13, P557, DOI 10.1007/s11739-017-1680-2; Alrajhi KN, 2015, J EMERG MED, V48, P137, DOI 10.1016/j.jemermed.2014.08.016; American College Of Surgeons' Committee on Trauma, 2013, ADV TRAUM LIF SUPP S, P2; [Anonymous], 2007, TRATTAMENTO TRAUMA C; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Chai-Adisaksopha C, 2015, J THROMB HAEMOST, V13, P2012, DOI 10.1111/jth.13139; Chauny JM, 2016, J EMERG MED, V51, P519, DOI 10.1016/j.jemermed.2016.05.045; Cohen DB, 2006, J TRAUMA, V60, P553, DOI 10.1097/01.ta.0000196542.54344.05; Cohn B, 2014, J EMERG MED, V46, P410, DOI 10.1016/j.jemermed.2013.08.107; Collins CE, 2014, AM J SURG, V208, P544, DOI 10.1016/j.amjsurg.2014.05.019; Dentali F, 2017, INTERN EMERG MED, V12, P1087, DOI 10.1007/s11739-017-1725-6; Dentali F, 2012, CIRCULATION, V126, P2381, DOI 10.1161/CIRCULATIONAHA.112.115410; Dossett LA, 2011, ARCH SURG-CHICAGO, V146, P565, DOI 10.1001/archsurg.2010.313; Hart RG, 2012, STROKE, V43, P1511, DOI 10.1161/STROKEAHA.112.650614; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Kaen A, 2010, J TRAUMA, V68, P895, DOI 10.1097/TA.0b013e3181b28a76; Leiblich A, 2011, EMERG MED J, V28, P115, DOI 10.1136/emj.2009.079442; Li J, 2012, ANN EMERG MED, V59, P457, DOI 10.1016/j.annemergmed.2012.01.010; Lim BL, 2016, AM J EMERG MED, V34, P75, DOI 10.1016/j.ajem.2015.09.009; Menditto VG, 2012, ANN EMERG MED, V59, P451, DOI 10.1016/j.annemergmed.2011.12.003; National Clinical Guideline Centre. National Institute for Health and Clinical Excellence: Guidance, 2014, HEAD INJ TRIAG ASS I; Nishijima DK, 2013, AM J EMERG MED, V31, P1244, DOI 10.1016/j.ajem.2013.04.035; Nishijima DK, 2012, ANN EMERG MED, V59, P460, DOI 10.1016/j.annemergmed.2012.04.007; Parra MW, 2013, J NEUROSURG, V119, P760, DOI 10.3171/2013.3.JNS12503; Peck KA, 2011, J TRAUMA, V71, P1600, DOI 10.1097/TA.0b013e31823b9ce1; Pieracci FM, 2007, J TRAUMA, V63, P519, DOI 10.1097/TA.0b013e31812e519b; Prisco D, 2017, INTERN EMERG MED, V12, P387, DOI 10.1007/s11739-017-1628-6; Qaseem A, 2012, ANN INTERN MED, V156, P147, DOI 10.7326/0003-4819-156-2-201201170-00011; Reynolds FD, 2003, J TRAUMA, V54, P492, DOI 10.1097/01.TA.0000051601.60556.FC; Riccardi A, 2017, AM J EMERG MED, V35, P1317, DOI 10.1016/j.ajem.2017.03.072; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Schaefer JH, 2014, J CEREBR BLOOD F MET, V34, P870, DOI 10.1038/jcbfm.2014.31; Schulman S, 2010, J THROMB HAEMOST, V8, P202, DOI 10.1111/j.1538-7836.2009.03678.x; Tibshirani R, 2012, J R STAT SOC B, V74, P245, DOI 10.1111/j.1467-9868.2011.01004.x; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Wilson D, 2017, NEUROLOGY, V88, P1693, DOI 10.1212/WNL.0000000000003886	36	17	17	0	0	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1828-0447	1970-9366		INTERN EMERG MED	Intern. Emerg. Med.	OCT	2018	13	7					1077	1087		10.1007/s11739-018-1806-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	GX7PZ	WOS:000447967800015	29520701				2022-02-06	
J	Huttunen, JK; Airaksinen, AM; Barba, C; Colicchio, G; Niskanen, JP; Shatillo, A; Lopez, AS; Ndode-Ekane, XE; Pitknen, A; Grhn, OH				Huttunen, Joanna K.; Airaksinen, Antti M.; Barba, Carmen; Colicchio, Gabriella; Niskanen, Juha-Pekka; Shatillo, Artem; Lopez, Alejandra Sierra; Ndode-Ekane, Xavier Ekolle; Pitkanen, Asla; Grohn, Olli H.			Detection of Hyperexcitability by Functional Magnetic Resonance Imaging after Experimental Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						epileptogenesis; functional imaging; lateral fluid-percussion injury; post-traumatic epilepsy	POSTTRAUMATIC EPILEPSY; INDUCED SEIZURES; BOLD-FMRI; NEURONAL-ACTIVITY; VASCULAR CHANGES; RAT; PENTYLENETETRAZOL; EPILEPTOGENESIS; MODEL; FLUID	Diagnosis of ongoing epileptogenesis and associated hyperexcitability after brain injury is a major challenge. Given that increased neuronal activity in the brain triggers a blood oxygenation level-dependent (BOLD) response in functional magnetic resonance imaging (fMRI), we hypothesized that fMRI could be used to identify the brain area(s) with hyperexcitability during post-injury epileptogenesis. We applied fMRI to detect onset and spread of BOLD activation after pentylenetetrazol (PTZ)-induced seizures (PTZ, 30mg/kg, intraperitoneally) in 16 adult male rats at 2 months after lateral fluid percussion (FPI)-induced traumatic brain injury (TBI). In sham-operated controls, onset of the PTZ-induced BOLD response was bilateral and first appeared in the cortex. After TBI, 5 of 9 (56%) rats exhibited ipsilateral perilesional cortical BOLD activation, followed by activation of the contralateral cortex. In 4 of 9 (44%) rats, onset of BOLD response was bilateral. Interestingly, latency from the PTZ injection to onset of the BOLD response increased in the following order: sham-operated controls (ipsilateral 132 +/- 57sec, contralateral 132 +/- 57sec; p>0.05) < TBI with bilateral BOLD onset (ipsilateral 176 +/- 54sec, contralateral 178 +/- 52sec; p>0.05) < TBI with ipsilateral BOLD onset (ipsilateral 406 +/- 178sec, contralateral 509 +/- 140sec; p<0.05). Cortical lesion area did not differ between rats with ipsilateral versus bilateral BOLD onset (p>0.05). In the group of rats with ipsilateral onset of PTZ-induced BOLD activation, none of the rats showed a robust bilateral thalamic BOLD response, only 1 of 5 rats had robust ipsilateral thalamic calcifications, and 4 of 5 rats had perilesional astrocytosis. These findings suggest the evolution of the epileptogenic zone in the perilesional cortex after TBI, which is sensitive to PTZ-induced hyperexcitability. Further studies are warranted to explore the evolution of thalamo-cortical pathology as a driver of epileptogenesis after lateral FPI.	[Huttunen, Joanna K.; Airaksinen, Antti M.; Niskanen, Juha-Pekka; Shatillo, Artem; Lopez, Alejandra Sierra; Ndode-Ekane, Xavier Ekolle; Pitkanen, Asla; Grohn, Olli H.] Univ Eastern Finland, AI Virtanen Inst Mol Sci, POB 1627, FI-70211 Kuopio, Finland; [Niskanen, Juha-Pekka] Univ Eastern Finland, Dept Appl Phys, Kuopio, Finland; [Barba, Carmen] Childrens Hosp Anna Meyer, Neurosci Dept, Florence, Italy; [Colicchio, Gabriella] Catholic Univ, Dept Neurosurg, Rome, Italy		Grhn, OH (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, POB 1627, FI-70211 Kuopio, Finland.	olli.grohn@uef.fi	Barba, Carmen/AAB-7162-2022; barba, carmen/K-4942-2016	barba, carmen/0000-0001-5445-5842; Sierra Lopez, Alejandra/0000-0001-5399-2056; Huttunen, Joanna/0000-0002-1188-5604; Ndode-Ekane, Xavier Ekolle/0000-0001-5682-5632	Academy of FinlandAcademy of FinlandEuropean Commission; FP7-HEALTH project [602102]	We thank Merja Lukkari, Maarit Pulkkinen, and Jarmo Hartikainen for their excellent technical help and Raimo Salo for statistical advice. This study was supported by the Academy of Finland (A.P., O.G., X.E.N.E., A.S.L.) and the FP7-HEALTH project 602102 (EPITARGET; A.P., O.G.).	Airaksinen AM, 2012, EPILEPSIA, V53, P1245, DOI 10.1111/j.1528-1167.2012.03539.x; Akhtari M, 2012, BRAIN TOPOGR, V25, P374, DOI 10.1007/s10548-012-0231-4; Andre V, 1998, EUR J NEUROSCI, V10, P2094, DOI 10.1046/j.1460-9568.1998.00223.x; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Ates N, 1999, PHARMACOL RES, V39, P305, DOI 10.1006/phrs.1998.0441; Barba C, 2009, EPILEPSY RES, V84, P6, DOI 10.1016/j.eplepsyres.2008.11.017; Barba C, 2007, EPILEPSIA, V48, P278, DOI 10.1111/j.1528-1167.2007.00935.x; Barba C, 2012, J NEUROL, V259, P1613, DOI 10.1007/s00415-011-6387-0; Blanco MM, 2009, EPILEPSIA, V50, P824, DOI 10.1111/j.1528-1167.2008.01797.x; Bragin A, 2016, EPILEPSIA, V57, P735, DOI 10.1111/epi.13359; Brevard ME, 2006, EPILEPSIA, V47, P745, DOI 10.1111/j.1528-1167.2006.00502.x; Chaudhary UJ, 2016, NEUROIMAGE-CLIN, V11, P486, DOI 10.1016/j.nicl.2016.03.010; Chaudhary UJ, 2013, HUM BRAIN MAPP, V34, P447, DOI 10.1002/hbm.21448; Curia G, 2011, CEREB CORTEX, V21, P1574, DOI 10.1093/cercor/bhq218; DeSalvo MN, 2010, NEUROIMAGE, V50, P902, DOI 10.1016/j.neuroimage.2010.01.006; Eells JB, 2004, NEUROSCIENCE, V123, P279, DOI 10.1016/j.neuroscience.2003.08.015; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; FRISTON K, 2007, STAT PARAMETRIC MAPP, DOI DOI 10.1227/01.NEU.0000429846.14579.41; Harris NG, 2016, EXP NEUROL, V277, P124, DOI 10.1016/j.expneurol.2015.12.020; Hayward NMEA, 2010, J NEUROTRAUM, V27, P2203, DOI 10.1089/neu.2010.1448; Herman ST, 2002, NEUROLOGY, V59, pS21, DOI 10.1212/WNL.59.9_suppl_5.S21; Hesdorffer DC, 1998, ANN NEUROL, V44, P908, DOI 10.1002/ana.410440609; Huttunen JK, 2008, NEUROIMAGE, V39, P775, DOI 10.1016/j.neuroimage.2007.06.042; INGVAR M, 1984, EPILEPSIA, V25, P191, DOI 10.1111/j.1528-1157.1984.tb04176.x; Karhunen H, 2007, NEUROSCIENCE, V148, P314, DOI 10.1016/j.neuroscience.2007.05.047; Keogh BP, 2005, EPILEPSY RES, V66, P75, DOI 10.1016/j.eplepsyres.2005.07.008; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kharatishvili I, 2007, BRAIN, V130, P3155, DOI 10.1093/brain/awm268; Laitinen T, 2010, NEUROIMAGE, V51, P521, DOI 10.1016/j.neuroimage.2010.02.077; Lehto LJ, 2012, NEUROIMAGE, V61, P761, DOI 10.1016/j.neuroimage.2012.03.002; Makinen S, 2008, J CEREBR BLOOD F MET, V28, P263, DOI 10.1038/sj.jcbfm.9600529; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MIRSKI MA, 1986, EPILEPSIA, V27, P194, DOI 10.1111/j.1528-1157.1986.tb03528.x; MIRSKI MA, 1986, BRAIN RES, V399, P212, DOI 10.1016/0006-8993(86)91511-8; MIRSKI MA, 1984, SCIENCE, V226, P72, DOI 10.1126/science.6433485; Ndode-Ekane XE, 2010, NEUROSCIENCE, V166, P312, DOI 10.1016/j.neuroscience.2009.12.002; Ndode-Ekane XE, 2017, J NEUROTRAUM, V34, P459, DOI 10.1089/neu.2016.4404; Niskanen JP, 2013, J NEUROTRAUM, V30, P546, DOI 10.1089/neu.2012.2416; Paxinos G., 2010, RAT BRAIN STEREOTAXI; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P286, DOI 10.1007/s13311-014-0260-7; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P231, DOI 10.1007/s13311-014-0257-2; Pitkanen A, 2011, NEUROSCI LETT, V497, P163, DOI 10.1016/j.neulet.2011.02.033; Pitkanen A, 2009, EPILEPSIA, V50, P21, DOI 10.1111/j.1528-1167.2008.02007.x; RAMZAN IM, 1985, J PHARMACOL EXP THER, V234, P624; Reid AY, 2016, EPILEPSIA, V57, P1558, DOI 10.1111/epi.13486; Salazar Andres M, 2015, Handb Clin Neurol, V128, P525, DOI 10.1016/B978-0-444-63521-1.00033-9; Semah F, 1998, NEUROLOGY, V51, P1256, DOI 10.1212/WNL.51.5.1256; Shultz SR, 2013, EPILEPSIA, V54, P1240, DOI 10.1111/epi.12223; Silva AC, 2007, MAGN RESON MED, V57, P1110, DOI 10.1002/mrm.21246; Tenney JR, 2004, EPILEPSIA, V45, P576, DOI 10.1111/j.0013-9580.2004.39303.x; Thornton RC, 2010, NEUROIMAGE, V53, P196, DOI 10.1016/j.neuroimage.2010.05.064; Van Camp N, 2003, NEUROIMAGE, V19, P627, DOI 10.1016/S1053-8119(03)00138-1; VEZZANI A, 1994, BRAIN RES, V660, P138, DOI 10.1016/0006-8993(94)90847-8; VOHLAND HW, 1976, N-S ARCH PHARMACOL, V293, P277, DOI 10.1007/BF00507350; Wang X, 2016, BRAIN RES, V1646, P174, DOI 10.1016/j.brainres.2016.05.055; WIESER HG, 1979, EPILEPSIA, V20, P47, DOI 10.1111/j.1528-1157.1979.tb04775.x	57	17	17	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2018	35	22					2708	2717		10.1089/neu.2017.5308		SEP 2018	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GZ0MO	WOS:000445769500001	30019618				2022-02-06	
J	Bauman, MD; Schumann, CM; Carlson, EL; Taylor, SL; Vazquez-Rosa, E; Cintron-Perez, CJ; Shin, MK; Williams, NS; Pieper, AA				Bauman, Melissa D.; Schumann, Cynthia M.; Carlson, Erin L.; Taylor, Sandra L.; Vazquez-Rosa, Edwin; Cintron-Perez, Coral J.; Shin, Min-Kyoo; Williams, Noelle S.; Pieper, Andrew A.			Neuroprotective efficacy of P7C3 compounds in primate hippocampus	TRANSLATIONAL PSYCHIATRY			English	Article							RETINAL GANGLION-CELLS; TRAUMATIC BRAIN-INJURY; ADULT NEUROGENESIS; DENTATE GYRUS; MACAQUE MONKEY; NEUROPSYCHIATRIC DISORDERS; AMINOPROPYL CARBAZOLES; MAJOR DEPRESSION; PROGENITOR CELLS; DRUG DEVELOPMENT	There is a critical need for translating basic science discoveries into new therapeutics for patients suffering from difficult to treat neuropsychiatric and neurodegenerative conditions. Previously, a target-agnostic in vivo screen in mice identified P7C3 aminopropyl carbazole as capable of enhancing the net magnitude of postnatal neurogenesis by protecting young neurons from death. Subsequently, neuroprotective efficacy of P7C3 compounds in a broad spectrum of preclinical rodent models has also been observed. An important next step in translating this work to patients is to determine whether P7C3 compounds exhibit similar efficacy in primates. Adult male rhesus monkeys received daily oral P7C3-A20 or vehicle for 38 weeks. During weeks 2-11, monkeys received weekly injection of 5'bromo- 2-deoxyuridine (BrdU) to label newborn cells, the majority of which would normally die over the following 27 weeks. BrdU+ cells were quantified using unbiased stereology. Separately in mice, the proneurogenic efficacy of P7C3-A20 was compared to that of NSI-189, a proneurogenic drug currently in clinical trials for patients with major depression. Orally-administered P7C3-A20 provided sustained plasma exposure, was well-tolerated, and elevated the survival of hippocampal BrdU+ cells in nonhuman primates without adverse central or peripheral tissue effects. In mice, NSI-189 was shown to be pro-proliferative, and P7C3-A20 elevated the net magnitude of hippocampal neurogenesis to a greater degree than NSI-189 through its distinct mechanism of promoting neuronal survival. This pilot study provides evidence that P7C3-A20 safely protects neurons in nonhuman primates, suggesting that the neuroprotective efficacy of P7C3 compounds is likely to translate to humans as well.	[Bauman, Melissa D.; Schumann, Cynthia M.; Carlson, Erin L.] Univ Calif Davis, Dept Psychiat & Behav Sci, Davis, CA 95616 USA; [Bauman, Melissa D.; Schumann, Cynthia M.] Univ Calif Davis, UC Davis MIND Inst, Davis, CA 95616 USA; [Bauman, Melissa D.] Calif Natl Primate Res Ctr, Davis, CA USA; [Bauman, Melissa D.; Taylor, Sandra L.] Univ Calif Davis, Dept Publ Hlth Sci, Davis, CA 95616 USA; [Vazquez-Rosa, Edwin; Cintron-Perez, Coral J.; Shin, Min-Kyoo; Pieper, Andrew A.] Case Western Reserve Univ, Dept Psychiat, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Vazquez-Rosa, Edwin; Cintron-Perez, Coral J.; Shin, Min-Kyoo; Pieper, Andrew A.] Harrington Discovery Inst, Louis Stokes Cleveland VAMC, Geriatr Res Educ Ctr, Cleveland, OH 44106 USA; [Vazquez-Rosa, Edwin; Cintron-Perez, Coral J.; Shin, Min-Kyoo; Pieper, Andrew A.] Harrington Discovery Inst, Louis Stokes Cleveland VAMC, Clin Ctr, Cleveland, OH 44106 USA; [Williams, Noelle S.] UT Southwestern Med Ctr, Dept Biochem, Dallas, TX USA		Pieper, AA (corresponding author), Case Western Reserve Univ, Dept Psychiat, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA.; Pieper, AA (corresponding author), Harrington Discovery Inst, Louis Stokes Cleveland VAMC, Geriatr Res Educ Ctr, Cleveland, OH 44106 USA.; Pieper, AA (corresponding author), Harrington Discovery Inst, Louis Stokes Cleveland VAMC, Clin Ctr, Cleveland, OH 44106 USA.	mdbauman@ucdavis.edu; Andrew.Pieper@HarringtonDiscovery.org	Bauman, Melissa/O-1256-2017	Bauman, Melissa/0000-0003-0701-3851; Pieper, Andrew/0000-0001-6299-6577	NIMHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R21 NS081487]; CNPRC [OD011107]; Hartwell Foundation; Brockman Medical Research Foundation; Calico LLC (California Life Company); NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U54 HD079125]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U54HD079125] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [T32CA078586] Funding Source: NIH RePORTER	This work was supported by NIMH R21 NS081487 to M.D.B. and A.A.P, the CNPRC base grant OD011107, funds from The Hartwell Foundation to A.A.P., funds from an anonymous donor to the Mary Alice Smith Fund for Neuropsychiatry Research to A.A.P, and funds from the Brockman Medical Research Foundation. Pathological analysis of tissue conducted by Abbvie Pharmaceuticals (North Chicago, Illinois, USA) was funded by Calico LLC (California Life Company). Special acknowledgements are due to Research Services and Primate Medicine staff at the California National Primate Research Center for care of the animals and in particular to T. Traill for her assistance with compound administration and to Dr. David Amaral for consultation on experimental design and use of microscopy equipment. Data analysis was supported by the NIH-funded MIND Institute Intellectual and Developmental Disabilities Research Center (U54 HD079125). We would like to thank Katherine Ku for her assistance in GCL volumetric data collection, Alicja Omanska for assistance with tissue processing and Casey Hogrefe for assistance with manuscript preparation. Finally, we thank Dr. Karl Murray for insightful comments on an early draft of the manuscript.	Allen KM, 2016, AUST NZ J PSYCHIAT, V50, P473, DOI 10.1177/0004867415589793; ALTMAN J, 1965, NATURE, V207, P953, DOI 10.1038/207953a0; Amaral DG, 2007, PROG BRAIN RES, V163, P3, DOI 10.1016/S0079-6123(07)63001-5; Bacchetti P, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001628; Bauman MD, 2005, NEUROSCIENCE, V136, P193, DOI 10.1016/j.neuroscience.2005.07.040; Bergmann O, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018994; Blaya MO, 2014, J NEUROTRAUM, V31, P476, DOI [10.1089/NEU.2013.3135, 10.1089/neu.2013.3135]; Boldrini M, 2018, CELL STEM CELL, V22, P589, DOI 10.1016/j.stem.2018.03.015; Boldrini M, 2013, NEUROPSYCHOPHARMACOL, V38, P1068, DOI 10.1038/npp.2013.5; Boldrini M, 2012, BIOL PSYCHIAT, V72, P562, DOI 10.1016/j.biopsych.2012.04.024; Boldrini M, 2009, NEUROPSYCHOPHARMACOL, V34, P2376, DOI 10.1038/npp.2009.75; Burke SN, 2012, FRONT AGING NEUROSCI, V4, DOI 10.3389/fnagi.2012.00015; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Cameron HA, 2015, ANNU REV PSYCHOL, V66, P53, DOI 10.1146/annurev-psych-010814-015006; Coe CL, 2003, BIOL PSYCHIAT, V54, P1025, DOI 10.1016/S0006-3223(03)00698-X; De Jesus-Cortes H, 2016, NEUROGENESIS AUSTIN, V3, pe1231160, DOI [10.1080/23262133.2016.1231160, DOI 10.1080/23262133.2016.1231160]; De Jesus-Cortes H, 2012, P NATL ACAD SCI USA, V109, P17010, DOI 10.1073/pnas.1213956109; De Jesus-Cortest H, 2015, NPJ PARKINSON DIS, V1, DOI 10.1038/npjparkd.2015.10; Dutca LM, 2014, INVEST OPHTH VIS SCI, V55, P8330, DOI 10.1167/iovs.14-15468; Engle JR, 2012, FRONT AGING NEUROSCI, V4, DOI [10.3389/fnagi.2012.00010, 10.3389/fnagi.2012.00036]; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Fava M, 2016, MOL PSYCHIATR, V21, P1483, DOI 10.1038/mp.2016.140; Galvan V, 2007, CLIN INTERV AGING, V2, P605; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Glover LR, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001154; Goetghebeur PJD, 2016, J PSYCHOPHARMACOL, V30, P586, DOI 10.1177/0269881116645269; Goncalves JT, 2016, CELL, V167, P897, DOI 10.1016/j.cell.2016.10.021; Gould E, 1998, P NATL ACAD SCI USA, V95, P3168, DOI 10.1073/pnas.95.6.3168; Gould E, 1999, P NATL ACAD SCI USA, V96, P5263, DOI 10.1073/pnas.96.9.5263; Gray DT, 2015, NEUROSCIENCE, V309, P17, DOI 10.1016/j.neuroscience.2015.08.001; Gribkoff VK, 2017, NEUROPHARMACOLOGY, V120, P11, DOI 10.1016/j.neuropharm.2016.03.021; Gu C, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.250; Hill AS, 2015, NEUROPSYCHOPHARMACOL, V40, P2368, DOI 10.1038/npp.2015.85; Jabes A, 2011, J COMP NEUROL, V519, P1051, DOI 10.1002/cne.22549; Jabes A, 2010, EUR J NEUROSCI, V31, P273, DOI 10.1111/j.1460-9568.2009.07061.x; Kemp SWP, 2015, NEUROSCIENCE, V284, P202, DOI 10.1016/j.neuroscience.2014.10.005; Kesselheim AS, 2015, NAT REV DRUG DISCOV, V14, P815, DOI 10.1038/nrd4793; Kohler SJ, 2011, P NATL ACAD SCI USA, V108, P10326, DOI 10.1073/pnas.1017099108; Kornack DR, 1999, P NATL ACAD SCI USA, V96, P5768, DOI 10.1073/pnas.96.10.5768; Kronmuller KT, 2009, PSYCHIAT RES-NEUROIM, V174, P62, DOI 10.1016/j.pscychresns.2008.08.001; Laplagne DA, 2006, PLOS BIOL, V4, P2349, DOI 10.1371/journal.pbio.0040409; Lavenex P, 2000, HIPPOCAMPUS, V10, P420, DOI 10.1002/1098-1063(2000)10:4<420::AID-HIPO8>3.0.CO;2-5; Lavenex P, 2009, J COMP NEUROL, V512, P27, DOI 10.1002/cne.21906; Lee AS, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0006-16.2016; LoCoco PM, 2017, ELIFE, V6, DOI 10.7554/eLife.29626; Loris ZB, 2018, TRANSL STROKE RES, V9, P146, DOI 10.1007/s12975-017-0565-z; Loris ZB, 2017, EXP NEUROL, V290, P63, DOI 10.1016/j.expneurol.2017.01.006; Lucassen PJ, 2010, NEUROPHARMACOLOGY, V58, P940, DOI 10.1016/j.neuropharm.2010.01.012; MacMillan KS, 2011, J AM CHEM SOC, V133, P1428, DOI 10.1021/ja108211m; McAvoy KM, 2017, NEUROTHERAPEUTICS, V14, P630, DOI 10.1007/s13311-017-0539-6; McIntyre RS, 2017, EXPERT OPIN INV DRUG, V26, P767, DOI 10.1080/13543784.2017.1324847; Naidoo J, 2014, J MED CHEM, V57, P3746, DOI 10.1021/jm401919s; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; Oku H, 2017, INVEST OPHTH VIS SCI, V58, P4877, DOI 10.1167/iovs.17-22179; Oku H, 2017, JPN J OPHTHALMOL, V61, P195, DOI 10.1007/s10384-016-0493-6; Pedraza O, 2004, J INT NEUROPSYCH SOC, V10, P664, DOI 10.1017/S1355617704105080; Perera TD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017600; Phillips KA, 2014, AM J PRIMATOL, V76, P801, DOI 10.1002/ajp.22281; Piatti VC, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00050; Pieper AA, 2017, NEUROTHERAPEUTICS, V14, P533, DOI 10.1007/s13311-017-0547-6; Pieper AA, 2014, CHEM SOC REV, V43, P6716, DOI 10.1039/c3cs60448a; Pieper AA, 2010, CELL, V142, P39, DOI 10.1016/j.cell.2010.06.018; Reif A, 2006, MOL PSYCHIATR, V11, P514, DOI 10.1038/sj.mp.4001791; Rosenzweig ES, 2018, NAT MED, V24, P484, DOI 10.1038/nm.4502; Rosenzweig ES, 2010, NAT NEUROSCI, V13, P1505, DOI 10.1038/nn.2691; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Schinder AF, 2004, PHYSIOLOGY, V19, P253, DOI 10.1152/physiol.00012.2004; Schoenfeld TJ, 2017, BIOL PSYCHIAT, V82, P914, DOI 10.1016/j.biopsych.2017.05.013; Schoenfeld TJ, 2015, NEUROPSYCHOPHARMACOL, V40, P113, DOI 10.1038/npp.2014.230; Serafini G, 2014, CNS NEUROL DISORD-DR, V13, P1708; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Sorrells SF, 2018, NATURE, V555, P377, DOI 10.1038/nature25975; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002; Tajiri N, 2017, J CELL PHYSIOL, V232, P2731, DOI 10.1002/jcp.25847; Terrillion CE, 2017, NEUROPSYCHOPHARMACOL, V42, P2242, DOI 10.1038/npp.2017.129; Tesla R, 2012, P NATL ACAD SCI USA, V109, P17016, DOI 10.1073/pnas.1213960109; Voorhees JR, 2018, BIOL PSYCHIAT, V84, P488, DOI 10.1016/j.biopsych.2017.10.023; Walker AK, 2015, MOL PSYCHIATR, V20, P500, DOI 10.1038/mp.2014.34; Walter A, 2016, NEUROSCI BIOBEHAV R, V71, P680, DOI 10.1016/j.neubiorev.2016.10.007; Walton NM, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.56; Wang G, 2014, CELL, V158, P1324, DOI 10.1016/j.cell.2014.07.040; Wang SN, 2016, CNS NEUROSCI THER, V22, P782, DOI 10.1111/cns.12576; Watson KK, 2012, J NEURODEV DISORD, V4, DOI 10.1186/1866-1955-4-21; WEST MJ, 1990, J COMP NEUROL, V296, P1, DOI 10.1002/cne.902960102; West MJ., 2012, BASIC STEREOLOGY BIO, P843; Woolard AA, 2012, PSYCHIAT RES-NEUROIM, V201, P48, DOI 10.1016/j.pscychresns.2011.07.016; Yin TC, 2014, CELL REP, V8, P1731, DOI 10.1016/j.celrep.2014.08.030; Yun S, 2018, NAT MED, V24, P658, DOI 10.1038/s41591-018-0002-1; Yun S, 2016, NAT MED, V22, P1239, DOI 10.1038/nm.4218; Zhang LQ, 2018, AM J PATHOL, V188, P1640, DOI 10.1016/j.ajpath.2018.04.004	93	17	18	2	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	2158-3188			TRANSL PSYCHIAT	Transl. Psychiatr.	SEP 26	2018	8								202	10.1038/s41398-018-0244-1			11	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Psychiatry	GV6XU	WOS:000446264100001	30258178	gold, Green Published			2022-02-06	
J	Zhang, Z; Rasmussen, L; Saraswati, M; Koehler, RC; Robertson, C; Kannan, S				Zhang, Zhi; Rasmussen, Lindsey; Saraswati, Manda; Koehler, Raymond C.; Robertson, Courtney; Kannan, Sujatha			Traumatic Injury Leads to Inflammation and Altered Tryptophan Metabolism in the Juvenile Rabbit Brain	JOURNAL OF NEUROTRAUMA			English	Article						IDO; inflammation; microglia; serotonin; TBI	TUMOR-NECROSIS-FACTOR; CEREBROSPINAL-FLUID; QUINOLINIC ACID; MESSENGER-RNA; FACTOR-ALPHA; TNF-ALPHA; INDOLEAMINE 2,3-DIOXYGENASE; KYNURENINE PATHWAY; CYTOKINE EXPRESSION; SEROTONIN	Neuroinflammation after traumatic brain injury (TBI) contributes to widespread cell death and tissue loss. Here, we evaluated sequential inflammatory response in the brain, as well as inflammation-induced changes in brain tryptophan metabolism over time, in a rabbit pediatric TBI model. On post-natal days 5-7 (P5-P7), New Zealand white rabbit littermates were randomized into three groups: naive (no injury), sham (craniotomy alone), and TBI (controlled cortical impact). Animals were sacrificed at 6h and 1, 3, 7, and 21 days post-injury for evaluating levels of pro- and anti-inflammatory cytokines, as well as the major components in the tryptophan-kynurenine pathway. We found that 1) pro- and anti-inflammatory cytokine levels in the brain injury area were differentially regulated in a time-dependent manner post-injury; 2) indoleamine 2,3 dioxygeenase 1 (IDO1) was upregulated around the injury area in TBI kits that persisted at 21 days post-injury; 3) mean length of serotonin-staining fibers was significantly reduced in the injured brain region in TBI kits for at least 21 days post-injury; and 4) kynurenine level significantly increased at 7 days post-injury. A significant decrease in serotonin/tryptophan ratio and melatonin/tryptophan ratio at 21 days post-injury was noted, suggesting that tryptophan metabolism is altered after TBI. A better understanding of the temporal evolution of immune responses and tryptophan metabolism during injury and repair after TBI is crucial for the development of novel therapeutic strategies targeting these pathways.	[Zhang, Zhi; Rasmussen, Lindsey; Saraswati, Manda; Koehler, Raymond C.; Robertson, Courtney; Kannan, Sujatha] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Bloomberg Childrens Bldg,6318D-C4,1800 Orleans St, Baltimore, MD 21287 USA; [Zhang, Zhi] Univ Michigan, Dept Nat Sci, Dearborn, MI 48128 USA		Kannan, S (corresponding author), Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Bloomberg Childrens Bldg,6318D-C4,1800 Orleans St, Baltimore, MD 21287 USA.	skannan3@jhmi.edu		Zhang, Zhi/0000-0001-6256-9516	Johns Hopkins Department of Anesthesiology and Critical Care StAAR grant;  [R01NS093416];  [R01NS092747]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS092747] Funding Source: NIH RePORTER	This study was funded in part by R01NS093416 (SK), R01NS092747 (CR), and by Johns Hopkins Department of Anesthesiology and Critical Care StAAR grant.	Aarum J, 2003, P NATL ACAD SCI USA, V100, P15983, DOI 10.1073/pnas.2237050100; Balasingam V, 1996, J NEUROSCI, V16, P2945; BANATI RB, 1993, GLIA, V7, P111, DOI 10.1002/glia.440070117; Bassani TB, 2014, BRAIN RES, V1593, P95, DOI 10.1016/j.brainres.2014.09.068; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; Bell MJ, 1999, CRIT CARE MED, V27, P493, DOI 10.1097/00003246-199903000-00023; Bendz LM, 2010, ANN PHARMACOTHER, V44, P185, DOI 10.1345/aph.1M365; BennettClarke CA, 1997, SOMATOSENS MOT RES, V14, P27; BENVENISTE EN, 1995, INT J DEV NEUROSCI, V13, P341, DOI 10.1016/0736-5748(94)00061-7; Berger RP, 2004, J NEUROTRAUM, V21, P1123; Bermpohl D, 2007, J CEREBR BLOOD F MET, V27, P1806, DOI 10.1038/sj.jcbfm.9600487; Bhutia YD, 2015, BBA-BIOMEMBRANES, V1848, P453, DOI 10.1016/j.bbamem.2014.10.021; BLIGHT AR, 1995, BRAIN, V118, P735, DOI 10.1093/brain/118.3.735; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Boutin H, 2001, J NEUROSCI, V21, P5528, DOI 10.1523/JNEUROSCI.21-15-05528.2001; BRENNER T, 1993, BRAIN RES, V608, P273, DOI 10.1016/0006-8993(93)91468-8; Brummelte S, 2017, NEUROSCIENCE, V342, P212, DOI 10.1016/j.neuroscience.2016.02.037; Buttram SDW, 2007, J NEUROTRAUM, V24, P1707, DOI 10.1089/neu.2007.0349; Carmody DP, 2004, NEURORADIOLOGY, V46, P781, DOI 10.1007/s00234-004-1241-z; Chiaretti A, 2005, CHILD NERV SYST, V21, P185, DOI 10.1007/s00381-004-1032-1; Chollet F, 2011, LANCET NEUROL, V10, P123, DOI 10.1016/S1474-4422(10)70314-8; Ciurea A V, 2011, J Med Life, V4, P234; Connor TJ, 2008, NEUROSCI LETT, V441, P29, DOI 10.1016/j.neulet.2008.06.007; COSTEFF H, 1990, J NEUROSURG, V73, P684, DOI 10.3171/jns.1990.73.5.0684; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Dalgard CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00006; DAMATO RJ, 1987, P NATL ACAD SCI USA, V84, P4322, DOI 10.1073/pnas.84.12.4322; Damiani JM, 2014, AM J HEALTH-SYST PH, V71, P95, DOI 10.2146/ajhp130215; Daubert EA, 2010, TRENDS NEUROSCI, V33, P424, DOI 10.1016/j.tins.2010.05.005; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Durkin MS, 1998, NEUROSURGERY, V42, P300, DOI 10.1097/00006123-199802000-00052; Elkhayat HA, 2010, PEDIATR NEUROL, V42, P249, DOI 10.1016/j.pediatrneurol.2009.11.002; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Fujigaki H, 2006, J BIOCHEM, V139, P655, DOI 10.1093/jb/mvj072; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; GOODMAN JC, 1990, J NEUROIMMUNOL, V30, P213; Grima NA, 2018, BMC MED, V16, DOI 10.1186/s12916-017-0995-1; Guillemin GJ, 2005, NEUROPATH APPL NEURO, V31, P395, DOI 10.1111/j.1365-2990.2005.00655.x; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; Haynes RL, 2005, J COMP NEUROL, V484, P156, DOI 10.1002/cne.20453; HEYES MP, 1992, BRAIN, V115, P1249, DOI 10.1093/brain/115.5.1249; Hide I, 2000, J NEUROCHEM, V75, P965, DOI 10.1046/j.1471-4159.2000.0750965.x; Hill A, 2007, DATA ANAL USING REGR; Holmin S, 1997, J NEUROSURG, V86, P493, DOI 10.3171/jns.1997.86.3.0493; Jorge RE, 2016, JAMA PSYCHIAT, V73, P1041, DOI 10.1001/jamapsychiatry.2016.2189; Kamm K, 2006, J TRAUMA, V60, P152, DOI 10.1097/01.ta.0000196345.81169.a1; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Knoblach SM, 1998, EXP NEUROL, V153, P143, DOI 10.1006/exnr.1998.6877; Koizumi H, 2004, BRAIN DEV-JPN, V26, P434, DOI 10.1016/j.braindev.2003.09.011; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; Kozak M, 2007, J CELL BIOCHEM, V102, P280, DOI 10.1002/jcb.21464; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lauder J M, 1981, Adv Exp Med Biol, V133, P477; Lebrand C, 1996, NEURON, V17, P823, DOI 10.1016/S0896-6273(00)80215-9; LEVIN H, 1994, J NEUROPSYCH CLIN N, V6, P443; Lobo-Silva D, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0763-8; Lorente L, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0922-2; Lu KT, 2005, J NEUROTRAUM, V22, P885, DOI 10.1089/neu.2005.22.885; Maddaloni G, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00202; Maier B, 2001, SHOCK, V15, P421, DOI 10.1097/00024382-200115060-00002; Marseglia L, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051053; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Mehra A, 2003, BIOTECHNOL BIOENG, V84, P822, DOI 10.1002/bit.10860; Meier TB, 2016, J NEUROTRAUM, V33, P1349, DOI 10.1089/neu.2015.4118; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; Miceli S, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00088; Michell-Robinson MA, 2015, BRAIN, V138, P1138, DOI 10.1093/brain/awv066; Miller E, 2015, CURR TOP MED CHEM, V15, P163, DOI 10.2174/1568026615666141209160556; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Moss DW, 2001, EUR J NEUROSCI, V13, P529, DOI 10.1046/j.1460-9568.2001.01418.x; Narboux-Neme N, 2008, NEUROPHARMACOLOGY, V55, P994, DOI 10.1016/j.neuropharm.2008.08.020; Nie L, 2006, GENETICS, V174, P2229, DOI 10.1534/genetics.106.065862; Ouellet MC, 2015, LANCET NEUROL, V14, P746, DOI 10.1016/S1474-4422(15)00068-X; Pardridge WM, 1998, NEUROCHEM RES, V23, P635, DOI 10.1023/A:1022482604276; PorteraCailliau C, 1997, J COMP NEUROL, V378, P88, DOI 10.1002/(SICI)1096-9861(19970203)378:1<88::AID-CNE5>3.0.CO;2-G; PRATT OE, 1979, J NEURAL TRANSM, P29; Raimondi A, 1987, Chemioterapia, V6, P103; Rasouli J, 2011, Einstein J Biol Med, V27, P74; Regan T, 2018, J LEUKOCYTE BIOL, V103, P681, DOI 10.1002/JLB.3A0617-261R; REID TR, 1989, J BIOL CHEM, V264, P4583; Richard DM, 2009, INT J TRYPTOPHAN RES, V2, P45; ROSS SA, 1994, BRIT J NEUROSURG, V8, P419, DOI 10.3109/02688699408995109; Rossignol DA, 2014, CURR CLIN PHARMACOL, V9, P326, DOI 10.2174/15748847113086660072; Ruppel RA, 2001, J PEDIATR-US, V138, P18, DOI 10.1067/mpd.2001.110979; Salmond CH, 2005, CURR OPIN CRIT CARE, V11, P111, DOI 10.1097/01.ccx.0000155358.31983.37; Sarkhosh K, 2003, J CELL BIOCHEM, V90, P206, DOI 10.1002/jcb.10593; Sawada M, 1999, J NEUROCHEM, V72, P1466, DOI 10.1046/j.1471-4159.1999.721466.x; SAWADA M, 1989, BRAIN RES, V491, P394, DOI 10.1016/0006-8993(89)90078-4; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; Seifman MA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00237; SEMENZATO G, 1990, BRIT J CANCER, V61, P354, DOI 10.1038/bjc.1990.78; Shebl FM, 2010, CANCER EPIDEM BIOMAR, V19, P978, DOI 10.1158/1055-9965.EPI-10-0064; Shiozaki T, 2005, SHOCK, V23, P406, DOI 10.1097/01.shk.0000161385.62758.24; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; Siepmann T, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.373; Sinz EH, 1998, J CEREBR BLOOD F MET, V18, P610, DOI 10.1097/00004647-199806000-00002; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Sodhi MSK, 2004, INT REV NEUROBIOL, V59, P111; Stein DM, 2011, J TRAUMA, V70, P1096, DOI 10.1097/TA.0b013e318216930d; Streit WJ, 2002, E SCHERING RES FDN W, V39, P11; Sullivan PG, 1999, J NEUROSCI, V19, P6248; SUSEL Z, 1991, NEUROSCI LETT, V121, P234, DOI 10.1016/0304-3940(91)90693-N; Suzuki T, 2004, J NEUROSCI, V24, P1, DOI 10.1523/JNEUROSCI.3792-03.2004; Tang LL, 2011, NEUROL RES, V33, P1064, DOI 10.1179/016164110X12700393823651; Trakhtenberg EF, 2012, INT REV NEUROBIOL, V106, P105, DOI 10.1016/B978-0-12-407178-0.00005-3; Tsuchiyama R, 2010, ACTA NEUROCHIR SUPPL, V106, P155, DOI 10.1007/978-3-211-98811-4_28; Vahidy FS, 2016, J CEREBR BLOOD F MET, V36, P1012, DOI 10.1177/0271678X15607880; Vasquez-Vivar J, 2017, REDOX BIOL, V13, P594, DOI 10.1016/j.redox.2017.08.002; Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17; Williamson LM, 2002, J EPIDEMIOL COMMUN H, V56, P285, DOI 10.1136/jech.56.4.285; Wu HJ, 2016, J PINEAL RES, V61, P241, DOI 10.1111/jpi.12344; Yan EB, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0328-2; Yue JK, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080093; Zhang Z, 2015, J NEUROTRAUM, V32, P1369, DOI 10.1089/neu.2014.3701; Zunszain PA, 2012, NEUROPSYCHOPHARMACOL, V37, P939, DOI 10.1038/npp.2011.277	120	17	18	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2019	36	1					74	86		10.1089/neu.2017.5450		SEP 2018	13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HF0PB	WOS:000444269100001	30019623				2022-02-06	
J	Keenan, HT; Presson, AP; Clark, AE; Cox, CS; Ewing-Cobbs, L				Keenan, Heather T.; Presson, Angela P.; Clark, Amy E.; Cox, Charles S.; Ewing-Cobbs, Linda			Longitudinal Developmental Outcomes after Traumatic Brain Injury in Young Children: Are Infants More Vulnerable Than Toddlers?	JOURNAL OF NEUROTRAUMA			English	Article						infant; neurodevelopment; pediatric; traumatic brain injury	FUNCTIONAL PLASTICITY; SOCIAL OUTCOMES; WHITE-MATTER; TERM; PREDICTORS	Children under 4 years of age have the highest incidence of traumatic brain injury (TBI) among the non-elderly and may be at high risk of poor developmental outcomes. We prospectively enrolled a cohort of children injured before 31 months old with TBI or orthopedic injury (OI), from 2013 to 2015 at two pediatric level 1 trauma centers to study very young children's developmental outcomes after injury. We used Ages & Stages-3 and Ages & Stages: Social-Emotional screening tools to measure children's development at pre-injury and 3 and 12 months post-injury. The cohort included 123 children with TBI categorized as mild (n=48), complicated-mild or moderate (n=54), and severe (n=21) and 45 children with OI. Generalized linear models examined effects of injury severity and age at injury controlling for pre-injury ratings. Children with mild or complicated-mild/moderate TBI generally remained on developmental track. Compared to OI, children with severe TBI tended to have a negative developmental trajectory with decrements in communication (-7.07; 95% confidence interval [CI], -13.7, -0.48), gross motor (-15.2; 95% CI, -21.1, -9.19), problem solving (-11.6; 95% CI, -17.9, -5.29), personal-social (-16.8; 95% CI, -22.8, -10.8), and social-emotional (21.0; 95% CI, 7.32, 34.7) domains 12 months post-injury. Developmental effects from TBI differed by age at injury: Infants had more difficulties than older children in communication and problem-solving domains. Despite low developmental scores in 28% of the cohort, only 5% were receiving Early Childhood Intervention (ECI) services 12 months after injury. Early age at injury is a vulnerability factor after TBI. Young age and severe injury should prompt evaluation for ECI.	[Keenan, Heather T.; Presson, Angela P.; Clark, Amy E.] Univ Utah, Dept Pediat, 295 Chipeta Way,POB 581289, Salt Lake City, UT 84158 USA; [Presson, Angela P.] Univ Utah, Dept Internal Med, Div Epidemiol, Salt Lake City, UT 84112 USA; [Cox, Charles S.] Univ Texas Houston, Med Sch Houston, Dept Pediat Surg, Houston, TX USA; [Ewing-Cobbs, Linda] Univ Texas Hlth Sci Ctr Houston, Dept Pediat, Houston, TX 77030 USA; [Ewing-Cobbs, Linda] Univ Texas Hlth Sci Ctr Houston, Childrens Learning Inst, Houston, TX 77030 USA		Keenan, HT (corresponding author), Univ Utah, Dept Pediat, 295 Chipeta Way,POB 581289, Salt Lake City, UT 84158 USA.	heather.keenan@hsc.utah.edu			CDCUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U01/CE002188]; National Institutes of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K24HD072984]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002538] Funding Source: NIH RePORTER; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U01CE002188] Funding Source: NIH RePORTER	This study was supported by the CDC under Cooperative Agreement U01/CE002188. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the CDC. This study was supported also by the National Institutes of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD; K24HD072984). Neither the NICHD nor the CDC played a role in the design or conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Bellerose J, 2017, NEUROPSYCHOLOGY, V31, P229, DOI 10.1037/neu0000341; Bernard CO, 2016, J INT NEUROPSYCH SOC, V22, P793, DOI 10.1017/S1355617716000709; BRONFENBRENNER U, 1977, AM PSYCHOL, V32, P513, DOI 10.1037/0003-066x.32.7.513; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cheong JL, 2017, JAMA PEDIATR, V171, DOI 10.1001/jamapediatrics.2016.4805; Crowe LM, 2013, CHILD NEUROPSYCHOL, V19, P113, DOI 10.1080/09297049.2011.651079; Crowe LM, 2012, PEDIATRICS, V129, pE262, DOI 10.1542/peds.2011-0438; Dennis M, 2014, NEUROPSYCHOL REV, V24, P389, DOI 10.1007/s11065-014-9261-x; Dubois J, 2014, NEUROSCIENCE, V276, P48, DOI 10.1016/j.neuroscience.2013.12.044; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Ewing-Cobbs L, 2003, DEV NEUROPSYCHOL, V24, P669, DOI 10.1207/S15326942DN242&3_08; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Ewing-Cobbs L, 2013, J INT NEUROPSYCH SOC, V19, P497, DOI 10.1017/S1355617713000210; GENNARELLI TA, 2008, ABBREVIATED INJURY S, DOI DOI 10.1089/NEU.2016.4744; HEBB D. O., 1942, PROC AMER PHIL SOC, V85, P275; Kaldoja ML, 2015, J CHILD NEUROL, V30, P860, DOI 10.1177/0883073814544705; Keenan HT, 2007, PEDIATRICS, V119, pE616, DOI 10.1542/peds.2006-2313; Keenan HT, 2018, J NEUROTRAUM, V35, P286, DOI 10.1089/neu.2017.5265; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Marr A., 2004, CENTRAL NERVOUS SYST; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; National Center for Injury Prevention and Control, 2003, C MILD TRAUM BRAIN I; Pinheiro JBD., 2016, NLME LINEAR NONLINEA; Prasad M.R, 2014, HDB NEUROPSYCHOLOGY; Prasad MR, 2017, J HEAD TRAUMA REHAB, V32, pE24, DOI 10.1097/HTR.0000000000000218; R Core Team, 2016, R LANG ENV STAT COMP; REILLY PL, 1988, CHILD NERV SYST, V4, P30; RISEN SR, 2014, J PEDIAT, V164; Rogers CE, 2016, PEDIATR RES, V79, P87, DOI 10.1038/pr.2015.172; Runyan DK, 1998, PEDIATRICS, V101, P12, DOI 10.1542/peds.101.1.12; Schonhaut L, 2013, PEDIATRICS, V131, pE1468, DOI 10.1542/peds.2012-3313; SQUIRES J, 2002, AGES STAGES QUESTION, DOI DOI 10.1016/J.FINEL.2011.05.007; SQUIRES J, 2009, THE ASQ USERS GUIDE, DOI DOI 10.1089/NEU.2013.3268; SQUIRES J, 2009, AGES STAGES QUESTION, DOI DOI 10.1007/S10439-014-1193-3; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; *TEX CAR CHILDR ME, 2016, LEFT OUT IMP STAT CU, DOI DOI 10.1148/RADIOL.2016160564; Wade SL, 2016, JAMA PEDIATR, V170, P343, DOI 10.1001/jamapediatrics.2015.4485; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535	43	17	17	1	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2019	36	2					282	292		10.1089/neu.2018.5687		SEP 2018	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	HM4LJ	WOS:000444042100001	30019631	Green Published			2022-02-06	
J	Bland, ML; McNally, C; Rowson, S				Bland, Megan L.; McNally, Craig; Rowson, Steven			Differences in Impact Performance of Bicycle Helmets During Oblique Impacts	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article						cycling; concussion; injury risk; impact attenuation; acceleration; biomechanics	SCHOOL FOOTBALL PLAYERS; HEAD-INJURIES; REAL-WORLD; CONCUSSION; RISK; ACCELERATION; DAMAGE	Cycling is a leading cause of sport-related head injuries in the U.S. Although bicycle helmets must comply with standards limiting head acceleration in severe impacts, helmets are not evaluated under more common, concussive-level impacts, and limited data are available indicating which helmets offer superior protection. Further, standards evaluate normal impacts, while real-world cyclist head impacts are oblique-involving normal and tangential velocities. The objective of this study was to investigate differences in protective capabilities of ten helmet models under common real-world accident conditions. Oblique impacts were evaluated through drop tests onto an angled anvil at common cyclist head impact velocities and locations. Linear and rotational accelerations were evaluated and related to concussion risk, which was then correlated with design parameters. Significant differences were observed in linear and rotational accelerations between models, producing concussion risks spanning >50% within single impact configurations. Risk differences were more attributable to linear acceleration, as rotational varied less between models. At the temporal location, shell thickness, vent configuration, and radius of curvature were found to influence helmet effective stiffness. This should be optimized to reduce impact kinematics. At the frontal, helmet rim location, liner thickness tapered off for some helmets, likely due to lack of standards testing at this location. This is a frequently impacted location for cyclists, suggesting that the standards testable area should be expanded to include the rim. These results can inform manufacturers, standards bodies, and consumers alike, aiding the development of improved bicycle helmet safety.	[Bland, Megan L.] Virginia Tech, Dept Biomed Engn & Mech, 440 Kelly Hall,325 Stanger St, Blacksburg, VA 24061 USA; [McNally, Craig] Virginia Tech, Ctr Injury Biomech, 2280 Kraft Dr VCOM 2 Bldg, Blacksburg, VA 24060 USA; [Rowson, Steven] Virginia Tech, Dept Biomed Engn & Mech, 343 Kelly Hall,325 Stanger St, Blacksburg, VA 24061 USA		Bland, ML (corresponding author), Virginia Tech, Dept Biomed Engn & Mech, 440 Kelly Hall,325 Stanger St, Blacksburg, VA 24061 USA.	mbland27@vt.edu; cmcnally@vt.edu; rowson@vt.edu	Rowson, Steven/B-1270-2012	Rowson, Steven/0000-0002-3227-0596	Virginia Tech Institute of Critical Technology and Applied Science (ICTAS, Blacksburg, VA); Insurance Institute for Highway Safety (IIHS, Ruckersville, VA)	This research was supported by the Virginia Tech Institute of Critical Technology and Applied Science (ICTAS, Blacksburg, VA) and the Insurance Institute for Highway Safety (IIHS, Ruckersville, VA).	AANS, 2014, SPORTS REL HEAD INJ; Aare Magnus, 2003, Traffic Inj Prev, V4, P240, DOI 10.1080/15389580309879; Amoros E, 2012, INJURY PREV, V18, P27, DOI 10.1136/ip.2011.031815; Bland ML, 2018, TRAFFIC INJ PREV, V19, pS158, DOI 10.1080/15389588.2017.1388915; Bourdet N, 2014, INT J CRASHWORTHINES, V19, P222, DOI 10.1080/13588265.2013.805293; Bourdet N, 2012, P I MECH ENG P-J SPO, V226, P282, DOI 10.1177/1754337112442326; Ching RP, 1997, ACCIDENT ANAL PREV, V29, P555, DOI 10.1016/S0001-4575(97)00008-0; Cobb BR, 2017, P I MECH ENG P; Cobb BR, 2016, P I MECH ENG P-J SPO, V230, P50, DOI 10.1177/1754337115599133; Cobb BR, 2015, P I MECH ENG P-J SPO, V229, P39, DOI 10.1177/1754337114548245; CPSC, 2015, NAT EL INJ SURV SYST; Cripton PA, 2014, ACCIDENT ANAL PREV, V70, P1, DOI 10.1016/j.aap.2014.02.016; Depreitere B, 2004, ACCIDENT ANAL PREV, V36, P561, DOI 10.1016/S0001-4575(03)00062-9; ECE, 1999, R2205 ECE; Elvik R, 2013, ACCIDENT ANAL PREV, V60, P245, DOI 10.1016/j.aap.2012.12.003; Fahlstedt M., 2012, 2012 IRCOBI C P INT, P787, DOI DOI 10.1177/1753193412460139; Gennarelli TA, 1972, 720970 SAE; Ghajari M, 2013, ACCIDENT ANAL PREV, V50, P263, DOI 10.1016/j.aap.2012.04.016; Halldin P., 2013, HELMET PERFORMANCE D; Hansen K, 2013, ACCIDENT ANAL PREV, V59, P109, DOI 10.1016/j.aap.2013.05.019; Hering A., 2000, P IRCOBI C MONTP FRA, P307; King A. I., 2003, IRCOBI C LISB PORT; Klug C., 2015, INT RES COUNC BIOM I; Laituri T. R., 2015, 2015011437 SAE; Langburt W, 2001, J CHILD NEUROL, V16, P83, DOI 10.1177/088307380101600203; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McIntosh A, 1998, ACCIDENT ANAL PREV, V30, P161, DOI 10.1016/S0001-4575(97)00089-4; McIntosh AS, 2013, TRAFFIC INJ PREV, V14, P501, DOI 10.1080/15389588.2012.727217; Mertz Harold J, 2003, Stapp Car Crash J, V47, P155; Mills NJ, 2008, INT J IMPACT ENG, V35, P1075, DOI 10.1016/j.ijimpeng.2007.05.005; Mills NJ, 2008, INT J IMPACT ENG, V35, P1087, DOI 10.1016/j.ijimpeng.2007.05.006; Mills N J, 1990, Br J Sports Med, V24, P55; Mills NJ, 1996, INT J CRASHWORTHINES, V2, P7; Milne G, 2014, INT J CRASHWORTHINES, V19, P323, DOI 10.1080/13588265.2013.859470; Newman J A, 2000, Stapp Car Crash J, V44, P215; Nightingale RW, 1996, J BIOMECH, V29, P307, DOI 10.1016/0021-9290(95)00056-9; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; Ommaya AK, 1966, P 10 STAPP CAR CRASH, V10, P314; Otte D, 1989, 892425 SAE; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Peng Y, 2012, SAFETY SCI, V50, P1749, DOI 10.1016/j.ssci.2012.03.005; Rowson B, 2015, ANN BIOMED ENG, V43, P2429, DOI 10.1007/s10439-015-1278-7; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, J APPL BIOMECH, V27, P8, DOI 10.1123/jab.27.1.8; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; SACKS JJ, 1991, JAMA-J AM MED ASSOC, V266, P3016, DOI 10.1001/jama.266.21.3016; Sances A, 2002, BIOMED SCI INSTRUM, V38, P459; Schulman J, 2002, INJ PREV, V8, P47, DOI 10.1136/ip.8.1.47; SMITH TA, 1994, ACCIDENT ANAL PREV, V26, P795, DOI 10.1016/0001-4575(94)90055-8; Stigson H., 2017, INT RES COUNC BIOM I; Thibault L., 1971, P 15 STAPP CAR CRASH; Thompson DC, 1996, JAMA-J AM MED ASSOC, V276, P1968, DOI 10.1001/jama.276.24.1968; Unterharnscheidt F. J., 1971, 710880 SAE; Verschueren P., 2009, BIOMECHANICAL ANAL H; WILLIAMS M, 1991, ACCIDENT ANAL PREV, V23, P119, DOI 10.1016/0001-4575(91)90043-5	56	17	17	0	16	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731	1528-8951		J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	SEP	2018	140	9							091005	10.1115/1.4040019			10	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biophysics; Engineering	GW9BN	WOS:000447276700005	29801168				2022-02-06	
J	Chien, L; Liang, ML; Chang, CY; Wang, C; Chen, LY				Chien, Ling; Liang, Min-Long; Chang, Chu-Yuan; Wang, Chen; Chen, Linyi			Mitochondrial therapy promotes regeneration of injured hippocampal neurons	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE			English	Article						Brain injury; Neuronal regeneration; Mitochondrial morphogenesis	TRAUMATIC BRAIN-INJURY; ISCHEMIA-REPERFUSION INJURY; MOUSE MODEL; TRANSPLANTATION; CELLS; FUSION; DAMAGE; DYSFUNCTION; TRANSPORT; DIVISION	Due to the inhibitory microenvironment and reduced intrinsic growth capacity of neurons, neuronal regeneration of central nervous system remains challenging. Neurons are highly energy demanding and require sufficient mitochondria to support cellular activities. In response to stimuli, mitochondria undergo fusion/fission cycles to adapt to environment. It is thus logical to hypothesize that the plasticity of mitochondrial dynamics is required for neuronal regeneration. In this study, we examined the role of mitochondrial dynamics during regeneration of rat hippocampal neurons. Quantitative analysis showed that injury induced mitochondrial fission. As mitochondrial dysfunction has been implicated in neurodegenerative diseases, we tested the possibility that the mitochondrial therapy may promote neuronal regeneration. Supplying freshly isolated mitochondria to the injured hippocampal neurons not only significantly increased neurite re-growth but also restored membrane potential of injured hippocampal neurons. Together, our findings support the importance of mitochondrial dynamics during regeneration of injured hippocampal neurons and highlight the therapeutic prospect of mitochondria to the injured central nervous system.	[Chien, Ling; Liang, Min-Long; Chang, Chu-Yuan; Chen, Linyi] Natl Tsing Hua Univ, Inst Mol Med, 101,Sect 2,Kuang Fu Rd, Hsinchu 30013, Taiwan; [Wang, Chen] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 30013, Taiwan; [Chen, Linyi] Natl Tsing Hua Univ, Dept Med Sci, 101,Sect 2,Kuang Fu Rd, Hsinchu 30013, Taiwan		Chen, LY (corresponding author), Natl Tsing Hua Univ, Inst Mol Med, 101,Sect 2,Kuang Fu Rd, Hsinchu 30013, Taiwan.; Chen, LY (corresponding author), Natl Tsing Hua Univ, Dept Med Sci, 101,Sect 2,Kuang Fu Rd, Hsinchu 30013, Taiwan.	lchen@life.nthu.edu.tw	Chen, Linyi/AAV-2632-2020	Chen, Linyi/0000-0001-7258-8817	National Health Research Institutes, TaiwanNational Health Research Institutes - Taiwan [NHRI-EX106-10206NI]	This works was supported by National Health Research Institutes, Taiwan (Grant# NHRI-EX106-10206NI).	Chang JC, 2016, TRANSL RES, V170, P40, DOI 10.1016/j.trsl.2015.12.003; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Chen CJ, 2015, J BIOL CHEM, V290, P6010, DOI 10.1074/jbc.M114.603795; Chien L, 2015, ONCOTARGET, V6, P30628, DOI 10.18632/oncotarget.5790; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Cruz-Haces M, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0088-2; Di Pietro V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09587-2; Fairless R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058260; Fischer TD, 2016, FRONT SYST NEUROSCI, V10, DOI [10.3389/fnsys.2016.00029, 10.3389/fnsys.2010.00020]; Gupta R, 2016, REV NEUROSCIENCE, V27, P93, DOI 10.1515/revneuro-2015-0017; Hayakawa K, 2016, NATURE, V535, P551, DOI 10.1038/nature18928; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kann O, 2007, AM J PHYSIOL-CELL PH, V292, pC641, DOI 10.1152/ajpcell.00222.2006; Katrangi E, 2007, REJUV RES, V10, P561, DOI 10.1089/rej.2007.0575; Kaza AK, 2017, J THORAC CARDIOV SUR, V153, P934, DOI 10.1016/j.jtcvs.2016.10.077; Li X, 2014, AM J RESP CELL MOL, V51, P455, DOI 10.1165/rcmb.2013-0529OC; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Lin HC, 2013, SHOCK, V39, P304, DOI 10.1097/SHK.0b013e318283035f; Masuzawa A, 2013, AM J PHYSIOL-HEART C, V304, pH966, DOI 10.1152/ajpheart.00883.2012; McCully JD, 2016, CLIN TRANSL MED, V5, DOI 10.1186/s40169-016-0095-4; McCully JD, 2009, AM J PHYSIOL-HEART C, V296, pH94, DOI 10.1152/ajpheart.00567.2008; Miller KE, 2004, J CELL SCI, V117, P2791, DOI 10.1242/jcs.01130; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Ni HM, 2015, REDOX BIOL, V4, P6, DOI 10.1016/j.redox.2014.11.006; Pacak CA, 2015, BIOL OPEN, V4, P622, DOI 10.1242/bio.201511478; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Plotnikov EY, 2015, BIOCHEMISTRY-MOSCOW+, V80, P542, DOI 10.1134/S0006297915050041; Rojo M, 2002, J CELL SCI, V115, P1663; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Shih CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079619; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Wang X, 2015, CELL DEATH DIFFER, V22, P1181, DOI 10.1038/cdd.2014.211; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Wu Q, 2016, BRAIN RES, V1630, P134, DOI 10.1016/j.brainres.2015.11.016	37	17	20	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-4439	0006-3002		BBA-MOL BASIS DIS	Biochim. Biophys. Acta-Mol. Basis Dis.	SEP	2018	1864	9	B				3001	3012		10.1016/j.bbadis.2018.06.012			12	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics; Cell Biology	GQ8ZR	WOS:000442056200023	29913215	Bronze			2022-02-06	
J	Landry-Roy, C; Bernier, A; Gravel, J; Beauchamp, MH				Landry-Roy, Catherine; Bernier, Annie; Gravel, Jocelyn; Beauchamp, Miriam H.			Executive Functions and Their Relation to Sleep Following Mild Traumatic Brain Injury in Preschoolers	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Brain injuries; Executive function; Sleep; Child; Cognition; Preschool	CHILD-BEHAVIOR CHECKLIST; SCHOOL-AGE-CHILDREN; YOUNG-CHILDREN; PREFRONTAL CORTEX; INDIVIDUAL-DIFFERENCES; FUNCTION OUTCOMES; CORTISOL-LEVELS; RESTRICTION; CONSEQUENCES; ADOLESCENTS	Objectives: Traumatic brain injury (TBI) sustained during childhood is known to impact children's executive functioning. However, few studies have focused specifically on executive functioning after preschool TBI. TBI has also been associated with sleep disturbances, which are known to impair executive functions in healthy children. The aim of this study was to investigate executive functions in preschoolers with mild TBI, and to determine the role of sleep in the links between TBI and executive functioning. Methods: The sample was drawn from a longitudinal study and included 167 children, aged 18 to 60 months, divided into 2 groups: children with accidental mild TBI (n = 84) and typically developing children (n = 83). Children were assessed 6 months post-injury on executive function measures (inhibition and cognitive flexibility) and sleep measures (actigraphy data and parental rating of sleep problems). Results: The two groups did not differ in their executive abilities. However, relative to controls, children with mild TBI and shorter nighttime sleep duration or increased sleep problems exhibited poorer executive functions. Conclusions: These results support a "double hazard" effect, whereby the combination of sleep disturbances and mild TBI results in poorer executive functions. The findings highlight the importance of assessing and monitoring the quality of sleep even after mild head injuries. Poor sleep may place children at risk for increased cognitive difficulties.	[Landry-Roy, Catherine; Bernier, Annie; Gravel, Jocelyn; Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada; [Landry-Roy, Catherine; Gravel, Jocelyn; Beauchamp, Miriam H.] CHU St Justine Res Ctr, Montreal, PQ, Canada		Beauchamp, MH (corresponding author), Univ Montreal, Dept Psychol, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	miriam.beauchamp@umontreal.ca			Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [MOP11036]	The authors declare no conflicts of interests. This study was funded by the Canadian Institutes of Health Research (MOP11036 to M.H.B.). Thank you to the lab members for their collaborative efforts.	Acebo C, 1999, SLEEP, V22, P95, DOI 10.1093/sleep/22.1.95; Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Alhola Paula, 2007, Neuropsychiatr Dis Treat, V3, P553; Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Anderson V, 1998, NEUROPSYCHOL REHABIL, V8, P319, DOI 10.1080/713755568; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Asikainen I, 1996, BRAIN INJURY, V10, P883, DOI 10.1080/026990596123864; Astill RG, 2012, PSYCHOL BULL, V138, P1109, DOI 10.1037/a0028204; Beauchamp M, 2011, DEV NEUROPSYCHOL, V36, P578, DOI 10.1080/87565641.2011.555572; Beauchamp MH, 2017, J NEUROTRAUM, V34, P2545, DOI 10.1089/neu.2016.4868; Beck DM, 2011, J COGN DEV, V12, P169, DOI 10.1080/15248372.2011.563485; Becker SP, 2015, SLEEP MED, V16, P79, DOI 10.1016/j.sleep.2014.09.008; Belanger ME, 2018, J CLIN CHILD ADOLESC, V47, P366, DOI 10.1080/15374416.2015.1079782; Belanger ME, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00158; Belanger ME, 2013, J CLIN SLEEP MED, V9, P701, DOI 10.5664/jcsm.2844; Bellerose J, 2017, NEUROPSYCHOLOGY, V31, P229, DOI 10.1037/neu0000341; Bellerose J, 2015, J INT NEUROPSYCH SOC, V21, P483, DOI 10.1017/S1355617715000569; Benington JH, 2003, PROG NEUROBIOL, V69, P71, DOI 10.1016/S0301-0082(03)00018-2; Bernier A, 2013, CHILD DEV, V84, P1542, DOI 10.1111/cdev.12063; Bernier A, 2010, CHILD DEV, V81, P1739, DOI 10.1111/j.1467-8624.2010.01507.x; BLISHEN BR, 1987, CAN REV SOC ANTHROP, V24, P465; Byars KC, 2011, SLEEP MED, V12, P898, DOI 10.1016/j.sleep.2011.05.002; Carlson SA, 2005, DEV NEUROPSYCHOL, V28, P595, DOI 10.1207/s15326942dn2802_3; Carlson SM, 2005, PSYCHOL SCI, V16, P609, DOI 10.1111/j.1467-9280.2005.01583.x; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Collins A, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001293; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Crowe LM, 2013, CHILD NEUROPSYCHOL, V19, P113, DOI 10.1080/09297049.2011.651079; Dahl RE, 1996, DEV PSYCHOPATHOL, V8, P3, DOI 10.1017/S0954579400006945; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Durston S, 2006, NEUROPSYCHOLOGIA, V44, P2149, DOI 10.1016/j.neuropsychologia.2005.10.010; Ennis Elaine, 2004, Pediatr Rehabil, V7, P205, DOI 10.1080/13638490410001703316; ESCALONA SK, 1982, PEDIATRICS, V70, P670; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; Friedman NP, 2009, SLEEP, V32, P323, DOI 10.1093/sleep/32.3.323; Gagner C, 2018, PSYCHOL MED, V48, P1551, DOI 10.1017/S0033291717003221; Gagner C, 2015, J NEUROTRAUM, V32, P1539, DOI 10.1089/neu.2014.3753; Ganesalingam K, 2011, NEUROPSYCHOLOGY, V25, P466, DOI 10.1037/a0022768; Garon N, 2008, PSYCHOL BULL, V134, P31, DOI 10.1037/0033-2909.134.1.31; Goldberg E, 2005, PSYCHIAT CLIN N AM, V28, P567, DOI 10.1016/j.psc.2005.05.005; Gregory AM, 2009, PEDIATRICS, V123, P1171, DOI 10.1542/peds.2008-0825; Gruber R, 2011, SLEEP, V34, P315, DOI 10.1093/sleep/34.3.315; Harrison Y, 2000, Q J EXP PSYCHOL-A, V53, P271, DOI 10.1080/027249800390772; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; HORNE JA, 1993, BRIT J PSYCHIAT, V162, P413, DOI 10.1192/bjp.162.3.413; INGVAR DH, 1979, ACTA NEUROL SCAND, V60, P12, DOI 10.1111/j.1600-0404.1979.tb02947.x; Isquith PK, 2005, MENT RETARD DEV D R, V11, P209, DOI 10.1002/mrdd.20075; Jacobs R, 2007, CORTEX, V43, P792, DOI 10.1016/S0010-9452(08)70507-0; Jones K, 2001, SLEEP MED REV, V5, P463, DOI 10.1053/smrv.2001.0203; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; KJELLBERG A, 1977, WAKING SLEEPING, V1, P145; Kochanska G, 2000, DEV PSYCHOL, V36, P220, DOI 10.1037//0012-1649.36.2.220; KOSLOWSKY M, 1992, CHRONOBIOL INT, V9, P132, DOI 10.3109/07420529209064524; Kreutzmann JC, 2015, NEUROSCIENCE, V309, P173, DOI 10.1016/j.neuroscience.2015.04.053; Lalonde G, 2016, J NEUROPSYCHOL, V12, P1; Landry-Roy C, 2017, J HEAD TRAUMA REHAB, V32, pE13, DOI 10.1097/HTR.0000000000000303; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; LEZAK MD, 1982, INT J PSYCHOL, V17, P281, DOI 10.1080/00207598208247445; Loher S, 2014, APPL NEUROPSYCH-CHIL, V3, P103, DOI 10.1080/21622965.2012.716752; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; Meerlo P, 2009, SLEEP MED REV, V13, P187, DOI 10.1016/j.smrv.2008.07.004; Meltzer LJ, 2012, SLEEP, V35, P159, DOI 10.5665/sleep.1608; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Mustafa AG, 2013, NEUROSCIENCES, V18, P222; Muzur A, 2002, TRENDS COGN SCI, V6, P475, DOI 10.1016/S1364-6613(02)01992-7; Nadebaum C, 2007, DEV NEUROPSYCHOL, V32, P703, DOI 10.1080/87565640701376086; Nelson TD, 2015, DEV NEUROPSYCHOL, V40, P167, DOI 10.1080/87565641.2015.1020946; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Owens JA, 2000, SLEEP, V23, P1043; Preacher KJ, 2006, J EDUC BEHAV STAT, V31, P437, DOI 10.3102/10769986031004437; Randazzo AC, 1998, SLEEP, V21, P861; Sadeh A, 2003, CHILD DEV, V74, P444, DOI 10.1111/1467-8624.7402008; Sadeh A, 2002, CHILD DEV, V73, P405, DOI 10.1111/1467-8624.00414; Sadeh A, 2015, MONOGR SOC RES CHILD, V80, P33, DOI 10.1111/mono.12143; Sadeh A, 2007, SLEEP MED CLIN, V2, P513, DOI 10.1016/j.jsmc.2007.05.012; Sazonov E, 2004, PHYSIOL MEAS, V25, P1291, DOI 10.1088/0967-3334/25/5/018; Scher A, 2010, DEV PSYCHOBIOL, V52, P44, DOI 10.1002/dev.20410; Shay N, 2014, J NEUROTRAUM, V31, P1305, DOI 10.1089/neu.2013.3275; Thurber S., 2012, ARCH ASSESSMENT PSYC, V2, P73; Tsujimoto S, 2008, NEUROSCIENTIST, V14, P345, DOI 10.1177/1073858408316002; Uttl B, 2005, PSYCHOL SCI, V16, P460; Wang LJ, 2008, MULTIVAR BEHAV RES, V43, P476, DOI 10.1080/00273170802285941; Ward TM, 2008, BIOL RES NURS, V9, P244, DOI 10.1177/1099800407310158; Wood AG, 2010, STUD NEUROPSYCHOL NE, P203; Zelazo PD, 2006, NAT PROTOC, V1, P297, DOI 10.1038/nprot.2006.46	86	17	17	1	8	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	SEP	2018	24	8					769	780		10.1017/S1355617718000401			12	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	HG6MJ	WOS:000455095800002	30113277				2022-02-06	
J	Wang, C; Iashchishyn, IA; Pansieri, J; Nystrom, S; Klementieva, O; Kara, J; Horvath, I; Moskalenko, R; Rofougaran, R; Gouras, G; Kovacs, GG; Shankar, SK; Morozova-Roche, LA				Wang, Chao; Iashchishyn, Igor A.; Pansieri, Jonathan; Nystrom, Sofie; Klementieva, Oxana; Kara, John; Horvath, Istvan; Moskalenko, Roman; Rofougaran, Reza; Gouras, Gunnar; Kovacs, Gabor G.; Shankar, S. K.; Morozova-Roche, Ludmilla A.			S100A9-Driven Amyloid-Neuroinflammatory Cascade in Traumatic Brain Injury as a Precursor State for Alzheimer's Disease	SCIENTIFIC REPORTS			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PRO-INFLAMMATORY S100A9; COGNITIVE IMPAIRMENT; PROTEIN; EXPRESSION; MRP8; MECHANISMS; PATHOLOGY; MEMORY; MRP-14	Pro-inflammatory and amyloidogenic S100A9 protein is an important contributor to Alzheimer's disease (AD) pathology. Traumatic brain injury (TBI) is viewed as a precursor state for AD. Here we have shown that S100A9-driven amyloid-neuroinflammatory cascade was initiated in TBI and may serve as a mechanistic link between TBI and AD. By analyzing the TBI and AD human brain tissues, we demonstrated that in post-TBI tissues S100A9, produced by neurons and microglia, becomes drastically abundant compared to A beta and contributes to both precursor-plaque formation and intracellular amyloid oligomerization. Conditions implicated in TBI, such as elevated S100A9 concentration, acidification and fever, provide strong positive feedback for S100A9 nucleation-dependent amyloid formation and delay in its proteinase clearance. Consequently, both intracellular and extracellular S100A9 oligomerization correlated with TBI secondary neuronal loss. Common morphology of TBI and AD plaques indicated their similar initiation around multiple aggregation centers. Importantly, in AD and TBI we found S100A9 plaques without A beta. S100A9 and A beta plaque pathology was significantly advanced in AD cases with TBI history at earlier age, signifying TBI as a risk factor. These new findings highlight the detrimental consequences of prolonged post-TBI neuroinflammation, which can sustain S100A9-driven amyloid-neurodegenerative cascade as a specific mechanism leading to AD development.	[Wang, Chao; Iashchishyn, Igor A.; Pansieri, Jonathan; Kara, John; Horvath, Istvan; Moskalenko, Roman; Rofougaran, Reza; Morozova-Roche, Ludmilla A.] Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden; [Iashchishyn, Igor A.] Sumy State Univ, Dept Gen Chem, UA-40000 Sumy, Ukraine; [Nystrom, Sofie] Linkoping Univ, Dept Chem, IFM, S-58183 Linkoping, Sweden; [Klementieva, Oxana; Gouras, Gunnar] Lund Univ, Dept Expt Med Sci, S-22184 Lund, Sweden; [Moskalenko, Roman] Sumy State Univ, Dept Pathol, UA-40000 Sumy, Ukraine; [Kovacs, Gabor G.] Med Univ Vienna, Inst Neurol, A-1097 Vienna, Austria; [Shankar, S. K.] Natl Inst Mental Hlth & Neurosci, Dept Neuropathol, Human Brain Tissue Repository, Bangalore 560029, Karnataka, India		Wang, C; Morozova-Roche, LA (corresponding author), Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden.	chao.wang@wustl.edu; Ludmilla.Morozova-Roche@umu.se	Iashchishyn, Igor/AAL-4677-2021; Kovacs, Gabor G/A-7468-2013; Gouras, Gunnar/B-3021-2010; Horvath, Istvan/B-1889-2009; Moskalenko, Roman/I-3208-2017; Morozova-Roche, Ludmilla A./AAU-9044-2021	Kovacs, Gabor G/0000-0003-3841-5511; Gouras, Gunnar/0000-0002-5500-6325; Horvath, Istvan/0000-0003-4262-1430; Moskalenko, Roman/0000-0002-2342-0337; Pansieri, Jonathan/0000-0001-8918-9943	ALF Vasterbotten Lans Landsting; Swedish Medical Research CouncilSwedish Medical Research Council (SMRC)European Commission; FP-7 Marie Curie Action "Nano-Guard"; Insamlingsstiftelsen; Swedish Alzheimer's Foundation; Swedish Institute	We thank Peter Nilsson for the gift of amyloid specific h-FTAA fluorescence dye, Fredrik Clausen for experimental TBI work, Per Hammarstrom for helpful discussion and analysis of immunofluorescence results, Vinod K Narayana for connecting us with S.K.S. and delivering pilot samples. We thank for financial support ALF Vasterbotten Lans Landsting (L.A.M.-R.), Swedish Medical Research Council (L.A.M.-R.), FP-7 Marie Curie Action "Nano-Guard" (I.A.I., R.M., L.A.M.-R.), Insamlingsstiftelsen (L.A.M.-R.), Swedish Alzheimer's Foundation (S.N.) and Swedish Institute (R.M.).	Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Botelho HM, 2012, J BIOL CHEM, V287, P42233, DOI 10.1074/jbc.M112.396416; Bresnick AR, 2015, NAT REV CANCER, V15, P96, DOI 10.1038/nrc3893; Breunig JJ, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00026; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Chen B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115828; Clark RSB, 1999, FASEB J, V13, P813, DOI 10.1096/fasebj.13.8.813; Cole GM, 2010, CNS NEUROL DISORD-DR, V9, P140, DOI 10.2174/187152710791011991; Di Virgilio TG, 2016, EBIOMEDICINE, V13, P66, DOI 10.1016/j.ebiom.2016.10.029; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Engel S, 2000, ACTA NEUROPATHOL, V100, P313, DOI 10.1007/s004019900172; Eremenko E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058218; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Fritz G, 2010, FEBS J, V277, P4578, DOI 10.1111/j.1742-4658.2010.07887.x; Frosch M, 2000, ARTHRITIS RHEUM-US, V43, P628, DOI 10.1002/1529-0131(200003)43:3<628::AID-ANR20>3.0.CO;2-X; Goldberg EL, 2017, CELL REP, V18, P2077, DOI 10.1016/j.celrep.2017.02.004; Gruden MA, 2018, ACS CHEM NEUROSCI, V9, P568, DOI 10.1021/acschemneuro.7b00379; Gruden MA, 2016, BEHAV BRAIN RES, V306, P106, DOI 10.1016/j.bbr.2016.03.016; Gupta AK, 2004, J NEUROTRAUM, V21, P678, DOI 10.1089/0897715041269722; Ha TY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008840; HESSIAN PA, 1993, J LEUKOCYTE BIOL, V53, P197, DOI 10.1002/jlb.53.2.197; Horvath I, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1210-9; Horvath I, 2016, ACS CHEM NEUROSCI, V7, P34, DOI 10.1021/acschemneuro.5b00265; Iashchishyn IA, 2018, ACS CHEM NEUROSCI, V9, P1338, DOI 10.1021/acschemneuro.7b00512; Iashchishyn IA, 2017, ACS CHEM NEUROSCI, V8, P2152, DOI 10.1021/acschemneuro.7b00251; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; in 't Veld BA, 2001, NEW ENGL J MED, V345, P1515, DOI 10.1056/NEJMoa010178; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Klingstedt T, 2011, ORG BIOMOL CHEM, V9, P8356, DOI 10.1039/c1ob05637a; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Leclerc Estelle, 2011, Front Biosci (Schol Ed), V3, P1232; Lodeiro M, 2017, J GERONTOL A-BIOL, V72, P319, DOI 10.1093/gerona/glw073; Ma LP, 2012, INT J CARDIOL, V155, P26, DOI 10.1016/j.ijcard.2011.01.082; Malisauskas M, 2010, J MOL BIOL, V396, P60, DOI 10.1016/j.jmb.2009.11.012; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McGeer EG, 2010, J ALZHEIMERS DIS, V19, P355, DOI 10.3233/JAD-2010-1219; Mork G, 2003, BRIT J DERMATOL, V149, P484, DOI 10.1046/j.1365-2133.2003.05536.x; Nacken W, 2003, MICROSC RES TECHNIQ, V60, P569, DOI 10.1002/jemt.10299; Nagareddy PR, 2013, CELL METAB, V17, P695, DOI 10.1016/j.cmet.2013.04.001; OOSAWA F, 1962, J MOL BIOL, V4, P10, DOI 10.1016/S0022-2836(62)80112-0; Postler E, 1997, GLIA, V19, P27, DOI 10.1002/(SICI)1098-1136(199701)19:1<27::AID-GLIA3>3.0.CO;2-7; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; Ryckman C, 2004, J LEUKOCYTE BIOL, V76, P433, DOI 10.1189/jlb.0603294; Sacho RH, 2008, BRIT J NEUROSURG, V22, P497, DOI 10.1080/02688690802245558; Schluesener HJ, 1998, ACTA NEUROPATHOL, V96, P575, DOI 10.1007/s004010050938; Selkoe DJ, 2000, ANN NY ACAD SCI, V924, P17; Shepherd CE, 2006, NEUROBIOL AGING, V27, P1554, DOI 10.1016/j.neurobiolaging.2005.09.033; Simard JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072138; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Soderberg L, 2005, FEBS J, V272, P2231, DOI 10.1111/j.1742-4658.2005.04647.x; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Swindell WR, 2013, SCI REP-UK, V3, DOI 10.1038/srep01215; TUTTE WT, 2001, GRAPH THEORY; van den Bosch MH, 2016, J RHEUMATOL, V43, P1874, DOI 10.3899/jrheum.160270; Vogl T, 2004, BLOOD, V104, P4260, DOI 10.1182/blood-2004-02-0446; Vogl T, 2006, BBA-MOL CELL RES, V1763, P1298, DOI 10.1016/j.bbamcr.2006.08.028; Vogl T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5593; Vogl T, 2012, INT J MOL SCI, V13, P2893, DOI 10.3390/ijms13032893; Wahlstrom A, 2008, FEBS J, V275, P5117, DOI 10.1111/j.1742-4658.2008.06643.x; Wang C, 2014, ACTA NEUROPATHOL, V127, P507, DOI 10.1007/s00401-013-1208-4; Washington PM, 2016, EXP NEUROL, V275, P381, DOI 10.1016/j.expneurol.2015.06.015; Yakovlev AG, 2001, MOL NEUROBIOL, V24, P131; Yanamandra K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005562; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950; Zhao LN, 2013, RSC ADV, V3, P24081, DOI 10.1039/c3ra43665a	67	17	17	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 27	2018	8								12836	10.1038/s41598-018-31141-x			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR7LI	WOS:000442870300014	30150640	Green Published, gold			2022-02-06	
J	Ignowski, E; Winter, AN; Duval, N; Fleming, H; Wallace, T; Manning, E; Koza, L; Huber, K; Serkova, NJ; Linseman, DA				Ignowski, Elizabeth; Winter, Aimee N.; Duval, Nathan; Fleming, Holly; Wallace, Tyler; Manning, Evan; Koza, Lilia; Huber, Kendra; Serkova, Natalie J.; Linseman, Daniel A.			The cysteine-rich whey protein supplement, Immunocal, preserves brain glutathione and improves cognitive, motor, and histopathological indices of traumatic brain injury in a mouse model of controlled cortical impact	FREE RADICAL BIOLOGY AND MEDICINE			English	Article						Traumatic brain injury; Glutathione; Motor function; Cognitive function; Neuroprotection	OXIDATIVE STRESS; ANTIOXIDANT THERAPIES; S-NITROSOGLUTATHIONE; N-ACETYLCYSTEINE; HEAD TRAUMA; RATS; NEURODEGENERATION; POSTINJURY; DEFICITS; DISEASE	Traumatic brain injury (TBI) is a major public health problem estimated to affect nearly 1.7 million people in the United States annually. Due to the often debilitating effects of TBI, novel preventative agents are highly desirable for at risk populations. Here, we tested a whey protein supplement, Immunocal (R), for its potential to enhance resilience to TBI. Immunocal (R) is a non-denatured whey protein preparation which has been shown to act as a cysteine delivery system to increase levels of the essential antioxidant glutathione (GSH). Twice daily oral supplementation of CD1 mice with Immunocal for 28 days prior to receiving a moderate TBI prevented an similar to 25% reduction in brain GSH/GSSG observed in untreated TBI mice. Immunocal (R) had no significant effect on the primary mechanical injury induced by TBI, as assessed by MRI, changes in Tau phosphorylation, and righting reflex time or apnea. However, pre-injury supplementation with Immunocal (R) resulted in statistically significant improvements in motor function (beam walk and rotarod) and cognitive function (Barnes maze). We also observed a significant preservation of corpus callosum width (axonal myelination), a significant decrease in degenerating neurons, a reduction in Ibal (microglial marker), decreased lipid peroxidation, and preservation of brain-derived neurotrophic factor (BDNF) in the brains of Immunocal (R)-pretreated mice compared to untreated TBI mice. Taken together, these data indicate that pre-injury supplementation with Immunocal (R) significantly enhances the resilience to TBI induced by a moderate closed head injury in mice. We conclude that Immunocal may hold significant promise as a preventative agent for TBI, particularly in certain high risk populations such as athletes and military personnel.	[Ignowski, Elizabeth; Winter, Aimee N.; Wallace, Tyler; Manning, Evan; Koza, Lilia] Univ Denver, Dept Biol Sci, Denver, CO 80208 USA; [Duval, Nathan; Fleming, Holly; Linseman, Daniel A.] Univ Denver, Knoebel Inst Hlth Aging, 2155 E Wesley Ave, Denver, CO 80208 USA; [Huber, Kendra; Serkova, Natalie J.] Univ Colorado, Ctr Canc, Aurora, CO 80045 USA; [Linseman, Daniel A.] Univ Denver, Dept Biol Sci, 2155 E Wesley Ave, Denver, CO 80208 USA		Linseman, DA (corresponding author), Univ Denver, Knoebel Inst Hlth Aging, 2155 E Wesley Ave, Denver, CO 80208 USA.; Linseman, DA (corresponding author), Univ Denver, Dept Biol Sci, 2155 E Wesley Ave, Denver, CO 80208 USA.	lizignowski@gmail.com; aimee.n.winter@gmail.com; ng.duval@gmail.com; holly.fleming@du.edu; tywall28@gmail.com; evan.manning@ucdenver.edu; koza.lilia@gmail.com; kendra.huber@ucdenver.edu; natalie.serkova@ucdenver.edu; daniel.linseman@du.edu	Linseman, Daniel/L-3846-2019; Duval, Nathan/N-9252-2019	Duval, Nathan/0000-0002-0287-1999	Immunotec Inc. (Quebec, Canada), Immunocal(R); Knoebel Institute for Healthy Aging at the University of Denver; University of Colorado Cancer Center [NCI P30 CA046934]; Colorado Clinical and Translational Sciences Institute [NIH/NCATS UL1 TR001082]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA046934] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001082] Funding Source: NIH RePORTER	This study was supported in large part by funding from Immunotec Inc. (Quebec, Canada), which is the manufacturer of Immunocal (R). Funding was also provided by a pilot grant from the Knoebel Institute for Healthy Aging at the University of Denver. The University of Colorado Animal Imaging Shared Resources are supported by the University of Colorado Cancer Center (NCI P30 CA046934) and the Colorado Clinical and Translational Sciences Institute (NIH/NCATS UL1 TR001082).	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Al Nimer F, 2013, ANTIOXID REDOX SIGN, V18, P784, DOI 10.1089/ars.2011.4440; Aoyama K, 2006, NAT NEUROSCI, V9, P119, DOI 10.1038/nn1609; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Ban VS, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.2.FOCUS15609; Baruchel S., 1998, OXIDATIVE STRESS CAN, P447; BOUNOUS G, 1993, CLIN INVEST MED, V16, P204; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Choi BY, 2016, AMINO ACIDS, V48, P1619, DOI 10.1007/s00726-016-2221-4; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Faul M., 2010, NATL CTR INJ PREV CO; Fleming SM, 2013, JOVE-J VIS EXP, DOI 10.3791/50303; Frey L, 2014, NEUROL RES, V36, P26, DOI 10.1179/1743132813Y.0000000269; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Grey Vijaylaxmi, 2003, J Cyst Fibros, V2, P195, DOI 10.1016/S1569-1993(03)00097-3; Gruenbaum SE, 2016, CNS DRUGS, V30, P791, DOI 10.1007/s40263-016-0355-2; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Henderson M, 2016, PROTEOM CLIN APPL, V10, P1218, DOI 10.1002/prca.201600004; Hicdonmez T, 2006, NEUROCHEM RES, V31, P473, DOI 10.1007/s11064-006-9040-z; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Khan M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-78; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Lok J, 2011, J NEUROCHEM, V118, P248, DOI 10.1111/j.1471-4159.2011.07294.x; Lulic D, 2011, NEUROSURGERY, V68, P1172, DOI 10.1227/NEU.0b013e31820c6cdc; Mao X, 2015, BRAIN INJURY, V29, P86, DOI 10.3109/02699052.2014.968621; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meister A, 1984, Nutr Rev, V42, P397, DOI 10.1111/j.1753-4887.1984.tb02277.x; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Pandya JD, 2014, EXP NEUROL, V257, P106, DOI 10.1016/j.expneurol.2014.04.020; Reed TT, 2009, J NEUROSCI RES, V87, P408, DOI 10.1002/jnr.21872; Ross EK, 2014, ANTIOXIDANTS, V3, P843, DOI 10.3390/antiox3040843; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Song W, 2017, FREE RADICAL BIO MED, V110, P162, DOI 10.1016/j.freeradbiomed.2017.05.025; TATEISHI N, 1974, J BIOCHEM, V75, P93, DOI 10.1093/oxfordjournals.jbchem.a130387; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; WINTER AN, 2017, OXID MED CELL LONGEV, V2017; Xiong Y, 1999, J NEUROTRAUM, V16, P1067, DOI 10.1089/neu.1999.16.1067; Xiong Ye, 2004, J Stroke Cerebrovasc Dis, V13, P129, DOI 10.1016/j.jstrokecerebrovasdis.2004.05.001; Xiong Y, 2010, DISCOV MED, V10, P434	49	17	17	1	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0891-5849	1873-4596		FREE RADICAL BIO MED	Free Radic. Biol. Med.	AUG 20	2018	124						328	341		10.1016/j.freeradbiomed.2018.06.026			14	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	GQ2VG	WOS:000441516300031	29940352	Bronze, Green Accepted			2022-02-06	
J	Hossain, I; Tan, C; Doughty, PT; Dutta, G; Murray, TA; Siddiqui, S; Iasemidis, L; Arumugamr, PU				Hossain, Imran; Tan, Chao; Doughty, Phillip T.; Dutta, Gaurab; Murray, Teresa A.; Siddiqui, Shabnam; Iasemidis, Leonidas; Arumugamr, Prabhu U.			A Novel Microbiosensor Microarray for Continuous ex vivo Monitoring o Gamma-Aminobutyric Acid in Real-Time	FRONTIERS IN NEUROSCIENCE			English	Article						electrochemical; GABA; glutamate; biosensor; microarray; neurochemical; ex vivo	PERFORMANCE LIQUID-CHROMATOGRAPHY; IN-VIVO; ELECTROCHEMICAL DETECTION; EXTRACELLULAR GLUTAMATE; SULFITE DERIVATIZATION; MICROELECTRODE ARRAYS; ALPHA-KETOGLUTARATE; HYDROGEN-PEROXIDE; BRAIN; GABA	Gamma-aminobutyric acid (GABA) is a major inhibitory neurotransmitter that is essential for normal brain function. It is involved in multiple neuronal activities, including plasticity, information processing, and network synchronization. Abnormal GABA levels result in severe brain disorders and therefore GABA has been the target of a wide range of drug therapeutics. GABA being non-electroactive is challenging to detect in real-time. To date, GABA is detected mainly via microdialysis with a high-performance liquid chromatography (HPLC) system that employs electrochemical (EC) and spectroscopic methodology. However, these systems are bulky and unsuitable for real-time continuous monitoring. As opposed to microdialysis, biosensors are easy to miniaturize and are highly suitable for in vivo studies; they selectively oxidize GABA into a secondary electroactive product (usually hydrogen peroxide, H2O2) in the presence of enzymes, which is then detected by amperometry. Unfortunately, this method requires a rather cumbersome process with prereactors and relies on externally applied reagents. Here, we report the design and implementation of a GABA microarray probe that operates on a newly conceived principle. it consists of two microbiosensors, one for glutamate (Glu) and one for GABA detection, modified with glutamate oxidase and GABASE enzymes, respectively. By simultaneously measuring and subtracting the H2O2 oxidation currents generated from these microbiosensors, GABA and Glu can be detected continuously in real-time in vitro and ex vivo and without the addition of any externally applied reagents. The detection of GABA by this probe is based upon the in-situ generation of alpha-ketoglutarate from the Glu oxidation that takes place at the Glu microbiosensor. A GABA sensitivity of 36 +/- 2.5 pA mu M-1 cm(-2), which is 26-fold higher than reported in the literature, and a limit of detection of 2 +/- 0.12 It M were achieved in an in vitro setting. The GABA probe was successfully tested in an adult rat brain slice preparation. These results demonstrate that the developed GABA probe constitutes a novel and powerful neuroscientific tool that could be employed in the future for in vivo longitudinal studies of the combined role of GABA and Glu (a major excitatory neurotransmitter) signaling in brain disorders, such as epilepsy and traumatic brain injury, as well as in preclinical trials of potential therapeutic agents for the treatment of these disorders.	[Hossain, Imran; Tan, Chao; Dutta, Gaurab; Arumugamr, Prabhu U.] Louisiana Tech Univ, Inst Micromfg, Ruston, LA 71270 USA; [Tan, Chao; Doughty, Phillip T.; Murray, Teresa A.; Siddiqui, Shabnam; Iasemidis, Leonidas; Arumugamr, Prabhu U.] Louisiana Tech Univ, Ctr Biomed Engn & Rehabil Sci, Ruston, LA 71270 USA		Arumugamr, PU (corresponding author), Louisiana Tech Univ, Inst Micromfg, Ruston, LA 71270 USA.; Arumugamr, PU (corresponding author), Louisiana Tech Univ, Ctr Biomed Engn & Rehabil Sci, Ruston, LA 71270 USA.	parumug@latech.edu	Murray, Teresa/AAG-3531-2019; Dutta, Gaurab/A-2675-2019; Murray, Teresa/AAV-3011-2020; TAN, CHAO/AAW-2201-2021	Murray, Teresa/0000-0002-8857-154X; Dutta, Gaurab/0000-0002-8347-5970; Hossain, Md Imran/0000-0002-0308-6052	National Science Foundation through the OIA/EPSCoR [1632891]	This work was supported by the National Science Foundation through the OIA/EPSCoR grant 1632891 on Probing and Understanding the Brain: Micro and Macro Dynamics of Seizure and Memory Networks.	Arima J, 2009, FEBS J, V276, P4318, DOI 10.1111/j.1742-4658.2009.07103.x; Auteri M, 2015, CURR PHARM DESIGN, V21, P4996, DOI 10.2174/1381612821666150914121518; Badalyan A., 2007, EP, Patent No. [2505658A1, 2505658]; Badalyan A, 2014, BIOSENSORS-BASEL, V4, P403, DOI 10.3390/bios4040403; Ben-Amor S, 2014, ELECTROCHIM ACTA, V126, P171, DOI 10.1016/j.electacta.2013.11.104; Bhat R, 2010, P NATL ACAD SCI USA, V107, P2580, DOI 10.1073/pnas.0915139107; Boddum K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13572; Burmeister JJ, 2013, ACS CHEM NEUROSCI, V4, P721, DOI 10.1021/cn4000555; Cahill PS, 1996, ANAL CHEM, V68, P3180, DOI 10.1021/ac960347d; CAUDILL WL, 1982, J CHROMATOGR, V227, P331, DOI 10.1016/S0378-4347(00)80387-4; Castro VHC, 2014, CURR NEUROPHARMACOL, V12, P490, DOI 10.2174/1570159X13666141223223657; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; GARGUILO MG, 1994, ANAL CHEM, V66, P2621, DOI 10.1021/ac00089a006; Grabauskas G, 2005, NEUROSCI LETT, V373, P10, DOI 10.1016/j.neulet.2004.09.051; Hascup KN, 2007, FRONT NEUROENG, V1, P407; Hertz Leif, 2013, Front Endocrinol (Lausanne), V4, P59, DOI 10.3389/fendo.2013.00059; Kanamori K, 2011, BRAIN RES, V1371, P180, DOI 10.1016/j.brainres.2010.11.064; Ke Y, 2000, PSYCHIAT RES-NEUROIM, V100, P169, DOI 10.1016/S0925-4927(00)00075-5; KEHR J, 1988, J NEUROCHEM, V51, P1308, DOI 10.1111/j.1471-4159.1988.tb03101.x; Khan R, 2011, ELECTROANAL, V23, P2357, DOI 10.1002/elan.201100348; Long LH, 2011, BIOCHEM BIOPH RES CO, V406, P20, DOI 10.1016/j.bbrc.2011.01.091; Mazzei F, 1996, ANAL CHIM ACTA, V328, P41, DOI 10.1016/0003-2670(96)00089-X; Medina-Ceja L, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0147-5; Monge-Acuna AA, 2009, J NEUROSCI METH, V183, P176, DOI 10.1016/j.jneumeth.2009.06.042; Moussawi K, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00094; NATH KA, 1995, AM J PHYSIOL-CELL PH, V268, pC227, DOI 10.1152/ajpcell.1995.268.1.C227; Niwa O, 1998, ANAL CHEM, V70, P89, DOI 10.1021/ac970740z; Reinhoud NJ, 2013, ACS CHEM NEUROSCI, V4, P888, DOI 10.1021/cn400044s; Robinson DL, 2008, CHEM REV, V108, P2554, DOI 10.1021/cr068081q; Robinson DL, 2007, FRONT NEUROENG, V1, P17; Robinson MB, 2016, NEUROCHEM INT, V98, P56, DOI 10.1016/j.neuint.2016.03.014; ROWLEY HL, 1995, J NEUROSCI METH, V57, P93, DOI 10.1016/0165-0270(94)00132-Z; ROWLEY HL, 1995, NEUROSCIENCE, V68, P415, DOI 10.1016/0306-4522(95)00159-G; Sandberg S. G., 2010, ADV NEUROSCIENCE ADD, P120; Sekioka N, 2008, SENSOR ACTUAT B-CHEM, V129, P442, DOI 10.1016/j.snb.2007.08.040; SETHI ML, 1993, J PHARMACEUT BIOMED, V11, P613, DOI 10.1016/0731-7085(93)80013-Q; SMITH S, 1994, J CHROMATOGR B, V652, P228, DOI 10.1016/0378-4347(93)E0391-3; Song CZ, 2005, NEUROPHARMACOLOGY, V48, P869, DOI 10.1016/j.neuropharm.2005.01.003; Tian JD, 2004, J IMMUNOL, V173, P5298, DOI 10.4049/jimmunol.173.8.5298; Ting Wong C. G., 2003, ANN NEUROL, V54, pS3, DOI DOI 10.1002/ANA.10696; Tretter L, 2005, PHILOS T R SOC B, V360, P2335, DOI 10.1098/rstb.2005.1764; Tseng TTC, 2014, MOLECULES, V19, P7341, DOI 10.3390/molecules19067341; Willuhn I, 2010, CURR TOP BEHAV NEURO, V3, P29, DOI 10.1007/7854_2009_27; Wilson LR, 2018, ANAL CHEM, V90, P888, DOI 10.1021/acs.analchem.7b03770	44	17	18	3	12	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-453X			FRONT NEUROSCI-SWITZ	Front. Neurosci.	AUG 7	2018	12								500	10.3389/fnins.2018.00500			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GP7HW	WOS:000441068000001	30131664	Green Published, gold			2022-02-06	
J	Andrews, PJD; Sinclair, HL; Rodriguez, A; Harris, B; Rhodes, JF; Watson, H; Murray, G				Andrews, Peter J. D.; Sinclair, H. Louise; Rodriguez, Aryelly; Harris, Bridget; Rhodes, Jonathan F.; Watson, Hannah; Murray, Gordon		Eurotherm3235 Trial Collaborators	Therapeutic hypothermia to reduce intracranial pressure after traumatic brain injury: the Eurotherm3235 RCT	HEALTH TECHNOLOGY ASSESSMENT			English	Article							FOCAL CEREBRAL-ISCHEMIA; SEVERE HEAD-INJURY; REQUIRING PROLONGED OBSERVATION; RANDOMIZED CONTROLLED-TRIAL; PROPOFOL INFUSION SYNDROME; TERM MILD HYPOTHERMIA; INTENSIVE-CARE-UNIT; MODERATE HYPOTHERMIA; CLINICAL-TRIALS; CARDIOPULMONARY BYPASS	Background: Traumatic brain injury (TBI) is a major cause of disability and death in young adults worldwide. It results in around 1 million hospital admissions annually in the European Union (EU), causes a majority of the 50,000 deaths from road traffic accidents and leaves a further approximate to 10,000 people severely disabled. Objective: The Eurotherm3235 Trial was a pragmatic trial examining the effectiveness of hypothermia (32-35 degrees C) to reduce raised intracranial pressure (ICP) following severe TBI and reduce morbidity and mortality 6 months after TBI. Design: An international, multicentre, randomised controlled trial. Setting: Specialist neurological critical care units. Participant We included adult participants following TBI. Eligible patients had ICP monitoring in place with an ICP of > 20 mmHg despite first-line treatments. Participants were randomised to receive standard care with the addition of hypothermia (32-35 degrees C) or standard care alone. Online randomisation and the use of an electronic case report form (CRF) ensured concealment of random treatment allocation. It was not possible to blind local investigators to allocation as it was obvious which participants were receiving hypothermia. We collected information on how well the participant had recovered 6 months after injury. This information was provided either by the participant themself (if they were able) and/or a person close to them by completing the Glasgow Outcome Scale - Extended (GOSE) questionnaire. Telephone follow-up was carried out by a blinded independent clinician. interventions: The primary intervention to reduce ICP in the hypothermia group after randomisation was induction of hypothermia. Core temperature was initially reduced to 35 degrees C and decreased incrementally to a lower limit of 32 degrees C if necessary to maintain ICP at < 20 mmHg. Rewarming began after 48 hours if ICP remained controlled. Participants in the standard-care group received usual care at that centre, but without hypothermia. Main outcome measures: The primary outcome measure was the GOSE [range 1 (dead) to 8 (upper good recovery)] at 6 months after the injury as assessed by an independent collaborator, blind to the intervention. A priori subgroup analysis tested the relationship between minimisation factors including being aged < 45 years, having a post-resuscitation Glasgow Coma Scale (GCS) motor score of < 2 on admission, having a time from injury of < 12 hours and patient outcome. Results: We enrolled 387 patients from 47 centres in 18 countries. The trial was closed to recruitment following concerns raised by the Data and Safety Monitoring Committee in October 2014. On an intentionto-treat basis, 195 participants were randomised to hypothermia treatment and 192 to standard care. Regarding participant outcome, there was a higher mortality rate and poorer functional recovery at 6 months in the hypothermia group. The adjusted common odds ratio (OR) for the primary statistical analysis of the GOSE was 1.54 [95% confidence interval (CI) 1.03 to 2.31]; when the GOSE was dichotomised the OR was 1.74 (95% CI 1.09 to 2.77). Both results favoured standard care alone. In this pragmatic study, we did not collect data on adverse events. Data on serious adverse events (SAEs) were collected but were subject to reporting bias, with most SAEs being reported in the hypothermia group. Conclusion: In participants following TBI and with an ICP of > 20 mmHg, titrated therapeutic hypothermia successfully reduced ICP but led to a higher mortality rate and worse functional outcome. limitation Inability to blind treatment allocation as it was obvious which participants were randomised to the hypothermia group; there was biased recording of SAEs in the hypothermia group. We now believe that more adequately powered clinical trials of common therapies used to reduce ICP, such as hypertonic therapy, barbiturates and hyperventilation, are required to assess their potential benefits and risks to patients.	[Andrews, Peter J. D.; Sinclair, H. Louise; Harris, Bridget] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland; [Rodriguez, Aryelly; Murray, Gordon] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Rhodes, Jonathan F.; Watson, Hannah] NHS Lothian, Edinburgh, Midlothian, Scotland		Andrews, PJD (corresponding author), Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland.	p.andrews@ed.ac.uk		Watson, Hannah/0000-0002-2728-0386	National Institute for Health Research (NIHR) Health Technology Assessment programmeNational Institute for Health Research (NIHR); European Society of Intensive Care Medicine	This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 22, No. 45. See the NIHR Journals Library website for further project information. The European Society of Intensive Care Medicine supported the pilot phase of this trial.	Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Adelson PD, 2009, J NEUROTRAUM, V26, P429, DOI 10.1089/neu.2008.0571; Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Aibiki M, 2000, CRIT CARE MED, V28, P3902, DOI 10.1097/00003246-200012000-00029; Akaji K, 2003, BRAIN RES, V975, P149, DOI 10.1016/S0006-8993(03)02622-2; Alderson P, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001048.pub2, DOI 10.1002/14651858.CD001048.PUB2]; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Andrews PJD, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-277; Andrews PJD, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-8; [Anonymous], 2005, CIRCULATION, V112, pIV1, DOI 10.1161/CIRCULATIONAHA.105.166550; Aziz KAA, 2010, INTERACT CARDIOV TH, V10, P271, DOI 10.1510/icvts.2009.214130; Badjatia N, 2008, STROKE, V39, P3242, DOI 10.1161/STROKEAHA.108.523654; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bernard SA, 1999, CRIT CARE, V3, P167, DOI 10.1186/cc371; Biswas AK, 2002, CRIT CARE MED, V30, P2742, DOI 10.1097/00003246-200212000-00020; Bjelland TW, 2013, DRUG METAB DISPOS, V41, P214, DOI 10.1124/dmd.112.045567; BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2001, J NEUROSURG, V95, P751, DOI 10.3171/jns.2001.95.5.0751; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; Clifton GL, 2011, THER HYPOTHERMIA TEM, V1, P3, DOI 10.1089/ther.2010.1500; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; ClinicalTrials.gov, RAND CONTR TRIAL LON; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Crompton EM, 2017, CRIT CARE MED, V45, P575, DOI 10.1097/CCM.0000000000002205; Crossley S, 2014, CRIT CARE, V18, DOI 10.1186/cc13835; DeKosky ST, 2004, J NEUROCHEM, V90, P998, DOI 10.1111/j.1471-4159.2004.02575.x; Dengler B, 2015, J CRIT CARE, V30, P823, DOI 10.1016/j.jcrc.2015.03.027; Dietrich WD, 2007, PROG BRAIN RES, V162, P201, DOI 10.1016/S0079-6123(06)62011-6; Dietrich WD, 2009, J NEUROTRAUM, V26, P301, DOI 10.1089/neu.2008.0806; DIETRICH WD, 1990, J NEUROPATH EXP NEUR, V49, P486, DOI 10.1097/00005072-199009000-00004; Dixon SR, 2005, HEART, V91, pIII2, DOI 10.1136/hrt.2005.060251; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; Flynn LMC, 2015, THER HYPOTHERMIA TEM, V5, P143, DOI 10.1089/ther.2015.0002; Friedman LK, 2001, MOL BRAIN RES, V86, P34, DOI 10.1016/S0169-328X(00)00252-7; Fudickar A, 2006, CURR OPIN ANESTHESIO, V19, P404, DOI 10.1097/01.aco.0000236140.08228.f1; Gal R, 2002, CLIN NEUROL NEUROSUR, V104, P318, DOI 10.1016/S0303-8467(02)00023-9; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; GOSS JR, 1995, J NEUROTRAUM, V12, P159, DOI 10.1089/neu.1995.12.159; Gressens P, 2008, BRAIN PATHOL, V18, P10, DOI 10.1111/j.1750-3639.2007.00095.x; Grieve R, 2016, BRIT J NEUROSURG, V30, P388, DOI 10.3109/02688697.2016.1161166; Guo W, 2004, J XINXIANG MED COLL, V21, P269; Harris OA, 2002, ARCH NEUROL-CHICAGO, V59, P1077, DOI 10.1001/archneur.59.7.1077; Harris OA, 2009, J NEUROSURG, V110, P1322, DOI 10.3171/2009.1.JNS081320a; Hashiguchi N, 2003, J TRAUMA, V55, P1054, DOI 10.1097/01.TA.0000033252.43742.8B; Heier T, 2006, ANESTHESIOLOGY, V104, P1070, DOI 10.1097/00000542-200605000-00025; Henderson WR, 2003, INTENS CARE MED, V29, P1637, DOI 10.1007/s00134-003-1848-2; Higgins JPT, 2008, COCHRANE BOOK SERIES, P194; Hirayama TKY, 1994, INTRACRANIAL PRESSUR, VIX, P233; Holzer M, 2002, NEW ENGL J MED, V346, P549; HU BR, 1995, NEUROSCIENCE, V68, P1003, DOI 10.1016/0306-4522(95)00213-3; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Hutchison JS, 2013, LANCET NEUROL, V12, P527, DOI 10.1016/S1474-4422(13)70058-9; Ilodigwe D, 2013, J NEUROSURG, V118, P3, DOI 10.3171/2012.9.JNS111383; Ishikura H, 1998, CRITICAL CARE MED S1, V26, pA82, DOI DOI 10.1097/00003246-199801001-00209; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; Jiang JY, 2006, J CEREBR BLOOD F MET, V26, P771, DOI 10.1038/sj.jcbfm.9600253; Kawai N, 2002, ACT NEUR S, V81, P233; Kinoshita K, 2002, J NEUROSURG, V97, P945, DOI 10.3171/jns.2002.97.4.0945; Kiziltan HT, 2003, ANESTH ANALG, V96, P644, DOI [10.1213/01.ANE.000048826.67870.85, 10.1213/01.ANE.0000048826.67870.85]; Kline AE, 2002, BRAIN RES, V937, P22, DOI 10.1016/S0006-8993(02)02458-7; Koizumi H, 1997, BRAIN RES, V747, P304, DOI 10.1016/S0006-8993(96)01240-1; KULUZ JW, 1993, AM J PHYSIOL, V265, pH824, DOI 10.1152/ajpheart.1993.265.3.H824; Kumar K, 1997, METAB BRAIN DIS, V12, P21, DOI 10.1007/BF02676351; Lee BK, 2010, ACAD EMERG MED, V17, P673, DOI 10.1111/j.1553-2712.2010.00748.x; Lee HC, 2010, WORLD NEUROSURG, V74, P654, DOI 10.1016/j.wneu.2010.06.019; LEI BP, 1994, STROKE, V25, P147, DOI 10.1161/01.STR.25.1.147; LESLIE K, 1995, ANESTH ANALG, V80, P1007, DOI 10.1097/00000539-199505000-00027; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2700; Liu WG, 2006, J INT MED RES, V34, P58, DOI 10.1177/147323000603400107; LO EH, 1993, NEUROL RES, V15, P281; LYETH BG, 1993, MOL CHEM NEUROPATHOL, V18, P247, DOI 10.1007/BF03160117; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Madden LK, 2015, J NEUROSCI NURS, V47, P190, DOI 10.1097/JNN.0000000000000142; Maekawa T., 2009, 3 INT HYP S LUND SWE; Maekawa T, 2015, J NEUROTRAUM, V32, P422, DOI 10.1089/neu.2013.3197; Mancuso A, 2000, BRAIN RES, V887, P34, DOI 10.1016/S0006-8993(00)02963-2; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Medical Research Council, 1998, MRC GUID GOOD CLIN P; Metz C, 1996, J NEUROSURG, V85, P533, DOI 10.3171/jns.1996.85.4.0533; MITANI A, 1991, NEUROSCIENCE, V42, P661, DOI 10.1016/0306-4522(91)90035-M; Morgan T J, 1999, Crit Care Resusc, V1, P93; MORRAY JP, 1990, ANESTHESIOLOGY, V72, P510, DOI 10.1097/00000542-199003000-00020; MURKIN JM, 1987, ANESTH ANALG, V66, P825; Murray GD, 2005, J NEUROTRAUM, V22, P511, DOI 10.1089/neu.2005.22.511; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Nagel S, 2008, BRAIN RES, V1188, P198, DOI 10.1016/j.brainres.2007.10.052; NHS Scotland, RES ETH STRUCT SCOTL; Nichol A, 2015, CRIT CARE RESUSC, V17, P92; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Nolan JP, 2005, RESUSCITATION, V67, pS39, DOI 10.1016/j.resuscitation.2005.10.009; Oddo M, 2012, INTENS CARE MED, V38, P1497, DOI 10.1007/s00134-012-2593-1; Oddo M, 2009, STROKE, V40, P1913, DOI 10.1161/STROKEAHA.108.534115; Pabello NG, 2005, BRAIN RES, V1038, P11, DOI 10.1016/j.brainres.2004.12.047; Park CK, 1997, INTRACRANIAL PRESSUR, P225; Peterson K, 2008, J NEUROTRAUM, V25, P62, DOI 10.1089/neu.2007.0424; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Polderman KH, 2005, CRIT CARE MED, V33, P2744, DOI 10.1097/01.CCM.0000190427.88735.19; Polderman KH, 2004, INTENS CARE MED, V30, P1860, DOI 10.1007/s00134-004-2383-5; Polderman KH, 2002, INTENS CARE MED, V28, P1563, DOI 10.1007/s00134-002-1511-3; Polderman KH, 2001, J NEUROSURG, V94, P697, DOI 10.3171/jns.2001.94.5.0697; Polderman KH, 2004, INTENS CARE MED, V30, P757, DOI 10.1007/s00134-003-2151-y; Presneill J, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2610-y; Qiu Wu-si, 2005, Chin J Traumatol, V8, P27; Qiu W, 2007, J CRIT CARE, V22, P229, DOI 10.1016/j.jcrc.2006.06.011; Qiu WS, 2006, J CLIN NEUROSCI, V13, P995, DOI 10.1016/j.jocn.2006.02.027; RESNICK DK, 1994, NEUROSURGERY, V34, P252, DOI 10.1227/00006123-199402000-00007; Rhodes JK, 2016, ACTA NEUROCHIR SUPPL, V122, P9, DOI 10.1007/978-3-319-22533-3_2; ROKKAS CK, 1995, J THORAC CARDIOV SUR, V110, P27, DOI 10.1016/S0022-5223(05)80006-6; Roozenbeek B, 2011, CRIT CARE, V15, DOI 10.1186/cc10240; ROSOMOFF HL, 1954, AM J PHYSIOL, V179, P85, DOI 10.1152/ajplegacy.1954.179.1.85; Sakamoto KI, 1997, J NEUROTRAUM, V14, P349, DOI 10.1089/neu.1997.14.349; Sakamoto T, 2004, J THORAC CARDIOV SUR, V127, P12, DOI 10.1016/j.jtcvs.2003.08.033; Sandercock P, 1997, LANCET, V349, P1569; Schulz KF, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-32; Shimohata T, 2007, STROKE, V38, P375, DOI 10.1161/01.STR.0000254616.78387.ee; Shiozaki T, 1999, J NEUROSURG, V91, P185, DOI 10.3171/jns.1999.91.2.0185; Shiozaki T, 1998, J NEUROSURG, V89, P206, DOI 10.3171/jns.1998.89.2.0206; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Shiozaki T, 2001, J NEUROSURG, V94, P50, DOI 10.3171/jns.2001.94.1.0050; Smrcka M, 2005, ACT NEUR S, V95, P273; Society EBI, 2004, EUR BRAIN INJ SOC; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Sydenham E, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001048.pub3; Tateishi A, 1998, NEUROSURGERY, V42, P1065, DOI 10.1097/00006123-199805000-00066; Temple A, 2012, BJA EDUC, V12, P283, DOI 10.1093/bjaceaccp/mks029; The CRASH trial management group, 2001, BMC Emerg Med, V1, P1; Tohyama Y, 1998, EXP BRAIN RES, V122, P333, DOI 10.1007/s002210050521; Tokutomi T, 2003, NEUROSURGERY, V52, P102, DOI 10.1097/00006123-200301000-00013; Van Hemelrijck A, 2005, EUR J NEUROSCI, V22, P1327, DOI 10.1111/j.1460-9568.2005.04331.x; Vasile B, 2003, INTENS CARE MED, V29, P1417, DOI 10.1007/s00134-003-1905-x; Vitarbo EA, 2004, NEUROSURGERY, V55, P416, DOI 10.1227/01.NEU.0000130036.52521.2C; Wang Wei-ping, 2005, Chin J Traumatol, V8, P54; Watson HI, 2018, CRIT CARE MED, V46, P972, DOI 10.1097/CCM.0000000000003125; Winfree CJ, 1996, NEUROSURGERY, V38, P1216, DOI 10.1097/00006123-199606000-00034; Yamamoto T, 2002, NEUROL RES, V24, P789, DOI 10.1179/016164102101200906; Yan Y, 2001, Chin J Traumatol, V4, P8; Zhang H, 2008, NEUROL RES, V30, P332, DOI 10.1179/174313208X300279; Zhang K, 2000, INNER MONGOLIA MED J, V32, P4; Zhao QJ, 2011, J CRIT CARE, V26, P311, DOI 10.1016/j.jcrc.2010.08.014; Zhi DS, 2003, SURG NEUROL, V59, P381, DOI 10.1016/S0090-3019(03)00148-4; Zhu HD, 2005, EXP NEUROL, V193, P361, DOI 10.1016/j.expneurol.2005.01.022; Zhu YF, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2391-2	155	17	21	0	14	NIHR JOURNALS LIBRARY	SOUTHAMPTON	UNIV SOUTHAMPTON, EVALUATION, TRIALS & STUDIES COORDINATING CENTRE, ALPHA HOUSE, ENTERPRISE RD, SOUTHAMPTON, SO16 7NS, ENGLAND	1366-5278	2046-4924		HEALTH TECHNOL ASSES	Health Technol. Assess.	AUG	2018	22	45					1	+		10.3310/hta22450			135	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services	GS0HE	WOS:000443170400001	30168413	gold, Green Published			2022-02-06	
J	Hawley, LA; Ketchum, JM; Morey, C; Collins, K; Charlifue, S				Hawley, Lenore A.; Ketchum, Jessica M.; Morey, Clare; Collins, Kathleen; Charlifue, Susan			Cannabis Use in Individuals With Spinal Cord Injury or Moderate to Severe Traumatic Brain Injury in Colorado	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						cannabis	CHRONIC PAIN; PREVALENCE; SLEEP; EPIDEMIOLOGY; MANAGEMENT; SPASTICITY; MARIJUANA	Objectives: To describe the prevalence of cannabis use in an adult sample with spinal cord injury (SCI) or traumatic brain injury (TBI) in Colorado, and to describe the self-reported reasons and side effects of cannabis use in this sample. Design: Mixed-methods observational study, using focus group data and telephone survey. Setting: Community. Participants: Colorado adults who sustained SCI or moderate to severe TBI and received services through Craig Hospital. Interventions: None. Main Outcome Measures: Survey. Results: Focus group participants identified issues that were then included in the survey development. Seventy percent of the 116 participants surveyed reported cannabis use before their injury (67% SCI, 74% TBI) and 48% reported use after their injury (53% SCI, 45% TBI). Overall, the most common reason for use was recreational (67%), followed by reducing stress/anxiety (62.5%) and improving sleep (59%). Among the respondents with SCI, the most common reasons for use were to reduce spasticity (70%), recreation (63%), and to improve sleep (63%). Among those with TBI, reasons endorsed were recreational (72%), reducing stress/anxiety (62%), and improving sleep (55%). Smoking was the most common method of use. Conclusions: A majority of this sample reported using cannabis before injury, and approximately half reported using cannabis after injury. Both groups reported recreational use, whereas the group with SCI also highly endorsed using cannabis to address chronic medical conditions. Clinicians should be aware of the high prevalence of cannabis use in these populations and the impact such use may have on the individual's medical management. Further research in this area is needed. (C) 2018 by the American Congress of Rehabilitation Medicine	[Hawley, Lenore A.; Ketchum, Jessica M.; Morey, Clare; Collins, Kathleen; Charlifue, Susan] Craig Hosp, Res Dept, Englewood, CO 80113 USA; [Ketchum, Jessica M.] Traumat Brain Injury Model Syst Natl Data & Stat, Englewood, CO USA		Hawley, LA (corresponding author), Craig Hosp, 3425 S Clarkson St, Englewood, CO 80113 USA.	lhawley@craighospital.org	Ketchum, Jessica/AAE-8200-2020	Collins, Kathleen/0000-0001-9233-5235	Craig Hospital Foundation	Supported by a grant from the Craig Hospital Foundation. The hospital foundation staff had no role in the study design or decisions.	Allen S, 2016, SUBST USE MISUSE, V51, P1577, DOI 10.1080/10826084.2016.1188955; Bonica JJ, 1999, PAIN CENTRAL NERVOUS, P13; Cardenas DD, 2006, J SPINAL CORD MED, V29, P109, DOI 10.1080/10790268.2006.11753864; Center for Behavioral Health Statistics and Quality Substance Abuse and Mental Health Services Administration, 2015, BEH HLTH TRENDS US R; Colorado Department of Public Health & Environment, 2014, MAR US COL COL AD AG; Drossel Claudia, 2016, Top Spinal Cord Inj Rehabil, V22, P3, DOI 10.1310/sci2201-3; ElSohly MA, 2017, PROG CHEM ORG NAT PR, V103, P1, DOI 10.1007/978-3-319-45541-9_1; Hart T, 2015, CONTEMP CLIN TRIALS, V40, P180, DOI 10.1016/j.cct.2014.12.005; Hill KP, 2015, JAMA-J AM MED ASSOC, V313, P2474, DOI 10.1001/jama.2015.6199; Kim SH, 1999, J NERV MENT DIS, V187, P327, DOI 10.1097/00005053-199906000-00001; MALEC J, 1982, ARCH PHYS MED REHAB, V63, P116; Mandelbaum DE, 2017, PEDIATR NEUROL, V66, P12, DOI 10.1016/j.pediatrneurol.2016.09.004; MAYNARD FM, 1990, ARCH PHYS MED REHAB, V71, P566; McCarberg Bill H, 2007, Am J Ther, V14, P475, DOI 10.1097/MJT.0b013e3180a5e581; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; National Academies of Sciences Engineering and Medicine, 2017, HLTH EFF CANN CANN C; Rao V, 2008, BRAIN INJURY, V22, P381, DOI 10.1080/02699050801935260; Viola-Saltzman M, 2012, NEUROL CLIN, V30, P1299, DOI 10.1016/j.ncl.2012.08.008; Walter JS, 2002, J REHABIL RES DEV, V39, P53; Whiting PF, 2015, JAMA-J AM MED ASSOC, V313, P2456, DOI 10.1001/jama.2015.6358; Widerstrom-Noga EG, 2001, ARCH PHYS MED REHAB, V82, P1571, DOI 10.1053/apmr.2001.26068; World Health Organization, CANN; Wyndaele M, 2006, SPINAL CORD, V44, P523, DOI 10.1038/sj.sc.3101893	23	17	17	1	17	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2018	99	8					1584	1590		10.1016/j.apmr.2018.02.003			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	GP0VE	WOS:000440528500019	29524396				2022-02-06	
J	Turner-Stokes, L; Ashford, S; Esquenazi, A; Wissel, J; Ward, AB; Francisco, G; Lains, J; Suputtitada, A; Serrano, S; Baguley, IJ; Barnes, M; Simpson, DM				Turner-Stokes, Lynne; Ashford, Stephen; Esquenazi, Alberto; Wissel, Joerg; Ward, Anthony B.; Francisco, Gerard; Lains, Jorge; Suputtitada, Areerat; Serrano, Simao; Baguley, Ian J.; Barnes, Michael; Simpson, David M.			A comprehensive person-centered approach to adult spastic paresis: a consensus-based framework	EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Spastic paraparesis; Muscle spasticity; Consensus; Person-centered therapy; Rehabilitation; Self-management	UPPER-LIMB SPASTICITY; QUALITY-OF-LIFE; THERAPEUTIC WORKING ALLIANCE; INDUCED MOVEMENT THERAPY; TRAUMATIC BRAIN-INJURY; BOTULINUM-TOXIN-A; GOAL ATTAINMENT; SELF-MANAGEMENT; STROKE PATIENTS; MOTOR FUNCTION	Spastic paresis is a common feature of an upper motor neuron impairment caused by stroke, brain injury, multiple sclerosis and other central nervous system (CNS) disorders. Existing national and international guidelines for the treatment of adult spastic paresis tend to focus on the treatment of muscle overactivity rather than the comprehensive approach to care, which may require life-long management. Person-centered care is increasingly adopted by healthcare systems in a shift of focus from "disease-oriented" towards "person-centered" medicine. The challenge is to apply this principle to the complex management of spastic paresis and to include an educative process that engages care providers and patients and encourages them to participate actively in the long-term management of their own disease. To address this issue, a group of 13 international clinicians and researchers used a pragmatic top-down methodology to evaluate the evidence and to formulate and grade the strength of recommendations for applying the principles of person-centered care to the management of spastic paresis. There is a distinct lack of clinical trial evidence regarding the application of person-centered medicine to the rehabilitation setting. However, the current evidence base supports the need to ensure that treatment interventions Mr spastic paresis should be centered on as far as reasonable on the patient's own priorities for treatment. Goal setting, negotiation and formal recording of agreed SMART goals should be an integral part of all spasticity management programs, and goal attainment scaling should be recorded alongside other standardized measures in the evaluation of outcome. When planning interventions for spastic paresis, the team should consider the patient and their family's capacity for self-rehabilitation, as well as ways to enhance this approach. Finally, the proposed intervention and treatment goals should consider the impact of any neuropsychological, cognitive and behavioral deficits on rehabilitation. These recommendations support a person-centric focus in the management of spastic paresis.	[Turner-Stokes, Lynne; Ashford, Stephen] Kings Coll London, Fac Life Sci & Med, Dept Palliat Care, London, England; [Turner-Stokes, Lynne; Ashford, Stephen] Northwick Pk Hosp & Clin Res Ctr, Unit Reg Hyperacute Rehabil, London, England; [Esquenazi, Alberto] MossRehab, MossRehab, PA USA; [Esquenazi, Alberto] Albert Einstein Med Ctr, MossRehab, PA USA; [Wissel, Joerg] Vivantes Hosp Berlin Spandau, Dept Neurorehabil & Phys Therapy, Berlin, Germany; [Ward, Anthony B.] Haywood Hosp, North Staffordshire Rehabil Ctr, Stoke On Trent, Staffs, England; [Ward, Anthony B.] Staffordshire Univ, Stoke On Trent, Staffs, England; [Francisco, Gerard] Mem Hermann Hosp, Inst Rehabil & Res, UTHlth NeuroRecovery Res Ctr, Houston, TX USA; [Lains, Jorge] Rovisco Pais Hosp, Ctr Rehabil Med Cent Reg, Tocha, Portugal; [Lains, Jorge] Portuguese Catholic Univ, Viseu, Portugal; [Lains, Jorge] Assoc Beneficiencia Popular Gouveia, Gouveia, Portugal; [Suputtitada, Areerat] Chulalongkorn Univ, Fac Med, Dept Rehabil Med, Bangkok, Thailand; [Serrano, Simao] Leiria Hosp Ctr, Dept Phys Med & Rehabil, Leiria, Portugal; [Baguley, Ian J.] Univ Sydney, Westmead Hosp, Western Med Sch, Brain Injury Rehabil Serv, Sydney, NSW, Australia; [Barnes, Michael] Rake House Farm, Christchurch Grp, Unit 14, North Shields, England; [Simpson, David M.] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA		Turner-Stokes, L (corresponding author), Northwick Pk Hosp & Clin Res Ctr, Reg Hyperacute Rehabil Unit, Watford Rd, Harrow HA1 3UJ, Middx, England.	lynne.tumer-stokes@dial.pipex.com	Turner-Stokes, Lynne/F-4418-2012; Baguley, Ian/AAM-5828-2021; Ashford, Stephen/D-6653-2013	Turner-Stokes, Lynne/0000-0002-3302-9462; Ashford, Stephen/0000-0001-5541-7063	Ipsen PharmaIpsen	The realization of the meeting and the consensus table was made possible by an unrestricted educational grant from Ipsen Pharma, who also funded independent medical writing support from Anita Chadha-Patel PhD (ACP Clinical Communications Ltd, UK). All medical writing (literature searching, compilation of comments, collation of forms, editing and referencing) was under the full direction and supervision of the authors. No member of the consensus group received any honoraria in connection with this project and Ipsen Pharma had no influence over the content of the manuscript.	Ada L, 2005, ARCH PHYS MED REHAB, V86, P230, DOI 10.1016/j.apmr.2004.02.031; [Anonymous], 2013, PROLONGED DISORDERS; Ashford S, 2006, PHYSIOTHER RES INT, V11, P24, DOI 10.1002/pri.36; Ashford S, 2016, CLIN REHABIL, V30, P617, DOI 10.1177/0269215515593391; Basch E, 2012, VALUE HEALTH, V15, P401, DOI 10.1016/j.jval.2012.03.1385; BECKER G, 1995, MED ANTHROPOL Q, V9, P165, DOI 10.1525/maq.1995.9.2.02a00040; Boa S, 2003, GOAL SETTING PEOPLE; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P2469, DOI 10.1001/jama.288.19.2469; Bordin ES, 1979, PSYCHOTHER THEORY RE, V16, P252, DOI DOI 10.1037/H0085885; Bovend'Eerdt TJH, 2009, CLIN REHABIL, V23, P352, DOI 10.1177/0269215508101741; Brown M, 2014, DISABIL REHABIL, V36, P1020, DOI 10.3109/09638288.2013.825653; Chen C, 2013, NEUROLOGY, V80, pS27, DOI 10.1212/WNL.0b013e3182762569; Cheok G, 2015, J AM MED DIR ASSOC, V16, P923, DOI 10.1016/j.jamda.2015.06.010; Coleman MT, 2005, AM FAM PHYSICIAN, V72, P1503; Committee on Quality of Health Care in America Institute of Medicine, 2001, CROSSING QUALITY CHA; Conroy S, 2009, ADV CARE PLANNING NA; D'Cruz K, 2016, INT J THER REHABIL, V23, P20, DOI 10.12968/ijtr.2016.23.1.20; Demetrios M, 2013, COCHRANE DB SYST REV, V2013; Dettmers C, 2005, ARCH PHYS MED REHAB, V86, P204, DOI 10.1016/j.apmr.2004.05.007; Doig E., 2015, REHABILITATION GOAL, P181; Esquenazi A, 2010, EUR J NEUROL, V17, P1, DOI 10.1111/j.1468-1331.2010.03125.x; Esquenazi A, 2015, TOXICON, V107, P109, DOI 10.1016/j.toxicon.2015.08.004; European Commission, EUR THEM NETW DEV ST; Flink M, 2016, CLIN REHABIL, V30, P1200, DOI 10.1177/0269215515620256; Gormley ME, 1997, MUSCLE NERVE, pS14; Gracies JM, 2015, LANCET NEUROL, V14, P992, DOI 10.1016/S1474-4422(15)00216-1; Gracies JM, 2005, MUSCLE NERVE, V31, P552, DOI 10.1002/mus.20285; Grady PA, 2014, AM J PUBLIC HEALTH, V104, pE25, DOI 10.2105/AJPH.2014.302041; Grahn B, 2000, DISABIL REHABIL, V22, P639, DOI 10.1080/096382800445443; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1294, DOI 10.1016/j.jclinepi.2011.03.017; Haghgoo HA, 2013, J NEUROL SCI, V328, P87, DOI 10.1016/j.jns.2013.02.027; Harris JE, 2009, STROKE, V40, P2123, DOI 10.1161/STROKEAHA.108.544585; Hurn J, 2006, CLIN REHABIL, V20, P756, DOI 10.1177/0269215506070793; Katalinic OM, 2011, PHYS THER, V91, P11, DOI 10.2522/ptj.20100265; Kelley RE, 2009, NEUROL RES, V31, P832, DOI 10.1179/016164109X12445505689689; KIRESUK TJ, 1968, COMMUNITY MENT HLT J, V4, P443, DOI 10.1007/BF01530764; Lance J.W., 1980, SPASTICITY DISORDERE, P185; Langhorne P, 2002, AGE AGEING, V31, P365, DOI 10.1093/ageing/31.5.365; Laver KE, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008349.pub3, 10.1002/14651858.CD008349.pub4, 10.1002/14651858.CD008349.pub2]; Leach E, 2010, DISABIL REHABIL, V32, P159, DOI 10.3109/09638280903036605; Levack, 2015, REHABILITATION GOAL, P3; Levack WMM, 2006, CLIN REHABIL, V20, P739, DOI 10.1177/0269215506070791; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Levine B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00009; Locke EA, 2002, AM PSYCHOL, V57, P705, DOI 10.1037//0003-066X.57.9.705; Martin DJ, 2000, J CONSULT CLIN PSYCH, V68, P438, DOI 10.1037//0022-006X.68.3.438; McCrory P, 2009, J REHABIL MED, V41, P536, DOI 10.2340/16501977-0366; McPherson KM, 2009, CLIN REHABIL, V23, P296, DOI 10.1177/0269215509102980; Meyer S, 2016, NEUROREHAB NEURAL RE, V30, P731, DOI 10.1177/1545968315624779; Moseley AM, 1997, PHYS THER, V77, P240, DOI 10.1093/ptj/77.3.240; Moseley AM, 2008, CLIN REHABIL, V22, P406, DOI 10.1177/0269215507083795; Nannetti L, 2005, DISABIL REHABIL, V27, P170, DOI 10.1080/09638280400009378; National Institute for Health and Clinical Excellence (NICE), 2012, DEVELOPMENT; NICE, 2013, FALLS OLD PEOPL ASS; Nijenhuis SM, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0080-y; Ozdemir F, 2001, AM J PHYS MED REHAB, V80, P410, DOI 10.1097/00002060-200106000-00003; Page SJ, 2004, ARCH PHYS MED REHAB, V85, P1377, DOI 10.1016/j.apmr.2003.12.031; Pandyan AD, 2005, DISABIL REHABIL, V27, P2, DOI 10.1080/09638280400014576; Pang MY, 2006, ARCH PHYS MED REHAB, V87, P1, DOI 10.1016/j.apmr.2005.08.113; Paquin K, 2016, DISABIL REHABIL, P1; Parry RH, 2004, CLIN REHABIL, V18, P668, DOI 10.1191/0269215504cr745oa; Playford ED, 2009, CLIN REHABIL, V23, P334, DOI 10.1177/0269215509103506; Plummer P, 2013, ARCH PHYS MED REHAB, V94, P2565, DOI 10.1016/j.apmr.2013.08.002; Pollock A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010820.pub2; Pollock A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001920.pub3; Pound P, 1994, Qual Health Care, V3, P69, DOI 10.1136/qshc.3.2.69; Rabadi MH, 2008, ARCH PHYS MED REHAB, V89, P441, DOI 10.1016/j.apmr.2007.11.014; Robinson W, 2008, AUST J PHYSIOTHER, V54, P33, DOI 10.1016/S0004-9514(08)70063-1; Roche N, 2015, J REHABIL MED, V47, P31, DOI 10.2340/16501977-1887; Roussel M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147602; Royal College of Physicians British Society of Rehabilitation Medicine Chartered Society of Physiotherapy, 2009, SPAST AD MAN US BOT; Schonberger M, 2007, BRAIN INJURY, V21, P825, DOI 10.1080/02699050701499433; Schonberger M, 2006, BRAIN INJURY, V20, P1271, DOI 10.1080/02699050601049395; Schunemann Holger J, 2006, Health Res Policy Syst, V4, P21, DOI 10.1186/1478-4505-4-21; Scottish Intercollegiate Guidelines Network (SIGN), 2010, MAN PAT STROK REH PR; Sheean G, 2010, EUR J NEUROL, V17, P74, DOI 10.1111/j.1468-1331.2010.03129.x; Siegert R.J., 2014, REHABILITATION GOAL; Simpson DM, 2016, NEUROLOGY, V86, P1818, DOI 10.1212/WNL.0000000000002560; Snaphaan L, 2007, STROKE, V38, P198, DOI 10.1161/01.STR.0000251842.34322.8f; Speight J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2921; Sterr A, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/970136; Sunnerhagen KS, 2013, ACTA NEUROL SCAND, V128, P305, DOI 10.1111/ane.12128; Sunnerhagen KS, 2013, NEUROLOGY, V80, pS35, DOI 10.1212/WNL.0b013e3182764aa2; Suputtitada A, 2005, DISABIL REHABIL, V27, P176, DOI 10.1080/09638280400009360; TATEMICHI TK, 1994, J NEUROL NEUROSUR PS, V57, P202, DOI 10.1136/jnnp.57.2.202; TAUB E, 1993, ARCH PHYS MED REHAB, V74, P347; Teasell R, 2014, EVIDENCE BASED REV S; Tennant A, 2007, DISABIL REHABIL, V29, P1583, DOI 10.1080/09638280701618828; Turner-Stokes L, 2006, CLIN MED, V6, P91, DOI 10.7861/clinmedicine.6-1-91; Turner-Stokes L, 2002, CLIN MED, V2, P128, DOI 10.7861/clinmedicine.2-2-128; Turner-Stokes L, 2013, BMJ OPEN, V3; Turner-Stokes L, 2007, DISABIL REHABIL, V29, P1806, DOI 10.1080/09638280701568205; Turner-Stokes L, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011157; Turner-Stokes L, 2015, INT J THER REHABIL, V22, P210, DOI 10.12968/ijtr.2015.22.5.210; Turner-Stokes L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002771; Turner-Stokes L, 2010, J REHABIL MED, V42, P81, DOI 10.2340/16501977-0474; Turner-Stokes L, 2010, CLIN REHABIL, V24, P66, DOI 10.1177/0269215509343846; Turner-Stokes L, 2009, CLIN REHABIL, V23, P362, DOI 10.1177/0269215508101742; Turner-Stokes L, 2009, J REHABIL MED, V41, P528, DOI 10.2340/16501977-0383; Veerbeek JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087987; Veterans Association / Department of Defense, 2010, CLIN PRACT GUID MAN; Wade DT, 2009, CLIN REHABIL, V23, P291, DOI 10.1177/0269215509103551; Ward AB, 2014, J REHABIL MED, V46, P504, DOI 10.2340/16501977-1817; Watanabe T, 2004, AM J PHYS MED REHAB, V83, pS45, DOI 10.1097/01.PHM.0000141130.58285.DA; Winstein CJ, 2004, ARCH PHYS MED REHAB, V85, P620, DOI 10.1016/j.apmr.2003.06.027; Wissel J, 2009, J REHABIL MED, V41, P13, DOI 10.2340/16501977-0303; Wolf SL, 2008, LANCET NEUROL, V7, P33, DOI 10.1016/S1474-4422(07)70294-6; World Health Organization, 2007, INT CLASS FUNCT DIS; Yelnik AP, 2010, J REHABIL MED, V42, P801, DOI 10.2340/16501977-0613	109	17	18	1	6	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	1973-9087	1973-9095		EUR J PHYS REHAB MED	Eur. J. Phys. Rehabil. Med.	AUG	2018	54	4					605	617		10.23736/S1973-9087.17.04808-0			13	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	GU5BE	WOS:000445298800011	29265792				2022-02-06	
J	Wu, T; Merkley, TL; Wilde, EA; Barnes, A; Li, XQ; Chu, ZD; McCauley, SR; Hunter, JV; Levin, HS				Wu, Trevor; Merkley, Tricia L.; Wilde, Elisabeth A.; Barnes, Amanda; Li, Xiaoqi; Chu, Zili David; McCauley, Stephen R.; Hunter, Jill V.; Levin, Harvey S.			A preliminary report of cerebral white matter microstructural changes associated with adolescent sports concussion acutely and subacutely using diffusion tensor imaging	BRAIN IMAGING AND BEHAVIOR			English	Article						Diffusion tensor imaging (DTI); Sports concussion; MRI; Longitudinal; Mild traumatic brain injury	TRAUMATIC BRAIN-INJURY; MAGNETIC-RESONANCE IMAGES; SURFACE-BASED ANALYSIS; CORTICAL SURFACE; NEUROCOGNITIVE PERFORMANCE; INTERNATIONAL-CONFERENCE; COGNITIVE SEQUELAE; COORDINATE SYSTEM; HEAD IMPACTS; SYMPTOMS	Diffusion tensor imaging (DTI) has demonstrated its utility in detecting microscopic post-concussion cerebral white matter structural changes, which are not routinely evident on conventional neuroimaging modalities. In this study, we compared 10 adolescents with sports concussion (SC) to 12 orthopedically-injured (OI) individuals within 96 h and three months post injury to 12 typically-developing (TD) participants using DTI and volumetric analyses. In terms of volume, no group differences were noted between SC, OI and TD groups at both 96 h and three months post concussion. Results did not show significant differences between SC, OI, and TD groups for both fractional anisotropy (FA) and apparent diffusion coefficient (ADC) in all regions of interest within 96 h post concussion. However, at three months post-injury, the SC group exhibited significantly lower FA than the TD group in various regions of interest. In terms of ADC, significant group differences between SC and TD groups were found in some regions, with SC group having higher ADC than TD. No group differences for FA and ADC were noted between SC and OI groups at three months post-injury. However, several moderate effect sizes on between-group analyses were noted such that FA was lower and ADC was higher in SC relative to OI. Longitudinally, the SC group demonstrated decreased FA and increased ADC in some areas. The findings highlight the fact that the brain continues to change during the post-injury recovery period, and raises the possibility that adverse changes may result from the neurometabolic cascade that purportedly ensues following SC. DTI may potentially be used to characterize the nature of brain changes that occur following sports-related concussions.	[Wu, Trevor] Michigan State Univ, Mercy Hlth St Marys, 220 Cherry St SE, Grand Rapids, MI 49503 USA; [Merkley, Tricia L.] Barrow Neurol Inst, 222 W Thomas Rd,Suite 315, Phoenix, AZ 85013 USA; [Wilde, Elisabeth A.; Li, Xiaoqi; Chu, Zili David; McCauley, Stephen R.; Hunter, Jill V.; Levin, Harvey S.] Baylor Coll Med, One Baylor Plaza BCM637, Houston, TX 77030 USA; [Barnes, Amanda] Univ Miami, Miller Sch Med, 1600 NW 10th Ave 1440, Miami, FL 33136 USA		Wilde, EA (corresponding author), Baylor Coll Med, One Baylor Plaza BCM637, Houston, TX 77030 USA.	trevor.wu@mercyhealth.com; tricia.merkley@dignityhealth.org; ewilde@bcm.edu; amandabarn@gmail.com; xiaoqil@bcm.edu; zchu@bcm.edu; mccauley@bcm.edu; jvhunter@texaschildrens.org; hlevin@bcm.edu	Merkley, Tricia L./AAN-2989-2020	Merkley, Tricia/0000-0002-0897-8391	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R21-NS086714, 5P01-NS056202]	This work was supported by the National Institutes of Health grants 5R21-NS086714 and 5P01-NS056202. The funding sources had no role in the interpretation of data, writing of this paper, or in the decision to submit for publication. The contents of this paper are solely the responsibility of the authors and do not represent the official views of the National Institutes of Health. The authors wish to thank James Montier and English Pratts, Baylor College of Medicine, for their assistance in the preparation of this manuscript, Drs. Claudia Robertson and James McCarthy for their help with recruitment, and Vipulkumar Patel for his assistance in MRI acquisition.	Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Bigler ED, 2010, NEUROIMAGE, V50, P1017, DOI 10.1016/j.neuroimage.2010.01.003; Borich M, 2013, J NEUROTRAUM, V30, P1243, DOI 10.1089/neu.2012.2818; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Cassidy D., 2016, BRIT J SPORT MED, DOI [10.1136/bjsports-2017-097699, DOI 10.1136/BJSPORTS-2017-097699]; Chrisman SPD, 2014, J ADOLESCENT HEALTH, V54, P582, DOI 10.1016/j.jadohealth.2013.10.006; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DALE AM, 1993, J COGNITIVE NEUROSCI, V5, P162, DOI 10.1162/jocn.1993.5.2.162; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dimou S, 2014, J NEUROTRAUM, V31, P413, DOI 10.1089/neu.2013.3050; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P241, DOI 10.3171/2015.1.PEDS14510; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Ewing-Cobbs L, 2016, HUM BRAIN MAPP, V37, P3929, DOI 10.1002/hbm.23286; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Ilie G, 2015, J PSYCHIATR RES, V69, P174, DOI 10.1016/j.jpsychires.2015.08.004; Iverson GL, 2015, NEUROSCI BIOBEHAV R, V56, P276, DOI 10.1016/j.neubiorev.2015.05.008; Jovicich J, 2006, NEUROIMAGE, V30, P436, DOI 10.1016/j.neuroimage.2005.09.046; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kaya A, 2008, J INT MED RES, V36, P9, DOI 10.1177/147323000803600102; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Mansell JL, 2010, BRAIN INJURY, V24, P1070, DOI 10.3109/02699052.2010.494589; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayers LB, 2013, J NEUROPSYCH CLIN N, V25, P115, DOI 10.1176/appi.neuropsych.11120374; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McCauley SR, 2014, J NEUROTRAUM, V31, P914, DOI 10.1089/neu.2012.2826; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McCrory PR, 2000, CLIN J SPORT MED, V10, P235, DOI 10.1097/00042752-200010000-00002; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; Meehan W, 2015, NEUROLOGY, V85, P1504, DOI 10.1212/WNL.0000000000001893; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Merkley TL, 2008, J NEUROTRAUM, V25, P1343, DOI 10.1089/neu.2008.0615; Murugavel M, 2014, J NEUROTRAUM, V31, P1860, DOI 10.1089/neu.2014.3368; Paus T, 2008, NAT REV NEUROSCI, V9, P947, DOI 10.1038/nrn2513; Pulsipher DT, 2011, CURR SPORT MED REP, V10, P14, DOI 10.1249/JSR.0b013e31820711b8; Rabinowitz AR, 2015, J NEUROTRAUM, V32, P1488, DOI 10.1089/neu.2014.3555; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Reuter M, 2010, NEUROIMAGE, V53, P1181, DOI 10.1016/j.neuroimage.2010.07.020; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Salat DH, 2009, NEUROIMAGE, V44, P1247, DOI 10.1016/j.neuroimage.2008.10.030; Schmithorst VJ, 2010, BRAIN COGNITION, V72, P16, DOI 10.1016/j.bandc.2009.06.005; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Siman R, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00190; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Steinberg L, 2005, TRENDS COGN SCI, V9, P69, DOI 10.1016/j.tics.2004.12.005; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Thomas TC, 2015, BRAIN NEUROTRAUMA MO, P531, DOI [10.1201/b18126-43, DOI 10.1201/B18126-43]; Topal NB, 2008, NEUROL RES, V30, P974, DOI 10.1179/016164108X323799; Tsushima WT, 2013, APPL NEUROPSYCH-CHIL, V2, P13, DOI 10.1080/09084282.2011.643967; Virji-Babul N, 2013, PEDIATR NEUROL, V48, P24, DOI 10.1016/j.pediatrneurol.2012.09.005; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Wilde EA, 2016, J NEUROTRAUM, V33, P2000, DOI 10.1089/neu.2015.4212; Wilde EA, 2012, BRAIN IMAGING BEHAV, V6, P319, DOI 10.1007/s11682-012-9174-3; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110; Yeates KO, 1997, J CLIN EXP NEUROPSYC, V19, P825, DOI 10.1080/01688639708403763; Zuckerman Scott L, 2012, Surg Neurol Int, V3, P130, DOI 10.4103/2152-7806.102945	85	17	18	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	AUG	2018	12	4					962	973		10.1007/s11682-017-9752-5			12	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GO6HY	WOS:000440141800004	28812290				2022-02-06	
J	Gagner, C; Landry-Roy, C; Bernier, A; Gravel, J; Beauchamp, MH				Gagner, Charlotte; Landry-Roy, Catherine; Bernier, Annie; Gravel, Jocelyn; Beauchamp, Miriam H.			Behavioral consequences of mild traumatic brain injury in preschoolers	PSYCHOLOGICAL MEDICINE			English	Article						Traumatic brain injury; childhood; behavioral problems; preschool period	5-YEAR FOLLOW-UP; HEAD-INJURY; PSYCHIATRIC-DISORDERS; BIRTH COHORT; CHILDREN; PREDICTORS; OUTCOMES; RECOVERY; RISK; AGE	Background. Pediatric traumatic brain injury (TBI) is a leading cause of long-term disability in children and adolescents worldwide. Amongst the wide array of consequences known to occur after pediatric TBI, behavioral impairments are among the most widespread and may particularly affect children who sustain injury early in the course of development. The aim of this study was to investigate the presence of internalizing and externalizing behavioral problems 6 months after preschool (i.e. 18-60 months old) mild TBI. Methods. This work is part of a prospective, longitudinal cohort study of preschool TBI. Participants (N = 229) were recruited to one of three groups: children with mild TBI, typically developing children and orthopedic injured (OI) children. Mothers of children in all three groups completed the Child Behavior Checklist as a measure of behavioral outcomes 6-month post-injury. Demographics, injury-related characteristics, level of parental distress, and estimates of pre-injury behavioral problems were also documented. Results. The three groups did not differ on baseline characteristics (e.g. demographics and pre-injury behavioral problems for the mild TBI and OI groups) and level of parental distress. Mothers' ratings of internalizing and externalizing behaviors were higher in the mild TBI group compared with the two control groups. Pre-injury behavioral problems and maternal distress were found to be significant predictors of outcome. Conclusion. Our results show that even in its mildest form, preschool TBI may cause disruption to the immature brain serious enough to result in behavioral changes, which persist for several months post-injury.	[Gagner, Charlotte; Landry-Roy, Catherine; Bernier, Annie; Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Gagner, Charlotte; Landry-Roy, Catherine; Gravel, Jocelyn; Beauchamp, Miriam H.] Ste Justine Hosp Res Ctr, Montreal, PQ, Canada		Beauchamp, MH (corresponding author), Univ Montreal, Dept Psychol, Montreal, PQ, Canada.; Beauchamp, MH (corresponding author), Ste Justine Hosp Res Ctr, Montreal, PQ, Canada.	miriam.beauchamp@umontreal.ca			Canadian Health Research Fund (CIHR) [MOP111036]	We are grateful for the work of Cindy Beaudoin and the members of the LION project. We also thank the Emergency Department team, in particular, Maryse Lagace, Ramona Cook, and the "PIEUVRES' group for their assistance with recruitment. All phases of this study were supported by the Canadian Health Research Fund (CIHR), grant number MOP111036.	Abidin R., 1990, PARENTING STRESS IND; Achenbach T.M., 2000, MANUAL ASEBA PRESCHO; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Babikian T, 2013, J INT NEUROPSYCH SOC, V19, P145, DOI 10.1017/S135561771200104X; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Beaudoin C., 2017, 12 WORLD C BRAIN INJ; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Caspi A, 1996, ARCH GEN PSYCHIAT, V53, P1033; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Christensen A., 1992, PSYCHOL ASSESSMENT, V4, P419, DOI DOI 10.1037/1040-3590.4.4.419; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Congeni Joseph, 2009, Adolesc Med State Art Rev, V20, P41; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Dennis M, 2000, SCI PRACT NEUROPSYCH, P3; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; Emond A, 2007, CHILD PSYCHIAT HUM D, V38, P221, DOI 10.1007/s10578-007-0058-5; Giza CC, 2006, INDIAN J NEUROTRAUM, V3, P19; Goldstrohm SL, 2005, ARCH CLIN NEUROPSYCH, V20, P675, DOI 10.1016/j.acn.2005.02.005; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; Hirshfeld-Becker DR, 2007, J DEV BEHAV PEDIATR, V28, P225, DOI 10.1097/01.DBP.0000268559.34463.d0; Innocenti GM, 2007, PROG BRAIN RES, V164, P23, DOI 10.1016/S0079-6123(07)64002-3; Keenan HT, 2007, PEDIATRICS, V119, pE616, DOI 10.1542/peds.2006-2313; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Langberg JM, 2010, J EMOT BEHAV DISORD, V18, P41, DOI 10.1177/1063426608330792; LERNER JA, 1985, J AM ACAD CHILD PSY, V24, P42, DOI 10.1016/S0002-7138(09)60408-8; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Liu JH, 2013, BRAIN INJURY, V27, P1263, DOI 10.3109/02699052.2013.804205; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Mesman J, 2001, J AM ACAD CHILD PSY, V40, P1029, DOI 10.1097/00004583-200109000-00011; Miller G, 2010, SCIENCE, V328, P297, DOI 10.1126/science.328.5976.297; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Neece CL, 2012, AJIDD-AM J INTELLECT, V117, P48, DOI 10.1352/1944-7558-117.1.48; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Petty CR, 2008, J ANXIETY DISORD, V22, P532, DOI 10.1016/j.janxdis.2007.04.003; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Schoemaker K, 2013, J ABNORM CHILD PSYCH, V41, P457, DOI 10.1007/s10802-012-9684-x; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; SHODA Y, 1990, DEV PSYCHOL, V26, P978, DOI 10.1037/0012-1649.26.6.978; Thurber S., 2012, ARCH ASSESSMENT PSYC, V2, P73; Treutler CM, 2003, J ABNORM CHILD PSYCH, V31, P13, DOI 10.1023/A:1021765114434; van der Veen-Mulders L, 2016, EUROPEAN CHILD ADOLE, V26, P365; Werker JF, 2005, DEV PSYCHOBIOL, V46, P233, DOI 10.1002/dev.20060; Wetherington CE, 2010, J PEDIATR PSYCHOL, V35, P662, DOI 10.1093/jpepsy/jsp081; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986	50	17	17	0	8	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0033-2917	1469-8978		PSYCHOL MED	Psychol. Med.	JUL	2018	48	9					1551	1559		10.1017/S0033291717003221			9	Psychology, Clinical; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Psychiatry	GJ8OR	WOS:000435649900017	29173217				2022-02-06	
J	Goverover, Y; Chiaravalloti, N; Genova, H; DeLuca, J				Goverover, Yael; Chiaravalloti, Nancy; Genova, Helen; DeLuca, John			A randomized controlled trial to treat impaired learning and memory in multiple sclerosis: The self-GEN trial	MULTIPLE SCLEROSIS JOURNAL			English	Article						Cognition; memory; transfer; activities of daily living; multiple sclerosis; randomized clinical trial	EVALUATE DISEASE PROGRESSION; TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; FUNCTIONAL ASSESSMENT; COGNITIVE IMPAIRMENT; GENERATION; STANDARDIZATION; REHABILITATION; SATISFACTION; PERFORMANCE	Background: Difficulties in learning and memory are among the most persistent and frequently reported cognitive symptoms in individuals with multiple sclerosis (MS). Objective: To examine the efficacy of the self-generation learning program (self-GEN trial) that consist of behavioral intervention sessions, teaching self-generation technique while using metacognitive strategies to improve learning and memory abilities in persons with MS. Additionally, the treatment aimed to address generalization of the treatment to activities of daily living. Methods: This double-blind, placebo-controlled, randomized clinical trial included 35 participants with clinically definite MS, 19 in the treatment group and 16 in the placebo control group. Participants completed a baseline neuropsychological assessment, including questionnaires assessing everyday memory and a repeat assessment immediately post-treatment. Results: The treatment group showed significantly improved learning and memory, self-regulation, and metacognition relative to the placebo post-treatment. Similar results were noted on measures of depression, functional status, and quality of life (QOL). Conclusion: This study provides initial Class I evidence that the self-GEN behavioral intervention improves memory, self-regulation, functional status, affective symptomatology, and QOL in patients with MS.	[Goverover, Yael] NYU, Steinhardt Sch Culture Educ & Human Dev, Dept Occupat Therapy, 82 Washington Sq East,6th Floor, New York, NY 10003 USA; [Goverover, Yael; Chiaravalloti, Nancy; Genova, Helen; DeLuca, John] Kessler Fdn, W Orange, NJ USA; [Chiaravalloti, Nancy; Genova, Helen; DeLuca, John] Rutgers State Univ, New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ USA		Goverover, Y (corresponding author), NYU, Steinhardt Sch Culture Educ & Human Dev, Dept Occupat Therapy, 82 Washington Sq East,6th Floor, New York, NY 10003 USA.	yg243@nyu.edu		Chiaravalloti, Nancy/0000-0003-2943-7567	National Multiple Sclerosis SocietyNational Multiple Sclerosis Society [PP2098]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was supported by the National Multiple Sclerosis Society (Grant No. PP2098).	Arnett PA, 2004, ARCH CLIN NEUROPSYCH, V19, P507, DOI 10.1016/j.acn.2003.07.006; Ball K, 2002, JAMA-J AM MED ASSOC, V288, P2271, DOI 10.1001/jama.288.18.2271; BAUM C, 1993, GERONTOLOGIST, V33, P403, DOI 10.1093/geront/33.3.403; Brenk A, 2008, EUR NEUROL, V60, P304, DOI 10.1159/000157885; Cella DF, 1996, NEUROLOGY, V47, P129, DOI 10.1212/WNL.47.1.129; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Chiaravalloti ND, 2002, ARCH PHYS MED REHAB, V83, P1070, DOI 10.1053/apmr.2002.33729; Delis D, 2000, CVLT 2 CALIFORNIA VE, P2; DeLuca J, 1998, J CLIN EXP NEUROPSYC, V20, P376, DOI 10.1076/jcen.20.3.376.819; DeWinstanley PA, 2004, MEM COGNITION, V32, P945, DOI 10.3758/BF03196872; deWinstanley PA, 1997, MEMORY, V5, P401, DOI 10.1080/741941392; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Fleming JM, 2005, BRAIN INJURY, V19, P1, DOI 10.1080/02699050410001720059; GILEWSKI MJ, 1992, PSYCHOL AGING, V7, P298, DOI 10.1037/h0090381; Goverover Y, 2008, ARCH PHYS MED REHAB, V89, P1514, DOI 10.1016/j.apmr.2007.11.059; Goverover Y, 2007, BRAIN INJURY, V21, P913, DOI 10.1080/02699050701553205; Goverover Y, 2016, MULT SCLER J, V22, P544, DOI 10.1177/1352458515593637; Goverover Y, 2014, NEUROPSYCHOL REHABIL, V24, P155, DOI 10.1080/09602011.2013.868815; Goverover Y, 2013, J CLIN EXP NEUROPSYC, V35, P775, DOI 10.1080/13803395.2013.824553; Goverover Y, 2010, ARCH PHYS MED REHAB, V91, P252, DOI 10.1016/j.apmr.2009.09.022; HANNAY HJ, 1985, J CLIN EXP NEUROPSYC, V7, P251, DOI 10.1080/01688638508401258; Hertzog Christopher, 2008, Psychol Sci Public Interest, V9, P1, DOI 10.1111/j.1539-6053.2009.01034.x; HOHOL MJ, 1995, NEUROLOGY, V45, P251, DOI 10.1212/WNL.45.2.251; Hohol MJ, 1999, MULT SCLER, V5, P349, DOI 10.1191/135245899678846375; Johnston MV, 2005, ARCH PHYS MED REHAB, V86, P735, DOI 10.1016/j.apmr.2004.10.031; Josman N., 2000, OCCUPATIONAL THERAPY, V7, P246, DOI DOI 10.1002/0TI.126; Kulasegaram K, 2012, ADV HEALTH SCI EDUC, V17, P489, DOI 10.1007/s10459-011-9326-z; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Nyenhuis DL, 1998, J PERS ASSESS, V70, P386, DOI 10.1207/s15327752jpa7002_14; O'Brien AR, 2008, ARCH PHYS MED REHAB, V89, P761, DOI 10.1016/j.apmr.2007.10.019; Ownsworth TL, 2000, CLIN NEUROPSYCHOL, V14, P76, DOI 10.1076/1385-4046(200002)14:1;1-8;FT076; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; SLAMECKA NJ, 1978, J EXP PSYCHOL-HUM L, V4, P592, DOI 10.1037/0278-7393.4.6.592; Spielberger CD, 1989, MANUAL STATE TRAIT A, V2nd; Toglia JP., 1993, CONTEXTUAL MEMORY TE; Woods SP, 2008, CLIN NEUROPSYCHOL, V22, P864, DOI 10.1080/13854040701595999; Zogg JB, 2012, J BEHAV MED, V35, P47, DOI 10.1007/s10865-011-9341-9	37	17	17	1	5	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1352-4585	1477-0970		MULT SCLER J	Mult. Scler. J.	JUL	2018	24	8					1096	1104		10.1177/1352458517709955			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GK3RI	WOS:000436062400012	28485659				2022-02-06	
J	Verhelst, H; Vander Linden, C; De Pauw, T; Vingerhoets, G; Caeyenberghs, K				Verhelst, Helena; Vander Linden, Catharine; De Pauw, Toon; Vingerhoets, Guy; Caeyenberghs, Karen			Impaired rich club and increased local connectivity in children with traumatic brain injury: Local support for the rich?	HUMAN BRAIN MAPPING			English	Article						diffusion-weighted imaging; graph theory; rich club; structural connectivity; traumatic brain injury	STATE FUNCTIONAL CONNECTIVITY; DIFFUSION MRI; STRUCTURAL CONNECTOME; SMALL-WORLD; ORGANIZATION; TRACTOGRAPHY; PLASTICITY; NETWORKS; DISORDER; SYSTEM	Recent evidence has shown the presence of a rich club in the brain, which constitutes a core network of highly interconnected and spatially distributed brain regions, important for high-order cognitive processes. This study aimed to map the rich club organization in 17 young patients with moderate to severe TBI (15.71 +/- 1.75 years) in the chronic stage of recovery and 17 age- and gender-matched controls. Probabilistic tractography was performed on diffusion weighted imaging data to construct the edges of the structural connectomes using number of streamlines as edge weight. In addition, the whole-brain network was divided into a rich club network, a local network and a feeder network connecting the latter two. Functional outcome was measured with a parent questionnaire for executive functioning. Our results revealed a significantly decreased rich club organization (p values<.05) and impaired executive functioning (p<.001) in young patients with TBI compared with controls. Specifically, we observed reduced density values in all three subnetworks (p values<.005) and a reduced mean strength in the rich club network (p=.013) together with an increased mean strength in the local network (p=.002) in patients with TBI. This study provides new insights into the nature of TBI-induced brain network alterations and supports the hypothesis that the local subnetwork tries to compensate for the biologically costly subnetwork of rich club nodes after TBI.	[Verhelst, Helena; Vingerhoets, Guy] Univ Ghent, Fac Psychol & Educ Sci, Dept Expt Psychol, Henri Dunantlaan 2, B-9000 Ghent, Belgium; [Vander Linden, Catharine] Ghent Univ Hosp, Dept Phys Med & Rehabil, Child Rehabil Ctr, Ghent, Belgium; [De Pauw, Toon] Odisee Univ Coll, Dept Elect & ICT, Fac Ind Sci & Technol, Brussels, Belgium; [Caeyenberghs, Karen] Australian Catholic Univ, Fac Hlth Sci, Sch Psychol, Melbourne, Vic, Australia		Verhelst, H (corresponding author), Univ Ghent, Fac Psychol & Educ Sci, Dept Expt Psychol, Henri Dunantlaan 2, B-9000 Ghent, Belgium.	helena.verhelst@ugent.be		Verhelst, Helena/0000-0002-6861-0249; Caeyenberghs, Karen/0000-0001-7009-6843	Special Research Fund (BOF) from the University of Ghent [01N00214]	Special Research Fund (BOF) from the University of Ghent, Grant/Award Number: 01N00214	Andersson JLR, 2016, NEUROIMAGE, V125, P1063, DOI 10.1016/j.neuroimage.2015.10.019; Antonakakis M, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00416; Baggio HC, 2015, J COGNITIVE NEUROSCI, V27, P1801, DOI 10.1162/jocn_a_00821; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Benjamini Y, 2010, J R STAT SOC B, V72, P405, DOI 10.1111/j.1467-9868.2010.00746.x; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; Caeyenberghs K, 2012, NEUROIMAGE-CLIN, V1, P106, DOI 10.1016/j.nicl.2012.09.011; Caeyenberghs K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00726; Castellanos NP, 2011, NEUROIMAGE, V55, P1189, DOI 10.1016/j.neuroimage.2010.12.046; Collin G., 2013, Society for Neuroscience Abstract Viewer and Itinerary Planner, V43, DOI 10.1093/schbul/sbt162; Collin G, 2014, CEREB CORTEX, V24, P2258, DOI 10.1093/cercor/bht064; Crossley NA, 2014, BRAIN, V137, P2382, DOI 10.1093/brain/awu132; Dall'Acqua P, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00127; de Reus MA, 2013, NEUROIMAGE, V70, P402, DOI 10.1016/j.neuroimage.2012.12.066; Dennis EL, 2013, I S BIOMED IMAGING, P624; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Fagerholm ED, 2015, BRAIN, V138, P1696, DOI 10.1093/brain/awv075; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Galantucci S, 2017, RADIOLOGY, V283, P515, DOI 10.1148/radiol.2016160274; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Hillary FG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104021; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Huizinga M., 2009, BRIEF VRAGENLIJST EX; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kim J, 2014, J INT NEUROPSYCH SOC, V20, P887, DOI 10.1017/S1355617714000812; Konigs M, 2017, HUM BRAIN MAPP, V38, P3603, DOI 10.1002/hbm.23614; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; McColgan P, 2015, BRAIN, V138, DOI 10.1093/brain/awv259; Meier J, 2016, BRAIN CONNECT, V6, P298, DOI 10.1089/brain.2015.0408; Mitra J, 2016, NEUROIMAGE, V129, P247, DOI 10.1016/j.neuroimage.2016.01.056; Moenninghoff C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122329; Mohammadi Dara, 2015, Lancet Neurol, V14, P462, DOI 10.1016/S1474-4422(15)00005-8; Opsahl T, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.168702; Raffelt D, 2012, NEUROIMAGE, V59, P3976, DOI 10.1016/j.neuroimage.2011.10.045; Ray S, 2014, HUM BRAIN MAPP, V35, P6032, DOI 10.1002/hbm.22603; Reijmer YD, 2015, NEUROIMAGE, V117, P222, DOI 10.1016/j.neuroimage.2015.05.054; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Skudlarski P, 2008, NEUROIMAGE, V43, P554, DOI 10.1016/j.neuroimage.2008.07.063; Smith RE, 2013, NEUROIMAGE, V67, P298, DOI 10.1016/j.neuroimage.2012.11.049; Smith RE, 2012, NEUROIMAGE, V62, P1924, DOI 10.1016/j.neuroimage.2012.06.005; Solmaz B, 2017, HUM BRAIN MAPP, V38, P2913, DOI 10.1002/hbm.23561; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Stellmann JP, 2017, NEUROL-NEUROIMMUNOL, V4, DOI 10.1212/NXI.0000000000000375; Tournier J.D., 2010, P INT SOC MAGNETIC R, P1670; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tournier JD, 2013, NMR BIOMED, V26, P1775, DOI 10.1002/nbm.3017; Tournier JD, 2012, INT J IMAG SYST TECH, V22, P53, DOI 10.1002/ima.22005; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; van den Heuvel MP, 2013, JAMA PSYCHIAT, V70, P783, DOI 10.1001/jamapsychiatry.2013.1328; van den Heuvel MP, 2012, P NATL ACAD SCI USA, V109, P11372, DOI 10.1073/pnas.1203593109; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; van den Heuvel MP, 2009, HUM BRAIN MAPP, V30, P3127, DOI 10.1002/hbm.20737; Veraart J, 2016, MAGN RESON MED, V76, P1582, DOI 10.1002/mrm.26059; Wieloch T, 2006, CURR OPIN NEUROBIOL, V16, P258, DOI 10.1016/j.conb.2006.05.011; Yeh CH, 2016, NEUROIMAGE, V142, P150, DOI 10.1016/j.neuroimage.2016.05.047; Yuan WH, 2017, NEUROREHAB NEURAL RE, V31, P190, DOI 10.1177/1545968316675430; Yuan WH, 2015, HUM BRAIN MAPP, V36, P779, DOI 10.1002/hbm.22664; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	65	17	17	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	JUL	2018	39	7					2800	2811		10.1002/hbm.24041			12	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	GL9TM	WOS:000437682100009	29528158	Green Published, Bronze			2022-02-06	
J	Trotta, A; Annaidh, AN; Burek, RO; Pelgrims, B; Ivens, J				Trotta, Antonia; Annaidh, Aisling Ni; Burek, Roy Owen; Pelgrims, Bart; Ivens, Jan			Evaluation of the head-helmet sliding properties in an impact test	JOURNAL OF BIOMECHANICS			English	Article						Scalp; Friction; Head impact; Helmet; Rotational acceleration	TRAUMATIC BRAIN-INJURIES; DIFFUSE AXONAL INJURY; HUMAN SKIN; FRICTION; RECONSTRUCTIONS; AGE	The scalp plays a crucial role in head impact biomechanics, being the first tissue involved in the impact and providing a sliding interface between the impactor and/or helmet and the skull. It is important to understand both the scalp-skull and the scalp-helmet sliding in order to determine the head response due to an impact. However, experimental data on the sliding properties of the scalp is lacking. The aim of this work was to identify the sliding properties of the scalp using cadaver heads, in terms of scalp skull and scalp-liner (internal liner of the helmet) friction and to compare these values with that of widely used artificial headforms (Hill and magnesium EN960). The effect of the hair, the direction of sliding, the speed of the test and the normal load were considered. The experiments revealed that the sliding behaviour of the scalp under impact loading is characterised by three main phases: (1) the low friction sliding of the scalp over the skull (scalp-skull friction), (2) the tensioning effect of the scalp and (3) the sliding of the liner fabric over the scalp (scalp-liner friction). Results showed that the scalp-skull coefficient of friction (COF) is very low (0.06 0.048), whereas the scalp-liner COF is 0.29 0.07. The scalp-liner COF is statistically different from the value of the HIII-liner (0.75 0.06) and the magnesium EN960-liner (0.16 0.026). These data will lead to the improvement of current headforms for head impact standard tests, ultimately leading to more realistic head impact simulations and the optimization of helmet designs. (C) 2018 Elsevier Ltd. All rights reserved.	[Trotta, Antonia; Annaidh, Aisling Ni] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 4, Ireland; [Annaidh, Aisling Ni] Univ Coll Dublin, Sch Med & Med Sci, UCD Charles Inst Dermatol, Dublin 4, Ireland; [Burek, Roy Owen] Charles Owen & Co Bow Ltd, Croesfoel Ind Pk, Wrexham LL14 4BJ, Wales; [Burek, Roy Owen] Cardiff Univ, Sch Engn, Queens Bldg, Cardiff CF24 3AA, S Glam, Wales; [Pelgrims, Bart; Ivens, Jan] Katholieke Univ Leuven, Dept Mat Engn, Kasteelpk Arenberg 44, B-3001 Leuven, Belgium		Trotta, A (corresponding author), Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 4, Ireland.	antonia.trotta@ucd.ie	Ivens, Jan ID/I-4339-2016; Ni Annaidh, Aisling/ABF-8938-2021	Ivens, Jan ID/0000-0002-2766-1381; Ni Annaidh, Aisling/0000-0002-9929-4541; Trotta, Antonia/0000-0003-0973-6420	European Union's Horizon 2020 research programme under the Marie Sklodowska - Curie grant [642662]	Funding was provided by the European Union's Horizon 2020 research programme under the Marie Sklodowska - Curie grant agreement No. 642662. The authors wish to thank Bart Depreitere, the ethical committee of KU Leuven and the anatomy skills centre for their support and approval.	Aare Magnus, 2003, Traffic Inj Prev, V4, P240, DOI 10.1080/15389580309879; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Amoros E, 2012, INJURY PREV, V18, P27, DOI 10.1136/ip.2011.031815; Annaidh AN, 2012, ANN BIOMED ENG, V40, P1666, DOI 10.1007/s10439-012-0542-3; Attewell RG, 2001, ACCIDENT ANAL PREV, V33, P345, DOI 10.1016/S0001-4575(00)00048-8; Belingardi G, 2005, P 19 INT TECHN C ENH; Christensen M.S., 1983, FACIAL OILINESS DRYN; COMAISH S, 1971, BRIT J DERMATOL, V84, P37, DOI 10.1111/j.1365-2133.1971.tb14194.x; Connor TA, 2016, CURRENT STANDARDS SP; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Deck C, 2008, INT J CRASHWORTHINES, V13, P667, DOI 10.1080/13588260802411523; Derler S, 2012, TRIBOL LETT, V45, P1, DOI 10.1007/s11249-011-9854-y; Di Landro L, 2002, POLYM TEST, V21, P217, DOI 10.1016/S0142-9418(01)00073-3; Ebrahimi I, 2015, TRAFFIC INJ PREV, V16, P404, DOI 10.1080/15389588.2014.937804; Fahlstedt M, 2015, J BIOMECH, V48, P1331, DOI 10.1016/j.jbiomech.2015.02.057; Finan JD, 2008, TRAFFIC INJ PREV, V9, P483, DOI 10.1080/15389580802272427; Fotoh C, 2008, SKIN RES TECHNOL, V14, P327, DOI 10.1111/j.1600-0846.2008.00299.x; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gennarelli TA, 1987, DIRECTIONAL DEPENDEN; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Gerhardt LC, 2008, SKIN RES TECHNOL, V14, P77, DOI 10.1111/j.1600-0846.2007.00264.x; Halldin P., 2013, P 1 INT C HELM PERF; Hasler RM, 2015, WORLD NEUROSURG, V84, DOI 10.1016/j.wneu.2015.05.016; Holbourn AHS, 1943, LANCET, V2, P438; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Jennett B, 1998, ARCH DIS CHILD, V78, P403, DOI 10.1136/adc.78.5.403; Keng SH, 2005, ACCIDENT ANAL PREV, V37, P349, DOI 10.1016/j.aap.2004.09.006; Kleiven S., 2013, FRONT BIOENG BIOTECH, V1; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Kondo S., 2002, J JPN RES ASS TEXT E, V43, P41; Langer K., 1861, BR J PLAST SURG, V17, P93; NOCSAE, 2018, STAND PNEUM RAM TEST; Ottenio M, 2015, J MECH BEHAV BIOMED, V41, P241, DOI 10.1016/j.jmbbm.2014.10.006; POCHI PE, 1979, J INVEST DERMATOL, V73, P108, DOI 10.1111/1523-1747.ep12532792; Povey LJ, 1999, ACCIDENT ANAL PREV, V31, P763, DOI 10.1016/S0001-4575(99)00033-0; Rueda MAF, 2011, COMPUT METHOD BIOMEC, V14, P1021, DOI 10.1080/10255842.2010.504922; Sivamani RK, 2003, SKIN RES TECHNOL, V9, P299, DOI 10.1034/j.1600-0846.2003.00034.x; Tang W, 2008, J BIONIC ENG, V5, P33, DOI 10.1016/S1672-6529(08)60004-9; Taylor CA, 2017, MMWR SURVEILL SUMM, P66; Thompson D.C., 1999, COCHR DATABASE SYST, V4; Thompson D. C., 1998, CYCLE HELMETS PREVEN; TOLHURST DE, 1991, PLAST RECONSTR SURG, V87, P603, DOI 10.1097/00006534-199104000-00001; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhang M, 1999, PROSTHET ORTHOT INT, V23, P135	44	17	17	1	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	JUN 25	2018	75						28	34		10.1016/j.jbiomech.2018.05.003			7	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biophysics; Engineering	GM3GQ	WOS:000437991500003	29784247	Green Submitted			2022-02-06	
J	Di Battista, AP; Churchill, N; Schweizer, TA; Rhind, SG; Richards, D; Baker, AJ; Hutchison, MG				Di Battista, Alex P.; Churchill, Nathan; Schweizer, Tom A.; Rhind, Shawn G.; Richards, Doug; Baker, Andrew J.; Hutchison, Michael G.			Blood biomarkers are associated with brain function and blood flow following sport concussion	JOURNAL OF NEUROIMMUNOLOGY			English	Article							NEURON-SPECIFIC ENOLASE; MINOR HEAD-INJURY; QUANTITATIVE-EVALUATION; COMPUTED-TOMOGRAPHY; CT FINDINGS; S100B; SERUM; PROTEIN; MCP-4; STRESS	Background: Secondary injury pathophysiology after sport-related concussion (SRC) is poorly understood. Blood biomarkers may be a useful tool for characterizing these processes, yet there are limitations in their application as a single modality. Combining blood biomarker analysis with advanced neuroimaging may help validate their continued utility in brain injury research by elucidating important secondary injury mechanisms. Hence, the purpose of this study was to evaluate co-modulation between peripheral blood biomarkers and advanced functional brain imaging after SRC. Methods: Forty-three university level athletes from 7 sports were recruited (16 recently concussed athletes; 15 healthy athletes with no prior history of concussion; 12 healthy athletes with a history of concussion). Seven blood biomarkers were evaluated: s100B, total tau (T-tau), von Willebrand factor (vWF), brain derived neurotrophic factor (BDNF), peroxiredoxin (PRDX)-6, monocyte chemoattractant protein (MCP)-1 and -4. Resting-state functional MRI was employed to assess global neural connectivity (Gconn), and arterial spin labelling was used to evaluate cerebral blood flow (CBF). We tested for concurrent alterations in blood biomarkers and MRI measures of brain function between athlete groups using a non-parametric, bootstrapped resampling framework. Results: Compared to healthy athletes, recently concussed athletes showed greater concurrent alterations in several peripheral blood biomarker and MRI measures: a decrease in T-Tau and Gconn, a decrease in T-Tau and CBF, a decrease in Gconn with elevated PRDX-6, a decrease in CBF with elevated PRDX-6, and a decrease in Gconn with elevated MCP-4. In addition, compared to healthy athletes with no concussion history, healthy athletes with a history of concussion displayed greater concurrent alterations in blood biomarkers and Gconn; lower GConn covaried with higher blood levels of s100B and MCP-4. Conclusion: We identified robust relationships between peripheral blood biomarkers and MRI measures in both recently concussed athletes and healthy athletes with a history of concussion. The results from this combinatorial approach further support that human concussion is associated with inflammation, oxidative stress, and cellular damage, and that physiological perturbations may extend chronically beyond recovery. Finally, our results support the continued implementation of blood biomarkers as a tool to investigate brain injury, particularly in a multimodal framework.	[Di Battista, Alex P.; Rhind, Shawn G.; Richards, Doug; Hutchison, Michael G.] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Di Battista, Alex P.; Rhind, Shawn G.] Def Res & Dev Canada, Toronto Res Ctr, Toronto, ON, Canada; [Churchill, Nathan; Schweizer, Tom A.; Hutchison, Michael G.] St Michaels Hosp, Neurosci Program, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada; [Schweizer, Tom A.; Baker, Andrew J.; Hutchison, Michael G.] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Toronto, ON, Canada; [Richards, Doug] Univ Toronto, Fac Kinesiol & Phys Educ, David L Macintosh Sport Med Clin, Toronto, ON, Canada; [Baker, Andrew J.] Univ Toronto, St Michaels Hosp, Dept Crit Care, Toronto, ON, Canada; [Baker, Andrew J.] Univ Toronto, St Michaels Hosp, Dept Anesthesia, Toronto, ON, Canada; [Baker, Andrew J.] Univ Toronto, St Michaels Hosp, Dept Surg, Toronto, ON, Canada		Di Battista, AP (corresponding author), Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada.	alex.dibattista@utoronto.ca; schweizerT@smh.ca; shawn.rhind@drdc-rddc.gc.ca; doug.richards@utoronto.ca; bakera@smh.ca; michael.hutchison@utoronto.ca		Rhind, Shawn/0000-0003-2300-0620; Di Battista, Alex/0000-0002-3325-6833	Canadian Institute of Military and Veteran Health Research [W7714-145967]	The authors would like to acknowledge Maria Shiu and Sarah Watling for their help with data collection during the study period. This study was funded by the Canadian Institute of Military and Veteran Health Research (W7714-145967) (CIMVHR) - Task 7.	Akhtar Javed I, 2003, Pediatr Crit Care Med, V4, P322; Baumann R, 2013, AM J RHINOL ALLERGY, V27, P266, DOI 10.2500/ajra.2013.27.3913; Becelewski Janusz, 2002, Neurol Neurochir Pol, V36, P1135; Breland UM, 2010, CARDIOVASC RES, V86, P265, DOI 10.1093/cvr/cvq044; Buonora JE, 2015, J NEUROTRAUM, V32, P1805, DOI 10.1089/neu.2014.3736; Buonora JE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00068; Catania A, 2009, BRAIN BEHAV IMMUN, V23, P877, DOI 10.1016/j.bbi.2009.04.006; Chrousos G P, 1997, Aging (Milano), V9, P25; Churchill N, 2017, J NEUROTRAUM, V34, P765, DOI 10.1089/neu.2016.4531; Churchill NW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07742-3; Churchill NW, 2017, NEUROIMAGE-CLIN, V14, P480, DOI 10.1016/j.nicl.2017.02.015; Cole MW, 2012, J NEUROSCI, V32, P8988, DOI 10.1523/JNEUROSCI.0536-12.2012; Dalgard C, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2016.285; Di Battista AP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159929; Di Battista AP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0500-3; Di Battista AP, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00044; Elenkov I., 2000, NEUROENDOCRINE EFFEC; Elenkov IJ, 1999, BEST PRACT RES CL EN, V13, P583, DOI 10.1053/beem.1999.0045; Falcone T, 2015, J PSYCHIATR RES, V62, P14, DOI 10.1016/j.jpsychires.2014.12.002; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Gempp E, 2014, DIVING HYPERB MED, V44, P26; Gentili A, 2016, HORM METAB RES, V48, P847, DOI 10.1055/s-0042-108731; Gill J, 2017, NEUROLOGY, V88, P595, DOI 10.1212/WNL.0000000000003587; Gill J, 2016, J HEAD TRAUMA REHAB, V31, P269, DOI 10.1097/HTR.0000000000000191; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iliff JJ, 2013, J NEUROSCI, V33, P18190, DOI 10.1523/JNEUROSCI.1592-13.2013; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Ingebrigtsen T, 1996, J NEUROSURG, V85, P945, DOI 10.3171/jns.1996.85.5.0945; Isgro MA, 2015, ADV EXP MED BIOL, V867, P125, DOI 10.1007/978-94-017-7215-0_9; Jaerve A, 2012, CELL TISSUE RES, V349, P229, DOI 10.1007/s00441-012-1427-3; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Jones Harlan P, 2012, Methods Mol Biol, V934, P77, DOI 10.1007/978-1-62703-071-7_4; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Koh SXT, 2014, SPORTS MED, V44, P369, DOI 10.1007/s40279-013-0119-9; Kou ZF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080296; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; Liezmann C, 2012, DERM-ENDOCRINOL, V4, DOI 10.4161/derm.22023; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Menard C, 2017, NEUROPSYCHOPHARMACOL, V42, P62, DOI 10.1038/npp.2016.90; Merchant-Borna K, 2016, J NEUROTRAUM, V33, P1576, DOI 10.1089/neu.2015.4191; Mishra SK, 2017, MOL CELL NEUROSCI, V78, P25, DOI 10.1016/j.mcn.2016.11.008; Muller K, 2007, J TRAUMA, V62, P1452, DOI 10.1097/TA.0b013e318047bfaa; Okugawa Y, 2016, J SURG ONCOL, V114, P483, DOI 10.1002/jso.24335; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Petzold A, 2003, NEUROSCI LETT, V336, P167, DOI 10.1016/S0304-3940(02)01257-0; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Pradeep AR, 2013, CYTOKINE, V61, P772, DOI 10.1016/j.cyto.2012.12.022; Relster MM, 2017, APMIS, V125, P148, DOI 10.1111/apm.12636; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sahu Seelora, 2017, World J Biol Chem, V8, P21, DOI 10.4331/wjbc.v8.i1.21; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P459, DOI 10.1038/jcbfm.2009.240; Shahim P, 2015, BRAIN INJURY, V29, P872, DOI 10.3109/02699052.2015.1018324; Siman R, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00190; Singh SP, 2016, AM J PHYSIOL-CELL PH, V310, pC1, DOI 10.1152/ajpcell.00229.2015; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Strothert SC, 2002, NEUROIMAGE, V15, P747, DOI 10.1006/nimg.2001.1034; Tolan NV, 2013, CLIN CHIM ACTA, V424, P216, DOI 10.1016/j.cca.2013.06.009; Unden J, 2010, J HEAD TRAUMA REHAB, V25, P228, DOI 10.1097/HTR.0b013e3181e57e22; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Webster EL, 1997, MOL PSYCHIATR, V2, P368, DOI 10.1038/sj.mp.4000305; Wiesmann M, 2010, ACTA NEUROL SCAND, V121, P178, DOI 10.1111/j.1600-0404.2009.01196.x; Woda A, 2016, PSYCHONEUROENDOCRINO, V71, P127, DOI 10.1016/j.psyneuen.2016.05.017; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3; Zhang Zhonghua, 2014, ScientificWorldJournal, V2014, P473651, DOI 10.1155/2014/473651; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413	74	17	17	1	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-5728	1872-8421		J NEUROIMMUNOL	J. Neuroimmunol.	JUN 15	2018	319						1	8		10.1016/j.jneuroim.2018.03.002			8	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	GG9JI	WOS:000433016400001	29685283	hybrid			2022-02-06	
J	Du, GL; Zhao, ZM; Chen, YH; Li, ZH; Tian, YH; Liu, ZF; Liu, B; Song, JQ				Du, Guoliang; Zhao, Zongmao; Chen, Yonghan; Li, Zonghao; Tian, Yaohui; Liu, Zhifeng; Liu, Bin; Song, Jianqiang			Quercetin protects rat cortical neurons against traumatic brain injury	MOLECULAR MEDICINE REPORTS			English	Article						quercetin; apoptosis; phosphatidylinositol 3-kinase PI3K/Akt; extracellular signal-regulated kinase 1/2; traumatic brain injury	CEREBRAL-ISCHEMIA; HEAD-INJURY; ACTIVATION; APOPTOSIS; MODEL; PATHOPHYSIOLOGY; PATHWAY; DEATH	Previous studies have demonstrated that traumatic brain injury (TBI) may cause neurological deficits and neuronal cell apoptosis. Quercetin, one of the most widely distributed flavonoids, possesses anti-inflammatory, anti-blood coagulation, anti-ischemic and anti-cancer activities, and neuroprotective effects in the context of brain injury. The purpose of the present study was to investigate the neuroprotective effects of quercetin in TBI. A total of 75 rats were randomly arranged into 3 groups as follows: Sham group (Sham); TBI group (TBI); and TBI + quercetin group (Que). Brain edema was evaluated by analysis of brain water content. The neurobehavioral status of the rats was evaluated by Neurological Severity Scoring. Immunohistochemical and western blot analyses were used to measure the expression of certain proteins. The results of the present study demonstrated that post-TBI administration of quercetin may attenuate brain edema, in addition to improving motor function in rats. Additionally, quercetin caused a marked inhibition of extracellular signal-regulated kinase 1/2 phosphorylation and activated Akt serine/threonine protein kinase phosphorylation, which may result in attenuation of neuronal apoptosis. The present study provided novel insights into the mechanism through which quercetin may exert its neuroprotective activity in a rat model of TBI.	[Du, Guoliang; Chen, Yonghan; Li, Zonghao; Tian, Yaohui; Liu, Zhifeng; Liu, Bin; Song, Jianqiang] Cent Hosp Cangzhou, Dept Neurosurg, 201 Xinhua Rd, Cangzhou 061001, Hebei, Peoples R China; [Zhao, Zongmao] Hebei Med Univ, Dept Neurosurg, Hosp 2, Shijiazhuang 060000, Hebei, Peoples R China		Du, GL (corresponding author), Cent Hosp Cangzhou, Dept Neurosurg, 201 Xinhua Rd, Cangzhou 061001, Hebei, Peoples R China.	guoliangdu2001@163.com					Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Chong YH, 2006, J BIOL CHEM, V281, P20315, DOI 10.1074/jbc.M601016200; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Dok-Go H, 2003, BRAIN RES, V965, P130, DOI 10.1016/S0006-8993(02)04150-1; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Du G., 2016, NEUROL RES, P1; Endo H, 2006, STROKE, V37, P2140, DOI 10.1161/01.STR.0000229888.55078.72; Eucker SA, 2011, EXP NEUROL, V227, P79, DOI 10.1016/j.expneurol.2010.09.015; Feng JF, 2012, BRAIN RES, V1469, P144, DOI 10.1016/j.brainres.2012.06.021; Kumar B, 2014, EXP EYE RES, V125, P193, DOI 10.1016/j.exer.2014.06.009; Legault J, 2011, J MED FOOD, V14, P1127, DOI 10.1089/jmf.2010.0198; Li WX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049064; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Park KR, 2011, CANCER LETT, V312, P178, DOI 10.1016/j.canlet.2011.08.001; Pu FL, 2007, J PHARMACOL SCI, V104, P329, DOI 10.1254/jphs.FP0070247; Silva B, 2008, NEUROTOX RES, V13, P265, DOI 10.1007/BF03033510; Verma AK, 2010, NAT PROD REP, V27, P1571, DOI 10.1039/c004698c; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yan L, 2008, INFLAMMATION, V31, P180, DOI 10.1007/s10753-008-9063-5; Yang T, 2014, CELL MOL NEUROBIOL, V34, P797, DOI 10.1007/s10571-014-0070-9; Yao RQ, 2012, NEUROCHEM RES, V37, P2777, DOI 10.1007/s11064-012-0871-5; Zhang HS, 2012, FOOD CHEM TOXICOL, V50, P1589, DOI 10.1016/j.fct.2012.01.025; Zhang ZJ, 2011, INT J MOL MED, V27, P195, DOI 10.3892/ijmm.2010.571	24	17	20	0	3	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	JUN	2018	17	6					7859	7865		10.3892/mmr.2018.8801			7	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	GJ5AQ	WOS:000435394000047	29620218	Bronze			2022-02-06	
J	Einarsen, CE; van der Naalt, J; Jacobs, B; Follestad, T; Moen, KG; Vik, A; Haberg, AK; Skandsen, T				Einarsen, Cathrine Elisabeth; van der Naalt, Joukje; Jacobs, Bram; Follestad, Turid; Moen, Kent Goran; Vik, Anne; Haberg, Asta Kristine; Skandsen, Toril			Moderate Traumatic Brain Injury: Clinical Characteristics and a Prognostic Model of 12-Month Outcome	WORLD NEUROSURGERY			English	Article						Cohort studies; Comparative study; Craniocerebral trauma; Prognosis; Statistical models	GLASGOW COMA SCALE; ACUTE ALCOHOL-INTOXICATION; HEAD-INJURY; PROSPECTIVE MULTICENTER; STRUCTURED INTERVIEWS; EMERGENCY-DEPARTMENT; EARLY PREDICTORS; CARE; CLASSIFICATION; EPIDEMIOLOGY	BACKGROUND: Patients with moderate traumatic brain injury (TBI) often are studied together with patients with severe TBI, even though the expected outcome of the former is better. Therefore, we aimed to describe patient characteristics and 12-month outcomes, and to develop a prognostic model based on admission data, specifically for patients with moderate TBI. METHODS: Patients with Glasgow Coma Scale scores of 9-13 and age >= 16 years were prospectively enrolled in 2 level I trauma centers in Europe. Glasgow Outcome Scale Extended (GOSE) score was assessed at 12 months. A prognostic model predicting moderate disability or worse (GOSE score <= 6), as opposed to a good recovery, was fitted by penalized regression. Model performance was evaluated by area under the curve of the receiver operating characteristics curves. RESULTS: Of the 395 enrolled patients, 81% had intracranial lesions on head computed tomography, and 71% were admitted to an intensive care unit. At 12 months, 44% were moderately disabled or worse (GOSE score <= 6), whereas 8% were severely disabled and 6% died (GOSE score <= 4). Older age, lower Glasgow Coma Scale score, no day-of-injury alcohol intoxication, presence of a subdural hematoma, occurrence of hypoxia and/or hypotension, and preinjury disability were significant predictors of GOSE score <= 6 (area under the curve = 0.80). CONCLUSIONS: Patients with moderate TBI exhibit characteristics of significant brain injury. Although few patients died or experienced severe disability, 44% did not experience good recovery, indicating that follow-up is needed. The model is a first step in development of prognostic models for moderate TBI that are valid across centers.	[Einarsen, Cathrine Elisabeth; Skandsen, Toril] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Phys Med & Rehabil, Trondheim, Norway; [Vik, Anne] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Neurosurg, Trondheim, Norway; [Haberg, Asta Kristine] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Radiol & Nucl Med, Trondheim, Norway; [Einarsen, Cathrine Elisabeth; Moen, Kent Goran; Vik, Anne; Haberg, Asta Kristine; Skandsen, Toril] Norwegian Univ Sci & Technol, NTNU, Fac Med & Hlth Sci, Dept Neuromed & Movement Sci, Trondheim, Norway; [Follestad, Turid] Norwegian Univ Sci & Technol, NTNU, Fac Med & Hlth Sci, Dept Publ Hlth & Nursing, Trondheim, Norway; [van der Naalt, Joukje; Jacobs, Bram] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol AB51, Groningen, Netherlands; [Moen, Kent Goran] Nord Trondelag Hosp Trust, Levanger Hosp, Dept Radiol, Levanger, Norway		Einarsen, CE (corresponding author), Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Phys Med & Rehabil, Trondheim, Norway.; Einarsen, CE (corresponding author), Norwegian Univ Sci & Technol, NTNU, Fac Med & Hlth Sci, Dept Neuromed & Movement Sci, Trondheim, Norway.	cathrine.einarsen@ntnu.no		van der Naalt, Joukje/0000-0001-9873-2418	Liaison Committee	This work was supported by funding from the Liaison Committee between the Central Norway Regional Health Authority (RHA) and the Norwegian University of Science and Technology (NTNU).	Alexander S, 2004, J NEUROTRAUM, V21, P575, DOI 10.1089/089771504774129900; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Cnossen MC, 2017, J NEUROTRAUM, V34, P2396, DOI 10.1089/neu.2016.4819; Compagnone C, 2009, NEUROSURGERY, V64, P690, DOI 10.1227/01.NEU.0000340796.18738.F7; Cnossen MC, 2017, CRIT CARE MED, V45, P660, DOI 10.1097/CCM.0000000000002263; de Guise E, 2015, BRAIN INJURY, V29, P558, DOI 10.3109/02699052.2014.976593; de Koning ME, 2015, BRAIN INJURY, V29, P423, DOI 10.3109/02699052.2014.982188; Dezeure R, 2015, STAT SCI, V30, P533, DOI 10.1214/15-STS527; Fabbri A, 2008, J NEUROL NEUROSUR PS, V79, P567, DOI 10.1136/jnnp.2007.120162; Fearnside M, 1998, AUST NZ J SURG, V68, P58, DOI 10.1111/j.1445-2197.1998.tb04638.x; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Gomez PA, 2014, NEUROCIRUGIA, V25, P199, DOI 10.1016/j.neucir.2014.05.001; Mena JH, 2011, J TRAUMA, V71, P1185, DOI 10.1097/TA.0b013e31823321f8; Husson EC, 2010, J REHABIL MED, V42, P425, DOI 10.2340/16501977-0566; Jacobs B, 2013, NEUROCRIT CARE, V19, P79, DOI 10.1007/s12028-012-9795-9; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Lund SB, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0269-5; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mahler SA, 2010, J EMERG MED, V39, P685, DOI 10.1016/j.jemermed.2009.05.016; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; Puljula J, 2007, ALCOHOL ALCOHOLISM, V42, P474, DOI 10.1093/alcalc/agm003; R Development Core Team, 2016, R LANG ENV STAT COMP; Raj R, 2015, J NEUROTRAUM, V32, P95, DOI 10.1089/neu.2014.3488; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; Roe C, 2015, BEHAV NEUROL, V2015, P845; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Rundhaug NP, 2015, J NEUROSURG, V122, P211, DOI 10.3171/2014.9.JNS14322; Scheenen ME, 2016, J NEUROTRAUM, V33, P339, DOI 10.1089/neu.2015.3926; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; STEIN SC, 1992, J NEUROSURG, V77, P562, DOI 10.3171/jns.1992.77.4.0562; STEIN SC, 1995, BRAIN INJURY, V9, P437, DOI 10.3109/02699059509008203; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Sturdivant RX, 2013, APPL LOGISTIC REGRES, V3rd; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Tosetti P, 2013, J NEUROTRAUM, V30, P1211, DOI 10.1089/neu.2013.2896; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson JTL, 2007, NEUROSURGERY, V61, P123, DOI 10.1227/01.neu.0000279732.21145.9e; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2002, J NEUROTRAUM, V19, P999, DOI 10.1089/089771502760341910	51	17	17	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUN	2018	114						E1199	E1210		10.1016/j.wneu.2018.03.176			12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GG8PI	WOS:000432959600141	29614364	Green Published, hybrid			2022-02-06	
J	Lucas, S; Ahn, AH				Lucas, Sylvia; Ahn, Andrew H.			Posttraumatic Headache: Classification by Symptom-Based Clinical Profiles	HEADACHE			English	Article						posttraumatic headache; traumatic brain injury; International Classification of Headache Disorders; secondary headache disorders	TRAUMATIC BRAIN-INJURY; US SOLDIERS; NATURAL-HISTORY; CONCUSSION; PREVALENCE; VETERANS; OUTCOMES; COHORT	There are currently no accepted therapies for posttraumatic headache (PTH). In order to meet the urgent need for effective therapies for PTH, we must continue to address fundamental gaps in our understanding of the clinical course and impact of PTH. Here we examine the existing schema used to characterize the clinical characteristics of PTH, including the International Classification of Headache Disorders (ICHD). There remain unresolved questions about whether to classify patients based on the extent of brain injury or on clinical symptom profiles. There also remain problematic issues of definition such as continuous headache, and chronic daily headache with features of embedded migraine-type within these headaches, which will need to be studied further. We make the case that a symptom-based classification is needed to begin an examination of these unresolved questions, and to establish clinically relevant endpoints for research and clinical trials for effective therapies.	[Lucas, Sylvia] Univ Washington, Med Ctr, Seattle, WA 98195 USA; [Ahn, Andrew H.] Elli Lilly & Co, Indianapolis, IN USA		Lucas, S (corresponding author), Univ Washington, Neurol Surg, 325 9th Ave,Box 359721, Seattle, WA 98104 USA.	lucass@uw.edu			Wadsworth Term Professorship in Headache Research and Practice at the University of Washington; National Institute for Disability, Independent Living and Rehabilitation Research; AmgenAmgen; AllerganAbbVieAllergan; Impel Biosciences	Sylvia Lucas receives research funding from the Wadsworth Term Professorship in Headache Research and Practice at the University of Washington and the National Institute for Disability, Independent Living and Rehabilitation Research. She has received research support from Amgen, Allergan, and Impel Biosciences, and honoraria for advisory board or consultation from Amgen, Teva, Lilly, Impel, and Kineta. Andrew H. Ahn is a Medical Fellow and full time employee at Eli Lilly and Company. He has reviewed for the NINDS, NCAM, and DoD.	Baandrup L, 2005, CEPHALALGIA, V25, P132, DOI 10.1111/j.1468-2982.2004.00818.x; Brenner C, 1944, J NEUROSURG, V1, P379, DOI 10.3171/jns.1944.1.6.0379; Cohen SP, 2012, CEPHALALGIA, V32, P94, DOI 10.1177/0333102411422382; Couch JR, 2009, EUR J NEUROL, V16, DOI 10.1111/j.1468-1331.2008.02362.x; Martins HAD, 2009, ARQ NEURO-PSIQUIAT, V67, P43; Department ofVeterans Affairs/DepartmentofDefense (VA/ DoD), 2009, CLIN PRACT GUID MAN; Erickson JC, 2011, HEADACHE, V51, P932, DOI 10.1111/j.1526-4610.2011.01909.x; Finkel AG, 2017, HEADACHE, V57, P719, DOI 10.1111/head.13056; Finkel AG, 2012, HEADACHE, V52, P957, DOI 10.1111/j.1526-4610.2012.02167.x; Friedman DI, 2017, HEADACHE, V57, P119; Haas DC, 1996, CEPHALALGIA, V16, P486, DOI 10.1046/j.1468-2982.1996.1607486.x; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Kjeldgaard D, 2014, CEPHALALGIA, V34, P191, DOI 10.1177/0333102413505236; Kuczynski A, 2013, DEV MED CHILD NEUROL, V55, P636, DOI 10.1111/dmcn.12152; Lieba-Samal D, 2011, CEPHALALGIA, V31, P1618, DOI 10.1177/0333102411428954; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Patil VK, 2011, HEADACHE, V51, P1112, DOI 10.1111/j.1526-4610.2011.01946.x; Ruff RL, 2008, J REHABIL RES DEV, V45, P941, DOI 10.1682/JRRD.2008.02.0028; Silberstein SD, 2000, NEUROLOGY, V55, P754, DOI 10.1212/WNL.55.6.754; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Stacey A, 2017, J NEUROTRAUM, V34, P1558, DOI 10.1089/neu.2016.4721; Stovner LJ, 2009, EUR J NEUROL, V16, P112, DOI 10.1111/j.1468-1331.2008.02363.x; Theeler BJ, 2012, HEADACHE, V52, P732, DOI 10.1111/j.1526-4610.2012.02112.x; Theeler BJ, 2010, HEADACHE, V50, P1262, DOI 10.1111/j.1526-4610.2010.01700.x; Theeler BJ, 2009, HEADACHE, V49, P529, DOI 10.1111/j.1526-4610.2009.01345.x; Watanabe TK, 2012, PM&R, V4, P129, DOI 10.1016/j.pmrj.2011.06.003	27	17	17	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0017-8748	1526-4610		HEADACHE	Headache	JUN	2018	58	6					873	882		10.1111/head.13311			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GK0EI	WOS:000435779900009	29737529				2022-02-06	
J	Rostami, E; Engquist, H; Howells, T; Johnson, U; Ronne-Engstrom, E; Nilsson, P; Hillered, L; Lewen, A; Enblad, P				Rostami, Elham; Engquist, Henrik; Howells, Timothy; Johnson, Ulf; Ronne-Engstrom, Elisabeth; Nilsson, Pelle; Hillered, Lars; Lewen, Anders; Enblad, Per			Early low cerebral blood flow and high cerebral lactate: prediction of delayed cerebral ischemia in subarachnoid hemorrhage	JOURNAL OF NEUROSURGERY			English	Article						xenon-CT; lactate; CBF; cerebral blood flow; lactate/pyruvate ratio; SAH; subarachnoid hemorrhage; DCI; delayed cerebral ischemia; vasospasm; vascular disorders	POSITRON-EMISSION-TOMOGRAPHY; TRAUMATIC BRAIN-INJURY; INTRACEREBRAL MICRODIALYSIS; SYMPTOMATIC VASOSPASM; BEDSIDE MICRODIALYSIS; NEUROINTENSIVE CARE; ENERGY-METABOLISM; XE-CT; DISTURBANCES; MANAGEMENT	OBJECTIVE Delayed cerebral ischemia (DCI) following subarachnoid hemorrhage (SAH) is one of the major contributors to poor outcome. It is crucial to be able to detect early signs of DCI to prevent its occurrence. The objective of this study was to determine if low cerebral blood flow (CBF) measurements and pathological microdialysis parameters measured at the bedside can be observed early in patients with SAH who later developed DCI. METHODS The authors included 30 patients with severe SAH. The CBF measurements were performed at Day 0-3 after disease onset, using bedside xenon-CT. Interstitial glucose, lactate, pyruvate, glycerol, and glutamate were measured using microdialysis. RESULTS Nine of 30 patients developed DCI. Patients with DCI showed significantly lower global and regional CBF, and lactate was significantly increased in these patients. A high lactate/pyruvate ratio was also detected in patients with DCI. CONCLUSIONS Early low CBF measurements and a high lactate and lactate/pyruvate ratio may be early warning signs of the risk of developing DCI. The clinical value of these findings needs to be confirmed in larger studies.	[Rostami, Elham; Engquist, Henrik; Howells, Timothy; Johnson, Ulf; Ronne-Engstrom, Elisabeth; Nilsson, Pelle; Hillered, Lars; Lewen, Anders; Enblad, Per] Uppsala Univ, Sect Neurosurg, Dept Neurosci, Uppsala, Sweden; [Engquist, Henrik] Uppsala Univ, Anesthesiol & Intens Care, Dept Surg Sci, Uppsala, Sweden; [Johnson, Ulf] Uppsala Univ, Dept Surg Sci & Radiol, Uppsala, Sweden		Rostami, E (corresponding author), Uppsala Univ Hosp, Sect Neurosurg, Dept Neurosci, SE-75185 Uppsala, Sweden.	elham.rostami@neuro.uu.se	Engquist, Henrik/S-1890-2016; Lewen, Anders/A-5156-2013	Lewen, Anders/0000-0003-4925-1348; Engquist, Henrik/0000-0002-9826-1422			BERGVALL U, 1973, NEURORADIOLOGY, V5, P24, DOI 10.1007/BF02464626; Cesarini KG, 2002, ACTA NEUROCHIR, V144, P1121, DOI 10.1007/s00701-002-1011-9; Chen HI, 2011, NEUROSURGERY, V69, P53, DOI 10.1227/NEU.0b013e3182191451; De Micheli E, 2001, ACT NEUR S, V77, P149; Diringer MN, 2011, NEUROCRIT CARE, V15, P211, DOI 10.1007/s12028-011-9605-9; Enblad P, 1996, J CEREBR BLOOD F MET, V16, P637, DOI 10.1097/00004647-199607000-00014; Frykholm P, 2004, ACTA NEUROL SCAND, V109, P25, DOI 10.1034/j.1600-0404.2003.00174.x; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; KETY SS, 1951, PHARMACOL REV, V3, P1; MEYER JS, 1988, NEURORADIOLOGY, V30, P283, DOI 10.1007/BF00328177; Nyberg C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099904; Oddo M, 2012, STROKE, V43, P1418, DOI 10.1161/STROKEAHA.111.648568; Qureshi AI, 2000, CRIT CARE MED, V28, P984, DOI 10.1097/00003246-200004000-00012; Ronne-Engstrom E, 2001, J NEUROSURG, V94, P397, DOI 10.3171/jns.2001.94.3.0397; Rostami E, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00089; Ryttlefors M, 2007, NEUROSURGERY, V61, P704, DOI 10.1227/01.NEU.0000298898.38979.E3; Samuelsson C, 2009, ACTA NEUROCHIR, V151, P437, DOI 10.1007/s00701-009-0265-x; Sarrafzadeh A, 2005, J NEURORADIOLOGY, V32, P348, DOI 10.1016/S0150-9861(05)83168-2; Sarrafzadeh A, 2004, J NEUROSURG, V100, P400, DOI 10.3171/jns.2004.100.3.0400; Sarrafzadeh AS, 2004, STROKE, V35, P638, DOI 10.1161/01.STR.0000116101.66624.F1; Sarrafzadeh AS, 2002, CRIT CARE MED, V30, P1062, DOI 10.1097/00003246-200205000-00018; Schmidt JM, 2011, STROKE, V42, P1351, DOI 10.1161/STROKEAHA.110.596874; Schulz MK, 2000, J NEUROSURG, V93, P808, DOI 10.3171/jns.2000.93.5.0808; Skoglund K, 2014, NEUROCRIT CARE, V20, P413, DOI 10.1007/s12028-013-9876-4; SOLENSKI NJ, 1995, CRIT CARE MED, V23, P1007, DOI 10.1097/00003246-199506000-00004; Sturnegk P, 2007, BRIT J NEUROSURG, V21, P332, DOI 10.1080/02688690701411574; Ungerstedt U, 2004, CURR PHARM DESIGN, V10, P2145, DOI 10.2174/1381612043384105; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; WEIR B, 1978, J NEUROSURG, V48, P173, DOI 10.3171/jns.1978.48.2.0173; Yonas H, 1996, NEUROSURG CLIN N AM, V7, P605; YONAS H, 1991, J CEREBR BLOOD F MET, V11, P716, DOI 10.1038/jcbfm.1991.128; YONAS H, 1984, LANCET, V1, P1357; YONAS H, 1989, NEUROSURGERY, V24, P368, DOI 10.1227/00006123-198903000-00010	36	17	18	0	4	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JUN	2018	128	6					1762	1770		10.3171/2016.11.JNS161140			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GP2IM	WOS:000440653000023	28574309	Bronze			2022-02-06	
J	Huang, TQ; Zhao, JJ; Guo, D; Pang, HG; Zhao, YL; Song, JN				Huang, Tingqin; Zhao, Junjie; Guo, Dan; Pang, Honggang; Zhao, Yonglin; Song, Jinning			Curcumin mitigates axonal injury and neuronal cell apoptosis through the PERK/Nrf2 signaling pathway following diffuse axonal injury	NEUROREPORT			English	Article						curcumin; diffuse axonal injury; endoplasmic reticulum stress; nuclear factor-erythroid 2-related factor 2; unfolded protein response	ENDOPLASMIC-RETICULUM-STRESS; TRAUMATIC BRAIN-INJURY; UNFOLDED PROTEIN RESPONSE; ACTIVATING TRANSCRIPTION FACTOR-4; INDUCED ER STRESS; OXIDATIVE STRESS; CLINICOPATHOLOGICAL ENTITY; DEPENDENT ACTIVATION; HEME OXYGENASE-1; RAT	Diffuse axonal injury (DAI) accounts for more than 50% of all traumatic brain injury. In response to the mechanical damage associated with DAI, the abnormal proteins produced in the neurons and axons, namely, -APP and p-tau, induce endoplasmic reticulum (ER) stress. Curcumin, a major component extracted from the rhizome of Curcuma longa, has shown potent anti-inflammatory, antioxidant, anti-infection, and antitumor activity in previous studies. Moreover, curcumin is an activator of nuclear factor-erythroid 2-related factor 2 (Nrf2) and promotes its nuclear translocation. In this study, we evaluated the therapeutic potential of curcumin for the treatment of DAI and investigated the mechanisms underlying the protective effects of curcumin against neural cell death and axonal injury after DAI. Rats subjected to a model of DAI by head rotational acceleration were treated with vehicle or curcumin to evaluate the effect of curcumin on neuronal and axonal injury. We observed that curcumin (20 mg/kg intraperitoneal) administered 1h after DAI induction alleviated the aggregation of p-tau and beta-APP in neurons, reduced ER-stress-related cell apoptosis, and ameliorated neurological deficits. Further investigation showed that the protective effect of curcumin in DAI was mediated by the PERK/Nrf2 pathway. Curcumin promoted PERK phosphorylation, and then Nrf2 dissociated from Keap1 and was translocated to the nucleus, which activated ATF4, an important bZIP transcription factor that maintains intracellular homeostasis, but inhibited the CHOP, a hallmark of ER stress and ER-associated programmed cell death. In summary, we demonstrate for the first time that curcumin confers protection against abnormal proteins and neuronal apoptosis after DAI, that the process is mediated by strengthening of the unfolded protein response to overcome ER stress, and that the protective effect of curcumin against DAI is dependent on the activation of Nrf2. Copyright (C) 2018 The Author(s). Published by Wolters Kluwer Health, Inc.	[Huang, Tingqin; Zhao, Junjie; Guo, Dan; Pang, Honggang; Zhao, Yonglin; Song, Jinning] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Neurosurg, 277 West Yanta Rd, Xian 710061, Shaanxi, Peoples R China		Song, JN (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Neurosurg, 277 West Yanta Rd, Xian 710061, Shaanxi, Peoples R China.	jinningsong@126.com					Aydin Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10087-6; Begum G, 2014, J NEUROSCI, V34, P3743, DOI 10.1523/JNEUROSCI.2872-13.2014; Blais JD, 2004, MOL CELL BIOL, V24, P7469, DOI 10.1128/MCB.24.17.7469-7482.2004; Boone DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127287; Chen FY, 2015, J MOL NEUROSCI, V55, P995, DOI 10.1007/s12031-014-0456-7; Chen WJ, 2013, INT J ONCOL, V42, P963, DOI 10.3892/ijo.2013.1774; Chen XH, 1999, J NEUROPATH EXP NEUR, V58, P588, DOI 10.1097/00005072-199906000-00003; Cong XQ, 2016, BIOL TRACE ELEM RES, V173, P390, DOI 10.1007/s12011-016-0668-5; Cui QL, 2016, MOL MED REP, V13, P1381, DOI 10.3892/mmr.2015.4657; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; Cullinan SB, 2006, INT J BIOCHEM CELL B, V38, P317, DOI 10.1016/j.biocel.2005.09.018; Cullinan SB, 2004, J BIOL CHEM, V279, P20108, DOI 10.1074/jbc.M314219200; Dash PK, 2015, J NEUROTRAUM, V32, P1608, DOI 10.1089/neu.2014.3772; Davceva N, 2012, J FORENSIC LEG MED, V19, P413, DOI 10.1016/j.jflm.2012.04.011; Davceva N, 2015, AM J FOREN MED PATH, V36, P127, DOI 10.1097/PAF.0000000000000168; Duan ZQ, 2014, NEUROTOXICOLOGY, V44, P149, DOI 10.1016/j.neuro.2014.06.005; Ehren JL, 2013, BIOCHEM PHARMACOL, V85, P1816, DOI 10.1016/j.bcp.2013.04.010; Fan Xiao-Fang, 2012, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V28, P561; GERMANO AF, 1994, J NEUROTRAUM, V11, P345, DOI 10.1089/neu.1994.11.345; GIUFFRIDA AM, 1975, J NEUROCHEM, V24, P749; Hayashi Takahito, 2009, Leg Med (Tokyo), V11 Suppl 1, pS171, DOI 10.1016/j.legalmed.2009.01.076; He CH, 2001, J BIOL CHEM, V276, P20858, DOI 10.1074/jbc.M101198200; He XS, 2010, ACTA NEUROL BELG, V110, P49; He XS, 2000, J NEUROSURG, V93, P626, DOI 10.3171/jns.2000.93.4.0626; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Hoozemans JJM, 2012, NEURODEGENER DIS, V10, P212, DOI 10.1159/000334536; Huang TQ, 2017, MOL MED REP, V15, P3001, DOI 10.3892/mmr.2017.6350; Imaizumi Kazunori, 2013, Clin Calcium, V23, P1759, DOI CliCa131217591766; Jiang H, 2011, BIOL PHARM BULL, V34, P1194, DOI 10.1248/bpb.34.1194; Kaur B, 1999, J CLIN PATHOL, V52, P203, DOI 10.1136/jcp.52.3.203; Kim JK, 2014, INT J MOL SCI, V15, P12149, DOI 10.3390/ijms150712149; Kim KM, 2007, CIRC RES, V101, P919, DOI 10.1161/CIRCRESAHA.107.154781; King MK, 2014, PHARMACOL THERAPEUT, V141, P1, DOI 10.1016/j.pharmthera.2013.07.010; Krajewska M, 2011, BRAIN RES, V1370, P227, DOI 10.1016/j.brainres.2010.11.015; Kuo CP, 2011, ANESTHESIOLOGY, V115, P1229, DOI 10.1097/ALN.0b013e31823306f0; Lee BW, 2011, TOXICOL APPL PHARM, V252, P47, DOI 10.1016/j.taap.2011.01.018; Li W, 2016, MICROVASC RES, V106, P117, DOI 10.1016/j.mvr.2015.12.008; Li Y, 2013, BRAIN RES, V1495, P95, DOI 10.1016/j.brainres.2012.12.005; Liu CL, 2014, INT J MOL MED, V33, P499, DOI 10.3892/ijmm.2013.1603; Logsdon AE, 2016, BRAIN RES, V1643, P140, DOI 10.1016/j.brainres.2016.04.063; Lu M, 2003, J NEUROSCI METH, V128, P183, DOI 10.1016/S0165-0270(03)00188-2; Luis A, 2014, FREE RADICAL BIO MED, V77, P217, DOI 10.1016/j.freeradbiomed.2014.09.008; Ma JW, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/9746313; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Miller DM, 2015, EXP NEUROL, V264, P103, DOI 10.1016/j.expneurol.2014.11.008; Mohajeri M, 2015, NEUROPHARMACOLOGY, V99, P156, DOI 10.1016/j.neuropharm.2015.07.013; Oakes SA, 2015, ANNU REV PATHOL-MECH, V10, P173, DOI 10.1146/annurev-pathol-012513-104649; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Pahl HL, 1999, PHYSIOL REV, V79, P683, DOI 10.1152/physrev.1999.79.3.683; Pang H., 2016, MEDIAT INFLAMM, V2016; Patel S, 2017, NEUROSCI BIOBEHAV R, V83, P589, DOI 10.1016/j.neubiorev.2017.08.025; Peidis P, 2011, CELL DEATH DIFFER, V18, P145, DOI 10.1038/cdd.2010.76; Periyasamy P, 2017, PROG RETIN EYE RES, V60, P1, DOI 10.1016/j.preteyeres.2017.08.003; Pluquet O, 2015, AM J PHYSIOL-CELL PH, V308, pC415, DOI 10.1152/ajpcell.00334.2014; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rao JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065568; RAVINDRANATH V, 1980, TOXICOLOGY, V16, P259, DOI 10.1016/0300-483X(80)90122-5; Rozpedek W, 2016, CURR MOL MED, V16, P533, DOI 10.2174/1566524016666160523143937; Ryu J, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0153-3; Sato Y, 2017, MOL GENET METAB REP, V10, P56, DOI 10.1016/j.ymgmr.2017.01.006; Shaw G, 2005, BIOCHEM BIOPH RES CO, V336, P1268, DOI 10.1016/j.bbrc.2005.08.252; Smith DH, 2003, NEUROMOL MED, V4, P59, DOI 10.1385/NMM:4:1-2:59; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Sprenkle NT, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0183-y; Su E, 2016, TRANSLATIONAL RES TR, P41; Su Q, 2008, J BIOL CHEM, V283, P469, DOI 10.1074/jbc.M704612200; Taniguchi M, 2015, CURR OPIN NEPHROL HY, V24, P345, DOI 10.1097/MNH.0000000000000141; Tao TQ, 2015, APOPTOSIS, V20, P285, DOI 10.1007/s10495-014-1081-1; Tenkerian C, 2015, MOL CANCER RES, V13, P1377, DOI 10.1158/1541-7786.MCR-15-0184-T; Urra H, 2013, BBA-MOL CELL RES, V1833, P3507, DOI 10.1016/j.bbamcr.2013.07.024; Vajtr D, 2012, Soud Lek, V57, P7; Wang JC, 2016, INT J CARDIOL, V203, P779, DOI 10.1016/j.ijcard.2015.11.033; Wu AG, 2006, EXP NEUROL, V197, P309, DOI 10.1016/j.expneurol.2005.09.004; Wu G, 2016, MED SCI MONITOR, V22, P2161, DOI 10.12659/MSM.896568; Yang CH, 2009, BRAIN RES, V1282, P133, DOI 10.1016/j.brainres.2009.05.009; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Yuruker V, 2015, METAB BRAIN DIS, V30, P223, DOI 10.1007/s11011-014-9623-3; Zhang C, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101523; Zhang HY, 2015, MOL NEUROBIOL, V51, P1343, DOI 10.1007/s12035-014-8813-7; Zhang P, 2016, J PROTEOMICS, V133, P93, DOI 10.1016/j.jprot.2015.12.014; Zhang RR, 2017, MOL NEUROBIOL, V54, P6006, DOI 10.1007/s12035-016-0111-0; Zhao YL, 2016, NEURAL REGEN RES, V11, P944, DOI 10.4103/1673-5374.184493; Zhao YL, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/1570917; Zhao YL, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/4706915; Zhao ZW, 2017, BIOMED PHARMACOTHER, V92, P1103, DOI 10.1016/j.biopha.2017.05.099; Zhu HT, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-59; Zhu YF, 2015, EUR J PHARMACOL, V762, P239, DOI 10.1016/j.ejphar.2015.06.002; Zong ZH, 2012, BBA-MOL CELL RES, V1823, P1395, DOI 10.1016/j.bbamcr.2012.06.001	89	17	18	1	23	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	MAY 23	2018	29	8					661	677		10.1097/WNR.0000000000001015			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GE5YR	WOS:000431301100009	29570500	Green Published, hybrid			2022-02-06	
J	Sauerbeck, AD; Fanizzi, C; Kim, JH; Gangolli, M; Bayly, PV; Wellington, CL; Brody, DL; Kummer, TT				Sauerbeck, A. D.; Fanizzi, C.; Kim, J. H.; Gangolli, M.; Bayly, P. V.; Wellington, C. L.; Brody, D. L.; Kummer, T. T.			modCHIMERA: a novel murine closed-head model of moderate traumatic brain injury	SCIENTIFIC REPORTS			English	Article							IMPACT MODEL; MILD; EPIDEMIOLOGY; BIOMECHANICS; HEMORRHAGE; DISORDERS; PATHOLOGY; TIME	Traumatic brain injury is a major source of global disability and mortality. Preclinical TBI models are a crucial component of therapeutic investigation. We report a tunable, monitored model of murine non-surgical, diffuse closed-head injury-modCHIMERA-characterized by impact as well as linear and rotational acceleration. modCHIMERA is based on the Closed-Head Impact Model of Engineered Rotational Acceleration (CHIMERA) platform. We tested this model at 2 energy levels: 1.7 and 2.1 Joules-substantially higher than previously reported for this system. Kinematic analysis demonstrated linear acceleration exceeding injury thresholds in humans, although outcome metrics tracked impact energy more closely than kinematic parameters. Acute severity metrics were consistent with a complicated-mild or moderate TBI, a clinical population characterized by high morbidity but potentially reversible pathology. Axonal injury was multifocal and bilateral, neuronal death was detected in the hippocampus, and microglial neuroinflammation was prominent. Acute functional analysis revealed prolonged post-injury unconsciousness, and decreased spontaneous behavior and stimulated neurological scores. Neurobehavioral deficits were demonstrated in spatial learning/memory and socialization at 1-month. The overall injury profile of modCHIMERA corresponds with the range responsible for a substantial portion of TBI-related disability in humans. modCHIMERA should provide a reliable platform for efficient analysis of TBI pathophysiology and testing of treatment modalities.	[Sauerbeck, A. D.; Fanizzi, C.; Kim, J. H.; Brody, D. L.; Kummer, T. T.] Washington Univ St Louis, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Fanizzi, C.] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Neurosurg, Milan, Italy; [Gangolli, M.] Washington Univ St Louis, Sch Med, Dept Biomed Engn, St Louis, MO USA; [Bayly, P. V.] Washington Univ St Louis, Mech Engn & Mat Sci, St Louis, MO USA; [Wellington, C. L.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada		Kummer, TT (corresponding author), Washington Univ St Louis, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	kummert@wustl.edu	Fanizzi, Claudia/AAI-4342-2021	Fanizzi, Claudia/0000-0001-5560-036X; Kummer, Terrance/0000-0001-8938-8280	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5K08NS094760-02, T32NS007205]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32NS007205, K08NS094760] Funding Source: NIH RePORTER	The authors would like to thank Richard Davenport, Samuel Kim, Maverick Salyards, Dhananjay R. Namjoshi, and Asma Bashir for technical support and advice. This work was supported by the National Institutes of Health [5K08NS094760-02, TTK; T32NS007205, ADS].	Godoy DA, 2016, NEUROCRIT CARE, V25, P306, DOI 10.1007/s12028-016-0253-y; [Anonymous], 2016, INJURY MODELS CENTRA; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Centers for Disease Control and Prevention, 2018, TRAUM BRAIN INJ CONC; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA, P1; Chang LC, 2005, MAGN RESON MED, V53, P1088, DOI 10.1002/mrm.20426; COLOHAN ART, 1992, J NEUROTRAUM, V9, pS259; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; DeWitt DS, 2013, J NEUROTRAUM, V30, P688, DOI 10.1089/neu.2012.2349; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Floyd CL, 2002, J NEUROTRAUM, V19, P303, DOI 10.1089/089771502753594873; Hasan KM, 2001, J MAGN RESON IMAGING, V13, P769, DOI 10.1002/jmri.1107; Heppner FL, 2015, NAT REV NEUROSCI, V16, P358, DOI 10.1038/nrn3880; Hessen E, 2009, BRAIN INJURY, V23, P234, DOI 10.1080/02699050902748349; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Hsiang JNK, 1997, J NEUROSURG, V87, P234, DOI 10.3171/jns.1997.87.2.0234; Iverson GL, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/415740; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; Kaidanovich-Beilin O, 2011, JOVE-J VIS EXP, DOI 10.3791/2473; Kalish BT, 2016, METHODS MOL BIOL, V1462, P193, DOI 10.1007/978-1-4939-3816-2_12; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Klemenhagen KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074510; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Lifshitz J., 2016, METHOD MOL BIOL, V1462, P369; M. o. C. M. T. W. G., 2009, CLIN PRACT GUID MAN, P1; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; McIntosh AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005078; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Morganti-Kossmann MC, 2010, INJURY, V41, P10, DOI 10.1016/j.injury.2010.03.032; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Namjoshi DR, 2017, EXP NEUROL, V292, P80, DOI 10.1016/j.expneurol.2017.03.003; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; Namjoshi DR, 2013, DIS MODEL MECH, V6, P1325, DOI 10.1242/dmm.011320; Ommaya A. K., 1967, P 11 STAPP CAR CRASH; Panzer MB, 2014, EXP NEUROL, V261, P120, DOI 10.1016/j.expneurol.2014.07.002; Parikh U, 2016, J NEUROPATH EXP NEUR, V75, P731, DOI 10.1093/jnen/nlw045; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Sauerbeck A, 2012, EXP NEUROL, V234, P85, DOI 10.1016/j.expneurol.2011.12.012; Sauerbeck AD, 2015, J NEUROTRAUM, V32, P159, DOI 10.1089/neu.2014.3497; Schoch KM, 2016, NEURON, V90, P941, DOI 10.1016/j.neuron.2016.04.042; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; Smits M, 2008, AM J NEURORADIOL, V29, P506, DOI 10.3174/ajnr.A0852; Spitz G, 2017, J NEUROTRAUM, V34, P807, DOI 10.1089/neu.2016.4527; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Tayim FM, 2016, J CLIN EXP NEUROPSYC, V38, P1005, DOI 10.1080/13803395.2016.1182968; TEASDALE G, 1974, LANCET, V2, P81; Titova E, 2009, NEUROL RES, V31, P568, DOI 10.1179/174313209X382412; Toyama M, 2017, CEPHALALGIA, V37, P1317, DOI 10.1177/0333102416678387; Veeramuthu V, 2015, J NEUROTRAUM, V32, P1497, DOI 10.1089/neu.2014.3750; Viano DC, 2009, NEUROSURGERY, V64, P1162, DOI 10.1227/01.NEU.0000345863.99099.C7; Wassenbergh S. V., 2007, BUTTERWORTH FILTER M; Wenk Gary L, 2004, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0805as26; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	65	17	17	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAY 16	2018	8								7677	10.1038/s41598-018-25737-6			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GF9CS	WOS:000432274300002	29769541	Green Published, gold			2022-02-06	
J	Edlow, BL; Keene, CD; Perl, DP; Iacono, D; Folkerth, RD; Stewart, W; Mac Donald, CL; Augustinack, J; Diaz-Arrastia, R; Estrada, C; Flannery, E; Gordon, WA; Grabowski, TJ; Hansen, K; Hoffman, J; Kroenke, C; Larson, EB; Lee, P; Mareyam, A; McNab, JA; McPhee, J; Moreau, AL; Renz, A; Richmire, K; Stevens, A; Tang, CY; Tirrell, LS; Trittschuh, EH; van der Kouwe, A; Varjabedian, A; Wald, LL; Wu, O; Yendiki, A; Young, L; Zollei, L; Fischl, B; Crane, PK; Dams-O'Connor, K				Edlow, Brian L.; Keene, C. Dirk; Perl, Daniel P.; Iacono, Diego; Folkerth, Rebecca D.; Stewart, William; Mac Donald, Christine L.; Augustinack, Jean; Diaz-Arrastia, Ramon; Estrada, Camilo; Flannery, Elissa; Gordon, Wayne A.; Grabowski, Thomas J.; Hansen, Kelly; Hoffman, Jeanne; Kroenke, Christopher; Larson, Eric B.; Lee, Patricia; Mareyam, Azma; McNab, Jennifer A.; McPhee, Jeanne; Moreau, Allison L.; Renz, Anne; Richmire, KatieRose; Stevens, Allison; Tang, Cheuk Y.; Tirrell, Lee S.; Trittschuh, Emily H.; van der Kouwe, Andre; Varjabedian, Ani; Wald, Lawrence L.; Wu, Ona; Yendiki, Anastasia; Young, Liza; Zollei, Lilla; Fischl, Bruce; Crane, Paul K.; Dams-O'Connor, Kristen			Multimodal Characterization of the Late Effects of Traumatic Brain Injury: A Methodological Overview of the Late Effects of Traumatic Brain Injury Project	JOURNAL OF NEUROTRAUMA			English	Article						dementia; MRI; neurodegeneration; neuropathology; traumatic brain injury	COMMON DATA ELEMENTS; ALZHEIMERS ASSOCIATION GUIDELINES; ASCENDING AROUSAL SYSTEM; NATIONAL INSTITUTE; NEUROPATHOLOGIC ASSESSMENT; AMYLOID-BETA; DISEASE; HEALTH; LIFE; CONNECTOME	Epidemiological studies suggest that a single moderate-to-severe traumatic brain injury (TBI) is associated with an increased risk of neurodegenerative disease, including Alzheimer's disease (AD) and Parkinson's disease (PD). Histopathological studies describe complex neurodegenerative pathologies in individuals exposed to single moderate-to-severe TBI or repetitive mild TBI, including chronic traumatic encephalopathy (CTE). However, the clinicopathological links between TBI and post-traumatic neurodegenerative diseases such as AD, PD, and CTE remain poorly understood. Here, we describe the methodology of the Late Effects of TBI (LETBI) study, whose goals are to characterize chronic post-traumatic neuropathology and to identify in vivo biomarkers of post-traumatic neurodegeneration. LETBI participants undergo extensive clinical evaluation using National Institutes of Health TBI Common Data Elements, proteomic and genomic analysis, structural and functional magnetic resonance imaging (MRI), and prospective consent for brain donation. Selected brain specimens undergo ultra-high resolution ex vivo MRI and histopathological evaluation including whole-mount analysis. Co-registration of ex vivo and in vivo MRI data enables identification of ex vivo lesions that were present during life. In vivo signatures of postmortem pathology are then correlated with cognitive and behavioral data to characterize the clinical phenotype(s) associated with pathological brain lesions. We illustrate the study methods and demonstrate proof of concept for this approach by reporting results from the first LETBI participant, who despite the presence of multiple in vivo and ex vivo pathoanatomic lesions had normal cognition and was functionally independent until her mid-80s. The LETBI project represents a multidisciplinary effort to characterize post-traumatic neuropathology and identify in vivo signatures of postmortem pathology in a prospective study.	Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Edlow, Brian L.] Harvard Med Sch, Boston, MA USA; [Edlow, Brian L.; Augustinack, Jean; Mareyam, Azma; Moreau, Allison L.; Stevens, Allison; Tirrell, Lee S.; van der Kouwe, Andre; Varjabedian, Ani; Wald, Lawrence L.; Wu, Ona; Yendiki, Anastasia; Zollei, Lilla; Fischl, Bruce] Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Edlow, Brian L.; Augustinack, Jean; Mareyam, Azma; Moreau, Allison L.; Stevens, Allison; Tirrell, Lee S.; van der Kouwe, Andre; Varjabedian, Ani; Wald, Lawrence L.; Wu, Ona; Yendiki, Anastasia; Zollei, Lilla; Fischl, Bruce] Harvard Med Sch, Charlestown, MA USA; [Keene, C. Dirk] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Mac Donald, Christine L.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Grabowski, Thomas J.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Grabowski, Thomas J.; Young, Liza] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Hoffman, Jeanne] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Trittschuh, Emily H.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Crane, Paul K.] Univ Washington, Dept Med, Seattle, WA USA; [Perl, Daniel P.; Iacono, Diego; Lee, Patricia] Uniformed Serv Univ Hlth Sci, Brain Tissue Repository & Neuropathol Core, Bethesda, MD USA; [Perl, Daniel P.] Uniformed Serv Univ Hlth Sci, Dept Pathol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; [Iacono, Diego; Lee, Patricia] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA; [Folkerth, Rebecca D.] Harvard Med Sch, Brigham & Womens Hosp, Dept Pathol, Boston, MA USA; [Folkerth, Rebecca D.] City New York Off, New York, NY USA; [Folkerth, Rebecca D.] NYU, Sch Med, New York, NY USA; [Stewart, William] Univ Glasgow, Queen Elizabeth Univ Hosp, Dept Neuropathol, Glasgow, Lanark, Scotland; [Stewart, William] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland; [Diaz-Arrastia, Ramon] Hosp Univ Penn, Dept Neurol, 3400 Spruce St, Philadelphia, PA 19104 USA; [Diaz-Arrastia, Ramon] Hosp Univ Penn, Ctr Brain Injury & Repair, 3400 Spruce St, Philadelphia, PA 19104 USA; [Estrada, Camilo; Hansen, Kelly; Larson, Eric B.; Renz, Anne; Richmire, KatieRose] Kaiser Permanente Washington Hlth Res Inst, Seattle, WA USA; [Flannery, Elissa; Gordon, Wayne A.; McPhee, Jeanne; Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Tang, Cheuk Y.] Icahn Sch Med Mt Sinai, Dept Radiol, New York, NY 10029 USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Kroenke, Christopher] Oregon Hlth & Sci Univ, Adv Imaging Res Ctr, Portland, OR 97201 USA; [McNab, Jennifer A.] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Trittschuh, Emily H.] VA Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Seattle, WA USA		Dams-O'Connor, K (corresponding author), Icahn Sch Med Mt Sinai, Dept Rehabil Med, Brain Injury Res Ctr, Box 1163,One Gustave L Levy Pl, New York, NY 10029 USA.	kristen.dams-o'connor@mountsinai.org	Melief, Erica/M-6436-2019; McNab, Jennifer/ABG-2746-2021; Iacono, Diego/K-8203-2016; Lang, Steven/AAE-8102-2021; Moreau, Allison L./T-2625-2019; Wald, Lawrence L/D-4151-2009	Iacono, Diego/0000-0001-5511-0950; Lang, Steven/0000-0003-1669-9146; Moreau, Allison L./0000-0002-8758-8622; Wald, Lawrence L/0000-0001-8278-6307; McNab, Jennifer/0000-0002-1763-0792; McPhee, Jeanne/0000-0001-9199-0393; Stewart, William/0000-0003-2199-2582; Wu, Ona/0000-0002-5509-9461; MICHAUD, ANI/0000-0001-9039-3212	National Institutes of Health/National Institute for Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); National Institute of Child Health and DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U01 NS086625]; National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [U24 RR021382]; National Institute for Biomedical Imaging and BioengineeringUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB015896, R01EB006758, R21EB018907, R01EB019956, 1R01EB023281]; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG022381, R01 AG016495, 5R01AG008122, U01AG006781, R21AG046657, P41RR014075, P50AG005136]; National Center for Alternative Medicine [RC1 AT005728-01]; National Institute for Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS094538, R01NS052585-01, 1R21NS072652-01, 1R01NS070963, R01NS083534, 5U01NS086625]; Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [1K01HD074651, R01HD071664]; National Institute on Disability Independent Living and Rehabilitation ResearchUnited States Department of Health & Human Services [H133B040033]; Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [1R49CE001171]; NIH Blueprint for Neuroscience ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5U01-MH093765]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1S10RR023401, 1S10RR019307, 1S10RR023043]; American Academy of Neurology/American Brain Foundation; James S. McDonnell Foundation; Nancy and Buster Alvord Endowment; University of Washington School of Medicine; Seton Brain Research Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K01HD074651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB023281, P41EB015896, R01EB019956, R21EB018907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS094538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [U01AG006781, R01AG016495, P50AG005136] Funding Source: NIH RePORTER	We thank Michelle Siciliano, Gregory Tirrell, Sebastian Valentin, Terrence Ott, Vahram Haroutunian, and Maxwell Bustamante for assistance in obtaining and processing brain specimens; William Lee for providing database management and data sharing support; and Thomas Benner for implementation of the DWSSFP sequence for ex vivo MRI. We would like to acknowledge Dylan Tisdall and Andre van der Kouwe (Athinoula A. Martinos Center for Biomedical Imaging) and Himanshu Bhat (Siemens Medical Center) for the provision of WIP711D (vNav Motion-Corrected Multiecho MPRAGE) used to acquire MEMPRAGE data. The LETBI Project is supported by the National Institutes of Health/National Institute for Neurological Disorders and Stroke and National Institute of Child Health and Development (U01 NS086625). This research also utilized resources provided by the National Center for Research Resources (U24 RR021382), the National Institute for Biomedical Imaging and Bioengineering (P41EB015896, R01EB006758, R21EB018907, R01EB019956, 1R01EB023281), the National Institute on Aging (AG022381, 5R01AG008122, R01 AG016495, 5R01AG008122, U01AG006781, R21AG046657, P41RR014075, P50AG005136), the National Center for Alternative Medicine (RC1 AT005728-01), the National Institute for Neurological Disorders and Stroke (K23NS094538, R01NS052585-01, 1R21NS072652-01, 1R01NS070963, R01NS083534, 5U01NS086625), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (1K01HD074651, R01HD071664), the National Institute on Disability Independent Living and Rehabilitation Research (H133B040033), and the Centers for Disease Control and Prevention (1R49CE001171). Additional support was provided by the NIH Blueprint for Neuroscience Research (5U01-MH093765), part of the multi-institutional Human Connectome Project. This research also utilized resources provided by National Institutes of Health shared instrumentation grants 1S10RR023401, 1S10RR019307, and 1S10RR023043. Additional support for this project comes from the American Academy of Neurology/American Brain Foundation, the James S. McDonnell Foundation, the Nancy and Buster Alvord Endowment, institutional funds from the University of Washington School of Medicine, and the Seton Brain Research Fund. The opinions expressed herein are those of the authors and are not necessarily representative of those of the Uniformed Services University of the Health Sciences, the Department of Defense, the United States Army, Navy or Air Force, or of any other agency or component of the United States government.	Ali R, 2002, ADDICTION, V97, P1183; [Anonymous], 2009, TRAUMATIC BRAIN INJU; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Bettcher BM, 2017, J ALZHEIMERS DIS, V59, P1307, DOI 10.3233/JAD-161224; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Cella D, 2012, NEUROLOGY, V78, P1860, DOI 10.1212/WNL.0b013e318258f744; Coccaro EF, 1997, PSYCHIAT RES, V73, P147, DOI 10.1016/S0165-1781(97)00119-4; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Crary JF, 2014, ACTA NEUROPATHOL, V128, P755, DOI 10.1007/s00401-014-1349-0; Dams-O'Connor K, 2016, NEURODEGENER DIS MAN, V6, P417, DOI 10.2217/nmt-2016-0017; Dams-O'Connor K, 2014, J HEAD TRAUMA REHAB, V29, P479, DOI 10.1097/HTR.0000000000000099; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC, 1987, CALIFORNIA VERBAL LE; Deoni SCL, 2005, MAGN RESON MED, V53, P237, DOI 10.1002/mrm.20314; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dijkers MP, 2010, J HEAD TRAUMA REHAB, V25, P81, DOI 10.1097/HTR.0b013e3181cd3528; Duhaime AC, 2010, ARCH PHYS MED REHAB, V91, P1661, DOI 10.1016/j.apmr.2010.07.238; Edlow BL, 2016, BRAIN CONNECT, V6, P187, DOI 10.1089/brain.2015.0378; Edlow BL, 2013, J NEUROPATH EXP NEUR, V72, P505, DOI 10.1097/NEN.0b013e3182945bf6; Edlow BL, 2012, J NEUROPATH EXP NEUR, V71, P531, DOI 10.1097/NEN.0b013e3182588293; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Gordon W.A., 1999, BRAIN INJURY SCREENI; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Hamsher K., 1989, MULTILINGUAL APHASIA; Hays RD, 1995, USERS MANUAL MED OUT; Health IOM COGWA, 2008, GULF WAR AND HLTH; Hibbard M., 1999, BRAIN INJURY SCREENI; Humeniuk R, 2008, ADDICTION, V103, P1039, DOI 10.1111/j.1360-0443.2007.02114.x; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kenney K, 2018, J NEUROPATH EXP NEUR, V77, P50, DOI 10.1093/jnen/nlx101; Kukull WA, 2002, ARCH NEUROL-CHICAGO, V59, P1737, DOI 10.1001/archneur.59.11.1737; Maas AI, 2010, ARCH PHYS MED REHAB, V91, P1641, DOI 10.1016/j.apmr.2010.07.232; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; Mahar I, 2017, NEUROSCI BIOBEHAV R, V83, P622, DOI 10.1016/j.neubiorev.2017.08.023; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McNab JA, 2013, NEUROIMAGE, V80, P234, DOI 10.1016/j.neuroimage.2013.05.074; Mcnab JA, 2009, NEUROIMAGE, V46, P775, DOI 10.1016/j.neuroimage.2009.01.008; Meyers J., REY COMPLEX FIGURE T; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Postelnicu G, 2009, IEEE T MED IMAGING, V28, P508, DOI 10.1109/TMI.2008.2004426; Postupna N, 2017, AM J PATHOL, V187, P884, DOI 10.1016/j.ajpath.2016.12.010; Postupna N, 2015, J NEUROPATH EXP NEUR, V74, P100, DOI 10.1097/NEN.0000000000000153; Postupna N, 2012, BRAIN PATHOL, V22, P472, DOI 10.1111/j.1750-3639.2011.00542.x; Ryff C, 2012, NATL SURVEY MIDLIFE; Saver JL, 2012, STROKE, V43, P967, DOI 10.1161/STROKEAHA.111.634352; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2013, NEUROIMAGE, V80, P144, DOI 10.1016/j.neuroimage.2013.05.039; Sonnen JA, 2007, ANN NEUROL, V62, P406, DOI 10.1002/ana.21208; Sours C, 2017, J NEUROTRAUM, V34, pS4, DOI 10.1089/neu.2017.29014.bb; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; van der Kouwe AJW, 2008, NEUROIMAGE, V40, P559, DOI 10.1016/j.neuroimage.2007.12.025; Ware J. E., 2001, SF 36 PHYS MENTAL HL, V2; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wechsler D, 1987, WECHSLER MEMORY SCAL; Wechsler D., 2008, WECHSLER ADULT INTEL; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Yendiki Anastasia, 2011, Front Neuroinform, V5, P23, DOI 10.3389/fninf.2011.00023; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	74	17	17	2	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2018	35	14					1604	1619		10.1089/neu.2017.5457		MAY 2018	16	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	GK9FP	WOS:000431463900001	29421973	Green Accepted, Green Published			2022-02-06	
J	Abu Hamdeh, S; Shevchenko, G; Mi, J; Musunuri, S; Bergquist, J; Marklund, N				Abu Hamdeh, Sami; Shevchenko, Ganna; Mi, Jia; Musunuri, Sravani; Bergquist, Jonas; Marklund, Niklas			Proteomic differences between focal and diffuse traumatic brain injury in human brain tissue	SCIENTIFIC REPORTS			English	Article							NORMAL-PRESSURE HYDROCEPHALUS; FATTY-ACID-BINDING; CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; AMYLOID-BETA; AXONAL INJURY; HEAD-INJURY; BIOMARKER CANDIDATES; TAU; PATHOLOGY	The early molecular response to severe traumatic brain injury (TBI) was evaluated using biopsies of structurally normal-appearing cortex, obtained at location for intracranial pressure (ICP) monitoring, from 16 severe TBI patients. Mass spectrometry (MS; label free and stable isotope dimethyl labeling) quantitation proteomics showed a strikingly different molecular pattern in TBI in comparison to cortical biopsies from 11 idiopathic normal pressure hydrocephalus patients. Diffuse TBI showed increased expression of peptides related to neurodegeneration (Tau and Fascin, p < 0.05), reduced expression related to antioxidant defense (Glutathione S-transferase Mu 3, Peroxiredoxin-6, Thioredoxindependent peroxide reductase; p < 0.05) and increased expression of potential biomarkers (e.g. Neurogranin, Fatty acid-binding protein, heart p < 0.05) compared to focal TBI. Proteomics of human brain biopsies displayed considerable molecular heterogeneity among the different TBI subtypes with consequences for the pathophysiology and development of targeted treatments for TBI.	[Abu Hamdeh, Sami; Marklund, Niklas] Uppsala Univ, Dept Neurosci, Neurosurg, Uppsala, Sweden; [Shevchenko, Ganna; Mi, Jia; Musunuri, Sravani; Bergquist, Jonas] Uppsala Univ, Dept Chem, BMC, Analyt Chem, Uppsala, Sweden; [Mi, Jia; Bergquist, Jonas] Binzhou Med Univ, Med & Pharm Res Ctr, Yantai, Peoples R China		Marklund, N (corresponding author), Uppsala Univ, Dept Neurosci, Neurosurg, Uppsala, Sweden.	niklas.marklund@neuro.uu.se		Marklund, Niklas/0000-0002-9797-5626; Bergquist, Jonas/0000-0002-4597-041X	Swedish Brain Foundation; Swedish Governmental Agency for Innovation SystemsVinnova; Swedish Research CouncilSwedish Research CouncilEuropean Commission; SRC [6211-2011-4423, 2015-4870]; Lars Hjartat Minne Stiftelse; Stiftelsen for Gamla Tjanarinnor; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31671139]	This work was financed by the Swedish Brain Foundation, the Swedish Governmental Agency for Innovation Systems, and the Swedish Research Council under the framework of EU-ERA-NET NEURON CnsAFlame, Uppsala University Hospital ALF-funds, and Uppsala University. J.B. further acknowledges SRC grant 6211-2011-4423, 2015-4870. Lars Hjartat Minne Stiftelse and Stiftelsen for Gamla Tjanarinnor are also gratefully acknowledged for financial support (GS grants). J.M acknowledges National Natural Science Foundation of China (31671139). We acknowledge Dr. Kristina Guiliana Cesarini for help with cortical biopsies of normal pressure hydrocephalus patients and Dag Sehlin for technical assistance with the A beta ELISA analysis.	Abu Hamdeh S, 2017, J NEUROTRAUM, V34, P341, DOI 10.1089/neu.2016.4426; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Angeloni C, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/370312; Arendt T, 2016, BRAIN RES BULL, V126, P238, DOI 10.1016/j.brainresbull.2016.08.018; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Bragge P, 2016, J NEUROTRAUM, V33, P1461, DOI 10.1089/neu.2015.4233; Brody DL, 2015, MOL CELL NEUROSCI, V66, P91, DOI 10.1016/j.mcn.2015.02.005; Cadosch D, 2010, ANZ J SURG, V80, P542, DOI 10.1111/j.1445-2197.2010.05268.x; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Cullen V, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-5; DeKosky ST, 2007, ARCH NEUROL-CHICAGO, V64, P541, DOI 10.1001/archneur.64.4.541; Elf K, 2002, CRIT CARE MED, V30, P2129, DOI 10.1097/00003246-200209000-00029; Elkhatib N, 2014, CURR BIOL, V24, P1492, DOI 10.1016/j.cub.2014.05.023; Elobeid A, 2016, J NEUROPATH EXP NEUR, V75, P316, DOI 10.1093/jnen/nlw002; Elobeid A, 2015, J NEUROPATH EXP NEUR, V74, P470, DOI 10.1097/NEN.0000000000000191; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Guo LH, 2013, EUR ARCH PSY CLIN N, V263, P553, DOI 10.1007/s00406-013-0405-4; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Halford J, 2017, J CEREBR BLOOD F MET, V37, P3278, DOI 10.1177/0271678X17724681; Hanrieder J, 2009, J NEUROSCI METH, V177, P469, DOI 10.1016/j.jneumeth.2008.10.038; Harish G, 2015, J NEUROCHEM, V134, P156, DOI 10.1111/jnc.13082; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Herrmann M, 2000, J NEUROTRAUM, V17, P113, DOI 10.1089/neu.2000.17.113; Herukka SK, 2015, J ALZHEIMERS DIS, V46, P261, DOI 10.3233/JAD-142862; Holmin S, 1998, NEUROSURGERY, V42, P291, DOI 10.1097/00006123-199802000-00047; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Koskinen LOD, 2013, ACTA NEUROCHIR, V155, P2141, DOI 10.1007/s00701-013-1856-0; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Magnoni S, 2015, BRAIN, V138, P2263, DOI 10.1093/brain/awv152; Magnoni S, 2012, BRAIN, V135, P1268, DOI 10.1093/brain/awr286; Manevich Y, 2014, FREE RADICAL BIO MED, V72, P210, DOI 10.1016/j.freeradbiomed.2014.04.002; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Musunuri S, 2014, J PROTEOME RES, V13, P2056, DOI 10.1021/pr401202d; Musunuri S, 2012, ELECTROPHORESIS, V33, P3779, DOI 10.1002/elps.201200474; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Ojo JO, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00057; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; PORTELIUS E, 2015, BRAIN 11, V138, DOI DOI 10.1093/BRAIN/AWV267; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Scheltens P, 2016, LANCET, V388, P505, DOI 10.1016/S0140-6736(15)01124-1; Sehlin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032014; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Sosvorova L, 2014, NEUROENDOCRINOL LETT, V35, P586; Stefini R, 2008, J NEUROSURG, V108, P958, DOI 10.3171/JNS/2008/108/5/0958; Stenh C, 2005, ANN NEUROL, V58, P147, DOI 10.1002/ana.20524; Stevens RJ, 2011, CURR BIOL, V21, pR402, DOI 10.1016/j.cub.2011.04.020; Stocchetti N, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0887-8; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Tian L, 2014, J ALZHEIMERS DIS, V42, P511, DOI 10.3233/JAD-132192; Van Landeghem FKH, 2006, J NEUROTRAUM, V23, P1518, DOI 10.1089/neu.2006.23.1518; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Walder B, 2013, J NEUROTRAUM, V30, P1631, DOI 10.1089/neu.2012.2791; Wetterhall M, 2011, ANAL BIOANAL CHEM, V400, P2827, DOI 10.1007/s00216-011-5037-9; Wheble JLC, 2016, J ROY ARMY MED CORPS, V162, P87, DOI 10.1136/jramc-2015-000472; Yokobori S, 2013, CNS NEUROSCI THER, V19, P556, DOI 10.1111/cns.12127; Zanier ER, 2013, BRIT J ANAESTH, V111, P424, DOI 10.1093/bja/aet149; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhou YL, 2016, CHEM-ASIAN J, V11, P805, DOI 10.1002/asia.201501355	72	17	17	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAY 1	2018	8								6807	10.1038/s41598-018-25060-0			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GE3KV	WOS:000431113100005	29717219	Green Published, gold			2022-02-06	
J	Chesnel, C; Jourdan, C; Bayen, E; Ghout, I; Darnoux, E; Azerad, S; Charanton, J; Aegerter, P; Pradat-Diehl, P; Ruet, A; Azouvi, P; Vallat-Azouvi, C				Chesnel, Camille; Jourdan, Claire; Bayen, Eleonore; Ghout, Idir; Darnoux, Emmanuelle; Azerad, Sylvie; Charanton, James; Aegerter, Philippe; Pradat-Diehl, Pascale; Ruet, Alexis; Azouvi, Philippe; Vallat-Azouvi, Claire			Self-awareness four years after severe traumatic brain injury: discordance between the patient's and relative's complaints. Results from the PariS-TBI study	CLINICAL REHABILITATION			English	Article						Traumatic brain injury; burden of care; anosognosia	QUALITY-OF-LIFE; IMPAIRED AWARENESS; ECOLOGICAL VALIDITY; COGNITIVE DEFICITS; SUBJECTIVE REPORTS; RATING-SCALE; HEALTH; REHABILITATION; PROXY; DEPRESSION	Objective: To evaluate the patient's awareness of his or her difficulties in the chronic phase of severe traumatic brain injury (TBI) and to determine the factors related to poor awareness. Design/Setting/Subjects: This study was part of a larger prospective inception cohort study of patients with severe TBI in the Parisian region (PariS-TBI study). Intervention/Main measures: Evaluation was carried out at four years and included the Brain Injury Complaint Questionnaire (BICoQ) completed by the patient and his or her relative as well as the evaluation of impairments, disability and quality of life. Results: A total of 90 patient-relative pairs were included. Lack of awareness was measured using the unawareness index that corresponded to the number of discordant results between the patient and relative in the direction of under evaluation of difficulties by the patient. The only significant relationship found with lack of awareness was the subjective burden perceived by the relative (Zarit Burden Inventory) (r = 0.5; P < 0.00001). There was no significant relationship between lack of awareness and injury severity, pre-injury socio-demographic data, cognitive impairments, mood disorders, functional independence (Barthel index), global disability (Glasgow Outcome Scale), return to work at four years or quality of life (Quality Of Life after Brain Injury scale (QOLIBRI)). Conclusion: Lack of awareness four years post severe TBI was not related to the severity of the initial trauma, sociodemographic data, the severity of impairments, limitations of activity and participation, or the patient's quality of life. However, poor awareness did significantly influence the weight of the burden perceived by the relative.	[Chesnel, Camille; Jourdan, Claire; Ruet, Alexis; Azouvi, Philippe] Hop Raymond Poincare, AP HP, Serv Med Phys & Readaptat, 104 Blvd Raymond Poincare, F-92380 Garches, France; [Jourdan, Claire; Azouvi, Philippe; Vallat-Azouvi, Claire] Univ Versailles St Quentin, HANDIReSP EA 4047, Montigny Le Bretonneux, France; [Bayen, Eleonore] Univ Paris 09, Lab Econ & Gest Org Sante LEDa LEGOS, Paris, France; [Bayen, Eleonore; Pradat-Diehl, Pascale] Univ Paris 06, Paris, France; [Bayen, Eleonore; Pradat-Diehl, Pascale] Hop Univ Pitie Salpetriere Charles Foix, AP HP, Serv Med Phys & Readaptat, Paris, France; [Ghout, Idir; Azerad, Sylvie; Aegerter, Philippe] Hop Ambroise Pare, AP HP, URC, Boulogne, France; [Darnoux, Emmanuelle; Charanton, James] CRFTC, Paris, France; [Aegerter, Philippe] Univ Versailles St Quentin, UMR S 1168, Versailles, France; [Vallat-Azouvi, Claire] Hop Raymond Poincare, Antenne UEROS, SAMSAH92, UGECAM IDF, Garches, France; [Vallat-Azouvi, Claire] EA 2027 Lab Psychopathol & Neuropsychol, Univ Paris 8, St Denis, France		Azouvi, P (corresponding author), Hop Raymond Poincare, AP HP, Serv Med Phys & Readaptat, 104 Blvd Raymond Poincare, F-92380 Garches, France.	philippe.azouvi@aphp.fr	RUET, Alexis/L-8726-2015; AEGERTER, Philippe/AAY-6003-2021	RUET, Alexis/0000-0002-5080-5734; AEGERTER, Philippe/0000-0002-9156-5028	French Ministry of Health (Programme hospitalier de recherche clinique) [AOM04084]; AP-HP (Departement de la recherche clinique et du developpement); Institut de recherche en sante publique (IRESP)	The author(s) disclosed receipt of the following financial support for the research, authorship and/or publication of this article: The first part of this study was funded by a grant from the French Ministry of Health (Programme hospitalier de recherche clinique 2004, AOM04084) and sponsored by AP-HP (Departement de la recherche clinique et du developpement). The second part of this study was funded by a grant from the Institut de recherche en sante publique (IRESP).	Anderson RL, 2010, CAN J OCCUP THER, V77, P22, DOI 10.2182/cjot.2010.77.1.4; Arnould A, 2016, ANN PHYS REHABIL MED, V59, P18, DOI 10.1016/j.rehab.2015.09.002; Azouvi P, 2015, NEUROPSYCHOL REHABIL, V25, P864, DOI 10.1080/09602011.2014.990907; Babinski J, 1914, REV NEUROL, V27, P845; Bayen E, 2016, J HEAD TRAUMA REHAB, V31, pE59, DOI 10.1097/HTR.0000000000000079; Bayen E, 2013, J HEAD TRAUMA REHAB, V28, P408, DOI 10.1097/HTR.0b013e31825413cf; Bivona U, 2008, J INT NEUROPSYCH SOC, V14, P862, DOI 10.1017/S1355617708081125; Bivona U, 2014, J HEAD TRAUMA REHAB, V29, P157, DOI 10.1097/HTR.0b013e3182864f0b; Bjorkdahl A, 2012, J STROKE CEREBROVASC, V21, P812, DOI 10.1016/j.jstrokecerebrovasdis.2011.04.013; Bland JM, 2010, INT J NURS STUD, V47, P931, DOI 10.1016/j.ijnurstu.2009.10.001; Bogod NM, 2003, J INT NEUROPSYCH SOC, V9, P450, DOI 10.1017/S1355617703930104; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; CAVALLO M M, 1992, Brain Injury, V6, P327, DOI 10.3109/02699059209034947; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; CLARRIDGE BR, 1989, MED CARE, V27, P352, DOI 10.1097/00005650-198904000-00003; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; Cusick CP, 2001, ARCH PHYS MED REHAB, V82, P1018, DOI 10.1053/apmr.2001.25098; Cusick CP, 2000, J HEAD TRAUMA REHAB, V15, P739, DOI 10.1097/00001199-200002000-00012; Draper K, 2009, NEUROPSYCHOL REHABIL, V19, P645, DOI 10.1080/17405620802613935; Fleming JM, 1996, BRAIN INJURY, V10, P1; Goverover Y, 2014, BRAIN INJURY, V28, P174, DOI 10.3109/02699052.2013.860474; Hoofien D, 2004, J CLIN EXP NEUROPSYC, V26, P278, DOI 10.1076/jcen.26.2.278.28084; Jehkonen M, 2006, ACTA NEUROL SCAND, V114, P293, DOI 10.1111/j.1600-0404.2006.00723.x; JENNETT B, 1975, LANCET, V1, P480; Jourdan C, 2016, ANN PHYS REHABIL MED, V59, P100, DOI 10.1016/j.rehab.2015.10.009; Jourdan C, 2013, BRAIN INJURY, V27, P1000, DOI 10.3109/02699052.2013.794971; Jourdan C, 2011, ANN PHYS REHABIL MED, V54, pe278; Jourdan C, 2016, J HEAD TRAUMA REHAB, V31, pE42, DOI 10.1097/HTR.0000000000000147; Jourdan C, 2015, BRAIN INJURY, V29, P701, DOI 10.3109/02699052.2015.1004646; Jourdan C, 2013, NEUROREHAB NEURAL RE, V27, P35, DOI 10.1177/1545968312440744; Kelley E, 2014, J HEAD TRAUMA REHAB, V29, P147, DOI 10.1097/HTR.0b013e31826db6b9; Kottorp A, 2011, SCAND J OCCUP THER, V18, P219, DOI 10.3109/11038128.2010.521947; Leathem JM, 1998, J CLIN EXP NEUROPSYC, V20, P694, DOI 10.1076/jcen.20.5.694.1122; Liaset IF, 2016, SCAND J OCCUP THER, V23, P446, DOI 10.3109/11038128.2016.1152294; MAGAZINER J, 1988, J CLIN EPIDEMIOL, V41, P1065, DOI 10.1016/0895-4356(88)90076-5; MAHONEY F I, 1965, Md State Med J, V14, P61; Malec JF, 2000, REHABIL PSYCHOL, V45, P227, DOI 10.1037/0090-5550.45.3.227; McCauley SR, 2001, J NEUROL NEUROSUR PS, V71, P643, DOI 10.1136/jnnp.71.5.643; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; Morton N, 2010, J INT NEUROPSYCH SOC, V16, P1089, DOI 10.1017/S1355617710000925; Noe E, 2005, J NEUROL, V252, P168, DOI 10.1007/s00415-005-0625-2; Orfei MD, 2009, CEREBROVASC DIS, V27, P280, DOI 10.1159/000199466; Ownsworth T, 2007, NEUROPSYCHOL REHABIL, V17, P129, DOI 10.1080/09602010600615506; Ownsworth T, 2006, CLIN PSYCHOL REV, V26, P783, DOI 10.1016/j.cpr.2006.05.003; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; PRIGATANO GP, 1990, CLIN NEUROPSYCHOL, V4, P163, DOI DOI 10.1080/13854049008401509; Prigatano GP, 1985, NEUROPSYCHOLOGICAL R; RANKIN ED, 1994, GERONTOLOGIST, V34, P828, DOI 10.1093/geront/34.6.828; ROTHMAN ML, 1991, MED CARE, V29, P115, DOI 10.1097/00005650-199102000-00004; Sasse N, 2013, J HEAD TRAUMA REHAB, V28, P464, DOI 10.1097/HTR.0b013e318263977d; Sawilowsky SS, 2009, J MOD APPL STAT METH, V8, P597, DOI 10.22237/jmasm/1257035100; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Smeets SMJ, 2017, NEUROPSYCHOL REHABIL, V27, P116, DOI 10.1080/09602011.2015.1077144; Smeets SMJ, 2014, NEUROPSYCHOLOGY, V28, P717, DOI 10.1037/neu0000068; Smeets SMJ, 2012, J HEAD TRAUMA REHAB, V27, P433, DOI 10.1097/HTR.0b013e3182242f98; Soury S., 2005, Annales de Readaptation et de Medecine Physique, V48, P61, DOI 10.1016/j.annrmp.2004.08.007; SPRANGERS MAG, 1992, J CLIN EPIDEMIOL, V45, P743, DOI 10.1016/0895-4356(92)90052-O; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; Vallat-Azouvi C, J NEUROSCI RES; WEINBERGER M, 1992, J AM GERIATR SOC, V40, P585, DOI 10.1111/j.1532-5415.1992.tb02107.x; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	66	17	17	0	4	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2155	1477-0873		CLIN REHABIL	Clin. Rehabil.	MAY	2018	32	5					692	704		10.1177/0269215517734294			13	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	GF6BZ	WOS:000432053100013	28982252				2022-02-06	
J	Johnson, BD; O'Leary, MC; McBryde, M; Sackett, JR; Schlader, ZJ; Leddy, JJ				Johnson, Blair D.; O'Leary, Morgan C.; McBryde, Muhamed; Sackett, James R.; Schlader, Zachary J.; Leddy, John J.			Face cooling exposes cardiac parasympathetic and sympathetic dysfunction in recently concussed college athletes	PHYSIOLOGICAL REPORTS			English	Article						Autonomic nervous system; blood pressure; heart rate; heart rate variability; mild traumatic brain injury; sympathetic nervous system	TRAUMATIC BRAIN-INJURY; HEART-RATE-VARIABILITY; TEMPORAL WINDOW; BLOOD-PRESSURE; NERVE ACTIVITY; EXERCISE; VULNERABILITY; INCREASES; RECOVERY; LIGHT	We tested the hypothesis that concussed college athletes (CA) have attenuated parasympathetic and sympathetic responses to face cooling (FC). Eleven symptomatic CA (age: 20 +/- 2 years, 5 women) who were within 10 days of concussion diagnosis and 10 healthy controls (HC; age: 24 +/- 4 years, 5 women) participated. During FC, a plastic bag filled with ice water (similar to 0 degrees C) was placed on the forehead, eyes, and cheeks for 3 min. Heart rate (ECG) and blood pressure (photoplethysmography) were averaged at baseline and every 60 sec during FC. High-frequency (HF) power was obtained from spectral analysis of the R-R interval. Data are presented as a change from baseline. Baseline heart rate (HC: 61 +/- 12, CA: 57 +/- 12 bpm; P = 0.69), mean arterial pressure (MAP) (HC: 94 +/- 10, CA: 96 +/- 13 mmHg; P = 0.74), and HF (HC: 2294 +/- 2314, CA: 2459 +/- 2058 msec(2); P = 0.86) were not different between groups. Heart rate in HC decreased at 2 min (+/- 7 +/- 11 bpm; P = 0.02) but did not change in CA (P > 0.43). MAP increased at 1 min (HC: 12 +/- 6, CA: 6 +/- 6 mmHg), 2 min (HC: 21 +/- 7, CA: 11 +/- 7 mmHg), and 3 min (HC: 20 +/- 6, CA: 13 +/- 7 mmHg) in both groups (P < 0.01 for all) but the increase was greater at each interval in HC (P < 0.02). HF increased at 1 min (12354 +/- 11489 msec(2); P < 0.01) and 2 min (5832 +/- 8002 msec(2); P = 0.02) in HC but did not change in CA (P > 0.58). The increase in HF at 1 min was greater in HC versus CA (P < 0.01). These data indicate that symptomatic concussed patients have impaired cardiac parasympathetic and sympathetic activation.	[Johnson, Blair D.; O'Leary, Morgan C.; McBryde, Muhamed; Sackett, James R.; Schlader, Zachary J.] Univ Buffalo, Dept Exercise & Nutr Sci, Ctr Res & Educ Special Environm, 208A Kimball Tower, Buffalo, NY 14214 USA; [Leddy, John J.] Univ Buffalo, Dept Orthopaed & Sports Med, UBMD, Buffalo, NY USA		Johnson, BD (corresponding author), Univ Buffalo, Dept Exercise & Nutr Sci, Ctr Res & Educ Special Environm, 208A Kimball Tower, Buffalo, NY 14214 USA.	blairjoh@buffalo.edu		Schlader, Zachary/0000-0003-3590-3958; Johnson, Blair/0000-0002-1731-4415; Sackett, James/0000-0002-1817-651X	National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R01NS094444]; National Center for Advancing Translational Sciences of the National Institutes of Health Pilot Grants Award Program [UL1TR001412]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001412] Funding Source: NIH RePORTER	Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under award number 1R01NS094444 and by the National Center for Advancing Translational Sciences of the National Institutes of Health Pilot Grants Award Program under award Number UL1TR001412.	Abaji JP, 2016, J NEUROTRAUM, V33, P811, DOI 10.1089/neu.2015.3989; Camm AJ, 1996, EUR HEART J, V17, P354; Clausen M, 2016, J HEAD TRAUMA REHAB, V31, P215, DOI 10.1097/HTR.0000000000000145; Darling SR, 2014, CLIN J SPORT MED, V24, P128, DOI 10.1097/JSM.0000000000000026; Dobson JL, 2017, AM J PHYSIOL-REG I, V312, pR575, DOI 10.1152/ajpregu.00499.2016; FINLEY JP, 1979, J APPL PHYSIOL, V47, P1218, DOI 10.1152/jappl.1979.47.6.1218; Fisher JP, 2015, AM J PHYSIOL-HEART C, V308, pH367, DOI 10.1152/ajpheart.00728.2014; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Goldstein B, 1998, AM J PHYSIOL-REG I, V275, pR1287, DOI 10.1152/ajpregu.1998.275.4.R1287; Goldstein B, 1996, CRIT CARE MED, V24, P234, DOI 10.1097/00003246-199602000-00009; Hayashi N, 1997, EUR J APPL PHYSIOL O, V76, P394, DOI 10.1007/s004210050267; HEISTAD DD, 1968, J APPL PHYSIOL, V25, P542, DOI 10.1152/jappl.1968.25.5.542; Hilz MJ, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0584-5; Hilz MJ, 2011, J NEUROTRAUM, V28, P1727, DOI 10.1089/neu.2010.1497; Hilz MJ, 1999, AM J PHYSIOL-REG I, V276, pR1833, DOI 10.1152/ajpregu.1999.276.6.R1833; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Johnson BD, 2017, AM J PHYSIOL-REG I, V313, pR594, DOI 10.1152/ajpregu.00253.2017; Joyner MJ, 2016, J PHYSIOL-LONDON, V594, P4009, DOI 10.1113/JP271875; King ML, 1997, BRAIN INJURY, V11, P445; Kozlowski KF, 2013, J ATHL TRAINING, V48, P627, DOI 10.4085/1062-6050-48.5.02; La Fountaine MF, 2009, AUTON NEUROSCI-BASIC, V148, P101, DOI 10.1016/j.autneu.2009.03.001; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; LOWENSOHN RI, 1977, LANCET, V1, P626; Mainwaring L, 2018, INT J PSYCHOPHYSIOL, V132, P39, DOI 10.1016/j.ijpsycho.2018.01.007; Michael S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00301; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Pendergast DR, 2015, COMPR PHYSIOL, V5, P1705, DOI 10.1002/cphy.c140018; Polak P, 2015, J HEAD TRAUMA REHAB, V30, pE32, DOI 10.1097/HTR.0000000000000037; Rickards CA, 2010, J CLIN MONIT COMPUT, V24, P61, DOI 10.1007/s10877-009-9210-z; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Schlader ZJ, 2018, EXP PHYSIOL, V103, P701, DOI 10.1113/EP086865; Schlader ZJ, 2016, AM J PHYSIOL-REG I, V311, pR643, DOI 10.1152/ajpregu.00164.2016; Shamsuzzaman A, 2014, AUTON NEUROSCI-BASIC, V181, P74, DOI 10.1016/j.autneu.2013.12.001; Sung CW, 2016, CLIN NEUROPHYSIOL, V127, P1629, DOI 10.1016/j.clinph.2015.08.006; Tavazzi B, 2007, NEUROSURGERY, V61, P390, DOI 10.1227/01.NEU.0000255525.34956.3F; Thiagarajan P, 2015, BRAIN INJURY, V29, P1420, DOI 10.3109/02699052.2015.1045029; Truong JQ, 2016, BRAIN INJURY, V30, P1378, DOI 10.1080/02699052.2016.1195922; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; WESSELING KH, 1993, J APPL PHYSIOL, V74, P2566, DOI 10.1152/jappl.1993.74.5.2566	44	17	18	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2051-817X			PHYSIOL REP	PHYSIOL. REP.	MAY	2018	6	9							e13694	10.14814/phy2.13694			11	Physiology	Emerging Sources Citation Index (ESCI)	Physiology	GF5SR	WOS:000432028600009	29741235	Green Published, gold			2022-02-06	
J	Kirkpatrick, CT; Wang, YX; Juarez, MML; Shivshankar, P; Garcia, JP; Plumer, AK; Kulkarni, VV; Ware, HH; Gulraiz, F; Cavasos, MAC; Zayes, GM; Wali, S; Rice, AP; Liu, HB; Tour, JM; Sikkema, WKA; Solbes, ASC; Youker, KA; Tuvim, MJ; Dickey, BF; Evans, SE				Kirkpatrick, Carson T.; Wang, Yongxing; Juarez, Miguel M. Leiva; Shivshankar, Pooja; Pantaleon Garcia, Jezreel; Plumer, Alexandria K.; Kulkarni, Vikram V.; Ware, Hayden H.; Gulraiz, Fahad; Cavasos, Miguel A. Chavez; Martinez Zayes, Gabriela; Wali, Shradha; Rice, Andrew P.; Liu, Hongbing; Tour, James M.; Sikkema, William K. A.; Solbes, Ana S. Cruz; Youker, Keith A.; Tuvim, Michael J.; Dickey, Burton F.; Evans, Scott E.			Inducible Lung Epithelial Resistance Requires Multisource Reactive Oxygen Species Generation To Protect against Viral Infections	MBIO			English	Article						inducible resistance; Toll-like receptors; lung epithelium; mucosal immunity; reactive oxygen species; viral pneumonia	INFLUENZA-A VIRUS; COMMUNITY-ACQUIRED PNEUMONIA; HYDROPHILIC CARBON CLUSTERS; TRAUMATIC BRAIN-INJURY; INNATE IMMUNE-RESPONSE; CEREBROVASCULAR DYSFUNCTION; BACTERICIDAL ACTIVITY; HYDROGEN-PEROXIDE; AIRWAY EPITHELIUM; NADPH OXIDASES	Viral pneumonias cause profound worldwide morbidity, necessitating novel strategies to prevent and treat these potentially lethal infections. Stimulation of intrinsic lung defenses via inhalation of synergistically acting Toll-like receptor (TLR) agonists protects mice broadly against pneumonia, including otherwise-lethal viral infections, providing a potential opportunity to mitigate infectious threats. As intact lung epithelial TLR signaling is required for the inducible resistance and as these cells are the principal targets of many respiratory viruses, the capacity of lung epithelial cells to be therapeutically manipulated to function as autonomous antiviral effectors was investigated. Our work revealed that mouse and human lung epithelial cells could be stimulated to generate robust antiviral responses that both reduce viral burden and enhance survival of isolated cells and intact animals. The antiviral protection required concurrent induction of epithelial reactive oxygen species (ROS) from both mitochondrial and dual oxidase sources, although neither type I interferon enrichment nor type I interferon signaling was required for the inducible protection. Taken together, these findings establish the sufficiency of lung epithelial cells to generate therapeutically inducible antiviral responses, reveal novel antiviral roles for ROS, provide mechanistic insights into inducible resistance, and may provide an opportunity to protect patients from viral pneumonia during periods of peak vulnerability. IMPORTANCE Viruses are the most commonly identified causes of pneumonia and inflict unacceptable morbidity, despite currently available therapies. While lung epithelial cells are principal targets of respiratory viruses, they have also been recently shown to contribute importantly to therapeutically inducible antimicrobial responses. This work finds that lung cells can be stimulated to protect themselves against viral challenges, even in the absence of leukocytes, both reducing viral burden and improving survival. Further, it was found that the protection occurs via unexpected induction of reactive oxygen species (ROS) from spatially segregated sources without reliance on type I interferon signaling. Coordinated multisource ROS generation has not previously been described against viruses, nor has ROS generation been reported for epithelial cells against any pathogen. Thus, these findings extend the potential clinical applications for the strategy of inducible resistance to protect vulnerable people against viral infections and also provide new insights into the capacity of lung cells to protect against infections via novel ROS-dependent mechanisms.	[Kirkpatrick, Carson T.; Wang, Yongxing; Juarez, Miguel M. Leiva; Shivshankar, Pooja; Kulkarni, Vikram V.; Ware, Hayden H.; Gulraiz, Fahad; Cavasos, Miguel A. Chavez; Tuvim, Michael J.; Dickey, Burton F.; Evans, Scott E.] Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX 77030 USA; [Pantaleon Garcia, Jezreel; Martinez Zayes, Gabriela] Tecnol Monterrey Sch Med, Monterrey, Mexico; [Plumer, Alexandria K.; Wali, Shradha; Dickey, Burton F.; Evans, Scott E.] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX USA; [Rice, Andrew P.; Liu, Hongbing] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Tour, James M.; Sikkema, William K. A.] Rice Univ, Smalley Inst Nanoscale Sci & Technol, Houston, TX USA; [Solbes, Ana S. Cruz; Youker, Keith A.] Houston Methodist Hosp, Michael E Debakey Heart & Vasc Inst, Houston, TX USA		Evans, SE (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX 77030 USA.; Evans, SE (corresponding author), Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX USA.	seevans@mdanderson.org		Wali, Shradha/0000-0002-6077-7618; Plumer, Alexandria/0000-0002-7889-7378; Youker, Keith/0000-0003-2535-7973; Kulkarni, Vikram/0000-0002-0498-3871	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 HL117976, DP2 HL123229, P30 CA016672]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA016672] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [DP2HL123229, R01HL117976] Funding Source: NIH RePORTER	This study was supported by NIH grants R01 HL117976 and DP2 HL123229 to S.E.E. and P30 CA016672 to the MD Anderson Cancer Center.	Alfaro VY, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00008; Bals R, 2004, EUR RESPIR J, V23, P327, DOI 10.1183/09031936.03.00098803; Bartlett Jennifer A., 2008, V15, P147, DOI 10.1159/000136349; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Bitner BR, 2012, ACS NANO, V6, P8007, DOI 10.1021/nn302615f; Cegolon L, 2014, INT J HYG ENVIR HEAL, V217, P17, DOI 10.1016/j.ijheh.2013.03.001; Cleaver JO, 2014, MUCOSAL IMMUNOL, V7, P78, DOI 10.1038/mi.2013.26; Cordero-Reyes AM, 2014, J MOL CELL CARDIOL, V68, P98, DOI 10.1016/j.yjmcc.2013.12.029; Dikalov SI, 2014, ANTIOXID REDOX SIGN, V20, P372, DOI 10.1089/ars.2012.4886; Duggan JM, 2011, J IMMUNOL, V186, P5916, DOI 10.4049/jimmunol.1002122; Dushoff J, 2006, AM J EPIDEMIOL, V163, P181, DOI 10.1093/aje/kwj024; Evans SE, 2011, BRIT J PHARMACOL, V163, P195, DOI 10.1111/j.1476-5381.2011.01237.x; Evans SE, 2010, ANNU REV PHYSIOL, V72, P413, DOI 10.1146/annurev-physiol-021909-135909; Evans SE, 2010, AM J RESP CELL MOL, V42, P40, DOI 10.1165/rcmb.2008-0260OC; Fahy JV, 2011, AM J RESP CRIT CARE, V184, P390, DOI 10.1164/rccm.201107-1258ED; Fang FC, 2011, MBIO, V2, DOI 10.1128/mBio.00141-11; Fischer AJ, 2011, AM J RESP CELL MOL, V45, P874, DOI 10.1165/rcmb.2010-0329OC; Fischer H, 2009, ANTIOXID REDOX SIGN, V11, P2453, DOI [10.1089/ars.2009.2558, 10.1089/ARS.2009.2558]; Forteza R, 2005, AM J RESP CELL MOL, V32, P462, DOI 10.1165/rcmb.2004-0302OC; Gattas MV, 2009, FREE RADICAL BIO MED, V47, P1450, DOI 10.1016/j.freeradbiomed.2009.08.017; Geng J, 2015, NAT IMMUNOL, V16, P1142, DOI 10.1038/ni.3268; Grandvaux N, 2015, CLIN SCI, V128, P337, DOI 10.1042/CS20140321; Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002; Hippenstiel S, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-97; Holtzman MJ, 2011, CURR OPIN IMMUNOL, V23, P487, DOI 10.1016/j.coi.2011.05.010; Ibricevic A, 2006, J VIROL, V80, P7469, DOI 10.1128/JVI.02677-05; Iwasaki A, 2014, NAT REV IMMUNOL, V14, P315, DOI 10.1038/nri3665; Jain S, 2015, NEW ENGL J MED, V373, P415, DOI 10.1056/NEJMoa1500245; Jain S, 2015, NEW ENGL J MED, V372, P835, DOI 10.1056/NEJMoa1405870; Jennings LC, 2008, THORAX, V63, P42, DOI 10.1136/thx.2006.075077; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Kim HJ, 2013, AM J RESP CELL MOL, V49, P855, DOI 10.1165/rcmb.2013-0003OC; Kim S, 2015, ANTIVIR RES, V119, P78, DOI 10.1016/j.antiviral.2015.04.011; Knust J, 2009, ANAT REC, V292, P113, DOI 10.1002/ar.20747; Leigh R, 2015, PHARMACOL THERAPEUT, V148, P185, DOI 10.1016/j.pharmthera.2014.12.005; Maghzal GJ, 2012, FREE RADICAL BIO MED, V53, P1903, DOI 10.1016/j.freeradbiomed.2012.09.002; Marcano DC, 2013, J NEUROTRAUM, V30, P789, DOI 10.1089/neu.2011.2301; Mizgerd JP, 2006, PLOS MED, V3, P155, DOI 10.1371/journal.pmed.0030076; Moron CG, 2005, P AM THORAC SOC, V2, pA452; Patton JS, 2010, J AEROSOL MED PULM D, V23, pS71, DOI 10.1089/jamp.2010.0836; Rahman I, 2006, EUR J PHARMACOL, V533, P222, DOI 10.1016/j.ejphar.2005.12.087; Rudan I, 2004, B WORLD HEALTH ORGAN, V82, P891; Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6; Samuel ELG, 2015, P NATL ACAD SCI USA, V112, P2343, DOI 10.1073/pnas.1417047112; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Shin N, 2015, BIOCHEM BIOPH RES CO, V459, P699, DOI 10.1016/j.bbrc.2015.03.010; Shornick LP, 2008, J IMMUNOL, V180, P3319, DOI 10.4049/jimmunol.180.5.3319; Strengert M, 2014, ANTIOXID REDOX SIGN, V20, P2695, DOI 10.1089/ars.2013.5353; Tsukagoshi H, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00278; Tuvim MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030596; van der Vliet A, 2008, FREE RADICAL BIO MED, V44, P938, DOI 10.1016/j.freeradbiomed.2007.11.016; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Wijkstrom-Frei C, 2003, AM J RESP CELL MOL, V29, P206, DOI 10.1165/rcmb.2002-0152OC; Wojtala A, 2014, METHOD ENZYMOL, V542, P243, DOI 10.1016/B978-0-12-416618-9.00013-3; World Health Organization ( WHO), 2004, WORLD HLTH REP 2004; WYDE PR, 1977, INFECT IMMUN, V15, P221, DOI 10.1128/IAI.15.1.221-229.1977; Yoshizumi T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5713; Zamojc K, 2016, CRIT REV ANAL CHEM, V46, P171, DOI 10.1080/10408347.2015.1014085; Zhang X, 2015, FREE RADICAL RES, V49, P374, DOI 10.3109/10715762.2015.1014813	59	17	17	1	3	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	2150-7511			MBIO	mBio	MAY-JUN	2018	9	3							e00696-18	10.1128/mBio.00696-18			18	Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Microbiology	GG9WG	WOS:000433051200043	29764948	gold, Green Published			2022-02-06	
J	van Hedel, HJA; Severini, G; Scarton, A; O'Brien, A; Reed, T; Gaebler-Spira, D; Egan, T; Meyer-Heim, A; Graser, J; Chua, K; Zutter, D; Schweinfurther, R; Moller, JC; Paredes, LP; Esquenazi, A; Berweck, S; Schroeder, S; Warken, B; Chan, A; Devers, A; Petioky, J; Paik, NJ; Kim, WS; Bonato, P; Boninger, M				van Hedel, Hubertus J. A.; Severini, Giacomo; Scarton, Alessandra; O'Brien, Anne; Reed, Tamsin; Gaebler-Spira, Deborah; Egan, Tara; Meyer-Heim, Andreas; Graser, Judith; Chua, Karen; Zutter, Daniel; Schweinfurther, Raoul; Moller, J. Carsten; Paredes, Liliana P.; Esquenazi, Alberto; Berweck, Steffen; Schroeder, Sebastian; Warken, Birgit; Chan, Anne; Devers, Amber; Petioky, Jakub; Paik, Nam-Jong; Kim, Won-Seok; Bonato, Paolo; Boninger, Michael		ARTIC network	Advanced Robotic Therapy Integrated Centers (ARTIC): an international collaboration facilitating the application of rehabilitation technologies	JOURNAL OF NEUROENGINEERING AND REHABILITATION			English	Article							SPINAL-CORD-INJURY; SUBACUTE STROKE PATIENTS; DRIVEN GAIT ORTHOSIS; CEREBRAL-PALSY; INTERRATER RELIABILITY; WALKING ABILITY; CHILDREN; PREVALENCE; CLASSIFICATION; RECOVERY	Background: The application of rehabilitation robots has grown during the last decade. While meta-analyses have shown beneficial effects of robotic interventions for some patient groups, the evidence is less in others. We established the Advanced Robotic Therapy Integrated Centers (ARTIC) network with the goal of advancing the science and clinical practice of rehabilitation robotics. The investigators hope to exploit variations in practice to learn about current clinical application and outcomes. The aim of this paper is to introduce the ARTIC network to the clinical and research community, present the initial data set and its characteristics and compare the outcome data collected so far with data from prior studies. Methods: ARTIC is a pragmatic observational study of clinical care. The database includes patients with various neurological and gait deficits who used the driven gait orthosis Lokomat (R) as part of their treatment. Patient characteristics, diagnosis-specific information, and indicators of impairment severity are collected. Core clinical assessments include the 10-Meter Walk Test and the Goal Attainment Scaling. Data from each Lokomat (R) training session are automatically collected. Results: At time of analysis, the database contained data collected from 595 patients (cerebral palsy: n = 208; stroke: n = 129; spinal cord injury: n = 93; traumatic brain injury: n = 39; and various other diagnoses: n = 126). At onset, average walking speeds were slow. The training intensity increased from the first to the final therapy session and most patients achieved their goals. Conclusions: The characteristics of the patients matched epidemiological data for the target populations. When patient characteristics differed from epidemiological data, this was mainly due to the selection criteria used to assess eligibility for Lokomat (R) training. While patients included in randomized controlled interventional trials have to fulfill many inclusion and exclusion criteria, the only selection criteria applying to patients in the ARTIC database are those required for use of the Lokomat (R). We suggest that the ARTIC network offers an opportunity to investigate the clinical application and effectiveness of rehabilitation technologies for various diagnoses. Due to the standardization of assessments and the use of a common technology, this network could serve as a basis for researchers interested in specific interventional studies expanding beyond the Lokomat (R).	[van Hedel, Hubertus J. A.; Meyer-Heim, Andreas; Graser, Judith] Univ Childrens Hosp Zurich, Rehabil Ctr Children & Adolescents, Muhlebergstr 104, CH-8910 Affoltern Am Albis, Switzerland; [Severini, Giacomo; Scarton, Alessandra; O'Brien, Anne; Bonato, Paolo] Harvard Med Sch, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Charlestown, MA USA; [Severini, Giacomo] Univ Coll Dublin, Dublin, Ireland; [Reed, Tamsin] Wellington Hosp, Acute Neurol Rehabil Unit, London, England; [Gaebler-Spira, Deborah; Egan, Tara] Shirley Ryan AbilityLab, Chicago, IL USA; [Chua, Karen] Tan Tock Seng Hosp Rehabil Ctr, Singapore, Singapore; [Zutter, Daniel; Schweinfurther, Raoul; Moller, J. Carsten; Paredes, Liliana P.] Rehaklin Zihlschlacht, Ctr Neurol Rehabil, Zihlschlacht, Switzerland; [Esquenazi, Alberto] MossRehab, Dept Phys Med & Rehabil, Philadelphia, PA USA; [Berweck, Steffen] Schon Klin Vogtareuth, Epilepsy Ctr Children & Adolescents, Clin Neuropediat & Neurol Rehabil, Vogtareuth, Germany; [Schroeder, Sebastian; Warken, Birgit] Ludwig Maximilians Univ Munchen, Hauner Childrens Hosp, Paediat Neurol Dev Med & Social Paediat, Munich, Germany; [Chan, Anne; Devers, Amber] Sheltering Arms Phys Rehabil Ctr, Richmond, VA USA; [Petioky, Jakub] Rehabil Ctr Kladruby, Kladruby, Czech Republic; [Paik, Nam-Jong; Kim, Won-Seok] Seoul Natl Univ, Bundang Hosp, Dept Rehabil Med, Seongnam, South Korea; [Boninger, Michael] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA USA; [Boninger, Michael] VA Pittsburgh Hlth Care Syst, Pittsburgh, PA USA		van Hedel, HJA (corresponding author), Univ Childrens Hosp Zurich, Rehabil Ctr Children & Adolescents, Muhlebergstr 104, CH-8910 Affoltern Am Albis, Switzerland.	hubertus.vanhedel@kispi.uzh.ch	Paik, Nam-Jong/D-5798-2012; /AAW-2804-2020; van Hedel, Hubertus/AAL-3818-2021; Berweck, Steffen/N-1422-2013; graser, judith/ABD-6346-2021; Bonato, Paolo/AAH-6111-2019; , 김원석/AAJ-2334-2020	Paik, Nam-Jong/0000-0002-5193-8678; /0000-0003-2619-765X; graser, judith/0000-0002-9921-8581; Bonato, Paolo/0000-0002-1818-1714; , 김원석/0000-0002-1199-5707; Boninger, Michael/0000-0001-6966-919X; Aurich (-Schuler), Tabea/0000-0002-1724-6846; Wee, Seng Kwee/0000-0002-5206-6269; Fabara, Eric/0000-0001-9983-0474; Severini, Giacomo/0000-0002-2289-9331; van Hedel, Hubertus/0000-0002-9577-5049	Hocoma AG, Volketswil, Switzerland; Swiss Foundation for Children with Cerebral Palsy; Maxi-Foundation	Funding for meetings in person has been financed by institutional or third party money of each network member. Hocoma AG, Volketswil, Switzerland (company) currently supports this network by means of financial support for programming the database and online meetings. Hocoma also provided personnel resources to aid communication between network members. Grants were obtained from the Swiss Foundation for Children with Cerebral Palsy and the Maxi-Foundation to further develop the database.	Alcobendas-Maestro M, 2012, NEUROREHAB NEURAL RE, V26, P1058, DOI 10.1177/1545968312448232; Arnao V, 2016, INT J STROKE, V11, P287, DOI 10.1177/1747493016632245; Aurich T, 2015, NEUROPEDIATRICS, V46, P248, DOI 10.1055/s-0035-1550150; Aurich-Schuler T, 2017, J NEUROENG REHABIL, V14, DOI 10.1186/s12984-017-0287-1; Bang DH, 2016, NEUROREHABILITATION, V38, P343, DOI 10.3233/NRE-161325; Bax M, 2005, DEV MED CHILD NEUROL, V47, P571, DOI 10.1017/S001216220500112X; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Bouwens SFM, 2009, CLIN REHABIL, V23, P310, DOI 10.1177/0269215508101744; Boyd LA, 2017, INT J STROKE, V12, P480, DOI 10.1177/1747493017714176; Brutsch K, 2011, J REHABIL MED, V43, P493, DOI 10.2340/16501977-0802; Center NSCIS, 2016, COMPL PUBL VERS 2016; Christensen D, 2014, DEV MED CHILD NEUROL, V56, P59, DOI 10.1111/dmcn.12268; Colombo G, 2001, SPINAL CORD, V39, P252, DOI 10.1038/sj.sc.3101154; Curt A, 2004, SPINAL CORD, V42, P1, DOI 10.1038/sj.sc.3101558; Dorenkamp S, 2015, FRONT PUBLIC HEALTH, V3, DOI 10.3389/fpubh.2015.00067; Druzbicki M, 2013, J REHABIL MED, V45, P358, DOI 10.2340/16501977-1114; Esclarin-Ruz A, 2014, ARCH PHYS MED REHAB, V95, P1023, DOI 10.1016/j.apmr.2013.12.017; Esquenazi A, 2013, PM&R, V5, P280, DOI 10.1016/j.pmrj.2012.10.009; Faul M, 2010, TRAUMATIC BRAIN INJU; Feigin VL, 2015, NEUROEPIDEMIOLOGY, V45, P161, DOI 10.1159/000441085; Field-Fote EC, 2011, PHYS THER, V91, P48, DOI 10.2522/ptj.20090359; Gandhi P, 2017, J NEUROTRAUM, V34, P1713, DOI 10.1089/neu.2016.4501; Graser JV, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0538-y; Gregson JM, 2000, AGE AGEING, V29, P223, DOI 10.1093/ageing/29.3.223; Hidler J, 2009, NEUROREHAB NEURAL RE, V23, P5, DOI 10.1177/1545968308326632; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1136/bmj.g1687, 10.1055/s-0041-111066]; Hurn J, 2006, CLIN REHABIL, V20, P756, DOI 10.1177/0269215506070793; Husemann B, 2007, STROKE, V38, P349, DOI 10.1161/01.STR.0000254607.48765.cb; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Kelley CP, 2013, DISABIL REHABIL-ASSI, V8, P161, DOI 10.3109/17483107.2012.714052; KIRESUK TJ, 1968, COMMUNITY MENT HLT J, V4, P443, DOI 10.1007/BF01530764; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Labruyere R, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-4; Labruyere R, 2013, RES DEV DISABIL, V34, P3906, DOI 10.1016/j.ridd.2013.07.031; Lam T, 2015, J REHABIL RES DEV, V52, P113, DOI 10.1682/JRRD.2014.03.0090; Mayr A, 2007, NEUROREHAB NEURAL RE, V21, P307, DOI 10.1177/1545968307300697; Mehrholz J, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006185.pub4; Mehrholz J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006876.pub4; Mehrholz J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006676.pub3; MSALL ME, 1994, CLIN PEDIATR, V33, P421, DOI 10.1177/000992289403300708; Ornstein SM, 2013, J AM BOARD FAM MED, V26, P518, DOI 10.3122/jabfm.2013.05.130012; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Rossier P, 2001, ARCH PHYS MED REHAB, V82, P9, DOI 10.1053/apmr.2001.9396; Salbach NM, 2001, ARCH PHYS MED REHAB, V82, P1204, DOI 10.1053/apmr.2001.24907; Schuler TA, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-78; Schwartz I, 2009, PM&R, V1, P516, DOI 10.1016/j.pmrj.2009.03.009; Sellier E, 2010, EUR J EPIDEMIOL, V25, P635, DOI 10.1007/s10654-010-9474-0; Steenbeek D, 2005, CLIN REHABIL, V19, P274, DOI 10.1191/0269215505cr859oa; Steenbeek D, 2007, DEV MED CHILD NEUROL, V49, P550, DOI 10.1111/j.1469-8749.2007.00550.x; Steenbeek D, 2010, ARCH PHYS MED REHAB, V91, P429, DOI 10.1016/j.apmr.2009.10.013; Swinnen E, 2014, TOP STROKE REHABIL, V21, P87, DOI 10.1310/tsr2102-87; Swinnen E, 2012, MULT SCLER INT, V2012, DOI 10.1155/2012/240274; Swinnen E, 2010, J REHABIL MED, V42, P520, DOI 10.2340/16501977-0538; Tollanes MC, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012777; Traumatic Brain Injury Model Systems National Data and Statistical Center, 2016, NAT DAT 2016 PROF PE; van Hedel H, 2006, SPINAL CORD, V44, P352, DOI 10.1038/sj.sc.3101853; van Hedel HJ, 2005, ARCH PHYS MED REHAB, V86, P190, DOI 10.1016/j.apmr.2004.02.010; van Hedel HJA, 2009, NEUROREHAB NEURAL RE, V23, P343, DOI 10.1177/1545968308324224; van Kammen K, 2016, CLIN BIOMECH, V36, P65, DOI 10.1016/j.clinbiomech.2016.04.013; van Nunen MPM, 2015, DISABIL REHABIL-ASSI, V10, P141, DOI 10.3109/17483107.2013.873489; Veerbeek JM., 2014, KNGF CLIN PRACTICE G; WADE DT, 1987, SCAND J REHABIL MED, V19, P25; Wallard L, 2017, EUR J PAEDIATR NEURO, V21, P557, DOI 10.1016/j.ejpn.2017.01.012; Westlake KP, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-18; Whiteneck G, 2009, J SPINAL CORD MED, V32, P249; Wirz M, 2017, J NEUROTRAUM, V34, P1891, DOI 10.1089/neu.2016.4643	66	17	17	2	15	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1743-0003		J NEUROENG REHABIL	J. NeuroEng. Rehabil.	APR 6	2018	15								30	10.1186/s12984-018-0366-y			16	Engineering, Biomedical; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Engineering; Neurosciences & Neurology; Rehabilitation	GC7WD	WOS:000430003200001	29625628	Green Accepted, Green Published, gold			2022-02-06	
J	Ambaw, A; Zheng, LX; Tambe, MA; Strathearn, KE; Acosta, G; Hubers, SA; Liu, F; Herr, SA; Tang, J; Truong, A; Walls, E; Pond, A; Rochet, JC; Shi, RY				Ambaw, Abeje; Zheng, Lingxing; Tambe, Mitali A.; Strathearn, Katherine E.; Acosta, Glen; Hubers, Scott A.; Liu, Fang; Herr, Seth A.; Tang, Jonathan; Truong, Alan; Walls, Elwood; Pond, Amber; Rochet, Jean-Christophe; Shi, Riyi			Acrolein-mediated neuronal cell death and alpha-synuclein aggregation: Implications for Parkinson's disease	MOLECULAR AND CELLULAR NEUROSCIENCE			English	Article						Oxidative stress; 3-HPMA; Aldehyde; Inflammation; Lipid peroxidation	SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; ALZHEIMERS-DISEASE; LIPID-PEROXIDATION; SUBSTANTIA-NIGRA; MYELIN DAMAGE; LEWY BODIES; PC12 CELLS; HYDRALAZINE	Growing evidence suggests that oxidative stress plays a critical role in neuronal destruction characteristic of Parkinson's disease (PD). However, the molecular mechanisms of oxidative stress-mediated dopaminergic cell death are far from clear. In the current investigation, we tested the hypothesis that acrolein, an oxidative stress and lipid peroxidation (LPO) product, is a key factor in the pathogenesis of PD. Using a combination of in vitro, in vivo, and cell free models, coupled with anatomical, functional, and behavioral examination, we found that acrolein was elevated in 6-OHDA-injected rats, and behavioral deficits associated with 6-OHDA could be mitigated by the application of the acrolein scavenger hydralazine, and mimicked by injection of acrolein in healthy rats. Furthermore, hydralazine alleviated neuronal cell death elicited by 6-OHDA and another PD-related toxin, rotenone, in vitro. We also show that acrolein can promote the aggregation of alpha-synuclein, suggesting that alpha-synuclein self-assembly, a key pathological phenomenon in human PD, could play a role in neurotoxic effects of acrolein in PD models. These studies suggest that acrolein is involved in the pathogenesis of PD, and the administration of anti-acrolein scavengers such as hydralazine could represent a novel strategy to alleviate tissue damage and motor deficits associated with this disease.	[Ambaw, Abeje; Zheng, Lingxing; Acosta, Glen; Herr, Seth A.; Tang, Jonathan; Walls, Elwood; Pond, Amber; Shi, Riyi] Purdue Univ, Sch Vet Med, Dept Basic Med Sci, W Lafayette, IN 47907 USA; [Tang, Jonathan; Truong, Alan; Shi, Riyi] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Tambe, Mitali A.; Strathearn, Katherine E.; Hubers, Scott A.; Liu, Fang; Rochet, Jean-Christophe] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; [Herr, Seth A.] Purdue Univ, Interdisciplinary Life Sci Program PULSe, W Lafayette, IN 47907 USA		Shi, RY (corresponding author), Purdue Univ, Weldon Sch Biomed Engn, Dept Basic Med Sci, W Lafayette, IN 47907 USA.	riyi@purdue.edu		Rochet, Jean-Christophe/0000-0002-6484-1541; Tambe, Mitali/0000-0001-9389-2308	Indiana State Department of Health [204200]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS073636, NS049221]; Bradman Family Foundation; National Institutes of Health, National Center for Advancing Translational Sciences [UL1TR001108]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS049221, R01NS073636] Funding Source: NIH RePORTER	This work was supported by the Indiana State Department of Health (Grant # 204200 to RS), National Institutes of Health (R01 grant # NS073636 to RS, and R01 grant # NS049221 and a grant from the Bradman Family Foundation to J.-C. R.). This publication was also made possible by the Stark Neurosciences Research Institute, Eli Lilly and Company, and by the Indiana Clinical and Translational Sciences Institute, funded in part by grant # UL1TR001108 from the National Institutes of Health, National Center for Advancing Translational Sciences.	Ayton S, 2013, NEUROSCI LETT, V543, P105, DOI 10.1016/j.neulet.2013.02.066; Bramlett HM, 2003, EXP NEUROL, V184, P27, DOI 10.1016/S0014-4886(03)00401-1; BROCK N, 1979, ARZNEIMITTEL-FORSCH, V29-1, P659; Burcham PC, 2000, REDOX REP, V5, P47, DOI 10.1179/rer.2000.5.1.47; Burcham PC, 2006, MOL PHARMACOL, V69, P1056, DOI 10.1124/mol.105.018168; Burcham PC, 2017, CHEM RES TOXICOL, V30, P145, DOI 10.1021/acs.chemrestox.6b00310; Cai J, 2009, CHEM RES TOXICOL, V22, P708, DOI 10.1021/tx800465m; Calingasan NY, 1999, J NEUROCHEM, V72, P751, DOI 10.1046/j.1471-4159.1999.0720751.x; Carley DW, 1997, J APPL PHYSIOL, V83, P1954, DOI 10.1152/jappl.1997.83.6.1954; Chi YC, 2014, J BIOL CHEM, V289, P15474, DOI 10.1074/jbc.M113.544049; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; CRAWFORD GD, 1992, J NEUROSCI, V12, P3392; Daiber A, 2005, BIOCHEM BIOPH RES CO, V338, P1865, DOI 10.1016/j.bbrc.2005.10.106; Daimon M, 2003, ENDOCR J, V50, P61, DOI 10.1507/endocrj.50.61; Decressac M, 2012, EXP NEUROL, V235, P306, DOI 10.1016/j.expneurol.2012.02.012; Due MR, 2014, J NEUROCHEM, V128, P776, DOI 10.1111/jnc.12500; Eckert E, 2010, J CHROMATOGR B, V878, P2506, DOI 10.1016/j.jchromb.2009.09.003; Eller M, 2011, CLIN CHEM LAB MED, V49, P403, DOI 10.1515/CCLM.2011.077; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Feng ZH, 2006, P NATL ACAD SCI USA, V103, P15404, DOI 10.1073/pnas.0607031103; Ghilarducci DP, 1995, REV ENVIRON CONTAM T, V144, P95; Goldman SM, 2012, ANN NEUROL, V71, P40, DOI 10.1002/ana.22499; Hamann K, 2008, J NEUROCHEM, V107, P712, DOI 10.1111/j.1471-4159.2008.05622.x; Hamann K, 2008, J NEUROCHEM, V104, P708, DOI 10.1111/j.1471-4159.2007.05002.x; Hamann K, 2009, J NEUROCHEM, V111, P1348, DOI 10.1111/j.1471-4159.2009.06395.x; Henchcliffe C, 2008, NAT CLIN PRACT NEURO, V4, P600, DOI 10.1038/ncpneuro0924; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; JONES BJ, 1968, J PHARM PHARMACOL, V20, P302, DOI 10.1111/j.2042-7158.1968.tb09743.x; Kalia LV, 2013, ANN NEUROL, V73, P155, DOI 10.1002/ana.23746; Kehrer JP, 2000, TOXICOL SCI, V57, P6, DOI 10.1093/toxsci/57.1.6; Khalaf O, 2014, J BIOL CHEM, V289, P21856, DOI 10.1074/jbc.M114.553297; Koob AO, 2006, J NEUROSCI METH, V157, P330, DOI 10.1016/j.jneumeth.2006.04.020; Leung G, 2011, NEUROSCIENCE, V173, P150, DOI 10.1016/j.neuroscience.2010.11.018; Liu F, 2008, FREE RADICAL BIO MED, V45, P242, DOI 10.1016/j.freeradbiomed.2008.03.022; Liu F, 2008, J NEUROCHEM, V105, P2435, DOI 10.1111/j.1471-4159.2008.05333.x; Liu-Snyder P, 2006, J NEUROSCI RES, V84, P209, DOI 10.1002/jnr.20863; Liu-Snyder P, 2006, J NEUROSCI RES, V84, P219, DOI 10.1002/jnr.20862; Lovell MA, 2001, NEUROBIOL AGING, V22, P187, DOI 10.1016/S0197-4580(00)00235-9; Luo H, 2004, NEUROCHEM INT, V44, P475, DOI 10.1016/j.neuint.2003.09.006; Luo J, 2005, NEUROCHEM INT, V46, P243, DOI 10.1016/j.neuint.2004.09.001; Luo J, 2005, NEUROCHEM INT, V47, P449, DOI 10.1016/j.neuint.2005.07.002; Luo J, 2005, NEUROCHEM RES, V30, P291, DOI 10.1007/s11064-005-2602-7; LYLES GA, 1983, BIOCHEM PHARMACOL, V32, P2515, DOI 10.1016/0006-2952(83)90012-6; McNaught KSP, 2002, EUR J NEUROSCI, V16, P2136, DOI 10.1046/j.1460-9568.2002.02301.x; Montine TJ, 2002, FREE RADICAL BIO MED, V33, P620, DOI 10.1016/S0891-5849(02)00807-9; Muqit MMK, 2004, HUM MOL GENET, V13, P117, DOI 10.1093/hmg/ddh012; Newell KL, 1999, J NEUROPATH EXP NEUR, V58, P1263, DOI 10.1097/00005072-199912000-00007; Norris EH, 2003, J BIOL CHEM, V278, P27230, DOI 10.1074/jbc.M212436200; Park J, 2014, J NEUROCHEM, V129, P339, DOI 10.1111/jnc.12628; Przedborski S, 2005, PARKINSONISM RELAT D, V11, pS3, DOI 10.1016/j.parkreldis.2004.10.012; Recasens A, 2014, ANN NEUROL, V75, P351, DOI 10.1002/ana.24066; Rochet JC, 2000, BIOCHEMISTRY-US, V39, P10619, DOI 10.1021/bi001315u; Rochet JC, 2012, PROG MOL BIOL TRANSL, V107, P125, DOI 10.1016/B978-0-12-385883-2.00011-4; Rutherford NJ, 2014, J NEUROCHEM, V131, P859, DOI 10.1111/jnc.12806; Schapira AHV, 2009, NEUROL CLIN, V27, P583, DOI 10.1016/j.ncl.2009.04.004; Schober A, 2004, CELL TISSUE RES, V318, P215, DOI 10.1007/s00441-004-0938-y; Shamoto-Nagai M, 2007, J NEURAL TRANSM, V114, P1559, DOI 10.1007/s00702-007-0789-2; Shi R, 2002, NEUROSCIENCE, V115, P337, DOI 10.1016/S0306-4522(02)00457-8; Shi R., 2006, APPL NEUROL, V2, P22; Shi RY, 2011, MOL NUTR FOOD RES, V55, P1320, DOI 10.1002/mnfr.201100217; Shi YZ, 2011, J NEUROCHEM, V117, P554, DOI 10.1111/j.1471-4159.2011.07226.x; Stevens JF, 2008, MOL NUTR FOOD RES, V52, P7, DOI 10.1002/mnfr.200700412; Strathearn KE, 2014, BRAIN RES, V1555, P60, DOI 10.1016/j.brainres.2014.01.047; Takalo Mari, 2013, Am J Neurodegener Dis, V2, P1; Tamamizu-Kato S, 2007, BIOCHEMISTRY-US, V46, P8392, DOI 10.1021/bi700289k; Trojanowski JQ, 1998, ARCH NEUROL-CHICAGO, V55, P151, DOI 10.1001/archneur.55.2.151; Tully M, 2013, INT J MOL SCI, V14, P20037, DOI 10.3390/ijms141020037; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Wigley WC, 1999, J CELL BIOL, V145, P481; Zarbiv Y, 2014, NEUROBIOL DIS, V70, P90, DOI 10.1016/j.nbd.2014.05.031; Zhang HY, 2013, BIOPHYS J, V104, P2706, DOI 10.1016/j.bpj.2013.04.050; Zheng J, 2010, FREE RADICAL RES, V44, P258, DOI 10.3109/10715760903456092; Zheng LX, 2013, J NEUROTRAUM, V30, P1334, DOI 10.1089/neu.2013.2888	75	17	18	1	14	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1044-7431	1095-9327		MOL CELL NEUROSCI	Mol. Cell. Neurosci.	APR	2018	88						70	82		10.1016/j.mcn.2018.01.006			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GE3ET	WOS:000431097300008	29414104				2022-02-06	
J	Fuller, GW; Govind, O; Tucker, R; Raftery, M				Fuller, G. W.; Govind, O.; Tucker, R.; Raftery, M.			Sport concussion assessment tool-Third edition normative reference values for professional Rugby Union players	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Brain concussion; SCAT3; Rugby; Normative values	BASE-LINE VALUES; EPIDEMIOLOGY; STATEMENT	Objectives: To establish normative reference data for the SCAT3 in professional Rugby Union players. Design: A cross sectional study in professional Rugby Union players competing in national and international professional competitions between 2015 and 2016. Methods: The SCAT3 was administered pre-season or prior to tournaments. Data was collected electronically using a custom tablet application. SCAT3 subcomponents distributions were described and normative ranges determined using percentile cut-offs for average, unusually low/high, and extremely low/high scores. The association between player characteristics and performance in SCAT3 subcomponents was also investigated in exploratory analyses. Results: A total of 3611 professional Rugby Union players were included. The most common baseline symptom was fatigue (14%). The symptom score median (md) was 0 (interquartile range (IQR) = 0-1). Symptom severity md was 0 (IQR = 0-1). The md of the SAC score was 28 (IQR = 26-29). The md of the MBESS was 2 (IQR = 0-4). The Tandem gait md was 11.1 s (IQR = 10.0-12.7 s). Upper limb coordination was normal in 98.4%. Younger age and lower educational level were associated with worse performance on delayed recall and reverse month sub-components of the SCAT3 (p < 0.0001). No statistically significant differences in SCAT3 subcomponents were evident across gender. Conclusions: Representative normative reference values for the SCAT3 among professional Rugby Union players are provided. Baseline performance on concentration and delayed recall tests may be lower in younger athletes or in those with lower educational level. (C) 2017 Published by Elsevier Ltd on behalf of Sports Medicine Australia.	[Fuller, G. W.] Univ Sheffield, Sch Hlth & Related Res, Ctr Urgent & Emergency Care Res, Sheffield, S Yorkshire, England; [Govind, O.] Univ Manchester, Humanitarian & Conflict Response Inst, Manchester, Lancs, England; [Tucker, R.; Raftery, M.] World Rugby, World Rugby House, Dublin, Ireland		Fuller, GW (corresponding author), Univ Sheffield, Sch Hlth & Related Res, Ctr Urgent & Emergency Care Res, Sheffield, S Yorkshire, England.	g.fuller@sheffield.ac.uk		Fuller, Gordon Ward/0000-0001-8532-3500	World Rugby; National Institute for Health ResearchNational Institute for Health Research (NIHR) [ACF-2015-06-015, CL-2015-04-005] Funding Source: researchfish	Data collection was funded by World Rugby. There was no influence of any sponsor in study design, data collection, analysis, interpretation of data, writing of the report, or the decision to submit the paper for publication. We would like to acknowledge the assistance of team doctors and physicians performing the SCAT3 assessments.	[Anonymous], 2013, Br J Sports Med, V47, P259; Brooks A, 2014, BR J SPORTS MED, V48, P573, DOI DOI 10.1136/BJSPORTS-2014-093494.38; Clay MB, 2013, J CHIROPR MED, V12, P230, DOI 10.1016/j.jcm.2012.11.005; Cross M, 2016, BRIT J SPORT MED, V50, P926, DOI 10.1136/bjsports-2015-094982; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Fuller CW, 2016, BJSM, V51, P64; Hanninen T, 2017, J SCI MED SPORT, V20, P424, DOI 10.1016/j.jsams.2016.09.009; Harrison AG, 2014, ARCH CLIN NEUROPSYCH, V29, P737, DOI 10.1093/arclin/acu048; Helmy A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5748; Jinguji TM, 2012, BRIT J SPORT MED, V46, P365, DOI 10.1136/bjsports-2011-090526; McCrea HJ, 2013, SPORTS HEALTH, V5, P160, DOI 10.1177/1941738112462203; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; Meeuwisse WH, 2017, BRIT J SPORT MED, DOI [10.1136/13jsports-2017-097569, DOI 10.1136/13JSPORTS-2017-097569.]; O'Connor P J, 1990, Fam Med, V22, P307; Programme UND, ED IND; Schuessler AA, 1999, P NATL ACAD SCI USA, V96, P10578, DOI 10.1073/pnas.96.19.10578; Snedden TR, 2016, CLIN J SPORT MED; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Yengo-Kahn AM, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15611	20	17	17	3	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	APR	2018	21	4					347	351		10.1016/j.jsams.2017.07.025			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	GB5DL	WOS:000429082500005	28843846	Green Accepted			2022-02-06	
J	Lin, L; Wang, QZ; Qian, K; Cao, ZY; Xiao, J; Wang, XY; Li, XK; Yu, ZY				Lin, Li; Wang, Qingzhi; Qian, Kenny; Cao, Zeyuan; Xiao, Jian; Wang, Xiaoying; Li, Xiaokun; Yu, Zhanyang			bFGF Protects Against Oxygen Glucose Deprivation/Reoxygenation-Induced Endothelial Monolayer Permeability via S1PR1-Dependent Mechanisms	MOLECULAR NEUROBIOLOGY			English	Article						Basic fibroblast growth factor (bFGF); Endothelial cell monolayer permeability; Oxygen-glucose deprivation and reoxygenation (OGD/R); Junction protein; FGF receptor 1 (FGFR1); Sphingosine-1-phosphate receptor 1 (S1PR1)	BLOOD-BRAIN-BARRIER; FIBROBLAST-GROWTH-FACTOR; FOCAL CEREBRAL INFARCTION; CENTRAL-NERVOUS-SYSTEM; FUNCTIONAL RECOVERY; STROKE; INJURY; DYSFUNCTION; INTEGRITY; HEPARIN	Blood-brain barrier (BBB) disruption is a common pathological feature of many neurological disorders including stroke and brain trauma, therefore is an important therapeutic target for treatment of these diseases. Basic fibroblast growth factor (bFGF) as a member of FGF superfamily plays critical roles in angiogenesis, neurogenesis, and neuron survival. We recently showed that recombinant bFGF protects against BBB disruption in traumatic brain injury in mice. In this study, we further investigated the mechanisms of recombinant bFGF in BBB protection by measuring the permeability of cultured endothelial cell monolayer induced by oxygen-glucose deprivation and reoxygenation (OGD/R). We found that recombinant bFGF significantly decreased OGD/R-induced permeability of primary human brain microvascular endothelial cell (HBMEC) monolayer and preserved OGD/R-induced decreases of trans-endothelial electrical resistance (TEER). Western blot and immunocytochemistry showed that bFGF significantly rescued OGD/R-induced downregulation of junction proteins ZO-1, occludin, and VE-cadherin. We further show that the BBB protective effect of bFGF is via FGF receptor 1 (FGFR1) activation as FGFR1 inhibitor can block this protection effect. Moreover, we revealed that the BBB protection effect of bFGF is at least partially through rescuing the OGD/R-induced downregulation of sphingosine-1- phosphate receptor 1 (S1PR1) protein, as S1PR1 inhibitor or SIPR1 small interfering RNA blocked the BBB protective effect of bFGF, whereas S1PR1 agonist alone has comparable BBB protection effect of bFGF. These findings will improve our understanding of the protective effect and mechanisms of bFGF on BBB and propose bFGF as a potential therapeutic agent against BBB damage in neurological disorders.	[Lin, Li; Xiao, Jian; Li, Xiaokun] Wenzhou Med Univ, Sch Pharmaceut Sci, Key Lab Biotechnol & Pharmaceut Engn, Wenzhou 325035, Zhejiang, Peoples R China; [Lin, Li; Wang, Qingzhi; Qian, Kenny; Cao, Zeyuan; Wang, Xiaoying; Yu, Zhanyang] Massachusetts Gen Hosp, Dept Radiol, Neuroprotect Res Lab, 149 13th St,Room 2401, Charlestown, MA 02129 USA; [Lin, Li; Wang, Qingzhi; Qian, Kenny; Cao, Zeyuan; Wang, Xiaoying; Yu, Zhanyang] Massachusetts Gen Hosp, Dept Neurol, Neuroprotect Res Lab, 149 13th St,Room 2401, Charlestown, MA 02129 USA; [Lin, Li; Wang, Qingzhi; Qian, Kenny; Cao, Zeyuan; Wang, Xiaoying; Yu, Zhanyang] Harvard Med Sch, 149 13th St,Room 2401, Charlestown, MA 02129 USA; [Wang, Qingzhi] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou 450000, Henan, Peoples R China		Li, XK (corresponding author), Wenzhou Med Univ, Sch Pharmaceut Sci, Key Lab Biotechnol & Pharmaceut Engn, Wenzhou 325035, Zhejiang, Peoples R China.; Yu, ZY (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Neuroprotect Res Lab, 149 13th St,Room 2401, Charlestown, MA 02129 USA.; Yu, ZY (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Neuroprotect Res Lab, 149 13th St,Room 2401, Charlestown, MA 02129 USA.; Yu, ZY (corresponding author), Harvard Med Sch, 149 13th St,Room 2401, Charlestown, MA 02129 USA.	linliwz@hotmail.com; qwang15@mgh.harvard.edu; keninqian2018@u.northwestern.edu; caozeyuan1230@126.com; xfxj2000@126.com; wangxi@helix.mgh.harvard.edu; xiaokunli@163.net; Yu.Zhanyang@mgh.harvard.edu		Qian, Kenin/0000-0003-0296-6207	AHA Scientist Development Grant (SDG) [15SDG25550035]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81470999]	This study was in part supported by the National Natural Science Foundation of China 81470999 (X. L.) and AHA Scientist Development Grant (SDG) 15SDG25550035 (Z.Y.).	Abe K, 2001, PHARMACOL RES, V43, P307, DOI 10.1006/phrs.2000.0794; Alluri H, 2015, METAB BRAIN DIS, V30, P1093, DOI 10.1007/s11011-015-9651-7; Ephstein Y, 2013, J BIOL CHEM, V288, P2191, DOI 10.1074/jbc.M112.404780; Faham S, 1996, SCIENCE, V271, P1116, DOI 10.1126/science.271.5252.1116; Feistritzer C, 2005, BLOOD, V105, P3178, DOI 10.1182/blood-2004-10-3985; Fernandez-Lopez D, 2012, J NEUROSCI, V32, P9588, DOI 10.1523/JNEUROSCI.5977-11.2012; Ford-Perriss M, 2001, CLIN EXP PHARMACOL P, V28, P493, DOI 10.1046/j.1440-1681.2001.03477.x; Gaengel K, 2012, DEV CELL, V23, P587, DOI 10.1016/j.devcel.2012.08.005; Jin R, 2010, NEUROBIOL DIS, V38, P376, DOI 10.1016/j.nbd.2010.03.008; Kassner A, 2015, STROKE, V46, P3310, DOI 10.1161/STROKEAHA.115.008861; Kawamata T, 1996, J CEREBR BLOOD F MET, V16, P542, DOI 10.1097/00004647-199607000-00003; Kawamata T, 1997, P NATL ACAD SCI USA, V94, P8179, DOI 10.1073/pnas.94.15.8179; Khatri R, 2012, NEUROLOGY, V79, pS52, DOI 10.1212/WNL.0b013e3182697e70; Matakidou A, 2007, BRIT J CANCER, V96, P1904, DOI 10.1038/sj.bjc.6603816; Nacer A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002982; Nugent MA, 2000, INT J BIOCHEM CELL B, V32, P115, DOI 10.1016/S1357-2725(99)00123-5; Prakash R, 2015, CURR OPIN NEUROL, V28, P556, DOI 10.1097/WCO.0000000000000248; Raballo R, 2000, J NEUROSCI, V20, P5012; Rosen L, 2000, Oncologist, V5 Suppl 1, P20; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Singh S, 2016, KIDNEY INT, V90, P985, DOI 10.1016/j.kint.2016.05.019; Stamatovic SM, 2016, TISSUE BARRIERS, V4, DOI 10.1080/21688370.2016.1154641; Sun N, 2016, STROKE, V47, P1899, DOI 10.1161/STROKEAHA.115.012236; Wang Z, 2015, ADV MATER SCI ENG, V2015, DOI 10.1155/2015/165631; Weiss N, 2009, BBA-BIOMEMBRANES, V1788, P842, DOI 10.1016/j.bbamem.2008.10.022; Xuan YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108182; Ye LB, 2016, NEUROTHERAPEUTICS, V13, P844, DOI 10.1007/s13311-016-0437-3; Zhao Z, 2015, CELL, V163, P1064, DOI 10.1016/j.cell.2015.10.067; Zuo SL, 2017, MOL NEUROBIOL, V54, P1213, DOI 10.1007/s12035-016-9732-6	29	17	19	1	15	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	APR	2018	55	4					3131	3142		10.1007/s12035-017-0544-0			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FY8EX	WOS:000427097500033	28466272				2022-02-06	
J	Shi, XD; Bai, YA; Zhang, GD; Liu, YG; Xiao, H; Liu, XG; Zhang, W				Shi, Xiaodong; Bai, Yunan; Zhang, Guodong; Liu, Yuguang; Xiao, Hang; Liu, Xiaogang; Zhang, Wei			Effects of over-expression of SOD2 in bone marrow-derived mesenchymal stem cells on traumatic brain injury	CELL AND TISSUE RESEARCH			English	Article						Traumatic brain injury (TBI); Mesenchymal stem cell (MSC); Superoxide dismutase 2 (SOD2); Oxidative stress; Antioxidant	OXIDATIVE STRESS; STROMAL CELLS; PHASE-I; THERAPY; DISEASE; CANCER; OVEREXPRESSION; IMPACT; RAT	Intravenous administration of bone marrow-derived mesenchymal stem cells (BM-MSCs) has been shown to promote nerve cell regeneration following traumatic brain injury (TBI). As the anti-oxidant defense systems in neuronal tissue including superoxide dismutase 2 (SOD2) are crucial to defend cell against oxidative stress. We proposed a new stratege to increase the therapeutic effect of MSCs by preventing cells death from oxidative stress. We overexpressed SOD2 in BM-MSCs, transplanted these MSCs into TBI model mice, assessed the protective effect of SOD2 against oxidation-induced apoptosis in BM-MSCs both in vitro and in vivo, evaluated brain functional recovery by the rotarod behavioral test, and tested the oxidation status of TBI mice brain after BM-MSCs transplantation by monitoring the superoxide dismutase, glutathione and malonaldehyde level. We found over-expression of SOD2 protected BM-MSCs from H2O2-induced cell apoptosis. Injection of SOD2 over-expressed BM-MSCs attenuated neuro-inflammation in the ipsilateral cortex of TBI mice, and protected TBI mice against loss of blood-brain barrier integrity. Furthermore, the rotarod behavioral test showed functional recovery of TBI mice after MSC treatment. Our experiments indicated that SOD2-over-expressed BM-MSCs have an improved therapeutic effect on brain injury treatment in TBI mice.	[Shi, Xiaodong; Liu, Yuguang; Zhang, Wei] Qilu Hosp, Wenhuaxi Rd, Jinan 250014, Shandong, Peoples R China; [Shi, Xiaodong; Bai, Yunan; Zhang, Guodong; Xiao, Hang; Liu, Xiaogang] Weifang Yidu Cent Hosp, Dept Neurosurg, 4138 Linglongshan Rd, Qingzhou 262500, Shandong, Peoples R China		Liu, YG (corresponding author), Qilu Hosp, Wenhuaxi Rd, Jinan 250014, Shandong, Peoples R China.; Bai, YA (corresponding author), Weifang Yidu Cent Hosp, Dept Neurosurg, 4138 Linglongshan Rd, Qingzhou 262500, Shandong, Peoples R China.	baiyunanydzx@sina.com; liuyuguangsddx@163.com			Medical and Healthy Technology Development Program of Shandong Province [2015WS0069]	This work was supported by Medical and Healthy Technology Development Program of Shandong Province (2015WS0069).	Abdi R, 2008, DIABETES, V57, P1759, DOI 10.2337/db08-0180; Barman A, 2016, INDIAN J PSYCHOL MED, V38, P172, DOI 10.4103/0253-7176.183086; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Gavioli M, 2005, DIS COLON RECTUM, V48, P1851, DOI 10.1007/s10350-005-0133-6; Hasan A, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00028; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Hynes K, 2016, SEMIN ARTHRITIS RHEU, V46, P1, DOI 10.1016/j.semarthrit.2016.02.008; Ikebe C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/951512; LAZARUS HM, 1995, BONE MARROW TRANSPL, V15, P935; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Meseguer-Olmo L, 2017, NUCL MED BIOL, V46, P36, DOI 10.1016/j.nucmedbio.2016.12.003; Moghadasali R, 2013, EXP TOXICOL PATHOL, V65, P595, DOI 10.1016/j.etp.2012.06.002; Nargesi AA, 2017, CURR GENE THER, V17, P29, DOI 10.2174/1566523217666170412110724; Peired AJ, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/4798639; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Rooney GE, 2008, TISSUE ENG PT A, V14, P681, DOI 10.1089/tea.2007.0260; Salehi H, 2017, ANN ANAT, V210, P52, DOI 10.1016/j.aanat.2016.11.010; Sevivas N, 2017, AM J SPORT MED, V45, P179, DOI 10.1177/0363546516657827; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Tseng WL, 2017, CELL TRANSPLANT, V26, P513, DOI 10.3727/096368916X694265; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Wang SH, 2016, CURR MOL PHARMACOL, V9, P289, DOI 10.2174/1874467208666150928153758; Xu LJ, 2010, GLIA, V58, P1042, DOI 10.1002/glia.20985; Yi HG, 2016, KOREAN J PHYSIOL PHA, V20, P63, DOI 10.4196/kjpp.2016.20.1.63; Yuan J, 2016, BRAIN RES BULL, V127, P171, DOI 10.1016/j.brainresbull.2016.09.010; Zhang XM, 2016, AM J TRANSL RES, V8, P4017; Zhang ZQ, 2017, ONCOTARGET, V8, P7791, DOI 10.18632/oncotarget.13954; Zhao YH, 2016, STEM CELLS, V34, P1263, DOI 10.1002/stem.2310	30	17	19	3	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0302-766X	1432-0878		CELL TISSUE RES	Cell Tissue Res.	APR	2018	372	1					67	75		10.1007/s00441-017-2716-7			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	GA0ZM	WOS:000428044400007	29082445				2022-02-06	
J	Vallat-Azouvi, C; Paillat, C; Bercovici, S; Morin, B; Paquereau, J; Charanton, J; Ghout, I; Azouvi, P				Vallat-Azouvi, Claire; Paillat, Cyrille; Bercovici, Stephanie; Morin, Benedicte; Paquereau, Julie; Charanton, James; Ghout, Idir; Azouvi, Philippe			Subjective complaints after acquired brain injury: presentation of the Brain Injury Complaint Questionnaire (BICoQ)	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						awareness; cognitive impairment; traumatic brain injury	QUALITY-OF-LIFE; HEAD-INJURY; AWARENESS; SCALE; MILD; DISABILITY; DEPRESSION; VALIDITY; OUTCOMES; FATIGUE	The objective of the present study was to present a new complaint questionnaire designed to assess a wide range of difficulties commonly reported by patients with acquired brain injury. Patients (n = 619) had been referred to a community re-entry service at a chronic stage after brain injury, mainly traumatic brain injury (TBI). The Brain Injury Complaint Questionnaire (BICoQ) includes 25 questions in the following domains: cognition, behavior, fatigue and sleep, mood, and somatic problems. A self and a proxy questionnaire were given. An additional question was given to the relative, about the patient's awareness of his difficulties. The questionnaires had a good internal coherence, as measured with Cronbach's alpha. The most frequent complaints were, in decreasing order, mental slowness, memory troubles, fatigue, concentration difficulties, anxiety, and dual tasking problems. Principal component analysis with varimax rotation yielded six underlying factors explaining 50.5% of total variance: somatic concerns, cognition, and lack of drive, lack of control, psycholinguistic disorders, mood, and mental fatigue/slowness. About 52% of patients reported fewer complaints than their proxy, suggesting lack of awareness. The total complaint scores were not significantly correlated with any injury severity measure, but were significantly correlated with disability and poorer quality of life (Note: only factor 2 [cognition/lack of drive] was significantly related to disability.) The BICoQ is a simple scale that can be used in addition to traditional clinical and cognitive assessment measures, and to assess awareness of everyday life problems.	[Vallat-Azouvi, Claire] Univ Paris 08, Lab Psychopathol & Neuropsychol, EA 2027, St Denis, France; [Vallat-Azouvi, Claire; Paillat, Cyrille; Bercovici, Stephanie; Morin, Benedicte; Paquereau, Julie] Hop Raymond Poincare, UGECAMIF, Antenne UEROS, Garches, France; [Paquereau, Julie; Azouvi, Philippe] Hop Raymond Poincare, AP HP, Serv Med Phys & Readaptat, Garches, France; [Charanton, James] CRFTC, Paris, France; [Ghout, Idir] Hop Ambroise Pare, AP HP, URC, Boulogne, France; [Azouvi, Philippe] Univ Versailles St Quentin, EA HANDIReSP 4047, Versailles, France		Azouvi, P (corresponding author), Hop Raymond Poincare, Dept Phys & Rehabil Med, F-92380 Garches, France.	philippe.azouvi@aphp.fr					Arnould A., 2016, J NEUROPSYCHOLOGY; Azouvi P, 2016, BRAIN INJURY, V30, P1665, DOI 10.1080/02699052.2016.1201593; Belmont A, 2009, NEUROREHAB NEURAL RE, V23, P939, DOI 10.1177/1545968309340327; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Chalmers RP, 2012, J STAT SOFTW, V48, P1; Crawford S, 1996, J NEUROL NEUROSUR PS, V60, P510, DOI 10.1136/jnnp.60.5.510; de Koning ME, 2016, INJURY, V47, P2041, DOI 10.1016/j.injury.2016.04.036; Draper K, 2009, NEUROPSYCHOL REHABIL, V19, P645, DOI 10.1080/17405620802613935; Fischer S, 2004, J INT NEUROPSYCH SOC, V10, P190, DOI 10.1017/S1355617704102051; Hooper D., 2008, EJBRM, V6, P53, DOI [10.21427/D7CF7R, DOI 10.21427/D7CF7R]; Jamora CW, 2012, BRAIN INJURY, V26, P36, DOI 10.3109/02699052.2011.635352; JENNETT B, 1975, LANCET, V1, P480; Jourdan C, 2016, ANN PHYS REHABIL MED, V59, P100, DOI 10.1016/j.rehab.2015.10.009; Jourdan C, 2015, BRAIN INJURY, V29, P701, DOI 10.3109/02699052.2015.1004646; Kelley E, 2014, J HEAD TRAUMA REHAB, V29, P147, DOI 10.1097/HTR.0b013e31826db6b9; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kinsinger SW, 2010, NEUROPSYCHOLOGY, V24, P573, DOI 10.1037/a0019222; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; MAHONEY F I, 1965, Md State Med J, V14, P61; Mailhan L, 2005, BRAIN INJURY, V19, P227, DOI 10.1080/02699050410001720149; Marino SE, 2009, EPILEPSY BEHAV, V14, P459, DOI 10.1016/j.yebeh.2008.12.007; Ownsworth T, 2007, NEUROPSYCHOL REHABIL, V17, P129, DOI 10.1080/09602010600615506; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Santos ME, 1998, BRAIN INJURY, V12, P759, DOI 10.1080/026990598122151; Sbordone RJ, 1998, BRAIN INJURY, V12, P505, DOI 10.1080/026990598122467; Scheenen ME, 2017, J NEUROTRAUM, V34, P31, DOI 10.1089/neu.2015.4381; TEASDALE G, 1974, LANCET, V2, P81; TRUELLE JL, 1992, SCAND J REHABIL MED, P115; Vallat-Azouvi C, 2012, NEUROPSYCHOL REHABIL, V22, P634, DOI 10.1080/09602011.2012.681110; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033	35	17	17	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	APR	2018	96	4			SI		601	611		10.1002/jnr.24180			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FV2DK	WOS:000424374300011	28976025				2022-02-06	
J	Fino, PC; Parrington, L; Walls, M; Sippel, E; Hullar, TE; Chesnutt, JC; King, LA				Fino, Peter C.; Parrington, Lucy; Walls, Merissa; Sippel, Emily; Hullar, Timothy E.; Chesnutt, James C.; King, Laurie A.			Abnormal Turning and Its Association with Self-Reported Symptoms in Chronic Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; gait; head stabilization; inertial sensors; turning	HEAD YAW MOVEMENTS; QUALITY-OF-LIFE; COORDINATION; CONCUSSION; GAIT; PERFORMANCE; STRATEGIES; STABILITY; DIRECTION; TRUNK	Turning is common in daily activity and requires rapid, coordinated reorientation of the head, trunk, and pelvis toward the new direction of travel. Yet, turning gait has not been well explored in populations with mild traumatic brain injury (mTBI) who may alter their turning behavior according to self-perceived symptoms or motor dysfunction. The purpose of this study was to examine turning velocities and coordination in adults with chronic mTBI (>3 months post-injury and still reporting balance complaints) during a task simulating everyday ambulation. We hypothesized that individuals with chronic mTBI would reduce their angular velocity when turning and increase the variability of head-pelvis coordination compared with controls, and that the reduction in velocity and increased variability would be associated with their self-reported symptom score. Forty-two adults (14 chronic mTBI, 28 controls) completed the Neurobehavioral Symptom Inventory before walking 12 laps around a marked course containing two 45-degree turns, four 90-degree turns, and two 135-degree turns. Inertial sensors collected angular velocities of the head and pelvis. After adjusting for covariates, participants with chronic mTBI had significantly slower lap times and peak angular velocities of the pelvis (p < 0.01) compared with the control group. The peak velocity timing (PVT) between peak velocities of the head and pelvis, and the variability of that timing was significantly greater in participants with chronic mTBI (p < 0.01). Within the chronic mTBI group, somatosensory symptoms were associated with slower angular velocities of the head and pelvis (p = 0.03) and increased PVT variability (p < 0.01). The results suggest individuals with chronic mTBI with worse somatic symptoms have impaired head stabilization during turning in situations similar to everyday life. These results encourage future research on turning gait to examine the causal relationship between symptoms and daily locomotor function in adults with chronic mTBI.	[Fino, Peter C.; Parrington, Lucy; Walls, Merissa; Sippel, Emily; King, Laurie A.] Oregon Hlth & Sci Univ, Dept Neurol, 3181 SW Sam Jackson Pk Rd,OP-32, Portland, OR 97239 USA; [Hullar, Timothy E.] Oregon Hlth & Sci Univ, Dept Otolaryngol Head & Neck Surg, Portland, OR 97201 USA; [Chesnutt, James C.] Oregon Hlth & Sci Univ, Dept Orthoped & Rehabil, Portland, OR 97201 USA; [Chesnutt, James C.] Oregon Hlth & Sci Univ, Dept Family Med, Portland, OR 97201 USA		Fino, PC (corresponding author), Oregon Hlth & Sci Univ, Dept Neurol, 3181 SW Sam Jackson Pk Rd,OP-32, Portland, OR 97239 USA.	fino@ohsu.edu		Fino, Peter/0000-0002-8621-3706; Parrington, Lucy/0000-0001-8507-9974	Assistant Secretary of Defense for Health Affairs [W81XWH-15-1-0620]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR002370, UL1TR002369] Funding Source: NIH RePORTER	The authors would like to thank Clayton Swanson and Heather Belding for assistance in early data collection, Marco Jurado, AuD and Sean Kampel, AuD for performing the vestibular testing, and Jenny Wilhelm, PT for referring subjects and evaluating the clinical diagnoses of participants. This work was supported by the Assistant Secretary of Defense for Health Affairs under Award No. W81XWH-15-1-0620. Opinions, interpretations, conclusions and recommendations are those of the author and are not necessarily endorsed by the Department of Defense.	Akin FW, 2011, OTOLARYNG CLIN N AM, V44, P323, DOI 10.1016/j.otc.2011.01.005; Alsalaheen BA, 2016, CLIN J SPORT MED, V26, P46, DOI 10.1097/JSM.0000000000000185; Anastasopoulos D, 2009, EXP BRAIN RES, V193, P323, DOI 10.1007/s00221-008-1627-y; Bernardin D, 2012, EXP BRAIN RES, V223, P65, DOI 10.1007/s00221-012-3241-2; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Buckley TA, 2013, GAIT POSTURE, V38, P549, DOI 10.1016/j.gaitpost.2013.02.008; Catena RD, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-25; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Fino PC, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0812-7; Fino PC, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0177-y; Glaister BC, 2007, GAIT POSTURE, V25, P289, DOI 10.1016/j.gaitpost.2006.04.003; Grasso R, 2000, NEUROREPORT, V11, P775, DOI 10.1097/00001756-200003200-00024; Grasso R, 1998, NEUROSCI LETT, V253, P115, DOI 10.1016/S0304-3940(98)00625-9; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Haran FJ, 2016, J NEUROTRAUM, V33, P705, DOI 10.1089/neu.2015.4060; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hollands MA, 2002, EXP BRAIN RES, V143, P221, DOI 10.1007/s00221-001-0983-7; Hollands MA, 2001, EXP BRAIN RES, V140, P223, DOI 10.1007/s002210100811; Howell DR, 2016, ACTA PAEDIATR, V105, pE426, DOI 10.1111/apa.13486; Hudson TE, 2005, EXP BRAIN RES, V165, P283, DOI 10.1007/s00221-005-2313-y; Kleffelgaard I, 2012, DISABIL REHABIL, V34, P788, DOI 10.3109/09638288.2011.619624; Kolev OI, 2016, FUNCT NEUROL, V31, P75; Land MF, 2004, EXP BRAIN RES, V159, P151, DOI 10.1007/s00221-004-1951-9; Littlefield PD, 2016, J NEUROTRAUM, V33, P71, DOI 10.1089/neu.2014.3824; Mancini M, 2015, NEUROREHABILITATION, V37, P3, DOI 10.3233/NRE-151236; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Parker TM, 2008, MED ENG PHYS, V30, P959, DOI 10.1016/j.medengphy.2007.12.006; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Patla AE, 1999, EXP BRAIN RES, V129, P629, DOI 10.1007/s002210050932; Powers KC, 2014, GAIT POSTURE, V39, P728, DOI 10.1016/j.gaitpost.2013.10.005; Raphan T, 2001, ANN NY ACAD SCI, V942, P128; Russell K, 2017, J NEUROTRAUM, V34, P2147, DOI 10.1089/neu.2016.4704; Sandel NK, 2013, APPL NEUROPSYCH-CHIL, V2, P64, DOI 10.1080/21622965.2012.670580; Schiehser DM, 2015, J HEAD TRAUMA REHAB, V30, pE21, DOI 10.1097/HTR.0000000000000065; Sessoms PH, 2015, MIL MED, V180, P135, DOI 10.7205/MILMED-D-14-00386; Solomon D, 2006, EXP BRAIN RES, V173, P475, DOI 10.1007/s00221-006-0393-y; Son EJ, 2015, AM J OTOLARYNG, V36, P823, DOI 10.1016/j.amjoto.2015.07.011; Sreenivasa MN, 2008, EXP BRAIN RES, V191, P313, DOI 10.1007/s00221-008-1525-3; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Taylor MJD, 2005, HUM MOVEMENT SCI, V24, P558, DOI 10.1016/j.humov.2005.07.005; Vallis LA, 2004, EXP BRAIN RES, V157, P94, DOI 10.1007/s00221-003-1824-7; Vallis LA, 2001, EXP BRAIN RES, V138, P128, DOI 10.1007/s002210100680; Whitney SL, 2004, OTOL NEUROTOL, V25, P139, DOI 10.1097/00129492-200403000-00010; Woodson J., 2015, TRAUMATIC BRAIN INJU; Xu DL, 2004, J MOTOR BEHAV, V36, P316, DOI 10.3200/JMBR.36.3.316-326	46	17	17	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	2018	35	10					1167	1177		10.1089/neu.2017.5231		MAR 2018	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	GF8DL	WOS:000428447700001	29078732	Green Published			2022-02-06	
J	Qin, Y; Li, GL; Xu, XH; Sun, ZY; Gu, JW; Gao, FB				Qin, Yang; Li, Gai-Li; Xu, Xian-Hua; Sun, Zhi-Yong; Gu, Jian-Wen; Gao, Fa-Bao			Brain structure alterations and cognitive impairment following repetitive mild head impact: An in vivo MRI and behavioral study in rat	BEHAVIOURAL BRAIN RESEARCH			English	Article						Traumatic brain injury; In vivo studies; Behavior; MRI; Diffusion tensor imaging	CHRONIC TRAUMATIC ENCEPHALOPATHY; MORRIS WATER MAZE; AXONAL INJURY; MOUSE MODEL; MEMORY; DEFICITS; PATHOPHYSIOLOGY; DEMENTIA; FORCE; DEATH	Mild traumatic brain injury (mTBI) or concussion is a common health issue. Several people repeatedly experience head impact milder than that causing concussion. The present study aimed to confirm the effects of such repeated impact on the brain structure and cognitive abilities. Rat models were established by closed skull weight-drop injury. The animals were anesthetized, subjected to single (s)-sham, s-mTBI, repetitive (r)-sham, and r-mTBI, and recovery times were recorded. MRI, including T2-weighted and diffusion tensor imaging (DTI), as well as, neurological severity scores (mNSS) were assessed for the dynamics of the brain structure and neurological function. Morris water maze (MWM) was used to evaluate the cognitive function. The histological examination of r-mTBI rats revealed the basis of structural changes in the brain. There was no significant difference in the recovery time, MRI, mNSS, and MWM between the s-sham and the s-mTBI groups. Compared with r-sham, r-mTBI induced significant differences in the following aspects. The recovery time was prolonged and beam balance test (BBT) in mNSS increased from day 5. MWM performances were worse even after the BBT was recovered. The volumes of the cortex (CT), hippocampus (HP), and lateral ventricle had changed from day 5, which reached a maximum at day 14. Abnormal DTI parameters were observed in CT, corpus callosum, and HP. Histological analyses showed that both in CT and HP, neuron counts reduced at the end of the experiment. Altogether, these findings indicate that non-symptomatic head injury may result in brain atrophy and cognitive impairment when occurred repeatedly. (C) 2016 Elsevier B.V. All rights reserved.	[Qin, Yang] Third Mil Med Univ, Dept Postgrad, Chongqing, Peoples R China; [Qin, Yang; Sun, Zhi-Yong; Gu, Jian-Wen] Chengdu Mil Gen Hosp, Dept Neurosurg, Chengdu, Sichuan, Peoples R China; [Li, Gai-Li; Xu, Xian-Hua] Chengdu Mil Gen Hosp, Dept Geriatr, Chengdu, Sichuan, Peoples R China; [Gu, Jian-Wen] 306th Hosp PLA, Dept Neurosurg, 9 North Anxiang Chaoyang Dist, Beijing 100101, Peoples R China; [Gao, Fa-Bao] Sichuan Univ, West China Hosp, Dept Radiol, 37 Guoxuexiang, Chengdu 610041, Sichuan, Peoples R China		Gu, JW (corresponding author), 306th Hosp PLA, Dept Neurosurg, 9 North Anxiang Chaoyang Dist, Beijing 100101, Peoples R China.; Gao, FB (corresponding author), Sichuan Univ, West China Hosp, Dept Radiol, 37 Guoxuexiang, Chengdu 610041, Sichuan, Peoples R China.	18712482@qq.com; gaofabao@yahoo.com			National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [81271395, 81130027]	This work was supported by grants from the National Natural Science Foundation of China (NSFC): Nos. 81271395 (JW Gu) and 81130027 (FB Gao). The authors thank Zhi Q. Wang and Lei Wang for technical assistance with the morris water maze and MRI.	Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Donovan V, 2014, J CEREBR BLOOD F MET, V34, P715, DOI 10.1038/jcbfm.2014.6; Farbood Y, 2015, LIFE SCI, V124, P120, DOI 10.1016/j.lfs.2015.01.013; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Friess SH, 2009, J NEUROTRAUM, V26, P1111, DOI [10.1089/neu.2008.0845, 10.1089/neu.2008-0845]; Gao C, 2014, J CEREBR BLOOD F MET, V34, P1070, DOI 10.1038/jcbfm.2014.56; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Goddeyne C, 2015, J NEUROPHYSIOL, V113, P3268, DOI 10.1152/jn.00970.2014; Gupta R, 2016, REV NEUROSCIENCE, V27, P93, DOI 10.1515/revneuro-2015-0017; Hui ES, 2010, NEUROIMAGE, V49, P2366, DOI 10.1016/j.neuroimage.2009.10.022; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kreipke CW, 2006, MICROVASC RES, V71, P197, DOI 10.1016/j.mvr.2006.02.002; Lafrenaye AD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0405-6; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Liao JC, 2013, MOL MED REP, V7, P1397, DOI 10.3892/mmr.2013.1369; Liu S., 2015, EXP BRAIN RES; Maneshi MM, 2015, J NEUROTRAUM, V32, P1020, DOI 10.1089/neu.2014.3677; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2012, BRAIN IMAGING BEHAV, V6, P343, DOI 10.1007/s11682-012-9178-z; Meyer DL, 2012, EXP NEUROL, V235, P574, DOI 10.1016/j.expneurol.2012.03.012; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Mychasiuk R, 2014, J NEUROTRAUM, V31, P749, DOI 10.1089/neu.2013.3132; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Omalu BI, 2005, NEUROSURGERY, V57, P128; Palacios EM, 2013, J NEUROTRAUM, V30, P1991, DOI 10.1089/neu.2012.2836; Pol-Bodetto S, 2011, BEHAV BRAIN RES, V218, P138, DOI 10.1016/j.bbr.2010.11.043; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; RINK A, 1995, AM J PATHOL, V147, P1575; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Smith C, 2013, NEUROPATH APPL NEURO, V39, P35, DOI 10.1111/nan.12006; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Tsitsopoulos PP, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00079; Vincent AS, 2014, ALZHEIMERS DEMENT, V10, pS174, DOI 10.1016/j.jalz.2014.04.006; von Holst H, 2004, J REHABIL MED, V36, P8, DOI 10.1080/16501960410023633; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Waljas M, 2014, J NEUROTRAUM, V31, P108, DOI 10.1089/neu.2013.2941; Weber JT, 2007, PROG BRAIN RES, V161, P253, DOI 10.1016/S0079-6123(06)61018-2; Wylie GR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126110; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739; Yoon KJ, 2015, J KOREAN MED SCI, V30, P1496, DOI 10.3346/jkms.2015.30.10.1496; Zhang HA, 2013, ANAT REC, V296, P1207, DOI 10.1002/ar.22715	51	17	18	2	42	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	MAR 15	2018	340				SI		41	48		10.1016/j.bbr.2016.08.008			8	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	FU9JY	WOS:000424173400005	27498246				2022-02-06	
J	Toth, A; Kornyei, B; Kovacs, N; Rostas, T; Buki, A; Doczi, T; Bogner, P; Schwarcz, A				Toth, Arnold; Kornyei, Balint; Kovacs, Noemi; Rostas, Tamas; Buki, Andras; Doczi, Tamas; Bogner, Peter; Schwarcz, Attila			Both hemorrhagic and non-hemorrhagic traumatic MRI lesions are associated with the microstructural damage of the normal appearing white matter	BEHAVIOURAL BRAIN RESEARCH			English	Article						MRI; Traumatic brain injury; Susceptibility weighted imaging; Diffusion tensor imaging; Traumatic microbleeds; Diffuse axonal injury	DIFFUSE AXONAL INJURY; BRAIN-INJURY; CORPUS-CALLOSUM; CEREBRAL MICROBLEEDS; HEAD-INJURY; DTI METRICS; ECHO MRI; TENSOR; MILD; MODERATE	Traumatic microbleeds (TMBs) and non-hemorrhagic lesions (NHLs) on MRI are regarded as surrogate markers of diffuse axonal injury. However, the actual relation between lesional and diffuse pathology remained unclear, since lesions were related to clinical parameters, largely influenced by extracranial factors. The aim of this study is to directly compare TMBs, NHLs and their regional features with the co-existing diffuse injury of the normal appearing white matter (NAWM) as measured by diffusion tensor imaging (DTI). Thirty-eight adults with a closed traumatic brain injury (12 mild, 4 moderate and 22 severe) who underwent susceptibility weighted imaging (SWI), Tl-, T2 weighted and FLAIR MRI and routine CT were included in the study. TMB (on SWI) and NHL (on T1-, T2 weighted and FLAIR images) features and Rotterdam scores were evaluated. DTI metrics such as fractional anisotropy (FA) and mean diffusivity (MD) were measured over different NAWM regions. Clinical parameters including age; Glasgow Coma Scale; Rotterdam score; TMB and NHL features were correlated to regional NAWM diffusivity using multiple regression. Overall NHL presence and basal ganglia area TMB load were significantly, negatively correlated with the subcortical NAWM FA values (partial r = -0.37 and -0.36; p = 0.006 and 0.025, respectively). The presence of any NHL, or TMBs located in the basal ganglia area indicates diffuse NAWM damage even after adjusting for clinical and CT parameters. To estimate DAI, a conventional lesional MRI pathology evaluation might at least in part substitute the use of quantitative DTI, which is yet not widely feasible in a clinical setting. (C) 2017 Elsevier B.V. All rights reserved.	[Toth, Arnold; Kornyei, Balint; Kovacs, Noemi; Buki, Andras; Doczi, Tamas; Bogner, Peter; Schwarcz, Attila] Pecs Med Sch, Dept Neurosurg, Ret U 2, H-7623 Pecs, Hungary; [Toth, Arnold; Rostas, Tamas; Bogner, Peter] Pecs Med Sch, Dept Radiol, Ifjusag Str 13, H-7624 Pecs, Hungary; [Doczi, Tamas] Diagnost Ctr Pecs, Ret U 2, H-7623 Pecs, Hungary; [Buki, Andras; Doczi, Tamas; Schwarcz, Attila] MTA PTE Clin Neurosci MR Res Grp, Pecs, Hungary		Toth, A (corresponding author), Dept Neurosurg, Ret U 2, H-7623 Pecs, Hungary.	prsarn@gmail.com	Kornyei, Balint/AAK-7548-2020		Hungarian Brain Research Program [KTIA_13_NAP-A-II/8, KTIA_13_NAP-A-II/9, SROP-4.2.2.A-11/1/KONV-2012-0017]; Hungarian Scientific Research FundOrszagos Tudomanyos Kutatasi Alapprogramok (OTKA) [OTKA/K-120356]	This study was funded by Hungarian Brain Research Program - Grant No. KTIA_13_NAP-A-II/8, Grant No. KTIA_13_NAP-A-II/9, SROP-4.2.2.A-11/1/KONV-2012-0017 and Hungarian Scientific Research Fund Grant No. OTKA/K-120356.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Akoudad S, 2013, NEUROLOGY, V81, P1930, DOI 10.1212/01.wnl.0000436609.20587.65; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Ashwal S, 2006, ARCH PHYS MED REHAB, V87, pS50, DOI 10.1016/j.apmr.2006.07.275; Babikian T, 2005, PEDIATR NEUROL, V33, P184, DOI 10.1016/j.pediatrneurol.2005.03.015; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Beauchamp MH, 2013, CORTEX, V49, P591, DOI 10.1016/j.cortex.2012.08.015; Beauchamp MH, 2011, J NEUROTRAUM, V28, P915, DOI 10.1089/neu.2010.1712; Bennett IJ, 2010, HUM BRAIN MAPP, V31, P378, DOI 10.1002/hbm.20872; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Caeyenberghs K, 2010, HUM BRAIN MAPP, V31, P992, DOI 10.1002/hbm.20911; Chang MC, 2010, NEUROREHABILITATION, V26, P339, DOI 10.3233/NRE-2010-0571; Chastain CA, 2009, J NEUROTRAUM, V26, P1183, DOI 10.1089/neu.2008.0650; Cheng AL, 2013, STROKE, V44, P2782, DOI 10.1161/STROKEAHA.113.002267; Colbert CA, 2010, RADIOLOGY, V256, P898, DOI 10.1148/radiol.10091842; Di Ieva A., 2015, J NEUROSURG, P1; Dinkel J, 2014, AM J NEURORADIOL, V35, P23, DOI 10.3174/ajnr.A3616; Engelter ST, 2000, AM J ROENTGENOL, V175, P425, DOI 10.2214/ajr.175.2.1750425; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Geurts B. H., 2012, BRAIN INJ; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Iwamura A, 2012, NEURORADIOLOGY, V54, P335, DOI 10.1007/s00234-011-0892-9; JENKINS A, 1986, LANCET, V2, P445; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kennedy M. R., 2009, J INT NEUROPSYCHOL S, V15; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Kumar R, 2013, BRAIN RES, V1512, P22, DOI 10.1016/j.brainres.2013.03.028; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; Liu J, 2014, NEURAL REGEN RES, V9, P1222, DOI 10.4103/1673-5374.135330; Ljungqvist J, 2011, BRAIN INJURY, V25, P370, DOI 10.3109/02699052.2011.558038; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Mannion RJ, 2007, J NEUROTRAUM, V24, P128, DOI 10.1089/neu.2006.0127; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Messori A, 2003, NEURORADIOLOGY, V45, P881, DOI 10.1007/s00234-003-1048-3; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; Moen KG, 2014, J NEUROTRAUM, V31, P1486, DOI 10.1089/neu.2013.3258; Moen KG, 2012, J NEUROL NEUROSUR PS, V83, P1193, DOI 10.1136/jnnp-2012-302644; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Newcombe VFJ, 2010, J NEUROL NEUROSUR PS, V81, P552, DOI 10.1136/jnnp.2009.196246; Oni MB, 2010, J CHILD NEUROL, V25, P976, DOI 10.1177/0883073809356034; Park JH, 2009, J KOREAN NEUROSURG S, V46, P365, DOI 10.3340/jkns.2009.46.4.365; Pfefferbaum A, 2003, MAGNET RESON MED, V49, P953, DOI 10.1002/mrm.10452; Pfefferbaum A, 2005, NEUROIMAGE, V26, P891, DOI 10.1016/j.neuroimage.2005.02.034; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Schoonjans F, 1995, COMPUT METH PROG BIO, V48, P257, DOI 10.1016/0169-2607(95)01703-8; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Spitz G, 2013, J NEUROTRAUM, V30, P2038, DOI 10.1089/neu.2013.3021; Stadlbauer A, 2008, RADIOLOGY, V247, P179, DOI 10.1148/radiol.2471070707; Sullivan EV, 2007, BRIT J RADIOL, V80, pS99, DOI 10.1259/bjr/22893432; Sullivan EV, 2001, NEUROREPORT, V12, P99, DOI 10.1097/00001756-200101220-00027; Tasker RC, 2010, DEV NEUROSCI-BASEL, V32, P374, DOI 10.1159/000316806; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Toth A, 2016, NEUROSCI LETT, V617, P207, DOI 10.1016/j.neulet.2016.02.028; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; van der Naalt J, 1999, ANN NEUROL, V46, P70, DOI 10.1002/1531-8249(199907)46:1<70::AID-ANA11>3.0.CO;2-L; Wang JY, 2011, NEUROLOGY, V77, P818, DOI 10.1212/WNL.0b013e31822c61d7; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208; Yallampalli R, 2013, J NEUROIMAGING, V23, P224, DOI 10.1111/j.1552-6569.2010.00537.x; Yuan W, 2007, AM J NEURORADIOL, V28, P1919, DOI 10.3174/ajnr.A0698; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	71	17	18	0	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	MAR 15	2018	340				SI		106	116		10.1016/j.bbr.2017.02.039			11	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	FU9JY	WOS:000424173400013	28249729				2022-02-06	
J	Giacci, MK; Bartlett, CA; Huynh, M; Kilburn, MR; Dunlop, SA; Fitzgerald, M				Giacci, Marcus K.; Bartlett, Carole A.; Minh Huynh; Kilburn, Matt R.; Dunlop, Sarah A.; Fitzgerald, Melinda			Three dimensional electron microscopy reveals changing axonal and myelin morphology along normal and partially injured optic nerves	SCIENTIFIC REPORTS			English	Article							RETINAL GANGLION-CELLS; SPINAL-CORD-INJURY; CENTRAL-NERVOUS-SYSTEM; CONDUCTION-VELOCITY; CATS RETINA; SECONDARY DEGENERATION; NITRIC-OXIDE; PROTEOLIPID PROTEIN; X-CELLS; Y-CELLS	Following injury to the central nervous system, axons and myelin distinct from the initial injury site undergo changes associated with compromised function. Quantifying such changes is important to understanding the pathophysiology of neurotrauma; however, most studies to date used 2 dimensional (D) electron microscopy to analyse single sections, thereby failing to capture changes along individual axons. We used serial block face scanning electron microscopy (SBF SEM) to undertake 3D reconstruction of axons and myelin, analysing optic nerves from normal uninjured female rats and following partial optic nerve transection. Measures of axon and myelin dimensions were generated by examining 2D images at 5 mu m intervals along the 100 mu m segments. In both normal and injured animals, changes in axonal diameter, myelin thickness, fiber diameter, G-ratio and percentage myelin decompaction were apparent along the lengths of axons to varying degrees. The range of values for axon diameter along individual reconstructed axons in 3D was similar to the range from 2D datasets, encompassing reported variation in axonal diameter attributed to retinal ganglion cell diversity. 3D electron microscopy analyses have provided the means to demonstrate substantial variability in ultrastructure along the length of individual axons and to improve understanding of the pathophysiology of neurotrauma.	[Giacci, Marcus K.; Bartlett, Carole A.; Dunlop, Sarah A.; Fitzgerald, Melinda] Univ Western Australia, Sch Biol Sci, Expt & Regenerat Neurosci, 35 Stirling Hwy, Perth, WA 6009, Australia; [Kilburn, Matt R.] Univ Western Australia, Ctr Microscopy Characterisat & Anal, 35 Stirling Hwy, Perth, WA 6009, Australia; [Minh Huynh] Univ Sydney, Australian Ctr Microscopy & Microanal, City Rd, Sydney, NSW 2006, Australia; [Fitzgerald, Melinda] Curtin Univ, Curtin Hlth Innovat Res Inst, Bentley, WA 6102, Australia; [Fitzgerald, Melinda] Sarich Neurosci Res Inst, Perron Inst Neurol & Translat Sci, 8 Verdun St, Nedlands, WA 6009, Australia		Fitzgerald, M (corresponding author), Univ Western Australia, Sch Biol Sci, Expt & Regenerat Neurosci, 35 Stirling Hwy, Perth, WA 6009, Australia.; Fitzgerald, M (corresponding author), Curtin Univ, Curtin Hlth Innovat Res Inst, Bentley, WA 6102, Australia.; Fitzgerald, M (corresponding author), Sarich Neurosci Res Inst, Perron Inst Neurol & Translat Sci, 8 Verdun St, Nedlands, WA 6009, Australia.	lindy.fitzgerald@curtin.edu.au	Fitzgerald, Melinda/C-4235-2011; Kilburn, Matthew/C-4515-2011	Fitzgerald, Melinda/0000-0002-4823-8179; Dunlop, Sarah/0000-0002-1306-3962; Kilburn, Matthew/0000-0002-1858-8485; Giacci, Marcus/0000-0002-8330-678X			Aiello GL, 2000, J NEUROSCI METH, V103, P145, DOI 10.1016/S0165-0270(00)00308-3; Ames A, 2000, BRAIN RES REV, V34, P42, DOI 10.1016/S0165-0173(00)00038-2; Arancibia-Carcamo IL, 2017, ELIFE, V6, DOI 10.7554/eLife.23329; BAKER GE, 1990, NATURE, V344, P342, DOI 10.1038/344342a0; BALENTINE JD, 1978, LAB INVEST, V39, P254; Bao F, 2004, NEUROSCIENCE, V126, P285, DOI 10.1016/j.neuroscience.2004.03.054; Belevich I, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002340; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Bizzozero OA, 2001, J NEUROCHEM, V76, P1129, DOI 10.1046/j.1471-4159.2001.00116.x; Bizzozero OA, 2001, NEUROCHEM RES, V26, P1127, DOI 10.1023/A:1012370822754; BLIGHT AR, 1983, NEUROSCIENCE, V10, P521, DOI 10.1016/0306-4522(83)90150-1; BOISON D, 1994, P NATL ACAD SCI USA, V91, P11709, DOI 10.1073/pnas.91.24.11709; BONGARZONE ER, 1995, J NEUROSCI RES, V41, P213, DOI 10.1002/jnr.490410209; Bros H, 2014, EXP NEUROL, V261, P127, DOI 10.1016/j.expneurol.2014.06.018; BUNT AH, 1974, BRAIN RES, V73, P215, DOI 10.1016/0006-8993(74)91045-2; Bushong E. A., 2010, MICROSCOPY-JPN, P6; Cao Y, 2013, BRAIN RES, V1522, P59, DOI 10.1016/j.brainres.2013.05.033; CARPENTER MB, 1983, HUMAN NEUROANATOMY; Chang KJ, 2016, NAT NEUROSCI, V19, P190, DOI 10.1038/nn.4200; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; CLELAND BG, 1974, J PHYSIOL-LONDON, V240, P421, DOI 10.1113/jphysiol.1974.sp010617; CLELAND BG, 1971, J PHYSIOL-LONDON, V217, P473, DOI 10.1113/jphysiol.1971.sp009581; CLELAND BG, 1974, J PHYSIOL-LONDON, V240, P457, DOI 10.1113/jphysiol.1974.sp010618; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Cummins N, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-98; Davis CHO, 2014, P NATL ACAD SCI USA, V111, P9633, DOI 10.1073/pnas.1404651111; DREHER B, 1985, BRAIN BEHAV EVOLUT, V26, P10, DOI 10.1159/000118764; Drenhaus U, 1997, ANAT REC, V249, P103, DOI 10.1002/(SICI)1097-0185(199709)249:1<103::AID-AR13>3.0.CO;2-T; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; Fitzgerald M, 2009, INVEST OPHTH VIS SCI, V50, P5456, DOI 10.1167/iovs.09-3717; FITZGIBBON T, 1994, VISUAL NEUROSCI, V11, P425, DOI 10.1017/S0952523800002364; FRAHER JP, 1978, J NEUROL SCI, V36, P427, DOI 10.1016/0022-510X(78)90049-7; FRAHER JP, 1976, BRAIN RES, V105, P193, DOI 10.1016/0006-8993(76)90421-2; FRAHER JP, 1978, J ANAT, V126, P509; Fu QL, 2008, INVEST OPHTH VIS SCI, V49, P975, DOI 10.1167/iovs.07-1199; FUKUDA Y, 1974, J NEUROPHYSIOL, V37, P749, DOI 10.1152/jn.1974.37.4.749; FUKUDA Y, 1977, BRAIN RES, V119, P327, DOI 10.1016/0006-8993(77)90314-6; GREENBERG MM, 1990, J NEUROCYTOL, V19, P978, DOI 10.1007/BF01186825; GUTIERREZ R, 1995, NEUROSCI LETT, V195, P93, DOI 10.1016/0304-3940(94)11789-L; GUY J, 1989, J COMP NEUROL, V287, P446, DOI 10.1002/cne.902870404; Hursh JB, 1939, AM J PHYSIOL, V127, P131, DOI 10.1152/ajplegacy.1939.127.1.131; Kann O, 2007, AM J PHYSIOL-CELL PH, V292, pC641, DOI 10.1152/ajpcell.00222.2006; Levkovitch-Verbin H, 2004, EYE, V18, P1066, DOI 10.1038/sj.eye.6701576; Levkovitch-Verbin H, 2001, INVEST OPHTH VIS SCI, V42, P975; Levkovitch-Verbin H, 2003, INVEST OPHTH VIS SCI, V44, P3388, DOI 10.1167/iovs.02-0646; Li HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068881; Maxwell WL, 1995, J NEUROCYTOL, V24, P925, DOI 10.1007/BF01215643; Mills EA, 2015, P NATL ACAD SCI USA, V112, P10509, DOI 10.1073/pnas.1506486112; Nguyen JV, 2011, P NATL ACAD SCI USA, V108, P1176, DOI 10.1073/pnas.1013965108; Patestas M. A., 2016, TXB NEUROANATOMY; Payne SC, 2012, INVEST OPHTH VIS SCI, V53, P6093, DOI 10.1167/iovs.12-10080; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; Raineteau O, 2001, NAT REV NEUROSCI, V2, P263, DOI 10.1038/35067570; REESE BE, 1987, NEUROSCIENCE, V22, P1015, DOI 10.1016/0306-4522(87)92977-0; RELES A, 1991, J NEUROCYTOL, V20, P450, DOI 10.1007/BF01252273; Salazar DL, 2008, DEV DEGENERATION REG, P297; SCHRODER JM, 1978, ACTA NEUROCHIR, V43, P169; Seidl AH, 2014, NEUROSCIENCE, V276, P126, DOI 10.1016/j.neuroscience.2013.06.047; Seidl AH, 2016, GLIA, V64, P487, DOI 10.1002/glia.22941; Seidl AH, 2014, J NEUROSCI, V34, P4914, DOI 10.1523/JNEUROSCI.5460-13.2014; SMITH RS, 1970, AM J PHYSIOL, V219, P1256, DOI 10.1152/ajplegacy.1970.219.5.1256; Snaidero N, 2014, CELL, V156, P277, DOI 10.1016/j.cell.2013.11.044; STANFORD LR, 1987, SCIENCE, V238, P358, DOI 10.1126/science.3659918; STONE J, 1974, J COMP NEUROL, V155, P377, DOI 10.1002/cne.901550402; STONE J, 1974, J NEUROPHYSIOL, V37, P722, DOI 10.1152/jn.1974.37.4.722; Szymanski CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066448; Titus HE, 2017, GLIA, V65, P1990, DOI 10.1002/glia.23209; Totoiu MO, 2005, J COMP NEUROL, V486, P373, DOI 10.1002/cne.20517; Walsh N, 1999, J NEUROCYTOL, V28, P989, DOI 10.1023/A:1007083920206; WAXMAN SG, 1980, MUSCLE NERVE, V3, P141, DOI 10.1002/mus.880030207; WAXMAN SG, 1972, NATURE-NEW BIOL, V238, P217, DOI 10.1038/newbio238217a0; Xing YL, 2014, J NEUROSCI, V34, P14128, DOI 10.1523/JNEUROSCI.3491-13.2014; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zhang CW, 2005, INVEST OPHTH VIS SCI, V46, P1497, DOI 10.1167/iovs.04-0664	75	17	17	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAR 5	2018	8								3979	10.1038/s41598-018-22361-2			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY0ZI	WOS:000426540800012	29507421	Green Published, gold			2022-02-06	
J	Beck, B; Gantner, D; Cameron, PA; Braaf, S; Saxena, M; Cooper, DJ; Gabbe, BJ				Beck, Ben; Gantner, Dashiell; Cameron, Peter A.; Braaf, Sandra; Saxena, Manoj; Cooper, D. James; Gabbe, Belinda J.			Temporal Trends in Functional Outcomes after Severe Traumatic Brain Injury: 2006-2015	JOURNAL OF NEUROTRAUMA			English	Article						disability; epidemiology; head injury; trauma; trends over time	MAJOR TRAUMA; HEAD-INJURY; DECOMPRESSIVE CRANIECTOMY; COMORBIDITY INDEX; EPIDEMIOLOGY; TRIAL; MANAGEMENT; AUSTRALIA; VICTORIA; MODERATE	Severe traumatic brain injury (TBI) is associated with poor outcomes; however, little is known about whether these outcomes are improving over time. This study examined temporal trends in functional outcomes of severe TBI at six months post-injury. We conducted a retrospective cohort study (January 1, 2006 to December 31, 2015) of hospitalized adult (16 years) patients with severe TBI using data from the population-based Victorian State Trauma Registry. The primary outcome was the Glasgow Outcome Scale-Extended (GOS-E) at six months post-injury, dichotomized as upper severe disability or worse (GOS-E <= 4, termed "unfavorable outcome") and lower moderate disability or better (GOS-E >= 5; termed "favorable outcome"). Multivariable logistic regression was used to investigate temporal trends in functional outcomes at six months post-injury. Of the 1966 patients with severe TBI who were followed up at six months post-injury (median age, 42 years (interquartile range [IQR]: 25-68); male, 73%), a majority of patients had an unfavorable outcome (GOS-E <= 4; n = 1372, 70%). After adjusting for confounders, there was no change in functional outcomes over time (adjusted odds ratio [AOR] = 1.02, 95% confidence interval [CI]: 0.98,1.06; p = 0.35). Similarly, there was no change in the adjusted odds of death (GOS-E = 1) at six months post-injury (AOR = 1.04, 95% CI: 1.00,1.08; p = 0.08). Using a population-wide, high quality, comprehensive registry, we demonstrated no change in death or functional outcomes after severe TBI between 2006 and 2015 in a mature trauma system. There is a clear need to identify targeted improvements in the treatment of these patients with the aim of reducing in-hospital death and improving long-term outcomes.	[Beck, Ben; Cameron, Peter A.; Braaf, Sandra; Gabbe, Belinda J.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Gantner, Dashiell; Cooper, D. James] Monash Univ, Australian & New Zealand Intens Care Res Ctr, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Gantner, Dashiell; Cooper, D. James] Alfred, Dept Intens Care & Hyperbar Med, Melbourne, Vic, Australia; [Cameron, Peter A.] Alfred Hosp, Emergency & Trauma Ctr, Melbourne, Vic, Australia; [Saxena, Manoj] St George Hosp, Intens Care Unit, Sydney, NSW, Australia; [Saxena, Manoj] Univ New South Wales, George Inst Global Hlth, Crit Care & Trauma Div, Sydney, NSW, Australia; [Gabbe, Belinda J.] Swansea Univ, Med Sch, Farr Inst, Swansea, W Glam, Wales		Beck, B (corresponding author), Monash Univ, Dept Epidemiol & Prevent Med, Sch Publ Hlth & Prevent Med, 553 St Kilda Rd, Melbourne, Vic 3004, Australia.	ben.beck@monash.edu	Cooper, D. James/G-7961-2013; Beck, Ben/ABD-5556-2020	Cooper, D. James/0000-0002-5872-9051; Beck, Ben/0000-0003-3262-5956; Reeder, Sandra/0000-0001-7942-0179; Saxena, Manoj/0000-0002-0385-6731; Cameron, Peter/0000-0002-1443-557X	Victorian State Trauma Registry (VSTR) is a Department of Health and Human Services, State Government of Victoria; Transport Accident Commission; National Health and Medical Research Council (NHRMC) Australian Resuscitation Outcomes Consortium (Aus-ROC) Centre of Research ExcellenceNational Health and Medical Research Council of Australia [1029983]; Practitioner Fellowship from the NHMRCNational Health and Medical Research Council of Australia [545926]; Career Development Fellowship from the NHMRCNational Health and Medical Research Council of Australia [GNT1048731]	The Victorian State Trauma Registry (VSTR) is a Department of Health and Human Services, State Government of Victoria and Transport Accident Commission funded project. The Victorian State Trauma Outcome Registry and Monitoring (VSTORM) group is thanked for the provision of VSTR data. The authors also thank Sue McLellan for her assistance with the data and Pam Simpson for statistical advice.; Ben Beck received salary support from the National Health and Medical Research Council (NHRMC) Australian Resuscitation Outcomes Consortium (Aus-ROC) Centre of Research Excellence (#1029983). Peter Cameron and Belinda Gabbe were supported by a Practitioner Fellowship (#545926), and a Career Development Fellowship (GNT1048731), from the NHMRC, respectively.	Ackland HM, 2016, INJURY, V47, P1109, DOI 10.1016/j.injury.2015.12.016; Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; [Anonymous], 2008, BMJ-BRIT MED J, V336, P425, DOI DOI 10.1136/bmj.39461.643438.25; Association for the Advancement of Automotive Medicine, 2008, ABBR INJ SCAL 2005 U; Beck B, 2016, MED J AUSTRALIA, V204, P407, DOI 10.5694/mja15.01369; Bragge P, 2016, J NEUROTRAUM, V33, P1461, DOI 10.1089/neu.2015.4233; Cameron PA, 2004, ANZ J SURG, V74, P424, DOI 10.1111/j.1445-1433.2004.03029.x; Cameron PA, 2008, MED J AUSTRALIA, V189, P546, DOI 10.5694/j.1326-5377.2008.tb02176.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Edwards P, 2005, LANCET, V365, P1957; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Fountain DM, 2017, ANN SURG, V265, P590, DOI 10.1097/SLA.0000000000001682; Fu TS, 2015, J TRAUMA ACUTE CARE, V79, P449, DOI 10.1097/TA.0000000000000733; Fuller G, 2011, BRIT J NEUROSURG, V25, P414, DOI 10.3109/02688697.2011.570882; Gabbe BJ, 2015, ANN SURG, V261, P565, DOI 10.1097/SLA.0000000000000522; Gabbe BJ, 2012, ANN SURG, V255, P1009, DOI 10.1097/SLA.0b013e31824c4b91; Gabbe BJ, 2010, J TRAUMA, V69, P532, DOI 10.1097/TA.0b013e3181e5125b; Gabbe BJ, 2005, ACAD EMERG MED, V12, P751, DOI 10.1197/j.aem.2005.03.527; Gabbe BJ, 2005, ACAD EMERG MED, V12, P318, DOI 10.1197/j.aem.2004.12.002; Helps Y., 2008, INJURY RES STAT SERI; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Kaukonen KM, 2014, JAMA-J AM MED ASSOC, V311, P1308, DOI 10.1001/jama.2014.2637; Kupas DF, 2016, ANN EMERG MED, V68, P744, DOI 10.1016/j.annemergmed.2016.06.017; Lefering R, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0476-2; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Palmer CS, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-29; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Roozenbeek B, 2012, J NEUROTRAUM, V29, P1306, DOI 10.1089/neu.2011.1988; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; TEASDALE G, 1974, LANCET, V2, P81; Udy AA, 2017, CRIT CARE MED, V45, pE138, DOI 10.1097/CCM.0000000000002059; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Van Essen TA, 2016, J NEUROTRAUM, V33, pA20; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Williamson OD, 2011, J TRAUMA, V71, P63, DOI 10.1097/TA.0b013e31820e898d; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zygun DA, 2005, CAN J NEUROL SCI, V32, P87, DOI 10.1017/S0317167100016930	49	17	17	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2018	35	8					1021	1029		10.1089/neu.2017.5287		MAR 2018	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GC0DM	WOS:000426658100001	29256832				2022-02-06	
J	Grassi, DC; da Conceicao, DM; Leite, CD; Andrade, CS				Grassi, Daphine Centola; da Conceicao, David Macedo; Leite, Claudia da Costa; Andrade, Celi Santos			Current contribution of diffusion tensor imaging in the evaluation of diffuse axonal injury	ARQUIVOS DE NEURO-PSIQUIATRIA			English	Article						magnetic resonance imaging; diffusion tensor imaging; diffuse axonal injury; brain injuries; traumatic.	TRAUMATIC BRAIN-INJURY; MAGNETIC-RESONANCE; SPATIAL STATISTICS; HEAD-INJURY; TRACTOGRAPHY; MRI; ABNORMALITIES; DEGENERATION; COEFFICIENT; PRINCIPLES	Traumatic brain injury (TBI) is the number one cause of death and morbidity among young adults. Moreover, survivors are frequently left with functional disabilities during the most productive years of their lives. One main aspect of TBI pathology is diffuse axonal injury, which is increasingly recognized due to its presence in 40% to 50% of all cases that require hospital admission. Diffuse axonal injury is defined as widespread axonal damage and is characterized by complete axotomy and secondary reactions due to overall axonopathy. These changes can be seen in neuroimaging studies as hemorrhagic focal areas and diffuse edema. However, the diffuse axonal injury findings are frequently under-recognized in conventional neuroimaging studies. In such scenarios, diffuse tensor imaging (DTI) plays an important role because it provides further information on white matter integrity that is not obtained with standard magnetic resonance imaging sequences. Extensive reviews concerning the physics of DTI and its use in the context of TBI patients have been published, but these issues are still hazy for many allied-health professionals. Herein, we aim to review the current contribution of diverse state-of-the-art DTI analytical methods to the understanding of diffuse axonal injury pathophysiology and prognosis, to serve as a quick reference for those interested in planning new studies and who are involved in the care of TBI victims. For this purpose, a comprehensive search in Pubmed was performed using the following keywords: "traumatic brain injury", "diffuse axonal injury", and "diffusion tensor imaging".	[Grassi, Daphine Centola; da Conceicao, David Macedo; Leite, Claudia da Costa; Andrade, Celi Santos] Univ Sao Paulo, Fac Med, Dept Radiol, Sao Paulo, SP, Brazil		Grassi, DC (corresponding author), HCFMUSP, Dept Radiol, Div Ressonancia Magnet, Av Dr Eneas Carvalho Aguiar 255, BR-05403900 Sao Paulo, SP, Brazil.	daphinecgrassi@gmail.com	Andrade, Celi Santos/AAR-9401-2021	Andrade, Celi Santos/0000-0003-0382-3232	Sao Paulo Research Foundation - FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2015/18136-1, 2016/05547-6, 2017/17065-9]	Grants 2015/18136-1, 2016/05547-6 and 2017/17065-9 from Sao Paulo Research Foundation - FAPESP.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Vieira RDA, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00178; Andrade AF, 1992, REV ASSOC MED BRAS, V55, P75, DOI [10.1590/S0104-42302009000100020, DOI 10.1590/S0104-42302009000100020]; Andrade CS, 2017, EVALUATION WHITE MAT, DOI [10.1594/ecr2017/C-0747, DOI 10.1594/ECR2017/C-0747]; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bach M, 2014, NEUROIMAGE, V100, P358, DOI 10.1016/j.neuroimage.2014.06.021; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Brandstack N, 2013, RADIOLOGY, V267, P231, DOI 10.1148/radiol.12112570; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Chen YJ, 2017, J NEUROIMAGING, V27, P272, DOI 10.1111/jon.12404; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Edlow BL, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-015-0525-8; Garin-Muga A, 2014, STUD HEALTH TECHNOL, V207, P27, DOI 10.3233/978-1-61499-474-9-27; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Karaarslan E, 2008, EUR J RADIOL, V65, P402, DOI 10.1016/j.ejrad.2007.04.023; Koch SBJ, 2017, J PSYCHIATR NEUROSCI, V42, P331, DOI 10.1503/jpn.160129; Le Bihan D, 2015, PLOS BIOL, V13, DOI [10.1371/journal.pbio.1002203, 10.1371/journal.pbio.1002246]; Le Bihan D, 2013, RADIOLOGY, V268, P318, DOI 10.1148/radiol.13130420; Li J, 2010, J TRAUMA, V69, P1610, DOI 10.1097/TA.0b013e3181f5a9ed; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Magnoni S, 2012, BRAIN, V135, P1268, DOI 10.1093/brain/awr286; Magnoni S, 2010, ARCH NEUROL-CHICAGO, V67, P1068, DOI 10.1001/archneurol.2010.214; Mechtler LL, 2014, NEUROL CLIN, V32, P31, DOI 10.1016/j.ncl.2013.08.002; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Morais DF, 2008, ARQ NEURO-PSIQUIAT, V66, P53, DOI 10.1590/S0004-282X2008000100013; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Nucifora PGP, 2007, RADIOLOGY, V245, P367, DOI 10.1148/radiol.2452060445; Ogura A, 2016, AM J ROENTGENOL, V207, P1239, DOI 10.2214/AJR.15.15945; Olsson A, 2004, J NEUROL, V251, P870, DOI 10.1007/s00415-004-0451-y; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Provenzale JM, 2010, AM J ROENTGENOL, V194, P16, DOI 10.2214/AJR.09.3687; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Sandsmark DK, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0654-5; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Snook L, 2007, NEUROIMAGE, V34, P243, DOI 10.1016/j.neuroimage.2006.07.021; Soares JM, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00031; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Winston GP, 2012, QUANT IMAGING MED SU, V2, P254, DOI 10.3978/j.issn.2223-4292.2012.12.05; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208; Yendiki Anastasia, 2011, Front Neuroinform, V5, P23, DOI 10.3389/fninf.2011.00023; Zhang H, 2006, MED IMAGE ANAL, V10, P764, DOI 10.1016/j.media.2006.06.004	52	17	18	1	7	ASSOC ARQUIVOS NEURO- PSIQUIATRIA	SAO PAULO SP	PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL	0004-282X	1678-4227		ARQ NEURO-PSIQUIAT	Arq. Neuro-Psiquiatr.	MAR	2018	76	3					189	199		10.1590/0004-282X20180007			11	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	GB9UH	WOS:000429419000011	29809237	Green Submitted, gold			2022-02-06	
J	Wolf, GK; Mauntel, GJ; Kretzmer, T; Crawford, E; Thors, C; Strom, TQ; Vanderploeg, RD				Wolf, Gregory K.; Mauntel, Gregory J.; Kretzmer, Tracy; Crawford, Eric; Thors, Christina; Strom, Thad Q.; Vanderploeg, Rodney D.			Comorbid Posttraumatic Stress Disorder and Traumatic Brain Injury: Generalization of Prolonged-Exposure PTSD Treatment Outcomes to Postconcussive Symptoms, Cognition, and Self-Efficacy in Veterans and Active Duty Service Members	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						concussion; postconcussive syndrome; postdeployment; posttraumatic stress disorder; rehabilitation; traumatic brain injury; Veteran	NEUROPSYCHOLOGICAL OUTCOMES; PSYCHOMETRIC PROPERTIES; RANDOMIZED-TRIAL; HEALTH; THERAPY; IRAQ; CARE; ASSOCIATIONS; AFGHANISTAN; INVENTORY	Objectives: To examine (a) generalization of the effectiveness of prolonged exposure (PE) therapy for posttraumatic stress disorder (PTSD) in improving postconcussive symptoms (PCSs) and other outcomes in military service members and Veterans (VA) with histories of mild to severe traumatic brain injury (TBI), and (b) factors associated with PCS reduction. Setting: VA polytrauma medical center. Participants: Consecutive referrals for PTSD treatment of Active Duty (n = 17) or Veterans (n = 27) diagnosed with PTSD and TBI (N = 44). Main Outcome Measures: Neurobehavioral Symptom Inventory, Key Behaviors Change Inventory, Self-Efficacy for Symptom Management, Posttraumatic Stress Disorder Checklist, and Beck Depression Inventory, 2nd edition. Design: Post hoc analysis of archival clinical effectiveness program evaluation data. Interventions: PE for PTSD. Results: There were significant improvements on all outcome measures with large effect sizes (Cohen's d ranging from 0.68 to 2.02). Improvement on PCS (Cohen's d = 1.21) was associated with lower levels of VA service-connected disability and PE treatment completion. Conclusion: PE treatment-related improvements for participants with comorbid PTSD and TBI generalize from PTSD outcomes to PCS and other TBI-related outcomes. Positive outcomes were independent of TBI severity, treatment setting, or Veteran status, but dependent upon PE treatment completion and lower levels of VA service-connected disability.	[Wolf, Gregory K.; Mauntel, Gregory J.; Kretzmer, Tracy; Thors, Christina; Vanderploeg, Rodney D.] James A Haley Vet Hosp, Mental Hlth & Behav Sci, Tampa, FL 33612 USA; [Kretzmer, Tracy; Vanderploeg, Rodney D.] Univ S Florida, Dept Psychiat & Behav Neurosci, Tampa, FL USA; [Vanderploeg, Rodney D.] Univ S Florida, Dept Psychol, Tampa, FL USA; [Vanderploeg, Rodney D.] Def & Vet Brain Injury Ctr, Tampa, FL USA; [Crawford, Eric] VA Midatlantic Reg Mental Illness Res Educ & Clin, Durham VA Med Ctr, Durham, NC USA; [Crawford, Eric] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA; [Strom, Thad Q.] Univ Minnesota, Med Ctr, Dept Vet Affairs, Minneapolis, MN 55455 USA; [Strom, Thad Q.] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA		Vanderploeg, RD (corresponding author), James A Haley Vet Hosp, Tampa, FL 33612 USA.	Rodney.Vanderploeg@va.gov		Strom, Thad/0000-0001-6743-9999	Department of Veterans AffairsUS Department of Veterans Affairs; Veterans Health AdministrationUS Department of Veterans Affairs; Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs	This research reported was supported by the Department of Veterans Affairs, Veterans Health Administration, and Defense and Veterans Brain Injury Center with resources and the use of facilities at the James A. Haley Veterans' Hospital. The views expressed herein are those of the authors and do not necessarily reflect the views or the official policy of the Department of Army, Department of Defense, Department of Veterans Affairs, or US Government.	[Anonymous], 2013, DIAGN STAT MAN MENT, V5th ed., DOI [DOI 10.1176/APPI.BOOKS, 10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Blake D, 2000, CLIN ADM PTSD SCALE; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cicerone KD, 2007, J HEAD TRAUMA REHAB, V22, P257, DOI 10.1097/01.HTR.0000290970.56130.81; Cooper DB, 2012, MIL MED, V177, P1157, DOI 10.7205/MILMED-D-12-00098; Crawford EF, 2017, J NERV MENT DIS, V205, P140, DOI 10.1097/NMD.0000000000000594; Department of Veteran Affairs, 2010, REP VA CONS C PRACT; Drag L, 2013, J HEAD TRAUMA REHAB, V28, P39, DOI 10.1097/HTR.0b013e318263bb61; Foa, 2003, J COGN PSYCHOTHER, V17, P113, DOI [10.1891/jcop.17.2.113.57434, DOI 10.1891/JC0P.17.2.113.57434]; Foa E.B., 2007, PROLONGED EXPOSURE T; Foa EB, 1999, J CONSULT CLIN PSYCH, V67, P194, DOI 10.1037/0022-006X.67.2.194; Foa EB, 2005, J CONSULT CLIN PSYCH, V73, P953, DOI 10.1037/0022-006X.73.5.953; Goodson JT, 2013, J TRAUMA STRESS, V26, P419, DOI 10.1002/jts.21830; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P745, DOI 10.1007/978-0-387-76978-3_24; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Kolitz BP, 2003, ARCH PHYS MED REHAB, V84, P277, DOI 10.1053/apmr.2003.50100; Lorig KR, 1999, MED CARE, V37, P5, DOI 10.1097/00005650-199901000-00003; Management of Concussion/mTBIWorking Group, 2009, J REHABIL RES DEV, V46, pCP1; Marx BP, 2009, ARCH GEN PSYCHIAT, V66, P996, DOI 10.1001/archgenpsychiatry.2009.109; Merritt VC, 2015, BRAIN INJURY, V29, P1325, DOI 10.3109/02699052.2015.1043948; Myers SS, 2013, P NATL ACAD SCI USA, V110, P18753, DOI 10.1073/pnas.1218656110; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Rauch SAM, 2009, DEPRESS ANXIETY, V26, P732, DOI 10.1002/da.20518; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Schnurr PP, 2003, ARCH GEN PSYCHIAT, V60, P481, DOI 10.1001/archpsyc.60.5.481; Silva MA, 2013, CLIN NEUROPSYCHOL, V27, P601; Sripada RK, 2013, J TRAUMA STRESS, V26, P369, DOI 10.1002/jts.21813; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Strom TQ, 2016, COGN BEHAV PRACT, V23, P148, DOI 10.1016/j.cbpra.2015.03.003; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Tuerk PW, 2013, PSYCHOL SERV, V10, P401, DOI 10.1037/a0030549; Uomoto JM, 2009, REHABIL PSYCHOL, V54, P259, DOI 10.1037/a0016907; US Department of Defense Congressional Report, US MIL CAS STAT OP N; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Vasterling JJ, 2012, J INT NEUROPSYCH SOC, V18, P390, DOI 10.1017/S1355617712000367; Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027; Walker RL, 2010, PSYCHOL SERV, V7, P136, DOI 10.1037/a0019684; Wang YP, 2013, REV BRAS PSIQUIATR, V35, P416, DOI 10.1590/1516-4446-2012-1048; Weathers F. W., 1993, 9 ANN M INT SOC TRAU; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; Wolf GK, 2015, J TRAUMA STRESS, V28, P339, DOI 10.1002/jts.22029; Wolf GK, 2012, J HEAD TRAUMA REHAB, V27, P26, DOI 10.1097/HTR.0b013e31823cd01f; Zatzick DF, 2010, ARCH GEN PSYCHIAT, V67, P1291, DOI 10.1001/archgenpsychiatry.2010.158	53	17	17	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2018	33	2					E53	E63		10.1097/HTR.0000000000000344			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GN6AI	WOS:000439152200006	28926486				2022-02-06	
J	Xu, Z; Wang, W; Ren, YT; Zhang, WC; Fang, PL; Huang, LF; Wang, X; Shi, P				Xu, Zhen; Wang, Wei; Ren, Yutian; Zhang, Wenchong; Fang, Peilin; Huang, Linfeng; Wang, Xin; Shi, Peng			Regeneration of cortical tissue from brain injury by implantation of defined molecular gradient of semaphorin 3A	BIOMATERIALS			English	Article						Tissue engineering; Molecular gradient; Brain regeneration; Chemotaxis; Semaphorin	NEURAL STEM-CELLS; GROWTH-FACTOR; SPINAL-CORD; MIGRATION; ISCHEMIA; TRANSPLANTATION; PROLIFERATION; NEUROGENESIS; MECHANISMS; SCAFFOLDS	Despite great efforts in the exploration of therapeutic strategies for treating brain injuries, it is still challenging to regenerate neural tissues and to restore the lost function within an injured brain. In this report, we employed a tissue engineering approach to regenerate cortical tissue from brain injury by implantation of defined semaphorin 3A (Sema3A) gradient packaged in a hydrogel based device. Over a thirty-day recovery period, the implanted Sema3A gradient was sufficient to induce substantial migration of neural progenitor cells to the hydrogel and to promote differentiation of these cells for neuroregeneration at the injury site. As revealed by molecular characterization and RNA transcriptome analysis, the regenerated tissues induced by Sema3A gradient exhibited significant similarity to normal cortical tissues. Many genes associated with neuronal migration and stem cell differentiation were significantly up-regulated. In addition, our result suggested a crosstalk between Sema3A and Wnt/beta-catenin pathways in course of induced brain regeneration. This study demonstrated an innovative strategy to regenerate brain tissue after traumatic injury by controlling the in vivo chemotactic environment with unprecedented sophistication, and also resolved new insights about Sema3A's role in adult neurogenesis. (C) 2017 Elsevier Ltd. All rights reserved.	[Xu, Zhen; Zhang, Wenchong; Fang, Peilin; Shi, Peng] City Univ Hong Kong, Dept Mech & Biomed Engn, Kowloon, Hong Kong, Peoples R China; [Wang, Wei; Ren, Yutian; Huang, Linfeng; Wang, Xin] City Univ Hong Kong, Dept Biomed Sci, Kowloon, Hong Kong, Peoples R China; [Huang, Linfeng; Shi, Peng] City Univ Hong Kong, Shenzhen Res Inst, Shenzhen 518000, Guangdong, Peoples R China		Shi, P (corresponding author), City Univ Hong Kong, Dept Mech & Biomed Engn, Kowloon, Hong Kong, Peoples R China.	pengshi@cityu.edu.hk	Wang, Xin/A-1130-2012	SHI, Peng/0000-0003-0629-4161; Huang, Linfeng/0000-0002-0322-4929	General Research Fund from RGC Hong Kong SAR [GRF11278616, GRF11218015, GRF11211314]; Health and Medical Research Fund from the Food and Health Bureau of Hong Kong SAR [HMRF 03141146]; Collaborative Research Fund from RGC Hong Kong SAR [C5015-15G, C1014-15G]	This work was support by General Research Fund from RGC Hong Kong SAR (GRF11278616, GRF11218015, GRF11211314), Health and Medical Research Fund from the Food and Health Bureau of Hong Kong SAR (HMRF 03141146), and also by Collaborative Research Fund from RGC Hong Kong SAR (C5015-15G, C1014-15G).	Bellenchi GC, 2013, J NEUROCHEM, V124, P159, DOI 10.1111/jnc.12084; Boyd AS, 2005, ADV DRUG DELIVER REV, V57, P1944, DOI 10.1016/j.addr.2005.08.004; Burns TC, 2009, J COMP NEUROL, V515, P125, DOI 10.1002/cne.22038; Chen G, 2008, NAT NEUROSCI, V11, P36, DOI 10.1038/nn2018; Cooke MJ, 2011, BIOMATERIALS, V32, P5688, DOI 10.1016/j.biomaterials.2011.04.032; Cooper JA, 2013, J CELL BIOL, V202, P725, DOI 10.1083/jcb.201305021; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Drive G., 2009, NAT REV NEUROSCI, V10, P682; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Guan J, 2013, BIOMATERIALS, V34, P5937, DOI 10.1016/j.biomaterials.2013.04.047; Hakanen J, 2011, DEV BIOL, V355, P101, DOI 10.1016/j.ydbio.2011.04.016; Hou ST, 2015, SCI REP-UK, V5, DOI 10.1038/srep07890; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Kaneko S, 2006, NAT MED, V12, P1380, DOI 10.1038/nm1505; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Klambt C, 2009, NAT REV NEUROSCI, V10, P769, DOI 10.1038/nrn2720; Kolodkin Alex L, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a001727; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Larpthaveesarp A, 2015, BRAIN SCI, V5, P165, DOI 10.3390/brainsci5020165; Lau TT, 2011, EXPERT OPIN BIOL TH, V11, P189, DOI 10.1517/14712598.2011.546338; Leipzig ND, 2011, BIOMATERIALS, V32, P57, DOI 10.1016/j.biomaterials.2010.09.031; Li SL, 2010, NAT NEUROSCI, V13, P1496, DOI 10.1038/nn.2674; LINDHOLM D, 1992, J CELL BIOL, V117, P395, DOI 10.1083/jcb.117.2.395; Lu HY, 2012, STROKE, V43, P838, DOI 10.1161/STROKEAHA.111.635235; Ma DK, 2005, CURR OPIN NEUROBIOL, V15, P514, DOI 10.1016/j.conb.2005.08.003; Majed HH, 2006, J NEUROSCI, V26, P1730, DOI 10.1523/JNEUROSCI.0702-05.2006; Marin O, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001834; Niu WZ, 2011, J NEUROSCI, V31, P13816, DOI 10.1523/JNEUROSCI.1038-11.2011; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Robin AM, 2006, J CEREBR BLOOD F MET, V26, P125, DOI 10.1038/sj.jcbfm.9600172; Sansom SN, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002519; Scafidi J, 2014, NATURE, V506, P230, DOI 10.1038/nature12880; Teramoto T, 2003, J CLIN INVEST, V111, P1125, DOI 10.1172/JCI200317170; Titomanlio L, 2011, ANN NEUROL, V70, P698, DOI 10.1002/ana.22518; Torisawa YS, 2014, NAT METHODS, V11, P663, DOI [10.1038/NMETH.2938, 10.1038/nmeth.2938]; Vulic K, 2014, BIOMACROMOLECULES, V15, P3867, DOI 10.1021/bm501084u; Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998	37	17	19	4	61	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0142-9612	1878-5905		BIOMATERIALS	Biomaterials	MAR	2018	157						125	135		10.1016/j.biomaterials.2017.12.010			11	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	FS1LZ	WOS:000419538800011	29268143				2022-02-06	
J	Haris, A; Lee, HP; Tan, VBC				Haris, Andi; Lee, Heow Pueh; Tan, Vincent Beng Chye			An experimental study on shock wave mitigation capability of polyurea and shear thickening fluid based suspension pads	DEFENCE TECHNOLOGY			English	Article						Shock wave mitigation; Polyurea; Shear thickening fluid; Suspension pad; Ballistic fabric; Primary blast injuries	TRAUMATIC BRAIN-INJURY; CONCENTRATED SUSPENSIONS; BLAST; AMPLIFICATION; MILITARY; RHEOLOGY; MODELS; IMPACT; HELMET	The present experimental study investigates shock wave mitigation capability of potentially new personal protective equipment (PPE) suspension pads made from polyurea and shear thickening fluid (STF). The shock tube test results show that when placed behind Twaron fabric systems with thickness ranging from 2 mm to 18 mm, the replacement of conventional flexible foam pad with STF and STF-infused foam pads with the same thickness of 20 mm greatly reduces the normalized peak pressure (by about 72% for each pad). However, this benefit is partially offset by a large increase in the normalized impulse (by about 78% for the STF pad and 131% for the STF-infused foam pad) which may cause the shock wave mitigation performance of these two pads to become less effective. Interestingly, the use of 4 mm thick polyurea pad can greatly reduce the normalized peak pressure and impulse as well (by about 74% and 49%, respectively). These results reveal that among the potentially new suspension pads tested, the polyurea pad displays the best shock wave mitigation performance. Therefore, polyurea has potential for use as a suspension pad in personal protective equipment requiring shock wave mitigation capability such as fabric ballistic vests, bomb suits and combat helmets. (C) 2018 Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license.	[Haris, Andi; Lee, Heow Pueh; Tan, Vincent Beng Chye] Natl Univ Singapore, Dept Mech Engn, 9 Engn Dr 1, Singapore 117576, Singapore		Tan, VBC (corresponding author), Natl Univ Singapore, Dept Mech Engn, 9 Engn Dr 1, Singapore 117576, Singapore.	mpetanbc@nus.edu.sg	Lee, Heow Pueh/I-7834-2014; Tan, Vincent/R-8040-2019	Lee, Heow Pueh/0000-0002-4380-3888; Tan, Vincent/0000-0003-1436-5337; Haris, Andi/0000-0002-8747-1408	Ministry of Education, SingaporeMinistry of Education, Singapore [R265000533112]	This work has been supported by the Ministry of Education, Singapore (R265000533112).	Arman B, 2012, MACROMOLECULES, V45, P3247, DOI 10.1021/ma3001934; Baker WE, 1977, TECHNICAL REPORT; Baker WE, 1981, TECHNICAL REPORT; BARNES HA, 1989, J RHEOL, V33, P329, DOI 10.1122/1.550017; Bhattacharjee Y, 2008, SCIENCE, V319, P406, DOI 10.1126/science.319.5862.406; Bowen IG, 1969, TECHNICAL REPORT; BRADY JF, 1985, J FLUID MECH, V155, P105, DOI 10.1017/S0022112085001732; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Chandra N, 2012, SHOCK WAVES, V22, P403, DOI 10.1007/s00193-012-0399-2; Chattopadhyay DK, 2007, PROG POLYM SCI, V32, P352, DOI 10.1016/j.progpolymsci.2006.05.003; Colombo M, 2011, EXP MECH, V51, P1143, DOI 10.1007/s11340-010-9430-7; Crawford NC, 2013, J COLLOID INTERF SCI, V396, P83, DOI 10.1016/j.jcis.2013.01.024; Cripps NPJ, 1996, J TRAUMA, V40, pS206, DOI 10.1097/00005373-199603001-00045; David NV, 2009, APPL MECH REV, V62, DOI 10.1115/1.3124644; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Ding J, 2013, TLIST, V2, P161; Ganpule S, 2012, COMPUT METHOD BIOMEC, V15, P1233, DOI 10.1080/10255842.2011.597353; Gawande A, 2004, NEW ENGL J MED, V351, P2471, DOI 10.1056/NEJMp048317; GIBSON PW, 1995, J TEXT I, V86, P119, DOI 10.1080/00405009508631315; Grujicic A, 2012, J MATER ENG PERFORM, V21, P1562, DOI 10.1007/s11665-011-0065-3; Grujicic M, 2012, J MATER SCI, V47, P8197, DOI 10.1007/s10853-012-6716-4; Grujicic M, 2011, MAT SCI ENG A-STRUCT, V528, P3799, DOI 10.1016/j.msea.2011.01.081; Grujicic M, 2010, MATER DESIGN, V31, P4050, DOI 10.1016/j.matdes.2010.05.002; Haris A, 2015, INT J IMPACT ENG, V80, P143, DOI 10.1016/j.ijimpeng.2015.02.008; HOFFMAN RL, 1974, J COLLOID INTERF SCI, V46, P491, DOI 10.1016/0021-9797(74)90059-9; Jazi Mehdi Salimi, 2014, International Journal of Experimental and Computational Biomechanics, V2, P223, DOI 10.1504/IJECB.2014.060400; Lew HL, 2005, AM J PHYS MED REHAB, V84, P393, DOI 10.1097/01.phm.0000163703.91647.a7; Liu SJ, 2010, MATER DESIGN, V31, P1711, DOI 10.1016/j.matdes.2009.01.044; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Mott D.R., 2008, P 20 INT S MIL ASP B; Nyein MK, 2011, P NATL ACAD SCI USA, V108, pE83, DOI 10.1073/pnas.1102626108; Owers C, 2011, BRIT J SURG, V98, P168, DOI 10.1002/bjs.7268; Peota Carmen, 2005, Minn Med, V88, P13; PHILLIPS YY, 1988, J TRAUMA, V28, pS149, DOI 10.1097/00005373-198801001-00030; Skews BW, 2006, TEXT RES J, V76, P328, DOI 10.1177/0040517506062264; Tham CY, 2008, INT J IMPACT ENG, V35, P304, DOI 10.1016/j.ijimpeng.2007.03.008; White CS, 1971, TECHNICAL REPORT; White EEB, 2010, RHEOL ACTA, V49, P119, DOI 10.1007/s00397-009-0415-3; Wilson C., 2005, CRS REP C; Zhu F, 2011, COMPOS PART B-ENG, V42, P1202, DOI 10.1016/j.compositesb.2011.02.014	40	17	18	1	9	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2214-9147			DEF TECHNOL	Def. Technol.	FEB	2018	14	1					12	18		10.1016/j.dt.2017.08.004			7	Engineering, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	FX9SL	WOS:000426445200002		gold			2022-02-06	
J	Pressly, JD; Mustafa, SM; Adibi, AH; Alghamdi, S; Pandey, P; Roy, KK; Doerksen, RJ; Moore, BM; Park, F				Pressly, Jeffrey D.; Mustafa, Suni M.; Adibi, Ammaar H.; Alghamdi, Sahar; Pandey, Pankaj; Roy, Kuldeep K.; Doerksen, Robert J.; Moore, Bob M., Jr.; Park, Frank			Selective Cannabinoid 2 Receptor Stimulation Reduces Tubular Epithelial Cell Damage after Renal Ischemia-Reperfusion Injury	JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS			English	Article							ACUTE KIDNEY INJURY; CISPLATIN-INDUCED NEPHROTOXICITY; TYPE-2 DIABETIC-NEPHROPATHY; TRAUMATIC BRAIN-INJURY; CB2 RECEPTOR; ENDOCANNABINOID SYSTEM; HOSPITALIZED-PATIENTS; INVERSE AGONIST; MOUSE MODEL; DISEASE	Ischemia-reperfusion injury (IRI) is a common cause of acute kidney injury (AKI), which is an increasing problem in the clinic and has been associated with elevated rates of mortality. Therapies to treat AKI are currently not available, so identification of new targets that can be modulated to ameliorate renal damage upon diagnosis of AKI is essential. In this study, a novel cannabinoid receptor 2 (CB2) agonist, SMM-295 [3'-methyl-4-(2-(thiophen-2-yl)propan-2-yl)biphenyl-2,6-diol], was designed, synthesized, and tested in vitro and in silico. Molecular docking of SMM-295 into a CB2 active-state homology model showed that SMM-295 interacts well with key amino acids to stabilize the active state. In human embryonic kidney 293 cells, SMM-295 was capable of reducing cAMP production with 66-fold selectivity for CB2 versus cannabinoid receptor 1 and dose-dependently increased mitogen-activated protein kinase and Akt phosphorylation. In vivo testing of the CB2 agonist was performed using a mouse model of bilateral IRI, which is a common model to mimic human AKI, where SMM-295 was immediately administered upon reperfusion of the kidneys after the ischemia episode. Histologic damage assessment 48 hours after reperfusion demonstrated reduced tubular damage in the presence of SMM-295. This was consistent with reduced plasma markers of renal dysfunction (i.e., creatinine and neutrophil gelatinase-associated lipocalin) in SMM-295-treated mice. Mechanistically, kidneys treated with SMM-295 were shown to have elevated activation of Akt with reduced terminal deoxynucleotidyl transferase-mediated digoxigenin-deoxyuridine nick-end labeling (TUNEL)-positive cells compared with vehicle-treated kidneys after IRI. These data suggest that selective CB2 receptor activation could be a potential therapeutic target in the treatment of AKI.	[Pressly, Jeffrey D.; Mustafa, Suni M.; Adibi, Ammaar H.; Alghamdi, Sahar; Moore, Bob M., Jr.; Park, Frank] Univ Tennessee, Hlth Sci Ctr, Coll Pharm, Dept Pharmaceut Sci, 881 Madison Ave,Room 442, Memphis, TN 38163 USA; [Pandey, Pankaj; Roy, Kuldeep K.; Doerksen, Robert J.] Univ Mississippi, Sch Pharm, Div Med Chem, Dept Biomol Sci, University, MS 38677 USA; [Doerksen, Robert J.] Univ Mississippi, Sch Pharm, Res Inst Pharmaceut Sci, University, MS 38677 USA; [Roy, Kuldeep K.] Natl Inst Pharmaceut Educ & Res, Kolkata, W Bengal, India		Moore, BM; Park, F (corresponding author), Univ Tennessee, Hlth Sci Ctr, Coll Pharm, Dept Pharmaceut Sci, 881 Madison Ave,Room 442, Memphis, TN 38163 USA.	bmoore@uthsc.edu; fpark@uthsc.edu	Pandey, Pankaj/AAW-4910-2020; Roy, Kuldeep K/R-1762-2016; Park, Frank/I-4590-2019	Park, Frank/0000-0003-2324-2937; , NIPERKolkata/0000-0003-4906-3988; Roy, Kuldeep/0000-0001-9623-0617; Abidi, Ammaar/0000-0003-1826-9377; Doerksen, Robert/0000-0002-3789-1842; Pressly, Jeffrey/0000-0003-2151-8864	University of Tennessee Health Science Center; National Institutes of Health National Institute of Diabetes and Digestive and Kidney DiseasesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01-DK090123]; National Institutes of Health National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20-GM104932, R15-GM119061]; National Science FoundationNational Science Foundation (NSF) [MRI1338056]; Mississippi Center for Supercomputer Research; National Institutes of Health Research Facilities Improvements ProgramUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [C06-RR14503]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [C06RR014503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK090123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM104932, R15GM119061] Funding Source: NIH RePORTER	This work was partially funded by the University of Tennessee Health Science Center [institutional funds (to F.P.)], the National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases [Grants R01-DK090123 (to F.P.), and the National Institutes of Health National Institute of General Medical Sciences [Grants P20-GM104932 and R15-GM119061 (to R.J.D.)]. Supercomputer support from the National Science Foundation [Grant MRI1338056] and the Mississippi Center for Supercomputer Research [both to (R.J.D.)] is acknowledged. This investigation was conducted in part in a facility constructed with support from the National Institutes of Health Research Facilities Improvements Program [Grant C06-RR14503 (to R.J.D.)].	Barutta F, 2011, DIABETES, V60, P2386, DOI 10.2337/db10-1809; Basile DP, 2012, COMPR PHYSIOL, V2, P1303, DOI 10.1002/cphy.c110041; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Brents LK, 2012, XENOBIOTICA, V42, P139, DOI 10.3109/00498254.2011.609570; Bu W, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00449; Cabral GA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000957; Calvaruso G, 2012, INT J ONCOL, V41, P407, DOI 10.3892/ijo.2012.1476; Cassano T., 2017, NEUROSCIENCE, V11, P30, DOI [10.3389/fnins.2017.0003028210207, DOI 10.3389/FNINS.2017.00030]; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Chawla LS, 2014, NEW ENGL J MED, V371, P58, DOI 10.1056/NEJMra1214243; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Cichero E, 2011, EUR J MED CHEM, V46, P4489, DOI 10.1016/j.ejmech.2011.07.023; Curtis MJ, 2015, BRIT J PHARMACOL, V172, P3461, DOI 10.1111/bph.12856; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Deutsch DG, 1997, J CLIN INVEST, V100, P1538, DOI 10.1172/JCI119677; Dore A, 2016, BIOORGAN MED CHEM, V24, P5291, DOI 10.1016/j.bmc.2016.08.055; Feizi A, 2008, EXP TOXICOL PATHOL, V60, P405, DOI 10.1016/j.etp.2008.04.006; Feng ZW, 2014, J CHEM INF MODEL, V54, P2483, DOI 10.1021/ci5002718; Fouad AA, 2012, LIFE SCI, V91, P284, DOI 10.1016/j.lfs.2012.07.030; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Glomme A, 2005, J PHARM SCI-US, V94, P1, DOI 10.1002/jps.20212; Guzman M, 2002, PHARMACOL THERAPEUT, V95, P175, DOI 10.1016/S0163-7258(02)00256-5; Harder E, 2016, J CHEM THEORY COMPUT, V12, P281, DOI 10.1021/acs.jctc.5b00864; Heung M, 2014, NEPHRON CLIN PRACT, V127, P30, DOI 10.1159/000363675; Horvath B, 2012, FREE RADICAL BIO MED, V52, P1325, DOI 10.1016/j.freeradbiomed.2012.01.014; Howlett AC, 2005, HANDB EXP PHARMACOL, V168, P53; Hryciw DH, 2016, CURR OPIN NEPHROL HY, V25, P459, DOI 10.1097/MNH.0000000000000249; Hu JP, 2016, J CHEM INF MODEL, V56, P1152, DOI 10.1021/acs.jcim.5b00739; Hurst DP, 2010, J BIOL CHEM, V285, P17954, DOI 10.1074/jbc.M109.041590; Jenkin KA, 2016, BRIT J PHARMACOL, V173, P1128, DOI 10.1111/bph.13056; Jenkin KA, 2013, CELL PHYSIOL BIOCHEM, V32, P1309, DOI 10.1159/000354529; Jenkin KA, 2010, CELL PHYSIOL BIOCHEM, V26, P879, DOI 10.1159/000323997; Jourdan T, 2014, P NATL ACAD SCI USA, V111, pE5420, DOI 10.1073/pnas.1419901111; Kazory A, 2013, CLIN KIDNEY J, V6, P330, DOI 10.1093/ckj/sft047; Klein TW, 2003, J LEUKOCYTE BIOL, V74, P486, DOI 10.1189/jlb.0303101; Kusakabe K, 2013, BIOORGAN MED CHEM, V21, P3154, DOI 10.1016/j.bmc.2013.03.030; Kwon M, 2012, P NATL ACAD SCI USA, V109, P21462, DOI 10.1073/pnas.1216830110; Lenarczyk M, 2015, J MOL HISTOL, V46, P123, DOI 10.1007/s10735-014-9605-0; Lucchesi V, 2014, J MED CHEM, V57, P8777, DOI 10.1021/jm500807e; Macedo E, 2009, CURR OPIN CRIT CARE, V15, P467, DOI 10.1097/MCC.0b013e328332f6e3; Mukhopadhyay P, 2016, BRIT J PHARMACOL, V173, P446, DOI 10.1111/bph.13338; Mukhopadhyay P, 2010, BRIT J PHARMACOL, V160, P657, DOI 10.1111/j.1476-5381.2010.00769.x; Mukhopadhyay P, 2010, FREE RADICAL BIO MED, V48, P457, DOI 10.1016/j.freeradbiomed.2009.11.022; National Research Council, 2011, GUIDE CARE USE LAB A; Nettekoven M, 2016, CHEMMEDCHEM, V11, P179, DOI 10.1002/cmdc.201500218; Ortega-Gutierrez S, 2005, FASEB J, V19, P1338, DOI 10.1096/fj.04-2464fje; Park F, 2008, J AM SOC NEPHROL, V19, P1929, DOI 10.1681/ASN.2007070771; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Presley C, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.159; Presley CS, 2015, BIOORGAN MED CHEM, V23, P5390, DOI 10.1016/j.bmc.2015.07.057; Pressly JD, 2017, SCI REP-UK, V7, DOI 10.1038/srep43196; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rastogi H., 2013, J DRUG DELIV THER, V3, P20, DOI DOI 10.22270/JDDT.V3I3.506; Reggio PH, 2010, CURR MED CHEM, V17, P1468, DOI 10.2174/092986710790980005; Regner KR, 2011, FASEB J, V25, P1844, DOI 10.1096/fj.10-169797; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Shohami E, 2011, BRIT J PHARMACOL, V163, P1402, DOI 10.1111/j.1476-5381.2011.01343.x; Soethoudt M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13958; Srisung Weeraporn, 2015, Proc (Bayl Univ Med Cent), V28, P475; Tetko IV, 2009, MOL DRUG PROPERTIES, P381; Thomas A, 2007, BRIT J PHARMACOL, V150, P613, DOI 10.1038/sj.bjp.0707133; Univ. Tennessee Res. Found, 2011, [No title captured], Patent No. [7,888,365, 7888365, 7888365B2]; Walter L, 2003, J NEUROSCI, V23, P1398, DOI 10.1523/JNEUROSCI.23-04-01398.2003; Wang HE, 2012, AM J NEPHROL, V35, P349, DOI 10.1159/000337487; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; White SM, 2014, MOL PHARMACOL, V86, P369, DOI 10.1124/mol.114.092346; Witkamp R, 2014, CURR OPIN CLIN NUTR, V17, P130, DOI 10.1097/MCO.0000000000000027; Yang L, 2011, CONTRIB NEPHROL, V174, P149, DOI 10.1159/000329385; Zarruk JG, 2012, STROKE, V43, P211, DOI 10.1161/STROKEAHA.111.631044; Zhang YX, 2011, INT IMMUNOPHARMACOL, V11, P1303, DOI 10.1016/j.intimp.2011.04.013; Zoja C, 2016, NEPHRON, V132, P59, DOI 10.1159/000442679	74	17	18	0	7	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0022-3565	1521-0103		J PHARMACOL EXP THER	J. Pharmacol. Exp. Ther.	FEB 1	2018	364	2					287	299		10.1124/jpet.117.245522			13	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	FS9BL	WOS:000422709100013	29187590	Green Published, Bronze			2022-02-06	
J	Staniloiu, A; Markowitsch, HJ; Kordon, A				Staniloiu, Angelica; Markowitsch, Hans J.; Kordon, Andreas			Psychological causes of autobiographical amnesia: A study of 28 cases	NEUROPSYCHOLOGIA			English	Article						Stress; Mild traumatic brain injury; Culture; Forensic context; Fugue; Effort; Anterograde amnesia	PERSISTENT ANTEROGRADE AMNESIA; FUNCTIONAL RETROGRADE-AMNESIA; GENDER-DIFFERENCES; PSYCHOGENIC AMNESIA; EPISODIC MEMORY; BRAIN; DISSOCIATION; RETRIEVAL; STRESS; TRAUMA	Autobiographical amnesia is found in patients with focal or diffuse brain damage ("organic amnesia"), but also without overt brain damage (at least when measured with conventional brain imaging methods). This last condition is usually named dissociative amnesia at present, and was originally described as hysteria. Classically and traditionally, dissociative amnesia is seen as a disorder that causes retrograde amnesia in the autobiographical domain in the aftermath of incidents of major psychological stress or trauma. In the present study one of the probably largest published collections of patients (28) with psychogenically caused autobiographical amnesia, who were assessed with comprehensive neuropsychological tests, will be described and documented in order to identify variables which are central for the occurrence of dissociative amnesia. The presented cases demonstrate that autobiographical amnesia without direct brain damage can have very mixed clinical presentations, causes and consequences. The described cases of psychogenic amnesia are clustered according to a number of manifestations and features, which include a reduced effort to perform cognitively at a normal level, a forensic background, anterograde (instead of retrograde) autobiographical amnesia, the fugue condition, concurrent somatic diseases, and their appearance in childhood and youth. It is concluded that autobiographical amnesia of a psychogenic origin may occur within a variety of symptom pictures. For all patients, it probably serves a protective function by offering them a mechanism to exit a life situation which appears to them unmanageable or adverse.	[Staniloiu, Angelica; Markowitsch, Hans J.] Univ Bielefeld, Physiol Psychol, Bielefeld, Germany; [Staniloiu, Angelica] Univ Bucharest, Dept Psychol, Bucharest, Romania; [Staniloiu, Angelica] Sunnybrook Hlth Sci Ctr, Traumat Brain Injury Clin, Toronto, ON, Canada; [Staniloiu, Angelica] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Kordon, Andreas] Oberbergklin Hornberg, Hornberg, Germany; [Kordon, Andreas] Univ Freiburg, Dept Psychiat, Freiburg, Germany		Markowitsch, HJ (corresponding author), Univ Bielefeld, Dept Physiol Psychol, POB 10 01 31, D-33501 Bielefeld, Germany.	hjmarkowitsch@uni-bielefeld.de					American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th; Anderson MC, 2014, TRENDS COGN SCI, V18, P279, DOI 10.1016/j.tics.2014.03.002; Baddeley A. D., 1990, AUTOBIOGRAPHICAL MEM; Baddeley A.D., 1994, DOORS PEOPLE TEST; Barbarotto R, 1996, NEUROPSYCHOLOGIA, V34, P575, DOI 10.1016/0028-3932(95)00141-7; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Bartsch T, 2010, LANCET NEUROL, V9, P205, DOI 10.1016/S1474-4422(09)70344-8; Borsutzky S., 2006, TESTBATTERIE ERFASSU; Bowers D., 1991, FLORIDA AFFECT BATTE; Brand M, 2009, PSYCHIAT RES-NEUROIM, V174, P32, DOI 10.1016/j.pscychresns.2009.03.008; Brand M, 2009, BRAIN COGNITION, V69, P279, DOI 10.1016/j.bandc.2008.08.003; Breitenstein C., 1996, NEUROLOGIE REHABILIT, V2, P93; Bremner J.D., 2010, PSYCHOL BULL, V136, P1, DOI DOI 10.1037/A0018021; Breuer J., 1895, STUDIEN OBER HYSTERI; Brickenkamp R., 1998, D2 TEST ATTENTION; Calabrese P, 2000, EISAI; Charcot JM., 1892, REV MED, V12, P81; Coons PM, 1992, DISSOCIATION, V5, P73; Dalenberg CJ, 2014, PSYCHOL BULL, V140, P911, DOI 10.1037/a0036685; Dalenberg CJ, 2012, PSYCHOL BULL, V138, P550, DOI 10.1037/a0027447; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Diseth TH, 2005, NORD J PSYCHIAT, V59, P278, DOI 10.1080/08039480500213683; Dong DB, 2017, SCHIZOPHR RES, V185, P41, DOI 10.1016/j.schres.2017.01.005; ELLISON G, 1994, BRAIN RES REV, V19, P223, DOI 10.1016/0165-0173(94)90012-4; Estupina FJ, 2012, SPAN J PSYCHOL, V15, P275, DOI 10.5209/rev_SJOP.2012.v15.n1.37334; Fahrenberg J., 2001, FREIHURGER PERSONLIC; Fink GR, 1996, J NEUROSCI, V16, P4275; Flechsig P, 1896, GEHIRN UND SEELE; Forstl H, 2008, ACTA PSYCHIAT SCAND, V118, P499, DOI 10.1111/j.1600-0447.2008.01269.x; Fujiwara E, 2008, CORTEX, V44, P29, DOI 10.1016/j.cortex.2005.09.001; Gast U., 2004, STRUKTURIERTES KLIN; Giesbrecht T, 2008, PSYCHOL BULL, V134, P617, DOI 10.1037/0033-2909.134.5.617; Giger P, 2010, J FORENSIC PSYCHOL P, V10, P440, DOI 10.1080/15228932.2010.489875; Hafner H., 2008, KONING WIRD BESEITIG; Hall, 2004, INT J FORENSIC PSYCH, V1, P33; Harting C., 2000, WECHSLER MEMORY SCAL; Hautzinger M., 2006, BECK DEPRESSIONSINVE; Hering E., 1870, P VIENN 30 MAY MDCCC; Hessel A, 2001, DIAGNOSTICA, V47, P27, DOI 10.1026//0012-1924.47.1.27; Heubrock D., 2000, TESTBATTERIE FORENSI; Janet P., 1907, MAJOR SYMPTOMS HYSTE; Janet P., 1893, REV GENERALE SCI, V4, P167; Kessler J, 1997, J CLIN EXP NEUROPSYC, V19, P604, DOI 10.1080/01688639708403746; Koch C, 2016, NAT REV NEUROSCI, V17, P307, DOI 10.1038/nrn.2016.22; KOPELMAN MD, 1994, NEUROPSYCHOLOGIA, V32, P675, DOI 10.1016/0028-3932(94)90028-0; Kritchevsky M, 2004, LEARN MEMORY, V11, P213, DOI 10.1101/lm.71404; Kroll NEA, 1997, BRAIN, V120, P1377, DOI 10.1093/brain/120.8.1377; Kruse K, 2010, SEIN GERLACHTNIS VER; LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825; Langnickel R, 2010, SIGMUND FREUD HEUTE, P149; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Lehr S, 2005, MEHRFACHWAHL WORTSCH; Leplow B, 1997, DIAGNOSTICA, V43, P192; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Maaranen P, 2005, J NERV MENT DIS, V193, P690, DOI 10.1097/01.nmd.0000181353.69821.44; Markowitsch HJ, 2016, HAND CLINIC, V139, P419, DOI 10.1016/B978-0-12-801772-2.00036-9; Markowitsch H J, 1997, Cogn Neuropsychiatry, V2, P135, DOI 10.1080/135468097396379; Markowitsch H. J, 2013, ISRN NEUROSCI; Markowitsch H. J., 2015, PERSONLICHKEITSSTORU, V19, P1; Markowitsch H. J., 2017, OXFORD HDB HIST CLIN; Markowitsch HJ, 2013, CORTEX, V49, P1494, DOI 10.1016/j.cortex.2012.05.020; Markowitsch HJ, 2012, LANCET, V380, P1429, DOI 10.1016/S0140-6736(11)61304-4; Markowitsch HJ, 2011, CONSCIOUS COGN, V20, P16, DOI 10.1016/j.concog.2010.09.005; Markowitsch Hans J, 2008, Handb Clin Neurol, V88, P155, DOI 10.1016/S0072-9752(07)88007-9; Markowitsch HJ, 1999, CORTEX, V35, P243, DOI 10.1016/S0010-9452(08)70797-4; Markowitsch HJ, 2000, NEUROPSY NEUROPSY BE, V13, P60; Markowitsch HJ, 1999, NEUROCASE, V5, P189, DOI 10.1093/neucas/5.3.189; Markowitsch HJ, 1998, NEUROPSYCHOLOGIA, V36, P77, DOI 10.1016/S0028-3932(97)00093-6; Markowitsch HJ, 1996, NEUROCASE, V2, P357; Markowitsch HJ, 2002, CORTEX, V38, P651, DOI 10.1016/S0010-9452(08)70030-3; Markowitsch HJ, 1997, PSYCHIAT RES-NEUROIM, V74, P119, DOI 10.1016/S0925-4927(97)03041-2; Markowitsch HJ, 1999, COGNITIVE NEUROSCIENCE OF MEMORY, P193; Markowitsch HJ, 1999, CURR OPIN PSYCHIATR, V12, P331, DOI 10.1097/00001504-199905000-00014; MARKOWITSCH HJ, 1990, TRANSIENT GLOBAL AMN; Maudsley Henry, 1870, BODY MIND INQUIRY TH; Metcalfe J., 2005, MISSING LINK COGNITI, P4, DOI DOI 10.1093/ACPROF:OSO/9780195161564.003.0001; Meynert T., 1884, PSYCHIAT KLIN ERKRAN; Minnich R., 2008, FORGETTING DAD; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Mubarik Ateeq, 2016, Trends Psychiatry Psychother., V38, P198, DOI 10.1590/2237-6089-2015-0088; Nazeri A., 2016, BIOL PSYCHIAT; Nelson KD, 2004, PSYCHOL REV, V111, P486, DOI 10.1037/0033-295X.111.2.486; NICHOLAS LE, 1989, APHASIOLOGY, V3, P569, DOI 10.1080/02687038908249023; OBrien JT, 1997, BRIT J PSYCHIAT, V170, P199, DOI 10.1192/S0007125000146513; OGDEN JA, 1993, NEUROPSYCHOLOGIA, V31, P571, DOI 10.1016/0028-3932(93)90053-3; PAKKENBERG B, 1992, SCHIZOPHR RES, V7, P95, DOI 10.1016/0920-9964(92)90038-7; Park CH, 2017, SCHIZOPHR RES, V188, P82, DOI 10.1016/j.schres.2017.01.025; Parwatikar S. D., 1990, TRANSIENT GLOBAL AMN, P191; Paulus C., 2012, SAARBRUCKER PERSONLI; Reinhardt S, 2008, ALCOHOL ALCOHOLISM, V43, P334, DOI 10.1093/alcalc/agn004; Reinhold N, 2007, J NEUROPSYCHOL, V1, P53, DOI 10.1348/174866407X180819; Reinhold N, 2009, NEUROPSYCHOLOGIA, V47, P2197, DOI 10.1016/j.neuropsychologia.2009.01.037; Rinne T., 2007, TRAUMATIC DISSOCIATI, P139; Schmand B., 2005, AMSTERDAMER KURZZEIT; Seidl U., 2006, WARUM MENSCHEN SICH, P286; SEIFFGEKRENKE I, 1993, J ADOLESCENCE, V16, P285, DOI 10.1006/jado.1993.1026; Seitz L, 2017, BRAIN IMAGING BEHAV; SPITZ HH, 1982, DEV PSYCHOL, V18, P922, DOI 10.1037/0012-1649.18.6.922; Spitzer C, 2003, PSYCHOPATHOLOGY, V36, P65, DOI 10.1159/000070360; Spitzer C, 2008, BUNDESGESUNDHEITSBLA, V51, P46, DOI 10.1007/s00103-008-0418-8; Spreen O., 1998, COMPENDIUM NEUROPSYC; Staniloiu A, 2017, DISSOCIATIVE DISORDE; Staniloiu A, 2015, INT ENCY SOCIAL BEHA, V1, P651; Staniloiu A, 2011, ADV BRAIN IMAGING, P11; Staniloiu A, 2012, FRONT PSYCHOL, V3, P1; Staniloiu A, 2012, FUNCTIONAL IMPAIRMEN, P87; Staniloiu A, 2017, DISSOZIATION MIGRATI; Staniloiu A., 2014, SUSTAINABLE DEV NURT, P22; Staniloiu A, 2012, J LIT THEORY, V6, P103, DOI 10.1515/jlt-2011-0012; Staniloiu A, 2014, LANCET PSYCHIAT, V1, P226, DOI 10.1016/S2215-0366(14)70279-2; Staniloiu A, 2012, BRAIN SCI, V2, P101, DOI 10.3390/brainsci2020101; Staniloiu A, 2010, CONSCIOUS COGN, V19, P778, DOI 10.1016/j.concog.2010.06.024; Staniloiu A, 2010, Z PSYCHOL, V218, P96, DOI 10.1027/0044-3409/a000017; Stone J, 2006, BRIT J PSYCHIAT, V188, P204, DOI 10.1192/bjp.188.3.204; Teichner G, 2004, ARCH CLIN NEUROPSYCH, V19, P455, DOI 10.1016/S0887-6177(03)00078-7; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tramoni E, 2009, NEUROPSYCHOLOGIA, V47, P611, DOI 10.1016/j.neuropsychologia.2008.11.012; Wittchen H.-U., 1997, STRUKTURIERTES KLIN; World Health Organization, 2010, INT CLASS MENT BEH D; Yang J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168239	121	17	17	0	26	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	FEB	2018	110				SI		134	147		10.1016/j.neuropsychologia.2017.10.017			14	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	FY9TZ	WOS:000427211100014	29050993				2022-02-06	
J	Sun, LQ; Zhao, MM; Liu, M; Su, P; Zhang, JB; Li, YX; Yang, XJ; Wu, ZX				Sun, Liqian; Zhao, Manman; Liu, Man; Su, Peng; Zhang, Jingbo; Li, Youxiang; Yang, Xinjian; Wu, Zhongxue			Suppression of FoxO3a attenuates neurobehavioral deficits after traumatic brain injury through inhibiting neuronal autophagy	BEHAVIOURAL BRAIN RESEARCH			English	Article						Traumatic brain injury; Neurobehavioral deficits; FoxO3a; Autophagy; Neuron	APOPTOSIS; CONTRIBUTES; ACTIVATION; DEGRADATION; ASTROCYTES; PATHWAY; DEATH; CELLS; MODEL; AXIS	Traumatic brain injury (TBI) is a serious insult that frequently leads to neurological impairments. Forkhead box O (FoxO) 3a, as transcription factor, has been confirmed to modulate autophagic process. Moreover, FoxO3a is expressed throughout the brain including the hippocampus. However, the role of FoxO3a in the pathophysiology of TBI is unclear. The present study is designed to investigate whether FoxO3a has the neuroprotective effects on rats subjected to TBI, and further to explore the potential molecular mechanisms. Thus, a rat model of TBI was created by using a modified weight-drop device to mimic the insults of TBI. The results showed that FoxO3a was significantly increased in the serum of patients with TBI as well as in experimental animals. Furthermore, our data also demonstrated that TBI stimulated the translocation of FoxO3a from the cytosol to the nucleus. Additionally, we found that knockdown of FoxO3a by siRNA silencing significantly improved neurobehavioral dysfunctions and conferred a better neuroprotective effects after TBI, evidenced by promoting motor behavioral recovery, attenuating learning and memory impairments, and partially reversing neuronal damage in the hippocampus. To further investigate the molecular mechanisms underlying this neuroprotection, we identified that nuclear accumulation of FoxO3a could induce highly expression of autophagy pathway genes including LC-3, Beclin-1, p62, ATG12, and ATG14, and finally initiate neurological impairments. Interestingly, silencing FoxO3a by siRNA remarkably inhibited the induction of neuronal autophagy after TBI, and activated autophagy was closely related to TBI-induced neurological deficits. Taken together, these findings indicated that FoxO3a knockdown conferred neuroprotective effects after TBI through inhibiting the activation of neuronal autophagy.	[Sun, Liqian; Zhang, Jingbo; Li, Youxiang; Yang, Xinjian; Wu, Zhongxue] Beijing Neurosurg Inst, Dept Intervent Neuroradiol, 6 Tiantan Xili, Beijing 100050, Peoples R China; [Sun, Liqian; Zhang, Jingbo; Li, Youxiang; Yang, Xinjian; Wu, Zhongxue] Capital Med Univ, Beijing Tiantan Hosp, 6 Tiantan Xili, Beijing 100050, Peoples R China; [Zhao, Manman; Liu, Man; Su, Peng] North China Univ Sci & Technol, Sch Basic Med Sci, Dept Histol & Embryol, Tangshan 063000, Hebei, Peoples R China		Sun, LQ (corresponding author), Beijing Neurosurg Inst, Dept Intervent Neuroradiol, 6 Tiantan Xili, Beijing 100050, Peoples R China.; Sun, LQ (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, 6 Tiantan Xili, Beijing 100050, Peoples R China.	slq20000@yeah.net		Yang, Xinjian/0000-0001-7306-0125	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81672481]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2015M580117]; Beijing Postdoctoral Research FoundationChina Postdoctoral Science Foundation [2015ZZ-49, 2016ZZ-38]	This work was supported by a grant from the National Natural Science Foundation of China (81672481), the China Postdoctoral Science Foundation (2015M580117), the Project supported by Beijing Postdoctoral Research Foundation (2015ZZ-49 and 2016ZZ-38).	Delbary-Gossart S, 2016, BRAIN, V139, P1762, DOI 10.1093/brain/aww074; Descalzo DLM, 2016, STEM CELL REP, V7, P55, DOI 10.1016/j.stemcr.2016.06.006; Hoekman MFM, 2006, GENE EXPR PATTERNS, V6, P134, DOI 10.1016/j.modgep.2005.07.003; Hsu YWA, 2014, J NEUROSCI, V34, P11366, DOI 10.1523/JNEUROSCI.1861-14.2014; Im J., 2015, AM J PHYSL LUNG CELL, V309; Kapoor S, 2013, J NEUROSCI, V33, P17398, DOI 10.1523/JNEUROSCI.2756-13.2013; Li D., 2014, PLOS ONE, V10; Li DY, 2009, J CEREBR BLOOD F MET, V29, P1903, DOI 10.1038/jcbfm.2009.102; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liu HG, 2010, SLEEP MED, V11, P205, DOI 10.1016/j.sleep.2009.05.015; Liu R, 2015, AUTOPHAGY, V11, P847, DOI 10.1080/15548627.2015.1037549; Liu W., 2016, LIFE SCI, V169, P699; Liu ZX, 2015, INT J ONCOL, V46, P721, DOI 10.3892/ijo.2014.2771; Lu DY, 2002, CELL TRANSPLANT, V11, P275; Lu M, 2003, J NEUROSCI METH, V128, P183, DOI 10.1016/S0165-0270(03)00188-2; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mojsilovic-Petrovic J, 2009, J NEUROSCI, V29, P8236, DOI 10.1523/JNEUROSCI.1805-09.2009; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Nepal S, 2015, ONCOTARGET, V6, P7166, DOI 10.18632/oncotarget.3347; Ni HM, 2013, AM J PATHOL, V183, P1815, DOI 10.1016/j.ajpath.2013.08.011; Nichols JN, 2016, BEHAV BRAIN RES, V298, P111, DOI 10.1016/j.bbr.2015.10.052; Rangarajan P, 2015, NEUROSCIENCE, V311, P398, DOI 10.1016/j.neuroscience.2015.10.048; Sanchez AMJ, 2012, J CELL BIOCHEM, V113, P695, DOI 10.1002/jcb.23399; Sengupta A, 2009, J BIOL CHEM, V284, P28319, DOI 10.1074/jbc.M109.024406; Shi C., 2016, J MATER SCI, P1; Shi C, 2016, J CELL SCI, V129, P1815, DOI 10.1242/jcs.185009; Staff T. P. O., 2015, PLOS ONE, V10; Stoica BA, 2014, J NEUROTRAUM, V31, P758, DOI 10.1089/neu.2013.3194; Sun LQ, 2015, MOL MED REP, V11, P4419, DOI 10.3892/mmr.2015.3264; Sun LQ, 2014, MOL MED REP, V9, P77, DOI 10.3892/mmr.2013.1787; Sun LQ, 2015, BEHAV BRAIN RES, V291, P315, DOI 10.1016/j.bbr.2015.05.049; Sun LQ, 2014, NEUROL SCI, V35, P677, DOI 10.1007/s10072-013-1575-6; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Tong WX, 2016, HEPATOL RES, V46, P933, DOI 10.1111/hepr.12634; TRAN H, 2003, SCI STKE; Warr MR, 2013, NATURE, V494, P323, DOI 10.1038/nature11895; Wong HKA, 2013, HUM MOL GENET, V22, P3077, DOI 10.1093/hmg/ddt164; Yoo KY, 2012, NEUROCHEM RES, V37, P588, DOI 10.1007/s11064-011-0648-2; Yu S, 2016, ONCOTARGET, V7, P34773, DOI 10.18632/oncotarget.8977; Zhao JH, 2008, AUTOPHAGY, V4, P378, DOI 10.4161/auto.5633; Zhao Lin, 2015, Zhonghua Yi Xue Za Zhi, V95, P457; Zhou JY, 2012, AUTOPHAGY, V8, P1712, DOI 10.4161/auto.21830	44	17	17	0	23	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	JAN 30	2018	337						271	279		10.1016/j.bbr.2017.08.042			9	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	FN1TL	WOS:000415774000032	28889023				2022-02-06	
J	Nordhaug, LH; Hagen, K; Vik, A; Stovner, LJ; Follestad, T; Pedersen, T; Gravdahl, GB; Linde, M				Nordhaug, Lena Hoem; Hagen, Knut; Vik, Anne; Stovner, Lars Jacob; Follestad, Turid; Pedersen, Torunn; Gravdahl, Goril Bruvik; Linde, Mattias			Headache following head injury: a population-based longitudinal cohort study (HUNT)	JOURNAL OF HEADACHE AND PAIN			English	Article						Headache attributed to head injury; Head injury; Traumatic brain injury; Secondary headache disorders; Post-traumatic headache; Population-based	TRAUMATIC BRAIN-INJURY; QUESTIONNAIRE; COMMUNITY	Background: Headache is the most frequent symptom following head injury, but long-term follow-up of headache after head injury entails methodological challenges. In a population-based cohort study, we explored whether subjects hospitalized due to a head injury more often developed a new headache or experienced exacerbation of previously reported headache compared to the surrounding population. Methods: This population-based historical cohort study included headache data from two large epidemiological surveys performed with an 11-year interval. This was linked with data from hospital records on exposure to head injury occurring between the health surveys. Participants in the surveys who had not been hospitalized because of a head injury comprised the control group. The head injuries were classified according to the Head Injury Severity Scale (HISS). Multinomial logistic regression was performed to investigate the association between head injury and new headache or exacerbation of pre-existing headache in a population with known pre-injury headache status, controlling for potential confounders. Results: The exposed group consisted of 294 individuals and the control group of 25,662 individuals. In multivariate analyses, adjusting for age, sex, anxiety, depression, education level, smoking and alcohol use, mild head injury increased the risk of new onset headache suffering (OR 1.74, 95% CI 1.05-2.87), stable headache suffering (OR 1.70, 95% CI 1.15-2.50) and exacerbation of previously reported headache (OR 1.93, 95% CI 1.24-3.02). The reference category was participants without headache in both surveys. Conclusion: Individuals hospitalized due to a head injury were more likely to have new onset and worsening of pre-existing headache and persistent headache, compared to the surrounding general population. The results support the entity of the ICHD-3 beta diagnosis "persistent headache attributed to traumatic injury to the head".	[Nordhaug, Lena Hoem; Hagen, Knut; Vik, Anne; Stovner, Lars Jacob; Linde, Mattias] Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, INB, Dept Neuromed & Movement Sci, Postbox 8905, N-7491 Trondheim, Norway; [Vik, Anne] St Olavs Univ Hosp, Dept Neurosurg, Trondheim, Norway; [Hagen, Knut; Stovner, Lars Jacob; Gravdahl, Goril Bruvik; Linde, Mattias] St Olavs Univ Hosp, Norwegian Advisory Unit Headaches, Trondheim, Norway; [Follestad, Turid] Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, Dept Publ Hlth & Nursing, Trondheim, Norway; [Pedersen, Torunn] Oslo Univ Hosp, Div Mental Hlth & Addict, Oslo, Norway		Nordhaug, LH (corresponding author), Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, INB, Dept Neuromed & Movement Sci, Postbox 8905, N-7491 Trondheim, Norway.	lena.h.nordhaug@ntnu.no		Gravdahl, Goril/0000-0001-7507-2082			Abu Bakar N, 2016, CEPHALALGIA, V36, P67, DOI 10.1177/0333102415580099; [Anonymous], 2011, ATLAS HEADACHE DISOR; [Anonymous], 2013, GUIDELINES CONCUSSIO; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; BOX GEP, 1962, TECHNOMETRICS, V4, P531, DOI 10.2307/1266288; Couch JR, 2007, NEUROLOGY, V69, P1169, DOI 10.1212/01.wnl.0000276985.07981.0a; Couch JR, 2001, HEADACHE, V41, P559, DOI 10.1046/j.1526-4610.2001.041006559.x; D'Onofrio F, 2014, NEUROL SCI, V35, pS203, DOI 10.1007/s10072-014-1771-z; de Dhaem OB, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0767-5; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; Evans RW, 2010, HEADACHE, V50, P716, DOI 10.1111/j.1526-4610.2010.01645.x; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Hagen K, 2000, CEPHALALGIA, V20, P244, DOI 10.1046/j.1468-2982.2000.00049.x; Hagen K, 2010, J HEADACHE PAIN, V11, P67, DOI 10.1007/s10194-009-0174-7; Heskestad B, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-32; Heskestad B, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-6; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Hong CK, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0774-6; Hong CK, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0755-9; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; JENSEN OK, 1990, CEPHALALGIA, V10, P285, DOI 10.1046/j.1468-2982.1990.1006285.x; Krokstad S, 2013, INT J EPIDEMIOL, V42, P968, DOI 10.1093/ije/dys095; Lebedeva ER, 2016, HEADACHE, V56, P341, DOI 10.1111/head.12757; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Linde M, 2012, EUR J NEUROL, V19, P703, DOI 10.1111/j.1468-1331.2011.03612.x; Linde M, 2011, CEPHALALGIA, V31, P585, DOI 10.1177/0333102410391488; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mathias JL, 2013, BRAIN INJURY, V27, P887, DOI 10.3109/02699052.2013.793398; MAYFIELD D, 1974, AM J PSYCHIAT, V131, P1121; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Nestvold K, 2007, NEUROEPIDEMIOLOGY, V29, P113, DOI 10.1159/000109825; Nordhaug LH, 2016, CEPHALALGIA, V36, P1009, DOI 10.1177/0333102415618948; Schwedt TJ, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0796-0; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Solomon S, 2009, HEADACHE, V49, P1112, DOI 10.1111/j.1526-4610.2009.01462.x; Stacey A, 2017, J NEUROTRAUM, V34, P1558, DOI 10.1089/neu.2016.4721; STEIN SC, 1995, BRAIN INJURY, V9, P437, DOI 10.3109/02699059509008203; Stovner LJ, 2009, EUR J NEUROL, V16, P112, DOI 10.1111/j.1468-1331.2008.02363.x; Theeler B, 2013, HEADACHE, V53, P881, DOI 10.1111/head.12123; Walker WC, 2013, CEPHALALGIA, V33, P998, DOI 10.1177/0333102413482197; Xu HM, 2016, WORLD NEUROSURG, V88, P289, DOI 10.1016/j.wneu.2015.12.028	43	17	18	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1129-2369	1129-2377		J HEADACHE PAIN	J. Headache Pain	JAN 22	2018	19								8	10.1186/s10194-018-0838-2			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FT4ZN	WOS:000423163900001	29356960	Green Published, gold			2022-02-06	
J	Hagmeyer, S; Cristovao, JS; Mulvihill, JJE; Boeckers, TM; Gomes, CM; Grabrucker, AM				Hagmeyer, Simone; Cristovao, Joana S.; Mulvihill, John J. E.; Boeckers, Tobias M.; Gomes, Claudio M.; Grabrucker, Andreas M.			Zinc Binding to S100B Affords Regulation of Trace Metal Homeostasis and Excitotoxicity in the Brain	FRONTIERS IN MOLECULAR NEUROSCIENCE			English	Article						Zn; zinc; S100B; DAMP; synapse; calcium; excitotoxicity; zinc sensor	CALCIUM-BINDING; NEURITE OUTGROWTH; NEURONAL SURVIVAL; PROTEIN; S100-BETA; RECEPTOR; ASTROCYTES; MICE; ACTIVATION; CONTRIBUTE	Neuronal metal ions such as zinc are essential for brain function. In particular synaptic processes are tightly related to metal and protein homeostasis, for example through extracellular metal-binding proteins. One such protein is neuronal S100B, a calcium and zinc binding damage-associated molecular pattern (DAMP), whose chronic upregulation is associated with aging, Alzheimer's disease (AD), motor neuron disease and traumatic brain injury (TBI). Despite gained insights on the structure of S100B, it remains unclear how its calcium and zinc binding properties regulate its function on cellular level. Here we report a novel role of S100B in trace metal homeostasis, in particular the regulation of zinc levels in the brain. Our results show that S100B at increased extracellular levels is not toxic, persists at high levels, and is taken up into neurons, as shown by cell culture and biochemical analysis. Combining protein bioimaging and zinc quantitation, along with a zinc-binding impaired S100B variant, we conclude that S100B effectively scavenges zinc ions through specific binding, resulting in a redistribution of the intracellular zinc pool. Our results indicate that scavenging of zinc by increased levels of S100B affects calcium levels in vitro. Thereby S100B is able to mediate the cross talk between calcium and zinc homeostasis. Further, we investigated a possible new neuroprotective role of S100B in excitotoxicity via its effects on calcium and zinc homeostasis. Exposure of cells to zinc-S100B but not the zinc-binding impaired S100B results in an inhibition of excitotoxicity. We conclude that in addition to its known functions, S100B acts as sensor and regulator of elevated zinc levels in the brain and this metal-buffering activity is tied to a neuroprotective role.	[Hagmeyer, Simone] Ulm Univ, WG Mol Anal Synaptopathies, Dept Neurol, Neuroctr, Ulm, Germany; [Hagmeyer, Simone; Grabrucker, Andreas M.] Univ Limerick, Dept Biol Sci, Cellular Neurobiol & Neuronanotechnol Lab, Limerick, Ireland; [Hagmeyer, Simone; Mulvihill, John J. E.; Grabrucker, Andreas M.] Univ Limerick, Bernal Inst, Limerick, Ireland; [Cristovao, Joana S.; Gomes, Claudio M.] Univ Lisbon, Biosyst & Integrat Sci Inst, Fac Ciencias, Lisbon, Portugal; [Cristovao, Joana S.; Gomes, Claudio M.] Univ Lisbon, Dept Quim & Bioquim, Fac Ciencias, Lisbon, Portugal; [Mulvihill, John J. E.; Grabrucker, Andreas M.] Univ Limerick, HRI, Limerick, Ireland; [Boeckers, Tobias M.] Ulm Univ, Inst Anat & Cell Biol, Ulm, Germany		Grabrucker, AM (corresponding author), Univ Limerick, Dept Biol Sci, Cellular Neurobiol & Neuronanotechnol Lab, Limerick, Ireland.; Grabrucker, AM (corresponding author), Univ Limerick, Bernal Inst, Limerick, Ireland.; Grabrucker, AM (corresponding author), Univ Limerick, HRI, Limerick, Ireland.	andreas.grabrucker@ul.ie	Mulvihill, John/T-8131-2019; Gomes, Claudio M/A-8152-2008; Mulvihill, John/AAA-9805-2021; Cristovao, Joana/B-6179-2018	Mulvihill, John/0000-0003-0437-0351; Gomes, Claudio M/0000-0003-4662-6933; Cristovao, Joana/0000-0003-3833-0016; Grabrucker, Andreas/0000-0003-0005-4810	Evangelisches Studienwerk Villigst e.V; Else KronerFresenius Stiftung; Bial FoundationBial Foundation [PT/FB/BL-2014-343]; Fundacao para a Ciencia e a Tecnologia (Portugal)Portuguese Foundation for Science and Technology [UID/MULTI/04046/2013, PTDC/NEU-NMC/2138/2014, IF/01046/2014, SFRH/BD/101171/2014]	SH is a member of the international PhD program in molecular medicine of Ulm University and funded by Evangelisches Studienwerk Villigst e.V. AMG is supported by the Else KronerFresenius Stiftung. Bial Foundation is acknowledged through grant PT/FB/BL-2014-343 (to CMG), as well as Fundacao para a Ciencia e a Tecnologia (Portugal) for the support through projects UID/MULTI/04046/2013 (to BioISI), PTDC/NEU-NMC/2138/ 2014 and IF/01046/2014 (to CMG) and for the Ph.D. grant SFRH/BD/101171/2014 (to JSC). The authors gratefully acknowledge the professional technical assistance of Katharina Mangus (Ulm) and Rodrigo David (Lisbon). G. Fritz (University Freiburg) is gratefully acknowledged for the kind gift of the S100B plasmid. The authors would like to acknowledge networking support and STSM Grant (to JSC and SH) by the COST Action TD1304-the Network for the Biology of Zinc (Zinc-Net).	Adlard PA, 2010, J NEUROSCI, V30, P1631, DOI 10.1523/JNEUROSCI.5255-09.2010; Ahlgren H, 2014, J BIOL CHEM, V289, P9970, DOI 10.1074/jbc.M113.502914; Bajor M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154822; Barnham KJ, 2014, CHEM SOC REV, V43, P6727, DOI 10.1039/c4cs00138a; BAUDIER J, 1986, J BIOL CHEM, V261, P8192; Bianchi R, 2011, J BIOL CHEM, V286, P7214, DOI 10.1074/jbc.M110.169342; Bluhm B, 2015, CEREBELLUM, V14, P119, DOI 10.1007/s12311-014-0606-z; Botelho HM, 2012, J BIOL CHEM, V287, P42233, DOI 10.1074/jbc.M112.396416; Botelho HM, 2012, METHODS MOL BIOL, V849, P373, DOI 10.1007/978-1-61779-551-0_25; Bush AI, 2013, J ALZHEIMERS DIS, V33, pS277, DOI 10.3233/JAD-2012-129011; Carvalho SB, 2014, BIONANOIMAGING, P197; Carvalho SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076629; Charpentier TH, 2008, J MOL BIOL, V382, P56, DOI 10.1016/j.jmb.2008.06.047; Cole TB, 1999, P NATL ACAD SCI USA, V96, P1716, DOI 10.1073/pnas.96.4.1716; Cristovao JS, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/9812178; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Donato Rosario, 2010, Cardiovasc Psychiatry Neurol, V2010, P929712, DOI 10.1155/2010/929712; Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009; Frederickson C. J., 1994, Biological Signals, V3, P127; Frederickson CJ, 2006, EXP NEUROL, V198, P285, DOI 10.1016/j.expneurol.2005.08.030; Frederickson CJ, 2004, NEUROSCIENTIST, V10, P18, DOI 10.1177/1073858403255840; Frederickson CJ, 2001, BIOMETALS, V14, P353, DOI 10.1023/A:1012934207456; FREDERICKSON CJ, 1989, BRAIN RES, V480, P317, DOI 10.1016/0006-8993(89)90199-6; Fritz G, 2010, FEBS J, V277, P4578, DOI 10.1111/j.1742-4658.2010.07887.x; GERLAI R, 1995, LEARN MEMORY, V2, P26, DOI 10.1101/lm.2.1.26; Grabrucker A, 2009, CELL TISSUE RES, V338, P333, DOI 10.1007/s00441-009-0881-z; Grabrucker AM, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-65; Grabrucker S, 2014, BRAIN, V137, P137, DOI 10.1093/brain/awt303; HUNT JB, 1985, ANAL BIOCHEM, V146, P150, DOI 10.1016/0003-2697(85)90409-9; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Kim CH, 2003, TOXICOL APPL PHARM, V190, P189, DOI 10.1016/S0041-008X(03)00167-4; Kim HSR, 2011, NEUROSCI LETT, V489, P148, DOI 10.1016/j.neulet.2010.12.005; Kleindienst A, 2013, ACTA NEUROCHIR, V155, P1351, DOI 10.1007/s00701-013-1720-2; Kocyla A, 2015, J INORG BIOCHEM, V152, P82, DOI 10.1016/j.jinorgbio.2015.08.024; Kubista H, 1999, NEUROSCIENCE, V90, P493, DOI 10.1016/S0306-4522(98)00422-9; Lasic E, 2016, J NEUROCHEM, V139, P309, DOI 10.1111/jnc.13754; Leal SS, 2013, J BIOL CHEM, V288, P25219, DOI 10.1074/jbc.M113.470740; Leclerc Estelle, 2010, Cardiovasc Psychiatry Neurol, V2010, P539581, DOI 10.1155/2010/539581; Leclerc E, 2009, BBA-MOL CELL RES, V1793, P993, DOI 10.1016/j.bbamcr.2008.11.016; Mazzone GL, 2014, J NEUROCHEM, V130, P598, DOI 10.1111/jnc.12748; Michetti F, 2012, J NEUROCHEM, V120, P644, DOI 10.1111/j.1471-4159.2011.07612.x; Mori T, 2010, GLIA, V58, P300, DOI 10.1002/glia.20924; Nishiyama H, 2002, NEUROSCI LETT, V321, P49, DOI 10.1016/S0304-3940(01)02549-6; Nishiyama H, 2002, P NATL ACAD SCI USA, V99, P4037, DOI 10.1073/pnas.052020999; Nuttall JR, 2012, NEUROTOX RES, V21, P128, DOI 10.1007/s12640-011-9291-6; Ostendorp T, 2007, EMBO J, V26, P3868, DOI 10.1038/sj.emboj.7601805; Ostendorp T, 2011, BBA-MOL CELL RES, V1813, P1083, DOI 10.1016/j.bbamcr.2010.10.006; Palmiter RD, 1996, P NATL ACAD SCI USA, V93, P14934, DOI 10.1073/pnas.93.25.14934; Park JS, 1996, NEUROBIOL DIS, V3, P215, DOI 10.1006/nbdi.1996.0022; Pfaender S, 2014, METALLOMICS, V6, P960, DOI 10.1039/c4mt00008k; Ponath G, 2007, J NEUROIMMUNOL, V184, P214, DOI 10.1016/j.jneuroim.2006.12.011; Prakash A, 2015, FUND CLIN PHARMACOL, V29, P131, DOI 10.1111/fcp.12110; Sabel CE, 2009, ANAL BIOCHEM, V391, P74, DOI 10.1016/j.ab.2009.05.007; Saleh A, 2013, EXP NEUROL, V249, P149, DOI 10.1016/j.expneurol.2013.08.018; Sorci G, 1998, BBA-MOL CELL RES, V1448, P277, DOI 10.1016/S0167-4889(98)00134-7; Takeda Atsushi, 2010, Int J Alzheimers Dis, V2011, P491597, DOI 10.4061/2011/491597; Villarreal A, 2014, J NEUROCHEM, V131, P190, DOI 10.1111/jnc.12790; Villarreal A, 2011, J NEUROCHEM, V117, P321, DOI 10.1111/j.1471-4159.2011.07207.x; Vincent AM, 2007, ENDOCRINOLOGY, V148, P548, DOI 10.1210/en.2006-0073; Wang C, 2014, ACTA NEUROPATHOL, V127, P507, DOI 10.1007/s00401-013-1208-4; Wilder PT, 2005, BIOCHEMISTRY-US, V44, P5690, DOI 10.1021/bi0475830; Wilder PT, 2003, BIOCHEMISTRY-US, V42, P13410, DOI 10.1021/bi035334q; WINNINGHAMMAJOR F, 1989, J CELL BIOL, V109, P3063, DOI 10.1083/jcb.109.6.3063; Yanamandra K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005562; Yu WH, 2001, J NEUROSCI, V21, P2240, DOI 10.1523/JNEUROSCI.21-07-02240.2001; Zimmer Danna B, 2010, Cardiovasc Psychiatry Neurol, V2010, DOI 10.1155/2010/728052	67	17	17	0	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5099			FRONT MOL NEUROSCI	Front. Molec. Neurosci.	JAN 17	2018	10								456	10.3389/fnmol.2017.00456			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FS9YG	WOS:000422775200001	29386995	Green Published, gold			2022-02-06	
J	Davies, M; Jacobs, A; Brody, DL; Friess, SH				Davies, McKenzie; Jacobs, Addison; Brody, David L.; Friess, Stuart H.			Delayed Hypoxemia After Traumatic Brain Injury Exacerbates Long-Term Behavioral Deficits	JOURNAL OF NEUROTRAUMA			English	Article						controlled cortical impact; delayed hypoxemia; long-term behavior; secondary injury; traumatic brain injury	CONTROLLED CORTICAL IMPACT; TAIL SUSPENSION TEST; COGNITIVE DEFICITS; CELL-DEATH; MODEL; MILD; DYSFUNCTION; HYPOXIA; ERYTHROPOIETIN; PROGESTERONE	Hypoxemia during initial stabilization of patients with severe traumatic brain injury (TBI) has been associated with poorer outcomes. However, the effects of delayed hypoxemia occurring during intensive care post-TBI on outcome is unclear. Pre-clinical models of TBI have rarely shown cognitive or behavioral deficits beyond 6 weeks post-injury and commonly have not included modeling of secondary insults. We have previously developed a murine model of TBI followed by delayed hypoxemia to model the secondary insult of hypoxemia and brain hypoxia occurring in the intensive care setting. Understanding long-term effects of delayed hypoxemia post-TBI in our murine model is critical for future testing of candidate therapeutics targeting secondary brain hypoxia. For this study, forty 5-week-old male mice were randomized to controlled cortical impact (CCI; N=24) or sham surgery (N=16). One day later, awake animals were randomized to 60min of hypoxemia or normoxemia. Six months after initial injury, animals underwent behavior testing (Morris water maze, social interaction, and tail suspension) before euthanasia for immunohistochemistry (IHC) assessments. At 6 months post-injury, mice experiencing CCI and hypoxemia (CCI+H) had longer swim distances to the hidden platform (51cm) compared to CCI alone (26cm) or sham animals (22cm). During social interaction assessments, CCI+H mice spent less time interacting with novel stimulus mice (79sec) than CCI alone (101sec) or sham animals (139sec). CCI+H had larger lesion volumes compared to CCI alone (14.0% vs. 9.9%; p<0.003). Glial fibrillary acidic protein IHC at 6 months post-injury demonstrated increased astrogliosis in the ipsilateral white matter of CCI+H compared to CCI alone. To summarize, this clinically relevant model of delayed hypoxia post-TBI resulted in long-term behavioral deficits and evidence of exacerbated structural injury.	[Davies, McKenzie; Jacobs, Addison; Friess, Stuart H.] Washington Univ, Dept Pediat, Sch Med, St Louis, MO 63110 USA; [Brody, David L.] Washington Univ, Dept Neurol, Sch Med, St Louis, MO 63110 USA		Friess, SH (corresponding author), Washington Univ, Sch Med, Campus Box 8208,One Childrens Pl, St Louis, MO 63110 USA.	Friess@wustl.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K08-NS064051, R01 NS097721, R01 NS065069]; Department of Pediatrics, Washington University School of Medicine; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS097721, R01NS065069] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health grants K08-NS064051 (to S.H.F.), R01 NS097721 (to S.H.F.), R01 NS065069 (to D.L.B.), and the Department of Pediatrics, Washington University School of Medicine (to S.H.F.)	Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Arango MF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005400.pub3; Bajwa NM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146886; Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; Bramlett HM, 2016, J NEUROTRAUM, V33, P538, DOI 10.1089/neu.2015.4116; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Browning M, 2014, J NEUROTRAUM, V31, pA108; Bruins B, 2013, ANESTH ANALG, V116, P838, DOI 10.1213/ANE.0b013e3182860fe7; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; Cohen J., 2013, STAT POWER ANAL BEHA, DOI [10.4324/9780203771587, DOI 10.4324/9780203771587]; CRAWLEY J, 1980, PHARMACOL BIOCHEM BE, V13, P167, DOI 10.1016/0091-3057(80)90067-2; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Davis DP, 2009, J NEUROTRAUM, V26, P2217, DOI 10.1089/neu.2009.0940; de Sousa A, 2012, J CLIN EXP NEUROPSYC, V34, P606, DOI 10.1080/13803395.2012.667067; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Dixon CE, 2016, J NEUROTRAUM, V33, P553, DOI 10.1089/neu.2015.4122; Fang Raymond, 2015, J Trauma Acute Care Surg, V79, pS181, DOI 10.1097/TA.0000000000000769; Feng JF, 2012, J NEUROTRAUM, V29, P1167, DOI 10.1089/neu.2011.1867; Ferguson JN, 2000, NAT GENET, V25, P284, DOI 10.1038/77040; Fox GB, 1999, J NEUROTRAUM, V16, P377, DOI 10.1089/neu.1999.16.377; Friess SH, 2015, J NEUROTRAUM, V32, P791, DOI 10.1089/neu.2014.3564; HANDLEY SL, 1984, N-S ARCH PHARMACOL, V327, P1, DOI 10.1007/BF00504983; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; Heron M, 2010, PEDIATRICS, V125, P4, DOI 10.1542/peds.2009-2416; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Huang RQ, 2010, NEUROSCI LETT, V473, P22, DOI 10.1016/j.neulet.2010.02.011; Huh JW, 2007, J NEUROTRAUM, V24, P1460, DOI 10.1089/neu.2006.3787; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Klemenhagen KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074510; Liu NK, 2014, BRAIN RES, V1576, P18, DOI 10.1016/j.brainres.2014.05.042; Mannix R, 2017, J NEUROTRAUM, V34, P495, DOI 10.1089/neu.2016.4457; Mannix R, 2014, J NEUROSURG, V121, P1342, DOI 10.3171/2014.7.JNS14272; McSwain NE, 2004, J TRAUMA, V57, P8; Mondello S, 2013, J NEUROTRAUM, V30, pA167; MORRIS RGM, 1990, EUR J NEUROSCI, V2, P1016, DOI 10.1111/j.1460-9568.1990.tb00014.x; Muthuswamy J, 2002, NEUROSCIENCE, V115, P917, DOI 10.1016/S0306-4522(02)00369-X; Nagamoto-Combs K, 2007, J NEUROTRAUM, V24, P1889, DOI 10.1089/neu.2007.9967; Nollet M, 2011, NEUROPHARMACOLOGY, V61, P336, DOI 10.1016/j.neuropharm.2011.04.022; Parikh U, 2016, J NEUROPATH EXP NEUR, V75, P731, DOI 10.1093/jnen/nlw045; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; RINK A, 1995, AM J PATHOL, V147, P1575; Semple BD, 2016, DEV NEUROSCI-BASEL, V38, P220, DOI 10.1159/000448089; Semple BD, 2012, J NEUROTRAUM, V29, P2672, DOI 10.1089/neu.2012.2595; Shear DA, 2016, J NEUROTRAUM, V33, P523, DOI 10.1089/neu.2015.4115; Shoykhet M, 2012, J NEUROSCI, V32, P4972, DOI 10.1523/JNEUROSCI.5597-11.2012; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Stiefel MF, 2006, J NEUROSURG, V105, P281, DOI 10.3171/ped.2006.105.4.281; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P4, DOI 10.1097/HTR.0b013e3182048e98; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Yan HQ, 2012, J NEUROTRAUM, V29, pA58	60	17	17	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2018	35	5					790	801		10.1089/neu.2017.5354		JAN 2018	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FX4ZY	WOS:000419869900001	29149808	Green Published, Green Submitted			2022-02-06	
J	Kong, T; Park, JM; Jang, JH; Kim, CY; Bae, SH; Choi, Y; Jeong, YH; Kim, C; Chang, SW; Kim, J; Moon, J				Kong, TaeHo; Park, Ji-Min; Jang, Ji Hyon; Kim, C-Yoon; Bae, Sang-Hun; Choi, Yuri; Jeong, Yun-Hwa; Kim, Chul; Chang, Sung Woon; Kim, Joopyung; Moon, Jisook			Immunomodulatory effect of CD200-positive human placenta-derived stem cells in the early phase of stroke	EXPERIMENTAL AND MOLECULAR MEDICINE			English	Article							MESENCHYMAL STROMAL CELLS; REGULATORY T-CELLS; TRAUMATIC BRAIN-INJURY; BONE-MARROW; ALZHEIMERS-DISEASE; ISCHEMIC-STROKE; CONDITIONED MEDIUM; CEREBRAL-ISCHEMIA; RATS; TRANSPLANTATION	Human placenta amniotic membrane-derived mesenchymal stem cells (AMSCs) regulate immune responses, and this property can be exploited to treat stroke patients via cell therapy. We investigated the expression profile of AMSCs cultured under hypoxic conditions and observed interesting expression changes in various genes involved in immune regulation. CD200, an anti-inflammatory factor and positive regulator of TGF-beta, was more highly expressed under hypoxic conditions than normoxic conditions. Furthermore, AMSCs exhibited inhibition of pro-inflammatory cytokine expression in co-cultures with LPS-primed BV2 microglia, and this effect was decreased in CD200-silenced AMSCs. The AMSCs transplanted into the ischemic rat model of stroke dramatically inhibited the expression of pro-inflammatory cytokines and up-regulated CD200, as compared with the levels in the sham-treated group. Moreover, decreased microglia activation in the boundary region and improvements in behavior were confirmed in AMSC-treated ischemic rats. The results suggested that the highly expressed CD200 from the AMSCs in a hypoxic environment modulates levels of inflammatory cytokines and microglial activation, thus increasing the therapeutic recovery potential after hypoxic-ischemic brain injury, and further demonstrated the immunomodulatory function of AMSCs in a stroke model.	[Kong, TaeHo; Park, Ji-Min; Kim, C-Yoon; Bae, Sang-Hun; Choi, Yuri; Jeong, Yun-Hwa; Moon, Jisook] CHA Univ, Coll Life Sci, Dept Biotechnol, Pangyo Ro 335 Beon Gil, Seongnam Si, Gyeonggi Do, South Korea; [Kong, TaeHo; Park, Ji-Min; Bae, Sang-Hun; Jeong, Yun-Hwa; Kim, Chul; Moon, Jisook] Bundang CHA Gen Hosp, Gen Res Inst, Seongnam Si, South Korea; [Jang, Ji Hyon; Chang, Sung Woon] CHA Univ, Bundang CHA Med Ctr, Dept OB & GYN, Bundang, South Korea; [Kim, C-Yoon] Seoul Natl Univ, Coll Vet Med, Dept Lab Anim Med, Seoul, South Korea; [Kim, Joopyung] CHA Univ, Sch Med, Bundang CHA Hosp, Dept Neurosurg, Seongnam Si, South Korea		Moon, J (corresponding author), CHA Univ, Coll Life Sci, Dept Biotechnol, Pangyo Ro 335 Beon Gil, Seongnam Si, Gyeonggi Do, South Korea.	jmoon@cha.ac.kr			Bio & Medical Technology Development Program through the National Research Foundation of Korea - Ministry of Science, ICT & Future Planning [NRF-2017M3A9B4025699, NRF-2017M3A9B4025709]	This study was supported by Bio & Medical Technology Development Program through the National Research Foundation of Korea funded by the Ministry of Science, ICT & Future Planning (NRF-2017M3A9B4025699 and NRF-2017M3A9B4025709).	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Blasko I, 2004, AGING CELL, V3, P169, DOI 10.1111/j.1474-9728.2004.00101.x; Calio ML, 2014, FREE RADICAL BIO MED, V70, P141, DOI 10.1016/j.freeradbiomed.2014.01.024; Ceulemans AG, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-74; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Collins E, 2014, J IMMUNOL, V193, P4381, DOI 10.4049/jimmunol.1401636; de Andrade AVG, 2015, STEM CELLS DEV, V24, P1374, DOI 10.1089/scd.2014.0563; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Donega V, 2014, EXP NEUROL, V261, P53, DOI 10.1016/j.expneurol.2014.06.009; Dooley D, 2014, PHARMACOL THERAPEUT, V141, P21, DOI 10.1016/j.pharmthera.2013.08.001; Du LL, 2016, LIFE SCI, V149, P51, DOI 10.1016/j.lfs.2016.02.050; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Hass R, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-12; Holmannova Drahomira, 2012, Acta Medica (Hradec Kralove), V55, P12; Ishimaru N, 2008, J IMMUNOL, V180, P6997, DOI 10.4049/jimmunol.180.10.6997; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Kim EY, 2014, BMB REP, V47, P135, DOI 10.5483/BMBRep.2014.47.3.289; Kim KS, 2016, CELL TRANSPLANT, V25, P1145, DOI 10.3727/096368915X688263; Kim KS, 2013, NEUROBIOL AGING, V34, P2408, DOI 10.1016/j.neurobiolaging.2013.03.029; Kim YK, 2016, PROG NEURO-PSYCHOPH, V64, P277, DOI 10.1016/j.pnpbp.2015.06.008; Kyurkchiev Dobroslav, 2014, World J Stem Cells, V6, P552, DOI 10.4252/wjsc.v6.i5.552; Lakhan SE, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-97; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r134; Lee JK, 2010, STEM CELLS, V28, P329, DOI 10.1002/stem.277; Lee JM, 2012, INT IMMUNOPHARMACOL, V13, P219, DOI 10.1016/j.intimp.2012.03.024; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Malcherek G, 2014, LEUKEMIA, V28, P2388, DOI 10.1038/leu.2014.273; Menche J, 2015, SCIENCE, V347, DOI 10.1126/science.1257601; Meuth SG, 2008, J NEUROIMMUNOL, V194, P62, DOI 10.1016/j.jneuroim.2007.11.013; Nicholls SM, 2015, EXP EYE RES, V130, P1, DOI 10.1016/j.exer.2014.11.006; Olajide OA, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/459723; Ooi YY, 2010, INT IMMUNOPHARMACOL, V10, P1532, DOI 10.1016/j.intimp.2010.09.001; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Patel Anita R, 2013, Int J Physiol Pathophysiol Pharmacol, V5, P73; Reynolds AD, 2007, J LEUKOCYTE BIOL, V82, P1083, DOI 10.1189/jlb.0507296; Salgado AJ, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00249; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI14002; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi M, 2011, CLIN EXP IMMUNOL, V164, P1, DOI 10.1111/j.1365-2249.2011.04327.x; Tsai MJ, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-5; Uccelli A, 2015, ANN NY ACAD SCI, V1351, P114, DOI 10.1111/nyas.12815; Vaine CA, 2014, ADV IMMUNOL, V121, P191, DOI 10.1016/B978-0-12-800100-4.00005-2; Wang LQ, 2014, CNS NEUROSCI THER, V20, P317, DOI 10.1111/cns.12216; Wang Z, 2015, STEM CELLS, V33, P456, DOI 10.1002/stem.1878; Wright GP, 2009, P NATL ACAD SCI USA, V106, P19078, DOI 10.1073/pnas.0907396106; Xie LK, 2014, J IMMUNOL, V192, P6009, DOI 10.4049/jimmunol.1303492; Yin F, 2014, BRAIN RES, V1561, P1, DOI 10.1016/j.brainres.2014.02.047; Yoo SW, 2008, EXP MOL MED, V40, P387, DOI 10.3858/emm.2008.40.4.387; Zhang YL, 2015, J NEUROSURG, V122, P856, DOI 10.3171/2014.11.JNS14770	51	17	19	4	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1226-3613	2092-6413		EXP MOL MED	Exp. Mol. Med.	JAN 12	2018	50								e425	10.1038/emm.2017.233			12	Biochemistry & Molecular Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Research & Experimental Medicine	FZ3JW	WOS:000427485000002	29328072	Green Published, gold			2022-02-06	
J	Badea, A; Kamnaksh, A; Anderson, RJ; Calabrese, E; Long, JB; Agoston, DV				Badea, Alexandra; Kamnaksh, Alaa; Anderson, Robert J.; Calabrese, Evan; Long, Joseph B.; Agoston, Denes V.			Repeated mild blast exposure in young adult rats results in dynamic and persistent microstructural changes in the brain	NEUROIMAGE-CLINICAL			English	Article						White matter injury; Neurodegeneration; Traumatic brain injury	CHRONIC TRAUMATIC ENCEPHALOPATHY; RESONANCE HISTOLOGY ATLAS; CENTRAL-NERVOUS-SYSTEM; WHITE-MATTER; DIFFUSION-TENSOR; SEXUAL-DIFFERENTIATION; FRONTAL-CORTEX; MOUSE MODEL; INJURY; SINGLE	A history of mild traumatic brain injury (mTBI), particularly repeated mTBI (rmTBI), has been identified as a risk factor for late-onset neurodegenerative conditions. The mild and transient nature of early symptoms often impedes diagnosis in young adults who are disproportionately affected by mTBIs. A proportion of the affected population will incur long-term behavioral and cognitive consequences but the underlying pathomechanism is currently unknown. Diffusion tensor imaging (DTI) provides sensitive and quantitative assessment of TBI-induced structural changes, including white matter injury, and may be used to predict long-term outcome. We used DTI in an animal model of blast rmTBI (rmbTBI) to quantify blast-induced structural changes at 7 and 90 days post-injury, and their evolution between the two time points. Young adult male rats (similar to P65 at injury) were exposed to repeated mild blast overpressure, or anesthetized as shams, and their fixed brains were imaged using high-field (7 T) MRI. We found that whole brain volumes similarly increased in injured and sham rats from 7 to 90 days. However, we detected localized volume increases in blast-exposed animals 7 days post-injury, mainly ipsilateral to incident blast waves. Affected regions included gray matter of the frontal association, cingulate, and motor cortex, thalamus, substantia nigra, and raphe nuclei (median and dorsal), as well as white matter of the internal capsule and cerebral peduncle. Conversely, we measured volume reductions in these and other regions, including the hippocampus and cerebellum, at 90 days post-injury. DTI also detected both transient and persistent microstructural changes following injury, with some changes showing distinct ipsilateral versus contralateral side differences relative to blast impact. Early changes in fractional anisotropy (FA) were subtle, becoming more prominent at 90 days in the cerebral and inferior cerebellar peduncles, and cerebellar white matter. Widespread increases in radial diffusivity (RD) and axial diffusivity (primary eigenvalue or E1) at 7 days post-injury largely subsided by 90 days, although RD was more sensitive than E1 at detecting white matter changes. E1 effects in gray and white matter, which paralleled increases in apparent diffusion, were likely more indicative of dysregulated water homeostasis than pathologic structural changes. Importantly, we found evidence for a different developmental trajectory following rmbTBI, as indicated by significant injury x age interactions on volume. Our findings demonstrate that rmbTBI initiates dynamic pathobiological processes that may negatively alter the course of late-stage neurodevelopment and adversely affect long-term cognitive and behavioral outcomes.	[Badea, Alexandra; Anderson, Robert J.; Calabrese, Evan] Duke Univ, Med Ctr, Dept Radiol, Ctr In Vivo Microscopy, Box 3302, Durham, NC 27710 USA; [Kamnaksh, Alaa; Agoston, Denes V.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Long, Joseph B.] Walter Reed Army Inst Res, Blast Induced Neurotrauma Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD USA		Badea, A (corresponding author), Duke Univ, Med Ctr, Dept Radiol, Ctr In Vivo Microscopy, Box 3302, Durham, NC 27710 USA.; Agoston, DV (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	alexandra.badea@duke.edu; denes.agoston@usuhs.edu	Badea, Alexandra/S-6052-2016; Badea, Alexandra/ABC-8324-2020	Badea, Alexandra/0000-0001-6621-4560; Badea, Alexandra/0000-0001-6621-4560	United States Army Medical Research Acquisition Activity (USAMRAA) grant [G1702174]; WRAIR grant [G170353315]; NIH/NIBIBUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41 EB015897, 1S10OD010683-01]; NIH/NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K01 AG041211]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB015897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM007171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K01AG041211, R56AG057895] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [S10OD010683] Funding Source: NIH RePORTER	We thank the Neurotrauma Team at the Walter Reed Army Institute of Research (WRAIR) for their technical help during the exposures. We also thank Dr. G. Allan Johnson for critically reading the manuscript. This work was supported by the United States Army Medical Research Acquisition Activity (USAMRAA) grant number G1702174, and WRAIR grant number G170353315. Imaging was done at the Center for In Vivo Microscopy, supported through NIH/NIBIB awards P41 EB015897 and 1S10OD010683-01. AB gratefully acknowledges support from NIH/NIA through K01 AG041211.	Acosta SA, 2015, J CELL PHYSIOL, V230, P1024, DOI 10.1002/jcp.24830; Agoston D., 2015, MODELING NEUROBEHAVI; Ahmed FA, 2013, ELECTROPHORESIS, V34, P2229, DOI 10.1002/elps.201300077; Asato MR, 2010, CEREB CORTEX, V20, P2122, DOI 10.1093/cercor/bhp282; Ashburner J., 2006, STAT PARAMETRIC MAPP, V1st ed.; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Avants BB, 2010, NEUROIMAGE, V49, P2457, DOI 10.1016/j.neuroimage.2009.09.062; Badea A, 2007, NEUROIMAGE, V37, P683, DOI 10.1016/j.neuroimage.2007.05.046; Badea A, 2012, NEUROIMAGE, V63, P1633, DOI 10.1016/j.neuroimage.2012.07.021; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Budde MD, 2007, MAGN RESON MED, V57, P688, DOI 10.1002/mrm.21200; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Calabrese E, 2014, J NEUROTRAUM, V31, P938, DOI 10.1089/neu.2013.3144; Calabrese E, 2013, NEUROIMAGE, V71, P196, DOI 10.1016/j.neuroimage.2013.01.017; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Daneshvar DH, 2015, MOL CELL NEUROSCI, V66, P81, DOI 10.1016/j.mcn.2015.03.007; Emery DL, 2003, J NEUROTRAUM, V20, P1271, DOI 10.1089/089771503322686085; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Giorgio A, 2010, NEUROIMAGE, V51, P943, DOI 10.1016/j.neuroimage.2010.03.004; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; Gritti A, 2002, J PHYSIOL-PARIS, V96, P81, DOI 10.1016/S0928-4257(01)00083-3; Groeschel S, 2010, INT J DEV NEUROSCI, V28, P481, DOI 10.1016/j.ijdevneu.2010.06.004; Harris NG, 2016, NEUROIMAGE, V133, P129, DOI 10.1016/j.neuroimage.2016.03.012; Hetherington HP, 2014, MAGN RESON MED, V71, P1358, DOI 10.1002/mrm.24814; Huang DP, 2017, PARKINSONS DIS-US, V2017, DOI 10.1155/2017/9349487; Institute of M, 2013, RET HOM IR AFGH ASS; Iverson GL, 2015, NEUROSCI BIOBEHAV R, V56, P276, DOI 10.1016/j.neubiorev.2015.05.008; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Johnson GA, 2012, NEUROIMAGE, V62, P1848, DOI 10.1016/j.neuroimage.2012.05.041; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Kamnaksh A, 2012, ELECTROPHORESIS, V33, P3680, DOI 10.1002/elps.201200319; Kamnaksh A, 2011, J NEUROTRAUM, V28, P2145, DOI 10.1089/neu.2011.1983; Kilpatrick L, 2003, NEUROIMAGE, V20, P2091, DOI 10.1016/j.neuroimage.2003.08.006; Kochunov P, 2012, NEUROBIOL AGING, V33, P9, DOI 10.1016/j.neurobiolaging.2010.01.014; Kolb B, 1998, BEHAV BRAIN RES, V91, P143, DOI 10.1016/S0166-4328(97)00111-3; Kovesdi E., 2014, TRANSL PROTEOM, V3, P22; Kovesdi E, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00042; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kwon Sook-Kyung C, 2011, Front Neurol, V2, P12, DOI 10.3389/fneur.2011.00012; Leow A., 2006, 1 MICCAI WORKSH MATH, P174; Lewis MH, 2004, MENT RETARD DEV D R, V10, P91, DOI 10.1002/mrdd.20017; Li J, 2017, NEURORADIOLOGY, V59, P1203, DOI 10.1007/s00234-017-1915-y; Ling GSF, 2011, CURR OPIN ANESTHESIO, V24, P124, DOI 10.1097/ACO.0b013e32834458da; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Mac Donald C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055823; Mac Donald CL, 2017, JAMA NEUROL, V74, P821, DOI 10.1001/jamaneurol.2017.0143; Mac Donald CL, 2017, NEUROIMAGE-CLIN, V14, P371, DOI 10.1016/j.nicl.2017.02.005; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; MacFarlane MP, 2015, BRAIN INJURY, V29, P139, DOI 10.3109/02699052.2014.965208; Matsushita M, 2011, J NEUROSURG, V115, P130, DOI 10.3171/2011.2.JNS101547; Matthews S, 2011, PSYCHIAT RES-NEUROIM, V191, P76, DOI 10.1016/j.pscychresns.2010.09.013; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Mengler L, 2014, NEUROIMAGE, V84, P35, DOI 10.1016/j.neuroimage.2013.08.034; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Pego JM, 2008, EUR J NEUROSCI, V27, P1503, DOI 10.1111/j.1460-9568.2008.06112.x; Perez AM, 2014, J NEUROTRAUM, V31, P1478, DOI 10.1089/neu.2013.3216; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Prins ML, 2012, INT J DEV NEUROSCI, V30, P185, DOI 10.1016/j.ijdevneu.2011.05.009; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Scahill RI, 2003, ARCH NEUROL-CHICAGO, V60, P989, DOI 10.1001/archneur.60.7.989; Selemon LD, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.7; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Signoretti S, 2011, PM&R, V3, pS359, DOI 10.1016/j.pmrj.2011.07.018; Simmonds DJ, 2014, NEUROIMAGE, V92, P356, DOI 10.1016/j.neuroimage.2013.12.044; Somerville LH, 2010, BIOL PSYCHIAT, V68, P416, DOI 10.1016/j.biopsych.2010.04.002; Sowell ER, 2001, J NEUROSCI, V21, P8819, DOI 10.1523/JNEUROSCI.21-22-08819.2001; Sowell ER, 1999, NAT NEUROSCI, V2, P859, DOI 10.1038/13154; Sowell ER, 2002, DEV MED CHILD NEUROL, V44, P4, DOI 10.1017/S0012162201001591; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Sumiyoshi A, 2017, NEUROSCI LETT, V642, P168, DOI 10.1016/j.neulet.2016.12.023; Swaab DF, 2007, BEST PRACT RES CL EN, V21, P431, DOI 10.1016/j.beem.2007.04.003; Tanaka-Arakawa MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118760; Tansey MG, 2007, EXP NEUROL, V208, P1, DOI 10.1016/j.expneurol.2007.07.004; U.S. Department of Health and Human Services, 2009, HEADS FACTS PHYS MIL; Voss JD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0506-z; Wang R., 2007, P INT SOC MAG RESON, V15, P3720; Winston CN, 2016, AM J PATHOL, V186, P552, DOI 10.1016/j.ajpath.2015.11.006; Yeh PH, 2017, HUM BRAIN MAPP, V38, P352, DOI 10.1002/hbm.23365; Zuckerman A, 2017, J NEUROTRAUM, V34, P145, DOI 10.1089/neu.2015.4310	93	17	17	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2018	18						60	73		10.1016/j.nicl.2018.01.007			14	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GH1NG	WOS:000433169000007	29868442	Green Published, gold			2022-02-06	
J	Barker-Collo, S; Theadom, A; Starkey, N; Kahan, M; Jones, K; Feigin, V				Barker-Collo, Suzanne; Theadom, Alice; Starkey, Nicola; Kahan, Michael; Jones, Kelly; Feigin, Valery			Factor structure of the Rivermead Post-Concussion Symptoms Questionnaire over the first year following mild traumatic brain injury	BRAIN INJURY			English	Article						Mild traumatic brain injury; factor structure; Rivermead Post-Concussion Symptom Questionnaire	POSTCONCUSSIVE SYMPTOMS; HEAD-INJURY; PREVALENCE	Background: We examined the factor structure of the Rivermead Post-Concussion Symptom Questionnaire (RPQ), the most commonly used measure of post-concussive symptoms, over the first year post-injury.Method: Factor analysis (orthogonal rotation) was used to examine the RPQ items that form coherent subsets/factors within 2-weeks, and 1, 6, and 12-months post-mTBI in 527 adults (age >16years).Results: At baseline, three factors accounted for 63.95% of the variance; factor 1 reflected cognitive and physiological disturbances; factor 2 included items reflecting mood, sleep, and nausea/vomiting; and factor 3 included visual/auditory disturbances, dizziness, and headaches. At 1 month, three factors were again extracted (63.26% variance). Factor 1 reflected cognitive and mood symptoms, factor 2 reflected mood with headache, nausea, and dizziness; and factor 3 reflected visual disturbances. Two factors were obtained at 6 and 12 months (63.7% and 63.38% of variance): factor 1 included mood/cognitive items, restlessness, sleep disturbance, and noise sensitivity; whereas, factor 2 included physiological symptoms.Conclusions: The factor structure of the RPQ changes over time; however, it was relatively stable from 6 to 12-months post-injury. Subject to further evaluation, assessments conducted from 6 months could consider using these two factors as subscales. Changing the factor structure of RPQ before 6 months suggests that timing of assessment should be considered in applying these factors.	[Barker-Collo, Suzanne] Univ Auckland, Sch Psychol, Fac Sci, Auckland 1141, New Zealand; [Theadom, Alice; Jones, Kelly; Feigin, Valery] AUT Univ, Natl Inst Stroke & Appl Neurosci, Sch Rehabil & Occupat Studies, Auckland, New Zealand; [Starkey, Nicola] Univ Waikato, Sch Psychol, Fac Arts & Social Sci, Hamilton, New Zealand; [Kahan, Michael] Waikato Occupat Serv Ltd, Hamilton, New Zealand		Barker-Collo, S (corresponding author), Univ Auckland, Sch Psychol, Fac Sci, Auckland 1141, New Zealand.	s.barker-collo@auckland.ac.nz	Feigin, Valery/AAF-2313-2019; Jones, Kelly/I-5199-2019; Starkey, Nicola/AAJ-3795-2020	Starkey, Nicola/0000-0002-4370-8186; Feigin, Valery L./0000-0002-6372-1740	New Zealand Health Research CouncilHealth Research Council of New Zealand [09/063A, 11/192]	This study was funded by the New Zealand Health Research Council; References 09/063A and 11/192.	Barker-Collo S, 2016, JSM BURNS TRAUMA, V1, P1006; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Carroll LJ, 2014, ARCH PHYS MED REH S3, V95; Cernich AN, 2012, J HEAD TRAUMA REHAB, V27, P253, DOI 10.1097/HTR.0b013e3182585cd5; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Ettenhofer ML, 2012, J INT NEUROPSYCH SOC, V18, P451, DOI 10.1017/S1355617711001895; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Franke LM, 2015, J HEAD TRAUMA REHAB, V30, pE34, DOI 10.1097/HTR.0000000000000042; Herrmann N, 2009, J NEUROPSYCH CLIN N, V21, P181, DOI 10.1176/appi.neuropsych.21.2.181; Iverson G, 2007, BRAIN INJURY MED PRI; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kraus J, 2005, J HEAD TRAUMA REHAB, V20, P239, DOI 10.1097/00001199-200505000-00007; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Masson F, 1996, BRAIN INJURY, V10, P487, DOI 10.1080/026990596124205; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Rimel RW, 1981, J HEAD TRAUMA REHAB, V6, P86; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Sveen U, 2010, SCAND J OCCUP THER, V17, P225, DOI 10.3109/11038120903171295; Tabachnick B.G., 2001, USING MULTIVARIATE S; Theadom A, 2012, NEUROEPIDEMIOLOGY, V38, P18, DOI 10.1159/000334746; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3	23	17	17	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	4					453	458		10.1080/02699052.2018.1429659			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FV9WZ	WOS:000424942400008	29355392				2022-02-06	
J	Bathke, AC; Friedrich, S; Pauly, M; Konietschke, F; Staffen, W; Strobl, N; Holler, Y				Bathke, Arne C.; Friedrich, Sarah; Pauly, Markus; Konietschke, Frank; Staffen, Wolfgang; Strobl, Nicolas; Hoeller, Yvonne			Testing Mean Differences among Groups: Multivariate and Repeated Measures Analysis with Minimal Assumptions	MULTIVARIATE BEHAVIORAL RESEARCH			English	Article						Bootstrap; closed testing; factorial designs; MANOVA; repeated measures	BEHRENS-FISHER PROBLEM; TRAUMATIC BRAIN-INJURY; NORMAL YOUNG-ADULTS; ONE-WAY MANOVA; CLINICAL-TRIALS; FACTORIAL-DESIGNS; DIAGNOSTIC UTILITY; ALZHEIMERS-DISEASE; PHOTIC-STIMULATION; BOOTSTRAP	To date, there is a lack of satisfactory inferential techniques for the analysis of multivariate data in factorial designs, when only minimal assumptions on the data can be made. Presently available methods are limited to very particular study designs or assume either multivariate normality or equal covariance matrices across groups, or they do not allow for an assessment of the interaction effects across within-subjects and between-subjects variables. We propose and methodologically validate a parametric bootstrap approach that does not suffer from any of the above limitations, and thus provides a rather general and comprehensive methodological route to inference for multivariate and repeated measures data. As an example application, we consider data from two different Alzheimer's disease (AD) examination modalities that may be used for precise and early diagnosis, namely, single-photon emission computed tomography (SPECT) and electroencephalogram (EEG). These data violate the assumptions of classical multivariate methods, and indeed classical methods would not have yielded the same conclusions with regards to some of the factors involved.	[Bathke, Arne C.] Univ Salzburg, Dept Math, A-5020 Salzburg, Austria; [Friedrich, Sarah; Pauly, Markus] Univ Kentucky, Dept Stat, Lexington, KY 40536 USA; [Konietschke, Frank] Univ Texas Dallas, Dept Math Sci, Dallas, TX USA; [Staffen, Wolfgang; Strobl, Nicolas; Hoeller, Yvonne] Paracelsus Med Univ, Christian Doppler Med Ctr, Dept Neurol, Salzburg, Austria; [Staffen, Wolfgang; Strobl, Nicolas; Hoeller, Yvonne] Paracelsus Med Univ, Ctr Cognit Neurosci, Salzburg, Austria		Bathke, AC (corresponding author), Univ Salzburg, Dept Math, A-5020 Salzburg, Austria.; Bathke, AC (corresponding author), Univ Kentucky, Dept Stat, Lexington, KY 40536 USA.	Arne.Bathke@sbg.ac.at	Friedrich, Sarah/AAF-9038-2020; Holler, Yvonne/I-8928-2017	Friedrich, Sarah/0000-0003-0291-4378; Holler, Yvonne/0000-0002-1727-8557; Pauly, Markus/0000-0002-0976-7190; Konietschke, Frank/0000-0002-5674-2076	Austrian Science Fund (FWF)Austrian Science Fund (FWF) [I 2697-N31, KLI 12-B00]; German Research Foundation (DFG)German Research Foundation (DFG) [DFG-PA 2409/3-1]	This work was supported by Grants I 2697-N31 and KLI 12-B00 from the Austrian Science Fund (FWF) and by Grant DFG-PA 2409/3-1 from the German Research Foundation (DFG).	Allignol A, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-86; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1111/j.1442-9993.2001.01070.pp.x; Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Bartlett MS, 1939, P CAMB PHILOS SOC, V35, P180; Bateman R, 2015, LANCET NEUROL, V14, P4, DOI 10.1016/S1474-4422(14)70301-1; Bathke AC, 2008, J STAT PLAN INFER, V138, P588, DOI 10.1016/j.jspi.2006.11.004; Bathke AC, 2008, COMPUT STAT DATA AN, V52, P4951, DOI 10.1016/j.csda.2008.04.006; Bathke AC, 2016, SPRINGER P MATH STAT, V168, P121, DOI 10.1007/978-3-319-39065-9_7; Bellon A, 2008, ANN STAT, V36, P2377, DOI 10.1214/07-AOS528; DEMPSTER AP, 1958, ANN MATH STAT, V29, P995, DOI 10.1214/aoms/1177706437; DEMPSTER AP, 1960, BIOMETRICS, V16, P41, DOI 10.2307/2527954; Ellis AR, 2017, J STAT SOFTW, V76, P1, DOI 10.18637/jss.v076.i04; Friedrich S., 2016, MANOVA RM ANAL MULTI; Hahn S, 2017, STAT PAP, V58, P123, DOI 10.1007/s00362-015-0690-2; Harrar SW, 2012, ANN I STAT MATH, V64, P135, DOI 10.1007/s10463-010-0299-0; Harrar SW, 2008, AM J MATH MANAGEMENT, V28, P309, DOI [10.1080/01966324.2008.10737731, DOI 10.1080/01966324.2008.10737731]; Huang P, 2009, MOVEMENT DISORD, V24, P1732, DOI 10.1002/mds.22645; Giron FJ, 2010, J MULTIVARIATE ANAL, V101, P2091, DOI 10.1016/j.jmva.2010.04.008; Kawasaki T, 2015, COMMUN STAT-SIMUL C, V44, P1850, DOI 10.1080/03610918.2013.824587; Konietschke F, 2015, J MULTIVARIATE ANAL, V140, P291, DOI 10.1016/j.jmva.2015.05.001; Krishnamoorthy K, 2004, STAT PROBABIL LETT, V66, P161, DOI 10.1016/j.spl.2003.10.012; Krishnamoorthy K, 2012, J MULTIVARIATE ANAL, V105, P141, DOI 10.1016/j.jmva.2011.08.019; Krishnamoorthy K, 2010, J STAT COMPUT SIM, V80, P873, DOI 10.1080/00949650902822564; Lawley DN, 1938, BIOMETRIKA, V30, P180, DOI 10.2307/2332232; Liu CX, 2011, STAT PROBABIL LETT, V81, P1502, DOI 10.1016/j.spl.2011.04.012; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P127, DOI 10.1016/j.nurt.2009.10.020; MARCUS R, 1976, BIOMETRIKA, V63, P655, DOI 10.2307/2335748; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Micanovic C, 2014, J NEURAL TRANSM, V121, P59, DOI 10.1007/s00702-013-1070-5; Moretti DV, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00031; NANDA DN, 1950, ANN MATH STAT, V21, P432, DOI 10.1214/aoms/1177729802; NEL DG, 1986, COMMUN STAT THEORY, V15, P3719, DOI 10.1080/03610928608829342; Neyman J, 1951, P 2 BERK S MATH STAT, P23; Pauly M, 2015, J R STAT SOC B, V77, P461, DOI 10.1111/rssb.12073; Pesarin F., 2010, PERMUTATION TESTS CO; Pesarin F, 2012, STAT COMPUT, V22, P639, DOI 10.1007/s11222-011-9261-0; PILLAI KCS, 1955, ANN MATH STAT, V26, P117, DOI 10.1214/aoms/1177728599; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Vallejo G, 2012, BEHAV RES METHODS, V44, P471, DOI 10.3758/s13428-011-0152-2; Van Aelst S, 2013, J STAT SOFTW, V53, P1; Van Aelst S, 2011, J AM STAT ASSOC, V106, P706, DOI 10.1198/jasa.2011.tm09748; Vecchio Fabrizio, 2013, Suppl Clin Neurophysiol, V62, P223; Vester J, 2014, COMMUNICATION; Wada Y, 1996, INT J PSYCHOPHYSIOL, V22, P45, DOI 10.1016/0167-8760(96)00011-6; WADA Y, 1994, CLIN ELECTROENCEPHAL, V25, P81, DOI 10.1177/155005949402500209; Wallis WA., 1947, TECHNIQUES STAT ANAL, P111; Whitehead J, 2010, STAT MED, V29, P521, DOI 10.1002/sim.3822; WILKS SS, 1946, ANN MATH STAT, V17, P257, DOI 10.1214/aoms/1177730940; Xu LW, 2013, J MULTIVARIATE ANAL, V115, P172, DOI 10.1016/j.jmva.2012.10.008; Yeo JM, 2013, EUR ARCH PSY CLIN N, V263, P539, DOI 10.1007/s00406-013-0426-z; Zhang J. Q., 2013, ADV MATER SCI ENG, V2013, P2, DOI DOI 10.1371/J0URNAL.P0NE.0057251; Zhang JN, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-63; Zhang JT, 2013, METRIKA, V76, P135, DOI 10.1007/s00184-011-0379-z; Zhang JT, 2011, TECHNOMETRICS, V53, P426, DOI 10.1198/TECH.2011.10128	55	17	17	6	15	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0027-3171	1532-7906		MULTIVAR BEHAV RES	Multivariate Behav. Res.		2018	53	3					348	359		10.1080/00273171.2018.1446320			12	Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods; Psychology, Experimental; Statistics & Probability	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Mathematics; Mathematical Methods In Social Sciences; Psychology	GF1PO	WOS:000431707100004	29565679	Green Published, hybrid			2022-02-06	
J	Callahan, ML; Binder, LM; O'Neil, ME; Zaccari, B; Roost, MS; Golshan, S; Huckans, M; Fann, JR; Storzbach, D				Callahan, Megan L.; Binder, Laurence M.; O'Neil, Maya E.; Zaccari, Belle; Roost, Mai S.; Golshan, Shahrokh; Huckans, Marilyn; Fann, Jesse R.; Storzbach, Daniel			Sensory sensitivity in operation enduring freedom/operation Iraqi freedom veterans with and without blast exposure and mild traumatic brain injury	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Blast exposure; concussion; light sensitivity; noise sensitivity; posttraumatic stress; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; PERSISTENT POSTCONCUSSION SYNDROME; MILITARY PERSONNEL; VISUAL FUNCTION; BASE RATES; SYMPTOMS; CONCUSSION; COMPLAINTS; CONSEQUENCES; ASSOCIATION	To examine factors associated with noise and light sensitivity among returning Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) Veterans with a self-reported history of mild traumatic brain injury (mTBI) due to blast exposure, we compared the self-report of noise and light sensitivity of 42 OEF/OIF Veterans diagnosed with mTBI resulting from combat blast-exposure to that of 36 blast-exposed OEF/OIF Veterans without a history of mTBI. Results suggest a statistically significant difference between Veterans with and without a history of mTBI in the experience of noise and light sensitivity, with sensory symptoms reported most frequently in the mTBI group. The difference remains significant even after controlling for symptoms of PTSD, depression, and somatization. These data suggest that while psychological distress is significantly associated with the complaints of noise and light sensitivity, it may not fully account for the experience of sensory sensitivity in a population with mTBI history.	[Callahan, Megan L.; O'Neil, Maya E.; Zaccari, Belle; Roost, Mai S.; Huckans, Marilyn; Storzbach, Daniel] VA Portland Hlth Care Syst, Portland, OR USA; [Binder, Laurence M.; O'Neil, Maya E.; Zaccari, Belle; Huckans, Marilyn; Storzbach, Daniel] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97201 USA; [Binder, Laurence M.; Storzbach, Daniel] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Binder, Laurence M.] Independent Practice, Beaverton, OR USA; [O'Neil, Maya E.] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA; [Zaccari, Belle] VA Portland Hlth Care Syst, Northwest Mental Illness Res Educ & Clin Ctr MIRE, Portland, OR USA; [Golshan, Shahrokh] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Fann, Jesse R.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Fann, Jesse R.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA		Callahan, ML (corresponding author), 3710 SW US Vet Hosp Rd, Portland, OR 97239 USA.	megan.callahan@va.gov		Zaccari, Belle/0000-0003-2260-6620	VA Merit Review Awardfrom the Department of Veterans Affairs [B5060R, CIN 13-404]; Agency for Healthcare Research QualityUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K12HS022981]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K12HS022981] Funding Source: NIH RePORTER	This work was supported by the VA Merit Review Award #B5060R to D.S. from the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Rehabilitation Research and Development, a Veterans Affairs Health Services Research and Development Center of Innovation grant, Center to Improve Veteran Involvement in Care, Award #CIN 13-404, and an Agency for Healthcare Research & Quality-funded PCOR K12 award to M.E.O. (#K12HS022981).	Al-Ozairi A, 2015, J HEAD TRAUMA REHAB, V30, P283, DOI 10.1097/HTR.0000000000000043; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; APA, 2013, DIAGNOSTIC STAT MANU, DOI DOI 10.1176/APPI.BOOKS.9780890425596; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bengtzen R, 2008, NEUROLOGY, V70, P218, DOI 10.1212/01.wnl.0000287090.98555.56; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; BOHNEN N, 1991, J NEUROL, V238, P443, DOI 10.1007/BF00314651; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Defense and Veterans Brain Injury Center, 2013, DOD NUMB TRAUM BRAIN; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Donnell AJ, 2012, CLIN NEUROPSYCHOL, V26, P1092, DOI 10.1080/13854046.2012.713984; Fields H., 1991, NEUROPSY NEUROPSY BE, V4, P83; FOX DD, 1995, NEUROPSYCHOLOGY, V9, P606, DOI 10.1037/0894-4105.9.4.606; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; Gasquoine P G, 2000, Appl Neuropsychol, V7, P83, DOI 10.1207/S15324826AN0702_3; Geisser ME, 2008, PSYCHOSOMATICS, V49, P235, DOI 10.1176/appi.psy.49.3.235; Goodrich GL, 2014, J REHABIL RES DEV, V51, P547, DOI 10.1682/JRRD.2013.02.0049; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Gunstad J, 2002, J INT NEUROPSYCH SOC, V8, P37, DOI 10.1017/S1355617701020045; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; IBM Corp, 2016, IBM SPSS STAT WINDOW; Iverson G.L, 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Kashluba S, 2004, ARCH CLIN NEUROPSYCH, V19, P805, DOI 10.1016/j.acn.2003.09.005; Lew HL, 2010, NEUROREHABILITATION, V26, P213, DOI 10.3233/NRE-2010-0557; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Lovell M, 2000, IMPACT IMMEDIATE POS; Machulda MM, 1998, ARCH CLIN NEUROPSYCH, V13, P415, DOI 10.1016/S0887-6177(97)00031-0; MacLeod C, 2002, J ABNORM PSYCHOL, V111, P107, DOI 10.1037//0021-843X.111.1.107; Mathews A, 2002, COGNITION EMOTION, V16, P331, DOI 10.1080/02699930143000518; McCrea M., 2008, MILD TRAUMATIC BRAIN; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Morey, 1991, PERSONALITY ASSESSME; Morey L. C., 1996, INTERPRETIVE GUIDE P; Murphy KR, 2004, STAT POWER ANAL; Nelson NW, 2015, BRIT J PSYCHIAT, V206, P237, DOI 10.1192/bjp.bp.114.149096; Nolle C, 2004, J NEUROTRAUM, V21, P251, DOI 10.1089/089771504322972040; O'Neil ME, 2014, J INT NEUROPSYCH SOC, V20, P249, DOI [10.1017/S1355617714000204, 10.1017/S135561771300146X]; OHRSTROM E, 1988, PSYCHOL MED, V18, P605, DOI 10.1017/S003329170000828X; Pinto PCL, 2014, J LARYNGOL OTOL, V128, P660, DOI 10.1017/S0022215114001030; Pogoda TK, 2012, J REHABIL RES DEV, V49, P971, DOI 10.1682/JRRD.2011.06.0099; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Sawchyn JM, 2000, ARCH CLIN NEUROPSYCH, V15, P1, DOI 10.1016/S0887-6177(98)00041-9; Silva MA, 2013, CLIN NEUROPSYCHOL, V27, P601; Stansfeld S.A, 1992, PSYCHOL MED        S, V22S, P1, DOI DOI 10.1017/S0264180100001119; STANSFELD SA, 1985, PSYCHOL MED, V15, P243, DOI 10.1017/S0033291700023527; Stelmack JA, 2009, OPTOMETRY, V80, P419, DOI 10.1016/j.optm.2009.02.011; Storzbach D, 2015, J INT NEUROPSYCH SOC, V21, P353, DOI 10.1017/S1355617715000326; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; WADDELL PA, 1984, ACTA NEUROL SCAND, V69, P270, DOI 10.1111/j.1600-0404.1984.tb07812.x; Weathers F. W., 1993, 9 ANN M INT SOC TRAU; Weathers FW, 1996, MEASUREMENT STRESS T, P250; World Health Organization, 2004, ICD 10 INT STAT CLAS	66	17	17	0	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2018	25	2					126	136		10.1080/23279095.2016.1261867			11	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	FT9MO	WOS:000423476400004	27929660				2022-02-06	
J	Chen, W; Guo, YJ; Yang, WJ; Chen, L; Ren, DB; Wu, CX; He, B; Zheng, P; Tong, W				Chen, Wei; Guo, Yijun; Yang, Wenjin; Chen, Lei; Ren, Dabin; Wu, Chenxing; He, Bin; Zheng, Ping; Tong, Wusong			Phosphorylation of connexin 43 induced by traumatic brain injury promotes exosome release	JOURNAL OF NEUROPHYSIOLOGY			English	Article						connexin 43; ERK; exosome-based therapy; hippocampus; traumatic brain injury	GAP-JUNCTIONAL COMMUNICATION; FIBRILLARY ACIDIC PROTEIN; NEUROVASCULAR PLASTICITY; REACTIVE ASTROCYTES; FUNCTIONAL RECOVERY; STROMAL CELLS; DEATH; REDUCTION; ISCHEMIA; MODEL	Traumatic brain injury (TBI) caused by the external force leads to the neuronal dysfunction and even death. TBI has been reported to significantly increase the phosphorylation of glial gap junction protein connexin 43 (Cx43), which in turn propagates damages into surrounding brain tissues. However, the neuroprotective and anti-apoptosis effects of glia-derived exosomes have also been implicated in recent studies. Therefore, we detected whether TBI-induced phosphorylation of Cx43 would promote exosome release in rat brain. To generate TBI model, adult male Sprague-Dawley rats were subjected to lateral fluid percussion injury. Phosphorylated Cx43 protein levels and exosome activities were quantified using Western blot analysis following TBI. Long-term potentiation (LTP) was also tested in rat hippocampal slices. TBI significantly increased the phosphorylated Cx43 and exosome markers expression in rat ipsilateral hippocampus, but not cortex. Blocking the activity of Cx43 or ERK, but not JNK, significantly suppressed TBI-induced exosome release in hippocampus. Furthermore, TBI significantly inhibited the induction of LTP in hippocampal slices, which could be partially but significantly restored by pretreatment with exosomes. The results imply that TBI-activated Cx43 could mediate a nociceptive effect by propagating the brain damages, as well as a neuroprotective effect by promoting exosome release. NEW & NOTEWORTHY We have demonstrated in rat traumatic brain injury (TBI) models that both phosphorylated connexin 43 (p-Cx43) expression and exosome release were elevated in the hippocampus following TBI. The promoted exosome release depends on the phosphorylation of Cx43 and requires ERK signaling activation. Exosome treatment could partially restore the attenuated long-term potentiation. Our results provide new insight for future therapeutic direction on the functional recovery of TBI by promoting p-Cx43-dependent exosome release but limiting the gap junction-mediated bystander effect.	[Chen, Wei; Guo, Yijun; Yang, Wenjin; Chen, Lei; Ren, Dabin; Wu, Chenxing; He, Bin; Zheng, Ping; Tong, Wusong] Peoples Hosp Pu Dong New Area, 490 South Chuanhuan Rd, Shanghai 201299, Peoples R China		Tong, W (corresponding author), Peoples Hosp Pu Dong New Area, 490 South Chuanhuan Rd, Shanghai 201299, Peoples R China.	wstong3@sina.com		Chen, Wei/0000-0001-7438-3241; Tong, Wusong/0000-0003-1072-7310	Outstanding Medical Talent Training Project of Health System of Pudong New Area, Shanghai [PWRq2015-16]; Science and Technology Committee Project of Pu dong New Area, Shanghai [PKJ2016-Y31]; Construction Specialty Project of Health and Family Planning Commission of Pudong New Area, Shanghai [PWZz2013-13]	This work was funded by Outstanding Medical Talent Training Project of Health System of Pudong New Area, Shanghai (PWRq2015-16); The Science and Technology Committee Project of Pu dong New Area, Shanghai (PKJ2016-Y31); and Construction Specialty Project of Health and Family Planning Commission of Pudong New Area, Shanghai (PWZz2013-13).	Bennett MVL, 2004, NEURON, V41, P495, DOI 10.1016/S0896-6273(04)00043-1; BENNETT MVL, 1991, NEURON, V6, P305, DOI 10.1016/0896-6273(91)90241-Q; Contreras JE, 2004, BRAIN RES REV, V47, P290, DOI 10.1016/j.brainresrev.2004.08.002; Cottrell GT, 2003, AM J PHYSIOL-CELL PH, V284, pC511, DOI 10.1152/ajpcell.00214.2002; Danesh-Meyer HV, 2008, J CLIN NEUROSCI, V15, P1253, DOI 10.1016/j.jocn.2008.08.002; Faden AI, 1999, AM J PHYSIOL-REG I, V277, pR1196, DOI 10.1152/ajpregu.1999.277.4.R1196; Frantseva MV, 2002, J NEUROSCI, V22, P644, DOI 10.1523/JNEUROSCI.22-03-00644.2002; Giaume C, 1996, TRENDS NEUROSCI, V19, P319, DOI 10.1016/0166-2236(96)10046-1; Gyorgy B, 2015, ANNU REV PHARMACOL, V55, P439, DOI 10.1146/annurev-pharmtox-010814-124630; Hao L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/468748; Ji H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110314; Lai CPK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00228; Lai RC, 2010, STEM CELL RES, V4, P214, DOI 10.1016/j.scr.2009.12.003; LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2; Li LZ, 2008, J CEREBR BLOOD F MET, V28, P468, DOI 10.1038/sj.jcbfm.9600546; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Mammis A, 2009, SURG NEUROL, V71, P527, DOI 10.1016/j.surneu.2008.02.040; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nagy JI, 2000, BRAIN RES REV, V32, P29, DOI 10.1016/S0165-0173(99)00066-1; Nakase T, 2004, AM J PATHOL, V164, P2067, DOI 10.1016/S0002-9440(10)63765-0; Naus CCG, 1997, J NEUROSCI RES, V49, P528, DOI 10.1002/(SICI)1097-4547(19970901)49:5<528::AID-JNR3>3.0.CO;2-D; Ohsumi A, 2006, ACTA NEUROCHIR SUPPL, V96, P148; Ohsumi A, 2010, J NEUROTRAUM, V27, P1255, DOI 10.1089/neu.2009.1234; Otani N, 2002, J CEREBR BLOOD F MET, V22, P327, DOI 10.1097/00004647-200203000-00010; Pekny M, 1999, J CELL BIOL, V145, P503, DOI 10.1083/jcb.145.3.503; Rami A, 2000, EXP NEUROL, V170, P297, DOI 10.1006/exnr.2001.7712; Siushansian R, 2001, J COMP NEUROL, V440, P387, DOI 10.1002/cne.1392; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Xin HQ, 2013, J CEREBR BLOOD F MET, V33, P1711, DOI 10.1038/jcbfm.2013.152; Xiong Y, 2017, NEURAL REGEN RES, V12, P19, DOI 10.4103/1673-5374.198966; Zhang YL, 2017, NEUROCHEM INT, V111, P69, DOI 10.1016/j.neuint.2016.08.003; Zhang YL, 2015, J NEUROSURG, V122, P856, DOI 10.3171/2014.11.JNS14770; Zhao ZQ, 2004, EXP NEUROL, V190, P356, DOI 10.1016/j.expneurol.2004.06.015	34	17	21	3	14	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-3077	1522-1598		J NEUROPHYSIOL	J. Neurophysiol.	JAN	2018	119	1					305	311		10.1152/jn.00654.2017			7	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	FU7RV	WOS:000424051300025	29046426				2022-02-06	
J	Churchill, NW; Hutchison, MG; Graham, SJ; Schweizer, TA				Churchill, Nathan W.; Hutchison, Michael G.; Graham, Simon J.; Schweizer, Tom A.			Connectomic markers of symptom severity in sport-related concussion: Whole-brain analysis of resting-state fMRI	NEUROIMAGE-CLINICAL			English	Article						fMRI; Functional connectivity; Concussion; Brain injury; Symptoms	FUNCTIONAL CONNECTIVITY; WHITE-MATTER; NETWORK; FOOTBALL; GYRUS	Concussion is associated with significant adverse effects within the first week post-injury, including physical complaints and altered cognition, sleep and mood. It is currently unknown whether these subjective disturbances have reliable functional brain correlates. Resting-state functional magnetic resonance imaging (rs-fMRI) has been used to measure functional connectivity of individuals after traumatic brain injury, but less is known about the relationship between functional connectivity and symptom assessments after a sport concussion. In this study, rs-fMRI was used to evaluate whole-brain functional connectivity for seventy (70) university-level athletes, including 35 with acute concussion and 35 healthy matched controls. Univariate analyses showed that greater symptom severity was mainly associated with lower pairwise connectivity in frontal, temporal and insular regions, along with higher connectivity in a sparser set of cerebellar regions. A novel multivariate approach also extracted two components that showed reliable covariation with symptom severity: (1) a network of frontal, temporal and insular regions where connectivity was negatively correlated with symptom severity (replicating the univariate findings); and (2) a network with anti-correlated elements of the default-mode network and sensorimotor system, where connectivity was positively correlated with symptom severity. These findings support the presence of connectomic signatures of symptom complaints following a sport-related concussion, including both increased and decreased functional connectivity within distinct functional brain networks.	[Churchill, Nathan W.; Hutchison, Michael G.; Schweizer, Tom A.] St Michaels Hosp, Neurosci Res Program, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON, Canada; [Hutchison, Michael G.] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Graham, Simon J.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Graham, Simon J.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Phys Sci Platform, Toronto, ON, Canada; [Schweizer, Tom A.] Univ Toronto, Fac Med Neurosurg, Toronto, ON, Canada; [Schweizer, Tom A.] Univ Toronto, Inst Biomat & Biomed Engn IBBME, Toronto, ON, Canada		Churchill, NW (corresponding author), 209 Victoria St, Toronto, ON M5B 1M8, Canada.	ChurchillN@smh.ca			Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [RN294001-367456]; Canadian Institutes of Military and Veterans Health (CIMVHR) [W7714-145967]; Siemens Canada Ltd.	This work was supported by the Canadian Institutes of Health Research (CIHR) [grant number RN294001-367456]; the Canadian Institutes of Military and Veterans Health (CIMVHR) [grant number W7714-145967]; and pilot funding from Siemens Canada Ltd.	Badre D, 2008, TRENDS COGN SCI, V12, P193, DOI 10.1016/j.tics.2008.02.004; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Bro R, 1996, MULTILINEAR PLS J CH, V10; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Churchill NW, 2017, NEUROIMAGE-CLIN, V14, P480, DOI 10.1016/j.nicl.2017.02.015; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Graham D., 2002, TRAUMA GREENFIELDS N; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Guskiewicz KM, 2006, FOUNDATIONS OF SPORT-RELATED BRAIN INJURIES, P65, DOI 10.1007/0-387-32565-4_4; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Hillary FG, 2015, NEUROPSYCHOLOGY, V29, P59, DOI 10.1037/neu0000110; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Krishnan A, 2011, NEUROIMAGE, V56, P455, DOI 10.1016/j.neuroimage.2010.07.034; Li W, 2013, NEUROIMAGE, V78, P46, DOI 10.1016/j.neuroimage.2013.04.011; Makdissi M, 2013, BRIT J SPORT MED, V47, P314, DOI 10.1136/bjsports-2013-092256; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Messe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065470; Mummery CJ, 2000, ANN NEUROL, V47, P36; Pearlson GD, 1997, PROG NEURO-PSYCHOPH, V21, P1203, DOI 10.1016/S0278-5846(97)00159-0; Putukian M, 2015, CLIN J SPORT MED, V25, P36, DOI 10.1097/JSM.0000000000000102; Rosipal R, 2006, LECT NOTES COMPUT SC, V3940, P34, DOI 10.1007/11752790_2; Sala-Llonch R, 2012, CORTEX, V48, P1187, DOI 10.1016/j.cortex.2011.07.006; Schweizer TA, 2008, NEUROREHAB NEURAL RE, V22, P72, DOI 10.1177/1545968307305303; Schweizer TA, 2007, NEUROPSYCHOLOGIA, V45, P3068, DOI 10.1016/j.neuropsychologia.2007.05.018; Shenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3; Slobounov S, 2012, BRAIN IMAGING BEHAV, V6, P224, DOI 10.1007/s11682-012-9167-2; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Strick PL, 2009, ANNU REV NEUROSCI, V32, P413, DOI 10.1146/annurev.neuro.31.060407.125606; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Vogt BA, 2016, J CHEM NEUROANAT, V74, P28, DOI 10.1016/j.jchemneu.2016.01.010; Wong CW, 2012, NEUROIMAGE, V63, P356, DOI 10.1016/j.neuroimage.2012.06.035; Yuh Esther L, 2014, Neurosurgery, V75 Suppl 4, pS50, DOI 10.1227/NEU.0000000000000491; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413	48	17	17	1	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2018	18						518	526		10.1016/j.nicl.2018.02.011			9	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GH1NG	WOS:000433169000053	29560308	Green Published, gold			2022-02-06	
J	Fridman, L; Scolnik, M; Macpherson, A; Rothman, L; Guttmann, A; Grool, AM; Duque, DR; Zemek, RL				Fridman, Liraz; Scolnik, Michal; Macpherson, Alison; Rothman, Linda; Guttmann, Astrid; Grool, Anne M.; Duque, Daniel Rodriguez; Zemek, Roger L.			Annual Trends in Follow-Up Visits for Pediatric Concussion in Emergency Departments and Physicians' Offices	JOURNAL OF PEDIATRICS			English	Article							TRAUMATIC BRAIN-INJURY; DISCHARGE; CHILDREN; SPORT; STATEMENT; SYMPTOMS	Objective To assess whether children and youth with concussion receive follow-up visits in accordance with the recommended guidelines. Study design We conducted a retrospective, population-based study using linked health administrative data from all concussion-related visits to emergency department and physician offices by children aged 5 through 18 years (range, 5.00-18.99) in Ontario between 2003 and 2013. We analyzed the percentage of children and youth seen for follow-up. The Mann-Kendall test for trends was used to assess a monotonic increasing trend over time in concussion follow-up visits. Results A total of 126 654 children and youth were evaluated for an index concussion visit. The number of children and youth assessed for concussion follow-up (N = 45 155) has increased significantly over time (P < .001). In 2003, 781 of 7126 patients (11.0%; 95% CI, 10.3-11.7) with an index visit for concussion had a follow-up assessment. By 2013, 6526 of 21 681 (30.1%; 95% CI, 29.5-30.7) patients received follow-up care. Conclusions The proportion of children and youth receiving follow-up after an acute concussion has significantly increased between 2003 and 2013. Nevertheless, more than two-thirds of all patients do not seek medical follow-up or clearance as recommended by current concussion guidelines, suggesting that ongoing efforts to improve and monitor compliance with recommended guidelines by patients and physicians are important.	[Fridman, Liraz; Macpherson, Alison; Rothman, Linda] York Univ, Toronto, ON, Canada; [Scolnik, Michal] Technion Amer Med Sch, Haifa, Israel; [Macpherson, Alison; Guttmann, Astrid; Duque, Daniel Rodriguez] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Guttmann, Astrid] Univ Toronto, Hosp Sick Children, Dept Pediat, Toronto, ON, Canada; [Grool, Anne M.; Zemek, Roger L.] Childrens Hosp, Eastern Ontario Res Inst, Toronto, ON, Canada; [Zemek, Roger L.] Univ Ottawa, Dept Pediat & Emergency Med, Ottawa, ON, Canada		Fridman, L (corresponding author), 4700 Keele St, Toronto, ON M3J1P3, Canada.	liraz@yorku.ca			Ontario Child Health SPOR Support Unit (OCHSU); Institute for Clinical Evaluative Sciences (ICES)University of Toronto; Ontario Ministry of Health and Long-Term Care (MOHLTC)Ministry of Health and Long-Term Care, Ontario; Canadian Institutes of Health Research (CIHR) Chairs in Reproductive and Child Health Services and Policy Research [126341]; Clinical Research Chair in Pediatric Concussion by the University of Ottawa	Supported by the Ontario Child Health SPOR Support Unit (OCHSU) and the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). Parts of this material are based on data and information compiled and provided by the Canadian Institute for Health Information (CIHI). A.M. and A.G. are supported by Canadian Institutes of Health Research (CIHR) Chairs in Reproductive and Child Health Services and Policy Research (# 126341). R.Z. is supported by a Clinical Research Chair in Pediatric Concussion by the University of Ottawa. The other authors declare no conflicts of interest.	American Academy of Neurology, 2013, SUMM EV BAS GUID CLI; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Brener I, 2004, J HEAD TRAUMA REHAB, V19, P405, DOI 10.1097/00001199-200409000-00005; Crandall M, 2014, BRAIN INJURY, V28, P1359, DOI 10.3109/02699052.2014.919533; Faul M, 2010, BRAIN INJURY; Fung M, 2006, BRAIN INJURY, V20, P889, DOI 10.1080/02699050600831934; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Haran HP, 2016, J SCI MED SPORT, V19, P194, DOI 10.1016/j.jsams.2015.02.009; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Henry LC, 2017, NEUROSCIENTIST, V23, P567, DOI 10.1177/1073858416651034; Hesselink G, 2013, INT J QUAL HEALTH C, V25, P66, DOI 10.1093/intqhc/mzs066; Macpherson A, 2014, PAED CHILD HEALT-CAN, V19, P543, DOI 10.1093/pch/19.10.543; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McLeod AI, 2011, Kendall: Kendall rank correlation and Mann-Kendall trend test; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Ontario Neurotrauma Foundation, 2014, GUID DIAGN MAN PED C, V1, P1; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Selassie AW, 2013, ANN EPIDEMIOL, V23, P750, DOI 10.1016/j.annepidem.2013.07.022; Upchurch C, 2015, CLIN J SPORT MED, V25, P297, DOI 10.1097/JSM.0000000000000123; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Zemek R, 2016, J PEDIAT, V181, pe2; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek RL, 2017, J PEDIATR-US, V181, P222, DOI 10.1016/j.jpeds.2016.10.067	24	17	17	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	JAN	2018	192						184	188		10.1016/j.jpeds.2017.09.018			5	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	FT7ST	WOS:000423353900035	29150146				2022-02-06	
J	Han, K; Chapman, SB; Krawczyk, DC				Han, Kihwan; Chapman, Sandra B.; Krawczyk, Daniel C.			Neuroplasticity of cognitive control networks following cognitive training for chronic traumatic brain injury	NEUROIMAGE-CLINICAL			English	Article						Traumatic brain injury; Rehabilitation; Cognitive function; Resting-state functional connectivity; Neuroplasticity; Cognitive control	INTRINSIC FUNCTIONAL CONNECTIVITY; CINGULO-OPERCULAR NETWORK; DEFAULT-MODE NETWORK; RESTING-STATE FMRI; OF-THE-LITERATURE; CEREBRAL-CORTEX; NUISANCE REGRESSION; SALIENCE NETWORK; WORKING-MEMORY; HEAD MOTION	Cognitive control is the ability to coordinate thoughts and actions to achieve goals. Cognitive control impairments are one of the most persistent and devastating sequalae of traumatic brain injuries (TBI). There have been efforts to improve cognitive control in individuals with post-acute TBI. Several studies have reported changes in neuropsychological measures suggesting the efficacy of cognitive training in improving cognitive control. Yet, the neural substrates of improved cognitive control after training remains poorly understood. In the current study, we identified neural plasticity induced by cognitive control training for TBI using resting-state functional connectivity (rsFC). Fifty-six individuals with chronic mild TBI (9 years post-injury on average) were randomized into either a strategy-based cognitive training group (N = 26) or a knowledge-based training group (active control condition; N = 30) for 8 weeks. We acquired a total of 109 resting-state functional magnetic resonance imaging from 45 individuals before training, immediately post-training, and 3 months post-training. Relative to the controls, the strategy-based cognitive training group showed monotonic increases in connectivity in two cognitive control networks (i.e., cingulo-opercular and fronto-parietal networks) across time points in multiple brain regions (p(voxel) < 0.001, p(cluster) < 0.05). Analyses of brain-behavior relationships revealed that frontoparietal network connectivity over three time points within the strategy-based cognitive training group was positively associated with the trail making scores (p(voxel) < 0.001, p(cluster) < 0.05). These findings suggest that training-induced neuroplasticity continues through chronic phases of TBI and that rsFC can serve as a neuroimaging biomarker of evaluating the efficacy of cognitive training for TBI.	[Han, Kihwan; Chapman, Sandra B.; Krawczyk, Daniel C.] Univ Texas Dallas, Sch Behav & Brain Sci, Ctr BrainHlth, 2200 West Mockingbird Lane,Mail Stop CBH, Dallas, TX 75235 USA; [Krawczyk, Daniel C.] Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dallas, TX USA		Han, K (corresponding author), Univ Texas Dallas, Sch Behav & Brain Sci, Ctr BrainHlth, 2200 West Mockingbird Lane,Mail Stop CBH, Dallas, TX 75235 USA.	kihwan.han@utdallas.edu; schapman@utdallas.edu; daniel.krawczyk@utdallas.edu	Han, Kihwan/I-1984-2019	Han, Kihwan/0000-0002-4574-7306	Department of DefenseUnited States Department of Defense [W81XWH-11-2-0194, W81XWH-11-2-0195]; Meadows Foundation; Sapphire Foundation Distinguished New Scientist Award	This work was supported by the Department of Defense (W81XWH-11-2-0194 to DCK and W81XWH-11-2-0195 to SBC), the Meadows Foundation to DCK and SBC, and the Sapphire Foundation Distinguished New Scientist Award to KH.	Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Bernal-Rusiel JL, 2013, NEUROIMAGE, V66, P249, DOI 10.1016/j.neuroimage.2012.10.065; Bertolero MA, 2015, P NATL ACAD SCI USA, V112, pE6798, DOI 10.1073/pnas.1510619112; Binder D., 2008, BRAIN HLTH WORKSHOP; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Bright MG, 2017, NEUROIMAGE, V154, P159, DOI 10.1016/j.neuroimage.2016.12.027; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cocchi L, 2013, TRENDS COGN SCI, V17, P493, DOI 10.1016/j.tics.2013.08.006; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Cox RW, 2017, BRAIN CONNECT, V7, P152, DOI 10.1089/brain.2016.0475; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; De Giglio L, 2016, RADIOLOGY, V280, P202, DOI 10.1148/radiol.2016150710; Delis D. C., 2001, D KEFS EXECUTIVE FUN; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Etkin A, 2009, ARCH GEN PSYCHIAT, V66, P1361, DOI 10.1001/archgenpsychiatry.2009.104; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Faul M, 2010, TRAUMATIC BRAIN INJU; Fornito A, 2012, P NATL ACAD SCI USA, V109, P12788, DOI 10.1073/pnas.1204185109; Frieden T.R., 2015, REPORT C TRAUMATIC B; Guerra-Carrillo B, 2014, NEUROSCIENTIST, V20, P522, DOI 10.1177/1073858414524442; Hallquist MN, 2013, NEUROIMAGE, V82, P208, DOI 10.1016/j.neuroimage.2013.05.116; Han K, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.687; Han K, 2016, J INT NEUROPSYCH SOC, V22, P263, DOI 10.1017/S1355617715001393; Han K, 2014, NEUROIMAGE, V84, P76, DOI 10.1016/j.neuroimage.2013.08.017; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Jilka SR, 2014, J NEUROSCI, V34, P10798, DOI 10.1523/JNEUROSCI.0518-14.2014; Jolles D, 2016, DEVELOPMENTAL SCI, V19, P613, DOI 10.1111/desc.12399; Jolles DD, 2013, HUM BRAIN MAPP, V34, P396, DOI 10.1002/hbm.21444; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Kelly C, 2014, NEUROPSYCHOL REV, V24, P63, DOI 10.1007/s11065-014-9252-y; Keshavan MS, 2017, NEUROIMAGE, V151, P55, DOI 10.1016/j.neuroimage.2016.11.060; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); Krawczyk DC, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-29; Lewisa CM, 2009, P NATL ACAD SCI USA, V106, P17558, DOI 10.1073/pnas.0902455106; Mackey AP, 2013, J NEUROSCI, V33, P4796, DOI 10.1523/JNEUROSCI.4141-12.2013; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Moll J, 2002, ARQ NEURO-PSIQUIAT, V60, P900, DOI 10.1590/S0004-282X2002000600002; Nomura EM, 2010, P NATL ACAD SCI USA, V107, P12017, DOI 10.1073/pnas.1002431107; Power JD, 2013, CURR OPIN NEUROBIOL, V23, P223, DOI 10.1016/j.conb.2012.12.009; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Sanchez-Cubillo I, 2009, J INT NEUROPSYCH SOC, V15, P438, DOI 10.1017/S1355617709090626; Scheinost D, 2014, NEUROIMAGE, V95, P13, DOI 10.1016/j.neuroimage.2014.03.035; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sestieri C, 2014, J COGNITIVE NEUROSCI, V26, P551, DOI 10.1162/jocn_a_00504; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sheffield JM, 2015, NEUROPSYCHOLOGIA, V73, P82, DOI 10.1016/j.neuropsychologia.2015.05.006; Silk TJ, 2008, BRAIN IMAGING BEHAV, V2, P123, DOI 10.1007/s11682-008-9021-8; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Spreng RN, 2014, J NEUROSCI, V34, P14108, DOI 10.1523/JNEUROSCI.2815-14.2014; Spreng RN, 2010, NEUROIMAGE, V53, P303, DOI 10.1016/j.neuroimage.2010.06.016; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Takeuchi H, 2013, CORTEX, V49, P2106, DOI 10.1016/j.cortex.2012.09.007; Tardif CL, 2016, NEUROIMAGE, V131, P55, DOI 10.1016/j.neuroimage.2015.08.047; Taubert M, 2011, NEUROIMAGE, V57, P1492, DOI 10.1016/j.neuroimage.2011.05.078; Tellier A, 2009, BRAIN INJURY, V23, P879, DOI 10.1080/02699050903200555; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Thomas C, 2013, NEUROIMAGE, V73, P225, DOI 10.1016/j.neuroimage.2012.03.069; Trujillo JP, 2015, HUM BRAIN MAPP, V36, P3703, DOI 10.1002/hbm.22873; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Van Essen DC, 2012, CEREB CORTEX, V22, P2241, DOI 10.1093/cercor/bhr291; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; Vas A, 2016, NEUROPSYCHOL REHABIL, V26, P502, DOI 10.1080/09602011.2015.1044013; Vas AK, 2011, J HEAD TRAUMA REHAB, V26, P224, DOI 10.1097/HTR.0b013e318218dd3d; Voss MW, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00032; Weathers F.W., 1993, ANN CONV INT SOC TRA; Wechsler D., 2011, WECHSLER ABBREVIATED; WechslerD, 2001, WECHSLER TEST ADULT; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wu XP, 2016, J AFFECT DISORDERS, V200, P275, DOI 10.1016/j.jad.2016.04.046; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zakzanis KK, 2005, NEUROPSYCHOLOGIA, V43, P1878, DOI 10.1016/j.neuropsychologia.2005.03.013; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	92	17	19	3	8	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2018	18						262	278		10.1016/j.nicl.2018.01.030			17	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GH1NG	WOS:000433169000026	29876247	Green Published, gold			2022-02-06	
J	Kerr, ZY; Register-Mihalik, JK; Kay, MC; DeFreese, JD; Marshall, SW; Guskiewicz, KM				Kerr, Zachary Y.; Register-Mihalik, Johna K.; Kay, Melissa C.; DeFreese, J. D.; Marshall, Stephen W.; Guskiewicz, Kevin M.			Concussion Nondisclosure During Professional Career Among a Cohort of Former National Football League Athletes	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						epidemiology; sport; underreporting; traumatic brain injury	SELF-REPORTED CONCUSSIONS; RECURRENT CONCUSSION; ATTITUDES; RISK; CONCORDANCE; DEPRESSION; QUALITY; HISTORY; RATES; RACE	Background: Despite a focus on the incidence and effects of concussion, nondisclosure of sports-related concussions among retired players from the National Football League (NFL) has yet to be examined. Purpose: Examine the prevalence of and factors associated with nondisclosure of sports-related concussions in former NFL athletes. Study Design: Cross-sectional study; Level of evidence, 3. Methods: A sample of 829 former NFL players completed a general health survey. This historical cohort included players who had played before World War II to 2001. Respondents retrospectively recalled sports-related concussions that they sustained during their professional careers and whether at least one of these sports-related concussions was not reported to medical staff. We computed the prevalence of nondisclosure among those recalling sport-related concussions during their professional careers. Multivariable binomial regression estimated adjusted prevalence ratios (PR) with 95% confidence intervals (CIs) controlling for race/ethnicity, number of years played, primary position played, professional career concussion history, and playing era. Playing era was categorized by whether the majority of a player's career was before or after a 1976 rule change to limit contact ("spearing"). Results: Overall, 417 (50.3%) respondents reported they had sustained a concussion and did not inform medical staff at least once during their professional playing career. Nonwhite respondents had a higher prevalence of nondisclosure than white/non-Hispanic respondents (adjusted PR = 1.19; 95% CI, 1.02-1.38). An interaction between professional career concussion history and playing era was also found (P = .08). Compared with those in the pre-spearing rule change group with 1 or 2 concussions, all other groups had larger prevalences of nondisclosure (increases ranging from 41% to 153% in multivariable models). Across concussion strata, nondisclosure prevalence was generally higher in the post-spearing rule change group than the pre-spearing rule change group, with the largest differences found among those with 1 or 2 concussions or those with 3 or 4 concussions. Conclusion: A large proportion of former NFL players in this historical cohort reported at least one instance of not disclosing sports-related concussions to medical staff. Future research on concussion nondisclosure needs to identify mechanisms to improve football players' intentions to disclose concussion-related symptoms to health care providers and to equip health care providers with more effective strategies for timely identification of concussion.	[Kerr, Zachary Y.; Register-Mihalik, Johna K.; Kay, Melissa C.; DeFreese, J. D.; Marshall, Stephen W.; Guskiewicz, Kevin M.] Univ North Carolina Chapel Hill, Chapel Hill, NC USA; [Kerr, Zachary Y.; Register-Mihalik, Johna K.; DeFreese, J. D.; Guskiewicz, Kevin M.] Univ N Carolina, Dept Exercise & Sport Sci, 313 Woollen Gym,CB 8700, Chapel Hill, NC 27599 USA; [Kerr, Zachary Y.; Register-Mihalik, Johna K.; Kay, Melissa C.; DeFreese, J. D.; Marshall, Stephen W.; Guskiewicz, Kevin M.] Univ N Carolina, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC 27599 USA; [Kerr, Zachary Y.; Register-Mihalik, Johna K.; DeFreese, J. D.; Marshall, Stephen W.; Guskiewicz, Kevin M.] Univ N Carolina, Ctr Study Retired Athletes, Chapel Hill, NC 27599 USA; [Kerr, Zachary Y.; Register-Mihalik, Johna K.; Marshall, Stephen W.; Guskiewicz, Kevin M.] Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC 27599 USA; [Kay, Melissa C.; Marshall, Stephen W.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA		Kerr, ZY (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, 313 Woollen Gym,CB 8700, Chapel Hill, NC 27599 USA.	zkerr@email.unc.edu			Matthew A. Gfeller Sport-Related Traumatic Brain Injury Research Center; Center for the Study of Retired Athletes; NFL Players Association	The authors acknowledge the support of the Matthew A. Gfeller Sport-Related Traumatic Brain Injury Research Center, the Center for the Study of Retired Athletes, and the NFL Players Association. The Matthew A. Gfeller Sport-Related Traumatic Brain Injury Research Center and the Center for the Study of Retired Athletes are funded by private donations and various grant funding agencies interested in understanding the late-life consequences and benefits of playing sports.	Association of American Medical Colleges, 2014, DIV PHYS WORKF FACTS; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Clark MD, 2017, AM J SPORT MED, V45, P929, DOI 10.1177/0363546516677793; Fraas MR, 2014, PHYS THER SPORT, V15, P136, DOI 10.1016/j.ptsp.2013.08.002; Greenland S, 2004, AM J EPIDEMIOL, V160, P301, DOI 10.1093/aje/kwh221; Guskiewicz K. M., 2003, Medicine & Science in Sports & Exercise, V35, pS50, DOI 10.1097/00005768-200305001-00277; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hagiwara N, 2013, SOC SCI MED, V87, P123, DOI 10.1016/j.socscimed.2013.03.016; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Kerr ZY, 2012, MED SCI SPORT EXER, V44, P377, DOI 10.1249/MSS.0b013e31823240f2; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Malat J, 2009, J NATL MED ASSOC, V101, P800, DOI 10.1016/S0027-9684(15)31009-9; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; National Football League, PROT PLAYERS NFL HEA; National Football League, 2016, NFL NFLPA ANN POL EN; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Sabin JA, 2008, MED CARE, V46, P678, DOI 10.1097/MLR.0b013e3181653d58; Saha S, 1999, ARCH INTERN MED, V159, P997, DOI 10.1001/archinte.159.9.997; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; University of Central Florida College of Business Administration, 2016 RAC GEND REP CA; Yi JY, 2013, CURR SPORT MED REP, V12, P28, DOI 10.1249/JSR.0b013e31827ec9e3; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	29	17	17	0	22	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	JAN	2018	46	1					22	29		10.1177/0363546517728264			8	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	FR4FG	WOS:000419020500002	28942673				2022-02-06	
J	Ouellet, S; Philippens, M				Ouellet, S.; Philippens, M.			The multi-modal responses of a physical head model subjected to various blast exposure conditions	SHOCK WAVES			English	Article						Blast neuro-trauma; Headform; Head biomechanics; Injury mechanisms; Intra-cranial pressure	TRAUMATIC BRAIN-INJURY; TRANSMISSION; ATTENUATION; SPEED; SOUND	The local and global biomechanical response of the body to a blast wave is the first step of a sequence that leads to the development of stresses and strains which can exceed the tolerance of brain tissue. These stresses and strains may then lead to neuro-physical changes in the brain and contribute to initiate a cascade of events leading to injury. The specific biomechanical pathways by which the blast energy is transmitted through the head structure are, however, not clearly understood. Multiple transmission mechanisms have been proposed to explain the generation of brain stresses following the impingement of a blast wave on the head. With the use of a physical head model, the work presented here aims at demonstrating that the proposed transmission mechanisms are not mutually exclusive. They are part of a continuum of head responses where, depending on the exposure conditions, a given mechanism may or may not dominate. This article presents the joint analysis of previous blast test results generated with the brain injury protection evaluation device (BIPED) headform under four significantly different exposure conditions. The focus of the analysis is to demonstrate how the nature of the recorded response is highly dependent on the exposure characteristics and consequently, on the method used to reproduce blast exposure in a laboratory environment. The timing and magnitude of the variations in intra-cranial pressures (ICP) were analysed relative to the external pressure field in order to better understand the wave dynamics occurring within the brain structure of the headform. ICP waveforms were also analysed in terms of their energy spectral density to better identify the energy partitioning between the different modes of response. It is shown that the BIPED response is multi-modal and that the energy partitioning between its different modes of response is greatly influenced by exposure characteristics such as external peak overpressure, impulse, blast wave structure, and direction of propagation. Convincing evidence of stresses generated from local skull deformation is presented along with evidence of stress transmission through relative brain-to-skull motion. These findings suggest that research aimed at defining exposure thresholds should not focus on a single stress transmission mechanism or use experimental designs unrepresentative of realistic blast loading conditions that may favour a given mechanism over another.	[Ouellet, S.] Def Res & Dev Canada, 2459 Bravoure Rd, Quebec City, PQ G3J 1X5, Canada; [Philippens, M.] TNO Rijswijk, Lange Kleiweg 137, NL-2288 GJ Rijswijk, Netherlands		Ouellet, S (corresponding author), Def Res & Dev Canada, 2459 Bravoure Rd, Quebec City, PQ G3J 1X5, Canada.	simon.ouellet@drdc-rddc.gc.ca					Appleby-Thomas GJ, 2014, J MECH BEHAV BIOMED, V33, P124, DOI 10.1016/j.jmbbm.2013.05.018; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Bhattacharjee Y, 2008, SCIENCE, V319, P406, DOI 10.1126/science.319.5862.406; Bir C., 2011, ADA547306 DTIC; Bir C., P HFM 207 NATO S SUR, DOI 10.14339/RTO-MP-HFM-207-27-doc; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; Brands D W, 2000, Stapp Car Crash J, V44, P249; Brands D. W. A., 1999, 99SC21 SAE; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Cooper GJ, 1996, J TRAUMA, V40, pS105, DOI 10.1097/00005373-199603001-00024; Courtney A., 2013, J BATTLEF TECHNOL, V16, P1, DOI [10.3316/informit.745340038848473, DOI 10.3316/INFORMIT.745340038848473]; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; Courtney A, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00221; Courtney M, 2011, NEUROSURGERY, V68, pE596, DOI 10.1227/NEU.0b013e3182041992; Foster J., 1977, SAE TECHNICAL PAPER, DOI [10.4271/770938, DOI 10.4271/770938]; FRY FJ, 1978, J ACOUST SOC AM, V63, P1576, DOI 10.1121/1.381852; Ganpule S, 2013, THESIS; Glasstone S., 1977, ADA087568 DITC US DE; Gupta RK, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00059; Hodgson V. R., 1967, 670911 SAE, DOI [10.4271/670911, DOI 10.4271/670911]; Hua Y, 2014, J COMPUT NONLIN DYN, V9, DOI 10.1115/1.4026156; Hutchinson J, 1998, APPL MATH COMPUT, V96, P1, DOI 10.1016/S0096-3003(97)10106-0; Josey T., 2016, P PERS ARM SYST S 20; KREMKAU FW, 1981, J ACOUST SOC AM, V70, P29, DOI 10.1121/1.386578; Leonardi AD, 2011, J NEUROTRAUM, V28, P85, DOI 10.1089/neu.2010.1324; Mediavilla Varas Jesus, 2011, Front Neurol, V2, P58, DOI 10.3389/fneur.2011.00058; Merkle AC, 2009, P ASME INT MECH ENG, P91, DOI DOI 10.1115/IMECE2009-11807; Moss WC, 2011, P NATL ACAD SCI USA, V108, pE82, DOI 10.1073/pnas.1101671108; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Needham CE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00072; Ono K, 1980, SAE TECHNICAL PAPER, DOI [10.4271/801303, DOI 10.4271/801303]; Ouellet S., 2014, P PERS ARM SYST S 20; Ouellet S., 2012, P PERS ARM SYST S 20; Pichardo S, 2011, PHYS MED BIOL, V56, P219, DOI 10.1088/0031-9155/56/1/014; Roberts J. C., 2014, U.S. Patent, Patent No. 8725449; Sawyer TW, 2016, J NEUROTRAUM, V33, P1181, DOI 10.1089/neu.2015.3914; STALNAKER RL, 1971, J BIOMECH, V4, P127, DOI 10.1016/0021-9290(71)90023-6; Stemper BD, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00031; Stenfelt S, 2005, J ACOUST SOC AM, V118, P2373, DOI 10.1121/1.2005847; Tikhonravov A. V., 2006, NUM METH PROG, V7, P23; van Dommelen J. A. W., 2009, V2, P249; Viano D. C., 1988, 881708 SAE, DOI [10.4271/881708, DOI 10.4271/881708]; Willinger R, 2003, INT J CRASHWORTHINES, V8, P605, DOI 10.1533/ijcr.2003.0264; WILLINGER R, 1995, J NEUROTRAUM, V12, P743, DOI 10.1089/neu.1995.12.743; Yoganandan N, 2009, J BIOMECH, V42, P1177, DOI 10.1016/j.jbiomech.2009.03.029; Young L, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00089; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	47	17	17	0	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0938-1287	1432-2153		SHOCK WAVES	Shock Waves	JAN	2018	28	1					19	36		10.1007/s00193-017-0771-3			18	Mechanics	Science Citation Index Expanded (SCI-EXPANDED)	Mechanics	FU0TF	WOS:000423562600003					2022-02-06	
J	Struebing, FL; King, R; Li, Y; Chrenek, MA; Lyuboslavsky, PN; Sidhu, CS; Iuvone, PM; Geisert, EE				Struebing, Felix L.; King, Rebecca; Li, Ying; Chrenek, Micah A.; Lyuboslavsky, Polina N.; Sidhu, Curran S.; Iuvone, P. Michael; Geisert, Eldon E.			Transcriptional Changes in the Mouse Retina after Ocular Blast Injury: A Role for the Immune System	JOURNAL OF NEUROTRAUMA			English	Article						axon injury; ocular blast injury; ocular immune system; systems genetics; transcriptome	TRAUMATIC BRAIN-INJURY; COMPLEMENT GENE-EXPRESSION; INFLAMMATION; NETWORK; MODEL; MICROGLIA; MIGRATION; ANTERIOR; DISEASE; CELLS	Ocular blast injury is a major medical concern for soldiers and explosion victims due to poor visual outcomes. To define the changes in gene expression following a blast injury to the eye, we examined retinal ribonucleic acid (RNA) expression in 54 mouse strains 5 days after a single 50-psi overpressure air wave blast injury. We observe that almost 40% of genes are differentially expressed with a false discovery rate (FDR) of <0.001, even though the nominal changes in RNA expression are rather small. Moreover, we find through machine learning approaches that genetic networks related to the innate and acquired immune system are activated. Accompanied by lymphocyte invasion into the inner retina, blast injury also results in progressive loss of visual function and retinal ganglion cells (RGCs). Collectively, these data demonstrate how systems genetics can be used to put meaning to the transcriptome changes following ocular blast injury that eventually lead to blindness.	[Struebing, Felix L.; King, Rebecca; Li, Ying; Chrenek, Micah A.; Lyuboslavsky, Polina N.; Sidhu, Curran S.; Iuvone, P. Michael; Geisert, Eldon E.] Emory Univ, Dept Ophthalmol, 1365B Clifton Rd NE,Room 5500, Atlanta, GA 30305 USA		Geisert, EE (corresponding author), Emory Univ, Dept Ophthalmol, 1365B Clifton Rd NE,Room 5500, Atlanta, GA 30305 USA.	egeiser@emory.edu	Struebing, Felix/ABD-7971-2021	Struebing, Felix/0000-0002-9436-6294	Department of Defense CDMRP Grant from the U.S. Army Medical Research and Materiel Command [W81XWH1210255, W81XWH-12-1-0436]; Department of Defense CDMRP Grant from Telemedicine and Advanced Technology; NEIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY178841, R01EY004864, P30EY06360]; Research to Prevent BlindnessResearch to Prevent Blindness (RPB); institutional training grant [T32EY007092-30]; Emory Integrated Genomics Core (EIGC); Emory University School of Medicine as one of the Emory Integrated Core Facilities; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [P30EY006360, R01EY017841, R01EY021592, T32EY007092] Funding Source: NIH RePORTER	This study was supported by the Department of Defense CDMRP Grants W81XWH1210255 and W81XWH-12-1-0436 from the U.S. Army Medical Research and Materiel Command and the Telemedicine and Advanced Technology (EEG, PMI), NEI grants R01EY178841 (EEG), R01EY004864 (PMI), P30EY06360 (Emory Vision Core, PMI), and unrestricted funds from Research to Prevent Blindness. FLS is supported by the institutional training grant T32EY007092-30 (PMI). Additional support was provided by the Emory Integrated Genomics Core (EIGC), which is subsidized by the Emory University School of Medicine as one of the Emory Integrated Core Facilities. We thank Dr. Robert Williams and Arthur Centeno (University of Tennessee Health Science Center) for maintaining the data on GeneNetwork, Dr. Xiangdi Wang and Dr. Justin Templeton for their technical assistance, as well as April Brooke Still for her help in breeding some BXD animals at Emory University.	Balu R, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0484-2; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Bricker-Anthony C, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0192-5; Bricker-Anthony C, 2014, INVEST OPHTH VIS SCI, V55, P4853, DOI 10.1167/iovs.14-14353; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Casanova T, 2015, J INTERF CYTOK RES, V35, P808, DOI 10.1089/jir.2014.0237; CHARTERIS DG, 1992, BRIT J OPHTHALMOL, V76, P499, DOI 10.1136/bjo.76.8.499; Chattopadhyay S, 2008, INT IMMUNOL, V20, P509, DOI 10.1093/intimm/dxn008; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; CHEN DH, 1978, J COMP NEUROL, V177, P635, DOI 10.1002/cne.901770407; Cockerham GC, 2011, NEW ENGL J MED, V364, P2172, DOI 10.1056/NEJMc1010683; Curreri AG, 2009, CLIN SPORT MED, V28, P591, DOI 10.1016/j.csm.2009.07.004; Dougherty AL, 2011, BRAIN INJURY, V25, P8, DOI 10.3109/02699052.2010.536195; Douglas RM, 2005, VISUAL NEUROSCI, V22, P677, DOI 10.1017/S0952523805225166; Fischer TD, 2016, FRONT SYST NEUROSCI, V10, DOI [10.3389/fnsys.2016.00029, 10.3389/fnsys.2010.00020]; Fuller TF, 2007, MAMM GENOME, V18, P463, DOI 10.1007/s00335-007-9043-3; Glasstone S., 1977, EFFECTS NUCL WEAPONS, V3; Gusnanto A, 2007, CURR OPIN LIPIDOL, V18, P187, DOI 10.1097/MOL.0b013e3280895d6f; Ha Y, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.281; Haga S, 1996, NEUROSCI LETT, V216, P191, DOI 10.1016/0304-3940(96)13040-8; Hines-Beard J, 2012, EXP EYE RES, V99, P63, DOI 10.1016/j.exer.2012.03.013; HOLMIN S, 1995, ACTA NEUROCHIR, V132, P110, DOI 10.1007/BF01404857; Imagawa T, 2003, J VET MED SCI, V65, P23, DOI 10.1292/jvms.65.23; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; King R, 2015, MOL VIS, V21, P1235; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061505; Luo C, 2011, MOL VIS, V17, P1588; Miyairi I, 2007, J IMMUNOL, V179, P1814, DOI 10.4049/jimmunol.179.3.1814; Mohan K, 2013, INVEST OPHTH VIS SCI, V54, P3440, DOI 10.1167/iovs.12-11522; Mulligan MK, 2017, METHODS MOL BIOL, V1488, P75, DOI 10.1007/978-1-4939-6427-7_4; Nemet AY, 2016, ISR MED ASSOC J, V18, P27; Richardson PRS, 1996, BRIT J OPHTHALMOL, V80, P1092, DOI 10.1136/bjo.80.12.1092; Rutar M, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-014-0224-1; Schwarzmaier SM, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-32; Stahl T, 2003, J NEUROIMMUNOL, V137, P67, DOI 10.1016/S0165-5728(03)00044-4; STREILEIN JW, 1981, J EXP MED, V153, P1058, DOI 10.1084/jem.153.5.1058; Struebing FL, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00169; Templeton JP, 2013, INVEST OPHTH VIS SCI, V54, P2599, DOI 10.1167/iovs.12-11175; Templeton JP, 2012, MOL VIS, V18, P2147; Vink R, 1990, J NEUROTRAUM, V7, P21, DOI 10.1089/neu.1990.7.21; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Weichel ED, 2008, CURR OPIN OPHTHALMOL, V19, P519, DOI 10.1097/ICU.0b013e3283140e98; Wickham H., 2009, GGPLOT2 ELEGANT GRAP, Vviii, P212; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498; Zhao S, 2017, NEUROSCI LETT, V643, P125, DOI 10.1016/j.neulet.2016.12.006; Zhao W, 2010, J BIOPHARM STAT, V20, P281, DOI 10.1080/10543400903572753; Zinkernagel MS, 2013, AM J PATHOL, V182, P875, DOI 10.1016/j.ajpath.2012.11.031	51	17	17	0	12	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2018	35	1					118	129		10.1089/neu.2017.5104			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FS1WO	WOS:000419569700014	28599600	Green Published			2022-02-06	
J	Tao, JL; Yang, MH; Wu, H; Ma, T; He, CJ; Chai, ML; Zhang, XS; Zhang, JL; Ding, FR; Wang, ST; Deng, SL; Zhu, KF; Song, YK; Ji, PY; Liu, HJ; Lian, ZX; Liu, GS				Tao, Jingli; Yang, Minghui; Wu, Hao; Ma, Teng; He, Changjiu; Chai, Menglong; Zhang, Xiaosheng; Zhang, Jinlong; Ding, Fangrong; Wang, Sutian; Deng, Shoulong; Zhu, Kuanfeng; Song, Yukun; Ji, Pengyun; Liu, Haijun; Lian, Zhengxing; Liu, Guoshi			Effects of AANAT overexpression on the inflammatory responses and autophagy activity in the cellular and transgenic animal levels	AUTOPHAGY			English	Article						AANAT; autophagy; goat; inflammation; melatonin; PBMCs; somatic cell nuclear transfer	TRAUMATIC BRAIN-INJURY; ARYLALKYLAMINE-N-ACETYLTRANSFERASE; NUCLEAR TRANSFER; IN-VITRO; OXIDATIVE STRESS; PRONUCLEAR MICROINJECTION; EMBRYONIC-DEVELOPMENT; MELATONIN PROMOTES; SHEEP; MILK	To explore the anti-inflammatory activity of endogenous produced melatonin, a melatonin-enriched animal model (goat) with AANAT transfer was successfully generated with somatic cell nuclear transfer (SCNT) technology. Basically, a pIRES2-EGFP-AANAT expression vector was constructed and was transferred into the female fetal fibroblast cells (FFCs) via electrotransfection and then the nuclear of the transgenic FFC was transferred to the eggs of the donor goats. The peripheral blood mononuclear cells (PBMCs) of the transgenic offspring expressed significantly higher levels of AANAT and melatonin synthetic function than those PBMCs from the wild-type (WT) animals. After challenge with lipopolysaccharide (LPS), the transgenic PBMCs had increased autophagosomes and LC3B expression while they exhibited suppressed production of the proinflammatory cytokines, IL1B and IL12 (IL12A-IL12B/p70), compared to their WT. The mechanistic analysis indicated that the anti-inflammatory activity of endogenous melatonin was mediated by MTNR1B (melatonin receptor 1B). MTNR1B stimulation activated the MAPK14 signaling pathway to promote cellular macroautophagy/autophagy, thus, suppressing the excessive inflammatory response of cellular. However, when the intact animals challenged with LPS, the serum proinflammatory cytokines were significantly higher in the transgenic goats than that in the WT. The results indicated that endogenous melatonin inhibited the MAPK1/3 signaling pathway and ROS production, subsequently downregulated gene expression of BECN1, ATG5 in PMBCs and then suppressed the autophagy activity of PBMCs and finally elevated levels of serum proinflammatory cytokines in transgenic animals, Herein we provided a novel melatonin-enriched animal model to study the potential effects of endogenously produced melatonin on inflammatory responses and autophagy activity.	[Tao, Jingli; Yang, Minghui; Wu, Hao; Ma, Teng; He, Changjiu; Chai, Menglong; Wang, Sutian; Zhu, Kuanfeng; Song, Yukun; Ji, Pengyun; Lian, Zhengxing; Liu, Guoshi] China Agr Univ, Coll Anim Sci & Technol, Beijing Key Lab Anim Genet Improvement, Minist Agr,Natl Engn Lab Anim Breeding,Key Lab An, Beijing 100193, Peoples R China; [He, Changjiu] Huazhong Agr Univ, Coll Anim Sci & Technol, Wuhan, Hubei, Peoples R China; [Zhang, Xiaosheng; Zhang, Jinlong; Liu, Haijun] Acad Agr Sci Tianjin, Inst Anim Husb & Vet, Tianjin, Peoples R China; [Ding, Fangrong] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing, Peoples R China; [Deng, Shoulong] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing, Peoples R China		Liu, GS (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Beijing Key Lab Anim Genet Improvement, Minist Agr,Natl Engn Lab Anim Breeding,Key Lab An, Beijing 100193, Peoples R China.	gshliu@cau.edu.cn	Changjiu, He/AAG-3308-2021	deng, shou-long/0000-0003-1187-3037; he, changjiu/0000-0002-0350-9799	Genetically Modified Organisms Breeding Major Projects of China [2014ZX08008002B, 2016ZX08008003]	This work was supported by the Genetically Modified Organisms Breeding Major Projects of China [2014ZX08008002B, 2016ZX08008003].	Abdelaziz DHA, 2015, IMMUNOL REV, V265, P194, DOI 10.1111/imr.12288; Abecia JA, 2002, VET RES COMMUN, V26, P151, DOI 10.1023/A:1014099719034; Agarwal A, 2006, FERTIL STERIL, V86, P503, DOI 10.1016/j.fertnstert.2006.02.088; Auldist MJ, 2007, J DAIRY RES, V74, P52, DOI 10.1017/S0022029906002160; Blomeke B, 2008, J TOXICOL ENV HEAL A, V71, P874, DOI 10.1080/15287390801988020; Carrillo-Vico A, 2013, INT J MOL SCI, V14, P8638, DOI 10.3390/ijms14048638; Chen JY, 2014, J PINEAL RES, V56, P12, DOI 10.1111/jpi.12086; Chen YN, 2016, CELL PHYSIOL BIOCHEM, V40, P1094, DOI 10.1159/000453164; Cho SJ, 2010, THERIOGENOLOGY, V73, P848, DOI 10.1016/j.theriogenology.2009.09.008; Choi J, 2008, MOL REPROD DEV, V75, P1127, DOI 10.1002/mrd.20861; Choi SI, 2013, J PINEAL RES, V54, P361, DOI 10.1111/jpi.12039; Cibelli JB, 1998, SCIENCE, V280, P1256, DOI 10.1126/science.280.5367.1256; Cornetta K, 2013, TRANSGENIC RES, V22, P737, DOI 10.1007/s11248-012-9674-3; Damak S, 1996, BIO-TECHNOL, V14, P185, DOI 10.1038/nbt0296-185; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Deretic V, 2012, J IMMUNOL, V189, P15, DOI 10.4049/jimmunol.1102108; Deretic V, 2012, CURR OPIN IMMUNOL, V24, P21, DOI 10.1016/j.coi.2011.10.006; Ding K, 2015, NEUROCHEM INT, V91, P46, DOI 10.1016/j.neuint.2015.10.008; Ding K, 2014, NEUROCHEM INT, V76, P23, DOI 10.1016/j.neuint.2014.06.015; Ding K, 2014, FREE RADICAL BIO MED, V73, P1, DOI 10.1016/j.freeradbiomed.2014.04.031; Effenberger-Neidnicht K, 2014, INFLAMMATION, V37, P738, DOI 10.1007/s10753-013-9792-y; Eriksson L, 1998, ACTA VET SCAND, V39, P301; EYESTONE WH, 1994, REPROD FERT DEVELOP, V6, P647, DOI 10.1071/RD9940647; Farez MF, 2015, CELL, V162, P1338, DOI 10.1016/j.cell.2015.08.025; Feng DY, 2017, J PINEAL RES, V62, DOI 10.1111/jpi.12395; Feng XJ, 2015, TRANSGENIC RES, V24, P73, DOI 10.1007/s11248-014-9818-8; Forman K, 2010, J PINEAL RES, V49, P312, DOI 10.1111/j.1600-079X.2010.00800.x; Francois A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138326; Galano A, 2013, J PINEAL RES, V54, P245, DOI 10.1111/jpi.12010; Gao C, 2012, J PINEAL RES, V52, P305, DOI 10.1111/j.1600-079X.2011.00944.x; Gomez-Florit M, 2013, BIOCHEM PHARMACOL, V86, P1784, DOI 10.1016/j.bcp.2013.10.009; Guo YC, 2010, J HUAZHONG U SCI-MED, V30, P1, DOI 10.1007/s11596-010-0101-9; HAMMER RE, 1985, NATURE, V315, P680, DOI 10.1038/315680a0; Han D, 2016, J PINEAL RES, V60, P178, DOI 10.1111/jpi.12299; Hevia D, 2015, J PINEAL RES, V58, P234, DOI 10.1111/jpi.12210; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P13603, DOI 10.1073/pnas.0702756104; Ishizuka B, 2000, J PINEAL RES, V28, P48, DOI 10.1034/j.1600-079x.2000.280107.x; Ivics Z, 2014, NAT PROTOC, V9, P773, DOI 10.1038/nprot.2014.008; Jeong JK, 2012, J PINEAL RES, V53, P138, DOI 10.1111/j.1600-079X.2012.00980.x; Kalinichenko LS, 2014, B EXP BIOL MED+, V156, P627, DOI 10.1007/s10517-014-2411-6; Kang K, 2010, J PINEAL RES, V49, P176, DOI 10.1111/j.1600-079X.2010.00783.x; Kim HJ, 2013, J IMMUNOL, V191, P2657, DOI 10.4049/jimmunol.1300358; Kimata H, 2007, J PSYCHOSOM RES, V62, P699, DOI 10.1016/j.jpsychores.2006.12.007; Kirik D, 2003, P NATL ACAD SCI USA, V100, P2884, DOI 10.1073/pnas.0536383100; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; Lan GC, 2006, MOL REPROD DEV, V73, P834, DOI 10.1002/mrd.20443; Lapaquette P, 2017, M S-MED SCI, V33, P305, DOI 10.1051/medsci/20173303018; Lee GS, 2005, THERIOGENOLOGY, V63, P973, DOI 10.1016/j.theriogenology.2004.04.017; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Li X, 2014, INFLAMMATION, V37, P1317, DOI 10.1007/s10753-014-9859-4; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lissoni P, 1997, J BIOL REG HOMEOS AG, V11, P157; Ma T, 2017, J PINEAL RES, V63, DOI 10.1111/jpi.12406; Manchester LC, 2015, J PINEAL RES, V59, P403, DOI 10.1111/jpi.12267; Marh J, 2012, P NATL ACAD SCI USA, V109, P19184, DOI 10.1073/pnas.1216473109; McCreath KJ, 2000, NATURE, V405, P1066, DOI 10.1038/35016604; MELCHIORRI D, 1994, LIFE SCI, V56, P83, DOI 10.1016/0024-3205(94)00928-7; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Nopparat C, 2017, J PINEAL RES, V63, DOI 10.1111/jpi.12407; Okazaki M, 2009, J PINEAL RES, V46, P373, DOI 10.1111/j.1600-079X.2009.00673.x; Pang YW, 2013, J PINEAL RES, V54, P389, DOI 10.1111/jpi.12024; Papis K, 2007, J PINEAL RES, V43, P321, DOI 10.1111/j.1600-079X.2007.00479.x; Permpoonputtana K, 2013, NEUROTOX RES, V23, P189, DOI 10.1007/s12640-012-9350-7; Peschke E, 2015, J PINEAL RES, V59, P1, DOI 10.1111/jpi.12240; Proikas-Cezanne T, 2015, J CELL SCI, V128, P207, DOI 10.1242/jcs.146258; Qi YL, 2014, CANCER RES, V74, P3740, DOI 10.1158/0008-5472.CAN-13-3182; Ren WK, 2017, J PINEAL RES, V62, DOI 10.1111/jpi.12394; Ritchie WA, 2009, MOL REPROD DEV, V76, P61, DOI 10.1002/mrd.20930; Rodriguez-Osorio N, 2007, J PINEAL RES, V43, P283, DOI 10.1111/j.1600-079X.2007.00475.x; Rosales-Corral SA, 2012, J PINEAL RES, V52, P167, DOI 10.1111/j.1600-079X.2011.00937.x; Rosas-Ballina M, 2015, BRAIN BEHAV IMMUN, V44, P19, DOI 10.1016/j.bbi.2014.07.010; Rowe SA, 2002, AM J PHYSIOL-REG I, V282, pR797, DOI 10.1152/ajpregu.00228.2001; Schnieke AE, 1997, SCIENCE, V278, P2130, DOI 10.1126/science.278.5346.2130; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Stefanova NA, 2015, J PINEAL RES, V59, P163, DOI 10.1111/jpi.12248; Su JM, 2015, J PINEAL RES, V59, P455, DOI 10.1111/jpi.12275; Sun TJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10159; Tan Dun-Xian, 2002, Current Topics in Medicinal Chemistry, V2, P181, DOI 10.2174/1568026023394443; Tsuyuki S, 2014, AUTOPHAGY, V10, P497, DOI 10.4161/auto.27419; Valtonen M, 2005, NORD J PSYCHIAT, V59, P217, DOI 10.1080/08039480510023034; Vilar A, 2014, FREE RADICAL RES, V48, P119, DOI 10.3109/10715762.2013.845295; Wall R J, 2001, Cloning Stem Cells, V3, P209, DOI 10.1089/15362300152725936; Wall RJ, 2005, NAT BIOTECHNOL, V23, P445, DOI 10.1038/nbt1078; Wang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093641; Wang F, 2014, J PINEAL RES, V56, P333, DOI 10.1111/jpi.12126; Wang F, 2013, J PINEAL RES, V55, P267, DOI 10.1111/jpi.12069; Wang L, 2014, J PINEAL RES, V56, P134, DOI 10.1111/jpi.12105; Wang P, 2015, J PINEAL RES, V58, P479, DOI 10.1111/jpi.12233; Wang P, 2013, J PINEAL RES, V55, P424, DOI 10.1111/jpi.12091; Wang YS, 2015, THERIOGENOLOGY, V84, P608, DOI 10.1016/j.theriogenology.2015.04.016; Xin ZL, 2015, J PINEAL RES, V58, P375, DOI 10.1111/jpi.12227; Yang Y, 2014, J PINEAL RES, V57, P357, DOI 10.1111/jpi.12175; Yin XJ, 2008, BIOL REPROD, V78, P425, DOI 10.1095/biolreprod.107.065185; Yuan S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01289; Yuk JM, 2013, MOL CELLS, V36, P393, DOI 10.1007/s10059-013-0298-0; Zhang HM, 2014, J PINEAL RES, V57, P131, DOI 10.1111/jpi.12162; Zhang WL, 2016, ONCOTARGET, V7, P52179, DOI 10.18632/oncotarget.10538; Zheng WP, 2001, CHEM BIOL, V8, P379, DOI 10.1016/S1074-5521(01)00020-5	100	17	18	3	18	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1554-8627	1554-8635		AUTOPHAGY	Autophagy		2018	14	11					1850	1869		10.1080/15548627.2018.1490852			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	GU2BH	WOS:000445072900002	29985091	Bronze, Green Published			2022-02-06	
J	Bodien, YG; Giacino, JT; Edlow, BL				Bodien, Yelena G.; Giacino, Joseph T.; Edlow, Brian L.			Functional MRI Motor imagery Tasks to Detect Command Following in Traumatic Disorders of Consciousness	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; consciousness; awareness; functional magnetic resonance imaging; motor imagery	PERSISTENT VEGETATIVE STATE; COMA RECOVERY SCALE; BRAIN-INJURY; ACUTE CONFUSION; MODEL SYSTEMS; FMRI; DIAGNOSIS; AWARENESS; ACTIVATION; COGNITION	Severe traumatic brain injury impairs arousal and awareness, the two components of consciousness. Accurate diagnosis of a patient's level of consciousness is critical for determining treatment goals, access to rehabilitative services, and prognosis. The bedside behavioral examination, the current clinical standard for diagnosis of disorders of consciousness, is prone to misdiagnosis, a finding that has led to the development of advanced neuroimaging techniques aimed at detection of conscious awareness. Although a variety of paradigms have been used in functional magnetic resonance imaging (fMRI) to reveal covert consciousness, the relative accuracy of these paradigms in the patient population is unknown. Here, we compare the rate of covert consciousness detection by hand squeezing and tennis playing motor imagery paradigms in 10 patients with traumatic disorders of consciousness [ six male, six acute, mean +/- SD age = 27.9 +/- 9.1 years, one coma, four unresponsive wakefulness syndrome, two minimally conscious without language function, and three minimally conscious with language function, per bedside examination with the Coma Recovery Scale-Revised (CRS-R)]. We also tested the same paradigms in 10 healthy subjects (nine male, mean +/- SD age = 28.5 +/- 9.4 years). In healthy subjects, the hand squeezing paradigm detected covert command following in 7/10 and the tennis playing paradigm in 9/10 subjects. In patients who followed commands on the CRS-R, the hand squeezing paradigm detected covert command following in 2/3 and the tennis playing paradigm in 0/3 subjects. In patients who did not follow commands on the CRS-R, the hand squeezing paradigm detected command following in 1/7 and the tennis playing paradigm in 2/7 subjects. The sensitivity, specificity, and accuracy (ACC) of detecting covert command following in patients who demonstrated this behavior on the CRS-R was 66.7, 85.7, and 80% for the hand squeezing paradigm and 0, 71.4, and 50% for the tennis playing paradigm, respectively. Overall, the tennis paradigm performed better than the hand squeezing paradigm in healthy subjects, but in patients, the hand squeezing paradigm detected command following with greater ACC. These findings indicate that current fMRI motor imagery paradigms frequently fail to detect command following and highlight the need for paradigm optimization to improve the accuracy of covert consciousness detection.	[Bodien, Yelena G.; Edlow, Brian L.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Ctr Neurotechnol & Neurorecovery, Boston, MA 02114 USA; [Bodien, Yelena G.; Edlow, Brian L.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Lab NeuroImaging Coma & Consciousness, Boston, MA 02114 USA; [Bodien, Yelena G.; Giacino, Joseph T.] Harvard Med Sch, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA 02129 USA; [Giacino, Joseph T.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Giacino, Joseph T.] Harvard Med Sch, Boston, MA USA; [Edlow, Brian L.] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Edlow, Brian L.] Harvard Med Sch, Charlestown, MA USA		Bodien, YG (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Ctr Neurotechnol & Neurorecovery, Boston, MA 02114 USA.; Bodien, YG (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Lab NeuroImaging Coma & Consciousness, Boston, MA 02114 USA.; Bodien, YG (corresponding author), Harvard Med Sch, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA 02129 USA.	ybodien@mgh.harvard.edu	Giacino, Joseph/AAF-1952-2021	Giacino, Joseph/0000-0002-7916-9698; Bodien, Yelena/0000-0003-4858-2903	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K23NS094538]; Center for Integration of Medicine & Innovative Technology (Boston, MA, USA); American Academy of Neurology/American Brain Foundation; James S. McDonnell Foundation; Massachusetts General Hospital Department of Neurology and Division of Neurocritical Care and Emergency Neurology; National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS094538] Funding Source: NIH RePORTER	The authors thank the nursing staffs of the Massachusetts General Hospital Neurosciences ICU, Multidisciplinary ICU, and the Surgical ICU. We also thank Kellie Cahill and the MRI technologists for their assistance with data acquisition. We would like to acknowledge Dylan Tisdall and Andre van der Kouwe (Athinoula A Martinos Center for Biomedical Imaging) and Himanshu Bhat (Siemens Medical Center) for the provision of WIP711D (vNav Motion-Corrected Multiecho MPRAGE) used to acquire MEMPRAGE data. We are grateful to the patients and families in this study for their participation and support. This work was supported by grants from the National Institutes of Health (K23NS094538), the Center for Integration of Medicine & Innovative Technology (Boston, MA, USA), the American Academy of Neurology/American Brain Foundation, the James S. McDonnell Foundation, the Massachusetts General Hospital Department of Neurology and Division of Neurocritical Care and Emergency Neurology, and the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR).	Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; Bardin JC, 2011, BRAIN, V134, P769, DOI 10.1093/brain/awr005; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Boly M, 2007, NEUROIMAGE, V36, P979, DOI 10.1016/j.neuroimage.2007.02.047; Bruno MA, 2012, J NEUROL, V259, P1087, DOI 10.1007/s00415-011-6303-7; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Coleman MR, 2009, PROG BRAIN RES, V177, P231, DOI 10.1016/S0079-6123(09)17716-6; Coleman MR, 2009, BRAIN, V132, P2541, DOI 10.1093/brain/awp183; Cruse D, 2012, NEUROLOGY, V78, P816, DOI 10.1212/WNL.0b013e318249f764; Cruse D, 2011, LANCET, V378, P2088, DOI 10.1016/S0140-6736(11)61224-5; Davis MH, 2007, P NATL ACAD SCI USA, V104, P16032, DOI 10.1073/pnas.0701309104; Di HB, 2008, CLIN MED, V8, P502, DOI 10.7861/clinmedicine.8-5-502; Edlow BL, 2017, BRAIN, V140, P2399, DOI 10.1093/brain/awx176; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Fernandez-Espejo D, 2008, BRAIN INJURY, V22, P882, DOI 10.1080/02699050802403573; Giacino JT, 2006, ARCH PHYS MED REHAB, V87, pS67, DOI 10.1016/j.apmr.2006.07.272; Giacino JT, 1997, J HEAD TRAUMA REHAB, V12, P36, DOI 10.1097/00001199-199708000-00005; Giacino JT, 2005, NEUROPSYCHOL REHABIL, V15, P166, DOI 10.1080/09602010443000498; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Gibson RM, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00950; Hirschberg R, 2011, NEUROL CLIN, V29, P773, DOI 10.1016/j.ncl.2011.07.009; JENNETT B, 1972, LANCET, V1, P734; Kalmar K, 2005, NEUROPSYCHOL REHABIL, V15, P454, DOI 10.1080/09602010443000425; KARNI A, 1995, NATURE, V377, P155; Kirsch M, 2017, ANESTH ANALG, V124, P588, DOI 10.1213/ANE.0000000000001721; Laureys S, 2012, NEUROIMAGE, V61, P478, DOI 10.1016/j.neuroimage.2011.12.041; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Moreno DR, 2010, NEUROLOGY, V75, P1871, DOI 10.1212/WNL.0b013e3181feb259; Naci L, 2013, JAMA NEUROL, V70, P1235, DOI 10.1001/jamaneurol.2013.3686; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Nakase-Thompson R, 2004, BRAIN INJURY, V18, P131, DOI 10.1080/0269905031000149542; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Rossetti AO, 2015, CLIN NEUROPHYSIOLOGY; Schiff ND, 2005, NEUROLOGY, V64, P514, DOI 10.1212/01.WNL.0000150883.10285.44; Schiff ND, 2015, JAMA NEUROL, V72, P1413, DOI 10.1001/jamaneurol.2015.2899; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Sherer M, 2005, ARCH PHYS MED REHAB, V86, P896, DOI 10.1016/j.apmr.2004.09.029; StataCorp, 2015, STAT STAT SOFTW REL; van der Kouwe AJW, 2008, NEUROIMAGE, V40, P559, DOI 10.1016/j.neuroimage.2007.12.025; Wannez S, 2017, ANN NEUROL, V81, P883, DOI 10.1002/ana.24962; Wannez S, 2017, J NEUROL, V264, P928, DOI 10.1007/s00415-017-8469-0; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1855, DOI 10.1016/j.apmr.2012.10.041; Woolrich MW, 2004, NEUROIMAGE, V21, P1732, DOI 10.1016/j.neuroimage.2003.12.023	48	17	18	3	9	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	DEC 18	2017	8								688	10.3389/fneur.2017.00688			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FQ1XZ	WOS:000418152500001	29326648	gold, Green Published			2022-02-06	
J	Ding, H; Wang, XL; Wang, HD; Zhu, L; Wang, Q; Jia, Y; Wei, WT; Zhou, CH; Wu, HM; Ding, K				Ding, Hui; Wang, Xiaoliang; Wang, Handong; Zhu, Lin; Wang, Qiang; Jia, Yue; Wei, Wuting; Zhou, Chenhui; Wu, Heming; Ding, Ke			Nrf2-ARE signaling provides neuroprotection in traumatic brain injury via modulation of the ubiquitin proteasome system	NEUROCHEMISTRY INTERNATIONAL			English	Article						Traumatic brain injury; Nrf2; Ubiquitin-proteasome; Redox homeostasis	RAT CEREBRAL-CORTEX; CLOSED-HEAD INJURY; OXIDATIVE STRESS; NEURODEGENERATIVE DISEASE; TERT-BUTYLHYDROQUINONE; GLUTATHIONE SYNTHESIS; RESPONSE ELEMENTS; CELL-DEATH; IN-VIVO; PATHWAY	The nuclear factor erythroid 2-related factor 2 (Nrf2)-antioxidant response element (ARE) pathway exhibits protective effects in a variety of neurological diseases. However, the role of this pathway in traumatic brain injury (TBI) is not fully understood. This study investigates whether the Nrf2-ARE pathway provides neuroprotection following TBI via regulation of the ubiquitin proteasome system (UPS), and examines the involvement of this pathway in redox homeostasis. We found that activation the Nrf2-ARE pathway can mitigate secondary brain injury induced by TBI. Furthermore, we found that inhibiting the Nrf2-ARE pathway weakened the UPS following TBI. Treatment of TBI with the proteasome inhibitor, MG132, increased neuronal apoptosis, and evidence of brain water content was found. These data suggest that the Nrf2-ARE pathway provides neuroprotection following TBI via modulation of the UPS. In addition, the results indicated that the content of glutathione (GSH) was significantly increased after activation of Nrf2, and the level of ROS decreased; however, this effect contradictory in the Nrf2 knockout mice. Further studies found that treatment with the ROS agonist, ferric ammonium citrate (FAC), resulted in additional damage exerted by the ubiquitin proteasome pathways, and a significant increase in the amount of ubiquitinated proteins. In contrast, the activity of the ubiquitin proteasome pathways was vastly enhanced, and the level of ubiquitination proteins was significantly decreased following treatment with the inhibitor, N-acetylcysteine (NAC). The above mentioned results were also verified in in vitro experiments. In conclusion, the activation the Nrf2-ARE pathway improves neurological impairment caused by TBI via modulation of the UPS, and the redox homeostasis is one of the vital regulatory mechanisms. (C) 2017 Elsevier Ltd. All rights reserved.	[Ding, Hui; Wang, Xiaoliang; Wang, Handong; Zhu, Lin; Wang, Qiang; Jia, Yue; Wei, Wuting; Zhou, Chenhui; Wu, Heming; Ding, Ke] Nanjing Univ, Jinling Hosp, Sch Med, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China		Wang, HD (corresponding author), Jinling Hosp, Dept Neurosurg, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China.	njhdwang@hotmail.com			Jiangsu Planned Projects for Postdoctoral Research Funds [1401002A]; Natural Science Fund of ChinaNational Natural Science Foundation of China (NSFC) [81371357, 81401026]; PLA medical science and technology youth training project plan [14QNP035]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2015T81136]	The authors would like to Dr. Chunxi Wang and Dr. Yanlin Han for their assistance with the experiments described herein. This work was supported by grants from the Natural Science Fund of China (grant Nos. 81371357 and 81401026), PLA medical science and technology youth training project plan (grant No.14QNP035) and Jiangsu Planned Projects for Postdoctoral Research Funds (grant No.1401002A), and a Special Financial Grant from the China Postdoctoral Science Foundation (grant No.2015T81136).	Abdul-Aziz A, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/454659; Aoyama K, 2013, INT J MOL SCI, V14, P21021, DOI 10.3390/ijms141021021; Bryan HK, 2013, BIOCHEM PHARMACOL, V85, P705, DOI 10.1016/j.bcp.2012.11.016; Chen M, 2009, J NEUROCHEM, V111, P1094, DOI 10.1111/j.1471-4159.2009.06401.x; Chi L, 2007, NEUROSCIENCE, V144, P991, DOI 10.1016/j.neuroscience.2006.09.064; De Clercq I, 2013, PLANT CELL, V25, P3472, DOI 10.1105/tpc.113.117168; de Vries HE, 2008, FREE RADICAL BIO MED, V45, P1375, DOI 10.1016/j.freeradbiomed.2008.09.001; Ding K, 2014, FREE RADICAL BIO MED, V73, P1, DOI 10.1016/j.freeradbiomed.2014.04.031; Escartin C, 2011, J NEUROSCI, V31, P7392, DOI 10.1523/JNEUROSCI.6577-10.2011; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gibney G., 2000, J PHARM EXP THER, V296; Gonzalez C, 2002, RESP PHYSIOL NEUROBI, V132, P17, DOI 10.1016/S1569-9048(02)00047-2; Hayes JD, 1999, FREE RADICAL RES, V31, P273, DOI 10.1080/10715769900300851; Hayter CL, 2004, NEUROSCI LETT, V362, P182, DOI 10.1016/j.neulet.2004.02.024; Herrmann J, 2007, CIRC RES, V100, P1276, DOI 10.1161/01.RES.0000264500.11888.f0; Hu BR, 2000, J NEUROSCI, V20, P3191, DOI 10.1523/JNEUROSCI.20-09-03191.2000; Huang TT, 2009, J NEUROTRAUM, V26, P1535, DOI [10.1089/neu.2008.0743, 10.1089/neu.2008-0743]; Itoh K, 2004, FREE RADICAL BIO MED, V36, P1208, DOI 10.1016/j.freeradbiomed.2004.02.075; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jin W, 2009, J NEUROTRAUM, V26, P131, DOI 10.1089/neu.2008.0655; Jin W, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/725174; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi M, 2006, ADV ENZYME REGUL, V46, P113, DOI 10.1016/j.advenzreg.2006.01.007; Li HY, 2011, J APPL TOXICOL, V31, P690, DOI 10.1002/jat.1654; Lu H, 2009, J CLIN NEUROSCI, V16, P684, DOI 10.1016/j.jocn.2008.04.021; Lu XY, 2014, J SURG RES, V188, P206, DOI 10.1016/j.jss.2013.11.1106; Ma YH, 2011, BRAIN RES BULL, V86, P441, DOI 10.1016/j.brainresbull.2011.07.007; Majetschak M, 2005, CRIT CARE MED, V33, P1589, DOI 10.1097/01.CCM.0000169883.41245.23; Martinez BA, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.270; Miller DM, 2014, J NEUROTRAUM, V31, P1194, DOI 10.1089/neu.2013.3218; Park WH, 2012, ONCOL REP, V27, P1284, DOI 10.3892/or.2012.1642; Patel SP, 2014, EXP NEUROL, V257, P95, DOI 10.1016/j.expneurol.2014.04.026; Petrucelli L, 2004, ANN MED, V36, P315, DOI 10.1080/07853890410031948; Rada P, 2012, MOL CELL BIOL, V32, P3486, DOI 10.1128/MCB.00180-12; Rahman I, 2000, EUR RESPIR J, V16, P534, DOI 10.1034/j.1399-3003.2000.016003534.x; Raza H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103379; Reddy NM, 2007, AM J RESP CELL MOL, V37, P3, DOI 10.1165/rcmb.2007-0004RC; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Saykally JN, 2012, NEUROSCIENCE, V223, P305, DOI 10.1016/j.neuroscience.2012.07.070; Shih AY, 2005, J NEUROSCI, V25, P10321, DOI 10.1523/JNEUROSCI.4014-05.2005; Song Juhyun, 2014, Exp Neurobiol, V23, P93, DOI 10.5607/en.2014.23.1.93; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Sun KJ, 2013, BRAIN RES, V1506, P132, DOI 10.1016/j.brainres.2013.02.011; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Xu JG, 2014, FREE RADICAL BIO MED, V71, P186, DOI 10.1016/j.freeradbiomed.2014.03.009; Yan W, 2008, NEUROSCI LETT, V431, P150, DOI 10.1016/j.neulet.2007.11.060; Yan W, 2009, J TRAUMA, V66, P1431, DOI 10.1097/TA.0b013e318180f5c7; Yao XL, 2008, J NEUROCHEM, V104, P353, DOI 10.1111/j.1471-4159.2007.04970.x; Yao XL, 2007, BRAIN RES, V1182, P116, DOI 10.1016/j.brainres.2007.08.076; You LH, 2015, NEUROSCIENCE, V284, P234, DOI 10.1016/j.neuroscience.2014.09.071; Zhang X, 2012, HUM EXP TOXICOL, V31, P931, DOI 10.1177/0960327112438287; Zorov DB, 2006, BBA-BIOENERGETICS, V1757, P509, DOI 10.1016/j.bbabio.2006.04.029	52	17	18	0	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	DEC	2017	111				SI		32	44		10.1016/j.neuint.2017.04.016			13	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	FR3OS	WOS:000418976600005	28465088				2022-02-06	
J	Pottker, B; Stober, F; Hummel, R; Angenstein, F; Radyushkin, K; Goldschmidt, J; Schafer, MKE				Poettker, Bruno; Stoeber, Franziska; Hummel, Regina; Angenstein, Frank; Radyushkin, Konstantin; Goldschmidt, Juergen; Schaefer, Michael K. E.			Traumatic brain injury causes long-term behavioral changes related to region-specific increases of cerebral blood flow	BRAIN STRUCTURE & FUNCTION			English	Article						Traumatic brain injury; Gliosis; Behavior; SPECT; Cerebral blood flow; Neural activity	CONTROLLED CORTICAL IMPACT; MICROGLIAL ACTIVATION; GAIT IMPAIRMENT; MOTOR; RAT; NEUROPROTECTION; INFLAMMATION; DEFICITS; AMYGDALA; DEGENERATION	Traumatic brain injury (TBI) is a leading cause of disability and death and survivors often suffer from long-lasting motor impairment, cognitive deficits, anxiety disorders and epilepsy. Few experimental studies have investigated long-term sequelae after TBI and relations between behavioral changes and neural activity patterns remain elusive. We examined these issues in a murine model of TBI combining histology, behavioral analyses and single-photon emission computed tomography (SPECT) imaging of regional cerebral blood flow (CBF) as a proxy for neural activity. Adult C57Bl/6N mice were subjected to unilateral cortical impact injury and investigated at early (15-57 days after lesion, dal) and late (184-225 dal) post-traumatic time points. TBI caused pronounced tissue loss of the parietal cortex and subcortical structures and enduring neurological deficits. Marked perilesional astro- and microgliosis was found at 57 dal and declined at 225 dal. Motor and gait pattern deficits occurred at early time points after TBI and improved over the time. In contrast, impaired performance in the Morris water maze test and decreased anxiety-like behavior persisted together with an increased susceptibility to pentylenetetrazole-induced seizures suggesting alterations in neural activity patterns. Accordingly, SPECT imaging of CBF indicated asymmetric hemispheric baseline neural activity patterns. In the ipsilateral hemisphere, increased baseline neural activity was found in the amygdala. In the contralateral hemisphere, homotopic to the structural brain damage, the hippocampus and distinct cortex regions displayed increased baseline neural activity. Thus, regionally elevated CBF along with behavioral alterations indicate that increased neural activity is critically involved in the long-lasting consequences of TBI.	[Poettker, Bruno; Hummel, Regina; Schaefer, Michael K. E.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anesthesiol, Langenbeckstr 1, D-55131 Mainz, Germany; [Stoeber, Franziska] Leibniz Inst Neurobiol, Brenneckestr 6, D-39118 Magdeburg, Germany; [Angenstein, Frank] DZNE, Funct Neuroimaging Grp, Leipziger Str 44, D-39120 Magdeburg, Germany; [Radyushkin, Konstantin] Johannes Gutenberg Univ Mainz, Mouse Behav Unit, Hanns Dieter Husch Weg 19, D-55128 Mainz, Germany; [Radyushkin, Konstantin; Schaefer, Michael K. E.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Focus Program Translat Neurosci FTN, Langenbeckstr 1, D-55131 Mainz, Germany		Schafer, MKE (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anesthesiol, Langenbeckstr 1, D-55131 Mainz, Germany.; Schafer, MKE (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Focus Program Translat Neurosci FTN, Langenbeckstr 1, D-55131 Mainz, Germany.	michael.schaefer@unimedizin-mainz.de	Schaefer, Michael K.E./S-1715-2019	Schaefer, Michael K.E./0000-0001-6055-6244			Acosta SA, 2013, PLOS ONE, V8, P3; Almeida-Suhett CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102627; Axelson HW, 2013, RESTOR NEUROL NEUROS, V31, P73, DOI 10.3233/RNN-2012-120242; Bhattacharya S, 2017, BIOL PSYCHIAT, V81, P124, DOI 10.1016/j.biopsych.2016.03.2107; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Cole JH, 2015, ANN NEUROL, V77, P571, DOI 10.1002/ana.24367; Collins R, 2012, TRAUMATIC BRAIN INJU, P223; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Endepols H, 2010, J NEUROSCI, V30, P9708, DOI 10.1523/JNEUROSCI.1202-10.2010; Erturk A, 2016, J NEUROSCI, V36, P9962, DOI 10.1523/JNEUROSCI.1898-15.2016; Ferraro TN, 1999, J NEUROSCI, V19, P6733, DOI 10.1523/JNEUROSCI.19-16-06733.1999; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Gold EM, 2013, REGEN MED, V8, P483, DOI 10.2217/rme.13.41; Goldschmidt J, 2010, NEUROIMAGE, V49, P303, DOI 10.1016/j.neuroimage.2009.08.012; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Harish G, 2015, J NEUROCHEM, V134, P156, DOI 10.1111/jnc.13082; Harris NG, 2016, EXP NEUROL, V277, P124, DOI 10.1016/j.expneurol.2015.12.020; HENNIG J, 1986, MAGNET RESON MED, V3, P823, DOI 10.1002/mrm.1910030602; Huang CS, 2016, GLIA, V64, P507, DOI 10.1002/glia.22944; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; Hunt RF, 2010, J NEUROPHYSIOL, V103, P1490, DOI 10.1152/jn.00957.2009; Johnk K, 1999, RESTOR NEUROL NEUROS, V14, P143; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Jones TA, 1996, BRAIN RES, V733, P142, DOI 10.1016/S0006-8993(96)00792-5; Jorge RE, 2014, PSYCHIAT CLIN N AM, V37, P13, DOI 10.1016/j.psc.2013.11.005; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kochanek PM, 2002, J NEUROTRAUM, V19, P1029, DOI 10.1089/089771502760341947; Kolodziej A, 2014, NEUROIMAGE, V103, P171, DOI 10.1016/j.neuroimage.2014.09.023; Kozlowski DA, 1998, BEHAV BRAIN RES, V97, P89, DOI 10.1016/S0166-4328(98)00030-8; Laitinen T, 2015, FRONT NEUROSCI-SWITZ, V9, DOI [10.3389/fnins.7015.00128, 10.3389/fnins.2015.00128]; Lee S, 2009, J NEUROSCI, V29, P234, DOI 10.1523/JNEUROSCI.5273-08.2009; Lindner MD, 1998, J NEUROTRAUM, V15, P199, DOI 10.1089/neu.1998.15.199; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Luh C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019948; Ma Y, 2005, NEUROSCIENCE, V135, P1203, DOI 10.1016/j.neuroscience.2005.07.014; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; Menzel L, 2017, GLIA, V65, P278, DOI 10.1002/glia.23091; Menzel L, 2016, ACTA NEUROPATHOL, V132, P703, DOI 10.1007/s00401-016-1607-4; Mishra AK, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086852, 10.1371/journal.pone.0095280]; Mukherjee S, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00028; Neumann M, 2009, J NEUROSCI METH, V176, P34, DOI 10.1016/j.jneumeth.2008.08.026; Nissinen J, 2000, EPILEPSY RES, V38, P177, DOI 10.1016/S0920-1211(99)00088-1; Ochi F, 1999, J HEAD TRAUMA REHAB, V14, P105, DOI 10.1097/00001199-199904000-00002; Osier ND, 2015, J NEUROTRAUM, V32, P1861, DOI 10.1089/neu.2014.3680; Palmer CP, 2016, EXP NEUROL, V277, P215, DOI 10.1016/j.expneurol.2016.01.004; Palmer LM, 2012, SCIENCE, V335, P989, DOI 10.1126/science.1217276; Peterson TC, 2015, BEHAV BRAIN RES, V294, P254, DOI 10.1016/j.bbr.2015.08.007; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Pitkanen A, 2014, EPILEPSY BEHAV, V38, P19, DOI 10.1016/j.yebeh.2014.01.013; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Ratcliff G, 2005, DISABIL REHABIL, V27, P305, DOI 10.1080/09638280400018338; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sashindranath M, 2015, BEHAV BRAIN RES, V286, P33, DOI 10.1016/j.bbr.2015.02.038; Schaible EV, 2014, J NEUROCHEM, V129, P940, DOI 10.1111/jnc.12708; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Sierra A, 2015, BRAIN STRUCT FUNCT, V220, P781, DOI 10.1007/s00429-013-0683-7; Soblosky JS, 1996, BEHAV BRAIN RES, V79, P79, DOI 10.1016/0166-4328(95)00264-2; Takeuchi N, 2006, BRAIN INJURY, V20, P991, DOI 10.1080/02699050600909771; Thanos PK, 2013, J NEUROSCI, V33, P6343, DOI 10.1523/JNEUROSCI.4997-12.2013; Timaru-Kast R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043829; Titianova EB, 2008, AGING CLIN EXP RES, V20, P131; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Velazquez A, 2015, BRAIN INJURY, V29, P1126, DOI 10.3109/02699052.2015.1018325; Villapol S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00082; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yang L, 2010, J NEUROTRAUM, V27, P1541, DOI 10.1089/neu.2009.1244; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067	78	17	18	1	11	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-2653	1863-2661		BRAIN STRUCT FUNCT	Brain Struct. Funct.	DEC	2017	222	9					4005	4021		10.1007/s00429-017-1452-9			17	Anatomy & Morphology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Anatomy & Morphology; Neurosciences & Neurology	FM8RL	WOS:000415357100010	28589257				2022-02-06	
J	Karelina, K; Gaier, KR; Weil, ZM				Karelina, Kate; Gaier, Kristopher R.; Weil, Zachary M.			Traumatic brain injuries during development disrupt dopaminergic signaling	EXPERIMENTAL NEUROLOGY			English	Article						Traumatic brain injury; Development; Alcohol; Dopamine; Hypodopaminergia	RAT FRONTAL-CORTEX; MESOLIMBIC DOPAMINE; NUCLEUS-ACCUMBENS; TYROSINE-HYDROXYLASE; ALCOHOL-CONSUMPTION; PARKINSONS-DISEASE; SUBSTANCE-ABUSE; EXPRESSION; AMPHETAMINE; TRANSPORTER	Traumatic brain injuries (TBI) sustained during peri-adolescent development produce lasting neuro-behavioral changes that render individuals at an increased risk for developing substance abuse disorders. Experimental and clinical evidence of a prolonged period of hypodopaminergia after TBI have been well documented, but the effect of juvenile TBI on dopaminergic dysfunction and its relationship with substance abuse have not been investigated. In order to determine the effect of juvenile brain injury on dopaminergic signaling, female mice were injured at 21 days of age and then beginning seven weeks later were assessed for behavioral sensitization to amphetamine, a drug that increases synaptic dopamine availability. Together with a histological analysis of tyrosine hydroxylase, dopamine transporter, and dopamine D2 receptor expression, our data are indicative of a persistent state of hypodopaminergia well into adulthood after a juvenile TBI. Further, mice that sustained a juvenile TBI exhibited a significantly reduced activation of cFos in the urocortin-positive cells of the Edinger Westphal nucleus in response to ethanol administration. Taken together, these data provide strong evidence for the vulnerability of juveniles to the development of lasting neuro-behavioral problems following TBI, and indicate a role of injury-induced hypodopaminergia as a risk factor for substance abuse later in life.	[Karelina, Kate; Gaier, Kristopher R.; Weil, Zachary M.] Ohio State Univ, Wexner Med Ctr, Ctr Brain & Spinal Cord Repair, Dept Neurosci,Grp Behav Neuroendocrinol, Columbus, OH 43210 USA		Karelina, K (corresponding author), Biomed Res Tower 618,460 West 12th Ave, Columbus, OH 43210 USA.	Ekaterina.karelina@osumc.edu	Weil, Zachary M/A-2439-2008	Weil, Zachary M/0000-0003-3758-1809; Karelina Weil, Kate/0000-0002-6628-0768	Huron Foundation; Ohio State University Wexner Medical Center; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NINDS NS045758]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS104177, P30NS045758] Funding Source: NIH RePORTER	This work was supported by the Huron Foundation and the Ohio State University Wexner Medical Center Neuroscience Program. Additional support for behavioral experiments was provided by the National Institutes of Health (NINDS NS045758).	Ajao DO, 2012, J NEUROTRAUM, V29, P2060, DOI 10.1089/neu.2011.1883; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Bachtell RK, 2002, J PHARMACOL EXP THER, V302, P516, DOI 10.1124/jpet.102.036046; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Bolton JM, 2009, J AFFECT DISORDERS, V115, P367, DOI 10.1016/j.jad.2008.10.003; Bombardier CH, 2002, ARCH PHYS MED REHAB, V83, P1765, DOI 10.1053/apmr.2002.36085; Calipari ES, 2013, J NEUROSCI, V33, P8923, DOI 10.1523/JNEUROSCI.1033-13.2013; Cantagrel S, 2001, BIOL NEONATE, V80, P68, DOI 10.1159/000047123; Carvey PM, 2003, FRONT BIOSCI-LANDMRK, V8, pS826, DOI 10.2741/1158; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Ceylan-Isik AF, 2010, LIFE SCI, V87, P133, DOI 10.1016/j.lfs.2010.06.002; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1940, DOI 10.1016/j.apmr.2013.05.018; Covassin T, 2003, J ATHL TRAINING, V38, P238; Dagher A, 2009, NEURON, V61, P502, DOI 10.1016/j.neuron.2009.01.031; Dalley JW, 2007, SCIENCE, V315, P1267, DOI 10.1126/science.1137073; Donnemiller E, 2000, EUR J NUCL MED, V27, P1410, DOI 10.1007/s002590000308; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Farin A, 2003, J NEUROSURG, V98, P32, DOI 10.3171/jns.2003.98.1.0032; Faul M, 2010, TRAUMATIC BRAIN INJU; Fazel S, 2006, ADDICTION, V101, P181, DOI 10.1111/j.1360-0443.2006.01316.x; Galvan A, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/neuro.09.006.2010; Giardino WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026997; GOLD LH, 1988, BEHAV NEUROSCI, V102, P544, DOI 10.1037/0735-7044.102.4.544; Graham DP, 2008, ANN NY ACAD SCI, V1141, P148, DOI 10.1196/annals.1441.029; Guerri C, 2010, ALCOHOL, V44, P15, DOI 10.1016/j.alcohol.2009.10.003; Heinz A, 2002, EUR PSYCHIAT, V17, P9, DOI 10.1016/S0924-9338(02)00628-4; Huang EYK, 2014, BEHAV BRAIN RES, V267, P156, DOI 10.1016/j.bbr.2014.03.033; Hutson CB, 2011, J NEUROTRAUM, V28, P1783, DOI 10.1089/neu.2010.1723; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; Iravani MM, 2002, NEUROSCIENCE, V110, P49, DOI 10.1016/S0306-4522(01)00562-0; Jonsson CA, 2004, BRAIN INJURY, V18, P921, DOI 10.1080/02699050410001671900; Karelina K, 2017, BRAIN BEHAV IMMUN, V60, P304, DOI 10.1016/j.bbi.2016.11.009; KELLY PH, 1976, EUR J PHARMACOL, V40, P45, DOI 10.1016/0014-2999(76)90352-6; Kobori N, 2006, J NEUROTRAUM, V23, P1094, DOI 10.1089/neu.2006.23.1094; Koob George F, 2013, Front Psychiatry, V4, P72, DOI 10.3389/fpsyt.2013.00072; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Massucci JL, 2004, NEUROSCI LETT, V372, P127, DOI 10.1016/j.neulet.2004.09.026; Melis M, 2005, INT REV NEUROBIOL, V63, P101, DOI 10.1016/S0074-7742(05)63005-X; Morean ME, 2010, ALCOHOL CLIN EXP RES, V34, P385, DOI 10.1111/j.1530-0277.2009.01103.x; NIELSEN JA, 1984, PHARMACOL BIOCHEM BE, V20, P227, DOI 10.1016/0091-3057(84)90247-8; Pascual M, 2009, J NEUROCHEM, V108, P920, DOI 10.1111/j.1471-4159.2008.05835.x; Pierce RC, 2006, NEUROSCI BIOBEHAV R, V30, P215, DOI 10.1016/j.neubiorev.2005.04.016; REGIER DA, 1990, JAMA-J AM MED ASSOC, V264, P2511; ROBERTS DCS, 1980, PHARMACOL BIOCHEM BE, V12, P781, DOI 10.1016/0091-3057(80)90166-5; Sami MB, 2015, ACTA NEUROPSYCHIATR, V27, P317, DOI 10.1017/neu.2015.17; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmidt K, 2001, PHARMACOPSYCHIATRY, V34, P66, DOI 10.1055/s-2001-15184; Scott C, 2015, NEUROPSYCHOLOGY, V29, P501, DOI 10.1037/neu0000074; Shimada R, 2014, NEUROL RES, V36, P239, DOI 10.1179/1743132813Y.0000000289; Shin SS, 2011, NEUROSCI LETT, V496, P168, DOI 10.1016/j.neulet.2011.04.009; Sullivan MA, 2001, ANN NY ACAD SCI, V931, P251, DOI 10.1111/j.1749-6632.2001.tb05783.x; Turker T, 1998, NEUROSCI LETT, V248, P147, DOI 10.1016/S0304-3940(98)00347-4; van Bregt DR, 2012, EXP NEUROL, V234, P8, DOI 10.1016/j.expneurol.2011.12.003; VEZINA P, 1989, BRAIN RES, V499, P108, DOI 10.1016/0006-8993(89)91140-2; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; Wagner AK, 2004, J NEUROTRAUM, V21, P125, DOI 10.1089/089771504322778596; Wagner AK, 2014, J CEREBR BLOOD F MET, V34, P1328, DOI 10.1038/jcbfm.2014.87; Wahlstrom D, 2010, NEUROSCI BIOBEHAV R, V34, P631, DOI 10.1016/j.neubiorev.2009.12.007; Weil ZM, 2016, J NEUROTRAUM, V33, P895, DOI 10.1089/neu.2015.3953; Weil ZM, 2016, NEUROSCI BIOBEHAV R, V62, P89, DOI 10.1016/j.neubiorev.2016.01.005; White A, 2015, ALCOHOL CLIN EXP RES, V39, P1712, DOI 10.1111/acer.12815; Yan HQ, 2007, BRAIN RES, V1134, P171, DOI 10.1016/j.brainres.2006.11.087; Yan HQ, 2002, NEUROREPORT, V13, P1899, DOI 10.1097/00001756-200210280-00013; Yan HQ, 2001, NEUROREPORT, V12, P2323, DOI 10.1097/00001756-200108080-00009; Yang ZJ, 2007, J CEREBR BLOOD F MET, V27, P1339, DOI 10.1038/sj.jcbfm.9600440	66	17	18	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	NOV	2017	297						110	117		10.1016/j.expneurol.2017.08.003			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FJ3GA	WOS:000412617300011	28802560	Green Accepted			2022-02-06	
J	Bonow, RH; Friedman, SD; Perez, FA; Ellenbogen, RG; Browd, SR; Mac Donald, CL; Vavilala, MS; Rivara, FP				Bonow, Robert H.; Friedman, Seth D.; Perez, Francisco A.; Ellenbogen, Richard G.; Browd, Samuel R.; Mac Donald, Christine L.; Vavilala, Monica S.; Rivara, Frederick P.			Prevalence of Abnormal Magnetic Resonance Imaging Findings in Children with Persistent Symptoms after Pediatric Sports-Related Concussion	JOURNAL OF NEUROTRAUMA			English	Article						brain concussion; magnetic resonance imaging; post-concussion syndrome	TRAUMATIC BRAIN-INJURY; RETURN-TO-PLAY; NATURAL-HISTORY; INCIDENTAL FINDINGS; OUTCOME PREDICTION; CLINICAL ARTICLE; ARACHNOID CYSTS; PINEAL CYSTS; YOUNG-ADULTS; HEAD-INJURY	A subset of patients experience persistent symptoms after pediatric concussion, and magnetic resonance imaging (MRI) is commonly used to evaluate for pathology. The utility of this practice is unclear. We conducted a retrospective cohort study to describe the MRI findings in children with concussion. A registry of all patients seen at our institution from January 2010 through March 2016 with pediatric sports-related concussion was cross-referenced with a database of radiographical studies. Radiology reports were reviewed for abnormal findings. Patients with abnormal computed tomographies or MRI scans ordered for reasons other than concussion were excluded. Among 3338 children identified with concussion, 427 underwent MRI. Only 2 (0.5%) had findings compatible with traumatic injury, consisting in both of microhemorrhage. Sixty-one patients (14.3%) had abnormal findings unrelated to trauma, including 24 nonspecific T-2 changes, 15 pineal cysts, eight Chiari I malformations, and five arachnoid cysts. One child underwent craniotomy for a cerebellar hemangioblastoma after presenting with ataxia; another had cortical dysplasia resected after seizure. The 2 patients with microhemorrhage each had three previous concussions, significantly more than patients whose scans were normal (median, 1) or abnormal without injury (median, 1.5; p = 0.048). MRI rarely revealed intracranial injuries in children post-concussion, and the clinical relevance of these uncommon findings remains unclear. Abnormalities unrelated to trauma are usually benign. However, MRI should be thoughtfully considered in children who present with concerning or atypical symptoms.	[Bonow, Robert H.; Vavilala, Monica S.; Rivara, Frederick P.] Univ Washington, Harborview Med Ctr, Harborview Injury Prevent Res Ctr, 325 9Th Ave, Seattle, WA 98104 USA; [Bonow, Robert H.; Ellenbogen, Richard G.; Browd, Samuel R.; Mac Donald, Christine L.] Univ Washington, Dept Neurol Surg, 325 9th Ave,Box 359924, Seattle, WA 98104 USA; [Bonow, Robert H.; Perez, Francisco A.; Ellenbogen, Richard G.; Browd, Samuel R.; Mac Donald, Christine L.; Rivara, Frederick P.] Seattle Childrens Hosp, Seattle, WA USA; [Friedman, Seth D.] Seattle Childrens Hosp, Ctr Clin & Translat Res, Radiol Clin Res Imaging Core, Seattle, WA USA; [Perez, Francisco A.] Univ Washington, Seattle Childrens Hosp, Dept Radiol, Seattle, WA 98195 USA; [Vavilala, Monica S.] Univ Washington, Harborview Med Ctr, Dept Anesthesia & Pain Med, 325 9Th Ave, Seattle, WA 98104 USA; [Rivara, Frederick P.] Univ Washington, Seattle Childrens Hosp, Dept Pediat, Seattle, WA 98195 USA		Bonow, RH (corresponding author), Univ Washington, Dept Neurol Surg, 325 9th Ave,Box 359924, Seattle, WA 98104 USA.	rbonow@uw.edu		friedman, seth/0000-0001-8785-7215	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32 HD057822] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD057822] Funding Source: NIH RePORTER		Al-Holou WN, 2013, J NEUROSURG, V118, P222, DOI 10.3171/2012.10.JNS12548; Al-Holou WN, 2010, J NEUROSURG-PEDIATR, V5, P578, DOI 10.3171/2010.2.PEDS09464; Al-Holou WN, 2010, J NEUROSURG-PEDIATR, V5, P162, DOI 10.3171/2009.9.PEDS09297; Al-Holou WN, 2009, J NEUROSURG-PEDIATR, V4, P230, DOI 10.3171/2009.4.PEDS0951; BERGMAN AB, 1967, NEW ENGL J MED, V276, P1008, DOI 10.1056/NEJM196705042761804; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Cantu RC, 2003, CLIN SPORT MED, V22, P593, DOI 10.1016/S0278-5919(02)00095-9; Cantu RC, 2011, PM&R, V3, pS440, DOI 10.1016/j.pmrj.2011.07.013; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P241, DOI 10.3171/2015.1.PEDS14510; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Katzman GL, 1999, JAMA-J AM MED ASSOC, V282, P36, DOI 10.1001/jama.282.1.36; Kim BS, 2002, AM J NEURORADIOL, V23, P1674; Kokotos Faye, 2009, Pediatr Rev, V30, P193, DOI 10.1542/pir.30-5-193; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; LEVY JC, 1980, PEDIATRICS, V65, P956; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Morgan CD, 2015, CHILD NERV SYST, V31, P2305, DOI 10.1007/s00381-015-2916-y; Pulsipher DT, 2011, CURR SPORT MED REP, V10, P14, DOI 10.1249/JSR.0b013e31820711b8; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Swartz RH, 2004, ARCH NEUROL-CHICAGO, V61, P1366, DOI 10.1001/archneur.61.9.1366; Tator CH, 2016, J NEUROSURG, V125, P1206, DOI 10.3171/2015.6.JNS15664; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wintermark M, 2015, AM J NEURORADIOL, V36, pE12, DOI 10.3174/ajnr.A4254; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Yuh Esther L, 2014, Neurosurgery, V75 Suppl 4, pS50, DOI 10.1227/NEU.0000000000000491; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	34	17	18	0	12	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2017	34	19					2706	2712		10.1089/neu.2017.4970			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FI1DZ	WOS:000411672700005	28490224	Green Published			2022-02-06	
J	Buckley, TA; Oldham, JR; Munkasy, BA; Evans, KM				Buckley, Thomas A.; Oldham, Jessie R.; Munkasy, Barry A.; Evans, Kelsey M.			Decreased Anticipatory Postural Adjustments During Gait Initiation Acutely Postconcussion	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain Injury; Locomotion; Rehabilitation	TRAUMATIC BRAIN-INJURY; ERROR SCORING SYSTEM; PROFESSIONAL FOOTBALL PLAYERS; MANAGEMENT PRACTICE PATTERNS; CONTROL FOLLOWING CONCUSSION; CHRONIC ANKLE INSTABILITY; SPORT-RELATED CONCUSSION; COGNITIVE DUAL-TASKS; BALANCE CONTROL; PARKINSONS-DISEASE	Objective: To investigate anticipatory postural adjustments (APAs) during the transitional movement task of gait initiation (GI) in individuals acutely after a concussion. Design: Cohort study. Setting: University research center. Participants: A population-based sample of participants (N=84) divided into 2 equal groups of acutely postconcussion and healthy student athletes. Intervention: Participants were tested on 2 occasions: a preinjury baseline test and then the concussion group was retested acutely postconcussion and the healthy student athlete group again at a similar time. All participants completed 5 trials of GI on 4 forceplates. Main Outcome Measures: The dependent variables were the displacement and velocity of the center of pressure (COP) during the APA phase and initial step kinematics. Comparisons were made with a 2 (group) x 2 (time) repeated-measures analysis of variance. Results: There was a significant interaction for COP posterior displacement (P<.001) and lateral displacement (P<.001). Posteriorly, post hoc testing identified a significant reduction in the concussion group (pretest: 5.7 +/- 1.6cm; posttest: 2.6 +/- 2.1cm; P<.001), but no difference in the healthy student athlete group (pretest: 4.0 +/- 1.6cm; posttest: 4.0 +/- 2.5cm; P=.921). Laterally, post hoc testing identified a significant reduction in the concussion group (pretest: 5.8 +/- 2.1cm; posttest: 3.8 +/- 1.8cm; P<.001), but no difference in the healthy student athlete group (pretest: 5.0 +/- 2.5cm; posttest: 5.2 +/- 2.4cm; P=.485). Conclusions: The results of this study suggest difficulty in the planning and execution of GI acutely postconcussion, and posterior APA displacement and velocity are highly effective measures of impaired postural control. Finally, the APA phase is linked to the supplementary motor area, which suggests a supraspinal contribution to postconcussion impaired postural control. (C) 2017 by the American Congress of Rehabilitation Medicine	[Buckley, Thomas A.; Oldham, Jessie R.] Univ Delaware, Dept Kinesiol & Appl Physiol, 150 Human Performance Lab,541 S Coll Ave, Newark, DE 19711 USA; [Buckley, Thomas A.] Univ Delaware, Binterdisciplinary Program Biomech & Movement Sci, Newark, DE 19711 USA; [Munkasy, Barry A.] Georgia Southern Univ, Sch Hlth & Kinesiol, Statesboro, GA USA; [Evans, Kelsey M.] East Carolina Univ, Brody Sch Med, Greenville, NC USA		Buckley, TA (corresponding author), Univ Delaware, Dept Kinesiol & Appl Physiol, 150 Human Performance Lab,541 S Coll Ave, Newark, DE 19711 USA.	Tbuckley@UDel.edu	Buckley, Thomas A/B-7525-2016	Buckley, Thomas A/0000-0002-0515-0150; Oldham, Jessie/0000-0003-2801-2110	National Institute of Health/Neurological Disorders and Stroke [NINDS 1R15NS070744-01A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R15NS070744] Funding Source: NIH RePORTER	Supported in part by the National Institute of Health/Neurological Disorders and Stroke (grant no. NINDS 1R15NS070744-01A1).	Buckley TA, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117702606; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P417, DOI 10.1016/j.jshs.2015.03.010; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P61, DOI 10.1016/j.jshs.2016.01.007; Buckley TA, 2015, J ATHL TRAINING, V50, P879, DOI 10.4085/1062-6050-50.7.04; Buckley TA, 2013, GAIT POSTURE, V38, P549, DOI 10.1016/j.gaitpost.2013.02.008; Burk JM, 2013, CLIN J SPORT MED, V23, P312, DOI 10.1097/JSM.0b013e318285633f; Caccese JB, 2016, J APPL BIOMECH, V32, P329, DOI 10.1123/jab.2015-0273; Caderby T, 2014, J BIOMECH, V47, P417, DOI 10.1016/j.jbiomech.2013.11.011; Catena RD, 2007, GAIT POSTURE, V25, P406, DOI 10.1016/j.gaitpost.2006.05.006; Cau N, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-82; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Chang HA, 1999, ARCH PHYS MED REHAB, V80, P490; Chang WH, 2010, GAIT POSTURE, V32, P487, DOI 10.1016/j.gaitpost.2010.07.007; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Cossette I, 2016, BRAIN INJURY, V30, P1648, DOI 10.1080/02699052.2016.1200143; Cossette I, 2014, ARCH PHYS MED REHAB, V95, P1594, DOI 10.1016/j.apmr.2014.03.019; Elble RJ, 1996, BRAIN, V119, P1705, DOI 10.1093/brain/119.5.1705; Fait P, 2013, J HEAD TRAUMA REHAB, V28, P293, DOI 10.1097/HTR.0b013e3182407ace; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Gao JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024446; Giza CC, 2001, J ATHL TRAINING, V36, P228; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Halliday SE, 1998, GAIT POSTURE, V8, P8, DOI 10.1016/S0966-6362(98)00020-4; Hartley EM, 2016, GAIT POSTURE, V49, P86, DOI 10.1016/j.gaitpost.2016.06.022; Hass CJ, 2008, CLIN BIOMECH, V23, P743, DOI 10.1016/j.clinbiomech.2008.02.012; Hass CJ, 2012, GAIT POSTURE, V35, P669, DOI 10.1016/j.gaitpost.2011.12.022; Hass CJ, 2010, AM J SPORT MED, V38, P829, DOI 10.1177/0363546509351562; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Honeine JL, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00445; Howell D, 2015, J BIOMECH, V48, P3364, DOI 10.1016/j.jbiomech.2015.06.014; Howell DR, 2015, AM J SPORT MED, V43, P625, DOI 10.1177/0363546514560994; Howell DR, 2015, J HEAD TRAUMA REHAB, V19, P19; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Kelly KC, 2014, J ATHL TRAINING, V49, P665, DOI 10.4085/1062-6050-49.3.25; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; MacKinnon CD, 2007, J NEUROPHYSIOL, V97, P4368, DOI 10.1152/jn.01136.2006; Malouin F, 2003, HUM BRAIN MAPP, V19, P47, DOI 10.1002/hbm.10103; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; MASSION J, 1992, PROG NEUROBIOL, V38, P35, DOI 10.1016/0301-0082(92)90034-C; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2017, BR J SPORTS MED; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Melzer I, 2010, J ELECTROMYOGR KINES, V20, P1082, DOI 10.1016/j.jelekin.2010.07.001; Munkasy B. A, 2017, CLIN J SPORT MED; Nocera JR, 2013, J REHABIL RES DEV, V50, P699, DOI 10.1682/JRRD.2012.06.0114; Oldham JR, 2016, GAIT POSTURE, V49, P437, DOI 10.1016/j.gaitpost.2016.07.327; Oldham JR, 2016, SPORTS HLTH; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Polcyn AF, 1998, ARCH PHYS MED REHAB, V79, P1582, DOI 10.1016/S0003-9993(98)90425-7; Rahn C, 2015, CLIN J SPORT MED, V25, P248, DOI 10.1097/JSM.0000000000000141; Slobounov S, 2005, NEUROSCI LETT, V383, P251, DOI 10.1016/j.neulet.2005.04.039; Vallabhajosula S, 2013, GAIT POSTURE, V37, P280, DOI 10.1016/j.gaitpost.2012.07.018; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Wang JJ, 2009, J NEURAL TRANSM, V116, P1087, DOI 10.1007/s00702-009-0269-y	60	17	17	0	13	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	OCT	2017	98	10					1962	1968		10.1016/j.apmr.2017.05.002			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	FJ5LZ	WOS:000412794300007	28583462	Green Accepted			2022-02-06	
J	Chandrasekar, A; Heuvel, FO; Palmer, A; Linkus, B; Ludolph, AC; Boeckers, TM; Relja, B; Huber-Lang, M; Roselli, F				Chandrasekar, Akila; Heuvel, Florian Olde; Palmer, Annette; Linkus, Birgit; Ludolph, Albert C.; Boeckers, Tobias M.; Relja, Borna; Huber-Lang, Markus; Roselli, Francesco			Acute ethanol administration results in a protective cytokine and neuroinflammatory profile in traumatic brain injury	INTERNATIONAL IMMUNOPHARMACOLOGY			English	Article						Traumatic brain injury; Ethanol; Cytokines; Microglia	BLOOD-ALCOHOL CONCENTRATION; LUNG EPITHELIAL-CELLS; SYSTEMIC INTERLEUKIN-6; UNITED-STATES; HEAD-INJURY; MICE; INTOXICATION; EXPRESSION; MORTALITY; RATS	Ethanol intoxication is a common comorbidity in traumatic brain injury. To date, the effect of ethanol on TBI pathogenic cascades and resulting outcomes remains debated. A closed blunt weight-drop murine TBI model has been implemented to investigate behavioral (by sensorimotor and neurological tests), and neuro-immunological (by tissue cytokine arrays and immuno-histology) effects of ethanol intoxication on TBI. The effect of the occurrence of traumatic intracerebral hemorrhage was also studied. The results indicate that ethanol pretreatment results in a faster and better recovery after TBI with reduced infiltration of leukocytes and reduced microglia activation. These outcomes correspond to reduced parenchymal levels of GM-CSF, IL-6 and IL-3 and to the transient upregulation of IL-13 and VEGF, indicating an early shift in the cytokine profile towards reduced inflammation. A significant difference in the cytokine profile was still observed 24 h post injury in the ethanol pretreated mice, as shown by the delayed peak in IL-6 and by the suppression of GM-CSF, IFN-gamma, and IL-3. Seven days post-injury, ethanol-pretreated mice displayed a significant decrease both in CD45 + cells infiltration and in microglial activation. On the other hand, in the case of traumatic intracerebral hemorrhage, the cytokine profile was dominated by KC, CCL5, M-CSF and several interleukins and ethanol pretreatment did not produce any modification. We can thus conclude that ethanol intoxication suppresses the acute neuro-inflammatory response to TBI, an effect which is correlated with a faster and complete neurological recovery, whereas, the presence of traumatic intracerebral hemorrhage overrides the effects of ethanol.	[Chandrasekar, Akila; Heuvel, Florian Olde; Linkus, Birgit; Ludolph, Albert C.; Roselli, Francesco] Univ Ulm, Sch Med, Dept Neurol, Ulm, Germany; [Palmer, Annette; Huber-Lang, Markus] Univ Ulm, Inst Clin & Expt Trauma Immunol, Ulm, Germany; [Boeckers, Tobias M.] Ulm Univ, Sch Med, Dept Anat & Cell Biol, Ulm, Germany; [Relja, Borna] Goethe Univ, Dept Gen & Visceral Surg, Frankfurt, Germany		Roselli, F (corresponding author), Ulm Univ, Dept Neurol, Sch Med, Ctr Biomed Res ZBF, Helinholtzstr 8-2,R1-44, D-89081 Ulm, Germany.	akila.chandrasekar@uni-ulm.de; annette.palmer@uniklinik-ulm.de; birgit.linkus@uni-ulm.de; albert.ludolph@rku.de; tobias.boeckers@uni-ulm.de; info@bornarelja.com; markus.huber-lang@uniklinik-ulm.de; francesco.roselli@uni-ulm.de	Huber-Lang, Markus/AAJ-2209-2020; roselli, francesco/O-8847-2019; Relja, Borna/B-6642-2016	roselli, francesco/0000-0001-9935-6899; Relja, Borna/0000-0002-5625-8823	DFGGerman Research Foundation (DFG)European Commission [SFB1149-B05]; ERANET-NEURON initiative as part of MICRONET consortium; Ulm University	This work has been supported by the DFG (SFB1149-B05) "Dangerresponse, disturbance factors and regenerative potential after acute trauma"-subproject B05. FR is also supported by the ERANET-NEURON initiative "European Research Projects on External Insults to the Nervous System" as part of the MICRONET consortium, and by the Ulm University-Medical Faculty Baustein Program.	Alonso M, 2012, INT J IMMUNOPATH PH, V25, P645, DOI 10.1177/039463201202500311; Berry C, 2011, AM SURGEON, V77, P1416; Bosurgi L, 2017, SCIENCE, V356, P1072, DOI 10.1126/science.aai8132; Bouchard JC, 2012, AM J PATHOL, V181, P845, DOI 10.1016/j.ajpath.2012.05.020; Brennan JH, 2015, J CLIN NEUROSCI, V22, P1375, DOI 10.1016/j.jocn.2015.02.030; Brombacher TM, 2017, J IMMUNOL, V198, P2681, DOI 10.4049/jimmunol.1601546; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cho JS, 2016, ALCOHOL CLIN EXP RES, V40, P1290, DOI 10.1111/acer.13065; Corne J, 2000, J CLIN INVEST, V106, P783, DOI 10.1172/JCI9674; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Cummings P, 2006, INJURY PREV, V12, P148, DOI 10.1136/ip.2005.010975; Dooley D, 2016, STEM CELL REP, V7, P1099, DOI 10.1016/j.stemcr.2016.11.005; FAULKNER TP, 1990, ALCOHOL CLIN EXP RES, V14, P82, DOI 10.1111/j.1530-0277.1990.tb00451.x; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Goodman MD, 2013, J SURG RES, V184, P1053, DOI 10.1016/j.jss.2013.04.058; Greiffenstein P, 2007, ALCOHOL CLIN EXP RES, V31, P704, DOI 10.1111/j.1530-0277.2007.00355.x; Gu JW, 2001, AM J PHYSIOL-REG I, V281, pR365, DOI 10.1152/ajpregu.2001.281.1.R365; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; HOLMIN S, 1995, ACTA NEUROCHIR, V132, P110, DOI 10.1007/BF01404857; Hsieh CL, 2013, EUR J IMMUNOL, V43, P2010, DOI 10.1002/eji.201243084; Janis LS, 1998, J NEUROTRAUM, V15, P105, DOI 10.1089/neu.1998.15.105; Joseph B, 2015, J TRAUMA ACUTE CARE, V78, P403, DOI 10.1097/TA.0000000000000504; Kelly DF, 1997, J NEUROSURG, V86, P876, DOI 10.3171/jns.1997.86.5.0876; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; Kiguchi N, 2017, J PHARMACOL SCI, V133, P53, DOI 10.1016/j.jphs.2016.11.005; Leo P., 2016, TRANSLATIONAL RES TR; Livy DJ, 2003, ALCOHOL, V29, P165, DOI 10.1016/S0741-8329(03)00025-9; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Mori S, 2016, BRAIN SCI, V6, DOI 10.3390/brainsci6020018; Pandit V, 2014, J SURG RES, V190, P634, DOI 10.1016/j.jss.2014.04.039; Penkowa M, 2003, EXP NEUROL, V181, P130, DOI 10.1016/S0014-4886(02)00051-1; Radek KA, 2005, AM J PHYSIOL-HEART C, V289, pH1084, DOI 10.1152/ajpheart.00080.2005; Raj R, 2016, J NEUROSURG, V124, P1684, DOI 10.3171/2015.4.JNS141746; Raj R, 2015, J NEUROTRAUM, V32, P95, DOI 10.1089/neu.2014.3488; Relja B, 2016, INJURY, V47, P640, DOI 10.1016/j.injury.2016.01.016; Relja B, 2016, INT J MOL MED, V37, P517, DOI 10.3892/ijmm.2015.2431; Relja B, 2015, MOL MED REP, V12, P2991, DOI 10.3892/mmr.2015.3764; Relja B, 2013, SCAND J GASTROENTERO, V48, P448, DOI 10.3109/00365521.2013.772228; Salim A, 2009, J TRAUMA, V67, P697, DOI 10.1097/TA.0b013e3181b5dcf2; Savola O, 2005, ALCOHOL ALCOHOLISM, V40, P269, DOI 10.1093/alcalc/agh159; Soares HD, 1995, J NEUROSCI, V15, P8223; Teng SX, 2014, J NEUROTRAUM, V31, P378, DOI 10.1089/neu.2013.3093; Tien HCN, 2006, ARCH SURG-CHICAGO, V141, P1185, DOI 10.1001/archsurg.141.12.1185; Vaagenes IC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120356; Wagner N, 2016, SHOCK, V46, P261, DOI 10.1097/SHK.0000000000000620; Wang T, 2013, J NEUROSURG, V118, P390, DOI 10.3171/2012.8.JNS12736; WILKINSON PK, 1980, ALCOHOL CLIN EXP RES, V4, P6, DOI 10.1111/j.1530-0277.1980.tb04785.x; Won SY, 2013, J NEUROIMMUNOL, V265, P36, DOI 10.1016/j.jneuroim.2013.09.014; Wu WC, 2014, BRIT J NEUROSURG, V28, P739, DOI 10.3109/02688697.2014.915007; Yang MS, 2002, GLIA, V38, P273, DOI 10.1002/glia.10057; Yang SH, 2013, SHOCK, V40, P471, DOI 10.1097/SHK.0000000000000037; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	52	17	17	1	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1567-5769	1878-1705		INT IMMUNOPHARMACOL	Int. Immunopharmacol.	OCT	2017	51						66	75		10.1016/j.intimp.2017.08.002			10	Immunology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Pharmacology & Pharmacy	FI2MC	WOS:000411772000009	28806641				2022-02-06	
J	Henry, LC; Tremblay, S; De Beaumont, L				Henry, Luke C.; Tremblay, Sebastien; De Beaumont, Louis			Long-Term Effects of Sports Concussions: Bridging the Neurocognitive Repercussions of the Injury with the Newest Neuroimaging Data	NEUROSCIENTIST			English	Article						concussion; chronic traumatic encephalopathy; neuroimaging; pathophysiology; dementia	TRAUMATIC BRAIN-INJURY; PROFESSIONAL SOCCER PLAYERS; FOOTBALL PLAYERS; AXONAL INJURY; ENCEPHALOPATHY; HISTORY; ABNORMALITIES; DYSFUNCTION; DEPRESSION; RECOVERY	Little is known of the long-term effects of sports-related concussion. Within the scientific literature, conclusions vary substantially where some work suggests there are no long-term consequences at all and other studies show rampant neurodegeneration thought to be caused by sometimes even a single concussive blow to the head. There is growing evidence that supports multiple long-term outcomes, showing both subclinical and clinically relevant changes in the brains of athletes, young and old alike. This article reviews the pathohistology of cerebral concussions and examines the extant literature with a focus on electrophysiological and neuroimaging findings. Neurobehavioral and neurocognitive changes are also reviewed, particularly as they are related to chronic traumatic encephalopathy. Lacunae within the literature are explored, and future research directions are proposed.	[Henry, Luke C.] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15261 USA; [Henry, Luke C.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Tremblay, Sebastien] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [De Beaumont, Louis] Univ Quebec Trois Rivieres, 3351 Blvd Forges,CP 500, Trois Rivieres, PQ G9A 5H7, Canada; [De Beaumont, Louis] Hop Sacre Coeur, Montreal, PQ, Canada		De Beaumont, L (corresponding author), Univ Quebec Trois Rivieres, 3351 Blvd Forges,CP 500, Trois Rivieres, PQ G9A 5H7, Canada.	louis.debeaumont@uqtr.ca					Arciniegas DB, 2011, INT J PSYCHOPHYSIOL, V82, P41, DOI 10.1016/j.ijpsycho.2011.03.004; Balabann CD, 2011, EXPERT REV NEUROTHER, V11, P379, DOI [10.1586/ern.11.19, 10.1586/ERN.11.19]; Barr WB, 2012, BRAIN INJURY, V26, P58, DOI 10.3109/02699052.2011.608216; Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Brenner LA, 2009, REHABIL PSYCHOL, V54, P390, DOI 10.1037/a0017802; Brettschneider J, 2015, NAT REV NEUROSCI, V16, P109, DOI 10.1038/nrn3887; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; De Beaumont L, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-109; De Beaumont L, 2012, CEREB CORTEX, V22, P112, DOI 10.1093/cercor/bhr096; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Fazel S, 2014, JAMA PSYCHIAT, V71, P326, DOI 10.1001/jamapsychiatry.2013.3935; Fjell AM, 2001, BRAIN TOPOGR, V14, P25, DOI 10.1023/A:1012563605837; Fjell AM, 2007, BIOL PSYCHOL, V75, P87, DOI 10.1016/j.biopsycho.2006.12.004; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Gardner RC, 2016, J NEUROTRAUM, V33, P157, DOI 10.1089/neu.2014.3805; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Gosselin N, 2006, NEUROSURGERY, V58, P1151, DOI 10.1227/01.NEU.0000215953.44097.FA; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Haneef Z, 2013, J NEUROTRAUM, V30, P653, DOI 10.1089/neu.2012.2585; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Hazrati LN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00222; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Henry LC, 2014, PROG NEUROL SURG, V28, P63, DOI 10.1159/000358763; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Ilvesmaki T, 2014, BRAIN, V137, P1876, DOI 10.1093/brain/awu095; Iverson GL, 2014, BRIT J SPORT MED, V48, P162, DOI 10.1136/bjsports-2013-092935; Jantzen KJ, 2010, J HEAD TRAUMA REHAB, V25, P256, DOI 10.1097/HTR.0b013e3181e5477c; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; JORDAN BD, 1990, NEUROLOGY, V40, P727; Klimesch W, 2012, TRENDS COGN SCI, V16, P606, DOI 10.1016/j.tics.2012.10.007; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Macleod AD, 2010, MED HYPOTHESES, V74, P1033, DOI 10.1016/j.mehy.2010.01.002; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; Mayer AR, 2009, HUM BRAIN MAPP, V30, P4152, DOI 10.1002/hbm.20836; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meehan WP, 2016, J NEUROTRAUM, V33, P254, DOI 10.1089/neu.2015.3930; Meier TB, 2016, J NEUROTRAUMA; Meier TB, 2016, HUM BRAIN MAPP, V37, P833, DOI 10.1002/hbm.23072; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Omalu B, 2014, PROG NEUROL SURG, V28, P38, DOI 10.1159/000358761; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Orr CA, 2016, J NEUROTRAUM, V33, P803, DOI 10.1089/neu.2014.3721; Papa L, 2015, J NEUROTRAUM, V32, P661, DOI 10.1089/neu.2014.3655; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Puvenna V, 2016, BRAIN RES, V1630, P225, DOI 10.1016/j.brainres.2015.11.007; Roberts AH, 1969, BRAIN DAMAGE BOXERS; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Simpson GK, 2007, MED J AUSTRALIA, V187, P229, DOI 10.5694/j.1326-5377.2007.tb01206.x; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Slobounov S, 2009, CLIN NEUROPHYSIOL, V120, P862, DOI 10.1016/j.clinph.2009.03.009; Small GW, 2013, AM J GERIAT PSYCHIAT, V21, P138, DOI 10.1016/j.jagp.2012.11.019; Solomon GS, 2016, PHYSICIAN SPORTSMED, V44, P14, DOI 10.1080/00913847.2016.1121091; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; Strain JF, 2015, JAMA NEUROL, V72, P773, DOI 10.1001/jamaneurol.2015.0206; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Tran HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025475; Tremblay S, 2014, CLIN NEUROPHYSIOL, V125, P1371, DOI 10.1016/j.clinph.2013.11.040; Tremblay S, 2014, BRAIN, V137, P2997, DOI 10.1093/brain/awu236; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Vagnozzi R, 2005, NEUROSURGERY, V57, P164, DOI 10.1227/01.NEU.0000163413.90259.85; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Victoroff J, 2013, NEUROREHABILITATION, V32, P211, DOI 10.3233/NRE-130839	86	17	17	3	63	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1073-8584	1089-4098		NEUROSCIENTIST	Neuroscientist	OCT	2017	23	5					567	578		10.1177/1073858416651034			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FI8RO	WOS:000412270000015	27188455				2022-02-06	
J	Schindler, AG; Meabon, JS; Pagulayan, KF; Hendrickson, RC; Meeker, KD; Cline, M; Li, G; Sikkema, C; Wilkinson, CW; Perl, DP; Raskind, MR; Peskind, ER; Clark, JJ; Cook, DG				Schindler, A. G.; Meabon, J. S.; Pagulayan, K. F.; Hendrickson, R. C.; Meeker, K. D.; Cline, M.; Li, G.; Sikkema, C.; Wilkinson, C. W.; Perl, D. P.; Raskind, M. R.; Peskind, E. R.; Clark, J. J.; Cook, D. G.			Blast-related disinhibition and risk seeking in mice and combat Veterans: Potential role for dysfunctional phasic dopamine release	NEUROBIOLOGY OF DISEASE			English	Article						Traumatic brain injury; Novelty; Dopamine; Blast; Veteran; Disinhibition	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; SUBSTANCE USE DISORDERS; PERSONALITY-TRAITS; NUCLEUS-ACCUMBENS; INDUCED NEUROTRAUMA; DECISION-MAKING; TEGMENTAL AREA; DRUG-ADDICTION; WAR VETERANS	Mild traumatic brain injury (mTBI) caused by exposure to high explosives has been called the "signature injury" of the wars in Iraq and Afghanistan. There is a wide array of chronic neurological and behavioral symptoms associated with blast-induced mTBI. However, the underlying mechanisms are not well understood. Here we used a battlefield-relevant mouse model of blast-induced mTBI and in vivo fast-scan cyclic voltammetry (FSCV) to investigate whether the mesolimbic dopamine system contributes to the mechanisms underlying blast-induced behavioral dysfunction. In mice, blast exposure increased novelty seeking, a behavior closely associated with disinhibition and risk for subsequent maladaptive behaviors. In keeping with this, we found that veterans with blast-related mTBI reported greater disinhibition and risk taking on the Frontal Systems Behavior Scale (FrSBe). In addition, in mice we report that blast exposure causes potentiation of evoked phasic dopamine release in the nucleus accumbens. Taken together these findings suggest that blast-induced changes in the dopaminergic system may mediate aspects of the complex array of behavioral dysfunctions reported in blast-exposed veterans. Published by Elsevier Inc.	[Schindler, A. G.; Meabon, J. S.; Pagulayan, K. F.; Hendrickson, R. C.; Li, G.; Wilkinson, C. W.; Raskind, M. R.; Peskind, E. R.; Clark, J. J.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Meabon, J. S.; Pagulayan, K. F.; Hendrickson, R. C.; Li, G.; Wilkinson, C. W.; Raskind, M. R.; Peskind, E. R.] VA Puget Sound Hlth Care Syst, Mental Illness Res Educ & Clin Ctr, Seattle, WA 98108 USA; [Schindler, A. G.; Meeker, K. D.; Cline, M.; Li, G.; Sikkema, C.; Wilkinson, C. W.; Cook, D. G.] VA Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr, 1660 S Columbian Way, Seattle, WA 98108 USA; [Perl, D. P.] Uniformed Serv Univ Hlth Sci, Dept Pathol, Ctr Neurosci & Regenerat Med, Sch Med, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Cook, D. G.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Cook, D. G.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA		Cook, DG (corresponding author), VA Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr, 1660 S Columbian Way, Seattle, WA 98108 USA.	dgcook@u.washington.edu	Pagulayan, Kati/AAR-9225-2020; Hendrickson, Rebecca/I-4923-2017; Wilkinson, Charles W/N-5969-2017	Hendrickson, Rebecca/0000-0003-2377-823X; Cline, Marcella/0000-0002-9590-3725; Wilkinson, Charles/0000-0002-5390-0294	Department of VA Office of Research and Development Medical Research Service; VA Rehabilitation Research and Development Service Merit Review Grant [B77421]; University of Washington Friends of Alzheimer's Research; UW Royalty Research Fund; Northwest Network Mental Illness Research Education and Clinical Center [CX000561]; Geriatric Research, Education, and Clinical Center (ARDIS) [0005]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01AA021121]; Veterans AffairsUS Department of Veterans Affairs [I01RX001612, IK2BX003258, I01BX002311, I01RX000521] Funding Source: NIH RePORTER	This work was supported by the Department of VA Office of Research and Development Medical Research Service (DGC), VA Rehabilitation Research and Development Service Merit Review Grant #B77421 (ERP), University of Washington Friends of Alzheimer's Research (DGC, ERP), UW Royalty Research Fund (DGC), Northwest Network Mental Illness Research Education and Clinical Center (JSM, KFP, MAR, ERP), a Clinical Science R&D Career Development Award Program #CX000561 (KFP), Geriatric Research, Education, and Clinical Center (CWW) (ARDIS No. 0005), and National Institutes of Health #R01AA021121 (AGS, JJC). We would like to thank Scott Ng-Evans for considerable technical assistance.	Ahlers Stephen Thomas, 2012, Front Neurol, V3, P32, DOI 10.3389/fneur.2012.00032; Ball SA, 2005, J RES PERS, V39, P84, DOI 10.1016/j.jrp.2004.09.008; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Clark JJ, 2010, NAT METHODS, V7, P126, DOI [10.1038/NMETH.1412, 10.1038/nmeth.1412]; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; DePalma R. G., 2015, COMBAT TBI HIST EPID; Di Chiara G, 2004, NEUROPHARMACOLOGY, V47, P227, DOI 10.1016/j.neuropharm.2004.06.032; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; First MB, 1995, STRUCTURED CLIN INTE; Flagel SB, 2011, NATURE, V469, P53, DOI 10.1038/nature09588; Flagel SB, 2010, NEUROPSYCHOPHARMACOL, V35, P388, DOI 10.1038/npp.2009.142; Forbes D, 2001, BEHAV RES THER, V39, P977, DOI 10.1016/S0005-7967(00)00084-X; Geisler S, 2007, J NEUROSCI, V27, P5730, DOI 10.1523/JNEUROSCI.0012-07.2007; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Grossbard J, 2017, PSYCHIAT SERV, V68, P48, DOI 10.1176/appi.ps.201500290; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; HOOKS MS, 1992, BRAIN RES, V587, P306; Huber BR, 2016, NEUROSCIENCE, V319, P206, DOI 10.1016/j.neuroscience.2016.01.022; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; James LM, 2014, MIL MED, V179, P357, DOI 10.7205/MILMED-D-13-00241; Jupp B, 2014, BRIT J PHARMACOL, V171, P4729, DOI 10.1111/bph.12787; Jupp B, 2014, NEUROPHARMACOLOGY, V76, P487, DOI 10.1016/j.neuropharm.2013.05.041; Kansagara D., 2013, COMPLICATIONS MILD T; Kelley AM, 2012, J PSYCHIATR RES, V46, P582, DOI 10.1016/j.jpsychires.2012.01.017; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Krebs RM, 2009, BIOL PSYCHIAT, V65, P103, DOI 10.1016/j.biopsych.2008.08.019; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Krueger RF, 2002, J ABNORM PSYCHOL, V111, P411, DOI 10.1037//0021-843X.111.3.411; Lawrence AD, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00086; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Malloy J. G. P., 2001, FRONTAL SYSTEMS BEHA; Marinelli M, 2000, J NEUROSCI, V20, P8876; Masse LC, 1997, ARCH GEN PSYCHIAT, V54, P62; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Meil WM, 2016, ADDICT BEHAV, V62, P135, DOI 10.1016/j.addbeh.2016.06.014; Miller SC, 2013, AM J PSYCHIAT, V170, P383, DOI 10.1176/appi.ajp.2012.12010126; Nadal R, 2002, PSYCHOPHARMACOLOGY, V162, P333, DOI 10.1007/s00213-002-1091-5; Nilsson T, 2010, PSYCHIAT RES, V178, P525, DOI 10.1016/j.psychres.2010.05.016; Olson-Madden JH, 2012, J HEAD TRAUMA REHAB, V27, P370, DOI 10.1097/HTR.0b013e318268d496; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Parker JG, 2011, J NEUROSCI, V31, P17103, DOI 10.1523/JNEUROSCI.1715-11.2011; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; PIAZZA PV, 1989, SCIENCE, V245, P1511, DOI 10.1126/science.2781295; Sajja VSSS, 2013, J NEUROSCI RES, V91, P593, DOI 10.1002/jnr.23179; Schindler AG, 2016, J NEUROSCI, V36, P3698, DOI 10.1523/JNEUROSCI.4394-15.2016; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Seidl JNT, 2015, J CLIN EXP NEUROPSYC, V37, P84, DOI 10.1080/13803395.2014.989817; SHER KJ, 1994, J ABNORM PSYCHOL, V103, P92, DOI 10.1037/0021-843X.103.1.92; Stadlbauer U, 2014, INT J NEUROPSYCHOPH, V17, P407, DOI 10.1017/S1461145713001223; Stopper CM, 2014, NEURON, V84, P177, DOI 10.1016/j.neuron.2014.08.033; Tanielian T., 2008, INVISIBLE WOUNDS WAR; van Gaalen MM, 2006, PSYCHOPHARMACOLOGY, V187, P73, DOI 10.1007/s00213-006-0396-1; Verdejo-Garcia A, 2006, J INT NEUROPSYCH SOC, V12, P405, DOI 10.1017/S1355617706060486; Wittmann BC, 2008, NEURON, V58, P967, DOI 10.1016/j.neuron.2008.04.027; YEHUDA R, 1992, J NERV MENT DIS, V180, P321, DOI 10.1097/00005053-199205000-00006; Zuckerman M., 1994, BEHAV EXPRESSION BIO	62	17	17	0	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	OCT	2017	106						23	34		10.1016/j.nbd.2017.06.004			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FE5ZW	WOS:000408290800003	28619545				2022-02-06	
J	Tajiri, N; Quach, DM; Kaneko, Y; Wu, S; Lee, D; Lam, T; Hayama, KL; Hazel, TG; Johe, K; Wu, MC; Borlongan, CV				Tajiri, Naoki; Quach, David M.; Kaneko, Yuji; Wu, Stephanie; Lee, David; Lam, Tina; Hayama, Ken L.; Hazel, Thomas G.; Johe, Karl; Wu, Michael C.; Borlongan, Cesar V.			NSI-189, a small molecule with neurogenic properties, exerts behavioral, and neurostructural benefits in stroke rats	JOURNAL OF CELLULAR PHYSIOLOGY			English	Article						behavioral recovery; cerebral ischemia; neurite outgrowth; neurogenesis; pharmacotherapy; trophic factors	NEURAL STEM-CELLS; FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; NEUROTROPHIC FACTORS; PRECURSOR CELLS; RECOVERY; NEUROPROTECTION; NEURONS; MODEL	Enhancing neurogenesis may be a powerful stroke therapy. Here, we tested in a rat model of ischemic stroke the beneficial effects of NSI-189, an orally active, new molecular entity (mol. wt. 366) with enhanced neurogenic activity, and indicated as an anti-depressant drug in a clinical trial (Fava et al., 2015, Molecular Psychiatry, DOI: 10.1038/mp. 2015.178) and being tested in a Phase 2 efficacy trial (ClinicalTrials. gov, 2016, ClinicalTrials. gov Identifier: NCT02695472) for treatment of major depression. Oral administration of NSI-189 in adult Sprague-Dawley rats starting at 6 hr after middle cerebral artery occlusion, and daily thereafter over the next 12 weeks resulted in significant amelioration of stroke-induced motor and neurological deficits, which was maintained up to 24 weeks post-stroke. Histopathological assessment of stroke brains from NSI-189-treated animals revealed significant increments in neurite outgrowth as evidencedbyMAP2immunoreactivity that was prominently detected in the hippocampus and partially in the cortex. These results suggest NSI-189 actively stimulated remodeling of the stroke brain. Parallel in vitro studies further probed this remodeling process and demonstrated that oxygen glucose deprivation and reperfusion (OGD/R) initiated typical cell death processes, which were reversed by NSI-189 treatment characterized by significant attenuation of OGD/R-mediated hippocampal cell death and increased Ki67 and MAP2 expression, coupled with upregulation of neurogenic factors such as BDNF and SCF. These findings support the use of oral NSI-189 as a therapeutic agent well beyond the initial 6-hr time window to accelerate and enhance the overall functional improvement in the initial6months post stroke.	[Tajiri, Naoki; Kaneko, Yuji; Borlongan, Cesar V.] Univ S Florida, Coll Med, Ctr Excellence Aging & Brain Repair, Dept Neurosurg & Brain Repair, Tampa, FL USA; [Quach, David M.; Wu, Stephanie; Lee, David; Lam, Tina; Hayama, Ken L.; Hazel, Thomas G.; Johe, Karl] Neuralstem Inc, Rockville, MD USA; [Wu, Michael C.] Neurodigitech LLC, San Diego, CA USA		Borlongan, CV (corresponding author), Univ S Florida, Res Dept Neurosurg & Brain Repair, Morsani Coll Med, Tampa, FL 33620 USA.	cborlong@health.usf.edu	Wu, Michael/AAP-2829-2021		National Institutes of Health, National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R01NS071956, 1R01NS090962, 1R21NS089851]; Department of DefenseUnited States Department of Defense [W81XWH-11-1-0634]; James and Esther King Foundation for Biomedical Research Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS071956, R21NS089851, R21NS094087] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Neurological Disorders and Stroke, Grant numbers: 1R01NS071956, 1R01NS090962, 1R21NS089851; Department of Defense, Grant number: W81XWH-11-1-0634; James and Esther King Foundation for Biomedical Research Program	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Borlongan CV, 2011, LEUKEMIA, V25, P1674, DOI 10.1038/leu.2011.167; Borlongan CV, 2011, PROG NEUROBIOL, V95, P213, DOI 10.1016/j.pneurobio.2011.08.005; Brill MS, 2009, NAT NEUROSCI, V12, P1524, DOI 10.1038/nn.2416; Chapman KZ, 2015, NEUROBIOL DIS, V83, P1, DOI 10.1016/j.nbd.2015.08.013; dela Pena I, 2015, TRANSL STROKE RES, V6, P421, DOI 10.1007/s12975-015-0430-x; Doeppner TR, 2009, NEUROBIOL DIS, V34, P87, DOI 10.1016/j.nbd.2008.12.013; Esposito E, 2015, STROKE, V46, P2691, DOI 10.1161/STROKEAHA.115.009070; Fava M, 2016, MOL PSYCHIATR, V21, P1372, DOI 10.1038/mp.2015.178; Hara K, 2007, J NEUROSCI RES, V85, P1240, DOI 10.1002/jnr.21234; Hermann DM, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00291; Hess DC, 2008, CELL PROLIFERAT, V41, P94, DOI 10.1111/j.1365-2184.2008.00486.x; Hess David C, 2008, Expert Rev Neurother, V8, P1193, DOI 10.1586/14737175.8.8.1193; Hu X, 2013, CURR MOL MED, V13, P1465; Jablonska A, 2016, MOL NEUROBIOL, V53, P6413, DOI 10.1007/s12035-015-9530-6; Kaneko Y, 2012, INT J MOL SCI, V13, P7424, DOI 10.3390/ijms13067424; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Kokaia Z, 2011, TRANSL STROKE RES, V2, P272, DOI 10.1007/s12975-011-0100-6; Kreuzberg M, 2010, EXP NEUROL, V226, P90, DOI 10.1016/j.expneurol.2010.08.006; Kuge A, 2009, NEUROL RES, V31, P969, DOI 10.1179/174313209X383312; Li Y, 2010, TRANSL STROKE RES, V1, P184, DOI 10.1007/s12975-010-0016-6; Lindvall O, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a019034; Llado J, 2004, MOL CELL NEUROSCI, V27, P322, DOI 10.1016/j.mcn.2004.07.010; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; Matsukawa N, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-126; Morimoto T, 2011, CELL TRANSPLANT, V20, P1049, DOI 10.3727/096368910X544915; Osman AM, 2011, STROKE, V42, P3559, DOI 10.1161/STROKEAHA.111.627802; Peron S, 2015, CURR OPIN GENET DEV, V34, P46, DOI 10.1016/j.gde.2015.07.004; Picard-Riera N, 2004, J NEUROSCI RES, V76, P223, DOI 10.1002/jnr.20040; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rosell A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073244; Seo JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103174; Sieber-Blum M, 1998, BIOCHEM CELL BIOL, V76, P1039, DOI 10.1139/bcb-76-6-1039; Sun CR, 2013, J NEUROSCI, V33, P17314, DOI 10.1523/JNEUROSCI.2129-13.2013; Sun XY, 2016, J MOL NEUROSCI, V58, P233, DOI 10.1007/s12031-015-0662-y; Tajiri N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074857; Tajiri N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043779; Venna VR, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.128; Wang LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087284; Watson N, 2015, CELL TRANSPLANT, V24, P591, DOI 10.3727/096368915X687723; Xia CF, 2006, HUM GENE THER, V17, P206, DOI 10.1089/hum.2006.17.206; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Yasuhara T, 2010, J CELL MOL MED, V14, P914, DOI 10.1111/j.1582-4934.2008.00671.x; Yasuhara T, 2006, J NEUROSCI, V26, P12497, DOI 10.1523/JNEUROSCI.3719-06.2006; Zhang WT, 2015, EXP NEUROL, V272, P170, DOI 10.1016/j.expneurol.2015.03.005; Zhang YL, 2012, EXP NEUROL, V235, P336, DOI 10.1016/j.expneurol.2012.02.015; Zhang ZG, 2015, TRENDS MOL MED, V21, P543, DOI 10.1016/j.molmed.2015.07.005	47	17	18	1	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9541	1097-4652		J CELL PHYSIOL	J. Cell. Physiol.	OCT	2017	232	10					2731	2740		10.1002/jcp.25847			10	Cell Biology; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Physiology	FC7KK	WOS:000407019900015	28181668	Green Published, hybrid			2022-02-06	
J	Vekaria, HJ; Watts, LT; Lin, AL; Sullivan, PG				Vekaria, Hemendra J.; Watts, Lora Talley; Lin, Ai-Ling; Sullivan, Patrick G.			Targeting mitochondrial dysfunction in CNS injury using Methylene Blue; still a magic bullet?	NEUROCHEMISTRY INTERNATIONAL			English	Article							TRAUMATIC BRAIN-INJURY; CYCLOSPORINE-A; CELL-DEATH; PERMEABILITY TRANSITION; OXYGEN-CONSUMPTION; ENERGY-METABOLISM; RATS; BIOENERGETICS; NEUROPROTECTION; DAMAGE	Complex, multi-factorial secondary injury cascades are initiated following traumatic brain injury, which makes this a difficult disease to treat. The secondary injury cascades following the primary mechanical tissue damage, are likely where effective therapeutic interventions may be targeted. One promising therapeutic target following brain injury are mitochondria. Mitochondria are complex organelles found within the cell, which act as powerhouses within all cells by supplying ATP. These organelles are also necessary for calcium cycling, redox signaling and play a major role in the initiation of cell death pathways. When mitochondria become dysfunctional, there is a tendency for the cell to loose cellular homeostasis and can lead to eventual cell death. Targeting of mitochondrial dysfunction in various diseases has proven a successful approach, lending support to mitochondria as a pivotal player in TBI cell death. and loss of behavioral function. Within this mixed mini review/research article there will be a general discussion of mitochondrial bioenergetics, followed by a brief discussion of traumatic brain injury and how mitochondria play an integral role in the neuropathological sequelae following an injury. We will also give an overview of one relatively new TBI therapeutic approach, Methylene Blue, currently being studied to ameliorate mitochondrial dysfunction following brain injury. We will also present novel experimental findings, that for the first time, characterize the ex vivo effect of Methylene Blue on mitochondrial function in synaptic and non-synaptic populations of mitochondria. (C) 2017 Elsevier Ltd. All rights reserved.	[Vekaria, Hemendra J.; Sullivan, Patrick G.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA; [Vekaria, Hemendra J.; Sullivan, Patrick G.] Univ Kentucky, Dept Neurosci, Lexington, KY 40536 USA; [Watts, Lora Talley] Univ Texas Hlth San Antonio, Dept Cell Syst & Anat, Neurol & Res Imaging Inst, San Antonio, TX USA; [Lin, Ai-Ling] Univ Kentucky, Dept Biomed Engn, Dept Pharmacol & Nutr Sci, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Sullivan, Patrick G.] Lexington VAMC, Lexington, KY USA		Sullivan, PG (corresponding author), Univ Kentucky, Spinal Cord & Brain Injury Res Ctr SCoBIRC, Chandler Coll Med, 475 BBSRB,741 South Limestone St, Lexington, KY 40536 USA.	patsull@uky.edu	Vekaria, Hemendra/AAQ-7450-2020	Vekaria, Hemendra/0000-0001-5945-5235	Kentucky Spinal Cord and Head Injury Research Trust [15-14A]; National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR); National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000117]; United States Department of Veterans Affairs Biomedical Laboratory Research and Development Program [I01BX003405]; NIH/NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K01AG040164]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K01AG040164] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX003405] Funding Source: NIH RePORTER	Kentucky Spinal Cord and Head Injury Research Trust #15-14A (PGS), part of this work was supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant UL1TR000117. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH CTSA UL1TR000117 (PGS). This work was supported in part by a Merit Review Award #I01BX003405 to (PGS) from the United States Department of Veterans Affairs Biomedical Laboratory Research and Development Program. The contents do not represent the views of the U.S. Department of Veterans Affairs or the United States Government. This work is also supported in part by a NIH/NIA K01 Mentored Career Development Award (K01AG040164) to (A-LL).	Adelson PD, 1998, ACT NEUR S, V71, P104; Akoachere M, 2005, ANTIMICROB AGENTS CH, V49, P4592, DOI 10.1128/AAC.49.11.4592-4597.2005; Ashurst John, 2011, Del Med J, V83, P203; Atamna H, 2008, FASEB J, V22, P703, DOI 10.1096/fj.07-9610com; Auchter A, 2014, J ALZHEIMERS DIS, V42, pS525, DOI 10.3233/JAD-141527; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Brooks MM, 1936, SCI MON, V43, P585; Brown MR, 2004, J NEUROSCI METH, V137, P299, DOI 10.1016/j.jneumeth.2004.02.028; Callaway NL, 2004, PHARMACOL BIOCHEM BE, V77, P175, DOI 10.1016/j.pbb.2003.10.007; Chaturvedi RK, 2008, ANN NY ACAD SCI, V1147, P395, DOI 10.1196/annals.1427.027; Collange O, 2013, EUR J VASC ENDOVASC, V45, P168, DOI 10.1016/j.ejvs.2012.11.011; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Crack PJ, 2005, FREE RADICAL BIO MED, V38, P1433, DOI 10.1016/j.freeradbiomed.2005.01.019; Draize J H, 1933, Science, V78, P145, DOI 10.1126/science.78.2016.145; Duchen MR, 2000, CELL CALCIUM, V28, P339, DOI 10.1054/ceca.2000.0170; Faul M, 2010, TRAUMATIC BRAIN INJU; Galluzzi L, 2009, CELL DEATH DIFFER, V16, P1093, DOI 10.1038/cdd.2009.44; Geddes JW, 2009, EXP NEUROL, V218, P169, DOI 10.1016/j.expneurol.2009.05.011; Gensini GF, 2007, J INFECTION, V54, P221, DOI 10.1016/j.jinf.2004.05.022; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Gunter TE, 2004, FEBS LETT, V567, P96, DOI 10.1016/j.febslet.2004.03.071; Gureev AP, 2016, NEUROSCI RES, V113, P19, DOI 10.1016/j.neures.2016.07.006; Hatton J, 2001, CNS DRUGS, V15, P553, DOI 10.2165/00023210-200115070-00005; Hatton J, 2008, J NEUROSURG, V109, P699, DOI 10.3171/JNS/2008/109/10/0699; Hosseinian L, 2016, ANESTH ANALG, V122, P194, DOI 10.1213/ANE.0000000000001045; HOVDA DA, 1992, J NEUROTRAUM, V9, pS47; Huang SL, 2013, NEUROIMAGE, V72, P237, DOI 10.1016/j.neuroimage.2013.01.027; Keir SL, 2000, STROKE, V31, P2723, DOI 10.1161/01.STR.31.11.2723; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Kudin AP, 2004, J BIOL CHEM, V279, P4127, DOI 10.1074/jbc.M310341200; Kuhlbrandt W, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0201-x; Kulbe JR, 2017, J NEUROTRAUM, V34, P1291, DOI 10.1089/neu.2016.4628; Kwok Edmund S H, 2006, J Intensive Care Med, V21, P359, DOI 10.1177/0885066606290671; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Lin AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046585; Marmorstein AD, 2000, P NATL ACAD SCI USA, V97, P3248, DOI 10.1073/pnas.070049497; Marr A., 2004, CENTRAL NERVOUS SYST; Maslow AD, 2006, ANESTH ANALG, V103, P2, DOI 10.1213/01.ane.0000221261.25310.fe; Mazzeo AT, 2009, J NEUROTRAUM, V26, P2195, DOI 10.1089/neu.2009.1012; Mbye LH, 2008, EXP NEUROL, V209, P243, DOI 10.1016/j.expneurol.2007.09.025; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Nicholls DG, 1999, ANN NY ACAD SCI, V893, P1, DOI 10.1111/j.1749-6632.1999.tb07813.x; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; Nukala VN, 2006, J NEUROSCI METH, V152, P48, DOI 10.1016/j.jneumeth.2005.08.017; Oz M, 2009, BIOCHEM PHARMACOL, V78, P927, DOI 10.1016/j.bcp.2009.04.034; Paciullo CA, 2010, PHARMACOTHERAPY, V30, P702, DOI 10.1592/phco.30.7.702; Pandya JD, 2007, J NEUROTRAUM, V24, P798, DOI 10.1089/neu.2006.3673; Pandya JD, 2016, METHODS MOL BIOL, V1462, P597, DOI 10.1007/978-1-4939-3816-2_32; Pandya JD, 2016, NEUROBIOL AGING, V42, P25, DOI 10.1016/j.neurobiolaging.2016.02.027; Pandya JD, 2014, EXP NEUROL, V257, P106, DOI 10.1016/j.expneurol.2014.04.020; Pandya Jignesh D, 2013, Front Neuroenergetics, V5, P10, DOI 10.3389/fnene.2013.00010; Pandya JD, 2009, EXP NEUROL, V218, P381, DOI 10.1016/j.expneurol.2009.05.023; Patel SP, 2014, EXP NEUROL, V257, P95, DOI 10.1016/j.expneurol.2014.04.026; Pellock J. M., 2001, PEDIAT EPILEPSY DIAG, pxv; Peter C, 2000, EUR J CLIN PHARMACOL, V56, P247, DOI 10.1007/s002280000124; Poteet E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048279; Readnower RD, 2011, J NEUROTRAUM, V28, P1845, DOI 10.1089/neu.2011.1755; Riha PD, 2005, EUR J PHARMACOL, V511, P151, DOI 10.1016/j.ejphar.2005.02.001; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Rojas JC, 2012, PROG NEUROBIOL, V96, P32, DOI 10.1016/j.pneurobio.2011.10.007; Sauerbeck A, 2011, J NEUROSCI METH, V198, P36, DOI 10.1016/j.jneumeth.2011.03.007; Scheindlin S, 2008, MOL INTERV, V8, P268, DOI 10.1124/mi.8.6.1; Schurr A, 2002, NEUROCHEM INT, V41, P1, DOI 10.1016/S0197-0186(01)00142-5; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Stowe DF, 2009, ANTIOXID REDOX SIGN, V11, P1373, DOI 10.1089/ARS.2008.2331; Sullivan PG, 2011, J NEUROTRAUM, V28, P311, DOI 10.1089/neu.2010.1646; Sullivan PG, 2000, NEUROSCIENCE, V101, P289, DOI 10.1016/S0306-4522(00)00380-8; Sullivan PG, 2004, J BIOENERG BIOMEMBR, V36, P353, DOI 10.1023/B:JOBB.0000041767.30992.19; Sullivan PG, 2005, EPILEPSY BEHAV, V7, pS12, DOI 10.1016/j.yebeh.2005.08.004; Sullivan PG, 2004, J COMP NEUROL, V474, P524, DOI 10.1002/cne.20130; Sullivan PG, 1998, J NEUROTRAUM, V15, P789, DOI 10.1089/neu.1998.15.789; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 2000, EXP NEUROL, V161, P631, DOI 10.1006/exnr.1999.7282; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Sullivan PG, 2002, BRAIN RES, V949, P88, DOI 10.1016/S0006-8993(02)02968-2; TBI, 2003, REP C MILD TRAUM BRA; The CDC NI H DoD and VA Leadership Panel, 2013, REP C TRAUM BRAIN IN; Tieu K, 2003, J CLIN INVEST, V112, P892, DOI 10.1172/JCI200318797; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Vink R, 1990, J NEUROTRAUM, V7, P21, DOI 10.1089/neu.1990.7.21; Visavadiya NP, 2016, REDOX BIOL, V8, P59, DOI 10.1016/j.redox.2015.12.011; Vutskits L, 2008, ANESTHESIOLOGY, V108, P684, DOI 10.1097/ALN.0b013e3181684be4; Wainwright M, 2002, J CHEMOTHERAPY, V14, P431, DOI 10.1179/joc.2002.14.5.431; Watts LT, 2016, J NEUROTRAUM, V33, P194, DOI 10.1089/neu.2015.3904; Watts LT, 2014, J NEUROTRAUM, V31, P1063, DOI 10.1089/neu.2013.3193; Watts LT, 2013, BRAIN SCI, V3, P540, DOI 10.3390/brainsci3020540; Wen Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.208447; Wiklund L, 2007, ANN NY ACAD SCI, V1122, P231, DOI 10.1196/annals.1403.016; Wrubel KM, 2007, PHARMACOL BIOCHEM BE, V86, P712, DOI 10.1016/j.pbb.2007.02.018; Xie LK, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00056; Yonutas HM, 2016, BRAIN RES, V1640, P77, DOI 10.1016/j.brainres.2016.02.007	93	17	17	2	9	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	OCT	2017	109				SI		117	125		10.1016/j.neuint.2017.04.004			9	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	FM3ER	WOS:000414887600013	28396091	Green Accepted, Green Published			2022-02-06	
J	Zhang, H; Wang, WZ; Jiang, SS; Zhang, Y; Heo, HY; Wang, XL; Peng, Y; Wang, J; Zhou, JY				Zhang, Hong; Wang, Wenzhu; Jiang, Shanshan; Zhang, Yi; Heo, Hye-Young; Wang, Xianlong; Peng, Yun; Wang, Jian; Zhou, Jinyuan			Amide proton transfer-weighted MRI detection of traumatic brain injury in rats	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Amide proton transfer-weighted imaging; hemorrhage; ischemia; neuroinflammation; traumatic brain injury	SATURATION-TRANSFER CEST; CEREBRAL-ISCHEMIA; DIFFUSION TENSOR; ENDOGENOUS PROTEIN; AXONAL INJURY; HEAD-INJURY; 3 TESLA; CONTRAST; STROKE; PATHOPHYSIOLOGY	The purpose of this study was to explore the capability and uniqueness of amide proton transfer-weighted (APTw) imaging in the detection of primary and secondary injury after controlled cortical impact (CCI)-induced traumatic brain injury (TBI) in rats. Eleven adult rats had craniotomy plus CCI surgery under isoflurane anesthesia. Multi-parameter MRI data were acquired at 4.7 T, at eight time points (1, 6 h, and 1, 2, 3, 7, 14, and 28 days after TBI). At one and six hours post-injury, average APTw signal intensities decreased significantly in the impacted and peri-lesional areas due to tissue acidosis. A slightly high APTw signal was seen in the core lesion area with respect to the peri-lesional area, which was due to hemorrhage, as shown by T-2*w. After the initial drop, the APTw signals dramatically increased in some peri-lesional areas at two and three days post-injury, likely due to the secondary inflammatory response. The use of APTw MRI has the potential to introduce a novel molecular neuroimaging approach for the simultaneous detection of ischemia, hemorrhage, and neuroinflammation in TBI.	[Zhang, Hong; Jiang, Shanshan; Zhang, Yi; Heo, Hye-Young; Wang, Xianlong; Zhou, Jinyuan] Johns Hopkins Univ, Div MR Res, Dept Radiol, Baltimore, MD USA; [Zhang, Hong; Peng, Yun] Capital Med Univ, Dept Radiol, Beijing Childrens Hosp, Beijing, Peoples R China; [Wang, Wenzhu; Wang, Jian] Johns Hopkins Univ, Dept Anesthesiol & Crit Care Med, 720 Rutland Ave,Ross 370B, Baltimore, MD 21205 USA; [Wang, Wenzhu] Huazhong Univ Sci & Technol, Dept Integrated Chinese & West Med, Union Hosp, Tongji Med Coll, Wuhan, Hubei, Peoples R China		Wang, J (corresponding author), Johns Hopkins Univ, Dept Anesthesiol & Crit Care Med, 720 Rutland Ave,Ross 370B, Baltimore, MD 21205 USA.; Zhou, JY (corresponding author), Johns Hopkins Univ, Dept Radiol, 600 N Wolfe St,Pk 336, Baltimore, MD 21287 USA.	jwang79@jhmi.edu; jzhou@mri.jhu.edu	Heo, Hye-Young/I-2711-2015; Wang, Jian/I-4874-2019; hong, zhang/AAM-3862-2020; Jiang, Shanshan/O-8265-2019; Zhang, Yi/AAC-8377-2019	Heo, Hye-Young/0000-0002-7297-2015; Wang, Jian/0000-0003-2291-640X; Jiang, Shanshan/0000-0003-2853-9991; Zhang, Yi/0000-0001-8738-1851	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS083435, R01NS078026, R01EB009731, R01CA166171, R01AT007317]; American Heart AssociationAmerican Heart Association [13GRNT15730001]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81361120392]; "Stimulating and Advancing ACCM Research (StAAR)'' grant from the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University; National Center for Complementary & Integrative HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01AT007317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB009731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS083435, R01NS078026] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported in part by grants from the National Institutes of Health (R01NS083435, R01NS078026, R01EB009731, R01CA166171, and R01AT007317), the American Heart Association (13GRNT15730001), and the National Natural Science Foundation of China (81361120392), and a "Stimulating and Advancing ACCM Research (StAAR)'' grant from the Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University.	Acosta SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090953; Amyot F, 2015, J NEUROTRAUM, V32, P1693, DOI 10.1089/neu.2013.3306; Bagley LJ, 2000, J MAGN RESON IMAGING, V11, P1, DOI 10.1002/(SICI)1522-2586(200001)11:1<1::AID-JMRI1>3.0.CO;2-H; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Cheng T, 2016, FREE RADICAL BIO MED, V92, P15, DOI 10.1016/j.freeradbiomed.2015.12.027; Dietrich WD, 1998, NEUROSURGERY, V43, P585, DOI 10.1097/00006123-199809000-00105; Faul M, 2010, TRAUMATIC BRAIN INJU; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; Grossman R, 2012, J NEURO-ONCOL, V110, P315, DOI 10.1007/s11060-012-0974-5; Han XN, 2016, J CEREBR BLOOD F MET, V36, P1059, DOI 10.1177/0271678X15606462; Heo HY, 2016, MAGN RESON MED, V75, P137, DOI 10.1002/mrm.25581; Holschneider DP, 2011, J NEUROTRAUM, V28, P1909, DOI 10.1089/neu.2011.1978; Immonen R, 2010, J CEREBR BLOOD F MET, V30, P1318, DOI 10.1038/jcbfm.2010.15; Immonen RJ, 2009, NEUROIMAGE, V45, P1, DOI 10.1016/j.neuroimage.2008.11.022; Jeong HK, 2017, EUR RADIOL, V27, P1577, DOI 10.1007/s00330-016-4477-1; Jiang SS, 2016, EUR RADIOL, V26, P64, DOI 10.1007/s00330-015-3805-1; Jin T, 2013, MAGN RESON MED, V69, P760, DOI 10.1002/mrm.24315; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Li CM, 2014, EUR RADIOL, V24, P2631, DOI 10.1007/s00330-014-3241-7; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; McVicar N, 2014, J CEREBR BLOOD F MET, V34, P690, DOI 10.1038/jcbfm.2014.12; MORI S, 1995, MAGNET RESON MED, V33, P41, DOI 10.1002/mrm.1910330107; NIH/NINDS, 2015, NIH PUBL; Potts MB, 2009, CEREBELLUM, V8, P211, DOI 10.1007/s12311-009-0114-8; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Sinson G, 2001, AM J NEURORADIOL, V22, P143; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Sun PZ, 2007, J CEREBR BLOOD F MET, V27, P1129, DOI 10.1038/sj.jcbfm.9600424; Sun PZ, 2011, J CEREBR BLOOD F MET, V31, P1743, DOI 10.1038/jcbfm.2011.23; Susarla BTS, 2014, ASN NEURO, V6, DOI 10.1042/AN20130034; Tee YK, 2014, NMR BIOMED, V27, P1019, DOI 10.1002/nbm.3147; Tietze A, 2014, NMR BIOMED, V27, P163, DOI 10.1002/nbm.3048; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Wagner AK, 2007, BEHAV BRAIN RES, V181, P200, DOI 10.1016/j.bbr.2007.04.006; Wang MY, 2015, MAGN RESON MED, V74, P42, DOI 10.1002/mrm.25690; Wang SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063511; Wang WZ, 2016, MOL NEUROBIOL, V53, P4809, DOI 10.1007/s12035-015-9385-x; Ward KM, 2000, J MAGN RESON, V143, P79, DOI 10.1006/jmre.1999.1956; Watts LT, 2015, J NEUROTRAUM, V32, P1001, DOI 10.1089/neu.2014.3737; Wen ZB, 2010, NEUROIMAGE, V51, P616, DOI 10.1016/j.neuroimage.2010.02.050; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Xiong Y, 2015, EXPERT OPIN INV DRUG, V24, P743, DOI 10.1517/13543784.2015.1021919; Yan K, 2015, MOL IMAGING BIOL, V17, P479, DOI 10.1007/s11307-015-0828-6; Yuan J, 2014, NMR BIOMED, V27, P1239, DOI 10.1002/nbm.3184; Zhang H, 2016, EUR RADIOL, V26, P3368, DOI 10.1007/s00330-015-4188-z; Zhang Y, 2016, J MAGN RESON IMAGING, V43, P756, DOI 10.1002/jmri.25027; Zhao XN, 2011, MAGN RESON MED, V66, P1033, DOI 10.1002/mrm.22891; Zheng SK, 2014, MAGN RESON MED, V71, P1082, DOI 10.1002/mrm.24770; Zhou JY, 2008, MAGN RESON MED, V60, P842, DOI 10.1002/mrm.21712; Zhou JY, 2006, PROG NUCL MAG RES SP, V48, P109, DOI 10.1016/j.pnmrs.2006.01.001; Zhou JY, 2013, J MAGN RESON IMAGING, V38, P1119, DOI 10.1002/jmri.24067; Zhou JY, 2011, NAT MED, V17, P130, DOI 10.1038/nm.2268; Zhou JY, 2003, NAT MED, V9, P1085, DOI 10.1038/nm907	57	17	17	1	11	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	OCT	2017	37	10					3422	3432		10.1177/0271678X17690165			11	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	FI7IV	WOS:000412171300015	28128026	Green Published, Bronze			2022-02-06	
J	Henderson, TA; Morries, LD				Henderson, Theodore A.; Morries, Larry D.			Multi-Watt Near-Infrared Phototherapy for the Treatment of Comorbid Depression: An Open-Label Single-Arm Study	FRONTIERS IN PSYCHIATRY			English	Article						major depression; near-infrared; laser; photobiomodulation; near-infrared light therapy; suicidal ideation; antidepressant	DEEP BRAIN-STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT-RESISTANT DEPRESSION; REPORT QIDS-SR; OXIDATIVE STRESS; MAJOR DEPRESSION; QUICK INVENTORY; KETAMINE; THERAPY; INJURY	Background: The treatment of depression has been hampered by low efficacy of antidepressant medications and safety concerns with alternative modalities. Recent work demonstrated that multi-Watt transcranial near-infrared light therapy (NILT) can effectively treat traumatic brain injury (TBI). The current objective is to explore multi-Watt NILT efficacy in a proof-of-concept study as a treatment for depression. Methods: Thirty-nine sequential patients treated for TBI between March 2013 and May 2017 provided depression self-assessment data and/or were administered the Hamilton depression rating scale. Each completed the Quick Inventory of Depression Symptomatology-Self Report (QIDS) before and after treatment. Patients received multi-Watt NILT using near-infrared lasers (810/980 nm at 8-15 W) applied to forehead and temporal regions bilaterally for 9-12 min to each area. Pre-and posttreatment scores were analyzed by paired t-tests. Results: All met QIDS criteria for mild to severe depression and 69% had prior antidepressant trials. For 36 of the 39 patients, after 16.82 +/- 6.26 treatments, QIDS scores indicated a robust response (decrease of QIDS total score by >= 50%). For 32 of 39 patients, posttreatment QIDS scores indicated a remission from depression (decrease of QIDS total score <= 5). Overall, the QIDS score fell from 14.10 +/- 3.39 to 3.41 +/- 3.30 SD (p = 6.29 x 10(-19)). With 12 or fewer treatments, QIDS score dropped from 14.83 +/- 2.55 to 4.17 +/- 3.93. Patients receiving >= 13 treatments showed a change in QIDS score from 13.67 +/- 3.64 to 3.11 +/- 3.14. Those (N = 15) who received the entire treatment course within <= 8 weeks (5.33 +/- 1.72 weeks) showed a change in QIDS score from 13.86 +/- 3.14 to 4.5 +/- 3.94. Suicidal ideation resolved in all, but two patients. Patients remained in remission for up to 55 months after a single course of treatment. Conclusion: This is the first report of high-powered NILT showing efficacy for depression. Multi-Watt NILT showed far greater efficacy and persistent benefit compared to low-power (<1 Watt) infrared light treatments. Patients saw benefit often within four treatments and resolution of depressive symptoms occurred within 4 weeks for some. These data raise an intriguing possibility-that multi-Watt NILT may be a safe, effective, and rapid treatment for depression comorbid with TBI and possibly primary major depression disorder. A double-blind, placebo controlled trial is warranted to verify these proof-of-concept data.	[Henderson, Theodore A.; Morries, Larry D.] Neurolaser Fdn, Centennial, CO 80122 USA; [Henderson, Theodore A.] Synapt Space Inc, Centennial, CO 80122 USA; [Henderson, Theodore A.] Neuroluminance Inc, Centennial, CO 80122 USA; [Henderson, Theodore A.] Dr Theodore Henderson Inc, Centennial, CO 80122 USA		Henderson, TA (corresponding author), Neurolaser Fdn, Centennial, CO 80122 USA.; Henderson, TA (corresponding author), Synapt Space Inc, Centennial, CO 80122 USA.; Henderson, TA (corresponding author), Neuroluminance Inc, Centennial, CO 80122 USA.; Henderson, TA (corresponding author), Dr Theodore Henderson Inc, Centennial, CO 80122 USA.	thesynapticspace7@gmail.com					Berlim MT, 2014, J AFFECT DISORDERS, V159, P31, DOI 10.1016/j.jad.2014.02.016; Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Browne CA, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00161; Campbell S, 2004, J PSYCHIATR NEUROSCI, V29, P417; Cassano Paolo, 2015, Psychiatry J, V2015, P352979, DOI 10.1155/2015/352979; Cassano P, 2016, NEUROPHOTONICS, V3, DOI 10.1117/1.NPh.3.3.031404; Chen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020333; Chung H, 2012, ANN BIOMED ENG, V40, P516, DOI 10.1007/s10439-011-0454-7; Connolly KR, 2011, DRUGS, V71, P43, DOI 10.2165/11587620-000000000-00000; Cook SC, 2004, J NEUROBIOL, V60, P236, DOI 10.1002/neu.20025; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Duman RS, 2012, SCIENCE, V338, P68, DOI 10.1126/science.1222939; Ghaemi N., 2013, MEDSCAPE CONNECT; Goldstein BJ, 1998, J PSYCHOPHARMACOL, V12, pS55, DOI 10.1177/0269881198012003041; Gumnick JF, 2000, J CLIN PSYCHIAT, V61, P5; Henderson TA, 2016, NEURAL REGEN RES, V11, P563, DOI 10.4103/1673-5374.180737; Henderson TA, 2016, NEURAL REGEN RES, V11, P195, DOI 10.4103/1673-5374.177708; Henderson Theodore A, 2015, Adv Mind Body Med, V29, P27; Henderson TA, 2015, NEUROPSYCH DIS TREAT, V11, P2191, DOI 10.2147/NDT.S78182; Iosifescu DV, 2008, BIOL PSYCHIAT, V63, P1127, DOI 10.1016/j.biopsych.2007.11.020; Janicak PG, 2015, NEUROPSYCH DIS TREAT, V11, P1549, DOI 10.2147/NDT.S67477; Karu TI, 2005, PHOTOMED LASER SURG, V23, P355, DOI 10.1089/pho.2005.23.355; Lapchak PA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127580; Lapchak PA, 2010, ANN MED, V42, P576, DOI 10.3109/07853890.2010.532811; Liu RJ, 2008, P NATL ACAD SCI USA, V105, P359, DOI 10.1073/pnas.0706679105; Mauri MC, 2014, ASIAN J PSYCHIATR, V12, P118, DOI 10.1016/j.ajp.2014.07.003; McAvoy K, 2015, HIPPOCAMPUS, V25, P1429, DOI 10.1002/hipo.22464; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Mohr P, 2011, NEUROPSYCHOBIOLOGY, V64, P170, DOI 10.1159/000325225; Morais M, 2014, J PSYCHOPHARMACOL, V28, P1178, DOI 10.1177/0269881114553646; Morishita T, 2014, NEUROTHERAPEUTICS, V11, P475, DOI 10.1007/s13311-014-0282-1; Morries LD, 2015, NEUROPSYCH DIS TREAT, V11, P2159, DOI 10.2147/NDT.S65809; Naeser MA, 2014, J NEUROTRAUM, V31, P1008, DOI 10.1089/neu.2013.3244; Naeser MA, 2011, PHOTOMED LASER SURG, V29, P351, DOI 10.1089/pho.2010.2814; Newport DJ, 2015, AM J PSYCHIAT, V172, P950, DOI 10.1176/appi.ajp.2015.15040465; Ozcan ME, 2004, INT CLIN PSYCHOPHARM, V19, P89, DOI 10.1097/01.yic.0000110796.97676.89; Pigott HE, 2010, PSYCHOTHER PSYCHOSOM, V79, P267, DOI 10.1159/000318293; Ren JJ, 2014, PROG NEURO-PSYCHOPH, V51, P181, DOI 10.1016/j.pnpbp.2014.02.004; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sarandol A, 2007, HUM PSYCHOPHARM CLIN, V22, P67, DOI 10.1002/hup.829; Scheuing L, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00249; Schiffer F, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-46; Sheline YI, 1996, P NATL ACAD SCI USA, V93, P3908, DOI 10.1073/pnas.93.9.3908; Simon NM, 2008, EUR NEUROPSYCHOPHARM, V18, P230, DOI 10.1016/j.euroneuro.2007.06.004; Steffens D C, 1997, Depress Anxiety, V6, P10, DOI 10.1002/(SICI)1520-6394(1997)6:1<10::AID-DA2>3.0.CO;2-9; Tedford CE, 2015, LASER SURG MED, V47, P312, DOI 10.1002/lsm.22343; Thase ME, 2001, BRIT J PSYCHIAT, V178, P234, DOI 10.1192/bjp.178.3.234; Trivedi MH, 2004, PSYCHOL MED, V34, P73, DOI 10.1017/S0033291703001107; Xuan WJ, 2015, J BIOPHOTONICS, V8, P502, DOI 10.1002/jbio.201400069; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856	52	17	17	1	8	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-0640			FRONT PSYCHIATRY	Front. Psychiatry	SEP 29	2017	8								187	10.3389/fpsyt.2017.00187			8	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	FI4IV	WOS:000411935500001	29033859	gold, Green Published			2022-02-06	
J	Beauchamp, MH; Landry-Roy, C; Gravel, J; Beaudoin, C; Bernier, A				Beauchamp, Miriam H.; Landry-Roy, Catherine; Gravel, Jocelyn; Beaudoin, Cindy; Bernier, Annie			Should Young Children with Traumatic Brain Injury Be Compared with Community or Orthopedic Control Participants?	JOURNAL OF NEUROTRAUMA			English	Article						community controls; injured controls; pediatric brain injury; traumatic brain injury	MILD HEAD-INJURY; EXECUTIVE FUNCTION; PRESCHOOL-CHILDREN; EARLY-CHILDHOOD; NEUROCOGNITIVE OUTCOMES; SYMPTOMS; ADOLESCENTS; RISK; PREVALENCE; PREDICTOR	Pediatric traumatic brain injury (TBI) research depends on comparisons of profiles and outcomes between brain-injured individuals and groups consisting either of injured controls (e.g., orthopedic injuries, OI) or uninjured, typically developing children recruited from the community (community controls, CC). Children with OI are thought to provide optimal comparisons for individuals with TBI because they share injury-related experiences and pre-morbid characteristics; however, a study by Mathias and colleagues (2013) 1 in adults has called into question the added value of injury control groups in TBI research. The comparability of these control groups has not been established in young children. Seventy-two children with OI and 84 CC aged between 18 and 60 months were compared on a range of demographic variables, developmental and medical history, pre-injury behavioral and adaptive profiles, as well as on measures of adaptive functioning, behavior, family functioning, post-concussive symptoms, and cognition (intellectual functioning, verbal abilities, executive functioning, social cognition) 6 months after the OI. There were no statistically significant differences between the OI and CC groups on any of the variables tested, whether they related to pre-injury or post-injury characteristics. The findings are applicable to studies seeking to identify appropriate control groups in the context of preschool TBI research, and suggest no clear advantage in recruiting OI controls based on the variables studied and the methodology used. However, further work is necessary to verify additional factors and outcomes relevant to pediatric TBI research, as well as to compare outcomes between these two groups at more acute stages (i.e., prior to 6 months post-injury).	[Beauchamp, Miriam H.; Landry-Roy, Catherine; Beaudoin, Cindy; Bernier, Annie] Univ Montreal, Dept Psychol, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada; [Beauchamp, Miriam H.; Landry-Roy, Catherine; Gravel, Jocelyn; Beaudoin, Cindy] Ste Justine Hosp Res Ctr, Montreal, PQ, Canada		Beauchamp, MH (corresponding author), Univ Montreal, Dept Psychol, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	miriam.beauchamp@umontreal.ca			Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [MOP11036]	This study was supported by the Canadian Institutes of Health Research (MOP11036 to M.H.B). Thank you to the LION study members and the ED team for their collaborative efforts.	Abidin, 1995, PARENTING STRESS IND; Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; ASARNOW RF, 1995, TRAUMATIC HEAD INJUR, P117; Babikian T, 2013, J INT NEUROPSYCH SOC, V19, P145, DOI 10.1017/S135561771200104X; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Bayley N., 2006, BAYLEY SCALES INFANT; Beck DM, 2011, J COGN DEV, V12, P169, DOI 10.1080/15248372.2011.563485; Bellerose J, 2015, J INT NEUROPSYCH SOC, V21, P483, DOI 10.1017/S1355617715000569; BIJUR PE, 1990, PEDIATRICS, V86, P337; BIJUR PE, 1995, TRAUMATIC HEAD INJUR, P147; BLISHEN BR, 1987, CAN REV SOC ANTHROP, V24, P465; Brooks BL, 2013, J NEUROTRAUM, V30, P1469, DOI 10.1089/neu.2012.2720; Carlson SA, 2005, DEV NEUROPSYCHOL, V28, P595, DOI 10.1207/s15326942dn2802_3; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Catroppa C, 2015, NEW FRONTIERS PEDIAT; Crowe LM, 2012, PEDIATRICS, V129, pE262, DOI 10.1542/peds.2011-0438; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Ettenhofer ML, 2012, J INT NEUROPSYCH SOC, V18, P451, DOI 10.1017/S1355617711001895; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; FAY GC, 1993, ARCH PHYS MED REHAB, V74, P895; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Goldstrohm SL, 2005, ARCH CLIN NEUROPSYCH, V20, P675, DOI 10.1016/j.acn.2005.02.005; Harrison P. L., 2003, ADAPTIVE BEHAV ASSES, V2nd; Hughes C, 2005, DEV NEUROPSYCHOL, V28, P645, DOI 10.1207/s15326942dn2802_5; Hughes C, 2011, J EXP CHILD PSYCHOL, V108, P96, DOI 10.1016/j.jecp.2010.07.012; Hung Ryan, 2014, Arch Phys Med Rehabil, V95, pS174, DOI 10.1016/j.apmr.2013.08.301; KLONOFF H, 1971, AM J PUBLIC HEALTH N, V61, P2405, DOI 10.2105/AJPH.61.12.2405; Kochanska G, 2000, DEV PSYCHOL, V36, P220, DOI 10.1037//0012-1649.36.2.220; Lee LC, 2008, RES DEV DISABIL, V29, P247, DOI 10.1016/j.ridd.2007.05.002; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Mathias JL, 2013, BRAIN INJURY, V27, P887, DOI 10.3109/02699052.2013.793398; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1595, DOI 10.1016/S0890-8567(09)66570-9; McDonald SJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0555-1; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2010, INJURY PREV, V16, P31, DOI 10.1136/ip.2009.022483; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Pears KC, 2003, SOC DEV, V12, P1, DOI 10.1111/1467-9507.00219; Repacholi BM, 1997, DEV PSYCHOL, V33, P12, DOI 10.1037/0012-1649.33.1.12; Rieger BP, 2013, BRAIN INJURY, V27, P169, DOI 10.3109/02699052.2012.729290; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; SPANIER GB, 1976, J MARRIAGE FAM, V38, P15, DOI 10.2307/350547; Studer M, 2014, J INT NEUROPSYCH SOC, V20, P982, DOI 10.1017/S1355617714000927; Uddin LQ, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00021; Wechsler D., 2002, WECHSLER PRESCHOOL P; WELSH MC, 1991, DEV NEUROPSYCHOL, V7, P131, DOI 10.1080/87565649109540483; Winqvist S, 2007, BRAIN INJURY, V21, P1079, DOI 10.1080/02699050701553221; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Zelazo PD, 2006, NAT PROTOC, V1, P297, DOI 10.1038/nprot.2006.46	55	17	17	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2017	34	17					2545	2552		10.1089/neu.2016.4868			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	FE6HI	WOS:000408310200007	28398160				2022-02-06	
J	Fuller, CW; Taylor, A; Raftery, M				Fuller, Colin W.; Taylor, Aileen; Raftery, Martin			2016 Rio Olympics: an epidemiological study of the men's and women's Rugby-7s tournaments	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							SEVENS WORLD SERIES; SPORTS INJURIES; CONCUSSION; UNION; MATCH; CUP	Objective To determine the incidence, severity and nature of injuries sustained during the men's and women's 2014/2015 and 2015/2016 Sevens World Series (SWS) and 2016 Olympic Games Rugby Sevens tournaments. Design A prospective cohort study. Participants All players from the core teams competing in the men's and women's 2014/2015 and 2015/2016 SWS (men: 15 teams; women: 11 teams) and all players from the men's (12 teams) and women's (12 teams) 2016 Rio Olympics tournaments. Results The gold, silver and bronze medal-winning women's teams contained bigger players (body mass and stature) than other teams but the men's medal winning teams came from across the size spectrum of men's teams competing at Rio 2016. The incidences of injury in the men's tournaments (2014/2015 SWS: 107.7 injuries/1000 player-match-hours (95% CI 90.9 to 127.4); 2015/2016 SWS: 109.7 (95% CI 93.7 to 128.6); Rio 2016: 124.5 (95% CI 73.7 to 210.2)) were higher but not statistically significant than those in the equivalent women's tournaments (2014/2015 SWS: 88.5 (95% CI 68.4 to 114.5), p=0.250; 2015/2016 SWS: 109.4 (95% CI 84.2 to 142.2), p=0.984; Rio 2016: 71.1 (95% CI 35.6 to 142.2), p=0.208). There were no statistically significant differences between the incidences of injury at the men's and women's 2016 Rio Olympics and the equivalent 2014/2015 (men: p=0.603; women: p=0.562) and 2015/2016 (men: p=0.652; women: p=0.254) SWS. Conclusions The incidence, severity and nature of the injuries sustained during the men's and women's Rio 2016 Rugby-7s tournaments fell within the normal range of values for international Rugby-7s tournaments.	[Fuller, Colin W.; Taylor, Aileen; Raftery, Martin] World Rugby, World Rugby House,Pembroke St Lower, Dublin 2, Ireland; [Fuller, Colin W.] Colin Fuller Consultancy Ltd, Loughborough, England		Fuller, CW (corresponding author), World Rugby, World Rugby House,Pembroke St Lower, Dublin 2, Ireland.	colin.fuller@f-marc.com			World Rugby, Dublin, Ireland	The study was funded by World Rugby, Dublin, Ireland.	Best JP, 2003, BRIT J SPORT MED, V2005, P812; Brooks JHM, 2005, BRIT J SPORT MED, V39, P757, DOI 10.1136/bjsm.2005.018135; Brooks JHM, 2008, J SPORT SCI, V26, P863, DOI 10.1080/02640410701832209; Chalmers DJ, 2004, J SCI MED SPORT, V7, P74, DOI 10.1016/S1440-2440(04)80046-X; Engebretsen L, 2013, BRIT J SPORT MED, V47, P407, DOI 10.1136/bjsports-2013-092380; Fuller CW, 2008, BRIT J SPORT MED, V42, P452, DOI 10.1136/bjsm.2008.047035; Fuller CW, 2007, BRIT J SPORT MED, V41, P328, DOI 10.1136/bjsm.2006.033282; Fuller CW, 2016, BRIT J SPORT MED, V50, P682, DOI 10.1136/bjsports-2016-096043; Fuller CW, 2015, BRIT J SPORT MED, V49, P458, DOI 10.1136/bjsports-2014-094369; Fuller CW, 2015, BRIT J SPORT MED, V49, P478, DOI 10.1136/bjsports-2013-093381; Fuller CW, 2013, BRIT J SPORT MED, V47, P1184, DOI 10.1136/bjsports-2012-091155; Fuller CW, 2016, BR J SPORTS MED; Fuller CW, 2016, BRIT J SPORT MED, P1; Fuller GW, 2015, BRIT J SPORT MED, V49, P529, DOI 10.1136/bjsports-2014-093498; Jakoet I, 1998, S AFR MED J, V88, P45; Junge A, 2009, AM J SPORT MED, V37, P2165, DOI 10.1177/0363546509339357; Kemp SPT, 2008, CLIN J SPORT MED, V18, P227, DOI 10.1097/JSM.0b013e31816a1c9a; Orchard J., 1995, SPORT HLTH, V11, P39; Quarrie KL, 2007, BRIT MED J, V334, P1150, DOI 10.1136/bmj.39185.605914.AE; Quarrie KL, 2016, BR J SPORTS MED; Rugby Football Union, 2016, ENGL PROF RUGB INJ S; Rugby W, HIST RUGBY 7; Rugby W, WORLD RUGBY RES FUND; Rugby W, HSBC WORLD RUGB 7 SE; WALLER AE, 1994, BRIT J SPORT MED, V28, P223, DOI 10.1136/bjsm.28.4.223; Windt J, 2016, BR J SPORTS MED	26	17	17	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	SEP	2017	51	17					1272	+		10.1136/bjsports-2016-097301			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	FE1ZB	WOS:000408015000006	28137789	Bronze, Green Submitted			2022-02-06	
J	Galan-Arriero, I; Serrano-Munoz, D; Gomez-Soriano, J; Goicoechea, C; Taylor, J; Velasco, A; Avila-Martin, G				Galan-Arriero, Iriana; Serrano-Munoz, Diego; Gomez-Soriano, Julio; Goicoechea, Carlos; Taylor, Julian; Velasco, Ana; Avila-Martin, Gerardo			The role of Omega-3 and Omega-9 fatty acids for the treatment of neuropathic pain after neurotrauma	BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES			English	Article						Omega-3,-6 and-9 fatty acids; Spared nerve injury; Spinal cord injury; Neurotrophic factor; Central sensitisation to noxious stimuli; Descending antinociception; Microglia; NMDA receptors	SPINAL-CORD-INJURY; ACTIVATED RECEPTOR-ALPHA; DOCOSAHEXAENOIC ACID; OLEIC-ACID; 2-HYDROXYOLEIC ACID; LIPOXIN A(4); NERVE INJURY; BRAIN-INJURY; MOUSE MODEL; RAT MODEL	Omega-3 polyunsaturated fatty acids (PUFAs), such as docosaexaenoic acid (DHA) and eicosapentaenoic acid (EPA), mediate neuroactive effects in experimental models of traumatic peripheral nerve and spinal cord injury. Cellular mechanisms of PUFAs include reduced neuroinflammation and oxidative stress, enhanced neurotrophic support, and activation of cell survival pathways. Bioactive Omega-9 monounsaturated fatty acids, such as oleic acid (OA) and 2-hydroxy oleic acid (2-OHOA), also show therapeutic effects in neurotrauma models. These FAs reduces noxious hyperreflexia and pain-related anxiety behavior following peripheral nerve injury and improves sensorimotor function following spinal cord injury (SCI), including facilitation of descending inhibitory antinociception. The relative safe profile of neuroactive fatty acids (FAs) holds promise for the future clinical development of these molecules as analgesic agents. This article is part of a Special Issue entitled: Membrane Lipid Therapy: Drugs Targeting Biomembranes edited by Pablo V. Escribia. (C) 2017 Elsevier B.V. All rights reserved.	[Galan-Arriero, Iriana; Serrano-Munoz, Diego; Taylor, Julian; Avila-Martin, Gerardo] Hosp Nacl Paraplej, SESCAM, Sensorimotor Funct Grp, Toledo 45071, Spain; [Gomez-Soriano, Julio] Univ Castilla La Mancha, Nursing & Physiotherapy Fac, GIFTO, Toledo 45072, Spain; [Goicoechea, Carlos] Univ Rey Juan Carlos, Hlth Sci Fac, Pharmacol & Nutr Dept, Madrid 28922, Spain; [Taylor, Julian] Buckinghamshire Healthcare NHS Trust, Natl Spinal Injuries Ctr, Stoke Mandeville Spinal Res, Aylesbury HP21 8AL, Bucks, England; [Taylor, Julian] Univ Oxford, Harris Manchester Coll, Oxford OX1 3TD, England; [Velasco, Ana] Inst Neurociencias Castilla & Leon, Salamanca 37007, Spain		Avila-Martin, G (corresponding author), Hosp Nacl Paraplej, SESCAM, Sensorimotor Funct Grp, Toledo 45071, Spain.	igalan@jccm.es; dserranomu@externas.sescam.jccm.es; julio.soriano@uclm.es; carlos.goicoechea@urjc.es; jscott@sescam.org; anvecri@usal.es; gavila@sescam.jccm.es	Velasco, Ana/L-6065-2014; Serrano-Munoz, Diego/AAD-2803-2019; Taylor, Julian/AAC-2802-2021; Gomez-Soriano, Julio/AAE-2990-2019; Goicoechea, Carlos/H-6890-2015; Arriero, Iriana Galan/S-2050-2019	Velasco, Ana/0000-0002-4091-8081; Serrano-Munoz, Diego/0000-0002-7521-5087; Taylor, Julian/0000-0003-2553-2348; Gomez-Soriano, Julio/0000-0002-5542-4105; Goicoechea, Carlos/0000-0002-6226-6934; Arriero, Iriana Galan/0000-0002-3291-1963; Avila Martin, Gerardo/0000-0001-8982-7634	Fundacion Mutua Madrilefla	We are grateful for the support of past and present members of the Sensorimotor Function group, who contributed to the experiments presented in this review. This work is supported by the Fundacion Mutua Madrilefla.	Abdelmoaty S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075543; Alberts GL, 2001, MOL PHARMACOL, V60, P1349, DOI 10.1124/mol.60.6.1349; Alemany R, 2007, BBA-BIOMEMBRANES, V1768, P964, DOI 10.1016/j.bbamem.2006.09.024; Alemany R, 2006, J LIPID RES, V47, P1762, DOI 10.1194/jlr.M500520-JLR200; Avila-Martin G, 2015, EUR J PAIN, V19, P111, DOI 10.1002/ejp.528; Avila-Martin G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026107; Bazan NG, 2007, CURR OPIN CLIN NUTR, V10, P136, DOI 10.1097/MCO.0b013e32802b7030; Bento-Abreu A, 2007, J NEUROCHEM, V103, P871, DOI 10.1111/j.1471-4159.2007.04807.x; Berbert AA, 2005, NUTRITION, V21, P131, DOI 10.1016/j.nut.2004.03.023; Brenna JT, 2014, J HUM EVOL, V77, P99, DOI 10.1016/j.jhevol.2014.02.017; Breuer S, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-15; Cappa M, 2012, J INHERIT METAB DIS, V35, P899, DOI 10.1007/s10545-011-9432-3; Casas J., 2017, BIOCH BIOPHYS ACTA; Champeil-Potokar G, 2006, EUR J NEUROSCI, V24, P3084, DOI 10.1111/j.1460-9568.2006.05185.x; Chang CY, 2013, J NUTR BIOCHEM, V24, P2127, DOI 10.1016/j.jnutbio.2013.08.004; Ciardo M.G., 2017, BIOCH BIOPHYS ACTA; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; Durrenberger PF, 2004, J PERIPHER NERV SYST, V9, P15, DOI 10.1111/j.1085-9489.2004.09104.x; Erkayiran U, 2016, J OBSTET GYNAECOL, V36, P444, DOI 10.3109/01443615.2015.1065230; Escriba PV, 2007, BBA-BIOMEMBRANES, V1768, P836, DOI 10.1016/j.bbamem.2006.09.001; Escriba PV, 2015, PROG LIPID RES, V59, P38, DOI 10.1016/j.plipres.2015.04.003; Fandel D, 2013, BRAIN RES, V1535, P89, DOI 10.1016/j.brainres.2013.08.022; Farooqui AA, 2007, J NEUROCHEM, V101, P577, DOI 10.1111/j.1471-4159.2006.04371.x; Fedorova I, 2001, J PHARMACOL EXP THER, V299, P332; Figueroa JD, 2013, NEUROSCIENCE, V255, P1, DOI 10.1016/j.neuroscience.2013.09.012; Figueroa JD, 2016, J NEUROTRAUM, V33, P1436, DOI 10.1089/neu.2015.4186; Finnerup NB, 2012, CURR PAIN HEADACHE R, V16, P207, DOI 10.1007/s11916-012-0259-x; Foster TS, 2007, DIABETES EDUCATOR, V33, P111, DOI 10.1177/0145721706297450; Gladman SJ, 2012, J NEUROSCI, V32, P563, DOI 10.1523/JNEUROSCI.3371-11.2012; Graeber MB, 2012, EXP NEUROL, V234, P255, DOI 10.1016/j.expneurol.2012.01.007; Granda B, 2003, BRAIN RES, V988, P1, DOI 10.1016/S0006-8993(03)03253-0; Gwak YS, 2009, NEUROSCIENCE, V161, P895, DOI 10.1016/j.neuroscience.2009.03.055; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Harrison JL, 2015, BRAIN BEHAV IMMUN, V47, P131, DOI 10.1016/j.bbi.2015.01.001; Hasadsri L, 2013, J NEUROTRAUM, V30, P897, DOI 10.1089/neu.2012.2672; Hostetler HA, 2005, J BIOL CHEM, V280, P18667, DOI 10.1074/jbc.M412062200; Huang WL, 2007, BRAIN, V130, P3004, DOI 10.1093/brain/awm223; JAMES MJ, 1993, J EXP MED, V178, P2261, DOI 10.1084/jem.178.6.2261; Javidan AN, 2014, SPINAL CORD, V52, P378, DOI 10.1038/sc.2014.30; Jicha GA, 2010, CLIN INTERV AGING, V5, P45; Kanda H, 2013, GLIA, V61, P943, DOI 10.1002/glia.22487; Kien CL, 2013, AM J CLIN NUTR, V97, P689, DOI 10.3945/ajcn.112.051730; Ko GD, 2010, CLIN J PAIN, V26, P168, DOI 10.1097/AJP.0b013e3181bb8533; Lauritzen I, 2000, EMBO J, V19, P1784, DOI 10.1093/emboj/19.8.1784; Lavado E, 1997, J NEUROCHEM, V69, P721; Lee YH, 2012, ARCH MED RES, V43, P356, DOI 10.1016/j.arcmed.2012.06.011; Lewis MD, 2016, J AM COLL NUTR, V35, P469, DOI 10.1080/07315724.2016.1150796; Lim SN, 2013, EXP NEUROL, V239, P13, DOI 10.1016/j.expneurol.2012.09.015; Liu ZH, 2015, J NEUROSCI, V35, P12733, DOI 10.1523/JNEUROSCI.0605-15.2015; Logan Alan C, 2003, Altern Med Rev, V8, P410; Luo CL, 2013, BRAIN RES, V1502, P1, DOI 10.1016/j.brainres.2013.01.037; Luo CM, 2014, J LIPID RES, V55, P1288, DOI 10.1194/jlr.M046466; MARTIN HA, 1988, J NEUROPHYSIOL, V60, P438, DOI 10.1152/jn.1988.60.2.438; Matsui T, 2010, ANESTH ANALG, V111, P554, DOI 10.1213/ANE.0b013e3181e3a2a2; McCracken LM, 1998, BEHAV RES THER, V36, P621, DOI 10.1016/S0005-7967(97)10039-0; Michael-Titus AT, 2014, TRENDS NEUROSCI, V37, P30, DOI 10.1016/j.tins.2013.10.005; MOLLGARD K, 1984, DEV BRAIN RES, V13, P49, DOI 10.1016/0165-3806(84)90076-2; Oh YT, 2009, NEUROSCI LETT, V464, P93, DOI 10.1016/j.neulet.2009.08.040; Palacios-Pelaez R, 2010, MOL NEUROBIOL, V41, P367, DOI 10.1007/s12035-010-8139-z; Pamplona FA, 2012, P NATL ACAD SCI USA, V109, P21134, DOI 10.1073/pnas.1202906109; Paterniti I, 2014, J NEUROINFLAMM, V11, DOI [10.1186/1742-2094-11-6, 10.1186/s12974-014-0136-0]; Perez J, 2005, ANESTH ANALG, V101, P444, DOI 10.1213/01.ANE.0000158469.11775.52; Perez J, 2004, PAIN, V111, P297, DOI 10.1016/j.pain.2004.07.006; Poveda JJ.A., 2017, BIOCH BIOPHYS ACTA; Przegalinski E, 2006, INT J IMMUNOPATH PH, V19, P897, DOI 10.1177/039463200601900419; Ramsden CE, 2015, PAIN, V156, P587, DOI 10.1097/01.j.pain.0000460348.84965.47; Richardson AJ, 2002, PROG NEURO-PSYCHOPH, V26, P233, DOI 10.1016/S0278-5846(01)00254-8; RIZZO WB, 1989, NEUROLOGY, V39, P1415, DOI 10.1212/WNL.39.11.1415; Rodriguez-Rodriguez RA, 2004, J NEUROCHEM, V88, P1041, DOI 10.1046/j.1471-4159.2003.02262.x; Sales C, 2009, REUMATISMO, V61, P10; Saravanan P, 2010, J AM COLL CARDIOL, V55, P410, DOI 10.1016/j.jacc.2009.09.032; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Sekiya M, 2003, HEPATOLOGY, V38, P1529, DOI 10.1016/j.hep.2003.09.028; Seminowicz DA, 2009, NEUROIMAGE, V47, P1007, DOI 10.1016/j.neuroimage.2009.05.068; Shah RC, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt224; Shir Y, 2001, ANESTH ANALG, V92, P1029, DOI 10.1097/00000539-200104000-00042; Stender S, 2004, ANN NUTR METAB, V48, P61, DOI 10.1159/000075591; Tabernero A, 2002, J BIOL CHEM, V277, P4240, DOI 10.1074/jbc.M108760200; Taylor J, 2012, PAIN MED, V13, P1457, DOI 10.1111/j.1526-4637.2012.01483.x; Taylor KC, 2017, BBA-BIOMEMBRANES, V1859, P586, DOI 10.1016/j.bbamem.2016.10.023; Trang T, 2004, EUR J PHARMACOL, V491, P21, DOI 10.1016/j.ejphar.2004.03.022; TROEGER MB, 1984, J NEUROCHEM, V42, P1735, DOI 10.1111/j.1471-4159.1984.tb12765.x; Vahidy WH, 2006, EXP BRAIN RES, V174, P781, DOI 10.1007/s00221-006-0672-7; Vigh L, 2005, PROG LIPID RES, V44, P303, DOI 10.1016/j.plipres.2005.08.001; Wall R, 2010, NUTR REV, V68, P280, DOI 10.1111/j.1753-4887.2010.00287.x; Ward RE, 2010, J NEUROTRAUM, V27, P1769, DOI 10.1089/neu.2010.1348; Xu ZZ, 2013, J NEUROIMMUNE PHARM, V8, P37, DOI 10.1007/s11481-012-9394-8; Zhang XL, 2014, EXP NEUROL, V251, P12, DOI 10.1016/j.expneurol.2013.10.020; Zhao P, 2007, J NEUROSCI, V27, P8893, DOI 10.1523/JNEUROSCI.2209-07.2007; Ziegler D, 2006, DIABETES CARE, V29, P2365, DOI 10.2337/dc06-1216	90	17	17	1	17	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0005-2736	1879-2642		BBA-BIOMEMBRANES	Biochim. Biophys. Acta-Biomembr.	SEP	2017	1859	9	B		SI		1629	1635		10.1016/j.bbamem.2017.05.003			7	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	FB2LD	WOS:000405974400013	28495596	Bronze			2022-02-06	
J	Heim, LR; Bader, M; Edut, S; Rachmany, L; Baratz-Goldstein, R; Lin, R; Elpaz, A; Qubty, D; Bikovski, L; Rubovitch, V; Schreiber, S; Pick, CG				Heim, Leore R.; Bader, Miaad; Edut, Shahaf; Rachmany, Lital; Baratz-Goldstein, Renana; Lin, Ran; Elpaz, Aviya; Qubty, Doaa; Bikovski, Lior; Rubovitch, Vardit; Schreiber, Shaul; Pick, Chaim G.			The Invisibility of Mild Traumatic Brain Injury: Impaired Cognitive Performance as a Silent Symptom	JOURNAL OF NEUROTRAUMA			English	Article						animal studies; behavioral assessment; cognitive function; head trauma; traumatic brain injury	CLOSED-HEAD-INJURY; CONTROLLED CORTICAL IMPACT; BEHAVIORAL SEQUELAE; EXPERIMENTAL-MODEL; AXONAL OUTGROWTH; OXIDATIVE STRESS; MOTOR DEFICITS; MOUSE MODEL; MICE; RAT	The present study was designed to tackle two notorious features of mild traumatic brain injury (mTBI)-heterogeneity and invisibility-by characterizing the full scope of mTBI symptoms. Mice were exposed to brain injuries of different intensities utilizing a weight-drop model (10, 30, 50, and 70 g) and subsequently subjected to a comprehensive battery of behavioral tests at different time points and immunohistochemical examination of cortical slices. Whereas the physiological, neurological, emotional, and motor function of mTBI mice (i.e., their well-being) remained largely intact, cognitive deficits were identified by the y-maze and novel object recognition. Results from these two cognitive tests were combined and a dose-response relationship was established between injury intensity and cognitive impairment, ranging from an 85% decline after a 70-g impact (p < 0.001) to a 20% decline after a 10-g impact (essentially no effect). In addition, higher intensities of injury were accompanied by decreased expression of axonal and synaptic markers. Thus, our mTBI mice showed a clear discrepancy between performance (poor cognitive function) and appearance (healthy demeanor). This is of major concern given that diagnosis of mTBI is established on the presence of clinical symptoms and emphasizes the need for an alternative diagnostic modality.	[Heim, Leore R.; Bader, Miaad; Edut, Shahaf; Rachmany, Lital; Baratz-Goldstein, Renana; Lin, Ran; Elpaz, Aviya; Qubty, Doaa; Rubovitch, Vardit; Pick, Chaim G.] Tel Aviv Univ, Sackler Sch Med, Dept Anat & Anthropol, 55 Chaim Levanon St, IL-69978 Tel Aviv, Israel; [Heim, Leore R.] Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, Tel Aviv, Israel; [Schreiber, Shaul] Tel Aviv Sourasky Med Ctr, Dept Psychiat, Tel Aviv, Israel; [Schreiber, Shaul; Pick, Chaim G.] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Pick, Chaim G.] Tel Aviv Univ, Dr Miriam & Sheldon G Adelson Chair, Tel Aviv, Israel; [Pick, Chaim G.] Tel Aviv Univ, Ctr Biol Addict Dis, Tel Aviv, Israel; [Bikovski, Lior] Tel Aviv Univ, Sackler Sch Med, Myers Neurobehav Core Facil, Tel Aviv, Israel		Heim, LR (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Anat & Anthropol, 55 Chaim Levanon St, IL-69978 Tel Aviv, Israel.	leoreheim@mail.tau.ac.il	Schreiber, Shaul/E-5821-2010	Schreiber, Shaul/0000-0002-2189-0693	Ari and Regine Aprijaskis Fund, Tel-Aviv University, Tel-Aviv, Israel	This work was supported, in part, by the Ari and Regine Aprijaskis Fund, Tel-Aviv University, Tel-Aviv, Israel.	Aggleton JP, 1997, BRAIN RES BULL, V43, P279, DOI 10.1016/S0361-9230(97)00007-5; [Anonymous], 2016, EST FUND VAR RES CON; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Baratz R, 2010, J NEUROTRAUM, V27, P555, DOI 10.1089/neu.2009.0891; Baratz-Goldstein R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157064; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Bodanapally UK, 2015, RADIOL CLIN N AM, V53, P695, DOI 10.1016/j.rcl.2015.02.011; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Davalos Deana B, 2002, Appl Neuropsychol, V9, P92, DOI 10.1207/S15324826AN0902_4; Edut S, 2011, PSYCHOPHARMACOLOGY, V214, P877, DOI 10.1007/s00213-010-2098-y; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Jamora CW, 2012, BRAIN INJURY, V26, P36, DOI 10.3109/02699052.2011.635352; JONES BJ, 1968, J PHARM PHARMACOL, V20, P302, DOI 10.1111/j.2042-7158.1968.tb09743.x; Klein F. C., 1982, WALL STREET J, V12, P1; Klonoff PS, 2004, ARCH CLIN NEUROPSYCH, V19, P1095, DOI 10.1016/j.acn.2003.12.012; Koerte IK, 2016, TRANSLATIONAL RES TR; Kosaka B., 2006, BRIT COLOMBIA MEDICA, V48, P447; Lee S, 2014, BIOL OPEN, V3, P974, DOI 10.1242/bio.20149779; Leinhase I, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-13; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; Li YZ, 2015, J NEUROCHEM, V135, P1203, DOI 10.1111/jnc.13169; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Mathew P, 1996, J NEUROSURG, V85, P860, DOI 10.3171/jns.1996.85.5.0860; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; National Research Council (US), 2011, GUIDE CARE USE LAB A; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; Pan WH, 2003, EXP BRAIN RES, V149, P195, DOI 10.1007/s00221-002-1355-7; PAPPIUS HM, 1981, ANN NEUROL, V9, P484, DOI 10.1002/ana.410090511; Patki G, 2013, BRAIN RES, V1539, P73, DOI 10.1016/j.brainres.2013.09.033; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Podell K, 2010, PSYCHIAT CLIN N AM, V33, P855, DOI 10.1016/j.psc.2010.08.003; Rachmany L, 2013, AGE, V35, P1621, DOI 10.1007/s11357-012-9464-0; Rapoport M, 2002, NEUROPSY NEUROPSY BE, V15, P123, DOI 10.1097/01.WNN.0000016801.80266.36; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Rubovitch V, 2017, SCI REP-UK, V7, DOI 10.1038/srep41269; Satz P, 1998, BRAIN INJURY, V12, P555, DOI 10.1080/026990598122322; Schmidt OI, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-13; Schreiber S, 2014, BEHAV BRAIN RES, V271, P59, DOI 10.1016/j.bbr.2014.05.060; Schreiber S, 2017, WORLD J BIOL PSYCHIA, V18, P300, DOI 10.3109/15622975.2015.1086492; Schreiber S, 2009, SLEEP MED, V10, P13, DOI 10.1016/j.sleep.2008.02.003; Schwarzbold ML, 2010, J NEUROTRAUM, V27, P1883, DOI 10.1089/neu.2010.1318; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; TEASDALE G, 1974, LANCET, V2, P81; Teresa L. S., 2001, BRAIN INJURY, V15, P149; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yang SH, 2013, J SURG RES, V184, P981, DOI 10.1016/j.jss.2013.03.075; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36	71	17	17	1	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2017	34	17					2518	2528		10.1089/neu.2016.4909			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FE6HI	WOS:000408310200004	28514188				2022-02-06	
J	Osborne, NN; Nunez-Alvarez, C; del Olmo-Aguado, S; Merrayo-Lloves, J				Osborne, Neville N.; Nunez-Alvarez, Claudia; del Olmo-Aguado, Susana; Merrayo-Lloves, Jesus			Visual light effects on mitochondria: The potential implications in relation to glaucoma	MITOCHONDRION			English	Article						Visual light; Mitochondria; Retinal ganglion cells; Corneal endothelial cells; Glaucoma	NEAR-INFRARED LIGHT; GANGLION-CELL DEATH; LEVEL LASER THERAPY; TRAUMATIC BRAIN-INJURY; INTRAOCULAR-PRESSURE; BLUE-LIGHT; OPTIC-NERVE; RED-LIGHT; PHOTODYNAMIC THERAPY; EMITTING-DIODES	Light of different wave-lengths have the potential to interact with four major mitochondrial protein complexes that are involved in the generation of ATP. Neurones of the central nervous system have an absolute dependence on mitochondrial generated ATP. Laboratory studies show that short-wave or blue light (400-480 nm) that impinges on the retina affect flavin and cytochrome constituents associated with mitochondria to decrease the rate of ATP formation, stimulate ROS and results in cell death. This suggests that blue light could potentially have a negative influence on retinal ganglion cell (RGC) mitochondria that are abundant and not shielded by macular pigments as occurs for photoreceptor mitochondria. This might be of significance in glaucoma where it is likely that RGC mitochondria are already affected and therefore be more susceptible to blue light. Thus simply filtering out some natural blue light from entering the eye might be beneficial for the treatment of glaucoma. Long-wave or red light (650-800 nm) affects mitochondrial complex IV or cytochrome oxidase to increase the rate of formation of ATP and ROS causing the generation of a number of beneficial factors. Significantly, laboratory studies show that increasing the normal amount of natural red light reaching rat RGC mitochondria in situ, subjected to ischemia, proved to be beneficial. A challenge now is to test whether extra red light delivered to the human retina can slow-down RGC loss in glaucoma. Such a methodology has also the advantage of being non-invasive. One very exciting possibility might be in the production of a lens where solar UV light is convertes to add to the amount of natural red light entering the eye. (C) 2016 Elsevier B.V. and Mitochondria Research Society. All rights reserved.	[Osborne, Neville N.; Nunez-Alvarez, Claudia; del Olmo-Aguado, Susana; Merrayo-Lloves, Jesus] Univ Oviedo, Fdn Invest Oftalmol, Inst Univ Fernandez Vega, Avda Doctores Fernandez Vega 34, E-33012 Oviedo, Asturias, Spain		Osborne, NN (corresponding author), Univ Oviedo, Fdn Invest Oftalmol, Inst Univ Fernandez Vega, Avda Doctores Fernandez Vega 34, E-33012 Oviedo, Asturias, Spain.	Neville.osborne@eye.ox.ac.uk	Nunez-Alvarez, Claudia/AAF-6528-2021; del Olmo Aguado, Susana/AAY-3497-2021	Nunez-Alvarez, Claudia/0000-0001-5287-4058; del Olmo Aguado, Susana/0000-0002-2867-7254	Fundacion BBVA; Fundacion Endesa	Financial support is gratefully acknowledged from the Fundacion BBVA and the Fundacion Endesa. NNO and is a Catedra de Biomedicina (Chair in Biomedicine).	Albarracin R, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-125; Albarracin R, 2012, PHOTOCHEM PHOTOBIOL, V88, P1418, DOI 10.1111/j.1751-1097.2012.01130.x; Albarracin R, 2011, INVEST OPHTH VIS SCI, V52, P3582, DOI 10.1167/iovs.10-6664; Albers DS, 2000, J NEURAL TRANSM-SUPP, P133; Almasieh M, 2012, PROG RETIN EYE RES, V31, P152, DOI 10.1016/j.preteyeres.2011.11.002; Andrews RM, 1999, BRIT J OPHTHALMOL, V83, P231, DOI 10.1136/bjo.83.2.231; Begum R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057828; Behar-Cohen F, 2011, PROG RETIN EYE RES, V30, P239, DOI 10.1016/j.preteyeres.2011.04.002; Beirne K, 2016, PHOTOCHEM PHOTOBIOL, V92, P624, DOI 10.1111/php.12606; Bell J. E., 1981, HEMOPROTEINS; BOETTNER EA, 1962, INVEST OPHTH VISUAL, V1, P776; BONNETT R, 1980, J CHEM SOC FARAD T 1, V76, P852, DOI 10.1039/f19807600852; Bristow EA, 2002, ARCH OPHTHALMOL-CHIC, V120, P791; Calkins DJ, 2012, PROG RETIN EYE RES, V31, P702, DOI 10.1016/j.preteyeres.2012.07.001; Caprioli J, 2010, AM J OPHTHALMOL, V149, P704, DOI 10.1016/j.ajo.2010.01.018; Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; CHANCE B, 1959, J BIOL CHEM, V234, P2404; Chen SJ, 2012, INT J OPHTHALMOL-CHI, V5, P750, DOI 10.3980/j.issn.2222-3959.2012.06.18; del Olmo-Aguado S, 2016, ACTA OPHTHALMOL, V94, pE481, DOI 10.1111/aos.12996; del Olmo-Aguado S, 2012, PHOTOCHEM PHOTOBIOL, V88, P1346, DOI 10.1111/j.1751-1097.2012.01120.x; DEMONTELLANO PRO, 1995, DRUG METAB DISPOS, V23, P1181; Dolmans DEJGJ, 2003, NAT REV CANCER, V3, P380, DOI 10.1038/nrc1071; Eells JT, 2004, MITOCHONDRION, V4, P559, DOI 10.1016/j.mito.2004.07.033; Eells JT, 2003, P NATL ACAD SCI USA, V100, P3439, DOI 10.1073/pnas.0534746100; Fitzgerald M, 2013, REV NEUROSCIENCE, V24, P205, DOI 10.1515/revneuro-2012-0086; Garcia J, 1997, J NUTR BIOCHEM, V8, P341, DOI 10.1016/S0955-2863(97)00024-7; Gkotsi D, 2014, EXP EYE RES, V122, P50, DOI 10.1016/j.exer.2014.02.023; Gorgidze LA, 1998, BIOSCIENCE REP, V18, P215, DOI 10.1023/A:1020104914726; Gueven N, 2016, MITOCHONDRION; Hayreh SS, 2001, PROG RETIN EYE RES, V20, P595, DOI 10.1016/S1350-9462(01)00005-2; Hockberger PE, 1999, P NATL ACAD SCI USA, V96, P6255, DOI 10.1073/pnas.96.11.6255; Huang LY, 2012, LASER SURG MED, V44, P490, DOI 10.1002/lsm.22045; Hunter JJ, 2012, PROG RETIN EYE RES, V31, P28, DOI 10.1016/j.preteyeres.2011.11.001; Ishiguro M, 2010, J ORTHOP SCI, V15, P233, DOI 10.1007/s00776-009-1438-4; Ivandic BT, 2008, PHOTOMED LASER SURG, V26, P241, DOI 10.1089/pho.2007.2132; Ji D, 2011, APOPTOSIS, V16, P425, DOI 10.1007/s10495-011-0574-4; Karu T, 1999, J PHOTOCH PHOTOBIO B, V49, P1, DOI 10.1016/S1011-1344(98)00219-X; Knels L, 2011, EUR J NEUROSCI, V34, P548, DOI 10.1111/j.1460-9568.2011.07790.x; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kunz D, 2002, METHOD ENZYMOL, V352, P135; Lascaratos G, 2007, VISION RES, V47, P1191, DOI 10.1016/j.visres.2006.12.014; Lee S, 2012, INVEST OPHTH VIS SCI, V53, P2431, DOI 10.1167/iovs.12-9596; Lee S, 2011, EXP EYE RES, V93, P204, DOI 10.1016/j.exer.2010.07.015; Leske MC, 2008, OPHTHALMOLOGY, V115, P85, DOI 10.1016/j.ophtha.2007.03.017; Li GY, 2008, BRAIN RES, V1188, P35, DOI 10.1016/j.brainres.2007.10.073; Li L, 2016, SCI REP-UK, V6, DOI 10.1038/srep20821; Liang HL, 2006, NEUROSCIENCE, V139, P639, DOI 10.1016/j.neuroscience.2005.12.047; MALAISESTALS J, 1984, OPHTHALMOLOGICA, V189, P104, DOI 10.1159/000309393; McCarron RM, 2003, ACTA NEUROCHIR SUPPL, V86, P271; MELAMED S, 1980, BRIT J OPHTHALMOL, V64, P164, DOI 10.1136/bjo.64.3.164; Mellerio J., 1994, PRINCIPLES PRACTICE, V1, P1326; Merry G, 2016, INVEST OPHTH VIS SCI, V57; Moreira PI, 2007, ANTIOXID REDOX SIGN, V9, P1621, DOI 10.1089/ars.2007.1703; Moreira PI, 2010, BBA-MOL BASIS DIS, V1802, P2, DOI 10.1016/j.bbadis.2009.10.006; Moro C, 2014, J NEUROSURG, V120, P670, DOI 10.3171/2013.9.JNS13423; Naeser MA, 2014, J NEUROTRAUM, V31, P1008, DOI 10.1089/neu.2013.3244; Natoli R, 2010, MOL VIS, V16, P1801; Nawashiro H, 2012, PHOTOMED LASER SURG, V30, P231, DOI 10.1089/pho.2011.3044; Oron U, 2001, CIRCULATION, V103, P296; Osborne N. N., 2016, EUR J PHARM; Osborne NN, 2008, J NEUROCHEM, V105, P2013, DOI 10.1111/j.1471-4159.2008.05320.x; Osborne NN, 2014, EXP EYE RES, V128, P8, DOI 10.1016/j.exer.2014.08.012; Osborne NN, 2010, EXP EYE RES, V90, P750, DOI 10.1016/j.exer.2010.03.008; Osborne NN, 2006, BRIT J OPHTHALMOL, V90, P237, DOI 10.1136/bjo.2005.082230; Peoples Cassandra, 2012, ISRN Neurol, V2012, P850150, DOI 10.5402/2012/850150; Porter J, 2006, ADAPTIVE OPTICS VISI; Quirk BJ, 2011, PHOTOMED LASER SURG, V29, P143, DOI 10.1089/pho.2011.3014; Rojas JC, 2008, J NEUROSCI, V28, P13511, DOI 10.1523/JNEUROSCI.3457-08.2008; SAID FS, 1959, GERONTOLOGY, V3, P213, DOI 10.1159/000210900; Saliba A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139003; Schon EA, 2003, J CLIN INVEST, V111, P303, DOI 10.1172/JCI200317741; Simunovic Z, 2000, J CLIN LASER MED SUR, V18, P67, DOI 10.1089/clm.2000.18.67; Smedowski A, 2014, INVEST OPHTH VIS SCI, V55, P666, DOI 10.1167/iovs.13-13172; Tang J, 2014, BRIT J OPHTHALMOL, V98, P1013, DOI 10.1136/bjophthalmol-2013-304477; Tang J, 2013, INVEST OPHTH VIS SCI, V54, P3681, DOI 10.1167/iovs.12-11018; Vecino E, 2016, PROG RETIN EYE RES, V51, P1, DOI 10.1016/j.preteyeres.2015.06.003; Wataha JC, 2004, J DENT RES, V83, P104, DOI 10.1177/154405910408300204; Wilson BC, 2008, PHYS MED BIOL, V53, pR61, DOI 10.1088/0031-9155/53/9/R01; Wong-Riley MTT, 2005, J BIOL CHEM, V280, P4761, DOI 10.1074/jbc.M409650200; Wood JPM, 2008, MOL VIS, V14, P334; Wu QH, 2012, LASER SURG MED, V44, P218, DOI 10.1002/lsm.22003; Ying R, 2008, BRAIN RES, V1243, P167, DOI 10.1016/j.brainres.2008.09.057; YTTEBORG J, 1965, ARCH OPHTHALMOL-CHIC, V74, P375, DOI 10.1001/archopht.1965.00970040377018; YTTEBORG J, 1965, ARCH OPHTHALMOL-CHIC, V74, P477, DOI 10.1001/archopht.1965.00970040479008; Yu-Wai-Man P, 2014, EYE, V28, P521, DOI 10.1038/eye.2014.37	86	17	18	0	20	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1567-7249	1872-8278		MITOCHONDRION	Mitochondrion	SEP	2017	36				SI		29	35		10.1016/j.mito.2016.11.009			7	Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Genetics & Heredity	FL0FW	WOS:000413888000006	27890822				2022-02-06	
J	Fares, J; Gebeily, S; Saad, M; Harati, H; Nabha, S; Said, N; Kanso, M; Rassou, RA; Fares, Y				Fares, Jawad; Gebeily, Souheil; Saad, Mohamad; Harati, Hayat; Nabha, Sanaa; Said, Najwane; Kanso, Mohamad; Rassou, Ronza Abdel; Fares, Youssef			Post-traumatic stress disorder in adult victims of cluster munitions in Lebanon: a 10-year longitudinal study	BMJ OPEN			English	Article							TRAUMATIC BRAIN-INJURY; PRECLINICAL MEDICAL-STUDENTS; SOUTH LEBANON; WAR VETERANS; PRIMARY-CARE; PSYCHOLOGICAL IMPACT; VIETNAM VETERANS; MENTAL-HEALTH; MAJOR TRAUMA; RISK-FACTORS	Objective This study aims to explore the short-term and long-term prevalence and effects of post-traumatic stress disorder (PTSD) among victims of cluster munitions. Design and setting A prospective 10-year longitudinal study that took place in Lebanon. Participants Two-hundred-and-forty-four Lebanese civilian victims of submunition blasts, who were injured in 2006 and were over 18 years old, were interviewed. Included were participants who had been diagnosed with PTSD according to the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) and the PTSD Checklist-Civilian Version in 2006. Interviewees were present for the 10-year follow-up. Main outcome measures PTSD prevalence rates of participants in 2006 and 2016 were compared. Analysis of the demographical data pertaining to the association of long-term PTSD with other variables was performed. p Values <0.05 were considered statistically significant for all analyses (95% CI). Results All the 244 civilians injured by cluster munitions in 2006 responded, and were present for long-term follow-up in 2016. The prevalence of PTSD decreased significantly from 98% to 43% after 10 years (p<0.001). A lower long-term prevalence was significantly associated with male sex (p<0.001), family support (p<0.001) and religion (p<0.001). Hospitalisation (p=0.005) and severe functional impairment (p<0.001) post-trauma were significantly associated with increased prevalence of long-term PTSD. Symptoms of negative cognition and mood were more common in the long run. In addition, job instability was the most frequent socioeconomic repercussion among the participants (88%). Conclusions Psychological symptoms, especially PTSD, remain high in war-affected populations many years after the war; this is particularly evident for Lebanese civilians who were victimised by cluster munitions. Screening programmes and psychological interventions need to be implemented in vulnerable populations exposed to war traumas. Officials and public health advocates should consider the socioeconomic implications, and help raise awareness against the harm induced by cluster munitions and similar weaponry.	[Fares, Jawad; Gebeily, Souheil; Saad, Mohamad; Harati, Hayat; Nabha, Sanaa; Said, Najwane; Kanso, Mohamad; Rassou, Ronza Abdel; Fares, Youssef] Lebanese Univ, Neurosci Res Ctr, Fac Med Sci, Beirut, Lebanon; [Fares, Jawad] Amer Univ Beirut, Fac Med, Beirut, Lebanon; [Gebeily, Souheil] Lebanese Univ, Fac Med Sci, Dept Neurol, Beirut, Lebanon; [Saad, Mohamad] Univ Washington, Dept Biostat, Div Stat Genet, Seattle, WA 98195 USA; [Kanso, Mohamad] Amer Univ, Beirut Med Ctr, Dept Emergency Med, Beirut, Lebanon; [Rassou, Ronza Abdel] Hop Robert Debre, Inst Natl Sante & Rech Med, UMR 1141, Paris, France; [Fares, Youssef] Lebanese Univ, Dept Neurosurg, Fac Med Sci, Beirut, Lebanon		Fares, J; Fares, Y (corresponding author), Lebanese Univ, Neurosci Res Ctr, Fac Med Sci, Beirut, Lebanon.; Fares, J (corresponding author), Amer Univ Beirut, Fac Med, Beirut, Lebanon.; Fares, Y (corresponding author), Lebanese Univ, Dept Neurosurg, Fac Med Sci, Beirut, Lebanon.	jyf04@mail.aub.edu; yfares@ul.edu.lb	Fares, Jawad/X-4341-2018	Fares, Jawad/0000-0002-5368-8764	Central Administration of the Lebanese University, Beirut, Lebanon	This research was funded by a grant from the Central Administration of the Lebanese University, Beirut, Lebanon.	Abou-Abbass H, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005342; Basoglu M, 2005, JAMA-J AM MED ASSOC, V294, P580, DOI 10.1001/jama.294.5.580; Bedrossian N, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00016; Beehner L., 2006, BACKGROUNDER; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Boscarino JA, 2004, ANN NY ACAD SCI, V1032, P141, DOI 10.1196/annals.1314.011; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Copeland-Linder N, 2006, J COMMUNITY PSYCHOL, V34, P577, DOI 10.1002/jcop.20116; de Jong JTVM, 2001, JAMA-J AM MED ASSOC, V286, P555, DOI 10.1001/jama.286.5.555; DiGrande L, 2011, AM J EPIDEMIOL, V173, P271, DOI 10.1093/aje/kwq372; Fares J, 2014, SCI AFRIC J SCI ISSU, V2, P469; Fares J, 2016, J EPIDEMIOL GLOB HEA, V6, P177, DOI 10.1016/j.jegh.2015.10.003; Fares J, 2016, N AM J MED SCI, V8, P75, DOI 10.4103/1947-2714.177299; Fares Y, 2017, WORLD NEUROSURG, V99, P524, DOI 10.1016/j.wneu.2016.12.014; Fares Y, 2014, NEUROL SCI, V35, P905, DOI 10.1007/s10072-013-1623-2; Fares Y, 2013, NEUROL SCI, V34, P2095, DOI 10.1007/s10072-013-1343-7; Fares Y, 2013, J INFECT PUBLIC HEAL, V6, P482, DOI 10.1016/j.jiph.2013.05.006; Fares Y, 2013, NEUROL SCI, V34, P1971, DOI 10.1007/s10072-013-1427-4; Farhood L.F., 2014, OPEN PSYCHIAT J, V8, P1, DOI [10.2174/1874354401408010001, DOI 10.2174/1874354401408010001]; Farhood L, 2006, J TRANSCULT NURS, V17, P333, DOI 10.1177/1043659606291549; Farhood LF, 2016, EUR J PSYCHOTRAUMATO, V7, DOI 10.3402/ejpt.v7.31509; Farhood LF, 2012, SOC PSYCH PSYCH EPID, V47, P639, DOI 10.1007/s00127-011-0368-6; Feder A, 2013, J AFFECT DISORDERS, V147, P156, DOI 10.1016/j.jad.2012.10.027; Freedman SA, 1999, BRIT J PSYCHIAT, V174, P353, DOI 10.1192/bjp.174.4.353; Freedy JR, 2010, FAM PRACT, V27, P615, DOI 10.1093/fampra/cmq049; Gates MA, 2012, PSYCHOL SERV, V9, P361, DOI 10.1037/a0027649; Greist J., 2014, POSTTRAUMATIC STRESS; Hall BJ, 2008, J TRAUMA STRESS, V21, P22, DOI 10.1002/jts.20301; Hasanovic M, 2010, PSYCHIAT DANUB, V22, P203; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Holbrook TL, 2002, J TRAUMA, V53, P882, DOI 10.1097/00005373-200211000-00012; Holbrook TL, 2005, J TRAUMA, V58, P764, DOI 10.1097/01.TA.0000159247.48547.7D; Hoteit A., 2016, CANADIAN SOCIAL SCI, V12, P1; Hoteit A, 2015, CANADIAN SOCIAL SCI, V11, P42, DOI DOI 10.3968/6435; Hoteit A., 2015, INT J DEV RES, V5; Javidi H, 2011, INT J OCCUP ENV MED, V3; Johnson H, 2008, CLIN PSYCHOL REV, V28, P36, DOI 10.1016/j.cpr.2007.01.017; JORDAN BK, 1992, J CONSULT CLIN PSYCH, V60, P916, DOI 10.1037/0022-006X.60.6.916; Karam EG, 2014, J TRAUMA STRESS, V27, P192, DOI 10.1002/jts.21895; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Khamis V, 2012, SOC SCI MED, V74, P2005, DOI 10.1016/j.socscimed.2012.02.025; Koren D, 2005, AM J PSYCHIAT, V162, P276, DOI 10.1176/appi.ajp.162.2.276; Kulka RA, 1990, TRAUMA VIETNAM WAR G; Long N, 1996, AUST NZ J PSYCHIAT, V30, P253, DOI 10.3109/00048679609076102; McAllister TW, 2010, ANN NY ACAD SCI, V1208, P46, DOI 10.1111/j.1749-6632.2010.05720.x; Mollica RF, 2002, BRIT J PSYCHIAT, V181, P339, DOI 10.1192/bjp.181.4.339; Mora AG, 2009, J TRAUMA, V66, pS178, DOI 10.1097/TA.0b013e31819ce2d6; O'Toole BI, 2009, AM J EPIDEMIOL, V170, P318, DOI 10.1093/aje/kwp146; Ohry A, 1996, BRAIN INJURY, V10, P687, DOI 10.1080/026990596124106; OZER EJ, 2008, ANN M INT SOC TRAUM; Priebe S, 2010, ARCH GEN PSYCHIAT, V67, P518, DOI 10.1001/archgenpsychiatry.2010.37; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Shalev AY, 1996, AM J PSYCHIAT, V153, P219; Shalev AY, 1998, AM J PSYCHIAT, V155, P630, DOI 10.1176/ajp.155.5.630; Smith Mark W, 2005, Ment Health Serv Res, V7, P89, DOI 10.1007/s11020-005-3780-2; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Verger P, 2004, AM J PSYCHIAT, V161, P1384, DOI 10.1176/appi.ajp.161.8.1384; Yeager DE, 2007, GEN HOSP PSYCHIAT, V29, P294, DOI 10.1016/j.genhosppsych.2007.03.004	59	17	18	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	AUG	2017	7	8							e017214	10.1136/bmjopen-2017-017214			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FI2UT	WOS:000411802700245	28821528	gold, Green Published			2022-02-06	
J	Gul, SS; Huesgen, KW; Wang, KK; Mark, K; Tyndall, JA				Gul, S. S.; Huesgen, K. W.; Wang, K. K.; Mark, K.; Tyndall, J. A.			Prognostic utility of neuroinjury biomarkers in post out-of-hospital cardiac arrest (OHCA) patient management	MEDICAL HYPOTHESES			English	Article						Out-of-hospital cardiac arrest; Prognostication; Neurologic outcome; Biomarkers	NEURON-SPECIFIC-ENOLASE; TRAUMATIC BRAIN-INJURY; ALPHA-II-SPECTRIN; FIBRILLARY ACIDIC PROTEIN; C-TERMINAL HYDROLASE-L1; MYELIN BASIC-PROTEIN; SOMATOSENSORY-EVOKED POTENTIALS; EUROPEAN RESUSCITATION COUNCIL; AMERICAN-HEART-ASSOCIATION; ADULT COMATOSE SURVIVORS	Despite aggressive intervention, patients who survive an out-of-hospital cardiac arrest (OHCA) generally have very poor prognoses, with nationwide survival rates of approximately 10-20%. Approximately 90% of survivors will have moderate to severe neurological injury ranging from moderate cognitive impairment to brain death. Currently, few early prognostic indicators are considered reliable enough to support patients' families and clinicians' in their decisions regarding medical futility. Blood biomarkers of neurological injury after OHCA may be of prognostic value in these cases. When most bodily tissues are oxygen deprived, cellular metabolism switches from aerobic to anaerobic respiration. Neurons are a notable exception, however, being dependent solely upon aerobic respiration. Thus, after several minutes without circulating oxygen, neurons sustain irreversible damage, and certain measurable biomarkers are released into the circulation. Prior studies have demonstrated value in blood biomarkers in prediction of survival and neurologic impairment after OHCA. We hypothesize that understanding peptide biomarker kinetics in the early return of spontaneous circulation (ROSC) period, especially in the setting of refractory cardiac arrest, may assist clinicians in determining prognosis earlier in acute resuscitation. Specifically, during and after immediate resuscitation and return of ROSC, clinicians and families face a series of important questions regarding patient prognosis, futility of care and allocation of scarce resources such as the early initiation of extracorporeal cardiopulmonary resuscitation (ECPR). The ability to provide early prognostic information in this setting is highly valuable. Currently available, as well as potential biomarkers that could be good candidates in prognostication of neurological outcomes after OHCA or in the setting of refractory cardiac arrest will be reviewed and discussed. (C) 2017 The Authors. Published by Elsevier Ltd.	[Gul, S. S.; Huesgen, K. W.; Mark, K.; Tyndall, J. A.] Univ Florida, Dept Emergency Med, 1329 SW 16th St,Suite 5270, Gainesville, FL 32608 USA; [Wang, K. K.] Univ Florida, McKnight Brain Inst, Dept Psychiat, Program Neurotrauma Neuroprote & Biomarker Res, 1149 Newell Dr, Gainesville, FL 32610 USA		Tyndall, JA (corresponding author), Univ Florida, Dept Emergency Med, 1329 SW 16th St,Suite 5270, Gainesville, FL 32608 USA.	tyndall@ufl.edu		Wang, Kevin/0000-0002-9343-6473			Adrie C, 2002, CIRCULATION, V106, P562, DOI 10.1161/01.CIR.0000023891.80661.AD; Albrecht-Schgoer K, 2012, CIRCULATION, V126, P2491, DOI 10.1161/CIRCULATIONAHA.111.076950; Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Annborn M, 2014, ACTA ANAESTH SCAND, V58, P428, DOI 10.1111/aas.12282; Arnaoutakis GJ, 2011, J THORAC CARDIOVASC, V142, P902; Avila J, 2004, PHYSIOL REV, V84, P361, DOI 10.1152/physrev.00024.2003; Balanescu S, 2011, J CLIN ENDOCR METAB, V96, P1046, DOI 10.1210/jc.2010-2499; BARBARESE E, 1988, J NEUROCHEM, V51, P1737, DOI 10.1111/j.1471-4159.1988.tb01153.x; Bel MS, 2003, REV ESP CARDIOL, V56, P703; Berger RP, 2012, J NEUROTRAUM, V29, P162, DOI 10.1089/neu.2011.1989; Berger RP., 2011, CHILD ABUSE NEGLECT, P429; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; Bitsch A, 2002, EUR NEUROL, V47, P45, DOI 10.1159/000047946; Blyth BJ, 2011, J NEUROTRAUM, V28, P2453, DOI 10.1089/neu.2010.1653; Boggs JM, 2006, CELL MOL LIFE SCI, V63, P1945, DOI 10.1007/s00018-006-6094-7; Broessner G, 2015, RESUSCITATION, V89, P75, DOI 10.1016/j.resuscitation.2015.01.013; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; Callaway CW, 2015, CIRCULATION, V132, pS465, DOI 10.1161/CIR.0000000000000262; Chan PS, 2014, CIRCULATION, V130, P1876, DOI 10.1161/CIRCULATIONAHA.114.009711; Chen SY, 2016, EXP THER MED, V11, P2049, DOI 10.3892/etm.2016.3153; Choi S, 2016, EMERG MED J; Chou SHY, 2014, NEUROCRIT CARE, V21, P187, DOI 10.1007/s12028-014-0039-z; Claassen J, 2013, INTENS CARE MED, V39, P1337, DOI 10.1007/s00134-013-2938-4; Cronberg T, 2011, NEUROLOGY, V77, P623, DOI 10.1212/WNL.0b013e31822a276d; Cronberg T, 2013, RESUSCITATION, V84, P867, DOI 10.1016/j.resuscitation.2013.01.019; Daubin C, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-48; Day INM, 2010, PROG NEUROBIOL, V90, P327, DOI 10.1016/j.pneurobio.2009.10.020; Dennis M, 2017, INT J CARDIOL, V231, P131, DOI 10.1016/j.ijcard.2016.12.003; Derwall M, 2009, CRIT CARE, V13, DOI 10.1186/cc7785; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Diaz-Romero J, 2014, J CELL PHYSIOL, V229, P1106, DOI 10.1002/jcp.24547; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Dong XQ, 2011, J TRAUMA, V71, P1194, DOI 10.1097/TA.0b013e31821283f2; Eikelenboom MJ, 2011, MULT SCLER INT, V2011, DOI 10.1155/2011/823176; Einav S, 2013, RESUSCITATION, V84, P1083, DOI 10.1016/j.resuscitation.2013.01.031; Einav S, 2012, J AM COLL CARDIOL, V60, P304, DOI 10.1016/j.jacc.2012.04.020; Elmer J, 2016, RESUSCITATION, V102, P127, DOI 10.1016/j.resuscitation.2016.01.016; Fink EL, 2014, CRIT CARE MED, V42, P664, DOI 10.1097/01.ccm.0000435668.53188.80; FISCHERCOLBRIE R, 1995, PROG NEUROBIOL, V46, P49, DOI 10.1016/0301-0082(94)00060-U; Franz G, 2003, NEUROLOGY, V60, P1457, DOI 10.1212/01.WNL.0000063313.57292.00; Gao JX, 2015, INT J CLIN EXP MED, V8, P19881; GARCIA JH, 1977, VIRCHOWS ARCH B, V25, P191; GOODMAN SR, 1995, BRAIN RES BULL, V36, P593, DOI 10.1016/0361-9230(94)00264-2; Greer DM, 2017, SEMIN NEUROL, V37, P66, DOI 10.1055/s-0036-1594253; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Hasslacher J, 2014, INTENS CARE MED, V40, P1518, DOI 10.1007/s00134-014-3423-4; Hayashida H, 2010, NEUROCRIT CARE, V12, P252, DOI 10.1007/s12028-009-9318-5; Huang CH, 2016, SCI REP-UK, V6, DOI 10.1038/srep27187; Huntgeburth M, 2014, NEUROCRIT CARE, V20, P358, DOI 10.1007/s12028-013-9848-8; Jain P, 2014, PEDIATR CRIT CARE ME, V15, P229, DOI 10.1097/PCC.0000000000000059; Jensen HA, 2011, CIRCULATION, V123, P714, DOI 10.1161/CIRCULATIONAHA.110.986497; Johnsson P, 2000, ANN THORAC SURG, V69, P750, DOI 10.1016/S0003-4975(99)01393-4; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; Kaneko T, 2009, RESUSCITATION, V80, P790, DOI 10.1016/j.resuscitation.2009.04.003; Katan M, 2009, ANN NEUROL, V66, P799, DOI 10.1002/ana.21783; Kawata K, 2016, NEUROSCI BIOBEHAV R, V68, P460, DOI 10.1016/j.neubiorev.2016.05.009; KOHLSCHUTTER A, 1978, EUR J PEDIATR, V127, P155, DOI 10.1007/BF00442056; Larsson IM, 2014, RESUSCITATION, V85, P1654, DOI 10.1016/j.resuscitation.2014.09.007; Laver S, 2004, INTENS CARE MED, V30, P2126, DOI 10.1007/s00134-004-2425-z; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lewis SB, 2010, J NEUROSCI RES, V88, P1475, DOI 10.1002/jnr.22323; Mailliot C, 2000, J CEREBR BLOOD F MET, V20, P543, DOI 10.1097/00004647-200003000-00013; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; Martens P, 1998, STROKE, V29, P2363, DOI 10.1161/01.STR.29.11.2363; Marty MC, 2002, P NATL ACAD SCI USA, V99, P8856, DOI 10.1073/pnas.122079599; Missler U, 1997, STROKE, V28, P1956, DOI 10.1161/01.STR.28.10.1956; Missler U, 1999, CLIN CHEM, V45, P138; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Mondello S, 2011, EXPERT REV MOL DIAGN, V11, P65, DOI 10.1586/ERM.10.104; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; Morgenthaler NG, 2006, CLIN CHEM, V52, P112, DOI 10.1373/clinchem.2005.060038; Morgenthaler NG, 2007, SHOCK, V28, P219, DOI 10.1097/SHK.0b013e318033e5da; Mortberg E, 2011, ACTA ANAESTH SCAND, V55, P1132, DOI 10.1111/j.1399-6576.2011.02505.x; Mortberg E, 2011, RESUSCITATION, V82, P26, DOI 10.1016/j.resuscitation.2010.10.011; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Muller B, 2007, EUR J CLIN INVEST, V37, P145, DOI 10.1111/j.1365-2362.2007.01762.x; Mussack T, 2002, CRIT CARE MED, V30, P2669, DOI 10.1097/00003246-200212000-00010; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Neumar RW, 2008, CIRCULATION, V118, P2452, DOI 10.1161/CIRCULATIONAHA.108.190652; Oda Y, 2012, RESUSCITATION, V83, P1006, DOI 10.1016/j.resuscitation.2012.01.030; Oliver JM, 2016, J NEUROTRAUM, V33, P1784, DOI 10.1089/neu.2015.4295; Ostadal P, 2012, CRIT CARE, V16, DOI 10.1186/cc11671; Ottesen AH, 2015, J AM COLL CARDIOL, V65, P339, DOI 10.1016/j.jacc.2014.10.065; Panickar KS, 2005, GLIA, V50, P287, DOI 10.1002/glia.20181; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Pelinka LE, 2004, SHOCK, V22, P88, DOI 10.1097/01.shk.0000130157.34382.3f; PETITO CK, 1982, ANN NEUROL, V11, P510, DOI 10.1002/ana.410110511; Petzold A, 2005, J NEUROL SCI, V233, P183, DOI 10.1016/j.jns.2005.03.015; Pfeifer R, 2014, ACTA ANAESTH SCAND, V58, P1093, DOI 10.1111/aas.12386; Pike BR, 2004, J CEREBR BLOOD F MET, V24, P98, DOI 10.1097/01.WCB.0000098520.11962.37; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Rana OR, 2013, INT J CARDIOL, V168, P1322, DOI 10.1016/j.ijcard.2012.12.016; Rana OR, 2011, J NEUROL SCI, V305, P80, DOI 10.1016/j.jns.2011.03.007; Randall J, 2013, RESUSCITATION, V84, P351, DOI 10.1016/j.resuscitation.2012.07.027; Ray P, 2010, ANESTHESIOLOGY, V112, P1023, DOI 10.1097/ALN.0b013e3181d47604; Rech TH, 2006, CRIT CARE, V10, DOI 10.1186/cc5046; Ren CH, 2013, BRAIN RES, V1540, P84, DOI 10.1016/j.brainres.2013.09.051; Ristagno G, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0831-y; Robinson LR, 2003, CRIT CARE MED, V31, P960, DOI 10.1097/01.CCM.0000053643.21751.3B; Rosen H, 2004, J NEUROL SCI, V221, P19, DOI 10.1016/j.jns.2004.03.003; Rosen H, 2001, RESUSCITATION, V49, P183, DOI 10.1016/S0300-9572(00)00348-8; Rossetti AO, 2016, LANCET NEUROL, V15, P597, DOI 10.1016/S1474-4422(16)00015-6; Rundgren M, 2012, CRIT CARE, V16, DOI 10.1186/cc11244; Rundgren M, 2009, RESUSCITATION, V80, P784, DOI 10.1016/j.resuscitation.2009.03.025; Sandroni C, 2017, SEMIN NEUROL, V37, P40, DOI 10.1055/s-0036-1593857; Sandroni C, 2015, CURR OPIN CRIT CARE, V21, P209, DOI 10.1097/MCC.0000000000000202; Sandroni C, 2014, RESUSCITATION, V85, P1779, DOI 10.1016/j.resuscitation.2014.08.011; Sandroni C, 2013, RESUSCITATION, V84, P1324, DOI 10.1016/j.resuscitation.2013.06.020; Sandroni C, 2013, RESUSCITATION, V84, P1310, DOI 10.1016/j.resuscitation.2013.05.013; Schoerkhuber W, 1999, STROKE, V30, P1598, DOI 10.1161/01.STR.30.8.1598; Scolletta S, 2012, EXPERT REV CLIN PHAR, V5, P687, DOI [10.1586/ecp.12.64, 10.1586/ECP.12.64]; Sharma HS, 2011, J NEURAL TRANSM, V118, P87, DOI 10.1007/s00702-010-0486-4; Shaw GJ, 2002, ANN EMERG MED, V39, P254, DOI 10.1067/mem.2002.121214; Shinozaki K, 2009, CRIT CARE, V13, DOI 10.1186/cc7973; Shinozaki K, 2009, RESUSCITATION, V80, P870, DOI 10.1016/j.resuscitation.2009.05.005; Siman R, 2005, J CEREBR BLOOD F MET, V25, P1433, DOI 10.1038/sj.jcbfm.9600138; Siman R, 2004, NEUROBIOL DIS, V16, P311, DOI 10.1016/j.nbd.2004.03.016; Siman R, 2008, BRAIN RES, V1213, P1, DOI 10.1016/j.brainres.2008.03.034; Siman R, 2015, J NEUROTRAUM, V32, P1294, DOI 10.1089/neu.2014.3698; Siman R, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00190; Stammet P, 2015, J AM COLL CARDIOL, V65, P2104, DOI 10.1016/j.jacc.2015.03.538; Stammet P, 2013, J AM COLL CARDIOL, V62, P851, DOI 10.1016/j.jacc.2013.04.039; Stern P, 2007, TUMOR BIOL, V28, P84, DOI 10.1159/000098441; Storm C, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-6; Taccone FS, 2014, CRIT CARE, V18, DOI 10.1186/cc13696; Tapiola T, 2009, ARCH NEUROL-CHICAGO, V66, P382, DOI 10.1001/archneurol.2008.596; Tiainen M, 2003, STROKE, V34, P2881, DOI 10.1161/01.STR.0000103320.90706.35; Voors AA, 2009, EUR HEART J, V30, P1187, DOI 10.1093/eurheartj/ehp098; Wang KIM, 2013, SYSTEMS BIOMARKERS A, V8723; Wang KKW, 1998, J BIOL CHEM, V273, P22490, DOI 10.1074/jbc.273.35.22490; Weiss ES, 2009, ANN THORAC SURG, V88, P543, DOI 10.1016/j.athoracsur.2009.04.016; Welch RD, 2016, J NEUROTRAUM, V33, P203, DOI 10.1089/neu.2015.4149; Wiedermann CJ, 1999, ACTA PHARMACOL SIN, V20, P789; Wiesmann M, 1998, CLIN CHEM, V44, P1056; Wijdicks EFM, 2006, NEUROLOGY, V67, P203, DOI 10.1212/01.wnl.0000227183.21314.cd; Wu AHB, 1999, CLIN CHIM ACTA, V284, P161, DOI 10.1016/S0009-8981(99)00078-9; Wunderlich MT, 2006, CLIN NEUROL NEUROSUR, V108, P558, DOI 10.1016/j.clineuro.2005.12.006; Youn CS, 2017, RESUSCITATION, V110, P120, DOI 10.1016/j.resuscitation.2016.10.024; Zellner T, 2013, RESUSCITATION, V84, P1382, DOI 10.1016/j.resuscitation.2013.03.021; Zhang ZQ, 2011, TRANSL STROKE RES, V2, P455, DOI 10.1007/s12975-011-0137-6; Zulfikaroglu E, 2011, J OBSTET GYNAECOL RE, V37, P1198, DOI 10.1111/j.1447-0756.2010.01498.x	145	17	18	0	3	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	AUG	2017	105						34	47		10.1016/j.mehy.2017.06.016			14	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	FD6SA	WOS:000407657000009	28735650	hybrid			2022-02-06	
J	Juengst, SB; Wagner, AK; Ritter, AC; Szaflarski, JP; Walker, WC; Zafonte, RD; Brown, AW; Hammond, FM; Pugh, MJ; Shea, T; Krellman, JW; Bushnik, T; Arenth, PM				Juengst, Shannon. B.; Wagner, Amy K.; Ritter, Anne C.; Szaflarski, Jerzy P.; Walker, William C.; Zafonte, Ross D.; Brown, Allen W.; Hammond, Flora M.; Pugh, Mary Jo; Shea, Timothy; Krellman, Jason W.; Bushnik, Tamara; Arenth, Patricia M.			Post-traumatic epilepsy associations with mental health outcomes in the first two years after moderate to severe TBI: A TBI Model Systems analysis	EPILEPSY & BEHAVIOR			English	Article						Traumatic brain injury; Post-traumatic epilepsy; Mental health disorders; Depression; Anxiety; Traumatic brain injury model system	TRAUMATIC BRAIN-INJURY; INPATIENT REHABILITATION; MINOR DEPRESSION; RISK-FACTORS; SEIZURE; PREVALENCE; STRESS; COMORBIDITY; DISORDERS; RATS	Purpose: Research suggests that there are reciprocal relationships between mental health (MH) disorders and epilepsy risk. However, MH relationships to post-traumatic epilepsy (PTE) have not been explored. Thus, the objective of this study was to assess associations between PTE and frequency of depression and/or anxiety in a cohort of individuals with moderate-to-severe TBI who received acute inpatient rehabilitation. Methods: Multivariate regression models were developed using a recent (2010-2012) cohort (n = 867 unique participants) from the TBI Model Systems (TBIMS) National Database, a time frame during which self-reported seizures, depression [Patient Health Questionnaire (PHQ)-9], and anxiety [Generalized Anxiety Disorder (GAD-7)] follow-up measures were concurrently collected at year-1 and year-2 after injury. Results: PTE did not significantly contribute to depression status in either the year-1 or year-2 cohort, nor did it contribute significantly to anxiety status in the year-1 cohort, after controlling for other known depression and anxiety predictors. However, those with PTE in year-2 had 3.34 times the odds (p = .002) of having clinically significant anxiety, even after accounting for other relevant predictors. In this model, participants who self-identified as Black were also more likely to report clinical symptoms of anxiety than those who identified as White. PTE was the only significant predictor of comorbid depression and anxiety at year-2 (Odds Ratio 2.71; p = 0.049). Conclusions: Our data suggest that PIE is associated with MH outcomes 2 years after TBI, findings whose significance may reflect reciprocal, biological, psychological, and/or experiential factors contributing to and resulting from both l It and MH status post-TBI. Future work should consider temporal and reciprocal relationships between PTE and MH as well as if/how treatment of each condition influences biosusceptibility to the other condition. (C) 2017 Elsevier Inc. All rights reserved.	[Juengst, Shannon. B.; Wagner, Amy K.; Ritter, Anne C.; Arenth, Patricia M.] Univ Pittsburgh, Phys Med & Rehabil, Pittsburgh, PA USA; [Wagner, Amy K.; Ritter, Anne C.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Wagner, Amy K.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Wagner, Amy K.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA; [Wagner, Amy K.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA; [Szaflarski, Jerzy P.] Univ Alabama Birmingham, Dept Neurol, UAB Stn, Birmingham, AL 35294 USA; [Szaflarski, Jerzy P.] UAB Epilepsy Ctr, Birmingham, AL USA; [Walker, William C.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Zafonte, Ross D.] Harvard Med Sch, Brigham & Womens Hosp, Massachusetts Gen Hosp, Spaulding Rehabil Hosp, Boston, MA USA; [Brown, Allen W.] Mayo Clin, Dept Phys Med & Rehabil, Rochester, MN USA; [Hammond, Flora M.] Carolinas Rehabil, Charlotte, NC USA; [Hammond, Flora M.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Pugh, Mary Jo] South Texas Vet Hlth Care Syst, Polytrauma Rehabil Ctr, San Antonio, TX USA; [Pugh, Mary Jo] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA; [Shea, Timothy] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Krellman, Jason W.] Columbia Univ, Dept Neurol, Med Ctr, New York, NY USA; [Bushnik, Tamara] NYU, Sch Med, Rusk Rehabil, New York, NY USA; [Bushnik, Tamara] Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, Dept Rehabil Counseling, Dallas, TX 75390 USA		Wagner, AK (corresponding author), Kaufmann Med Bldg,Ste 202,3471 5th Ave, Pittsburgh, PA 15213 USA.	wagnerak@upmc.edu	Pugh, Mary Jo/K-5336-2019; Juengst, Shannon B/AAC-5891-2019	Pugh, Mary Jo/0000-0003-4196-7763; Juengst, Shannon B/0000-0003-4709-545X; Bushnik, Tamara/0000-0003-3328-257X	National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [90DP0041, 90DP0038, 90DP0036, 90DP0033, 90DP0039]; Polytrauma Rehabilitation Center Traumatic Brain Injury Model System; Polytrauma Rehabilitation Center TBI Model System	This work was supported by the National Institute on Disability, Independent Living, and Rehabilitation Research [Grants numbers 90DP0041 (SBJ, ACR, PMA), 90DP0038 (JWK), 90DP0036 (FH), 90DP0033 (WCW), 90DP0039 (RDZ)]; the Polytrauma Rehabilitation Center Traumatic Brain Injury Model System (MJP). The Polytrauma Rehabilitation Center TBI Model System is a funded collaboration between the Department of Veterans Affairs (VA) and NIDILRR. NIDILRR is a Center within the Administration for Community Living (ACL), U.S. Department of Health and Human Services (HHS). The contents of this manuscript do not necessarily represent the policy of the VA, NIDILRR, ACL, or HHS, and endorsement of this content by the Federal Government should not be assumed.	Alper K, 2007, BIOL PSYCHIAT, V62, P345, DOI 10.1016/j.biopsych.2006.09.023; Barker-Collo S, 2013, BRAIN INJURY, V27, P1124, DOI 10.3109/02699052.2013.801513; Beghi E, 2016, PHARMACOL RES, V107, P79, DOI 10.1016/j.phrs.2016.03.003; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bushnik T, 2012, J HEAD TRAUMA REHAB, V27, pE36, DOI 10.1097/HTR.0b013e318273375c; Corrigan JD, 2014, J HEAD TRAUMA REHABI; Coupland C, BMJ, V343, pd4551; de Kloet CS, 2007, PROG BRAIN RES, V167, P287, DOI 10.1016/S0079-6123(07)67025-3; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Fisher LB, 2016, BRAIN INJURY, V30, P1311, DOI 10.1080/02699052.2016.1195517; Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550; Fisher RS, 2012, EPILEPSY BEHAV, V24, P304, DOI 10.1016/j.yebeh.2012.04.128; Hammond FM, 2015, ARCH PHYS MED REHAB, V96, pS256, DOI 10.1016/j.apmr.2015.01.025; Harrison-Felix C, 2015, J NEUROTRAUM, V32, P1893, DOI 10.1089/neu.2014.3353; Hart T, 2015, ARCH PHYS MED REHABI; Hart T, 2012, ARCH PHYS MED REHAB, V93, P1343, DOI 10.1016/j.apmr.2012.03.036; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; HAUSER WA, 1991, EPILEPSIA, V32, P429, DOI 10.1111/j.1528-1157.1991.tb04675.x; Hesdorffer DC, 2012, ANN NEUROL, V72, P184, DOI 10.1002/ana.23601; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; Joels M, 2009, EPILEPSIA, V50, P586, DOI 10.1111/j.1528-1167.2008.01902.x; Juengst SB, 2017, J NEUROPSYCHIATRY CL; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Kumlien E, 2010, SEIZURE-EUR J EPILEP, V19, P69, DOI 10.1016/j.seizure.2009.11.005; Miller MC, 2013, JAMA PSYCHIAT, V70, P1131, DOI 10.1001/jamapsychiatry.2013.3493; Myrga JM, 2016, NEUROREHAB NEURAL RE, V30, P920, DOI 10.1177/1545968316648409; Nevalainen O, 2016, EUR J EPIDEMIOL, V31, P445, DOI 10.1007/s10654-015-0095-5; NICKELS JL, 1994, BRAIN INJURY, V8, P709, DOI 10.3109/02699059409151025; Osman A, 2016, EPILEPSY BEHAV, V58, P44, DOI 10.1016/j.yebeh.2016.02.033; Perrin PB, 2015, J HEAD TRAUMA REHAB, V30, P136, DOI 10.1097/HTR.0000000000000026; Pineda E, 2014, EPILEPSY BEHAV, V31, P267, DOI 10.1016/j.yebeh.2013.10.004; Reddy DS, 2002, J NEUROSCI, V22, P3795; Ritter AC, 2016, EPILEPSIA, V57, P1968, DOI 10.1111/epi.13582; Ritter AC, 2016, EPILEPSIA, V57, P1503, DOI 10.1111/epi.13470; Selassie AW, 2014, EPILEPSY RES, V108, P305, DOI 10.1016/j.eplepsyres.2013.12.002; Selassie AW, 2013, J HEAD TRAUMA REHABI; Sillanpad M, 2016, EPILEPTIC DISORD INT; Specht U, 2015, EPILEPSY BEHAV, V51, P243, DOI 10.1016/j.yebeh.2015.07.037; Valente KDR, 2013, ARQ NEURO-PSIQUIAT, V71, P183, DOI 10.1590/S0004-282X2013000300011; Vermoesen K, 2012, EPILEPSIA, V53, P870, DOI 10.1111/j.1528-1167.2012.03436.x; Walker WC, 2015, J HEAD TRAUMA REHAB, V30, P231, DOI 10.1097/HTR.0000000000000127; Yablon SA, 1998, ARCH PHYS MED REHAB, V79, P594; [No title captured]	44	17	18	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	AUG	2017	73						240	246		10.1016/j.yebeh.2017.06.001			7	Behavioral Sciences; Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	FD6TE	WOS:000407660000039	28658654	Green Submitted			2022-02-06	
J	Juengst, SB; Switzer, G; Oh, BM; Arenth, PM; Wagner, AK				Juengst, Shannon B.; Switzer, Galen; Oh, Byung Mo; Arenth, Patricia M.; Wagner, Amy K.			Conceptual model and cluster analysis of behavioral symptoms in two cohorts of adults with traumatic brain injuries	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Behavioral symptoms; Brain injuries; Emotions; Cluster analysis; Cognition	SEVERE TBI; COPING STRATEGIES; NEGATIVE AFFECT; SCALE FRSBE; DEPRESSION; VALIDITY; MODERATE; ASSOCIATIONS; PREDICTORS; PANAS	Introduction. Behavioral changes often occur after moderate-to-severe traumatic brain injury (TBI) and can lead to poor health, psychosocial functioning, and quality of life. Challenges in evaluating these behaviors often result from the complexity and variability in the way they are conceptualized and defined. We propose and test a conceptual model that is specific to behavioral symptoms after TBI, to serve as a basis for better assessment and treatment. We hypothesized that clusters of individuals, with unique emotional, cognitive, and behavioral characteristics, would emerge that would illustrate this conceptual model. Methods. We conducted model-based cluster analyses in two cohorts, 6-months post-injury (n=79) and >6months post-injury (n=62), of adults with moderate-to-severe TBI to explore the face validity of our conceptual model by evaluating how participants clustered with regard to emotional (Patient Health Questionnaire 9, Positive and Negative Affect Schedule), cognitive (neuropsychological test battery), and frontal behavioral (Frontal Systems Behavior Scale) symptoms. Results. In each cohort, unique clusters of participants emerged that differed significantly with regard to emotional state, cognition, and behavior (ps<.05). Those 6-months post-injury clustered along a general continuum of symptom severity in emotional and behavioral symptom domains, from no impairment to severe impairment. Clusters in the chronic cohort (>6months) demonstrated a more complex pattern of symptoms; the most severe behavioral symptoms occurred in the context of severe emotional symptoms, even in the absence of cognitive impairment. However, problematic behavioral symptoms were also present in the context of severe cognitive impairment, even in the absence of emotional symptoms. Conclusions. Emotional, cognitive, and behavioral characteristics were represented as expected, based on the proposed conceptual model of behavior. This conceptual model provides the basis for evaluating behavioral changes after moderate-to-severe TBI and identifying modifiable targets and relevant subpopulations for behavioral intervention, with the goal of improved evidence-based personalized medicine for this population.	[Juengst, Shannon B.; Arenth, Patricia M.; Wagner, Amy K.] Univ Pittsburgh, Sch Med, Dept Phys Med & Rehabil, Pittsburgh, PA 15260 USA; [Switzer, Galen] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Switzer, Galen] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; [Oh, Byung Mo] Seoul Natl Univ Hosp, Dept Rehabil, Seoul, South Korea; [Wagner, Amy K.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA USA; [Wagner, Amy K.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA		Juengst, SB (corresponding author), CRC Kaufmann Med Bldg,Suite 202,3471 Fifth Ave, Pittsburgh, PA 15213 USA.	sbj7@pitt.edu	Juengst, Shannon B/AAC-5891-2019	Juengst, Shannon B/0000-0003-4709-545X	Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49 CCR 323155]; National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [90DP0041]; National Science FoundationNational Science Foundation (NSF) [DGE-0549352]; U.S. Department of DefenseUnited States Department of Defense [W81XWH-071-0701]; University of Pittsburgh School of Health and Rehabilitation Sciences Research Development Fund	This work was supported by the Centers for Disease Control and Prevention [Grant Number R49 CCR 323155]; National Institute on Disability, Independent Living, and Rehabilitation Research [Grant Number 90DP0041]; the National Science Foundation [Grant Number DGE-0549352]; the U.S. Department of Defense [Grant Number W81XWH-071-0701], and by the University of Pittsburgh School of Health and Rehabilitation Sciences Research Development Fund.	Ahlquist JS, 2012, POLIT ANAL, V20, P92, DOI 10.1093/pan/mpr039; American Educational Research Association; American Psychological Association; National Council on Measurement in Education; Joint Committee on Standards for Educational & Psychological Testing (U.S.), 2014, STAND ED PSYCH TEST; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; Carvalho JO, 2013, ASSESSMENT, V20, P632, DOI 10.1177/1073191113492845; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; CLARK LA, 1991, J ABNORM PSYCHOL, V100, P316, DOI 10.1037/0021-843X.100.3.316; Clatworthy J, 2005, BRIT J HEALTH PSYCH, V10, P329, DOI 10.1348/135910705X25697; Crawford JR, 2004, BRIT J CLIN PSYCHOL, V43, P245, DOI 10.1348/0144665031752934; Dawson JD, 2010, J AM GERIATR SOC, V58, P1090, DOI 10.1111/j.1532-5415.2010.02872.x; Duclot F, 2015, J EXP BIOL, V218, P21, DOI 10.1242/jeb.107086; Failla M. D., 2015, NEUROREHABILITATION, DOI [10.1177/1545968315600525, DOI 10.1177/1545968315600525]; Failla MD, 2013, BRAIN INJURY, V27, P696, DOI 10.3109/02699052.2013.775481; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Finset A, 2000, BRAIN INJURY, V14, P887; Fonseca JRS, 2007, INTELL DATA ANAL, V11, P155, DOI 10.3233/IDA-2007-11204; Fraley C, 1998, COMPUT J, V41, P578, DOI 10.1093/comjnl/41.8.578; Fraley C., 2012, 597 U WASH; Gould KR, 2011, J NEUROTRAUM, V28, P1155, DOI 10.1089/neu.2010.1528; Gray E.K., 2001, EMOTION MOOD TEMPERA, P21; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS16, DOI 10.1016/j.apmr.2008.09.551; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; Juengst S, 2014, ARCH PHYS MED REHAB, V95, pE71, DOI [10.1016/j.apmr.2014.07.227, DOI 10.1016/J.APMR.2014.07.227]; Juengst SB, 2014, BRAIN BEHAV IMMUN, V41, P134, DOI 10.1016/j.bbi.2014.05.020; Juengst SB, 2015, J HEAD TRAUMA REHAB, V30, P207, DOI 10.1097/HTR.0000000000000031; Juengst SB, 2014, REHABIL PSYCHOL, V59, P242, DOI 10.1037/a0036294; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kumar RG, 2015, J HEAD TRAUMA REHAB, V30, P369, DOI 10.1097/HTR.0000000000000067; MALIA K, 1995, BRAIN INJURY, V9, P607, DOI 10.3109/02699059509008219; Malloy P, 2005, COGN BEHAV NEUROL, V18, P18, DOI 10.1097/01.wnn.0000152232.47901.88; Markos SM, 2017, J HEAD TRAUMA REHAB, V32, pE24, DOI 10.1097/HTR.0000000000000224; Myrga JM, 2016, NEUROREHAB NEURAL RE, V30, P920, DOI 10.1177/1545968316648409; Myrga JM, 2016, J HEAD TRAUMA REHAB, V31, pE15, DOI 10.1097/HTR.0000000000000199; Niemeier JP, 2013, REHABIL PSYCHOL, V58, P51, DOI 10.1037/a0031612; Nievergelt CM, 2015, PSYCHONEUROENDOCRINO, V51, P459, DOI 10.1016/j.psyneuen.2014.10.017; Pett MA., 2003, MAKING SENSE FACTOR; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Sabaz M, 2014, J HEAD TRAUMA REHAB, V29, pE19, DOI 10.1097/HTR.0b013e31828dc590; Santarsieri M, 2014, J NEUROTRAUM, V31, P699, DOI 10.1089/neu.2013.3177; Seel RT, 2010, J HEAD TRAUMA REHAB, V25, P99, DOI 10.1097/HTR.0b013e3181ce3966; Singh-Taylor A, 2015, NEUROBIOL STRESS, V1, P109, DOI 10.1016/j.ynstr.2014.10.007; TEASDALE G, 1974, LANCET, V2, P81; van der Horn HJ, 2016, J NEUROTRAUM, V33, P1, DOI 10.1089/neu.2015.3905; Wagner AK, 2012, BRAIN INJURY, V26, P1658, DOI 10.3109/02699052.2012.700089; Wagner AK, 2012, BRAIN INJURY, V26, P1226, DOI 10.3109/02699052.2012.667594; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063	45	17	17	0	25	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	AUG	2017	39	6					513	524		10.1080/13803395.2016.1240758			12	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	ES7QM	WOS:000399745400001	27750469				2022-02-06	
J	Boone, DK; Weisz, HA; Bi, M; Falduto, MT; Torres, KEO; Willey, HE; Volsko, CM; Kumar, AM; Micci, MA; Dewitt, DS; Prough, DS; Hellmich, HL				Boone, Deborah Kennedy; Weisz, Harris A.; Bi, Min; Falduto, Michael T.; Torres, Karen E. O.; Willey, Hannah E.; Volsko, Christina M.; Kumar, Anjali M.; Micci, Maria-Adelaide; Dewitt, Douglas S.; Prough, Donald S.; Hellmich, Helen L.			Evidence linking microRNA suppression of essential prosurvival genes with hippocampal cell death after traumatic brain injury	SCIENTIFIC REPORTS			English	Article							NEURODEGENERATIVE DISEASES; NEURONAL VULNERABILITY; NETWORKS; NEUROPATHOLOGY; DISORDERS; CHANNELS; GENOME; TARGET	The underlying molecular mechanisms of how dysregulated microRNAs (miRNAs) cause neurodegeneration after traumatic brain injury (TBI) remain elusive. Here we analyzed the biological roles of approximately 600 genes - we previously found these dysregulated in dying and surviving rat hippocampal neurons - that are targeted by ten TBI-altered miRNAs. Bioinformatic analysis suggests that neurodegeneration results from a global miRNA-mediated suppression of genes essential for maintaining proteostasis; many are hub genes - involved in RNA processing, cytoskeletal metabolism, intracellular trafficking, cell cycle progression, repair/maintenance, bioenergetics and cell-cell signaling - whose disrupted expression is linked to human disease. Notably, dysregulation of these essential genes would significantly impair synaptic function and functional brain connectivity. In surviving neurons, upregulated miRNA target genes are co-regulated members of prosurvival pathways associated with cellular regeneration, neural plasticity, and development. This study captures the diversity of miRNA-regulated genes that may be essential for cell repair and survival responses after TBI.	[Boone, Deborah Kennedy; Weisz, Harris A.; Bi, Min; Willey, Hannah E.; Volsko, Christina M.; Kumar, Anjali M.; Micci, Maria-Adelaide; Dewitt, Douglas S.; Prough, Donald S.; Hellmich, Helen L.] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA; [Falduto, Michael T.; Torres, Karen E. O.] Genus Biosyst Inc, Northbrook, IL USA		Hellmich, HL (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA.	hhellmic@utmb.edu	Prough, Donald S/G-5793-2013	Prough, Donald S/0000-0001-7994-532X; Willey, Hannah/0000-0002-5164-4127	department of Anesthesiology (UTMB); Moody Foundation;  [RO1 NS052532]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS052532] Funding Source: NIH RePORTER	Supported by RO1 NS052532 (HLH), and in part by the department of Anesthesiology (UTMB) and a Moody Foundation grant to the Moody Project for Translational Traumatic Brain Injury Research (DSP and DSD). We thank Laurie Bolding and Christine Courteau for editorial assistance, Dr. Stacy Sell for critical reading of the manuscript and Christy Perry for all illustrations and figures.	Bai M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046921; Balchin D, 2016, SCIENCE, V353, DOI 10.1126/science.aac4354; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Becker L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033297; Behar M, 2013, CELL, V155, P448, DOI 10.1016/j.cell.2013.09.018; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Bota M, 2003, NAT NEUROSCI, V6, P795, DOI 10.1038/nn1096; Browning M, 2016, J NEUROTRAUM, V33, P581, DOI 10.1089/neu.2015.4131; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Catterall WA, 2010, J PHYSIOL-LONDON, V588, P1849, DOI 10.1113/jphysiol.2010.187484; Chen LH, 2010, AGEING RES REV, V9, pS59, DOI 10.1016/j.arr.2010.08.002; Eacker SM, 2009, NAT REV NEUROSCI, V10, P837, DOI 10.1038/nrn2726; Fornito A, 2015, EUR NEUROPSYCHOPHARM, V25, P733, DOI 10.1016/j.euroneuro.2014.02.011; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Hayden EC, 2016, NATURE, V538, P154; Hullinger TG, 2012, CIRC RES, V110, P71, DOI 10.1161/CIRCRESAHA.111.244442; Imbrici Paola, 2013, Frontiers in Genetics, V4, P76, DOI 10.3389/fgene.2013.00076; Jalles A., 2016, MOL SCI, V2, P259; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Junn E, 2012, PHARMACOL THERAPEUT, V133, P142, DOI 10.1016/j.pharmthera.2011.10.002; Klein U, 2010, CANCER CELL, V17, P28, DOI 10.1016/j.ccr.2009.11.019; KORSMEYER SJ, 1993, SEMIN CANCER BIOL, V4, P327; Kruman II, 2004, NEURON, V41, P549, DOI 10.1016/S0896-6273(04)00017-0; Levin H, 2013, LANCET NEUROL, V12, P15, DOI 10.1016/S1474-4422(12)70300-9; Lewohl JM, 2011, ALCOHOL CLIN EXP RES, V35, P1928, DOI 10.1111/j.1530-0277.2011.01544.x; McNeill E, 2012, NEURON, V75, P363, DOI 10.1016/j.neuron.2012.07.005; Messina A, 2016, NAT NEUROSCI, V19, P835, DOI 10.1038/nn.4298; O'Donovan MC, 2016, NAT MED, V22, P1214, DOI 10.1038/nm.4196; Puchta O, 2016, SCIENCE, V352, P840, DOI 10.1126/science.aaf0965; Rapoport MJ, 2012, CNS DRUGS, V26, P111, DOI 10.2165/11599560-000000000-00000; Richiardi J, 2015, SCIENCE, V348, P1241, DOI 10.1126/science.1255905; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Rojo DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023111; Sass S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-136; Saxena S, 2011, NEURON, V71, P35, DOI 10.1016/j.neuron.2011.06.031; Schmiedel JM, 2015, SCIENCE, V348, P128, DOI 10.1126/science.aaa1738; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Simmons DA, 2009, P NATL ACAD SCI USA, V106, P4906, DOI 10.1073/pnas.0811228106; Sin O, 2015, CELL MOL LIFE SCI, V72, P4027, DOI 10.1007/s00018-015-1985-0; Sours C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134019; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Truettner JS, 2013, BRAIN RES, V1533, P122, DOI 10.1016/j.brainres.2013.08.011; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wood SH, 2013, AGE, V35, P763, DOI 10.1007/s11357-012-9410-1; Xiong Y., 2015, EXPERT OPIN INV DRUG, V1, P1; Yue JM, 2010, MAMM GENOME, V21, P88, DOI 10.1007/s00335-009-9240-3; Zeltner N, 2016, NAT MED, V22, P1421, DOI 10.1038/nm.4220	47	17	17	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 27	2017	7								6645	10.1038/s41598-017-06341-6			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB8CH	WOS:000406366000003	28751711	Green Published, gold			2022-02-06	
J	Truss, K; Godfrey, C; Takagi, M; Babl, FE; Bressan, S; Hearps, S; Clarke, C; Dunne, K; Anderson, V				Truss, Katherine; Godfrey, Celia; Takagi, Michael; Babl, Franz E.; Bressan, Silvia; Hearps, Stephen; Clarke, Cathriona; Dunne, Kevin; Anderson, Vicki			Trajectories and Risk Factors for Post-Traumatic Stress Symptoms following Pediatric Concussion	JOURNAL OF NEUROTRAUMA			English	Article						concussion; group-based trajectory modeling; mild traumatic brain injury; pediatrics; post-traumatic stress	TRAUMATIC BRAIN-INJURY; CHILD PTSD; POSTCONCUSSIVE SYMPTOMS; PSYCHOMETRIC PROPERTIES; HEAD-INJURY; DISORDER; EPIDEMIOLOGY; ADOLESCENTS; PREDICTORS; SCALE	A substantial minority of children experience post-traumatic stress symptoms (PTSS) following injury. Research indicates variation in the trajectory of PTSS following pediatric injury, but investigation of PTSS following concussion has assumed homogeneity. This study aimed to identify differential trajectories of PTSS following pediatric concussion and to investigate risk factors, including acute post-concussive symptoms (PCS), associated with these trajectories. A total of 120 children ages 8-18 years reported PTSS for 3 months following concussion diagnosis using the Child PTSD Symptom Scale, with a score of 16 or above indicating probable post-traumatic stress disorder diagnosis. Age, gender, injury mechanism, loss of consciousness, previous concussions, prior hospitalization, prior diagnosis of depression or anxiety, and acute PCS were assessed as risk factors. Data were analyzed using group-based trajectory modeling. Results revealed 16% of children had clinically significant PTSS 2 weeks post-concussion, declining to 10% at 1 month and 6% at 3 months post-injury. Group-based trajectory modeling identified three trajectories of PTSS post-concussion: resilient (70%); recovering (25%), in which children experienced elevated acute symptoms that declined over time; and chronic symptomatology (5%). Due to small size, the chronic group should be interpreted with caution. Higher acute PCS and prior diagnosis of depression or anxiety both significantly increased predicted probability of recovering trajectory group membership. These findings establish that most children are resilient to PTSS following concussion, but that PTSS do occur acutely in a substantial minority of children. The study indicates mental health factors, particularly PTSS, depression, and anxiety, should be considered integral to models of concussion management and treatment.	[Truss, Katherine; Godfrey, Celia; Takagi, Michael; Babl, Franz E.; Bressan, Silvia; Hearps, Stephen; Clarke, Cathriona; Dunne, Kevin; Anderson, Vicki] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Truss, Katherine; Anderson, Vicki] Univ Melbourne, Sch Psychol Sci, Melbourne, Vic, Australia; [Godfrey, Celia; Babl, Franz E.; Dunne, Kevin] Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia; [Babl, Franz E.] Royal Childrens Hosp, Emergency Dept, Melbourne, Vic, Australia; [Bressan, Silvia] Univ Padua, Dept Womens & Childrens Hlth, Padua, Italy; [Dunne, Kevin] Royal Childrens Hosp, Dept Rehabil Med, Melbourne, Vic, Australia; [Anderson, Vicki] Royal Childrens Hosp, Psychol Serv, Melbourne, Vic, Australia		Anderson, V (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	vicki.anderson@rch.org.au	Hearps, Stephen/L-6853-2016	Takagi, Michael/0000-0003-2903-7598; Hearps, Stephen/0000-0003-2984-1172	Royal Children's Hospital Research Foundation; Victorian Government Operational Infrastructure Scheme; Australian National Health and Medical Research Council (NHMRC) Development grantNational Health and Medical Research Council of Australia; NHMRC Senior Practitioner FellowshipNational Health and Medical Research Council of Australia	This study was funded by the Royal Children's Hospital Research Foundation and the Victorian Government Operational Infrastructure Scheme. SH was funded by an Australian National Health and Medical Research Council (NHMRC) Development grant, FEB was funded by the Royal Children's Hospital Research Foundation, and VA by an NHMRC Senior Practitioner Fellowship. The funding organizations did not have a role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication.	Albicini M., 2015, FRESH LOOK ANXIETY D; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; American Psychiatric Association A, 1994, DIAGNOSTIC STAT MANU; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Barlow KM, 2016, J CHILD NEUROL, V31, P57, DOI 10.1177/0883073814543305; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Blume HK, 2011, PHYS MED REH CLIN N, V22, P665, DOI 10.1016/j.pmr.2011.08.007; Bonanno GA, 2005, CURR DIR PSYCHOL SCI, V14, P135, DOI 10.1111/j.0963-7214.2005.00347.x; Bressan S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009427; Brosbe MS, 2011, J PEDIATR PSYCHOL, V36, P718, DOI 10.1093/jpepsy/jsq115; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Clayton GH, 2013, CURR PHYS MED REHABI, V1, P88; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Copeland WE, 2007, ARCH GEN PSYCHIAT, V64, P577, DOI 10.1001/archpsyc.64.5.577; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Donlon K, 2015, CHILD NEUROPSYCHOL, V21, P803, DOI 10.1080/09297049.2014.944491; Drotar, 2006, TRAUMATOLOGY, V12, P148, DOI [DOI 10.1177/1534765606294562, 10.77/1534765606294562]; Foa EB, 2001, J CLIN CHILD PSYCHOL, V30, P376, DOI 10.1207/S15374424JCCP3003_9; Gerring JP, 2002, J AM ACAD CHILD PSY, V41, P157, DOI 10.1097/00004583-200202000-00009; Gillies ML, 2003, J TRAUMA STRESS, V16, P523, DOI 10.1023/A:1025774915005; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Guo XY, 2017, NEUROPSYCHOLOGY, V31, P84, DOI 10.1037/neu0000305; Hajek CA, 2010, BRAIN INJURY, V24, P100, DOI 10.3109/02699050903508226; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hong SB, 2014, J CHILD PSYCHOL PSYC, V55, P1226, DOI 10.1111/jcpp.12241; Hung Ryan, 2014, Arch Phys Med Rehabil, V95, pS174, DOI 10.1016/j.apmr.2013.08.301; Iselin G, 2010, J ANXIETY DISORD, V24, P774, DOI 10.1016/j.janxdis.2010.05.011; Jones BL, 2012, STATA PLUGIN ESTIMAT; Kassam-Adams N, 2004, J AM ACAD CHILD PSY, V43, P403, DOI 10.1097/00004583-200404000-00006; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Layne CM, 2009, TREATING TRAUMATIZED, P13; Le Brocque RM, 2010, J PEDIATR PSYCHOL, V35, P637, DOI 10.1093/jpepsy/jsp050; Levi RB, 1999, J CLIN CHILD PSYCHOL, V28, P232, DOI 10.1207/s15374424jccp2802_10; Marshall RD, 2001, AM J PSYCHIAT, V158, P1467, DOI 10.1176/appi.ajp.158.9.1467; Mather FJ, 2003, BRAIN INJURY, V17, P1077, DOI 10.1080/0269905031000114045; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Nagin D.S., 2005, GROUP BASED MODELING; Nagin DS, 2010, ANNU REV CLIN PSYCHO, V6, P109, DOI 10.1146/annurev.clinpsy.121208.131413; Nagin DS, 1999, PSYCHOL METHODS, V4, P139, DOI 10.1037/1082-989X.4.2.139; Nixon RDV, 2013, PSYCHOL ASSESSMENT, V25, P1025, DOI 10.1037/a0033324; Olsson KA, 2008, J ANXIETY DISORD, V22, P1447, DOI 10.1016/j.janxdis.2008.02.007; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Trickey D, 2012, CLIN PSYCHOL REV, V32, P122, DOI 10.1016/j.cpr.2011.12.001; WONG JL, 1994, ARCH CLIN NEUROPSYCH, V9, P411, DOI 10.1016/0887-6177(94)90004-3; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216; Ziegler MF, 2005, PEDIATRICS, V115, P1261, DOI 10.1542/peds.2004-1217	52	17	17	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2017	34	14					2272	2279		10.1089/neu.2016.4842			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	EZ8RQ	WOS:000404995000010	28293983				2022-02-06	
J	Wolf, JA; Johnson, BN; Johnson, VE; Putt, ME; Browne, KD; Mietus, CJ; Brown, DP; Wofford, KL; Smith, DH; Grady, MS; Cohen, AS; Cullen, DK				Wolf, John A.; Johnson, Brian N.; Johnson, Victoria E.; Putt, Mary E.; Browne, Kevin D.; Mietus, Constance J.; Brown, Daniel P.; Wofford, Kathryn L.; Smith, Douglas H.; Grady, M. Sean; Cohen, Akiva S.; Cullen, D. Kacy			Concussion Induces Hippocampal Circuitry Disruption in Swine	JOURNAL OF NEUROTRAUMA			English	Article						axonal pathology; concussion; epileptogenesis; hippocampus; mild TBI; traumatic brain injury	TRAUMATIC BRAIN-INJURY; DIFFUSE AXONAL INJURY; AMYLOID PRECURSOR PROTEIN; CLOSED-HEAD-INJURY; COGNITIVE IMPAIRMENT; PYRAMIDAL CELLS; SODIUM-CHANNELS; AREA CA1; NEURONS; MEMORY	Hippocampal-dependent deficits in learning and memory formation are a prominent feature of traumatic brain injury (TBI); however, the role of the hippocampus in cognitive dysfunction after concussion (mild TBI) is unknown. We therefore investigated functional and structural changes in the swine hippocampus following TBI using a model of head rotational acceleration that closely replicates the biomechanics and neuropathology of closed-head TBI in humans. We examined neurophysiological changes using a novel ex vivo hippocampal slice paradigm with extracellular stimulation and recording in the dentate gyrus and CA1 occurring at 7 days following non-impact inertial TBI in swine. Hippocampal neurophysiology post-injury revealed reduced axonal function, synaptic dysfunction, and regional hyperexcitability at one week following even mild injury levels. Moreover, these neurophysiological changes occurred in the apparent absence of intra-hippocampal neuronal or axonal degeneration. Input-output curves demonstrated an elevated excitatory post-synaptic potential (EPSP) output for a given fiber volley input in injured versus sham animals, suggesting a form of homeostatic plasticity that manifested as a compensatory response to decreased axonal function in post-synaptic regions. These data indicate that closed-head rotational acceleration-induced TBI, the common cause of concussion in humans, may induce significant alterations in hippocampal circuitry function that have not resolved at 7 days post-injury. This circuitry dysfunction may underlie some of the post-concussion symptomatology associated with the hippocampus, such as post-traumatic amnesia and ongoing cognitive deficits.	[Wolf, John A.; Johnson, Victoria E.; Browne, Kevin D.; Mietus, Constance J.; Brown, Daniel P.; Wofford, Kathryn L.; Smith, Douglas H.; Grady, M. Sean; Cullen, D. Kacy] Univ Penn, Dept Neurosurg, Perelman Sch Med, Philadelphia, PA 19104 USA; [Putt, Mary E.] Univ Penn, Dept Biostat & Epidemiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Wolf, John A.; Browne, Kevin D.; Brown, Daniel P.; Wofford, Kathryn L.; Cullen, D. Kacy] Corporal Michael J Crescenz Vet Affairs Med Ctr, Ctr Neurotrauma Neurodegenerat & Restorat, Philadelphia, PA USA; [Johnson, Brian N.; Cohen, Akiva S.] Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care Med, Philadelphia, PA 19104 USA		Cullen, DK (corresponding author), Univ Penn, Dept Neurosurg, Room 105,Hayden Hall,3320 Smith Walk, Philadelphia, PA 19104 USA.	dkacy@mail.med.upenn.edu	Wolf, John A/A-1034-2007	Wolf, John A/0000-0002-6950-2303; Wofford, Kathryn/0000-0002-0391-2641	National Institutes of Health [NINDS]United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01-NS-050598, R01-NS-069629, T32-NS043126]; National Institutes of Health [NICHD]United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R37-HD-059288]; National Institutes of Health [NICH] [U54 HD086984]; Department of Veterans Affairs [Rehabilitation Research & Development (Merit Review Award) [B1097-I]; Department of Veterans Affairs [Rehabilitation Research & Development (Career Development Award) [IK2-RX001479]; CURE Taking Flight Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R37HD059288, U54HD086984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32NS043126, R01NS101108, R01NS069629, R01NS050598] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [IK2RX001479, I01RX001097] Funding Source: NIH RePORTER	We wish to thank Dr. William Stewart of the Dept. of Neuropathology and Glasgow TBI Archive, Southern General Hospital, Glasgow, United Kingdom for helpful advice and provision of immunohistochemical protocols. We wish to thank Professor Max Morris of the Department of Statistics, Iowa State University, for consultation on the statistical analyses. This work was made possible due to financial support provided by the National Institutes of Health [NINDS (R01-NS-050598, R01-NS-069629, T32-NS043126), NICHD (R37-HD-059288) & NICH (U54 HD086984)], the Department of Veterans Affairs [Rehabilitation Research & Development (Merit Review Award #B1097-I & Career Development Award #IK2-RX001479)], and the CURE Taking Flight Award.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Akam T, 2014, NAT REV NEUROSCI, V15, P111, DOI 10.1038/nrn3668; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; BRAAK H, 1992, NEUROSCI RES, V15, P6, DOI 10.1016/0168-0102(92)90014-4; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879, DOI 10.1016/S0733-8619(18)30185-3; Christidi F, 2011, J NEUROTRAUM, V28, P711, DOI 10.1089/neu.2010.1644; Cole JT, 2010, P NATL ACAD SCI USA, V107, P366, DOI 10.1073/pnas.0910280107; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; CREAGER R, 1980, J PHYSIOL-LONDON, V299, P409, DOI 10.1113/jphysiol.1980.sp013133; Cullen D. K., 2016, INJURY MODELS CENTRA; de Kruijk JR, 2001, BRAIN INJURY, V15, P99, DOI 10.1080/026990501458335; De Monte VE, 2006, BRAIN INJURY, V20, P1345, DOI 10.1080/02699050601082073; Dinocourt C, 2011, EPILEPSIA, V52, P1656, DOI 10.1111/j.1528-1167.2011.03113.x; Eucker SA, 2011, EXP NEUROL, V227, P79, DOI 10.1016/j.expneurol.2010.09.015; Fisher D C, 2000, Appl Neuropsychol, V7, P126, DOI 10.1207/S15324826AN0703_2; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; GIBSON KL, 1991, MICROSURG, V12, P80, DOI 10.1002/micr.1920120205; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Griesemer D, 2007, J NEUROTRAUM, V24, P1823, DOI 10.1089/neu.2006.0237; Hanell A, 2015, J NEUROTRAUM, V32, P1590, DOI 10.1089/neu.2014.3592; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; HYMAN BT, 1986, ANN NEUROL, V20, P472, DOI 10.1002/ana.410200406; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Johnson VE, 2016, ACTA NEUROPATHOL, V131, P115, DOI 10.1007/s00401-015-1506-0; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Kirkby DL, 1998, EUR J NEUROSCI, V10, P823, DOI 10.1046/j.1460-9568.1998.00087.x; KOTAPKA MJ, 1992, ACTA NEUROPATHOL, V83, P530, DOI 10.1007/BF00310031; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee DJ, 2013, J NEUROTRAUM, V30, P131, DOI 10.1089/neu.2012.2646; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LOMO T, 1971, EXP BRAIN RES, V12, P46; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; Maurer AP, 2007, TRENDS NEUROSCI, V30, P325, DOI 10.1016/j.tins.2007.05.002; Maxwell WL, 2003, J NEUROPATH EXP NEUR, V62, P272, DOI 10.1093/jnen/62.3.272; MCNAUGHTON BL, 1980, BRAIN RES, V199, P1, DOI 10.1016/0006-8993(80)90226-7; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; MORRIS MD, 2011, DESIGN EXPT INTRO BA; Norris CM, 2009, J NEUROTRAUM, V26, P2269, DOI 10.1089/neu.2009.1029; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Pajevic S, 2014, NEUROSCIENCE, V276, P135, DOI 10.1016/j.neuroscience.2013.11.007; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; R Core Team, 2018, R LANGUAGE ENV STAT; Reeves TM, 2000, J NEUROSCI RES, V60, P370, DOI 10.1002/(SICI)1097-4547(20000501)60:3<370::AID-JNR12>3.0.CO;2-B; Rutishauser U, 2010, NATURE, V464, P903, DOI 10.1038/nature08860; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Santhakumar V, 2001, ANN NEUROL, V50, P708, DOI 10.1002/ana.1230; Schwarzbach E, 2006, HIPPOCAMPUS, V16, P541, DOI 10.1002/hipo.20183; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; Smith CJ, 2015, FRONT NEUROL, V6, DOI [10.3389/fneur.2015.00240, 10.3389/fneur.2015.00073]; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Stone JR, 2001, EXP NEUROL, V172, P320, DOI 10.1006/exnr.2001.7818; TROJANOWSKI JQ, 1986, J NEUROSCI, V6, P650; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Wolf JA, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00043; Yallampalli R, 2013, J NEUROIMAGING, V23, P224, DOI 10.1111/j.1552-6569.2010.00537.x; Yuen TJ, 2009, J NEUROSCI RES, V87, P3620, DOI 10.1002/jnr.22161; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.ne.12.030189.000305	73	17	17	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2017	34	14					2303	2314		10.1089/neu.2016.4848			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EZ8RQ	WOS:000404995000013	28298170	Green Published			2022-02-06	
J	Boudreau, RM; Johnson, M; Veile, R; Friend, LA; Goetzman, H; Pritts, TA; Caldwell, CC; Makley, AT; Goodman, MD				Boudreau, Ryan M.; Johnson, Mark; Veile, Rosalie; Friend, Lou Ann; Goetzman, Holly; Pritts, Timothy A.; Caldwell, Charles C.; Makley, Amy T.; Goodman, Michael D.			Impact of tranexamic acid on coagulation and inflammation in murine models of traumatic brain injury and hemorrhage	JOURNAL OF SURGICAL RESEARCH			English	Article; Proceedings Paper	Association-for-Academic-Surgery/Society-of-University-Surgeons 12th Annual Meeting of the Academic-Surgical-Congress (ASC)	FEB 07-09, 2017	Las Vegas, NV	Acad Surg Congress, Assoc Acad Surg, Soc Univ Surg			RESUSCITATION; COAGULOPATHY; PARAMETERS	Background: Posttraumatic coagulopathy and inflammation can exacerbate secondary cerebral damage after traumatic brain injury (TBI). Tranexamic acid (TXA) has been shown clinically to reduce mortality in hemorrhaging and head-injured trauma patients and has the potential to mitigate secondary brain injury with its reported antifibrinolytic and antiinflammatory properties. We hypothesized that TXA would improve posttraumatic coagulation and inflammation in a murine model of TBI alone and in a combined injury model of TBI and hemorrhage (TBI/H). Methods: An established murine weight drop model was used to induce a moderate TBI. Mice were administered intraperitoneal injections of 10mg/kg TXA or equivalent volume of saline 10 min after injury. An additional group of mice was subjected to TBI followed by hemorrhagic shock using a pressure-controlled model. TBI/Hmice were given intraperitoneal injections of TXA or saline during resuscitation. Blood was collected at intervals after injury to assess coagulation by rotational thromboelastometry (ROTEM) and inflammation by Multiplex cytokine analysis. Soluble P-selectin, a biomarker of platelet activation, and serumneuron-specific enolase, a biomarker of cerebral injury, were measured at intervals. Brain homogenates were analyzed for inflammatory changes by Multiplex enzyme-linked immunosorbent assay, and splenic tissue was collected for splenic cell population assessment by flow cytometry. Results: There were no coagulation, serum or cerebral cytokine, P-selectin, or neuron-specific enolase differences between mice treated with TXA or saline after TBI. After the addition of hemorrhagic shock and resuscitation to TBI, TXA administration still did not affect coagulation parameters, systemic or cerebral inflammation, or platelet activation, as compared with saline alone. At 24 hours after TBI, mice given TXA demonstrated lower splenic total cell counts central memory CD8, effector CD8, B cell, and increased naive CD4 cell populations. By contrast, TXA did not affect splenic leukocyte populations after combined TBI/H. Conclusions: Despite clinical data suggesting a mortality benefit, TXA did not modulate coagulation, inflammation, or biomarker generation in either the TBI or TBI/H murine models. Administration of TXA after TBI altered splenic leukocyte populations, which may contribute to a change in posttraumatic immune status. Future studies should be done to investigate the role of TXA in the development of posttraumatic immunosuppression and risk of nosocomial infections. (C) 2017 Elsevier Inc. All rights reserved.	[Boudreau, Ryan M.; Johnson, Mark; Veile, Rosalie; Friend, Lou Ann; Goetzman, Holly; Pritts, Timothy A.; Caldwell, Charles C.; Makley, Amy T.; Goodman, Michael D.] Univ Cincinnati, Coll Med, Dept Surg, Div Trauma Crit Care, Cincinnati, OH 45267 USA		Goodman, MD (corresponding author), Univ Cincinnati, Dept Surg, Div Trauma Crit Care, 231 Albert Sabin Way,ML 0558, Cincinnati, OH 45267 USA.	michael.goodman@uc.edu		Goodman, Michael/0000-0001-7218-4855; Caldwell, Charles/0000-0003-1692-4550	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [T35DK060444] Funding Source: NIH RePORTER		Bambakidis T, 2016, TRAUMA INDUCED COAGU, P545, DOI DOI 10.1007/978-3-319-28308-1_34; Centers for Disease Control and Prevention, 2014, C REP, P19; Dewan Y, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-87; Fiechtner BK, 2001, ANESTH ANALG, V92, P1131; Goodman MD, 2011, J SURG RES, V165, P30, DOI 10.1016/j.jss.2010.05.055; Gorlinger K., 2016, TRAUMA INDUCED COAGU, P267, DOI DOI 10.1007/978-3-319-28308-1_18; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Harvin JA, 2015, J TRAUMA ACUTE CARE, V78, P905, DOI 10.1097/TA.0000000000000612; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Hsia TY, 2010, ANN THORAC SURG, V89, P1843, DOI 10.1016/j.athoracsur.2010.02.069; Johnson BL, 2016, SHOCK, V46, P541, DOI 10.1097/SHK.0000000000000648; Lederer JA, 1999, SHOCK, V11, P153, DOI 10.1097/00024382-199903000-00001; Liou DZ, 2016, NEUROCRIT CARE, V25, P145, DOI 10.1007/s12028-015-0223-9; Lord JM, 2014, LANCET, V384, P1455, DOI 10.1016/S0140-6736(14)60687-5; Makley AT, 2012, J SURG RES, V175, pE75, DOI 10.1016/j.jss.2011.11.1028; Makley AT, 2010, J TRAUMA, V68, P305, DOI 10.1097/TA.0b013e3181cb4472; May S, PREHOSPITAL TRANEXAM; Midura EF, 2015, J SURG RES, V197, P25, DOI 10.1016/j.jss.2015.02.064; Morrison JJ, 2012, ARCH SURG-CHICAGO, V147, P113, DOI 10.1001/archsurg.2011.287; Nakae R, 2016, J NEUROTRAUM, V33, P688, DOI 10.1089/neu.2015.4039; Napolitano LM, 2013, J TRAUMA ACUTE CARE, V74, P1575, DOI 10.1097/TA.0b013e318292cc54; Parr MJ, 2008, J TRAUMA, V65, P766, DOI 10.1097/TA.0b013e31818606d2; Paterson HM, 2003, J IMMUNOL, V171, P1473, DOI 10.4049/jimmunol.171.3.1473; Perel P, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16130; Pfeifer R, 2013, CYTOKINE, V61, P585, DOI 10.1016/j.cyto.2012.10.022; Pleines UE, 2001, J NEUROTRAUM, V18, P491, DOI 10.1089/089771501300227297; Roy M, 2017, J SURG RES, V208, P104, DOI 10.1016/j.jss.2016.09.023; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Shein SL, 2014, J NEUROTRAUM, V31, P1386, DOI 10.1089/neu.2013.2985; Sillesen M, 2014, J TRAUMA ACUTE CARE, V76, P12, DOI 10.1097/TA.0b013e3182aaa675; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; Whitmore RG, 2012, J NEUROSURG, V116, P1106, DOI 10.3171/2012.1.JNS11962; Wu X, 2016, SHOCK, V47, P500; Yutthakasemsunt S, 2013, BMC EMERG MED, V13, DOI 10.1186/1471-227X-13-20	35	17	17	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	JUL	2017	215						47	54		10.1016/j.jss.2017.03.031			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	FA3RZ	WOS:000405363400008	28688660				2022-02-06	
J	Feng, Y; Ju, YR; Cui, JZ; Wang, LQ				Feng, Yan; Ju, Yaru; Cui, Jianzhong; Wang, Liqun			Bone marrow stromal cells promote neuromotor functional recovery, via upregulation of neurotrophic factors and synapse proteins following traumatic brain injury in rats	MOLECULAR MEDICINE REPORTS			English	Article						bone marrow stromal cells; traumatic brain injury; vascular endothelial growth factor; brain derived neurotrophic factor; sex determining region Y; synaptophysin	MESENCHYMAL STEM-CELLS; EXPERIMENTAL ISCHEMIC-STROKE; SPINAL-CORD-INJURY; TRANSPLANTATION; SIMVASTATIN; MARKERS; MODEL; MICE; BMSC	It has previously been demonstrated that bone marrow stromal cells (BMSCs) exhibit great therapeutic potential in neuronal injuries; however, there is limited understanding of the precise underlying mechanisms that contribute to functional improvement following brain injury. The aim of the present study was to assess the effect of BMSC treatment on traumatic brain injury (TBI) in rats, and investigate if they migrate to injured areas and promote neuromotor functional recovery via upregulation of neurotrophic factors and synaptic proteins. BMSCs were cultured in vitro from female Sprague Dawley (SD) rat bone marrow and were subsequently infused into male adult SD rats via the tail vein, following induction of TBI. The results demonstrated that treatment with BMSCs significantly reduced TBI-induced neuromotor impairment and neuronal loss, as assessed by rota rod testing, western blot analysis, modified neurological severity score and immunohistochemistry. The distribution of transplanted BMSCs was tracked by monitoring the expression of sex determining region Y (SRY) in rats. The number of cells double-positive for SRY/neuronal nuclear antigen or SRY/glial fibrillary acidic protein was increased in the BMSC group, which demonstrated that BMSCs migrated to injured areas and differentiated into neurons and astrocytes, following TBI. Furthermore, administration of BMSCs increased expression of vascular endothelial growth factor and brain derived neurotrophic factor. Protein expression levels of synaptophysin were downregulated following TBI and this was reversed in part by treatment with BMSCs. These findings uncovered some underlying mechanisms of action of BMSCs, and may lead to their potential use as a future effective therapeutic agent for the treatment of TBI.	[Feng, Yan; Wang, Liqun] Hebei Med Univ, Hosp 2, Dept Neurosurg, 215 Heping West Rd, Shijiazhuang 050000, Hebei, Peoples R China; [Ju, Yaru] Fourth Hosp Shijiazhuang, Dept Obstet, Shijiazhuang 050011, Hebei, Peoples R China; [Cui, Jianzhong] Tangshan Workers Hosp, Dept Neurosurg, Tangshan 063000, Hebei, Peoples R China		Wang, LQ (corresponding author), Hebei Med Univ, Hosp 2, Dept Neurosurg, 215 Heping West Rd, Shijiazhuang 050000, Hebei, Peoples R China.	lqwangdr@163.com					Aizawa-Kohama M, 2013, CELL TRANSPLANT, V22, P1613, DOI 10.3727/096368912X658791; Bae KS, 2011, YONSEI MED J, V52, P401, DOI 10.3349/ymj.2011.52.3.401; Bhakta S, 2006, CARDIOVASC REVASCULA, V7, P19, DOI 10.1016/j.carrev.2005.10.008; BROCK TO, 1987, J NEUROSCI, V7, P931; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Cui X, 2009, NEUROBIOL DIS, V36, P35, DOI 10.1016/j.nbd.2009.06.012; Dharmasaroja P, 2009, J CLIN NEUROSCI, V16, P12, DOI 10.1016/j.jocn.2008.05.006; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Guan J, 2003, PROG NEUROBIOL, V70, P443, DOI 10.1016/j.pneurobio.2003.08.002; Gutierrez-Fernandez M, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt159; Haar CV, 2012, RESTOR NEUROL NEUROS, V30, P291, DOI 10.3233/RNN-2012-110196; Han XG, 2012, NEUROSCI LETT, V521, P136, DOI 10.1016/j.neulet.2012.05.071; Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736; Kim JH, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-22; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Logan TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059250; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Nishida H, 2012, VET SURG, V41, P437, DOI 10.1111/j.1532-950X.2011.00959.x; Osanai T, 2012, NEUROSURGERY, V70, P435, DOI 10.1227/NEU.0b013e318230a795; Pati S, 2016, CURR STEM CELL RES T, V11, P149, DOI 10.2174/1574888X10666151019120050; Pavlichenko N, 2008, BRAIN RES, V1233, P203, DOI 10.1016/j.brainres.2008.06.123; Song MK, 2013, CELL TRANSPLANT, V22, P2001, DOI 10.3727/096368912X657909; Tohill M, 2004, NEUROSCI LETT, V362, P200, DOI 10.1016/j.neulet.2004.03.077; Ye XC, 2013, INT J MOL SCI, V14, P22221, DOI 10.3390/ijms141122221; Zhang HY, 2011, ASIAN J ANDROL, V13, P231, DOI 10.1038/aja.2010.162; Zhao L, 2012, HEPATO-GASTROENTEROL, V59, P2389, DOI 10.5754/hge12288	26	17	18	1	4	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	JUL	2017	16	1					654	660		10.3892/mmr.2017.6619			7	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	EZ9TZ	WOS:000405074100086	28560414	Green Published, hybrid, Green Submitted			2022-02-06	
J	Fraser, MA; Grooms, DR; Guskiewicz, KM; Kerr, ZY				Fraser, Melissa A.; Grooms, Dustin R.; Guskiewicz, Kevin M.; Kerr, Zachary Y.			Ball-Contact Injuries in 11 National Collegiate Athletic Association Sports: The Injury Surveillance Program, 2009-2010 Through 2014-2015	JOURNAL OF ATHLETIC TRAINING			English	Article						injury rates; injury prevention; protective equipment; head injuries; hand injuries	WOMENS GYMNASTICS INJURIES; DESCRIPTIVE EPIDEMIOLOGY; HIGH-SCHOOL; BASKETBALL INJURIES; LACROSSE INJURIES; SOCCER INJURIES; UNITED-STATES; SYSTEM; BASEBALL; CONCUSSIONS	Context: Surveillance data regarding injuries caused by ball contact in collegiate athletes have not been well examined and are mostly limited to discussions of concussions and catastrophic injuries. Objective: To describe the epidemiology of ball-contact injuries in 11 National Collegiate Athletic Association (NCAA) sports during the 2009-2010 through 2014-2015 academic years. Design: Descriptive epidemiology study. Setting: Convenience sample of NCAA programs in 11 sports (men's football, women's field hockey, women's volleyball, men's baseball, women's softball, men's and women's basketball, men's and women's lacrosse, and men's and women's soccer) during the 2009-2010 through 2014-2015 academic years. Patients or Other Participants: Collegiate student-athletes participating in 11 sports. Main Outcome Measure(s): Ball-contact-injury rates, proportions, rate ratios, and proportion ratios with 95% confidence intervals were based on data from the NCAA Injury Surveillance Program during the 2009-2010 through 2014-2015 academic years. Results: During the 2009-2010 through 2014-2015 academic years, 1123 ball-contact injuries were reported, for an overall rate of 3.54/10 000 AEs. The sports with the highest rates were women's softball (8.82/10 000 AEs), women's field hockey (7.71/10 000 AEs), and men's baseball (7.20/10 000 AEs). Most ball-contact injuries were to the hand/wrist (32.7%) and head/face (27.0%) and were diagnosed as contusions (30.5%), sprains (23.1%), and concussions (16.1%). Among sex-comparable sports (ie, baseball/softball, basketball, and soccer), women had a larger proportion of ball-contact injuries diagnosed as concussions than men (injury proportion ratio = 2.33; 95% confidence interval = 1.63, 3.33). More than half (51.0%) of ball-contact injuries were non-time loss (ie, participation-restriction time,24 hours), and 6.6% were severe (ie, participation-restriction time >= 21 days). The most common severe ball-contact injuries were concussions (n = 18) and finger fractures (n = 10). Conclusion: Ball-contact-injury rates were the highest in women's softball, women's field hockey, and men's baseball. Although more than half were non-time-loss injuries, severe injuries such as concussions and fractures were reported.	[Fraser, Melissa A.] Univ N Carolina, Human Movement Sci Curriculum, Chapel Hill, NC USA; [Guskiewicz, Kevin M.; Kerr, Zachary Y.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC USA; [Grooms, Dustin R.] Ohio Univ, Sch Appl Hlth & Wellness, Div Athlet Training, Athens, OH 45701 USA; [Kerr, Zachary Y.] Datalys Ctr Sports Injury Res & Prevent Inc, Indianapolis, IN USA; [Fraser, Melissa A.] Texas State Univ, Div Athlet Training, Dept Hlth & Human Performance, 601 Univ Dr,Jowers A126, San Marcos, TX 78666 USA		Fraser, MA (corresponding author), Texas State Univ, Div Athlet Training, Dept Hlth & Human Performance, 601 Univ Dr,Jowers A126, San Marcos, TX 78666 USA.	missyfraser@txstate.edu		Fraser, Missy/0000-0002-5753-8798	NCAA	The NCAA-ISP data were provided by the Datalys Center for Sports Injury Research and Prevention, Inc. The ISP was funded by the NCAA. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the NCAA. We thank the many ATs who have volunteered their time and efforts to submit data to the NCAA-ISP. Their efforts are greatly appreciated and have had a tremendously positive effect on the safety of collegiate athletes.	Agel J, 2007, J ATHL TRAINING, V42, P295; Agel J, 2007, J ATHL TRAINING, V42, P270; Agel J, 2007, J ATHL TRAINING, V42, P202; [Anonymous], STUD ATHL PART 1981; Boden BP, 2004, AM J SPORT MED, V32, P1189, DOI 10.1177/0363546503262161; Carniol ET, 2015, OTOLARYNG HEAD NECK, V153, P957, DOI 10.1177/0194599815602668; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Dalton SL, 2015, AM J SPORT MED, V43, P2671, DOI 10.1177/0363546515599631; Darrow CJ, 2009, AM J SPORT MED, V37, P1798, DOI 10.1177/0363546509333015; Dick R, 2007, J ATHL TRAINING, V42, P278; Dick R, 2007, J ATHL TRAINING, V42, P262; Dick R, 2007, J ATHL TRAINING, V42, P255; Dick R, 2007, J ATHL TRAINING, V42, P221; Dick R, 2007, J ATHL TRAINING, V42, P183; Dick R, 2007, J ATHL TRAINING, V42, P194; Fuller CW, 2007, BRIT J SPORT MED, V41, pI20, DOI 10.1136/bjsm.2007.037267; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kerr ZY, 2015, MMWR-MORBID MORTAL W, V64, P1330, DOI 10.15585/mmwr.mm6448a2; Kerr ZY, 2015, J ATHL TRAINING, V50, P870, DOI 10.4085/1062-6050-50.7.02; Kerr ZY, 2015, AM J SPORT MED, V43, P1134, DOI 10.1177/0363546515570622; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Kerr ZY, 2011, CLIN PEDIATR, V50, P594, DOI 10.1177/0009922810390513; Kucera KL, 2011, J ATHL TRAINING, V46, P489; Marshall SW, 2007, J ATHL TRAINING, V42, P286; Marshall SW, 2007, J ATHL TRAINING, V42, P234; Marshall SW, 2003, JAMA-J AM MED ASSOC, V289, P568, DOI 10.1001/jama.289.5.568; Nicholls RL, 2004, SPORTS MED, V34, P17, DOI 10.2165/00007256-200434010-00003; Post A, 2016, COMPUT METHOD BIOMEC, V19, P1; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; Yamamoto K, 2009, DENT TRAUMATOL, V25, P194, DOI 10.1111/j.1600-9657.2008.00747.x; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	34	17	17	0	12	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JUL	2017	52	7					698	707		10.4085/1062-6050-52.3.10			10	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	FB4RH	WOS:000406128700010	28535098	Green Published, Bronze			2022-02-06	
J	Nakase-Richardson, R; Stevens, LF; Tang, X; Lamberty, GJ; Sherer, M; Walker, WC; Pugh, MJ; Eapen, BC; Finn, JA; Saylors, M; Dillahunt-Aspillaga, C; Adams, RS; Garofano, JS				Nakase-Richardson, Risa; Stevens, Lillian Flores; Tang, Xinyu; Lamberty, Greg J.; Sherer, Mark; Walker, William C.; Pugh, Mary Jo; Eapen, Blessen C.; Finn, Jacob A.; Saylors, Mimi; Dillahunt-Aspillaga, Christina; Adams, Rachel Sayko; Garofano, Jeffrey S.			Comparison of the VA and NIDILRR TBI Model System Cohorts	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						civilians; outcomes; traumatic brain injury; Veterans	TRAUMATIC BRAIN-INJURY; FUNCTIONAL INDEPENDENCE MEASURE; POSTTRAUMATIC AMNESIA; GALVESTON ORIENTATION; OUTCOME MEASURES; PRACTICAL SCALE; REHABILITATION; SEVERITY; COMA; INDIVIDUALS	Objective: Within the same time frame, compare the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) and VA Traumatic Brain Injury Model System (TBIMS) data sets to inform future research and generalizability of findings across cohorts. Setting: Inpatient comprehensive interdisciplinary rehabilitation facilities. Participants: Civilians, Veterans, and active duty service members in the VA (n = 550) and NIDILRR civilian settings (n = 5270) who were enrolled in TBIMS between August 2009 and July 2015. Design: Prospective, longitudinal, multisite study. Main Measures: Demographics, Injury Characteristics, Functional Independence Measures, Disability Rating Scale. Results: VA and NIDILRR TBIMS participants differed on 76% of comparisons (18 Important, 8 Minor), with unique differences shown across traumatic brain injury etiology subgroups. The VA cohort was more educated, more likely to be employed at the time of injury, utilized mental health services premorbidly, and experienced greater traumatic brain injury severity. As expected, acute and rehabilitation lengths of stay were longer in the VA with no differences in death rate found between cohorts. Conclusions: Substantial baseline differences between the NIDILRR and VA TBIMS participants warrant caution when comparing rehabilitation outcomes. A substantive number of NIDILRR enrollees had a history of military service (>13%) warranting further focused study. The TBIMS participant data collected across cohorts can be used to help evidence-informed policy for the civilian and military-related healthcare systems.	[Nakase-Richardson, Risa] James A Haley Vet Hosp, MHBS, Polytrauma Mail Code 117,13000 Bruce B Downs Blvd, Tampa, FL 33612 USA; [Nakase-Richardson, Risa] Def & Vet Brain Injury Ctr, Tampa, FL USA; [Nakase-Richardson, Risa] Univ S Florida, Dept Internal Med, Tampa, FL USA; [Nakase-Richardson, Risa] VA HSRD Ctr Innovat Disabil & Rehabil Res, Tampa, FL USA; [Stevens, Lillian Flores; Walker, William C.] Hunter Holmes McGuire Vet AffairsMed Ctr, Richmond, VA USA; [Stevens, Lillian Flores] Virginia Commonwealth Univ, Dept Psychol, Box 2018, Richmond, VA 23284 USA; [Stevens, Lillian Flores; Walker, William C.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Stevens, Lillian Flores; Walker, William C.] Def & Vet Brain Injury Ctr, Richmond, VA USA; [Tang, Xinyu; Saylors, Mimi] Univ Arkansas Med Sci, Dept Pediat, Biostat Program, Little Rock, AR 72205 USA; [Lamberty, Greg J.; Finn, Jacob A.] Minneapolis VA Hlth Care Syst, Mental Hlth Serv, Minneapolis, MN USA; [Lamberty, Greg J.; Finn, Jacob A.] Univ Minnesota, Sch Med, Dept Psychiat, Minneapolis, MN 55455 USA; [Lamberty, Greg J.; Finn, Jacob A.] DVBIC, Minneapolis, MN USA; [Sherer, Mark] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA; [Pugh, Mary Jo; Eapen, Blessen C.] South Texas Vet Hlth Care Syst, Polytrauma Rehabil Ctr, San Antonio, TX USA; [Pugh, Mary Jo] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA; [Dillahunt-Aspillaga, Christina] Univ S Florida, Coll Behav & Community Sci, Tampa, FL USA; [Adams, Rachel Sayko] Brandeis Univ, Boston, MA USA; [Garofano, Jeffrey S.] Univ S Florida, Coll Educ, Tampa, FL USA		Nakase-Richardson, R (corresponding author), James A Haley Vet Hosp, MHBS, Polytrauma Mail Code 117,13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.	Risa.Richardson@va.gov	Adams, Rachel/AAH-4653-2020; Garofano, Jeffrey/AAK-9469-2021; Pugh, Mary Jo/K-5336-2019	Pugh, Mary Jo/0000-0003-4196-7763	US Department of Veterans Affairs Health Services Research and Development COIN grant (CINDRR) [1 I50 HX00123301]; Department of Veterans AffairsUS Department of Veterans Affairs; Department of Health & Human Services (National Institute on Disability, Independent Living, and Rehabilitation Research); VHA Central Office VA TBI Model System Program of Research; General Dynamics Health Solutions from the Defense and Veterans Brain Injury Center within the Defense Health Agency [W91YTZ-13-C-0015]; National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [90DP0028, 90DP00303]	The authors acknowledge the support of US Department of Veterans Affairs Health Services Research and Development COIN grant (1 I50 HX00123301; CINDRR) for assistance in manuscript preparation.; The Polytrauma Rehabilitation Center Traumatic Brain Injury (TBI) Model System collaboration is funded through an Interagency Agreement between the Department of Veterans Affairs and the Department of Health & Human Services (National Institute on Disability, Independent Living, and Rehabilitation Research). This research is sponsored by VHA Central Office VA TBI Model System Program of Research, and Subcontract from General Dynamics Health Solutions (W91YTZ-13-C-0015) from the Defense and Veterans Brain Injury Center within the Defense Health Agency.; The contents of this publication were developed under grants from the National Institute on Disability, Independent Living, and Rehabilitation Research (grant numbers 90DP0028 [PI: Sherer] and 90DP00303 [PI: Kreutzer]). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this publication do not necessarily represent the policy of NIDILRR, ACL, HHS, and Veterans Affairs, and endorsement by the Federal Government should not be assumed.	Adams RS, 2016, J HEAD TRAUMA REHAB, V31, P13, DOI 10.1097/HTR.0000000000000082; Bailey EK, 2017, J HEAD TRAUMA REHAB, V32, P245, DOI 10.1097/HTR.0000000000000317; Bode RK, 2000, J HEAD TRAUMA REHAB, V15, P637, DOI 10.1097/00001199-200002000-00004; Corrigan JD, 2013, AM J PSYCHIAT, V170, P351, DOI 10.1176/appi.ajp.2012.12121602; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Corrigan JD, 2010, J TRAUMA, V69, P722, DOI 10.1097/TA.0b013e3181e904cc; Dijkers MP, 2010, J HEAD TRAUMA REHAB, V25, P81, DOI 10.1097/HTR.0b013e3181cd3528; Dillahunt-Aspillaga C, 2017, J HEAD TRAUMA REHAB, V32, P271, DOI 10.1097/HTR.0000000000000275; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Donaghy S, 1998, ARCH PHYS MED REHAB, V79, P1231, DOI 10.1016/S0003-9993(98)90267-2; Farrell-Carnahan L, 2015, BRAIN INJURY, V29, P1400, DOI 10.3109/02699052.2015.1063161; Gause LR, 2017, J HEAD TRAUMA REHAB, V32, P255, DOI 10.1097/HTR.0000000000000309; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Hamilton BB, 1987, REHABILITATION OUTCO, P137; Hammond FM, 2004, J HEAD TRAUMA REHAB, V19, P314, DOI 10.1097/00001199-200407000-00006; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Institute of Medicine, 2008, GULF WAR HLTH, V7; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Lamberty GJ, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829a64d1; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McGarity S, 2017, J HEAD TRAUMA REHAB, V32, P34, DOI 10.1097/HTR.0000000000000242; Nakase-Richardson R, 2011, J NEUROL NEUROSUR PS, V82, P494, DOI 10.1136/jnnp.2010.222489; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; Nakase-Richardson R, 2009, ARCH PHYS MED REHAB, V90, P17, DOI 10.1016/j.apmr.2008.06.030; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Stevens LF, 2017, J HEAD TRAUMA REHAB, V32, P234, DOI 10.1097/HTR.0000000000000324; TEASDALE G, 1974, LANCET, V2, P81; Tran J, 2017, J HEAD TRAUMA REHAB, V32, P264, DOI 10.1097/HTR.0000000000000296; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033	34	17	17	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2017	32	4					221	233		10.1097/HTR.0000000000000334			13	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FA2KB	WOS:000405269200010	28678118				2022-02-06	
J	Papa, L; Mittal, MK; Ramirez, J; Silvestri, S; Giordano, P; Braga, CF; Tan, CN; Ameli, NJ; Lopez, MA; Haeussler, CA; Giordano, DM; Zonfrillo, MR				Papa, Linda; Mittal, Manoj K.; Ramirez, Jose; Silvestri, Salvatore; Giordano, Philip; Braga, Carolina F.; Tan, Ciara N.; Ameli, Neema J.; Lopez, Marco A.; Haeussler, Crystal A.; Giordano, Diego Mendez; Zonfrillo, Mark R.			Neuronal Biomarker Ubiquitin C-Terminal Hydrolase Detects Traumatic Intracranial Lesions on Computed Tomography in Children and Youth with Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						adolescents; biomarkers; children; computed tomography; concussion; diagnosis; head trauma; mild traumatic brain injury; pediatric; sensitivity; specificity; ubiquitin C-terminal hydrolase (UCH-L1); youth	FIBRILLARY ACIDIC PROTEIN; SERUM CONCENTRATIONS; RECOMMENDATIONS	This study examined the performance of serum ubiquitin C-terminal hydrolase (UCH-L1) in detecting traumatic intracranial lesions on computed tomography (CT) scan (+CT) in children and youth with mild and moderate TBI (mmTBI) and assessed its performance in trauma control patients without head trauma. This prospective cohort study enrolled children and youth presenting to three level 1 trauma centers after blunt head trauma and a Glasgow Coma Scale (GCS) score of 9-15 as well as trauma control patients with GCS 15 that did not have blunt head trauma. The primary outcome measure was the presence of intracranial lesions on initial CT scan. Blood samples were obtained in all patients within 6 h of injury and measured by enzyme-linked immunosorbent assay ELISA for UCH-L1 (ng/mL). A total of 256 children and youth were enrolled in the study and had serum samples drawn within 6 h of injury for analysis; 196 had blunt head trauma and 60 were trauma controls. CT scan of the head was performed in 151 patients and traumatic intracranial lesions on CT scan were evident in 17 (11%), all of whom had a GCS of 13-15. The area under the receiver operating characteristic curve (AUC) for UCH-L1 in detecting children and youth with traumatic intracranial lesions on CT was 0.83 (95% confidence interval [CI], 0.73-0.93). In those presenting with a GCS of 15, the AUC for detecting lesions was 0.83 (95% CI, 0.72-0.94). Similarly, in children under 5 years of age, the AUC was 0.79 (95% CI, 0.59-1.00). Performance for detecting intracranial lesions at a UCH-L1 cut-off level of 0.18 ng/mL yielded a sensitivity of 100%, a specificity of 47%, and a negative predictive value of 100%. UCH-L1 showed good performance in infants and toddlers younger than 5 years and performed well in children and youth with a GCS score of 15. Before clinical application, further study in larger cohort of children and youth with mild TBI is warranted.	[Papa, Linda; Silvestri, Salvatore; Giordano, Philip; Braga, Carolina F.; Tan, Ciara N.; Ameli, Neema J.; Lopez, Marco A.; Haeussler, Crystal A.; Giordano, Diego Mendez] Orlando Reg Med Ctr Inc, Dept Emergency Med, 86 West Underwood S-200, Orlando, FL 32806 USA; [Papa, Linda; Ramirez, Jose; Silvestri, Salvatore; Giordano, Philip] Arnold Palmer Hosp Children, Dept Pediat Emergency Med, Orlando, FL USA; [Mittal, Manoj K.] Childrens Hosp Philadelphia, Div Emergency Med, Philadelphia, PA 19104 USA; [Mittal, Manoj K.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Zonfrillo, Mark R.] Brown Univ, Dept Emergency Med, Alpert Med Sch, Providence, RI 02912 USA; [Zonfrillo, Mark R.] Hasbro Childrens Hosp, Providence, RI USA		Papa, L (corresponding author), Orlando Reg Med Ctr Inc, Dept Emergency Med, 86 West Underwood S-200, Orlando, FL 32806 USA.	1pstat@aol.com	Zonfrillo, Mark R./H-9403-2017	Zonfrillo, Mark R./0000-0002-0610-9563	National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS057676]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS057676] Funding Source: NIH RePORTER	The project described was supported, in part, by Award Number R01NS057676 from the National Institute of Neurological Disorders and Stroke (NINDS). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NINDS or the National Institutes of Health.	Berger RP, 2012, J NEUROTRAUM, V29, P672, DOI 10.1089/neu.2011.1861; Berger RP, 2012, J NEUROTRAUM, V29, P162, DOI 10.1089/neu.2011.1989; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Brenner DJ, 2010, RADIAT RES, V174, P809, DOI 10.1667/RR1859.1; de Gonzalez AB, 2009, ARCH INTERN MED, V169, P2071, DOI 10.1001/archinternmed.2009.440; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Easter JS, 2014, ANN EMERG MED, V64, P145, DOI 10.1016/j.annemergmed.2014.01.030; Faul M, 2010, TRAUMATIC BRAIN INJU; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Long A E, 1985, Emerg Med Clin North Am, V3, P437; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Mondello S, 2016, SCI REP-UK, V6, DOI 10.1038/srep28203; Nigrovic LE, 2011, PEDIATRICS, V127, P1067, DOI 10.1542/peds.2010-3373; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Papa L, 2016, SPORTS MED ARTHROSC, V24, P108, DOI 10.1097/JSA.0000000000000117; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2016, J NEUROTRAUM, V33, P58, DOI 10.1089/neu.2015.3869; Papa L, 2015, ACAD EMERG MED, V22, P1274, DOI 10.1111/acem.12795; Papa L, 2015, J NEUROTRAUM, V32, P661, DOI 10.1089/neu.2014.3655; Papa L, 2013, J NEUROTRAUM, V30, P324, DOI 10.1089/neu.2012.2545; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Rhine T, 2016, BRAIN INJURY, V30, P1231, DOI 10.1080/02699052.2016.1178396; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Welch RD, 2016, J NEUROTRAUM, V33, P203, DOI 10.1089/neu.2015.4149	26	17	18	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2017	34	13					2132	2140		10.1089/neu.2016.4806			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EZ2HM	WOS:000404530400451	28158951	Green Published			2022-02-06	
J	Werff, KRV; Rieger, B				Werff, Kathy R. Vander; Rieger, Brian			Brainstem Evoked Potential Indices of Subcortical Auditory Processing After Mild Traumatic Brain Injury	EAR AND HEARING			English	Article						Audiology; Auditory brainstem response; Auditory dysfunction; Central auditory processing; Concussion; Mild traumatic brain injury	CLOSED-HEAD INJURY; DIFFUSE AXONAL INJURY; POST-CONCUSSION SYNDROME; HEARING-LOSS; LEARNING-PROBLEMS; NERVOUS-SYSTEM; SPEECH; RESPONSES; DYSFUNCTION; CHILDREN	Objectives: The primary aim of this study was to assess subcortical auditory processing in individuals with chronic symptoms after mild traumatic brain injury (mTBI) by measuring auditory brainstem responses (ABRs) to standard click and complex speech stimuli. Consistent with reports in the literature of auditory problems after mTBI (despite normal-hearing thresholds), it was hypothesized that individuals with mTBI would have evidence of impaired neural encoding in the auditory brainstem compared to noninjured controls, as evidenced by delayed latencies and reduced amplitudes of ABR components. We further hypothesized that the speech-evoked ABR would be more sensitive than the click-evoked ABR to group differences because of its complex nature, particularly when recorded in a background noise condition. Design: Click- and speech-ABRs were collected in 32 individuals diagnosed with mTBI in the past 3 to 18 months. All mTBI participants were experiencing ongoing injury symptoms for which they were seeking rehabilitation through a brain injury rehabilitation management program. The same data were collected in a group of 32 age-and gender-matched controls with no history of head injury. ABRs were recorded in both left and right ears for all participants in all conditions. Speech-ABRs were collected in both quiet and in a background of continuous 20-talker babble ipsilateral noise. Peak latencies and amplitudes were compared between groups and across subgroups of mTBI participants categorized by their behavioral auditory test performance. Results: Click-ABR results were not significantly different between the mTBI and control groups. However, when comparing the control group to only those mTBI subjects with measurably decreased performance on auditory behavioral tests, small differences emerged, including delayed latencies for waves I, III, and V. Similarly, few significant group differences were observed for peak amplitudes and latencies of the speech-ABR when comparing at the whole group level but were again observed between controls and those mTBI subjects with abnormal behavioral auditory test performance. These differences were seen for the onset portions of the speech-ABR waveforms in quiet and were close to significant for the onset wave. Across groups, quiet versus noise comparisons were significant for most speech-ABR measures but the noise condition did not reveal more group differences than speech-ABR in quiet, likely because of variability and overall small amplitudes in this condition for both groups. Conclusions: The outcomes of this study indicate that subcortical neural encoding of auditory information is affected in a significant portion of individuals with long-term problems after mTBI. These subcortical differences appear to relate to performance on tests of auditory processing and perception, even in the absence of significant hearing loss on the audiogram. While confounds of age and slight differences in audiometric thresholds cannot be ruled out, these preliminary results are consistent with the idea that mTBI can result in neuronal changes within the subcortical auditory pathway that appear to relate to functional auditory outcomes. Although further research is needed, clinical audiological evaluation of individuals with ongoing post-mTBI symptoms is warranted for identification of individuals who may benefit from auditory rehabilitation as part of their overall treatment plan.	[Werff, Kathy R. Vander] Syracuse Univ, Dept Commun Sci & Disorders, Syracuse, NY USA; [Rieger, Brian] SUNY Upstate Med Univ, Dept Phys Med & Rehabil, Syracuse, NY 13210 USA		Werff, KRV (corresponding author), Dept Commun Sci & Disorders, 621 Skytop Rd,Suite 1200, Syracuse, NY 13244 USA.	kvander@syr.edu		Vander Werff, Kathy/0000-0003-0526-9490	National Institutes of Health/National Institute on Deafness and Other Communication DisordersUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R03 DC010246]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R03DC010246] Funding Source: NIH RePORTER	This work was funded by National Institutes of Health/National Institute on Deafness and Other Communication Disorders, R03 DC010246.	Ahadi M, 2014, INT J AUDIOL, V53, P243, DOI 10.3109/14992027.2013.866281; Aiken SJ, 2008, EAR HEARING, V29, P139, DOI 10.1097/AUD.0b013e31816453dc; American Academy of Audiology, 2010, CLIN PRACT GUID; American National Standards Institute, 2010, S361996 ANSI; American National Standards Institute, 2008, S311999 ANSI; Anderson S, 2012, J NEUROSCI, V32, P14156, DOI 10.1523/JNEUROSCI.2176-12.2012; Anderson S, 2011, EAR HEARING, V32, P750, DOI 10.1097/AUD.0b013e31822229d3; Banai K, 2005, J NEUROSCI, V25, P9850, DOI 10.1523/JNEUROSCI.2373-05.2005; BARBER HO, 1969, ANN OTO RHINOL LARYN, V78, P239, DOI 10.1177/000348946907800204; Bergemalm PO, 2005, INT J AUDIOL, V44, P39, DOI 10.1080/14992020400022546; Bergemalm PO, 2003, ACTA OTO-LARYNGOL, V123, P836, DOI 10.1080/00016480310002474; Bergemalm PO, 2001, ACTA OTO-LARYNGOL, V121, P724, DOI 10.1080/00016480152583674; Biasca N, 2007, PROG BRAIN RES, V161, P263, DOI 10.1016/S0079-6123(06)61019-4; BOHNEN N, 1993, ACTA NEUROL BELG, V93, P23; Murphy CFB, 2011, CLINICS, V66, P713, DOI 10.1590/S1807-59322011000400030; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; COCKRELL J L, 1992, Brain Injury, V6, P261, DOI 10.3109/02699059209029667; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Fligor BJ, 2002, ARCH PHYS MED REHAB, V83, P141, DOI 10.1053/apmr.2002.26813; Flood GM, 2005, BRAIN INJURY, V19, P1019, DOI 10.1080/02699050500110223; Folmer RL, 2011, INT J PSYCHOPHYSIOL, V82, P4, DOI 10.1016/j.ijpsycho.2011.03.005; Fourtassi M, 2011, CLIN NEUROL NEUROSUR, V113, P716, DOI 10.1016/j.clineuro.2011.07.010; Gallun FJ, 2012, J REHABIL RES DEV, V49, P1005, DOI 10.1682/JRRD.2012.03.0038; Gennarelli, 1998, Semin Clin Neuropsychiatry, V3, P160; Gennarelli TA, 1998, NEUROSCIENTIST, V4, P202, DOI 10.1177/107385849800400316; Green P, 2004, GREENS MED SYMPTOM V; GREENBERG RP, 1977, J NEUROSURG, V47, P163, DOI 10.3171/jns.1977.47.2.0163; Gutierrez-Cadavid JE., 2005, IMAGING NERVOUS SYST, P869; HALL JW, 1983, OTOLARYNG HEAD NECK, V91, P50, DOI 10.1177/019459988309100110; Hayes EA, 2003, CLIN NEUROPHYSIOL, V114, P673, DOI 10.1016/S1388-2457(02)00414-5; Hornickel J, 2009, AUDIOL NEURO-OTOL, V14, P198, DOI 10.1159/000188533; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Johnson KL, 2005, EAR HEARING, V26, P424, DOI 10.1097/01.aud.0000179687.71662.6e; Johnson KL, 2008, J NEUROSCI, V28, P4000, DOI 10.1523/JNEUROSCI.0012-08.2008; Jury MA, 2001, NEW ZEAL MED J, V114, P286; Katz J, 1991, Ann N Y Acad Sci, V620, P233; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; Lew HL, 2007, J REHABIL RES DEV, V44, P963, DOI 10.1682/JRRD.2006.12.0169; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Munjal SK, 2010, J TRAUMA, V68, P13, DOI 10.1097/TA.0b013e3181c9f274; Munjal SK, 2010, J NEUROTRAUM, V27, P309, DOI 10.1089/neu.2009.0957; Musiek FE, 2005, EAR HEARING, V26, P608, DOI 10.1097/01.aud.0000188069.80699.41; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Nolle C, 2004, J NEUROTRAUM, V21, P251, DOI 10.1089/089771504322972040; NOSEWORTHY JH, 1981, ARCH NEUROL-CHICAGO, V38, P275, DOI 10.1001/archneur.1981.00510050041004; OTTAVIANI F, 1986, ELECTROEN CLIN NEURO, V65, P196, DOI 10.1016/0168-5597(86)90054-7; Parbery-Clark A, 2011, EUR J NEUROSCI, V33, P549, DOI 10.1111/j.1460-9568.2010.07546.x; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROWE MJ, 1980, ARCH NEUROL-CHICAGO, V37, P679, DOI 10.1001/archneur.1980.00500600027002; Russo N, 2004, CLIN NEUROPHYSIOL, V115, P2021, DOI 10.1016/j.clinph.2004.04.003; Russo NM, 2005, BEHAV BRAIN RES, V156, P95, DOI 10.1016/j.bbr.2004.05.012; SCHOENHUBER R, 1986, NEUROSURGERY, V19, P532, DOI 10.1227/00006123-198610000-00006; SCHOENHUBER R, 1988, J NEUROSURG, V68, P742, DOI 10.3171/jns.1988.68.5.0742; Song JH, 2006, AUDIOL NEURO-OTOL, V11, P233, DOI 10.1159/000093058; SOUSTIEL JF, 1995, BRAIN INJURY, V9, P805, DOI 10.3109/02699059509008236; Tillman T.W., 1966, SAMTR6655 USAF SCH A; Tremblay K, 2001, EAR HEARING, V22, P79, DOI 10.1097/00003446-200104000-00001; Tremblay KL, 2002, J SPEECH LANG HEAR R, V45, P564, DOI 10.1044/1092-4388(2002/045); Turgeon C, 2011, EAR HEARING, V32, P667, DOI 10.1097/AUD.0b013e31821209d6; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Werff KRV, 2011, EAR HEARING, V32, P168, DOI 10.1097/AUD.0b013e3181f534b5; Wible B, 2004, BIOL PSYCHOL, V67, P299, DOI 10.1016/j.biopsycho.2004.02.002; Wible B, 2005, BRAIN, V128, P417, DOI 10.1093/brain/awh367; Wilson RH, 2007, J AM ACAD AUDIOL, V18, P813, DOI 10.3766/jaaa.18.10.2; Wilson RH, 2005, J REHABIL RES DEV, V42, P839, DOI 10.1682/JRRD.2005.01.0009; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906	70	17	17	1	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0196-0202	1538-4667		EAR HEARING	Ear Hear.	JUL-AUG	2017	38	4					E200	E214		10.1097/AUD.0000000000000411			15	Audiology & Speech-Language Pathology; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Otorhinolaryngology	EY6VS	WOS:000404122300001	28319479	Green Accepted			2022-02-06	
J	Tan, HJ; Yang, WJ; Wu, CG; Liu, BL; Lu, H; Wang, H; Yan, H				Tan, Huajun; Yang, Weijian; Wu, Chenggang; Liu, Baolong; Lu, Hao; Wang, Hong; Yan, Hua			Assessment of the role of intracranial hypertension and stress on hippocampal cell apoptosis and hypothalamic-pituitary dysfunction after TBI	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; EXPERIMENTAL EPIDURAL HEMATOMA; SUBARACHNOID HEMORRHAGE; MASS LESION; HYPOPITUITARISM; RATS; RODENTS; AXIS	In recent years, hypopituitarism caused by traumatic brain injury (TBI) has been explored in many clinical studies; however, few studies have focused on intracranial hypertension and stress caused by TBI. In this study, an intracranial hypertension model, with epidural hematoma as the cause, was used to explore the physiopathological and neuroendocrine changes in the hypothalamic-pituitary axis and hippocampus. The results demonstrated that intracranial hypertension increased the apoptosis rate, caspase-3 levels and proliferating cell nuclear antigen (PCNA) in the hippocampus, hypothalamus, pituitary gland and showed a consistent rate of apoptosis within each group. The apoptosis rates of hippocampus, hypothalamus and pituitary gland were further increased when intracranial pressure (ICP) at 24 hour (h) were still increased. The change rates of apoptosis in hypothalamus and pituitary gland were significantly higher than hippocampus. Moreover, the stress caused by surgery may be a crucial factor in apoptosis. To confirm stress leads to apoptosis in the hypothalamus and pituitary gland, we used rabbits to establish a standard stress model. The results confirmed that stress leads to apoptosis of neuroendocrine cells in the hypothalamus and pituitary gland, moreover, the higher the stress intensity, the higher the apoptosis rate in the hypothalamus and pituitary gland.	[Tan, Huajun; Yang, Weijian; Lu, Hao] Tianjin Med Univ, Grad Sch, Tianjin 300070, Peoples R China; [Tan, Huajun; Yang, Weijian; Wang, Hong; Yan, Hua] Tianjin Huanhu Hosp, Dept Neurosurg, Tianjin 300350, Peoples R China; [Wu, Chenggang] Tianjin Univ Tradit Chinese Med, Affiliated Hosp 2, Dept Neurosurg, Tianjin 300151, Peoples R China; [Liu, Baolong] Tianjin Huanhu Hosp, Dept Ultrasonog, Tianjin 300350, Peoples R China; [Yan, Hua] Tianjin Key Lab Cerebral Vasc & Neurodegenerat Di, Tianjin 300350, Peoples R China		Yan, H (corresponding author), Tianjin Huanhu Hosp, Dept Neurosurg, Tianjin 300350, Peoples R China.; Yan, H (corresponding author), Tianjin Key Lab Cerebral Vasc & Neurodegenerat Di, Tianjin 300350, Peoples R China.	yanhua20042007@sina.com			Tianjin Municipal Commission of Health and Family Planning [15KG106, 14KG115, 2015KY15, 12KG115]	This study was financially supported by the grants (No. 15KG106, No. 14KG115, No. 2015KY15, No. 12KG115) awarded by Tianjin Municipal Commission of Health and Family Planning.	Balikci M, 2008, NEUROL RES, V30, P450, DOI 10.1179/016164107X251637; Bavisetty S, 2008, NEUROSURGERY, V62, P1080, DOI 10.1227/01.neu.0000325870.60129.6a; Burger R, 2003, J NEUROTRAUM, V20, P543, DOI 10.1089/089771503767168474; Burger R, 2002, J NEUROSURG, V97, P1410, DOI 10.3171/jns.2002.97.6.1410; Ciccocioppo R, 2014, J NEUROSCI, V34, P363, DOI 10.1523/JNEUROSCI.2400-13.2014; Conti AC, 1998, J NEUROSCI, V18, P5663; Dusick Joshua R, 2012, Pituitary, V15, P2, DOI 10.1007/s11102-008-0130-6; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Fernandez-Rodriguez E, 2015, ENDOCRIN METAB CLIN, V44, P151, DOI 10.1016/j.ecl.2014.10.012; Gardner CJ, 2015, EUR J ENDOCRINOL, V172, P371, DOI 10.1530/EJE-14-0654; Giannoudis PV, 2006, INJURY, V37, pS3, DOI 10.1016/S0020-1383(07)70005-0; Goncharova Nadezhda D, 2013, Front Endocrinol (Lausanne), V4, P26, DOI 10.3389/fendo.2013.00026; Gong S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117503; Griesbach GS, 2011, NEUROSCIENCE, V178, P147, DOI 10.1016/j.neuroscience.2011.01.028; Grundy PL, 2001, J NEUROTRAUM, V18, P1373, DOI 10.1089/08977150152725669; Karamouzis I, 2016, ENDOCRINE, V52, P441, DOI 10.1007/s12020-015-0796-2; Kasturi BS, 2009, J NEUROTRAUM, V26, P1315, DOI [10.1089/neu.2008.0751, 10.1089/neu.2008-0751]; Klose M, 2007, CLIN ENDOCRINOL, V67, P193, DOI 10.1111/j.1365-2265.2007.02860.x; Krahulik D, 2010, J NEUROSURG, V113, P581, DOI 10.3171/2009.10.JNS09930; Lavrnja I, 2014, PHYSIOL BEHAV, V125, P30, DOI 10.1016/j.physbeh.2013.11.005; Lipponen A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31570; Marina D, 2015, EUR J ENDOCRINOL, V172, P813, DOI 10.1530/EJE-14-1152; Masel BE, 2015, J NEUROTRAUM, V32, P1902, DOI 10.1089/neu.2014.3526; Olivecrona Z, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-33; Pan AH, 2013, J NEUROSCI RES, V91, P249, DOI 10.1002/jnr.23148; Patchev Vladimir K, 2006, Dialogues Clin Neurosci, V8, P417; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Prasanna KL, 2015, BRAIN INJURY, V29, P336, DOI 10.3109/02699052.2014.955882; Richmond E, 2014, ENDOCRINE, V45, P3, DOI 10.1007/s12020-013-0049-1; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2007, LANCET, V369, P1461, DOI 10.1016/S0140-6736(07)60673-4; Tanriverdi F, 2015, ENDOCR REV, V36, P305, DOI 10.1210/er.2014-1065; Taylor AN, 2013, J NEUROTRAUM, V30, P1250, DOI 10.1089/neu.2012.2847; Tritos NA, 2015, ENDOCR PRACT, V21, P823, DOI 10.4158/EP14567.DSCR; Wang H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142561; Wang XT, 2016, J NEUROTRAUM, V33, P721, DOI 10.1089/neu.2015.4097; XU BN, 1993, NEUROSURGERY, V32, P289, DOI 10.1227/00006123-199302000-00019	37	17	18	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUN 19	2017	7								3805	10.1038/s41598-017-04008-w			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EY0LT	WOS:000403650300048	28630478	Green Published, gold			2022-02-06	
J	Streijger, F; Skinnider, MA; Rogalski, JC; Balshaw, R; Shannon, CP; Prudova, A; Belanger, L; Ritchie, L; Tsang, A; Christie, S; Parent, S; Mac-Thiong, JM; Bailey, C; Urquhart, J; Ailon, T; Paquette, S; Boyd, M; Street, J; Fisher, CG; Dvorak, MF; Borchers, CH; Foster, LJ; Kwon, BK				Streijger, Femke; Skinnider, Michael A.; Rogalski, Jason C.; Balshaw, Robert; Shannon, Casey P.; Prudova, Anna; Belanger, Lise; Ritchie, Leanna; Tsang, Angela; Christie, Sean; Parent, Stefan; Mac-Thiong, Jean-Marc; Bailey, Christopher; Urquhart, Jennifer; Ailon, Tamir; Paquette, Scott; Boyd, Michael; Street, John; Fisher, Charles G.; Dvorak, Marcel F.; Borchers, Christoph H.; Foster, Leonard J.; Kwon, Brian K.			A Targeted Proteomics Analysis of Cerebrospinal Fluid after Acute Human Spinal Cord Injury	JOURNAL OF NEUROTRAUMA			English	Article						biomarkers; CSF; injury severity; proteomics; SCI	TRAUMATIC BRAIN-INJURY; COAGULATION-FACTOR-XII; ISCHEMIA-REPERFUSION INJURY; KALLIKREIN-KININ SYSTEM; CLINICAL-TRIALS; NEUROLOGICAL CLASSIFICATION; INTERNATIONAL STANDARDS; STRUCTURAL BIOMARKERS; THERAPEUTIC TARGET; CONTUSION INJURY	Efforts to validate novel therapies in acute clinical trials for spinal cord injury (SCI) are impeded by the lack of objective quantitative measures that reflect injury severity and accurately predict neurological recovery. Therefore, a strong rationale exists for establishing neurochemical biomarkers that objectively quantify injury severity and predict outcome. Here, we conducted a targeted proteomics analysis of cerebrospinal fluid (CSF) samples derived from 29 acute SCI patients (American Spinal Injury Association Impairment Scale [AIS] A, B, or C) acquired at 24, 48, and 72h post-injury. From a total of 165 proteins, we identified 27 potential biomarkers of injury severity (baseline AIS A, B, or C), with triosephosphate isomerase having the strongest relationship to AIS grade. The majority of affected proteins (24 of 27) were more abundant in samples from AIS A patients than in those from AIS C patients, suggesting that for the most part, these proteins are released into the CSF more readily with more severe trauma to the spinal cord. We then analyzed the relationship between CSF protein abundance and neurological recovery. For AIS grade improvement over 6 months, we identified 34 proteins that were associated with AIS grade conversion (p<0.05); however, these associations were not statistically significant after adjusting for multiple comparisons. For total motor score (TMS) recovery over 6 months, after adjusting for baseline neurological injury level, we identified 46 proteins with a statistically significant association with TMS recovery. Twenty-two of these proteins were among the 27 proteins that were related to baseline AIS grade, consistent with the notion that protein markers that reflect a more severe injury also appropriately predict a poorer recovery of motor function. In summary, this study provides a description of the CSF proteome changes that occur after acute human SCI, and reveals a number of protein candidates for further validation as potential biomarkers of injury severity.	[Streijger, Femke; Kwon, Brian K.] Univ British Columbia, Int Collaborat Repair Discoveries ICORD, Blusson Spinal Cord Ctr, Vancouver, BC, Canada; [Skinnider, Michael A.; Rogalski, Jason C.; Prudova, Anna; Foster, Leonard J.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC, Canada; [Skinnider, Michael A.; Rogalski, Jason C.; Prudova, Anna; Foster, Leonard J.] Univ British Columbia, Michael Smith Labs, Vancouver, BC, Canada; [Skinnider, Michael A.] Univ British Columbia, Genome Sci & Technol Grad Program, Vancouver, BC, Canada; [Ailon, Tamir; Paquette, Scott; Boyd, Michael] Univ British Columbia, Vancouver Spine Surg Inst, Div Neurosurg, Vancouver, BC, Canada; [Ailon, Tamir; Paquette, Scott; Boyd, Michael] Univ British Columbia, Dept Orthopaed, Vancouver, BC, Canada; [Balshaw, Robert] BC Ctr Dis Control, Vancouver, BC, Canada; [Balshaw, Robert; Shannon, Casey P.] PROOF Ctr Excellence, Vancouver, BC, Canada; [Belanger, Lise; Ritchie, Leanna; Tsang, Angela] Vancouver Spine Program, Vancouver, BC, Canada; [Christie, Sean] Dalhousie Univ, Halifax Infirm Halifax, Div Neurosurg, Halifax, NS, Canada; [Parent, Stefan; Mac-Thiong, Jean-Marc] Univ Montreal, Hop Sacre Coeur Montreal, Dept Surg, Montreal, PQ, Canada; [Parent, Stefan; Mac-Thiong, Jean-Marc] Univ Montreal, Dept Surg, Chu St Justine, Montreal, PQ, Canada; [Bailey, Christopher; Urquhart, Jennifer] Univ Western Ontario, London Hlth Sci Ctr, Div Orthopaed Surg, London, ON, Canada; [Borchers, Christoph H.] UVic Genome BC Prote Ctr, Victoria, BC, Canada		Kwon, BK (corresponding author), Univ British Columbia, Dept Orthopaed, Int Collaborat Repair Discoveries ICORD, Blusson Spinal Cord Ctr, 6th Floor,VGH 818 West 10th Ave, Vancouver, BC V5Z 1M9, Canada.	brian.kwon@ubc.ca	Urquhart, Jennifer/Q-7604-2016; BORCHERS, Christoph/U-5964-2019; Parent, Stefan/AAO-7492-2020; Bailey, Chris S/L-7522-2015	Urquhart, Jennifer/0000-0002-9393-814X; Parent, Stefan/0000-0002-4854-2816; Bailey, Chris S/0000-0001-5508-8415; Dvorak, Marcel/0000-0002-9404-8448; Shannon, Casey/0000-0002-5687-3156; Christie, Sean/0000-0002-3540-6022; Skinnider, Michael/0000-0002-2168-1621	Rick Hansen Institute; Paralyzed Veterans of America; Craig Neilsen Foundation; Brain Canada; VGH & UBC Hospital Foundation	The authors gratefully acknowledge the assistance of Allan Aludino and Leilani Reichl of the Vancouver Spine Research Program for support of the clinical trial, Daniel Rogers of the Rick Hansen Institute for managing the Canadian Multicentre CSF Monitoring and Biomarker (CAMPER) study, and Sara Assadian for managing the Brain Canada Multi-Investigator Research Initiative (MIRI). The clinical trial and proteomics analysis were generously supported by the Rick Hansen Institute, Paralyzed Veterans of America, Craig Neilsen Foundation, Brain Canada, and the VGH & UBC Hospital Foundation. The mass spectrometry infrastructure used here was supported by the Canada Foundation for Innovation, the BC Knowledge Development Fund and the BC Proteomics Network. M.F.D. is the Paetzold Chair in Spinal Cord Injury, and B.K.K. is the Canada Research Chair in Spinal Cord Injury and the VGH & UBC Hospital Foundation Dvorak Chair of Spinal Trauma.	Adams RA, 2007, CURR MED CHEM, V14, P2925, DOI 10.2174/092986707782360015; Albert-Weissenberger C, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00345; Austinat M, 2009, STROKE, V40, P285, DOI 10.1161/STROKEAHA.108.526673; Bergamaschini L, 1998, ALZ DIS ASSOC DIS, V12, P102, DOI 10.1097/00002093-199806000-00008; Bost F, 1998, EUR J BIOCHEM, V252, P339, DOI 10.1046/j.1432-1327.1998.2520339.x; Boulos S, 2007, J NEUROSCI RES, V85, P3089, DOI 10.1002/jnr.21429; Burkhard PR, 2001, NEUROLOGY, V56, P1528, DOI 10.1212/WNL.56.11.1528; Burns AS, 2003, J NEUROTRAUM, V20, P477, DOI 10.1089/089771503765355540; Cao F, 2008, J CLIN NEUROSCI, V15, P541, DOI 10.1016/j.jocn.2007.05.014; Cao KAL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-253; Chan QWT, 2006, MOL CELL PROTEOMICS, V5, P2252, DOI 10.1074/mcp.M600197-MCP200; Chen AS, 2013, NEUROCHEM RES, V38, P2247, DOI 10.1007/s11064-013-1132-y; Chen AS, 2010, J NEUROTRAUM, V27, P263, DOI 10.1089/neu.2009.1051; Davalos D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2230; De Simoni MG, 2004, AM J PATHOL, V164, P1857, DOI 10.1016/S0002-9440(10)63744-3; Ding QX, 2006, PROTEOMICS, V6, P505, DOI 10.1002/pmic.200500296; Fawcett JW, 2007, SPINAL CORD, V45, P190, DOI 10.1038/sj.sc.3102007; Fehlings MG, 2010, SPINE, V35, pS166, DOI 10.1097/BRS.0b013e3181f386f6; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Gao Q, 2012, NEURAL REGEN RES, V7, P1534, DOI 10.3969/j.issn.1673-5374.2012.20.002; Gesuete R, 2009, ANN NEUROL, V66, P332, DOI 10.1002/ana.21740; Gilmer LK, 2009, J NEUROTRAUM, V26, P1271, DOI 10.1089/neu.2008.0857; Gobel K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11626; Gomes-Osman J, 2016, J NEUROTRAUM, V33, P425, DOI 10.1089/neu.2014.3812; Hawryluk GWJ, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E14; Heydenreich N, 2012, STROKE, V43, P2457, DOI 10.1161/STROKEAHA.112.660340; Hopp S, 2016, ANN NEUROL, V79, P970, DOI 10.1002/ana.24655; Hopp S, 2015, NEURAL REGEN RES, V10, P885, DOI 10.4103/1673-5374.158339; Hsich G, 1996, NEW ENGL J MED, V335, P924, DOI 10.1056/NEJM199609263351303; Kang SK, 2006, PROTEOMICS, V6, P2797, DOI 10.1002/pmic.200500621; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Kleinschnitz C, 2006, J EXP MED, V203, P513, DOI 10.1084/jem.20052458; Krenzlin H, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010084; Krueger H, 2013, CHRON DIS INJ CAN, V33, P113; Kuhle J, 2015, J NEUROL NEUROSUR PS, V86, P273, DOI 10.1136/jnnp-2013-307454; Kwon BK, 2017, J NEUROTRAUM, V34, P567, DOI 10.1089/neu.2016.4435; Kwon BK, 2011, CLIN CHEM LAB MED, V49, P425, DOI 10.1515/CCLM.2011.068; Kwon BK, 2010, J NEUROTRAUM, V27, P669, DOI 10.1089/neu.2009.1080; Lammertse DP, 2013, SPINAL CORD, V51, P2, DOI 10.1038/sc.2012.137; Lee RS, 2012, J CLIN NEUROSCI, V19, P1338, DOI 10.1016/j.jocn.2012.02.015; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; Longhi L, 2008, ACTA NEUROCHIR SUPPL, V102, P381, DOI 10.1007/978-3-211-85578-2_73; Longhi L, 2009, CRIT CARE MED, V37, P659, DOI 10.1097/CCM.0b013e318195998a; Loy DN, 2005, NEUROSURGERY, V56, P391, DOI 10.1227/01.NEU.0000148906.83616.D2; Lubieniecka JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019247; Marincola FM, 2011, J INTERN MED, V270, P123, DOI 10.1111/j.1365-2796.2011.02402.x; Marklund N, 2006, NEUROCHEM RES, V31, P1085, DOI 10.1007/s11064-006-9120-0; Moghieb A, 2016, MOL CELL PROTEOMICS, V15, P2379, DOI 10.1074/mcp.M116.058115; Mohammed Y, 2014, J PROTEOMICS, V106, P151, DOI 10.1016/j.jprot.2014.04.018; Mostacada K, 2015, EXP NEUROL, V271, P390, DOI 10.1016/j.expneurol.2015.07.006; Namikawa K, 1998, MOL BRAIN RES, V55, P315, DOI 10.1016/S0169-328X(98)00012-6; Ng MTL, 2011, TRANSL STROKE RES, V2, P474, DOI 10.1007/s12975-011-0109-x; Noonan VK, 2012, NEUROEPIDEMIOLOGY, V38, P219, DOI 10.1159/000336014; Percy AJ, 2014, J PROTEOME RES, V13, P3733, DOI 10.1021/pr500317d; Pouw MH, 2014, SPINAL CORD, V52, P428, DOI 10.1038/sc.2014.26; Priebe MM, 2007, ARCH PHYS MED REHAB, V88, pS84, DOI 10.1016/j.apmr.2006.12.005; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Raslan F, 2010, J CEREBR BLOOD F MET, V30, P1477, DOI 10.1038/jcbfm.2010.28; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sengupta MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110885; Siman R, 2004, NEUROBIOL DIS, V16, P311, DOI 10.1016/j.nbd.2004.03.016; Singh A, 2014, CLIN EPIDEMIOL, V6, P309, DOI 10.2147/CLEP.S68889; Sullivan PG, 2007, J NEUROTRAUM, V24, P991, DOI 10.1089/neu.2006.0242; Takahashi H, 1999, CLIN DIAGN LAB IMMUN, V6, P983, DOI 10.1128/CDLI.6.6.983-985.1999; Tator CH, 2006, NEUROSURGERY, V59, P957, DOI 10.1227/01.NEU.0000245591.16087.89; Tei R, 2008, NEUROL RES, V30, P761, DOI 10.1179/174313208X284241; Van Dijk W., 2013, LANDES BIOSCIENCE, P633; Walden K, 2016, SPINAL CORD, V54, P197, DOI 10.1038/sc.2015.137; Wang CY, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-13; Xie J, 2003, BLOOD, V101, P4005, DOI 10.1182/blood-2002-11-3368; Yan XD, 2010, NEUROCHEM INT, V56, P971, DOI 10.1016/j.neuint.2010.04.007; Yan XD, 2009, J NEUROTRAUM, V26, P179, DOI 10.1089/NEU.2008.0533; Yokobori S, 2015, WORLD NEUROSURG, V83, P867, DOI 10.1016/j.wneu.2013.03.012; Zetterberg H., 2016, REV CELL BIOL MOL ME, V2, P62	74	17	18	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 15	2017	34	12					2054	2068		10.1089/neu.2016.4879			15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EX0AN	WOS:000402880600006	28276985				2022-02-06	
J	Hall, AA; Mendoza, MI; Zhou, HB; Shaughness, M; Maudlin-Jeronimo, E; McCarron, RM; Ahlers, ST				Hall, Aaron A.; Mendoza, Mirian I.; Zhou, Hanbing; Shaughness, Michael; Maudlin-Jeronimo, Eric; McCarron, Richard M.; Ahlers, Stephen T.			Repeated Low Intensity Blast Exposure Is Associated with Damaged Endothelial Glycocalyx and Downstream Behavioral Deficits	FRONTIERS IN BEHAVIORAL NEUROSCIENCE			English	Article						blast; glycocalyx; behavioral deficits; traumatic brain injury; repeated low intensity	TRAUMATIC BRAIN-INJURY; LOW-LEVEL BLAST; CEREBRAL-BLOOD-FLOW; RAT-BRAIN; IN-VIVO; MODEL; MICE; HYALURONIDASE; PRESSURE; SIZE	Current clinical research into mild traumatic brain injury (mTBI) has focused on white matter changes as identified by advanced MRI based imaging techniques. However, perivascular tau accumulation in the brains of individuals diagnosed with mTBI suggests that the vasculature plays a key role in the pathology. This study used a rat model to examine whether the endothelial glycocalyx, a layer of the vasculature responsible for sensing luminal shear forces, is damaged by exposure to repeated low intensity blast, and whether this layer is associated with observed behavioral deficits. The blast exposure used consisted of 12, 40 kPa blast exposures conducted with a minimum of 24 h between blasts. We found that repeated blast exposure reduced glycocalyx length and density in various brain regions indicating damage. This blast exposure paradigm was associated with a mild performance decrement in the Morris water maze (MWM) which assesses learning and memory. Administration of hyaluronidase, an enzyme that binds to and degrades hyaluronan (a major structural component of the glycocalyx) prior to blast exposure reduced the observed behavioral deficits and induced a thickening of the glycocalyx layer. Taken together these findings demonstrate that the endothelial glycocalyx degradation following repeated blast is associated with behavioral decrements which can be prevented by treatment with hyaluronidase.	[Hall, Aaron A.; Mendoza, Mirian I.; Zhou, Hanbing; Shaughness, Michael; Maudlin-Jeronimo, Eric; McCarron, Richard M.; Ahlers, Stephen T.] Naval Med Res Ctr, Neurotrauma Dept, Operat & Undersea Med, Silver Spring, MD 20910 USA		Hall, AA (corresponding author), Naval Med Res Ctr, Neurotrauma Dept, Operat & Undersea Med, Silver Spring, MD 20910 USA.	aaron.a.hall6.civ@mail.mil			DMRDP [D61_I_10_J6_243]	The views expressed here are those of the authors and do not necessarily reflect the official policy of position of the Department of the Navy, Department of Defense, nor the U.S. Government. This work was funded by the DMRDP award number D61_I_10_J6_243. This work was prepared as a part of official duties; Title 17 USC (sic) 105 provides that 'Copyright protection under this title is not available for any work of the U.S. Government.' Title 17 (sic) USC 101 defines a US Government work as a work prepared by a military service member of employee of the US Government as part of that person's official duties.	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Ahlers Stephen Thomas, 2012, Front Neurol, V3, P32, DOI 10.3389/fneur.2012.00032; Ahmed F, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00114; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; Carr W, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00049; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; Eskens BJM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055399; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Jepsen CH, 2014, J TRAUMA ACUTE CARE, V77, P292, DOI 10.1097/TA.0000000000000333; Jespersen SN, 2012, J CEREBR BLOOD F MET, V32, P264, DOI 10.1038/jcbfm.2011.153; Landsverk SA, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/842545; Lennon FE, 2011, AM J CARDIOVASC DIS, V1, P200; Lucca JJD, 2012, J NEUROL SCI, V318, P146, DOI 10.1016/j.jns.2012.02.002; McConnell ED, 2016, J CEREBR BLOOD F MET, V36, P1537, DOI 10.1177/0271678X15608389; Muckenschnabel I, 1998, CANCER LETT, V131, P71, DOI 10.1016/S0304-3835(98)00203-1; Potter DR, 2009, CIRC RES, V104, P1318, DOI 10.1161/CIRCRESAHA.108.191585; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Saljo A, 2011, NEUROIMAGE, V54, pS83, DOI 10.1016/j.neuroimage.2010.05.050; Saljo A, 2010, J NEUROTRAUM, V27, P383, DOI 10.1089/neu.2009.1053; Shetty AK, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00232; Sosa MAG, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-67; Sverrisson K, 2014, AM J PHYSIOL-RENAL, V307, pF1136, DOI 10.1152/ajprenal.00181.2014; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; van den Berg BM, 2003, CIRC RES, V92, P592, DOI 10.1161/01.RES.0000065917.53950.75; Vogel J, 2000, J CEREBR BLOOD F MET, V20, P1571, DOI 10.1097/00004647-200011000-00007; Zeng Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043168	29	17	17	0	3	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1662-5153			FRONT BEHAV NEUROSCI	Front. Behav. Neurosci.	JUN 9	2017	11								104	10.3389/fnbeh.2017.00104			10	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	EX2LK	WOS:000403057600001	28649193	Green Published, gold			2022-02-06	
J	Vascak, M; Sun, JL; Baer, M; Jacobs, KM; Povlishock, JT				Vascak, Michal; Sun, Jianli; Baer, Matthew; Jacobs, Kimberle M.; Povlishock, John T.			Mild Traumatic Brain Injury Evokes Pyramidal Neuron Axon Initial Segment Plasticity and Diffuse Presynaptic Inhibitory Terminal Loss	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						mild traumatic brain injury; axon initial segment; GABAergic synapse; plasticity; action potential initiation; layer 5 pyramidal neurons; transgenic mouse models; excitation-inhibition balance	ACTION-POTENTIAL INITIATION; ACTIVITY-DEPENDENT RELOCATION; LAYER-V; FUNCTIONAL CONNECTIVITY; PARVALBUMIN INTERNEURONS; PERISOMATIC INHIBITION; SYNAPTIC PROPERTIES; CHANDELIER CELLS; SODIUM-CHANNELS; CEREBRAL-CORTEX	The axon initial segment (AIS) is the site of action potential (AP) initiation, thus a crucial regulator of neuronal activity. In excitatory pyramidal neurons, the high density of voltage-gated sodium channels (NaV1.6) at the distal AIS regulates AP initiation. A surrogate AIS marker, ankyrin-G (ankG) is a structural protein regulating neuronal functional via clustering voltage-gated ion channels. In neuronal circuits, changes in presynaptic input can alter postsynaptic output via AIS structural-functional plasticity. Recently, we showed experimental mild traumatic brain injury (mTBI) evokes neocortical circuit disruption via diffuse axonal injury (DAI) of excitatory and inhibitory neuronal systems. A key finding was that mTBI-induced neocortical electrophysiological changes involved non-DAI/intact excitatory pyramidal neurons consistent with AIS-specific alterations. In the current study we employed Thy1-yellow fluorescent protein (YFP)-H mice to test if mTBI induces AIS structural and/or functional plasticity within intact pyramidal neurons 2 days after mTBI. We used confocal microscopy to assess intact YFP+ pyramidal neurons in layer 5 of primary somatosensory barrel field (S1BF), whose axons were continuous from the soma of origin to the subcortical white matter (SCWM). YFP+ axonal traces were superimposed on ankG and NaV1.6 immunofluorescent profiles to determine AIS position and length. We found that while mTBI had no effect on ankG start position, the length significantly decreased from the distal end, consistent with the site of AP initiation at the AIS. However, NaV1.6 structure did not change after mTBI, suggesting uncoupling from ankG. Parallel quantitative analysis of presynaptic inhibitory terminals along the postsynaptic perisomatic domain of these same intact YFP+ excitatory pyramidal neurons revealed a significant decrease in GABAergic bouton density. Also within this non-DAI population, patch-clamp recordings of intact YFP+ pyramidal neurons showed AP acceleration decreased 2 days post-mTBI, consistent with AIS functional plasticity. Simulations of realistic pyramidal neuron computational models using experimentally determined AIS lengths showed a subtle decrease is NaV1.6 density is sufficient to attenuate AP acceleration. Collectively, these findings highlight the complexity of mTBI-induced neocortical circuit disruption, involving changes in extrinsic/presynaptic inhibitory perisomatic input interfaced with intrinsic/postsynaptic intact excitatory neuron AIS output.	[Vascak, Michal; Sun, Jianli; Baer, Matthew; Jacobs, Kimberle M.; Povlishock, John T.] Virginia Commonwealth Univ, Sch Med, Dept Anat & Neurobiol, Richmond, VA 23284 USA		Povlishock, JT (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Anat & Neurobiol, Richmond, VA 23284 USA.	john.povlishock@vcuhealth.org	Jacobs, Kimberle/AAW-7526-2020	Vascak, Michal/0000-0001-8916-0796	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS077675]	This work was funded by National Institutes of Health (NIH) Grant NS077675.	Aarts E, 2014, NAT NEUROSCI, V17, P491, DOI 10.1038/nn.3648; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; [Anonymous], 2011, EUR J NEUROSCI, V34, P1609, DOI [10.1111/j.1460-9568.2011.07875.x, DOI 10.1111/J.1460-9568.2011.07875.X]; Anton-Fernandez A, 2015, BRAIN STRUCT FUNCT, V220, P869, DOI 10.1007/s00429-013-0689-1; Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Baalman KL, 2013, J NEUROTRAUM, V30, P741, DOI 10.1089/neu.2012.2478; Bashir S, 2012, RESTOR NEUROL NEUROS, V30, P277, DOI 10.3233/RNN-2012-110207; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bender KJ, 2012, ANNU REV NEUROSCI, V35, P249, DOI 10.1146/annurev-neuro-062111-150339; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Bouix S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066205; Brechet A, 2008, J CELL BIOL, V183, P1101, DOI 10.1083/jcb.200805169; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Campbell JN, 2012, J NEUROTRAUM, V29, P201, DOI 10.1089/neu.2011.1761; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cesarovic N, 2010, LAB ANIM-UK, V44, P329, DOI 10.1258/la.2010.009085; CHAGNACAMITAL Y, 1990, J COMP NEUROL, V296, P598, DOI 10.1002/cne.902960407; Clark KC, 2016, GLIA, V64, P1190, DOI 10.1002/glia.22991; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Cohen AS, 2007, PROG BRAIN RES, V161, P143, DOI 10.1016/S0079-6123(06)61010-8; Coronado VG, 2011, MMWR SURVEILL SUMM, V60, P1; DeFelipe J, 2002, J NEUROCYTOL, V31, P299, DOI 10.1023/A:1024130211265; DEFELIPE J, 1992, PROG NEUROBIOL, V39, P563, DOI 10.1016/0301-0082(92)90015-7; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Evans MD, 2015, CELL REP, V13, P1233, DOI 10.1016/j.celrep.2015.09.066; Evans MD, 2013, J NEUROSCI, V33, P6950, DOI 10.1523/JNEUROSCI.0277-13.2013; Ewald Andrew J, 2011, Cold Spring Harb Protoc, V2011, DOI 10.1101/pdb.prot5563; Fairen A, 1984, CEREB CORTEX, P201; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fish KN, 2011, CEREB CORTEX, V21, P2450, DOI 10.1093/cercor/bhr007; Freund TF, 2007, NEURON, V56, P33, DOI 10.1016/j.neuron.2007.09.012; Freund TF, 2003, TRENDS NEUROSCI, V26, P489, DOI 10.1016/S0166-2236(03)00227-3; Galbraith S, 2010, J NEUROSCI, V30, P10601, DOI 10.1523/JNEUROSCI.0362-10.2010; Garrido JJ, 2003, SCIENCE, V300, P2091, DOI 10.1126/science.1085167; Gasser A, 2012, J NEUROSCI, V32, P7232, DOI 10.1523/JNEUROSCI.5434-11.2012; Greer JE, 2013, ACTA NEUROPATHOL, V126, P59, DOI 10.1007/s00401-013-1119-4; Greer JE, 2012, J NEUROSCI, V32, P6682, DOI 10.1523/JNEUROSCI.0881-12.2012; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Grimm, 2015, VET ANESTHESIA ANALG; Grubb MS, 2011, J NEUROSCI, V31, P16049, DOI 10.1523/JNEUROSCI.4064-11.2011; Grubb MS, 2010, NATURE, V465, P1070, DOI 10.1038/nature09160; Gulyas AI, 1999, J NEUROSCI, V19, P10082; Gutzmann A, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00011; Hallermann S, 2012, NAT NEUROSCI, V15, P1007, DOI 10.1038/nn.3132; Hamada MS, 2016, P NATL ACAD SCI USA, V113, P14841, DOI 10.1073/pnas.1607548113; Hamada MS, 2015, J NEUROSCI, V35, P7272, DOI 10.1523/JNEUROSCI.4747-14.2015; Hanell A, 2015, J NEUROTRAUM, V32, P1590, DOI 10.1089/neu.2014.3592; Hanell A, 2015, ACTA NEUROPATHOL, V129, P317, DOI 10.1007/s00401-014-1376-x; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Hattox AM, 2007, J NEUROPHYSIOL, V98, P3330, DOI 10.1152/jn.00397.2007; Hedstrom KL, 2007, J CELL BIOL, V178, P875, DOI 10.1083/jcb.200705119; Hedstrom KL, 2008, J CELL BIOL, V183, P635, DOI 10.1083/jcb.200806112; Hinman JD, 2013, STROKE, V44, P182, DOI 10.1161/STROKEAHA.112.668749; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hu H, 2014, SCIENCE, V345, P529, DOI 10.1126/science.1255263; Hu WQ, 2009, NAT NEUROSCI, V12, P996, DOI 10.1038/nn.2359; Huang MX, 2017, J NEUROTRAUM, V34, P1412, DOI 10.1089/neu.2016.4581; Hund TJ, 2010, J CLIN INVEST, V120, P3508, DOI 10.1172/JCI43621; Ilvesmaki T, 2014, BRAIN, V137, P1876, DOI 10.1093/brain/awu095; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Jacob V, 2012, NEURON, V73, P391, DOI 10.1016/j.neuron.2011.11.034; Jenkins SM, 2001, J CELL BIOL, V155, P739, DOI 10.1083/jcb.200109026; Jiao Y, 1999, J NEUROSCI METH, V93, P149, DOI 10.1016/S0165-0270(99)00142-9; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kaphzan H, 2011, J NEUROSCI, V31, P17637, DOI 10.1523/JNEUROSCI.4162-11.2011; Khaliq ZM, 2006, J NEUROSCI, V26, P1935, DOI 10.1523/JNEUROSCI.4664-05.2006; King AN, 2014, J COMP NEUROL, V522, P2594, DOI 10.1002/cne.23551; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kole MHP, 2008, NAT NEUROSCI, V11, P178, DOI 10.1038/nn2040; Kole MHP, 2007, NEURON, V55, P633, DOI 10.1016/j.neuron.2007.07.031; Kole MHP, 2012, NEURON, V73, P235, DOI 10.1016/j.neuron.2012.01.007; Kriebel M, 2012, INT J BIOCHEM CELL B, V44, P694, DOI 10.1016/j.biocel.2012.01.012; Kuba H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9815; Kuba H, 2014, J NEUROSCI, V34, P3443, DOI 10.1523/JNEUROSCI.4357-13.2014; Kuba H, 2012, J PHYSIOL-LONDON, V590, P5571, DOI 10.1113/jphysiol.2012.237305; Kuba H, 2010, NATURE, V465, P1075, DOI 10.1038/nature09087; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lazarus MS, 2015, CEREB CORTEX, V25, P1290, DOI 10.1093/cercor/bht322; Le Be JV, 2007, CEREB CORTEX, V17, P2204, DOI 10.1093/cercor/bhl127; Lichtman JW, 2005, NAT METHODS, V2, P910, DOI 10.1038/NMETH817; Ling JM, 2013, NEUROLOGY, V81, P2121, DOI 10.1212/01.wnl.0000437302.36064.b1; Lorincz A, 2008, J NEUROSCI, V28, P9083, DOI 10.1523/JNEUROSCI.2494-08.2008; Lorincz A, 2008, J NEUROSCI, V28, P14329, DOI 10.1523/JNEUROSCI.4833-08.2008; Maas CJM, 2004, STAT NEERL, V58, P127, DOI 10.1046/j.0039-0402.2003.00252.x; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Manning CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038313; Mannix R, 2016, NAT REV NEUROL, V12, P486, DOI 10.1038/nrneurol.2016.99; Marmarou CR, 2006, EXP NEUROL, V197, P353, DOI 10.1016/j.expneurol.2005.10.003; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Meeks JP, 2007, J NEUROPHYSIOL, V97, P3460, DOI 10.1152/jn.01288.2006; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Molnar Z, 2006, NEUROSCI RES, V55, P105, DOI 10.1016/j.neures.2006.02.008; MOREHEAD M, 1994, J NEUROTRAUM, V11, P657, DOI 10.1089/neu.1994.11.657; Mountcastle V.B., 1979, NEUROSCIENCES 4 STUD, P21; Newcombe VFJ, 2011, BRAIN, V134, P759, DOI 10.1093/brain/awq388; Nieuwenhuis S, 2011, NAT NEUROSCI, V14, P1105, DOI 10.1038/nn.2886; Packer AM, 2011, J NEUROSCI, V31, P13260, DOI 10.1523/JNEUROSCI.3131-11.2011; Palacios EM, 2017, J NEUROTRAUM, V34, P1546, DOI 10.1089/neu.2016.4752; Palmer LM, 2006, J NEUROSCI, V26, P1854, DOI 10.1523/JNEUROSCI.4812-05.2006; Popovic MA, 2011, J PHYSIOL-LONDON, V589, P4167, DOI 10.1113/jphysiol.2011.209015; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Pouille F, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.67; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Ratcliffe CF, 2001, J CELL BIOL, V154, P427, DOI 10.1083/jcb.200102086; Reeves TM, 2007, BRAIN RES, V1154, P225, DOI 10.1016/j.brainres.2007.04.002; Reichle ME, 2010, TRENDS COGN SCI, V14, P180, DOI 10.1016/j.tics.2010.01.008; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Scholl B, 2015, NEURON, V87, P424, DOI 10.1016/j.neuron.2015.06.030; Schrader Harald, 2009, BMC Med Imaging, V9, P11, DOI 10.1186/1471-2342-9-11; Schubert D, 2001, J NEUROSCI, V21, P3580, DOI 10.1523/JNEUROSCI.21-10-03580.2001; Schubert D, 2006, CEREB CORTEX, V16, P223, DOI 10.1093/cercor/bhi100; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Shultz SR, 2017, NEUROSCI BIOBEHAV R, V76, P396, DOI 10.1016/j.neubiorev.2016.09.014; Singleton RH, 2001, J NEUROTRAUM, V18, P607, DOI 10.1089/089771501750291846; Singleton RH, 2002, J NEUROSCI, V22, P791, DOI 10.1523/JNEUROSCI.22-03-00791.2002; SNIJDERS TAB, 1993, J EDUC STAT, V18, P237, DOI 10.3102/10769986018003237; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; Sun JL, 2016, FRONT SYST NEUROSCI, V10, DOI [10.3389/fnsys.2016.00063, 10.3389/hsys.2015.00063]; Takacs VT, 2015, BRAIN STRUCT FUNCT, V220, P919, DOI 10.1007/s00429-013-0692-6; Taniguchi H, 2013, SCIENCE, V339, P70, DOI 10.1126/science.1227622; Thome C, 2014, NEURON, V83, P1418, DOI 10.1016/j.neuron.2014.08.013; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tremblay S, 2011, J NEUROTRAUM, V28, P493, DOI 10.1089/neu.2010.1615; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vascak M, 2018, CEREB CORTEX, V28, P1625, DOI 10.1093/cercor/bhx058; Waljas M, 2014, J NEUROTRAUM, V31, P108, DOI 10.1089/neu.2013.2941; WALSH JE, 1947, ANN MATH STAT, V18, P88, DOI 10.1214/aoms/1177730495; Wefelmeyer W, 2015, P NATL ACAD SCI USA, V112, P9757, DOI 10.1073/pnas.1502902112; Wolf JA, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00043; Woodruff AR, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00201; Yang Y, 2007, J CELL BIOL, V176, P509, DOI 10.1083/jcb.200610128; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295; Zonta B, 2011, NEURON, V69, P945, DOI 10.1016/j.neuron.2011.02.021	154	17	17	0	6	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1662-5102			FRONT CELL NEUROSCI	Front. Cell. Neurosci.	JUN 6	2017	11								157	10.3389/fncel.2017.00157			24	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	EX5WA	WOS:000403312200001	28634442	gold, Green Published			2022-02-06	
J	Sufrinko, AM; Kontos, AP; Apps, JN; McCrea, M; Hickey, RW; Collins, MW; Thomas, DG				Sufrinko, Alicia M.; Kontos, Anthony P.; Apps, Jennifer N.; McCrea, Michael; Hickey, Robert W.; Collins, Michael W.; Thomas, Danny G.			The Effectiveness of Prescribed Rest Depends on Initial Presentation After Concussion	JOURNAL OF PEDIATRICS			English	Article							SPORT-RELATED CONCUSSION; TEST-RETEST RELIABILITY; HIGH-SCHOOL; ACTIVITY LEVEL; SYMPTOMS; RECOVERY; DURATION; SPECIFICITY; SENSITIVITY; DEFICITS	Objective To evaluate if patients with signs of injury respond differently to prescribed rest after concussion compared with patients with symptoms only. Study design Secondary analysis was completed of a prospective randomized controlled trial (NCT01101724) of pediatric concussion patients aged 11-18 years. Patients completed computerized neurocognitive testing and standardized balance assessment at the emergency department within 24 hours of injury and on follow-up (3 and 10 days). Patients were randomized to rest or usual care and completed activity and symptom diaries for 10 days after injury. A series of 2 x 2 ANOVAs with grouping factors of patient group (symptoms, signs) and treatment arm (prescribed rest, standard of care) were used to examine differences on clinical measures. Univariate nonparametric test (ie, X-2 with ORs and 95% CIs) was used to examine the association between treatment arm and symptom status 1-9 days after injury. Results A 2 x 2 factorial ANOVA revealed a significant patient group x treatment arm interaction for symptom score at 3 days after injury (F = 6.31, P = .01, eta(2) = 0.07). Prescribed rest increased the likelihood of still being symptomatic at days 1-6 and 8 (P < .05) for the symptoms group. Rest was beneficial for patients in the signs group on verbal memory performance (t = -2.28, P = .029), but not for the symptoms group. Conclusion Compared with patients with signs of injury, patients with predominantly symptoms were more likely to remain symptomatic after injury if prescribed rest, whereas patients with signs of injury benefited from rest after a concussion. Individualized treatment planning after concussion should start in the emergency department.	[Sufrinko, Alicia M.; Kontos, Anthony P.; Collins, Michael W.] Univ Pittsburgh, Med Ctr, Dept Orthopaed Surg, Sports Med Concuss Program, Pittsburgh, PA USA; [Apps, Jennifer N.] Med Coll Wisconsin, Dept Psychiat & Behav Med, Milwaukee, WI 53226 USA; [McCrea, Michael] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Hickey, Robert W.] Univ Pittsburgh, Pediat Emergency Med, Pittsburgh, PA USA; [Thomas, Danny G.] Med Coll Wisconsin, Dept Pediat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA		Thomas, DG (corresponding author), Childrens Hosp Wisconsin, Corp Ctr, Dept Pediat, Emergency Med, 999 N 92nd St,Ste C550, Milwaukee, WI 53226 USA.	dthomas@mcw.edu		Thomas, Danny/0000-0002-7470-9835; Kontos, Anthony/0000-0002-3749-4310	Injury Research Center of the Medical College of Wisconsin	Funded by the Injury Research Center of the Medical College of Wisconsin. M.C. is a co-founder and 10% shareholder of ImPACT. The other authors declare no conflicts of interest.	Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Bondi CO, 2014, J NEUROTRAUM, V31, P873, DOI 10.1089/neu.2014.3328; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Buckley TA, 2016, J HEAD TRAUMA REHAB, V31, P233, DOI 10.1097/HTR.0000000000000165; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P61, DOI 10.1016/j.jshs.2016.01.007; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Chrisman SP, 2013, BRAIN INJURY, V27, P1, DOI 10.3109/02699052.2012.722251; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Craton N, 2014, CLIN J SPORT MED, V24, P93, DOI 10.1097/JSM.0000000000000023; Custer A, 2016, J ATHL TRAINING, V51, P136, DOI 10.4085/1062-6050-51.2.12; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P167, DOI 10.1136/jnnp.73.2.167; Dijk DJ, 2015, J SLEEP RES, V24, P475, DOI 10.1111/jsr.12352; Easter JS, 2014, ANN EMERG MED, V64, P145, DOI 10.1016/j.annemergmed.2014.01.030; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Gibson SR, 2010, MED SCI SPORT EXER, V42, P752, DOI 10.1249/01.MSS.0000386182.12785.e9; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Howell DR, 2016, AM J SPORT MED, V44, P1040, DOI 10.1177/0363546515625045; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Kirkwood MW, 2012, CLIN J SPORT MED, V22, P383, DOI 10.1097/JSM.0b013e31826396fc; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Leddy JJ, 2016, PHYS MED REH CLIN N, V27, P437, DOI 10.1016/j.pmr.2015.12.003; Lovati C, 2017, EXPERT REV NEUROTHER, V17, P239, DOI 10.1080/14737175.2016.1226133; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Marshall S, 2015, INJURY EPIDEMIOLOGY, V2, P1; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McLeod TCV, 2015, BRAIN INJURY, V29, P175, DOI 10.3109/02699052.2014.965206; Moser RS, 2015, BRAIN INJURY, V29, P58, DOI 10.3109/02699052.2014.964771; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Schneider KJ, 2013, BRIT J SPORT MED, V47, pe1; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Waldron-Perrine B, 2015, BRAIN INJURY, V29, P1051, DOI 10.3109/02699052.2015.1004742; Wells EM, 2016, J CHILD NEUROL, V31, P86, DOI 10.1177/0883073815570152	44	17	17	0	7	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	JUN	2017	185						167	172		10.1016/j.jpeds.2017.02.072			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	FB1JJ	WOS:000405899400033	28365025				2022-02-06	
J	Badachhape, AA; Okamoto, RJ; Durham, RS; Efron, BD; Nadell, SJ; Johnson, CL; Bayly, PV				Badachhape, Andrew A.; Okamoto, Ruth J.; Durham, Ramona S.; Efron, Brent D.; Nadell, Sam J.; Johnson, Curtis L.; Bayly, Philip V.			The Relationship of Three-Dimensional Human Skull Motion to Brain Tissue Deformation in Magnetic Resonance Elastography Studies	JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME			English	Article						magnetic resonance elastography; mechanical characterization; brain deformation; tissue	MR ELASTOGRAPHY; INJURY; STIFFNESS; VISCOELASTICITY; ANISOTROPY; INVERSION; HEAD	In traumatic brain injury (TBI), membranes such as the dura mater, arachnoid mater, and pia mater play a vital role in transmitting motion from the skull to brain tissue. Magnetic resonance elastography (MRE) is an imaging technique developed for noninvasive estimation of soft tissue material parameters. In MRE, dynamic deformation of brain tissue is induced by skull vibrations during magnetic resonance imaging (MRI); however, skull motion and its mode of transmission to the brain remain largely uncharacterized. In this study, displacements of points in the skull, reconstructed using data from an array of MRI-safe accelerometers, were compared to displacements of neighboring material points in brain tissue, estimated from MRE measurements. Comparison of the relative amplitudes, directions, and temporal phases of harmonic motion in the skulls and brains of six human subjects shows that the skull-brain interface significantly attenuates and delays transmission of motion from skull to brain. In contrast, in a cylindrical gelatin "phantom," displacements of the rigid case (reconstructed from accelerometer data) were transmitted to the gelatin inside (estimated from MRE data) with little attenuation or phase lag. This quantitative characterization of the skull-brain interface will be valuable in the parameterization and validation of computer models of TBI.	[Badachhape, Andrew A.; Durham, Ramona S.; Bayly, Philip V.] Washington Univ, Biomed Engn, St Louis, MO 63105 USA; [Okamoto, Ruth J.; Efron, Brent D.; Nadell, Sam J.; Bayly, Philip V.] Washington Univ, Mech Engn & Mat Sci, St Louis, MO 63105 USA; [Johnson, Curtis L.] Univ Delaware, Biomed Engn, Newark, DE 19716 USA		Badachhape, AA (corresponding author), Washington Univ, Biomed Engn, St Louis, MO 63105 USA.	abadachhape@wustl.edu	Johnson, Curtis/U-8372-2019	Badachhape, Andrew/0000-0002-5857-9495; Okamoto, Ruth/0000-0002-3085-3878	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS055951]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS055951] Funding Source: NIH RePORTER	Financial support for this study was provided by National Institutes of Health (NIH) Grant No. R01 NS055951.	Arani A, 2015, NEUROIMAGE, V111, P59, DOI 10.1016/j.neuroimage.2015.02.016; Atay SM, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2899575; Barnhill E, 2015, MAGN RESON MED, V73, P2321, DOI 10.1002/mrm.25332; Clayton EH, 2012, J R SOC INTERFACE, V9, P2899, DOI 10.1098/rsif.2012.0325; Cloots RJH, 2011, BIOMECH MODEL MECHAN, V10, P413, DOI 10.1007/s10237-010-0243-5; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; GINSBERG G, 1995, DYNAMICS; Giordano C, 2014, J BIOMECH, V47, P1052, DOI 10.1016/j.jbiomech.2013.12.036; Guo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071807; GURDJIAN ES, 1970, J BIOMECH, V3, P239, DOI 10.1016/0021-9290(70)90025-4; Hutson M, 2011, SPORTS INJURIES; Johnson CL, 2016, HUM BRAIN MAPP, V37, P4221, DOI 10.1002/hbm.23314; Johnson CL, 2013, MAGN RESON MED, V70, P404, DOI 10.1002/mrm.24473; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kruse SA, 2000, PHYS MED BIOL, V45, P1579, DOI 10.1088/0031-9155/45/6/313; Kruse SA, 2008, NEUROIMAGE, V39, P231, DOI 10.1016/j.neuroimage.2007.08.030; Manduca A, 2001, MED IMAGE ANAL, V5, P237, DOI 10.1016/S1361-8415(00)00039-6; Mazumder MMG, 2013, ACTA BIOENG BIOMECH, V15, P3, DOI 10.5277/abb130201; McGarry MDJ, 2012, MED PHYS, V39, P6388, DOI 10.1118/1.4754649; McGarry MDJ, 2011, PHYS MED BIOL, V56, pN153, DOI 10.1088/0031-9155/56/13/N02; Murphy MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081668; Murphy MC, 2011, J MAGN RESON IMAGING, V34, P494, DOI 10.1002/jmri.22707; MUTHUPILLAI R, 1995, SCIENCE, V269, P1854, DOI 10.1126/science.7569924; Naunheim RS, 2003, MED SCI SPORT EXER, V35, P1406, DOI 10.1249/01.MSS.0000078933.84527.AE; Okamoto RJ, 2011, PHYS MED BIOL, V56, P6379, DOI 10.1088/0031-9155/56/19/014; Oliphant TE, 2001, MAGNET RESON MED, V45, P299, DOI 10.1002/1522-2594(200102)45:2<299::AID-MRM1039>3.0.CO;2-O; Romano A, 2014, MAGN RESON MED, V72, P1755, DOI 10.1002/mrm.25067; Sack I, 2008, NMR BIOMED, V21, P265, DOI 10.1002/nbm.1189; Scharnhorst K, 2001, ACTA APPL MATH, V69, P95, DOI 10.1023/A:1012692601098; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Steen RG, 2007, AM J NEURORADIOL, V28, P1119, DOI 10.3174/ajnr.A0537; Streitberger KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029888; Streitberger KJ, 2011, NMR BIOMED, V24, P385, DOI 10.1002/nbm.1602; Wang HF, 2011, PHYS MED BIOL, V56, P3935, DOI 10.1088/0031-9155/56/13/012; Woolsey T. A., 2013, BRAIN ATLAS VISUAL G	36	17	17	1	12	ASME	NEW YORK	TWO PARK AVE, NEW YORK, NY 10016-5990 USA	0148-0731	1528-8951		J BIOMECH ENG-T ASME	J. Biomech. Eng.-Trans. ASME	MAY	2017	139	5							051002	10.1115/1.4036146			12	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	ES2XB	WOS:000399390100002	28267188	Green Published			2022-02-06	
J	Ducharme-Crevier, L; Press, CA; Kurz, JE; Mills, MG; Goldstein, JL; Wainwright, MS				Ducharme-Crevier, Laurence; Press, Craig A.; Kurz, Jonathan E.; Mills, Michele G.; Goldstein, Joshua L.; Wainwright, Mark S.			Early Presence of Sleep Spindles on Electroencephalography Is Associated With Good Outcome After Pediatric Cardiac Arrest	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						cardiac arrest; critical care outcomes; electroencephalography; sleep spindles	TRAUMATIC BRAIN-INJURY; INITIAL NEUROLOGIC EXAMINATION; PROGNOSTIC VALUE; CONTINUOUS EEG; CHILDREN; PREDICTION; FEATURES; COMA; COMBINATION; HYPOTHERMIA	Objectives: The role of sleep architecture as a biomarker for prognostication after resuscitation from cardiac arrest in children hospitalized in an ICU remains poorly defined. We sought to investigate the association between features of normal sleep architecture in children after cardiac arrest and a favorable neurologic outcome at 6 months. Design: Retrospective review of medical records and continuous electroencephalography monitoring. Setting: Cardiac and PICU of a tertiary children's hospital. Patients: All patients from 6 months to 18 years old resuscitated from cardiac arrest who underwent continuous electroencephalography monitoring in the first 24 hours after in-or out-of-hospital cardiac arrest from January 2010 to June 2015. Interventions: None. Measurements and Main Results: Thirty-four patients underwent continuous electroencephalography monitoring after cardiac arrest. The median age was 6.1 years (interquartile range, 1.5-12.5 yr), 20 patients were male (59%). Most cases (n = 23, 68%) suffered from in-hospital cardiac arrest. Electroencephalography monitoring was initiated a median of 9.3 hours (5.8-14.9 hr) after return of spontaneous circulation, for a median duration of 14.3 hours (6.0-16.0 hr) within the first 24-hour period after the cardiac arrest. Five patients had normal spindles, five had abnormal spindles, and 24 patients did not have any sleep architecture. The presence of spindles was associated with a favorable neurologic outcome at 6-month postcardiac arrest (p = 0.001). Conclusions: Continuous electroencephalography monitoring can be used in children to assess spindles in the ICU. The presence of spindles on continuous electroencephalography monitoring in the first 24 hours after resuscitation from cardiac arrest is associated with a favorable neurologic outcome. Assessment of sleep architecture on continuous electroencephalography after cardiac arrest could improve outcome prediction.	[Ducharme-Crevier, Laurence; Press, Craig A.; Kurz, Jonathan E.; Mills, Michele G.; Goldstein, Joshua L.; Wainwright, Mark S.] Northwestern Univ, Ann & Robert H Lurie Childrens Hosp Chicago, Ruth D & Ken M Davee Pediat Neurocrit Care Progra, Feinberg Sch Med, Chicago, IL 60611 USA; [Kurz, Jonathan E.; Goldstein, Joshua L.; Wainwright, Mark S.] Northwestern Univ, Ann & Robert H Lurie Childrens Hosp Chicago, Feinberg Sch Med, Dept Pediat,Div Neurol, Chicago, IL 60611 USA		Wainwright, MS (corresponding author), Northwestern Univ, Ann & Robert H Lurie Childrens Hosp Chicago, Ruth D & Ken M Davee Pediat Neurocrit Care Progra, Feinberg Sch Med, Chicago, IL 60611 USA.; Wainwright, MS (corresponding author), Northwestern Univ, Ann & Robert H Lurie Childrens Hosp Chicago, Feinberg Sch Med, Dept Pediat,Div Neurol, Chicago, IL 60611 USA.	m-wainwright@northwestern.edu	Press, Craig Adam/K-1307-2019; Ducharme-Crevier, Laurence/AAJ-6728-2020	Press, Craig Adam/0000-0003-4435-206X; Kurz, Jonathan/0000-0002-2259-4263	Ruth D. & Ken M. Davee Pediatric Neurocritical Care Program; Lyndsey Whittingham Foundation; Sage Therapeutics	Supported, in part, by the Ruth D. & Ken M. Davee Pediatric Neurocritical Care Program and by the Lyndsey Whittingham Foundation.; Dr. Wainwright received funding from Sage Therapeutics, received support for article research from the Ruth D. & Ken M. Davee Pediatric Neurocritical Care Program and Lyndsey Whittingham Foundation, and disclosed that he was a scientific consultant to TransMed Systems. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Abend NS, 2009, NEUROLOGY, V72, P1931, DOI 10.1212/WNL.0b013e3181a82687; Abend NS, 2011, J CLIN NEUROPHYSIOL, V28, P15, DOI 10.1097/WNP.0b013e3182051123; Berry RB, 2016, AL AASM SCORING MANU; CHELIOUT-HERAUT F, 1991, Neurophysiologie Clinique, V21, P121, DOI 10.1016/S0987-7053(05)80066-8; Cheliout-Heraut F, 2001, NEUROPHYSIOL CLIN, V31, P283, DOI 10.1016/S0987-7053(01)00270-2; Cote KA, 2015, AIMS NEUROSCI, V2, P203, DOI 10.3934/Neuroscience.2015.4.203; De Gennaro L, 2003, SLEEP MED REV, V7, P423, DOI 10.1053/smrv.2002.0252; EVANS BM, 1995, J NEUROL NEUROSUR PS, V59, P17, DOI 10.1136/jnnp.59.1.17; Fink EL, 2014, CRIT CARE MED, V42, P664, DOI 10.1097/01.ccm.0000435668.53188.80; Fink EL, 2013, NEUROCRIT CARE, V19, P31, DOI 10.1007/s12028-012-9706-0; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Fugate JE, 2010, NEUROCRIT CARE, V13, P205, DOI 10.1007/s12028-010-9407-5; Herman ST, 2015, J CLIN NEUROPHYSIOL, V32, P87, DOI 10.1097/WNP.0000000000000166; Hirsch LJ, 2013, J CLIN NEUROPHYSIOL, V30, P1, DOI 10.1097/WNP.0b013e3182784729; Hofmeijer J, 2015, NEUROLOGY, V85, P137, DOI 10.1212/WNL.0000000000001742; Kessler SK, 2011, NEUROCRIT CARE, V14, P37, DOI 10.1007/s12028-010-9450-2; Manchester LC, 2016, J PEDIATR-US, V169, P28, DOI 10.1016/j.jpeds.2015.10.003; Mandel R, 2002, J PEDIATR-US, V141, P45, DOI 10.1067/mpd.2002.125005; Meyer L, 2012, CIRCULATION, V126, P1363, DOI 10.1161/CIRCULATIONAHA.111.076810; Moler FW, 2011, CRIT CARE MED, V39, P141, DOI 10.1097/CCM.0b013e3181fa3c17; Moler FW, 2009, CRIT CARE MED, V37, P2259, DOI 10.1097/CCM.0b013e3181a00a6a; Nishisaki A, 2007, PEDIATR CRIT CARE ME, V8, P10, DOI 10.1097/01.pcc.0000256621.63135.4b; Ostendorf AP, 2016, PEDIATR CRIT CARE ME, V17, P667, DOI 10.1097/PCC.0000000000000791; RUMPL E, 1983, ELECTROEN CLIN NEURO, V56, P420, DOI 10.1016/0013-4694(83)90224-9; Sandsmark DK, 2016, J HEAD TRAUMA REHAB, V31, P101, DOI 10.1097/HTR.0000000000000217; Schabus M, 2004, SLEEP, V27, P1479, DOI 10.1093/sleep/27.7.1479; Steriade M, 2000, NEUROSCIENCE, V101, P243, DOI 10.1016/S0306-4522(00)00353-5; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Topjian AA, 2016, PEDIATR CRIT CARE ME, V17, P547, DOI 10.1097/PCC.0000000000000740; Urakami Y, 2012, CLIN EEG NEUROSCI, V43, P39, DOI 10.1177/1550059411428718; Valente M, 2002, CLIN NEUROPHYSIOL, V113, P1798, DOI 10.1016/S1388-2457(02)00218-3; Wijdicks EFM, 2006, NEUROLOGY, V67, P203, DOI 10.1212/01.wnl.0000227183.21314.cd; Wiseman-Hakes C, 2016, NEUROREHAB NEURAL RE, V30, P713, DOI 10.1177/1545968315619697; Youn CS, 2017, RESUSCITATION, V110, P120, DOI 10.1016/j.resuscitation.2016.10.024; Youn CS, 2015, RESUSCITATION, V94, P73, DOI 10.1016/j.resuscitation.2015.06.016	35	17	17	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	MAY	2017	18	5					452	460		10.1097/PCC.0000000000001137			9	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	EW8BF	WOS:000402742400013	28328788				2022-02-06	
J	Finkel, AG; Yerry, JA; Klaric, JS; Ivins, BJ; Scher, A; Choi, YS				Finkel, Alan G.; Yerry, Juanita A.; Klaric, John S.; Ivins, Brian J.; Scher, Ann; Choi, Young S.			Headache in military service members with a history of mild traumatic brain injury: A cohort study of diagnosis and classification	CEPHALALGIA			English	Article						Traumatic brain injury; military; headache; migraine; chronic migraine; diagnosis	POSTTRAUMATIC-STRESS-DISORDER; US SOLDIERS; POSTCONCUSSION SYNDROME; TERTIARY CARE; MIGRAINE PAIN; PREVALENCE; VETERANS; CRITERIA; IMPACT	Introduction: Headaches after concussion are highly prevalent, relatively persistent and are being treated like primary headaches, especially migraine. Methods: We studied all new patients seen between August 2008 and December 2009 assessed by a civilian headache specialist at the TBI Center at Womack Army Medical Center, Fort Bragg, NC. We report sample demographics, injuries and headache characteristics, including time from injury to headache onset, detailed descriptions and International Classification of Headache Disorders second edition primary headache diagnosis type. Results: A total of 95 soldiers reported 166 headaches. The most common injury cited was a blast (53.7%). Most subjects (76.8%) recalled the onset of any headache within 7 days of injury. The most commonly diagnosed headache was a continuous type with migraine features (n=31 (18.7%)), followed by chronic migraine (type 1.5.1, n=14 (8.4%)), migraine with aura (type 1.2.1, n=10 (6.0%)), hemicrania continua (type 4.7, n=12 (7.2%)), chronic cluster (type 3.1.2, n=6 (3.6%)) and headaches not otherwise classifiable (type 14.1, n=5 (3.0%)) also present. The most clinically important was a continuous headache with migraine features. Conclusion: We present a series of patients seen in a military treatment facility for headache diagnosis after concussion in whom we found migraine, as well as uncommon primary headache types, at frequencies that were much higher than expected.	[Finkel, Alan G.; Yerry, Juanita A.; Klaric, John S.; Choi, Young S.] WAMC, Ft Bragg, NC USA; [Finkel, Alan G.; Ivins, Brian J.] Def & Vet Brain Injury Ctr, Silver Spring, MD USA; [Finkel, Alan G.] Carolina Headache Inst, Chapel Hill, NC USA; [Scher, Ann] Uniformed Serv Univ Hlth Sci, Bethesda, MD USA		Finkel, AG (corresponding author), 6114 Fayetteville Rd,Suite 109, Durham, NC 27713 USA.	finkela@chi09.com		Scher, Ann/0000-0003-4599-9834	Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs	The authors disclosed receipt of the following financial support for the research, authorship and/or publication of this article: Funding was received from the Defense and Veterans Brain Injury Center.	Armed Forces Health Surveillance Branch, 2013, MED SURV MONTHL REP; Baandrup L, 2005, CEPHALALGIA, V25, P240, DOI 10.1111/j.1468-2982.2004.00909.x; Bigal ME, 2004, HEADACHE, V44, P684, DOI 10.1111/j.1526-4610.2004.04128.x; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Cohen SP, 2012, CEPHALALGIA, V32, P94, DOI 10.1177/0333102411422382; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; De Marco AP, 2016, J CHILD NEUROL, V31, P68, DOI 10.1177/0883073814559645; Defense and Veterans Brain Injury Center, 2014, PROGR RET ACT FOLL A; Defense and Veterans Brain Injury Center, 2009, MILD TRAUM BRAIN INJ; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Erickson JC, 2011, HEADACHE, V51, P932, DOI 10.1111/j.1526-4610.2011.01909.x; Evans RW, 2010, HEADACHE, V50, P716, DOI 10.1111/j.1526-4610.2010.01645.x; Finkel AG, 2012, HEADACHE, V52, P957, DOI 10.1111/j.1526-4610.2012.02167.x; Friedman AP, 1962, CLASSIFICATION HEADA, V12, P378; Gallai V, 2002, HEADACHE, V42, P1016, DOI 10.1046/j.1526-4610.2002.02231.x; Gardner A, 2014, J NEUROTRAUM, V31, P1, DOI 10.1089/neu.2013.3079; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Hartmann JE, 2006, J NEUROL SCI, V241, P83, DOI 10.1016/j.jns.2005.11.002; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kelman L, 2007, CEPHALALGIA, V27, P394, DOI 10.1111/j.1468-2982.2007.01303.x; Kelman L, 2006, CEPHALALGIA, V26, P548, DOI 10.1111/j.1468-2982.2006.01075.x; Kelman L, 2005, HEADACHE, V45, P1038, DOI 10.1111/j.1526-4610.2005.05185.x; Kelman L, 2004, CEPHALALGIA, V24, P728, DOI 10.1111/j.1468-2982.2004.00748.x; Kelman L, 2006, HEADACHE, V46, P942, DOI 10.1111/j.1526-4610.2006.00443.x; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Lambru G, 2012, CURR PAIN HEADACHE R, V16, P162, DOI 10.1007/s11916-012-0248-0; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; MacFarlane MP, 2015, BRAIN INJURY, V29, P139, DOI 10.3109/02699052.2014.965208; Manzoni Gian Camillo, 2006, Curr Pain Headache Rep, V10, P130, DOI 10.1007/s11916-006-0024-0; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Nash JM, 2003, HEADACHE, V43, P2, DOI 10.1046/j.1526-4610.2003.03002.x; Niederland T, 2007, J NEUROTRAUM, V24, P119, DOI 10.1089/neu.2005.369ER; Patil VK, 2011, HEADACHE, V51, P1112, DOI 10.1111/j.1526-4610.2011.01946.x; Rapp PE, 2012, J TRAUMA ACUTE CARE, V73, pS13, DOI 10.1097/TA.0b013e318260604b; Rigg JL, 2011, PM R S2, V3, pS380; Rosenthal JF, 2013, HEADACHE, V53, P1564, DOI 10.1111/head.12200; Ruff RL, 2012, J REHABIL RES DEV, V49, P1305, DOI 10.1682/JRRD.2011.12.0251; Ruff RL, 2009, J REHABIL RES DEV, V46, P1071, DOI 10.1682/JRRD.2009.05.0062; Shevel D, 2014, J BIOMED SCI ENG, V7, P112; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Solomon S, 1997, NEUROL CLIN, V15, P15, DOI 10.1016/S0733-8619(05)70292-9; SOLOMON S, 1993, CEPHALALGIA, V13, P63, DOI 10.1177/0333102493013S1213; SORGE F, 1988, CEPHALALGIA, V8, P1, DOI 10.1046/j.1468-2982.1988.0801001.x; Sullivan KA, 2014, J HEAD TRAUMA REHAB, V29, P54, DOI 10.1097/HTR.0b013e31828c708a; Tanriverdi F, 2010, PITUITARY, V13, P146, DOI 10.1007/s11102-009-0215-x; Theeler B, 2013, HEADACHE, V53, P881, DOI 10.1111/head.12123; Theeler BJ, 2008, HEADACHE, V48, P876, DOI 10.1111/j.1526-4610.2008.01159.x; Theeler BJ, 2009, HEADACHE, V49, P529, DOI 10.1111/j.1526-4610.2009.01345.x; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; TURKEWITZ LJ, 1992, HEADACHE, V32, P504, DOI 10.1111/j.1526-4610.1992.hed3210504.x; US Army, 2009, ARMY MED        0227; van Reekum R, 2013, BRAIN INJURY, V27, P1210, DOI 10.3109/02699052.2013.801515; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Walker Russell W, 2007, Curr Pain Headache Rep, V11, P137, DOI 10.1007/s11916-007-0011-0; Walker WC, 2005, ARCH PHYS MED REHAB, V86, P1793, DOI 10.1016/j.apmr.2004.12.042; Ward Thomas N, 2012, Continuum (Minneap Minn), V18, P753, DOI 10.1212/01.CON.0000418640.07405.31; Watanabe TK, 2012, PM&R, V4, P129, DOI 10.1016/j.pmrj.2011.06.003; Wheeler SD, 2009, NEUROLOGIST, V15, P59, DOI 10.1097/NRL.0b013e318165eb94; Yerry JA, 2015, HEADACHE, V55, P395, DOI 10.1111/head.12495	66	17	17	0	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	MAY	2017	37	6					548	559		10.1177/0333102416651285			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	EU4UG	WOS:000401026600007	27206963				2022-02-06	
J	Hoffman, JR; Zuckerman, A; Ram, O; Sadot, O; Stout, JR; Ostfeld, I; Cohen, H				Hoffman, Jay R.; Zuckerman, Amitai; Ram, Omri; Sadot, Oren; Stout, Jeffrey R.; Ostfeld, Ishay; Cohen, Hagit			Behavioral and inflammatory response in animals exposed to a low-pressure blast wave and supplemented with beta-alanine	AMINO ACIDS			English	Article						Supplementation; Carnosine; Mild traumatic brain injury; GFAP BDNF	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; NEUROTROPHIC FACTOR; NEUROPEPTIDE-Y; MEMORY DEFICITS; SPATIAL MEMORY; HIPPOCAMPAL; MODEL; RAT; PTSD	This study investigated the benefit of beta-alanine (BA) supplementation on behavioral and cognitive responses relating to mild traumatic brain injury (mTBI) and post-traumatic stress disorder (PTSD) in rats exposed to a low-pressure blast wave. Animals were fed a normal diet with or without (PL) BA supplementation (100 mg kg(-1)) for 30-day, prior to being exposed to a low-pressure blast wave. A third group of animals served as a control (CTL). These animals were fed a normal diet, but were not exposed to the blast. Validated cognitive-behavioral paradigms were used to assess both mTBI and PTSD-like behavior on days 7-14 following the blast. Brain-derived neurotrophic factor (BDNF), neuropeptide Y, glial fibrillary acidic protein (GFAP) and tau protein expressions were analyzed a day later. In addition, brain carnosine and histidine content was assessed as well. The prevalence of animals exhibiting mTBI-like behavior was significantly lower (p = 0.044) in BA than PL (26.5 and 46%, respectively), but no difference (p = 0.930) was noted in PTSD-like behavior between the groups (10.2 and 12.0%, respectively). Carnosine content in the cerebral cortex was higher (p = 0.048) for BA compared to PL, while a trend towards a difference was seen in the hippocampus (p = 0.058) and amygdala (p = 0.061). BDNF expression in the CA1 subregion of PL was lower than BA (p = 0.009) and CTL (p < 0.001), while GFAP expression in CA1 (p = 0.003) and CA3 (p = 0.040) subregions were higher in PL than other groups. Results indicated that BA supplementation for 30-day increased resiliency to mTBI in animals exposed to a low-pressure blast wave.	[Hoffman, Jay R.; Stout, Jeffrey R.] Univ Cent Florida, Burnett Sch Biomed Sci, Inst Exercise Physiol & Wellness Sport & Exercise, Orlando, FL 32816 USA; [Zuckerman, Amitai; Cohen, Hagit] Ben Gurion Univ Negev, Beer Sheva Mental Hlth Ctr, Fac Hlth Sci, Div Psychiat,Anxiety & Stress Res Unit, Beer Sheva, Israel; [Ram, Omri; Sadot, Oren] Ben Gurion Univ Negev, Dept Mech Engn, Beer Sheva, Israel; [Ostfeld, Ishay] Med Corps, Israel Def Forces, Tel Aviv, Israel		Hoffman, JR (corresponding author), Univ Cent Florida, Burnett Sch Biomed Sci, Inst Exercise Physiol & Wellness Sport & Exercise, Orlando, FL 32816 USA.	jay.hoffman@ucf.edu	Hoffman, Jay/AAF-2005-2019; Stout, Jeffrey R/F-5805-2014; ostfeld, ishay/AAC-3781-2020	Hoffman, Jay/0000-0002-0073-6603; Stout, Jeffrey R/0000-0001-6114-1649; RAM, OMRI/0000-0002-2398-9822; Sadot, Oren/0000-0002-2627-550X	Natural Alternatives International (Carlsbad, CA, USA)	The authors would like to thank Natural Alternatives International (Carlsbad, CA, USA) for providing support for this study.	Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Bellia F, 2014, MOLECULES, V19, P2299, DOI 10.3390/molecules19022299; Bhaskar K, 2010, NEURON, V68, P19, DOI 10.1016/j.neuron.2010.08.023; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Casetta B, 2000, CLIN CHEM LAB MED, V38, P391, DOI 10.1515/CCLM.2000.057; Chesnoy-Marchais D, 2016, NEUROSCIENCE, V330, P191, DOI 10.1016/j.neuroscience.2016.05.048; Cohen H, 2004, NEUROPSYCHOPHARMACOL, V29, P1962, DOI 10.1038/sj.npp.1300523; Cohen H, 2003, BIOL PSYCHIAT, V53, P463, DOI 10.1016/S0006-3223(02)01909-1; Cohen H, 2010, J NEUROENDOCRINOL, V22, P889, DOI 10.1111/j.1365-2826.2010.02003.x; Cohen H, 2004, ANN NY ACAD SCI, V1032, P167, DOI 10.1196/annals.1314.014; Cohen H, 2014, EUR NEUROPSYCHOPHARM, V24, P1925, DOI 10.1016/j.euroneuro.2014.09.009; Cohen H, 2012, NEUROPSYCHOPHARMACOL, V37, P350, DOI 10.1038/npp.2011.230; Cowansage Kiriana K, 2010, Curr Mol Pharmacol, V3, P12; Croce N, 2012, ACS CHEM NEUROSCI, V3, P312, DOI 10.1021/cn200127e; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Doppenberg EMR, 2004, J NEUROSURG ANESTH, V16, P87, DOI 10.1097/00008506-200401000-00019; dos Santos VV, 2013, BEHAV BRAIN RES, V244, P107, DOI 10.1016/j.bbr.2013.01.039; Dougherty KD, 2000, NEUROBIOL DIS, V7, P574, DOI 10.1006/nbdi.2000.0318; Du XP, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/4159357; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Feldman Z, 1996, J NEUROSURG, V85, P131, DOI 10.3171/jns.1996.85.1.0131; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gotzsche CR, 2016, NEUROPEPTIDES, V55, P79, DOI 10.1016/j.npep.2015.09.010; Hattiangady B, 2005, EXP NEUROL, V195, P353, DOI 10.1016/j.expneurol.2005.05.014; Heilig M, 2004, NEUROPEPTIDES, V38, P213, DOI 10.1016/j.npep.2004.05.002; Hoffman JR, 2015, MED SCI SPORT EXER, V47, P2043, DOI 10.1249/MSS.0000000000000642; Hoffman JR, 2015, AMINO ACIDS, V47, P1247, DOI 10.1007/s00726-015-1952-y; Hylin MJ, 2013, J NEUROTRAUM, V30, P702, DOI 10.1089/neu.2012.2630; Jacobowitz DM, 2012, BRAIN RES, V1465, P80, DOI 10.1016/j.brainres.2012.05.008; Jaffee MS, 2009, J REHABIL RES DEV, V46, P655, DOI 10.1682/JRRD.2008.09.0114; Kaplan GB, 2010, BEHAV PHARMACOL, V21, P427, DOI 10.1097/FBP.0b013e32833d8bc9; Kesner RP, 2004, REV NEUROSCIENCE, V15, P333; Kochanek AR, 2006, DEV NEUROSCI-BASEL, V28, P410, DOI 10.1159/000094167; KOHEN R, 1988, P NATL ACAD SCI USA, V85, P3175, DOI 10.1073/pnas.85.9.3175; Koponen E, 2004, MOL BRAIN RES, V130, P81, DOI 10.1016/j.molbrainres.2004.07.010; Kozlovsky N, 2007, INT J NEUROPSYCHOPH, V10, P741, DOI 10.1017/S1461145707007560; KUNZE N, 1986, EUR J BIOCHEM, V160, P605, DOI 10.1111/j.1432-1033.1986.tb10081.x; Malva JO, 2012, NEUROPEPTIDES, V46, P299, DOI 10.1016/j.npep.2012.09.001; Marshall KR, 2012, MIL MED, V177, P67, DOI 10.7205/MILMED-D-12-00110; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McAllister TW, 2012, J NEUROTRAUM, V29, P1111, DOI 10.1089/neu.2011.1930; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Murakami T, 2010, AMINO ACIDS, V39, P427, DOI 10.1007/s00726-009-0458-x; Ojo JO, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00213; Ozawa T, 2014, BEHAV BRAIN RES, V263, P210, DOI 10.1016/j.bbr.2014.01.034; Pape TLB, 2013, PM&R, V5, P856, DOI 10.1016/j.pmrj.2013.06.007; Perez-Polo JR, 2015, J NEUROSCI RES, V93, P549, DOI 10.1002/jnr.23513; Ram O, 2012, EXP FLUIDS, V53, P1335, DOI 10.1007/s00348-012-1339-8; Sajja VSSS, 2016, FRONT INTEGR NEUROSC, V10, DOI [10.3389/fnint.2016.00007, 10.3389/fnint.7016.00007]; Sajja VSSS, 2014, NEUROSCI LETT, V570, P33, DOI 10.1016/j.neulet.2014.03.072; Storzbach D, 2015, J INT NEUROPSYCH SOC, V21, P353, DOI 10.1017/S1355617715000326; Teufel M, 2003, J BIOL CHEM, V278, P6521, DOI 10.1074/jbc.M209764200; Tiedje KE, 2010, NEUROCHEM INT, V57, P177, DOI 10.1016/j.neuint.2010.06.001; Walcott BP, 2011, NEW ENGL J MED, V365, P860, DOI 10.1056/NEJMc1107891; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wilson CB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076146; Yang SH, 2013, J SURG RES, V184, P981, DOI 10.1016/j.jss.2013.03.075; Zohar J, 2011, EUR NEUROPSYCHOPHARM, V21, P796, DOI 10.1016/j.euroneuro.2011.06.001; Zuckerman A, 2017, J NEUROTRAUM, V34, P145, DOI 10.1089/neu.2015.4310	60	17	19	0	8	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0939-4451	1438-2199		AMINO ACIDS	Amino Acids	MAY	2017	49	5					871	886		10.1007/s00726-017-2383-8			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ER9VV	WOS:000399176200003	28161798	Green Published, hybrid			2022-02-06	
J	Karr, JE; Garcia-Barrera, MA; Holdnack, JA; Iverson, GL				Karr, Justin E.; Garcia-Barrera, Mauricio A.; Holdnack, James A.; Iverson, Grant L.			Using Multivariate Base Rates to Interpret Low Scores on an Abbreviated Battery of the Delis-Kaplan Executive Function System	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Executive functions; Assessment; Norms/normative studies	HEALTHY OLDER-ADULTS; NEUROPSYCHOLOGICAL ASSESSMENT; FRONTOTEMPORAL DEMENTIA; SUPPLEMENTARY METHODS; MEMORY SCORES; WAIS-IV; PREVALENCE; VARIABILITY; DYSFUNCTION; IMPAIRMENT	Objective: Executive function consists of multiple cognitive processes that operate as an interactive system to produce volitional goaloriented behavior, governed in large part by frontal microstructural and physiological networks. Identification of deficits in executive function in those with neurological or psychiatric conditions can be difficult because the normal variation in executive function test scores, in healthy adults when multiple tests are used, is largely unknown. This study addresses that gap in the literature by examining the prevalence of low scores on a brief battery of executive function tests. Method: The sample consisted of 1,050 healthy individuals (ages 16-89) from the standardization sample for the Delis-Kaplan Executive Function System (D-KEFS). Seven individual test scores from the Trail Making Test, Color-Word Interference Test, and Verbal Fluency Test were analyzed. Results: Low test scores, as defined by commonly used clinical cut-offs (i. e., <= 25th, 16th, 9th, 5th, and 2nd percentiles), occurred commonly among the adult portion of the D-KEFS normative sample (e.g., 62.8% of the sample had one or more scores <= 16th percentile, 36.1% had one or more scores <= 5th percentile), and the prevalence of low scores increased with lower intelligence and fewer years of education. Conclusions: The multivariate base rates (BR) in this article allow clinicians to understand the normal frequency of low scores in the general population. By use of these BRs, clinicians and researchers can improve the accuracy with which they identify executive dysfunction in clinical groups, such as those with traumatic brain injury or neurodegenerative diseases.	[Karr, Justin E.; Garcia-Barrera, Mauricio A.] Univ Victoria, Dept Psychol, POB 1700 STN CSC, Victoria, BC V8W 2Y2, Canada; [Holdnack, James A.] Pearson, Clin Assessment, Bear, DE 19701 USA; [Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02129 USA; [Iverson, Grant L.] Spaulding Rehabil Hosp, Boston, MA 02129 USA; [Iverson, Grant L.] MassGen Hosp Children, Sports Concuss Program, Boston, MA 02129 USA; [Iverson, Grant L.] Red Sox Fdn, Home Base, Boston, MA 02129 USA; [Iverson, Grant L.] Massachusetts Gen Hosp Program, Boston, MA 02129 USA		Karr, JE (corresponding author), Univ Victoria, Dept Psychol, POB 1700 STN CSC, Victoria, BC V8W 2Y2, Canada.	jkarr@uvic.ca	Garcia-Barrera, Mauricio A./AAO-9757-2021	Garcia-Barrera, Mauricio A./0000-0002-4302-4964; Iverson, Grant/0000-0001-7348-9570	Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR	Standardization data from the Delis-Kaplan Executive Function System (D-KEFS), (C) 2001 NCS Pearson, Inc. Used with permission. All rights reserved. J.E.K. is a Vanier Canada Graduate Scholar and thanks the Natural Sciences and Engineering Research Council of Canada for their support of his graduate studies. G.L.I. notes that this work is related in part to the TBI Endpoints Development Initiative and a grant entitled Development and Validation of a Cognition Endpoint for Traumatic Brain Injury Clinical Trials. He acknowledges unrestricted philanthropic support from the Mooney-Reed Charitable Foundation and ImPACT Applications, Inc. M.G.B. also note that this work is related in part to his grant entitled Characteristics and Correlates of Intraindividual Variability in Executive Control Processes (Natural Sciences and Engineering Research Council of Canada).	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; [Anonymous], 1999, WECHSLER ABBREVIATED; Aron AR, 2008, CURR DIR PSYCHOL SCI, V17, P124, DOI 10.1111/j.1467-8721.2008.00561.x; Binder LM, 2009, ARCH CLIN NEUROPSYCH, V24, P31, DOI 10.1093/arclin/acn001; Brooks B. L., 2012, PEDIAT FORENSIC NEUR, P66; Brooks BL, 2008, J INT NEUROPSYCH SOC, V14, P463, DOI 10.1017/S1355617708080521; Brooks BL, 2007, J INT NEUROPSYCH SOC, V13, P490, DOI 10.1017/D1355617707070531; Brooks BL, 2013, PRACT RESOUR MENT, P75, DOI 10.1016/B978-0-12-386934-0.00002-X; Brooks BL, 2012, APPL NEUROPSYCH-ADUL, V19, P61, DOI 10.1080/09084282.2012.651951; Brooks BL, 2011, ASSESSMENT, V18, P156, DOI 10.1177/1073191110385316; Brooks BL, 2010, ARCH CLIN NEUROPSYCH, V25, P182, DOI 10.1093/arclin/acq005; Brooks BL, 2009, DEMENT GERIATR COGN, V27, P439, DOI 10.1159/000215390; Bush G, 2005, BIOL PSYCHIAT, V57, P1273, DOI 10.1016/j.biopsych.2005.01.034; Collette F, 2005, HUM BRAIN MAPP, V25, P409, DOI 10.1002/hbm.20118; Crawford JR, 2012, J NEUROPSYCHOL, V6, P192, DOI 10.1111/j.1748-6653.2011.02022.x; Crawford JR, 2011, PSYCHOL ASSESSMENT, V23, P888, DOI 10.1037/a0023712; Delis DC., 2001, DELIS KAPLAN EXECUTI; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Homack S, 2005, J CLIN EXP NEUROPSYC, V27, P599, DOI 10.1080/13803390490918444; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P923, DOI 10.1007/978-0-387-76978-3_32; Jurado MB, 2007, NEUROPSYCHOL REV, V17, P213, DOI 10.1007/s11065-007-9040-z; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Liberzon I, 2007, PROG BRAIN RES, V167, P151, DOI 10.1016/S0079-6123(07)67011-3; Lorenzetti V, 2009, J AFFECT DISORDERS, V117, P1, DOI 10.1016/j.jad.2008.11.021; MacDonald SWS, 2006, TRENDS NEUROSCI, V29, P474, DOI 10.1016/j.tins.2006.06.011; McKhann GM, 2001, ARCH NEUROL-CHICAGO, V58, P1803, DOI 10.1001/archneur.58.11.1803; Pearson Inc., 2001, STAND DAT DEL KAPL E; Rabin LA, 2016, ARCH CLIN NEUROPSYCH, V31, P206, DOI 10.1093/arclin/acw007; Reynolds CR, 2006, TEST VERBAL CONCEPTU; Rosen HJ, 2002, NEUROLOGY, V58, P198, DOI 10.1212/WNL.58.2.198; Schretlen DJ, 2008, J INT NEUROPSYCH SOC, V14, P436, DOI 10.1017/S1355617708080387; Shunk AW., 2006, APPL NEUROPSYCHOLOGY, V13, P275, DOI [DOI 10.1207/S15324826AN1304_9, DOI 10.1207/S15324826AN1304_]; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Wechsler D., 2009, WECHSLER MEMORY SCAL	35	17	17	1	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2017	32	3					297	305		10.1093/arclin/acw105			9	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	EU2WN	WOS:000400890700005	28431030	Bronze			2022-02-06	
J	Maguigan, KL; Dennis, BM; Hamblin, SE; Guillamondegui, OD				Maguigan, Kelly L.; Dennis, Bradley M.; Hamblin, Susan E.; Guillamondegui, Oscar D.			Method of Hypertonic Saline Administration: Effects on Osmolality in Traumatic Brain Injury Patients	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Traumatic brain injury; Hypertonic saline; Osmolality; Intracranial pressure	RAISED INTRACRANIAL-PRESSURE; ACUTE KIDNEY INJURY; ILL PATIENTS; HYPERTENSION; CARE; MANAGEMENT; MANNITOL; INFUSION; CHLORIDE; THERAPY	Hypertonic saline (HTS) is an effective therapy for reducing intracranial pressure (ICP). The ideal method of administration is unknown. The purpose of this study was to evaluate the method of HTS infusion and time to goal osmolality. A retrospective cohort analysis was conducted in severe TBI patients with ICP monitoring in place who received 2 doses of HTS. Patients were divided into bolus versus continuous infusion HTS cohorts. The primary outcome was median time to goal osmolality. Secondary outcomes included percentage of patients reaching goal osmolality, percent time at goal osmolality, mean cerebral perfusion pressure (CPP) and ICP, ICU length of stay, and mortality. Safety outcomes included rates of hyperchloremia, hypernatremia, and acute kidney injury (AKI). 162 patients were included with similar baseline characteristics. Time to goal osmolality was similar between cohorts (bolus 9.78 h vs. continuous 11.4 h, p = 0.817). A significant difference in the percentage of patients reaching goal osmolality favoring the continuous group was found (93.9% vs 73.3%, p = 0.003). The continuous group was maintained at goal osmolality for a higher percentage of osmolality values after reaching goal (80% vs. 50%, p = 0.032). No difference was seen in CPP, ICP, length of stay and mortality. Rates of hypernatremia were similar, but significant higher rates of hyperchloremia (0.77 vs 1.58 events per HTS days, p < 0.001) and AKI (0% vs 12.9%, p = 0.025) were observed in the continuous cohort. Although no difference in time to goal osmolality was observed, continuous HTS was associated with a higher percentage of patients achieving goal osmolality. (C) 2017 Elsevier Ltd. All rights reserved.	[Maguigan, Kelly L.; Hamblin, Susan E.] Vanderbilt Univ, Med Ctr, Dept Pharmaceut Serv, 1211 Med Ctr Dr,B131 VUH, Nashville, TN 37232 USA; [Dennis, Bradley M.; Guillamondegui, Oscar D.] Vanderbilt Univ, Med Ctr, Dept Trauma & Surg Crit Care, 1211 21st Ave South,404 Med Arts Bldg, Nashville, TN 37232 USA; [Guillamondegui, Oscar D.] Vanderbilt Univ, Med Ctr, Dept Neurol Surg, 1161 21st Ave So,T4224 Med Ctr North, Nashville, TN 37232 USA		Hamblin, SE (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pharmaceut Serv, 1211 Med Ctr Dr,B131 VUH, Nashville, TN 37232 USA.	Susan.hamblin@vanderbilt.edu					Adrogue HJ, 2000, NEW ENGL J MED, V342, P1493, DOI 10.1056/NEJM200005183422006; Bratton S, 2007, J NEUROTRAUM, V24, P14; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Fink Matthew E, 2012, Continuum (Minneap Minn), V18, P640, DOI 10.1212/01.CON.0000415432.84147.1e; Forsyth LL, 2008, PHARMACOTHERAPY, V28, P469, DOI 10.1592/phco.28.4.469; Froelich M, 2009, CRIT CARE MED, V37, P1433, DOI 10.1097/CCM.0b013e31819c1933; Harukuni Izumi, 2002, J Anesth, V16, P229, DOI 10.1007/s005400200030; Huang SJ, 2006, SURG NEUROL, V65, P539, DOI 10.1016/j.surneu.2005.11.019; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Li M, 2015, MEDICINE, V94; Luo XY, 2014, CRIT CARE, V18, DOI 10.1186/cc13977; Marshall GT, 2010, J TRAUMA, V69, P275, DOI 10.1097/TA.0b013e3181de74c7; Mortazavi MM, 2012, J NEUROSURG, V116, P210, DOI 10.3171/2011.7.JNS102142; Muizelaar JP, 2009, CRIT CARE MED, V37, P1521, DOI 10.1097/CCM.0b013e31819d3ea0; Ropper AH, 2012, NEW ENGL J MED, V367, P746, DOI 10.1056/NEJMct1206321; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Sakowitz OW, 2007, J TRAUMA, V62, P292, DOI 10.1097/01.ta.0000203560.03937.2d; Scalfani MT, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.10.008; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Wagner I, 2011, STROKE, V42, P1540, DOI 10.1161/STROKEAHA.110.609479; WILCOX CS, 1983, J CLIN INVEST, V71, P726, DOI 10.1172/JCI110820; Young P, 2015, JAMA-J AM MED ASSOC, V314, P1701, DOI 10.1001/jama.2015.12334; Yunos NM, 2012, JAMA-J AM MED ASSOC, V308, P1566, DOI 10.1001/jama.2012.13356	25	17	18	0	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	MAY	2017	39						147	150		10.1016/j.jocn.2017.01.025			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ET0ND	WOS:000399958200036	28215427				2022-02-06	
J	Weinstein, AA; Chin, LMK; Collins, J; Goel, D; Keyser, RE; Chan, L				Weinstein, Ali A.; Chin, Lisa M. K.; Collins, John; Goel, Divya; Keyser, Randall E.; Chan, Leighton			Effect of Aerobic Exercise Training on Mood in People With Traumatic Brain Injury: A Pilot Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						affect; brain injuries; exercise therapy; rehabilitation	PHYSICAL-ACTIVITY; MODERATE EXERCISE; AFFECTIVE RESPONSES; SELF-EFFICACY; UNITED-STATES; PROFILE; INDIVIDUALS; DEPRESSION; HEALTH; EPIDEMIOLOGY	Background: Exercise training is associated with elevations in mood in patients with various chronic illnesses and disabilities. However, little is known regarding the effect of exercise training on short and long-term mood changes in those with traumatic brain injury (TBI). Objective: The purpose of this study was to examine the time course of mood alterations in response to a vigorous, 12-week aerobic exercise training regimen in ambulatory individuals with chronic TBI (>6 months postinjury). Methods: Short and long-term mood changes were measured using the Profile of Mood States-Short Form, before and after specific aerobic exercise bouts performed during the 12-week training regimen. Results: Ten subjects with nonpenetrating TBI (6.6 6.8 years after injury) completed the training regimen. A significant improvement in overall mood was observed following 12 weeks of aerobic exercise training (P = .04), with moderate to large effect sizes observed for short-term mood improvements following individual bouts of exercise. Conclusions: Specific improvements in long-term mood state and short-term mood responses following individual exercise sessions were observed in these individuals with TBI. The largest improvement in overall mood was observed at 12 weeks of exercise training, with improvements emerging as early as 4 weeks into the training regimen.	[Weinstein, Ali A.; Goel, Divya] George Mason Univ, Ctr Study Chron Illness & Disabil, 4400 Univ Dr MS 2G7, Fairfax, VA 22030 USA; [Chin, Lisa M. K.; Collins, John; Keyser, Randall E.] George Mason Univ, Coll Hlth & Human Serv, Dept Rehabil Sci, 4400 Univ Dr MS 2G7, Fairfax, VA 22030 USA; [Chin, Lisa M. K.; Collins, John; Keyser, Randall E.; Chan, Leighton] NIH, Dept Rehabil Med, Ctr Clin, Bethesda, MD 20892 USA; [Chan, Leighton] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA		Chin, LMK (corresponding author), George Mason Univ, Coll Hlth & Human Serv, Dept Rehabil Sci, 4400 Univ Dr MS 2G7, Fairfax, VA 22030 USA.	lchin2@gmu.edu	Chin, Lisa MK/O-4706-2014	Chin, Lisa MK/0000-0002-0178-739X; Collins, John/0000-0002-3863-0329; Weinstein, Ali/0000-0002-3371-6086	Department of Defense in the Center for Neuroscience and Regenerative MedicineUnited States Department of Defense [G192HI-H]; Intramural Research Program of the National Institutes of Health, Clinical Center (Rehabilitation Medicine Department intramural funds)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA	Support for this work included funding from Department of Defense in the Center for Neuroscience and Regenerative Medicine (grant no. G192HI-H) and the Intramural Research Program of the National Institutes of Health, Clinical Center (Rehabilitation Medicine Department intramural funds).	Archer T, 2012, NEUROTOX RES, V21, P418, DOI 10.1007/s12640-011-9297-0; Bailie JM, 2015, J HEAD TRAUMA REHAB, V30, P12, DOI 10.1097/HTR.0000000000000024; Bellon K, 2014, BRAIN INJURY, V29, P1; Berger BG, 2000, J APPL SPORT PSYCHOL, V12, P69, DOI 10.1080/10413200008404214; Bhambhani Y, 2005, ARCH PHYS MED REHAB, V86, P268, DOI 10.1016/j.apmr.2004.04.022; Bodin T, 2004, J SPORT EXERCISE PSY, V26, P623, DOI 10.1123/jsep.26.4.623; Chin LM, 2015, ARCH PHYS MED REHAB, V96, P754, DOI 10.1016/j.apmr.2014.11.009; Chin LMK, 2015, J HEAD TRAUMA REHAB, V30, P382, DOI 10.1097/HTR.0000000000000062; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; CRAMER SR, 1991, J PSYCHOSOM RES, V35, P437, DOI 10.1016/0022-3999(91)90039-Q; Cunningham LLC, 1998, HEALTH PSYCHOL, V17, P371, DOI 10.1037/0278-6133.17.4.371; CURRAN SL, 1995, PSYCHOL ASSESSMENT, V7, P80, DOI 10.1037/1040-3590.7.1.80; DiLorenzo TM, 1999, PREV MED, V28, P75, DOI 10.1006/pmed.1998.0385; Driver S, 2004, BRAIN INJURY, V18, P847, DOI 10.1080/02699050410001671856; Driver S, 2012, DISABIL HEALTH J, V5, P117, DOI 10.1016/j.dhjo.2011.11.002; Driver S, 2009, BRAIN INJURY, V23, P203, DOI 10.1080/02699050802695574; Ernst C, 2006, J PSYCHIATR NEUROSCI, V31, P84; Fabel K, 2003, EUR J NEUROSCI, V18, P2803, DOI 10.1111/j.1460-9568.2003.03041.x; Faul M, 2010, TRAUMATIC BRAIN INJU, P74; Gordon WA, 1998, J HEAD TRAUMA REHAB, V13, P58, DOI 10.1097/00001199-199808000-00006; Grealy MA, 1999, ARCH PHYS MED REHAB, V80, P661, DOI 10.1016/S0003-9993(99)90169-7; Guszkowska Monika, 2004, Psychiatr Pol, V38, P611; HASKELL WL, 1994, MED SCI SPORT EXER, V26, P649, DOI 10.1249/00005768-199406000-00001; Hassmen P, 2000, PREV MED, V30, P17, DOI 10.1006/pmed.1999.0597; Hay EL, 2010, PSYCHOL AGING, V25, P118, DOI 10.1037/a0018747; Helmick KM, 2015, BRAIN IMAGING BEHAV, V9, P358, DOI 10.1007/s11682-015-9399-z; Hoffman JM, 2010, PM&R, V2, P911, DOI 10.1016/j.pmrj.2010.06.008; HUNTER M, 1990, PHYS THER, V70, P363, DOI 10.1093/ptj/70.6.363; Ide K, 2000, PROG NEUROBIOL, V61, P397, DOI 10.1016/S0301-0082(99)00057-X; JANKOWSKI LW, 1990, ARCH PHYS MED REHAB, V71, P500; KARVONEN MJ, 1957, ANN MED EXP BIOL FEN, V35, P307; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; LeUnes A, 2000, J APPL SPORT PSYCHOL, V12, P5, DOI 10.1080/10413200008404210; Lutgendorf SK, 1999, J GERONTOL A-BIOL, V54, pM434, DOI 10.1093/gerona/54.9.M434; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; MARTINSEN EW, 1990, SPORTS MED, V9, P380, DOI 10.2165/00007256-199009060-00006; McCabe MP, 2009, J CLIN PSYCHOL MED S, V16, P355, DOI 10.1007/s10880-009-9168-5; McGuirk M., MOOD ANXIETY RPE MHR; McNair D. M, 1971, MANUAL PROFILE MOOD; Monshouwer K, 2013, CLIN PSYCHOL SCI, V1, P67, DOI 10.1177/2167702612450485; North T C, 1990, Exerc Sport Sci Rev, V18, P379; Paluska SA, 2000, SPORTS MED, V29, P167, DOI 10.2165/00007256-200029030-00003; Rao V, 2002, PSYCHIAT CLIN N AM, V25, P43, DOI 10.1016/S0193-953X(03)00052-2; Rimmele U, 2009, PSYCHONEUROENDOCRINO, V34, P190, DOI 10.1016/j.psyneuen.2008.08.023; Ryan MP, 2008, PSYCHOL HEALTH, V23, P279, DOI 10.1080/14768320601185502; Rzezak P, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00839; Schrepf A, 2013, BRAIN BEHAV IMMUN, V30, pS126, DOI 10.1016/j.bbi.2012.07.022; Schwandt M, 2012, J HEAD TRAUMA REHAB, V27, P99, DOI 10.1097/HTR.0b013e31820e6858; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; SHACHAM S, 1983, J PERS ASSESS, V47, P305, DOI 10.1207/s15327752jpa4703_14; SMITH RB, 1994, BRAIN INJURY, V8, P357, DOI 10.3109/02699059409150986; Stanton JM, 1996, J PSYCHOSOM RES, V40, P637, DOI 10.1016/0022-3999(95)00643-5; Stark R, 2012, NEUROPSYCHIATRIE, V26, P166, DOI 10.1007/s40211-012-0033-7; Szabo Attila, 2003, J Sports Sci Med, V2, P77; Thompson PD, 2001, MED SCI SPORT EXER, V33, pS438, DOI 10.1097/00005768-200106001-00012; Unick JL, 2012, PSYCHOL SPORT EXERC, V13, P528, DOI 10.1016/j.psychsport.2012.02.012; Van Schaik P, 2008, CYBERPSYCHOL BEHAV, V11, P103, DOI 10.1089/cpb.2007.9925; Wegner M, 2014, CNS NEUROL DISORD-DR, V13, P1002, DOI 10.2174/1871527313666140612102841; Weinstein A. A., 2014, POSITIVE HUMAN FUNCT, V2, P147; Wise EK, 2012, ARCH PHYS MED REHAB, V93, P1319, DOI 10.1016/j.apmr.2012.05.009; Wolfe GI, 2004, MUSCLE NERVE, V30, P3, DOI 10.1002/mus.20057; Wolman RL, 1994, CLIN REHABIL, V8, P253; Yeung RR, 1996, J PSYCHOSOM RES, V40, P123, DOI 10.1016/0022-3999(95)00554-4; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	66	17	18	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2017	32	3					E49	E56		10.1097/HTR.0000000000000253			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EV4GM	WOS:000401716900012	27603762	Green Accepted			2022-02-06	
J	Zheng, SL; Han, F; Shi, YX; Wen, LL; Han, D				Zheng, Shilei; Han, Fang; Shi, Yuxiu; Wen, Lili; Han, Dan			Single-Prolonged-Stress-Induced Changes in Autophagy-Related Proteins Beclin-1, LC3, and p62 in the Medial Prefrontal Cortex of Rats with Post-traumatic Stress Disorder	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Post-traumatic stress disorder; Autophagy; Medial prefrontal cortex; Single-prolonged stress; Beclin-1; Microtubule-associated protein 1 light chain 3; p62/SQSTM1	UP-REGULATION; ALZHEIMERS-DISEASE; BRAIN-INJURY; CELL-DEATH; MODEL; BCL-2; PTSD; ACTIVATION; APOPTOSIS; TRAUMA	Autophagy, or type II programmed cell death, plays a crucial role in many nervous system diseases. However, few studies have examined the role of autophagy in post-traumatic stress disorder (PTSD), and the mechanisms underlying PTSD are poorly understood. The objective of this research was to explore the expression of three important autophagy-related proteins, Beclin-1, microtubule-associated protein 1 light chain 3 (LC3), and p62/SQSTM1 (p62), in the medial prefrontal cortex (mPFC) of an animal model of PTSD to identify changes in autophagic activity during PTSD pathogenesis. PTSD was induced in rats by exposure to a single-prolonged stress (SPS). The Morris water maze was used to assess cognitive changes in rats from the SPS and control groups. Transmission electron microscopy (TEM) was employed to observe mPFC morphological changes. Immunohistochemistry, immunofluorescence, and Western blotting techniques were used to detect expression of Beclin-1, LC3, and p62 in the mPFC. The Morris water maze test results showed that the escape latency time was increased and that the percent time in the target quadrant was decreased in the SPS group compared with that in the control group. Numerous visible autolysosomes in mPFC neurons were observed using TEM after SPS stimulation. Compared with that in the control group, the expression of Beclin-1 and the LC3-II/I ratio significantly decreased at 1 day, then increased and peaked at 7 days, and slightly decreased at 14 days after SPS stimulation, whereas the converse was found for p62 expression. In conclusion, dysregulation of autophagic activity in the mPFC may play a crucial role in PTSD pathogenesis.	[Zheng, Shilei; Han, Fang; Shi, Yuxiu; Wen, Lili; Han, Dan] China Med Univ, Inst Pathol & Pathophysiol, Basic Med Sci Coll, PTSD Lab,Dept Histol & Embryol, 77 Puhe Rd, Shenyang 110122, Liaoning, Peoples R China; [Zheng, Shilei] Jinzhou Med Univ, Dept Radiol, Affiliated Hosp 1, 2 Fifth Duan,Renmin St, Jinzhou 121001, Liaoning, Peoples R China		Shi, YX (corresponding author), China Med Univ, Inst Pathol & Pathophysiol, Basic Med Sci Coll, PTSD Lab,Dept Histol & Embryol, 77 Puhe Rd, Shenyang 110122, Liaoning, Peoples R China.	shiyuxiu@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571324]; Specialized Research Fund for the Doctoral Program of Higher EducationSpecialized Research Fund for the Doctoral Program of Higher Education (SRFDP) [20132104110021]	This research was supported by grants from the National Natural Science Foundation of China (No. 81571324) and Specialized Research Fund for the Doctoral Program of Higher Education (No. 20132104110021). The authors would like to thank the reviewers for their valuable comments.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Bailey CR, 2013, CNS DRUGS, V27, P221, DOI 10.1007/s40263-013-0051-4; Boccia M, 2016, BRAIN IMAGING BEHAV, V10, P226, DOI 10.1007/s11682-015-9387-3; Caccamo A., 2016, MOL PSYCHIAT; Carloni S, 2008, NEUROBIOL DIS, V32, P329, DOI 10.1016/j.nbd.2008.07.022; Chaudhury D, 2013, NATURE, V493, P532, DOI 10.1038/nature11713; Chen YQ, 2011, J CELL SCI, V124, P161, DOI 10.1242/jcs.064576; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Ding JL, 2010, J PSYCHIATR RES, V44, P48, DOI 10.1016/j.jpsychires.2009.06.001; Diskin T, 2005, J NEUROTRAUM, V22, P750, DOI 10.1089/neu.2005.22.750; Dodson M, 2013, FREE RADICAL BIO MED, V63, P207, DOI 10.1016/j.freeradbiomed.2013.05.014; Fleming A, 2011, NAT CHEM BIOL, V7, P9, DOI 10.1038/NCHEMBIO.500; Gibson BM, 2016, LEARN BEHAV, V44, P97, DOI 10.3758/s13420-016-0214-5; Giustino TF, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00298; Hughes KC, 2011, EXPERT REV NEUROTHER, V11, P275, DOI [10.1586/ern.10.198, 10.1586/ERN.10.198]; Itakura E, 2011, J CELL BIOL, V192, P17, DOI 10.1083/jcb.201009067; Jiang PD, 2014, CELL RES, V24, P69, DOI 10.1038/cr.2013.161; Khan S, 2004, PSYCHOPHARMACOLOGY, V172, P225, DOI 10.1007/s00213-003-1634-4; Kim JH, 2014, EXP CELL RES, V327, P340, DOI 10.1016/j.yexcr.2014.08.001; Kohda K, 2007, NEUROSCIENCE, V148, P22, DOI 10.1016/j.neuroscience.2007.05.041; Kuusisto E, 2002, NEUROPATH APPL NEURO, V28, P228, DOI 10.1046/j.1365-2990.2002.00394.x; Larsen KE, 2002, HISTOL HISTOPATHOL, V17, P897, DOI 10.14670/HH-17.897; Lee JY, 2009, BRAIN RES, V1287, P126, DOI 10.1016/j.brainres.2009.06.028; Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260; Li YN, 2013, J MOL NEUROSCI, V51, P127, DOI 10.1007/s12031-013-9965-z; Longatti A, 2010, CELL RES, V20, P1181, DOI 10.1038/cr.2010.132; Lucin KM, 2013, NEURON, V79, P873, DOI 10.1016/j.neuron.2013.06.046; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Mellman TA, 2009, DEPRESS ANXIETY, V26, P993, DOI 10.1002/da.20627; Meng LH, 2016, SCI REP-UK, V6, DOI 10.1038/srep33748; Moghaddam B, 2004, NEUROTOX RES, V6, P73, DOI 10.1007/BF03033299; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Oral O, 2016, HISTOL HISTOPATHOL, V31, P479, DOI 10.14670/HH-11-714; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pollice R, 2012, RIV PSICHIATR, V47, P59, DOI 10.1708/1034.11292; Pratchett LC, 2011, EXPERT OPIN PHARMACO, V12, P2339, DOI 10.1517/14656566.2011.604030; Rami A, 2008, NEUROBIOL DIS, V29, P132, DOI 10.1016/j.nbd.2007.08.005; Rangaraju S, 2011, AUTOPHAGY, V7, P238, DOI 10.4161/auto.7.2.14278; Rangaraju S, 2010, J NEUROSCI, V30, P11388, DOI 10.1523/JNEUROSCI.1356-10.2010; Roozendaal B, 2009, J NEUROSCI, V29, P14299, DOI 10.1523/JNEUROSCI.3626-09.2009; Sahani MH, 2014, AUTOPHAGY, V10, P431, DOI 10.4161/auto.27344; Sheng R, 2010, AUTOPHAGY, V6, P482, DOI 10.4161/auto.6.4.11737; Sherin Jonathan E, 2011, Dialogues Clin Neurosci, V13, P263; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Son JH, 2012, EXP MOL MED, V44, P89, DOI 10.3858/emm.2012.44.2.031; Spellman T, 2015, NATURE, V522, P309, DOI 10.1038/nature14445; Wan JL, 2016, ACTA HISTOCHEM, V118, P10, DOI 10.1016/j.acthis.2015.11.003; Wang DK, 2015, J ETHNOPHARMACOL, V161, P99, DOI 10.1016/j.jep.2014.12.005; Wang QW, 2013, BIOCHEM BIOPH RES CO, V438, P186, DOI 10.1016/j.bbrc.2013.07.050; Wang T, 2016, SCI REP-UK, V6, DOI 10.1038/srep27131; Weidberg H, 2010, EMBO J, V29, P1792, DOI 10.1038/emboj.2010.74; Williams LM, 2006, NEUROIMAGE, V29, P347, DOI 10.1016/j.neuroimage.2005.03.047; Wu C, 2014, OSTEOARTHR CARTILAGE, V22, P1936, DOI 10.1016/j.joca.2014.08.010; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yamamoto A, 2014, ANNU REV NEUROSCI, V37, P55, DOI 10.1146/annurev-neuro-071013-014149; Yang Z, 2015, J MOL MED, V93, P707, DOI 10.1007/s00109-015-1297-8; Yehuda R, 2005, HANDB EXP PHARM, V169, P371; Yu B, 2014, BMC NEUROSCI, V15, DOI 10.1186/s12868-014-0115-5; Zhao DM, 2014, J MOL NEUROSCI, V54, P147, DOI 10.1007/s12031-014-0263-1; Zhou L, 2013, ACTA PHARMACOL SIN, V34, P651, DOI 10.1038/aps.2013.12	61	17	20	1	12	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	MAY	2017	62	1					43	54		10.1007/s12031-017-0909-x			12	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	EV1PY	WOS:000401519700007	28341893				2022-02-06	
J	Manktelow, AE; Menon, DK; Sahakian, BJ; Stamatakis, EA				Manktelow, Anne E.; Menon, David K.; Sahakian, Barbara J.; Stamatakis, Emmanuel A.			Working Memory after Traumatic Brain Injury: The Neural Basis of Improved Performance with Methylphenidate	FRONTIERS IN BEHAVIORAL NEUROSCIENCE			English	Article						traumatic brain injury; working memory; methylphenidate; functional connectivity; cerebellum; fMRI; cognitive function	BASAL GANGLIA; CEREBELLAR CONTRIBUTIONS; FUNCTIONAL-ORGANIZATION; SUBTHALAMIC NUCLEUS; RESPONSE-INHIBITION; TEMPORAL DYNAMICS; CEREBRAL-CORTEX; DOPAMINE; NETWORKS; ANATOMY	Traumatic brain injury (TBI) often results in cognitive impairments for patients. The aim of this proof of concept study was to establish the nature of abnormalities, in terms of activity and connectivity, in the working memory network of TBI patients and how these relate to compromised behavioral outcomes. Further, this study examined the neural correlates of working memory improvement following the administration of methylphenidate. We report behavioral, functional and structural MRI data from a group of 15 Healthy Controls (HC) and a group of 15 TBI patients, acquired during the execution of the N-back task. The patients were studied on two occasions after the administration of either placebo or 30mg ofmethylphenidate. Between group tests revealed a significant difference in performance when HCs were compared to TBI patients on placebo [F (1, 28) = 4.426, p < 0.05, eta p(2) = 0.136]. This difference disappeared when the patients took methylphenidate [F (1, 28) = 3.665, p = 0.66]. Patients in the middle range of baseline performance demonstrated the most benefit from methylphenidate. Changes in the TBI patient activation levels in the Left Cerebellum significantly and positively correlated with changes in performance (r = 0.509, df = 13, p = 0.05). Whole-brain connectivity analysis using the Left Cerebellum as a seed revealed widespread negative interactions between the Left Cerebellumand parietal and frontal cortices as well as subcortical areas. Neither the TBI group onmethylphenidate nor the HC group demonstrated any significant negative interactions. Our findings indicate that (a) TBI significantly reduces the levels of activation and connectivity strength between key areas of the working memory network and (b) Methylphenidate improves the cognitive outcomes on a working memory task. Therefore, we conclude that methylphenidate may render the working memory network in a TBI group more consistent with that of an intact working memory network.	[Manktelow, Anne E.; Menon, David K.; Stamatakis, Emmanuel A.] Univ Cambridge, Div Anaesthesia, Cambridge, England; [Menon, David K.; Sahakian, Barbara J.; Stamatakis, Emmanuel A.] Univ Cambridge, Dept Clin Neurosci, Wolfson Brain Imaging Ctr, Cambridge, England; [Sahakian, Barbara J.] Univ Cambridge, Dept Psychiat, MRC Wellcome Trust Behav & Clin Neurosci Inst, Cambridge, England		Manktelow, AE (corresponding author), Univ Cambridge, Div Anaesthesia, Cambridge, England.	am807@cam.ac.uk	Sahakian, Barbara/AAW-1198-2020	Sahakian, Barbara/0000-0001-7352-1745; Stamatakis, Emmanuel Andreas/0000-0001-6955-9601; Verma, Vishwajit/0000-0003-2428-2391	Evelyn Trust [06/20]; Neuroscience Theme of the NIHR Cambridge Biomedical; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0512-10090] Funding Source: researchfish	This work was supported by the Evelyn Trust (grant number 06/20). The Evelyn Trust had no role in the conduct of the research for the preparation of the manuscript. DM is supported by the Neuroscience Theme of the NIHR Cambridge Biomedical	Aarts E, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00163; Allen G, 2005, NEUROIMAGE, V28, P39, DOI 10.1016/j.neuroimage.2005.06.013; Aravamuthan BR, 2007, NEUROIMAGE, V37, P694, DOI 10.1016/j.neuroimage.2007.05.050; Arnsten AFT, 2005, BIOL PSYCHIAT, V57, P1377, DOI 10.1016/j.biopsych.2004.08.019; Baddeley A., 2007, WORKING MEMORY THOUG, V45, DOI [0.1093/acprof:oso/9780198528012.001.0001, DOI 10.1093/ACPROF:OSO/9780198528012.001.0001]; Baddeley A.D., 1986, WORKING MEMORY; Baddeley A, 2012, ANNU REV PSYCHOL, V63, P1, DOI 10.1146/annurev-psych-120710-100422; Ben-Yehudah G, 2007, CEREBELLUM, V6, P193, DOI 10.1080/14734220701286195; Bostan AC, 2013, TRENDS COGN SCI, V17, P241, DOI 10.1016/j.tics.2013.03.003; Bostan AC, 2010, P NATL ACAD SCI USA, V107, P8452, DOI 10.1073/pnas.1000496107; Bright P, 2002, J INT NEUROPSYCH SOC, V8, P847, DOI 10.1017/S1355617702860131; Brown P, 2001, J NEUROSCI, V21, P1033, DOI 10.1523/JNEUROSCI.21-03-01033.2001; Buckner RL, 2013, NEURON, V80, P807, DOI 10.1016/j.neuron.2013.10.044; Chen SHA, 2005, NEUROPSYCHOLOGIA, V43, P1227, DOI 10.1016/j.neuropsychologia.2004.12.015; Chen SHA, 2005, NEUROIMAGE, V24, P332, DOI 10.1016/j.neuroimage.2004.08.032; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Cools R, 2004, PHILOS T R SOC A, V362, P2871, DOI 10.1098/rsta.2004.1468; Cools R, 2011, BIOL PSYCHIAT, V69, pE113, DOI 10.1016/j.biopsych.2011.03.028; Costa A, 2013, CEREB CORTEX, V23, P1179, DOI 10.1093/cercor/bhs107; Creelman, 2005, DETECTION THEORY USE; D'Angelo E, 2013, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00116; Desmond JE, 1997, J NEUROSCI, V17, P9675; Dreher JC, 2002, EUR J NEUROSCI, V16, P1609, DOI 10.1046/j.1460-9568.2002.02212.x; Elliott R, 1997, PSYCHOPHARMACOLOGY, V131, P196, DOI 10.1007/s002130050284; Fallon SJ, 2017, J COGNITIVE NEUROSCI, V29, P652, DOI 10.1162/jocn_a_01065; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; GEVINS A, 1993, ELECTROEN CLIN NEURO, V87, P128, DOI 10.1016/0013-4694(93)90119-G; Gilbert DL, 2006, NEUROPSYCHOPHARMACOL, V31, P442, DOI 10.1038/sj.npp.1300806; Goldman-Rakic PS, 2000, BRAIN RES REV, V31, P295, DOI 10.1016/S0165-0173(99)00045-4; Green D.M., 1966, SOCIETY; Haber SN, 2009, BRAIN RES BULL, V78, P69, DOI 10.1016/j.brainresbull.2008.09.013; Hayter AL, 2007, NEUROIMAGE, V36, P943, DOI 10.1016/j.neuroimage.2007.03.011; Henson RNA, 2000, NEUROPSYCHOLOGIA, V38, P426, DOI 10.1016/S0028-3932(99)00098-6; Hillary FG, 2011, BRAIN, V134, P1555, DOI 10.1093/brain/awr043; Hockey A, 2004, INTELLIGENCE, V32, P591, DOI 10.1016/j.intell.2004.07.009; Hoshi E, 2005, NAT NEUROSCI, V8, P1491, DOI 10.1038/nn1544; Ivry RB, 2004, CURR OPIN NEUROBIOL, V14, P225, DOI 10.1016/j.conb.2004.03.013; Jaeggi SM, 2010, MEMORY, V18, P394, DOI 10.1080/09658211003702171; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kasahara M, 2011, BRAIN INJURY, V25, P1170, DOI 10.3109/02699052.2011.608210; Kim YH, 2006, CLIN REHABIL, V20, P24, DOI 10.1191/0269215506cr927oa; Klauer KC, 2004, J EXP PSYCHOL GEN, V133, P355, DOI 10.1037/0096-3445.133.3.355; Koch G, 2007, EXP BRAIN RES, V179, P291, DOI 10.1007/s00221-006-0791-1; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Landau SM, 2009, CEREB CORTEX, V19, P445, DOI 10.1093/cercor/bhn095; Leung HC, 2007, NEUROIMAGE, V35, P368, DOI 10.1016/j.neuroimage.2006.12.012; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; Lewis SJG, 2004, EUR J NEUROSCI, V19, P755, DOI 10.1111/j.1460-9568.2004.03108.x; Mangels JA, 1998, COGNITIVE BRAIN RES, V7, P15, DOI 10.1016/S0926-6410(98)00005-6; Marquand AF, 2011, NEUROPSYCHOPHARMACOL, V36, P1237, DOI 10.1038/npp.2011.9; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; McDonald BC, 2017, NEUROPSYCHOPHARMACOL, V42, P1766, DOI 10.1038/npp.2016.261; McGurn B, 2004, NEUROLOGY, V62, P1184, DOI 10.1212/01.WNL.0000103169.80910.8B; Medaglia JD, 2012, HUM BRAIN MAPP, V33, P979, DOI 10.1002/hbm.21264; Mehta MA, 2000, J NEUROSCI, V20; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Middleton FA, 1997, INT REV NEUROBIOL, V41, P61, DOI 10.1016/S0074-7742(08)60347-5; MIDDLETON FA, 1994, SCIENCE, V266, P458, DOI 10.1126/science.7939688; Moreno-Lopez L, 2017, EUR NEUROPSYCHOPHARM, V27, P159, DOI 10.1016/j.euroneuro.2016.12.002; Mueller S, 2014, HUM BRAIN MAPP, V35, P5379, DOI 10.1002/hbm.22557; Newcombe VFJ, 2016, NEUROREHAB NEURAL RE, V30, P49, DOI 10.1177/1545968315584004; Newsome MR, 2009, BRAIN IMAGING BEHAV, V3, P298, DOI 10.1007/s11682-009-9072-5; Nichelli P, 1996, NEUROPSYCHOLOGIA, V34, P863, DOI 10.1016/0028-3932(96)00001-2; Oliveri M, 2007, CEREBELLUM, V6, P95, DOI 10.1080/14734220701213421; Owen AM, 1999, EUR J NEUROSCI, V11, P567, DOI 10.1046/j.1460-9568.1999.00449.x; Owen AM, 1997, EUR J NEUROSCI, V9, P1329, DOI 10.1111/j.1460-9568.1997.tb01487.x; PARENT A, 1995, BRAIN RES REV, V20, P91, DOI 10.1016/0165-0173(94)00007-C; PARENT A, 1995, BRAIN RES REV, V20, P128, DOI 10.1016/0165-0173(94)00008-D; Parente R, 2011, NEUROREHABILITATION, V29, P117, DOI 10.3233/NRE-2011-0685; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Ramasubbu Rajamannar, 2008, Neuropsychiatr Dis Treat, V4, P1251; Ravizza SM, 2004, NEUROIMAGE, V22, P562, DOI 10.1016/j.neuroimage.2004.01.039; Salmon E, 1996, BRAIN, V119, P1617, DOI 10.1093/brain/119.5.1617; Salmond CH, 2005, CURR OPIN CRIT CARE, V11, P111, DOI 10.1097/01.ccx.0000155358.31983.37; Sanchez-Carrion R, 2008, NEUROIMAGE, V43, P421, DOI 10.1016/j.neuroimage.2008.08.003; Schmahmann JD, 1997, INT REV NEUROBIOL, V41, P31, DOI 10.1016/S0074-7742(08)60346-3; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Smith EE, 1996, CEREB CORTEX, V6, P11, DOI 10.1093/cercor/6.1.11; Stamatakis EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014496; Stoodley CJ, 2012, CEREBELLUM, V11, P352, DOI 10.1007/s12311-011-0260-7; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Swets JA., 1982, EVALUATION DIAGNOSTI; Tomasi D, 2011, NEUROIMAGE, V54, P3101, DOI 10.1016/j.neuroimage.2010.10.060; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; Volkow N D, 2001, J Neurosci, V21, pRC121; Williams D, 2002, BRAIN, V125, P1558, DOI 10.1093/brain/awf156	92	17	18	0	9	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5153			FRONT BEHAV NEUROSCI	Front. Behav. Neurosci.	APR 5	2017	11								58	10.3389/fnbeh.2017.00058			15	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	EQ9NO	WOS:000398411400001	28424597	Green Published, gold			2022-02-06	
J	Catroppa, C; Hearps, S; Crossley, L; Yeates, K; Beauchamp, M; Fusella, J; Anderson, V				Catroppa, Cathy; Hearps, Stephen; Crossley, Louise; Yeates, Keith; Beauchamp, Miriam; Fusella, Jessica; Anderson, Vicki			Social and Behavioral Outcomes following Childhood Traumatic Brain Injury: What Predicts Outcome at 12 Months Post-Insult?	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; behavioral; children; predictors; social	FAMILY ASSESSMENT DEVICE; FUNCTIONAL RECOVERY; SELF-ESTEEM; HEAD-INJURY; CHILDREN; ADOLESCENTS; PARTICIPATION; FRIENDSHIP; SCHOOL; RELIABILITY	This study sought to investigate social and behavioral outcomes 12 months following childhood traumatic brain injury (TBI) and to identify predictors of these outcomes. The study also compared rates of impairment in social and behavioral outcomes at 12 months post-injury between children with TBI and a typically developing (TD) control group. The study comprised 114 children ages 5.5 to 16.0 years, 79 with mild, moderate, or severe TBI and 35 TD children, group-matched for age, sex and socio-economic status. Children with TBI were recruited via consecutive hospital admissions and TD children from the community. Social and behavioral outcomes were measured via parent-rated questionnaires. Analysis of covariance models identified a significant mean difference between the mild and moderate groups for social problems only, but the moderate and severe TBI groups showed a higher rate of impairment, particularly in externalizing problems. Pre-injury function, injury severity, parent mental health, and child self-esteem all contributed significantly to predicting social and behavioral outcomes. Both injury and non-injury factors should be considered when identifying children at risk for long-term difficulties in social and behavioral domains.	[Catroppa, Cathy; Hearps, Stephen; Crossley, Louise] Murdoch Childrens Res Inst, 4th Floor West,50 Flemington Rd, Parkville, Vic 3052, Australia; [Yeates, Keith] Alberta Childrens Prov Gen Hosp, Res Inst, Calgary, AB, Canada; [Beauchamp, Miriam] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Fusella, Jessica] Royal Melbourne Hosp, Melbourne, Vic, Australia; [Anderson, Vicki] Royal Childrens Hosp, Dept Psychol, Melbourne, Vic, Australia; [Anderson, Vicki] Univ Melbourne, Dept Psychol Sci & Pediat, Melbourne, Vic, Australia		Catroppa, C (corresponding author), Murdoch Childrens Res Inst, 4th Floor West,50 Flemington Rd, Parkville, Vic 3052, Australia.	cathy.catroppa@mcri.edu.au	Yeates, Keith/AAJ-4223-2020; Catroppa, Cathy/AAX-9458-2021; Hearps, Stephen/L-6853-2016	Catroppa, Cathy/0000-0002-9750-0436; Hearps, Stephen/0000-0003-2984-1172; Yeates, Keith/0000-0001-7680-2892	Victorian Neurotrauma Initiative; Victorian Government Operational Infrastructure Scheme	The Victorian Neurotrauma Initiative funded this research, and it also was supported by the Victorian Government Operational Infrastructure Scheme.	Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Anaby D, 2012, DEV MED CHILD NEUROL, V54, P339, DOI 10.1111/j.1469-8749.2011.04204.x; Anderson V., 2013, J INT PSYCHOL SOC, V19, P1; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Beauchamp MH, 2010, PSYCHOL BULL, V136, P39, DOI 10.1037/a0017768; Bedell G, 2008, J HEAD TRAUMA REHAB, V23, P341, DOI 10.1097/01.HTR.0000336850.29574.7a; Bedell GM, 2004, NEUROREHABILITATION, V19, P191; Bohnert AM, 1997, DEV NEUROPSYCHOL, V13, P477, DOI 10.1080/87565649709540688; Catroppa C, 2015, J NEUROTRAUM, V32, P109, DOI 10.1089/neu.2013.3276; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; COFFEY CE, 1991, AM PSYCHOP, P243; Cohen J., 2013, STAT POWER ANAL BEHA; Di Battista A, 2014, J REHABIL MED, V46, P975, DOI 10.2340/16501977-1883; Di Battista A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101842; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Eren S, 2014, SOCIAL CARE NEURODIS, V5, P135, DOI [10.1108/SCN-06-2013-0022, DOI 10.1108/SCN-06-2013-0022]; Fidell L.S., 2000, USING MULTIVARIATE S; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Galvin J, 2010, AUST OCCUP THER J, V57, P118, DOI 10.1111/j.1440-1630.2009.00822.x; Harrison P. L., 2003, ADAPTIVE BEHAV ASSES, V2nd; Harter S., 1985, MANUAL SELF PERCEPTI; Hawley CA, 2004, ARCH DIS CHILD, V89, P136, DOI 10.1136/adc.2002.025577; Hawley CA, 2012, NEUROREHABILITATION, V30, P173, DOI 10.3233/NRE-2012-0742; Heverly-Fitt S, 2014, J INT NEUROPSYCH SOC, V20, P684, DOI 10.1017/S1355617714000393; Jackson C, 2007, OCCUP MED-OXFORD, V57, P79, DOI 10.1093/occmed/kql169; Keightley Michelle L, 2014, Arch Phys Med Rehabil, V95, pS192, DOI 10.1016/j.apmr.2013.12.018; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Max JE, 2012, INT J DEV NEUROSCI, V30, P239, DOI 10.1016/j.ijdevneu.2011.12.005; McMillan J, 2009, J SOCIOL, V45, P123, DOI 10.1177/1440783309103342; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; Muris P, 2003, PERS INDIV DIFFER, V35, P1791, DOI 10.1016/S0191-8869(03)00004-7; Pastore V, 2015, BRAIN INJURY, V29, P937, DOI 10.3109/02699052.2015.1008045; Prigatano G.P., 2010, PED HLTH, V4, P447; Prigatano GP, 2006, J HEAD TRAUMA REHAB, V21, P505, DOI 10.1097/00001199-200611000-00005; Prigatano GP, 2008, J HEAD TRAUMA REHAB, V23, P378, DOI 10.1097/01.HTR.0000341433.67251.01; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Ross KA, 2011, BRAIN INJURY, V25, P1206, DOI 10.3109/02699052.2011.609519; Ryan NP, 2013, INT J DEV NEUROSCI, V31, P811, DOI 10.1016/j.ijdevneu.2013.10.002; Schmidt AT, 2010, BRAIN INJURY, V24, P1550, DOI 10.3109/02699052.2010.523047; Sharp NL, 2006, DISABIL REHABIL, V28, P767, DOI 10.1080/09638280500386668; Sonnenberg LK, 2010, BRAIN INJURY, V24, P1003, DOI 10.3109/02699052.2010.489033; Taylor HG, 2015, J HEAD TRAUMA REHAB, V30, P302, DOI 10.1097/HTR.0000000000000106; TEASDALE G, 1974, LANCET, V2, P81; Thaler NS, 2012, APPL NEUROPSYCH-CHIL, V1, P30, DOI 10.1080/21622965.2012.665776; Thompson H, 2012, J NEUROTRAUM, V29, pA189; UCLA: Academic Technology Services, 2012, STAT DAT AN EX TOB A; van Tol E, 2011, BRAIN INJURY, V25, P1279, DOI 10.3109/02699052.2011.613089; Vickers AJ, 2001, BMJ-BRIT MED J, V323, P1123, DOI 10.1136/bmj.323.7321.1123; Warschausky S, 1997, Pediatr Rehabil, V1, P77; WECHSLER D, 1990, WECHSLER ABBREVIATED; Wells R, 2009, DEV NEUROREHABIL, V12, P12, DOI 10.1080/17518420902773109; Yeates K. O., 2013, J INT NEUROPSYCH SOC, V19, P1; Yeates KO, 2014, CLIN PSYCHOL SCI, V2, P97, DOI 10.1177/2167702613499734; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Ylvisaker Mark, 2007, Phys Med Rehabil Clin N Am, V18, P133, DOI 10.1016/j.pmr.2006.11.007	56	17	17	0	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2017	34	7					1439	1447		10.1089/neu.2016.4594			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	ER0FB	WOS:000398461600013	27809667				2022-02-06	
J	Galetta, KM; Chapman, KR; Essis, MD; Alosco, ML; Gillard, D; Steinberg, E; Dixon, D; Martin, B; Chaisson, CE; Kowall, NW; Tripodis, Y; Balcer, LJ; Stern, RA				Galetta, Kristin M.; Chapman, Kimberly R.; Essis, Maritza D.; Alosco, Michael L.; Gillard, Danielle; Steinberg, Eric; Dixon, Diane; Martin, Brett; Chaisson, Christine E.; Kowall, Neil W.; Tripodis, Yorghos; Balcer, Laura J.; Stern, Robert A.			Screening Utility of the King-Devick Test in Mild Cognitive Impairment and Alzheimer Disease Dementia	ALZHEIMER DISEASE & ASSOCIATED DISORDERS			English	Article						Alzheimer disease; dementia; mild cognitive impairment; saccadic eye movements; King-Devick test; screening test	DIAGNOSTIC-ACCURACY; EYE-MOVEMENTS; SACCADE; RECOMMENDATIONS; BIOMARKERS; BATTERY; TOOL	The King-Devick (K-D) test is a 1 to 2 minute, rapid number naming test, often used to assist with detection of concussion, but also has clinical utility in other neurological conditions (eg, Parkinson disease). The K-D involves saccadic eye and other eye movements, and abnormalities thereof may be an early indicator of Alzheimer disease (AD)-associated cognitive impairment. No study has tested the utility of the K-D in AD and we sought to do so. The sample included 206 [ 135 controls, 39 mild cognitive impairment (MCI), and 32 AD dementia] consecutive subjects from the Boston University Alzheimer's Disease Center registry undergoing their initial annual evaluation between March 2013 and July 2015. The K-D was administered during this period. Areas under the receiver operating characteristic curves generated from logistic regression models revealed the K-D test distinguished controls from subjects with cognitive impairment (MCI and AD dementia) [ area under the curve (AUC) - 0.72], MCI (AUC - 0.71) and AD dementia (AUC - 0.74). K-D time scores between 48 and 52 seconds were associated with high sensitivity (> 90.0%) and negative predictive values (> 85.0%) for each diagnostic group. The K-D correlated strongly with validated attention, processing speed, and visual scanning tests. The K-D test may be a rapid and simple effective screening tool to detect cognitive impairment associated with AD.	[Galetta, Kristin M.] Brigham & Womens Hosp, Dept Neurol, 75 Francis St, Boston, MA 02115 USA; [Galetta, Kristin M.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Boston, MA USA; [Chapman, Kimberly R.; Essis, Maritza D.; Alosco, Michael L.; Gillard, Danielle; Steinberg, Eric; Dixon, Diane; Martin, Brett; Chaisson, Christine E.; Kowall, Neil W.; Tripodis, Yorghos; Stern, Robert A.] Boston Univ, Alzheimers Dis & CTE Ctr, Boston, MA 02215 USA; [Kowall, Neil W.; Stern, Robert A.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Kowall, Neil W.] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA; [Stern, Robert A.] Boston Univ, Sch Med, Dept Neurosurg & Anat & Neurobiol, Boston, MA USA; [Dixon, Diane; Martin, Brett; Chaisson, Christine E.] Data Coordinating Ctr, Boston, MA USA; [Tripodis, Yorghos] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Kowall, Neil W.] VA Boston Healthcare Syst, Boston, MA USA; [Balcer, Laura J.] NYU, Sch Med, Dept Neurol, New York, NY USA; [Balcer, Laura J.] NYU, Sch Med, Dept Populat Hlth, New York, NY USA; [Balcer, Laura J.] NYU, Sch Med, Dept Ophthalmol, New York, NY USA		Stern, RA (corresponding author), Boston Univ, Alzheimers Dis & CTE Ctr, Sch Med, 72 East Concord St,B7800, Boston, MA 02118 USA.	bobstern@bu.edu	, Bob/ABA-8507-2020; Kowall, Neil/M-5378-2019	Kowall, Neil/0000-0002-6624-0213; Tripodis, Yorghos/0000-0003-2190-7608	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30 AG13846, R01 NS 078337, U01 NS093334]; Avid Radiopharmaceuticals Inc. (Philadelphia, PA); Biogen (Cambridge, MA); Amarantus BioScience Holdings Inc. (San Francisco, CA); Avanir Pharmaceuticals Inc. (Aliso Viejo, CA);  [T32-AG06697]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [TL1TR001443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS078337, F32NS096803, U01NS093334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG013846, T32AG036697] Funding Source: NIH RePORTER	Supported by grants from the NIH (P30 AG13846; R01 NS 078337; U01 NS093334). M.L.A. is supported by the T32-AG06697 postdoctoral fellowship.; R.A.S. has received research funding from Avid Radiopharmaceuticals Inc. (Philadelphia, PA). He is a member of the Mackey-White Committee of the NFL Players Association. He is a paid consultant to Amarantus BioScience Holdings Inc. (San Francisco, CA), Avanir Pharmaceuticals Inc. (Aliso Viejo, CA), and Biogen (Cambridge, MA). He receives royalties for published neuropsychological tests from Psychological Assessment Resources Inc. (Lutz, FL), as well as compensation from expert legal opinion. L.J.B. has received consulting fees from Biogen (Cambridge, MA). The remaining authors declare no conflicts of interest.	Alzheimer's Association, 2015, 2015 ALZH DIS FACTS; Ashendorf L, 2009, J CLIN EXP NEUROPSYC, V31, P605, DOI 10.1080/13803390802375557; Borson S, 2000, INT J GERIATR PSYCH, V15, P1021, DOI 10.1002/1099-1166(200011)15:11<1021::AID-GPS234>3.0.CO;2-6; Chang LYL, 2014, ALZHEIMERS DEMENT, V10, P251, DOI 10.1016/j.jalz.2013.06.004; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohn J., 1998, STAT POWER ANAL BEHA; Connolly A, 2011, AGING MENT HEALTH, V15, P978, DOI 10.1080/13607863.2011.596805; Cordell CB, 2013, ALZHEIMERS DEMENT, V9, P141, DOI 10.1016/j.jalz.2012.09.011; Fernandez G, 2013, INVEST OPHTH VIS SCI, V54, P8345, DOI 10.1167/iovs.13-12877; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Gavett BE, 2012, APPL NEUROPSYCH-ADUL, V19, P108, DOI 10.1080/09084282.2011.643947; Gavett BE, 2009, J INT NEUROPSYCH SOC, V15, P121, DOI 10.1017/S1355617708090176; Geldmacher DS, 2013, PRIM CARE COMPANION, V15; Heuer HW, 2013, NEUROLOGY, V81, P1235, DOI 10.1212/WNL.0b013e3182a6cbfe; Jefferson AL, 2007, APPL NEUROPSYCHOL, V14, P215, DOI 10.1080/09084280701509166; Karantzoulis S, 2011, EXPERT REV NEUROTHER, V11, P1579, DOI [10.1586/ERN.11.155, 10.1586/ern.11.155]; King AT., 1976, PROPOSED KING DEVICK; King D, 2015, J NEUROL SCI, V357, P75, DOI 10.1016/j.jns.2015.06.069; Leong DF, 2014, J SPORT MED PHYS FIT, V54, P70; Leong Danielle F, 2015, J Optom, V8, P131, DOI 10.1016/j.optom.2014.12.005; Lin TP, 2014, PARKINSONISM RELAT D, V20, P226, DOI 10.1016/j.parkreldis.2013.10.009; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mitchell AJ, 2010, AM J GERIAT PSYCHIAT, V18, P759, DOI 10.1097/JGP.0b013e3181cdecb8; Molitor RJ, 2015, J ALZHEIMERS DIS, V44, P1, DOI 10.3233/JAD-141173; Moster S, 2014, J NEUROL SCI, V343, P105, DOI 10.1016/j.jns.2014.05.047; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Palmqvist S, 2015, NEUROLOGY, V85, P1240, DOI 10.1212/WNL.0000000000001991; Panza F, 2005, AM J GERIAT PSYCHIAT, V13, P633, DOI 10.1176/appi.ajgp.13.8.633; Peltsch A, 2011, NEUROBIOL AGING, V32, P669, DOI 10.1016/j.neurobiolaging.2009.04.001; Peltsch A, 2014, EUR J NEUROSCI, V39, P2000, DOI 10.1111/ejn.12617; Reiman EM, 2012, LANCET NEUROL, V11, P1048, DOI 10.1016/S1474-4422(12)70228-4; Shakespeare TJ, 2015, BRAIN, V138, P1976, DOI 10.1093/brain/awv103; Spering CC, 2012, J GERONTOL A-BIOL, V67, P890, DOI 10.1093/gerona/gls006; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Weintraub S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006171; Weintraub S, 2009, ALZ DIS ASSOC DIS, V23, P91, DOI 10.1097/WAD.0b013e318191c7dd; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Yang Q, 2013, AGE, V35, P1287, DOI 10.1007/s11357-012-9420-z	40	17	17	0	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0893-0341			ALZ DIS ASSOC DIS	Alzheimer Dis. Assoc. Dis.	APR-JUN	2017	31	2					152	158		10.1097/WAD.0000000000000157			7	Clinical Neurology; Pathology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pathology	EV6RL	WOS:000401899300011	27299935	Green Accepted			2022-02-06	
J	Greenberg, JK; Yan, Y; Carpenter, CR; Lumba-Brown, A; Keller, MS; Pineda, JA; Brownson, RC; Limbrick, DD				Greenberg, Jacob K.; Yan, Yan; Carpenter, Christopher R.; Lumba-Brown, Angela; Keller, Martin S.; Pineda, Jose A.; Brownson, Ross C.; Limbrick, David D.			Development and Internal Validation of a Clinical Risk Score for Treating Children With Mild Head Trauma and Intracranial Injury	JAMA PEDIATRICS			English	Article							BRAIN-INJURY; MULTIPLE IMPUTATION; EPIDEMIOLOGY	IMPORTANCE The appropriate treatment of children with mild traumatic brain injury (mTBI) and intracranial injury (ICI) on computed tomographic imaging remains unclear. Evidence-based risk assessments may improve patient safety and reduce resource use. OBJECTIVE To derive a risk score predicting the need for intensive care unit observation in children with mTBI and ICI. DESIGN, SETTING, AND PARTICIPANTS This retrospective analysis of the prospective Pediatric Emergency Care Applied Research Network (PECARN) head injury cohort study included patients enrolled in 25 North American emergency departments from 2004 to 2006. We included patients younger than 18 years with mTBI (Glasgow Coma Scale [GCS] score, 13-15) and ICI on computed tomography. The data analysis was conducted from May 2015 to October 2016. MAIN OUTCOMES AND MEASURES The primary outcome was the composite of neurosurgical intervention, intubation for more than 24 hours for TBI, or death from TBI. Multivariate logistic regression was used to predict the outcome. The C statistic was used to quantify discrimination, and model performance was internally validated using 10-fold cross-validation. Based on this modeling, the Children's Intracranial Injury Decision Aid score was created. RESULTS Among 15 162 children with GCS 13 to 15 head injuries who received head computed tomographic imaging in the emergency department, 839 (5.5%) had ICI. The median ages of those with and without a composite outcome were 7 and 5 years, respectively. Among those patients with ICI, 8.7%(n = 73) experienced the primary outcome, including 8.3%(n = 70) who had a neurosurgical intervention. The only clinical variable significantly associated with outcome was GCS score (odds ratio [OR], 3.4; 95% CI, 1.5-7.4 for GCS score 13 vs 15). Significant radiologic predictors included midline shift (OR, 6.8; 95% CI, 3.4-13.8), depressed skull fracture (OR, 6.5; 95% CI, 3.7-11.4), and epidural hematoma (OR, 3.4; 95% CI, 1.8-6.2). The model C statistic was 0.84 (95% CI, 0.79-0.88); the 10-fold cross-validated C statistic was 0.83. Based on this modeling, we developed the Children's Intracranial Injury Decision Aid score, which ranged from 0 to 24 points. The negative predictive value of having 0 points (ie, none of these risk factors) was 98.8% (95% CI, 97.3%-99.6%). CONCLUSIONS AND RELEVANCE Lower GCS score, midline shift, depressed skull fracture, and epidural hematoma are key risk factors for needing intensive care unit-level care in children with mTBI and ICI. Based on these results, the Children's Intracranial Injury Decision Aid score is a potentially novel tool to risk stratify this population, thereby aiding management decisions.	[Greenberg, Jacob K.; Limbrick, David D.] Washington Univ, Sch Med St Louis, Dept Neurosurg, St Louis, MO USA; [Yan, Yan; Keller, Martin S.; Brownson, Ross C.] Washington Univ, Sch Med St Louis, Dept Surg, St Louis, MO USA; [Carpenter, Christopher R.; Pineda, Jose A.] Washington Univ, Sch Med St Louis, Dept Neurol, Div Emergency Med, St Louis, MO USA; [Lumba-Brown, Angela; Pineda, Jose A.] Washington Univ, Dept Pediat, Sch Med St Louis, St Louis, MO 63130 USA; [Brownson, Ross C.] Washington Univ, Alvin J Siteman Canc Ctr, Sch Med St Louis, St Louis, MO USA; [Brownson, Ross C.] Washington Univ, Prevent Res Ctr, Sch Med St Louis, St Louis, MO USA		Greenberg, JK (corresponding author), Washington Univ, Sch Med, St Louis Childrens Hosp, 1 Childrens Pl,Ste 4S20, St Louis, MO 63110 USA.	greenbergj@wudosis.wustl.edu	Pineda, Jose/W-2806-2019; Carpenter, Christopher R./E-3720-2013	Carpenter, Christopher R./0000-0002-2603-7157; Lumba-Brown, Angela/0000-0002-9102-8791; Yan, Yan/0000-0002-5917-1475	Washington University School of Medicine Faculty Practice Plan [FPP-1501]; St Louis Children's Hospital Foundation; Health Resources Services Administration/Maternal Child Health Bureau/Emergency Medical Services for Children	This work was supported by grant FPP-1501 from the Washington University School of Medicine Faculty Practice Plan and the St Louis Children's Hospital Foundation. The Pediatric Emergency Care Applied Research Network was funded by the Health Resources Services Administration/Maternal Child Health Bureau/Emergency Medical Services for Children.	Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; [Anonymous], 2015, RMS REGR MOD STRAT C; Atabaki SM, 2008, ARCH PEDIAT ADOL MED, V162, P439, DOI 10.1001/archpedi.162.5.439; Balluffi Andrew, 2004, Pediatr Crit Care Med, V5, P547, DOI 10.1097/01.PCC.0000137354.19807.44; Bell MJ, 2016, INTENS CARE MED, V42, P1618, DOI 10.1007/s00134-016-4401-9; Boran BO, 2006, PEDIATR NEUROSURG, V42, P203, DOI 10.1159/000092355; Bowman SM, 2008, PEDIATRICS, V122, P988, DOI 10.1542/peds.2007-3511; Bullock AR, 2006, NEUROSURGERY, V58, pVI; Burns EC, 2019, PEDIATR EMERG CARE, V35, P161, DOI 10.1097/PEC.0000000000000950; Collins GS, 2015, ANN INTERN MED, V162, P55, DOI [10.7326/M14-0697, 10.1002/bjs.9736, 10.1111/dme.12654, 10.1038/bjc.2014.639, 10.1016/j.jclinepi.2014.11.010, 10.1186/s12916-014-0241-z, 10.1136/bmj.g7594]; Colville Gillian, 2009, Intensive Crit Care Nurs, V25, P72, DOI 10.1016/j.iccn.2008.10.002; Di F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142983; Greenberg JK, 2014, J TRAUMA ACUTE CARE, V76, P1089, DOI 10.1097/TA.0000000000000155; Halpern NA, 2010, CRIT CARE MED, V38, P65, DOI 10.1097/CCM.0b013e3181b090d0; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hess EP, 2015, ACAD EMERG MED, V22, P856, DOI 10.1111/acem.12703; Holsti M, 2005, PEDIATR EMERG CARE, V21, P639, DOI 10.1097/01.pec.0000181426.25342.a9; Hunter B, 2015, DOING RES EMERGENCY, P139; Kanzaria HK, 2015, ACAD EMERG MED, V22, P399, DOI 10.1111/acem.12627; Koepsell TD, 2011, PEDIATRICS, V128, P946, DOI 10.1542/peds.2010-2259; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Mannix R, 2013, NEUROSURGERY, V73, P129, DOI 10.1227/01.neu.0000429846.14579.41; Mannix R, 2012, J PEDIATR-US, V160, P136, DOI 10.1016/j.jpeds.2011.06.024; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Quayle KS, 2014, NEW ENGL J MED, V371, P1945, DOI 10.1056/NEJMc1407902; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; RUBIN DB, 1991, STAT MED, V10, P585, DOI 10.1002/sim.4780100410; Shudy M, 2006, PEDIATRICS, V118, pS203, DOI 10.1542/peds.2006-0951B; Simon B, 2001, J TRAUMA, V51, P231, DOI 10.1097/00005373-200108000-00004; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; van Buuren S, 2011, J STAT SOFTW, V45, P1; Wang HE, 2012, ANN EMERG MED, V60, P632, DOI 10.1016/j.annemergmed.2012.02.020; Wang MY, 2000, NEUROSURGERY, V46, P1093, DOI 10.1097/00006123-200005000-00014; Wells BJ, 2008, DIABETES CARE, V31, P2301, DOI 10.2337/dc08-1047; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056	38	17	18	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6203	2168-6211		JAMA PEDIATR	JAMA Pediatr.	APR 1	2017	171	4					342	349		10.1001/jamapediatrics.2016.4520			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	ER1FO	WOS:000398535500013	28192567				2022-02-06	
J	Miller, AP; Shah, AS; Aperi, BV; Kurpad, SN; Stemper, BD; Glavaski-Joksimovic, A				Miller, Anna P.; Shah, Alok S.; Aperi, Brandy V.; Kurpad, Shekar N.; Stemper, Brian D.; Glavaski-Joksimovic, Aleksandra			Acute death of astrocytes in blast-exposed rat organotypic hippocampal slice cultures	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; CONTROLLED CORTICAL IMPACT; FIBRILLARY ACIDIC PROTEIN; IN-VITRO MODEL; AMYOTROPHIC-LATERAL-SCLEROSIS; AUTOPHAGIC ASTROGLIAL DEATH; GLUTAMATE TRANSPORTER GLT-1; EXCITATORY AMINO-ACIDS; CLOSED-HEAD INJURY; CELL-DEATH	Blast traumatic brain injury (bTBI) affects civilians, soldiers, and veterans worldwide and presents significant health concerns. The mechanisms of neurodegeneration following bTBI remain elusive and current therapies are largely ineffective. It is important to better characterize blast-evoked cellular changes and underlying mechanisms in order to develop more effective therapies. In the present study, our group utilized rat organotypic hippocampal slice cultures (OHCs) as an in vitro system to model bTBI. OHCs were exposed to either 138 +/- 22 kPa (low) or 273 +/- 23 kPa (high) overpressures using an open-ended helium-driven shock tube, or were assigned to sham control group. At 2 hours (h) following injury, we have characterized the astrocytic response to a blast overpressure. Immunostaining against the astrocytic marker glial fibrillary acidic protein (GFAP) revealed acute shearing and morphological changes in astrocytes, including clasmatodendrosis. Moreover, overlap of GFAP immunostaining and propidium iodide (PI) indicated astrocytic death. Quantification of the number of dead astrocytes per counting area in the hippocampal cornu Ammonis 1 region (CA1), demonstrated a significant increase in dead astrocytes in the low- and high-blast, compared to sham control OHCs. However only a small number of GFAP-expressing astrocytes were co-labeled with the apoptotic marker Annexin V, suggesting necrosis as the primary type of cell death in the acute phase following blast exposure. Moreover, western blot analyses revealed calpain mediated breakdown of GFAP. The dextran exclusion additionally indicated membrane disruption as a potential mechanism of acute astrocytic death. Furthermore, although blast exposure did not evoke significant changes in glutamate transporter 1 (GLT-1) expression, loss of GLT-1-expressing astrocytes suggests dysregulation of glutamate uptake following injury. Our data illustrate the profound effect of blast overpressure on astrocytes in OHCs at 2 h following injury and suggest increased calpain activity and membrane disruption as potential underlying mechanisms.	[Miller, Anna P.; Shah, Alok S.; Aperi, Brandy V.; Kurpad, Shekar N.; Stemper, Brian D.; Glavaski-Joksimovic, Aleksandra] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Miller, Anna P.; Kurpad, Shekar N.; Glavaski-Joksimovic, Aleksandra] Med Coll Wisconsin, Dept Cell Biol, Milwaukee, WI 53226 USA; [Miller, Anna P.; Shah, Alok S.; Aperi, Brandy V.; Kurpad, Shekar N.; Stemper, Brian D.; Glavaski-Joksimovic, Aleksandra] Clement J Zablocki Vet Affairs Med Ctr, Milwaukee, WI USA		Glavaski-Joksimovic, A (corresponding author), Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA.	aglavaski@mcw.edu	Kurpad, Shekar/V-2188-2019; Stemper, Brian/AAX-7611-2020	Miller, Anna/0000-0002-6823-0852	Department of Neurosurgery, Medical College of Wisconsin; VA Medical ResearchUS Department of Veterans Affairs	This work was supported by the Department of Neurosurgery, Medical College of Wisconsin and the VA Medical Research.	Adamchik Y, 2000, BRAIN RES PROTOC, V5, P153, DOI 10.1016/S1385-299X(00)00007-6; Arun P, 2013, NEUROSCI LETT, V552, P87, DOI 10.1016/j.neulet.2013.07.047; Arun P, 2012, NEUROREPORT, V23, P342, DOI 10.1097/WNR.0b013e328351b58d; Arun P, 2011, NEUROREPORT, V22, P379, DOI 10.1097/WNR.0b013e328346b138; BAHR BA, 1995, J NEUROSCI RES, V42, P294, DOI 10.1002/jnr.490420303; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Benediktsson AM, 2012, GLIA, V60, P175, DOI 10.1002/glia.21249; Benediktsson AM, 2005, J NEUROSCI METH, V141, P41, DOI 10.1016/j.jneumeth.2004.05.013; Bezzi P, 2001, NAT NEUROSCI, V4, P702, DOI 10.1038/89490; Bi Dan, 2015, Yichuan, V37, P140, DOI 10.16288/j.yczz.14-207; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; Bralic M, 2012, MED HYPOTHESES, V79, P358, DOI 10.1016/j.mehy.2012.05.034; BUCHS PA, 1993, DEV BRAIN RES, V71, P81, DOI 10.1016/0165-3806(93)90108-M; Budde MD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00154; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; Burda JE, 2015, EXP NEUROL; Campbell SL, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00425; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chechneva O, 2005, NEUROSCIENCE, V136, P343, DOI 10.1016/j.neuroscience.2005.07.058; Chen JL, 2013, CELL BIOCHEM BIOPHYS, V67, P1015, DOI 10.1007/s12013-013-9597-5; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Chen Y, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00117; Cho S, 2007, CURR NEUROPHARMACOL, V5, P19, DOI 10.2174/157015907780077105; Choi HB, 2012, NEURON, V75, P1094, DOI 10.1016/j.neuron.2012.08.032; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Cimarosti H, 2009, NEUROPHARMACOLOGY, V56, P1088, DOI 10.1016/j.neuropharm.2009.03.007; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; CLEMEDSON CJ, 1956, PHYSIOL REV, V36, P336, DOI 10.1152/physrev.1956.36.3.336; Coburn M, 2008, CRIT CARE MED, V36, P588, DOI 10.1097/01.CCM.0B013E3181611F8A6; Collin C, 1997, J NEUROPHYSIOL, V77, P1614, DOI 10.1152/jn.1997.77.3.1614; Coltman BW, 1996, INT J DEV NEUROSCI, V14, P707, DOI 10.1016/S0736-5748(96)00071-8; Conti AC, 1998, J NEUROSCI, V18, P5663; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; Cummings Brian S, 2004, Curr Protoc Pharmacol, VChapter 12, DOI 10.1002/0471141755.ph1208s25; Czapiga M, 1999, J NEUROSCI RES, V56, P644, DOI 10.1002/(SICI)1097-4547(19990615)56:6<644::AID-JNR10>3.0.CO;2-9; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; de Lanerolle NC, 2011, J NEUROPATH EXP NEUR, V70, P1046, DOI 10.1097/NEN.0b013e318235bef2; De Simoni A, 2003, J PHYSIOL-LONDON, V550, P135, DOI 10.1113/jphysiol.2003.039099; Diskin T, 2005, J NEUROTRAUM, V22, P750, DOI 10.1089/neu.2005.22.750; Effgen GB, 2016, JOURNAL OF NEUROTRAU; Effgen GB, 2014, J NEUROTRAUM, V31, P1202, DOI 10.1089/neu.2013.3227; Effgen Gwen B, 2012, Front Neurol, V3, P23, DOI 10.3389/fneur.2012.00023; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Fahlenkamp AV, 2011, INFLAMM RES, V60, P379, DOI 10.1007/s00011-010-0281-6; Farkas O, 2006, J NEUROSCI, V26, P3130, DOI 10.1523/JNEUROSCI.5119-05.2006; Floyd CL, 2007, PROG BRAIN RES, V161, P61, DOI 10.1016/S0079-6123(06)61005-4; Foraker JE, 2011, J NEUROCHEM, V119, P1052, DOI 10.1111/j.1471-4159.2011.07511.x; Foran E, 2009, ANTIOXID REDOX SIGN, V11, P1587, DOI 10.1089/ars.2009.2444; Furness DN, 2008, NEUROSCIENCE, V157, P80, DOI 10.1016/j.neuroscience.2008.08.043; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Giffard RG, 2005, GLIA, V50, P299, DOI 10.1002/glia.20167; Glavaski-Joksimovic A, 2009, NEUROSCIENCE, V162, P472, DOI 10.1016/j.neuroscience.2009.04.070; Glavaski-Joksimovic A, 2008, CLONING STEM CELLS, V10, P75, DOI 10.1089/clo.2007.0065; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gullotti DM, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027873; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Heales SJR, 2004, NEUROCHEM RES, V29, P513, DOI 10.1023/B:NERE.0000014822.69384.0f; Heldt SA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00002; Hlavac Nora, 2015, Biomed Sci Instrum, V51, P439; Hoffer Michael E, 2009, Int Tinnitus J, V15, P115; Huang QY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061345; Hue CD, 2013, J NEUROTRAUM, V30, P1652, DOI 10.1089/neu.2012.2773; Hulse RE, 2001, GLIA, V33, P169, DOI 10.1002/1098-1136(200102)33:2<169::AID-GLIA1016>3.0.CO;2-B; Humpel C, 2015, NEUROSCIENCE, V305, P86, DOI 10.1016/j.neuroscience.2015.07.086; Ibolja Cernak FAA, 2010, MEDICAL DATA, V2, P297; Jayakumar AR, 2008, J NEUROPATH EXP NEUR, V67, P417, DOI 10.1097/NEN.0b013e31816fc9d4; Jayakumar AR, 2014, J NEUROTRAUM, V31, P1249, DOI 10.1089/neu.2013.3169; Jeftinija SD, 1996, J NEUROCHEM, V66, P676; Jeremic A, 2001, J NEUROCHEM, V77, P664, DOI 10.1046/j.1471-4159.2001.00272.x; Johnson EA, 2005, EXP BRAIN RES, V167, P17, DOI 10.1007/s00221-005-2362-2; Castejon OJ, 2015, FOLIA NEUROPATHOL, V53, P173, DOI 10.5114/fn.2015.54419; Jurado-Arjona J, 2015, BRAIN RES, V1611, P84, DOI 10.1016/j.brainres.2015.03.016; Kabu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127971; Kato K, 2007, J NEUROSURG, V106, P667, DOI 10.3171/jns.2007.106.4.667; Kaur C., 1997, Annals Academy of Medicine Singapore, V26, P27; Kobeissy F, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00186; Kodama T, 1998, ULTRASOUND MED BIOL, V24, P1459, DOI 10.1016/S0301-5629(98)00094-5; Krishnamurthy K, 2016, TRANSLATIONAL RESEAR; Kuehn R, 2011, J NEUROTRAUM, V28, P2155, DOI 10.1089/neu.2010.1532; Lee JY, 2015, J KOREAN NEUROSURG S, V58, P93, DOI 10.3340/jkns.2015.58.2.93; Lee YB, 2000, BRAIN RES, V864, P220, DOI 10.1016/S0006-8993(00)02180-6; Lei J, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1081-8; Levine J, 2015, GLIA; Li B, 2009, NEUROSURGERY, V65, P179, DOI 10.1227/01.NEU.0000346272.76537.DC; Lim YW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125130; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Liu D, 1999, MOL BRAIN RES, V68, P29, DOI 10.1016/S0169-328X(99)00063-7; Liu J, 2008, SCI SIGNAL, V1, DOI [10.1126/stke.114re1, 10.1126/scisignal.123tr3]; Liu MC, 2006, BIOCHEM J, V394, P715, DOI 10.1042/BJ20050905; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Lu J, 2012, J NEUROTRAUM, V29, P1434, DOI 10.1089/neu.2010.1591; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Macdonald CL, 2014, JOURNAL OF NEUROTRAU; MACKLIS JD, 1990, J NEUROSCI METH, V31, P43, DOI 10.1016/0165-0270(90)90007-3; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Mari C, 2004, EUR J NUCL MED MOL I, V31, P733, DOI 10.1007/s00259-004-1473-5; Matute C, 2002, EUR J PHARMACOL, V447, P239, DOI 10.1016/S0014-2999(02)01847-2; Mendez MF, 2013, NEUROREHABILITATION, V32, P397, DOI 10.3233/NRE-130861; Mennerick S, 1998, J NEUROSCI, V18, P4490; Mewes A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045017; Miller AP, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00020; MILLER LDP, 1994, NEUROSCIENCE, V63, P471, DOI 10.1016/0306-4522(94)90544-4; Molofsky AV, 2012, GENE DEV, V26, P891, DOI 10.1101/gad.188326.112; Morin-Brureau M, 2011, J NEUROSCI, V31, P10677, DOI 10.1523/JNEUROSCI.5692-10.2011; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Morrison B, 2000, NEUROSCIENCE, V96, P131, DOI 10.1016/S0306-4522(99)00537-0; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Mouser PE, 2006, AM J PATHOL, V168, P936, DOI 10.2353/ajpath.2006.050798; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Newcomb JK, 1999, EXP NEUROL, V158, P76, DOI 10.1006/exnr.1999.7071; Noraberg J, 1999, BRAIN RES PROTOC, V3, P278, DOI 10.1016/S1385-299X(98)00050-6; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Panzer Matthew B, 2012, Front Neurol, V3, P46, DOI 10.3389/fneur.2012.00046; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; Pellerin L, 2007, GLIA, V55, P1251, DOI 10.1002/glia.20528; Petersen MA, 2004, GLIA, V46, P195, DOI 10.1002/glia.10362; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; Pun Pamela B L, 2011, Front Neurol, V2, P19, DOI 10.3389/fneur.2011.00019; Ralay R. H., 2011, J NEUROTRAUM, V28, P1757, DOI DOI 10.1089/NEU.2011.1799; Rao VLR, 1998, J NEUROCHEM, V70, P2020; Rigg JL, 2011, PM&R, V3, pS380, DOI 10.1016/j.pmrj.2011.08.005; Rossi D, 2008, CELL DEATH DIFFER, V15, P1691, DOI 10.1038/cdd.2008.99; Rossi D, 2005, J BIOL CHEM, V280, P42088, DOI 10.1074/jbc.M504124200; Rossi D, 2009, BRAIN RES BULL, V80, P224, DOI 10.1016/j.brainresbull.2009.07.012; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Rytter A, 2003, J CEREBR BLOOD F MET, V23, P23, DOI 10.1097/01.WCB.0000034361.37277.1B; Ryu HJ, 2011, BRAIN RES BULL, V85, P368, DOI 10.1016/j.brainresbull.2011.05.007; Ryu HJ, 2011, CELL MOL NEUROBIOL, V31, P1071, DOI 10.1007/s10571-011-9706-1; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Sadasivan S, 2008, BIOCHEM BIOPH RES CO, V373, P478, DOI 10.1016/j.bbrc.2008.05.031; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Sakai K, 2013, BRAIN INJURY, V27, P1692, DOI 10.3109/02699052.2013.837198; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; Saljo A, 2011, NEUROIMAGE, V54, pS83, DOI 10.1016/j.neuroimage.2010.05.050; Sarnowska A, 2009, EXP NEUROL, V215, P317, DOI 10.1016/j.expneurol.2008.10.023; Sawyer TW, 2016, JOURNAL OF NEUROTRAU; Schousboe Arne, 2013, Front Endocrinol (Lausanne), V4, P102, DOI 10.3389/fendo.2013.00102; Shah AS, 2012, BIOMED SCI INSTRUM, V48, P1; Shah AS, 2011, THE AMERICAN SOCIETY, P17; Shively SB, 2012, J HEAD TRAUMA REHAB, V27, P234, DOI 10.1097/HTR.0b013e318250e9dd; Simard M, 2004, NEUROSCIENCE, V129, P877, DOI 10.1016/j.neuroscience.2004.09.053; Singleton RH, 2004, J NEUROSCI, V24, P3543, DOI 10.1523/JNEUROSCI.5048-03.2004; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sosa MAG, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-51; Stemper BD, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00031; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Su T, 2011, BRAIN RES, V1385, P68, DOI 10.1016/j.brainres.2011.01.115; Suh EC, 2008, NEUROTOXICOLOGY, V29, P691, DOI 10.1016/j.neuro.2008.04.001; SUNESON A, 1989, J TRAUMA, V29, P10, DOI 10.1097/00005373-198901000-00003; Svetlov Stanislav I, 2012, Front Neurol, V3, P15, DOI 10.3389/fneur.2012.00015; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Takuma K, 2004, PROG NEUROBIOL, V72, P111, DOI 10.1016/j.pneurobio.2004.02.001; Tanielian T., 2008, INVISIBLE WOUNDS OF; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tilleux S, 2007, J NEUROSCI RES, V85, P2059, DOI 10.1002/jnr.21325; Valiyaveettil M, 2014, BRAIN RES, V1549, P32, DOI 10.1016/j.brainres.2013.12.031; Van Landeghem FKH, 2001, GLIA, V35, P167, DOI 10.1002/glia.1082; Van Landeghem FKH, 2006, J NEUROTRAUM, V23, P1518, DOI 10.1089/neu.2006.23.1518; VandeVord PJ, 2008, NEUROSCI LETT, V434, P247, DOI 10.1016/j.neulet.2008.01.056; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; Vogel EW, 2016, J NEUROTRAUM, V33, P652, DOI 10.1089/neu.2015.4045; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wang Ke-Wan, 2002, Di Yi Jun Yi Da Xue Xue Bao, V22, P687; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Whalen MJ, 2008, J CEREBR BLOOD F MET, V28, P490, DOI 10.1038/sj.jcbfm.9600544; Willoughby KA, 2004, J NEUROCHEM, V91, P1284, DOI 10.1111/j.1471-4159.2004.02812.x; Wong J, 2005, NEUROCRIT CARE, V3, P177, DOI 10.1385/NCC:3:2:177; Yang ZH, 2015, TRENDS NEUROSCI, V38, P364, DOI 10.1016/j.tins.2015.04.003; Yang ZH, 2014, J CEREBR BLOOD F MET, V34, P1444, DOI 10.1038/jcbfm.2014.105; Ye ZC, 2003, J NEUROSCI, V23, P3588, DOI 10.1523/jneurosci.23-09-03588.2003; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Yi JH, 2005, GLIA, V49, P121, DOI 10.1002/glia.20099; Yong-Ming Z, 2012, AFR HEALTH SCI, V12, P552, DOI 10.4314/ahs.v12i4.24; Zhang ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092698; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283; Zhou SD, 2011, BIOTECHNOL J, V6, P513, DOI 10.1002/biot.201000254; Zhu F, 2015, CHIN J TRAUMATOL, V18, P10, DOI 10.1016/j.cjtee.2014.10.001; Zimmer J, 2000, AMINO ACIDS, V19, P7, DOI 10.1007/s007260070029; Zou J, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00077; Zuo HY, 2014, INT J MED SCI, V11, P426, DOI 10.7150/ijms.6540	193	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2017	12	3							e0173167	10.1371/journal.pone.0173167			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN5OE	WOS:000396054300042	28264063	Green Published, Green Submitted, gold			2022-02-06	
J	Chapple, LAS; Deane, AM; Williams, LT; Strickland, R; Schultz, C; Lange, K; Heyland, DK; Chapman, MJ				Chapple, Lee-Anne S.; Deane, Adam M.; Williams, Lauren T.; Strickland, Richard; Schultz, Chris; Lange, Kylie; Heyland, Daren K.; Chapman, Marianne J.			Longitudinal changes in anthropometrics and impact on self-reported physical function after traumatic brain injury	CRITICAL CARE AND RESUSCITATION			English	Article							X-RAY ABSORPTIOMETRY; INTENSIVE-CARE-UNIT; QUADRICEPS MUSCLE; NUTRITIONAL ASSESSMENT; CLINICAL-TRIALS; ULTRASOUND; STRENGTH; MASS; RELIABILITY; RECOVERY	Background and aims: Patients admitted to the ICU with a traumatic brain injury (TBI) are at risk of muscle wasting but this has not been quantified. Our aims were to describe longitudinal changes in anthropometrical data, compare the accuracy of non-invasive methodologies to the validated dual-energy x-ray absorptiometry (DXA), and assess the relationships between anthropometrical data and self-reported physical function. Methods: In a prospective observational study, we recruited patients admitted to the ICU with a moderate-to-severe TBI over 12 months. Anthropometric measurements included the subjective global assessment (SGA), bodyweight and ultrasound derived quadriceps muscle layer thickness (QMLT), which we performed weekly in hospital and 3 months after admission. We assessed total body composition using DXA within 7 days of ICU discharge, and compared the total lean muscle mass with ultrasound-derived QMLT taken within 5 days of the DXA measurement. We assessed functional outcomes at 3 months using the physical component score of the Short Form-36 (SF-36) and the Extended Glasgow Outcome Scale (GOS-E). Results: Thirty-seven patients were included, with a mean age of 45 years (SD, 16 years), and 87% were men. Participants were admitted to the ICU for a mean of 13 days (IQR, 6-18 days) and to hospital for a mean of 38 days (IQR, 19-52 days). They had significant weight loss in hospital (mean, 4.9% [SD, 7.7%]; P= 0.001). Malnutrition, measured with the SGA, was twice as prevalent at hospital discharge than at admission (P = 0.005). A reduction in QMLT occurred in the ICU but stabilised after ICU discharge. DXA-derived total lean mass taken within 7 days of ICU discharge strongly correlated with ultrasound-derived QMLT taken within 5 days of DXA measurements (rho = 0.74, P = 0.037). Improvements in self-reported physical function, using the SF 36 and GOS-E at 3 months, were associated with a greater QMLT at hospital discharge (SF-36: rho = 0.536, P= 0.010; GOS-E: rho = 0.595, P = 0.003, n = 23) and at 3 months (SF-36: rho = 0.658, P = 0.020; GOS-E: rho = 0.642, P = 0.025, n = 12). Conclusions: Patients with a TBI lose muscle thickness while in the ICU but the trajectory of loss stabilises after ICU discharge. Ultrasound-derived QMLT is related to total lean mass and physical function after discharge. Further studies are needed to confirm that ultrasound measurement of QMLT is a useful surrogate measure of muscle mass and functional outcomes after trauma and critical illness.	[Chapple, Lee-Anne S.; Deane, Adam M.] Univ Adelaide, Discipline Acute Care Med, Adelaide, SA, Australia; [Chapple, Lee-Anne S.; Deane, Adam M.; Lange, Kylie; Chapman, Marianne J.] Natl Hlth & Med Res Council, Ctr Clin Res Nutr Physiol & Outcomes, Ctr Excellence Nutr Physiol & Outcomes, Adelaide, SA, Australia; [Deane, Adam M.; Strickland, Richard; Chapman, Marianne J.] Royal Adelaide Hosp, Intens Care Unit, Adelaide, SA, Australia; [Williams, Lauren T.] Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Qld, Australia; [Schultz, Chris] Royal Adelaide Hosp, Dept Nucl Med & Bone Densitometry, Adelaide, SA, Australia; [Heyland, Daren K.] Kingston Gen Hosp, Clin Evaluat Res Unit, Kingston, ON, Canada		Chapple, LAS (corresponding author), Univ Adelaide, Discipline Acute Care Med, Adelaide, SA, Australia.; Chapple, LAS (corresponding author), Natl Hlth & Med Res Council, Ctr Clin Res Nutr Physiol & Outcomes, Ctr Excellence Nutr Physiol & Outcomes, Adelaide, SA, Australia.	lee-anne.costello@adelaide.edu.au	Williams, Lauren T./G-6301-2013; Chapple, Lee-anne/AAN-7751-2021; Deane, Adam/AAF-7370-2020	Williams, Lauren T./0000-0002-7860-0319; Deane, Adam/0000-0002-7620-5577; Chapple, Lee-anne S/0000-0002-9818-2484	Australasian Society of Parenteral and Enteral Nutrition (AuSPEN); Neurosurgical Research Foundation; Australian Post-Graduate AwardAustralian Government; Royal Adelaide Hospital Dawes Top-Up Scholarship; School of Medicine Top-Up Scholarship	We thank Amelia Kranz, Research Assistant, Discipline of Acute Care Medicine, University of Adelaide, for her contribution to data entry. Our research was funded by an Australasian Society of Parenteral and Enteral Nutrition (AuSPEN) small project grant and a Neurosurgical Research Foundation grant. L C was supported by an Australian Post-Graduate Award, a Royal Adelaide Hospital Dawes Top-Up Scholarship and a School of Medicine Top-Up Scholarship	Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; BAKER JP, 1982, NEW ENGL J MED, V306, P969, DOI 10.1056/NEJM198204223061606; Chapple LS, 2016, CLIN NUTR, DOI [10.1016/j.clftu.2016.02.0Q9, DOI 10.1016/J.CLFTU.2016.02.0Q9]; Chrispin PS, 1997, ANAESTHESIA, V52, P15, DOI 10.1111/j.1365-2044.1997.015-az014.x; Crenn P, 2014, CLIN NUTR, V33, P348, DOI 10.1016/j.clnu.2013.06.003; DETSKY AS, 1987, JPEN-PARENTER ENTER, V11, P8, DOI 10.1177/014860718701100108; Dhandapani SS, 2007, INDIAN J NEUROTRAUM, V4, P35, DOI 10.1016/S0973-0508(07)80009-8; Duz S, 2009, EUR J SPORT SCI, V9, P181, DOI 10.1080/17461390902763425; Foley N, 2008, J NEUROTRAUM, V25, P1415, DOI 10.1089/neu.2008.0628; Fuller NJ, 1999, INT J OBESITY, V23, P1295, DOI 10.1038/sj.ijo.0801070; Gruther W, 2008, J REHABIL MED, V40, P185, DOI 10.2340/16501977-0139; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Kondrup J, 2003, CLIN NUTR, V22, P415, DOI 10.1016/S0261-5614(03)00098-0; Krakau K, 2007, NUTRITION, V23, P308, DOI 10.1016/j.nut.2007.01.010; Mador MJ, 2002, AM J RESP CRIT CARE, V166, P787, DOI 10.1164/rccm.2206003; MITCHELL CO, 1982, JPEN-PARENTER ENTER, V6, P226, DOI 10.1177/0148607182006003226; Mizner RL, 2005, J ORTHOP SPORT PHYS, V35, P424, DOI 10.2519/jospt.2005.35.7.424; Modlesky CM, 2004, J APPL PHYSIOL, V96, P561, DOI 10.1152/japplphysiol.00207.2003; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Needham DM, 2008, JAMA-J AM MED ASSOC, V300, P1685, DOI 10.1001/jama.300.14.1685; Paris MT, 2017, JPEN-PARENTER ENTER, V41, P171, DOI 10.1177/0148607116637852; Parry SM, 2015, J CRIT CARE, V30, DOI 10.1016/j.jcrc.2015.05.024; Powell JM, 2001, ARCH PHYS MED REHAB, V82, P1025, DOI 10.1053/apmr.2001.25082; Puthucheary ZA, 2013, JAMA-J AM MED ASSOC, V310, P1591, DOI 10.1001/jama.2013.278481; Reid DB, 2016, ANAESTH INTENS CARE, V44, P406, DOI 10.1177/0310057X1604400309; Rogers J, 1997, ANAESTHESIA, V52, P1137, DOI 10.1111/j.1365-2044.1997.240-az0374.x; Segers J, 2015, INTENS CARE MED, V41, P562, DOI 10.1007/s00134-015-3668-6; Seymour JM, 2009, THORAX, V64, P418, DOI 10.1136/thx.2008.103986; SIPILA S, 1991, MUSCLE NERVE, V14, P527, DOI 10.1002/mus.880140607; Strasser EM, 2013, AGE, V35, P2377, DOI 10.1007/s11357-013-9517-z; Tillquist M, 2014, JPEN-PARENTER ENTER, V38, P886, DOI 10.1177/0148607113501327; Toombs RJ, 2012, OBESITY, V20, P30, DOI 10.1038/oby.2011.211; Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008; Worsley PR, 2014, MANUAL THER, V19, P259, DOI 10.1016/j.math.2014.02.002	34	17	17	0	2	AUSTRALASIAN MED PUBL CO LTD	PYRMONT	LEVEL 2, 26-32 PYRMONT BRIDGE RD, PYRMONT, NSW 2009, AUSTRALIA	1441-2772			CRIT CARE RESUSC	Crit. Care Resusc.	MAR	2017	19	1					29	36					8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL9DT	WOS:000394920300006	28215129				2022-02-06	
J	Erdodi, LA; Nussbaum, S; Sagar, S; Abeare, CA; Schwartz, ES				Erdodi, Laszlo A.; Nussbaum, Shayna; Sagar, Sanya; Abeare, Christopher A.; Schwartz, Eben S.			Limited English Proficiency Increases Failure Rates on Performance Validity Tests with High Verbal Mediation	PSYCHOLOGICAL INJURY & LAW			English	Article						Cross-cultural neuropsychology; Performance validity testing; Bilingualism; Word Choice Test; Complex Ideational Material	TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL ASSESSMENT; CLASSIFICATION ACCURACY; RECOGNITION TRIAL; SYMPTOM VALIDITY; SUSPECT EFFORT; MEMORY TEST; SCORES; SAMPLE; ACCULTURATION	This study was designed to examine the effect of language proficiency and level of verbal mediation on failure rates on performance validity tests (PVTs). PVTs with high and low verbal mediation were administered to 80 healthy community-dwelling English-Arabic bilinguals. Digit Span and Animal Fluency were administered in both English and Arabic, in counterbalanced order, as part of a brief battery of neuropsychological tests. Participants with Arabic as their dominant language were 2 to 16 times more likely to fail PVTs with high verbal mediation compared to native speakers of English. When Digit Span and Animal Fluency were administered in the nondominant language, participants were 2 to 18 times more likely to fail the validity cutoffs. Language dominance explained between 6 and 31% of variance in dichotomized outcomes (pass/fail) on PVTs with high verbal mediation. None of the participants failed any PVTs with low verbal mediation. Limited language proficiency may result in dramatic increases in false positive rates on PVTs with high verbal mediation. Failure on a PVT administered in English to an examinee with a different linguistic background should be interpreted with great caution.	[Erdodi, Laszlo A.; Nussbaum, Shayna; Sagar, Sanya; Abeare, Christopher A.] Univ Windsor, Dept Psychol, 168 Chrysler Hall South,401 Sunset Ave, Windsor, ON N9B 3P4, Canada; [Schwartz, Eben S.] Waukesha Mem Hosp, Waukesha, WI USA		Erdodi, LA (corresponding author), Univ Windsor, Dept Psychol, 168 Chrysler Hall South,401 Sunset Ave, Windsor, ON N9B 3P4, Canada.	lerdodi@gmail.com		Abeare, Christopher/0000-0002-7163-7434; Sagar, Sanya/0000-0001-7381-0803			An KY, 2017, CLIN NEUROPSYCHOL, V31, P193, DOI 10.1080/13854046.2016.1217046; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Barhon LI, 2015, APPL NEUROPSYCH-ADUL, V22, P114, DOI 10.1080/23279095.2013.863775; Bigler ED, 2015, BRAIN IMAGING BEHAV, V9, P421, DOI 10.1007/s11682-015-9409-1; Bigler ED, 2012, J INT NEUROPSYCH SOC, V18, P632, DOI 10.1017/S1355617712000252; Boone K., 2002, DOT COUNTING TEST; Boone K.B., 2013, CLIN PRACTICE FORENS; Boone K.B., 2007, ASSESSMENT FEIGNED C; Boone KB, 2007, ARCH CLIN NEUROPSYCH, V22, P355, DOI 10.1016/j.acn.2007.01.010; Borod JC, 1980, J CLIN NEUROPSYCHOLO, V2, P209, DOI DOI 10.1080/01688638008403793; Burton V, 2012, ARCH CLIN NEUROPSYCH, V27, P262, DOI 10.1093/arclin/acs026; Bush SS, 2014, PSYCHOL INJ LAW, V7, P197, DOI 10.1007/s12207-014-9198-7; Coffey DM, 2005, ARCH CLIN NEUROPSYCH, V20, P795, DOI 10.1016/j.acn.2005.04.009; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P1278, DOI 10.1080/13854046.2014.975844; Erdodi L, 2017, APPL NEUROPSYCH-ADUL, V24, P264, DOI 10.1080/23279095.2016.1154856; Erdodi L, 2012, HUMOR, V25, P459, DOI 10.1515/humor-2012-0024; Erdodi LA, 2017, J CLIN EXP NEUROPSYC, V39, P369, DOI 10.1080/13803395.2016.1230181; Erdodi LA, 2016, PSYCHOL INJ LAW, V9, P112, DOI 10.1007/s12207-016-9254-6; Erdodi LA, 2017, PSYCHOL ASSESSMENT, V29, P148, DOI 10.1037/pas0000319; Erdodi LA, 2017, CLIN NEUROPSYCHOL, V31, P168, DOI 10.1080/13854046.2016.1224392; Erdodi LA, 2014, PSYCHOL INJ LAW, V7, P255, DOI 10.1007/s12207-014-9197-8; Goodglass H., 2001, BOSTON DIAGNOSTIC AP; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; HAYWARD L, 1987, AUST NZ J PSYCHIAT, V21, P87, DOI 10.3109/00048678709160904; Heaton R. K., 2004, REVISED COMPREHENSIV; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Larrabee GJ, 2012, FORENSIC NEUROPSYCHO, P2; Leighton A, 2014, J INT NEUROPSYCH SOC, V20, P873, DOI 10.1017/S135561771400085X; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Lichtenstein JD, 2018, CHILD NEUROPSYCHOL, V24, P247, DOI 10.1080/09297049.2016.1259402; Lichtenstein JD, 2014, AM J SPORT MED, V42, P479, DOI 10.1177/0363546513509225; Lu PH, 2003, CLIN NEUROPSYCHOL, V17, P426, DOI 10.1076/clin.17.3.426.18083; Mitrushina MN, 1999, HDB NORMATIVE DATA N; Moreno EM, 2005, COGNITIVE BRAIN RES, V22, P205, DOI 10.1016/j.cogbrainres.2004.08.010; Morse CL, 2013, CLIN NEUROPSYCHOL, V27, P1395, DOI 10.1080/13854046.2013.832385; O'Bryant SE, 2003, CLIN NEUROPSYCHOL, V17, P69, DOI 10.1076/clin.17.1.69.15624; Pearson, 2009, ADV CLIN SOL WAIS WM; Razani J, 2007, CLIN NEUROPSYCHOL, V21, P776, DOI 10.1080/13854040701437481; Razani J, 2007, ARCH CLIN NEUROPSYCH, V22, P333, DOI 10.1016/j.acn.2007.01.008; Rey A., 1964, EXAMEN CLIN PSYCHOL; Reznek L, 2005, BRAIN INJURY, V19, P539, DOI 10.1080/02699050400005242; Russeler J, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-37; Salazar X.F., 2007, ASSESSMENT FEIGNED C, P405; Sugarman MA, 2015, APPL NEUROPSYCH-ADUL, V22, P141, DOI 10.1080/23279095.2013.873439; Trueblood W., 1994, J CLIN EXPT NEUROPSY, V4, P697, DOI DOI 10.1080/01688639408402671; Vilar-Lopez R, 2008, J CLIN EXP NEUROPSYC, V30, P710, DOI 10.1080/13803390701684562; Youngjohn JR, 1999, ARCH CLIN NEUROPSYCH, V14, P511, DOI 10.1016/S0887-6177(98)00049-3	49	17	17	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1938-971X	1938-9728		PSYCHOL INJ LAW	Psychol. Inj. Law	MAR	2017	10	1					96	103		10.1007/s12207-017-9282-x			8	Psychology, Clinical	Emerging Sources Citation Index (ESCI)	Psychology	FG6NF	WOS:000410497200004					2022-02-06	
J	Genet, GF; Bentzer, P; Ostrowski, SR; Johansson, PI				Genet, Gustav Folmer; Bentzer, Peter; Ostrowski, Sisse Rye; Johansson, Paer Ingemar			Resuscitation with Pooled and Pathogen-Reduced Plasma Attenuates the Increase in Brain Water Content following Traumatic Brain Injury and Hemorrhagic Shock in Rats	JOURNAL OF NEUROTRAUMA			English	Article						brain water content; fluid percussion brain injury; hemorrhagic shock; plasma resuscitation	LARGE ANIMAL-MODEL; COLLOID ONCOTIC THERAPY; INTRACRANIAL-PRESSURE; EDEMA; VOLUME; PERMEABILITY; ELECTROLYTE; NEUTROPHILS; GLYCOCALYX; OSMOLALITY	Traumatic brain injury and hemorrhagic shock is associated with blood-brain barrier (BBB) breakdown and edema formation. Recent animal studies have shown that fresh frozen plasma (FFP) resuscitation reduces brain swelling and improves endothelial function compared to isotonic NaCl (NS). The aim of this study was to investigate whether pooled and pathogen-reduced plasma (OctaplasLG((R)) [OCTA]; Octapharma, Stockholm, Sweden) was comparable to FFP with regard to effects on brain water content, BBB permeability, and plasma biomarkers of endothelial glycocalyx shedding and cell damage. After fluid percussion brain injury, hemorrhage (20mL/kg), and 90-min shock, 48 male Sprague-Dawley rats were randomized to resuscitation with OCTA, FFP, or NS (n=16/group). Brain water content (wet/dry weight) and BBB permeability (transfer constant for Cr-51-EDTA) were measured at 24h. Plasma osmolality, oncotic pressure, and biomarkers of systemic glycocalyx shedding (syndecan-1) and cell damage (histone-complexed DNA) were measured at 0 and 23h. At 24h, brain water content was 80.44 +/- 0.39%, 80.82 +/- 0.82%, and 81.15 +/- 0.86% in the OCTA, FFP, and NS groups (lower in OCTA vs. NS; p=0.026), with no difference in BBB permeability. Plasma osmolality and oncotic pressures were highest in FFP and OCTA resuscitated, and osmolality was further highest in OCTA versus FFP (p=0.027). In addition, syndecan-1 was highest in FFP and OCTA resuscitated (p=0.010). These results suggest that pooled solvent-detergent (SD)-treated plasma attenuates the post-traumatic increase in brain water content, and that this effect may, in part, be explained by a high crystalloid and colloid osmotic pressure in SD-treated plasma.	[Genet, Gustav Folmer; Ostrowski, Sisse Rye; Johansson, Paer Ingemar] Univ Copenhagen, Rigshosp, Capital Reg Blood Bank, Transfus Med Sect, Blegdamsvej 9, DK-2100 Copenhagen, Denmark; [Bentzer, Peter] Helsingborg Hosp, Dept Anesthesia & Intens Care, Helsingborg, Sweden; [Bentzer, Peter] Lund Univ, Lund, Sweden; [Johansson, Paer Ingemar] Univ Texas Med Sch Houston, CeTIR, Dept Surg, Houston, TX USA		Genet, GF (corresponding author), Univ Copenhagen, Rigshosp, Capital Reg Blood Bank, Transfus Med Sect, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	gustavgenet@hotmail.com	Ostrowski, Sisse R/E-7423-2011	Ostrowski, Sisse R/0000-0001-5288-3851; Johansson, Par Ingemar/0000-0001-9778-5964			Abrams ST, 2013, AM J RESP CRIT CARE, V187, P160, DOI 10.1164/rccm.201206-1037OC; Bansch P, 2014, ANESTHESIOLOGY, V121, P817, DOI 10.1097/ALN.0000000000000363; BENSON RE, 1980, ANAESTH INTENS CARE, V8, P152, DOI 10.1177/0310057X8000800209; Bentzer P, 2003, J NEUROTRAUM, V20, P447, DOI 10.1089/089771503765355522; Bentzer P, 2012, SCAND J CLIN LAB INV, V72, P490, DOI 10.3109/00365513.2012.699099; Bicakci Z, 2014, TRANSFUS APHER SCI, V50, P418, DOI 10.1016/j.transci.2014.03.002; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2007, NAT REV MICROBIOL, V5, P577, DOI 10.1038/nrmicro1710; Brown LM, 2011, J TRAUMA, V71, pS358, DOI 10.1097/TA.0b013e318227f152; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Drummond JC, 1998, ANESTHESIOLOGY, V88, P993, DOI 10.1097/00000542-199804000-00020; Drummond JC, 2010, ANESTHESIOLOGY, V112, P1079, DOI 10.1097/ALN.0b013e3181d94e53; DUNN FL, 1973, J CLIN INVEST, V52, P3212, DOI 10.1172/JCI107521; Fenstermacher J.D., 1984, EDEMA, P384; Haywood-Watson RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023530; Heger A, 2009, VOX SANG, V97, P219, DOI 10.1111/j.1423-0410.2009.01190.x; Imam A, 2015, J NEUROTRAUM, V32, P307, DOI 10.1089/neu.2014.3535; Imam AM, 2013, J TRAUMA ACUTE CARE, V75, P976, DOI 10.1097/TA.0b013e31829e2186; Jankowski S, 1995, J Intensive Care Med, V10, P91; Jin G, 2012, SHOCK, V38, P49, DOI 10.1097/SHK.0b013e3182574778; Johansson PI, 2014, BLOOD, V124, P3052, DOI 10.1182/blood-2014-05-575340; Johansson Par I, 2013, J Emerg Trauma Shock, V6, P171, DOI 10.4103/0974-2700.115327; Jungner M, 2013, MICROVASC RES, V88, P48, DOI 10.1016/j.mvr.2013.03.004; Jungner M, 2016, MINERVA ANESTESIOL, V82, P525; Jungner M, 2010, ANESTHESIOLOGY, V112, P1194, DOI 10.1097/ALN.0b013e3181d94d6e; KLATZO I, 1987, ACTA NEUROPATHOL, V72, P236, DOI 10.1007/BF00691095; Kozar RA, 2015, J TRAUMA ACUTE CARE, V78, pS83, DOI 10.1097/TA.0000000000000631; Kozar RA, 2011, ANESTH ANALG, V112, P1289, DOI 10.1213/ANE.0b013e318210385c; Kraut JA, 2014, NEW ENGL J MED, V371, P2309, DOI 10.1056/NEJMra1309483; Lescot T, 2006, CRIT CARE MED, V34, P3029, DOI 10.1097/01.CCM.0000243797.42346.64; LINKO K, 1986, ACTA ANAESTH SCAND, V30, P139, DOI 10.1111/j.1399-6576.1986.tb02384.x; Liu FC, 2014, SHOCK, V41, P491, DOI 10.1097/SHK.0000000000000146; Ma AC, 2008, J THROMB HAEMOST, V6, P415, DOI 10.1111/j.1538-7836.2007.02865.x; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Mycielska ME, 2009, BIOESSAYS, V31, P10, DOI 10.1002/bies.080137; Nelson Axel, 2016, Intensive Care Med Exp, V4, P6, DOI 10.1186/s40635-016-0080-7; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/S0165-3806(96)00098-3; Schauer C, 2014, NAT MED, V20, P511, DOI 10.1038/nm.3547; Sillesen M, 2014, DAN MED J, V61; Sillesen M, 2013, SURGERY, V154, P197, DOI 10.1016/j.surg.2013.04.002; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; TOMITA H, 1994, ACTA NEUROCHIR, P547; TONE O, 1994, ACTA NEUROCHIR, P568; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; WILSON RF, 1992, AM SURGEON, V58, P535; Woodcock TE, 2012, BRIT J ANAESTH, V108, P384, DOI 10.1093/bja/aer515; ZORNOW MH, 1989, J TRAUMA, V29, P484, DOI 10.1097/00005373-198904000-00011	48	17	19	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2017	34	5					1054	1062		10.1089/neu.2016.4574			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EM6EI	WOS:000395405200010	27626366				2022-02-06	
J	Merritt, VC; Meyer, JE; Cadden, MH; Roman, CAF; Ukueberuwa, DM; Shapiro, MD; Arnett, PA				Merritt, Victoria C.; Meyer, Jessica E.; Cadden, Margaret H.; Roman, Cristina A. F.; Ukueberuwa, Dede M.; Shapiro, Michael D.; Arnett, Peter A.			Normative Data for a Comprehensive Neuropsychological Test Battery used in the Assessment of Sports-Related Concussion	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Assessment; Head injury; Traumatic brain injury; Norms/normative studies	TEST-RETEST RELIABILITY; TRAUMATIC BRAIN-INJURY; PROFESSIONAL ICE HOCKEY; VERBAL-LEARNING TEST; HIGH-SCHOOL; NEUROCOGNITIVE PERFORMANCE; SEX-DIFFERENCES; IMPACT; SYMPTOMS; VALIDITY	Objective: The use of normative data is a hallmark of the neuropsychological assessment process. Within the context of sports-related concussion, utilizing normative data is especially essential when individualized baseline data are unavailable for comparison. The primary purpose of this study was to establish normative data for a comprehensive neuropsychological test battery used in the assessment of sports-related concussion. A secondary aim was to provide normative data for pertinent demographic variables relevant to the assessment of college athletes, including sex, previous head injuries (PHI), and history of attention deficit hyperactivity disorder (ADHD)/learning disability (LD). Method: Participants included male and female college athletes (N = 794) who were involved in a concussion management program at an NCAA Division I university between 2002 and 2015. Athletes were administered a comprehensive neuropsychological test battery at baseline designed to assess the following cognitive domains: learning and memory, attention and concentration, processing speed, and executive functioning. The test battery primarily comprises paper-and-pencil measures. Results: Normative data are presented for the overall athlete sample. Additional sub-norms are then provided for specified demographic populations (i.e., sex, PHIs, and history of ADHD/LD). Findings indicate that there are mild cognitive differences between men and women, as well as between those athletes with and without a history of ADHD/LD. Given these findings, additional norms are provided for men and women with and without a history of ADHD/LD. Conclusions: In the absence of baseline testing, the normative data presented here can be used clinically to assess athletes' cognitive functioning post-concussion.	[Merritt, Victoria C.; Meyer, Jessica E.; Cadden, Margaret H.; Roman, Cristina A. F.; Ukueberuwa, Dede M.; Shapiro, Michael D.; Arnett, Peter A.] Penn State Univ, Dept Psychol, 372 Moore Bldg, University Pk, PA 16802 USA		Merritt, VC (corresponding author), Penn State Univ, Dept Psychol, 372 Moore Bldg, University Pk, PA 16802 USA.	vcabarnes@gmail.com		Merritt, Victoria/0000-0001-5683-4168	Wayne Sebastianelli and Penn State Sports Medicine	The authors would like to thank Wayne Sebastianelli and Penn State Sports Medicine for their generous support of our research. We would also like to thank Gray Vargas, Amanda Rabinowitz, Fiona Barwick, Aaron Rosenbaum, and Chris Bailey for their help as project coordinators of the program over the years.	Arnett P., 2014, CONCUSSION ATHLETICS, P35; Bailey CM, 2006, J INT NEUROPSYCH SOC, V12, P475, DOI 10.1017/S1355617706060619; Barr WB, 2003, ARCH CLIN NEUROPSYCH, V18, P91, DOI 10.1016/S0887-6177(01)00185-8; Barth JT, 1989, MILD HEAD INJURY SPO; Benedict, 2001, HOPKINS VERBAL LEARN; Benedict R., 1997, BRIEF VISUOSPATIAL M; Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; Benedict RHB, 1996, PSYCHOL ASSESSMENT, V8, P145, DOI 10.1037/1040-3590.8.2.145; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Bruce J, 2016, APPL NEUROPSYCH-ADUL, V23, P336, DOI 10.1080/23279095.2015.1064002; Bruce J, 2014, CLIN NEUROPSYCHOL, V28, P14, DOI 10.1080/13854046.2013.866272; Bruce JM, 2003, NEUROPSYCHOLOGY, V17, P622, DOI 10.1037/0894-4105.17.4.622; Cegalis J.A., 1994, VIGIL W CONTINUOUS P; Collie A, 2006, BRIT J SPORT MED, V40, P550, DOI 10.1136/bjsm.2005.019802; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Conder RL, 2015, APPL NEUROPSYCH-CHIL, V4, P141, DOI 10.1080/21622965.2013.816849; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; Crawford JR, 1998, J CLIN EXP NEUROPSYC, V20, P755, DOI 10.1076/jcen.20.5.755.1132; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Echemendia RJ, 2001, NEUROPSYCHOL REV, V11, P69, DOI 10.1023/A:1016651217141; Echemendia RJ, 2016, CLIN NEUROPSYCHOL, V30, P311, DOI 10.1080/13854046.2016.1158320; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Ellemberg D, 2009, J NEUROTRAUM, V26, P2365, DOI 10.1089/neu.2009.0906; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Gray R, 2006, J PSYCHOEDUC ASSESS, V24, P88; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; IBM Corp, 2015, IBM SPSS STAT WIND V; ImPACT Applications Inc., 2012, IMPACT TEST TECHN MA; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Lovell M, 2000, IMPACT IMMEDIATE POS; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meyer J. E., 2016, CLIN SENSITIVI UNPUB; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Nelson LD, 2015, AM J SPORT MED, V43, P2018, DOI 10.1177/0363546515587714; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Psychological Corporation, 1997, WAIS 3 WMS 3 TECHNIC; Rabinowitz AR, 2012, J INT NEUROPSYCH SOC, V18, P139, DOI 10.1017/S1355617711001275; Randolph C, 2011, CURR SPORT MED REP, V10, P21, DOI 10.1249/JSR.0b013e318207831d; Rao S., 1990, MANUAL BRIEF REPEATA; Reynolds C.R., 2002, COMPREHENSIVE TRAIL; Schatz P, 2011, NEUROSURGERY, V68, P1562, DOI 10.1227/NEU.0b013e31820e382e; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Shapiro AM, 1999, CLIN NEUROPSYCHOL, V13, P348, DOI 10.1076/clin.13.3.348.1749; Smith A., 1991, SYMBOL DIGIT MODALIT; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Trenerry MR, 1989, STROOP NEUROPSYCHOLO; Tsushima WT, 2016, ARCH CLIN NEUROPSYCH, V31, P105, DOI 10.1093/arclin/acv066; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	58	17	19	0	11	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAR	2017	32	2					168	183		10.1093/arclin/acw090			16	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	EQ4EG	WOS:000398026400004	28365744	Bronze			2022-02-06	
J	Pattuwage, L; Olver, J; Martin, C; Lai, F; Piccenna, L; Gruen, R; Bragge, P				Pattuwage, Loyal; Olver, John; Martin, Caius; Lai, Francis; Piccenna, Loretta; Gruen, Russell; Bragge, Peter			Management of Spasticity in Moderate and Severe Traumatic Brain Injury: Evaluation of Clinical Practice Guidelines	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						AGREE instrument; craniocerebral trauma (MeSH); head injuries (MeSH); methodological quality; muscle spasticity (MeSH); practice guideline (MeSH); quality appraisal; spasticity management; TBI; traumatic brain injury	EASTERN ASSOCIATION; AGREE II; REHABILITATION; QUALITY; IMPLEMENTATION; SURGERY	Introduction: Moderate to severe traumatic brain injury (TBI) can result in development of spasticity, which adversely affects function and quality of life. Given the foundation of optimal clinical practice is use of the best available evidence, we aimed to identify, describe, and evaluate methodological quality of evidence-based spasticity clinical practice guidelines (CPGs). Methods: A comprehensive search for CPGs encompassed electronic databases and online sources. Eligible CPGs were evaluated using the validated Appraisal of Guidelines for Research and Evaluation II (AGREE II) instrument. Results: Five CPGs were eligible for review; 2 were specific to acquired brain injury and 1 to TBI. The 3 brain injury-specific CPGs contained 423 recommendations overall, but only 8 spasticity recommendations. On the basis of AGREE appraisals, all CPGs performed well in the areas of reporting scope and purpose; clearly presenting recommendations; including various stakeholders in the CPG development process; and reporting conflict of interest. However, only one CPG performed adequately on describing facilitators and barriers to implementation, advice, and tools on how to implement recommendations and provision of audit criteria. Intraclass correlation coefficient (ICC) for agreement between raters showed high agreement (ICC > 0.80) for most guidelines. Conclusion: Given the unique etiological features and treatment challenges associated with managing spasticity after TBI, more TBI-specific spasticity CPGs are required. These should incorporate information on the facilitators and barriers to implementation, advice on implementing recommendations, and audit criteria.	[Pattuwage, Loyal] Monash Univ, Alfred Hosp, Natl Trauma Res Inst, Melbourne, Vic, Australia; [Olver, John] Monash Univ, Epworth Hosp, Richmond, Vic, Australia; [Lai, Francis] Monash Hlth, Melbourne, Vic, Australia; [Martin, Caius] Monash Univ, Melbourne, Vic, Australia; [Piccenna, Loretta] La Trobe Univ, Sch Allied Hlth, Melbourne, Vic, Australia; [Gruen, Russell] Nanyang Technol Univ, Singapore, Singapore; [Bragge, Peter] Monash Univ, Monash Sustainabil Inst, Melbourne, Vic, Australia		Pattuwage, L (corresponding author), Monash Univ, Natl Trauma Res Inst, Level 1,549 St Kilda Rd, Melbourne, Vic 3004, Australia.; Pattuwage, L (corresponding author), Alfred Hosp, Level 1,549 St Kilda Rd, Melbourne, Vic 3004, Australia.	loyal.pattuwage@gmail.com	piccenna, Loretta/I-2533-2014	piccenna, Loretta/0000-0003-3895-8145; Olver, John/0000-0001-7069-1191; Bragge, Peter/0000-0003-0745-5131	Victorian Transport Accident Commission	This project was funded by the Victorian Transport Accident Commission as part of a project entitled "Harnessing Victoria's Neurotrauma Expertise: Promoting Excellence and Realising Value."	Adelson PD, 2012, J NEUROTRAUM, V29, P639, DOI 10.1089/neu.2011.1952; Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Arabi YM, 2010, J CRIT CARE, V25, P190, DOI 10.1016/j.jcrc.2009.05.004; Barbosa RR, 2012, J TRAUMA ACUTE CARE, V73, pS307, DOI 10.1097/TA.0b013e3182701885; Bell MJ, 2013, CRIT CARE CLIN, V29, P223, DOI 10.1016/j.ccc.2012.11.004; Berrigan L, 2011, BRAIN INJURY, V25, P742, DOI 10.3109/02699052.2011.580317; Bragge P, 2014, J HEAD TRAUMA REHAB, V29, P277, DOI 10.1097/HTR.0000000000000066; Bragge P, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-92; Bromberg WJ, 2010, J TRAUMA, V68, P471, DOI 10.1097/TA.0b013e3181cb43da; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE472, DOI 10.1503/cmaj.091716; Brouwers MC, 2010, CAN MED ASSOC J, V182, P1045, DOI 10.1503/cmaj.091714; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cincinnati Children's Hospital Medical Center, 2009, EV BAS CAR GUID SER; Alarcon JD, 2013, J TRAUMA ACUTE CARE, V75, P311, DOI 10.1097/TA.0b013e3182924bf8; Dressler D, 2005, ARQ NEURO-PSIQUIAT, V63, P180, DOI 10.1590/S0004-282X2005000100035; Elbasiouny SM, 2010, NEUROREHAB NEURAL RE, V24, P23, DOI 10.1177/1545968309343213; Elliott JH, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001603; Field MJ, 1990, CLIN PRACTICE GUIDEL; Glasziou P, 2011, BMJ QUAL SAF, V20, pI13, DOI 10.1136/bmjqs.2010.046524; Harrison MB, 2010, CAN MED ASSOC J, V182, pE78, DOI 10.1503/cmaj.081232; Hurdowar A, 2007, J EVAL CLIN PRACT, V13, P657, DOI 10.1111/j.1365-2753.2007.00708.x; Katrak Persis, 2004, BMC Med Res Methodol, V4, P22, DOI 10.1186/1471-2288-4-22; Keris V, 2007, WORLD J SURG, V31, P1352, DOI 10.1007/s00268-007-9002-x; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kwakkel G, 1999, LANCET, V354, P191, DOI 10.1016/S0140-6736(98)09477-X; Lance J.W., 1980, SPASTICITY DISORDERE, P485; Lundstrom E, 2010, STROKE, V41, P319, DOI 10.1161/STROKEAHA.109.558619; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; Marshall S, 2012, CAN FAM PHYSICIAN, V58, pE128; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Puerto MAN, 2008, INT J TECHNOL ASSESS, V24, P333, DOI 10.1017/S0266462308080446; New Zealand Guidelines Group, 2006, 9780478279344 ACC CO; Pandyan AD, 2005, DISABIL REHABIL, V27, P2, DOI 10.1080/09638280400014576; Royal College of Physicians British Society of Rehabilitation Medicine Chartered Society of Physiotherapy, 2009, SPAST AD MAN US BOT; Rusnak M, 2008, BRATISL MED J, V109, P374; Sagher O, 2013, J NEUROSURG, V119, P1246, DOI 10.3171/2013.4.JNS13634; Saulino Michael, 2006, J Neurosci Nurs, V38, P456; Scottish Intercollegiate Guidelines Network (SIGN), 2013, BRAIN INJ REH AD NAT; Shigemori M, 2012, NEUROL MED-CHIR, V52, P1; Singer BJ, 2004, ARCH PHYS MED REHAB, V85, P1465, DOI 10.1016/j.apmr.2003.08.103; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tavender EJ, 2011, ACAD EMERG MED, V18, P880, DOI 10.1111/j.1553-2712.2011.01134.x; The AGREE Next Steps Consortium, 2009, APPR GUID RES EV 2 A; Truchon C, 2014, BRAIN INJURY, V28, P773; Woolf SH, 1999, BRIT MED J, V318, P527, DOI 10.1136/bmj.318.7182.527	46	17	20	1	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2017	32	2					E1	E12		10.1097/HTR.0000000000000234			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EN3YU	WOS:000395944700003	27120291				2022-02-06	
J	Seeger, TA; Kirton, A; Esser, MJ; Gallagher, C; Dunn, J; Zewdie, E; Damji, O; Ciechanski, P; Barlow, KM				Seeger, Trevor A.; Kirton, Adam; Esser, Michael J.; Gallagher, Clare; Dunn, Jeff; Zewdie, Ephrem; Damji, Omar; Ciechanski, Patrick; Barlow, Karen M.			Cortical excitability after pediatric mild traumatic brain injury	BRAIN STIMULATION			English	Article						Transcranial magnetic stimulus; Mild traumatic brain injury; Pediatrics; Cortical silent period; Long interval intracortical inhibition	TRANSCRANIAL MAGNETIC STIMULATION; PRIMARY MOTOR CORTEX; HEAD-INJURY; SPORTS CONCUSSION; BASIC MECHANISMS; IFCN COMMITTEE; CHILDREN; SYMPTOMS; EPIDEMIOLOGY; METAANALYSIS	Introduction: Mild traumatic brain injury (mTBI) outcomes are variable, and 10-15% may suffer from prolonged symptoms beyond 3 months that impair the child's return to normal activities. Neurophysiological mechanisms of mTBI are incompletely understood, particularly in children, but alterations in cortical excitability have been proposed to underlie post-concussion syndrome. Improved understanding is required to advance interventions and improve outcomes. Objective/Hypothesis: To determine if cortical excitability is altered in children with mTBI, and its association with clinical symptoms. Methods: This was a cross-sectional controlled cohort study. School-aged children (8-18 years) with mTBI were compared to healthy controls. Cortical excitability was measured using multiple TMS paradigms in children with (symptomatic) and without (recovered) persistent symptoms one-month post injury. Primary outcome was the cortical silent period (cSP), a potential neurophysiological biomarlcer of GABAergic inhibition. Secondary outcomes included additional TMS neurophysiology, safety and tolerability. Associations between neurophysiology parameters and clinical symptoms were evaluated. Results: Fifty-three children with mTBI (55% male; mean age 14.1 SD: 2.4 years; 35 symptomatic and 27 asymptomatic participants) and 28 controls (46% male; mean age 14.3 SD: 3.1 years) were enrolled. cSP duration was similar between groups (F (2, 73) = 0.55, p = 0.582). Log(10) long interval intracortical inhibition (LICI) was reduced in symptomatic participants compared to healthy controls (F (2, 59) = 3.83, p = 0.027). Procedures were well tolerated with no serious adverse events. Conclusions: TMS measures of cortical excitability are altered at one month in children with mTBI. Long interval cortical inhibition is decreased in children who remain symptomatic at one month post-injury. (C) 2016 Elsevier Inc. All rights reserved.	[Seeger, Trevor A.; Kirton, Adam; Esser, Michael J.; Gallagher, Clare; Dunn, Jeff; Zewdie, Ephrem; Damji, Omar; Ciechanski, Patrick; Barlow, Karen M.] Univ Calgary, Cumming Sch Med, Calgary, AB, Canada; [Seeger, Trevor A.; Kirton, Adam; Gallagher, Clare; Dunn, Jeff; Zewdie, Ephrem; Ciechanski, Patrick; Barlow, Karen M.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Seeger, Trevor A.; Kirton, Adam; Esser, Michael J.; Gallagher, Clare; Dunn, Jeff; Zewdie, Ephrem; Ciechanski, Patrick; Barlow, Karen M.] Alberta Childrens Prov Gen Hosp, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada		Barlow, KM (corresponding author), Univ Calgary, Cumming Sch Med, Calgary, AB, Canada.	karen.barlow@albertahealthservices.ca	Barlow, Karen/I-6492-2019; Barlow, Karen/C-1323-2014	Barlow, Karen/0000-0003-2612-8507; Barlow, Karen/0000-0003-2612-8507	Alberta Innovates [201400252] Funding Source: researchfish		Adeyemo BO, 2014, J ATTEN DISORD, V18, P576, DOI 10.1177/1087054714543371; Barlow KM, 2016, J CHILD NEUROL, V31, P57, DOI 10.1177/0883073814543305; Barlow KM, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-271; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Barlow KM, PEDIAT BRAIN STIMULA; Barlow KM, 2015, PEDIAT NEUROL; Boroojerdi B, 2001, CLIN NEUROPHYSIOL, V112, P931, DOI 10.1016/S1388-2457(01)00523-5; Boroojerdi B, 2001, P NATL ACAD SCI USA, V98, P14698, DOI 10.1073/pnas.251357198; Brooks BL, 2014, J NEUROTRAUM, V1749, P1; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Chen R, 2008, CLIN NEUROPHYSIOL, V119, P504, DOI 10.1016/j.clinph.2007.10.014; Chistyakov AV, 2001, J NEUROL NEUROSUR PS, V70, P580, DOI 10.1136/jnnp.70.5.580; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; De Beaumont L, 2012, CEREB CORTEX, V22, P112, DOI 10.1093/cercor/bhr096; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Dennis EL, 2015, J NEUROSCI, V35, P10202, DOI 10.1523/JNEUROSCI.1595-15.2015; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Faul M, 2010, TRAUMATIC BRAIN INJU, P74; Garvey MA, 2003, CLIN NEUROPHYSIOL, V114, P1662, DOI 10.1016/S1388-2457(03)00130-5; Garvey MA, 2001, J CHILD NEUROL, V16, P891, DOI 10.1177/088307380101601205; Garvey MA, 2001, CLIN NEUROPHYSIOL, V112, P1451, DOI 10.1016/S1388-2457(01)00581-8; Garvey MA, 2008, CLIN NEUROPHYSIOL, V119, P973, DOI 10.1016/j.clinph.2007.11.048; Gilbert DL, 2011, NEUROLOGY, V76, P615, DOI 10.1212/WNL.0b013e31820c2ebd; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza CC, 2007, CURR OPIN CRIT CARE, V13, P143, DOI 10.1097/MCC.0b013e32808255dc; Giza CC, 2006, J NEUROTRAUM, V23, P950, DOI 10.1089/neu.2006.23.950; Giza CC, 2009, DEV NEUROREHABIL, V12, P255, DOI 10.3109/17518420903087558; Groppa S, 2012, CLIN NEUROPHYSIOL, V123, P858, DOI 10.1016/j.clinph.2012.01.010; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Huusko N, 2014, NEUROSCIENCE, V267, P30, DOI 10.1016/j.neuroscience.2014.02.026; Jung P, 2006, MUSCLE NERVE, V34, P431, DOI 10.1002/mus.20604; Keel JC, 2001, CLIN NEUROPHYSIOL, V112, P720, DOI 10.1016/S1388-2457(00)00518-6; King N, 2014, NEUROREHABILITATION, V34, P741, DOI 10.3233/NRE-141072; Kumar A, 2002, J NEUROSCI RES, V67, P781, DOI 10.1002/jnr.10181; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lao Y, 2015, PROCSPIE INTSOCOPTEN, V9287, P1, DOI DOI 10.1117/12.20; Lefebvre G, 2015, BRAIN INJURY, V29, P1032, DOI 10.3109/02699052.2015.1028447; Liepert J, 1997, J NEURAL TRANSM, V104, P1207, DOI 10.1007/BF01294721; Livingston SC, 2012, J CLIN NEUROPHYSIOL, V29, P23, DOI 10.1097/WNP.0b013e318246ae46; Macpherson A, 2014, PAED CHILD HEALT-CAN, V19, P543, DOI 10.1093/pch/19.10.543; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Miller J, 2014, NEUROSURGERY S1, V61, P222; Miller NR, 2014, BRAIN INJURY, V28, P1270, DOI 10.3109/02699052.2014.915987; Mohammadi B, 2006, MUSCLE NERVE, V33, P778, DOI 10.1002/mus.20531; Moran LM, 2012, J PEDIATR PSYCHOL, V37, P736, DOI 10.1093/jpepsy/jsr087; Nardone R, 2004, NEUROSCI LETT, V355, P65, DOI 10.1016/j.neulet.2003.10.055; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Pearce AJ, 2014, J NEUROTRAUM, V31, P1139, DOI 10.1089/neu.2013.3219; Powers KC, 2014, BRAIN INJURY, V28, P465, DOI 10.3109/02699052.2014.888759; Raible DJ, 2012, J NEUROTRAUMA, V2554; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Ryu WHA, 2009, CAN J NEUROL SCI, V36, P429, DOI 10.1017/S0317167100007745; Sady MD, 2014, ARCH CLIN NEUROPSYCH; Shrey DW, 2011, PHYS MED REH CLIN N, V22, P577, DOI 10.1016/j.pmr.2011.08.002; Solinas C, 2008, EUR J NEUROL, V15, P501, DOI 10.1111/j.1468-1331.2008.02110.x; Takeuchi N, 2006, BRAIN INJURY, V20, P991, DOI 10.1080/02699050600909771; Terao Y, 2002, J CLIN NEUROPHYSIOL, V19, P322, DOI 10.1097/00004691-200208000-00006; Tremblay S, 2011, CLIN NEUROPHYSIOL, V122, pS185; Tremblay S, 2014, CLIN NEUROPHYSIOL, V125, P1371, DOI 10.1016/j.clinph.2013.11.040; Tremblay S, 2011, J NEUROTRAUM, V28, P493, DOI 10.1089/neu.2010.1615; Urban KJ, 2015, J NEUROTRAUM, V32, P833, DOI 10.1089/neu.2014.3577; Wu P, 2013, J NEUROTRAUM, V30, P775, DOI 10.1089/neu.2012.2391; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	67	17	17	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1935-861X	1876-4754		BRAIN STIMUL	Brain Stimul.	MAR-APR	2017	10	2					305	314		10.1016/j.brs.2016.11.011			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EN2LN	WOS:000395841800016	27916406	Green Submitted			2022-02-06	
J	Singh, S; Mishra, A; Srivastava, N; Shukla, S				Singh, Sonu; Mishra, Akanksha; Srivastava, Neha; Shukla, Shubha			MK-801 (Dizocilpine) Regulates Multiple Steps of Adult Hippocampal Neurogenesis and Alters Psychological Symptoms via Wnt/beta-Catenin Signaling in Parkinsonian Rats	ACS CHEMICAL NEUROSCIENCE			English	Article						MK-801; neural stem cells; hippocampal neurogenesis; Parkinson's disease; nonmotor symptoms	MIDBRAIN DOPAMINERGIC-NEURONS; NMDA RECEPTOR ANTAGONISTS; NEURAL PROGENITOR CELLS; TRAUMATIC BRAIN-INJURY; DENTATE GYRUS; MOUSE HIPPOCAMPUS; SUBSTANTIA-NIGRA; PRECURSOR CELLS; SELF-RENEWAL; DISEASE	Adult hippocampal neurogenesis is directly involved in regulation of stress, anxiety, and depression that are commonly observed nonmotor symptoms in Parkinson's disease (PD). These symptoms do not respond to pharmacological dopamine replacement therapy. Excitotoxic damage to neuronal cells by N-methyl-D-aspartate (NMDA) receptor activation is also a major contributing factor in PD development, but whether it regulates hippocampal neurogenesis and nonmotor symptoms in PD is yet unexplored. Herein, for the first time, we studied the effect of MK-801, an NMDA receptor antagonist, on adult hippocampal neurogenesis and behavioral functions in 6-OHDA (6-hydroxydopamine) induced rat model of PD. MK-801 treatment (0.2 mg/kg, ip) increased neural stem cell (NSC) proliferation, self-renewal capacity, long-term survival, and neuronal differentiation in the hippocampus of rat model of PD. MK-801 potentially enhanced long-term survival, improved dendritic arborization of immature neurons, and reduced 6-01-IDA induced neurodegeneration via maintaining the NSC pool in hippocampus, leading to decreased anxiety and depression-like phenotypes in the PD model. MK-801 inhibited glycogen synthase kinase-3 beta (GSK-3/3) through up-regulation of Wnt-3a, which resulted in the activation of Wnt/beta-catenin signaling leading to enhanced hippocampal neurogenesis in PD model. Additionally, MK-801 treatment protected the dopaminergic (DAergic) neurons in the nigrostriatal pathway and improved motor functions by increasing the expression of Nurr-1 and Pitx-3 in the PD model. Therefore, MK-801 treatment serves as a valuable tool to enhance hippocampal neurogenesis in PD, but further studies are needed to revisit the role of MK-801 in the neurodegenerative disorder before proposing a potential therapeutic candidate.	[Singh, Sonu; Mishra, Akanksha; Srivastava, Neha; Shukla, Shubha] CSIR CDRI, Pharmacol Div, BS-10-1,Sect 10,Jankipuram Extens,Sitapur Rd, Lucknow 226031, Uttar Pradesh, India		Shukla, S (corresponding author), CSIR CDRI, Pharmacol Div, BS-10-1,Sect 10,Jankipuram Extens,Sitapur Rd, Lucknow 226031, Uttar Pradesh, India.	shubha_shulda@cdri.res.in		Singh, Sonu/0000-0002-2389-6685	Council of Scientific and Industrial Research (CSIR) Network grant miND [BSC0115]; Indian Council of Medical Research (ICMR)Indian Council of Medical Research (ICMR); CSIR, New Delhi, IndiaCouncil of Scientific & Industrial Research (CSIR) - India	The authors thank Director of CSIR-Central Drug Research Institute (CDRI), Lucknow, India, for constant support and direction in the study. This research work is supported by Council of Scientific and Industrial Research (CSIR) Network grant miND (BSC0115) to Shubha Shukla. Sonu Singh and Akanksha Mishra are supported by a research fellowship from Indian Council of Medical Research (ICMR) and CSIR, New Delhi, India, respectively. The CSIR-CDRI manuscript communication number for this article is 9391.	Ahlander M, 1999, NEUROPSYCHOPHARMACOL, V21, P414, DOI 10.1016/S0893-133X(98)00116-X; Ahn YM, 2005, INT J NEUROPSYCHOPH, V8, P607, DOI 10.1017/S1461145705005353; Aimone JB, 2014, PHYSIOL REV, V94, P991, DOI 10.1152/physrev.00004.2014; Arvidsson A, 2001, EUR J NEUROSCI, V14, P10, DOI 10.1046/j.0953-816x.2001.01611.x; Baker SA, 2004, EUR J NEUROSCI, V20, P575, DOI 10.1111/j.1460-9568.2004.03486.x; Barkus C, 2010, EUR J PHARMACOL, V626, P49, DOI 10.1016/j.ejphar.2009.10.014; Bernabeu R, 2000, J CEREBR BLOOD F MET, V20, P1669, DOI 10.1097/00004647-200012000-00006; Bond AM, 2015, CELL STEM CELL, V17, P385, DOI 10.1016/j.stem.2015.09.003; Broussard JI, 2016, CELL REP, V14, P1930, DOI 10.1016/j.celrep.2016.01.070; CAMERON HA, 1995, J NEUROSCI, V15, P4687; Carvalho MM, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-14; Chen Y, 2005, J NEUROSCI, V25, P8209, DOI 10.1523/JNEUROSCI.1951-05.2005; Choi JH, 2011, CELL MOL NEUROBIOL, V31, P285, DOI 10.1007/s10571-010-9619-4; Crawley JN, 2007, BRAIN PATHOL, V17, P448, DOI 10.1111/j.1750-3639.2007.00096.x; De Biase LM, 2011, J NEUROSCI, V31, P12650, DOI 10.1523/JNEUROSCI.2455-11.2011; Fong HL, 2008, STEM CELLS, V26, P1931, DOI 10.1634/stemcells.2007-1002; Gonera EG, 1997, MOVEMENT DISORD, V12, P871, DOI 10.1002/mds.870120607; Gould E, 1998, P NATL ACAD SCI USA, V95, P3168, DOI 10.1073/pnas.95.6.3168; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Hack I, 2002, NAT NEUROSCI, V5, P939, DOI 10.1038/nn923; Han RZ, 2009, NEUROSCI BULL, V25, P367, DOI 10.1007/s12264-009-0608-x; Hegarty SV, 2013, DEV BIOL, V379, P123, DOI 10.1016/j.ydbio.2013.04.014; Hewett SJ, 2006, J PHARMACOL EXP THER, V319, P1219, DOI 10.1124/jpet.106.109876; Hill AS, 2015, NEUROPSYCHOPHARMACOL, V40, P2368, DOI 10.1038/npp.2015.85; Hoglinger GU, 2014, J COMP NEUROL, V522, P2336, DOI 10.1002/cne.23537; Hoglinger GU, 2004, NAT NEUROSCI, V7, P726, DOI 10.1038/nn1265; Hsu KS, 1996, J NEUROPHYSIOL, V76, P1887, DOI 10.1152/jn.1996.76.3.1887; Joelving FC, 2006, HIPPOCAMPUS, V16, P826, DOI 10.1002/hipo.20212; Jonkers N, 2000, EUR J PHARMACOL, V407, P281, DOI 10.1016/S0014-2999(00)00753-6; Kaidanovich-Beilin O, 2004, BIOL PSYCHIAT, V55, P781, DOI 10.1016/j.biopsych.2004.01.008; Karadottir R, 2005, NATURE, V438, P1162, DOI 10.1038/nature04302; Kitayama T, 2004, J NEUROSCI RES, V76, P599, DOI 10.1002/jnr.20095; L'Episcopo F, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-49; Langen B, 2012, PSYCHOPHARMACOLOGY, V221, P249, DOI 10.1007/s00213-011-2567-y; Latysheva NV, 2003, PROG NEURO-PSYCHOPH, V27, P787, DOI 10.1016/S0278-5846(03)00110-6; Lazarini F, 2014, J NEUROSCI, V34, P14430, DOI 10.1523/JNEUROSCI.5366-13.2014; Le W, 1999, J NEUROCHEM, V73, P2218; Lemke MR, 2008, EUR J NEUROL, V15, P21, DOI 10.1111/j.1468-1331.2008.02058.x; Li C, 2013, GLIA, V61, P732, DOI 10.1002/glia.22469; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Maxwell SL, 2005, DEV BIOL, V282, P467, DOI 10.1016/j.ydbio.2005.03.028; Michetti C, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00095; MILNER TA, 1989, J COMP NEUROL, V281, P479, DOI 10.1002/cne.902810311; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Morales M, 2013, BEHAV BRAIN RES, V250, P18, DOI 10.1016/j.bbr.2013.04.050; MURASE S, 1993, J NEURAL TRANSM-GEN, V91, P13, DOI 10.1007/BF01244915; Nacher J, 2003, NEUROBIOL AGING, V24, P273, DOI 10.1016/S0197-4580(02)00096-9; Niu S, 2004, NEURON, V41, P71, DOI 10.1016/S0896-6273(03)00819-5; Okuyama N, 2004, J NEUROCHEM, V88, P717, DOI 10.1046/j.1471-4159.2003.02215.x; PAPP M, 1994, EUR J PHARMACOL, V263, P1, DOI 10.1016/0014-2999(94)90516-9; Paquette MA, 2010, NEUROPHARMACOLOGY, V58, P1002, DOI 10.1016/j.neuropharm.2010.01.003; Park D, 2010, STEM CELLS, V28, P2162, DOI 10.1002/stem.541; Park JS, 1996, NEUROBIOL DIS, V3, P215, DOI 10.1006/nbdi.1996.0022; Petrus DS, 2009, EUR J NEUROSCI, V29, P244, DOI 10.1111/j.1460-9568.2008.06579.x; Qiu JH, 2009, STEM CELLS, V27, P920, DOI 10.1002/stem.1; Racca C, 2000, J NEUROSCI, V20, P2512; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013; Schaefer A, 2008, DEV NEUROBIOL, V68, P590, DOI 10.1002/dneu.20601; Schoenfeld TJ, 2015, NEUROPSYCHOPHARMACOL, V40, P113, DOI 10.1038/npp.2014.230; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Shin JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050496; Shulman LM, 2001, MOVEMENT DISORD, V16, P507, DOI 10.1002/mds.1099; Singh S, 2016, MOL NEUROBIOL, V53, P4286, DOI 10.1007/s12035-015-9361-5; Sonmez A, 2015, NEUROSCI LETT, V597, P137, DOI 10.1016/j.neulet.2015.05.001; Suzuki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009260; Szatmari E, 2005, J BIOL CHEM, V280, P37526, DOI 10.1074/jbc.M502699200; TURSKI L, 1991, NATURE, V349, P414, DOI 10.1038/349414a0; van den Munckhof P, 2003, DEVELOPMENT, V130, P2535, DOI 10.1242/dev.00464; Varela-Nallar L, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00100; Wilkinson MB, 2011, J NEUROSCI, V31, P9084, DOI 10.1523/JNEUROSCI.0039-11.2011; Winner B, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a021287; Won SJ, 2006, EXP NEUROL, V198, P250, DOI 10.1016/j.expneurol.2005.12.008; Yan JQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020945; Zarrindast MR, 2012, PHARMACOL BIOCHEM BE, V103, P102, DOI 10.1016/j.pbb.2012.07.016; Zou H, 2008, PHARMACOL BIOCHEM BE, V90, P753, DOI 10.1016/j.pbb.2008.06.002	76	17	17	0	10	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-7193			ACS CHEM NEUROSCI	ACS Chem. Neurosci.	MAR	2017	8	3					592	605		10.1021/acschemneuro.6b00354			14	Biochemistry & Molecular Biology; Chemistry, Medicinal; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Neurosciences & Neurology	EO6MT	WOS:000396807900020	27977132				2022-02-06	
J	Fino, PC; Peterka, RJ; Hullar, TE; Murchison, C; Horak, FB; Chesnutt, JC; King, LA				Fino, Peter C.; Peterka, Robert J.; Hullar, Timothy E.; Murchison, Chad; Horak, Fay B.; Chesnutt, James C.; King, Laurie A.			Assessment and rehabilitation of central sensory impairments for balance in mTBI using auditory biofeedback: a randomized clinical trial	BMC NEUROLOGY			English	Article						Sensorimotor integration; mTBI; Concussion; Balance; Gait; Biofeedback	TRAUMATIC BRAIN-INJURY; ERROR SCORING SYSTEM; POSTURAL-CONTROL; SENSORIMOTOR INTEGRATION; HEAD-INJURY; GAIT; DIZZINESS; CONCUSSION; STABILITY; DEFICITS	Background: Complaints of imbalance are common non-resolving signs in individuals with post-concussive syndrome. Yet, there is no consensus rehabilitation for non-resolving balance complaints following mild traumatic brain injury (mTBI). The heterogeneity of balance deficits and varied rates of recovery suggest varied etiologies and a need for interventions that address the underlying causes of poor balance function. Our central hypothesis is that most chronic balance deficits after mTBI result from impairments in central sensorimotor integration that may be helped by rehabilitation. Two studies are described to 1) characterize balance deficits in people with mTBI who have chronic, non-resolving balance deficits compared to healthy control subjects, and 2) determine the efficacy of an augmented vestibular rehabilitation program using auditory biofeedback to improve central sensorimotor integration, static and dynamic balance, and functional activity in patients with chronic mTBI. Methods: Two studies are described. Study 1 is a cross-sectional study to take place jointly at Oregon Health and Science University and the VA Portland Health Care System. The study participants will be individuals with non-resolving complaints of balance following mTBI and age-and gender-matched controls who meet all inclusion criteria. The primary outcome will be measures of central sensorimotor integration derived from a novel central sensorimotor integration test. Study 2 is a randomized controlled intervention to take place at Oregon Health & Science University. In this study, participants from Study 1 with mTBI and abnormal central sensorimotor integration will be randomized into two rehabilitation interventions. The interventions will be 6 weeks of vestibular rehabilitation 1) with or 2) without the use of an auditory biofeedback device. The primary outcome measure is the daily activity of the participants measured using an inertial sensor. Discussion: The results of these two studies will improve our understanding of the nature of balance deficits in people with mTBI by providing quantitative metrics of central sensorimotor integration, balance, and vestibular and ocular motor function. Study 2 will examine the potential for augmented rehabilitation interventions to improve central sensorimotor integration.	[Fino, Peter C.; Murchison, Chad; King, Laurie A.] Oregon Hlth & Sci Univ, Dept Neurol, 3181 SW Sam Jackson Pk Rd,L226, Portland, OR 97239 USA; [Peterka, Robert J.] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA; [Hullar, Timothy E.] Oregon Hlth & Sci Univ, Dept Otolaryngol Head & Neck Surg, Portland, OR 97201 USA; [Chesnutt, James C.] Oregon Hlth & Sci Univ, Dept Orthopaed & Rehabil, Portland, OR 97201 USA; [Peterka, Robert J.; King, Laurie A.] Vet Affairs Portland Hlth Care Syst, Natl Ctr Rehabil Auditory Res, Portland, OR USA; [Fino, Peter C.; Horak, Fay B.] Vet Affairs Portland Hlth Care Syst, Portland, OR USA		King, LA (corresponding author), Oregon Hlth & Sci Univ, Dept Neurol, 3181 SW Sam Jackson Pk Rd,L226, Portland, OR 97239 USA.; King, LA (corresponding author), Vet Affairs Portland Hlth Care Syst, Natl Ctr Rehabil Auditory Res, Portland, OR USA.	kingla@ohsu.edu		Fino, Peter/0000-0002-8621-3706	 [W81XWH-15-1-0620]	This work was supported by the Assistant Secretary of Defense for Health Affairs under Award No. W81XWH-15-1-0620. Opinions, interpretations, conclusions and recommendations are those of the author and are not necessarily endorsed by the Department of Defense.	Alberts JL, 2015, MED SCI SPORT EXER, V47, P2233, DOI 10.1249/MSS.0000000000000656; Alberts JL, 2015, J ATHL TRAINING, V50, P578, DOI 10.4085/1062-6050-50.2.01; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Basta D, 2005, HUM MOVEMENT SCI, V24, P268, DOI 10.1016/j.humov.2005.04.002; Beck A. T., 1996, BECK DEPRESSION INVE, P78204; Bennett RM, 2014, ARTHRIT CARE RES, V66, P1364, DOI 10.1002/acr.22301; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Capo-Aponte J. E., 2012, MIL MED, V177, P804; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; DAVIES RA, 1995, J NEUROL, V242, P222, DOI 10.1007/BF00919595; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; Dozza M, 2005, ARCH PHYS MED REHAB, V86, P1401, DOI 10.1016/j.apmr.2004.12.036; Dozza M, 2007, EXP BRAIN RES, V178, P37, DOI 10.1007/s00221-006-0709-y; Drew AS, 2007, NEUROSCI LETT, V417, P61, DOI 10.1016/j.neulet.2007.02.038; Eckner JT, 2010, J ATHL TRAINING, V45, P327, DOI 10.4085/1062-6050-45.4.327; Ernst A, 2005, SOLID MECH APPL, V124, P213; Fife TD, 2015, ANN NY ACAD SCI, V1343, P97, DOI 10.1111/nyas.12678; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Fino PC, 2016, GAIT POSTURE, V50, P69, DOI 10.1016/j.gaitpost.2016.08.026; Fino PC, 2016, J BIOMECH, V49, P1983, DOI 10.1016/j.jbiomech.2016.05.004; Friend R, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3311; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Herdman SJ, 1998, OTOLARYNG HEAD NECK, V119, P49, DOI 10.1016/S0194-5998(98)70195-0; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Horak F, 2015, PHYS THER, V95, P461, DOI 10.2522/ptj.20140253; Howell D, 2015, J BIOMECH, V48, P3364, DOI 10.1016/j.jbiomech.2015.06.014; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Kansagara D, 2013, COMPLICATIONS MILD T; KATZMAN R, 1983, AM J PSYCHIAT, V140, P734; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Mancini M, 2010, EUR J PHYS REHAB MED, V46, P239; Mancini M., 2011, J BIOENG BIOMED S S1, V1, P7, DOI DOI 10.4172/2155-9538.S1-007; Mayagoitia RE, 2002, J BIOMECH, V35, P537, DOI 10.1016/S0021-9290(01)00231-7; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrory P, 2012, BR J SPORTS MED; McGowan JC, 2000, AM J NEURORADIOL, V21, P875; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; MONTGOMERY EA, 1991, PSYCHOL MED, V21, P375, DOI 10.1017/S0033291700020481; NASHNER LM, 1990, NEUROL CLIN, V8, P331, DOI 10.1016/S0733-8619(18)30359-1; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Peterka RJ, 2004, J NEUROPHYSIOL, V91, P410, DOI 10.1152/jn.00516.2003; Peterka RJ, 2003, IEEE ENG MED BIOL, V22, P63, DOI 10.1109/MEMB.2003.1195698; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Peterka Robert J, 2011, Front Neurol, V2, P57, DOI 10.3389/fneur.2011.00057; Pintelon R, 2001, IEEE T INSTRUM MEAS, V50, P1753, DOI 10.1109/19.982976; Reeves DL, 2007, ARCH CLIN NEUROPSYCH, V22, pS15, DOI 10.1016/j.acn.2006.10.013; SHEPARD NT, 1995, OTOLARYNG HEAD NECK, V112, P173, DOI 10.1016/S0194-5998(95)70317-9; SHUMWAYCOOK A, 1986, PHYS THER, V66, P1548, DOI 10.1093/ptj/66.10.1548; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Suh M, 2006, NEUROSCI LETT, V410, P203, DOI 10.1016/j.neulet.2006.10.001; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074; TOGLIA JU, 1970, ARCHIV OTOLARYNGOL, V92, P485; Weathers F. W, 1993, ANN CONVENTION INT S; Weightman MM, 2010, J HEAD TRAUMA REHAB, V25, P206, DOI 10.1097/HTR.0b013e3181dc82d3	65	17	17	0	16	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2377			BMC NEUROL	BMC Neurol.	FEB 23	2017	17								41	10.1186/s12883-017-0812-7			14	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	EL5XJ	WOS:000394694500003	28231824	Green Published, gold			2022-02-06	
J	Cui, DM; Zeng, T; Ren, J; Wang, K; Jin, Y; Zhou, L; Gao, L				Cui, Da-Ming; Zeng, Tao; Ren, Jie; Wang, Ke; Jin, Yi; Zhou, Lin; Gao, Liang			KLF4 Knockdown Attenuates TBI-Induced Neuronal Damage through p53 and JAK-STAT3 Signaling	CNS NEUROSCIENCE & THERAPEUTICS			English	Article						Kruppel-like factor 4; Nrf2; P53; STAT3; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; TUMOR-SUPPRESSOR; INHIBITION; ACTIVATION; INDUCTION; APOPTOSIS; PROTECTS; PATHWAY; CELLS	AimsTraumatic brain injury (TBI) is induced by complex primary and secondary mechanisms that give rise to cell death, inflammation, and neurological dysfunction. Understanding the mechanisms that drive neurological damage as well as those that promote repair can guide the development of therapeutic drugs for TBI. Kruppel-like factor 4 (KLF4) has been reported to negatively regulate axon regeneration of injured retinal ganglion cells (RGCs) through inhibition of JAK-STAT3 signaling. However, the role of KLF4 in TBI remains unreported. Reactive oxygen species (ROS)-induced neuronal death is a pathophysiological hallmark of TBI. MethodsIn this study, we used H2O2-treated RGCs in vitro and the optic nerve crush model in vivo to simulate neuronal damage in TBI. The function of KLF4 in RGC survival and axon regeneration in these models was investigated. In addition, the effects of KLF4 knockdown on neuronal damage after a brain impact that mimics moderate TBI were studied. ResultsThe results show that H2O2 induces p53-dependent apoptosis of RGCs in vitro through upregulation of KLF4. Additionally, KLF4 knockdown in vivo significantly enhances CNTF-induced axon regeneration of RGCs after optic nerve crush, and more importantly, prevents neuronal damage after a moderate brain impact in rats. Our Western blot analysis and immunoprecipitation assay results indicate that these effects of KLF4 knockdown are mediated by the p53 and JAK-STAT3 pathways. ConclusionThese findings provide evidence that KLF4 plays an important role in the pathophysiology of TBI. Blocking KLF4 may be a potential therapeutic strategy for the treatment of TBI, either alone or in combination with agents that target complementary mechanisms.	[Cui, Da-Ming; Zeng, Tao; Ren, Jie; Wang, Ke; Jin, Yi; Zhou, Lin; Gao, Liang] Tongji Univ, Shanghai Peoples Hosp 10, Sch Med, Dept Neurosurg, 301 Middle Yanchang Rd, Shanghai 200072, Peoples R China		Gao, L (corresponding author), Tongji Univ, Shanghai Peoples Hosp 10, Sch Med, Dept Neurosurg, 301 Middle Yanchang Rd, Shanghai 200072, Peoples R China.	kalantes@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81201979]	This study was supported by the Youth Fund of the National Natural Science Foundation of China (81201979).	Brandt T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048252; Cardaci S, 2010, BIOCHEM J, V430, P439, DOI 10.1042/BJ20100503; CDC, 2014, INJ PREV CONTR TRAUM; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Culmsee C, 2001, J NEUROCHEM, V77, P220, DOI 10.1046/j.1471-4159.2001.00220.x; Hybertson BM, 2011, MOL ASPECTS MED, V32, P234, DOI 10.1016/j.mam.2011.10.006; Kim SO, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054790, 10.1371/journal.pone.0053908, 10.1371/journal.pone.0063749, 10.1371/journal.pone.0068092]; Lee S, 2015, INT J MOL SCI, V16, P19657, DOI 10.3390/ijms160819657; Leibinger M, 2009, J NEUROSCI, V29, P14334, DOI 10.1523/JNEUROSCI.2770-09.2009; Liu Y, 2005, J BIOL CHEM, V280, P9719, DOI 10.1074/jbc.M412862200; Michikami I, 2012, EXP CELL RES, V318, P311, DOI 10.1016/j.yexcr.2011.12.013; Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737; Napieralski JA, 1999, MOL BRAIN RES, V71, P78, DOI 10.1016/S0169-328X(99)00155-2; Oliva AA, 2012, J NEUROCHEM, V120, P710, DOI 10.1111/j.1471-4159.2011.07610.x; Qin S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3633; Qin S, 2012, MOL CELL BIOL, V32, P4297, DOI 10.1128/MCB.00838-12; Qin S, 2011, P NATL ACAD SCI USA, V108, P21117, DOI 10.1073/pnas.1112351109; Rachmany L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079837; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Smith PD, 2009, NEURON, V64, P617, DOI 10.1016/j.neuron.2009.11.021; Song YX, 2014, APOPTOSIS, V19, P984, DOI 10.1007/s10495-014-0982-3; Wassmann S, 2007, J MOL CELL CARDIOL, V43, P301, DOI 10.1016/j.yjmcc.2007.06.001; Yoshida T, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000622; Yoshida T, 2012, J BIOL CHEM, V287, P25706, DOI 10.1074/jbc.M112.361360; Yoshida T, 2008, AM J PHYSIOL-CELL PH, V295, pC1175, DOI 10.1152/ajpcell.00288.2008; Zhang QG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034504; Zhang WQ, 2000, J BIOL CHEM, V275, P18391, DOI 10.1074/jbc.C000062200; Zhao JB, 2011, NEUROSCI LETT, V498, P147, DOI 10.1016/j.neulet.2011.05.001; Zhou GJ, 2012, J CLIN INVEST, V122, P4727, DOI 10.1172/JCI66056	31	17	18	3	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-5930	1755-5949		CNS NEUROSCI THER	CNS Neurosci. Ther.	FEB	2017	23	2					106	118		10.1111/cns.12633			13	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	EK8EY	WOS:000394157900001	27671232	Bronze, Green Published			2022-02-06	
J	Dunser, MW; Towey, RM; Amito, J; Mer, M				Duenser, M. W.; Towey, R. M.; Amito, J.; Mer, M.			Intensive care medicine in rural sub-Saharan Africa	ANAESTHESIA			English	Article						Africa; epidemiology; intensive care medicine; mechanical ventilation; mortality	LOW-INCOME COUNTRIES; SEVERE SEPSIS; UNITED-STATES; ANESTHESIA; ZAMBIA	We undertook an audit in a rural Ugandan hospital that describes the epidemiology and mortality of 5147 patients admitted to the intensive care unit. The most frequent admission diagnoses were postoperative state (including following trauma) (2014/5147; 39.1%), medical conditions (709; 13.8%) and traumatic brain injury (629; 12.2%). Intensive care unit mortality was 27.8%, differing between age groups (p < 0.001). Intensive care unit mortality was highest for neonatal tetanus (29/37; 78.4%) and lowest for foreign body aspiration (4/204; 2.0%). Intensive care unit admission following surgery (333/1431; 23.3%), medical conditions (327/1431; 22.9%) and traumatic brain injury (233/1431; 16.3%) caused the highest number of deaths. Of all deaths in the hospital, (1431/11,357; 12.6%) occurred in the intensive care unit. Although the proportion of hospitalised patients admitted to the intensive care unit increased over time, from 0.7% in 2005/6 to 2.8% in 2013/4 (p < 0.001), overall hospital mortality decreased (2005/6, 4.8%; 2013/14, 4.0%; p < 0.001). The proportion of intensive care patients whose lungs were mechanically ventilated was 18.7% (961/5147). This subgroup of patients did not change over time (2006, 16%; 2015, 18.4%; p = 0.12), but their mortality decreased (2006, 59.5%; 2015, 44.3%; p < 0.001).	[Duenser, M. W.] Salzburg Univ Hosp, Dept Anesthesiol Perioperat Med & Gen Intens Care, Intens Care, Salzburg, Austria; [Duenser, M. W.; Mer, M.] Paracelsus Private Med Univ, Salzburg, Austria; [Towey, R. M.] European Soc Intens Care Med, Global Intens Care Working Grp, Brussels, Belgium; [Amito, J.] St Marys Hosp Lacor, Dept Anaesthet & Intens Care, Gulu, Uganda; [Mer, M.] Charlotte Maxeke Johannesburg Acad Hosp, Intens Care Unit, Intens Care, Johannesburg, South Africa; [Mer, M.] Univ Witwatersrand, Johannesburg, South Africa		Dunser, MW (corresponding author), Salzburg Univ Hosp, Dept Anesthesiol Perioperat Med & Gen Intens Care, Intens Care, Salzburg, Austria.; Dunser, MW (corresponding author), Paracelsus Private Med Univ, Salzburg, Austria.	martin.duenser@i-med.ac.at					Andrews B, 2014, CRIT CARE MED, V42, P2315, DOI 10.1097/CCM.0000000000000541; Baelani I, 2011, CRIT CARE, V15, DOI 10.1186/cc9410; Baker T, 2009, PEDIATR ANESTH, V19, P23, DOI 10.1111/j.1460-9592.2008.02868.x; Baker T, 2009, TROP MED INT HEALTH, V14, P143, DOI 10.1111/j.1365-3156.2008.02202.x; Dondorp AM, 2016, JAMA-J AM MED ASSOC, V315, P753, DOI 10.1001/jama.2016.0976; Dunser MW, 2008, WIEN KLIN WOCHENSCHR, V120, P600, DOI 10.1007/s00508-008-1064-8; Fernando Jlin, 2012, Int J Crit Illn Inj Sci, V2, P11, DOI 10.4103/2229-5151.94884; GROEGER JS, 1993, CRIT CARE MED, V21, P279, DOI 10.1097/00003246-199302000-00022; Jochberger S, 2008, ANESTH ANALG, V106, P942, DOI 10.1213/ane.0b013e318166ecb8; Kahn JM, 2015, CRIT CARE MED, V43, P282, DOI 10.1097/CCM.0000000000000710; Kissoon N, 2011, PEDIATR CRIT CARE ME, V12, P73, DOI 10.1097/PCC.0b013e3181ce74ef; Phua J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3245; Sawe HR, 2014, BMC INT HEALTH HUM R, V14, DOI 10.1186/1472-698X-14-26; Sprung CL, 2003, JAMA-J AM MED ASSOC, V290, P790, DOI 10.1001/jama.290.6.790; UNAIDS, 2015, 2015 PROGR REP GLOB	15	17	17	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0003-2409	1365-2044		ANAESTHESIA	Anaesthesia	FEB	2017	72	2					181	189		10.1111/anae.13710			9	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	EJ6EZ	WOS:000393313100006	27868190				2022-02-06	
J	Gagne, M; Moore, L; Sirois, MJ; Simard, M; Beaudoin, C; Kuimi, BLB				Gagne, Mathieu; Moore, Lynne; Sirois, Marie-Josee; Simard, Marc; Beaudoin, Claudia; Kuimi, Brice Lionel Batomen			Performance of International Classification of Diseases-based injury severity measures used to predict in-hospital mortality and intensive care admission among traumatic brain-injured patients	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						In-hospital mortality; International Classification of Diseases; trauma severity indices; traumatic brain injury	GLASGOW COMA SCALE; ADMINISTRATIVE DATA; MULTIPLE INJURIES; PROGNOSTIC VALUE; HEAD-INJURIES; SCORE; OUTCOMES; IMPACT; RISK; VALIDATION	BACKGROUND: The International Classification of Diseases (ICD) is the main classification system used for population-based traumatic brain injury (TBI) surveillance activities but does not contain direct information on injury severity. International Classification of Diseases-based injury severity measures can be empirically derived or mapped to the Abbreviated Injury Scale, but no single approach has been formally recommended for TBI. OBJECTIVE: The aim of this study was to compare the accuracy of different ICD-based injury severity measures for predicting in-hospital mortality and intensive care unit (ICU) admission in TBI patients. METHODS: We conducted a population-based retrospective cohort study. We identified all patients 16 years or older with a TBI diagnosis who received acute care between April 1, 2006, and March 31, 2013, from the Quebec Hospital Discharge Database. The accuracy of five ICD-based injury severity measures for predicting mortality and ICU admission was compared using measures of discrimination (area under the receiver operating characteristic curve [AUC]) and calibration (calibration plot and the Hosmer-Lemeshow goodness-of-fit statistic). RESULTS: Of 31,087 traumatic brain-injured patients in the study population, 9.0% died in hospital, and 34.4% were admitted to the ICU. Among ICD-based severity measures that were assessed, the multiplied derivative of ICD-based Injury Severity Score (ICISS-Multiplicative) demonstrated the best discriminative ability for predicting in-hospital mortality (AUC, 0.858; 95% confidence interval, 0.852-0.864) and ICU admissions (AUC, 0.813; 95% confidence interval, 0.808-0.818). Calibration assessments showed good agreement between observed and predicted in-hospital mortality for ICISS measures. All severity measures presented high agreement between observed and expected probabilities of ICU admission for all deciles of risk. CONCLUSIONS: The ICD-based injury severity measures can be used to accurately predict in-hospitalmortality and ICU admission in TBI patients. The ICISS-Multiplicative generally outperformed other ICD-based injury severity measures and should be preferred to control for differences in baseline characteristics between TBI patients in surveillance activities or injury research when only ICD codes are available. (Copyright (C) 2016 Wolters Kluwer Health, Inc. All rights reserved.)	[Gagne, Mathieu; Simard, Marc; Beaudoin, Claudia] Inst Natl Sante Publ Quebec, Bur Informat & Etud Sante Populat, Quebec City, PQ, Canada; [Gagne, Mathieu; Moore, Lynne; Beaudoin, Claudia; Kuimi, Brice Lionel Batomen] Univ Laval, Fac Med, Dept Med Sociale & Prevent, Quebec City, PQ, Canada; [Moore, Lynne; Kuimi, Brice Lionel Batomen] Ctr Hosp Univ CHU Quebec, Hop Enfants Jesus, Ctr Rech, Populat Hlth & Optimal Hlth Practices Res Unit, Quebec City, PQ, Canada; [Moore, Lynne; Kuimi, Brice Lionel Batomen] Ctr Hosp Univ CHU Quebec, Hop Enfants Jesus, Ctr Rech, Trauma Emergency Crit Care Med, Quebec City, PQ, Canada; [Sirois, Marie-Josee] Ctr Excellence Vieillissement Quebec, Quebec City, PQ, Canada; [Sirois, Marie-Josee] Ctr Hosp Univ CHU Quebec, Hop Enfants Jesus, Ctr Rech, Quebec City, PQ, Canada; [Sirois, Marie-Josee] Univ Laval, Fac Med, Dept Readaptat, Quebec City, PQ, Canada		Gagne, M (corresponding author), Bur Informat & Etud Sante Populat, 945 Ave Wolfe,5e Etage St Foy, Quebec City, PQ G1V 5B3, Canada.	mathieu.gagne@inspq.qc.ca	Kuimi, Brice Lionel Batomen/AAF-3970-2020; Simard, Marc/AAA-8541-2019	Kuimi, Brice Lionel Batomen/0000-0002-5772-120X; Sirois, Marie-josee/0000-0001-9775-6960			Baum J, 2016, WORLD NEUROSURG, V90, P525, DOI 10.1016/j.wneu.2015.12.012; Bergstrom MF, 2011, INJURY PREV, V17, P108, DOI 10.1136/ip.2010.028951; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Butcher I, 2007, J NEUROTRAUM, V24, P281, DOI 10.1089/neu.2006.0030; Carroll CP, 2012, NEUROSURGERY, V71, P1064, DOI 10.1227/NEU.0b013e31826f7c16; Collins GS, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7594; Cook A., 2013, ICD9 ICD 10 COD; Cook Alan, 2014, J Trauma Acute Care Surg, V76, P47, DOI 10.1097/TA.0b013e3182ab0d5d; COX DR, 1958, BIOMETRIKA, V45, P562, DOI 10.1093/biomet/45.3-4.562; Cryer C, 2006, INJURY PREV, V12, P67, DOI 10.1136/ip.2006.011668; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; Di Bartolomeo S, 2011, ACCIDENT ANAL PREV, V43, P1955, DOI 10.1016/j.aap.2011.05.013; Faul M, 2010, TRAUMATIC BRAIN INJU; Fu TS, 2015, J TRAUMA ACUTE CARE, V79, P449, DOI 10.1097/TA.0000000000000733; Gagne M, 2016, J TRAUMA ACUTE CARE, V80, P419, DOI 10.1097/TA.0000000000000944; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gedeborg R, 2014, J TRAUMA ACUTE CARE, V76, P358, DOI 10.1097/TA.0b013e3182a9cd31; Glance LG, 2009, ANN SURG, V249, P1032, DOI 10.1097/SLA.0b013e3181a38f28; Haas B, 2012, CAN J SURG, V55, P21, DOI 10.1503/cjs.017510; Haider AH, 2012, J TRAUMA ACUTE CARE, V72, P1695, DOI 10.1097/TA.0b013e318256a010; Haring RS, 2015, J SURG RES, V195, P1, DOI 10.1016/j.jss.2015.01.017; Hosmer DW, 2000, APPL LOGISTIC REGRES, P143, DOI [10.1002/0471722146.ch5, DOI 10.1002/0471722146.CH5]; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kilgo PD, 2003, J TRAUMA, V55, P599, DOI 10.1097/01.TA.0000085721.47738.BD; Kramer AA, 2007, CRIT CARE MED, V35, P2052, DOI 10.1097/01.CCM.0000275267.64078.B0; Lavoie A, 2005, INJURY, V36, P477, DOI 10.1016/j.injury.2004.09.039; Lavoie A, 2004, J TRAUMA, V56, P1312, DOI 10.1097/01.TA.0000075342.36072.EF; Leitgeb J, 2013, ARCH ORTHOP TRAUM SU, V133, P659, DOI 10.1007/s00402-013-1710-0; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; Meredith JW, 2003, J TRAUMA, V55, P933, DOI 10.1097/01.TA.0000085646.71451.5F; Moore L, ANN SURG; Moore L, 2008, J TRAUMA, V64, P420, DOI 10.1097/01.ta.0000241201.34082.d4; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Nakahara S, 2011, B WORLD HEALTH ORGAN, V89, P238, DOI 10.2471/BLT.10.078964; Orman JAL., 2012, INJURY RES, P61; Osler T, 1996, J TRAUMA, V41, P380, DOI 10.1097/00005373-199609000-00002; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; Parsons Daria, 2012, BMC Res Notes, V5, P584, DOI 10.1186/1756-0500-5-584; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Shore AD, 2005, BRAIN INJURY, V19, P613, DOI 10.1080/02699050400013568; Steyerberg EW, 2014, EUR HEART J, V35, P1925, DOI 10.1093/eurheartj/ehu207; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Te Ao B, 2014, NEUROLOGY, V83, P1645, DOI 10.1212/WNL.0000000000000933; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Tepas JJ, 2013, J TRAUMA ACUTE CARE, V74, P143, DOI 10.1097/TA.0b013e3182788b5a; Timmons SD, 2011, J TRAUMA, V71, P1172, DOI 10.1097/TA.0b013e31822b0f4b; Van Belleghem G, 2016, INJURY, V47, P141, DOI 10.1016/j.injury.2015.08.025; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549	50	17	18	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	FEB	2017	82	2					374	382		10.1097/TA.0000000000001319			9	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	EJ8GO	WOS:000393463600025	28107311				2022-02-06	
J	Karelina, K; Gaier, KR; Prabhu, M; Wenger, V; Corrigan, TED; Weil, ZM				Karelina, Kate; Gaier, Kristopher R.; Prabhu, Maya; Wenger, Vanessa; Corrigan, Timothy E. D.; Weil, Zachary M.			Binge ethanol in adulthood exacerbates negative outcomes following juvenile traumatic brain injury	BRAIN BEHAVIOR AND IMMUNITY			English	Article						Traumatic brain injury; Alcohol; Axon degeneration; Microglia; Neuroinflammation; Learning and memory; Neurogenesis	SEIZURE-INDUCED NEUROGENESIS; INDUCED NEUROINFLAMMATION; ALCOHOLIC BRAINS; SUBSTANCE-ABUSE; MICROGLIA; EXPRESSION; CELLS; EPIDEMIOLOGY; RECEPTORS; DRINKING	Traumatic brain injuries (TBI) are a major public health problem with enormous costs in terms of health care dollars, lost productivity, and reduced quality of life. Alcohol is bidirectionally linked to TBI as many TBI patients are intoxicated at the time of their injury and we recently reported that, in accordance with human epidemiological data, animals injured during juvenile development self-administered significantly more alcohol as adults than did sham injured mice. There are also clinical data that drinking after TBI significantly reduces the efficacy of rehabilitation and leads to poorer long-term outcomes. In order to determine whether juvenile traumatic brain injury also increased the vulnerability of the brain to the toxic effects of high dose alcohol, mice were injured at 21 days of age and then seven weeks later treated daily with binge-like levels of alcohol 5 g/kg (by oral gavage) for ten days. Binge-like alcohol produced a greater degree of neuronal damage and neuroinflammation in mice that sustained a TBI. Further, mice that sustained a juvenile TBI exhibited mild learning and memory impairments in adulthood following binge alcohol and express a significant increase in hippocampal ectopic localization of newborn neurons. Taken together, these data provide strong evidence that a mild brain injury occurring early in life renders the brain highly vulnerable to the consequences of binge-like alcohol consumption. (C) 2016 Elsevier Inc. All rights reserved.	Ohio State Univ, Dept Neurosci, Grp Behav Neuroendocrinol, Wexner Med Ctr, Columbus, OH 43210 USA; Ohio State Univ, Wexner Med Ctr, Ctr Brain & Spinal Cord Repair, Columbus, OH 43210 USA		Karelina, K (corresponding author), Biomed Res Tower 618,460 West 12th Ave, Columbus, OH 43210 USA.	Ekaterina.karelina@osumc.edu	Weil, Zachary M/B-5003-2008; Weil, Zachary M/A-2439-2008	Weil, Zachary M/0000-0003-3758-1809; Weil, Zachary M/0000-0003-3758-1809; Karelina Weil, Kate/0000-0002-6628-0768	OSU Neurological Institute Pilot Award; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS045758]	This work was supported by an OSU Neurological Institute Pilot Award and the National Institutes of Health (NS045758). The authors gratefully acknowledge Joseph Abraham, Katie Centner, Samuel Nicholson, Benjamin Sarac, and Lauren Martin for their assistance and support on these experiments. We also thank Dr. Kristina Kigerl for guidance through the microglial extraction protocol and Dr. Jacqueline Barker for assistance with the BEC assay.	Abramoff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI [DOI 10.1117/1.3589100, DOI 10.1201/9781420005615.AX4]; Alfonso-Loeches S, 2010, J NEUROSCI, V30, P8285, DOI 10.1523/JNEUROSCI.0976-10.2010; Berry C, 2011, AM SURGEON, V77, P1416; Bertola A, 2013, NAT PROTOC, V8, P627, DOI 10.1038/nprot.2013.032; Bilbo SD, 2008, BRAIN BEHAV IMMUN, V22, P451, DOI 10.1016/j.bbi.2007.10.003; Bilbo SD, 2010, PSYCHONEUROENDOCRINO, V35, P369, DOI 10.1016/j.psyneuen.2009.07.014; Bjork JM, 2009, J NEUROTRAUM, V26, P1077, DOI [10.1089/neu.2008.0849, 10.1089/neu.2008-0849]; Bombardier CH, 2003, ARCH PHYS MED REHAB, V84, P185, DOI 10.1053/apmr.2003.50002; Bowers M. S., ALCOHOL CLI IN PRESS; Boyadjieva NI, 2010, ALCOHOL CLIN EXP RES, V34, P1835, DOI 10.1111/j.1530-0277.2010.01271.x; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Chastain LG, 2014, INT REV NEUROBIOL, V118, P81, DOI [10.1016/B978-0-12-801284-0.00001-X, 10.1016/B978-0-12-801284-0.00004-X]; Chen CM, 2012, J STUD ALCOHOL DRUGS, V73, P531, DOI 10.15288/jsad.2012.73.531; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1940, DOI 10.1016/j.apmr.2013.05.018; Crews FT, 2011, BRAIN BEHAV IMMUN, V25, pS4, DOI 10.1016/j.bbi.2011.03.003; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Dodd PR, 2000, NEUROCHEM INT, V37, P509, DOI 10.1016/S0197-0186(00)00061-9; Fenn AM, 2014, BIOL PSYCHIAT, V76, P575, DOI 10.1016/j.biopsych.2013.10.014; Fernandez-Lizarbe S, 2009, J IMMUNOL, V183, P4733, DOI 10.4049/jimmunol.0803590; Harper C, 2003, PROG NEURO-PSYCHOPH, V27, P951, DOI 10.1016/S0278-5846(03)00155-6; Hayes DM, 2013, ALCOHOL CLIN EXP RES, V37, P425, DOI 10.1111/j.1530-0277.2012.01955.x; He J, 2008, EXP NEUROL, V210, P349, DOI 10.1016/j.expneurol.2007.11.017; Ikegami Y, 2003, NEUROSCI LETT, V349, P201, DOI 10.1016/S0304-3940(03)00826-7; Jorge RE, 2005, ARCH GEN PSYCHIAT, V62, P742, DOI 10.1001/archpsyc.62.7.742; Karelina K, 2016, EUR J NEUROSCI, V43, P1034, DOI 10.1111/ejn.13194; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; KREUTZER J S, 1990, Brain Injury, V4, P1, DOI 10.3109/02699059009026142; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McClain JA, 2011, BRAIN BEHAV IMMUN, V25, pS120, DOI 10.1016/j.bbi.2011.01.006; Montesinos J, 2016, BRAIN BEHAV IMMUN, V53, P159, DOI 10.1016/j.bbi.2015.12.006; Opreanu RC, 2010, J AM COLL SURGEONS, V210, P997, DOI 10.1016/j.jamcollsurg.2010.01.036; Pandit V, 2014, J SURG RES, V190, P634, DOI 10.1016/j.jss.2014.04.039; Parent JM, 2006, ANN NEUROL, V59, P81, DOI 10.1002/ana.20699; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; PRENCIPE L, 1987, CLIN CHEM, V33, P486; Qin LY, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-130; Scharfman HE, 2000, J NEUROSCI, V20, P6144, DOI 10.1523/JNEUROSCI.20-16-06144.2000; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Vaaramo K, 2014, EUR J NEUROL, V21, P293, DOI 10.1111/ene.12302; Vaaramo K, 2014, J NEUROL NEUROSUR PS, V85, P598, DOI 10.1136/jnnp-2012-304457; Vetreno RP, 2012, NEUROSCIENCE, V226, P475, DOI 10.1016/j.neuroscience.2012.08.046; Weil ZM, 2016, J NEUROTRAUM, V33, P895, DOI 10.1089/neu.2015.3953; Weil ZM, 2016, NEUROSCI BIOBEHAV R, V62, P89, DOI 10.1016/j.neubiorev.2016.01.005; Weil ZM, 2014, NEUROBIOL DIS, V70, P108, DOI 10.1016/j.nbd.2014.06.016; Yang JY, 2014, PHARMACOL THERAPEUT, V144, P321, DOI 10.1016/j.pharmthera.2014.07.002	48	17	17	0	21	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	FEB	2017	60						304	311		10.1016/j.bbi.2016.11.009			8	Immunology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology; Psychiatry	EH6UA	WOS:000391908200031	27845195				2022-02-06	
J	Ndode-Ekane, XE; Kharatishvili, I; Pitkanen, A				Ndode-Ekane, Xavier Ekolle; Kharatishvili, Irina; Pitkanen, Asla			Unfolded Maps for Quantitative Analysis of Cortical Lesion Location and Extent after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						beam balance; lateral fluid percussion; Morris water-maze; MRI; TBI; unfolded map	LATERAL FLUID-PERCUSSION; MORRIS WATER MAZE; PERIRHINAL CORTEX; CEREBRAL-CORTEX; TIME-COURSE; RAT; DEFICITS; EPIDEMIOLOGY; MRI; SEVERITY	We aimed to generate two-dimensional (2D) unfolded cortical maps from magnetic resonance (MR) images to delineate the location of traumatic brain injury (TBI)-induced cortical damage in functionally diverse cytoarchitectonic areas of the cerebral cortex, and to predict the severity of functional impairment after TBI based on the lesion location and extent. Lateral fluid-percussion injury was induced in adult rats and T2 maps were acquired with magnetic resonance imaging (MRI) at 3 days post-TBI. Somatomotor deficits were assessed based on the composite neuroscore and beam balance test, and spatial learning was assessed in the Morris water maze. Animals were perfused for histology at 13 days post-injury. A 2D template was generated by unfolding the cerebral cortex from 26 sections of the rat brain atlas, covering the lesion extent. Next, 2D unfolded maps were generated from T2 maps and thionin-stained histological sections from the same animals. Unfolding of the T2 maps revealed the lesion core in the auditory, somatosensory, and visual cortices. The unfolded histological lesion at 13 days post-injury was 12% greater than the MRI lesion at 3 days post-TBI, as the lesion area increased laterally and caudally; the larger the MRI lesion area, the larger the histological lesion area. Further, the larger the MRI lesion area in the barrel field of the primary somatosensory cortex (S1BF), upper lip of the primary somatosensory cortex (S1ULp), secondary somatosensory division (S2), and ectorhinal (Ect) and perirhinal (PRh) cortices, the more impaired the performance in the beam balance and Morris water maze tests. Subsequent receiver operating characteristic analysis indicated that severity of the MRI lesion in S1ULp and S2 was a sensitive and specific predictor of poor performance in the beam balance test. Moreover, MRI lesions in the S1ULp, S2, S1BF, and Ect and PRh cortices predicted poor performance in the Morris water maze test. Our findings indicate that 2D-unfolded cortical maps generated from MR images delineate the distribution of cortical lesions in functionally different cytoarchitectonic regions, which can be used to predict the TBI-induced functional impairment.	[Ndode-Ekane, Xavier Ekolle; Kharatishvili, Irina; Pitkanen, Asla] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Neurobiol, POB 1627, FI-70211 Kuopio, Finland		Pitkanen, A (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Neurobiol, POB 1627, FI-70211 Kuopio, Finland.	asla.pitkanen@uef.fi		Ndode-Ekane, Xavier Ekolle/0000-0001-5682-5632	Academy of FinlandAcademy of FinlandEuropean Commission; ERA-NET Neuron (TBI Epilepsy); FP7-HEALTH project [602102]	This study was supported by the Academy of Finland, ERA-NET Neuron (TBI Epilepsy), and FP7-HEALTH project 602102 (EPITARGET). We thank Dr. Olli Grohn for his helpful comments regarding the manuscript, and Jarmo Hartikainen and Merja Lukkari for their excellent technical assistance.	Assaf Y, 1997, MAGN RESON IMAGING, V15, P77, DOI 10.1016/S0730-725X(96)00246-9; Bota M, 2015, P NATL ACAD SCI USA, V112, pE2093, DOI 10.1073/pnas.1504394112; Bouilleret V, 2009, J NEUROTRAUM, V26, P1999, DOI 10.1089/neu.2009.0943; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Burwell RD, 1995, HIPPOCAMPUS, V5, P390, DOI 10.1002/hipo.450050503; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Draper K, 2009, NEUROPSYCHOL REHABIL, V19, P645, DOI 10.1080/17405620802613935; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Hicks RR, 1999, J NEUROTRAUM, V16, P501, DOI 10.1089/neu.1999.16.501; Immonen RJ, 2009, EXP NEUROL, V215, P29, DOI 10.1016/j.expneurol.2008.09.009; Kharatishvili I, 2007, BRAIN, V130, P3155, DOI 10.1093/brain/awm268; Kharatishvili I, 2009, EXP NEUROL, V217, P154, DOI 10.1016/j.expneurol.2009.01.026; Kim J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00052; Liu P, 1998, HIPPOCAMPUS, V8, P114; Liu P, 1998, BEHAV NEUROSCI, V112, P304, DOI 10.1037/0735-7044.112.2.304; Long JA, 2015, J NEUROTRAUM, V32, P598, DOI 10.1089/neu.2014.3563; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Paxinos G., 2007, MOUSE BRAIN STEREOTA; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Ramos JMJ, 2005, PHYSIOL BEHAV, V86, P118, DOI 10.1016/j.physbeh.2005.07.004; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Saatman KE, 1996, P NATL ACAD SCI USA, V93, P3428, DOI 10.1073/pnas.93.8.3428; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; SOARES HD, 1992, J NEUROCHEM, V58, P1845, DOI 10.1111/j.1471-4159.1992.tb10061.x; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thompson HJ, 2006, RESTOR NEUROL NEUROS, V24, P109; VANESSEN DC, 1980, J COMP NEUROL, V191, P255, DOI 10.1002/cne.901910208; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456	34	17	17	0	12	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2017	34	2					459	474		10.1089/neu.2016.4404			16	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EH4QD	WOS:000391754800022	26997032				2022-02-06	
J	Alosco, ML; Jarnagin, J; Tripodis, Y; Martin, B; Chaisson, C; Baugh, CM; Torres, A; Nowinski, CJ; Cantu, RC; Stern, RA				Alosco, Michael L.; Jarnagin, Johnny; Tripodis, Yorghos; Martin, Brett; Chaisson, Christine; Baugh, Christine M.; Torres, Alcy; Nowinski, Christopher J.; Cantu, Robert C.; Stern, Robert A.			Utility of providing a concussion definition in the assessment of concussion history in former NFL players	BRAIN INJURY			English	Article						American football; concussion knowledge; depression; impulsivity; mild traumatic brain injury	RECURRENT CONCUSSION; SPORTS; DEPRESSION; FREQUENCY; IMPACT; GUIDELINES; INCREASES; STATEMENT; DIAGNOSIS; EDUCATION	Objective: Former National Football League (NFL) players' working knowledge of concussion has not yet been evaluated, despite this population being a major clinical research target due to the association between repetitive head impacts (RHI) and long-term clinical impairments. This study examined former NFL players' understanding of the current concussion definition, and the association between number of concussions with, clinical function. Methods: 95 former NFL players (mean age = 55.29; mean NFL year = 8.10) self-reported number of concussions before being provided with a concussion definition and after being read a modern definition of concussion. Subjects reported number of concussions with loss of consciousness (LOC), Principal Component Analysis of a battery of tests generated behaviour/mood, psychomotor speed/executive function, and verbal and visual memory factor scores. Restilts: Post-definition number of concussions (median = 50); Was five times the pre-definition (median = 10; p < 0.001). Greater pre- (p = 0.019) and post-definition concussions (p = 0.036) correlated with worse behaviour/Mood scores, after controlling for years of football played, with specific effects for depressive symptoms and impulsivity. LOC did not account for variance beyond number of concussions. Conclusions: Practitioners and clinical researchers should provide a definition of concussion in the assessment of concussion history in former football players to facilitate accuracy and standardization.	[Alosco, Michael L.; Jarnagin, Johnny; Martin, Brett; Chaisson, Christine; Baugh, Christine M.; Cantu, Robert C.; Stern, Robert A.] Boston Univ, Sch Med, Alzheimers Dis & CTE Ctr, 72 East Concord St,87800, Boston, MA 02118 USA; [Alosco, Michael L.; Jarnagin, Johnny; Baugh, Christine M.; Cantu, Robert C.; Stern, Robert A.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Tripodis, Yorghos; Chaisson, Christine] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA; [Martin, Brett; Chaisson, Christine] Boston Univ, Sch Publ Hlth, Data Coordinating Ctr, Boston, MA 02118 USA; [Baugh, Christine M.] Harvard Univ, Interfac Initiat Hlth Policy, Cambridge, MA 02138 USA; [Torres, Alcy] Boston Univ, Sch Med, Pediat Neurol, Boston, MA 02118 USA; [Torres, Alcy] Boston Med Ctr, Pediat Neurol, Boston, MA USA; [Nowinski, Christopher J.; Cantu, Robert C.] Concuss Legacy Fdn, Waltham, MA USA; [Cantu, Robert C.; Stern, Robert A.] Boston Univ, Sch Med, Dept Neurosurg, Boston, MA 02118 USA; [Stern, Robert A.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA		Stern, RA (corresponding author), Boston Univ, Sch Med, Alzheimers Dis & CTE Ctr, 72 East Concord St,87800, Boston, MA 02118 USA.	bobstern@bu.edu	, Bob/ABA-8507-2020; Baugh, Christine/AAG-2324-2020	Baugh, Christine/0000-0002-9340-6338; Tripodis, Yorghos/0000-0003-2190-7608	NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR001430] Funding Source: Medline; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30 AG013846, P30 AG019610] Funding Source: Medline; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32 MH019733] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01 NS093334, R01 NS078337, R56 NS078337, F32 NS096803] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH019733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS078337, R56NS078337, U01NS093334, F32NS096803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG019610, P30AG013846] Funding Source: NIH RePORTER		Alosco ML, 2016, J NEUROTRAUMA; Baugh CM, 2016, CONCUSSION, V1, P1; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Casson IR, 2011, SPORTS HEALTH, V3, P11, DOI 10.1177/1941738110391413; Cheng G, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/205903; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Denny-Brown D, 1943, Bull N Y Acad Med, V19, P3; Gardner Raquel C, 2015, Neurol Clin Pract, V5, P285; Goswami R, 2015, BRAIN STRUCT FUNCT; Guo WB, 2012, PROG NEURO-PSYCHOPH, V38, P201, DOI 10.1016/j.pnpbp.2012.03.012; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kerr ZY, 2015, AM J SPORT MED, V43, P606, DOI 10.1177/0363546514562180; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Kerr ZY, 2012, MED SCI SPORT EXER, V44, P377, DOI 10.1249/MSS.0b013e31823240f2; Kroshus E, 2016, HEALTH EDUC BEHAV, V43, P182, DOI 10.1177/1090198115599380; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Lawrence DW, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115583653; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; Mannings C, 2014, J TRAUMA ACUTE CARE, V77, pS18, DOI 10.1097/TA.0000000000000371; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Montenigro P. H., 2016, J NEUROTRAUMA, V33, P1; Oldham J, 2015, NEUROLOGY S, V84; Peng HJ, 2012, J AFFECT DISORDERS, V136, P249, DOI 10.1016/j.jad.2011.12.006; Peper JS, 2013, CEREB CORTEX, V23, P1695, DOI 10.1093/cercor/bhs163; Pietrosimone B, 2015, MED SCI SPORT EXER, V47, P2366, DOI 10.1249/MSS.0000000000000684; Robbins CA, 2014, OPEN ACCESS J SPORTS, V5, P99, DOI 10.2147/OAJSM.S58005; Seichepine DR, 2013, J NEUROTRAUM, V30, P1299, DOI 10.1089/neu.2012.2690; Stein TD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0522-z; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Wright MJ, 2016, J CLIN EXP NEUROPSYC, V38, P561, DOI 10.1080/13803395.2016.1139057	40	17	17	1	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	8					1116	1123		10.1080/02699052.2017.1294709			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FC3JI	WOS:000406734500012	28471243	Green Accepted			2022-02-06	
S	Czosnyka, M; Pickard, JD; Steiner, LA		Wijdicks, EFM; Kramer, AH		Czosnyka, M.; Pickard, J. D.; Steiner, L. A.			Principles of intracranial pressure monitoring and treatment	CRITICAL CARE NEUROLOGY, PT I	Handbook of Clinical Neurology		English	Article; Book Chapter							CEREBRAL PERFUSION-PRESSURE; TRAUMATIC BRAIN-INJURY; PROMISING TREATMENT MODALITY; DECOMPRESSIVE CRANIECTOMY; INTENSIVE-CARE; BLOOD-PRESSURE; PLATEAU WAVES; CEREBROVASCULAR REACTIVITY; INTRACEREBRAL HEMORRHAGE; THERAPEUTIC HYPOTHERMIA	Intracranial pressure (ICP) is governed by volumes of intracranial blood, cerebrospinal fluid, and brain tissue. Expansion of any of these volumes will trigger compensatory changes in the other compartments, resulting in initially limited change in ICP. Due to the rigid skull, once compensatory mechanisms are exhausted, ICP rises very rapidly. Intracranial hypertension is associated with unfavorable outcome in brain-injured patients. This chapter discusses the pathophysiology of raised ICP, as well as typical waveforms, monitoring techniques, and clinical management. The dynamics of ICP are more important than the absolute value at any given time point, but mean ICP exceeding 20 - 25 mmHg is usually treated aggressively. Algorithms based on data from patients with traumatic brain injury are applied also in other conditions. However, an understanding of the underlying pathophysiology allows adaptation of therapies to other pathologies. Typically, a three-staged approach is used, starting with restoration of systemic physiology, sedation, and analgesia. If these measures are insufficient, surgical options, such as drainage of cerebrospinal fluid or evacuation of mass lesions, are considered. In the absence of surgical options, stage 2 treatments are initiated, consisting of either mannitol or hypertonic saline. If these measures are insufficient, stage 3 therapies include hypothermia, metabolic suppression, or craniectomy.	[Czosnyka, M.; Pickard, J. D.] Univ Cambridge, Dept Clin Neurosci, Cambridge, England; [Steiner, L. A.] Univ Hosp Basel, Dept Anesthesia Surg Intens Care Prehosp Emergenc, Basel, Switzerland		Czosnyka, M (corresponding author), Univ Cambridge, Dept Clin Neurosci, Brain Phys, Cambridge, England.	mc141@medschl.cam.ac.uk	Steiner, Luzius/J-1987-2019		Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0001237, G0600986, G9439390] Funding Source: Medline; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9439390, G0001237, G0600986] Funding Source: UKRI		AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Aaslid R, 1986, INTRACRANIAL PRESSUR, VVI, P229; Adams HP, 2003, STROKE, V34, P1056, DOI 10.1161/01.STR.0000064841.47697.22; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS31; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS25; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Balestreri M, 2005, ACT NEUR S, V95, P25; BARZO P, 1993, NEUROSURGERY, V32, P611; Bijlenga P, 2010, NEUROCRIT CARE, V13, P17, DOI 10.1007/s12028-010-9362-1; Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; Brady KM, 2009, PEDIATRICS, V124, pE1205, DOI 10.1542/peds.2009-0550; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS87; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS65; Brain Trauma Foundation, 2016, GUID MAN SEV TRAUM B; Bratton SL, 2007, J NEUROTRAUMA S1, V24, P555, DOI DOI 10.1089/NEU.2007.9988; Broderick JP, 1999, STROKE, V30, P905, DOI 10.1161/01.STR.30.4.905; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; CARDOSO ER, 1983, J NEUROSURG, V59, P817, DOI 10.3171/jns.1983.59.5.0817; Castellani G, 2009, NEUROCRIT CARE, V11, P143, DOI 10.1007/s12028-009-9235-7; Chesnut RM, 2015, J NEUROTRAUM, V32, P1722, DOI 10.1089/neu.2015.3976; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; CZOSNYKA M, 1994, ACTA NEUROCHIR, V126, P113, DOI 10.1007/BF01476419; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; da Costa CS, 2015, J PEDIATR-US, V167, P86, DOI 10.1016/j.jpeds.2015.03.041; DAVSON H, 1970, Brain Behavior and Evolution, V93, P665, DOI 10.1093/brain/93.4.665; Depreitere B, 2014, J NEUROSURG, V120, P1451, DOI 10.3171/2014.3.JNS131500; DEWEY RC, 1974, J NEUROSURG, V41, P597, DOI 10.3171/jns.1974.41.5.0597; Dias C, 2014, NEUROCRIT CARE, V21, P124, DOI 10.1007/s12028-013-9918-y; Erdman MJ, 2014, CRIT CARE MED, V42, P1696, DOI 10.1097/CCM.0000000000000328; Grof TM, 2010, NEUROCRIT CARE, V12, P356, DOI 10.1007/s12028-008-9156-x; GUILLAUME J, 1951, REV NEUROL, V84, P131; Guiza F, 2013, CRIT CARE MED, V41, P554, DOI 10.1097/CCM.0b013e3182742d0a; Higgins JNP, 2002, LANCET, V359, P228, DOI 10.1016/S0140-6736(02)07440-8; Holsgrove DT, 2014, ACTA NEUROCHIR SUPPL, V119, P53, DOI 10.1007/978-3-319-02411-0_9; Hu X, 2010, PHYSIOL MEAS, V31, P679, DOI 10.1088/0967-3334/31/5/006; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Kam PCA, 2007, ANAESTHESIA, V62, P690, DOI 10.1111/j.1365-2044.2007.05055.x; Koskinen LOD, 2013, ACTA NEUROCHIR, V155, P2141, DOI 10.1007/s00701-013-1856-0; Lam JMK, 1997, STROKE, V28, P906, DOI 10.1161/01.STR.28.5.906; LASSEN NA, 1964, CIRC RES, V15, P201; Lazaridis C, 2014, J NEUROSURG, V120, P893, DOI 10.3171/2014.1.JNS131292; Lazaridis C, 2013, CRIT CARE MED, V41, P1353, DOI 10.1097/CCM.0b013e31827ca4b3; LOFGREN J, 1973, ACTA NEUROL SCAND, V49, P557; Lu CW, 2012, BRAIN, V135, P2399, DOI 10.1093/brain/aws155; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; MARMAROU A, 1978, J NEUROSURG, V48, P332, DOI 10.3171/jns.1978.48.3.0332; Miller J D, 1972, Prog Brain Res, V35, P411; Munch EC, 2001, CRIT CARE MED, V29, P976; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Oddo M, 2008, CURR OPIN CLIN NUTR, V11, P134, DOI 10.1097/MCO.0b013e3282f37b43; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; PIPER IR, 1993, NEUROSURGERY, V32, P805, DOI 10.1227/00006123-199305000-00014; PIPER IR, 1990, J NEUROSURG, V73, P871, DOI 10.3171/jns.1990.73.6.0871; Polderman KH, 2004, INTENS CARE MED, V30, P556, DOI 10.1007/s00134-003-2152-x; Polderman KH, 2004, INTENS CARE MED, V30, P757, DOI 10.1007/s00134-003-2151-y; Radolovich DK, 2011, NEUROCRIT CARE, V15, P379, DOI 10.1007/s12028-011-9553-4; Ragauskas A, 2012, NEUROLOGY, V78, P1684, DOI 10.1212/WNL.0b013e3182574f50; Robba C, 2016, ACTA NEUROL SCAND, V134, P4, DOI 10.1111/ane.12527; Roberts I, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000033.pub2; ROBERTSON CS, 1989, J NEUROSURG, V71, P673, DOI 10.3171/jns.1989.71.5.0673; Rogatsky GG, 2003, J NEUROTRAUM, V20, P1315, DOI 10.1089/089771503322686111; ROSNER MJ, 1984, J NEUROSURG, V60, P312, DOI 10.3171/jns.1984.60.2.0312; Santos E, 2011, ACTA NEUROCHIR, V153, P2189, DOI 10.1007/s00701-011-1148-5; Schmidt B, 1997, STROKE, V28, P2465, DOI 10.1161/01.STR.28.12.2465; Schmidt EA, 2001, J NEUROL NEUROSUR PS, V70, P198, DOI 10.1136/jnnp.70.2.198; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Steiner LA, 2003, STROKE, V34, P2404, DOI 10.1161/01.STR.0000089014.59668.04; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Varelas PN, 2013, NEUROSURG CLIN N AM, V24, P393, DOI 10.1016/j.nec.2013.03.005; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; Wakai A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001049.pub5; Zweifel C, 2010, J NEUROTRAUM, V27, P1951, DOI 10.1089/neu.2010.1388	79	17	20	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0072-9752		978-0-12-803563-4; 978-0-44-463600-3	HAND CLINIC			2017	140						67	89		10.1016/B978-0-444-63600-3.00005-2			23	Critical Care Medicine; Clinical Neurology	Book Citation Index – Science (BKCI-S)	General & Internal Medicine; Neurosciences & Neurology	BJ3DL	WOS:000422931500007	28187815				2022-02-06	
J	Ellis, MJ; Ritchie, LJ; McDonald, PJ; Cordingley, D; Reimer, K; Nijjar, S; Koltek, M; Hosain, S; Johnston, J; Mansouri, B; Sawyer, S; Silver, N; Girardin, R; Larkins, S; Vis, S; Selci, E; Davidson, M; Gregoire, S; Sam, A; Black, B; Bunge, M; Essig, M; MacDonald, P; Leiter, J; Russell, K				Ellis, Michael J.; Ritchie, Lesley J.; McDonald, Patrick J.; Cordingley, Dean; Reimer, Karen; Nijjar, Satnam; Koltek, Mark; Hosain, Shahid; Johnston, Janine; Mansouri, Behzad; Sawyer, Scott; Silver, Norm; Girardin, Richard; Larkins, Shannon; Vis, Sara; Selci, Erin; Davidson, Michael; Gregoire, Scott; Sam, Angela; Black, Brian; Bunge, Martin; Essig, Marco; MacDonald, Peter; Leiter, Jeff; Russell, Kelly			Multidisciplinary Management of Pediatric Sports-Related Concussion	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article						Sports-related concussion; traumatic brain injury; pediatric; healthcare utilization; multidisciplinary; concussion program	TRAUMATIC BRAIN-INJURY; CERVICAL-SPINE; POSITION STATEMENT; PSYCHIATRIC-DISORDERS; SYMPTOM SEVERITY; CHILDREN; RECOVERY; ADOLESCENTS; ASSOCIATION; MODIFIERS	Objectives: To summarize the clinical characteristics and outcomes of pediatric sports-related concussion (SRC) patients who were evaluated and managed at a multidisciplinary pediatric concussion program and examine the healthcare resources and personnel required to meet the needs of this patient population. Methods: We conducted a retrospective review of all pediatric SRC patients referred to the Pan Am Concussion Program from September 1(st), 2013 to May 25(th), 2015. Initial assessments and diagnoses were carried out by a single neurosurgeon. Return-to-Play decision-making was carried out by the multidisciplinary team. Results: 604 patients, including 423 pediatric SRC patients were evaluated at the Pan Am Concussion Program during the study period. The mean age of study patients was 14.30 years (SD: 2.32, range 7-19 years); 252 (59.57%) were males. Hockey (182; 43.03%) and soccer (60; 14.18%) were the most commonly played sports at the time of injury. Overall, 294 (69.50%) of SRC patients met the clinical criteria for concussion recovery, while 75 (17.73%) were lost to follow-up, and 53 (12.53%) remained in active treatment at the end of the study period. The median duration of symptoms among the 261 acute SRC patients with complete follow-up was 23 days (IQR: 15, 36). Overall, 25.30% of pediatric SRC patients underwent at least one diagnostic imaging test and 32.62% received referral to another member of our multidisciplinary clinical team. Conclusion: Comprehensive care of pediatric SRC patients requires access to appropriate diagnostic resources and the multidisciplinary collaboration of experts with national and provincially-recognized training in TBI.	[Ellis, Michael J.; McDonald, Patrick J.; Black, Brian; MacDonald, Peter; Leiter, Jeff] Univ Manitoba, Dept Surg, Winnipeg, MB R3T 2N2, Canada; [Ellis, Michael J.; McDonald, Patrick J.; Sawyer, Scott; Silver, Norm; Selci, Erin; Black, Brian; Bunge, Martin; Russell, Kelly] Univ Manitoba, Pediat & Child Hlth, Winnipeg, MB R3T 2N2, Canada; [Ritchie, Lesley J.] Univ Manitoba, Clin Hlth Psychol, Winnipeg, MB R3T 2N2, Canada; [Reimer, Karen; Larkins, Shannon] Univ Manitoba, Rehabil Sci, Winnipeg, MB R3T 2N2, Canada; [Nijjar, Satnam; Johnston, Janine; Mansouri, Behzad] Univ Manitoba, Neurol, Winnipeg, MB R3T 2N2, Canada; [Koltek, Mark; Hosain, Shahid] Univ Manitoba, Psychiat, Winnipeg, MB R3T 2N2, Canada; [Davidson, Michael; Gregoire, Scott; Sam, Angela; Bunge, Martin; Essig, Marco] Univ Manitoba, Diagnost Imaging, Winnipeg, MB R3T 2N2, Canada; [Ellis, Michael J.; McDonald, Patrick J.] Univ Manitoba, Neurosurg Sect, Winnipeg, MB R3T 2N2, Canada; [Black, Brian; MacDonald, Peter] Univ Manitoba, Orthoped, Winnipeg, MB R3T 2N2, Canada; [Ellis, Michael J.; Ritchie, Lesley J.; McDonald, Patrick J.; Cordingley, Dean; Reimer, Karen; Nijjar, Satnam; Koltek, Mark; Hosain, Shahid; Johnston, Janine; Mansouri, Behzad; Sawyer, Scott; Silver, Norm; Girardin, Richard; Larkins, Shannon; Vis, Sara; Davidson, Michael; Gregoire, Scott; Sam, Angela; Black, Brian; Bunge, Martin; Essig, Marco; MacDonald, Peter; Leiter, Jeff] Pan Am Clin, 75 Poseidon Bay, Winnipeg, MB R3M 3E4, Canada; [Ellis, Michael J.; Ritchie, Lesley J.; McDonald, Patrick J.; Cordingley, Dean; Reimer, Karen; Nijjar, Satnam; Koltek, Mark; Hosain, Shahid; Johnston, Janine; Mansouri, Behzad; Sawyer, Scott; Silver, Norm; Girardin, Richard; Larkins, Shannon; Vis, Sara; Davidson, Michael; Gregoire, Scott; Sam, Angela; Black, Brian; Bunge, Martin; Essig, Marco; MacDonald, Peter; Leiter, Jeff] Pan Am Concuss Program, Winnipeg, MB, Canada; [Ellis, Michael J.; McDonald, Patrick J.; Reimer, Karen] Childrens Hosp Res Inst Manitoba, Winnipeg, MB, Canada; [Ellis, Michael J.; Ritchie, Lesley J.; McDonald, Patrick J.; Cordingley, Dean; Reimer, Karen; Nijjar, Satnam; Koltek, Mark; Hosain, Shahid; Johnston, Janine; Mansouri, Behzad; Sawyer, Scott; Silver, Norm; Girardin, Richard; Larkins, Shannon; Vis, Sara; Davidson, Michael; Gregoire, Scott; Sam, Angela; Black, Brian; Bunge, Martin; Essig, Marco; MacDonald, Peter; Leiter, Jeff] Canada North Concuss Network, Winnipeg, MB, Canada		Ellis, MJ (corresponding author), Pan Am Clin, 75 Poseidon Bay, Winnipeg, MB R3M 3E4, Canada.	mellis@panamclinic.com		essig, marco/0000-0002-7964-2297; Russell, Kelly/0000-0002-9159-9201	Pan Am Clinic Foundation; Winnipeg Jets True North Foundation	This study was supported by funding provided by the Pan Am Clinic Foundation, the Winnipeg Jets True North Foundation, and a generous donation by Leonard and Susan Asper.	Anderson RC, 2016, NEUROSURG FOCUS, V20, pE3; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Baker JG, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/705309; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Boake C, 2004, J NEUROPSYCH CLIN N, V16, P493, DOI 10.1176/appi.neuropsych.16.4.493; Boutis K, 2015, J PEDIATR-US, V166, P1214, DOI 10.1016/j.jpeds.2015.02.013; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Chung S, 2011, J TRAUMA, V70, P873, DOI 10.1097/TA.0b013e3182108823; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Colvin JD, 2013, ARCH DIS CHILD, V98, P934, DOI 10.1136/archdischild-2012-303588; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Cusimano MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058868; Echemendia RJ, 2012, ARCH CLIN NEUROPSYCH, V27, P119, DOI 10.1093/arclin/acr077; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P241, DOI 10.3171/2015.1.PEDS14510; Ellis MJ, 2015, CURR SPORT MED REP, V14, P20, DOI 10.1249/JSR.0000000000000108; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Ellis MJ, CLIN J SPOR IN PRESS; Ellis MJ, CURRENT SPO IN PRESS; Ellis MJ, 2015, J NEUROSURG PEDIAT, P1; Ellis MJ, CANADIAN MED ASS J; Eubanks Jason David, 2006, J Am Acad Orthop Surg, V14, P552; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Grubenhoff JA, 2014, PEDIATRICS, V134, P54, DOI 10.1542/peds.2013-2988; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Henry M, 2013, CHILD NERV SYST, V29, P1333, DOI 10.1007/s00381-013-2092-x; Henry M, 2013, J NEUROSURG-PEDIATR, V12, P30, DOI 10.3171/2013.4.PEDS12477; Kozlowski KF, 2013, J ATHL TRAINING, V48, P627, DOI 10.4085/1062-6050-48.5.02; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Kutcher JS, 2010, CURR SPORT MED REP, V9, P16, DOI 10.1249/JSR.0b013e3181caa89d; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Leddy JJ, 2015, CLIN J SPORT MED, V25, P237, DOI 10.1097/JSM.0000000000000128; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Leong DF, 2015, J OPTOM; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Makdissi M, 2013, BRIT J SPORT MED, V47, P314, DOI 10.1136/bjsports-2013-092256; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; Max JE, 2014, PSYCHIAT CLIN N AM, V37, P125, DOI 10.1016/j.psc.2013.11.003; Max JE, 2013, J NEUROPSYCH CLIN N, V25, P272, DOI 10.1176/appi.neuropsych.12040078; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory PR, 1998, SPORTS MED, V25, P131, DOI 10.2165/00007256-199825020-00005; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Moreau WJ, 2013, J CHIROPR MED, V12, P269, DOI 10.1016/j.jcm.2013.07.002; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Mucha A, 2014, AM J SPORTS MED; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Reynolds E, 2014, NEUROSURGERY S4, V75, P71; Ritchie LJ, 2015, CURR RES CONCUSSION, V2, P8; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Scopaz KA, 2013, SPORTS HEALTH, V5, P537, DOI 10.1177/1941738112473059; Seeger TA, 2015, J CHILD NEUROL, V30, P1142, DOI 10.1177/0883073814553973; Seifert T, 2014, CURR PAIN HEADACHE R, V18, DOI 10.1007/s11916-014-0448-x; Slack SE, 2004, EMERG MED J, V21, P189, DOI 10.1136/emj.2003.012310; Stewart TC, 2014, J TRAUMA ACUTE CARE, V76, P736, DOI 10.1097/TA.0b013e3182aafdf5; Stiell IG, 2010, CAN MED ASSOC J, V182, P1173, DOI 10.1503/cmaj.091430; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003	64	17	17	1	6	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0317-1671	2057-0155		CAN J NEUROL SCI	Can. J. Neurol. Sci.	JAN	2017	44	1					24	34		10.1017/cjn.2016.312			11	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	EK3VP	WOS:000393856800005	27772532	Bronze			2022-02-06	
J	Erdodi, LA; Lichtenstein, JD; Rai, JK; Flaro, L				Erdodi, Laszlo A.; Lichtenstein, Jonathan D.; Rai, Jaspreet K.; Flaro, Lloyd			Embedded validity indicators in Conners' CPT-II: Do adult cutoffs work the same way in children?	APPLIED NEUROPSYCHOLOGY-CHILD			English	Article						Conners' CPT-II; pediatric neuropsychology; performance validity assessment; traumatic brain injury	TRAUMATIC BRAIN-INJURY; PERFORMANCE TEST-II; SYMPTOM VALIDITY; NEUROPSYCHOLOGICAL ASSESSMENT; PEDIATRIC SAMPLE; TEST FAILURE; TESTS; EXAGGERATION; DISORDER; CURVE	In previous research, several subscales of Conners' CPT-II were found to be useful as performance validity tests (PVTs) when administered to adults with traumatic brain injury (TBI). Furthermore, invalid response sets were associated with inflated scores on several CPT-II scales. The present study proposed to investigate whether these findings would replicate in a pediatric sample. The analyses were based on archival data from 15 children with TBI. The Omissions, Hit RT, Perseverations, and Hit RT BC scales proved effective at differentiating valid and invalid response sets. However, Commission errors were unrelated to scores on PVTs. A composite measure based on these four scores was a superior and more stable validity indicator than individual scales. Two or more T-scores >65 on any of these scales resulted in acceptable overall specificity (.86-1.00) and variable sensitivity (.00-1.00). Scores on CPT-II scales were generally higher among those who failed the reference PVTs. Results suggest that embedded CPT-II validity indices developed in adult TBI samples function similarly in children with TBI, with some notable exceptions. Although the use of adult PVT cutoffs in pediatric assessment is a common practice, and broadly supported by the present findings, there remains a clear need for the independent empirical validation of adult PVTs in children.	[Erdodi, Laszlo A.; Rai, Jaspreet K.] Univ Windsor, Dept Psychol, 168 Chrysler Hall South,401 Sunset Ave, Windsor, ON N9B 3P4, Canada; [Lichtenstein, Jonathan D.] Geisel Sch Med Dartmouth, Dept Psychiat, Hanover, NH USA		Erdodi, LA (corresponding author), Univ Windsor, Dept Psychol, 168 Chrysler Hall South,401 Sunset Ave, Windsor, ON N9B 3P4, Canada.	lerdodi@gmail.com					BABIKIAN T, 2007, ASSESSMENT FEIGNED C, P00103; Baker DA, 2014, CLIN NEUROPSYCHOL, V28, P116, DOI 10.1080/13854046.2013.858184; BALDESSARINI RJ, 1983, ARCH GEN PSYCHIAT, V40, P569; Baron I. S., 2004, NEUROPSYCHOLOGICAL E; Bigler ED, 2015, BRAIN IMAGING BEHAV, V9, P421, DOI 10.1007/s11682-015-9409-1; Bigler ED, 2012, J INT NEUROPSYCH SOC, V18, P632, DOI 10.1017/S1355617712000252; Boone, 2007, ASSESSMENT FEIGNED C, P152; Boone K.B., 2013, CLIN PRACTICE FORENS; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Conners, 2004, CONNERS CONTINUOUS P; Constantinou M, 2003, CHILD NEUROPSYCHOL, V9, P81, DOI 10.1076/chin.9.2.81.14505; Delis DC, 2007, ARCH CLIN NEUROPSYCH, V22, P589, DOI 10.1016/j.acn.2007.04.001; Donders J, 2005, CHILD NEUROPSYCHOL, V11, P221, DOI 10.1080/09297040490917298; Dunn L.M., 1997, PEABODY PICTURE VOCA, V3rd Edition; Erdodi L, 2017, APPL NEUROPSYCH-ADUL, V24, P264, DOI 10.1080/23279095.2016.1154856; Erdodi LA, 2016, PSYCHOL INJ LAW, V9, P112, DOI 10.1007/s12207-016-9254-6; Erdodi LA, 2017, PSYCHOL ASSESSMENT, V29, P148, DOI 10.1037/pas0000319; Erdodi LA, 2014, ARCH CLIN NEUROPSYCH, V29, P456, DOI 10.1093/arclin/acu026; Frederick RI, 2000, ARCH CLIN NEUROPSYCH, V15, P281, DOI 10.1016/S0887-6177(99)00002-5; Frederick RI, 2009, J HEAD TRAUMA REHAB, V24, P105, DOI 10.1097/HTR.0b013e31819b1210; Gioia G.A., 2000, BRIEF BEHAV RATING I; Green P, 2003, CHILD NEUROPSYCHOL, V9, P189, DOI 10.1076/chin.9.3.189.16460; Green P., 2003, MANUAL COMPUTERIZED; Green P., 2004, MANUAL MED SYMPTOM V; Green P., 2008, MANUAL GREENS NONVER; Green P, 2012, DETECTION OF MALINGERING DURING HEAD INJURY LITIGATION, SECOND EDITION, P201, DOI 10.1007/978-1-4614-0442-2_6; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Hanczar B, 2010, BIOINFORMATICS, V26, P822, DOI 10.1093/bioinformatics/btq037; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Iverson GL, 2002, CLIN NEUROPSYCHOL, V16, P398, DOI 10.1076/clin.16.3.398.13861; Kirkwood MW, 2012, PSYCHOL ASSESSMENT, V24, P36, DOI 10.1037/a0024628; Kirkwood MW, 2010, CLIN NEUROPSYCHOL, V24, P860, DOI 10.1080/13854040903527287; Lange RT, 2013, PSYCHOL ASSESSMENT, V25, P339, DOI 10.1037/a0030915; Larrabee G.J., 2005, FORENSIC NEUROPSYCHO; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Lichtenstein JD, 2017, CHILD NEUROPSYCHOL, V23, P284, DOI 10.1080/09297049.2015.1135422; Lu P. H., 2007, ASSESSMENT FEIGNED C, P128; MacAllister WS, 2009, CHILD NEUROPSYCHOL, V15, P521, DOI 10.1080/09297040902748226; Marshall P, 2010, CLIN NEUROPSYCHOL, V24, P1204, DOI 10.1080/13854046.2010.514290; Meyers JE., 1995, REY COMPLEX FIGURE T; Miele AS, 2012, ARCH CLIN NEUROPSYCH, V27, P10, DOI 10.1093/arclin/acr084; Morey, 1991, PERSONALITY ASSESSME; Morey L.C., 2007, PERSONALITY ASSESSME; Nagle AM, 2006, ARCH CLIN NEUROPSYCH, V21, P777, DOI 10.1016/j.acn.2006.06.011; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P380, DOI 10.1080/13803390903066881; Reitan R, 1985, HALSTEAD REITAN NEUR; Suhr JA, 1999, J CLIN EXP NEUROPSYC, V21, P701, DOI 10.1076/jcen.21.5.701.868; Suhr J, 2008, ARCH CLIN NEUROPSYCH, V23, P521, DOI 10.1016/j.acn.2008.05.003; Wald NJ, 2014, J MED SCREEN, V21, P51, DOI 10.1177/0969141313517497; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; Wilkinson G.S., 1993, WIDE RANGE ACHIEVEME	51	17	17	0	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2162-2965	2162-2973		APPL NEUROPSYCH-CHIL	Appl. Neuropsychol.-Child		2017	6	4					355	363		10.1080/21622965.2016.1198908			9	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	FK7SD	WOS:000413706600012	27383142				2022-02-06	
J	Goldstein, FC; Caveney, AF; Hertzberg, VS; Silbergleit, R; Yeatts, SD; Palesch, YY; Levin, HS; Wright, DW				Goldstein, Felicia C.; Caveney, Angela F.; Hertzberg, Vicki S.; Silbergleit, Robert; Yeatts, Sharon D.; Palesch, Yuko Y.; Levin, Harvey S.; Wright, David W.		NETT Investigators	Very Early Administration of Progesterone Does Not Improve Neuropsychological Outcomes in Subjects with Moderate to Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						adult brain injury; clinical trial; cognitive function; head trauma; prospective study	PRACTICAL SCALE; CLINICAL-TRIAL; HEAD-INJURY	A Phase III, double-blind, placebo-controlled trial (ProTECT III) found that administration of progesterone did not reduce mortality or improve functional outcome as measured by the Glasgow Outcome Scale Extended (GOSE) in subjects with moderate to severe traumatic brain injury. We conducted a secondary analysis of neuropsychological outcomes to evaluate whether progesterone is associated with improved recovery of cognitive and motor functioning. ProTECT III was conducted at 49 level I trauma centers in the United States. Adults with moderate to severe TBI were randomized to receive intravenous progesterone or placebo within 4 h of injury for a total of 4 days. At 6 months, subjects underwent evaluation of memory, attention, executive functioning, language, and fine motor coordination/dexterity. Chi-square analysis revealed no significant difference in the proportion of subjects (263/280 progesterone, 283/295 placebo) with Galveston Orientation and Amnesia Test scores >= 75. Analyses of covariance did not reveal significant treatment effects for memory (Buschke immediate recall, p = 0.53; delayed recall, p = 0.94), attention (Trails A speed, p = 0.81 and errors, p = 0.22; Digit Span Forward length, p = 0.66), executive functioning (Trails B speed, p = 0.97 and errors, p = 0.93; Digit Span Backward length, p = 0.60), language (timed phonemic fluency, p = 0.05), and fine motor coordination/dexterity (Grooved Pegboard dominant hand time, p = 0.75 and peg drops, p = 0.59; nondominant hand time, p = 0.74 and peg drops, p = 0.61). Pearson Product Moment Correlations demonstrated significant (p < 0.001) associations between better neuropsychological performance and higher GOSE scores. Similar to the ProTECT III trial's results of the primary outcome, the secondary outcomes do not provide evidence of a neuroprotective effect of progesterone.	[Goldstein, Felicia C.] Emory Univ, Sch Med, Dept Neurol, 12 Execut Pk Dr, Atlanta, GA 30329 USA; [Hertzberg, Vicki S.] Emory Univ, Sch Med, Sch Nursing, Atlanta, GA USA; [Wright, David W.] Emory Univ, Sch Med, Dept Emergency Med, Atlanta, GA USA; [Caveney, Angela F.] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Silbergleit, Robert] Univ Michigan, Dept Emergency Med, Sch Med, Ann Arbor, MI USA; [Yeatts, Sharon D.; Palesch, Yuko Y.] Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC USA; [Levin, Harvey S.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA		Goldstein, FC (corresponding author), Emory Univ, Sch Med, Dept Neurol, 12 Execut Pk Dr, Atlanta, GA 30329 USA.	fgoldst@emory.edu			National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS062778, 5U10NS059032, U01NS056975]; National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000454]; Emory Emergency Neurosciences Laboratory in the Department of Emergency Medicine, Emory School of Medicine, and Grady Memorial Hospital; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS062778, U10NS059032] Funding Source: NIH RePORTER	Supported by grants from the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NS062778, 5U10NS059032, and U01NS056975) and the National Center for Advancing Translational Sciences of the National Institutes of Health (UL1TR000454) and by the Emory Emergency Neurosciences Laboratory in the Department of Emergency Medicine, Emory School of Medicine, and Grady Memorial Hospital.	Army Individual Test Battery, 1944, MAN DIR SCOR; Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benton AL, 1994, MULTILINGUAL APHASIA; BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; CLIFTON GL, 1992, NEUROSURGERY, V31, P975, DOI 10.1227/00006123-199211000-00028; Deutsch ER, 2013, BRAIN RES, V1530, P82, DOI 10.1016/j.brainres.2013.07.014; Gregoire J, 1997, AGING NEUROPSYCHOL C, V4, P140, DOI 10.1080/13825589708256642; Hannay HJ, 1996, J HEAD TRAUMA REHAB, V11, P41, DOI 10.1097/00001199-199612000-00007; JENNETT B, 1975, LANCET, V1, P480; Klove H., 1963, CLIN NEUROPSYCHOLOGY; Larrabee GJ, 2000, CLIN NEUROPSYCHOL, V14, P110, DOI 10.1076/1385-4046(200002)14:1;1-8;FT110; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; RUFF RM, 1993, PERCEPT MOTOR SKILL, V76, P1219, DOI 10.2466/pms.1993.76.3c.1219; Ruff RM, 1996, ARCH CLIN NEUROPSYCH, V11, P329, DOI 10.1016/0887-6177(95)00033-X; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Stein DG, 2008, ANN EMERG MED, V51, P164, DOI 10.1016/j.annemergmed.2007.05.001; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Stuss DT, 1988, CLIN NEUROPSYCHOL, V2, P246, DOI [DOI 10.1080/13854048808520107, 10.1080/13854048808520107]; Wechsler D., 1997, WAIS 3 ADM SCORING M WAIS 3 ADM SCORING M; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887	26	17	17	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2017	34	1					115	120		10.1089/neu.2015.4313			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	EF6DE	WOS:000390420100014	26973025	Green Published			2022-02-06	
J	Grossbard, J; Malte, CA; Lapham, G; Pagulayan, K; Turner, AP; Rubinsky, AD; Bradley, KA; Saxon, AJ; Hawkins, EJ				Grossbard, Joel; Malte, Carol A.; Lapham, Gwen; Pagulayan, Kathleen; Turner, Aaron P.; Rubinsky, Anna D.; Bradley, Katharine A.; Saxon, Andrew J.; Hawkins, Eric J.			Prevalence of Alcohol Misuse and Follow-Up Care in a National Sample of OEF/OIF VA Patients With and Without TBI	PSYCHIATRIC SERVICES			English	Article							TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; PERSISTENT POSTCONCUSSIVE SYMPTOMS; IDENTIFICATION TEST AUDIT; SERVICES-TASK-FORCE; BRIEF INTERVENTION; MILITARY PERSONNEL; CONSUMPTION QUESTIONS; RISK DRINKING; US VETERANS	Objective: Information on prevalence and management of alcohol misuse among Afghanistan and Iraq veterans with traumatic brain injury (TBI) is limited. This study compared rates of alcohol misuse and follow-up care-brief intervention (BI) and addiction treatment-among Afghanistan and Iraq veterans with and without TBI receiving care from the Department of Veterans Affairs (VA). Methods: The sample included veterans ages 18 and older screened with the Alcohol Use Disorders Identification Test alcohol consumption questions (AUDIT-C) in 2012 who received VA health care in the prior year (N=358,417). Overall and age-specific estimates of alcohol misuse (AUDIT-C score >= 5) were compared for men and women with and without TBI by logistic regression. BI and addiction treatment after screening were compared between groups by using multivariable logistic regression. Results: Alcohol misuse was higher among men with TBI than among men without TBI (20.3%, 95% confidence interval [CI]=19.9-20.8, versus 16.4%, CI=16.3-16.6) and among women with TBI than among women without TBI (6.8%, CI=5.8-8.1, versus 5.6%, CI=5.4-5.8); younger (age<30) patients with TBI had the highest rates. BI rates did not differ by TBI status (76.4%-280.2%). Addiction treatment rates for those with severe misuse were higher among those with TBI (men, 20.0%, CI=18.4-21.6, versus 15.4%, CI=14.9-15.9; women, 36.6%, CI=21.8-51.3, versus 21.1%, CI=18.2-24.0). Conclusions: Alcohol misuse is common among Iraq and Afghanistan veterans with TBI, particularly young men. BI rates were high and did not vary by TBI status, although addiction treatment rates were higher among patients with TBI than among those without TBI.	[Grossbard, Joel; Malte, Carol A.; Turner, Aaron P.; Rubinsky, Anna D.; Saxon, Andrew J.; Hawkins, Eric J.] Puget Sound Hlth Care Syst, Dept Vet Affairs VA, Ctr Excellence Substance Abuse Treatment & Educ, Seattle, WA 98108 USA; [Turner, Aaron P.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Pagulayan, Kathleen; Saxon, Andrew J.; Hawkins, Eric J.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Rubinsky, Anna D.] Seattle Ctr Innovat Vet Ctr & Value Driven Care, VA Hlth Serv Res & Dev HSR&D, Seattle, WA USA; [Lapham, Gwen; Bradley, Katharine A.] Grp Hlth Res Inst, Seattle, WA USA; [Bradley, Katharine A.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA		Hawkins, EJ (corresponding author), Puget Sound Hlth Care Syst, Dept Vet Affairs VA, Ctr Excellence Substance Abuse Treatment & Educ, Seattle, WA 98108 USA.	eric.hawkins@va.gov	Turner, Aaron/A-7902-2009; Rubinsky, Anna D/U-8314-2018; Pagulayan, Kati/AAR-9225-2020; Rubinsky, Anna/AAJ-7065-2021	Turner, Aaron/0000-0001-6897-8003; Rubinsky, Anna D/0000-0002-8977-4779; 	VA Polytrauma and Blast-Related Injury Quality Enhancement Research Initiative [QLP 56-007]; Veterans Health AdministrationUS Department of Veterans Affairs; VA Center of Excellence in Substance Abuse Treatment and Education; National Institute on Alcohol Abuse and AlcoholismUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [1R21AA02894-01A1]; VA Clinical Sciences R&D Career Development Award Program [IK2 CX000516]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [K24AA022128] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [IK2CX000516] Funding Source: NIH RePORTER	The research reported here was supported by VA Polytrauma and Blast-Related Injury Quality Enhancement Research Initiative (QLP 56-007), Veterans Health Administration; by the VA Center of Excellence in Substance Abuse Treatment and Education; by the National Institute on Alcohol Abuse and Alcoholism (grant 1R21AA02894-01A1); and by VA Clinical Sciences R&D Career Development Award Program (IK2 CX000516). These organizations had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the manuscript for publication.	Adams RS, 2012, J SOC WORK PRACT ADD, V12, P28, DOI 10.1080/1533256X.2012.647580; Adams RS, 2012, J HEAD TRAUMA REHAB, V27, P349, DOI 10.1097/HTR.0b013e318268db94; Bombardier CH, 2003, ARCH PHYS MED REHAB, V84, P185, DOI 10.1053/apmr.2003.50002; Bradley KA, 2003, ARCH INTERN MED, V163, P821, DOI 10.1001/archinte.163.7.821; Bradley KA, 1998, ALCOHOL CLIN EXP RES, V22, P1842, DOI 10.1097/00000374-199811000-00034; Bradley KA, 2004, ALCOHOL CLIN EXP RES, V28, P448, DOI 10.1097/01.ALC.0000117836.38108.38; Bradley KA, 2007, ALCOHOL CLIN EXP RES, V31, P1208, DOI 10.1111/j.1530-0277.2007.00403.x; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Carlson KF, 2013, BRAIN INJURY, V27, P640, DOI 10.3109/02699052.2013.771795; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Corrigan JD, 2010, J TRAUMA, V69, P722, DOI 10.1097/TA.0b013e3181e904cc; Dawson DA, 2005, ALCOHOL CLIN EXP RES, V29, P844, DOI 10.1097/01.ALC.0000164374.32229.A2; Grossbard JR, 2013, J SUBST ABUSE TREAT, V45, P409, DOI 10.1016/j.jsat.2013.04.007; Hawkins EJ, 2010, DRUG ALCOHOL DEPEN, V109, P147, DOI 10.1016/j.drugalcdep.2009.12.025; Heltemes KJ, 2012, INJURY, V43, P1990, DOI 10.1016/j.injury.2011.07.021; Heltemes KJ, 2011, MIL MED, V176, P147, DOI 10.7205/MILMED-D-10-00191; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jonas DE, 2012, ANN INTERN MED, V157, P645, DOI 10.7326/0003-4819-157-9-201211060-00544; Jorge RE, 2005, CURR OPIN PSYCHIATR, V18, P289, DOI 10.1097/01.yco.0000165600.90928.92; Kaner EFS, 2001, BRIT J GEN PRACT, V51, P822; Lapham GT, 2012, MED CARE, V50, P179, DOI 10.1097/MLR.0b013e3181e35743; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Mainio A, 2007, BRAIN INJURY, V21, P851, DOI 10.1080/02699050701504265; Mashhoon Y, 2014, ALCOHOL CLIN EXP RES, V38, P1955, DOI 10.1111/acer.12475; Miles SR, 2015, MIL MED, V180, P45, DOI 10.7205/MILMED-D-14-00187; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; National Institute on Alcohol Abuse Alcoholism, 2007, HELP PAT WHO DRINK T; Olson-Madden JH, 2013, COMMUNITY MENT HLT J, V49, P220, DOI 10.1007/s10597-012-9572-4; Opreanu RC, 2010, J AM COLL SURGEONS, V210, P997, DOI 10.1016/j.jamcollsurg.2010.01.036; Polusny MA, 2011, PSYCHOL MED, V41, P687, DOI 10.1017/S0033291710002047; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; Ponsford J, 2013, J CLIN EXP NEUROPSYC, V35, P103, DOI 10.1080/13803395.2012.752437; Ponsford J, 2012, J HEAD TRAUMA REHAB, V27, P342, DOI 10.1097/HTR.0b013e318265a576; Rona RJ, 2012, J HEAD TRAUMA REHAB, V27, P33, DOI 10.1097/HTR.0b013e318212f814; Rubinsky AD, 2010, DRUG ALCOHOL DEPEN, V108, P29, DOI 10.1016/j.drugalcdep.2009.11.009; Sander AM, 2012, J HEAD TRAUMA REHAB, V27, P319, DOI 10.1097/HTR.0b013e318269838c; Scholten JD, 2012, BRAIN INJURY, V26, P1177, DOI 10.3109/02699052.2012.661914; Shu IW, 2014, PSYCHIAT RES-NEUROIM, V224, P58, DOI 10.1016/j.pscychresns.2014.07.010; Solberg LI, 2008, AM J PREV MED, V34, P143, DOI 10.1016/j.amepre.2007.09.035; Taylor BC, 2014, J REHABIL RES DEV, V51, pVII, DOI 10.1682/JRRD.2014.06.0155; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; United States Department of Veterans Affairs & Department of Defense. VA/DoD clinical practice guideline for the management of substance use disorders (Version 3.0), 2015, VA DOD CLIN PRACT GU; Volk RJ, 1996, J STUD ALCOHOL, V57, P203, DOI 10.15288/jsa.1996.57.203; Whitlock EP, 2004, ANN INTERN MED, V140, P557, DOI 10.7326/0003-4819-140-7-200404060-00017; Williams EC, 2014, ADDICTION, V109, P1472, DOI 10.1111/add.12600; Winqvist S, 2008, BRAIN INJURY, V22, P780, DOI 10.1080/02699050802339397; Zatzick D, 2014, ADDICTION, V109, P754, DOI 10.1111/add.12492	50	17	17	0	4	AMER PSYCHIATRIC PUBLISHING, INC	ARLINGTON	1000 WILSON BOULEVARD, STE 1825, ARLINGTON, VA 22209-3901 USA	1075-2730	1557-9700		PSYCHIAT SERV	Psychiatr. Serv.	JAN 1	2017	68	1					48	55		10.1176/appi.ps.201500290			8	Health Policy & Services; Public, Environmental & Occupational Health; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health; Psychiatry	EP0PQ	WOS:000397089600009	27476804	Green Accepted, Bronze			2022-02-06	
J	Hellstrom, T; Westlye, LT; Sigurdardottir, S; Brunborg, C; Soberg, HL; Holthe, O; Server, A; Lund, MJ; Andreassen, OA; Andelic, N				Hellstrom, T.; Westlye, L. T.; Sigurdardottir, S.; Brunborg, C.; Soberg, H. L.; Holthe, O.; Server, A.; Lund, M. J.; Andreassen, O. A.; Andelic, N.			Longitudinal changes in brain morphology from 4 weeks to 12 months after mild traumatic brain injury: Associations with cognitive functions and clinical variables	BRAIN INJURY			English	Article						Mild brain injury; longitudinal; radiology; neuroimaging; intracranial injury; cortical thickness	POST-CONCUSSION SYMPTOMS; HUMAN CEREBRAL-CORTEX; MRI; VOLUME; SEGMENTATION; THICKNESS; PATHOLOGY; CINGULATE; ATROPHY	Objective: To investigate longitudinal changes in cortical and subcortical volumes in patients with mild traumatic brain injury (MTBI) and to evaluate whether such changes were associated with self-reported post-concussive symptoms, global functional outcomes and neuropsychological functioning.Methods: This was a prospecitve, longitudinal cohort study of patients with complicated (i.e presence of intracranial abnormalities on the day of injury CT) and uncomplicated MTBI (i.e, absence of intracranial abnormalities). Magnetic resonance imaging (MRI) was performed at approximately 4 weeks and 12 months. We utilized a 3T MRI system, cortical reconstruction and volumetric segmentation by FreeSurfer software. We included 33 patients with uncomplicated and 29 with complicated MTBI, who were aged 16-65 years.Results: 12 months after MTBI, significant within-group volume reductions were detected in the left accumbens area and right caudate nucleus for both patients groups, but no significant differences between the groups were revealed. No associations between volumetric variables and post-concussive symptoms or global functioning were found. The left temporal thickness was significantly associated with executive functioning.Conclusion: Structural subcortical alterations occur after complicated and uncomplicated MTBIs but these findings were not associated with symptoms burden or functional outcomes. Nonetheless, worse executive functioning was found in patients with shrinkage of the left temporal lobe.	[Hellstrom, T.; Soberg, H. L.; Holthe, O.; Andelic, N.] Oslo Univ Hosp, Dept Phys Med & Rehabil, N-0407 Oslo, Norway; [Westlye, L. T.; Lund, M. J.; Andreassen, O. A.] Oslo Univ Hosp, Div Mental Hlth & Addict, KG Jebsen Ctr Psychosis Res, Norwegian Ctr Mental Disorder Res NORMENT, Oslo, Norway; [Westlye, L. T.] Univ Oslo, Dept Psychol, Oslo, Norway; [Sigurdardottir, S.] Sunnaas Rehabil Hosp, Dept Res, Nesoddtangen, Norway; [Sigurdardottir, S.; Andelic, N.] CHARM Resarch Ctr Habilitat & Rehabil Models & Se, Oslo, Norway; [Brunborg, C.] Oslo Univ Hosp, Oslo Ctr Biostat & Epidemiol, Res Support Serv, Oslo, Norway; [Server, A.] Oslo Univ Hosp, Dept Radiol & Nucl Med, Oslo, Norway		Hellstrom, T (corresponding author), Oslo Univ Hosp, Dept Phys Med & Rehabil, N-0407 Oslo, Norway.	torgeir.hellstrom@ous-hf.no	Hellstrom, Torgeir/AAW-4301-2021; Hellstrom, Torgeir/AAY-6043-2021; Andreassen, Ole A./AAY-7531-2020	Hellstrom, Torgeir/0000-0003-0831-3274; Andelic, Nada/0000-0002-3719-4406; Westlye, Lars T./0000-0001-8644-956X	Department of Physical Medicine and Rehabilitation, Oslo University Hospital	The authors thank the Department of Physical Medicine and Rehabilitation, Oslo University Hospital for institutional and financial support. The authors report no conflict of interest. The authors alone are responsible for the content and writing of this paper.	Anderson CV, 1996, J NEUROTRAUM, V13, P59, DOI 10.1089/neu.1996.13.59; Ansell EB, 2012, BIOL PSYCHIAT, V72, P57, DOI 10.1016/j.biopsych.2011.11.022; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Benson RR, 2012, NEUROREHABILITATION, V31, P261, DOI 10.3233/NRE-2012-0795; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; Bigler ED, 2015, BRAIN NEUROTRAUMA MO, P1; Bigler ED, 2010, NEUROLOGY, V74, P626, DOI 10.1212/WNL.0b013e3181d3e43a; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Byrnes Kimberly R, 2014, Front Neuroenergetics, V5, P13, DOI 10.3389/fnene.2013.00013; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cohen BA, 2007, AM J NEURORADIOL, V28, P907; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Delis DC., 2001, DELIS KAPLAN EXECUTI; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fjell AM, 2013, NEUROBIOL AGING, V34, P2239, DOI 10.1016/j.neurobiolaging.2013.04.006; Gennarelli, 1998, Semin Clin Neuropsychiatry, V3, P160; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Lannsjo M, 2013, J REHABIL MED, V45, P721, DOI 10.2340/16501977-1169; Ling JM, 2013, NEUROLOGY, V81, P2121, DOI 10.1212/01.wnl.0000437302.36064.b1; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Narayana PA, 2015, NEUROIMAGE-CLIN, V7, P87, DOI 10.1016/j.nicl.2014.07.010; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Ross DE, 2012, BRAIN INJURY, V26, P1500, DOI 10.3109/02699052.2012.694570; Ross DE, 2011, BRAIN INJURY, V25, P1271, DOI 10.3109/02699052.2011.624568; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Silver JM, 2011, TXB TRAUMATIC BRAIN, VSecond; Taylor LA, 2003, BRAIN INJURY, V17, P295, DOI 10.1080/0269905021000038401; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; Wang X, 2015, J NEUROTRAUM, V32, P455, DOI 10.1089/neu.2014.3492; Wechsler, 1997, WECHSLER ADULT INTEL; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wu WC, 2011, NEUROIMAGE, V56, P1244, DOI 10.1016/j.neuroimage.2011.02.080; Yount R, 2002, J NEUROPSYCH CLIN N, V14, P416, DOI 10.1176/appi.neuropsych.14.4.416; Zagorchev L, 2016, J NEUROTRAUM, V33, P29, DOI 10.1089/neu.2014.3831; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	46	17	17	1	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	5					674	685		10.1080/02699052.2017.1283537			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EV8OA	WOS:000402039900013	28414250	Green Accepted			2022-02-06	
J	Merkel, SF; Andrews, AM; Lutton, EM; Razmpour, R; Cannella, LA; Ramirez, SH				Merkel, Steven F.; Andrews, Allison M.; Lutton, Evan M.; Razmpour, Roshanak; Cannella, Lee Anne; Ramirez, Servio H.			Dexamethasone Attenuates the Enhanced Rewarding Effects of Cocaine Following Experimental Traumatic Brain Injury	CELL TRANSPLANTATION			English	Article						traumatic brain injury; nucleus accumbens; conditioned place preference; cocaine; dexamethasone	GLUCOCORTICOIDS INDUCE; LY6C(-) MONOCYTES; BLOOD MONOCYTES; DENDRITIC CELLS; IN-VITRO; EXPRESSION; ADDICTION; MICRODIALYSIS; MACROPHAGES; SUBSETS	Clinical studies have identified traumatic brain injury (TBI) as a risk factor for the development of cocaine dependence. This claim is supported by our recent preclinical studies showing enhancement of the rewarding effects of cocaine in mice sustaining moderate controlled cortical impact (CCI) injury during adolescence. Here we test the efficacy of dexamethasone, an anti-inflammatory corticosteroid, to attenuate augmentation of the behavioral response to cocaine observed in CCI-TBI animals using the conditioned place preference (CPP) assay. These studies were performed in order to determine whether proinflammatory activity in the nucleus accumbens (NAc), a key brain nucleus in the reward pathway, mediates enhanced cocaine-induced CPP in adolescent animals sustaining moderate CCI-TBI. Our data reveal robust glial activation in the NAc following CCI-TBI and a significant increase in the cocaine-induced CPP of untreated CCI-TBI mice. Furthermore, our results show that dexamethasone treatment following CCI-TBI can attenuate the cocaine place preference of injured animals without producing aversion in the CPP assay. Our studies also found that dexamethasone treatment significantly reduced the expression of select immune response genes including Monocyte chemoattractant protein-1 (MCP-1/CCL2) and intercellular adhesion molecule-1 (ICAM-1), returning their expression to control levels, which prompted an investigation of peripheral blood monocytes in dexamethasone-treated animals. Experimental findings showed that no craniectomy/dexamethasone mice had a significant increase, while CCI-TBI/dexamethasone animals had a significant decrease in the percentage of circulating nonclassical patrolling monocytes. These results suggest that a portion of these monocytes may migrate to the brain in response to CCI-TBI, potentially sparing the development of chronic neuroinflammation in regions associated with the reward circuitry such as the NAc. Overall, our findings indicate that anti-inflammatory agents, such as dexamethasone, may be effective in normalizing the rewarding effects of cocaine following CCI-TBI.	[Merkel, Steven F.; Andrews, Allison M.; Lutton, Evan M.; Razmpour, Roshanak; Cannella, Lee Anne; Ramirez, Servio H.] Temple Univ, Lewis Katz Sch Med, Dept Pathol & Lab Med, 3500 N Broad St,MERB 844, Philadelphia, PA 19140 USA; [Merkel, Steven F.; Andrews, Allison M.; Cannella, Lee Anne; Ramirez, Servio H.] Temple Univ, Lewis Katz Sch Med, Ctr Subst Abuse Res, Philadelphia, PA 19122 USA; [Ramirez, Servio H.] Temple Univ, Shriners Hosp Pediat Res Ctr, Lewis Katz Sch Med, Philadelphia, PA 19122 USA		Ramirez, SH (corresponding author), Temple Univ, Lewis Katz Sch Med, Dept Pathol & Lab Med, 3500 N Broad St,MERB 844, Philadelphia, PA 19140 USA.	servio@temple.edu		ramirez, servio/0000-0002-4609-5653	National Institutes of Health/National Institute on Drug Abuse (NIH/NIDA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [F32 DA041282, T32 DA007237, P30 DA013429-16]; NIH/National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS086570-01]; Shriners Hospitals for Children [85110-PHI-14]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS086570] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [F32DA041282, T32DA007237, P30DA013429] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by National Institutes of Health/National Institute on Drug Abuse (NIH/NIDA) F32 DA041282 (AMA), T32 DA007237 (LAC), and P30 DA013429-16 (SHR); NIH/National Institute of Neurological Disorders and Stroke (NINDS) R01 NS086570-01 (SHR); and The Shriners Hospitals for Children 85110-PHI-14 (SHR).	Adler MW, 2005, J LEUKOCYTE BIOL, V78, P1204, DOI 10.1189/jlb.0405222; Administration SAMHS, 2014, 144863 SMA ADM SAMHS; Administration SAMHS, 2014, NSDUH SER H, V48; Alhilali LM, 2015, RADIOLOGY, V277, P793, DOI 10.1148/radiol.2015142974; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Bellavance MA, 2015, BRAIN STRUCT FUNCT, V220, P1759, DOI 10.1007/s00429-014-0759-z; Blednov YA, 2011, BRAIN BEHAV IMMUN, V25, pS92, DOI 10.1016/j.bbi.2011.01.008; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Carlin LM, 2013, CELL, V153, P362, DOI 10.1016/j.cell.2013.03.010; Chen X, 2009, J NEUROTRAUM, V26, P253, DOI 10.1089/neu.2007.0504; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1940, DOI 10.1016/j.apmr.2013.05.018; Crews FT, 2011, BRAIN BEHAV IMMUN, V25, pS4, DOI 10.1016/j.bbi.2011.03.003; Ehrchen J, 2007, BLOOD, V109, P1265, DOI 10.1182/blood-2006-02-001115; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2008, IMMUNOL CELL BIOL, V86, P398, DOI 10.1038/icb.2008.19; GIULIAN D, 1989, J NEUROSCI, V9, P4416; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Hanna RN, 2012, CIRC RES, V110, P416, DOI 10.1161/CIRCRESAHA.111.253377; Hanna RN, 2011, NAT IMMUNOL, V12, P778, DOI 10.1038/ni.2063; Hue CD, 2015, J CEREBR BLOOD F MET, V35, P1191, DOI 10.1038/jcbfm.2015.38; Hutchinson MR, 2012, J NEUROSCI, V32, P11187, DOI 10.1523/JNEUROSCI.0684-12.2012; Hutchinson MR, 2014, NEUROPHARMACOLOGY, V76, P218, DOI 10.1016/j.neuropharm.2013.05.039; Jaquins-Gerstl A, 2011, ANAL CHEM, V83, P7662, DOI 10.1021/ac200782h; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kozai TDY, 2016, BIOMATERIALS, V87, P157, DOI 10.1016/j.biomaterials.2016.02.013; Lee J, 2014, J TRAUMA ACUTE CARE, V77, P709, DOI 10.1097/TA.0000000000000445; Lee S, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0544-4; Lowing JL, 2014, J NEUROTRAUM, V31, P1700, DOI 10.1089/neu.2013.3286; Mayeux JP, 2015, BEHAV BRAIN RES, V279, P22, DOI 10.1016/j.bbr.2014.10.053; Merkel SF, 2017, J NEUROTRAUM, V34, P165, DOI 10.1089/neu.2015.4275; Michaud JP, 2014, J CEREBR BLOOD F MET, V34, P1253, DOI 10.1038/jcbfm.2014.80; Misharin AV, 2014, CELL REP, V9, P591, DOI 10.1016/j.celrep.2014.09.032; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nesbitt KM, 2015, ACS CHEM NEUROSCI, V6, P163, DOI 10.1021/cn500257x; Nesbitt KM, 2013, ANAL CHEM, V85, P8173, DOI 10.1021/ac401201x; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Osterndorff-Kahanek EA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121522; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Pei LM, 2005, J BIOL CHEM, V280, P29256, DOI 10.1074/jbc.M502606200; Ramesh D, 2015, AM J ADDICTION, V24, P341, DOI 10.1111/ajad.12192; Roberts ES, 2004, J NEUROPATH EXP NEUR, V63, P1255, DOI 10.1093/jnen/63.12.1255; Saber M, 2017, J NEUROTRAUM, V34, P423, DOI 10.1089/neu.2016.4401; Sajja VSSS, 2013, J NEUROSCI RES, V91, P593, DOI 10.1002/jnr.23179; Schwulst SJ, 2013, J TRAUMA ACUTE CARE, V75, P780, DOI 10.1097/TA.0b013e318299616a; Shah S, 2012, BRAIN INJURY, V26, P201, DOI 10.3109/02699052.2012.654591; Spataro L, 2005, EXP NEUROL, V194, P289, DOI 10.1016/j.expneurol.2004.08.037; Thal SC, 2013, CRIT CARE MED, V41, P1305, DOI 10.1097/CCM.0b013e31827ca494; Thomas G, 2015, ARTERIOSCL THROM VAS, V35, P1306, DOI 10.1161/ATVBAHA.114.304650; Vachharajani V, 2006, MICROCIRCULATION, V13, P477, DOI 10.1080/10739680600777599; Varga G, 2008, J LEUKOCYTE BIOL, V84, P644, DOI 10.1189/jlb.1107768; Wang XH, 2012, P NATL ACAD SCI USA, V109, P6325, DOI 10.1073/pnas.1200130109; Wen ZH, 2005, NEUROSCIENCE, V133, P807, DOI 10.1016/j.neuroscience.2005.03.015; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Xiao GD, 2013, J NEUROL SCI, V330, P78, DOI 10.1016/j.jns.2013.04.010; Yang B, 2014, CELL, V158, P945, DOI 10.1016/j.cell.2014.07.017; Yang JY, 2014, BIOMARK RES, V2, DOI 10.1186/2050-7771-2-1; Zhang ZR, 2008, ACTA NEUROPATHOL, V115, P335, DOI 10.1007/s00401-007-0301-y; Zhang ZY, 2007, ACTA NEUROPATHOL, V113, P675, DOI 10.1007/s00401-007-0195-8; Zhao Y, 2010, ARTERIOSCL THROM VAS, V30, P1535, DOI 10.1161/ATVBAHA.109.191163; Zhong YH, 2007, BRAIN RES, V1148, P15, DOI 10.1016/j.brainres.2007.02.024; Zhou Y, 2007, J NEUROCHEM, V102, P667, DOI 10.1111/j.1471-4159.2007.04535.x	63	17	17	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0963-6897	1555-3892		CELL TRANSPLANT	Cell Transplant.		2017	26	7					1178	1192		10.1177/0963689717714341			15	Cell & Tissue Engineering; Medicine, Research & Experimental; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine; Transplantation	EZ4GO	WOS:000404671800007	28933216	gold, Green Accepted, Green Published			2022-02-06	
J	Peltz, CB; Gardner, RC; Kenney, K; Diaz-Arrastia, R; Kramer, JH; Yaffe, K				Peltz, Carrie B.; Gardner, Raquel C.; Kenney, Kimbra; Diaz-Arrastia, Ramon; Kramer, Joel H.; Yaffe, Kristine			Neurobehavioral Characteristics of Older Veterans With Remote Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						cognitive impairment; psychiatric disorders; traumatic brain injury; veterans	LONG-TERM OUTCOMES; ALZHEIMERS-DISEASE; HEAD-INJURY; NEUROPSYCHOLOGICAL OUTCOMES; RISK; DEPRESSION; PREVALENCE; HISTORY; STATE	Objective: While traumatic brain injury (TBI) is common across the life span, the detailed neurobehavioral characteristics of older adults with prior TBI remain unclear. Our goal was to compare the clinical profile of older independently living veterans with and without prior TBI. Setting: Two veterans' retirement communities. Participants: Seventy-five participants with TBI and 71 without (mean age = 78 years). Design: Cross-sectional. Main Measures: TBI history was determined by the Ohio State University TBI Questionnaire. We assessed psychiatric and medical history via interviews and chart review and conducted measures assessing functional/lifestyle, psychiatric, and cognitive outcomes. Regression analyses (adjusted for demographics, diabetes, prior depression, substance abuse, and site) were performed to compare between TBI and non-TBI participants. Results: Compared with veterans without TBI, those with TBI had greater functional impairment (adjusted P = .05), endorsed more current depressive (adjusted P = .04) and posttraumatic stress disorder symptoms (adjusted P = .01), and had higher rates of prior depression and substance abuse (both adjusted Ps < .01). While composite memory and language scores did not differ between groups, participants with TBI performed worse on tests of executive functioning/processing speed (adjusted P = .01). Conclusions: Our results suggest that TBI may have adverse long-term neurobehavioral consequences and that TBI-exposed adults may require careful screening and follow-up.	[Peltz, Carrie B.; Gardner, Raquel C.; Yaffe, Kristine] San Francisco VA Med Ctr, 4150 Clement St,116H, San Francisco, CA 94121 USA; [Peltz, Carrie B.; Yaffe, Kristine] NCIRE, San Francisco, CA USA; [Gardner, Raquel C.; Kramer, Joel H.; Yaffe, Kristine] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Kenney, Kimbra; Diaz-Arrastia, Ramon] Uniformed Serv Univ Hlth Sci, Rockville, MD USA		Peltz, CB (corresponding author), San Francisco VA Med Ctr, 4150 Clement St,116H, San Francisco, CA 94121 USA.	carrie.peltz2@va.gov		Gardner, Raquel C./0000-0003-4028-440X; Diaz-Arrastia, Ramon/0000-0001-6051-3594	Department of DefenseUnited States Department of Defense [W81XWH-12-1-0581]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23 NS095755]; American Federation for Aging Research; UCSF Pepper Center; Center for Neuroscience and Regenerative MedicineUnited States Department of Defense; Military Clinical Neurosciences Center of Excellence; Department of DefenseUnited States Department of Defense; VAUS Department of Veterans Affairs [W81XWH-12-PHTBI-CENC, W81XHW-14-2-0137]; NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K24 AG031155]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS095755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K24AG031155, P30AG044281] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01CX001246] Funding Source: NIH RePORTER	This project was supported by the Department of Defense (W81XWH-12-1-0581). R.C.G. receives support from the National Institute of Neurological Disorders and Stroke (K23 NS095755), the American Federation for Aging Research, and the UCSF Pepper Center. K.K. and R.D.-A. receive support from the Center for Neuroscience and Regenerative Medicine and the Military Clinical Neurosciences Center of Excellence. K. Y. receives support from the Department of Defense and VA (W81XWH-12-PHTBI-CENC, W81XHW-14-2-0137) and NIA (K24 AG031155). The authors thank their research participants, the Armed Forces Retirement Home in Washington, District of Columbia, the Veterans Home of California in Yountville, California, and their dedicated study staff including Kim Kelley, Ross Passo, and Leah Harburg.	Brown AW, 2011, J NEUROTRAUM, V28, P167, DOI 10.1089/neu.2010.1400; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Dahm J, 2015, INJURY, V46, P142, DOI 10.1016/j.injury.2014.07.012; Delis DC., 2001, DELIS KAPLAN EXECUTI; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; DIKMEN S, 1986, ARCH PHYS MED REHAB, V67, P507; Farias ST, 2011, ALZHEIMERS DEMENT, V7, P593, DOI 10.1016/j.jalz.2011.02.007; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Halldorsson JG, 2013, BRAIN INJURY, V27, P1106, DOI 10.3109/02699052.2013.765599; Hamster K., 1983, MULTILINGUAL APHASIA; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kaplan E.F., 1978, BOSTON NAMING TEST; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; MORRIS JC, 1988, PSYCHOPHARMACOL BULL, V24, P641; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Ossenkoppele R, 2015, BRAIN, V138, P2732, DOI 10.1093/brain/awv191; PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Rassovsky Y, 2015, J CLIN EXP NEUROPSYC, V37, P354, DOI 10.1080/13803395.2015.1015498; Rey A., 1964, EXAMEN CLIN PSYCHOL; Rooks RN, 2002, J GERONTOL B-PSYCHOL, V57, pS247, DOI 10.1093/geronb/57.4.S247; Ruff RL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000312; Staudenmayer KL, 2007, J TRAUMA, V63, P1364, DOI 10.1097/TA.0b013e31815b897b; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Swan AR, 2015, J NEUROTRAUM, V32, P1510, DOI 10.1089/neu.2014.3654; Tanielian T. L., 2008, INVISIBLE WOUNDS WAR, V720; Taylor, 1998, Semin Clin Neuropsychiatry, V3, P224; Taylor E., 1959, PSYCHOL APPRAISAL CH; Trudeau DL, 1998, J NEUROPSYCH CLIN N, V10, P308, DOI 10.1176/jnp.10.3.308; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Wang S, 2013, ALZHEIMERS ASS INT C; Weathers FW., PTSD CHECKLIST CIVIL; Wechsler D., 1997, WAIS 3 ADM SCORING M WAIS 3 ADM SCORING M; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140; YESAVAGE JA, 1988, PSYCHOPHARMACOL BULL, V24, P709; Zumstein MA, 2011, J TRAUMA, V71, P120, DOI 10.1097/TA.0b013e3181f2d670	44	17	17	1	16	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2017	32	1					E8	E15		10.1097/HTR.0000000000000245			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EI2GH	WOS:000392304400015	27323220	Green Accepted			2022-02-06	
